PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Vernier, JP; Thomason, LW; Fairlie, TD; Minnis, P; Palikonda, R; Bedka, KM				Vernier, J. -P.; Thomason, L. W.; Fairlie, T. D.; Minnis, P.; Palikonda, R.; Bedka, K. M.			Comment on "Large Volcanic Aerosol Load in the Stratosphere Linked to Asian Monsoon Transport"	SCIENCE			English	Editorial Material								Bourassa et al. (Reports, 6 July 2012, p. 78) have suggested that deep convection associated with the Asian monsoon played a critical role in transporting sulfur dioxide associated with the Nabro volcanic eruption (13 June 2011) from the upper troposphere (9 to 14 kilometers) into the lower stratosphere. An analysis of the CALIPSO lidar data indicates, however, that the main part of the Nabro volcanic plume was injected directly into the lower stratosphere during the initial eruption well before reaching the Asian monsoon deep convective region.	[Vernier, J. -P.; Palikonda, R.; Bedka, K. M.] Sci Syst & Applicat Inc, Hampton, VA 23666 USA; [Thomason, L. W.; Fairlie, T. D.; Minnis, P.] NASA, Langley Res Ctr, Hampton, VA 23681 USA	Science Systems and Applications Inc; National Aeronautics & Space Administration (NASA); NASA Langley Research Center	Vernier, JP (corresponding author), Sci Syst & Applicat Inc, Hampton, VA 23666 USA.	jeanpaul.vernier@nasa.gov	Minnis, Patrick/G-1902-2010	Minnis, Patrick/0000-0002-4733-6148; Thomason, Larry/0000-0002-1902-0840				Bourassa AE, 2012, SCIENCE, V337, P78, DOI 10.1126/science.1219371; Liu ZY, 2009, J ATMOS OCEAN TECH, V26, P1198, DOI 10.1175/2009JTECHA1229.1; Park M, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008294; Prata AJ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007955; Setvak M, 2013, ATMOS RES, V123, P229, DOI 10.1016/j.atmosres.2012.06.020; Smithsonian Institution, GLOB VOLC PROGR; Winker DM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016499	7	36	36	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120								10.1126/science.1227817	http://dx.doi.org/10.1126/science.1227817			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393246				2022-12-28	WOS:000314585600020
J	Fromm, M; Nedoluha, G; Charvat, Z				Fromm, Michael; Nedoluha, Gerald; Charvat, Zdenek			Comment on "Large Volcanic Aerosol Load in the Stratosphere Linked to Asian Monsoon Transport"	SCIENCE			English	Editorial Material								Bourassa et al. (Reports, 6 July 2012, p. 78) report on the 13 June 2011 eruption of the Nabro volcano and satellite observations of stratospheric aerosol that they attribute to troposphere to stratosphere ascent via the Asian monsoon. They claim (citing another source) that the 13 June top injection height was well below the tropopause. We will show that the 13 June Nabro eruption plume was clearly stratospheric and contained both volcanic gases and aerosols. Moreover, we will show height-resolved stratospheric sulfur dioxide and volcanic aerosol enhancements 1 to 3 days old, unaffected by the Asian monsoon, precisely connected to the volcano. The observed stratospheric aerosols and gases are fully explained by the 13 June eruption and do not require a monsoon vehicle.	[Fromm, Michael; Nedoluha, Gerald] USN, Res Lab, Washington, DC 20375 USA; [Charvat, Zdenek] Czech Hydrometeorol Inst, Prague 14306, Czech Republic	United States Department of Defense; United States Navy; Naval Research Laboratory; Czech Hydrometeorological Institute	Fromm, M (corresponding author), USN, Res Lab, Washington, DC 20375 USA.	mike.fromm@nrl.navy.mil	Minnis, Patrick/G-1902-2010	Minnis, Patrick/0000-0002-4733-6148; Thomason, Larry/0000-0002-1902-0840				Bourassa AE, 2012, SCIENCE, V337, P78, DOI 10.1126/science.1219371; de Vries MJMP, 2009, ATMOS CHEM PHYS, V9, P9555; Holasek RE, 1996, J GEOPHYS RES-SOL EA, V101, P27635, DOI 10.1029/96JB01179; NASA, FORM FLYING AFT TRAI; Platnick S, 2003, IEEE T GEOSCI REMOTE, V41, P459, DOI 10.1109/TGRS.2002.808301; Rose W.I., 2003, GEOPHYS MONOGR SER, V139, P107, DOI [10.1029/139GM07, DOI 10.1029/139GM07]; Smithsonian Institution, GLOB VOLC PROGR	7	36	36	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120								10.1126/science.1228605	http://dx.doi.org/10.1126/science.1228605			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393246				2022-12-28	WOS:000314585600019
J	Snowden, JA; Akil, M; Kiely, DG				Snowden, John A.; Akil, Mohammed; Kiely, David G.			Improving safety in autologous HSCT for systemic sclerosis	LANCET			English	Editorial Material							STEM-CELL TRANSPLANTATION; PULMONARY ARTERIAL-HYPERTENSION; AUTOIMMUNE-DISEASES; BLOOD		[Snowden, John A.] Sheffield Teaching Hosp Natl Hlth Serv Fdn Trust, Dept Haematol, Sheffield S10 2JF, S Yorkshire, England; [Akil, Mohammed] Sheffield Teaching Hosp Natl Hlth Serv Fdn Trust, Dept Rheumatol, Sheffield S10 2JF, S Yorkshire, England; [Kiely, David G.] Sheffield Teaching Hosp Natl Hlth Serv Fdn Trust, Sheffield Pulm Vasc Dis Unit, Sheffield S10 2JF, S Yorkshire, England; Univ Sheffield, Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Snowden, JA (corresponding author), Sheffield Teaching Hosp Natl Hlth Serv Fdn Trust, Dept Haematol, Sheffield S10 2JF, S Yorkshire, England.	john.snowden@sth.nhs.uk		SNOWDEN, JOHN/0000-0001-6819-3476				Burt RK, 2011, LANCET, V378, P498, DOI 10.1016/S0140-6736(11)60982-3; Burt RK, 2013, LANCET; Farge D, 2012, BLOOD, V120; Gratwohl A, 2011, J CLIN ONCOL, V29, P1980, DOI 10.1200/JCO.2010.30.4121; Hachulla AL, 2009, ANN RHEUM DIS, V68, P1878, DOI 10.1136/ard.2008.095836; Hagger D, 2009, RHEUMATOLOGY, V48, P1137, DOI 10.1093/rheumatology/kep187; MARMONT A, 1995, LANCET, V345, P978, DOI 10.1016/S0140-6736(95)90720-3; Pasquini MC, 2012, BIOL BLOOD MARROW TR, V18, P1471, DOI 10.1016/j.bbmt.2012.06.003; Rajaram S, 2012, J RHEUMATOL, V39, P1265, DOI 10.3899/jrheum.110987; Snowden JA, 2012, BONE MARROW TRANSPL, V47, P770, DOI 10.1038/bmt.2011.185; Snowden JA, 1996, LANCET, V348, P1112, DOI 10.1016/S0140-6736(05)65267-1; Snowden JA, 2012, BRIT J HAEMATOL, V157, P742, DOI 10.1111/j.1365-2141.2012.09122.x; Sullivan KM, 2012, LANCET, V379, P219, DOI 10.1016/S0140-6736(12)60100-7; Swift AJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-40	14	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 30	2013	381	9872					1081	1083		10.1016/S0140-6736(12)62176-X	http://dx.doi.org/10.1016/S0140-6736(12)62176-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WL	23363663				2022-12-28	WOS:000317348900009
J	Losman, JA; Looper, RE; Koivunen, P; Lee, S; Schneider, RK; McMahon, C; Cowley, GS; Root, DE; Ebert, BL; Kaelin, WG				Losman, Julie-Aurore; Looper, Ryan E.; Koivunen, Peppi; Lee, Sungwoo; Schneider, Rebekka K.; McMahon, Christine; Cowley, Glenn S.; Root, David E.; Ebert, Benjamin L.; Kaelin, William G., Jr.			(R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible	SCIENCE			English	Article							ACUTE MYELOID-LEUKEMIA; ISOCITRATE DEHYDROGENASE 1; ONCOMETABOLITE 2-HYDROXYGLUTARATE; MUTATIONS; HYPOXIA; TET2; DIFFERENTIATION; MORTALITY; ALTITUDE; CANCER	Mutations in IDH1 and IDH2, the genes coding for isocitrate dehydrogenases 1 and 2, are common in several human cancers, including leukemias, and result in overproduction of the (R)-enantiomer of 2-hydroxyglutarate [(R)-2HG]. Elucidation of the role of IDH mutations and (R)-2HG in leukemogenesis has been hampered by a lack of appropriate cell-based models. Here, we show that a canonical IDH1 mutant, IDH1 R132H, promotes cytokine independence and blocks differentiation in hematopoietic cells. These effects can be recapitulated by (R)-2HG, but not (S)-2HG, despite the fact that (S)-2HG more potently inhibits enzymes, such as the 5'-methylcytosine hydroxylase TET2, that have previously been linked to the pathogenesis of IDH mutant tumors. We provide evidence that this paradox relates to the ability of (S)-2HG, but not (R)-2HG, to inhibit the EglN prolyl hydroxylases. Additionally, we show that transformation by (R)-2HG is reversible.	[Losman, Julie-Aurore; Lee, Sungwoo; McMahon, Christine; Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Losman, Julie-Aurore; Schneider, Rebekka K.; Ebert, Benjamin L.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02215 USA; [Looper, Ryan E.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Koivunen, Peppi] Univ Oulu, Oulu Ctr Cell Matrix Res, Dept Med Biochem & Mol Biol, Bioctr Oulu, FIN-90014 Oulu, Finland; [Cowley, Glenn S.; Root, David E.; Ebert, Benjamin L.] Broad Inst MIT & Harvard, Cambridge, MA 02143 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Utah System of Higher Education; University of Utah; University of Oulu; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	william_kaelin@dfci.harvard.edu		Looper, Ryan/0000-0003-1626-1363	NIH; HHMI; NATIONAL CANCER INSTITUTE [R01CA068490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Yen, M. Su, and Agios Pharmaceuticals for the IDH1 inhibitor and for sharing unpublished data; R. Bejar and A. Mullally for their valuable input; A. Lane and D. Sykes for assistance with the SCF ER-Hoxb8 cells; M. Paktinat and R. Mathieu for assistance with flow cytometry; and members of the Kaelin and Ebert lab for technical help and valuable discussion. This work was supported by the NIH (W. G. K. and J.-A.L.) and HHMI (W. G. K.). W. G. K. is a HHMI Investigator and a paid Scientific Advisor for Agios, a biotechnology company developing IDH inhibitors. W. G. K. is also a paid consultant for and owns equity in Fibrogen, Inc., a biotechnology company developing EglN inhibitors.	Abdel-Wahab O, 2011, HEMATOL ONCOL CLIN N, V25, P1119, DOI 10.1016/j.hoc.2011.09.013; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Chow DC, 2001, BIOPHYS J, V81, P675, DOI 10.1016/S0006-3495(01)75732-3; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; ECKHOFF ND, 1974, HEALTH PHYS, V27, P377, DOI 10.1097/00004032-197410000-00006; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Forristal CE, 2013, BLOOD, V121, P759, DOI 10.1182/blood-2012-02-408419; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Jensen PO, 2000, CELL PROLIFERAT, V33, P381, DOI 10.1046/j.1365-2184.2000.00183.x; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Liu W, 2006, BLOOD, V107, P698, DOI 10.1182/blood-2005-03-1278; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Popovici-Muller J, 2012, ACS MED CHEM LETT, V3, P850, DOI 10.1021/ml300225h; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Salomon-Nguyen F, 2000, P NATL ACAD SCI USA, V97, P6757, DOI 10.1073/pnas.120162297; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Song LP, 2008, ONCOGENE, V27, P519, DOI 10.1038/sj.onc.1210670; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; WEINBERG CR, 1987, RADIAT RES, V112, P381, DOI 10.2307/3577265; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	28	515	552	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1621	1625		10.1126/science.1231677	http://dx.doi.org/10.1126/science.1231677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23393090	Green Accepted			2022-12-28	WOS:000316731600053
J	Okamoto, K; Bartocci, C; Ouzounov, I; Diedrich, JK; Yates, JR; Denchi, EL				Okamoto, Keiji; Bartocci, Cristina; Ouzounov, Iliana; Diedrich, Jolene K.; Yates, John R., III; Denchi, Eros Lazzerini			A two-step mechanism for TRF2-mediated chromosome-end protection	NATURE			English	Article							DNA-DAMAGE; MAMMALIAN TELOMERES; TRF2; COMPLEX; UBIQUITINATION; PROTEINS; REPAIR; SITES; BRCA1; NHEJ	Mammalian telomeres repress DNA-damage activation at natural chromosome ends by recruiting specific inhibitors of the DNA-damage machinery that form a protective complex termed shelterin. Within this complex, TRF2 (also known as TERF2) has a crucial role in end protection through the suppression of ATM activation and the formation of end-to-end chromosome fusions(1,2). Here we address the molecular properties of TRF2 that are both necessary and sufficient to protect chromosome ends in mouse embryonic fibroblasts. Our data support a two-step mechanism for TRF2-mediated end protection. First, the dimerization domain of TRF2 is required to inhibit ATM activation, the key initial step involved in the activation of a DNA-damage response (DDR). Next, TRF2 independently suppresses the propagation of DNA-damage signalling downstream of ATM activation. This novel modulation of the DDR at telomeres occurs at the level of the E3 ubiquitin ligase RNF168 (ref. 3). Inhibition of RNF168 at telomeres involves the deubiquitinating enzyme BRCC3 and the ubiquitin ligase UBR5, and is sufficient to suppress chromosome end-to-end fusions. This two-step mechanism for TRF2-mediated end protection helps to explain the apparent paradox of frequent localization of DDR proteins at functional telomeres without concurrent induction of detrimental DNA-repair activities.	[Okamoto, Keiji; Bartocci, Cristina; Ouzounov, Iliana; Denchi, Eros Lazzerini] Scripps Res Inst, Dept Mol & Expt Med, Lab Chromosome Biol & Genom Stabil, La Jolla, CA 92037 USA; [Diedrich, Jolene K.; Yates, John R., III] Scripps Res Inst, Dept Chem Physiol & Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Denchi, EL (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Lab Chromosome Biol & Genom Stabil, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	edenchi@scripps.edu	lazzerini denchi, eros/F-7913-2010; Denchi, Eros Lazzerini/AAD-8208-2020	lazzerini denchi, eros/0000-0001-5378-4644; Diedrich, Jolene/0000-0001-6489-4558	Pew Scholars Award; Novartis Advanced Discovery Institute; National Institutes of Health [AG038677]; National Center for Research Resources [5P41RR011823-17]; National Institute of General Medical Sciences [8 P41 GM103533-17]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038677] Funding Source: NIH RePORTER	Pew Scholars Award; Novartis Advanced Discovery Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. de Lange, M. D. Weitzman, D. Durucher, X. Yu and X. Wu for providing reagents. We are grateful to A. Sfeir, T. Stracker, K. Miller and C. Attwooll for critical reading of the manuscript This work was supported by a Pew Scholars Award (E.L.D.), the Novartis Advanced Discovery Institute (E.L.D.), National Institutes of Health AG038677 (E.L.D.), National Center for Research Resources (5P41RR011823-17) (J.R.Y.) and National Institute of General Medical Sciences (8 P41 GM103533-17) (J.R.Y.).	Al-Wahiby S, 2005, CYTOGENET GENOME RES, V109, P491, DOI 10.1159/000084208; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Carneiro T, 2010, NATURE, V467, P228, DOI 10.1038/nature09353; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; McPherson JP, 2006, HUM MOL GENET, V15, P831, DOI 10.1093/hmg/ddl002; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang Y, 2000, GENE DEV, V14, P927; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	29	148	155	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					502	505		10.1038/nature11873	http://dx.doi.org/10.1038/nature11873			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23389450	Green Accepted			2022-12-28	WOS:000315661500044
J	Ma, DL; Vano-Galvan, S				Ma, Dong-Lai; Vano-Galvan, Sergio			Syphilitic Chancres of the Lips	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ma, Dong-Lai] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Vano-Galvan, Sergio] Hosp Ramon & Cajal, E-28034 Madrid, Spain	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Hospital Universitario Ramon y Cajal	Ma, DL (corresponding author), Beijing Union Med Coll Hosp, Beijing, Peoples R China.	mdonglai@sohu.com		Vano-Galvan, Sergio/0000-0003-2773-7494					0	4	5	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					E8	E8		10.1056/NEJMicm1202329	http://dx.doi.org/10.1056/NEJMicm1202329			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194VA	23406049				2022-12-28	WOS:000322659600001
J	Morgan, JF				Morgan, John F.			MAUDSLEY DEBATE Does the emphasis on risk in psychiatry serve the interests of patients or the public? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morgan, John F.] Leeds & York Partnership NHS Fdn Trust, Leeds, W Yorkshire, England		Morgan, JF (corresponding author), Seacroft Hosp, Ctr Eating Disorders, Leeds LS14 6UH, W Yorkshire, England.	jmorgan@sgul.ac.uk						Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Morgan J. F., 2008, GIVING CULTURE BLAME; Royal College of Psychiatrists, 2009, RETH RISK OTH; Royal College of Psychiatrists, 2010, SELF HARM SUIC RISK; Szmukler G., 2003, PSYCHIATRIC B, V27, P205, DOI [DOI 10.1192/PB.27.6.205, 10.1192/pb.27.6.205, DOI 10.1017/S0955603600002257]	5	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2013	346								f902	10.1136/bmj.f902	http://dx.doi.org/10.1136/bmj.f902			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZG	23404163				2022-12-28	WOS:000315087700006
J	Ziegler, B; Booken, N				Ziegler, Birgit; Booken, Nina			Papulonodular Syphilis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ziegler, Birgit; Booken, Nina] Univ Hosp Mannheim, Mannheim, Germany	Ruprecht Karls University Heidelberg	Ziegler, B (corresponding author), Univ Hosp Mannheim, Mannheim, Germany.	birgit.ziegler@umm.de							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					561	561		10.1056/NEJMicm1203977	http://dx.doi.org/10.1056/NEJMicm1203977			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083VU	23388007				2022-12-28	WOS:000314494100007
J	Rubinstein, F; Micone, P; Bonotti, A; Wainer, V; Schwarcz, A; Augustovski, F; Riviere, AP; Karolinski, A				Rubinstein, F.; Micone, P.; Bonotti, A.; Wainer, V.; Schwarcz, A.; Augustovski, F.; Riviere, A. Pichon; Karolinski, A.		Eva Study Res Grp Estudio Embarazo	Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							2009 H1N1 INFLUENZA; A H1N1; VIRUS-INFECTION; RISK; HOSPITALIZATIONS; IMMUNIZATION; AUSTRALIA; EXPOSURE; INFANTS; IMPACT	Objective To assess the risk of adverse perinatal events of vaccination of pregnant women with an MF59 adjuvanted vaccine. Design Cross sectional multicentre study. Setting 49 public hospitals in major cities in Argentina, from September 2010 to May 2011. Participants 30 448 mothers (7293 vaccinated) and their 30 769 newborns. Main outcome measure Primary composite outcome of low birth weight, preterm delivery, or fetal or early neonatal death up to seven days postpartum. Results Vaccinated women had a lower risk of the primary composite outcome (7.0% (n=513) v 9.3% (n=2160); adjusted odds ratio 0.80, 95% confidence interval 0.72 to 0.89). The propensity score analysis showed similar results. Adjusted odds ratios for vaccinated women were 0.74 (0.65 to 0.83) for low birth weight, 0.79 (0.69 to 0.90) for preterm delivery, and 0.68 (0.42 to 1.06) for perinatal mortality. These findings were consistent in further subgroup analysis. No significant differences in maternal outcomes were found. Conclusion This large study using primary data collection found that MF59 adjuvanted A/H1N1 influenza vaccine did not result in an increased risk of adverse perinatal events and suggested a lower risk among vaccinated women. These findings should contribute to inform stakeholders and decision makers on the prescription of vaccination against influenza A/H1N1 in pregnant women.	[Rubinstein, F.; Bonotti, A.; Augustovski, F.; Riviere, A. Pichon] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Rubinstein, F.; Augustovski, F.; Riviere, A. Pichon] Univ Buenos Aires, Sch Publ Hlth, Buenos Aires, DF, Argentina; [Rubinstein, F.; Augustovski, F.] Hosp Italiano Buenos Aires, Div Family & Community Med, Buenos Aires, DF, Argentina; [Micone, P.; Wainer, V.; Schwarcz, A.; Karolinski, A.] Hosp Durand, Ctr Invest Salud Poblac CISAP, Populat Hlth Res Ctr, Buenos Aires, DF, Argentina	University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; University of Buenos Aires	Rubinstein, F (corresponding author), Inst Clin Effectiveness & Hlth Policy, Emilio Ravignani 2024, Buenos Aires, DF, Argentina.	frubinstein@iecs.org.ar	rubinstein, fernando/W-1805-2019	Pichon-Riviere, Andres/0000-0001-6052-025X	Novartis Argentina SA [V111_17TP.2010]	Novartis Argentina SA	This study was funded by an independent research grant from Novartis Argentina SA (Internal Protocol No V111_17TP.2010). The investigators designed and conducted the study; performed the analysis and interpretation of the data; and are responsible for the results, conclusions, and recommendations.	Afinogenova V. P., 2010, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P114; Ahluwalia IB, 2010, OBSTET GYNECOL, V116, P949, DOI 10.1097/AOG.0b013e3181f1039f; [Anonymous], 2010, Obstet Gynecol, V116, P1006, DOI 10.1097/AOG.0b013e3181fae845; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Bone A, 2010, VACCINE, V28, P8157, DOI 10.1016/j.vaccine.2010.09.096; Centers for Disease Control and Prevention, 2010, 2009 H1N1 PANDEMIC S; Chan M., 2009, WORLD NOW START 2009; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Direccion de Estadisticas e Informacion de Salud, 2010, DIR EST INF SAL; Direccion de Estadisticas e Informacion de Salud, 2011, DIR EST INF SAL EST; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; European Medicines Agency, 2009, EMEA6816652009; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Folkenberg M, 2011, VACCINE, V29, P1180, DOI 10.1016/j.vaccine.2010.12.008; Hanquet G, 2011, VACCINE, V29, P370, DOI 10.1016/j.vaccine.2010.10.079; Harmark L, 2011, VACCINE, V29, P1941, DOI 10.1016/j.vaccine.2010.12.123; Heikkinen T, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.007; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Karolinski A, 2012, CLAP SMR PUBLICATION, V1592; Knight M, 2012, BRIT MED J, V344, pe3091; KORT BA, 1986, AM J PERINAT, V3, P179, DOI 10.1055/s-2007-999862; Lacroix I, 2011, VACCINE, V29, P1357, DOI 10.1016/j.vaccine.2010.12.011; lark TW, 1959, NEW ENGL J MED, V361, P2424; Lau JTF, 2010, VACCINE, V28, P5389, DOI 10.1016/j.vaccine.2010.05.071; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Lim SH, 2010, VACCINE, V28, P7455, DOI 10.1016/j.vaccine.2010.08.087; Lineamentos tecnicos gripe 2011, 2011, LIN TECN GRIP 2011; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Moro PL, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.050; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nokleby H, 2010, EUROSURVEILLANCE, V15, P23; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; Pan American Health Organization, 2009, PAND H1N1; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Pasternak B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2794; Perez-Rubio A, 2010, MED CLIN-BARCELONA, V135, P543, DOI 10.1016/j.medcli.2010.05.016; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Puleston RL, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14550-01; The ANZIC Influenza Investigators and AMOSS, 2010, BMJ-BRIT MED J, V340, P1279; Tsai T, 2010, VACCINE, V28, P1877, DOI 10.1016/j.vaccine.2009.11.077; White SW, 2010, MED J AUSTRALIA, V193, P405, DOI 10.5694/j.1326-5377.2010.tb03970.x; World Health Organization, 2010, WHO REC PAND H1N1 20; Zuccotti G, 2010, JAMA-J AM MED ASSOC, V304, P2360, DOI 10.1001/jama.2010.1729	49	44	44	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2013	346								f393	10.1136/bmj.f393	http://dx.doi.org/10.1136/bmj.f393			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088AL	23381200	Green Published, hybrid			2022-12-28	WOS:000314806100001
J	Menz, MHM; Dixon, KW; Hobbs, RJ				Menz, Myles H. M.; Dixon, Kingsley W.; Hobbs, Richard J.			Hurdles and Opportunities for Landscape-Scale Restoration	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES; BIODIVERSITY; CONSERVATION; SCIENCE; NEED		[Menz, Myles H. M.; Dixon, Kingsley W.] Kings Pk & Bot Gardens, Perth, WA 6005, Australia; [Menz, Myles H. M.; Dixon, Kingsley W.; Hobbs, Richard J.] Univ Western Australia, Perth, WA 6009, Australia	University of Western Australia	Menz, MHM (corresponding author), Kings Pk & Bot Gardens, Perth, WA 6005, Australia.	myles.menz@bgpa.wa.gov.au	Hobbs, Richard J/F-5883-2010; Dixon, Kingsley W/A-8133-2016; Menz, Myles/A-2238-2017; Menz, Myles H. M./AAP-6756-2020; Menz, Myles/HHZ-9580-2022; Dixon, Kingsley W/B-1042-2011	Hobbs, Richard J/0000-0003-4047-3147; Dixon, Kingsley W/0000-0001-5989-2929; Menz, Myles/0000-0002-3347-5411; Menz, Myles H. M./0000-0002-3347-5411; Menz, Myles/0000-0002-3347-5411; 				Arlettaz R, 2010, BIOSCIENCE, V60, P835, DOI 10.1525/bio.2010.60.10.10; Aronson J, 2011, LANDSCAPE ECOL, V26, P457, DOI 10.1007/s10980-011-9586-2; Biggs R, 2012, ANNU REV ENV RESOUR, V37, P421, DOI 10.1146/annurev-environ-051211-123836; Birch JC, 2010, P NATL ACAD SCI USA, V107, P21925, DOI 10.1073/pnas.1003369107; Brito L, 2012, SCIENCE, V336, P1396, DOI [10.1126/science.1224531, 10.1126/science.1224006]; Brudvig LA, 2011, AM J BOT, V98, P549, DOI 10.3732/ajb.1000285; Buch A, 2009, SUSTAIN DEV, V17, P129, DOI 10.1002/sd.370; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cunningham S, 2008, REWEALTH; Dixon KW, 2009, SCIENCE, V325, P571, DOI 10.1126/science.1176295; Harris J, 2009, SCIENCE, V325, P573, DOI 10.1126/science.1172975; Hobbs RJ, 2007, AUST J BOT, V55, P371, DOI 10.1071/BT06088; Hobbs RJ, 2007, RESTOR ECOL, V15, P354, DOI 10.1111/j.1526-100X.2007.00225.x; Hobbs RJ, 2011, BIOSCIENCE, V61, P442, DOI 10.1525/bio.2011.61.6.6; IUCN, REST LOST FOR; Keeneleyside KA., 2012, ECOLOGICAL RESTORATI, DOI [10.25607/OBP-171, DOI 10.25607/OBP-171]; Martinez ML, 2012, FRONT ECOL ENVIRON, V10, P44, DOI 10.1890/100151; MAATHAI W, 2006, GREEN BELT MOVEMENT; Maron M, 2012, BIOL CONSERV, V155, P141, DOI 10.1016/j.biocon.2012.06.003; Menz MHM, 2011, TRENDS PLANT SCI, V16, P4, DOI 10.1016/j.tplants.2010.09.006; Merritt DJ, 2011, SCIENCE, V332, P424, DOI 10.1126/science.1203083; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Richardson CJ, 2005, SCIENCE, V307, P1307, DOI 10.1126/science.1105750; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Tollefson J, 2012, NATURE, V486, P12, DOI 10.1038/486013a; Tongway DJ, 1996, RESTOR ECOL, V4, P388, DOI 10.1111/j.1526-100X.1996.tb00191.x; van Wilgen BW, 2012, BIOL CONSERV, V148, P28, DOI 10.1016/j.biocon.2011.12.035; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Wilson KA, 2011, J APPL ECOL, V48, P715, DOI 10.1111/j.1365-2664.2011.01975.x; Xu JC, 2011, NATURE, V477, P370, DOI 10.1038/477371a	32	250	263	16	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					526	527		10.1126/science.1228334	http://dx.doi.org/10.1126/science.1228334			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372001				2022-12-28	WOS:000314270000042
J	Gammon, K				Gammon, Katharine			DRUGS Blood battles	NATURE			English	Editorial Material							STATIN											Bulbulia R, 2011, LANCET, V378, P2013, DOI 10.1016/S0140-6736(11)61125-2; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Gutierrez J, 2012, ARCH INTERN MED, V172, P909, DOI 10.1001/archinternmed.2012.2145; Redberg RF, 2012, JAMA-J AM MED ASSOC, V307, P1491, DOI 10.1001/jama.2012.423; Wald DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041297	5	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S14	S15		10.1038/493S14a	http://dx.doi.org/10.1038/493S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364766				2022-12-28	WOS:000314219600011
J	Garner, HR; McIver, LJ; Waitzkin, MB				Garner, Harold R.; McIver, Lauren J.; Waitzkin, Michael B.			Same work, twice the money?	NATURE			English	Editorial Material									[Garner, Harold R.; McIver, Lauren J.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Waitzkin, Michael B.] Genomeon, Floyd, VA USA	Virginia Polytechnic Institute & State University	Garner, HR (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Washington St, Blacksburg, VA 24061 USA.	garner@vbi.vt.edu; mbwaitzkin@gmail.com						Errami M, 2008, BIOINFORMATICS, V24, P243, DOI 10.1093/bioinformatics/btm574; Errami M, 2008, NATURE, V451, P397, DOI 10.1038/451397a; Kaiser J., 2012, SCI INSIDER     0120; Lewis J, 2006, BIOINFORMATICS, V22, P2298, DOI 10.1093/bioinformatics/btl388; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Reich ES, 2012, NATURE, V482, P146, DOI 10.1038/482146a; Rockey S., 2012, PILOTING 1 5M SPECIA; US Government Accountability Office, 2012, REP C ADDR 2012 ANN	8	10	11	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					599	601		10.1038/493599a	http://dx.doi.org/10.1038/493599a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080CU	23364724				2022-12-28	WOS:000314219600026
J	Noller, H				Noller, Harry			Carl Woese (1928-2012) Obituary	NATURE			English	Biographical-Item									Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Noller, H (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu						WOESE CR, PUBLICATION LIST	1	4	4	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2013	493	7434					610	610		10.1038/493610a	http://dx.doi.org/10.1038/493610a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364736				2022-12-28	WOS:000314219600038
J	Srivastava, R				Srivastava, Ranjana			Speaking Up - When Doctors Navigate Medical Hierarchy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia	Monash University	Srivastava, R (corresponding author), Monash Med Ctr, Dept Med Oncol, Melbourne, Vic, Australia.								0	41	41	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					302	305		10.1056/NEJMp1212410	http://dx.doi.org/10.1056/NEJMp1212410			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075KX	23343060				2022-12-28	WOS:000313885900003
J	Spence, D				Spence, Des			FROM THE FRONTLINE Journalistic licence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2013	346								f418	10.1136/bmj.f418	http://dx.doi.org/10.1136/bmj.f418			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BX	23344548				2022-12-28	WOS:000314217300009
J	Bolland, MJ; Jackson, R; Gamble, GD; Grey, A				Bolland, Mark J.; Jackson, Rod; Gamble, Greg D.; Grey, Andrew			Discrepancies in predicted fracture risk in elderly people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIANS SURVIVAL PREDICTIONS; POSTMENOPAUSAL WOMEN; ZOLEDRONIC ACID; OSTEOPOROSIS; PREVENTION; MANAGEMENT; DEATH; AGE		[Bolland, Mark J.; Gamble, Greg D.; Grey, Andrew] Univ Auckland, Dept Med, Auckland 1142, New Zealand; [Jackson, Rod] Univ Auckland, Epidemiol & Biostat Sect, Auckland 1142, New Zealand	University of Auckland; University of Auckland	Bolland, MJ (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland 1142, New Zealand.	m.bolland@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674; Jackson, Rod/0000-0001-5914-6934; Gamble, Greg/0000-0003-0412-3203				Berry SD, 2010, J AM GERIATR SOC, V58, P783, DOI 10.1111/j.1532-5415.2010.02767.x; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 2012, NEW ENGL J MED, V366, P2051, DOI 10.1056/NEJMp1202623; Bolland MJ, 2011, J BONE MINER RES, V26, P420, DOI 10.1002/jbmr.215; Bolland MJ, 2010, J CLIN ENDOCR METAB, V95, P1856, DOI 10.1210/jc.2009-2157; Collins GS, 2011, BMJ-BRIT MED J, V342; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dawson-Hughes B, 2008, J CLIN ENDOCR METAB, V93, P2463, DOI 10.1210/jc.2008-0926; Ensrud KE, 2009, ARCH INTERN MED, V169, P2087, DOI 10.1001/archinternmed.2009.404; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Langsetmo L, 2011, CAN MED ASSOC J, V183, pE107, DOI 10.1503/cmaj.100458; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Melton LJ, 1999, OSTEOPOROSIS INT, V9, P29, DOI 10.1007/s001980050113; Poses RM, 1997, ARCH INTERN MED, V157, P1001, DOI 10.1001/archinte.157.9.1001; Singer BR, 1998, J BONE JOINT SURG BR, V80B, P243, DOI 10.1302/0301-620X.80B2.7762; Siontis GCM, 2011, ARCH INTERN MED, V171, P1721, DOI 10.1001/archinternmed.2011.334; Steurer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019994	19	21	21	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2013	346								e8669	10.1136/bmj.e8669	http://dx.doi.org/10.1136/bmj.e8669			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BA	23338005				2022-12-28	WOS:000314215000003
J	Goldsmith, JC; Wang, WC				Goldsmith, Jonathan C.; Wang, Winfred C.			Preoperative transfusion in patients with sickle-cell disease	LANCET			English	Editorial Material							SURGERY		[Goldsmith, Jonathan C.] NHLBI, Div Blood Dis & Resources, Bethesda, MD 20892 USA; [Wang, Winfred C.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); St Jude Children's Research Hospital	Goldsmith, JC (corresponding author), NHLBI, Div Blood Dis & Resources, Bldg 10, Bethesda, MD 20892 USA.	goldsmithjc@nhlbi.nih.gov						Ashley-Koch AE, 2011, BRIT J HAEMATOL, V155, P386, DOI 10.1111/j.1365-2141.2011.08832.x; Haberkern CM, 1997, BLOOD, V89, P1533; HIRST C, 2012, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003149.PUB2; Howard J, 2013, LANCET; KOSHY M, 1995, BLOOD, V86, P3676, DOI 10.1182/blood.V86.10.3676.bloodjournal86103676; Neumayr L, 1998, AM J HEMATOL, V57, P101, DOI 10.1002/(SICI)1096-8652(199802)57:2<101::AID-AJH2>3.0.CO;2-#; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; VICHINSKY EP, 1995, NEW ENGL J MED, V333, P206, DOI 10.1056/NEJM199507273330402; Vichinsky EP, 1999, AM J HEMATOL, V62, P129, DOI 10.1002/(SICI)1096-8652(199911)62:3<129::AID-AJH1>3.3.CO;2-A	9	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					886	888		10.1016/S0140-6736(12)61995-3	http://dx.doi.org/10.1016/S0140-6736(12)61995-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105LB	23352053				2022-12-28	WOS:000316069700009
J	Mehilli, J				Mehilli, Julinda			Degradable polymer drug-eluting stents: a durable benefit?	LANCET			English	Editorial Material							BARE-METAL STENTS; PERCUTANEOUS CORONARY INTERVENTION; NON-INFERIORITY TRIAL; BIODEGRADABLE POLYMER; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIALS; THROMBOSIS; LEADERS; METAANALYSIS; LESIONS		Klinikum Univ Munich, Med Klin 1, D-81377 Munich, Germany	University of Munich	Mehilli, J (corresponding author), Klinikum Univ Munich, Med Klin 1, Campus Grosshadern, D-81377 Munich, Germany.	julinda.mehilli@med.uni-muenchen.de	Mehilli, Julinda/F-2629-2016					Barlis P, 2010, EUR HEART J, V31, P165, DOI 10.1093/eurheartj/ehp480; Byrne RA, 2009, EUR HEART J, V30, P2441, DOI 10.1093/eurheartj/ehp352; Chevalier B, 2009, CIRC-CARDIOVASC INTE, V2, P188, DOI 10.1161/CIRCINTERVENTIONS.108.823443; Danzi GB, 2012, EUROINTERVENTION, V8, P109, DOI 10.4244/EIJV8I1A17; de Waha A, 2012, CLIN RES CARDIOL, V101, P461, DOI 10.1007/s00392-012-0414-8; Hamilos MI, 2008, J AM COLL CARDIOL, V51, P2123, DOI 10.1016/j.jacc.2007.12.059; Hildick-Smith D, 2010, CIRCULATION, V121, P1235, DOI 10.1161/CIRCULATIONAHA.109.888297; Kastrati A, 2011, NEW ENGL J MED, V365, P1980, DOI 10.1056/NEJMoa1109596; Mehilli J, 2011, LANCET, V378, P1071, DOI 10.1016/S0140-6736(11)61255-5; Nakazawa G, 2009, JACC-CARDIOVASC IMAG, V2, P625, DOI 10.1016/j.jcmg.2009.01.011; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Smits PC, 2013, LANCET; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	21	0	1	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2013	381	9867					607	609		10.1016/S0140-6736(12)62193-X	http://dx.doi.org/10.1016/S0140-6736(12)62193-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093JY	23374651				2022-12-28	WOS:000315189300007
J	Lin, HY; Chin, CY; Huang, HL; Huang, WY; Sie, MJ; Huang, LH; Lee, YH; Lin, CH; Lii, KH; Bu, XH; Wang, SL				Lin, Hsin-Yau; Chin, Chih-Yuan; Huang, Hui-Lin; Huang, Wen-Yen; Sie, Ming-Jhe; Huang, Li-Hsun; Lee, Yuan-Han; Lin, Chia-Her; Lii, Kwang-Hwa; Bu, Xianhui; Wang, Sue-Lein			Crystalline Inorganic Frameworks with 56-Ring, 64-Ring, and 72-Ring Channels	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORKS; MOLECULAR-SIEVE; POROUS MATERIALS; LIGHT PHOSPHOR; ZEOLITE; GALLOPHOSPHATE	The development of zeolite-like structures with extra-large pores (>12-membered rings, 12R) has been sporadic and is currently at 30R. In general, templating via molecules leads to crystalline frameworks, whereas the use of organized assemblies that permit much larger pores produces noncrystalline frameworks. Synthetic methods that generate crystallinity from both discrete templates and organized assemblies represent a viable design strategy for developing crystalline porous inorganic frameworks spanning the micro and meso regimes. We show that by integrating templating mechanisms for both zeolites and mesoporous silica in a single system, the channel size for gallium zincophosphites can be systematically tuned from 24R and 28R to 40R, 48R, 56R, 64R, and 72R. Although the materials have low thermal stability and retain their templating agents, single-activator doping of Mn2+ can create white-light photoluminescence.	[Lin, Hsin-Yau; Chin, Chih-Yuan; Huang, Hui-Lin; Huang, Wen-Yen; Sie, Ming-Jhe; Huang, Li-Hsun; Lee, Yuan-Han; Wang, Sue-Lein] Natl Tsing Hua Univ, Dept Chem, Frontier Res Ctr Fundamental & Appl Sci Matters, Hsinchu 30013, Taiwan; [Lin, Chia-Her] Chung Yuan Christian Univ, Dept Chem, Chungli 320, Taiwan; [Lii, Kwang-Hwa] Natl Cent Univ, Dept Chem, Chungli 320, Taiwan; [Bu, Xianhui] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA	National Tsing Hua University; Chung Yuan Christian University; National Central University; California State University System; California State University Long Beach	Wang, SL (corresponding author), Natl Tsing Hua Univ, Dept Chem, Frontier Res Ctr Fundamental & Appl Sci Matters, Hsinchu 30013, Taiwan.	slwang@mx.nthu.edu.tw	Lin, Chia-Her/X-7961-2019; Lin, Chia-Her/L-7009-2014; huang, wen/GXW-0661-2022; Bu, Xianhui/L-9403-2013	Lin, Chia-Her/0000-0002-1360-0828; Lin, Chia-Her/0000-0002-1360-0828; Bu, Xianhui/0000-0002-2994-4051	National Science Council of Taiwan [NSC100-2113-M-007-016-MY3, NSC101-2113-M-033-007-MY3, NSC101-2113-M-008-006-MY3]; NSF [DMR-0846958]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); NSF(National Science Foundation (NSF))	Supported by National Science Council of Taiwan grants NSC100-2113-M-007-016-MY3, NSC101-2113-M-033-007-MY3, and NSC101-2113-M-008-006-MY3. X. B. was supported by NSF grant DMR-0846958. Crystallographic data for the reported crystal structures have been deposited at the Cambridge Crystallographic Data Centre with codes 892384-892387 and 915187-915191.	Bae YS, 2011, ANGEW CHEM INT EDIT, V50, P11586, DOI 10.1002/anie.201101891; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; DAVIS ME, 1988, NATURE, V331, P698, DOI 10.1038/331698a0; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Deng HX, 2012, SCIENCE, V336, P1018, DOI 10.1126/science.1220131; ESTERMANN M, 1991, NATURE, V352, P320, DOI 10.1038/352320a0; Freyhardt CC, 1996, NATURE, V381, P295, DOI 10.1038/381295a0; Furukawa H, 2010, SCIENCE, V329, P424, DOI 10.1126/science.1192160; Guillou N, 2001, ANGEW CHEM INT EDIT, V40, P2831, DOI 10.1002/1521-3773(20010803)40:15<2831::AID-ANIE2831>3.0.CO;2-Z; HUO QS, 1994, NATURE, V368, P317, DOI 10.1038/368317a0; Jhang PC, 2009, ANGEW CHEM INT EDIT, V48, P742, DOI 10.1002/anie.200804744; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Lai YL, 2007, J AM CHEM SOC, V129, P5350, DOI 10.1021/ja070733k; Liao YC, 2005, J AM CHEM SOC, V127, P9986, DOI 10.1021/ja0512879; Lin CH, 2001, J AM CHEM SOC, V123, P4649, DOI 10.1021/ja0100468; MOORE PB, 1983, NATURE, V306, P356, DOI 10.1038/306356a0; Peskov MV, 2011, J PHYS CHEM C, V115, P7729, DOI 10.1021/jp112270e; Rosi NL, 2003, SCIENCE, V300, P1127, DOI 10.1126/science.1083440; Spek A., 1990, ACTA CRYSTALLOGR A, V46, pc34, DOI DOI 10.1107/S0108767390099780; Sun JL, 2009, NATURE, V458, P1154, DOI 10.1038/nature07957; Tang LQ, 2008, NAT MATER, V7, P381, DOI 10.1038/nmat2169; WILSON ST, 1982, J AM CHEM SOC, V104, P1146, DOI 10.1021/ja00368a062; Yang GY, 1999, J AM CHEM SOC, V121, P8389, DOI 10.1021/ja991985r; Yang YC, 2008, J AM CHEM SOC, V130, P1146, DOI 10.1021/ja7101423; Zou XD, 2005, NATURE, V437, P716, DOI 10.1038/nature04097	25	146	147	4	320	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					811	813		10.1126/science.1232097	http://dx.doi.org/10.1126/science.1232097			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23348508				2022-12-28	WOS:000314874400046
J	Heikkila, K; Nyberg, ST; Theorell, T; Fransson, EI; Alfredsson, L; Bjorner, JB; Bonenfant, S; Borritz, M; Bouillon, K; Burr, H; Dragano, N; Geuskens, GA; Goldberg, M; Hamer, M; Hooftman, WE; Houtman, IL; Joensuu, M; Knutsson, A; Koskenvuo, M; Koskinen, A; Kouvonen, A; Madsen, IEH; Magnusson, LL; Marmot, MG; Nielsen, ML; Nordin, M; Oksanen, T; Pentti, J; Salo, P; Rugulies, R; Steptoe, A; Suominen, S; Vahtera, J; Virtanen, M; Vaananen, A; Westerholm, P; Westerlund, H; Zins, M; Ferrie, JE; Singh-Manoux, A; Batty, GD; Kivimaki, M				Heikkila, Katriina; Nyberg, Solja T.; Theorell, Tores; Fransson, Eleonor I.; Alfredsson, Lars; Bjorner, Jakob B.; Bonenfant, Sebastien; Borritz, Marianne; Bouillon, Kim; Burr, Herman; Dragano, Nico; Geuskens, Goedele A.; Goldberg, Marcel; Hamer, Mark; Hooftman, Wendela E.; Houtman, Irene L.; Joensuu, Matti; Knutsson, Anders; Koskenvuo, Markku; Koskinen, Aki; Kouvonen, Anne; Madsen, Ida E. H.; Magnusson, Linda L.; Marmot, Michael G.; Nielsen, Martin L.; Nordin, Maria; Oksanen, Tuula; Pentti, Jaana; Salo, Paula; Rugulies, Reiner; Steptoe, Andrew; Suominen, Sakari; Vahtera, Jussi; Virtanen, Marianna; Vaananen, Ari; Westerholm, Peter; Westerlund, Hugo; Zins, Marie; Ferrie, Jane E.; Singh-Manoux, Archana; Batty, G. David; Kivimaki, Mika		IPD-Work Consortium	Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116 000 European men and women	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; BREAST-CANCER; PROSPECTIVE COHORT; COLORECTAL-CANCER; JOB STRAIN; BASE-LINE; GAZEL COHORT; SWEDISH; ENVIRONMENT; MORTALITY	Objective To investigate whether work related stress, measured and defined as job strain, is associated with the overall risk of cancer and the risk of colorectal, lung, breast, or prostate cancers. Design Meta-analysis of pooled prospective individual participant data from 12 European cohort studies including 116 056 men and women aged 17-70 who were free from cancer at study baseline and were followed-up for a median of 12 years. Work stress was measured and defined as job strain, which was self reported at baseline. Incident cancers (all n=5765, colorectal cancer n=522, lung cancer n=374, breast cancer n=1010, prostate cancer n=865) were ascertained from cancer, hospital admission, and death registers. Data were analysed in each study with Cox regression and the study specific estimates pooled in meta-analyses. Models were adjusted for age, sex, socioeconomic position, body mass index (BMI), smoking, and alcohol intake Results A harmonised measure of work stress, high job strain, was not associated with overall risk of cancer (hazard ratio 0.97, 95% confidence interval 0.90 to 1.04) in the multivariable adjusted analyses. Similarly, no association was observed between job strain and the risk of colorectal (1.16, 0.90 to 1.48), lung (1.17, 0.88 to 1.54), breast (0.97, 0.82 to 1.14), or prostate (0.86, 0.68 to 1.09) cancers. There was no clear evidence for an association between the categories of job strain and the risk of cancer. Conclusions These findings suggest that work related stress, measured and defined as job strain, at baseline is unlikely to be an important risk factor for colorectal, lung, breast, or prostate cancers.	[Heikkila, Katriina; Nyberg, Solja T.; Joensuu, Matti; Koskinen, Aki; Virtanen, Marianna; Vaananen, Ari] Finnish Inst Occupat Hlth, Helsinki 00250, Finland; [Theorell, Tores; Fransson, Eleonor I.; Magnusson, Linda L.; Westerlund, Hugo] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Fransson, Eleonor I.; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Fransson, Eleonor I.] Jonkoping Univ, Sch Hlth Sci, Jonkoping, Sweden; [Bjorner, Jakob B.; Madsen, Ida E. H.; Rugulies, Reiner] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Bonenfant, Sebastien; Goldberg, Marcel; Zins, Marie] Versailles St Quentin Univ, Versailles, France; [Bonenfant, Sebastien; Goldberg, Marcel; Zins, Marie; Singh-Manoux, Archana] Ctr Res Epidemiol & Populat Hlth, Inserm, U1018, Villejuif, France; [Borritz, Marianne; Nielsen, Martin L.] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Bouillon, Kim; Hamer, Mark; Marmot, Michael G.; Steptoe, Andrew; Ferrie, Jane E.; Singh-Manoux, Archana; Batty, G. David; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Burr, Herman] Fed Inst Occupat Safety & Hlth BAuA, Berlin, Germany; [Dragano, Nico] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Geuskens, Goedele A.; Hooftman, Wendela E.; Houtman, Irene L.] TNO, Hoofddorp, Netherlands; [Knutsson, Anders] Mid Sweden Univ, Dept Hlth Sci, Sundsvall, Sweden; [Koskenvuo, Markku] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Kouvonen, Anne] Queens Univ Belfast, Sch Sociol Social Policy & Social Work, Belfast, Antrim, North Ireland; [Nordin, Maria] Umea Univ, Dept Publ Hlth & Clin Med Occupat & Environm, Umea, Sweden; [Oksanen, Tuula; Pentti, Jaana; Salo, Paula; Vahtera, Jussi] Finnish Inst Occupat Hlth, Turku, Finland; [Salo, Paula] Univ Turku, Dept Psychol, Turku, Finland; [Rugulies, Reiner] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Suominen, Sakari] Folkhalsan Res Ctr, Helsinki, Finland; [Suominen, Sakari; Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Westerholm, Peter] Uppsala Univ, Uppsala, Sweden; [Ferrie, Jane E.] Univ Bristol, Sch Community & Social Med, Bristol, Avon, England; [Batty, G. David] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	Finnish Institute of Occupational Health; Stockholm University; Karolinska Institutet; Jonkoping University; National Research Centre for the Working Environment; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Aarhus University; University of Copenhagen; Bispebjerg Hospital; University of London; University College London; University of Duisburg Essen; Netherlands Organization Applied Science Research; Mid-Sweden University; University of Helsinki; Queens University Belfast; Umea University; Finnish Institute of Occupational Health; University of Turku; University of Copenhagen; University of Copenhagen; Folkhalsan Research Center; University of Turku; Uppsala University; University of Bristol; University of Edinburgh	Heikkila, K (corresponding author), Finnish Inst Occupat Hlth, Helsinki 00250, Finland.	katriina.heikkila@ttl.fi	Rugulies, Reiner/E-8140-2010; Steptoe, Andrew/Y-2440-2019; Hanson, Linda L Magnusson/D-2435-2017; Hamer, Mark/C-1602-2008; Westerlund, Hugo/A-3049-2012; Fransson, Eleonor I/J-7792-2013; Vahtera, Jussi/J-3271-2013; Kivimaki, Mika/B-3607-2012; Salo, Paula/D-6649-2013; Nielsen, Martin Lindhardt/E-3071-2012; Goldberg, Marcel/I-7834-2012; Zins, Marie/AAX-6551-2021; Ferrie, Jane/AAZ-2009-2020; Singh-Manoux, Archana/F-6804-2013; Hamer, Mark/AAJ-6814-2021; Batty, GD/Y-4401-2018; Alfredsson, Lars/AAC-9007-2019; Marmot, M G/Y-3920-2019; Oksanen, Tuula/AAK-5599-2021	Rugulies, Reiner/0000-0002-7752-131X; Hanson, Linda L Magnusson/0000-0002-2908-1903; Hamer, Mark/0000-0002-8726-7992; Westerlund, Hugo/0000-0002-8806-5698; Fransson, Eleonor I/0000-0001-9042-4832; Kivimaki, Mika/0000-0002-4699-5627; Salo, Paula/0000-0002-0812-277X; Nielsen, Martin Lindhardt/0000-0002-1523-0453; Goldberg, Marcel/0000-0002-6161-5880; Singh-Manoux, Archana/0000-0002-1244-5037; Hamer, Mark/0000-0002-8726-7992; Batty, GD/0000-0003-1822-5753; Alfredsson, Lars/0000-0003-1688-6697; Marmot, M G/0000-0002-2431-6419; Vahtera, Jussi/0000-0002-6036-061X; Suominen, Sakari B./0000-0001-6648-603X; Madsen, Ida/0000-0003-3635-3900; Kouvonen, Anne/0000-0001-6997-8312; Burr, Hermann/0000-0002-3864-6347; Steptoe, Andrew/0000-0001-7808-4943; Theorell, Tores/0000-0003-1956-7931	EU New OSH ERA research programme; Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research, Sweden; Danish National Research Centre for the Working Environment, Denmark; Academy of Finland [132944]; BUPA Foundation [22094477]; Economic and Social Research Council, UK; Ministry of Social Affairs and Employment, Netherlands; Medical Research Council; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [G0902037, MR/K013351/1] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [G0100222, G0902037, G8802774, MR/K013351/1, G19/35] Funding Source: researchfish	EU New OSH ERA research programme; Finnish Work Environment Fund, Finland; Swedish Research Council for Working Life and Social Research, Sweden; Danish National Research Centre for the Working Environment, Denmark; Academy of Finland(Academy of Finland); BUPA Foundation; Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Ministry of Social Affairs and Employment, Netherlands; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The IPD-Work Consortium is supported by the EU New OSH ERA research programme (funded by the Finnish Work Environment Fund, Finland, the Swedish Research Council for Working Life and Social Research, Sweden, the Danish National Research Centre for the Working Environment, Denmark), the Academy of Finland (grant 132944), the BUPA Foundation (grant 22094477), and the Economic and Social Research Council, UK. POLS is funded by the Ministry of Social Affairs and Employment, Netherlands. MK is supported by the Medical Research Council and a professorial fellowship from the Economic and Social Research Council, UK. AS is a British Heart Foundation professor. At the time of preparation of the manuscript, GDB was a Wellcome Trust Fellow. The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredsson L, 2002, SCAND J WORK ENV HEA, V28, P238, DOI 10.5271/sjweh.671; Alleyne R, 2010, TELEGRAPH; [Anonymous], 2011, SUMM QUAL REP CANC R; Antonova L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2836; Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Borritz M, 2006, SCAND J PUBLIC HEALT, V34, P49, DOI 10.1080/14034940510032275; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; Burr H, 2003, SCAND J WORK ENV HEA, V29, P270, DOI 10.5271/sjweh.731; Cabaniols C, 2011, J NEURO-ONCOL, V103, P307, DOI 10.1007/s11060-010-0388-1; Chevalier A, 1996, REV EPIDEMIOL SANTE, V44, P25; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; COLEMAN MP, 1988, INT J CANCER, V42, P339, DOI 10.1002/ijc.2910420306; De Groot W, 2001, DUTCH SYSTEM OFFICIA; Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653; Feveile H, 2007, STAT TRANSIT, V8, P441; Fransson EI, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-62; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040101; Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035463; Henkel Dieter, 2011, Curr Drug Abuse Rev, V4, P4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huncharek M, 2010, AM J PUBLIC HEALTH, V100, P693, DOI 10.2105/AJPH.2008.150508; IARC, 2022, AG CLASS IARC MON, V1-132; Jansson C, 2009, CANCER EPIDEMIOL, V33, P473, DOI 10.1016/j.canep.2009.10.008; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R., 1990, HLTH WORK STRESS PRO; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kivimaki M, 2007, AM J PUBLIC HEALTH, V97, P874, DOI 10.2105/AJPH.2005.078691; Kojima M, 2005, PSYCHOSOM MED, V67, P72, DOI 10.1097/01.psy.0000151742.43774.6d; Korkeila K, 2001, EUR J EPIDEMIOL, V17, P991, DOI 10.1023/A:1020016922473; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; Kruk J, 2004, CANCER DETECT PREV, V28, P399, DOI 10.1016/j.cdp.2004.07.009; Kuper H, 2007, EPIDEMIOLOGY, V18, P764, DOI 10.1097/EDE.0b013e318142c534; Santos MCL, 2009, CAD SAUDE PUBLICA, V25, pS453, DOI 10.1590/S0102-311X2009001500010; Lynge E, 1997, IARC Sci Publ, P353; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Nakaya N, 2010, AM J EPIDEMIOL, V172, P377, DOI 10.1093/aje/kwq046; Nielsen ML, 2002, WORK STRESS, V16, P191, DOI 10.1080/02678370210164003; Nielsen ML, 2004, WORK STRESS, V18, P323, DOI 10.1080/02678370412331324806; Nielsen NR, 2005, BRIT MED J, V331, P548, DOI 10.1136/bmj.38547.638183.06; Nyberg ST, 2012, J INTERN MED, V272, P65, DOI 10.1111/j.1365-2796.2011.02482.x; Peter R, 1998, J EPIDEMIOL COMMUN H, V52, P540, DOI 10.1136/jech.52.9.540; Russ TC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4933; Schernhammer ES, 2004, AM J EPIDEMIOL, V160, P1079, DOI 10.1093/aje/kwh327; SPIEGELMAN D, 1985, JNCI-J NATL CANCER I, V75, P813, DOI 10.1093/jnci/75.5.813; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430; Vaananen A, 2009, PREV MED, V49, P142, DOI 10.1016/j.ypmed.2009.06.026; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Weinberg RA, 2007, GARLAND SCI; WHO, 2012, EUCAN CANC FACTSH; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Zins M, 2009, ADV LIFE COURSE RES, V14, P135, DOI 10.1016/j.alcr.2010.02.003; [No title captured]	58	84	85	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2013	346								f165	10.1136/bmj.f165	http://dx.doi.org/10.1136/bmj.f165			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AV	23393080	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-28	WOS:000314807100002
J	Ford, AC; Moayyedi, P; Hanauer, SB				Ford, Alexander C.; Moayyedi, Paul; Hanauer, Steven B.			Ulcerative colitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; TOPICAL 5-AMINOSALICYLATES; CROHNS-DISEASE; FOLLOW-UP; INFLIXIMAB; EFFICACY; RISK; MANAGEMENT; PREGNANCY		[Ford, Alexander C.] St James Univ Hosp, Leeds Gastroenterol Inst, Leeds LS9 7TF, W Yorkshire, England; [Ford, Alexander C.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Moayyedi, Paul] McMaster Univ, Med Ctr, Hamilton, ON, Canada; [Hanauer, Steven B.] Univ Chicago, Chicago, IL 60637 USA	Saint James's University Hospital; University of Leeds; McMaster University; University of Chicago	Ford, AC (corresponding author), St James Univ Hosp, Leeds Gastroenterol Inst, Leeds LS9 7TF, W Yorkshire, England.	alexf12399@yahoo.com	Moayyedi, Paul/M-6178-2014; Ford, Alexander/K-5491-2012	Moayyedi, Paul/0000-0002-3616-9292; Ford, Alexander/0000-0001-6371-4359	Shire Pharmaceuticals; MSD; Ferring; Abbott; Warner-Chilcott; Janssen	Shire Pharmaceuticals; MSD; Ferring(Ferring Pharmaceuticals); Abbott(Abbott Laboratories); Warner-Chilcott; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; ACF has received speaker's fees from Shire Pharmaceuticals and MSD; PM has received speaker's fees from Shire Pharmaceuticals; SBH has consulted for Shire, Ferring, Abbott, Warner-Chilcott, and Janssen and has received speaker's fees from Ferring, Abbott, Warner-Chilcott, and Janssen.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Angelberger S, 2011, J CROHNS COLITIS, V5, P95, DOI 10.1016/j.crohns.2010.10.005; Bernklev T, 2006, INFLAMM BOWEL DIS, V12, P402, DOI 10.1097/01.MIB.0000218762.61217.4a; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Christensen LA, 2008, ALIMENT PHARM THER, V28, P1209, DOI 10.1111/j.1365-2036.2008.03843.x; Cleary BJ, 2009, BIRTH DEFECTS RES A, V85, P647, DOI 10.1002/bdra.20583; Cornish J, 2007, GUT, V56, P830, DOI 10.1136/gut.2006.108324; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Deepak P, 2013, AM J GASTROENTEROL, V108, P99, DOI 10.1038/ajg.2012.334; Feagan BG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000543.pub3; Feagan BG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000544.pub3; Ford AC, 2012, CLIN GASTROENTEROL H, V10, P513, DOI 10.1016/j.cgh.2011.10.043; Ford AC, 2012, AM J GASTROENTEROL, V107, P167, DOI 10.1038/ajg.2011.410; Ford AC, 2011, AM J GASTROENTEROL, V106, P2070, DOI 10.1038/ajg.2011.296; Ford AC, 2011, AM J GASTROENTEROL, V106, P601, DOI 10.1038/ajg.2011.67; Ford AC, 2011, AM J GASTROENTEROL, V106, P644, DOI 10.1038/ajg.2011.73; Ford AC, 2011, AM J GASTROENTEROL, V106, P590, DOI 10.1038/ajg.2011.70; Heikens JT, 2012, COLORECTAL DIS, V14, P536, DOI 10.1111/j.1463-1318.2010.02538.x; Henriksen M, 2006, SCAND J GASTROENTERO, V41, P1037, DOI 10.1080/00365520600554527; Holubar SD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001176.pub2; Ilnyckyj A, 1999, AM J GASTROENTEROL, V94, P3274, DOI 10.1111/j.1572-0241.1999.01537.x; Jarnerot G, 2005, GASTROENTEROLOGY, V128, P1805, DOI 10.1053/j.gastro.2005.03.003; Jess T, 2013, CLIN GASTROENTEROL H, V11, P43, DOI 10.1016/j.cgh.2012.09.026; Jess T, 2012, GASTROENTEROLOGY, V143, P375, DOI 10.1053/j.gastro.2012.04.016; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Kane SV, 2006, ALIMENT PHARM THER, V23, P577, DOI 10.1111/j.1365-2036.2006.02809.x; Kane SV, 2001, AM J GASTROENTEROL, V96, P2929; Kennedy AP, 2004, GUT, V53, P1639, DOI 10.1136/gut.2003.034256; Khan KJ, 2011, AM J GASTROENTEROL, V106, P630, DOI 10.1038/ajg.2011.64; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Laharie D, 2012, LANCET, V380, P1909, DOI 10.1016/S0140-6736(12)61084-8; LANGHOLZ E, 1994, GASTROENTEROLOGY, V107, P3, DOI 10.1016/0016-5085(94)90054-X; Langholz E, 1996, SCAND J GASTROENTERO, V31, P260, DOI 10.3109/00365529609004876; LEWIS NR, 2007, GUIDELINES OSTEOPORO; Lichtenstein GR, 2012, AM J GASTROENTEROL, V107, P1409, DOI 10.1038/ajg.2012.218; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; Marshall JK, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004115.pub2; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Moody GA, 1997, ALIMENT PHARM THERAP, V11, P999; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; National Institute for Health and Clinical Excellence, 2008, INFL AC EX ULC COL; Neurath MF, 2012, GUT, V61, P1619, DOI 10.1136/gutjnl-2012-302830; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Probert CSJ, 2003, GUT, V52, P998, DOI 10.1136/gut.52.7.998; Rahimi R, 2008, REPROD TOXICOL, V25, P271, DOI 10.1016/j.reprotox.2007.11.010; Rajaratnam SG, 2011, INT J COLORECTAL DIS, V26, P1365, DOI 10.1007/s00384-011-1274-9; Reddy D, 2008, AM J GASTROENTEROL, V103, P1203, DOI 10.1111/j.1572-0241.2007.01756.x; Reinisch W, 2011, GUT, V60, P780, DOI 10.1136/gut.2010.221127; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Sands BE, 2001, INFLAMM BOWEL DIS, V7, P83, DOI 10.1097/00054725-200105000-00001; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Solberg IC, 2009, SCAND J GASTROENTERO, V44, P431, DOI 10.1080/00365520802600961; Talley NJ, 2011, AM J GASTROENTEROL, V106, pS2, DOI 10.1038/ajg.2011.58; Targownik LE, 2012, AM J GASTROENTEROL, V107, P1228, DOI 10.1038/ajg.2012.127; Travis SPL, 2008, J CROHNS COLITIS, V2, P24, DOI 10.1016/j.crohns.2007.11.002; Vavricka SR, 2011, AM J GASTROENTEROL, V106, P110, DOI 10.1038/ajg.2010.343	57	101	108	1	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2013	346								f432	10.1136/bmj.f432	http://dx.doi.org/10.1136/bmj.f432			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088AR	23386404				2022-12-28	WOS:000314806700007
J	Chaudhuri, M				Chaudhuri, Mohuya			What can India do about dengue fever?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mohuya.chaudhuri@gmail.com						[Anonymous], DENG CAS DEATHS COUN; Bush KF, 2011, ENVIRON HEALTH PERSP, V119, P765, DOI 10.1289/ehp.1003000; Duggal R., PRIVATE HLTH SECTOR; Nature, 2021, NATURE; Sankari T, 2012, INDIAN J MED RES, V136, P649; Singh PK, 2012, J VECTOR DIS, V49, P55	6	3	3	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2013	346								f643	10.1136/bmj.f643	http://dx.doi.org/10.1136/bmj.f643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AL	23381202				2022-12-28	WOS:000314806100009
J	Kouwer, PHJ; Koepf, M; Le Sage, VAA; Jaspers, M; van Buul, AM; Eksteen-Akeroyd, ZH; Woltinge, T; Schwartz, E; Kitto, HJ; Hoogenboom, R; Picken, SJ; Nolte, RJM; Mendes, E; Rowan, AE				Kouwer, Paul H. J.; Koepf, Matthieu; Le Sage, Vincent A. A.; Jaspers, Maarten; van Buul, Arend M.; Eksteen-Akeroyd, Zaskia H.; Woltinge, Tim; Schwartz, Erik; Kitto, Heather J.; Hoogenboom, Richard; Picken, Stephen J.; Nolte, Roeland J. M.; Mendes, Eduardo; Rowan, Alan E.			Responsive biomimetic networks from polyisocyanopeptide hydrogels	NATURE			English	Article							ELASTICITY; MEDICINE; ACTIN	Mechanical responsiveness is essential to all biological systems down to the level of tissues and cells(1,2). The intra- and extracellular mechanics of such systems are governed by a series of proteins, such as microtubules, actin, intermediate filaments and collagen(3,4). As a general design motif, these proteins self-assemble into helical structures and superstructures that differ in diameter and persistence length to cover the full mechanical spectrum(1). Gels of cytoskeletal proteins display particular mechanical responses (stress stiffening) that until now have been absent in synthetic polymeric and low-molar-mass gels. Here we present synthetic gels that mimic in nearly all aspects gels prepared from intermediate filaments. They are prepared from polyisocyanopeptides(5-7) grafted with oligo(ethylene glycol) side chains. These responsive polymers possess a stiff and helical architecture, and show a tunable thermal transition where the chains bundle together to generate transparent gels at extremely low concentrations. Using characterization techniques operating at different length scales (for example, macroscopic rheology, atomic force microscopy and molecular force spectroscopy) combined with an appropriate theoretical network model(8-10), we establish the hierarchical relationship between the bulk mechanical properties and the single-molecule parameters. Our results show that to develop artificial cytoskeletal or extracellular matrix mimics, the essential design parameters are not only the molecular stiffness, but also the extent of bundling. In contrast to the peptidic materials, our polyisocyanide polymers are readily modified, giving a starting point for functional biomimetic hydrogels with potentially a wide variety of applications(11-14), in particular in the biomedical field.	[Kouwer, Paul H. J.; Koepf, Matthieu; Le Sage, Vincent A. A.; Jaspers, Maarten; van Buul, Arend M.; Eksteen-Akeroyd, Zaskia H.; Woltinge, Tim; Schwartz, Erik; Kitto, Heather J.; Hoogenboom, Richard; Nolte, Roeland J. M.; Rowan, Alan E.] Radboud Univ Nijmegen, Inst Mol & Mat, Dept Mol Mat, NL-6525 AJ Nijmegen, Netherlands; [Picken, Stephen J.; Mendes, Eduardo] Delft Univ Technol, Dept NanoStruct Mat, NL-2628 BL Delft, Netherlands	Radboud University Nijmegen; Delft University of Technology	Kouwer, PHJ (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Dept Mol Mat, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	p.kouwer@science.ru.nl; a.rowan@science.ru.nl	Schwartz, Erik/C-7346-2011; Kouwer, Paul H. J./B-4847-2008; Schwartz, Erik/AAS-9329-2021; Mendes, Eduardo/K-7280-2012; Nolte, Roeland/C-9930-2013; Hoogenboom, Richard/B-8977-2008; Rowan, Alan E/F-9702-2015; Eksteen-Akeroyd, Zaskia H/F-2179-2015	Kouwer, Paul H. J./0000-0002-2760-191X; Mendes, Eduardo/0000-0002-7519-0668; Nolte, Roeland/0000-0002-5612-7815; Hoogenboom, Richard/0000-0001-7398-2058; Rowan, Alan E/0000-0003-0728-3851; Eksteen-Akeroyd, Zaskia H/0000-0002-5999-3110; Picken, Stephen/0000-0002-6003-518X	Technology Foundation STW; Council for the Chemical Sciences of the Netherlands Organisation for Scientific Research [NWO-CW-7005644]; NRSCC; Royal Academy for Arts and Sciences; EU [PITN-CT-2007-215851, PITN-CT-2009-238177]	Technology Foundation STW(Technologiestichting STW); Council for the Chemical Sciences of the Netherlands Organisation for Scientific Research; NRSCC; Royal Academy for Arts and Sciences; EU(European Commission)	We thank B. Norder for assistance with rheological experiments, C. Broersz for support with nonlinear rheology, F. MacKintosh for discussions on the interpretation of the semi-flexible polymer network theory and E. Cator for work on the statistical analysis of the AFM images. We acknowledge financial support from Technology Foundation STW, the Council for the Chemical Sciences of the Netherlands Organisation for Scientific Research (NWO-CW-7005644), NRSCC, the Royal Academy for Arts and Sciences and EU projects Hierarchy (PITN-CT-2007-215851) and Superior (PITN-CT-2009-238177).	Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743; Broedersz CP, 2011, SOFT MATTER, V7, P3186, DOI 10.1039/c0sm01004a; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cornelissen JJLM, 2001, SCIENCE, V293, P676, DOI 10.1126/science.1062224; Fernandez P, 2006, BIOPHYS J, V90, P3796, DOI 10.1529/biophysj.105.072215; Fernandez-Gonzalez R, 2012, CELL, V149, P965, DOI 10.1016/j.cell.2012.05.006; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Grason GM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098101; Han S, 2003, MACROMOLECULES, V36, P8312, DOI 10.1021/ma0347971; Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022; Huisman EM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208103; Kamm R. D., 2006, CYTOSKELETAL MECH MO, P1; Keereweer B, 2011, FUNCTIONAL SUPRAMOLE, V1, P135; Leterrier JF, 1996, J BIOL CHEM, V271, P15687, DOI 10.1074/jbc.271.26.15687; Lin YC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058101; Lutz JF, 2006, MACROMOLECULES, V39, P893, DOI 10.1021/ma0517042; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mason TG, 1998, MACROMOLECULES, V31, P3600, DOI 10.1021/ma970564w; Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Rowan A. E, 2011, European Patent, Patent No. [2,287,221, 2287221]; Schwartz E, 2010, CHEM SOC REV, V39, P1576, DOI 10.1039/b922160c; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Tiller JC, 2003, ANGEW CHEM INT EDIT, V42, P3072, DOI 10.1002/anie.200301647; Van Buul A. M, CHEM SCI UNPUB; Wang HM, 2011, SOFT MATTER, V7, P3897, DOI 10.1039/c0sm01405b	28	349	358	31	857	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					651	655		10.1038/nature11839	http://dx.doi.org/10.1038/nature11839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23354048	Green Published			2022-12-28	WOS:000314219600052
J	Willis, MS; Patterson, C				Willis, Monte S.; Patterson, Cam			Mechanisms of Disease Proteotoxicity and Cardiac Dysfunction - Alzheimer's Disease of the Heart?	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ALPHA-B-CRYSTALLIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-PROTEIN INTERACTIONS; MUSCLE RING FINGER-1; ISCHEMIA/REPERFUSION INJURY; AUTOPHAGIC DEGENERATION; PREAMYLOID OLIGOMER; TRANSGENIC MODEL; COMMON MECHANISM; TAU AGGREGATION		[Willis, Monte S.; Patterson, Cam] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Willis, Monte S.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Patterson, Cam] Univ N Carolina, Dept Med, Cardiol Sect, Chapel Hill, NC USA; [Patterson, Cam] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Patterson, Cam] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Patterson, C (corresponding author), Dept Internal Med, Div Cardiol, 8200 Med Biomol Res Bldg, Chapel Hill, NC 27599 USA.	cpatters@med.unc.edu	Willis, Monte S/J-9994-2015	Willis, Monte S/0000-0002-0769-5816	NHLBI NIH HHS [R01 HL104129] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104129] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Boudrez H, 2000, ACTA CARDIOL, V55, P341, DOI 10.2143/AC.55.6.2005765; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Buschert V, 2010, NAT REV NEUROL, V6, P508, DOI 10.1038/nrneurol.2010.113; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; COLE DR, 1954, CIRCULATION, V9, P321, DOI 10.1161/01.CIR.9.3.321; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Crowe A, 2007, BIOCHEM BIOPH RES CO, V358, P1, DOI 10.1016/j.bbrc.2007.03.056; David R, 2012, PHYSIOLOGY, V27, P119, DOI 10.1152/physiol.00044.2011; DECKER RS, 1980, AM J PATHOL, V98, P425; den Engelsman J, 2003, J BIOL CHEM, V278, P4699, DOI 10.1074/jbc.M211403200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; DIMOND GE, 1961, CIRCULATION, V23, P881, DOI 10.1161/01.CIR.23.6.881; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Douglas PM, 2009, PRION, V3, P51, DOI 10.4161/pri.3.2.8587; Fatouros C, 2012, HUM MOL GENET, V21, P3587, DOI 10.1093/hmg/dds190; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Finsterer J, 2008, SCAND CARDIOVASC J, V42, P9, DOI 10.1080/14017430701854953; Fu L, 2003, INVEST OPHTH VIS SCI, V44, P1155, DOI 10.1167/iovs.02-0950; Fu L, 2002, J BIOL CHEM, V277, P4255, DOI 10.1074/jbc.M110027200; Golenhofen N, 2002, J MOL CELL CARDIOL, V34, P309, DOI 10.1006/jmcc.2001.1513; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HERSHKO A, 1981, J BIOL CHEM, V256, P1525; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; Ho L, 2010, EXPERT REV PROTEOMIC, V7, P579, DOI 10.1586/EPR.10.69; Huang CQ, 2010, J CARDIOVASC TRANSL, V3, P365, DOI 10.1007/s12265-010-9189-3; Huang CQ, 2010, AM J PHYSIOL-HEART C, V298, pH570, DOI 10.1152/ajpheart.00716.2009; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; KARIM MA, 1991, AM J PHYSIOL, V260, pC316, DOI 10.1152/ajpcell.1991.260.2.C316; Kassiotis C, 2009, CIRCULATION, V120, pS191, DOI 10.1161/CIRCULATIONAHA.108.842252; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Kumarapeli ARK, 2004, J MOL CELL CARDIOL, V37, P1097, DOI 10.1016/j.yjmcc.2004.07.004; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2011, J CLIN INVEST, V121, P3689, DOI 10.1172/JCI45709; Lu LH, 2009, INT J CARDIOL, V134, P82, DOI 10.1016/j.ijcard.2008.01.043; Lubamba B, 2012, CLIN BIOCHEM, V45, P1132, DOI 10.1016/j.clinbiochem.2012.05.034; Lublin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027762; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Maesako M, 2012, J BIOL CHEM, V287, P23024, DOI 10.1074/jbc.M112.367011; MAGID NM, 1993, CARDIOLOGY, V82, P20, DOI 10.1159/000175849; Maloyan A, 2007, P NATL ACAD SCI USA, V104, P5995, DOI 10.1073/pnas.0609202104; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mohamed BA, 2012, J MOL CELL CARDIOL, V53, P459, DOI 10.1016/j.yjmcc.2012.07.014; Nowis D, 2010, AM J PATHOL, V176, P2658, DOI 10.2353/ajpath.2010.090690; Ooie T, 2001, CIRCULATION, V104, P1837, DOI 10.1161/hc3901.095771; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Pattison JS, 2008, CIRCULATION, V117, P2743, DOI 10.1161/CIRCULATIONAHA.107.750232; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; PREEDY VR, 1984, BIOCHEM J, V222, P395, DOI 10.1042/bj2220395; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; Rodriguez JE, 2009, CURR HYPERTENS REP, V11, P396, DOI 10.1007/s11906-009-0069-7; Roger, 2011, CIRCULATION, V124, pE426, DOI 10.1161/CIR.0b013e3182365a06; Roger, 2011, CIRCULATION, V123, pE240, DOI 10.1161/CIR.0b013e3182117650; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saijo M, 2004, INTERNAL MED, V43, P700, DOI 10.2169/internalmedicine.43.700; SAMAREL AM, 1987, CIRC RES, V60, P933, DOI 10.1161/01.RES.60.6.933; Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Shimomura H, 2001, JPN CIRC J, V65, P965, DOI 10.1253/jcj.65.965; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Tian ZW, 2012, CIRC RES, V111, P532, DOI 10.1161/CIRCRESAHA.112.270983; Tsunemi T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003799; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vos MJ, 2009, BBA-MOL CELL RES, V1793, P1929, DOI 10.1016/j.bbamcr.2009.10.005; Wang XJ, 2003, CIRC RES, V93, P998, DOI 10.1161/01.RES.0000102401.77712.ED; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Wang XJ, 2001, CIRCULATION, V103, P2402, DOI 10.1161/01.cir.103.19.2402; WEISS MM, 1956, AM J MED SCI, V231, P9, DOI 10.1097/00000441-195601000-00002; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Willis MS, 2009, CIRC RES, V105, P80, DOI 10.1161/CIRCRESAHA.109.194928; Willis MS, 2009, CARDIOVASC RES, V81, P439, DOI 10.1093/cvr/cvn289; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zhang HL, 2010, J MOL CELL CARDIOL, V49, P918, DOI 10.1016/j.yjmcc.2010.09.004	93	195	198	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					455	464		10.1056/NEJMra1106180	http://dx.doi.org/10.1056/NEJMra1106180			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BE	23363499				2022-12-28	WOS:000314215400010
J	Dahl-Jensen, D; Albert, MR; Aldahan, A; Azuma, N; Balslev-Clausen, D; Baumgartner, M; Berggren, AM; Bigler, M; Binder, T; Blunier, T; Bourgeois, JC; Brook, EJ; Buchardt, SL; Buizert, C; Capron, E; Chappellaz, J; Chung, J; Clausen, HB; Cvijanovic, I; Davies, SM; Ditlevsen, P; Eicher, O; Fischer, H; Fisher, DA; Fleet, LG; Gfeller, G; Gkinis, V; Gogineni, S; Goto-Azuma, K; Grinsted, A; Gudlaugsdottir, H; Guillevic, M; Hansen, SB; Hansson, M; Hirabayashi, M; Hong, S; Hur, SD; Huybrechts, P; Hvidberg, CS; Iizuka, Y; Jenk, T; Johnsen, SJ; Jones, TR; Jouzel, J; Karlsson, NB; Kawamura, K; Keegan, K; Kettner, E; Kipfstuhl, S; Kjaer, HA; Koutnik, M; Kuramoto, T; Kohler, P; Laepple, T; Landais, A; Langen, PL; Larsen, LB; Leuenberger, D; Leuenberger, M; Leuschen, C; Li, J; Lipenkov, V; Martinerie, P; Maselli, OJ; Masson-Delmotte, V; McConnell, JR; Miller, H; Mini, O; Miyamoto, A; Montagnat-Rentier, M; Mulvaney, R; Muscheler, R; Orsi, AJ; Paden, J; Panton, C; Pattyn, F; Petit, JR; Pol, K; Popp, T; Possnert, G; Prie, F; Prokopiou, M; Quiquet, A; Rasmussen, SO; Raynaud, D; Ren, J; Reutenauer, C; Ritz, C; Rockmann, T; Rosen, JL; Rubino, M; Rybak, O; Samyn, D; Sapart, CJ; Schilt, A; Schmidt, AMZ; Schwander, J; Schupbach, S; Seierstad, I; Severinghaus, JP; Sheldon, S; Simonsen, SB; Sjolte, J; Solgaard, AM; Sowers, T; Sperlich, P; Steen-Larsen, HC; Steffen, K; Steffensen, JP; Steinhage, D; Stocker, TF; Stowasser, C; Sturevik, AS; Sturges, WT; Sveinbjornsdottir, A; Svensson, A; Tison, JL; Uetake, J; Vallelonga, P; van de Wal, RSW; van der Wel, G; Vaughn, BH; Vinther, B; Waddington, E; Wegner, A; Weikusat, I; White, JWC; Wilhelms, F; Winstrup, M; Witrant, E; Wolff, EW; Xiao, C; Zheng, J				Dahl-Jensen, D.; Albert, M. R.; Aldahan, A.; Azuma, N.; Balslev-Clausen, D.; Baumgartner, M.; Berggren, A. -M.; Bigler, M.; Binder, T.; Blunier, T.; Bourgeois, J. C.; Brook, E. J.; Buchardt, S. L.; Buizert, C.; Capron, E.; Chappellaz, J.; Chung, J.; Clausen, H. B.; Cvijanovic, I.; Davies, S. M.; Ditlevsen, P.; Eicher, O.; Fischer, H.; Fisher, D. A.; Fleet, L. G.; Gfeller, G.; Gkinis, V.; Gogineni, S.; Goto-Azuma, K.; Grinsted, A.; Gudlaugsdottir, H.; Guillevic, M.; Hansen, S. B.; Hansson, M.; Hirabayashi, M.; Hong, S.; Hur, S. D.; Huybrechts, P.; Hvidberg, C. S.; Iizuka, Y.; Jenk, T.; Johnsen, S. J.; Jones, T. R.; Jouzel, J.; Karlsson, N. B.; Kawamura, K.; Keegan, K.; Kettner, E.; Kipfstuhl, S.; Kjaer, H. A.; Koutnik, M.; Kuramoto, T.; Koehler, P.; Laepple, T.; Landais, A.; Langen, P. L.; Larsen, L. B.; Leuenberger, D.; Leuenberger, M.; Leuschen, C.; Li, J.; Lipenkov, V.; Martinerie, P.; Maselli, O. J.; Masson-Delmotte, V.; McConnell, J. R.; Miller, H.; Mini, O.; Miyamoto, A.; Montagnat-Rentier, M.; Mulvaney, R.; Muscheler, R.; Orsi, A. J.; Paden, J.; Panton, C.; Pattyn, F.; Petit, J. -R.; Pol, K.; Popp, T.; Possnert, G.; Prie, F.; Prokopiou, M.; Quiquet, A.; Rasmussen, S. O.; Raynaud, D.; Ren, J.; Reutenauer, C.; Ritz, C.; Rockmann, T.; Rosen, J. L.; Rubino, M.; Rybak, O.; Samyn, D.; Sapart, C. J.; Schilt, A.; Schmidt, A. M. Z.; Schwander, J.; Schuepbach, S.; Seierstad, I.; Severinghaus, J. P.; Sheldon, S.; Simonsen, S. B.; Sjolte, J.; Solgaard, A. M.; Sowers, T.; Sperlich, P.; Steen-Larsen, H. C.; Steffen, K.; Steffensen, J. P.; Steinhage, D.; Stocker, T. F.; Stowasser, C.; Sturevik, A. S.; Sturges, W. T.; Sveinbjornsdottir, A.; Svensson, A.; Tison, J. -L.; Uetake, J.; Vallelonga, P.; van de Wal, R. S. W.; van der Wel, G.; Vaughn, B. H.; Vinther, B.; Waddington, E.; Wegner, A.; Weikusat, I.; White, J. W. C.; Wilhelms, F.; Winstrup, M.; Witrant, E.; Wolff, E. W.; Xiao, C.; Zheng, J.		NEEM Community	Eemian interglacial reconstructed from a Greenland folded ice core	NATURE			English	Article							ANTARCTIC ICE; AIR CONTENT; SEA-LEVEL; CLIMATE; RECORD; TEMPERATURE; SHEET; GRIP; VARIABILITY; DELTA-O-18	Efforts to extract a Greenland ice core with a complete record of the Eemian interglacial (130,000 to 115,000 years ago) have until now been unsuccessful. The response of the Greenland ice sheet to the warmer-than-present climate of the Eemian has thus remained unclear. Here we present the new North Greenland Eemian Ice Drilling ('NEEM') ice core and show only a modest ice-sheet response to the strong warming in the early Eemian. We reconstructed the Eemian record from folded ice using globally homogeneous parameters known from dated Greenland and Antarctic ice-core records. On the basis of water stable isotopes, NEEM surface temperatures after the onset of the Eemian (126,000 years ago) peaked at 8 +/- 4 degrees Celsius above the mean of the past millennium, followed by a gradual cooling that was probably driven by the decreasing summer insolation. Between 128,000 and 122,000 years ago, the thickness of the northwest Greenland ice sheet decreased by 400 +/- 250 metres, reaching surface elevations 122,000 years ago of 130 +/- 300 metres lower than the present. Extensive surface melt occurred at the NEEM site during the Eemian, a phenomenon witnessed when melt layers formed again at NEEM during the exceptional heat of July 2012. With additional warming, surface melt might become more common in the future.	[Dahl-Jensen, D.; Balslev-Clausen, D.; Blunier, T.; Buchardt, S. L.; Buizert, C.; Clausen, H. B.; Cvijanovic, I.; Ditlevsen, P.; Gkinis, V.; Grinsted, A.; Guillevic, M.; Hansen, S. B.; Hvidberg, C. S.; Jenk, T.; Johnsen, S. J.; Karlsson, N. B.; Kettner, E.; Kjaer, H. A.; Langen, P. L.; Larsen, L. B.; Panton, C.; Popp, T.; Rasmussen, S. O.; Reutenauer, C.; Rubino, M.; Schmidt, A. M. Z.; Seierstad, I.; Sheldon, S.; Simonsen, S. B.; Sjolte, J.; Solgaard, A. M.; Sperlich, P.; Steffensen, J. P.; Stowasser, C.; Svensson, A.; Vallelonga, P.; Vinther, B.; Winstrup, M.] Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, DK-2100 Copenhagen K, Denmark; [Albert, M. R.; Keegan, K.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Aldahan, A.; Berggren, A. -M.; Samyn, D.; Sturevik, A. S.] Uppsala Univ, Dept Earth Sci, S-75236 Uppsala, Sweden; [Azuma, N.; Samyn, D.] Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan; [Baumgartner, M.; Bigler, M.; Eicher, O.; Fischer, H.; Gfeller, G.; Leuenberger, D.; Leuenberger, M.; Mini, O.; Schilt, A.; Schwander, J.; Schuepbach, S.; Stocker, T. F.; van der Wel, G.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Baumgartner, M.; Bigler, M.; Eicher, O.; Fischer, H.; Gfeller, G.; Leuenberger, D.; Leuenberger, M.; Mini, O.; Schilt, A.; Schwander, J.; Schuepbach, S.; Stocker, T. F.; van der Wel, G.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Binder, T.] Heidelberg Univ, IWR, D-69115 Heidelberg, Germany; [Bourgeois, J. C.; Fisher, D. A.; Zheng, J.] Geol Survey Canada, Nat Resources Canada, Ottawa, ON K1A 0E8, Canada; [Brook, E. J.; Buizert, C.; Rosen, J. L.; Schilt, A.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Capron, E.; Guillevic, M.; Jouzel, J.; Landais, A.; Masson-Delmotte, V.; Pol, K.; Prie, F.] CEA CNRS UVSQ, CEA Saclay, Lab Sci Climat & Environm, IPSL, F-91191 Gif Sur Yvette, France; [Capron, E.; Fleet, L. G.; Mulvaney, R.; Pol, K.; Wolff, E. W.] British Antarctic Survey, Cambridge CB3 0ET, England; [Chappellaz, J.; Martinerie, P.; Montagnat-Rentier, M.; Petit, J. -R.; Quiquet, A.; Raynaud, D.; Ritz, C.] UJF Grenoble 1, CNRS, LGGE, F-38402 St Martin Dheres, France; [Chung, J.; Hur, S. D.] Korea Polar Res Inst, Inchon 406840, South Korea; [Davies, S. M.] Swansea Univ, Coll Sci, Dept Geog, Swansea SA2 8PP, W Glam, Wales; [Gkinis, V.; Jones, T. R.; Vaughn, B. H.; White, J. W. C.] Univ Colorado, INSTAAR, Boulder, CO 80309 USA; [Gogineni, S.; Leuschen, C.; Li, J.; Paden, J.] Univ Kansas, CReSIS, Lawrence, KS 66045 USA; [Goto-Azuma, K.; Hirabayashi, M.; Kawamura, K.; Kuramoto, T.; Uetake, J.] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Gudlaugsdottir, H.; Sveinbjornsdottir, A.] Univ Iceland, Inst Earth & Sci, IS-107 Reykjavik, Iceland; [Hansson, M.; Iizuka, Y.] Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden; [Hong, S.; Steen-Larsen, H. C.] Inha Univ, Dept Ocean Sci, Inchon 402751, South Korea; [Huybrechts, P.; Rybak, O.] Vrije Univ Brussel, Dept Geog, B-1050 Brussels, Belgium; [Kuramoto, T.] Shinshu Univ, Inst Mt Sci, Matsumoto, Nagano 3908621, Japan; [Kipfstuhl, S.; Koehler, P.; Laepple, T.; Miller, H.; Steinhage, D.; Wegner, A.; Weikusat, I.; Wilhelms, F.] Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; [Koutnik, M.; Waddington, E.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Lipenkov, V.] Arctic & Antarctic Res Inst, St Petersburg 199397, Russia; [Maselli, O. J.; McConnell, J. R.] Nevada Syst Higher Educ, Desert Res Inst, Reno, NV 89512 USA; [Iizuka, Y.; Miyamoto, A.] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Muscheler, R.; Sjolte, J.] Lund Univ, Dept Geol, SE-22362 Lund, Sweden; [Orsi, A. J.; Severinghaus, J. P.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Pattyn, F.; Tison, J. -L.] Univ Libre Bruxelles, Lab Glaciol, B-1050 Brussels, Belgium; [Possnert, G.] Uppsala Univ, Tandem Lab, S-75120 Uppsala, Sweden; [Prokopiou, M.; Rockmann, T.; Sapart, C. J.; van de Wal, R. S. W.] Univ Utrecht, Inst Marine & Atmospher Res Utrecht IMAU, NL-3584 CC Utrecht, Netherlands; [Ren, J.; Xiao, C.] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryospher Sci, Lanzhou 730000, Peoples R China; [Rubino, M.] CSIRO Marine & Atmospher Res, Ctr Australian Weather & Climate Res, Aspendale, Vic 3195, Australia; [Sowers, T.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Steffen, K.] Univ Colorado, CIRES, Boulder, CO 80309 USA; [Sturges, W. T.] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Witrant, E.] UJF Grenoble 1, Grenoble Image Parole Signal Automat GIPSA Lab, CNRS, UMR 5216, F-38402 St Martin Dheres, France; [Xiao, C.] Chinese Acad Meteorol Sci, China Inst Climate Syst, Beijing 100081, Peoples R China	University of Copenhagen; Niels Bohr Institute; Dartmouth College; Uppsala University; Nagaoka University of Technology; University of Bern; University of Bern; Ruprecht Karls University Heidelberg; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; Oregon State University; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Swansea University; University of Colorado System; University of Colorado Boulder; University of Kansas; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; University of Iceland; Stockholm University; Inha University; Vrije Universiteit Brussel; Shinshu University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Washington; University of Washington Seattle; Arctic & Antarctic Research Institute; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Hokkaido University; Lund University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Universite Libre de Bruxelles; Uppsala University; Utrecht University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Colorado System; University of Colorado Boulder; University of East Anglia; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Chinese Academy of Meteorological Sciences (CAMS)	Dahl-Jensen, D (corresponding author), Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, Juliane Maries Vej 30, DK-2100 Copenhagen K, Denmark.	ddj@gfy.ku.dk	Winstrup, Mai/M-5844-2014; Jenk, Theo M/D-5777-2017; Köhler, Peter/F-7293-2010; Karlsson, Nanna B. B./M-4519-2014; Brook, Edward/AAB-7807-2021; Quiquet, Aurélien/P-6180-2014; Cvijanovic, Ivana/D-9886-2018; Vaughn, Bruce/AAO-8867-2020; Karlsson, Nanna Bjørnholt/G-4621-2018; Masson-Delmotte, Valerie L/G-1995-2011; Wolff, Eric W/D-7925-2014; Hvidberg, Christine S./E-8934-2015; Wolff, Eric/AAB-1097-2021; Rasmussen, Sune/B-5560-2008; Davies, Siwan M/E-6915-2011; Rubino, Mauro/Q-5578-2016; Pattyn, Frank/AAA-9640-2019; White, James W.C./A-7845-2009; Sjolte, Jesper/O-2942-2016; clausen, henrik/AAD-8016-2021; Rasmussen, Sune Olander/AAA-3190-2021; Blunier, Thomas/M-4609-2014; Stocker, Thomas/B-1273-2013; Svensson, Anders/A-2643-2010; Kjær, Helle Astrid/HGC-7941-2022; Solgaard, Anne/H-2042-2018; Fischer, Hubertus/A-1211-2014; Sjolte, Jesper/N-7833-2019; Panton, Christian/M-6045-2014; Steen-Larsen, Hans Christian/F-9927-2013; Leuenberger, Markus C/K-9655-2016; Langen, Peter L/AAR-1120-2021; Weikusat, Ilka/E-8826-2015; Lipenkov, Vladimir Y/Q-8262-2016; Raynaud, Dominique/H-9626-2016; Kjær, Helle Astrid/AHD-2685-2022; Sperlich, Peter/B-4646-2018; Laepple, Thomas/M-8783-2015; Martinerie, Patricia/N-5731-2017; Rybak, Oleg/B-7308-2014; Uetake, Jun/V-4853-2018; Steffen, Konrad/C-6027-2013; Vallelonga, Paul/I-9650-2016; Gkinis, Vasileios/E-8185-2011; Maselli, Olivia/A-6687-2013; Simonsen, Sebastian Bjerregaard/F-4791-2013; Dahl-Jensen, Dorthe/AAO-6951-2020; Chappellaz, Jérôme A./A-4872-2011; Iizuka, Yoshinori/D-9112-2012; Dahl-Jensen, Dorthe/N-4401-2016; Röckmann, Thomas/F-4479-2015; Mulvaney, Robert/K-3929-2012; raynaud, dominique/ABG-4718-2020; Rybak, Oleg/AAQ-8467-2020; van de wal, roderik/D-1705-2011; Grinsted, Aslak/J-9273-2012; Kawamura, Kenji/C-7660-2011; Huybrechts, Philippe/J-5278-2013; Tison, Jean-Louis/F-4065-2015	Winstrup, Mai/0000-0002-4794-4004; Jenk, Theo M/0000-0001-6820-8615; Köhler, Peter/0000-0003-0904-8484; Karlsson, Nanna B. B./0000-0003-0423-8705; Quiquet, Aurélien/0000-0001-6207-3043; Cvijanovic, Ivana/0000-0002-1738-7745; Karlsson, Nanna Bjørnholt/0000-0003-0423-8705; Masson-Delmotte, Valerie L/0000-0001-8296-381X; Wolff, Eric W/0000-0002-5914-8531; Hvidberg, Christine S./0000-0002-9665-1339; Wolff, Eric/0000-0002-5914-8531; Rasmussen, Sune/0000-0002-4177-3611; Davies, Siwan M/0000-0003-0999-7233; Pattyn, Frank/0000-0003-4805-5636; White, James W.C./0000-0001-6041-4684; Sjolte, Jesper/0000-0003-0870-5331; Rasmussen, Sune Olander/0000-0002-4177-3611; Blunier, Thomas/0000-0002-6065-7747; Svensson, Anders/0000-0002-4364-6085; Kjær, Helle Astrid/0000-0002-3781-9509; Solgaard, Anne/0000-0002-8693-620X; Fischer, Hubertus/0000-0002-2787-4221; Sjolte, Jesper/0000-0003-0870-5331; Panton, Christian/0000-0003-4438-271X; Steen-Larsen, Hans Christian/0000-0002-7202-5907; Leuenberger, Markus C/0000-0003-4299-6793; Langen, Peter L/0000-0003-2185-012X; Weikusat, Ilka/0000-0002-3023-6036; Lipenkov, Vladimir Y/0000-0003-4221-5440; Kjær, Helle Astrid/0000-0002-3781-9509; Laepple, Thomas/0000-0001-8108-7520; Martinerie, Patricia/0000-0002-6820-2296; Rybak, Oleg/0000-0003-3923-7163; Steffen, Konrad/0000-0001-8658-1026; Vallelonga, Paul/0000-0003-1055-7235; Gkinis, Vasileios/0000-0002-5910-1549; Simonsen, Sebastian Bjerregaard/0000-0001-9569-1294; Dahl-Jensen, Dorthe/0000-0002-1474-1948; Iizuka, Yoshinori/0000-0001-7241-6062; Dahl-Jensen, Dorthe/0000-0002-1474-1948; Röckmann, Thomas/0000-0002-6688-8968; Mulvaney, Robert/0000-0002-5372-8148; Rybak, Oleg/0000-0002-7234-0544; van de wal, roderik/0000-0003-2543-3892; Grinsted, Aslak/0000-0003-1634-6009; LANDAIS, Amaelle/0000-0002-5620-5465; POL, Katy/0000-0002-3467-3698; Vinther, Bo/0000-0002-6078-771X; Kawamura, Kenji/0000-0003-1163-700X; Miller, Heinrich/0000-0003-1015-2828; Albert, Mary/0000-0001-7842-2359; Rubino, Mauro/0000-0002-8721-4508; Sperlich, Peter/0000-0003-1455-0903; Keegan, Kaitlin/0000-0002-1241-2681; Guillevic, Mathieu/0000-0002-0081-785X; Steffensen, Jorgen Peder/0000-0002-5516-1093; VAUGHN, BRUCE/0000-0001-6503-957X; Muscheler, Raimund/0000-0003-2772-3631; Schupbach, Simon/0000-0003-3188-2635; Schilt, Adrian/0000-0001-6312-7947; Sapart, Celia Julia/0000-0003-0745-4825; Huybrechts, Philippe/0000-0003-1406-0525; Buizert, Christo/0000-0002-2227-1747; Ritz, Catherine/0000-0003-0785-8571; Tison, Jean-Louis/0000-0002-9758-3454; Wilhelms, Frank/0000-0001-7688-3135	Belgium (FNRS-CFB); Belgium (FWO); Canada (NRCan/GSC); China (CAS); Denmark (FIST); France (IPEV); France (CNRS/INSU); France (CEA); France (ANR); Germany (AWI); Iceland (RannIs); Japan (NIPR); South Korea (KOPRI); The Netherlands (NWO/ALW); Sweden (VR); Switzerland (SNF); United Kingdom (NERC); USA (US NSF, Office of Polar Programs); EU; Directorate For Geosciences [0806387] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [0806407, 0806377, 0909541] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [22221002, 21671001] Funding Source: KAKEN; Natural Environment Research Council [bas0100024, NE/F020600/1, NE/F021194/1] Funding Source: researchfish; NERC [NE/F020600/1, bas0100024] Funding Source: UKRI	Belgium (FNRS-CFB)(Fonds de la Recherche Scientifique - FNRS); Belgium (FWO)(FWO); Canada (NRCan/GSC)(Natural Resources Canada); China (CAS)(Chinese Academy of Sciences); Denmark (FIST)(Department of Science & Technology (India)); France (IPEV); France (CNRS/INSU); France (CEA); France (ANR)(French National Research Agency (ANR)); Germany (AWI); Iceland (RannIs); Japan (NIPR); South Korea (KOPRI); The Netherlands (NWO/ALW)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Sweden (VR)(Swedish Research Council); Switzerland (SNF); United Kingdom (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); USA (US NSF, Office of Polar Programs); EU(European Commission); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the many persons involved in logistics, drill developments and drilling, and ice-core processing and analysis in the field and in our laboratories. NEEM is directed and organized by the Centre of Ice and Climate at the Niels Bohr Institute and US NSF, Office of Polar Programs. It is supported by funding agencies and institutions in Belgium (FNRS-CFB and FWO), Canada (NRCan/GSC), China (CAS), Denmark (FIST), France (IPEV, CNRS/INSU, CEA and ANR), Germany (AWI), Iceland (RannIs), Japan (NIPR), South Korea (KOPRI), The Netherlands (NWO/ALW), Sweden (VR), Switzerland (SNF), the United Kingdom (NERC) and the USA (US NSF, Office of Polar Programs) and the EU Seventh Framework programmes Past4Future and WaterundertheIce. NASA is acknowledged for the OIB 2011 programme.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Axford Y, 2011, GEOL SOC AM BULL, V123, P1275, DOI 10.1130/B30329.1; AZUMA N, 1984, ANN GLACIOL, V5, P1; Bamber JL, 2001, J GEOPHYS RES-ATMOS, V106, P33773, DOI 10.1029/2001JD900054; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bell RE, 2011, SCIENCE, V331, P1592, DOI 10.1126/science.1200109; BERGER A, 1992, SCIENCE, V255, P560, DOI 10.1126/science.255.5044.560; Born A., 2011, CRYOSPHERE DISCUSS, V5, P3517, DOI [10.5194/tcd-5-3517-2011, DOI 10.5194/TCD-5-3517-2011]; Bradley SL, 2012, GLOBAL PLANET CHANGE, V88-89, P64, DOI 10.1016/j.gloplacha.2012.03.004; Buchardt SL, 2012, CLIM PAST, V8, P2053, DOI 10.5194/cp-8-2053-2012; Buchardt S. L, 2009, THESIS U COPENHAGEN; Buchardt SL, 2008, ANN GLACIOL, V48, P100, DOI 10.3189/172756408784700617; Caillon N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017838; Capron E, 2010, QUATERNARY SCI REV, V29, P222, DOI 10.1016/j.quascirev.2009.07.014; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; Dahl-Jensen D., 1989, ANN GLACIOL, V12, P200; Dahl-Jensen D., 1987, INT ASS HYDROLOGICAL, V170, P31; Dahl-Jensen D., 2011, SNOW WATER ICE PERMA; Dutton A, 2012, SCIENCE, V337, P216, DOI 10.1126/science.1205749; Francis DR, 2006, PALAEOGEOGR PALAEOCL, V236, P107, DOI 10.1016/j.palaeo.2006.01.005; Goujon C, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003319; Huybrechts P, 2007, CLIM PAST, V3, P577, DOI 10.5194/cp-3-577-2007; JACKA TH, 1984, COLD REG SCI TECHNOL, V10, P31, DOI 10.1016/0165-232X(84)90031-4; Johnsen SJ, 2001, J QUATERNARY SCI, V16, P299, DOI 10.1002/jqs.622; Kopp RE, 2009, NATURE, V462, P863, DOI 10.1038/nature08686; Landais A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003147; Leuschen C., 2010, AM GEOPH UN FALL M; Lunt DJ, 2013, CLIM PAST, V9, P699, DOI 10.5194/cp-9-699-2013; MARTINERIE P, 1994, J GEOPHYS RES-ATMOS, V99, P10565, DOI 10.1029/93JD03223; Masson-Delmotte V, 2011, CLIM PAST, V7, P1041, DOI 10.5194/cp-7-1041-2011; Masson-Delmotte V, 2010, P NATL ACAD SCI USA, V107, P12091, DOI 10.1073/pnas.0914536107; Masson-Delmotte V, 2010, QUATERNARY SCI REV, V29, P113, DOI 10.1016/j.quascirev.2009.09.030; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pedro JB, 2011, CLIM PAST, V7, P671, DOI 10.5194/cp-7-671-2011; Raynaud D, 1997, J GEOPHYS RES-OCEANS, V102, P26607, DOI 10.1029/97JC01908; RAYNAUD D, 1979, NATURE, V281, P289, DOI 10.1038/281289a0; Raynaud D, 2007, EARTH PLANET SC LETT, V261, P337, DOI 10.1016/j.epsl.2007.06.025; Rodriguez-Morales F., IEEE T GEOS IN PRESS; Ruth U, 2007, CLIM PAST, V3, P475, DOI 10.5194/cp-3-475-2007; Schilt A, 2010, QUATERNARY SCI REV, V29, P182, DOI 10.1016/j.quascirev.2009.03.011; Severinghaus JP, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000GC000146; Steen-Larsen HC, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014311; Stenni B, 2011, NAT GEOSCI, V4, P46, DOI [10.1038/ngeo1026, 10.1038/NGEO1026]; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Suwa M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006032; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Turney CSM, 2010, J QUATERNARY SCI, V25, P839, DOI 10.1002/jqs.1423; van de Berg WJ, 2011, NAT GEOSCI, V4, P679, DOI [10.1038/ngeo1245, 10.1038/NGEO1245]; Vinther BM, 2009, NATURE, V461, P385, DOI 10.1038/nature08355; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013	50	443	453	9	570	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					489	494		10.1038/nature11789	http://dx.doi.org/10.1038/nature11789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23344358	Green Accepted, Green Submitted			2022-12-28	WOS:000313871400029
J	Thun, MJ; Carter, BD; Feskanich, D; Freedman, ND; Prentice, R; Lopez, AD; Hartge, P; Gapstur, SM				Thun, Michael J.; Carter, Brian D.; Feskanich, Diane; Freedman, Neal D.; Prentice, Ross; Lopez, Alan D.; Hartge, Patricia; Gapstur, Susan M.			50-Year Trends in Smoking-Related Mortality in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CIGARETTE-SMOKING; TOBACCO USE; HEALTH; CANCER; DESIGN; COHORT	Background The disease risks from cigarette smoking increased in the United States over most of the 20th century, first among male smokers and later among female smokers. Whether these risks have continued to increase during the past 20 years is unclear. Methods We measured temporal trends in mortality across three time periods (1959-1965, 1982-1988, and 2000-2010), comparing absolute and relative risks according to sex and self-reported smoking status in two historical cohort studies and in five pooled contemporary cohort studies, among participants who became 55 years of age or older during follow-up. Results For women who were current smokers, as compared with women who had never smoked, the relative risks of death from lung cancer were 2.73, 12.65, and 25.66 in the 1960s, 1980s, and contemporary cohorts, respectively; corresponding relative risks for male current smokers, as compared with men who had never smoked, were 12.22, 23.81, and 24.97. In the contemporary cohorts, male and female current smokers also had similar relative risks for death from chronic obstructive pulmonary disease (COPD) (25.61 for men and 22.35 for women), ischemic heart disease (2.50 for men and 2.86 for women), any type of stroke (1.92 for men and 2.10 for women), and all causes combined (2.80 for men and 2.76 for women). Mortality from COPD among male smokers continued to increase in the contemporary cohorts in nearly all the age groups represented in the study and within each stratum of duration and intensity of smoking. Among men 55 to 74 years of age and women 60 to 74 years of age, all-cause mortality was at least three times as high among current smokers as among those who had never smoked. Smoking cessation at any age dramatically reduced death rates. Conclusions The risk of death from cigarette smoking continues to increase among women and the increased risks are now nearly identical for men and women, as compared with persons who have never smoked. Among men, the risks associated with smoking have plateaued at the high levels seen in the 1980s, except for a continuing, unexplained increase in mortality from COPD.	[Thun, Michael J.] Amer Canc Soc, Natl Home Off, Dept Epidemiol, Atlanta, GA 30303 USA; [Feskanich, Diane] Harvard Univ, Brigham & Womens Hosp, Channing Div Network Med, Dept Med,Med Sch, Boston, MA 02115 USA; [Freedman, Neal D.; Hartge, Patricia] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Prentice, Ross] Fred Hutchison Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA; [Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	American Cancer Society; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; University of Queensland	Thun, MJ (corresponding author), Amer Canc Soc, Natl Home Off, Dept Epidemiol, 250 Williams St NW, Atlanta, GA 30303 USA.	michael.thun@cancer.org	Lopez, Alan D/F-1487-2010; Lopez, Alan/AAA-2734-2022; Freedman, Neal David/B-9741-2015	Lopez, Alan D/0000-0001-5818-6512; Freedman, Neal David/0000-0003-0074-1098; Carter, Brian/0000-0003-1166-6521	Intramural Research Program of the National Cancer Institute (NCI), NIH; Intramural Research Programs of the ACS; NCI [P01 CA87969, P01 CA055075]; National Heart, Lung, and Blood Institute [N01WH22110, N01WH24152, N01WH32100-32102, N01WH32105, N01WH32106, N01WH32108, N01WH32109, N01WH32111, N01WH32112, N01WH32113, N01WH32115, N01WH32118, N01WH32119, N01WH32122, N01WH42107-N01WH42126, N01WH42129-N01WH42132, N01WH44221]; NATIONAL CANCER INSTITUTE [ZIACP010196, P01CA087969, U01CA098710, P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [N01WH32100, N01WH32118] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH042117, N01WH042107, N01WH042114, N01WH042119, N01WH042129, N01WH042123, N01WH042120, N01WH042113, N01WH032113, N01WH042132, N01WH042109, N01WH032108, N01WH032112, N01WH032118, N01WH032115, N01WH042124, N01WH042131, N01WH022110, N01WH032119, N01WH042118, N01WH032105, N01WH042126, N01WH042115, N01WH032122, N01WH032102, N01WH042122, N01WH042116, N01WH042125, N01WH042112, N01WH032106, N01WH042130, N01WH032101, N01WH032100, N01WH032109, N01WH042108, N01WH042121, N01WH042110, N01WH032111, N01WH042111] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute (NCI), NIH; Intramural Research Programs of the ACS; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support for the National Institutes of Health (NIH)-AARP Diet and Health Study was provided by the Intramural Research Program of the National Cancer Institute (NCI), NIH. Support for all the American Cancer Society (ACS) cohort studies was provided by the Intramural Research Programs of the ACS. Support for the Nurses' Health Study and the Health Professionals Follow-up Study was provided by grants (P01 CA87969 and P01 CA055075, respectively) from the NCI. Support for the Women's Health Initiative program is provided by contracts (N01WH22110, N01WH24152, N01WH32100-32102, N01WH32105, N01WH32106, N01WH32108, N01WH32109, N01WH32111, N01WH32112, N01WH32113, N01WH32115, N01WH32118, N01WH32119, N01WH32122, N01WH42107-N01WH42126, N01WH42129-N01WH42132, and N01WH44221) from the National Heart, Lung, and Blood Institute.	ANDERSON C, 2001, SMOKING TOBACCO CONT, V14; Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; [Anonymous], 2002, SCI BLOG         JUL; [Anonymous], 2003, SMOKING TOBACCO CONT; [Anonymous], CURR POP SURV ANN SO; [Anonymous], AM FAM LIV ARR 2010; [Anonymous], 1964, PHS PUBL, P387; Burns D, 2001, SMOKING TOBACCO CONT, V15, P1; Burns DM, 1997, CIGARETTE SMOKING BE, V8, P13; BURNS DM, 2001, SMOKING TOBACCO CONT, V13, P65; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Centers for Disease Control and Prevention, 2011, HLTH US 2011; Chahine T, 2011, SOC SCI MED, V73, P752, DOI 10.1016/j.socscimed.2011.06.032; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; *DEP HLTH HUM SERV, 1989, DHHS PUBL; Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; Department of Health and Human Services, 2001, WOM SMOK REP SURG GE; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dorn H., 1958, P SOC STAT SECT AM S, P34; Garfinkel L, 1985, Natl Cancer Inst Monogr, V67, P49; Green J, 2012, LANCET; HAMMOND E. CUYLER, 1966, NAT CANCER INST MONOGR, V19, P127; HAMMOND EC, 1958, JAMA-J AM MED ASSOC, V166, P1294, DOI 10.1001/jama.1958.02990110030007; HAMMOND EC, 1954, JAMA-J AM MED ASSOC, V155, P1316, DOI 10.1001/jama.1954.03690330020006; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; THUN MJ, 1995, AM J PUBLIC HEALTH, V85, P1223, DOI 10.2105/AJPH.85.9.1223; Thun MJ, 1997, JNCI-J NATL CANCER I, V89, P1580, DOI 10.1093/jnci/89.21.1580; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; Thun MJ., 1997, CHANGES CIGARETTE RE, V8, P305	36	708	727	1	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					351	364		10.1056/NEJMsa1211127	http://dx.doi.org/10.1056/NEJMsa1211127			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075KX	23343064	Green Accepted			2022-12-28	WOS:000313885900008
J	Gazda, L; Pokrzywa, W; Hellerschmied, D; Lowe, T; Forne, I; Mueller-Planitz, F; Hoppe, T; Clausen, T				Gazda, Linn; Pokrzywa, Wojciech; Hellerschmied, Doris; Loewe, Thomas; Forne, Ignasi; Mueller-Planitz, Felix; Hoppe, Thorsten; Clausen, Tim			The Myosin Chaperone UNC-45 Is Organized in Tandem Modules to Support Myofilament Formation in C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; ZEBRAFISH EMBRYOS; SKELETAL-MUSCLES; MOTOR DOMAIN; HEAVY-CHAIN; PROTEIN; MYOFIBRIL; COLOCALIZES; DEGRADATION; FILAMENTS	The UCS (UNC-45/CRO1/She4) chaperones play an evolutionarily conserved role in promoting myosin-dependent processes, including cytokinesis, endocytosis, RNA transport, and muscle development. To investigate the protein machinery orchestrating myosin folding and assembly, we performed a comprehensive analysis of Caenorhabditis elegans UNC-45. Our structural and biochemical data demonstrate that UNC-45 forms linear protein chains that offer multiple binding sites for cooperating chaperones and client proteins. Accordingly, Hsp70 and Hsp90, which bind to the TPR domain of UNC-45, could act in concert and with defined periodicity on captured myosin molecules. In vivo analyses reveal the elongated canyon of the UCS domain as a myosin-binding site and show that multimeric UNC-45 chains support organization of sarcomeric repeats. In fact, expression of transgenes blocking UNC-45 chain formation induces dominant-negative defects in the sarcomere structure and function of wild-type worms. Together, these findings uncover a filament assembly factor that directly couples myosin folding with myofilament formation.	[Gazda, Linn; Hellerschmied, Doris; Clausen, Tim] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Pokrzywa, Wojciech; Loewe, Thomas; Hoppe, Thorsten] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Pokrzywa, Wojciech; Loewe, Thomas; Hoppe, Thorsten] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Forne, Ignasi] Univ Munich, Adolf Butenandt Inst, Prot Anal Unit, D-81377 Munich, Germany; [Forne, Ignasi] Univ Munich, Ctr Integrated Prot Sci CIPSM, Prot Anal Unit, D-81377 Munich, Germany; [Mueller-Planitz, Felix] Univ Munich, Adolf Butenandt Inst, Mol Biol Unit, D-81377 Munich, Germany; [Mueller-Planitz, Felix] Univ Munich, Ctr Integrated Prot Sci CIPSM, Mol Biol Unit, D-81377 Munich, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Cologne; University of Cologne; University of Munich; University of Munich; University of Munich; University of Munich	Hoppe, T (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47A, D-50674 Cologne, Germany.	thorsten.hoppe@uni-koeln.de; clausen@imp.univie.ac.at	Mueller-Planitz, Felix/P-8461-2014; Forne, Ignasi/B-3837-2016; Pokrzywa, Wojciech/AAL-5766-2021; Hoppe, Thorsten/AAC-7880-2020	Mueller-Planitz, Felix/0000-0001-8273-6473; Pokrzywa, Wojciech/0000-0002-5110-4462; Hoppe, Thorsten/0000-0002-4734-9352; Hellerschmied, Doris/0000-0003-1431-2470; Clausen, Tim/0000-0003-1582-6924	NIH National Center for Research Resources; European Community Network of Excellence RUBICON [LSHC-CT-2005-018683]; Deutsche Forschungsgemeinschaft [CECAD, FOR885, SFB635, HO2541/1-1, HO2541/4-1]; Austrian Science Fund [FWF P22570-B09]; Boehringer Ingelheim; Austrian Science Fund (FWF) [P 22570] Funding Source: researchfish	NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); European Community Network of Excellence RUBICON; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF)); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to the beamline staff at the SLS and ESRF, in particular to Andrew McCarthy and MaxNanao, for their assistance during data collection; Mathias Madalinski for peptide synthesis; Axel Imhof and Peter Becker for providing access to the mass spectrometry infrastructure; the Caenorhabditis Genetics Center (funded by the NIH National Center for Research Resources) for strains; Richard I. Morimoto and Patricija van Oosten-Hawle for providing the Hsp90 antibody; and Peter G. Schultz for providing the pDULE-pBpa plasmid. With regards to author contributions, L.G. and T.C. performed the structural studies; L. G. and D.H. performed the protein biochemistry; T.L. prepared the UNC-45 antibody; W.P. performed C. elegans experiments; and I.F. and F.M.-P. performed MS analysis. T. C. outlined the structural and mechanistic part of the work and T. H. the C. elegans part. All authors contributed to writing the manuscript. This work was supported by grants from the European Community Network of Excellence RUBICON (LSHC-CT-2005-018683 to T.H.), the Deutsche Forschungsgemeinschaft (CECAD, FOR885, SFB635, HO2541/1-1, and HO2541/4-1 to T.H.), and the Austrian Science Fund (FWF P22570-B09 to D.H. and L.G.). The IMP is funded by Boehringer Ingelheim.	Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; Craig R, 2006, CURR OPIN STRUC BIOL, V16, P204, DOI 10.1016/j.sbi.2006.03.006; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Etard C, 2008, J CELL BIOL, V180, P1163, DOI 10.1083/jcb.200709128; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Gaiser AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025485; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; Geach TJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-75; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Kachur T, 2004, J CELL SCI, V117, P5313, DOI 10.1242/jcs.01389; Kachur TM, 2008, INT J MOL SCI, V9, P1863, DOI 10.3390/ijms9091863; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lee CF, 2011, STRUCTURE, V19, P397, DOI 10.1016/j.str.2011.01.002; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Melkani GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022579; Melkani GC, 2010, BIOCHEM BIOPH RES CO, V396, P317, DOI 10.1016/j.bbrc.2010.04.090; Myhre JL, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/712315; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Sanger JW, 2005, J MUSCLE RES CELL M, V26, P343, DOI 10.1007/s10974-005-9016-7; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shi H, 2010, P NATL ACAD SCI USA, V107, P21382, DOI 10.1073/pnas.1013038107; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; Stanley BA, 2007, CIRCULATION, V116, P170; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Toi H, 2003, MOL BIOL CELL, V14, P2237, DOI 10.1091/mbc.E02-09-0616; Venolia L, 1999, CELL MOTIL CYTOSKEL, V42, P163, DOI 10.1002/(SICI)1097-0169(1999)42:3&lt;163::AID-CM1&gt;3.0.CO;2-E; VENOLIA L, 1990, GENETICS, V126, P345; Walker Michael G., 2001, Mini-Reviews in Medicinal Chemistry, V1, P197, DOI 10.2174/1389557013407034; Wesche S, 2003, CURR BIOL, V13, P715, DOI 10.1016/S0960-9822(03)00264-1; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Yu Q, 2003, CURR BIOL, V13, pR525, DOI 10.1016/S0960-9822(03)00447-0	40	64	64	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					183	195		10.1016/j.cell.2012.12.025	http://dx.doi.org/10.1016/j.cell.2012.12.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332754	hybrid, Green Published			2022-12-28	WOS:000313719800016
J	Miller, JW; Ulrich, CM				Miller, Joshua W.; Ulrich, Cornelia M.			Folic acid and cancer-where are we today?	LANCET			English	Editorial Material							NEURAL-TUBE DEFECTS; UNITED-STATES; FORTIFICATION; INCREASE; RISK		[Miller, Joshua W.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA; [Ulrich, Cornelia M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Ulrich, Cornelia M.] German Canc Res Ctr, Div Prevent Oncol, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany	Rutgers State University New Brunswick; Fred Hutchinson Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Ulrich, CM (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	neli.ulrich@nct-heidelberg.de						Bailey RL, 2010, AM J CLIN NUTR, V91, P231, DOI 10.3945/ajcn.2009.28427; Bayston R, 2007, LANCET, V370, P2004, DOI 10.1016/S0140-6736(07)61861-3; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; Ly A, 2011, CANCER RES, V71, P988, DOI 10.1158/0008-5472.CAN-10-2379; Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329; Petersen LF, 2012, BJU INT, V109, P788, DOI 10.1111/j.1464-410X.2011.10437.x; Sie KKY, 2011, GUT, V60, P1687, DOI 10.1136/gut.2011.238782; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Vollset SE, 2013, LANCET; Williams LJ, 2002, TERATOLOGY, V66, P33, DOI 10.1002/tera.10060	12	30	30	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2013	381	9871					974	976		10.1016/S0140-6736(13)60110-5	http://dx.doi.org/10.1016/S0140-6736(13)60110-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EU	23352551				2022-12-28	WOS:000316936800007
J	Lee, K; Kim, SW; Toda, Y; Matsuishi, S; Hosono, H				Lee, Kimoon; Kim, Sung Wng; Toda, Yoshitake; Matsuishi, Satoru; Hosono, Hideo			Dicalcium nitride as a two-dimensional electride with an anionic electron layer	NATURE			English	Article							TEMPERATURE STABLE ELECTRIDE; ROOM-TEMPERATURE; WORK FUNCTION; ALUMINUM; SURFACE; CA2N	Recent studies suggest that electrides-ionic crystals in which electrons serve as anions-are not exceptional materials but rather a generalized form, particularly under high pressure(1-3). The topology of the cavities confining anionic electrons determines their physical.properties(4). At present, reported confining sites consist only of zero-dimensional cavities or weakly linked channels(4). Here we report a layered-structure electride of dicalcium nitride, Ca2N, which possesses two-dimensionally confined anionic electrons whose concentration agrees well with that for the chemical formula of [Ca2N](+).e(-). Two-dimensional transport characteristics are demonstrated by a high electron mobility (520 cm(2) V-1 s(-1)) and long mean scattering time (0.6 picoseconds) with a mean free path of 0.12 micrometres. The quadratic temperature dependence of the resistivity up to 120 Kelvin indicates the presence of an electron-electron interaction. A striking anisotropic magnetoresistance behaviour with respect to the direction of magnetic field (negative for the field perpendicular to the conducting plane and positive for the field parallel to it) is observed, confirming diffusive two-dimensional transport in dense electron layers. Additionally, band calculations support confinement of anionic electrons within the interlayer space, and photoemission measurements confirm anisotropic low work functions of 3.5 and 2.6 electronvolts, revealing the loosely bound nature of the anionic electrons. We conclude that Ca2N is a two-dimensional electride in terms of [Ca2N](+).e(-).	[Lee, Kimoon; Kim, Sung Wng; Toda, Yoshitake; Hosono, Hideo] Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Kim, Sung Wng] Sungkyunkwan Univ, Dept Energy Sci, Suwon 440746, Gyeonggi Do, South Korea; [Matsuishi, Satoru; Hosono, Hideo] Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology; Sungkyunkwan University (SKKU); Tokyo Institute of Technology	Hosono, H (corresponding author), Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	hosono@msl.titech.ac.jp	Hosono, Hideo/T-1845-2019; Kim, Sung Wng/A-4747-2013; Hosono, HIdeo/J-3489-2013	Kim, Sung Wng/0000-0002-4802-5421; Hosono, HIdeo/0000-0001-9260-6728	Funding Program for World-Leading Innovative R&D On Science and Technology (FIRST); JSPS; Element Strategy Initiative Project, MEXT, Japan	Funding Program for World-Leading Innovative R&D On Science and Technology (FIRST)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Element Strategy Initiative Project, MEXT, Japan	This work was supported by the Funding Program for World-Leading Innovative R&D On Science and Technology (FIRST), JSPS, and the Element Strategy Initiative Project, MEXT, Japan.	ANDO T, 1982, REV MOD PHYS, V54, P437, DOI 10.1103/RevModPhys.54.437; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; DEMUTH JE, 1986, PHYS REV LETT, V56, P1408, DOI 10.1103/PhysRevLett.56.1408; Dye JL, 2009, ACCOUNTS CHEM RES, V42, P1564, DOI 10.1021/ar9000857; Fox M., 2010, OPTICAL PROPERTIES S, V2; Gregory DH, 2000, J MATER CHEM, V10, P1635, DOI 10.1039/b001911i; GREPSTAD JK, 1976, SURF SCI, V57, P348, DOI 10.1016/0039-6028(76)90187-4; Kasap S. O., 2002, PRINCIPLES OF ELECTR; Kim SW, 2011, SCIENCE, V333, P71, DOI 10.1126/science.1204394; Kitano M, 2012, NAT CHEM, V4, P934, DOI [10.1038/NCHEM.1476, 10.1038/nchem.1476]; Kittel C, 2021, INTRO SOLID STATE PH; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Li ZY, 2004, ANGEW CHEM INT EDIT, V43, P6479, DOI 10.1002/anie.200461200; Ma YM, 2009, NATURE, V458, P182, DOI 10.1038/nature07786; Matsuishi S, 2008, J PHYS CHEM C, V112, P4753, DOI 10.1021/jp711631j; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Oslen J. L., 1962, ELECTRON TRANSPORT I; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pickard CJ, 2010, NAT MATER, V9, P624, DOI [10.1038/nmat2796, 10.1038/NMAT2796]; Pickard CJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.146401; PIRAUX L, 1990, J MATER RES, V5, P1285, DOI 10.1557/JMR.1990.1285; Reckeweg O, 2002, SOLID STATE SCI, V4, P575, DOI 10.1016/S1293-2558(02)01300-6; Rourke PMC, 2012, COMPUT PHYS COMMUN, V183, P324, DOI 10.1016/j.cpc.2011.10.015; Steinbrenner U, 1998, J PHYS CHEM SOLIDS, V59, P1527, DOI 10.1016/S0022-3697(98)00071-7; Sundar VC, 2004, SCIENCE, V303, P1644, DOI 10.1126/science.1094196; TASKER PW, 1979, J PHYS C SOLID STATE, V12, P4977, DOI 10.1088/0022-3719/12/22/036; Toda Y, 2004, ADV MATER, V16, P685, DOI 10.1002/adma.200306484; Toda Y, 2007, ADV MATER, V19, P3564, DOI 10.1002/adma.200700663; Uijttewaal MA, 2004, J APPL PHYS, V96, P1751, DOI 10.1063/1.1767611	30	301	315	17	433	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					336	340		10.1038/nature11812	http://dx.doi.org/10.1038/nature11812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23364689				2022-12-28	WOS:000315312900034
J	Zhou, HY; Dick, HJB				Zhou, Huaiyang; Dick, Henry J. B.			Thin crust as evidence for depleted mantle supporting the Marion Rise	NATURE			English	Article							SOUTHWEST INDIAN RIDGE; MID-ATLANTIC-RIDGE; GLOBAL CORRELATIONS; GRAVITY-ANOMALIES; BASALT CHEMISTRY; CORE COMPLEX; AXIAL DEPTH; OCEAN; ORIGIN; PERIDOTITE	The global ridge system is dominated by oceanic rises reflecting large variations in axial depth associated with mantle hotspots. The little-studied Marion Rise is as large as the Icelandic Rise, considering both length and depth, but has an axial rift (rather than a high) nearly its entire length. Uniquely along the Southwest Indian Ridge systematic sampling allows direct examination of crustal architecture over its full length. Here we show that, unlike the Icelandic Rise, peridotites are extensively exposed high on the rise, revealing that the crust is generally thin, and often missing, over a rifted rise. Therefore the Marion Rise must be largely an isostatic response to ancient melting events that created low-density depleted mantle beneath the Southwest Indian Ridge rather than thickened crust or a large thermal anomaly. The origin of this depleted mantle is probably the mantle emplaced into the African asthenosphere during the Karoo and Madagascar flood basalt events.	[Zhou, Huaiyang] Tongji Univ, State Key Lab Marine Geol, Shanghai 200092, Peoples R China; [Dick, Henry J. B.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Tongji University; Woods Hole Oceanographic Institution	Dick, HJB (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	zhouhy@tongji.edu.cn; hdick@whoi.edu			Chinese National Key Basic Research Program [2012CB417300]; China Ocean Mineral Resources Research and Development Association; US National Science Foundation [OCE-0526905]	Chinese National Key Basic Research Program(National Basic Research Program of China); China Ocean Mineral Resources Research and Development Association; US National Science Foundation(National Science Foundation (NSF))	This work was supported by the Chinese National Key Basic Research Program (2012CB417300), China Ocean Mineral Resources Research and Development Association, and the US National Science Foundation (grant OCE-0526905). We thank the crew and scientists of RV Dayang Yihao Cruise 21. M. Sulanowska provided technical support. Z. Chen and Y. Liu analysed chrome spinels for us at the Guangzhou Institute of Geochemistry, Chinese Academy of Sciences. A glass sample from 53 degrees E was analysed by F. Ji at the state Key Laboratory for Mineral Deposits Research, Nanjing University. We thank the Core and Rock Storage Facility of the Woods Hole Oceanographic Institution for curatorial support and access to samples. D. Sauter, R. Fisher and E. Bonatti provided additional unpublished sample descriptions and locations for the eastern and western SWIR. A review by Y. Niu encouraged us to provide more appropriate measurements of ridge depth and directed us to several important papers, greatly benefiting the manuscript and its conclusions.	Blackman DK., 2006, P IODP, DOI [10.2204/iodp.proc.304305.2006, DOI 10.2204/IODP.PROC.304305.2006]; Cadio C, 2012, EARTH PLANET SC LETT, V359, P40, DOI 10.1016/j.epsl.2012.10.006; Canales JP, 2000, J GEOPHYS RES-SOL EA, V105, P2699, DOI 10.1029/1999JB900379; Canales JP, 2002, EARTH PLANET SC LETT, V203, P311, DOI 10.1016/S0012-821X(02)00843-9; Cannat M, 1997, TECTONOPHYSICS, V279, P193, DOI 10.1016/S0040-1951(97)00113-3; Cannat M, 1999, J GEOPHYS RES-SOL EA, V104, P22825, DOI 10.1029/1999JB900195; Cannat M, 2006, GEOLOGY, V34, P605, DOI 10.1130/G22486.1; Cannat M, 2009, EARTH PLANET SC LETT, V288, P174, DOI 10.1016/j.epsl.2009.09.020; DETRICK RS, 1995, J GEOPHYS RES-SOL EA, V100, P3767, DOI 10.1029/94JB02649; Dick H.B.J, 1989, GEOL SOC LOND SPEC P, V42, P71, DOI DOI 10.1144/GSL.SP.1989.042.01.06; Dick H. J., 2005, EOS, V86; Dick H. J., 2003, EOS, V84; Dick H. J., 2002, EOS, V83; Dick H. J. B., 2001, GEOPH RES ABSTR, V3, P794; Dick HJB, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001645; DICK HJB, 1984, EARTH PLANET SC LETT, V69, P88, DOI 10.1016/0012-821X(84)90076-1; Dick HJB, 2003, NATURE, V426, P405, DOI 10.1038/nature02128; Dick HJB, 2000, EARTH PLANET SC LETT, V179, P31, DOI 10.1016/S0012-821X(00)00102-3; DUNCAN RA, 1981, TECTONOPHYSICS, V74, P29, DOI 10.1016/0040-1951(81)90126-8; Fisher R. L., 1986, OFIOLITI, V11, P147; Georgen J. E., 1998, EOS, V79, pabstr 854; Georgen JE, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000542; Georgen JE, 2001, EARTH PLANET SC LETT, V187, P283, DOI 10.1016/S0012-821X(01)00293-X; Hellebrand E, 2001, NATURE, V410, P677, DOI 10.1038/35070546; Ildefonse B, 2007, GEOLOGY, V35, P623, DOI 10.1130/G23531A.1; Ito G, 1999, EARTH PLANET SC LETT, V165, P81, DOI 10.1016/S0012-821X(98)00216-7; Ito G, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001970; Jaroslow GE, 1996, TECTONOPHYSICS, V256, P17, DOI 10.1016/0040-1951(95)00163-8; Jokat W, 2003, NATURE, V423, P962, DOI 10.1038/nature01706; Jordan T. H., 1979, MANTLE SAMPLE INCLUS, P1, DOI DOI 10.1029/SP016P0001; Karson JA, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001109; Kelemen P. B., 2004, P ODP INIT REP, V209; Kincaid C, 1996, EARTH PLANET SC LETT, V137, P29, DOI 10.1016/0012-821X(95)00201-M; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; LEROEX AP, 1989, J PETROL, V30, P947, DOI 10.1093/petrology/30.4.947; MORGAN WJ, 1972, AM ASSOC PETR GEOL B, V56, P203; Morishita T, 2009, J PETROL, V50, P1299, DOI 10.1093/petrology/egp025; Muller MR, 1997, EARTH PLANET SC LETT, V148, P93, DOI 10.1016/S0012-821X(97)00030-7; Muller MR, 1999, GEOLOGY, V27, P867, DOI 10.1130/0091-7613(1999)027<0867:SAMSAT>2.3.CO;2; Niu YL, 2008, J PETROL, V49, P633, DOI 10.1093/petrology/egm051; OHARA MJ, 1975, NATURE, V253, P708, DOI 10.1038/253708a0; PATRIAT P, 1988, TECTONOPHYSICS, V155, P211, DOI 10.1016/0040-1951(88)90267-3; PRESNALL DC, 1982, PHYS EARTH PLANET IN, V29, P148, DOI 10.1016/0031-9201(82)90069-3; Sclater JG, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000951; SUN SS, 1982, GEOCHIM COSMOCHIM AC, V46, P179, DOI 10.1016/0016-7037(82)90245-9; Teagle D. A., 2006, EOS, V87; Wang TT, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003402; Weir NRW, 2001, J GEOPHYS RES-SOL EA, V106, P6347, DOI 10.1029/2000JB900358; Xu M, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002586; Zhang T, 2011, SCI CHINA EARTH SCI, V54, P1177, DOI 10.1007/s11430-011-4219-9	50	108	129	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					195	200		10.1038/nature11842	http://dx.doi.org/10.1038/nature11842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23389441	Green Submitted			2022-12-28	WOS:000315137700031
J	Kulendran, M; Leff, DR; Kerr, K; Tekkis, PP; Athanasiou, T; Darzi, A				Kulendran, Myutan; Leff, Daniel R.; Kerr, Karen; Tekkis, Paris P.; Athanasiou, Thanos; Darzi, Ara			Global cancer burden and sustainable health development	LANCET			English	Editorial Material									[Kulendran, Myutan; Leff, Daniel R.; Kerr, Karen; Tekkis, Paris P.; Athanasiou, Thanos; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Div Surg, Acad Surg Unit, Dept Canc & Surg, London W2 1NY, England; [Tekkis, Paris P.; Darzi, Ara] Royal Marsden Hosp, Dept Colorectal Surg, London SW3 6JJ, England	Imperial College London; Royal Marsden NHS Foundation Trust	Kulendran, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Surg, Acad Surg Unit, Dept Canc & Surg, London W2 1NY, England.	m.kulendran09@imperial.ac.uk		Leff, Daniel/0000-0002-5310-1046	National Institute for Health Research [NF-SI-0510-10186] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Consortium of Social Science Association (COSSA), 2004, COSSA WASHINGTON UPD, V23, P4; Frenk J, 2009, B WORLD HEALTH ORGAN, V87, P542, DOI 10.2471/BLT.08.053199; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, 2011, CLOS CANC DIV BLUEP; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Hwang J, 2008, HEALTH AFFAIR, V27, P1329, DOI 10.1377/hlthaff.27.5.1329; International Agency for Research on Cancer and Cancer research UK, 2012, WORLD CANC FACTSH; Sarhan M, 2010, 3 REG C CANC BLOOD D; Silver HJ, SOCIAL BEHAV SCI RES; UNGA, 2012, FUTURE WE WANT; World Health Organization and International Agency for Research on Cancer, 2012, PREV CERV CANC SCREE	11	7	7	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2013	381	9865					427	429		10.1016/S0140-6736(13)60138-5	http://dx.doi.org/10.1016/S0140-6736(13)60138-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088CH	23388076				2022-12-28	WOS:000314810900007
J	[Anonymous]				[Anonymous]			Stop Cancer Now!	LANCET			English	Editorial Material																			0	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2013	381	9865					426	+		10.1016/S0140-6736(13)60060-4	http://dx.doi.org/10.1016/S0140-6736(13)60060-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088CH	23388079				2022-12-28	WOS:000314810900006
J	Bartels-Rausch, T				Bartels-Rausch, Thorsten			Ten things we need to know about ice and snow	NATURE			English	Editorial Material									Paul Scherrer Inst, Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Bartels-Rausch, T (corresponding author), Paul Scherrer Inst, Villigen, Switzerland.	thorsten.bartels-rausch@psi.ch	Bartels-Rausch, Thorsten/A-7651-2008	Bartels-Rausch, Thorsten/0000-0002-7548-2572				Bartels-Rausch T., 2012, ATMOS CHEM PHYS DISC, V12, P30, DOI [10.5194/acpd-12-30409-2012, DOI 10.5194/ACPD-12-30409-2012]; Bartels-Rausch T, 2012, REV MOD PHYS, V84, P885, DOI 10.1103/RevModPhys.84.885	2	119	123	6	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					27	29		10.1038/494027a	http://dx.doi.org/10.1038/494027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389527	Bronze			2022-12-28	WOS:000314741200015
J	DeFina, LF; Willis, BL; Radford, NB; Gao, A; Leonard, D; Haskell, WL; Weiner, MF; Berry, JD				DeFina, Laura F.; Willis, Benjamin L.; Radford, Nina B.; Gao, Ang; Leonard, David; Haskell, William L.; Weiner, Myron F.; Berry, Jarett D.			The Association Between Midlife Cardiorespiratory Fitness Levels and Later-Life Dementia	ANNALS OF INTERNAL MEDICINE			English	Review							PHYSICAL-ACTIVITY; ALZHEIMERS-DISEASE; MEDICARE CLAIMS; RISK-FACTORS; COGNITIVE FUNCTION; DIABETES-MELLITUS; EXERCISE; MORTALITY; MEN; AGE	Background: Primary prevention of Alzheimer disease and other types of dementia (all-cause dementia) is an important public health goal. Evidence to date is insufficient to recommend any lifestyle change to prevent or delay the onset of dementia. Objective: To assess the association between objectively measured midlife cardiorespiratory fitness ("fitness") levels and development of all-cause dementia in advanced age. Design: Prospective, observational cohort study. Setting: Preventive medicine clinic. Patients: 19 458 community-dwelling, nonelderly adults who had a baseline fitness examination. Measurements: Fitness levels, assessed using the modified Balke treadmill protocol between 1971 and 2009, and incident all-cause dementia using Medicare Parts A and B claims data from 1999 to 2009. Results: 1659 cases of incident all-cause dementia occurred during 125 700 person-years of Medicare follow-up (median follow-up, 25 years [interquartile range, 19 to 30 years]). After multivariable adjustment, participants in the highest quintile of fitness level had lower hazard of all-cause dementia than those in the lowest quintile (hazard ratio, 0.64 [95% CI, 0.54 to 0.77]). Higher fitness levels were associated with lower hazard of all-cause dementia with previous stroke (hazard ratio, 0.74 [CI, 0.53 to 1.04]) or without previous stroke (hazard ratio, 0.74 [CI, 0.61 to 0.90]). Limitations: Dementia diagnoses were based on Medicare claims, and participants generally were non-Hispanic white, healthy, and well-educated and had access to preventive health care. This study evaluated fitness levels, so a specific exercise prescription cannot be generated from results and the findings may not be causal. Conclusion: Higher midlife fitness levels seem to be associated with lower hazards of developing all-cause dementia later in life. The magnitude and direction of the association were similar with or without previous stroke, suggesting that higher fitness levels earlier in life may lower risk for dementia later in life, independent of cerebrovascular disease. Primary Funding Source: The Cooper Institute; University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute; and American Heart Association. Ann Intern Med. 2013;158:162-168.	[DeFina, Laura F.] Cooper Inst, Dallas, TX 75230 USA; Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA	Cooper Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University	DeFina, LF (corresponding author), Cooper Inst, 12330 Preston Rd, Dallas, TX 75230 USA.	ldefina@cooperinst.org		Weiner, Myron/0000-0001-5682-4410; Radford, Nina/0000-0003-0847-9514	Dedman Family Scholar in Clinical Care endowment at the University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092229] Funding Source: NIH RePORTER	Dedman Family Scholar in Clinical Care endowment at the University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Cooper Institute. Dr. Berry receives funding from the Dedman Family Scholar in Clinical Care endowment at the University of Texas Southwestern Medical Center; the National Heart, Lung, and Blood Institute; and the American Heart Association.	Abbott RD, 2004, JAMA-J AM MED ASSOC, V292, P1447, DOI 10.1001/jama.292.12.1447; Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; American College of Sports Medicine, 2009, ACSMS GUID EX TEST P, VV; Andel R, 2008, J GERONTOL A-BIOL, V63, P62, DOI 10.1093/gerona/63.1.62; Barnes DE, 2003, J AM GERIATR SOC, V51, P459, DOI 10.1046/j.1532-5415.2003.51153.x; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Bullitt E, 2009, AM J NEURORADIOL, V30, P1857, DOI 10.3174/ajnr.A1695; Burns JM, 2008, NEUROLOGY, V71, P210, DOI 10.1212/01.wnl.0000317094.86209.cb; Carlson MC, 2008, ALZHEIMERS DEMENT, V4, P324, DOI 10.1016/j.jalz.2008.07.002; Chapman Daniel P, 2006, Prev Chronic Dis, V3, pA34; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Daviglus ML, 2010, NIH CONSENS STATE SC, P27; DUNCAN JJ, 1991, JAMA-J AM MED ASSOC, V266, P3295, DOI 10.1001/jama.266.23.3295; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; Honea RA, 2009, ALZ DIS ASSOC DIS, V23, P188, DOI 10.1097/WAD.0b013e31819cb8a2; Hooker SP, 2008, STROKE, V39, P2950, DOI 10.1161/STROKEAHA.107.495275; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Liu R, 2012, MED SCI SPORT EXER, V44, P253, DOI 10.1249/MSS.0b013e31822cf717; Martin CK, 2009, ARCH INTERN MED, V169, P269, DOI 10.1001/archinternmed.2008.545; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; POLLOCK ML, 1982, AM HEART J, V103, P363, DOI 10.1016/0002-8703(82)90275-7; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Ravaglia G, 2008, NEUROLOGY, V70, P1786, DOI 10.1212/01.wnl.0000296276.50595.86; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Skinner JS, 2001, J APPL PHYSIOL, V90, P1770, DOI 10.1152/jappl.2001.90.5.1770; Sui X, 2008, DIABETES CARE, V31, P550, DOI 10.2337/dc07-1870; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Taylor DH, 2000, J AM GERIATR SOC, V48, P639, DOI 10.1111/j.1532-5415.2000.tb04721.x; Taylor DH, 2004, J GERONTOL A-BIOL, V59, P762; Taylor DH, 2002, J CLIN EPIDEMIOL, V55, P929, DOI 10.1016/S0895-4356(02)00452-3; Taylor DH, 2009, J ALZHEIMERS DIS, V17, P807, DOI 10.3233/JAD-2009-1099; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Willis BL, 2011, MED SCI SPORT EXER, V43, P2134, DOI 10.1249/MSS.0b013e31821c00a7; Yamada M, 2003, J AM GERIATR SOC, V51, P410, DOI 10.1046/j.1532-5415.2003.51117.x	45	103	109	1	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					162	+		10.7326/0003-4819-158-3-201302050-00005	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23381040	Green Accepted			2022-12-28	WOS:000314757900003
J	Dye, C; Mertens, T; Hirnschall, G; Mpanju-Shumbusho, W; Newman, RD; Raviglione, MC; Savioli, L; Nakatani, H				Dye, Christopher; Mertens, Thierry; Hirnschall, Gottfried; Mpanju-Shumbusho, Winnie; Newman, Robert D.; Raviglione, Mario C.; Savioli, Lorenzo; Nakatani, Hiroki			WHO and the future of disease control programmes	LANCET			English	Article							DEVELOPMENT ASSISTANCE; TUBERCULOSIS; HEALTH	Huge increases in funding for international health over the past two decades have led to a proliferation of donors, partnerships, and health organisations. Over the same period, the global burden of non-communicable diseases has increased absolutely and relative to communicable diseases. In this changing landscape, national programmes for the control of HIV/AIDS, tuberculosis, malaria, and neglected tropical diseases must be reinforced and adapted for three reasons: the global burden of these communicable diseases remains enormous, disease control programmes have an integral and supporting role in developing health systems, and the health benefits of these control programmes go beyond the containment of specific infections. WHO's traditional role in promoting communicable disease control programmes must also adapt to new circumstances. Among a multiplicity of actors, WHO's task is to enhance its normative role as convenor, coordinator, monitor, and standard-setter, fostering greater coherence in global health.	[Dye, Christopher; Mertens, Thierry; Hirnschall, Gottfried; Mpanju-Shumbusho, Winnie; Newman, Robert D.; Raviglione, Mario C.; Savioli, Lorenzo; Nakatani, Hiroki] World Hlth Org, CH-1211 Geneva 27, Switzerland	World Health Organization	Dye, C (corresponding author), World Hlth Org, CH-1211 Geneva 27, Switzerland.	dyec@who.int	Dye, Christopher/AIC-4659-2022; Mertens, Thomas M/E-9826-2013	RAVIGLIONE, Mario/0000-0002-9331-2067; Mertens, Thierry Eric/0000-0002-1593-6608; Dye, Christopher/0000-0002-2957-1793				ALONSO PL, 1993, T ROY SOC TROP MED H, V87, P37, DOI 10.1016/0035-9203(93)90174-O; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P257; [Anonymous], 2008, GLOB MAL ACT PLAN; [Anonymous], 2011, WORLD HLTH STAT; [Anonymous], 2011, GLOB PLAN ART RES CO; [Anonymous], 2010, PUBL PRIV MIX TB CAR; [Anonymous], WORK OV GLOB IMP NEG; Atun RA, 2008, DO VERTICAL STAND AL; Atun R, 2010, LANCET, V376, P940, DOI 10.1016/S0140-6736(10)61428-6; Bobadilla JL, 1993, DIS CONTROL PRIORITI, P351; Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466; Gabrielli AF, 2011, T ROY SOC TROP MED H, V105, P683, DOI 10.1016/j.trstmh.2011.08.013; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Hotez PJ, 2011, NEW ENGL J MED, V364, P2086, DOI 10.1056/NEJMp1014637; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Mahler H, 1966, B INT UNION TUBERC, V37, P77; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Prime Minister, 2012, DECISION NO 418QD TT; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; *UNAIDS, 2010, REP GLOB AIDS EP; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; WHO, 2010, WOR HEALT REP, P1; WHO, 2011, WHOHTMTB201115 INT U; WHO, 2008, PHARMAFORUM 0121; WHO, EEBS22 WHO; WHO, 2010, GLOB TUB CONTR 2010; WHO (World Health Organization), 2010, EQ SOC DET PUBL HLTH; World Health Organization, 2010, WHO REC MAN DIARRH P; World Health Organization, 1999, WORLD HLTH REP, P13; World Health Organization, 2011, GLOB HLTH SECT STRAT; World Health Organization, 2010, UN ACC SCAL PRIOR HI	40	36	37	0	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2013	381	9864					413	418		10.1016/S0140-6736(12)61812-1	http://dx.doi.org/10.1016/S0140-6736(12)61812-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084ZA	23374479				2022-12-28	WOS:000314578900038
J	Debs, JE; Robins, NP; Close, JD				Debs, John E.; Robins, Nicholas P.; Close, John D.			Measuring Mass in Seconds	SCIENCE			English	Editorial Material							ATOMIC INTERFEROMETRY		[Debs, John E.; Robins, Nicholas P.; Close, John D.] Australian Natl Univ, Dept Quantum Sci, Res Sch Phys & Engn, Canberra, ACT 0200, Australia	Australian National University	Debs, JE (corresponding author), Australian Natl Univ, Dept Quantum Sci, Res Sch Phys & Engn, GPO Box 4, Canberra, ACT 0200, Australia.	john.debs@anu.edu.au; nick.robins@anu.edu.au; john.close@anu.edu.au	Robins, N P/A-3725-2008; Debs, John E/L-2289-2015	Robins, N P/0000-0003-1529-5983; Debs, John E/0000-0003-4544-8741	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099534] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01GM099534-01] Funding Source: Medline; NIH HHS [DP1OD000964] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BORDE CJ, 1989, PHYS LETT A, V140, P10, DOI 10.1016/0375-9601(89)90537-9; Bouchendira R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.080801; Hall JL, 2005, FEMTOSECOND OPTICAL; Heavner TP, 2005, METROLOGIA, V42, P411, DOI 10.1088/0026-1394/42/5/012; KASEVICH M, 1991, PHYS REV LETT, V67, P181, DOI 10.1103/PhysRevLett.67.181; Lan SY, 2013, SCIENCE, V339, P554, DOI 10.1126/science.1230767; Muller H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.180405; Muller H, 2006, APPL PHYS B-LASERS O, V84, P633, DOI 10.1007/s00340-006-2279-x	9	2	2	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					532	533		10.1126/science.1232923	http://dx.doi.org/10.1126/science.1232923			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372004				2022-12-28	WOS:000314270000046
J	Deindl, S; Hwang, WL; Hota, SK; Blosser, TR; Prasad, P; Bartholomew, B; Zhuang, XW				Deindl, Sebastian; Hwang, William L.; Hota, Swetansu K.; Blosser, Timothy R.; Prasad, Punit; Bartholomew, Blaine; Zhuang, Xiaowei			ISWI Remodelers Slide Nucleosomes with Coordinated Multi-Base-Pair Entry Steps and Single-Base-Pair Exit Steps	CELL			English	Article							VIRUS NS3 HELICASE; DNA TRANSLOCATION; SACCHAROMYCES-CEREVISIAE; ISW2-NUCLEOSOME COMPLEX; HISTONE OCTAMER; ENERGY-TRANSFER; LOOP FORMATION; CORE PARTICLE; PCRA HELICASE; IN-VIVO	ISWI-family enzymes remodel chromatin by sliding nucleosomes along DNA, but the nucleosome translocation mechanism remains unclear. Here we use single-molecule FRET to probe nucleosome translocation by ISWI-family remodelers. Distinct ISWI-family members translocate nucleosomes with a similar stepping pattern maintained by the catalytic subunit of the enzyme. Nucleosome remodeling begins with a 7 bp step of DNA translocation followed by 3 bp subsequent steps toward the exit side of nucleosomes. These multi-bp, compound steps are comprised of 1 bp substeps. DNA movement on the entry side of the nucleosome occurs only after 7 bp of exit-side translocation, and each entry-side step draws in a 3 bp equivalent of DNA that allows three additional base pairs to be moved to the exit side. Our results suggest a remodeling mechanism with well-defined coordination at different nucleosomal sites featuring DNA translocation toward the exit side in 1 bp steps preceding multi-bp steps of DNA movement on the entry side.	[Deindl, Sebastian; Hwang, William L.; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Deindl, Sebastian; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Hwang, William L.; Blosser, Timothy R.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Hwang, William L.] Harvard Univ, Sch Med, Harvard MIT MD PhD Program, Boston, MA 02115 USA; [Hota, Swetansu K.; Prasad, Punit; Bartholomew, Blaine] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University; Harvard University; Harvard Medical School; Southern Illinois University System; Southern Illinois University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Hota, Swetansu/GRR-2697-2022; Hota, Swetansu/E-6067-2015	Hota, Swetansu/0000-0003-3105-9729; Hota, Swetansu/0000-0003-3105-9729; Deindl, Sebastian/0000-0001-6807-8654; Prasad, Punit/0000-0002-9132-6078	Howard Hughes Medical Institute; National Institutes of Health [GM 70864]; NIH Molecular Biophysics Training Grant; Medical Scientist Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM096450, R01GM070864, R01GM105637] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Molecular Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Widom for providing the plasmid containing the 601 positioning sequence and G. Narlikar for providing histone protein expression plasmids. This work is supported in part by the Howard Hughes Medical Institute (to X.Z.) and the National Institutes of Health GM 70864 (to B.B.). X.Z. is a Howard Hughes Medical Institute investigator. S.D. is a Merck fellow of the Jane Coffin Childs Memorial Fund for Medical Research. W.L.H. is supported by the NIH Molecular Biophysics Training Grant and Medical Scientist Training Program.	Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Cheng W, 2011, SCIENCE, V333, P1746, DOI 10.1126/science.1206023; Chua EYD, 2012, NUCLEIC ACIDS RES, V40, P6338, DOI 10.1093/nar/gks261; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Flaus A, 2003, BIOPOLYMERS, V68, P563, DOI 10.1002/bip.10323; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Hota S.K., 2013, NAT STRUCT MOL BIOL; Hota SK, 2011, BBA-GENE REGUL MECH, V1809, P476, DOI 10.1016/j.bbagrm.2011.05.007; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kassabov SR, 2002, MOL CELL BIOL, V22, P7524, DOI 10.1128/MCB.22.21.7524-7534.2002; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kulic IM, 2003, BIOPHYS J, V84, P3197, DOI 10.1016/S0006-3495(03)70044-7; Kulic IM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148103; Langst G, 2004, BBA-GENE STRUCT EXPR, V1677, P58, DOI 10.1016/j.bbaexp.2003.10.011; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Lorch Y, 2005, P NATL ACAD SCI USA, V102, P1329, DOI 10.1073/pnas.0409413102; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; McConnell AD, 2004, MOL CELL BIOL, V24, P2605, DOI 10.1128/MCB.24.7.2605-2613.2004; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Prasad TK, 2007, J MOL BIOL, V369, P940, DOI 10.1016/j.jmb.2007.04.005; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Sirinakis G, 2011, EMBO J, V30, P2364, DOI 10.1038/emboj.2011.141; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Suto RK, 2003, J MOL BIOL, V326, P371, DOI 10.1016/S0022-2836(02)01407-9; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; van Holde K, 2003, BIOCHEM CELL BIOL, V81, P169, DOI 10.1139/o03-038; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	65	107	108	3	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 31	2013	152	3					442	452		10.1016/j.cell.2012.12.040	http://dx.doi.org/10.1016/j.cell.2012.12.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374341	Green Accepted, Bronze			2022-12-28	WOS:000314362800015
J	Gunes, C; Rudolph, KL				Guenes, Cagatay; Rudolph, K. Lenhard			The Role of Telomeres in Stem Cells and Cancer	CELL			English	Review							CHROMOSOMAL INSTABILITY; SELF-RENEWAL; CHECKPOINTS; TRF1	Telomere shortening impairs proliferation of transformed cells but also leads to cancer initiation by inducing chromosomal instability. Here, we discuss recent developments in our understanding of the role of telomeres in replication stress and how telomerase expression in somatic stem cells may affect genome integrity control and carcinogenesis.	[Guenes, Cagatay; Rudolph, K. Lenhard] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Rudolph, KL (corresponding author), Fritz Lipmann Inst, Leibniz Inst Age Res, Beutenbergstr 11, D-07745 Jena, Germany.	klrudolph@fli-leibniz.de		Rudolph, Karl Lenhard/0000-0002-4839-2862				Begus-Nahrmann Y, 2012, J CLIN INVEST, V122, P2283, DOI 10.1172/JCI61745; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Chang M, 2009, GENETICS, V183, P779, DOI 10.1534/genetics.109.107631; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Ding ZH, 2012, CELL, V148, P896, DOI 10.1016/j.cell.2012.01.039; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Sperka T, 2012, NAT CELL BIOL, V14, P73, DOI 10.1038/ncb2388; Suram A, 2012, EMBO J, V31, P2839, DOI 10.1038/emboj.2012.132; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040	18	167	179	2	160	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					390	393		10.1016/j.cell.2013.01.010	http://dx.doi.org/10.1016/j.cell.2013.01.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374336	Bronze			2022-12-28	WOS:000314362800010
J	Zhao, X; Cho, H; Evans, RM				Zhao, Xuan; Cho, Han; Evans, Ronald M.			SRF'ing Around the Clock	CELL			English	Editorial Material							CIRCADIAN CLOCKS	Central circadian clock oscillators, located in the suprachiasmatic nucleus (SCN) of the hypothalamus, align peripheral clock systems with geosynchronous time. Gerber et al. (2013) identify actin polymerization and serum response factor (SRF) activation as key steps linking the central master clock to peripheral oscillators.	[Zhao, Xuan; Cho, Han; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965				Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Gerber A, 2013, CELL, V152, P492, DOI 10.1016/j.cell.2012.12.027; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430	9	2	2	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 31	2013	152	3					381	382		10.1016/j.cell.2013.01.028	http://dx.doi.org/10.1016/j.cell.2013.01.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374332	Bronze			2022-12-28	WOS:000314362800006
J	Fu, DW; Cai, HL; Liu, YM; Ye, Q; Zhang, W; Zhang, Y; Chen, XY; Giovannetti, G; Capone, M; Li, JY; Xiong, RG				Fu, Da-Wei; Cai, Hong-Ling; Liu, Yuanming; Ye, Qiong; Zhang, Wen; Zhang, Yi; Chen, Xue-Yuan; Giovannetti, Gianluca; Capone, Massimo; Li, Jiangyu; Xiong, Ren-Gen			Diisopropylammonium Bromide Is a High-Temperature Molecular Ferroelectric Crystal	SCIENCE			English	Article							BEHAVIOR	Molecular ferroelectrics are highly desirable for their easy and environmentally friendly processing, light weight, and mechanical flexibility. We found that diisopropylammonium bromide (DIPAB), a molecular crystal processed from aqueous solution, is a ferroelectric with a spontaneous polarization of 23 microcoulombs per square centimeter [close to that of barium titanate (BTO)], high Curie temperature of 426 kelvin (above that of BTO), large dielectric constant, and low dielectric loss. DIPAB exhibits good piezoelectric response and well-defined ferroelectric domains. These attributes make it a molecular alternative to perovskite ferroelectrics and ferroelectric polymers in sensing, actuation, data storage, electro-optics, and molecular or flexible electronics.	[Fu, Da-Wei; Cai, Hong-Ling; Ye, Qiong; Zhang, Wen; Zhang, Yi; Xiong, Ren-Gen] Southeast Univ, Ordered Matter Sci Res Ctr, Nanjing 211189, Jiangsu, Peoples R China; [Liu, Yuanming; Li, Jiangyu] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Chen, Xue-Yuan] Chinese Acad Sci, Fujian Inst Res Struct Matter, Fuzhou 350002, Peoples R China; [Giovannetti, Gianluca; Capone, Massimo] CNR IOM Democritos Natl Simulat Ctr, I-34136 Trieste, Italy; [Giovannetti, Gianluca; Capone, Massimo] Int Sch Adv Studies SISSA, I-34136 Trieste, Italy; [Giovannetti, Gianluca] IFW Dresden, Inst Theoret Solid State Phys, D-01171 Dresden, Germany	Southeast University - China; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); International School for Advanced Studies (SISSA); Institute for Integrative Nanosciences (IIN); Leibniz Institute for Solid State & Materials Research Dresden	Li, JY (corresponding author), Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.	jjli@u.washington.edu; xiongrg@seu.edu.cn	Capone, Massimo/U-6924-2019; Chen, Xueyuan/C-5613-2012; Liu, Yuanming/D-5031-2012; Capone, Massimo/A-7762-2008; Giovannetti, Gianluca/L-4339-2013; Li, Jiangyu/B-3191-2008; Cai, Hong-ling/K-2855-2012; Zhang, Wen/F-9902-2011	Chen, Xueyuan/0000-0003-0493-839X; Capone, Massimo/0000-0002-9811-5089; Li, Jiangyu/0000-0003-0533-1397; Cai, Hong-ling/0000-0002-2855-3016; Zhang, Wen/0000-0001-9400-9740	NSFC [20931002, 90922005]; NSF [CMMI 1100339]; European Research Council [240524]	NSFC(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission)	Supported by NSFC key fund grants 20931002 and 90922005 (R.-G. X.), NSF grant CMMI 1100339 (J.L.), and the European Research Council under starting independent research grant 240524 "SUPERBAD" (M. C. and G. G.). Numerical calculations were performed at CINECA. J.L. and R.-G. X. contributed to the design of the study, analysis of the data, and writing of the paper. D.-W.F. did the sample preparation. H.-L. C. made the dielectric constant and ferroelectric hysteresis loop measurements. Y.L. did the PFM studies. W.Z. wrote parts of the paper. Q.Y. contributed ideas and wrote some key parts of the paper. Y.Z. carried out the powder diffraction studies. X.-Y.C. carried out SHG measurements. G. G. and M. C. made ab initio calculations and wrote part of the manuscript.	Bonnell DA, 2009, MRS BULL, V34, P648, DOI 10.1557/mrs2009.176; Cai HL, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.147601; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Fiebig M, 2002, NATURE, V419, P818, DOI 10.1038/nature01077; Foster CM, 1997, J APPL PHYS, V81, P2349, DOI 10.1063/1.364239; Fu DW, 2011, ADV MATER, V23, P5658, DOI 10.1002/adma.201102938; Giovannetti G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1407; Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137; Horiuchi S, 2010, NATURE, V463, P789, DOI 10.1038/nature08731; JAFFE B, 1954, J APPL PHYS, V25, P809, DOI 10.1063/1.1721741; Kalinin SV, 2007, ANNU REV MATER RES, V37, P189, DOI 10.1146/annurev.matsci.37.052506.084323; Kanno I, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064103; KociokKohn G, 1996, ACTA CRYSTALLOGR C, V52, P2309, DOI 10.1107/S010827019600354X; Kroumova E., 2001, J APPL CRYSTALLOGR, V34, P783, DOI DOI 10.1107/S0021889801011852; Lee JH, 2010, NATURE, V466, P954, DOI 10.1038/nature09331; Lines M. E., 2001, PRINCIPLES APPL FERR, DOI DOI 10.1093/ACPROF:OSO/9780198507789.001.0001.; LOVINGER AJ, 1983, SCIENCE, V220, P1115, DOI 10.1126/science.220.4602.1115; LURIO A, 1960, J APPL PHYS, V31, P1125, DOI 10.1063/1.1735762; MEGAW HD, 1945, NATURE, V155, P484; Neacsu CC, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.100107; Nye JF, 1985, PHYS PROPERTIES CRYS; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Scott JF, 2007, SCIENCE, V315, P954, DOI 10.1126/science.1129564; Valasek J, 1921, PHYS REV, V17, P475, DOI 10.1103/PhysRev.17.475; Veithen M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.187401; Zhang W, 2012, CHEM REV, V112, P1163, DOI 10.1021/cr200174w	28	591	606	71	1096	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					425	428		10.1126/science.1229675	http://dx.doi.org/10.1126/science.1229675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349285				2022-12-28	WOS:000313960700037
J	Singer, SR; Schwarz, JA; Manduca, CA; Fox, SP; Iverson, ER; Taylor, BJ; Cannon, SB; May, GD; Maki, SL; Farmer, AD; Doyle, JJ				Singer, Susan R.; Schwarz, Jodi A.; Manduca, Cathryn A.; Fox, Sean P.; Iverson, Ellen R.; Taylor, Benjamin J.; Cannon, Steven B.; May, Gregory D.; Maki, Sonja L.; Farmer, Andrew D.; Doyle, Jeffrey J.			Keeping an Eye on Biology	SCIENCE			English	Editorial Material									[Singer, Susan R.; Maki, Sonja L.] Carleton Coll, Dept Biol, Northfield, MN 55057 USA; [Schwarz, Jodi A.] Vassar Coll, Dept Biol, Poughkeepsie, NY 12604 USA; [Manduca, Cathryn A.; Fox, Sean P.; Iverson, Ellen R.] Carleton Coll, Sci Educ Resource Ctr, Northfield, MN 55057 USA; [Taylor, Benjamin J.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Cannon, Steven B.] Iowa State Univ, USDA ARS, Ames, IA 50010 USA; [May, Gregory D.; Farmer, Andrew D.] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [Doyle, Jeffrey J.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	Carleton College; Vassar College; Carleton College; University of Wisconsin System; University of Wisconsin Madison; Iowa State University; United States Department of Agriculture (USDA); National Center for Genome Resources (NCGR); Cornell University	Singer, SR (corresponding author), Carleton Coll, Dept Biol, Northfield, MN 55057 USA.	ssinger@carleton.edu						Banta LM, 2012, CBE-LIFE SCI EDUC, V11, P203, DOI 10.1187/cbe.11-12-0105; Brewer CA, 2011, VISION CHANGE UNDERG; Laursen S., 2010, UNDERGRADUATE RES SC; Lopatto D., 2009, SCI SOLUTION IMPACT; National Research Council, 2011, FRAM K 12 SCI ED PRA; National Research Council, 2005, AM LAB REP INV HIGH, DOI [10.17226/11311, DOI 10.17226/11311]; National Research Council, 2012, DISCIPLINE BASED ED, DOI 10.17226/13362; Singer SR, 2009, PLANT PHYSIOL, V151, P1041, DOI 10.1104/pp.109.144774; Wei CA, 2011, CBE-LIFE SCI EDUC, V10, P123, DOI 10.1187/cbe.11-03-0028	9	3	3	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					408	409		10.1126/science.1229848	http://dx.doi.org/10.1126/science.1229848			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	076MN	23349282				2022-12-28	WOS:000313960700031
J	Vaduganathan, M; Bonow, RO; Gheorghiade, M				Vaduganathan, Muthiah; Bonow, Robert O.; Gheorghiade, Mihai			Thirty-Day Readmissions The Clock Is Ticking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEART-FAILURE		[Vaduganathan, Muthiah] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA; [Bonow, Robert O.; Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Med, Chicago, IL 60611 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Northwestern University; Feinberg School of Medicine	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Med, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu						Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; GARNICK DW, 1995, HEALTH SERV RES, V29, P679; Gheorghiade M, 2012, HEART FAIL REV, V17, P485, DOI 10.1007/s10741-011-9280-0; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; O'Connor CM, 2010, AM HEART J, V159, P841, DOI 10.1016/j.ahj.2010.02.023; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; van Walraven C, 2011, CAN MED ASSOC J, V183, pE1067, DOI 10.1503/cmaj.110400	8	97	97	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					345	346		10.1001/jama.2012.205110	http://dx.doi.org/10.1001/jama.2012.205110			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074FT	23340632				2022-12-28	WOS:000313799000018
J	Kourrich, S; Hayashi, T; Chuang, JY; Tsai, SY; Su, TP; Bonci, A				Kourrich, Said; Hayashi, Teruo; Chuang, Jian-Ying; Tsai, Shang-Yi; Su, Tsung-Ping; Bonci, Antonello			Dynamic Interaction between Sigma-1 Receptor and Kv1.2 Shapes Neuronal and Behavioral Responses to Cocaine	CELL			English	Article							NUCLEUS-ACCUMBENS NEURONS; K+ CHANNELS; POTASSIUM CHANNELS; BINDING-SITES; DOPAMINE D-1; KINASE-II; ACTIVATION; REWARD; EXCITABILITY; PLASTICITY	The sigma-1 receptor (Sig-1R), an endoplasmic reticulum (ER) chaperone protein, is an interorganelle signaling modulator that potentially plays a role in drug-seeking behaviors. However, the brain site of action and underlying cellular mechanisms remain unidentified. We found that cocaine exposure triggers a Sig-1R-dependent upregulation of D-type K+ current in the nucleus accumbens (NAc) that results in neuronal hypoactivity and thereby enhances behavioral cocaine response. Combining ex vivo and in vitro studies, we demonstrated that this neuroadaptation is caused by a persistent protein-protein association between Sig-1Rs and Kv1.2 channels, a phenomenon that is associated to a redistribution of both proteins from intracellular compartments to the plasma membrane. In conclusion, the dynamic Sig-1R-Kv1.2 complex represents a mechanism that shapes neuronal and behavioral response to cocaine. Functional consequences of Sig-1R binding to K+ channels may have implications for other chronic diseases where maladaptive intrinsic plasticity and Sig-1Rs are engaged.	[Kourrich, Said; Bonci, Antonello] NIDA, Cellular Neurobiol Branch, Intramural Res Program, Baltimore, MD 21224 USA; [Hayashi, Teruo] NIDA, Cellular Stress Signaling Unit, Intramural Res Program, Baltimore, MD 21224 USA; [Hayashi, Teruo; Chuang, Jian-Ying; Tsai, Shang-Yi; Su, Tsung-Ping] NIDA, Cellular Pathobiol Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94608 USA; [Bonci, Antonello] Johns Hopkins Univ, Sch Med, Solomon H Snyder Neurosci Inst, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Johns Hopkins University	Bonci, A (corresponding author), NIDA, Cellular Neurobiol Branch, Intramural Res Program, Baltimore, MD 21224 USA.	antonello.bonci@nih.gov	Kourrich, Said/M-3916-2014		Intramural Research Program at the National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000581, ZICDA000555, ZIADA000206] Funding Source: NIH RePORTER	Intramural Research Program at the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Billy T. Chen, Beate C. Finger, and Roy A. Wise for careful reading of the manuscript. We thank Dhara V. Patel, Stephanie Goddard, Janice Joo, and Keenan Hope for technical help. This work was supported by the Intramural Research Program at the National Institute on Drug Abuse. Viral vectors provided by the NIDA Optogenetics and Transgenic Technology Core facility (Lab head: Brandon K. Harvey).	Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Chen YM, 2007, BIOCHEMISTRY-US, V46, P3532, DOI 10.1021/bi061727o; Crottes D, 2011, J BIOL CHEM, V286, P27947, DOI 10.1074/jbc.M111.226738; Dong LY, 2007, NEUROPHARMACOLOGY, V52, P966, DOI 10.1016/j.neuropharm.2006.10.015; GUNDLACH AL, 1986, J NEUROSCI, V6, P1757; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; He YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041303; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hopf FW, 2003, J NEUROSCI, V23, P5079; Hu XT, 2004, J NEUROPHYSIOL, V92, P1597, DOI 10.1152/jn.00217.2004; Ikemoto S, 2010, NEUROSCI BIOBEHAV R, V35, P129, DOI 10.1016/j.neubiorev.2010.02.001; Ishikawa M, 2009, J NEUROSCI, V29, P5820, DOI 10.1523/JNEUROSCI.5703-08.2009; KAHOUN JR, 1992, P NATL ACAD SCI USA, V89, P1393, DOI 10.1073/pnas.89.4.1393; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kinoshita M, 2012, BRAIN RES, V1452, P1, DOI 10.1016/j.brainres.2012.02.070; Kourrich S, 2012, TRENDS NEUROSCI, V35, P762, DOI 10.1016/j.tins.2012.09.007; Kourrich S, 2012, J NEUROSCI, V32, P6578, DOI 10.1523/JNEUROSCI.6391-11.2012; Kourrich S, 2009, J NEUROSCI, V29, P12275, DOI 10.1523/JNEUROSCI.3028-09.2009; Krause M, 2010, J NEUROSCI, V30, P4746, DOI 10.1523/JNEUROSCI.0197-10.2010; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; MATSUMOTO RR, 1995, EUR J PHARMACOL, V280, P301, DOI 10.1016/0014-2999(95)00208-3; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Mavlyutov TA, 2010, NEUROSCIENCE, V167, P247, DOI 10.1016/j.neuroscience.2010.02.022; Moriguchi S, 2011, J NEUROCHEM, V117, P879, DOI 10.1111/j.1471-4159.2011.07256.x; Mu P, 2010, J NEUROSCI, V30, P3689, DOI 10.1523/JNEUROSCI.4063-09.2010; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; NISENBAUM ES, 1994, J NEUROPHYSIOL, V71, P1174, DOI 10.1152/jn.1994.71.3.1174; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perez MF, 2006, J NEUROPHYSIOL, V96, P2217, DOI 10.1152/jn.00254.2006; Reynolds SM, 2002, J NEUROSCI, V22, P7308; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Shen WX, 2004, J NEUROPHYSIOL, V91, P1337, DOI 10.1152/jn.00414.2003; Soriani O, 1998, J PHARMACOL EXP THER, V286, P163; Stewart J, 2004, NEBR SYM MOTIV, V50, P197; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; Varga AW, 2000, LEARN MEMORY, V7, P321, DOI 10.1101/lm.35300; Zhang HL, 2005, J PHARMACOL EXP THER, V313, P1387, DOI 10.1124/jpet.105.084152	44	150	154	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					236	247		10.1016/j.cell.2012.12.004	http://dx.doi.org/10.1016/j.cell.2012.12.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332758	Green Accepted, Bronze			2022-12-28	WOS:000313719800020
J	Niederman, MS; Krilov, LR				Niederman, Michael S.; Krilov, Leonard R.			Acute lower respiratory infections in developing countries	LANCET			English	Editorial Material							PNEUMONIA ETIOLOGY RESEARCH; CHILDHOOD PNEUMONIA; CHILDREN		[Niederman, Michael S.] SUNY Stony Brook, Winthrop Univ Hosp, Dept Med, Mineola, NY 11501 USA; [Krilov, Leonard R.] SUNY Stony Brook, Winthrop Univ Hosp, Dept Pediat, Mineola, NY 11501 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Winthrop University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Winthrop University Hospital	Niederman, MS (corresponding author), SUNY Stony Brook, Winthrop Univ Hosp, Dept Med, Mineola, NY 11501 USA.	mniederman@winthrop.org						Adegbola RA, 2012, CLIN INFECT DIS, V54, pS89, DOI 10.1093/cid/cir1051; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Gilani Z, 2012, CLIN INFECT DIS, V54, pS102, DOI 10.1093/cid/cir1053; Johnston IDA, 1998, NEW ENGL J MED, V338, P581, DOI 10.1056/NEJM199802263380904; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Madhi SA, 2013, PEDIATR INFECT DIS J, V32, pE119, DOI 10.1097/INF.0b013e3182784b26; Nair H, 2012, LANCET; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Wonodi CB, 2012, CLIN INFECT DIS, V54, pS124, DOI 10.1093/cid/cir1067	11	15	16	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1341	1342		10.1016/S0140-6736(12)62178-3	http://dx.doi.org/10.1016/S0140-6736(12)62178-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130EF	23369798				2022-12-28	WOS:000317894800009
J	Warr, MR; Binnewies, M; Flach, J; Reynaud, D; Garg, T; Malhotra, R; Debnath, J; Passegue, E				Warr, Matthew R.; Binnewies, Mikhail; Flach, Johanna; Reynaud, Damien; Garg, Trit; Malhotra, Ritu; Debnath, Jayanta; Passegue, Emmanuelle			FOXO3A directs a protective autophagy program in haematopoietic stem cells	NATURE			English	Article							GENE ATG5; MITOCHONDRIA; MAINTENANCE; MECHANISMS; SURVIVAL; PATHWAYS; PLAYS; DEATH	Blood production is ensured by rare, self-renewing haematopoietic stem cells (HSCs). How HSCs accommodate the diverse cellular stresses associated with their life-long activity remains elusive. Here we identify autophagy as an essential mechanism protecting HSCs from metabolic stress. We show that mouse HSCs, in contrast to their short-lived myeloid progeny, robustly induce autophagy after ex vivo cytokine withdrawal and in vivo calorie restriction. We demonstrate that FOXO3A is critical to maintain a gene expression program that poises HSCs for rapid induction of autophagy upon starvation. Notably, we find that old HSCs retain an intact FOXO3A-driven pro-autophagy gene program, and that ongoing autophagy is needed to mitigate an energy crisis and allow their survival. Our results demonstrate that autophagy is essential for the life-long maintenance of the HSC compartment and for supporting an old, failing blood system.	[Warr, Matthew R.; Binnewies, Mikhail; Flach, Johanna; Reynaud, Damien; Garg, Trit; Passegue, Emmanuelle] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Malhotra, Ritu; Debnath, Jayanta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Passegue, E (corresponding author), Univ Calif San Francisco, Dept Med, Div Hematol Oncol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	PassegueE@stemcell.ucsf.edu		Reynaud, Damien/0000-0001-8765-8419; Passegue, Emmanuelle/0000-0002-3516-297X; Debnath, Jayanta/0000-0002-8745-4069	Culpepper Scholar Award; NIH [CA126792, HL092471]; CIRM New Faculty Award; NATIONAL CANCER INSTITUTE [R01CA126792, R01CA184014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092471, R01HL111266] Funding Source: NIH RePORTER	Culpepper Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM New Faculty Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Brunet for Foxo3a<SUP>-/-</SUP> mice, S. Oakes for Bak<SUP>-/-</SUP> Sax<SUP>fl/fl</SUP> mice, N. Mizushima for GFP-LC3 transgenic mice, J. Wong for electron microscopy analyses, M. Kissner for management of our Flow Cytometry Core Facility, and all members of the Passegue, particularly E. Pietras, and Debnath laboratories for critical insights and suggestions. M.R.W. is an LLS Special Fellow. This work was supported by a Culpepper Scholar Award (Partnership for Cures) and NIH grant CA126792 to J.D., and a CIRM New Faculty Award and NIH grant HL092471 to E.P.	Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730; Ferraro E, 2007, ARCH BIOCHEM BIOPHYS, V462, P210, DOI 10.1016/j.abb.2007.02.006; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Oguro H, 2007, CURR OPIN IMMUNOL, V19, P503, DOI 10.1016/j.coi.2007.05.001; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Warr MR, 2011, WIRES SYST BIOL MED, V3, P681, DOI 10.1002/wsbm.145; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005	33	411	429	2	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					323	327		10.1038/nature11895	http://dx.doi.org/10.1038/nature11895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23389440	Green Accepted, Green Submitted			2022-12-28	WOS:000315312900031
J	Cang, CL; Zhou, YD; Navarro, B; Seo, YJ; Aranda, K; Shi, L; Battaglia-Hsu, S; Nissim, I; Clapham, DE; Ren, DJ				Cang, Chunlei; Zhou, Yandong; Navarro, Betsy; Seo, Young-jun; Aranda, Kimberly; Shi, Lucy; Battaglia-Hsu, Shyuefang; Nissim, Itzhak; Clapham, David E.; Ren, Dejian			mTOR Regulates Lysosomal ATP-Sensitive Two-Pore Na+ Channels to Adapt to Metabolic State	CELL			English	Article							CALCIUM-CHANNELS; RAG GTPASES; SODIUM; ACTIVATION; NUTRIENT; AUTOPHAGY; PROTEINS; TARGETS; SENSOR; CELLS	Survival in the wild requires organismal adaptations to the availability of nutrients. Endosomes and lysosomes are key intracellular organelles that couple nutrition and metabolic status to cellular responses, but how they detect cytosolic ATP levels is not well understood. Here, we identify an endolysosomal ATP-sensitive Na+ channel (lysoNa(ATP)). The channel is a complex formed by two-pore channels (TPC1 and TPC2), ion channels previously thought to be gated by nicotinic acid adenine dinucleotide phosphate (NAADP), and the mammalian target of rapamycin (mTOR). The channel complex detects nutrient status, becomes constitutively open upon nutrient removal and mTOR translocation off the lysosomal membrane, and controls the lysosome's membrane potential, pH stability, and amino acid homeostasis. Mutant mice lacking lysoNa(ATP) have much reduced exercise endurance after fasting. Thus, TPCs make up an ion channel family that couples the cell's metabolic state to endolysosomal function and are crucial for physical endurance during food restriction.	[Cang, Chunlei; Zhou, Yandong; Seo, Young-jun; Aranda, Kimberly; Shi, Lucy; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Navarro, Betsy; Clapham, David E.] Childrens Hosp, Dept Cardiol, Howard Hughes Med Inst, Boston, MA 02115 USA; [Battaglia-Hsu, Shyuefang] Univ Lorraine, Fac Med, INSERM, U954, F-54505 Vandoeuvre Les Nancy, France; [Nissim, Itzhak] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div Child Dev & Metab Dis,Dept Pediat Biochem & B, Philadelphia, PA 19104 USA	University of Pennsylvania; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Ren, DJ (corresponding author), Univ Penn, Dept Biol, 415 S Univ Ave, Philadelphia, PA 19104 USA.	dren@sas.upenn.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019; Cang, Chunlei/D-9185-2019	Clapham, David/0000-0002-4459-9428; Cang, Chunlei/0000-0002-3302-0927; Shi, Lucy/0000-0002-4652-6089	American Heart Association; NIH [DK-053761]; University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053761, R56DK053761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074257, R01NS055293] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Ren lab for discussion, Amita Tiyaboonchai for starting our interest in macrophages, Drs. Morris Birnbaum and Russell Miller for AMPK1/2 dKO MEF cells, Dr. Sara Cherry for the use of plate reader, Dr. Jie Chen for mTOR and S6K1 clones, and Dr. Denia Ramirez-Montealegre for advice on amino acid efflux assay. This work was supported, in part, by funding from American Heart Association, NIH, and the University of Pennsylvania Research Foundation. Embryonic stem cell injections were performed in the Gene Manipulation Facility of the Children's Hospital Boston (tpc1) and the Transgenic and the Chimeric Mouse Facility at University of Pennsylvanian (tpc2). Amino acid measurement was performed by Ilana Nissim in the Metabolomic Core Facility, Children's Hospital of Philadelphia Research Institute (supported, in part, by NIH grant number DK-053761). C.C. designed experiments and contributed all of the patch-clamp recordings. Y.Z. did protein chemistry experiments, immunocytochemistry, and lysosomal pH imaging. Y.-j.S. performed protein chemistry and ATP measurements. Y.S. and I.N. did amino acid analysis. C.C. and Y.Z. performed amino acid efflux assay. D.R. initiated the project, designed experiments, developed cDNA constructs and the mouse models, and performed the behavior studies. B.N. and S.B.-H. performed pilot studies. K.A. and L.S. developed reagents. D.R. and D.E.C. supervised the projects. C.C., D.E.C., and D.R. wrote the manuscript.	Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; BRADY LJ, 1978, J NUTR, V108, P648, DOI 10.1093/jn/108.4.648; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Challet E, 1997, BEHAV BRAIN RES, V84, P275, DOI 10.1016/S0166-4328(97)83335-9; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Foster DB, 2008, BIOCHEM BIOPH RES CO, V366, P649, DOI 10.1016/j.bbrc.2007.11.154; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Grimm C, 2012, J BIOL CHEM, V287, P22701, DOI 10.1074/jbc.M112.368876; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Laplante M., 2012, COLD SPRING HARB PER, V4, P4; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; McTaggart JS, 2010, J PHYSIOL-LONDON, V588, P3201, DOI 10.1113/jphysiol.2010.191767; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	51	251	256	2	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					778	790		10.1016/j.cell.2013.01.023	http://dx.doi.org/10.1016/j.cell.2013.01.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23394946	Bronze, Green Accepted			2022-12-28	WOS:000314945600013
J	Cui, GH; Jun, SB; Jin, X; Pham, MD; Vogel, SS; Lovinger, DM; Costa, RM				Cui, Guohong; Jun, Sang Beom; Jin, Xin; Pham, Michael D.; Vogel, Steven S.; Lovinger, David M.; Costa, Rui M.			Concurrent activation of striatal direct and indirect pathways during action initiation	NATURE			English	Article							BASAL GANGLIA; IN-VIVO; NEURONS; POPULATIONS; CIRCUITS	The basal ganglia are subcortical nuclei that control voluntary actions, and they are affected by a number of debilitating neurological disorders(1-4). The prevailing model of basal ganglia function proposes that two orthogonal projection circuits originating from distinct populations of spiny projection neurons (SPNs) in the striatum(5,6)-the so-called direct and indirect pathways have opposing effects on movement: activity of direct-pathway SPNs is thought to facilitate movement, whereas activity of indirect-pathway SPNs is presumed to inhibit movement(1,2). This model has been difficult to test owing to the lack of methods to selectively measure the activity of direct- and indirect-pathway SPNs in freely moving animals: Here we develop a novel in vivo method to specifically measure direct- and indirect-pathway SPN activity, using Cre-dependent viral expression of the genetically encoded calcium indicator (GECI) GCaMP3 in the dorsal striatum of D1-Cre (direct-pathway-specific(6,7)) and A2A-Cre (indirect-pathway-specific(8,9)) mice. Using fibre optics and time-correlated single-photon counting (TCSPC) in mice performing an operant task, we observed transient-increases in neural activity in both direct- and indirect-pathway SPNs when animals initiated actions, but not when they were inactive. Concurrent activation of SPNs from both pathways in one hemisphere preceded the initiation of contraversive movements and predicted the occurrence of specific movements within 500 ms. These observations challenge the classical view of basal ganglia function and may have implications for understanding the origin of motor symptoms in basal ganglia disorders.	[Cui, Guohong; Jin, Xin; Pham, Michael D.; Lovinger, David M.; Costa, Rui M.] NIAAA, Sect Vivo Neural Funct, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Jun, Sang Beom] Ewha Womans Univ, Dept Elect Engn, Seoul 120750, South Korea; [Jin, Xin] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Vogel, Steven S.] NIAAA, Sect Cellular Biophoton, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Lovinger, David M.] NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Costa, Rui M.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal; [Costa, Rui M.] Champalimaud Ctr Unknown, P-1400038 Lisbon, Portugal	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Ewha Womans University; Salk Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Fundacao Champalimaud; Instituto Gulbenkian de Ciencia; Fundacao Champalimaud	Vogel, SS (corresponding author), NIAAA, Sect Cellular Biophoton, Lab Mol Physiol, NIH, 5625 Fishers Lane, Bethesda, MD 20892 USA.	stevevog@mail.nih.gov; lovindav@mail.nih.gov; ruicosta@fchampalimaud.org	Cui, Guohong/E-4089-2019	Cui, Guohong/0000-0002-4555-028X; Costa, Rui M./0000-0003-0495-8374; Vogel, Steven/0000-0002-3005-2667	Division of Intramural Clinical and Biological Research of the NIAAA; European Research Council [STG 243393]; International Early Career Scientist grant from the Howard Hughes Medical Institute; National Research Foundation of Korea [2011-0029485, 2012-0004003]; SmartIT Convergence System Research Center from the Korean government (MEST) [SIRC-2011-0031866]; Ellison Medical Foundation [AG-NS-0944-12]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416, ZIAAA000452] Funding Source: NIH RePORTER	Division of Intramural Clinical and Biological Research of the NIAAA; European Research Council(European Research Council (ERC)European Commission); International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Research Foundation of Korea(National Research Foundation of Korea); SmartIT Convergence System Research Center from the Korean government (MEST); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank C. R. Gerfen for gifts of multiple bacterial artificial chromosome (BAC) transgenic mouse lines; L. L. Looger and the Howard Hughes Medical Institute (HHMI) for permission to use AAV GCaMP3 vectors and GCaMP3 mice; S. R. Ikeda for assistance with Ca<SUP>2+</SUP> imaging in brain slices; G. Luo for mouse genotyping; C. Thaler for assistance with FLIM curve analysis; B. Mathur and M. Davis for assistance with brain slice electrophysiology and histology; and A. Martin for assistance with AAV vector injection. This work was supported by the Division of Intramural Clinical and Biological Research of the NIAAA, European Research Council STG 243393, an International Early Career Scientist grant from the Howard Hughes Medical Institute to R.M.C., a National Research Foundation of Korea grant (2011-0029485,2012-0004003) and SmartIT Convergence System Research Center (SIRC-2011-0031866) from the Korean government (MEST) to S.B.J., and by an Ellison Medical Foundation grant (AG-NS-0944-12) to X.J.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Bateup HS, 2010, P NATL ACAD SCI USA, V107, P14845, DOI 10.1073/pnas.1009874107; Brown P, 2007, CURR OPIN NEUROBIOL, V17, P656, DOI 10.1016/j.conb.2007.12.001; Chan CS, 2005, NEUROSIGNALS, V14, P281, DOI 10.1159/000093043; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Elangovan M, 2002, J MICROSC-OXFORD, V205, P3, DOI 10.1046/j.0022-2720.2001.00984.x; FULLER DRG, 1975, BRAIN RES, V96, P337, DOI 10.1016/0006-8993(75)90744-1; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Goldberg JH, 2012, NAT NEUROSCI, V15, P620, DOI 10.1038/nn.3047; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Nambu A, 2008, CURR OPIN NEUROBIOL, V18, P595, DOI 10.1016/j.conb.2008.11.001; Parent A, 2000, TRENDS NEUROSCI, V23, pS20, DOI 10.1016/S1471-1931(00)00022-7; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; SCHIFFMANN SN, 1991, J NEUROCHEM, V57, P1062, DOI 10.1111/j.1471-4159.1991.tb08257.x; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Schweitzer D, 2007, MICROSC RES TECHNIQ, V70, P410, DOI 10.1002/jemt.20427; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012	30	707	721	4	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					238	242		10.1038/nature11846	http://dx.doi.org/10.1038/nature11846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23354054	Green Accepted			2022-12-28	WOS:000315137700040
J	Lin, WR; Conin, M; Moore, JC; Chester, FM; Nakamura, Y; Mori, JJ; Anderson, L; Brodsky, EE; Eguchi, N				Lin, Weiren; Conin, Marianne; Moore, J. Casey; Chester, Frederick M.; Nakamura, Yasuyuki; Mori, James J.; Anderson, Louise; Brodsky, Emily E.; Eguchi, Nobuhisa		Expedition 343 Scientists	Stress State in the Largest Displacement Area of the 2011 Tohoku-Oki Earthquake	SCIENCE			English	Article							M-W 9.0; PACIFIC COAST; TRENCH; ACCRETIONARY; RUPTURE; MARGIN; MODEL; SLIP	The 2011 moment magnitude 9.0 Tohoku-Oki earthquake produced a maximum coseismic slip of more than 50 meters near the Japan trench, which could result in a completely reduced stress state in the region. We tested this hypothesis by determining the in situ stress state of the frontal prism from boreholes drilled by the Integrated Ocean Drilling Program approximately 1 year after the earthquake and by inferring the pre-earthquake stress state. On the basis of the horizontal stress orientations and magnitudes estimated from borehole breakouts and the increase in coseismic displacement during propagation of the rupture to the trench axis, in situ horizontal stress decreased during the earthquake. The stress change suggests an active slip of the frontal plate interface, which is consistent with coseismic fault weakening and a nearly total stress drop.	[Lin, Weiren] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kochi Inst Core Sample Res, Nankoku, Kochi, Japan; [Lin, Weiren] Kochi Univ, Grad Sch Arts & Sci, Geol Course, Kochi 780, Japan; [Lin, Weiren] China Univ Geosci, Minist Educ, Key Lab Tecton & Petr Resources, Wuhan 430074, Peoples R China; [Conin, Marianne] CEREGE, Aix En Provence, France; [Moore, J. Casey; Brodsky, Emily E.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Chester, Frederick M.] Texas A&M Univ, Dept Geol & Geophys, Ctr Tectonophys, College Stn, TX USA; [Nakamura, Yasuyuki] JAMSTEC, Inst Res Earth Evolut, Yokohama, Kanagawa, Japan; [Mori, James J.] Kyoto Univ, Disaster Prevent Res Inst, Uji, Kyoto, Japan; [Anderson, Louise] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Eguchi, Nobuhisa] JAMSTEC, Ctr Deep Earth Explorat, Yokohama, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kochi University; China University of Geosciences; UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California Santa Cruz; Texas A&M University System; Texas A&M University College Station; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kyoto University; University of Leicester; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Lin, WR (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Kochi Inst Core Sample Res, Nankoku, Kochi, Japan.	lin@jamstec.go.jp	Sample, James/A-9622-2015; Chester, Frederick/X-4706-2019; Chester, Frederick M/U-6789-2017; Lin, Weiren/AAC-2088-2020; Mishima, Toshiaki/B-3056-2012; Toy, Virginia/F-9912-2014; Brodsky, Emily/B-9139-2014; remitti, francesca/E-7856-2012	Chester, Frederick M/0000-0001-7665-3647; Lin, Weiren/0000-0003-3228-2789; Mishima, Toshiaki/0000-0003-2290-5743; Toy, Virginia/0000-0002-7621-2064; Kirkpatrick, James/0000-0001-7504-6968; Ishikawa, Tsuyoshi/0000-0003-2886-7282; Fulton, Patrick/0000-0002-6259-2369; Regalla, Christine/0000-0003-2975-8336; Rowe, Christie/0000-0002-9208-3960; Nakamura, Yasuyuki/0000-0001-6750-2791; Brodsky, Emily/0000-0002-6855-6860; Conin, Marianne/0000-0002-6072-3919; Bose, Santanu/0000-0003-0137-4322; remitti, francesca/0000-0002-0720-1927	KAKENHI (Japan Society for the Promotion of Science) [22403008]; Ministry of Education, Culture, Sports, Science and Technology of Japan [21107006]; U.S. Science Support Program of IODP; NERC [NE/K00123X/1] Funding Source: UKRI; Natural Environment Research Council [NE/K00123X/1] Funding Source: researchfish	KAKENHI (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); U.S. Science Support Program of IODP; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	For our research, we used data provided by IODP. The data will be distributed by IODP (www.iodp.org/access-data-and-samples). We thank all drilling and logging operation staff on board the D/V Chikyu during expedition 343. We gratefully acknowledge two anonymous reviewers for their constructive comments, which helped us to greatly improve this manuscript. Part of this work was supported by grant KAKENHI 22403008 (Japan Society for the Promotion of Science), grant 21107006 (Ministry of Education, Culture, Sports, Science and Technology of Japan), and the U.S. Science Support Program of IODP.	[Anonymous], 2012, P IODP, DOI [DOI 10.2204/IODP.PROC.334.103.2012, 10.2204/iodp.proc.334.103.2012]; Argus DF, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003751; Chang CD, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003261; Chester FM, 2012, 343343T IODP, DOI [10.2204/ iodp. pr. 343343T, DOI 10.2204/I0DP.PR.343343T]; Conin M, 2012, EARTH PLANET SC LETT, V341, P170, DOI 10.1016/j.epsl.2012.06.003; Fujii Y, 2011, EARTH PLANETS SPACE, V63, P815, DOI 10.5047/eps.2011.06.010; Fujiwara T, 2011, SCIENCE, V334, P1240, DOI 10.1126/science.1211554; Hasegawa A, 2012, EARTH PLANET SC LETT, V355, P231, DOI 10.1016/j.epsl.2012.08.042; Hasegawa A, 2011, EARTH PLANETS SPACE, V63, P703, DOI 10.5047/eps.2011.06.007; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Ienaga M, 2006, TECTONOPHYSICS, V426, P207, DOI 10.1016/j.tecto.2006.02.018; Imanishi K, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051491; Ito Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048355; Jones N, 2011, NATURE, V479, P16, DOI 10.1038/479016a; Kato A, 2011, EARTH PLANETS SPACE, V63, P745, DOI 10.5047/eps.2011.06.014; Kido M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050057; Kimura G, 2012, EARTH PLANET SC LETT, V339, P32, DOI 10.1016/j.epsl.2012.04.002; Kodaira S, 2012, NAT GEOSCI, V5, P646, DOI [10.1038/ngeo1547, 10.1038/NGEO1547]; Koketsu K, 2011, EARTH PLANET SC LETT, V310, P480, DOI 10.1016/j.epsl.2011.09.009; Lay T, 2011, EARTH PLANETS SPACE, V63, P687, DOI 10.5047/eps.2011.05.033; Lin W, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030515; Lin WR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049097; Lin WR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043158; McNeill LC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018799; Mori J., 2012, IODP SCI PROSP, V343, DOI [10.2204/iodp.sp.343.2012, DOI 10.2204/IODP.SP.343.2012]; Obana K, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050399; Sato M, 2011, SCIENCE, V332, P1395, DOI 10.1126/science.1207401; Tsuru T, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001664; VONHUENE R, 1994, J GEOPHYS RES-SOL EA, V99, P22349, DOI 10.1029/94JB01198; Wu HY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028050; Yoshida K, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049729; Zoback M.D., 2007, RESERVOIR GEOMECHANI, DOI DOI 10.1017/CBO9780511586477	32	87	100	9	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					687	690		10.1126/science.1229379	http://dx.doi.org/10.1126/science.1229379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393262				2022-12-28	WOS:000314585600040
J	Ogo, S; Ichikawa, K; Kishima, T; Matsumoto, T; Nakai, H; Kusaka, K; Ohhara, T				Ogo, Seiji; Ichikawa, Koji; Kishima, Takahiro; Matsumoto, Takahiro; Nakai, Hidetaka; Kusaka, Katsuhiro; Ohhara, Takashi			A Functional [NiFe]Hydrogenase Mimic That Catalyzes Electron and Hydride Transfer from H-2	SCIENCE			English	Article							HYDROGENASE	Chemists have long sought to mimic enzymatic hydrogen activation with structurally simpler compounds. Here, we report a functional [NiFe]-based model of [NiFe] hydrogenase enzymes. This complex heterolytically activates hydrogen to form a hydride complex that is capable of reducing substrates by either hydride ion or electron transfer. Structural investigations were performed by a range of techniques, including x-ray diffraction and neutron scattering, resulting in crystal structures and the finding that the hydrido ligand is predominantly associated with the Fe center. The ligand's hydridic character is manifested in its reactivity with strong acid to liberate H-2.	[Ogo, Seiji; Matsumoto, Takahiro; Nakai, Hidetaka] Kyushu Univ, World Premier Int Res Ctr Initiat, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan; [Ogo, Seiji; Ichikawa, Koji; Kishima, Takahiro; Matsumoto, Takahiro; Nakai, Hidetaka] Kyushu Univ, Grad Sch Engn, Dept Chem & Biochem, Nishi Ku, Fukuoka 8190395, Japan; [Ogo, Seiji] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan; [Kusaka, Katsuhiro] Ibaraki Univ, Frontier Res Ctr Appl Atom Sci, Tokai, Ibaraki 3191106, Japan; [Ohhara, Takashi] Comprehens Res Org Sci & Soc, Res Ctr Neutron Sci & Technol, Tokai, Ibaraki 3191106, Japan	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST); Ibaraki University	Ogo, S (corresponding author), Kyushu Univ, World Premier Int Res Ctr Initiat, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan.	ogotcm@mail.cstm.kyushu-u.ac.jp	Matsumoto, Takahiro/AAF-6046-2021	Nakai, Hidetaka/0000-0002-8548-1987; Matsumoto, Takahiro/0000-0002-8985-0006; Ohhara, Takashi/0000-0002-1215-6032	WPI; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [23655053, 24750058, 24109016]; Basic Research Programs CREST Type, "Development of the Foundation for Nano-Interface Technology" from JST, Japan; Grants-in-Aid for Scientific Research [24109016, 24681016] Funding Source: KAKEN	WPI; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Basic Research Programs CREST Type, "Development of the Foundation for Nano-Interface Technology" from JST, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the WPI; grants-in-aid 23655053, 24750058, and 24109016 (Scientific Research on Innovative Areas "Stimuli-responsive Chemical Species") from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; and the Basic Research Programs CREST Type, "Development of the Foundation for Nano-Interface Technology" from JST, Japan. Crystallographic data for [1](BPh<INF>4</INF>)<INF>2</INF>, [2](BPh<INF>4</INF>), and [Ni<SUP>II</SUP>(X')Fe<SUP>II</SUP>(Br)<INF>2</INF>] have been deposited with the Cambridge Crystallographic Data Center under reference numbers CCDC-904876 (x-ray diffraction, 1), 904877 (x-ray diffraction, 2), 904874 (neutron scattering, 2), and 904875 {x-ray diffraction, [Ni<SUP>II</SUP>(X')Fe<SUP>II</SUP>(Br)<INF>2</INF>]}, respectively.	Barton BE, 2009, J AM CHEM SOC, V131, P6942, DOI 10.1021/ja902570u; Cammack R., 2001, HYDROGEN FUEL LEARNI; Gloaguen F, 2009, CHEM SOC REV, V38, P100, DOI 10.1039/b801796b; Higuchi Y, 1999, STRUCT FOLD DES, V7, P549, DOI 10.1016/S0969-2126(99)80071-9; Kubas GJ, 2007, CHEM REV, V107, P4152, DOI 10.1021/cr050197j; Ogo S, 2007, SCIENCE, V316, P585, DOI 10.1126/science.1138751; Ogo S, 2009, CHEM COMMUN, P3317, DOI 10.1039/b900297a; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; Tye JW, 2005, P NATL ACAD SCI USA, V102, P16911, DOI 10.1073/pnas.0508740102	9	197	198	2	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					682	684		10.1126/science.1231345	http://dx.doi.org/10.1126/science.1231345			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393260				2022-12-28	WOS:000314585600038
J	Hawton, K; Bergen, H; Simkin, S; Dodd, S; Pocock, P; Bernal, W; Gunnell, D; Kapur, N				Hawton, Keith; Bergen, Helen; Simkin, Sue; Dodd, Sue; Pocock, Phil; Bernal, William; Gunnell, David; Kapur, Navneet			Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: interrupted time series analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-KINGDOM; SELF-HARM; CHANGING PATTERNS; UK; ACETAMINOPHEN; LEGISLATION; SUICIDE; FAILURE; IMPACT; AVAILABILITY	Objective To assess the long term effect of United Kingdom legislation introduced in September 1998 to restrict pack sizes of paracetamol on deaths from paracetamol poisoning and liver unit activity. Design Interrupted time series analyses to assess mean quarterly changes from October 1998 to the end of 2009 relative to projected deaths without the legislation based on pre-legislation trends. Setting Mortality (1993-2009) and liver unit activity (1995-2009) in England and Wales, using information from the Office for National Statistics and NHS Blood and Transplant, respectively. Participants Residents of England and Wales. Main outcome measures Suicide, deaths of undetermined intent, and accidental poisoning deaths involving single drug ingestion of paracetamol and paracetamol compounds in people aged 10 years and over, and liver unit registrations and transplantations for paracetamol induced hepatotoxicity. Results Compared with the pre-legislation level, following the legislation there was an estimated average reduction of 17 (95% confidence interval -25 to -9) deaths per quarter in England and Wales involving paracetamol alone (with or without alcohol) that received suicide or undetermined verdicts. This decrease represented a 43% reduction or an estimated 765 fewer deaths over the 11 1/4 years after the legislation. A similar effect was found when accidental poisoning deaths were included, and when a conservative method of analysis was used. This decrease was largely unaltered after controlling for a non-significant reduction in deaths involving other methods of poisoning and also suicides by all methods. There was a 61% reduction in registrations for liver transplantation for paracetamol induced hepatotoxicity (-11 (-20 to -1) registrations per quarter). But no reduction was seen in actual transplantations (-3 (-12 to 6)), nor in registrations after a conservative method of analysis was used. Conclusions UK legislation to reduce pack sizes of paracetamol was followed by significant reductions in deaths due to paracetamol overdose, with some indication of fewer registrations for transplantation at liver units during the 11 years after the legislation. The continuing toll of deaths suggests, however, that further preventive measures should be sought.	[Hawton, Keith; Bergen, Helen; Simkin, Sue] Univ Oxford, Ctr Suicide Res, Dept Psychiat, Warneford Hosp, Oxford OX3 7JX, England; [Dodd, Sue] Med & Healthcare Prod Regulatory Agcy, Post Authorisat Signal Unit, London, England; [Pocock, Phil] NHS Blood & Transplant, Stat & Clin Audit, Bristol, Avon, England; [Bernal, William] Kings Coll Hosp London, Liver Intens Therapy Unit, Inst Liver Studies, London, England; [Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Kapur, Navneet] Univ Manchester, Ctr Suicide Prevent, Manchester, Lancs, England	University of Oxford; The Medicines & Healthcare Products Regulatory Agency; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Bristol; University of Manchester	Hawton, K (corresponding author), Univ Oxford, Ctr Suicide Res, Dept Psychiat, Warneford Hosp, Oxford OX3 7JX, England.	keith.hawton@psych.ox.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Kapur, Nav/0000-0002-3100-3234	National Institute for Health Research (NIHR) [RP-PG-0606-1247]; Oxford Health NHS Foundation Trust; Department of Health under the NHS Research and Development Programme [DH/DSH2008]; Manchester Mental Health and Social Care Trust; National Institute for Health Research [NF-SI-0508-10053, RP-PG-0606-1247, NF-SI-0512-10068] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Oxford Health NHS Foundation Trust; Department of Health under the NHS Research and Development Programme; Manchester Mental Health and Social Care Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RP-PG-0606-1247) as part of a programme of work related to suicide prevention. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health, or the Medicines and Healthcare Products Regulatory Agency. The funder had no role in the study design; collection, analysis, and interpretation of data; writing of the report; and decision to submit the paper for publication. KH and DG are NIHR senior investigators. KH is also supported by the Oxford Health NHS Foundation Trust, HB by the Department of Health under the NHS Research and Development Programme (DH/DSH2008), and NK by the Manchester Mental Health and Social Care Trust.	Bateman DN, 2006, BRIT J CLIN PHARMACO, V62, P573, DOI 10.1111/j.1365-2125.2006.02668.x; Bateman DN, 2009, CLIN TOXICOL, V47, P536, DOI 10.1080/15563650903093192; Bergen H, 2010, BRIT J PSYCHIAT, V197, P493, DOI 10.1192/bjp.bp.110.077651; Bernal W, 2003, SEMIN LIVER DIS, V23, P227; Bernal W, 2008, SEMIN LIVER DIS, V28, P188, DOI 10.1055/s-2008-1073118; Bialas MC, 1996, QJM-INT J MED, V89, P893; BRAY GP, 1993, BRIT MED J, V306, P157, DOI 10.1136/bmj.306.6871.157; Buckley NA, 2007, PLOS MED, V4, P612, DOI 10.1371/journal.pmed.0040152; Charlton J., 1993, POPULATION TRENDS, V71, P34; Gottlieb S, 2005, BRIT MED J, V330, P9, DOI 10.1136/bmj.330.7481.9-c; Gow PJ, 1999, J GASTROEN HEPATOL, V14, P817, DOI 10.1046/j.1440-1746.1999.01959.x; Greene SL, 2006, POSTGRAD MED J, V82, P520, DOI 10.1136/pgmj.2005.042036; Gunnell D, 1997, J EPIDEMIOL COMMUN H, V51, P175, DOI 10.1136/jech.51.2.175; Gunnell D, 2000, SUICIDE LIFE-THREAT, V30, P313; Gunnell D, 1997, CURRENT PROBLEMS PHA, V23, P9; Hawkins LC, 2007, DRUG SAFETY, V30, P465, DOI 10.2165/00002018-200730060-00002; HAWTON K, 1995, BRIT MED J, V310, P164, DOI 10.1136/bmj.310.6973.164; Hawton K, 2004, BMJ-BRIT MED J, V329, P1076, DOI 10.1136/bmj.38253.572581.7C; Hawton K, 2001, BMJ-BRIT MED J, V322, P1203, DOI 10.1136/bmj.322.7296.1203; Hawton K, 1997, BRIT J PSYCHIAT, V171, P556, DOI 10.1192/bjp.171.6.556; Hawton K, 1996, BRIT J PSYCHIAT, V168, P43, DOI 10.1192/bjp.168.1.43; Hawton K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001213; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Moller LR, 2004, EUR J CLIN PHARMACOL, V59, P911, DOI 10.1007/s00228-003-0713-0; Morgan O, 2005, J PUBLIC HEALTH, V27, P19, DOI 10.1093/pubmed/fdh216; Morgan OW, 2007, PLOS MED, V4, P654, DOI 10.1371/journal.pmed.0040105; Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730; Prince MI, 2000, LANCET, V355, P2047, DOI 10.1016/S0140-6736(00)02354-0; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Sheen CL, 2002, PHARMACOEPIDEM DR S, V11, P329, DOI 10.1002/pds.701; Simkin S, 2012, QJM-INT J MED, V105, P41, DOI 10.1093/qjmed/hcr135; *STAT CORP, 2007, STAT STAT SOFTW REL; U.S. Food and Drug Administration, 2011, FDA LIM AC PRESCR CO; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Zhang F, 2002, ESTIMATING CONFIDENC	36	127	128	0	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2013	346								f403	10.1136/bmj.f403	http://dx.doi.org/10.1136/bmj.f403			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088AV	23393081	hybrid, Green Published			2022-12-28	WOS:000314807100001
J	Kornfeld, JW; Baitzel, C; Konner, AC; Nicholls, HT; Vogt, MC; Herrmanns, K; Scheja, L; Haumaitre, C; Wolf, AM; Knippschild, U; Seibler, J; Cereghini, S; Heeren, J; Stoffel, M; Bruning, JC				Kornfeld, Jan-Wilhelm; Baitzel, Catherina; Koenner, A. Christine; Nicholls, Hayley T.; Vogt, Merly C.; Herrmanns, Karolin; Scheja, Ludger; Haumaitre, Cecile; Wolf, Anna M.; Knippschild, Uwe; Seibler, Jost; Cereghini, Silvia; Heeren, Joerg; Stoffel, Markus; Bruening, Jens C.			Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b	NATURE			English	Article							INSULIN; CDKN2A/B; CDKAL1; TCF2	Insulin resistance represents a hallmark during the development of type 2 diabetes mellitus and in the pathogenesis of obesity-associated disturbances of glucose and lipid metabolism(1-3). MicroRNA (miRNA)-dependent post-transcriptional gene silencing has been recognized recently to control gene expression in disease development and progression, including that of insulin-resistant type 2 diabetes. The deregulation of miRNAs miR-143 (ref. 4), miR-181 (ref. 5), and miR-103 and miR-107 (ref. 6) alters hepatic insulin sensitivity. Here we report that the expression of miR-802 is increased in the liver of two obese mouse models and obese human subjects. Inducible transgenic overexpression of miR-802 in mice causes impaired glucose tolerance and attenuates insulin sensitivity, whereas reduction of miR-802 expression improves glucose tolerance and insulin action. We identify Hnf1b (also known as Tcf2) as a target of miR-802-dependent silencing, and show that short hairpin RNA (shRNA)-mediated reduction of Hnf1b in liver causes glucose intolerance, impairs insulin signalling and promotes hepatic gluconeogenesis. In turn, hepatic overexpression of Hnf1b improves insulin sensitivity in Lepr(db/db) mice. Thus, this study defines a critical role for deregulated expression of miR-802 in the development of obesity-associated impairment of glucose metabolism through targeting of Hnf1b, and assigns Hnf1b an unexpected role in the control of hepatic insulin sensitivity.	[Kornfeld, Jan-Wilhelm; Baitzel, Catherina; Koenner, A. Christine; Nicholls, Hayley T.; Vogt, Merly C.; Bruening, Jens C.] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Kornfeld, Jan-Wilhelm; Baitzel, Catherina; Koenner, A. Christine; Nicholls, Hayley T.; Vogt, Merly C.; Bruening, Jens C.] Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Kornfeld, Jan-Wilhelm; Baitzel, Catherina; Koenner, A. Christine; Nicholls, Hayley T.; Vogt, Merly C.; Bruening, Jens C.] Univ Cologne, Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Dept Mouse Genet & Metab,Inst Genet, D-50674 Cologne, Germany; [Kornfeld, Jan-Wilhelm; Baitzel, Catherina; Koenner, A. Christine; Nicholls, Hayley T.; Vogt, Merly C.; Bruening, Jens C.] Ctr Mol Med Cologne, D-50674 Cologne, Germany; [Herrmanns, Karolin; Stoffel, Markus] Swiss Fed Inst Technol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Scheja, Ludger; Heeren, Joerg] Univ Hosp Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, D-20246 Hamburg, Germany; [Haumaitre, Cecile; Cereghini, Silvia] INSERM, U969, F-75005 Paris, France; [Haumaitre, Cecile; Cereghini, Silvia] Univ Paris 06, CNRS, UMR7622, F-75005 Paris, France; [Wolf, Anna M.; Knippschild, Uwe] Univ Hosp Ulm, Dept Gen & Visceral Surg, D-89081 Ulm, Germany; [Seibler, Jost] TaconicArtemis GmbH, D-51063 Cologne, Germany	Max Planck Society; University of Cologne; University of Cologne; University of Cologne; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Ulm University	Bruning, JC (corresponding author), Max Planck Inst Neurol Res, Gleueler Str 50A, D-50931 Cologne, Germany.	bruening@nf.mpg.de	Haumaitre, Cecile/E-5455-2017; Kornfeld, Jan-Wilhelm/AAF-1170-2019; Vogt, Merly/AAF-3789-2021	Haumaitre, Cecile/0000-0003-3526-7832; Kornfeld, Jan-Wilhelm/0000-0002-6802-4442; Stoffel, Markus/0000-0003-1304-5817	EMBO; CECAD; INSERM; CNRS; EU FP7 (Mane Curie Initial Training Network BOLD); ERC; DFG [SFB 841, Br1492-7]	EMBO(European Molecular Biology Organization (EMBO)); CECAD; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); EU FP7 (Mane Curie Initial Training Network BOLD); ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG))	J.-W.K. was supported by stipends from EMBO and CECAD. S.C. received funds from INSERM, CNRS and EU FP7 (Mane Curie Initial Training Network BOLD). This work was in part supported by ERC grant 'Metabolomirs' (to M.S.), by a grant to J.H. by the DFG (SFB 841) and DFG funding to J.C.B. (Br1492-7). We thank D. Wagner-Stippich, J. Alber, P. Scholl and B. Hampel for technical assistance.	Barbacci E, 1999, DEVELOPMENT, V126, P4795; Bellanne-Chantelot C, 2004, ANN INTERN MED, V140, P510, DOI 10.7326/0003-4819-140-7-200404060-00009; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Haumaitre C, 2006, HUM MOL GENET, V15, P2363, DOI 10.1093/hmg/ddl161; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Lindner TH, 1999, HUM MOL GENET, V8, P2001, DOI 10.1093/hmg/8.11.2001; Ma ZD, 2007, P NATL ACAD SCI USA, V104, P20386, DOI 10.1073/pnas.0705957104; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Wen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009153; Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8	17	238	257	3	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					111	115		10.1038/nature11793	http://dx.doi.org/10.1038/nature11793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389544				2022-12-28	WOS:000314741200044
J	Kesselheim, AS; Mello, MM; Avorn, J				Kesselheim, Aaron S.; Mello, Michelle M.; Avorn, Jerry			FDA Regulation of Off-label Drug Promotion Under Attack	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHARMACEUTICAL PROMOTION		[Kesselheim, Aaron S.; Avorn, Jerry] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Mello, Michelle/0000-0003-2877-4270	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER; AHRQ HHS [K08HS18465-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Gagnon MA, 2008, PLOS MED, V5, P29, DOI 10.1371/journal.pmed.0050001; Jazz Pharmaceuticals Inc, 2007, AGR PAY 20 MILL RES; Kesselheim AS, 2008, NEW ENGL J MED, V358, P1727, DOI 10.1056/NEJMsb0708920; Mello MM, 2011, NEW ENGL J MED, V365, P1248, DOI 10.1056/NEJMhle1107678; Orphan Medical, 2002, XYR DRUG LAB	5	9	10	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					445	446		10.1001/jama.2012.207972	http://dx.doi.org/10.1001/jama.2012.207972			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083LY	23385267				2022-12-28	WOS:000314466900022
J	Hemmer, P				Hemmer, Philip			Toward Molecular-Scale MRI	SCIENCE			English	Editorial Material							MAGNETIC-RESONANCE; SPIN		Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Hemmer, P (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.	prhemmer@ece.tamu.edu						Barasubramanian G., 2008, NATURE, V455, P648; Degen CL, 2009, P NATL ACAD SCI USA, V106, P1313, DOI 10.1073/pnas.0812068106; Grotz B, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/055004; Mamin HJ, 2013, SCIENCE, V339, P557, DOI 10.1126/science.1231540; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; RUGAR D, 1994, SCIENCE, V264, P1560, DOI 10.1126/science.264.5165.1560; Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675	9	11	11	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					529	530		10.1126/science.1233222	http://dx.doi.org/10.1126/science.1233222			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372003				2022-12-28	WOS:000314270000044
J	Arkhipov, A; Shan, YB; Das, R; Endres, NF; Eastwood, MP; Wemmer, DE; Kuriyan, J; Shaw, DE				Arkhipov, Anton; Shan, Yibing; Das, Rahul; Endres, Nicholas F.; Eastwood, Michael P.; Wemmer, David E.; Kuriyan, John; Shaw, David E.			Architecture and Membrane Interactions of the EGF Receptor	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; TRANSMEMBRANE DOMAIN; JUXTAMEMBRANE REGION; ONCOGENIC MUTATIONS; LIGAND-BINDING; ACTIVATION; DIMERIZATION; KINASE	Dimerization-driven activation of the intracellular kinase domains of the epidermal growth factor receptor (EGFR) upon extracellular ligand binding is crucial to cellular pathways regulating proliferation, migration, and differentiation. Inactive EGFR can exist as both monomers and dimers, suggesting that the mechanism regulating EGFR activity may be subtle. The membrane itself may play a role but creates substantial difficulties for structural studies. Our molecular dynamics simulations of membrane-embedded EGFR suggest that, in ligand-bound dimers, the extracellular domains assume conformations favoring dimerization of the transmembrane helices near their N termini, dimerization of the juxtamembrane segments, and formation of asymmetric (active) kinase dimers. In ligand-free dimers, by holding apart the N termini of the transmembrane helices, the extracellular domains instead favor C-terminal dimerization of the transmembrane helices, juxtamembrane segment dissociation and membrane burial, and formation of symmetric (inactive) kinase dimers. Electrostatic interactions of EGFR's intracellular module with the membrane are critical in maintaining this coupling.	[Arkhipov, Anton; Shan, Yibing; Eastwood, Michael P.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Das, Rahul; Endres, Nicholas F.; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Das, Rahul; Endres, Nicholas F.; Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Columbia University	Shan, YB (corresponding author), DE Shaw Res, New York, NY 10036 USA.	yibing.shan@deshawresearch.com; david.shaw@deshawresearch.com	Arkhipov, Anton/AAE-7801-2020; Das, Rahul/AAU-5123-2020	Arkhipov, Anton/0000-0003-1106-8310; Das, Rahul/0000-0001-7841-8229	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; National Cancer Institute (NCI) [2-R01-CA096504-06]; NATIONAL CANCER INSTITUTE [R01CA096504] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Morten Jensen, Stefano Piana, and Kresten Lindorff-Larsen for helpful discussions, Ansgar Philipsen for assistance with graphics, and Mollie Kirk and Berkman Frank for editorial assistance. N.F.E. was a Leukemia and Lymphoma Society Fellow. R.D. was supported by postdoctoral fellowships from the Natural Sciences and Engineering Research Council of Canada (2009-2011) and the Canadian Institutes of Health Research (2011-2012). This work was supported by a grant from the National Cancer Institute (NCI) to J.K. (2-R01-CA096504-06).	Alvarado D, 2009, NATURE, V461, P287, DOI 10.1038/nature08297; Bessman NJ, 2012, NAT STRUCT MOL BIOL, V19, P1, DOI 10.1038/nsmb.2221; Bocharov EV, 2008, J BIOL CHEM, V283, P6950, DOI 10.1074/jbc.M709202200; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Choowongkomon K, 2005, J BIOL CHEM, V280, P24043, DOI 10.1074/jbc.M502698200; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; Du Y, 2012, J AM CHEM SOC, V134, P6720, DOI 10.1021/ja211941d; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kastner J, 2009, J STRUCT BIOL, V167, P117, DOI 10.1016/j.jsb.2009.04.007; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; Landau M, 2008, BBA-REV CANCER, V1785, P12, DOI 10.1016/j.bbcan.2007.08.001; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Liu P, 2012, PROTEIN SCI, V21, P152, DOI 10.1002/pro.753; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Mi LZ, 2011, NAT STRUCT MOL BIOL, V18, P984, DOI 10.1038/nsmb.2092; Michailidis IE, 2011, PFLUG ARCH EUR J PHY, V461, P387, DOI 10.1007/s00424-010-0904-3; Odaka M, 1997, J BIOCHEM-TOKYO, V122, P116; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Riese DJ, 2007, BIOESSAYS, V29, P558, DOI 10.1002/bies.20582; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Scheck RA, 2012, ACS CHEM BIOL, V7, P1367, DOI 10.1021/cb300216f; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Shaw D. E., 2009, P C HIGH PERF COMP N, V39, P1, DOI DOI 10.1145/1654059.1654099; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Wang ZH, 2011, NAT STRUCT MOL BIOL, V18, P1388, DOI 10.1038/nsmb.2168; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	45	337	341	1	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					557	569		10.1016/j.cell.2012.12.030	http://dx.doi.org/10.1016/j.cell.2012.12.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374350	Bronze, Green Accepted			2022-12-28	WOS:000314362800024
J	Casazza, K; Fontaine, KR; Astrup, A; Birch, LL; Brown, AW; Brown, MMB; Durant, N; Dutton, G; Foster, EM; Heymsfield, SB; McIver, K; Mehta, T; Menachemi, N; Newby, PK; Pate, R; Rolls, BJ; Sen, B; Smith, DL; Thomas, DM; Allison, DB				Casazza, Krista; Fontaine, Kevin R.; Astrup, Arne; Birch, Leann L.; Brown, Andrew W.; Brown, Michelle M. Bohan; Durant, Nefertiti; Dutton, Gareth; Foster, E. Michael; Heymsfield, Steven B.; McIver, Kerry; Mehta, Tapan; Menachemi, Nir; Newby, P. K.; Pate, Russell; Rolls, Barbara J.; Sen, Bisakha; Smith, Daniel L., Jr.; Thomas, Diana M.; Allison, David B.			Myths, Presumptions, and Facts about Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEIGHT-LOSS; ENERGY-INTAKE; PHYSICAL-ACTIVITY; EXERCISE; INTERVENTIONS; ASSOCIATION; MAINTENANCE; CONSUMPTION; DISEASE; BALANCE	BACKGROUND Many beliefs about obesity persist in the absence of supporting scientific evidence (presumptions); some persist despite contradicting evidence (myths). The promulgation of unsupported beliefs may yield poorly informed policy decisions, inaccurate clinical and public health recommendations, and an unproductive allocation of research resources and may divert attention away from useful, evidence-based information. METHODS Using Internet searches of popular media and scientific literature, we identified, reviewed, and classified obesity-related myths and presumptions. We also examined facts that are well supported by evidence, with an emphasis on those that have practical implications for public health, policy, or clinical recommendations. RESULTS We identified seven obesity-related myths concerning the effects of small sustained increases in energy intake or expenditure, establishment of realistic goals for weight loss, rapid weight loss, weight-loss readiness, physical-education classes, breast-feeding, and energy expended during sexual activity. We also identified six presumptions about the purported effects of regularly eating breakfast, early childhood experiences, eating fruits and vegetables, weight cycling, snacking, and the built (i.e., human-made) environment. Finally, we identified nine evidence-supported facts that are relevant for the formulation of sound public health, policy, or clinical recommendations. CONCLUSIONS False and scientifically unsupported beliefs about obesity are pervasive in both scientific literature and the popular press. (Funded by the National Institutes of Health.)	[Casazza, Krista; Brown, Michelle M. Bohan; Smith, Daniel L., Jr.; Allison, David B.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Fontaine, Kevin R.] Univ Alabama Birmingham, Dept Hlth Behav, Birmingham, AL 35294 USA; [Durant, Nefertiti] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Dutton, Gareth] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Foster, E. Michael; Menachemi, Nir; Sen, Bisakha] Univ Alabama Birmingham, Dept Hlth Care Org & Policy, Birmingham, AL 35294 USA; [Mehta, Tapan; Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Brown, Andrew W.; Allison, David B.] Univ Alabama Birmingham, Sch Publ Hlth, Off Energet, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Astrup, Arne] Univ Copenhagen, OPUS Ctr, Copenhagen, Denmark; [Astrup, Arne] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Birch, Leann L.] Penn State Univ, Dept Dev & Family Studies, University Pk, PA 16802 USA; [Rolls, Barbara J.] Penn State Univ, Dept Nutrit Sci, University Pk, PA 16802 USA; [Heymsfield, Steven B.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [McIver, Kerry; Pate, Russell] Univ S Carolina, Childrens Phys Act Res Grp, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Newby, P. K.] Boston Univ, Dept Pediat, Program Grad Med Nutr Sci, Boston, MA 02215 USA; [Newby, P. K.] Boston Univ, Dept Epidemiol, Program Grad Med Nutr Sci, Boston, MA 02215 USA; [Newby, P. K.] Boston Univ, Program Gastron Culinary Arts & Wine Studies, Boston, MA 02215 USA; [Thomas, Diana M.] Montclair State Univ, Ctr Quantitat Obes Res, Montclair, NJ USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Copenhagen; University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Boston University; Boston University; Boston University; Montclair State University	Allison, DB (corresponding author), Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.	dallison@uab.edu	Rolls, Barbara J/AAE-3899-2019; Bohan Brown, Michelle/L-7778-2014; Robles-Sardin, Alma E/M-7714-2015; Brown, Andrew W/N-1826-2013; Heymsfield, Steven B/N-1968-2017; Astrup, Arne/B-1407-2015	Bohan Brown, Michelle/0000-0002-7959-9225; Robles-Sardin, Alma E/0000-0003-2044-7793; Brown, Andrew W/0000-0002-1758-8205; Heymsfield, Steven B/0000-0003-1127-9425; Smith Jr, Daniel/0000-0002-1602-2023; Astrup, Arne/0000-0001-8968-8996; Allison, David/0000-0003-3566-9399	National Institutes of Health [P30DK056336]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK083333, T32DK062710, P30DK056336, P01DK042618, P30DK026687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by a grant (P30DK056336) from the National Institutes of Health.	Astrup A, 2000, Obes Rev, V1, P17, DOI 10.1046/j.1467-789x.2000.00004.x; BOHLEN JG, 1984, ARCH INTERN MED, V144, P1745, DOI 10.1001/archinte.144.9.1745; Brisbois TD, 2012, OBES REV, V13, P347, DOI 10.1111/j.1467-789X.2011.00965.x; Carroll S, 2004, SPORTS MED, V34, P371, DOI 10.2165/00007256-200434060-00004; Casazza K., 2012, Nutrition Today, V47, P33; Dobbins M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651; Fairman KA, 2011, J MANAGE CARE PHARM, V17, P224, DOI 10.18553/jmcp.2011.17.3.224; Federal Trade Commission, 2001, DIET SUPPL ADV GUID; Ferdinand AO, 2012, AM J PUBLIC HEALTH, V102, pE7, DOI 10.2105/AJPH.2012.300740; Fontaine KR, 1999, J AM DIET ASSOC, V99, P664, DOI 10.1016/S0002-8223(99)00159-5; Gillman MW, 2011, INT J EPIDEMIOL, V40, P681, DOI 10.1093/ije/dyr085; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Hewitt JK, 1997, BEHAV GENET, V27, P353, DOI 10.1023/A:1025687930765; Heymsfield SB, 2011, AM J CLIN NUTR, V94, P3, DOI 10.3945/ajcn.111.018630; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Horta BL, 2007, EVIDENCE LONG TERM E; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Kahneman D., 2011, THINKING FAST SLOW; Kramer MS, 2008, PEDIATRICS, V121, pE435, DOI 10.1542/peds.2007-1248; Kriemler S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c785; Lilienfeld SO, 2009, PERSPECT PSYCHOL SCI, V4, P390, DOI 10.1111/j.1745-6924.2009.01144.x; Linde JA, 2005, INT J OBESITY, V29, P1002, DOI 10.1038/sj.ijo.0802990; McLean N, 2003, INT J OBESITY, V27, P987, DOI 10.1038/sj.ijo.0802383; Middleton KMR, 2012, OBES REV, V13, P509, DOI 10.1111/j.1467-789X.2011.00972.x; Nackers LM, 2010, INT J BEHAV MED, V17, P161, DOI 10.1007/s12529-010-9092-y; Rolls BJ, 2004, NUTR REV, V62, P1, DOI [10.1301/nr.2004.jan.1-17, 10.1301/nr.2004.jan.1&ndash;17, 10.1111/j.1753-4887.2004.tb00001.x]; SCHLUNDT DG, 1992, AM J CLIN NUTR, V55, P645, DOI 10.1093/ajcn/55.3.645; Shermer M., 2007, WHY PEOPLE BELIEVE W; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; TAUBES G, 1995, SCIENCE, V269, P164, DOI 10.1126/science.7618077; Thomas Diana M., 2011, Journal of Biological Dynamics, V5, P579, DOI 10.1080/17513758.2010.508541; Thomas DM, 2010, AM J CLIN NUTR, V92, P1326, DOI 10.3945/ajcn.2010.29687; Vasselli JR, 2005, OBES RES, V13, P693, DOI 10.1038/oby.2005.78; Whately, 1875, ELEMENTS LOGIC; Whybrow S, 2007, OBESITY, V15, P673, DOI 10.1038/oby.2007.567; Wing RR, 2001, OBES RES, V9, p271S, DOI 10.1038/oby.2001.130; Wright SM, 2011, NAT REV ENDOCRINOL, V7, P69, DOI 10.1038/nrendo.2010.231; Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.x	40	287	295	1	248	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					446	454		10.1056/NEJMsa1208051	http://dx.doi.org/10.1056/NEJMsa1208051			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BE	23363498	Green Accepted, Green Published			2022-12-28	WOS:000314215400009
J	Tang, YC; Amon, A				Tang, Yun-Chi; Amon, Angelika			Gene Copy-Number Alterations: A Cost-Benefit Analysis	CELL			English	Review							HUMAN-BREAST-CANCER; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL INSTABILITY; RIBOSOMAL-RNA; MOUSE MODEL; CONSTITUTIONAL ANEUPLOIDY; DOSAGE COMPENSATION; ADAPTIVE EVOLUTION; DNA-REPLICATION; STRESS-RESPONSE	Changes in DNA copy number, whether confined to specific genes or affecting whole chromosomes, have been identified as causes of diseases and developmental abnormalities and as sources of adaptive potential. Here, we discuss the costs and benefits of DNA copy-number alterations. Changes in DNA copy number are largely detrimental. Amplifications or deletions of specific genes can elicit discrete defects. Large-scale changes in DNA copy number can also cause detrimental phenotypes that are due to the cumulative effects of copy-number alterations of many genes simultaneously. On the other hand, studies in microorganisms show that DNA copy-number alterations can be beneficial, increasing survival under selective pressure. As DNA copy-number alterations underlie many human diseases, we will end with a discussion of gene copy-number changes as therapeutic targets.	[Tang, Yun-Chi; Amon, Angelika] MIT, Howard Hughes Med Inst, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Howard Hughes Med Inst, David H Koch Inst Integrat Canc Res, 76-561,500 Main St, Cambridge, MA 02139 USA.	angelika@mit.edu	Tang, Yun-Chi/GRE-8205-2022	tang, yun qi/0000-0001-9385-2787; Amon, Angelika/0000-0001-9837-0314	NIH [GM56800]; Human Frontier Science Program Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056800, R01GM056800] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Fellowship(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Pellman, M. Dunham, F. Solomon, S. Pfau, J. Sheltzer, J. Rock, and K. Knouse for their critical reading of this manuscript. Work in the Amon lab was supported by NIH grant GM56800. A.A. is also an Investigator of the Howard Hughes Medical Institute. Y.-C.T. is supported by a Human Frontier Science Program Fellowship.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baselga J, 1998, CANCER RES, V58, P2825; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Brown CJ, 1998, MOL BIOL EVOL, V15, P931, DOI 10.1093/oxfordjournals.molbev.a026009; BROWN DD, 1968, SCIENCE, V160, P272, DOI 10.1126/science.160.3825.272; Burds AA, 2005, P NATL ACAD SCI USA, V102, P11296, DOI 10.1073/pnas.0505053102; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chikashige Y, 2007, CHROMOSOMA, V116, P497, DOI 10.1007/s00412-007-0114-8; Claycomb JM, 2005, TRENDS GENET, V21, P149, DOI 10.1016/j.tig.2005.01.009; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Duncan AW, 2012, J CLIN INVEST, V122, P3307, DOI 10.1172/JCI64026; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; EDLUND T, 1981, NATURE, V292, P269, DOI 10.1038/292269a0; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; FUTCHER B, 1986, MOL CELL BIOL, V6, P2213, DOI 10.1128/MCB.6.6.2213; GALL JG, 1968, P NATL ACAD SCI USA, V60, P553, DOI 10.1073/pnas.60.2.553; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch AP, 2007, YEAST, V24, P961, DOI 10.1002/yea.1512; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gresham D, 2010, P NATL ACAD SCI USA, V107, P18551, DOI 10.1073/pnas.1014023107; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; GROPP A, 1975, CYTOGENET CELL GENET, V14, P42, DOI 10.1159/000130318; GUO M, 1994, SCIENCE, V266, P1999, DOI 10.1126/science.266.5193.1999; Hanemann CO, 1998, TRENDS NEUROSCI, V21, P282, DOI 10.1016/S0166-2236(97)01222-8; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Huettel B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000226; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jones L, 2010, J EXP MED, V207, P2581, DOI 10.1084/jem.20091071; KACSER H, 1981, GENETICS, V97, P639; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kaizu K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000919; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; KATZ W, 1990, MOL CELL BIOL, V10, P5286, DOI 10.1128/MCB.10.10.5286; Kim JC, 2011, GENE DEV, V25, P1384, DOI 10.1101/gad.2043111; Kingsbury MA, 2006, CELL MOL LIFE SCI, V63, P2626, DOI 10.1007/s00018-006-6169-5; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; KRUSHINSKY LV, 1986, GENETIKA+, V22, P434; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Larsson J, 2001, P NATL ACAD SCI USA, V98, P6273, DOI 10.1073/pnas.111581298; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Li M, 2009, J CELL BIOL, V185, P983, DOI 10.1083/jcb.200904020; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lyle R, 2004, GENOME RES, V14, P1268, DOI 10.1101/gr.2090904; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Miclaus M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002131; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Nordman J, 2012, DEVELOPMENT, V139, P455, DOI 10.1242/dev.061838; Oakes ML, 2006, MOL CELL BIOL, V26, P6223, DOI 10.1128/MCB.02324-05; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Prestel M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-216; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; RUNGE KW, 1989, MOL CELL BIOL, V9, P1488, DOI 10.1128/MCB.9.4.1488; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sheltzer JM, 2012, P NATL ACAD SCI USA, V109, P12644, DOI 10.1073/pnas.1209227109; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SPRADLING AC, 1981, CELL, V27, P193, DOI 10.1016/0092-8674(81)90373-1; Stenberg P, 2011, CHROMOSOMA, V120, P213, DOI 10.1007/s00412-011-0319-8; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stingele S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.40; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Su XL, 2011, MOL CELL, V43, P751, DOI 10.1016/j.molcel.2011.06.027; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Upender MB, 2004, CANCER RES, V64, P6941, DOI 10.1158/0008-5472.CAN-04-0474; Vacik T, 2005, P NATL ACAD SCI USA, V102, P4500, DOI 10.1073/pnas.0500802102; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Westra JW, 2008, J COMP NEUROL, V507, P1944, DOI 10.1002/cne.21648; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wolman SR, 2002, BLOOD, V100, P29, DOI 10.1182/blood.V100.1.29; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; YAO MC, 1974, P NATL ACAD SCI USA, V71, P3082, DOI 10.1073/pnas.71.8.3082; Yona A.H., 2012, P NATL ACAD SCI US; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zhu J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002719	114	215	219	1	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					394	405		10.1016/j.cell.2012.11.043	http://dx.doi.org/10.1016/j.cell.2012.11.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374337	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000314362800011
J	Vardy, E; Roth, BL				Vardy, Eyal; Roth, Bryan L.			Conformational Ensembles in GPCR Activation	CELL			English	Editorial Material							BINDING	Recent advances in G-protein-coupled receptor structural biology have provided only limited insight into the active conformations of these key signaling molecules. A paper from Nygaard et al. reveals the dynamic nature of GPCRs along the activation pathway by complementing NMR experiments with ultralong-timescale molecular dynamics simulations.	[Vardy, Eyal; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Roth, BL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	bryan_roth@med.unc.edu	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520				Allen JA, 2011, ANNU REV PHARMACOL, V51, P117, DOI 10.1146/annurev-pharmtox-010510-100553; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Yan F, 2008, BIOCHEMISTRY-US, V47, P1567, DOI 10.1021/bi701476b	11	22	23	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					385	386		10.1016/j.cell.2013.01.025	http://dx.doi.org/10.1016/j.cell.2013.01.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374334	Bronze			2022-12-28	WOS:000314362800008
J	Zhang, J; Li, DH; Chen, RJ; Xiong, QH				Zhang, Jun; Li, Dehui; Chen, Renjie; Xiong, Qihua			Laser cooling of a semiconductor by 40 kelvin	NATURE			English	Article							RECOMBINATION; LUMINESCENCE	Optical irradiation accompanied by spontaneous anti-Stokes emission can lead to cooling of matter, in a phenomenon known as laser cooling, or optical refrigeration, which was proposed by Pringsheim in 1929(1). In gaseous matter, an extremely low temperature can be obtained in diluted atomic gases by Doppler cooling(2), and laser cooling of ultradense gas has been demonstrated by collisional redistribution of radiation(3). In solid-state materials, laser cooling is achieved by the annihilation of phonons, which are quanta of lattice vibrations, during anti-Stokes luminescence. Since the first experimental demonstration in glasses doped with rare-earth metals(4), considerable progress has been made, particularly in ytterbium-doped glasses or crystals: recently a record was set of cooling to about 110 kelvin from the ambient temperature, surpassing the thermoelectric Peltier cooler(5,6). It would be interesting to realize laser cooling in semiconductors, in which excitonic resonances dominate(7-9), rather than in systems doped with rare-earth metals, where atomic resonances dominate. However, so far no net cooling in semiconductors has been achieved despite much experimental(10-12) and theoretical(7-9,13,14) work, mainly on group-III-V gallium arsenide quantum wells. Here we report a net cooling by about 40 kelvin in a semiconductor using group-II-VI cadmium sulphide nanoribbons, or nanobelts, starting from 290 kelvin. We use a pump laser with a wavelength of 514 nanometres, and obtain an estimated cooling efficiency of about 1.3 per cent and an estimated cooling power of 180 microwatts. At 100 kelvin, 532-nm pumping leads to a net cooling of about 15 kelvin with a cooling efficiency of about 2.0 per cent. We attribute the net laser cooling in cadmium sulphide nanobelts to strong coupling between excitons and longitudinal optical phonons (LOPs), which allows the resonant annihilation of multiple LOPs in luminescence up-conversion processes, high external quantum efficiency and negligible background absorption. Our findings suggest that, alternatively, group-II-VI semiconductors with strong exciton-LOP coupling could be harnessed to achieve laser cooling and open the way to optical refrigeration based on semiconductors.	[Zhang, Jun; Li, Dehui; Chen, Renjie; Xiong, Qihua] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, Singapore 637371, Singapore; [Xiong, Qihua] Nanyang Technol Univ, Sch Elect & Elect Engn, Div Microelect, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Xiong, QH (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, Singapore 637371, Singapore.	qihua@ntu.edu.sg	Li, Dehui/AAF-8421-2019; Zhang, Jun/K-7978-2012; Xiong, Qihua/A-4979-2011; Zhang, Jun/GFO-7061-2022; Chen, Renjie/U-9814-2019; Zhang, Jun/GLN-6254-2022; Chen, Renjie/B-5639-2017; Li, Dehui/A-5061-2013	Li, Dehui/0000-0002-5945-220X; Zhang, Jun/0000-0002-9831-6796; Xiong, Qihua/0000-0002-2555-4363; Zhang, Jun/0000-0002-9831-6796; Chen, Renjie/0000-0002-3145-6882; Zhang, Jun/0000-0002-9831-6796; Chen, Renjie/0000-0002-3145-6882; 	Singapore National Research Foundation [NRF-RF2009-06]; Singapore Ministry of Education [MOE2011-T2-2-051]; Nanyang Technological University [M58113004]	Singapore National Research Foundation(National Research Foundation, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); Nanyang Technological University(Nanyang Technological University)	We thank M. Sheik-Bahae and R. Merlin for helpful discussions. Q. X. acknowledges the support from the Singapore National Research Foundation through a fellowship grant (NRF-RF2009-06). This work was also supported in part by the Singapore Ministry of Education via a Tier 2 grant (MOE2011-T2-2-051) and start-up grant support (M58113004) from Nanyang Technological University.	Basu P. K., 2003, THEORY OPTICAL PROCE; Epstein R. I., 2009, OPTICAL REFRIGERATIO; EPSTEIN RI, 1995, NATURE, V377, P500, DOI 10.1038/377500a0; Eshlaghi S, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.245317; Finkeissen E, 1999, APPL PHYS LETT, V75, P1258, DOI 10.1063/1.124660; Gauck H, 1997, APPL PHYS A-MATER, V64, P143, DOI 10.1007/s003390050455; HUPPERT D, 1984, J VAC SCI TECHNOL A, V2, P532, DOI 10.1116/1.572438; Imangholi B, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1868068; Imangholi B, 2006, THESIS U NEW MEXICO, P46; Khurgin JB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.177401; Khurgin JB, 2006, J APPL PHYS, V100, DOI 10.1063/1.2395599; Khurgin JB, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235206; Li DH, 2012, NANO LETT, V12, P2993, DOI [10.1021/n1300749z, 10.1021/nl300749z]; MERLIN R, 1978, PHYS REV B, V17, P4951, DOI 10.1103/PhysRevB.17.4951; Nemova G, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/8/086501; Phillips WD, 1998, REV MOD PHYS, V70, P721, DOI 10.1103/RevModPhys.70.721; Pringsheim P, 1929, Z PHYS, V57, P739, DOI 10.1007/BF01340652; Rivlin LA, 1997, OPT COMMUN, V139, P219, DOI 10.1016/S0030-4018(97)00123-5; Rupper G, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245203; Rupper G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.117401; Sadao A., 2009, PROPERTIES SEMICONDU, P103; Seletskiy DV, 2011, OPT EXPRESS, V19, P18229, DOI 10.1364/OE.19.018229; Seletskiy DV, 2010, NAT PHOTONICS, V4, P161, DOI 10.1038/NPHOTON.2009.269; Sheik-Bahae M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.247403; Sheik-Bahae M, 2007, NAT PHOTONICS, V1, P693, DOI 10.1038/nphoton.2007.244; Sheik-Bahae M, 2009, LASER PHOTONICS REV, V3, P67, DOI 10.1002/lpor.200810038; Vogl U, 2009, NATURE, V461, P70, DOI 10.1038/nature08203; Xu XL, 2011, ACS NANO, V5, P3660, DOI 10.1021/nn2008832; Zhang Q, 2012, PHYS REV B, V85	29	226	232	15	432	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					504	508		10.1038/nature11721	http://dx.doi.org/10.1038/nature11721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23344360				2022-12-28	WOS:000313871400032
J	Makino, DL; Baumgartner, M; Conti, E				Makino, Debora Lika; Baumgaertner, Marc; Conti, Elena			Crystal structure of an RNA-bound 11-subunit eukaryotic exosome complex	NATURE			English	Article							HUMAN PM-SCL; YEAST EXOSOME; ARCHAEAL EXOSOME; CORE EXOSOME; DEGRADATION; SUBUNIT; EXORIBONUCLEASE; RECONSTITUTION; PURIFICATION; RECRUITMENT	The exosome is the major 3'-5' RNA-degradation complex in eukaryotes. The ubiquitous core of the yeast exosome (Exo-10) is formed by nine catalytically inert subunits (Exo-9) and a single active RNase, Rrp44. In the nucleus, the Exo-10 core recruits another nuclease, Rrp6. Here we crystallized an approximately 440-kilodalton complex of Saccharomyces cerevisiae Exo-10 bound to a carboxy-terminal region of Rrp6 and to an RNA duplex with a 3'-overhang of 31 ribonucleotides. The 2.8 angstrom resolution structure shows how RNA is funnelled into the Exo-9 channel in a single-stranded conformation by an unwinding pore. Rrp44 adopts a closed conformation and captures the RNA 3'-end that exits from the side of Exo-9. Exo-9 subunits bind RNA with-sequence-unspecific interactions reminiscent of archaeal exosomes. The substrate binding and channelling mechanisms of 3'-5' RNA degradation complexes are conserved in all kingdoms of life.	[Makino, Debora Lika; Baumgaertner, Marc; Conti, Elena] MPI Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Conti, E (corresponding author), MPI Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	conti@biochem.mpg.de		Conti, Elena/0000-0003-1254-5588	Max Planck Gesellschaft; ERC [294371]; Deutsche Forschungsgemeinschaft [SFB646, SFB1035, GRK1721, CIPSM]; Max Planck Institute Biochemistry Core Facility and Crystallization Facility	Max Planck Gesellschaft(Max Planck Society); ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Institute Biochemistry Core Facility and Crystallization Facility	We would like to thank the Max Planck Institute Biochemistry Core Facility and Crystallization Facility; the staff members at beamlines X10SA (Swiss Light Source) and ID23-2 (European Synchrotron Radiation Facility)for support; F. Bonneau for the assay in Supplementary Fig. 6; J. Ebert, J. Basquin and F. Bonneau for initial materials and reagents; and P. Birle and T. Krywcun for technical assistance. We also thank members of our laboratory for discussions and critical reading of the manuscript This study was supported by the Max Planck Gesellschaft, the ERC Advanced Investigator Grant 294371 and the Deutsche Forschungsgemeinschaft (SFB646, SFB1035, GRK1721 and CIPSM) to E.C.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Cristodero M, 2008, MOL BIOCHEM PARASIT, V159, P24, DOI 10.1016/j.molbiopara.2007.12.012; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Greimann JC, 2008, METHOD ENZYMOL, V448, P185, DOI 10.1016/S0076-6879(08)02610-4; Hardwick SW, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120028; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Lorentzen E, 2007, EMBO REP, V8, P470, DOI 10.1038/sj.embor.7400945; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P399, DOI 10.1016/S0968-0004(97)01117-1; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Malet H, 2010, EMBO REP, V11, P936, DOI 10.1038/embor.2010.164; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Navarro MVAS, 2008, J BIOL CHEM, V283, P14120, DOI 10.1074/jbc.M801005200; Noguchi E, 1996, EMBO J, V15, P5595, DOI 10.1002/j.1460-2075.1996.tb00944.x; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012	28	170	170	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					70	75		10.1038/nature11870	http://dx.doi.org/10.1038/nature11870			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23376952				2022-12-28	WOS:000316039800041
J	Aachoui, Y; Leaf, IA; Hagar, JA; Fontana, MF; Campos, CG; Zak, DE; Tan, MH; Cotter, PA; Vance, RE; Aderem, A; Miao, EA				Aachoui, Youssef; Leaf, Irina A.; Hagar, Jon A.; Fontana, Mary F.; Campos, Cristine G.; Zak, Daniel E.; Tan, Michael H.; Cotter, Peggy A.; Vance, Russell E.; Aderem, Alan; Miao, Edward A.			Caspase-11 Protects Against Bacteria That Escape the Vacuole	SCIENCE			English	Article							INFLAMMASOME ACTIVATION; SALMONELLA; SECRETION; FLAGELLIN; INTERLEUKIN-1-BETA; MAINTAINS; INFECTION; INTEGRITY; DEFENSE	Caspases are either apoptotic or inflammatory. Among inflammatory caspases, caspase-1 and -11 trigger pyroptosis, a form of programmed cell death. Whereas both can be detrimental in inflammatory disease, only caspase-1 has an established protective role during infection. Here, we report that caspase-11 is required for innate immunity to cytosolic, but not vacuolar, bacteria. Although Salmonella typhimurium and Legionella pneumophila normally reside in the vacuole, specific mutants (sifA and sdhA, respectively) aberrantly enter the cytosol. These mutants triggered caspase-11, which enhanced clearance of S. typhimurium sifA in vivo. This response did not require NLRP3, NLRC4, or ASC inflammasome pathways. Burkholderia species that naturally invade the cytosol also triggered caspase-11, which protected mice from lethal challenge with B. thailandensis and B. pseudomallei. Thus, caspase-11 is critical for surviving exposure to ubiquitous environmental pathogens.	[Aachoui, Youssef; Hagar, Jon A.; Campos, Cristine G.; Cotter, Peggy A.; Miao, Edward A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Aachoui, Youssef; Hagar, Jon A.; Miao, Edward A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Leaf, Irina A.; Zak, Daniel E.; Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Fontana, Mary F.; Tan, Michael H.; Vance, Russell E.] Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Center for Infectious Disease Research; University of California System; University of California Berkeley	Miao, EA (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	emiao@med.unc.edu	Pacific-Southwest, RCE/B-6155-2009	Miao, Edward/0000-0001-7295-3490	NIH [AI097518, AI057141, AI065359, AI075039, AI080749, AI063302]; Investigator Awards from the Burroughs Wellcome Fund; Cancer Research Institute; NSF graduate fellowship; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097518, U54AI057141, P01AI063302, U54AI065359, R01AI080749, R01AI075039, U19AI100627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investigator Awards from the Burroughs Wellcome Fund; Cancer Research Institute; NSF graduate fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank V. Dixit for sharing mice (a material transfer agreement is on file) and M. Heise for sharing mice and S. Miller, J. Mougous, and H. Schweizer for sharing bacterial strains. We also thank D. Rodriguez and Z. Zhou for managing mouse colonies. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by NIH grants AI097518 (E. A. M.), AI057141 (E. A. M. and A. A.), AI065359 (P. A. C.), AI075039 (R. E. V.), AI080749 (R. E. V.), and AI063302 (R. E. V.); Investigator Awards from the Burroughs Wellcome Fund and Cancer Research Institute (R. E. V.); and an NSF graduate fellowship (M.F.F.).	Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Creasey EA, 2012, P NATL ACAD SCI USA, V109, P3481, DOI 10.1073/pnas.1121286109; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Ge JN, 2012, P NATL ACAD SCI USA, V109, P6193, DOI 10.1073/pnas.1117490109; Ge JN, 2011, CELL MICROBIOL, V13, P1870, DOI 10.1111/j.1462-5822.2011.01710.x; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Miao EA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00085; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Schroeder N, 2011, TRENDS MICROBIOL, V19, P268, DOI 10.1016/j.tim.2011.01.006; Shoma S, 2008, INFECT IMMUN, V76, P1547, DOI 10.1128/IAI.01269-07; van der Heijden J, 2012, FUTURE MICROBIOL, V7, P685, DOI [10.2217/FMB.12.49, 10.2217/fmb.12.49]; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	26	372	384	7	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2013	339	6122					975	978		10.1126/science.1230751	http://dx.doi.org/10.1126/science.1230751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23348507	Green Accepted, Green Submitted			2022-12-28	WOS:000315149600054
J	Ralston, SH				Ralston, Stuart H.			Paget's Disease of Bone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; ZOLEDRONIC ACID; BISPHOSPHONATE THERAPY; SINGLE INFUSION; RISK-FACTORS; MANAGEMENT; ALENDRONATE; ETIDRONATE; FRACTURES; TRIAL	A 73-year-old man presents with a 5-year history of low back pain that is exacerbated by standing. During the past year, pain has developed in his buttocks and legs when he walks, and it is not relieved by acetaminophen. The neurologic examination is unremarkable. Radiographs of the spine show coarsening of the trabecular pattern in several lumbar and lower thoracic vertebrae and expansion of several lumbar vertebral bodies. The total serum alkaline phosphatase level is 350 U per liter (reference range, 40 to 125); the results of liver-function tests and other routine laboratory tests are normal. How should he be further evaluated and treated?	Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Ralston, SH (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland.	stuart.ralston@ed.ac.uk			Merck; Novartis; Amgen; Eli Lilly; Watson Pharmaceuticals; Medical Research Council [G0701625] Funding Source: researchfish; Versus Arthritis [19520, 19799, 18163] Funding Source: researchfish; MRC [G0701625] Funding Source: UKRI	Merck(Merck & Company); Novartis(Novartis); Amgen(Amgen); Eli Lilly(Eli Lilly); Watson Pharmaceuticals; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr. Ralston reports receiving consulting fees on behalf of his institution from Merck and Novartis, lecture fees on behalf of his institution from Amgen and Eli Lilly, and payment on behalf of his institution from Watson Pharmaceuticals for expert testimony relating to ibandronate use in osteoporosis. No other potential conflict of interest relevant to this article was reported.	Abrahamsen B, 2010, CALCIFIED TISSUE INT, V86, P421, DOI 10.1007/s00223-010-9364-1; Albagha OME, 2011, NAT GENET, V43, P685, DOI 10.1038/ng.845; Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; ALTMAN RD, 1980, ARTHRITIS RHEUM-US, V23, P1121, DOI 10.1002/art.1780231008; [Anonymous], 2004, J BONE MINER RES, V19, P566; BOYCE BF, 1984, LANCET, V1, P821; Chung PYJ, 2012, SEMIN ARTHRITIS RHEU, V41, P619, DOI 10.1016/j.semarthrit.2011.07.005; Daroszewska A, 2011, HUM MOL GENET, V20, P2734, DOI 10.1093/hmg/ddr172; FRANCK WA, 1974, AM J MED, V56, P592, DOI 10.1016/0002-9343(74)90629-9; GALBRAITH HJB, 1977, POSTGRAD MED J, V53, P33, DOI 10.1136/pgmj.53.615.33; GALLACHER SJ, 1989, LANCET, V2, P42; Goldhahn J, 2012, CALCIFIED TISSUE INT, V90, P343, DOI 10.1007/s00223-012-9587-4; HARINCK HIJ, 1987, BRIT MED J, V295, P1301, DOI 10.1136/bmj.295.6609.1301; Joshi Shashank R, 2006, J Assoc Physicians India, V54, P535; Kilcoyne A, 2011, AM J ROENTGENOL, V197, pW196, DOI 10.2214/AJR.10.6343; Langston AL, 2010, J BONE MINER RES, V25, P20, DOI 10.1359/jbmr.090709; Lyles KW, 2001, J BONE MINER RES, V16, P1379, DOI 10.1359/jbmr.2001.16.8.1379; Mangham DC, 2009, BONE, V44, P431, DOI 10.1016/j.bone.2008.11.002; Mays S, 2010, J BONE MINER RES, V25, P1839, DOI 10.1002/jbmr.64; Miller PD, 1999, AM J MED, V106, P513, DOI 10.1016/S0002-9343(99)00062-5; Nguyen MT, 2012, SEMIN ARTHRITIS RHEU, V42, P254, DOI 10.1016/j.semarthrit.2012.05.006; Parvizi J, 2006, J BONE MINER RES, V21, pP75, DOI 10.1359/JBMR.06S214; Poor G, 2006, J BONE MINER RES, V21, P1545, DOI [10.1359/JBMR.060704, 10.1359/jbmr.060704]; Ralston SH, 2012, CALCIFIED TISSUE INT, V91, P97, DOI 10.1007/s00223-012-9599-0; RAVAULT A, 1989, REV RHUM, V56, P293; REBEL A, 1974, REV RHUM, V41, P767; REDDEN JF, 1981, INT ORTHOP, V5, P103, DOI 10.1007/BF00267839; Reid IR, 2010, J CLIN ENDOCR METAB, V95, P4380, DOI 10.1210/jc.2010-0597; Reid IR, 2011, J BONE MINER RES, V26, P2261, DOI 10.1002/jbmr.438; Reid IR, 1996, AM J MED, V101, P341, DOI 10.1016/S0002-9343(96)00227-6; Reid IR, 2005, NEW ENGL J MED, V353, P898, DOI 10.1056/NEJMoa044241; Reid IR, 2004, BONE, V35, P224, DOI 10.1016/j.bone.2004.03.023; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Schwarz P, 2012, BONE, V50, P1023, DOI 10.1016/j.bone.2012.01.020; SCHWINDINGER WF, 1993, TRENDS ENDOCRIN MET, V4, P238, DOI 10.1016/1043-2760(93)90128-2; Selby PL, 2002, BONE, V31, P366, DOI 10.1016/S8756-3282(02)00817-7; Sharma H, 2005, INT ORTHOP, V29, P319, DOI 10.1007/s00264-005-0673-3; Silverman SL, 2011, OSTEOPOROSIS INT, V22, P2337, DOI 10.1007/s00198-010-1448-2; SINGER FR, 1991, CALCIFIED TISSUE INT, V49, pS7, DOI 10.1007/BF02561369; Siris E, 1996, J CLIN ENDOCR METAB, V81, P961, DOI 10.1210/jc.81.3.961; Siris ES, 2012, PRIMER METABOLIC BON, P335; Takata S, 2006, J BONE MINER METAB, V24, P359, DOI 10.1007/s00774-006-0696-x; Tiegs RD, 2000, BONE, V27, P423, DOI 10.1016/S8756-3282(00)00333-1; Van Staa TP, 2002, J BONE MINER RES, V17, P465, DOI 10.1359/jbmr.2002.17.3.465; Walsh JP, 2004, BONE, V34, P747, DOI 10.1016/j.bone.2003.12.011; WOODHOUSE NJ, 1971, LANCET, V1, P1139	47	89	96	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					644	650		10.1056/NEJMcp1204713	http://dx.doi.org/10.1056/NEJMcp1204713			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194VA	23406029				2022-12-28	WOS:000322659600009
J	Prokocimer, P; De Anda, C; Fang, E; Mehra, P; Das, A				Prokocimer, Philippe; De Anda, Carisa; Fang, Edward; Mehra, Purvi; Das, Anita			Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections The ESTABLISH-1 Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SOFT-TISSUE INFECTIONS; COMPLICATED SKIN; CLINICAL-TRIALS; DOUBLE-BLIND; END-POINTS; MULTICENTER; PNEUMONIA; EFFICACY; MODEL	Importance Acute bacterial skin and skin structure infections (ABSSSIs), including cellulitis or erysipelas, major cutaneous abscesses, and wound infections, can be life-threatening and may require surgery and hospitalization. Increasingly, ABSSSIs are associated with drug-resistant pathogens, and many antimicrobial agents have adverse effects restricting their use. Tedizolid phosphate is a novel oxazolidinone in development for the treatment of ABSSSIs. Objectives To establish the noninferiority of tedizolid phosphate vs linezolid in treating ABSSSIs and compare the safety of the 2 agents. Design, Setting, and Patients The Efficacy and Safety of 6-day Oral Tedizolid in Acute Bacterial Skin and Skin Structure Infections vs 10-day Oral Linezolid Therapy (ESTABLISH-1) was a phase 3, randomized, double-blind, noninferiority trial that was conducted from August 2010 through September 2011 at 81 study centers in North America, Latin America, and Europe. The intent-to-treat analysis set consisted of data from 667 adults aged 18 years or older with ABSSSIs treated with tedizolid phosphate (n=332) or linezolid (n=335). Interventions A 200 mg once daily dose of oral tedizolid phosphate for 6 days or 600 mg of oral linezolid every 12 hours for 10 days. Main Outcome Measures The primary efficacy outcome was early clinical response at the 48- to 72-hour assessment (no increase in lesion surface area from baseline and oral temperature of <= 37.6 degrees C, confirmed by a second temperature measurement within 24 hours). A 10% noninferiority margin was predefined. Results In the intent-to-treat analysis set, the early clinical treatment response rates were 79.5% (95% CI, 74.8% to 83.7%) of 332 patients in the tedizolid phosphate group and 79.4% (95% CI, 74.7% to 83.6%) of 335 patients in the linezolid group (a treatment difference of 0.1% [95% CI, -6.1% to 6.2%]). The sustained clinical treatment response rates at the end of treatment (day 11) were 69.3% (95% CI, 64.0% to 74.2%) in the tedizolid phosphate group and 71.9% (95% CI, 66.8% to 76.7%) in the linezolid group (a treatment difference of -2.6% [95% CI, -9.6% to 4.2%]). Results of investigator-assessed clinical treatment success rates at a posttherapy evaluation visit (1-2 weeks after the end-of-treatment visit) were 85.5% (95% CI, 81.3% to 89.1%) in the tedizolid phosphate group and 86.0% (95% CI, 81.8% to 89.5%) in the linezolid group (a treatment difference of -0.5% [95% CI, -5.8% to 4.9%), and were similar for 178 patients with methicillin-resistant Staphylococcus aureus isolated from the primary lesion. Conclusions and Relevance Tedizolid phosphate was a statistically noninferior treatment to linezolid in early clinical response at 48 to 72 hours after initiating therapy for an ABSSSI. Tedizolid phosphate may be a reasonable alternative to linezolid for treating ABSSSI. Trial Registration clinicaltrials.gov Identifier: NCT01170221 JAMA. 2013;309(6):559-569 www.jama.com	[Prokocimer, Philippe; De Anda, Carisa; Fang, Edward] Trius Therapeut Inc, San Diego, CA 92121 USA; [Mehra, Purvi] EStudySite, Chula Vista, CA USA; [Das, Anita] AxiStat Inc, San Francisco, CA USA		Prokocimer, P (corresponding author), Trius Therapeut Inc, 6310 Nancy Ridge Dr,Ste 104, San Diego, CA 92121 USA.	pprokocimer@triusrx.com			Trius Therapeutics	Trius Therapeutics	Trius Therapeutics funded and conducted the trial.	Bishop E, 2006, ANTIMICROB AGENTS CH, V50, P1599, DOI 10.1128/AAC.50.4.1599-1602.2006; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Corey GR, 2011, CLIN INFECT DIS, V52, pS469, DOI 10.1093/cid/cir162; Corey GR, 2010, CLIN INFECT DIS, V51, P641, DOI 10.1086/655827; Corwin P, 2005, BRIT MED J, V330, P129, DOI 10.1136/bmj.38309.447975.EB; Covington P, 2011, ANTIMICROB AGENTS CH, V55, P5790, DOI 10.1128/AAC.05044-11; Drusano GL, 2011, ANTIMICROB AGENTS CH, V55, P5300, DOI 10.1128/AAC.00502-11; Drusano GL, 2012, ANTIMICROB AGENTS CH, V56, P2221, DOI 10.1128/AAC.00157-12; Dunne M, 2012, INF DIS WEEK OCT 17; Eron LJ, 2001, ARCH INTERN MED, V161, P61, DOI 10.1001/archinte.161.1.61; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Flanagan S, 2012, 52 ANN INT C ANT AG; Klein E, 2009, EMERG INFECT DIS, V15, P1925, DOI 10.3201/eid1512.081341; Langemo Diane, 2008, Adv Skin Wound Care, V21, P42, DOI 10.1097/01.ASW.0000284967.69863.2f; LoVecchio F, 2009, AM J EMERG MED, V27, P68, DOI 10.1016/j.ajem.2008.01.023; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Minson Q, 2010, PHARMACOTHERAPY, V30, P895, DOI 10.1592/phco.30.9.895; Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574; Napolitano LM, 2008, SURG INFECT, V9, pS17, DOI 10.1089/sur.2008.063.supp; Pfizer, ZYV LIN INJ; Pohlman J, CROSS DISCIPLINE TEA; Prokocimer P, 2011, ANTIMICROB AGENTS CH, V55, P583, DOI 10.1128/AAC.00076-10; Reyes J, 2009, CLIN INFECT DIS, V49, P1861, DOI 10.1086/648426; Shaw KJ, 2008, ANTIMICROB AGENTS CH, V52, P4442, DOI 10.1128/AAC.00859-08; Shaw KJ, 2011, ANN NY ACAD SCI, V1241, P48, DOI 10.1111/j.1749-6632.2011.06330.x; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; Snodgrass W R, 1937, Br Med J, V2, P101; Snodgrass WR, 1937, BRIT MED J, V2, P1156; Spellberg B, 2009, CLIN INFECT DIS, V49, P383, DOI 10.1086/600296; Talbot GH, 2012, CLIN INFECT DIS, V55, P1114, DOI 10.1093/cid/cis566; Toerner JG, 2012, CLIN INFECT DIS, V55, P1122, DOI 10.1093/cid/cis567; US Food and Drug Administration, GUID IND AC BACT SKI; US Food and Drug Administration, US FDA BRIEF ANT DRU; Westfall PH, 2001, J STAT PLAN INFER, V99, P25, DOI 10.1016/S0378-3758(01)00077-5	35	256	269	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					559	569		10.1001/jama.2013.241	http://dx.doi.org/10.1001/jama.2013.241			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087PH	23403680				2022-12-28	WOS:000314773700028
J	Watts, G				Watts, Geoff			Profile Marge Berer: battling for women's reproductive rights	LANCET			English	Editorial Material																			0	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2013	381	9865					444	444		10.1016/S0140-6736(13)60235-4	http://dx.doi.org/10.1016/S0140-6736(13)60235-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088CH	23399060	Bronze			2022-12-28	WOS:000314810900018
J	Leach, RM; Brotherton, A; Stroud, M; Thompson, R				Leach, Richard M.; Brotherton, Ailsa; Stroud, Michael; Thompson, Richard			Nutrition and fluid balance must be taken seriously	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MALNUTRITION		[Leach, Richard M.] Guys & St Thomas NHS Fdn Trust, London, England; [Brotherton, Ailsa] Salford Royal NHS Fdn Trust, NHS Quest, Salford, Lancs, England; [Stroud, Michael] Southampton Univ Hosp NHS Trust, Southampton, Hants, England; [Thompson, Richard] Royal Coll Physicians, London NW1 4LE, England	Guy's & St Thomas' NHS Foundation Trust; Salford Royal NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal College of Physicians	Leach, RM (corresponding author), Guys & St Thomas NHS Fdn Trust, London, England.	richard.leach@gstt.nhs.uk						Academy of Medical Royal Colleges, UNEIG UND CURR; Age UK, 2010, STILL HEARD SCAND PE; Arieff AI, 1999, CHEST, V115, P1371, DOI 10.1378/chest.115.5.1371; BISTRIAN BR, 1976, JAMA-J AM MED ASSOC, V235, P1567, DOI 10.1001/jama.235.15.1567; Brotherton A., 2010, MALNUTRITION MATTERS; Callum KG, 2002 REP NAT CONF EN; Care Quality Commission, 2011, NAT REP DIGN NUTR; Elia M, 2005, COST DIS RELATED MAL; Elia M, 2009, COMBATING MALNUTRITI; Gosling P, 2011, BRIT CONSENSUS GUIDE; Guest JF, 2011, CLIN NUTR, V30, P422, DOI 10.1016/j.clnu.2011.02.002; Marcos A, 2003, EUR J CLIN NUTR, V57, pS66, DOI 10.1038/sj.ejcn.1601819; MCWHIRTER JP, 1994, BRIT MED J, V308, P945, DOI 10.1136/bmj.308.6934.945; Milne AC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003288.pub3; National Institute for Health and Clinical Excellence, 2006, NUTR SUPP AD CLIN GU; National Patient Safety Agency, 1994, RED HARM CAUS MISPL; NCEPOD, 2010, ART NUTR ENQ REP MIX; NHS Institute for Innovation and Improvement, 2009, HIGH IMP ACT NURS MI; NICE, 2009, COST SAV GUID; Parliamentary and Health Service Ombudsman, 2011, CAR COMP REP HLTH SE; Patients' Association, 2011, MALNUTRITION COMMUNI; Powell AGMT, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2741; Rooker JC, 2007, CLIN MED, V7, P482, DOI 10.7861/clinmedicine.7-5-482; Royal College of Physicians, 2012, WARD ROUNDS MED; Russell CA, NUTR SCREENING SURVE; Schneider SM, 2004, BRIT J NUTR, V92, P105, DOI 10.1079/BJN20041152; Soong JBV, 2012, IMPROVING WARD ROUND; Sorensen J, 2008, CLIN NUTR, V27, P340, DOI 10.1016/j.clnu.2008.03.012; Stechmiller JK, 2010, NUTR CLIN PRACT, V25, P61, DOI 10.1177/0884533609358997; Stratton RJ, 2003, DIS RELATED MALNUTRI; Tang VCY., 2010, CLIN RISK, V16, P10, DOI [10.1258/cr.2009.090005, DOI 10.1258/CR.2009.090005]; Walsh SR, 2008, INT J CLIN PRACT, V62, P492, DOI 10.1111/j.1742-1241.2007.01386.x; Walsh SR, 2005, ANN ROY COLL SURG, V87, P126, DOI 10.1308/147870805X28127	33	20	21	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2013	346								f801	10.1136/bmj.f801	http://dx.doi.org/10.1136/bmj.f801			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AY	23396386				2022-12-28	WOS:000314807400006
J	Chatzigeorgiou, M; Bang, S; Hwang, SW; Schafer, WR				Chatzigeorgiou, Marios; Bang, Sangsu; Hwang, Sun Wook; Schafer, William R.			tmc-1 encodes a sodium-sensitive channel required for salt chemosensation in C. elegans	NATURE			English	Article							NUCLEOTIDE-GATED CHANNEL; ASH NEURONS; HEARING-LOSS; GENE FAMILY; HAIR-CELLS; TASTE; AVOIDANCE; ADAPTATION; BEHAVIORS; MUTATIONS	Transmembrane channel-like (TMC) genes encode a broadly conserved family of multipass integral membrane proteins in animals(1,2). Human TMC1 and TMC2 genes are linked to human deafness and required for hair-cell mechanotransduction; however, the molecular functions of these and other TMC proteins have not been determined(3-6). Here we show that the Caenorhabditis elegans tmc-1 gene encodes a sodium sensor that functions specifically in salt taste chemosensation. tmc-1 is expressed in the ASH polymodal avoidance neurons, where it is required for salt-evoked neuronal activity and behavioural avoidance of high concentrations of NaCl. However, tmc-1 has no effect on responses to other stimuli sensed by the ASH neurons including high osmolarity and chemical repellents, indicating a specific role in salt sensation. When expressed in mammalian cell culture, C. elegans TMC-1 generates a predominantly cationic conductance activated by high extracellular sodium but not by other cations or uncharged small molecules. Thus, TMC-1 is both necessary for salt sensation in vivo and sufficient to generate a sodium-sensitive channel in vitro, identifying it as a probable ionotropic sensory receptor.	[Chatzigeorgiou, Marios; Schafer, William R.] MRC Lab Mol Biol, Div Cell Biol, Cambridge CB2 0QH, England; [Bang, Sangsu; Hwang, Sun Wook] Korea Univ, Coll Med, Dept Biomed Sci, Seoul 136705, South Korea	MRC Laboratory Molecular Biology; Korea University; Korea University Medicine (KU Medicine)	Hwang, SW (corresponding author), Korea Univ, Coll Med, Dept Biomed Sci, Seoul 136705, South Korea.	sunhwang@korea.ac.kr; wschafer@mrc-lmb.cam.ac.uk	bang, sangsu/U-4313-2017; Bang, Sangsu/AAN-7238-2020	bang, sangsu/0000-0002-9092-0075; Hwang, Sun Wook/0000-0001-8460-7480; Schafer, William/0000-0002-6676-8034	Medical Research Council; National Research Foundation of Korea [2012000540]; Ministry of Health Welfare [A111373]; MRC [MC_U105185857] Funding Source: UKRI; Medical Research Council [MC_U105185857] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Health Welfare; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Caenorhabditis Genetics Center and M. de Bono for strains, and A. Patapoutian, J. R. Holt, J. Hao, B. Zhao, D. Miller and R. Branicky for suggestions and comments on the manuscript. This research was supported by the Medical Research Council (W.R.S.) and grants to S.W.H. from the National Research Foundation of Korea (2012000540) and Korea Health technology R&D Project of Ministry of Health & Welfare (A111373).	BARGMANN CI, 1990, COLD SPRING HARB SYM, V55, P529; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Geffeney SL, 2011, NEURON, V71, P845, DOI 10.1016/j.neuron.2011.06.038; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Jang H, 2012, NEURON, V75, P585, DOI 10.1016/j.neuron.2012.06.034; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Keresztes G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-24; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kurima K, 2003, GENOMICS, V82, P300, DOI 10.1016/S0888-7543(03)00154-X; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Lyall V, 2004, J PHYSIOL-LONDON, V558, P147, DOI 10.1113/jphysiol.2004.065656; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; Ohta T, 2008, J BIOL CHEM, V283, P9377, DOI 10.1074/jbc.M709377200; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Wakabayashi T, 2009, BBA-GEN SUBJECTS, V1790, P765, DOI 10.1016/j.bbagen.2009.03.032; Zhou Y, 2004, BIOCHEMISTRY-US, V43, P4978, DOI 10.1021/bi049876z	30	93	102	4	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					95	99		10.1038/nature11845	http://dx.doi.org/10.1038/nature11845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23364694	Green Accepted			2022-12-28	WOS:000314741200041
J	Macilwain, C				Macilwain, Colin			Scottish science is ready to go it alone	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	1	1	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2013	493	7434					579	579		10.1038/493579a	http://dx.doi.org/10.1038/493579a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080CU	23364703	Bronze			2022-12-28	WOS:000314219600016
J	Forrest, LR				Forrest, Lucy R.			(Pseudo-)Symmetrical Transport	SCIENCE			English	Editorial Material							FACING CONFORMATION; MECHANISM		Max Planck Inst Biophys, Computat Struct Biol Grp, D-60438 Frankfurt, Germany	Max Planck Society	Forrest, LR (corresponding author), Max Planck Inst Biophys, Computat Struct Biol Grp, Max von Laue Str 3, D-60438 Frankfurt, Germany.	lucy.forrest@biophys.mpg.de	Forrest, Lucy/E-8113-2016	Forrest, Lucy/0000-0003-1855-7985				Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lolkema JS, 2008, J MOL BIOL, V378, P596, DOI 10.1016/j.jmb.2008.03.005; Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542; Nasie I, 2010, J BIOL CHEM, V285, P15234, DOI 10.1074/jbc.M110.108746; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Schushan M, 2012, J BIOL CHEM, V287, P18249, DOI 10.1074/jbc.M111.336446; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104	15	42	42	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					399	401		10.1126/science.1228465	http://dx.doi.org/10.1126/science.1228465			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349276				2022-12-28	WOS:000313960700025
J	Gardosi, J; Madurasinghe, V; Williams, M; Malik, A; Francis, A				Gardosi, Jason; Madurasinghe, Vichithranie; Williams, Mandy; Malik, Asad; Francis, Andre			Maternal and fetal risk factors for stillbirth: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL-AGE FETUSES; ANTENATAL DETECTION; BIRTH-WEIGHT; DEATH; CLASSIFICATION; SMOKE; WOMEN	Objective To assess the main risk factors associated with stillbirth in a multiethnic English maternity population. Design Cohort study. Setting National Health Service region in England. Population 92 218 normally formed singletons including 389 stillbirths from 24 weeks of gestation, delivered during 2009-11. Main outcome measure Risk of stillbirth. Results Multivariable analysis identified a significant risk of stillbirth for parity (para 0 and para >= 3), ethnicity (African, African-Caribbean, Indian, and Pakistani), maternal obesity (body mass index >= 30), smoking, pre-existing diabetes, and history of mental health problems, antepartum haemorrhage, and fetal growth restriction (birth weight below 10th customised birthweight centile). As potentially modifiable risk factors, maternal obesity, smoking in pregnancy, and fetal growth restriction together accounted for 56.1% of the stillbirths. Presence of fetal growth restriction constituted the highest risk, and this applied to pregnancies where mothers did not smoke (adjusted relative risk 7.8, 95% confidence interval 6.6 to 10.9), did smoke (5.7, 3.6 to 10.9), and were exposed to passive smoke only (10.0, 6.6 to 15.8). Fetal growth restriction also had the largest population attributable risk for stillbirth and was fivefold greater if it was not detected antenatally than when it was (32.0% v 6.2%). In total, 195 of the 389 stillbirths in this cohort had fetal growth restriction, but in 160 (82%) it had not been detected antenatally. Antenatal recognition of fetal growth restriction resulted in delivery 10 days earlier than when it was not detected: median 270 (interquartile range 261-279) days v 280 (interquartile range 273-287) days. The overall stillbirth rate (per 1000 births) was 4.2, but only 2.4 in pregnancies without fetal growth restriction, increasing to 9.7 with antenatally detected fetal growth restriction and 19.8 when it was not detected. Conclusion Most normally formed singleton stillbirths are potentially avoidable. The single largest risk factor is unrecognised fetal growth restriction, and preventive strategies need to focus on improving antenatal detection.	[Gardosi, Jason; Madurasinghe, Vichithranie; Williams, Mandy; Malik, Asad; Francis, Andre] W Midlands Perinatal Inst, Birmingham B6 5RQ, W Midlands, England; [Gardosi, Jason] Univ Warwick, Sch Med, Coventry CV4 7AL, W Midlands, England	University of Warwick	Gardosi, J (corresponding author), W Midlands Perinatal Inst, Birmingham B6 5RQ, W Midlands, England.	jason.gardosi@pi.nhs.uk	Gardosi, Jason/GXN-1375-2022; Francis, Andre/AAY-3807-2021	Madurasinghe, Vichithranie/0000-0002-3853-3422; Gardosi, Jason/0000-0002-3230-1292	NHS West Midlands Strategic Health Authority	NHS West Midlands Strategic Health Authority	Data collection and analytical staff were financially supported by NHS West Midlands Strategic Health Authority and all primary care trusts. The funders had no influence on the study design, analysis, interpretation, writing up of the manuscript, or the decision to submit for publication.	ALFIREVIC Z, 1995, AM J OBSTET GYNECOL, V172, P1379, DOI 10.1016/0002-9378(95)90466-2; [Anonymous], 2012, KEY HLTH DAT W MIDL; [Anonymous], 2009, SAV BAB LIV REP STIL; [Anonymous], 2012, W MIDL COR MAT DAT V; [Anonymous], 2012, GROW GEST REL OPT WE; [Anonymous], 2012, PREGN NOT; [Anonymous], 2012, PER EP EL REC PEER; [Anonymous], 2011, W MIDL PER KPI REP Q; Bai J, 2002, AM J OBSTET GYNECOL, V186, P274, DOI 10.1067/mob.2002.119639; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2469, DOI 10.1001/jama.2011.1798; Confidential Enquiry into Maternal and Child Health, 2009, PER MORT 2007, P21; Confidential Enquiry into Maternal and Child Health (CEMACH), 2008, PER MORT 2006 ENGL W; De Jong CLD, 2000, ULTRASOUND OBST GYN, V15, P36, DOI 10.1046/j.1469-0705.2000.00001.x; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Froen JF, 2004, ACTA OBSTET GYNECOL, P81; Gardosi J, 1999, BRIT J OBSTET GYNAEC, V106, P309, DOI 10.1111/j.1471-0528.1999.tb08267.x; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gardosi J, 1998, BRIT J OBSTET GYNAEC, V105, P524, DOI 10.1111/j.1471-0528.1998.tb10153.x; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Gardosi J, 2001, CESDI 8 ANN REPORT C, P40; Gardosi J, 2012, ARCH DIS CHILD-FETAL, V97, pF314, DOI 10.1136/fetalneonatal-2012-301708; GENEST DR, 1992, OBSTET GYNECOL, V80, P575; Goy J, 2008, PAEDIATR PERINAT EP, V22, P314, DOI 10.1111/j.1365-3016.2008.00947.x; Hollier LM, 2000, OBSTET GYNECOL, V96, P701, DOI 10.1016/S0029-7844(00)01019-X; King-Hele S, 2009, ARCH DIS CHILD-FETAL, V94, pF105, DOI 10.1136/adc.2007.135459; KOOPERBERG C, 1991, EPIDEMIOLOGY, V2, P363, DOI 10.1097/00001648-199109000-00009; Korteweg FJ, 2008, PLACENTA, V29, P71, DOI 10.1016/j.placenta.2007.07.003; Leonardi-Bee J, 2011, PEDIATRICS, V127, P734, DOI 10.1542/peds.2010-3041; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; McCowan LME, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1081; Office of National Statistics, 2012, DEATH REG SUMM TABL; Persson M, 2009, DIABETES CARE, V32, P2005, DOI 10.2337/dc09-0656; Reeske A, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-63; Roex A, 2012, AUST NZ J OBSTET GYN, V52, P78, DOI 10.1111/j.1479-828X.2011.01408.x; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; Stacey T, 2012, AUST NZ J OBSTET GYN, DOI [10.1111/j.1479-828X.2011.01406, DOI 10.1111/J.1479-828X.2011.01406]; Vergani P, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.098	41	473	482	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2013	346								f108	10.1136/bmj.f108	http://dx.doi.org/10.1136/bmj.f108			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080CD	23349424	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000314217900010
J	Richardson, R				Richardson, Ruth			The art of medicine A London inquest jury inspects a corpse	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Richardson, R (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 1829, MORNING CHRONICLE; [Anonymous], 1836, MORNING POST; [Anonymous], 1829, TIMES; Burney Ian, 2000, BODIES OF EVIDENCE M; Heathcote B, 2005, VIEWING THE LIFELESS	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2013	381	9862					196	197		10.1016/S0140-6736(13)60078-1	http://dx.doi.org/10.1016/S0140-6736(13)60078-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	075LL	23346592				2022-12-28	WOS:000313887600016
J	Burd, CE; Sorrentino, JA; Clark, KS; Darr, DB; Krishnamurthy, J; Deal, AM; Bardeesy, N; Castrillon, DH; Beach, DH; Sharpless, NE				Burd, Christin E.; Sorrentino, Jessica A.; Clark, Kelly S.; Darr, David B.; Krishnamurthy, Janakiraman; Deal, Allison M.; Bardeesy, Nabeel; Castrillon, Diego H.; Beach, David H.; Sharpless, Norman E.			Monitoring Tumorigenesis and Senescence In Vivo with a p16(INK4a)-Luciferase Model	CELL			English	Article							P16(INK4A) TUMOR-SUPPRESSOR; CELLULAR SENESCENCE; FIBROBLAST SENESCENCE; METASTATIC MELANOMA; TRANSGENIC MICE; STEM-CELLS; LIFE-SPAN; T-CELLS; EXPRESSION; CANCER	Monitoring cancer and aging in vivo remains experimentally challenging. Here, we describe a luciferase knockin mouse (p16(LUC)), which faithfully reports expression of p16(INK4a), a tumor suppressor and aging biomarker. Lifelong assessment of luminescence in p16(+/LUC) mice revealed an exponential increase with aging, which was highly variable in a cohort of contemporaneously housed, syngeneic mice. Expression of p16(INK4a) with aging did not predict cancer development, suggesting that the accumulation of senescent cells is not a principal determinant of cancer-related death. In 14 of 14 tested tumor models, expression of p16(LUC) was focally activated by early neoplastic events, enabling visualization of tumors with sensitivity exceeding other imaging modalities. Activation of p16(INK4a) was noted in the emerging neoplasm and surrounding stromal cells. This work suggests that p16(INK4a) activation is a characteristic of all emerging cancers, making the p16(LUC) allele a sensitive, unbiased reporter of neoplastic transformation.	[Burd, Christin E.; Clark, Kelly S.; Darr, David B.; Krishnamurthy, Janakiraman; Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Burd, Christin E.; Clark, Kelly S.; Darr, David B.; Krishnamurthy, Janakiraman; Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Burd, Christin E.; Sorrentino, Jessica A.; Clark, Kelly S.; Darr, David B.; Krishnamurthy, Janakiraman; Deal, Allison M.; Sharpless, Norman E.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bardeesy, Nabeel] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Canc Ctr, Boston, MA 02114 USA; [Castrillon, Diego H.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Beach, David H.] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, London E1 2AT, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; Queen Mary University London	Sharpless, NE (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA.	nes@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; , Animal Studies Core/AAF-4432-2022; , Animal Studies Core/ADK-4234-2022; , BRIC Small Animal Imaging Facility/AEV-1023-2022; , Pathology Services Core/CEZ-2246-2022	, BRIC Small Animal Imaging Facility/0000-0002-0535-3214; Sharpless, Norman/0000-0001-7078-9455	NIH [AG024379, CA137181, CA163896, AG036817]; Paul Glenn Foundation; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA137181, R01CA163896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024379, R00AG036817, K99AG036817] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul Glenn Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Yuan, K. Guley, and the UNC BRIC Small Animal Imaging Facility for imaging assistance; A. Moisan (MGH Cancer) for technical assistance; C.G. Pena (UT Southwestern), E.A. Akbay (UT Southwestern), D.T. Gammons (UNC), W.Y. Kim (UNC), and W. Liu (UNC) for providing reagents; the UNC Animal Clinical Chemistry, Animal Histopathology, and Gene Expression Laboratories, as well as G. Aloisio (UT Southwestern), for tissue processing and routine genotyping; the UNC Microscopy Services Laboratory and UNC Animal Studies facility for technical assistance; and the UNC Mouse Phase I unit for providing animals and expertise. This work was supported by the NIH (AG024379; CA137181; CA163896; AG036817), the Paul Glenn Foundation, and the Burroughs Wellcome Fund.	Austad SN, 1997, EXP GERONTOL, V32, P23, DOI 10.1016/S0531-5565(96)00059-9; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Berent-Maoz B, 2012, BLOOD, V119, P5715, DOI 10.1182/blood-2011-12-400002; Bishop CL, 2010, MOL CELL, V40, P533, DOI 10.1016/j.molcel.2010.10.027; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Chrisp CE, 1996, VET PATHOL, V33, P735, DOI 10.1177/030098589603300620; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Contreras CM, 2010, DIS MODEL MECH, V3, P181, DOI 10.1242/dmm.004440; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Gadd M, 2001, CANCER RES, V61, P8811; Goldman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018269; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lemster BH, 2008, J IMMUNOL, V180, P1979, DOI 10.4049/jimmunol.180.3.1979; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Liu WJ, 2012, CANCER CELL, V21, P751, DOI 10.1016/j.ccr.2012.03.048; Liu Y, 2011, BLOOD, V117, P3257, DOI 10.1182/blood-2010-09-304402; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; Maroulakou IG, 1999, ONCOGENE, V18, P5435, DOI 10.1038/sj.onc.1202926; McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Natarajan E, 2003, AM J PATHOL, V163, P477, DOI 10.1016/S0002-9440(10)63677-2; Nielsen GP, 1999, LAB INVEST, V79, P1137; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Pavey S, 1999, CANCER RES, V59, P4185; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	64	245	256	3	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					340	351		10.1016/j.cell.2012.12.010	http://dx.doi.org/10.1016/j.cell.2012.12.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332765	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000313719800028
J	Johnston, BC; Ma, SSY; Goldenberg, JZ; Thorlund, K; Vandvik, PO; Loeb, M; Guyatt, GH				Johnston, Bradley C.; Ma, Stephanie S. Y.; Goldenberg, Joshua Z.; Thorlund, Kristian; Vandvik, Per O.; Loeb, Mark; Guyatt, Gordon H.			Probiotics for the Prevention of Clostridium difficile-Associated Diarrhea A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							ANTIBIOTIC-ASSOCIATED DIARRHEA; LACTOBACILLUS-ACIDOPHILUS CL1285; SACCHAROMYCES-BOULARDII; DOUBLE-BLIND; NORTH-AMERICA; EPIDEMIOLOGY; INFECTION; EFFICACY; QUALITY; GRADE	Background: Antibiotic treatment may disturb the resistance of gastrointestinal flora to colonization. This may result in complications, the most serious of which is Clostridium difficile-associated diarrhea (CDAD). Purpose: To assess the efficacy and safety of probiotics for the prevention of CDAD in adults and children receiving antibiotics. Data Sources: Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL, Allied and Complementary Medicine Database, Web of Science, and 12 gray-literature sources. Study Selection: Randomized, controlled trials including adult or pediatric patients receiving antibiotics that compared any strain or dose of a specified probiotic with placebo or with no treatment control and reported the incidence of CDAD. Data Extraction: Two reviewers independently screened potentially eligible articles; extracted data on populations, interventions, and outcomes; and assessed risk of bias. The Grading of Recommendations Assessment, Development and Evaluation guidelines were used to independently rate overall confidence in effect estimates for each outcome. Data Synthesis: Twenty trials including 3818 participants met the eligibility criteria. Probiotics reduced the incidence of CDAD by 66% (pooled relative risk, 0.34 [95% CI, 0.24 to 0.49]; I-2 = 0%). In a population with a 5% incidence of antibiotic-associated CDAD (median control group risk), probiotic prophylaxis would prevent 33 episodes (CI, 25 to 38 episodes) per 1000 persons. Of probiotic-treated patients, 9.3% experienced adverse events, compared with 12.6% of control patients (relative risk, 0.82 [CI, 0.65 to 1.05]; I-2 = 17%). Limitations: In 13 trials, data on CDAD were missing for 5% to 45% of patients. The results were robust to worst-plausible assumptions regarding event rates in studies with missing outcome data. Conclusion: Moderate-quality evidence suggests that probiotic prophylaxis results in a large reduction in CDAD without an increase in clinically important adverse events.	[Johnston, Bradley C.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; Bastyr Univ, Washington, DC USA; McMaster Univ, Hamilton, ON, Canada; Innlandet Hosp Trust, Gjovik, Norway	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; Innlandet Hospital Trust	Johnston, BC (corresponding author), Hosp Sick Children, Res Inst, Room 2420,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	bradley.johnston@sickkids.ca			SickKids Foundation; Bastyr Center for Student Research [BUCSR-Y2-005, BUCSR-Y2-019]	SickKids Foundation; Bastyr Center for Student Research	Grant Support: Dr. Johnston was supported in part by a postdoctoral fellowship from the SickKids Foundation. Mr. Goldenberg is supported by grants BUCSR-Y2-005 and BUCSR-Y2-019 from the Bastyr Center for Student Research.	Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Arvola T, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.5.e64; Beausoleil M, 2007, CAN J GASTROENTEROL, V21, P732, DOI 10.1155/2007/720205; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berrington A, 2004, J HOSP INFECT, V56, P1, DOI 10.1016/j.jhin.2003.10.016; Bravo MV, 2008, REV MED CHILE, V136, P981, DOI /S0034-98872008000800004; Can M, 2006, MED SCI MONITOR, V12, pPI19; Dendukuri N, 2005, CAN MED ASSOC J, V173, P167, DOI 10.1503/cmaj.050350; Drisko J, 2005, DIGEST DIS SCI, V50, P1113, DOI 10.1007/s10620-005-2714-6; Duman DG, 2005, EUR J GASTROEN HEPAT, V17, P1357, DOI 10.1097/00042737-200512000-00015; Dylewski J, 2010, ARCH MED SCI, V6, P56, DOI 10.5114/aoms.2010.13508; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eggertson L, 2004, CAN MED ASSOC J, V171, P19, DOI 10.1503/cmaj.1040979; Gao XW, 2010, AM J GASTROENTEROL, V105, P1636, DOI 10.1038/ajg.2010.11; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Gueimonde Miguel, 2006, Dig Liver Dis, V38 Suppl 2, pS242, DOI 10.1016/S1590-8658(07)60003-6; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hempel S, 2011, AHRQ PUBLICATION, V11-EHC045-EF; Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507; Hickson M, 2007, BMJ-BRIT MED J, V335, P80, DOI 10.1136/bmj.39231.599815.55; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Johnson BC, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004827.pub2; JOHNSON S, 1990, LANCET, V336, P97, DOI 10.1016/0140-6736(90)91605-A; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kotowska M, 2005, ALIMENT PHARM THER, V21, P583, DOI 10.1111/j.1365-2036.2005.02356.x; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Lewis SJ, 1998, J INFECTION, V36, P171, DOI 10.1016/S0163-4453(98)80008-X; Lonnermark E, 2010, J CLIN GASTROENTEROL, V44, P106, DOI 10.1097/MCG.0b013e3181b2683f; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McFarland LV, 1998, DIGEST DIS, V16, P292, DOI 10.1159/000016879; MCFARLAND LV, 1995, AM J GASTROENTEROL, V90, P439; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; MCFARLAND LV, 1995, AM J INFECT CONTROL, V23, P295, DOI 10.1016/0196-6553(95)90060-8; McFarland LV, 2008, FUTURE MICROBIOL, V3, P563, DOI 10.2217/17460913.3.5.563; McFarland LV, 2010, WORLD J GASTROENTERO, V16, P2202, DOI 10.3748/wjg.v16.i18.2202; Miller M., 2008, Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy, V48, P578; Oake N, 2010, ARCH INTERN MED, V170, P1804, DOI 10.1001/archinternmed.2010.405; Parkes GC, 2009, LANCET INFECT DIS, V9, P237, DOI 10.1016/S1473-3099(09)70059-3; Plummer S, 2004, INT MICROBIOL, V7, P59; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Rafiq R, 2007, GASTROENTEROLOGY, V132, pA187; Ruszczynski M, 2008, ALIMENT PHARM THER, V28, P154, DOI 10.1111/j.1365-2036.2008.03714.x; Safdar N, 2008, J CLIN PHARM THER, V33, P663, DOI 10.1111/j.1365-2710.2008.00980.x; Selinger C, 2011, GUT, V60, pA4, DOI 10.1136/gut.2011.239301.7; Sullivan A, 2002, J ANTIMICROB CHEMOTH, V50, P625, DOI 10.1093/jac/dkf194; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; SURAWICZ CM, 1989, GASTROENTEROLOGY, V96, P981, DOI 10.1016/0016-5085(89)91613-2; Thomas MR, 2001, MAYO CLIN PROC, V76, P883; Thorlund K., 2011, USER MANUAL TRIAL SE, P1, DOI DOI 10.1158/1055-9965.EPI-08-0169; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Whelan K, 2010, AM J CLIN NUTR, V91, P687, DOI 10.3945/ajcn.2009.28759; Williamson PR, 2005, STAT MED, V24, P1547, DOI 10.1002/sim.2025; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P929, DOI 10.3201/eid1406.071447	57	248	259	1	103	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12					878	U225		10.7326/0003-4819-157-12-201212180-00563	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-00563			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23362517				2022-12-28	WOS:000312583200017
J	Celum, C; Baeten, JM				Celum, Connie; Baeten, Jared M.			Serodiscordancy and HIV prevention in sub-Saharan Africa	LANCET			English	Editorial Material							COUPLES; PROPHYLAXIS		[Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA; Univ Washington, Dept Med, Seattle, WA 98104 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Celum, C (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA.	ccelum@uw.edu						Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bellan SE, 2013, LANCET; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Chemaitelly H, 2013, AIDS, V27, P251, DOI 10.1097/QAD.0b013e32835ad459; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Ndase P, 2012, JAIDS-J ACQ IMM DEF, V59, P65, DOI 10.1097/QAI.0b013e318237b864; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; World Health Organization, 2012, GU OR PRE PROPHYL PR; World Health Organization, 2012, GUID OR PREEXP PROPH	13	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 4	2013	381	9877					1519	1521		10.1016/S0140-6736(13)60147-6	http://dx.doi.org/10.1016/S0140-6736(13)60147-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139UF	23391463				2022-12-28	WOS:000318609600008
J	Burns, MB; Lackey, L; Carpenter, MA; Rathore, A; Land, AM; Leonard, B; Refsland, EW; Kotandeniya, D; Tretyakova, N; Nikas, JB; Yee, D; Temiz, NIA; Donohue, DE; McDougle, RM; Brown, WL; Law, EK; Harris, RS				Burns, Michael B.; Lackey, Lela; Carpenter, Michael A.; Rathore, Anurag; Land, Allison M.; Leonard, Brandon; Refsland, Eric W.; Kotandeniya, Delshanee; Tretyakova, Natalia; Nikas, Jason B.; Yee, Douglas; Temiz, Nuri I. A.; Donohue, Duncan E.; McDougle, Rebecca M.; Brown, William L.; Law, Emily K.; Harris, Reuben S.			APOBEC3B is an enzymatic source of mutation in breast cancer	NATURE			English	Article							FOREIGN DNA; LANDSCAPE; AID	Several mutations are required for cancer development, and genome sequencing has revealed that many cancers, including breast cancer, have somatic mutation spectra dominated by C-to-T transitions(1-9). Most of these mutations occur at hydrolytically disfavoured(10) non-methylated cytosines throughout the genome, and are sometimes clustered(8). Here we show that the DNA cytosine deaminase APOBEC3B is a probable source of these mutations. APOBEC3B messenger RNA is upregulated in most primary breast tumours and breast cancer cell lines. Tumours that express high levels of APOBEC3B have twice as many mutations as those that express low levels and are more likely to have mutations in TP53. Endogenous APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts. Knockdown experiments show that endogenous APOBEC3B correlates with increased levels of genomic uracil, increased mutation frequencies, and C-to-T transitions. Furthermore, induced APOBEC3B overexpression causes cell cycle deviations, cell death, DNA fragmentation, gamma-H2AX accumulation and C-to-T mutations. Our data suggest a model in which APOBEC3B-catalysed deamination provides a chronic source of DNA damage in breast cancers that could select TP53 inactivation and explain how some tumours evolve rapidly and manifest heterogeneity.	[Burns, Michael B.; Lackey, Lela; Carpenter, Michael A.; Rathore, Anurag; Land, Allison M.; Refsland, Eric W.; McDougle, Rebecca M.; Brown, William L.; Law, Emily K.; Harris, Reuben S.] Univ Minnesota, Biochem Mol Biol & Biophys Dept, Minneapolis, MN 55455 USA; [Burns, Michael B.; Lackey, Lela; Carpenter, Michael A.; Rathore, Anurag; Land, Allison M.; Leonard, Brandon; Refsland, Eric W.; Kotandeniya, Delshanee; Tretyakova, Natalia; Nikas, Jason B.; Yee, Douglas; McDougle, Rebecca M.; Brown, William L.; Law, Emily K.; Harris, Reuben S.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Burns, Michael B.; Lackey, Lela; Carpenter, Michael A.; Rathore, Anurag; Land, Allison M.; Leonard, Brandon; Refsland, Eric W.; McDougle, Rebecca M.; Brown, William L.; Law, Emily K.; Harris, Reuben S.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Burns, Michael B.; Lackey, Lela; Carpenter, Michael A.; Rathore, Anurag; Land, Allison M.; Leonard, Brandon; Refsland, Eric W.; McDougle, Rebecca M.; Brown, William L.; Law, Emily K.; Harris, Reuben S.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Leonard, Brandon; Harris, Reuben S.] Univ Minnesota, Microbiol Canc Biol & Immunol Grad Program, Minneapolis, MN 55455 USA; [Kotandeniya, Delshanee; Tretyakova, Natalia] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Temiz, Nuri I. A.; Donohue, Duncan E.] SAIC Frederick Inc, In Silico Res Ctr Excellence, Adv Biomed Comp Ctr, Informat Syst Program,Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Harris, RS (corresponding author), Univ Minnesota, Biochem Mol Biol & Biophys Dept, Minneapolis, MN 55455 USA.	rsh@umn.edu	Brown, William/GXN-2777-2022; Nikas, Jason B./K-7060-2014	Nikas, Jason B./0000-0001-9703-0422; Burns, Michael/0000-0001-9791-4359; Yee, Douglas/0000-0002-3387-4009; Lackey, Lela/0000-0003-2163-4005; Donohue, Duncan/0000-0002-3137-8773; Carpenter, Michael/0000-0001-9524-5323	Academic Health Center; National Institutes of Health (NIH) [P30 CA77598, P50 CA101955, KL2 RR033182]; Cancer Biology Training Grant [NIH NCI T32 CA009138]; Department of Defense Breast Cancer Research Program Predoctoral Fellowship [BC101124]; National Science Foundation Predoctoral Fellowship; Institute for Molecular Virology Training Grant NIH [T32 AI083196]; NIH [F32 GM095219, F31 DA033186, R01 AI064046, NIH P01 GM091743, 1UL1RR033183]; CIHR; National Cancer Institute, NIH, CBIIT/caBIG ISRCE [09-260]; Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE [T32CA009138, P30CA077598, P50CA101955] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR033182, UL1RR033183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064046, T32AI083196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM095219, P01GM091743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA033186] Funding Source: NIH RePORTER	Academic Health Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Biology Training Grant; Department of Defense Breast Cancer Research Program Predoctoral Fellowship(United States Department of Defense); National Science Foundation Predoctoral Fellowship(National Science Foundation (NSF)); Institute for Molecular Virology Training Grant NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); National Cancer Institute, NIH, CBIIT/caBIG ISRCE; Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Hultquist and R. Vogel for statistics, T. Hwang for bioinformatic assistance, V. Polunovsky for hTERT-HMECs, V. Simon for shRNA, S. Kaufmann, C. Lange and D. Largaespada for consultation, and the Masonic Cancer Center Breast Cancer Research Fund for purchasing the ATCC breast cancer panel. Tissues were obtained from the Masonic Cancer Center Tissue Procurement Facility, which is part of BioNet, supported by the Academic Health Center and National Institutes of Health (NIH) grants P30 CA77598 (D.Y.), P50 CA101955 (D. Buchsbaum) and KL2 RR033182 (B. Blazar). M.B.B. was supported in part by a Cancer Biology Training Grant (NIH NCI T32 CA009138) and a Department of Defense Breast Cancer Research Program Predoctoral Fellowship (BC101124). L.L. was supported in part by a National Science Foundation Predoctoral Fellowship and by a position on the Institute for Molecular Virology Training Grant NIH T32 AI083196. MAC. was supported by an NIH postdoctoral fellowship (F32 GM095219). A.M.L. was supported by a CIHR postdoctoral fellowship. E.W.R. was supported by a position on the Institute for Molecular Virology Training Grant NIH T32 AI083196 and subsequently by an NIH predoctoral fellowship (F31 DA033186). Computational analyses (N.A.T. and D.E.D.) were supported by federal funds from the National Cancer Institute, NIH, CBIIT/caBIG ISRCE yellow task 09-260. The Harris laboratory was supported in part by NIH R01 AI064046, NIH P01 GM091743, the Children's Cancer Research Fund, and a seed grant from the University of Minnesota Clinical and Translational Science Institute (supported by NIH 1UL1RR033183).	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lackey L, 2012, J MOL BIOL, V419, P301, DOI 10.1016/j.jmb.2012.03.011; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; LOEB LA, 1974, CANCER RES, V34, P2311; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Zhang J, 2011, DISCRETE DYN NAT SOC, V2011, DOI [10.1155/2011/958381, 10.1093/database/bar026]	27	560	574	2	106	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					366	370		10.1038/nature11881	http://dx.doi.org/10.1038/nature11881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23389445	Green Accepted			2022-12-28	WOS:000315312900041
J	Campos, GEP; Moran, MS; Huete, A; Zhang, YG; Bresloff, C; Huxman, TE; Eamus, D; Bosch, DD; Buda, AR; Gunter, SA; Scalley, TH; Kitchen, SG; McClaran, MP; McNab, WH; Montoya, DS; Morgan, JA; Peters, DPC; Sadler, EJ; Seyfried, MS; Starks, PJ				Campos, Guillermo E. Ponce; Moran, M. Susan; Huete, Alfredo; Zhang, Yongguang; Bresloff, Cynthia; Huxman, Travis E.; Eamus, Derek; Bosch, David D.; Buda, Anthony R.; Gunter, Stacey A.; Scalley, Tamara Heartsill; Kitchen, Stanley G.; McClaran, Mitchel P.; McNab, W. Henry; Montoya, Diane S.; Morgan, Jack A.; Peters, Debra P. C.; Sadler, E. John; Seyfried, Mark S.; Starks, Patrick J.			Ecosystem resilience despite large-scale altered hydroclimatic conditions	NATURE			English	Article							RAIN-USE EFFICIENCY; CLIMATE-CHANGE; DROUGHT; WATER; EVAPOTRANSPIRATION; BIOMES	Climate change is predicted to increase both drought frequency and duration, and when coupled with substantial warming, will establish a new hydroclimatological model for many regions(1). Large-scale, warm droughts have recently occurred in North America, Africa, Europe, Amazonia and Australia, resulting in major effects on terrestrial ecosystems, carbon balance and food security(2,3). Here we compare the functional response of above-ground net primary production to contrasting hydroclimatic periods in the late twentieth century (1975-1998), and drier, warmer conditions in the early twenty-first century (2000-2009) in the Northern and Southern Hemispheres. We find a common ecosystem water-use efficiency (WUEe: above-ground net primary production/evapotranspiration) across biomes ranging from grassland to forest that indicates an intrinsic system sensitivity to water availability across rainfall regimes, regardless of hydroclimatic conditions. We found higher WUEe in drier years that increased significantly with drought to a maximum WUEe across all biomes; and a minimum native state in wetter years that was common across hydroclimatic periods. This indicates biome-scale resilience to the interannual variability associated with the early twenty-first century drought-that is, the capacity to tolerate low, annual precipitation and to respond to subsequent periods of favourable water balance. These findings provide a conceptual model of ecosystem properties at the decadal scale applicable to the widespread altered hydroclimatic conditions that are predicted for later this century. Understanding the hydroclimatic threshold that will break down ecosystem resilience and alter maximum WUEe may allow us to predict land-surface consequences as large regions become more arid, starting with water-limited, low-productivity grasslands.	[Campos, Guillermo E. Ponce; Moran, M. Susan; Zhang, Yongguang] ARS SW Watershed Res, USDA, Tucson, AZ 85719 USA; [Campos, Guillermo E. Ponce; Bresloff, Cynthia] Univ Arizona, Tucson, AZ 85721 USA; [Huete, Alfredo; Eamus, Derek] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Huxman, Travis E.] Univ Calif Irvine, Irvine, CA USA; [Huxman, Travis E.] Univ Calif Irvine, Ctr Environm Biol, Irvine, CA 92697 USA; [Bosch, David D.] ARS, USDA, SE Watershed Res Lab, Tifton, GA 31793 USA; [Buda, Anthony R.] ARS, USDA, Pasture Syst & Watershed Management Res Unit, University Pk, PA 16802 USA; [Gunter, Stacey A.] ARS, USDA, So Plains Range Res Stn, Woodward, OK 73801 USA; [Scalley, Tamara Heartsill] USDA FS Int Inst Trop Forestry, Rio Piedras, PR 00926 USA; [Kitchen, Stanley G.] USDA, FS Rocky Mt Res Stn, Shrub Sci Lab, Provo, UT 84606 USA; [McClaran, Mitchel P.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [McNab, W. Henry] USDA FS So Res Stn, Asheville, NC 28806 USA; [Montoya, Diane S.] USDA FS Pacific SW Res Stn, Arcata, CA 95521 USA; [Morgan, Jack A.] ARS, USDA, Rangeland Resources Res Unit, Ft Collins, CO 80526 USA; [Peters, Debra P. C.] New Mexico State Univ, USDA ARS Jornada Expt Range & Jornada Basin Long, Las Cruces, NM 88012 USA; [Sadler, E. John] ARS, USDA, Cropping Syst & Water Qual Res Unit, Columbia, MO 65211 USA; [Seyfried, Mark S.] ARS, USDA, NW Watershed Res Ctr, Boise, ID 83712 USA; [Starks, Patrick J.] ARS, USDA, Grazinglands Res Lab, El Reno, OK 73036 USA	United States Department of Agriculture (USDA); University of Arizona; University of Technology Sydney; University of California System; University of California Irvine; University of California System; University of California Irvine; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Arizona; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); New Mexico State University; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Campos, GEP (corresponding author), ARS SW Watershed Res, USDA, Tucson, AZ 85719 USA.	geponce@gmail.com; susan.moran@ars.usda.gov	Buda, Anthony/ABA-3525-2021; Eamus, Derek/F-7375-2017; Huete, Alfredo R/C-1294-2008; Gunter, Stacey/AAB-6971-2019; Heartsill-Scalley, Tamara/AAO-2832-2020; Eamus, Derek/AAX-1276-2021	Eamus, Derek/0000-0003-2765-8040; Huete, Alfredo R/0000-0003-2809-2376; Gunter, Stacey/0000-0002-0840-3555; Heartsill-Scalley, Tamara/0000-0003-0550-4147; Zhang, Yongguang/0000-0001-8286-300X; Ponce-Campos, Guillermo E./0000-0003-4332-338X; Peters, Debra/0000-0002-5842-8099; Sadler, Edward/0000-0003-3524-8340	NASA SMAP Science Definition Team [08-SMAPSDT08-0042]; Australian Research Council (ARC) [DP1115479]; Terrestrial Ecosystem Research Network (TERN) EIF: AusCover; Direct For Biological Sciences [1235828] Funding Source: National Science Foundation	NASA SMAP Science Definition Team; Australian Research Council (ARC)(Australian Research Council); Terrestrial Ecosystem Research Network (TERN) EIF: AusCover; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was-supported in part by the NASA SMAP Science Definition Team under agreement 08-SMAPSDT08-0042, the Australian Research Council (ARC) Discover Project (DP1115479) and the Terrestrial Ecosystem Research Network (TERN) EIF: AusCover. We thank the Australian Bureau of Meteorology for providing the precipitation data. We also thank J. Overpeck, T. McVicar, R. Donohue and M. Walbridge for their input.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Australian. . Government Bureau of Meteorology, 2011, AUSTR CLIM CHANG DAT; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; LEHOUEROU HN, 1984, J ARID ENVIRON, V7, P213; MacDonald GM, 2010, P NATL ACAD SCI USA, V107, P21256, DOI 10.1073/pnas.0909651107; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Monson RK, 2010, OECOLOGIA, V162, P491, DOI 10.1007/s00442-009-1465-z; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; National Drought Mitigation Center, 2012, US DROUGHT MON; National Oceanic and Atmospheric Administration, 2012, US CLIM DIV DAT PLOT; Roxburgh SH, 2005, FUNCT ECOL, V19, P378, DOI 10.1111/j.1365-2435.2005.00983.x; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Scott RL, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001348; Walker B, 2004, ECOL SOC, V9; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325	22	364	387	30	605	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					349	352		10.1038/nature11836	http://dx.doi.org/10.1038/nature11836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23334410	Green Submitted			2022-12-28	WOS:000315312900037
J	Kopetz, H				Kopetz, Heinz			Build a biomass energy market	NATURE			English	Editorial Material									World Bioenergy Assoc, Stockholm, Sweden		Kopetz, H (corresponding author), World Bioenergy Assoc, Stockholm, Sweden.	hg.kopetz@netway.at						[Anonymous], 2010, GLOBAL FOREST RESOUR; [Anonymous], REN 2012 GLOB STAT R; International Energy Agency, 2011, WORLD EN OUTL 2011; International Energy Agency, 2012, KEY WORLD EN STAT 20; World Bioenergy Association, 2009, WBO POS PAP GLOB POT; WWF, 2011, FULLY DECARBONISING	6	90	93	2	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					29	31		10.1038/494029a	http://dx.doi.org/10.1038/494029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087DJ	23389528	Bronze			2022-12-28	WOS:000314741200016
J	Carter, P; Jarman, B				Carter, Philip; Jarman, Brian			Who knew what, and when, at Mid Staffs?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STAFFORDSHIRE; CARE; MORTALITY; TRUST; HEAD		[Jarman, Brian] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dr Foster Unit, London, England	Imperial College London	Jarman, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dr Foster Unit, London, England.	b.jarman@ic.ac.uk						[Anonymous], 2011, INQ COUNS CLOS SUBM, P1578; [Anonymous], 2009, HCC INV REP 18 MARCH; [Anonymous], 1 STAT C BOW PAR 115; [Anonymous], 2011, INQ COUNS WRITT CLOS, P983; Aylin P, 2004, BRIT MED J, V329, P825, DOI 10.1136/bmj.329.7470.825; Bailey J, 2012, WARD WHIT DIS MIDST; Dyer C, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7566; Dyer C, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6562; Dyer C, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5744; Dyer C, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4189; Dyer C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2900; Dyer C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1581; Ernst & Young, 2013, MON CONT PLANN TEAM; Francis R, 2010, INDEPENDENT INQUIRY, VI; Hawkes N, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1396; Healthcare Commission, 2009, INV MIDST NHS FDN TR, P122; Mashta O, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1141; Mid Staffordshire Public Inquiry, STAT READ INQ REC EX; Mid Staffordshire Public Inquiry, 2011, COMMUNICATION   0302; Mid Staffordshire Public Inquiry, COMMUNICATION; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; Mooney H, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1137; O'Dowd A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6956; Wise J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1608	24	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2013	346								f726	10.1136/bmj.f726	http://dx.doi.org/10.1136/bmj.f726			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AT	23390239				2022-12-28	WOS:000314806900013
J	Berdahl, A; Torney, CJ; Ioannou, CC; Faria, JJ; Couzin, ID				Berdahl, Andrew; Torney, Colin J.; Ioannou, Christos C.; Faria, Jolyon J.; Couzin, Iain D.			Emergent Sensing of Complex Environments by Mobile Animal Groups	SCIENCE			English	Article							SALMON ONCORHYNCHUS-TSHAWYTSCHA; BEHAVIOR; AVOIDANCE; MOVEMENTS; HATCHERY; WRONGS; SIZE	The capacity for groups to exhibit collective intelligence is an often-cited advantage of group living. Previous studies have shown that social organisms frequently benefit from pooling imperfect individual estimates. However, in principle, collective intelligence may also emerge from interactions between individuals, rather than from the enhancement of personal estimates. Here, we reveal that this emergent problem solving is the predominant mechanism by which a mobile animal group responds to complex environmental gradients. Robust collective sensing arises at the group level from individuals modulating their speed in response to local, scalar, measurements of light and through social interaction with others. This distributed sensing requires only rudimentary cognition and thus could be widespread across biological taxa, in addition to being appropriate and cost-effective for robotic agents.	[Berdahl, Andrew; Torney, Colin J.; Ioannou, Christos C.; Faria, Jolyon J.; Couzin, Iain D.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Ioannou, Christos C.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	Princeton University; University of Bristol	Berdahl, A (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	aberdahl@princeton.edu; icouzin@princeton.edu	Couzin, Iain D./Q-6862-2018; Torney, Colin/C-6082-2015	Couzin, Iain D./0000-0001-8556-4558; Torney, Colin/0000-0003-1673-7835; Ioannou, Christos/0000-0002-9739-889X	NSF [PHY-0848755, EAGER-1251585, CNH-1211972]; U.S. Office of Naval Research [N00014-09-1-1074]; U.S. Army Research Office [W911NG-11-1-0385]; Leverhulme Early Career Fellowship; Natural Sciences and Engineering Research Council of Canada; Yukon Foundation; Direct For Biological Sciences [1251585] Funding Source: National Science Foundation; Direct For Mathematical & Physical Scien [0848755] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); U.S. Office of Naval Research(Office of Naval Research); U.S. Army Research Office; Leverhulme Early Career Fellowship(Leverhulme Trust); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Yukon Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank J. Herbert-Read for experimental assistance, N. O. Handegard for providing code and advice for track linking, and A. Haenssen for technical support. Suggestions from members of the Couzin laboratory and two anonymous reviewers greatly improved this manuscript. Funded by NSF awards PHY-0848755, EAGER-1251585, and CNH-1211972; U.S. Office of Naval Research award N00014-09-1-1074; U.S. Army Research Office grant W911NG-11-1-0385; Leverhulme Early Career Fellowship; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship Fellowship; and the Yukon Foundation. All experiments were conducted in accordance with federal and state regulations and were approved by the Princeton University Institutional Animal Care and Use Committee. Code freely available at http://icouzin.princeton.edu.	Bauer S, 2011, ANIMAL MIGRATION: A SYNTHESIS, P68; Camperi M, 2012, INTERFACE FOCUS, V2, P715, DOI 10.1098/rsfs.2012.0026; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Codling EA, 2007, ECOLOGY, V88, P1864, DOI 10.1890/06-0854.1; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; HALL DJ, 1979, J FISH RES BOARD CAN, V36, P1029, DOI 10.1139/f79-145; HALL LW, 1982, J TOXICOL ENV HEALTH, V10, P1017, DOI 10.1080/15287398209530313; Hard JJ, 1999, CAN J FISH AQUAT SCI, V56, P578, DOI 10.1139/cjfas-56-4-578; HUTH A, 1994, ECOL MODEL, V75, P135, DOI 10.1016/0304-3800(94)90013-2; Kils U., 1987, THESIS U KIEL GERMAN; LARKIN PA, 1969, J FISH RES BOARD CAN, V26, P1372, DOI 10.1139/f69-121; McNicol RE, 1996, ENVIRON BIOL FISH, V47, P311, DOI 10.1007/BF00000503; Pitcher T. J., 1993, BEHAV TELEOST FISHES, V2, P369; Poli Riccardo, 2007, Swarm Intelligence, V1, P33, DOI 10.1007/s11721-007-0002-0; QUINN TP, 1984, CAN J FISH AQUAT SCI, V41, P1078, DOI 10.1139/f84-126; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; STEELE CW, 1991, J FISH BIOL, V38, P553, DOI 10.1111/j.1095-8649.1991.tb03142.x; Torney C, 2009, P NATL ACAD SCI USA, V106, P22055, DOI 10.1073/pnas.0907929106; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147	26	308	313	4	215	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					574	576		10.1126/science.1225883	http://dx.doi.org/10.1126/science.1225883			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372013	Green Submitted			2022-12-28	WOS:000314270000057
J	Kikuchi, S; Bedard, J; Hirano, M; Hirabayashi, Y; Oishi, M; Imai, M; Takase, M; Ide, T; Nakai, M				Kikuchi, Shingo; Bedard, Jocelyn; Hirano, Minako; Hirabayashi, Yoshino; Oishi, Maya; Imai, Midori; Takase, Mai; Ide, Toru; Nakai, Masato			Uncovering the Protein Translocon at the Chloroplast Inner Envelope Membrane	SCIENCE			English	Article							IMPORT MACHINERY; IN-VIVO; TIC20; CHANNEL; ARABIDOPSIS; FORMS; BIOGENESIS; COMPONENTS; APPARATUS; COMPLEX	Chloroplasts require protein translocons at the outer and inner envelope membranes, termed TOC and TIC, respectively, to import thousands of cytoplasmically synthesized preproteins. However, the molecular identity of the TIC translocon remains controversial. Tic20 forms a 1-megadalton complex at the inner membrane and directly interacts with translocating preproteins. We purified the 1-megadalton complex from Arabidopsis, comprising Tic20 and three other essential components, one of which is encoded by the enigmatic open reading frame ycf1 in the chloroplast genome. All four components, together with well-known TOC components, were found stoichiometrically associated with different translocating preproteins. When reconstituted into planar lipid bilayers, the purified complex formed a preprotein-sensitive channel. Thus, this complex constitutes a general TIC translocon.	[Kikuchi, Shingo; Bedard, Jocelyn; Hirabayashi, Yoshino; Oishi, Maya; Imai, Midori; Takase, Mai; Nakai, Masato] Osaka Univ, Inst Prot Res, Lab Regulat Biol React, Suita, Osaka 5650871, Japan; [Hirano, Minako; Ide, Toru] Grad Sch Creat New Photon Ind, Nishi Ku, Hamamatsu, Shizuoka 4311202, Japan	Osaka University	Nakai, M (corresponding author), Osaka Univ, Inst Prot Res, Lab Regulat Biol React, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nakai@protein.osaka-u.ac.jp	Ide, Toru/L-7110-2015	Kikuchi, Shingo/0000-0001-9033-6242; Hirano, Minako/0000-0002-7246-0087	Ministry of Education, Culture, Sports, Science and Technology, Japan [20059022, 22020024, 24117511, 24657073, 21107518, 22370059, 23770190, 23113519]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24117511, 22020024, 22370059] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Iwasaki, N. Miyazaki, S. Thompson, T. Takao, C. Awada, H. Mori, and J. Mima for helpful suggestions and valuable discussions; P. Jarvis, D. Schnell, and I. Nishimura for vectors; the Arabidopsis Biological Resource Center, Institut National de la Recherche Agronomique, and Cold Spring Harbor Laboratory for the T-DNA lines; and RIKEN Bioresource Center for the full-length cDNAs. Supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (20059022, 22020024, 24117511, and 24657073, M. N.; 21107518 and 22370059, T. I.; 23770190 and 23113519, M. H.) and by a Japan Society for the Promotion of Science postdoctoral fellowship for foreign researchers (J. B.). S. K., J. B., Y.H., M.O., M. I., M. T., and M. N. performed biochemical and genetic analyses; M. H. and T. I. performed electrophysiological analyses; M. N. conceived and supervised the whole project and wrote the paper.	Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Boudreau E, 1997, MOL GEN GENET, V253, P649, DOI 10.1007/s004380050368; Chen XJ, 2002, PLANT CELL, V14, P641, DOI 10.1105/tpc.010336; Chou ML, 2006, J CELL BIOL, V175, P893, DOI 10.1083/jcb.200609172; Chou ML, 2003, EMBO J, V22, P2970, DOI 10.1093/emboj/cdg281; Cline K, 2008, CURR OPIN PLANT BIOL, V11, P585, DOI 10.1016/j.pbi.2008.10.008; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hirabayashi Y, 2011, PLANT CELL PHYSIOL, V52, P469, DOI 10.1093/pcp/pcr010; Inaba T, 2003, J BIOL CHEM, V278, P38617, DOI 10.1074/jbc.M306367200; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kasmati AR, 2011, PLANT J, V66, P877, DOI 10.1111/j.1365-313X.2011.04551.x; Kessler F, 1996, P NATL ACAD SCI USA, V93, P7684, DOI 10.1073/pnas.93.15.7684; KESSLER F, 1994, SCIENCE, V266, P1035, DOI 10.1126/science.7973656; Kessler F, 2009, CURR OPIN CELL BIOL, V21, P494, DOI 10.1016/j.ceb.2009.03.004; Kikuchi S, 2009, PLANT CELL, V21, P1781, DOI 10.1105/tpc.108.063552; Kouranov A, 1998, J CELL BIOL, V143, P991, DOI 10.1083/jcb.143.4.991; Kovacs-Bogdan E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-133; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Liang QJ, 2010, PHYSIOL PLANTARUM, V140, P380, DOI 10.1111/j.1399-3054.2010.01407.x; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Schwenkert S, 2011, BBA-BIOMEMBRANES, V1808, P901, DOI 10.1016/j.bbamem.2010.07.021; Teng YS, 2006, PLANT CELL, V18, P2247, DOI 10.1105/tpc.106.044305; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726	27	220	228	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					571	574		10.1126/science.1229262	http://dx.doi.org/10.1126/science.1229262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372012				2022-12-28	WOS:000314270000056
J	Alt, FW; Zhang, Y; Meng, FL; Guo, CG; Schwer, B				Alt, Frederick W.; Zhang, Yu; Meng, Fei-Long; Guo, Chunguang; Schwer, Bjoern			Mechanisms of Programmed DNA Lesions and Genomic Instability in the Immune System	CELL			English	Review							CLASS SWITCH RECOMBINATION; B-CELL DEVELOPMENT; CHROMOSOMAL TRANSLOCATIONS; IGH LOCUS; HOMOLOGOUS RECOMBINATION; ANTISENSE TRANSCRIPTION; V(D)J RECOMBINATION; SEQUENCING REVEALS; BREAK REPAIR; END	Chromosomal translocations involving antigen receptor loci are common in lymphoid malignancies. Translocations require DNA double-strand breaks (DSBs) at two chromosomal sites, their physical juxtaposition, and their fusion by end-joining. Ability of lymphocytes to generate diverse repertoires of antigen receptors and effector antibodies derives from programmed genomic alterations that produce DSBs. We discuss these lymphocyte-specific processes, with a focus on mechanisms that provide requisite DSB target specificity and mechanisms that suppress DSB translocation. We also discuss recent work that provides new insights into DSB repair pathways and the influences of three-dimensional genome organization on physiological processes and cancer genomes.	[Alt, Frederick W.; Zhang, Yu; Meng, Fei-Long; Guo, Chunguang; Schwer, Bjoern] Howard Hughes Med Inst, Boston, MA 02115 USA; [Alt, Frederick W.; Zhang, Yu; Meng, Fei-Long; Guo, Chunguang; Schwer, Bjoern] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Alt, Frederick W.; Zhang, Yu; Meng, Fei-Long; Guo, Chunguang; Schwer, Bjoern] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Alt, Frederick W.; Zhang, Yu; Meng, Fei-Long; Guo, Chunguang; Schwer, Bjoern] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Alt, FW (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu		Meng, Feilong/0000-0003-0333-6872	NIH/NIA [K01AG043630]; NIH; Leukemia and Lymphoma Society of America Marshall A. Lichtman Specialized Center of Research Grant [7009-121]; Howard Hughes Medical Institute Investigator; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG043630] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America Marshall A. Lichtman Specialized Center of Research Grant; Howard Hughes Medical Institute Investigator(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Andre Nussenzweig, Duane Wesemann, and David Weinstock for helpful comments. As this Review cites only primary publications from the past 5 years, we apologize that space restrictions make it impossible to cite all relevant publications. However, for each area covered, we cite very recent reviews in which additional details and references can be found. F.M. and C.G. are supported by Cancer Research Institute Fellowships, and B.S. is supported by NIH/NIA grant K01AG043630. F.W.A. is supported by NIH grants and a Leukemia and Lymphoma Society of America Marshall A. Lichtman Specialized Center of Research Grant (7009-121), and he is a Howard Hughes Medical Institute Investigator.	Abarrategui I, 2007, EMBO J, V26, P4380, DOI 10.1038/sj.emboj.7601866; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; Boboila C, 2010, P NATL ACAD SCI USA, V107, P3034, DOI 10.1073/pnas.0915067107; Boboila C, 2010, J EXP MED, V207, P417, DOI 10.1084/jem.20092449; Bossen C, 2012, ANNU REV IMMUNOL, V30, P337, DOI 10.1146/annurev-immunol-020711-075003; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Chatterji M, 2004, IMMUNOL REV, V200, P261, DOI 10.1111/j.0105-2896.2004.00167.x; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Cui X., 2012, MOL CELL BIOL; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Desiderio S, 2010, SEMIN IMMUNOL, V22, P362, DOI 10.1016/j.smim.2010.09.001; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Franco S, 2008, J EXP MED, V205, P557, DOI 10.1084/jem.20080044; Frappart PO, 2008, DNA REPAIR, V7, P1051, DOI 10.1016/j.dnarep.2008.03.007; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Fudenberg G, 2012, CURR OPIN GENET DEV, V22, P115, DOI 10.1016/j.gde.2012.01.006; Giallourakis CC, 2010, P NATL ACAD SCI USA, V107, P22207, DOI 10.1073/pnas.1015954107; Gilfillan S, 1995, IMMUNOL REV, V148, P201, DOI 10.1111/j.1600-065X.1995.tb00099.x; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Gostissa M, 2009, P NATL ACAD SCI USA, V106, P2265, DOI 10.1073/pnas.0812763106; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Han L, 2011, P NATL ACAD SCI USA, V108, P11584, DOI 10.1073/pnas.1018726108; Helmink BA, 2012, ANNU REV IMMUNOL, V30, P175, DOI 10.1146/annurev-immunol-030409-101320; Hewitt SL, 2010, IMMUNOL REV, V237, P43, DOI 10.1111/j.1600-065X.2010.00931.x; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu XY, 2012, P NATL ACAD SCI USA, V109, P3903, DOI 10.1073/pnas.1120160109; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lucas JS, 2011, CURR OPIN CELL BIOL, V23, P318, DOI 10.1016/j.ceb.2010.11.007; MacPherson MJ, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-101; Maher CA, 2012, CELL, V148, P29, DOI 10.1016/j.cell.2012.01.006; Mahowald GK, 2009, P NATL ACAD SCI USA, V106, P18339, DOI 10.1073/pnas.0902545106; Marti-Renom MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002125; Matheson LS, 2012, CURR TOP MICROBIOL, V356, P65, DOI 10.1007/82_2011_137; Matthews AGW, 2009, NAT IMMUNOL, V10, P817, DOI 10.1038/ni.1776; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1111/j.1600-065X.2000.imr017510.x; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mostoslavsky R, 2004, CELL, V118, P539, DOI 10.1016/j.cell.2004.08.023; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; Oksenych V, 2012, P NATL ACAD SCI USA, V109, P2455, DOI 10.1073/pnas.1121458109; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pinaud E, 2011, ADV IMMUNOL, V110, P27, DOI 10.1016/B978-0-12-387663-8.00002-8; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Robbiani D.F., 2012, ANNU REV PATHOL-MECH, V2012, P4; Schatz David G., 2004, Cell, VS116, pS103, DOI 10.1016/S0092-8674(04)00042-X; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Sleckman BP, 2012, J IMMUNOL, V188, P7, DOI 10.4049/jimmunol.1103195; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Soulas-Sprauel P, 2007, ONCOGENE, V26, P7780, DOI 10.1038/sj.onc.1210875; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Subrahmanyam R, 2012, CURR TOP MICROBIOL, V356, P39, DOI 10.1007/82_2011_153; Tsai AG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S1; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Volpi SA, 2012, J IMMUNOL, V188, P2556, DOI 10.4049/jimmunol.1102763; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yu KF, 2003, DNA REPAIR, V2, P1163, DOI 10.1016/j.dnarep.2003.08.010; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	99	305	309	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					417	429		10.1016/j.cell.2013.01.007	http://dx.doi.org/10.1016/j.cell.2013.01.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374339	Bronze, Green Accepted			2022-12-28	WOS:000314362800013
J	Lavrijsen, R; Lee, JH; Fernandez-Pacheco, A; Petit, DCMC; Mansell, R; Cowburn, RP				Lavrijsen, Reinoud; Lee, Ji-Hyun; Fernandez-Pacheco, Amalio; Petit, Dorothee C. M. C.; Mansell, Rhodri; Cowburn, Russell P.			Magnetic ratchet for three-dimensional spintronic memory and logic	NATURE			English	Article							ANISOTROPY	One of the key challenges for future electronic memory and logic devices is finding viable ways of moving from today's two-dimensional structures, which hold data in an x-y mesh of cells, to three-dimensional structures in which data are stored in an x-y-z lattice of cells. This could allow a many-fold increase in performance. A suggested solution is the shift register(1,2)-a digital building block that passes data from cell to cell along a chain. In conventional digital microelectronics, two-dimensional shift registers are routinely constructed from a number of connected transistors. However, for three-dimensional devices the added process complexity and space needed for such transistors would largely cancel out the benefits of moving into the third dimension. 'Physical' shift registers, in which an intrinsic physical phenomenon is used to move data near-atomic distances, without requiring conventional transistors, are therefore much preferred. Here we demonstrate a way of implementing a spintronic unidirectional vertical shift register between perpendicularly magnetized ferromagnets of subnanometre thickness, similar to the layers used in non-volatile magnetic random-access memory(3). By carefully controlling the thickness of each magnetic layer and the exchange coupling between the layers, we form a ratchet that allows information in the form of a sharp magnetic kink soliton to be unidirectionally pumped (or 'shifted') from one magnetic layer to another. This simple and efficient shift-register concept suggests a route to the creation of three-dimensional microchips for memory and logic applications.	[Lavrijsen, Reinoud; Lee, Ji-Hyun; Fernandez-Pacheco, Amalio; Petit, Dorothee C. M. C.; Mansell, Rhodri; Cowburn, Russell P.] Univ Cambridge, Cavendish Lab, Thin Film Magnetism Grp, Cambridge CB3 0HE, England	University of Cambridge	Cowburn, RP (corresponding author), Univ Cambridge, Cavendish Lab, Thin Film Magnetism Grp, JJ Thomson Ave, Cambridge CB3 0HE, England.	rpc12@cam.ac.uk	Cowburn, Russell/D-5820-2015; Fernandez-Pacheco, Amalio/GSJ-4044-2022; Lavrijsen, Reinoud/AAC-2248-2019; Fernandez-Pacheco, Amalio/AAM-2312-2020; Mansell, Rhodri/A-1450-2013	Cowburn, Russell/0000-0003-0867-8900; Mansell, Rhodri/0000-0002-6026-0731; Lavrijsen, Reinoud/0000-0002-1209-5858; Fernandez-Pacheco, Amalio/0000-0002-3862-8472	Netherlands Organization for Scientific Research and Marie Curie Cofund Action (NWO) [680-50-1024]; Marie Curie IEF within the Seventh European Community [251698, 3DMAG-NANOW]; European Community [247368: 3SPIN]	Netherlands Organization for Scientific Research and Marie Curie Cofund Action (NWO); Marie Curie IEF within the Seventh European Community; European Community(European Commission)	R.L. was supported by the Netherlands Organization for Scientific Research and Marie Curie Cofund Action (NWO-Rubicon 680-50-1024). A.F.-P. was supported by a Marie Curie IEF within the Seventh European Community Framework Programme No. 251698; 3DMAG-NANOW. We acknowledge research funding from the European Community under the Seventh Framework Programme Contract No. 247368: 3SPIN.	Allwood DA, 2005, SCIENCE, V309, P1688, DOI 10.1126/science.1108813; Baltz V, 2007, EUR PHYS J-APPL PHYS, V39, P33, DOI 10.1051/epjap:2007107; Baltz V, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3078523; Baryakhtar V., 1994, DYNAMICS TOPOLOGICAL; BRUNO P, 1990, J APPL PHYS, V68, P5759, DOI 10.1063/1.346944; Gajek M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694270; Hellwig O, 2007, J MAGN MAGN MATER, V319, P13, DOI 10.1016/j.jmmm.2007.04.035; Kawahara T, 2012, MICROELECTRON RELIAB, V52, P613, DOI 10.1016/j.microrel.2011.09.028; Kronmller H., 2007, HDB MAGNETISM ADV MA, V1-5; Langholz G., 1998, FDN DIGITAL LOGIC DE; Lavrijsen R, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3682103; Lavrijsen R, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3280373; Lemerle S, 1998, PHYS REV LETT, V80, P849, DOI 10.1103/PhysRevLett.80.849; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Sbiaa R, 2011, PHYS STATUS SOLIDI-R, V5, P413, DOI 10.1002/pssr.201105420; Seki S, 2012, SCIENCE, V336, P198, DOI 10.1126/science.1214143; Thomson T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.257204; Tudosa I, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3441402; WANG RW, 1994, PHYS REV LETT, V72, P920, DOI 10.1103/PhysRevLett.72.920	20	154	167	3	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					647	650		10.1038/nature11733	http://dx.doi.org/10.1038/nature11733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364743				2022-12-28	WOS:000314219600051
J	Vrontou, S; Wong, AM; Rau, KK; Koerber, HR; Anderson, DJ				Vrontou, Sophia; Wong, Allan M.; Rau, Kristofer K.; Koerber, H. Richard; Anderson, David J.			Genetic identification of C fibres that detect massage-like stroking of hairy skin in vivo	NATURE			English	Article							UNMYELINATED TACTILE AFFERENTS; SENSORY NEURONS; MICE; TOUCH; PAIN; POPULATIONS; PREFERENCE; PARADIGM; SUBSETS; REWARD	Stroking of the skin produces pleasant sensations that can occur during social interactions with conspecifics, such as grooming(1). Despite numerous physiological studies (reviewed in ref. 2), molecularly defined sensory neurons that detect pleasant stroking of hairy skin(3,4) in vivo have not been reported. Previously, we identified a rare population of unmyelinated sensory neurons in mice that express the G-protein-coupled receptor MRGPRB4 (refs 5, 6). These neurons exclusively innervate hairy skin with large terminal arborizations(7) that resemble the receptive fields of C-tactile (CT) afferents in humans(8). Unlike other molecularly defined mechanosensory C-fibre subtypes(9,10), MRGPRB(+) neurons could not be detectably activated by sensory stimulation of the skin ex vivo. Therefore, we developed a preparation for calcium imaging in the spinal projections of these neurons during stimulation of the periphery in intact mice. Here we show that MRGPRB41 neurons are activated by massage-like stroking of hairy skin, but not by noxious punctate mechanical stimulation. By contrast, a different population of C fibres expressing MRGPRD(11) was activated by pinching but not by stroking, consistent with previous physiological and behavioural data(10,12). Pharmacogenetic activation of Mrgprb4-expressing neurons in freely behaving mice promoted conditioned place preference(13), indicating that such activation is positively reinforcing and/or anxiolytic. These data open the way to understanding the function of MRGPRB4 neurons during natural behaviours, and provide a general approach to the functional chargenetically identified subsets of somatosensory neurons in vivo.	[Vrontou, Sophia; Wong, Allan M.; Anderson, David J.] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; [Wong, Allan M.; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Rau, Kristofer K.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA; [Koerber, H. Richard] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15261 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Louisville; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Anderson, DJ (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	wuwei@caltech.edu			NIH [5PO1NS-48499, 5R01 NS023476]; EMBO; Human Frontiers Science Program; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048499, R01NS023725, R01NS023476] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Robertson for programming and imaging data analysis; M. Walsh and T. Heitzman for the stimulus delivery system and associated electronics; M. Zelikowsky for help with statistical analysis of behavioural data; H. Inagaki for experimental advice and comments on the manuscript; S. Pease for help with generation of knock-in mice; N. Verduzco, K. Lee and R. Sauza for mice colony maintenance; M. Visel and J. Flannery for training in AAV8 preparation; A. Anderson and C. Pagan for initial experiments using their stereotaxic apparatus; J. Zhang and A. Basbaum for teaching the dorsal laminectomy and for comments on the manuscript; D. Davalos, K. Akassoglou and H. Johanssen for help with the in vivo imaging preparation; L. Lagnado and B. Odermatt for SypHyand SyGCamp2 plasmids; C. Shea and M. Martinez for technical assistance; H. Oates-Barker for laboratory management and G. Mancuso for administrative assistance. This work was supported by NIH grants 5PO1NS-48499 and 5R01 NS023476, and by fellowships from EMBO and the Human Frontiers Science Program (S.V.) and the Helen Hay Whitney Foundation (A.M.W.). D.J.A. is an Investigator of the Howard Hughes Medical Institute.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Cunningham CL, 2003, PSYCHOPHARMACOLOGY, V170, P409, DOI 10.1007/s00213-003-1559-y; Davalos D, 2008, J NEUROSCI METH, V169, P1, DOI 10.1016/j.jneumeth.2007.11.011; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; Dussor G, 2008, J NEUROPHYSIOL, V99, P1581, DOI 10.1152/jn.01396.2007; EDIN BB, 1995, J NEUROSCI, V15, P830; Foust KD, 2008, HUM GENE THER, V19, P61, DOI 10.1089/hum.2007.093; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hamilton SG, 2001, J PHYSIOL-LONDON, V534, P437, DOI 10.1111/j.1469-7793.2001.00437.x; Johannssen HC, 2010, J PHYSIOL-LONDON, V588, P3397, DOI 10.1113/jphysiol.2010.191833; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; LaBuda CJ, 2000, EXP NEUROL, V163, P490, DOI 10.1006/exnr.2000.7395; Le Foll B, 2005, PSYCHOPHARMACOLOGY, V178, P481, DOI 10.1007/s00213-004-2021-5; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; McGlone F, 2007, CAN J EXP PSYCHOL, V61, P173, DOI 10.1037/cjep2007019; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Morrison I, 2010, EXP BRAIN RES, V204, P305, DOI 10.1007/s00221-009-2007-y; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Olausson H, 2010, NEUROSCI BIOBEHAV R, V34, P185, DOI 10.1016/j.neubiorev.2008.09.011; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Panksepp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021236; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Raymond CS, 2010, GENESIS, V48, P603, DOI 10.1002/dvg.20659; Shields SD, 2010, PAIN, V151, P422, DOI 10.1016/j.pain.2010.08.001; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Wessberg J, 2003, J NEUROPHYSIOL, V89, P1567, DOI 10.1152/jn.00256.2002; Woodbury CJ, 2001, J COMP NEUROL, V436, P304; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	39	162	165	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					669	+		10.1038/nature11810	http://dx.doi.org/10.1038/nature11810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364746	Green Accepted			2022-12-28	WOS:000314219600056
J	Myung, SK; Ju, W; Cho, B; Oh, SW; Park, SM; Koo, BK; Park, BJ				Myung, Seung-Kwon; Ju, Woong; Cho, Belong; Oh, Seung-Won; Park, Sang Min; Koo, Bon-Kwon; Park, Byung-Joo		Korean Meta Anal KORMA Study Grp	Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							STAGE RENAL-DISEASE; HORMONE REPLACEMENT THERAPY; CORONARY-HEART-DISEASE; FOLIC-ACID; BETA-CAROTENE; B-VITAMINS; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; HIGH-RISK; SELENIUM SUPPLEMENTATION	Objective To assess the efficacy of vitamin and antioxidant supplements in the prevention of cardiovascular diseases. Design Meta-analysis of randomised controlled trials. Data sources and study selection PubMed, EMBASE, the Cochrane Library, Scopus, CINAHL, and ClinicalTrials.gov searched in June and November 2012. Two authors independently reviewed and selected eligible randomised controlled trials, based on predetermined selection criteria. Results Out of 2240 articles retrieved from databases and relevant bibliographies, 50 randomised controlled trials with 294 478 participants (156 663 in intervention groups and 137 815 in control groups) were included in the final analyses. In a fixed effect meta-analysis of the 50 trials, supplementation with vitamins and antioxidants was not associated with reductions in the risk of major cardiovascular events (relative risk 1.00, 95% confidence interval 0.98 to 1.02; I-2=42%). Overall, there was no beneficial effect of these supplements in the subgroup meta-analyses by type of prevention, type of vitamins and antioxidants, type of cardiovascular outcomes, study design, methodological quality, duration of treatment, funding source, provider of supplements, type of control, number of participants in each trial, and supplements given singly or in combination with other supplements. Among the subgroup meta-analyses by type of cardiovascular outcomes, vitamin and antioxidant supplementation was associated with a marginally increased risk of angina pectoris, while low dose vitamin B-6 supplementation was associated with a slightly decreased risk of major cardiovascular events. Those beneficial or harmful effects disappeared in subgroup meta-analysis of high quality randomised controlled trials within each category. Also, even though supplementation with vitamin B-6 was associated with a decreased risk of cardiovascular death in high quality trials, and vitamin E supplementation with a decreased risk of myocardial infarction, those beneficial effects were seen only in randomised controlled trials in which the supplements were supplied by the pharmaceutical industry. Conclusion There is no evidence to support the use of vitamin and antioxidant supplements for prevention of cardiovascular diseases.	[Myung, Seung-Kwon; Cho, Belong; Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Myung, Seung-Kwon] Natl Canc Ctr, Res Inst & Hosp, Carcinogenesis Res Branch, Goyang, South Korea; [Myung, Seung-Kwon] Natl Canc Ctr, Res Inst & Hosp, Dept Family Med, Goyang, South Korea; [Ju, Woong] Ewha Womans Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Ju, Woong] Ewha Womans Univ, Coll Med, Med Res Inst, Seoul, South Korea; [Oh, Seung-Won] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Inst Healthcare Res, Seoul 110744, South Korea; [Oh, Seung-Won] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Family Med, Seoul 110744, South Korea; [Koo, Bon-Kwon] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Park, Byung-Joo] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Seoul National University (SNU); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Ewha Womans University; Ewha Womans University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Cho, B (corresponding author), 101 Daehak Ro, Seoul 110744, South Korea.	msk@ncc.re.kr; belong@snu.ac.kr	Cho, Belong/GLU-3443-2022; Park, Sang Min/V-9194-2019; Myung, Seung-Kwon/C-2449-2011; Oh, Seung-Won/GLS-0494-2022	Cho, Belong/0000-0001-9558-689X; Myung, Seung-Kwon/0000-0001-8911-1345				Aguirre R, 2008, PHARMACOL THERAPEUT, V119, P96, DOI 10.1016/j.pharmthera.2008.05.002; Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Berggren M, 2008, OSTEOPOROSIS INT, V19, P801, DOI 10.1007/s00198-007-0507-9; Bhupathiraju SN, 2011, CLIN CHIM ACTA, V412, P1493, DOI 10.1016/j.cca.2011.04.038; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bjelakovic G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007176.pub2, 10.1590/1516-3180.20151332T1]; Boaz M, 2000, LANCET, V356, P1213, DOI 10.1016/S0140-6736(00)02783-5; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Bostom AG, 2011, CIRCULATION, V123, P1763, DOI 10.1161/CIRCULATIONAHA.110.000588; Brazier M, 2005, CLIN THER, V27, P1885, DOI 10.1016/j.clinthera.2005.12.010; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Crawford RS, 1998, ARTERIOSCL THROM VAS, V18, P1506, DOI 10.1161/01.ATV.18.9.1506; Dauchet L, 2009, NAT REV CARDIOL, V6, P599, DOI 10.1038/nrcardio.2009.131; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Eidelman RS, 2004, ARCH INTERN MED, V164, P1552, DOI 10.1001/archinte.164.14.1552; Elamin MB, 2011, J CLIN ENDOCR METAB, V96, P1931, DOI 10.1210/jc.2011-0398; Farbstein D, 2010, MOLECULES, V15, P8098, DOI 10.3390/molecules15118098; Flores-Mateo G, 2006, AM J CLIN NUTR, V84, P762, DOI 10.1093/ajcn/84.4.762; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Greenberg ER, 1996, JAMA-J AM MED ASSOC, V275, P699, DOI 10.1001/jama.275.9.699; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Heinz J, 2010, CIRCULATION, V121, P1432, DOI 10.1161/CIRCULATIONAHA.109.904672; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENRIKSEN T, 1981, P NATL ACAD SCI-BIOL, V78, P6499, DOI 10.1073/pnas.78.10.6499; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hodis HN, 2009, STROKE, V40, P730, DOI 10.1161/STROKEAHA.108.526798; House AA, 2010, JAMA-J AM MED ASSOC, V303, P1603, DOI 10.1001/jama.2010.490; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jamison RL, 2007, JAMA-J AM MED ASSOC, V298, P1163, DOI 10.1001/jama.298.10.1163; Komulainen M, 1999, J CLIN ENDOCR METAB, V84, P546, DOI 10.1210/jc.84.2.546; KORPELA H, 1989, RES COMMUN CHEM PATH, V65, P249; KUKLINSKI B, 1994, MOL ASPECTS MED, V15, P143, DOI 10.1016/0098-2997(94)90023-X; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lee M, 2010, STROKE, V41, P1205, DOI 10.1161/STROKEAHA.109.573410; Liem A, 2003, J AM COLL CARDIOL, V41, P2105, DOI 10.1016/S0735-1097(03)00485-6; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Mark SD, 1996, AM J EPIDEMIOL, V143, P658, DOI 10.1093/oxfordjournals.aje.a008798; Mei W, 2010, INT J CLIN PRACT, V64, P208, DOI 10.1111/j.1742-1241.2009.02207.x; Mendis S, 2011, J CLIN EPIDEMIOL, V64, P1451, DOI 10.1016/j.jclinepi.2011.02.001; Milman U, 2008, ARTERIOSCL THROM VAS, V28, P341, DOI 10.1161/ATVBAHA.107.153965; Myung SK, 2010, ANN ONCOL, V21, P166, DOI 10.1093/annonc/mdp286; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; PARKER RA, 1995, ARTERIOSCL THROM VAS, V15, P349, DOI 10.1161/01.ATV.15.3.349; Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685; Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31; Qin XH, 2011, CLIN J AM SOC NEPHRO, V6, P482, DOI 10.2215/CJN.05310610; QUINN MT, 1987, P NATL ACAD SCI USA, V84, P2995, DOI 10.1073/pnas.84.9.2995; Rafiee P, 2002, CIRCULATION, V106, P239, DOI 10.1161/01.CIR.0000022018.68965.6D; Rapola JM, 1997, LANCET, V349, P1715, DOI 10.1016/S0140-6736(97)01234-8; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Righetti M, 2003, MED SCI MONITOR, V9, pPI19; Schnyder G, 2002, JAMA-J AM MED ASSOC, V288, P973, DOI 10.1001/jama.288.8.973; SCHWARTZ CJ, 1991, CLIN CARDIOL, V14, P1, DOI 10.1002/clc.4960141302; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Sesso HD, 2012, JAMA-J AM MED ASSOC, V308, P1751, DOI 10.1001/jama.2012.14805; Shekelle PG, 2004, J GEN INTERN MED, V19, P380, DOI 10.1111/j.1525-1497.2004.30090.x; STEINER M, 1995, AM J CLIN NUTR, V62, P1381, DOI 10.1093/ajcn/62.6.1381S; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Stranges S, 2006, AM J EPIDEMIOL, V163, P694, DOI 10.1093/aje/kwj097; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Ulrich-Merzenich G, 2002, EUR J NUTR, V41, P27, DOI 10.1007/s003940200003; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Virtamo J, 1998, ARCH INTERN MED, V158, P668, DOI 10.1001/archinte.158.6.668; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432; Wrone EM, 2004, J AM SOC NEPHROL, V15, P420, DOI 10.1097/01.ASN.0000110181.64655.6C; You WC, 2001, EUR J CANCER PREV, V10, P257, DOI 10.1097/00008469-200106000-00009; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zhou YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025142; Zoungas S, 2006, J AM COLL CARDIOL, V47, P1108, DOI 10.1016/j.jacc.2005.10.064	83	307	319	10	100	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2013	346								f10	10.1136/bmj.f10	http://dx.doi.org/10.1136/bmj.f10			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075FW	23335472	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000313870300001
J	Willmund, F; del Alamo, M; Pechmann, S; Chen, TT; Albanese, V; Dammer, EB; Peng, JM; Frydman, J				Willmund, Felix; del Alamo, Marta; Pechmann, Sebastian; Chen, Taotao; Albanese, Veronique; Dammer, Eric B.; Peng, Junmin; Frydman, Judith			The Cotranslational Function of Ribosome-Associated Hsp70 in Eukaryotic Protein Homeostasis	CELL			English	Article							IN-VIVO; CHAPERONE NETWORKS; TRIGGER FACTOR; PREDICTION; DNAK; SPECIFICITY; MACHINERY; GENOME; VITRO; SSB	In eukaryotic cells a molecular chaperone network associates with translating ribosomes, assisting the maturation of emerging nascent polypeptides. Hsp70 is perhaps the major eukaryotic ribosome-associated chaperone and the first reported to bind cotranslationally to nascent chains. However, little is known about the underlying principles and function of this interaction. Here, we use a sensitive and global approach to define the cotranslational substrate specificity of the yeast Hsp70 SSB. We find that SSB binds to a subset of nascent polypeptides whose intrinsic properties and slow translation rates hinder efficient cotranslational folding. The SSB-ribosome cycle and substrate recognition is modulated by its ribosome-bound cochaperone, RAC. Deletion of SSB leads to widespread aggregation of newly synthesized polypeptides. Thus, cotranslationally acting Hsp70 meets the challenge of folding the eukaryotic proteome by stabilizing its longer, more slowly translated, and aggregation-prone nascent polypeptides.	[Willmund, Felix; del Alamo, Marta; Pechmann, Sebastian; Chen, Taotao; Albanese, Veronique; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Willmund, Felix; del Alamo, Marta; Pechmann, Sebastian; Chen, Taotao; Albanese, Veronique; Frydman, Judith] Stanford Univ, BioX Program, Stanford, CA 94305 USA; [Dammer, Eric B.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Dammer, Eric B.] Emory Univ, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Struct Biol & Dev Neurobiol, Memphis, TN 38105 USA	Stanford University; Stanford University; Emory University; Emory University; St Jude Children's Research Hospital	Frydman, J (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Dammer, Eric B/V-8652-2019; Peng, Junmin/N-2614-2018	Dammer, Eric B/0000-0003-2947-7606; Peng, Junmin/0000-0003-0472-7648; Chen, Taotao/0000-0002-9359-8069; , judith/0000-0003-2302-6943; del Alamo, Marta/0000-0002-8254-9990; Willmund, Felix/0000-0002-3988-4590	EMBO; Spanish Ministry of Education/FECYT postdoctoral fellowship;  [NIH1RO1 GM-56433];  [NIH R21RR025822];  [NIHF32AG038259]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056433, R01GM056433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG038259] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); Spanish Ministry of Education/FECYT postdoctoral fellowship; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Patrick Brown and Dr. Dan Hogan for help and advice with the microarray experiments. We also thank Dr. Raul Andino, Karolin Dorn, and members of the J.F. laboratory for critical reading of the manuscript; Dr. Elke Deuerling for the kind gift of anti-Sse antibody as well as the protocol for aggregate isolation; and Dr. Scott W. Moye-Rowley for the kind gift of the anti-Ssz1 antibody. This work was supported by the Grant NIH1RO1 GM-56433 to J.F. and NIH R21RR025822 to J.P., as well as NIHF32AG038259 to E.B.D. F.W. and S.P. were supported by the EMBO Long-term Fellowship. M.d.A was partially supported by the Spanish Ministry of Education/FECYT postdoctoral fellowship.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Duncan CDS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002398; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lin MM, 2012, P NATL ACAD SCI USA, V109, P9851, DOI 10.1073/pnas.1207382109; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Luheshi LM, 2008, CURR OPIN CHEM BIOL, V12, P25, DOI 10.1016/j.cbpa.2008.02.011; Malmstrom L, 2007, PLOS BIOL, V5, P758, DOI 10.1371/journal.pbio.0050076; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; O'Brien EP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1850; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Peisker K, 2010, BBA-MOL CELL RES, V1803, P662, DOI 10.1016/j.bbamcr.2010.03.005; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Tartaglia GG, 2010, J MOL BIOL, V400, P579, DOI 10.1016/j.jmb.2010.03.066; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; von Plehwe U, 2009, GENE DEV, V23, P2102, DOI 10.1101/gad.529409; Wang ML, 2011, P NATL ACAD SCI USA, V108, P11954, DOI 10.1073/pnas.1017361108; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zheng OY, 2008, PROTEIN SCI, V17, P1256, DOI 10.1110/ps.034660.108	49	173	175	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					196	209		10.1016/j.cell.2012.12.001	http://dx.doi.org/10.1016/j.cell.2012.12.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332755	Green Accepted, Bronze			2022-12-28	WOS:000313719800017
J	Knaul, FM; Atun, R; Farmer, P; Frenk, J				Knaul, Felicia Marie; Atun, Rifat; Farmer, Paul; Frenk, Julio			Seizing the opportunity to close the cancer divide	LANCET			English	Editorial Material							COVERAGE		[Knaul, Felicia Marie] Harvard Global Equ Initiat, Boston, MA 02115 USA; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Sch Business, London, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Farmer, Paul] Harvard Univ, Sch Med, Boston, MA USA; [Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Imperial College London; Imperial College London; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Knaul, FM (corresponding author), Harvard Global Equ Initiat, Boston, MA 02115 USA.	felicia_knaul@harvard.edu	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983; Knaul, Felicia/0000-0002-0512-4788				Atun R, 2013, LANCET; Bhadelia A, 2012, CLOSING CANC DIVIDE, P129; Binagwaho A, 2012, B WORLD HEALTH ORGAN, V90, P623, DOI 10.2471/BLT.11.097253; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Hazin R, 2010, LANCET ONCOL, V11, P204, DOI 10.1016/S1470-2045(09)70288-8; Institute for Health Metrics and Evaluation, GBD 2010 PATT BROAD; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pickhardt M., 2012, CLOSING CANC DIVIDE, P3; Shafey O, 2009, TOBACCO ATLAS, V3, P37	11	21	22	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2238	2239		10.1016/S0140-6736(13)60176-2	http://dx.doi.org/10.1016/S0140-6736(13)60176-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173SU	23388077				2022-12-28	WOS:000321100300011
J	Ho, AL; Grewal, RK; Leboeuf, R; Sherman, EJ; Pfister, DG; Deandreis, D; Pentlow, KS; Zanzonico, PB; Haque, S; Gavane, S; Ghossein, RA; Ricarte, JC; Dominguez, JM; Shen, RL; Tuttle, RM; Larson, SM; Fagin, JA				Ho, Alan L.; Grewal, Ravinder K.; Leboeuf, Rebecca; Sherman, Eric J.; Pfister, David G.; Deandreis, Desiree; Pentlow, Keith S.; Zanzonico, Pat B.; Haque, Sofia; Gavane, Somali; Ghossein, Ronald A.; Ricarte-Filho, Julio C.; Dominguez, Jose M.; Shen, Ronglai; Tuttle, R. Michael; Larson, Steve M.; Fagin, James A.			Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRAF MUTATIONS; RADIOACTIVE IODINE; PHASE-II; CARCINOMA; PAPILLARY; THERAPY; CELLS; DIFFERENTIATION; ACTIVATION; EXPRESSION	BACKGROUND Metastatic thyroid cancers that are refractory to radioiodine (iodine-131) are associated with a poor prognosis. In mouse models of thyroid cancer, selective mitogen-activated protein kinase (MAPK) pathway antagonists increase the expression of the sodium-iodide symporter and uptake of iodine. Their effects in humans are not known. METHODS We conducted a study to determine whether the MAPK kinase (MEK) 1 and MEK2 inhibitor selumetinib (AZD6244, ARRY-142886) could reverse refractoriness to radioiodine in patients with metastatic thyroid cancer. After stimulation with thyrotropin alfa, dosimetry with iodine-124 positron-emission tomography (PET) was performed before and 4 weeks after treatment with selumetinib (75 mg twice daily). If the second iodine-124 PET study indicated that a dose of iodine-131 of 2000 cGy or more could be delivered to the metastatic lesion or lesions, therapeutic radioiodine was administered while the patient was receiving selumetinib. RESULTS Of 24 patients screened for the study, 20 could be evaluated. The median age was 61 years (range, 44 to 77), and 11 patients were men. Nine patients had tumors with BRAF mutations, and 5 patients had tumors with mutations of NRAS. selumetinib increased the uptake of iodine-124 in 12 of the 20 patients (4 of 9 patients with BRAF mutations and 5 of 5 patients with NRAS mutations). Eight of these 12 patients reached the dosimetry threshold for radioiodine therapy, including all 5 patients with NRAS mutations. Of the 8 patients treated with radioiodine, 5 had confirmed partial responses and 3 had stable disease; all patients had decreases in serum thyroglobulin levels (mean reduction, 89%). No toxic effects of grade 3 or higher attributable by the investigators to selumetinib were observed. One patient received a diagnosis of myelodysplastic syndrome more than 51 weeks after radioiodine treatment, with progression to acute leukemia. CONCLUSIONS selumetinib produces clinically meaningful increases in iodine uptake and retention in a subgroup of patients with thyroid cancer that is refractory to radioiodine; the effectiveness may be greater in patients with RAS-mutant disease.	[Ho, Alan L.; Sherman, Eric J.; Pfister, David G.] Mem Sloan Kettering Canc Ctr, Dept Med, Head & Neck Oncol Serv, New York, NY 10065 USA; [Leboeuf, Rebecca; Tuttle, R. Michael; Fagin, James A.] Mem Sloan Kettering Canc Ctr, Dept Med, Serv Endocrinol, New York, NY 10065 USA; [Grewal, Ravinder K.; Deandreis, Desiree; Haque, Sofia; Gavane, Somali; Larson, Steve M.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA; [Pentlow, Keith S.; Zanzonico, Pat B.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10065 USA; [Ghossein, Ronald A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Ricarte-Filho, Julio C.; Dominguez, Jose M.; Fagin, James A.] Mem Sloan Kettering Canc Ctr, Dept Human Oncol & Pathogenesis, New York, NY 10065 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Epidemiol Biostat Program, New York, NY 10065 USA; [Larson, Steve M.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Fagin, JA (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.		Ricarte-Filho, Julio C/J-9389-2012; Deandreis, Desiree/AAA-3136-2022	Larson, Steven/0000-0002-6111-7507; , Somali/0000-0002-7859-0894; DEANDREIS, Desiree'/0000-0002-3817-6648; Dominguez, Jose M/0000-0002-6157-8055	American Thyroid Association; NATIONAL CANCER INSTITUTE [R01CA072598, P30CA008748, R01CA050706] Funding Source: NIH RePORTER	American Thyroid Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the American Thyroid Association and others; ClinicalTrials.gov number, NCT00970359.)	Chakravarty D, 2011, J CLIN INVEST, V121, P4700, DOI 10.1172/JCI46382; Coelho SM, 2004, J ENDOCRINOL INVEST, V27, P334, DOI 10.1007/BF03351058; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; De Vita G, 1998, CELL GROWTH DIFFER, V9, P97; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Durante C, 2007, J CLIN ENDOCR METAB, V92, P2840, DOI 10.1210/jc.2006-2707; Feine U, 1996, J NUCL MED, V37, P1468; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P5793, DOI 10.1128/MCB.12.12.5793; Handkiewicz-Junak D, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-8; Hayes DN, 2012, CLIN CANCER RES, V18, P2056, DOI 10.1158/1078-0432.CCR-11-0563; Ho Alan L, 2011, Clin Adv Hematol Oncol, V9, P32; Kimura ET, 2003, CANCER RES, V63, P1454; Kirkwood JM, 2012, CLIN CANCER RES, V18, P555, DOI 10.1158/1078-0432.CCR-11-1491; Knauf JA, 2003, ONCOGENE, V22, P4406, DOI 10.1038/sj.onc.1206602; Knauf JA, 2009, CURR OPIN CELL BIOL, V21, P296, DOI 10.1016/j.ceb.2009.01.013; Liu DX, 2007, CLIN CANCER RES, V13, P1341, DOI 10.1158/1078-0432.CCR-06-1753; Liu YY, 2006, CLIN ENDOCRINOL, V64, P617, DOI 10.1111/j.1365-2265.2006.02515.x; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Pentlow KS, 1996, J NUCL MED, V37, P1557; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Robbins RJ, 2006, J CLIN ENDOCR METAB, V91, P498, DOI 10.1210/jc.2005-1534; Robbins RJ, 2002, J NUCL MED, V43, P1482; Sgouros G, 2004, J NUCL MED, V45, P1366; Simon D, 2002, EUR J NUCL MED MOL I, V29, P775, DOI 10.1007/s00259-001-0737-6; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Wang WP, 2001, THYROID, V11, P1169, DOI 10.1089/10507250152741028	27	503	524	3	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					623	632		10.1056/NEJMoa1209288	http://dx.doi.org/10.1056/NEJMoa1209288			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194VA	23406027	Green Accepted			2022-12-28	WOS:000322659600007
J	Silverio, DL; Torker, S; Pilyugina, T; Vieira, EM; Snapper, ML; Haeffner, F; Hoveyda, AH				Silverio, Daniel L.; Torker, Sebastian; Pilyugina, Tatiana; Vieira, Erika M.; Snapper, Marc L.; Haeffner, Fredrik; Hoveyda, Amir H.			Simple organic molecules as catalysts for enantioselective synthesis of amines and alcohols	NATURE			English	Article							ASYMMETRIC ALLYLATION; HYDRAZONO ESTERS; ANALOGS; ALLYLBORATION; CROTYLATION; DERIVATIVES; EFFICIENT; IMINES	The discovery of catalysts that can be used to synthesize complex organic compounds by enantioselective transformations is central to advances in the life sciences(1); for this reason, many chemists aim to discover catalysts that allow for preparation of chiral molecules as predominantly one mirror-image isomer(2). The ideal catalyst should not contain precious elements' and should bring reactions to completion in a few hours through operationally simple procedures. Here we introduce a set of small organic molecules that can catalyse reactions of unsaturated organoboron reagents with imines and carbonyls; the products of the reactions are enantiomerically pure amines and alcohols, which might serve as intermediates in the preparation of biologically active molecules. A distinguishing feature of this catalyst class is the presence of a 'key' proton embedded within their structure. Catalysts are derived from the abundant amino add valine and are prepared in large quantities in four steps with inexpensive reagents. Reactions are scalable, do not demand stringent conditions, and can be performed with as little as 0.25 mole per cent catalyst in less than six hours at room temperature to generate products in more than 85 per cent yield and >= 97:3 enantiomeric ratio. The efficiency, selectivity and operational simplicity of the transformations and the range of boron-based reagents are expected to render this advance important for future progress in syntheses of amines and alcohols, which are useful in chemistry, biology and medicine.	[Silverio, Daniel L.; Torker, Sebastian; Pilyugina, Tatiana; Vieira, Erika M.; Snapper, Marc L.; Haeffner, Fredrik; Hoveyda, Amir H.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA	Boston College	Hoveyda, AH (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Silverio, Daniel/C-4953-2016	Silverio, Daniel/0000-0003-3240-2816	US National Institutes of Health, Institute of General Medical Sciences [GM-57212]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057212] Funding Source: NIH RePORTER	US National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Institutes of Health, Institute of General Medical Sciences (grant GM-57212). S.T. was a Swiss National Science Foundation Postdoctoral Fellow; E.M.V. was an AstraZeneca Graduate Fellow. We thank B. Li for assistance in securing X-ray structures, S. J. Meek, S. J. Malcolmson and K. L Tan for discussions, Boston College for providing access to computational facilities and Frontier Scientific for gifts of various organoboron reagents.	Aydin J, 2007, J ORG CHEM, V72, P4689, DOI 10.1021/jo070288b; Barnett DS, 2009, ANGEW CHEM INT EDIT, V48, P8679, DOI 10.1002/anie.200904715; Borzilleri RM, 2000, J AM CHEM SOC, V122, P8890, DOI 10.1021/ja001899n; Chakrabarti A, 2010, ANGEW CHEM INT EDIT, V49, P1838, DOI 10.1002/anie.200906308; Coste A, 2008, CR CHIM, V11, P1544, DOI 10.1016/j.crci.2008.06.003; Cravotto G, 2006, TETRAHEDRON-ASYMMETR, V17, P3070, DOI 10.1016/j.tetasy.2006.11.021; Ferraris D, 2002, J AM CHEM SOC, V124, P67, DOI 10.1021/ja016838j; Fujita M, 2008, J AM CHEM SOC, V130, P2914, DOI 10.1021/ja710627x; Guzman-Martinez A, 2010, J AM CHEM SOC, V132, P10634, DOI 10.1021/ja104254d; Hamada T, 2003, ANGEW CHEM INT EDIT, V42, P3927, DOI 10.1002/anie.200351778; Hanhan NV, 2010, ANGEW CHEM INT EDIT, V49, P744, DOI 10.1002/anie.200904393; Itoh J, 2009, ANGEW CHEM INT EDIT, V48, P6313, DOI 10.1002/anie.200902328; Itoh T, 2009, ORG LETT, V11, P3854, DOI 10.1021/ol901432a; Kargbo R, 2007, J AM CHEM SOC, V129, P3846, DOI 10.1021/ja070742t; Kim SJ, 2010, J AM CHEM SOC, V132, P12168, DOI 10.1021/ja1035336; Lou S, 2007, J AM CHEM SOC, V129, P15398, DOI 10.1021/ja075204v; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Nakamura E, 2011, NAT MATER, V10, P158, DOI 10.1038/nmat2969; Naodovic M, 2009, EUR J ORG CHEM, V2009, P5129, DOI 10.1002/ejoc.200900669; Ojima I., 2010, CATALYTIC ASYMMETRIC; Peddibhotla S., 2009, CURR BIOACT COMPD, V5, P20, DOI [10.2174/157340709787580900, DOI 10.2174/157340709787580900]; Sirasani G, 2011, ORG LETT, V13, P4736, DOI 10.1021/ol202056w; Tan KL, 2007, ANGEW CHEM INT EDIT, V46, P1315, DOI 10.1002/anie.200603354; Vieira EM, 2012, ANGEW CHEM INT EDIT, V51, P6618, DOI 10.1002/anie.201202694; Vieira EM, 2011, J AM CHEM SOC, V133, P3332, DOI 10.1021/ja200311n; Wada R, 2006, J AM CHEM SOC, V128, P7687, DOI 10.1021/ja061510h; Weinreb SM, 2005, SYNTHESIS-STUTTGART, P1205, DOI 10.1055/s-2005-865315; Xie WQ, 2005, ORG LETT, V7, P2775, DOI 10.1021/ol050991r; Yamamoto D, 2006, BIOORG MED CHEM LETT, V16, P2807, DOI 10.1016/j.bmcl.2006.01.107; Yus M, 2011, CHEM REV, V111, P7774, DOI 10.1021/cr1004474	30	160	162	3	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					216	221		10.1038/nature11844	http://dx.doi.org/10.1038/nature11844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23407537	Green Accepted			2022-12-28	WOS:000315137700035
J	Ben Salah, A; Ben Messaoud, N; Guedri, E; Zaatour, A; Ben Alaya, N; Bettaieb, J; Gharbi, A; Hamida, NB; Boukthir, A; Chlif, S; Abdelhamid, K; El Ahmadi, Z; Louzir, H; Mokni, M; Morizot, G; Buffet, P; Smith, PL; Kopydlowski, KM; Kreishman-Deitrick, M; Smith, KS; Nielsen, CJ; Ullman, DR; Norwood, JA; Thorne, GD; McCarthy, WF; Adams, RC; Rice, RM; Tang, D; Berman, J; Ransom, J; Magill, AJ; Grogl, M				Ben Salah, Afif; Ben Messaoud, Nathalie; Guedri, Evelyn; Zaatour, Amor; Ben Alaya, Nissaf; Bettaieb, Jihene; Gharbi, Adel; Hamida, Nabil Belhadj; Boukthir, Aicha; Chlif, Sadok; Abdelhamid, Kidar; El Ahmadi, Zaher; Louzir, Hechmi; Mokni, Mourad; Morizot, Gloria; Buffet, Pierre; Smith, Philip L.; Kopydlowski, Karen M.; Kreishman-Deitrick, Mara; Smith, Kirsten S.; Nielsen, Carl J.; Ullman, Diane R.; Norwood, Jeanne A.; Thorne, George D.; McCarthy, William F.; Adams, Ryan C.; Rice, Robert M.; Tang, Douglas; Berman, Jonathan; Ransom, Janet; Magill, Alan J.; Grogl, Max			Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; AMINOSIDINE PAROMOMYCIN; OINTMENT; THERAPY	Background There is a need for a simple and efficacious treatment for cutaneous leishmaniasis with an acceptable side-effect profile. Methods We conducted a randomized, vehicle-controlled phase 3 trial of topical treatments containing 15% paromomycin, with and without 0.5% gentamicin, for cutaneous leishmaniasis caused by Leishmania major in Tunisia. We randomly assigned 375 patients with one to five ulcerative lesions from cutaneous leishmaniasis to receive a cream containing 15% paromomycin-0.5% gentamicin (called WR 279,396), 15% paromomycin alone, or vehicle control (with the same base as the other two creams but containing neither paromomycin nor gentamicin). Each lesion was treated once daily for 20 days. The primary end point was the cure of the index lesion. Cure was defined as at least 50% reduction in the size of the index lesion by 42 days, complete reepithelialization by 98 days, and absence of relapse by the end of the trial (168 days). Any withdrawal from the trial was considered a treatment failure. Results The rate of cure of the index lesion was 81% (95% confidence interval [CI], 73 to 87) for paromomycin-gentamicin, 82% (95% CI, 74 to 87) for paromomycin alone, and 58% (95% CI, 50 to 67) for vehicle control (P<0.001 for each treatment group vs. the vehicle-control group). Cure of the index lesion was accompanied by cure of all other lesions except in five patients, one in each of the paromomycin groups and three in the vehicle-control group. Mild-to-moderate application-site reactions were more frequent in the paromomycin groups than in the vehicle-control group. Conclusions This trial provides evidence of the efficacy of paromomycin-gentamicin and paromomycin alone for ulcerative L. major disease. (Funded by the Department of the Army; ClinicalTrials.gov number, NCT00606580.)	[Ben Salah, Afif; Ben Messaoud, Nathalie; Guedri, Evelyn; Zaatour, Amor; Ben Alaya, Nissaf; Bettaieb, Jihene; Gharbi, Adel; Hamida, Nabil Belhadj; Boukthir, Aicha; Chlif, Sadok; Louzir, Hechmi] Inst Pasteur Tunis, Tunis, Tunisia; [Mokni, Mourad] Univ Hosp la Rabta, Dept Dermatol, Tunis, Tunisia; [Abdelhamid, Kidar] Reg Hosp Gafsa, Gafsa, Tunisia; [El Ahmadi, Zaher] Reg Directorate Hlth, Sidi Bouzid, Tunisia; [Morizot, Gloria; Buffet, Pierre] Inst Pasteur, Paris, France; [Buffet, Pierre] Univ Paris 06, INSERM, Unite Mixte Rech S 945, Paris, France; [Smith, Philip L.; Kopydlowski, Karen M.; Kreishman-Deitrick, Mara; Smith, Kirsten S.; Nielsen, Carl J.; Ullman, Diane R.; Norwood, Jeanne A.; Thorne, George D.; McCarthy, William F.; Adams, Ryan C.; Rice, Robert M.] USA, Ft Detrick, MD USA; [Tang, Douglas; Berman, Jonathan; Ransom, Janet] Fast Track Drugs & Biol, N Potomac, MD USA; [Magill, Alan J.; Grogl, Max] Walter Reed Army Inst Res, Div Expt Therapeut, Silver Spring, MD 20910 USA	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Hopital La Rabta; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Grogl, M (corresponding author), Walter Reed Army Inst Res, Div Expt Therapeut, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	max.grogl@amedd.army.mil	Ben Salah, Afif/AGW-8941-2022; Buffet, Pierre A/O-6189-2017	Ben Salah, Afif/0000-0002-6696-4713; Buffet, Pierre A/0000-0003-4010-929X; Bouafif ep Ben Alaya, Nissaf/0000-0002-3326-9861	Department of the Army; U.S.-French-Tunisia collaboration; U.S. Army Medical Materiel Development Activity; Institut Pasteur, Paris; U.S. Army Medical Research and Materiel Command; Walter Reed Army Institute of Research	Department of the Army; U.S.-French-Tunisia collaboration; U.S. Army Medical Materiel Development Activity; Institut Pasteur, Paris; U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Walter Reed Army Institute of Research	Supported by the Department of the Army. The investigators have adhered to the policies for protection of human subjects as prescribed in Army Regulation 70-25.; We thank the Regional Directorates of Health of Sidi Bouzid, Kairouan, and Gafsa, Tunisia; Farhat Mighri, Primary Health Center, El Mnara, Tunisia; the World Health Organization Reference Laboratory, Montpellier, France, for characterization of all isolated leishmania parasites; Prof. Dellagi Koussay, M. D., for his support of the U.S.-French-Tunisia collaboration; the Institut Pasteur, Paris, for management of the Cooperative Agreement between the U.S. Army Medical Materiel Development Activity and the Institut Pasteur; William Ellis, for ensuring investigational product transport and import in accordance with current Good Manufacturing Practice guidelines; Shirley Roach and Denise McKinney for clinical monitoring; senior leaders of the U.S. Army Medical Materiel Development Activity, U.S. Army Medical Research and Materiel Command, and Walter Reed Army Institute of Research for their support; and the volunteers for their participation and the parents who allowed their children to participate in the study.	[Anonymous], GLOB BURD DIS 2004 U; Arana BA, 2001, AM J TROP MED HYG, V65, P466, DOI 10.4269/ajtmh.2001.65.466; Asilian A, 1995, AM J TROP MED HYG, V53, P648, DOI 10.4269/ajtmh.1995.53.648; Ben Salah A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000432; BENSALAH A, 1995, AM J TROP MED HYG, V53, P162, DOI 10.4269/ajtmh.1995.53.162; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Bryceson A., 1987, LEISHMANIASES BIOL M, VII, P847; BRYCESON ADM, 1994, T ROY SOC TROP MED H, V88, P226, DOI 10.1016/0035-9203(94)90308-5; Buffet PA, 2011, PRESSE MED, V40, P173, DOI 10.1016/j.lpm.2010.09.023; Daneshvar H, 2003, J INFECT DIS, V187, P1662, DOI 10.1086/374783; Daneshvar H, 2009, PARASITOLOGY, V136, P1243, DOI 10.1017/S0031182009990679; ELON J, 1986, J INVEST DERMATOL, V87, P284, DOI 10.1111/1523-1747.ep12696697; ELON J, 1984, ANTIMICROB AGENTS CH, V26, P745, DOI 10.1128/AAC.26.5.745; ELSAFI SH, 1990, T ROY SOC TROP MED H, V84, P690, DOI 10.1016/0035-9203(90)90146-6; Garnier Tracy, 2002, Curr Opin Investig Drugs, V3, P538; GONZALEZ U, 2008, COCHRANE DB SYST REV, V4; Gonzalez U, 2009, COCHRANE DB SYST REV, V15, DOI DOI 10.1002/14651858.CD004834; Gonzalez U, 2010, CLIN INFECT DIS, V51, P409, DOI 10.1086/655134; Grogl M, 1999, J PARASITOL, V85, P354, DOI 10.2307/3285646; HEPBURN NC, 1994, T ROY SOC TROP MED H, V88, P700, DOI 10.1016/0035-9203(94)90237-2; Kanyok TP, 1997, ANTIMICROB AGENTS CH, V41, P982, DOI 10.1128/AAC.41.5.982; Kim DH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000381; Llanos-Cuentas A, 2007, AM J TROP MED HYG, V76, P1128, DOI 10.4269/ajtmh.2007.76.1128; Modabber Farrokh, 2007, Kinetoplastid Biol Dis, V6, P3, DOI 10.1186/1475-9292-6-3; NEAL RA, 1995, J ANTIMICROB CHEMOTH, V35, P577, DOI 10.1093/jac/35.5.577; Seifert K, 2006, ANTIMICROB AGENTS CH, V50, P73, DOI 10.1128/AAC.50.1.73-79.2006; SOTO J, 1994, T ROY SOC TROP MED H, V88, P695, DOI 10.1016/0035-9203(94)90235-6; Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536; WHO, 2010, WHO TECH REP SER, V949, P1	29	146	148	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					524	532		10.1056/NEJMoa1202657	http://dx.doi.org/10.1056/NEJMoa1202657			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083VU	23388004	Green Published, Bronze			2022-12-28	WOS:000314494100003
J	Teno, JM; Gozalo, PL; Bynum, JPW; Leland, NE; Miller, SC; Morden, NE; Scupp, T; Goodman, DC; Mor, V				Teno, Joan M.; Gozalo, Pedro L.; Bynum, Julie P. W.; Leland, Natalie E.; Miller, Susan C.; Morden, Nancy E.; Scupp, Thomas; Goodman, David C.; Mor, Vincent			Change in End-of-Life Care for Medicare Beneficiaries Site of Death, Place of Care, and Health Care Transitions in 2000, 2005, and 2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NURSING-HOME RESIDENTS; PALLIATIVE CARE; DECISION-MAKING; HOSPICE; OUTCOMES; CANCER; COST	Importance A recent Centers for Disease Control and Prevention report found that more persons die at home. This has been cited as evidence that persons dying in the United States are using more supportive care. Objective To describe changes in site of death, place of care, and health care transitions between 2000, 2005, and 2009. Design, Setting, and Patients Retrospective cohort study of a random 20% sample of fee-for-service Medicare beneficiaries, aged 66 years and older, who died in 2000 (n=270 202), 2005 (n=291 819), or 2009 (n=286 282). A multivariable regression model examined outcomes in 2000 and 2009 after adjustment for sociodemographic characteristics. Based on billing data, patients were classified as having a medical diagnosis of cancer, chronic obstructive pulmonary disease, or dementia in the last 180 days of life. Main Outcome Measures Site of death, place of care, rates of health care transitions, and potentially burdensome transitions (eg, health care transitions in the last 3 days of life). Results Comparing 2000, 2005, and 2009 shows a decrease in deaths in acute care hospitals and increases in intensive care unit (ICU) use in the last 30 days, hospice use at the time of death, and health care transitions at the end of the life (test of trend P < .001 for each). [GRAPHICS] In 2009, 28.4% (95% CI, 27.9%-28.5%) of hospice use at the time of death was for 3 days or less. Of these late hospice referrals, 40.3% (95% CI, 39.7%-40.8%) were preceded by hospitalization with an ICU stay. Conclusion and Relevance Among Medicare beneficiaries who died in 2009 and 2005 compared with 2000, a lower proportion died in an acute care hospital, although both ICU use and the rate of health care transitions increased in the last month of life. JAMA. 2013; 309(5): 470-477 www.jama.	[Teno, Joan M.; Gozalo, Pedro L.; Miller, Susan C.; Scupp, Thomas; Mor, Vincent] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Bynum, Julie P. W.; Morden, Nancy E.; Goodman, David C.] Dartmouth Med Sch, Lebanon, NH USA; [Leland, Natalie E.] Univ So Calif, Los Angeles, CA USA; [Mor, Vincent] Providence VA Med Ctr, Hlth Serv Res & Dev, Providence, RI USA	Brown University; Dartmouth College; University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Teno, JM (corresponding author), Brown Univ, Warren Alpert Med Sch, 121 S Main St, Providence, RI 02912 USA.	joan_teno@brown.edu	Miller, Susan/J-5450-2014; Goodman, David/AAG-7497-2020; Leland, Natalie/F-7223-2012	Miller, Susan/0000-0003-2008-6385; Leland, Natalie/0000-0002-0329-3772	National Institutes of Health; Center for Gerontology and Healthcare Research of Brown University; AmericanOccupational Therapy Association; Robert Wood Johnson Foundation; World Congress; Illinois Hospital Association; National Hospice Workgroup; National Association of Health Data Organizations; St Peters University Hospital; Massachusetts Hospital Association; Cooper Health System; Organizzato dal Laboratoria Management e Sanit a Scuola Superiore Sant'Anna di Pisa; Kentucky Academy of Family Physicians; Southern Illinois University Health Policy Institute; Ohio University College of Osteopathic Medicine; Institute for Clinical Quality and Value; Marwood Group; American Society of Clinical Oncologists; Delta Health Alliance; SUNY Upstate University; Intermountain Healthcare; Canadian Health Services Research Foundation; Massachusetts Health Data Consortium; Organisation for Economic Cooperation and Development; NATIONAL INSTITUTE ON AGING [P01AG027296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Gerontology and Healthcare Research of Brown University; AmericanOccupational Therapy Association; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); World Congress; Illinois Hospital Association; National Hospice Workgroup; National Association of Health Data Organizations; St Peters University Hospital; Massachusetts Hospital Association; Cooper Health System; Organizzato dal Laboratoria Management e Sanit a Scuola Superiore Sant'Anna di Pisa; Kentucky Academy of Family Physicians; Southern Illinois University Health Policy Institute; Ohio University College of Osteopathic Medicine; Institute for Clinical Quality and Value; Marwood Group; American Society of Clinical Oncologists; Delta Health Alliance; SUNY Upstate University; Intermountain Healthcare; Canadian Health Services Research Foundation; Massachusetts Health Data Consortium; Organisation for Economic Cooperation and Development; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Teno reported having received honoraria for speeches and lectures from nonprofit organizations. Dr Bynum reported having received a grant from the National Institutes of Health. Dr Leland reported having received grants from the National Institutes of Health; having received a fellowship from the Center for Gerontology and Healthcare Research of Brown University; and having received a stipend for collaboratively writing practice guidelines for productive aging from the AmericanOccupational Therapy Association. Dr Miller reported having received funding as a co-investigator to design and simulate modification to the Medicare hospice benefit payment system from the National Hospice and Palliative CareOrganization. Dr Morden reported having received a grant from the Robert Wood Johnson Foundation. Dr Goodman reported having received grants from the Robert Wood Johnson Foundation and National Institutes of Health; having served as a consultant for HealthDialog; and having received speakers' fees from the World Congress, Illinois Hospital Association, National Hospice Workgroup, National Association of Health Data Organizations, St Peters University Hospital, Massachusetts Hospital Association, Cooper Health System, Organizzato dal Laboratoria Management e Sanit a Scuola Superiore Sant'Anna di Pisa, Kentucky Academy of Family Physicians, Southern Illinois University Health Policy Institute, Ohio University College of Osteopathic Medicine, Institute for Clinical Quality and Value, Marwood Group, American Society of Clinical Oncologists, OR Manager, Delta Health Alliance, SUNY Upstate University, Intermountain Healthcare, Canadian Health Services Research Foundation, Massachusetts Health Data Consortium, and Organisation for Economic Cooperation and Development. Dr Mor reported having received grants or having grants pending from the National Institutes of Health, Agency for Healthcare Research and Quality, National Institute on Aging, Commonwealth Fund, American Health Care Association, and Kidney Care Partners; having received travel support from the National Institutes of Health and Agency for Healthcare Research and Quality; having received speakers' fees from the Alliance for Long Term Care Quality; having served on a board for PointRight and HCR Manor Care; having consulted for Abt Associates, Research Triangle Institute, and Welsh Carson Investment; and owning stock in PointRight. No other disclosures were reported.	[Anonymous], HOSP SERV; Bakitas Marie, 2009, Palliat Support Care, V7, P75, DOI 10.1017/S1478951509000108; Barnato AE, 2012, INTENS CARE MED, V38, P1886, DOI 10.1007/s00134-012-2661-6; Berke EM, 2009, J PALLIAT MED, V12, P128, DOI 10.1089/jpm.2008.0239; Brody AA, 2010, J PALLIAT MED, V13, P541, DOI 10.1089/jpm.2009.0300; Gallup GH, 1997, SPIRITUAL BELIEFS DY; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; GREER DS, 1986, J CHRON DIS, V39, P5, DOI 10.1016/0021-9681(86)90102-5; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; Higginson IJ, 2002, J PAIN SYMPTOM MANAG, V23, P96, DOI 10.1016/S0885-3924(01)00406-7; Intrator O, 2011, HEALTH SERV RES, V46, P120, DOI 10.1111/j.1475-6773.2010.01194.x; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Meier DE, 2011, MILBANK Q, V89, P343, DOI 10.1111/j.1468-0009.2011.00632.x; Morrison RS, 2008, ARCH INTERN MED, V168, P1783, DOI 10.1001/archinte.168.16.1783; Morrison RS, 2005, J PALLIAT MED, V8, P1127, DOI 10.1089/jpm.2005.8.1127; National Center for Health Statistics, HLTH US 2010 SPEC FE; National Hospice and Palliative Care Organization, 2019, NHPCO FACTS FIG HOSP; Smith TJ, 2009, J PAIN SYMPTOM MANAG, V38, P32, DOI 10.1016/j.jpainsymman.2009.05.001; Taylor DH, 2007, SOC SCI MED, V65, P1466, DOI 10.1016/j.socscimed.2007.05.028; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM., FACTS DYING BROWN AT; Teno JM, 2012, J PAIN SYMPTOM MANAG, V43, P732, DOI 10.1016/j.jpainsymman.2011.05.012; Teno JM, 2011, J AM GERIATR SOC, V59, P881, DOI 10.1111/j.1532-5415.2011.03385.x; Unroe KT, 2011, ARCH INTERN MED, V171, P196, DOI 10.1001/archinternmed.2010.371; Waldrop DP, 2005, J PALLIAT CARE, V21, P88, DOI 10.1177/082585970502100204; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863	27	716	718	6	120	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					470	477		10.1001/jama.2012.207624	http://dx.doi.org/10.1001/jama.2012.207624			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083LY	23385273	Green Accepted, Bronze			2022-12-28	WOS:000314466900028
J	Hawkes, N				Hawkes, Nigel			Did the government ignore criticisms of the NHSin the run up to the Mid Staffs scandal?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Hawkes N, 2007, BRIT MED J, V335, P1239, DOI 10.1136/bmj.39423.645729.94; Institute for Healthcare Improvement, 2008, ACH VIS EXC QUAL REC; Jarman B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8239; Joint Commission International, 2008, QUAL OV ENGL FIND OB; McGlynn E. A., 2008, DEV DISSEMINATING AS; Moore A, 2010, HLTH SERV J     0624	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2013	346								f652	10.1136/bmj.f652	http://dx.doi.org/10.1136/bmj.f652			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AR	23386538				2022-12-28	WOS:000314806700010
J	Neuert, G; Munsky, B; Tan, RZ; Teytelman, L; Khammash, M; van Oudenaarden, A				Neuert, Gregor; Munsky, Brian; Tan, Rui Zhen; Teytelman, Leonid; Khammash, Mustafa; van Oudenaarden, Alexander			Systematic Identification of Signal-Activated Stochastic Gene Regulation	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EXPRESSION; TRANSCRIPTION; FLUCTUATIONS; ADAPTATION; RECRUITMENT; DEPENDENCE; PATHWAY; NOISE	Although much has been done to elucidate the biochemistry of signal transduction and gene regulatory pathways, it remains difficult to understand or predict quantitative responses. We integrate single-cell experiments with stochastic analyses, to identify predictive models of transcriptional dynamics for the osmotic stress response pathway in Saccharomyces cerevisiae. We generate models with varying complexity and use parameter estimation and cross-validation analyses to select the most predictive model. This model yields insight into several dynamical features, including multistep regulation and switchlike activation for several osmosensitive genes. Furthermore, the model correctly predicts the transcriptional dynamics of cells in response to different environmental and genetic perturbations. Because our approach is general, it should facilitate a predictive understanding for signal-activated transcription of other genes in other pathways or organisms.	[Neuert, Gregor; Tan, Rui Zhen; Teytelman, Leonid; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Neuert, Gregor; Tan, Rui Zhen; Teytelman, Leonid; van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Neuert, Gregor; Tan, Rui Zhen; Teytelman, Leonid; van Oudenaarden, Alexander] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Neuert, Gregor] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Munsky, Brian] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Munsky, Brian] Los Alamos Natl Lab, Informat Sci Grp, Los Alamos, NM 87545 USA; [Khammash, Mustafa] ETH Zuerich, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Tan, Rui Zhen] ASTAR, Bioinformat Inst, Singapore 138671, Singapore; [Tan, Rui Zhen] Harvard Univ, Sch Med, Harvard Univ Grad Biophys Program, Boston, MA 02115 USA; [Khammash, Mustafa] Univ Calif Santa Barbara, Ctr Control Dynam Syst & Computat, Santa Barbara, CA 93106 USA; [Khammash, Mustafa] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA; [van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Vanderbilt University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Harvard University; Harvard Medical School; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	a.vanoudenaarden@hubrecht.eu	van Oudenaarden, Alexander/AAA-1705-2019; Teytelman, Lenny/AAX-2835-2021; Munsky, Brian/A-1947-2016	Teytelman, Lenny/0000-0001-8573-8351; Munsky, Brian/0000-0001-6147-7329	NSF [ECCS-0835847, ECCS-0835623]; Human Frontier Science Program [RGP0061/2011]; National Institutes of Health-National Cancer Institute Physical Sciences Oncology Center at Massachusetts Institute of Technology [U54CA143874]; NIH [1DP1OD003936]; Los Alamos National Laboratory-Laboratory Directed Research and Development; Deutsche Forschungsgemeinschaft (Forschungs Stipendium); A*STAR program, Singapore; NATIONAL CANCER INSTITUTE [U54CA143874, DP1CA174420] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health-National Cancer Institute Physical Sciences Oncology Center at Massachusetts Institute of Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Los Alamos National Laboratory-Laboratory Directed Research and Development(United States Department of Energy (DOE)Los Alamos National Laboratory); Deutsche Forschungsgemeinschaft (Forschungs Stipendium)(German Research Foundation (DFG)); A*STAR program, Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the NSF (ECCS-0835847) and Human Frontier Science Program (RGP0061/2011) to M. K.; the NSF (ECCS-0835623), National Institutes of Health-National Cancer Institute Physical Sciences Oncology Center at Massachusetts Institute of Technology (U54CA143874), and an NIH Pioneer award (1DP1OD003936) to A.v.O.; Los Alamos National Laboratory-Laboratory Directed Research and Development to B. M.; the Deutsche Forschungsgemeinschaft (Forschungs Stipendium) to G.N.; and the A*STAR program, Singapore, to R.Z.T. We thank F. van Werven for the yeast crosses and N. Hengartner, B. Pando, S. Klemm, J. van Zon, and M. Wall for discussions on the model. We also thank M. Bienko, N. Crosetto, C. Engert, S. Itzkovitz, J. P. Junker, S. Klemm, S. Semrau, J. van Zon, and H. Youk for comments on the manuscript.	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Ferreira C, 2005, MOL BIOL CELL, V16, P2068, DOI 10.1091/mbc.E04-10-0884; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; KO MSH, 1990, EMBO J, V9, P2835, DOI 10.1002/j.1460-2075.1990.tb07472.x; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Munsky B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.75; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Zechner C, 2012, P NATL ACAD SCI USA, V109, P8340, DOI 10.1073/pnas.1200161109	26	168	168	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					584	587		10.1126/science.1231456	http://dx.doi.org/10.1126/science.1231456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372015	Green Accepted			2022-12-28	WOS:000314270000060
J	Graham-Rowe, D				Graham-Rowe, Duncan			PUBLIC PLANNING Designs fit for purpose	NATURE			English	Editorial Material																		Hanks AS, 2012, J PUBLIC HEALTH-UK, V34, P370, DOI 10.1093/pubmed/fds003; Heath Gregory W, 2006, J Phys Act Health, V3, pS55, DOI 10.1123/jpah.3.s1.s55; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Meyer P, 2010, EUR J CARDIOV PREV R, V17, P569, DOI 10.1097/HJR.0b013e328338a4dd; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; USDA, 2009, ACCESS AFFORDABLE NU; Yang L, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5293	7	1	1	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S4	S5		10.1038/493S4a	http://dx.doi.org/10.1038/493S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080CU	23364769				2022-12-28	WOS:000314219600005
J	Wilt, TJ; Ahmed, HU				Wilt, Timothy J.; Ahmed, Hashim U.			Prostate cancer screening and the management of clinically localized disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; ASSOCIATION; DIAGNOSIS; ACCURACY; MEN		[Wilt, Timothy J.] Minneapolis Vet Affairs VA Hlth Care Syst, Minneapolis VA Ctr Chron Dis Outcomes Res, Gen Internal Med Sect, Minneapolis, MN USA; [Wilt, Timothy J.] Univ Minnesota, Sch Med, Gen Internal Med Sect, Minneapolis, MN 55455 USA; [Ahmed, Hashim U.] UCL, MRC, Div Surg & Intervent Sci, London, England; [Ahmed, Hashim U.] Univ Coll London Hosp NHS Fdn Trust, Dept Urol, MRC, London, England	University of Minnesota System; University of Minnesota Twin Cities; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Wilt, TJ (corresponding author), Minneapolis Vet Affairs VA Hlth Care Syst, Minneapolis VA Ctr Chron Dis Outcomes Res, Gen Internal Med Sect, Minneapolis, MN USA.	tim.wilt@va.gov	Ahmed, Hashim U./AAU-1037-2020; Ahmed, Hashim U/C-5744-2008	Ahmed, Hashim U./0000-0003-1674-6723; 	MRC (UK); National Institute for Health Research Health Technology Assessment programme; Pelican Cancer Foundation charity; Prostate Cancer UK charity; USHIFU; Advanced Medical Diagnostics; Steba Biotech; Oncura/GE Healthcare; NIHR Health Technology Assessment programme [09/22/67]; Medical Research Council [G1002509, G0701302] Funding Source: researchfish; Pelican Cancer Foundation [1305] Funding Source: researchfish; MRC [G1002509, G0701302] Funding Source: UKRI	MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Health Technology Assessment programme(National Institute for Health Research (NIHR)); Pelican Cancer Foundation charity; Prostate Cancer UK charity; USHIFU; Advanced Medical Diagnostics; Steba Biotech; Oncura/GE Healthcare; NIHR Health Technology Assessment programme(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Pelican Cancer Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: HUA is co-principal investigator in several investigator led diagnostic and focal therapy trials in prostate cancer supported by the MRC (UK), National Institute for Health Research Health Technology Assessment programme, Pelican Cancer Foundation charity, and Prostate Cancer UK charity; HUA receives funding from USHIFU and Advanced Medical Diagnostics for clinical trials; HUA has received consultancy payments in the past from Steba Biotech and Oncura/GE Healthcare and payment for conference travel from USHIFU; TJW is a volunteer member of the US Preventive Services Task Force and chairman of the Prostate cancer Intervention Versus Observation Trial (PIVOT).; The PROMIS trial is funded by the NIHR Health Technology Assessment programme (project number 09/22/67) and will be published in full in Health Technology Assessment. The views and opinions expressed therein and in any media associated with this study are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS, or the Department of Health.	Ahmed HU, 2012, LANCET ONCOL, V13, P622, DOI 10.1016/S1470-2045(12)70121-3; Ahmed HU, 2009, NAT REV CLIN ONCOL, V6, P197, DOI 10.1038/nrclinonc.2009.18; Ahmed HU, 2011, J UROLOGY, V186, P458, DOI 10.1016/j.juro.2011.03.147; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Burford DC, 2010, PROSTRATE CANC RISK; Cancer Research UK, 2012, PROSTR CANC STAT; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Cooperberg MR, 2004, J CLIN ONCOL, V22, P2141, DOI 10.1200/JCO.2004.10.062; Dahabreh IJ, 2012, ANN INTERN MED, V156, P582, DOI [10.7326/0003-4819-156-8-201204170-00009, 10.7326/0003-4819-156-8-201204170-00397]; Dennert G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005195.pub2; Dickinson L, 2011, EUR UROL, V59, P477, DOI 10.1016/j.eururo.2010.12.009; Donovan J, 2003, Health Technol Assess, V7, P1; Fleshner NE, 2012, LANCET, V379, P1103, DOI 10.1016/S0140-6736(11)61619-X; Ganz PA, 2012, ANN INTERN MED, V156, P591, DOI [10.7326/0003-4819-156-8-201204170-00401, 10.7326/0003-4819-156-8-201204170-00010]; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; IVERSEN P, 1995, SCAND J UROL NEPHROL, P65; Lord SJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4684; Mcvey GP, 2010, BJU INT, V106, P1161, DOI 10.1111/j.1464-410X.2010.09288.x; Medical Research Council Clinical Trials Unit, PROMIS PROST MRI IM; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; National Institute for Health and Clinical Excellence, 2012, IPG424 NAT I HLTH CL; National Institute for Health and Clinical Excellence, 2012, IPG423 NAT I HLTH CL; National Institute for Health and Clinical Excellence, 2008, CG58 NAT I HLTH CLIN; Nguyen PL, 2011, JAMA-J AM MED ASSOC, V306, P2359, DOI 10.1001/jama.2011.1745; Onik G, 2009, J CLIN ONCOL, V27, P4321, DOI 10.1200/JCO.2008.20.3497; Relton C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1066; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Van der Kwast TH, 2012, EUR UROL, V62, P469, DOI 10.1016/j.eururo.2012.04.017; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; Widmark A, 2011, 53 ANN ASTRO M 2 6 O; Wilt TJ, 2006, BMJ-BRIT MED J, V333, P1102, DOI 10.1136/bmj.39022.423588.DE; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Wilt TJ, 2010, BJU INT, V106, P1444, DOI 10.1111/j.1464-410X.2010.09714.x; Zhu XY, 2012, EUR UROL, V61, P652, DOI 10.1016/j.eururo.2011.11.029	36	52	52	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2013	346								f325	10.1136/bmj.f325	http://dx.doi.org/10.1136/bmj.f325			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084BH	23360718	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000314510400013
J	Cappa, CD; Onasch, TB; Massoli, P; Worsnop, DR; Bates, TS; Cross, ES; Davidovits, P; Hakala, J; Hayden, KL; Jobson, BT; Kolesar, KR; Lack, DA; Lerner, BM; Li, SM; Mellon, D; Nuaaman, I; Olfert, JS; Petaja, T; Quinn, PK; Song, C; Subramanian, R; Williams, EJ; Zaveri, RA				Cappa, Christopher D.; Onasch, Timothy B.; Massoli, Paola; Worsnop, Douglas R.; Bates, Timothy S.; Cross, Eben S.; Davidovits, Paul; Hakala, Jani; Hayden, Katherine L.; Jobson, B. Tom; Kolesar, Katheryn R.; Lack, Daniel A.; Lerner, Brian M.; Li, Shao-Meng; Mellon, Daniel; Nuaaman, Ibraheem; Olfert, Jason S.; Petaja, Tuukka; Quinn, Patricia K.; Song, Chen; Subramanian, R.; Williams, Eric J.; Zaveri, Rahul A.			Response to Comment on "Radiative Absorption Enhancements Due to the Mixing State of Atmospheric Black Carbon"	SCIENCE			English	Editorial Material								Jacobson argues that our statement that "many climate models may overestimate warming by BC" has not been demonstrated. Jacobson challenges our results on the basis that we have misinterpreted some model results, omitted optical focusing under high relative humidity conditions and by involatile components, and because our measurements consist of only two locations over short atmospheric time periods. We address each of these arguments, acknowledging important issues and clarifying some misconceptions, and stand by our observations. We acknowledge that Jacobson identified one detail in our experimental technique that places an additional constraint on the interpretation of our observations and reduces somewhat the potential consequences of the stated implications.	[Cappa, Christopher D.; Kolesar, Katheryn R.; Mellon, Daniel] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Onasch, Timothy B.; Massoli, Paola; Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Onasch, Timothy B.; Cross, Eben S.; Davidovits, Paul] Boston Coll, Dept Chem, Boston, MA USA; [Worsnop, Douglas R.; Hakala, Jani; Petaja, Tuukka] Univ Helsinki, Dept Phys, Helsinki, Finland; [Bates, Timothy S.; Quinn, Patricia K.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Hayden, Katherine L.; Li, Shao-Meng; Nuaaman, Ibraheem] Environm Canada, Air Qual Res Div, Toronto, ON, Canada; [Jobson, B. Tom] Washington State Univ, Dept Civil & Environm Engn, Pullman, WA 99164 USA; [Lack, Daniel A.; Lerner, Brian M.; Williams, Eric J.] NOAA, Earth Syst Res Lab, Boulder, CO USA; [Lack, Daniel A.; Lerner, Brian M.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Nuaaman, Ibraheem] York Univ, Ctr Atmospher Chem, Toronto, ON M3J 2R7, Canada; [Olfert, Jason S.] Univ Alberta, Dept Mech Engn, Edmonton, AB T6G 2M7, Canada; [Song, Chen; Zaveri, Rahul A.] Pacific NW Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99352 USA; [Subramanian, R.] RTI Int, Res Triangle Pk, NC USA	University of California System; University of California Davis; Aerodyne Research; Boston College; University of Helsinki; National Oceanic Atmospheric Admin (NOAA) - USA; Environment & Climate Change Canada; Washington State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; York University - Canada; University of Alberta; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Research Triangle Institute	Cappa, CD (corresponding author), Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA.	cdcappa@ucdavis.edu; onasch@aerodyne.com	Quinn, Patricia/R-1493-2016; Worsnop, Douglas R/D-2817-2009; Onasch, Tim/AAY-4998-2020; Lerner, Brian M/H-6556-2013; Bates, Timothy S/L-6080-2016; Petäjä, Tuukka/A-8009-2008; Zaveri, Rahul/G-4076-2014	Quinn, Patricia/0000-0003-0337-4895; Worsnop, Douglas R/0000-0002-8928-8017; Onasch, Tim/0000-0001-7796-7840; Lerner, Brian M/0000-0001-8721-8165; Petäjä, Tuukka/0000-0002-1881-9044; Olfert, Jason/0000-0002-9681-5428; Jobson, Bertram/0000-0003-1812-9745; Zaveri, Rahul/0000-0001-9874-8807; Li, Shao-Meng/0000-0002-7628-6581				Cappa CD, 2012, SCIENCE, V337, P1078, DOI 10.1126/science.1223447; Jacobson M. Z., 2012, SCIENCE, V339, P393; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Myhre G, 2013, ATMOS CHEM PHYS, V13, P1853, DOI 10.5194/acp-13-1853-2013; Peixoto JP, 1996, J CLIMATE, V9, P3443, DOI 10.1175/1520-0442(1996)009<3443:TCORHI>2.0.CO;2	5	28	29	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118								10.1126/science.1230260	http://dx.doi.org/10.1126/science.1230260			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349273				2022-12-28	WOS:000313960700020
J	Mattmann, CA				Mattmann, Chris A.			A vision for data science	NATURE			English	Editorial Material									[Mattmann, Chris A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Mattmann, Chris A.] Univ So Calif, Los Angeles, CA 90089 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Southern California	Mattmann, CA (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	chris.a.mattmann@nasa.gov		Mattmann, Christian/0000-0002-9414-2901				Cinquini L, 2012, P IEEE INT C E-SCI; Foster I, 2001, INT J HIGH PERFORM C, V15, P200, DOI 10.1177/109434200101500302; Lynch C, 2008, NATURE, V455, P28, DOI 10.1038/455028a; MATTMANN C, 2006, P 28 INT C SOFTW ENG, P721; Morin A, 2012, SCIENCE, V336, P159, DOI 10.1126/science.1218263; Painter TH, 2012, GEOPHYS RES LETT, V39, DOI [10.1029/2012GL052457, 10.1029/2012GL053340]; Spinellis D, 2012, J SYST SOFTWARE, V85, P666, DOI 10.1016/j.jss.2011.09.037; Ven K, 2008, IEEE SOFTWARE, V25, P54, DOI 10.1109/MS.2008.73; White T., 2010, HADOOP DEFINITIVE GU; Zitting J, 2011, TIKA ACTION	10	92	102	2	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					473	475		10.1038/493473a	http://dx.doi.org/10.1038/493473a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23344342	Bronze			2022-12-28	WOS:000313871400013
J	Xu, B; Hsu, PK; Stark, KL; Karayiorgou, M; Gogos, JA				Xu, Bin; Hsu, Pei-Ken; Stark, Kimberly L.; Karayiorgou, Maria; Gogos, Joseph A.			Derepression of a Neuronal Inhibitor due to miRNA Dysregulation in a Schizophrenia-Related Microdeletion	CELL			English	Article							MICRORNA BIOGENESIS; MOUSE MODEL; MUTATIONS; PROTEIN; TRANSCRIPTION; TRAFFICKING; MECHANISMS; PATTERNS; DEFICITS; GROWTH	22q11.2 microdeletions result in specific cognitive deficits and schizophrenia. Analysis of Df(16)A(+/-) mice, which model this microdeletion, revealed abnormalities in the formation of neuronal dendrites and spines, as well as altered brain microRNAs. Here, we show a drastic reduction of miR-185, which resides within the 22q11.2 locus, to levels more than expected by a hemizygous deletion, and we demonstrate that this reduction alters dendritic and spine development. miR-185 represses, through an evolutionarily conserved target site, a previously unknown inhibitor of these processes that resides in the Golgi apparatus and shows higher prenatal brain expression. Sustained derepression of this inhibitor after birth represents the most robust transcriptional disturbance in the brains of Df(16)A(+/-) mice and results in structural alterations in the hippocampus. Reduction of miR-185 also has milder age- and region-specific effects on the expression of some Golgi-related genes. Our findings illuminate the contribution of microRNAs in psychiatric disorders and cognitive dysfunction.	[Xu, Bin; Stark, Kimberly L.; Karayiorgou, Maria] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Gogos, Joseph A.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Xu, Bin; Hsu, Pei-Ken; Stark, Kimberly L.; Gogos, Joseph A.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Hsu, Pei-Ken] Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Karayiorgou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	mk2758@columbia.edu; jag90@columbia.edu			Simons Foundation; US National Institute of Mental Health [MH67068, MH077235, MH97879]; March of Dimes Foundation; McKnight Endowment Fund for Neuroscience; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award; NARSAD Suzanne and John Golden Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077235, R01MH067068, R01MH097879] Funding Source: NIH RePORTER	Simons Foundation; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); March of Dimes Foundation(March of Dimes); McKnight Endowment Fund for Neuroscience; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award(NARSAD); NARSAD Suzanne and John Golden Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Yan Sun, Merilee Teylan, Xuanyi Zou, and Megan Sribour for support with the maintenance of the mouse colony and technical assistance. We are also grateful to Drs. David Sulzer and Guomei Tang for their kind help with the diolistic assays. We thank Drs. Jun Mukai and Mirna Kvajo for help and insights with the immunocytochemistry assays. We also thank Dr. Mirna Kvajo and Rebbeca Levy for critical reading of the manuscript. This work was supported by a grant from the Simons Foundation (to J.A.G.), US National Institute of Mental Health grants MH67068 (to M.K. and J.A.G.), MH077235, and MH97879 (to J.A.G.), and by grants from the March of Dimes Foundation and the McKnight Endowment Fund for Neuroscience (to M.K.). B.X. was supported in part by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award. K.L.S. was supported by a NARSAD Suzanne and John Golden Young Investigator Award. B.X., P.-K.H., M.K., and J.A.G. designed the research; B.X. and P.-K.H. performed the experiments and analyzed the data; K.L.S. contributed to the generation of the mouse strains; M.K. and J.A.G. supervised experiments and data analysis; and B.X., P.-K.H., M.K., and J.A.G. wrote the paper.	Ambros V, 2010, CURR BIOL, V20, pR598, DOI 10.1016/j.cub.2010.05.054; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Arguello PA, 2012, TRENDS NEUROSCI, V35, P3, DOI 10.1016/j.tins.2011.11.007; Arguello PA, 2010, SCHIZOPHRENIA BULL, V36, P289, DOI 10.1093/schbul/sbp153; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bearden CE, 2009, CEREB CORTEX, V19, P115, DOI 10.1093/cercor/bhn064; Brenner JL, 2010, CURR BIOL, V20, P1321, DOI 10.1016/j.cub.2010.05.062; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chow EWC, 2002, BIOL PSYCHIAT, V51, P208, DOI 10.1016/S0006-3223(01)01246-X; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Evans SF, 2011, J BIOL CHEM, V286, P29556, DOI 10.1074/jbc.M111.219675; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Gilman SR, 2012, NAT NEUROSCI, V15, P1723, DOI 10.1038/nn.3261; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Junes-Gill KS, 2011, J NEURO-ONCOL, V102, P197, DOI 10.1007/s11060-010-0314-6; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rodriguez-Murillo L, 2012, ANNU REV MED, V63, P63, DOI 10.1146/annurev-med-072010-091100; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xu B, 2010, BRAIN RES, V1338, P78, DOI 10.1016/j.brainres.2010.03.109; Zhang L, 2009, DEVELOPMENT, V136, P3043, DOI 10.1242/dev.039008	43	104	108	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					262	275		10.1016/j.cell.2012.11.052	http://dx.doi.org/10.1016/j.cell.2012.11.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332760	Bronze, Green Accepted			2022-12-28	WOS:000313719800022
J	Swanson, J				Swanson, Jeffrey			Mental Illness and New Gun Law Reforms The Promise and Peril of Crisis-Driven Policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27701 USA	Duke University	Swanson, J (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Box 3071 Med Ctr, Durham, NC 27701 USA.	jeffrey.swanson@duke.edu						Appelbaum PS, 2010, PSYCHIAT SERV, V61, P652, DOI 10.1176/ps.2010.61.7.652; Centers for Disease Control and Prevention, 2013, INJ PREV CONTR DAT S; Davis AC, 2013, WASHINGTON POST; Dooley P, 2013, REPORT TASK FORCE ST; Kaplan Thomas, 2013, NY TIMES; Krouse WJ, 2012, RL32842 C RES SERV F; McGinty Emma E., 2013, REDUCING GUN VIOLENC; Nahmias L., 2013, WALL STREET J; Schwartz LJ, 2009, J COLL STUD PSYCHOTH, V23, P78, DOI 10.1080/87568220902743058; Swanson Jeffrey, 2013, REDUCING GUN VIOLENC	10	27	27	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2013	309	12					1233	1234		10.1001/jama.2013.1113	http://dx.doi.org/10.1001/jama.2013.1113			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	112WO	23392291				2022-12-28	WOS:000316625200020
J	Broderick, JP; Palesch, YY; Demchuk, AM; Yeatts, SD; Khatri, P; Hill, MD; Jauch, EC; Jovin, TG; Yan, B; Silver, FL; von Kummer, R; Molina, CA; Demaerschalk, BM; Budzik, R; Clark, WM; Zaidat, OO; Malisch, TW; Goyal, M; Schonewille, WJ; Mazighi, M; Engelter, ST; Anderson, C; Spilker, J; Carrozzella, J; Ryckborst, KJ; Janis, LS; Martin, RH; Foster, LD; Tomsick, TA				Broderick, Joseph P.; Palesch, Yuko Y.; Demchuk, Andrew M.; Yeatts, Sharon D.; Khatri, Pooja; Hill, Michael D.; Jauch, Edward C.; Jovin, Tudor G.; Yan, Bernard; Silver, Frank L.; von Kummer, Ruediger; Molina, Carlos A.; Demaerschalk, Bart M.; Budzik, Ronald; Clark, Wayne M.; Zaidat, Osama O.; Malisch, Tim W.; Goyal, Mayank; Schonewille, Wouter J.; Mazighi, Mikael; Engelter, Stefan T.; Anderson, Craig; Spilker, Judith; Carrozzella, Janice; Ryckborst, Karla J.; Janis, L. Scott; Martin, Renee H.; Foster, Lydia D.; Tomsick, Thomas A.		Interventional Management Stroke	Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE ISCHEMIC-STROKE; PERCUTANEOUS CORONARY INTERVENTION; TISSUE-PLASMINOGEN ACTIVATOR; MYOCARDIAL-INFARCTION; CLINICAL-TRIALS; POOLED ANALYSIS; MERCI TRIAL; III TRIAL; MANAGEMENT; TIME	BACKGROUND Endovascular therapy is increasingly used after the administration of intravenous tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic stroke, but whether a combined approach is more effective than intravenous t-PA alone is uncertain. METHODS We randomly assigned eligible patients who had received intravenous t-PA within 3 hours after symptom onset to receive additional endovascular therapy or intravenous t-PA alone, in a 2: 1 ratio. The primary outcome measure was a modified Rankin scale score of 2 or less (indicating functional independence) at 90 days (scores range from 0 to 6, with higher scores indicating greater disability). RESULTS The study was stopped early because of futility after 656 participants had undergone randomization (434 patients to endovascular therapy and 222 to intravenous t-PA alone). The proportion of participants with a modified Rankin score of 2 or less at 90 days did not differ significantly according to treatment (40.8% with endovascular therapy and 38.7% with intravenous t-PA; absolute adjusted difference, 1.5 percentage points; 95% confidence interval [CI], -6.1 to 9.1, with adjustment for the National Institutes of Health Stroke Scale [NIHSS] score [8-19, indicating moderately severe stroke, or >= 20, indicating severe stroke]), nor were there significant differences for the predefined subgroups of patients with an NIHSS score of 20 or higher (6.8 percentage points; 95% CI, -4.4 to 18.1) and those with a score of 19 or lower (-1.0 percentage point; 95% CI, -10.8 to 8.8). Findings in the endovascular-therapy and intravenous t-PA groups were similar for mortality at 90 days (19.1% and 21.6%, respectively; P = 0.52) and the proportion of patients with symptomatic intracerebral hemorrhage within 30 hours after initiation of t-PA (6.2% and 5.9%, respectively; P = 0.83). CONCLUSIONS The trial showed similar safety outcomes and no significant difference in functional independence with endovascular therapy after intravenous t-PA, as compared with intravenous t-PA alone. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00359424.)	[Broderick, Joseph P.; Khatri, Pooja; Spilker, Judith; Carrozzella, Janice; Tomsick, Thomas A.] Univ Cincinnati, Acad Hlth Ctr, Inst Neurosci, Dept Neurol, Cincinnati, OH 45267 USA; [Broderick, Joseph P.; Khatri, Pooja; Spilker, Judith; Carrozzella, Janice; Tomsick, Thomas A.] Univ Cincinnati, Acad Hlth Ctr, Inst Neurosci, Dept Rehabil Med & Radiol, Cincinnati, OH 45267 USA; [Palesch, Yuko Y.; Yeatts, Sharon D.; Foster, Lydia D.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Jauch, Edward C.] Med Univ S Carolina, Div Emergency Med, Charleston, SC USA; [Demchuk, Andrew M.; Hill, Michael D.; Goyal, Mayank; Ryckborst, Karla J.] Univ Calgary, Hotchkiss Brain Inst, Seaman Family Magnet Resonance Res Ctr, Dept Clin Neurosci, Calgary, AB, Canada; [Demchuk, Andrew M.; Hill, Michael D.; Goyal, Mayank; Ryckborst, Karla J.] Univ Calgary, Hotchkiss Brain Inst, Seaman Family Magnet Resonance Res Ctr, Dept Radiol, Calgary, AB, Canada; [Jovin, Tudor G.] Univ Pittsburgh, Med Ctr, Stroke Inst, Pittsburgh, PA USA; [Yan, Bernard] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Melbourne, Vic 3050, Australia; [Silver, Frank L.] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Silver, Frank L.] Univ Hlth Network, Toronto, ON, Canada; [von Kummer, Ruediger] Dresden Univ, Stroke Ctr, Univ Hosp, Dept Neuroradiol, Dresden, Germany; [Molina, Carlos A.] Hosp Univ Vall dHebron, Dept Neurol, Neurovasc Unit, Barcelona, Spain; [Demaerschalk, Bart M.] Mayo Clin, Dept Neurol, Phoenix, AZ USA; [Budzik, Ronald] Riverside Methodist Hosp, OhioHlth Neurosci Inst, Columbus, OH 43214 USA; [Clark, Wayne M.] Oregon Hlth & Sci Univ, Oregon Stroke Ctr, Portland, OR 97201 USA; [Zaidat, Osama O.] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA; [Malisch, Tim W.] Alexian Bros Med Ctr, Elk Grove Village, IL USA; [Schonewille, Wouter J.] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands; [Schonewille, Wouter J.] St Antonius Hosp, Nieuwegein, Netherlands; [Mazighi, Mikael] Hop Xavier Bichat, Dept Neurol, Paris, France; [Mazighi, Mikael] Hop Xavier Bichat, Stroke Ctr, Paris, France; [Engelter, Stefan T.] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Anderson, Craig] Univ Sydney, Royal Prince Alfred Hosp, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Janis, L. Scott] NINDS, NIH, Bethesda, MD 20892 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Medical University of South Carolina; Medical University of South Carolina; University of Calgary; University of Calgary; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Royal Melbourne Hospital; University of Melbourne; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Hospital Universitari Vall d'Hebron; Mayo Clinic; Mayo Clinic Phoenix; Oregon Health & Science University; Medical College of Wisconsin; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Basel; George Institute for Global Health; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Broderick, JP (corresponding author), Univ Cincinnati, Dept Neurol, Inst Neurosci, 260 Stetson St,Suite 2300,POB 670525, Cincinnati, OH 45267 USA.	joseph.broderick@uc.edu	Hill, Michael D/C-9073-2012; Goyal, Mayank/AAE-7323-2019; von Kummer, Rüdiger/AAA-4478-2019; Demchuk, Andrew M/E-1103-2012	Hill, Michael D/0000-0002-6269-1543; von Kummer, Rüdiger/0000-0003-0119-4604; Demchuk, Andrew M/0000-0002-4930-7789; Anderson, Craig/0000-0002-7248-4863; Mazighi, Mikael/0000-0003-0911-8999; Engelter, Stefan/0000-0003-3855-6234; Yan, Bernard/0000-0001-8802-9606	National Institutes of Health; National Institute of Neurological Disorders and Stroke [UC U01NS052220, MUSC U01NS054630, U01NS077304]; Genentech; EKOS; Concentric Medical; Cordis Neurovascular; Boehringer Ingelheim; Oakstone Publishing; BrainsGate; Edge Therapeutics; Covidien; Penumbra; Janssen Pharmaceuticals; Medical Dialogues; Vernalis Group; Hoffmann-La Roche Canada; Servier Canada; Bristol-Myers Squibb Canada; Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut; Alberta Innovates-Health Solutions; Silk Road Medical; Boehringer Ingelheim Canada; Lundbeck; GE Healthcare; Photo-Thera; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS077304, U01NS054630, U01NS052220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Genentech(Roche HoldingGenentech); EKOS; Concentric Medical; Cordis Neurovascular; Boehringer Ingelheim(Boehringer Ingelheim); Oakstone Publishing; BrainsGate; Edge Therapeutics(General Electric); Covidien; Penumbra; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Medical Dialogues; Vernalis Group; Hoffmann-La Roche Canada(Hoffmann-La Roche); Servier Canada(Servier); Bristol-Myers Squibb Canada(Bristol-Myers Squibb); Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut; Alberta Innovates-Health Solutions; Silk Road Medical; Boehringer Ingelheim Canada(Boehringer Ingelheim); Lundbeck(Lundbeck Corporation); GE Healthcare(General ElectricGE Healthcare); Photo-Thera; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00359424.); Supported by grants from the National Institutes of Health and the National Institute of Neurological Disorders and Stroke (UC U01NS052220, MUSC U01NS054630, and U01NS077304) and by Genentech, EKOS, Concentric Medical, Cordis Neurovascular, and Boehringer Ingelheim.; Dr. Broderick reports receiving consulting fees from Photo-Thera, receiving lecture fees from Oakstone Publishing, and receiving a drug from Schering-Plough for use in a study funded by the National Institutes of Health. Dr. Palesch reports receiving consulting fees from BrainsGate and Edge Therapeutics. Dr. Demchuk reports receiving grant support and lecture fees from Covidien. Dr. Khatri reports receiving consulting fees from Penumbra, Genentech, and Janssen Pharmaceuticals; providing expert testimony for Medico-Legal Consulting; receiving lecture fees from Medical Dialogues; receiving royalties from Informa, and receiving travel support from Genentech. Dr. Hill reports receiving consulting fees from Vernalis Group; receiving grant support from Hoffmann-La Roche Canada; receiving lecture fees from Hoffmann-La Roche Canada, Servier Canada, and Bristol-Myers Squibb Canada; receiving stock options from Calgary Scientific; receiving support from the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut and Alberta Innovates-Health Solutions; and serving as an unpaid board member for the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut and the Institute of Circulatory and Respiratory Health of the Canadian Institutes of Health Research. Dr. Jovin reports receiving consulting fees and stock options from Silk Road Medical. Dr. Silver reports serving as an unpaid board member for Boehringer Ingelheim Canada, Bayer Canada, and Bristol-Myers Squibb and Pfizer Canada; receiving lecture fees from Boehringer Ingelheim Canada and Servier Canada; and receiving travel support from Boehringer Ingelheim Canada. Dr. von Kummer reports serving as a board member for Lundbeck and Boehringer Ingelheim; receiving consulting fees from Lundbeck; and receiving lecture fees from Penumbra, Boehringer Ingelheim, and Lundbeck. Dr. Demaerschalk reports receiving grant support and consultant fees from Genentech. Dr. Budzik reports receiving consulting and lecture fees from Concentric Medical. Dr. Goyal reports receiving consulting and lecture fees from Covidien; receiving grant support from Covidien; and owning stock options in Calgary Scientific and NoNO. Dr. Engelter reports serving as a board member for Boehringer Ingelheim and receiving travel support from Boehringer Ingelheim. Dr. Anderson reports receiving lecture fees and travel support from GE Healthcare. Ms. Spilker reports receiving payment for the development of educational presentations from The Stroke Group and serving as a board member for The Stroke Interventionalist: The Clinical Journal of Acute Stroke Treatment. Dr. Tomsick reports receiving grant support from Covidien. No other potential conflict of interest relevant to this article was reported.	Abou-Chebl A, 2010, STROKE, V41, P1175, DOI 10.1161/STROKEAHA.109.574129; Alexandrov AV, 2004, J NEUROIMAGING, V14, P113, DOI 10.1177/1051228403261462; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Broderick J, 2004, STROKE, V35, P904, DOI 10.1161/01.STR.0000121641.77121.98; Broderick JP, 2007, STROKE, V38, P2127, DOI 10.1161/STROKEAHA.107.483131; De Luca G, 2009, AM J EMERG MED, V27, P712, DOI 10.1016/j.ajem.2008.04.026; Fischer U, 2005, STROKE, V36, P2121, DOI 10.1161/01.STR.0000182099.04994.fc; Hall DB, 2000, HANDB STAT, V18, P483, DOI 10.1016/S0169-7161(00)18018-6; Hirano T, 2010, STROKE, V41, P2828, DOI 10.1161/STROKEAHA.110.594333; Khatri P, 2009, NEUROLOGY, V73, P1066, DOI 10.1212/WNL.0b013e3181b9c847; Khatri P, 2008, INT J STROKE, V3, P130, DOI 10.1111/j.1747-4949.2008.00151.x; Khatri P, 2007, STROKE, V38, P431, DOI 10.1161/01.STR.0000254524.23708.c9; la Rosa FD, 2012, STROKE, V43, P1591, DOI 10.1161/STROKEAHA.111.645986; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lewandowski CA, 1999, STROKE, V30, P2598, DOI 10.1161/01.STR.30.12.2598; Mackey J, 2010, AJNR Am J Neuroradiol, V31, pE34, DOI 10.3174/ajnr.A1996; Marks MP, 2008, RADIOLOGY, V249, P614, DOI 10.1148/radiol.2492071751; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mazighi M, 2009, LANCET NEUROL, V8, P802, DOI 10.1016/S1474-4422(09)70182-6; Meyers PM, 2011, CIRCULATION, V123, P2591, DOI 10.1161/CIRCULATIONAHA.110.971564; Nakajima M, 2004, AM J NEURORADIOL, V25, P238; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Riedel CH, 2011, STROKE, V42, P1775, DOI 10.1161/STROKEAHA.110.609693; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Shaltoni HM, 2007, STROKE, V38, P80, DOI 10.1161/01.STR.0000251720.25337.b0; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Tomsick TA, 2010, NEUROLOGY, V74, P1069, DOI 10.1212/WNL.0b013e3181d76b8f; Tomsick T, 2007, AM J NEURORADIOL, V28, P382; Tonarelli SB, 2012, J STROKE CEREBROVASC, V21, P121, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.011; van Elteren PH, 1960, B INT STAT I, V37, P351; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604	34	1308	1375	1	96	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					893	903		10.1056/NEJMoa1214300	http://dx.doi.org/10.1056/NEJMoa1214300			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BG	23390923	Green Accepted			2022-12-28	WOS:000315669100005
J	Huang, FW; Hodis, E; Xu, MJ; Kryukov, GV; Chin, L; Garraway, LA				Huang, Franklin W.; Hodis, Eran; Xu, Mary Jue; Kryukov, Gregory V.; Chin, Lynda; Garraway, Levi A.			Highly Recurrent TERT Promoter Mutations in Human Melanoma	SCIENCE			English	Article								Systematic sequencing of human cancer genomes has identified many recurrent mutations in the protein-coding regions of genes but rarely in gene regulatory regions. Here, we describe two independent mutations within the core promoter of telomerase reverse transcriptase (TERT), the gene coding for the catalytic subunit of telomerase, which collectively occur in 50 of 70 (71%) melanomas examined. These mutations generate de novo consensus binding motifs for E-twenty-six (ETS) transcription factors, and in reporter assays, the mutations increased transcriptional activity from the TERT promoter by two-to fourfold. Examination of 150 cancer cell lines derived from diverse tumor types revealed the same mutations in 24 cases (16%), with preliminary evidence of elevated frequency in bladder and hepatocellular cancer cells. Thus, somatic mutations in regulatory regions of the genome may represent an important tumorigenic mechanism.	[Huang, Franklin W.; Hodis, Eran; Xu, Mary Jue; Kryukov, Gregory V.; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Huang, Franklin W.; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Huang, Franklin W.; Hodis, Eran; Xu, Mary Jue; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hodis, Eran; Xu, Mary Jue] MIT, Harvard Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Garraway, LA (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	levi_garraway@dfci.harvard.edu	Gotoh, Osamu/B-4704-2012; Kryukov, Gregory V/A-9592-2008	Kryukov, Gregory/0000-0002-6131-9483	NIH [T32 CA009172]; Mittelman Family Fellowship; National Institute of General Medical Sciences [T32GM07753]; American Cancer Society; NIH New Innovator Award [DP2OD002750]; National Cancer Institute [R33CA126674]; Novartis Institutes for Biomedical Research; Melanoma Research Alliance; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [R33CA126674, P01CA163222, T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mittelman Family Fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novartis Institutes for Biomedical Research; Melanoma Research Alliance; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. N. Wagner, D. Schadendorf, J. A. Wargo, and D. S. B. Hoon for contribution of samples; K. Cibulskis for assistance with whole-genome sequence data analysis; and E. Nickerson for coordination of validation/extension studies. This work was supported by NIH grant T32 CA009172 (F. W. H.), the Mittelman Family Fellowship (F. W. H.), National Institute of General Medical Sciences grant T32GM07753 (E. H.), the American Cancer Society (M. J. X.), NIH New Innovator Award DP2OD002750 (L. A. G.), National Cancer Institute grant R33CA126674 (L. A. G.), the Novartis Institutes for Biomedical Research (G. V. K. and L. A. G.), the Melanoma Research Alliance (L. A. G.), and the Starr Cancer Consortium (L. C. and L. A. G.). L. A. G. is on the Scientific Advisory Board of Millennium Pharmaceuticals, is a paid consultant for and holds equity in Foundation Medicine, and is a paid consultant for and sponsored research recipient from Novartis. The BAM files for the CCLE Whole Genome Sequencing data corresponding to the TERT locus can be accessed at ftp://tertguest:broad@ftp.broadinstitute.org.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bennett D. C., 2008, MELANOMA RES, V21, P27; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Pirker C, 2003, MELANOMA RES, V13, P483, DOI 10.1097/00008390-200310000-00007; Rutter JL, 1998, CANCER RES, V58, P5321; Zhang A., 2000, CANCER RES, V22, P6320	10	1260	1286	5	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					957	959		10.1126/science.1229259	http://dx.doi.org/10.1126/science.1229259			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23348506	Green Accepted			2022-12-28	WOS:000315149600049
J	Cox, PM; Pearson, D; Booth, BB; Friedlingstein, P; Huntingford, C; Jones, CD; Luke, CM				Cox, Peter M.; Pearson, David; Booth, Ben B.; Friedlingstein, Pierre; Huntingford, Chris; Jones, Chris D.; Luke, Catherine M.			Sensitivity of tropical carbon to climate change constrained by carbon dioxide variability	NATURE			English	Article							CYCLE; FEEDBACK; DROUGHT; BIOMASS; RISK	The release of carbon from tropical forests may exacerbate future climate change(1), but the magnitude of the effect in climate models remains uncertain(2). Coupled climate-carbon-cycle models generally agree that carbon storage on land will increase as a result of the simultaneous enhancement of plant photosynthesis and water use efficiency under higher atmospheric CO2 concentrations, but will decrease owing to higher soil and plant respiration rates associated with warming temperatures(3). At present, the balance between these effects varies markedly among coupled climate-carbon-cycle models, leading to a range of 330 gigatonnes in the projected change in the amount of carbon stored on tropical land by 2100. Explanations for this large uncertainty include differences in the predicted change in rainfall in Amazonia(4,5) and variations in the responses of alternative vegetation models to warming(6). Here we identify an emergent linear relationship, across an ensemble of models(7), between the sensitivity of tropical land carbon storage to warming and the sensitivity of the annual growth rate of atmospheric CO2 to tropical temperature anomalies(8). Combined with contemporary observations of atmospheric CO2 concentration and tropical temperature, this relationship provides a tight constraint on the sensitivity of tropical land carbon to climate change. We estimate that over tropical land from latitude 30 degrees north to 30 degrees south, warming alone will release 53 +/- 17 gigatonnes of carbon per kelvin. Compared with the unconstrained ensemble of climate-carbon-cycle projections, this indicates a much lower risk of Amazon forest die-back under CO2-induced climate change if CO2 fertilization effects are as large as suggested by current models(9). Our study, however, also implies greater certainty that carbon will be lost from tropical land if warming arises from reductions in aerosols(10) or increases in other greenhouse gases(11).	[Cox, Peter M.; Friedlingstein, Pierre; Luke, Catherine M.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England; [Pearson, David; Booth, Ben B.; Jones, Chris D.] Hadley Ctr, Met Off, Exeter EX1 3PB, Devon, England; [Huntingford, Chris] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England	University of Exeter; Met Office - UK; Hadley Centre; UK Centre for Ecology & Hydrology (UKCEH)	Cox, PM (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England.	p.m.cox@exeter.ac.uk	Friedlingstein, Pierre/H-2700-2014; Huntingford, Christopher/A-4307-2008; Jones, Chris/I-2983-2014; Kushnir, Yochanan/B-4472-2013; Cox, Peter Michae;/B-3299-2012	Friedlingstein, Pierre/0000-0003-3309-4739; Huntingford, Christopher/0000-0002-5941-7770; Jones, Chris/0000-0002-7141-9285; Cox, Peter Michae;/0000-0002-0679-2219	NERC NCEO; EU; DECC/Defra Met Office Hadley Centre [GA01101]; CEH Science Budget; Newton Institute; Natural Environment Research Council [earth010002, ceh010023] Funding Source: researchfish; NERC [earth010002] Funding Source: UKRI	NERC NCEO(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU(European Commission); DECC/Defra Met Office Hadley Centre; CEH Science Budget; Newton Institute; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We acknowledge funding from the NERC NCEO programme (P.M.C. and C.M.L.); the EU Greencycles II-project (P.M.C. and P.F.); the EU FP7 'CARBONES' project (D.P. and C.D.J.); the Joint DECC/Defra Met Office Hadley Centre Climate Programme (GA01101)(D.P.,B.B.B.and C.D.J.); the CEH Science Budget(C.H.) and the Newton Institute programme on 'Mathematical and Statistical Approaches to Climate Modelling and Prediction', during which this research was first formulated (P.M.C., B.B.B. and C.H.). We also acknowledge the modelling groups that provided results to C<SUP>4</SUP>MIP.	[Anonymous], 2000, SPECIAL REPORT EMISS; BACASTOW RB, 1976, NATURE, V261, P116, DOI 10.1038/261116a0; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Booth BBB, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024002; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Friedlingstein P, 2003, TELLUS B, V55, P692, DOI 10.1034/j.1600-0889.2003.01461.x; Galbraith D, 2010, NEW PHYTOL, V187, P647, DOI 10.1111/j.1469-8137.2010.03350.x; Hall A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025127; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Huntingford C, 2011, PHILOS T R SOC A, V369, P2026, DOI 10.1098/rsta.2010.0314; Jones CD, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023027; Jupp TE, 2010, NEW PHYTOL, V187, P682, DOI 10.1111/j.1469-8137.2010.03368.x; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; MASARIE KA, 1995, J GEOPHYS RES-ATMOS, V100, P11593, DOI 10.1029/95JD00859; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Rammig A, 2010, NEW PHYTOL, V187, P694, DOI 10.1111/j.1469-8137.2010.03318.x; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Zaehle S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041345	29	460	472	26	679	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					341	344		10.1038/nature11882	http://dx.doi.org/10.1038/nature11882			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23389447	Green Accepted			2022-12-28	WOS:000315312900035
J	Rochman, CM; Browne, MA; Halpern, BS; Hentschel, BT; Hoh, E; Karapanagioti, HK; Rios-Mendoza, LM; Takada, H; Teh, S; Thompson, RC				Rochman, Chelsea M.; Browne, Mark Anthony; Halpern, Benjamin S.; Hentschel, Brian T.; Hoh, Eunha; Karapanagioti, Hrissi K.; Rios-Mendoza, Lorena M.; Takada, Hideshige; Teh, Swee; Thompson, Richard C.			Classify plastic waste as hazardous	NATURE			English	Editorial Material									[Rochman, Chelsea M.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Browne, Mark Anthony] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA	University of California System; University of California Davis; National Center for Ecological Analysis & Synthesis	Rochman, CM (corresponding author), Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA.	cmrochman@ucdavis.edu; browne@nceas.ucsb.edu	Karapanagioti, Hrissi K./AAW-9344-2020; Takada, Hideshige/G-1096-2013; Karapanagioti, Hrissi/AAI-1461-2020	Karapanagioti, Hrissi K./0000-0002-0297-5229; Browne, Mark Anthony/0000-0002-7508-1015; Hoh, Eunha/0000-0002-4075-040X; Thompson, Richard/0000-0003-2262-6621				Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Gaylor MO, 2012, CHEMOSPHERE, V86, P500, DOI 10.1016/j.chemosphere.2011.10.014; Lithner D, 2011, SCI TOTAL ENVIRON, V409, P3309, DOI 10.1016/j.scitotenv.2011.04.038; Mettang T, 1996, NEPHROL DIAL TRANSPL, V11, P2439, DOI 10.1093/oxfordjournals.ndt.a027211; Pauly JL, 1998, CANCER EPIDEM BIOMAR, V7, P419; Rochman C. M., 2012, ENV SCI TECHNOL; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Uhnn A.V., 2011, MAR POLLUT B, V62, P2605; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713	10	812	851	62	643	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					169	171		10.1038/494169a	http://dx.doi.org/10.1038/494169a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23407523	Bronze			2022-12-28	WOS:000315137700015
J	Lukas, J; Lukas, C				Lukas, Jiri; Lukas, Claudia			Shielding Broken DNA for a Quick Fix	SCIENCE			English	Editorial Material							GENOME; DAMAGE; RIF1		[Lukas, Jiri; Lukas, Claudia] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	University of Copenhagen	Lukas, J (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	jiri.lukas@cpr.ku.dk; claudia.lukas@cpr.ku.dk		Lukas, Claudia/0000-0001-7169-6883; Lukas, Jiri/0000-0001-9087-506X	Novo Nordisk Foundation Center for Protein Research [PI Jiri Lukas] Funding Source: researchfish	Novo Nordisk Foundation Center for Protein Research		Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	10	13	13	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					652	653		10.1126/science.1234602	http://dx.doi.org/10.1126/science.1234602			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393250				2022-12-28	WOS:000314585600025
J	Kim, HS; Minna, JD; White, MA				Kim, Hyun Seok; Minna, John D.; White, Michael A.			GWAS Meets TCGA to Illuminate Mechanisms of Cancer Predisposition	CELL			English	Editorial Material								Genome-wide association studies (GWASs) have unraveled a large number of cancer risk alleles. Understanding how these allelic variants predispose to disease is a major bottleneck confronting translational application. In this issue, Li and colleagues combine GWASs with The Cancer Genome Atlas (TCGA) to disambiguate the contributions of germline and somatic variants to tumorigenic gene expression programs. They find that close to half of the known risk alleles for estrogen receptor (ER)-positive breast cancer are expression quantitative trait loci (eQTLs) acting upon major determinants of gene expression in tumors.	[Kim, Hyun Seok; White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Minna, John D.; White, Michael A.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	White, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu			NATIONAL CANCER INSTITUTE [P50CA070907, R01CA071443, R01CA129451] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA70907, CA129451, CA71443, R01 CA129451, R01 CA071443, P50 CA070907] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Hindorff LA, 2011, CARCINOGENESIS, V32, P945, DOI 10.1093/carcin/bgr056; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Loo LWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030477; Sille FCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029632; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606	8	39	41	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 31	2013	152	3					387	389		10.1016/j.cell.2013.01.027	http://dx.doi.org/10.1016/j.cell.2013.01.027			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374335	Green Accepted, Bronze			2022-12-28	WOS:000314362800009
J	Jin, MY; Liu, X; Klionsky, DJ				Jin, Meiyan; Liu, Xu; Klionsky, Daniel J.			SnapShot: Selective Autophagy	CELL			English	Editorial Material									[Jin, Meiyan] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jin, MY (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053396] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cebollero E., 2012, INT J CELL BIOL, V2012, P1, DOI DOI 10.1155/2012/182834; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Mijaljica D, 2012, AUTOPHAGY, V8, P1701, DOI 10.4161/auto.21332; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	10	70	74	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					368	U400		10.1016/j.cell.2013.01.004	http://dx.doi.org/10.1016/j.cell.2013.01.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332767	Bronze, Green Accepted			2022-12-28	WOS:000313719800033
J	Nair, H; Simoes, EAF; Rudan, I; Gessner, BD; Azziz-Baumgartner, E; Zhang, JSF; Feikin, DR; Mackenzie, GA; Moisi, JC; Roca, A; Baggett, HC; Zaman, SMA; Singleton, RJ; Lucero, MG; Chandran, A; Gentile, A; Cohen, C; Krishnan, A; Bhutta, ZA; Arguedas, A; Clara, AW; Andrade, AL; Ope, M; Ruvinsky, RO; Hortal, M; McCracken, JP; Madhi, SA; Bruce, N; Qazi, SA; Morris, SS; El Arifeen, S; Weber, MW; Scott, JAG; Brooks, WA; Breiman, RF; Campbell, H				Nair, Harish; Simoes, Eric A. F.; Rudan, Igor; Gessner, Bradford D.; Azziz-Baumgartner, Eduardo; Zhang, Jian Shayne F.; Feikin, Daniel R.; Mackenzie, Grant A.; Moisi, Jennifer C.; Roca, Anna; Baggett, Henry C.; Zaman, Syed M. A.; Singleton, Rosalyn J.; Lucero, Marilla G.; Chandran, Aruna; Gentile, Angela; Cohen, Cheryl; Krishnan, Anand; Bhutta, Zulfiqar A.; Arguedas, Adriano; Clara, Alexey Wilfrido; Andrade, Ana Lucia; Ope, Maurice; Ruvinsky, Raul Oscar; Hortal, Maria; McCracken, John P.; Madhi, Shabir A.; Bruce, Nigel; Qazi, Shamim A.; Morris, Saul S.; El Arifeen, Shams; Weber, Martin W.; Scott, J. Anthony G.; Brooks, W. Abdullah; Breiman, Robert F.; Campbell, Harry		Severe Acute Lower Resp Infections	Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis	LANCET			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; COMMUNITY CASE-MANAGEMENT; AGED 2-59 MONTHS; SEVERE PNEUMONIA; TRACT INFECTIONS; CONJUGATE VACCINE; ORAL AMOXICILLIN; SYNCYTIAL VIRUS; TIME TRENDS; POPULATION	Background The annual number of hospital admissions and in-hospital deaths due to severe acute lower respiratory infections (ALRI) in young children worldwide is unknown. We aimed to estimate the incidence of admissions and deaths for such infections in children younger than 5 years in 2010. Methods We estimated the incidence of admissions for severe and very severe ALRI in children younger than 5 years, stratified by age and region, with data from a systematic review of studies published between Jan 1, 1990, and March 31, 2012, and from 28 unpublished population-based studies. We applied these incidence estimates to population estimates for 2010, to calculate the global and regional burden in children admitted with severe ALRI in that year. We estimated in-hospital mortality due to severe and very severe ALRI by combining incidence estimates with case fatality ratios from hospital-based studies. Findings We identified 89 eligible studies and estimated that in 2010, 11.9 million (95% CI 10.3-13.9 million) episodes of severe and 3.0 million (2.1-4.2 million) episodes of very severe ALRI resulted in hospital admissions in young children worldwide. Incidence was higher in boys than in girls, the sex disparity being greatest in South Asian studies. On the basis of data from 37 hospital studies reporting case fatality ratios for severe ALRI, we estimated that roughly 265 000 (95% CI 160 000-450 000) in-hospital deaths took place in young children, with 99% of these deaths in developing countries. Therefore, the data suggest that although 62% of children with severe ALRI are treated in hospitals, 81% of deaths happen outside hospitals. Interpretation Severe ALRI is a substantial burden on health services worldwide and a major cause of hospital referral and admission in young children. Improved hospital access and reduced inequities, such as those related to sex and rural status, could substantially decrease mortality related to such infection. Community-based management of severe disease could be an important complementary strategy to reduce pneumonia mortality and health inequities.	[Nair, Harish; Rudan, Igor; Campbell, Harry] Univ Edinburgh, Global Hlth Acad, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Nair, Harish] Publ Hlth Fdn India, New Delhi, India; [Simoes, Eric A. F.] Univ Colorado Denver, Denver, CO USA; [Simoes, Eric A. F.] Childrens Hosp, Denver, CO 80218 USA; [Simoes, Eric A. F.] Padjadjaran State Univ, Bandung, Indonesia; [Gessner, Bradford D.] Agence Med Prevent, Paris, France; [Azziz-Baumgartner, Eduardo] Ctr Dis Control & Prevent CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Zhang, Jian Shayne F.] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Feikin, Daniel R.; Breiman, Robert F.] Ctr Dis Control & Prevent, Nairobi, Kenya; [Feikin, Daniel R.; Chandran, Aruna] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Mackenzie, Grant A.; Zaman, Syed M. A.] Gambia Unit, MRC, Banjul, Gambia; [Moisi, Jennifer C.; Scott, J. Anthony G.] Wellcome Trust Res Programme, Kenya Med Res Inst, Kilifi, Kenya; [Roca, Anna] Univ Barcelona, IDIBAPS, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Roca, Anna] Minist Saude, Ctr Invest Saude Manhica, Maputo, Mozambique; [Baggett, Henry C.] Thailand MOPH US CDC Collaborat, Global Dis Detect Reg Ctr, Int Emerging Infect Program, Nonthaburi, Thailand; [Zaman, Syed M. A.] Hlth Protect Agcy, Hlth Protect Serv Colindale, London, England; [Singleton, Rosalyn J.] CDC, Arctic Invest Program, Natl Ctr Emerging & Zoonot Infect Dis, Anchorage, AK USA; [Singleton, Rosalyn J.] Alaska Native Tribal Hlth Consortium, Anchorage, AK USA; [Lucero, Marilla G.] Res Inst Trop Med, Dept Hlth, Alabang, Muntinlupa, Philippines; [Gentile, Angela] Ricardo Gutierrez Childrens Hosp, Buenos Aires, DF, Argentina; [Cohen, Cheryl; Madhi, Shabir A.] Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Krishnan, Anand] All India Inst Med Sci, Ctr Community Med, New Delhi, India; [Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan; [Arguedas, Adriano] Univ Ciencias Med Ctr Amer, Inst Atenc Pediat, San Jose, Costa Rica; [Clara, Alexey Wilfrido] CDC Cent Amer Reg, Guatemala City, Guatemala; [Andrade, Ana Lucia] Univ Fed Goias, Goiania, Go, Brazil; [Ope, Maurice] East African Community Secretariat, Arusha, Tanzania; [Ruvinsky, Raul Oscar] Natl Univ Buenos Aires, Buenos Aires, DF, Argentina; [Hortal, Maria] Natl Univ PNUD, Program Basic Sci Dev, Montevideo, Uruguay; [McCracken, John P.] Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala; [Bruce, Nigel] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Qazi, Shamim A.] WHO, Dept Maternal Neonatal & Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Morris, Saul S.] Bill & Melinda Gates Fdn, Seattle, WA USA; [El Arifeen, Shams; Brooks, W. Abdullah] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Weber, Martin W.] WHO, Indonesia Country Off, Jakarta, Indonesia	University of Edinburgh; Public Health Foundation of India; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; Universitas Padjadjaran; Agence de Medecine Preventive; Centers for Disease Control & Prevention - USA; University of Melbourne; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro de Investigacao em Saude de Manhica; Health Protection Agency; Centers for Disease Control & Prevention - USA; Alaska Native Tribal Health Consortium; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; Hospital de Ninos Doctor Ricardo Gutierrez; Instituto Nacional de Saude Dr. Ricardo Jorge; University of Buenos Aires; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; All India Institute of Medical Sciences (AIIMS) New Delhi; Aga Khan University; Universidade Federal de Goias; Universidad del Valle de Guatemala; University of Liverpool; World Health Organization; Bill & Melinda Gates Foundation; International Centre for Diarrhoeal Disease Research (ICDDR); World Health Organization	Nair, H (corresponding author), Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland.	harish.nair@ed.ac.uk	Andrade, Ana Lucia/L-5751-2013; Campbell, Harry/E-2959-2010; Nair, Harish/E-7431-2010; Theodoratou, Evropi/C-3430-2014; Rudan, Igor/I-1467-2012; Brooks, W. Abdullah/AAD-3876-2021; Krishnan, Anand/D-8537-2012; Weber, Martin/GPW-6095-2022	Campbell, Harry/0000-0002-6169-6262; Nair, Harish/0000-0002-9432-9100; Theodoratou, Evropi/0000-0001-5887-9132; Rudan, Igor/0000-0001-6993-6884; Brooks, W. Abdullah/0000-0001-9871-5546; Krishnan, Anand/0000-0002-9173-7811; Mackenzie, Grant/0000-0002-4994-2627; Cohen, Cheryl/0000-0003-0376-2302; Munywoki, Patrick K./0000-0001-9419-7155; Arifeen, Shams/0000-0002-5372-5932; Morris, Saul/0000-0002-9372-7342; McAllister, David/0000-0003-3550-1764; Gupta, Vivek/0000-0002-6157-3705; Hanlon, Peter/0000-0002-5828-3934	WHO Global Influenza Program [HQGIP1002906]; GlaxoSmithKline (GSK); Wyeth; Pfizer; Sanofi Pasteur; Crucell; Merck; Novartis; Bill & Melinda Gates Foundation; MRC [MC_UP_A900_1124] Funding Source: UKRI; Medical Research Council [MC_UP_A900_1124] Funding Source: researchfish	WHO Global Influenza Program; GlaxoSmithKline (GSK)(GlaxoSmithKline); Wyeth(Wyeth); Pfizer(Pfizer); Sanofi Pasteur; Crucell; Merck(Merck & Company); Novartis(Novartis); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AA has received research grants, honoraria for participation in advisory boards, and travel grants from GlaxoSmithKline (GSK), Wyeth, and Pfizer. BDG works for Agence de Medecine Preventive, which receives unrestricted funding from Sanofi Pasteur, and has received grant support from Crucell, GSK, Merck, Pfizer, and Sanofi Pasteur. JAGS has received research funding from GSK and a travel grant from Merck. SAM has been a clinical trialist in studies of vaccines against pneumonia-causing pathogens from GSK, Pfizer, Sanofi-Aventis, Novartis, and Medimmune; his institution has received research grants from GSK, Pfizer, and Novartis; and he has been on the speaker's bureau of GSK, Pfizer, and Sanofi-Aventis, has received travel support and honoraria, and has acted on advisory boards of GSK, Pfizer, and Novartis. HNo is part of ARIVAC consortium that includes Sanofi Pasteur, undertook a phase 3 trial of an 11-valent pneumococcal conjugate vaccine (Sanofi Pasteur, Lyon, France) in the Philippines in 2002-04, and has received research funding from GSK. ALA has received research grant from GSK, financial support from Pfizer and GSK to attend meetings, and has served as an adviser to Pfizer. WAB has received funding from the Bill & Melinda Gates Foundation for vaccine-related work related to childhood pneumonia; donation of vaccine from Sanofi Pasteur for a vaccine trial against early childhood pneumonia; project funding from Sanofi Pasteur for pneumococcal vaccine trials and a study in pneumococcal pneumonia disease burden in young children; and has been on the speakers bureau for Sanofi Pasteur. SSM is an employee of the Bill & Melinda Gates Foundation. SAQ, AWM, and MWW are WHO staff members. All other authors declare that they have no conflicts of interest.; Financial support for this work was provided by WHO Global Influenza Program (Grant number HQGIP1002906). The findings and conclusions in this report are those of the authors and do not necessarily represent the policies of the United States Centers for Disease Control and Prevention or WHO. This work was done as part of the wider programme of the Child Health Epidemiology Working Group (CHERG) and Global Health Epidemiology Reference Group (GHERG) to establish the major causes of global childhood disease burden. Endang Sedyaningsih sadly died suddenly and unexpectedly while this paper was being prepared for publication. We would like to acknowledge her important contribution to this study and her role as a promoter of child health in Indonesia. We thank Johannes Forster (Department of Paediatrics, St Josefskrankenhaus Freiburg and University of Freiburg, Freiburg, Germany); Gabriele Ihorst (Clinical Trials Center, University Medical Center Freiburg, Freiburg, Germany); and Carlos G Grijalva (Vanderbilt University, US) for providing additional data from their published papers. We are grateful to Felicity Cutts (London School of Hygiene and Tropical Medicine, London, UK); Fatema Khatun, Peter Kim Streatfield, Sajal Kumar Saha, Kamrun Nahar, Amina Tahia Sharmeen, Anjali Bilkis Ara, Sultana Yeasmin (International Centre for Diarrhoeal Disease Research, Bangladesh); Leilani T Nillos (Research Institute for Tropical Medicine, Philippines); Elias Jimenez, Ana Laura Jimenez, Carolina Soley (Instituto de Atencion Pediatrica, Costa Rica); Ron Dagan, Nurith Porat (Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Guiron University of the Negav, Beer-Sheva, Israel); Gail Rodgers, Sharon Gray, Darmendra Ramcharran (Pfizer Inc. Collegeville, PA, USA); Uchendu Uchendu, David Ameh, Bolanle Akinsola, Readon Ideh, Bernard Ebruke, Debasish Saha, Momodou Jasseh (MRC Unit, The Gambia); Pedro L Alonso, Llorenc Quinto (Barcelona Centre for International Health Research (CRESIB, Hospital Clinic-Universitat de Barcelona) and Centro de Investigacao em Saude de Manhica, Mozambique); Maria Aparecida da Silva Vieira (Pontifical Catholic University of Goias, Goiania, Brazil); Renato Mauricio Oliveira (Federal University of Goias, Goiania, Brazil); Vicente Porfirio Pessoa-Jr (Secretariat of Health of Municipality of Goiania, Brazil); Simonne Nouer (UTHSC-Department of Preventive Medicine, Memphis, TN, USA); Licia Kamilla Assis Melo Thorn (Karolinska Institutet, Stockholm); Luiza Helena Ribeiro (Samaritano Hospital, Goiania, Brazil); Jose Cassio de Moraes (Santa Casa School of Medical Sciences, Sao Paulo, Brazil); David Rodriguez (Ministry of Health of El Salvador); Celina de Lozano (National Influenza Center of El Salvador); Kim A Lindblade, Jennifer Verani (US Centers for Disease Control and Prevention Regional Office for Central America and Panama, International Emerging Infections Program, Guatemala); Somsak Thamthitiwat, Sununta Henchaichon, Prabda Prapasiri, Sathapana Naorat (International Emerging Infections Program, Global Disease Detection Regional Center, Thailand Ministry of Public Health - U. S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand); Peera Areerat (Nakhon Phanom Provincial Health Office, Nakhon Phanom, Thailand); Asadang Ruayajin (Sa Kaeo Provincial Health Office, Sa Kaeo, Thailand) for their assistance.; The Indian Council for Medical Research (ICMR) led a multisite study with funding provided by the Hib Initiative; we thank the investigators at ICMR and the study sites of Christian Medical College, Vellore; Post Graduate Institute of Medical Education and Research, Chandigarh; and the National Institute of Cholera and Enteric Diseases, Kolkata. Costa Rica's LEAP study team thank all the physicians within the study area, in private practice, and from the Caja Costarricense de Seguro Social for referring their patients to participate in the active epidemiological surveillance. We thank the South African Severe Acute Respiratory Infections Surveillance Group, Wyeth-Pfizer, CNPq-Brazilian Council for Scientific Development and Technology, MRC Gambia Pneumococcal Surveillance Project and Severe Pneumonia Studies teams, MRC Gambia Basse Health and Demographic Surveillance System, Gambia Government, Basse Health Centre staff, the MRC Gambia Pneumococcal Vaccine Trial team for their assistance; Ana Ceballos, (CEDEPAP, Cordoba, Argentina), Jane Crawley (University of Oxford), and Olaf Muller (Ruprecht-Karls-University Heidelberg, Germany) for participating in the Working Group Meeting and providing valuable inputs; and Arti Nair (University of Edinburgh) for assistance with extracting data from the DHS and MICS databases.	Alam N, 2009, MATERN CHILD HLTH J, V13, P119, DOI 10.1007/s10995-008-0320-x; Anh DD, 2009, CLIN INFECT DIS, V48, pS57, DOI 10.1086/596483; [Anonymous], 2012, REC MAN COMM CHILDH; Ansaldi F, 2008, J INT MED RES, V36, P1255, DOI 10.1177/147323000803600612; Banajeh SM, 1998, J TROP PEDIATRICS, V44, P343, DOI 10.1093/tropej/44.6.343; Baqui AH, 2007, J HEALTH POPUL NUTR, V25, P179; Bari A, 2011, LANCET, V378, P1796, DOI 10.1016/S0140-6736(11)61140-9; Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7; BYASS P, 1991, J TROP MED HYG, V94, P22; Campbell D, 2004, J TROP PEDIATRICS, V50, P158, DOI 10.1093/tropej/50.3.158; Carroll KN, 2008, PEDIATRICS, V122, P58, DOI 10.1542/peds.2007-2087; Chandyo RK, 2010, J NUTR, V140, P1677, DOI 10.3945/jn.109.117978; Che D, 2010, EPIDEMIOL INFECT, V138, P573, DOI 10.1017/S0950268809990951; Chen W, 1997, CHINESE J RURAL MED, V25, P25; Cheng P, 1996, JIANGSU J PREV MED, V2, P48; Chi XX, 1996, STRAIT J PREV MED, V2, P1; Chowdhury EK, 2008, LANCET, V372, P822, DOI 10.1016/S0140-6736(08)61166-6; Cilla G, 2009, EPIDEMIOL INFECT, V137, P66, DOI 10.1017/S0950268808000666; Comes Castellano A M, 2005, An Med Interna, V22, P118; Department of Child and Adolescent Health, 2005, HDB IMCI INT MAN CHI; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Forster J, 2004, EUR J PEDIATR, V163, P709, DOI 10.1007/s00431-004-1523-9; Gao JY, 2004, CHINESE J MATERNAL C, V19, P13; Garces-Sanchez M D, 2005, An Pediatr (Barc), V63, P125; Gil A, 2002, J INFECTION, V44, P84, DOI 10.1053/jinf.2002.0966; Grant CC, 1998, J PAEDIATR CHILD H, V34, P355, DOI 10.1046/j.1440-1754.1998.00237.x; Grijalva CG, 2010, CLIN INFECT DIS, V50, P805, DOI 10.1086/650573; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Ho PL, 2007, VACCINE, V25, P6837, DOI 10.1016/j.vaccine.2007.07.039; Hoo AF, 2002, AM J RESP CRIT CARE, V165, P1084, DOI 10.1164/ajrccm.165.8.2103035; Hu YC, 1996, SHANGHAI J PREV MED, V8, P94; Huang WH, 1999, STRAIT J PREV MED, V5, P21; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Lee GE, 2010, PEDIATRICS, V126, P204, DOI 10.1542/peds.2009-3109; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Liu Q, 1994, ACTA ACAD MED QINGDA, V30, P232; Lou LY, 1995, CHINESE J PRIMARY HL, V9, P39; Lowther SA, 2000, PEDIATR INFECT DIS J, V19, P11, DOI 10.1097/00006454-200001000-00004; Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828; Magree HC, 2005, B WORLD HEALTH ORGAN, V83, P427; Mo JZ, 1998, CHINESE J PRIMARY HL, V12, P26; Monge V, 2001, INFECTION, V29, P3, DOI 10.1007/s15010-001-0024-2; Moore HC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-757; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nizami Shaikh Qamaruddin, 2006, JPMA Journal of the Pakistan Medical Association, V56, P163; Owais A, 2010, TROP MED INT HEALTH, V15, P1029, DOI 10.1111/j.1365-3156.2010.02591.x; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Pandey A, 2002, J HEALTH POPUL NUTR, V20, P306; Peck AJ, 2005, PEDIATR INFECT DIS J, V24, P342, DOI 10.1097/01.inf.0000157250.95880.91; Qu JS, 2009, QILU J MED, V24, P37; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Roxburgh CSD, 2008, ARCH DIS CHILD, V93, P316, DOI 10.1136/adc.2007.126540; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Russell FM, 2009, ANN TROP PAEDIATR, V29, P111, DOI 10.1179/146532809X440725; Shah AS, 2009, CLIN INFECT DIS, V48, pS123, DOI 10.1086/596490; Shah Aparna S, 2009, Indian J Med Sci, V63, P498; Soofi S, 2012, LANCET, V379, P729, DOI 10.1016/S0140-6736(11)61714-5; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; Sun YF, 1992, CHINESE MATERNAL CHI, V7, P42; Sutanto A, 2002, AM J TROP MED HYG, V66, P175, DOI 10.4269/ajtmh.2002.66.175; Tornheim JA, 2007, INT J INFECT DIS, V11, P536, DOI 10.1016/j.ijid.2007.03.006; TUPASI TE, 1990, REV INFECT DIS, V12, pS940; van Gageldonk-Lafeber AB, 2009, EPIDEMIOL INFECT, V137, P1472, DOI 10.1017/S0950268809002258; Vicente D, 2003, EPIDEMIOL INFECT, V131, P867, DOI 10.1017/S0950268803008926; Wang L, 1997, CHINESE J PRIMARY HL, V11, P28; Weber MW, 2002, B WORLD HEALTH ORGAN, V80, P562; Weigl JAI, 2005, KLIN PADIATR, V217, P211, DOI 10.1055/s-2004-822699; Weinberg GA, 2009, J PEDIATR-US, V154, P694, DOI 10.1016/j.jpeds.2008.11.034; Williams EJ, 2009, CLIN INFECT DIS, V48, pS114, DOI 10.1086/596488; Williams P, 1997, INT J EPIDEMIOL, V26, P797, DOI 10.1093/ije/26.4.797; Wu PS, 2009, PEDIATR PULM, V44, P162, DOI 10.1002/ppul.20969; Xie SM, 1993, CHONGQING MED J, V22, P375; Xu GL, 2000, MATERN CHILD HLTH J, V14, P36; Yorita KL, 2008, PEDIATRICS, V121, P244, DOI 10.1542/peds.2007-1392; Yoshida LM, 2010, PEDIATR INFECT DIS J, V29, P75, DOI 10.1097/INF.0b013e3181af61e9; Zaman K, 1997, J TROP PEDIATRICS, V43, P133, DOI 10.1093/tropej/43.3.133	79	448	466	4	68	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1380	1390		10.1016/S0140-6736(12)61901-1	http://dx.doi.org/10.1016/S0140-6736(12)61901-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23369797	Green Published, Green Accepted			2022-12-28	WOS:000317894800035
J	Chang, CY; Pasolli, HA; Giannopoulou, EG; Guasch, G; Gronostajski, RM; Elemento, O; Fuchs, E				Chang, Chiung-Ying; Pasolli, H. Amalia; Giannopoulou, Eugenia G.; Guasch, Geraldine; Gronostajski, Richard M.; Elemento, Olivier; Fuchs, Elaine			NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche	NATURE			English	Article							HAIR FOLLICLE; EPIDERMAL MELANOCYTES; DIFFERENTIATION; SKIN; REGENERATION; ENDOTHELIN; MAINTENANCE; ACTIVATION; EXPRESSION; ROLES	Adult stem cells reside in specialized niches where they receive environmental cues to maintain tissue homeostasis. In mammals, the stem cell niche within hair follicles is home to epithelial hair follicle stem cells and melanocyte stem cells, which sustain cyclical bouts of hair regeneration and pigmentation(1-4). To generate pigmented hairs, synchrony is achieved such that upon initiation of a new hair cycle, stem cells of each type activate lineage commitment(2,5). Dissecting the inter-stem-cell crosstalk governing this intricate coordination has been difficult, because mutations affecting one lineage often affect the other. Here we identify transcription factor NFIB as. an unanticipated coordinator of stem cell behaviour. Hair follicle stem-cell-specific conditional targeting of Nfib in mice uncouples stem cell synchrony. Remarkably, this happens not by perturbing hair cycle and follicle architecture, but rather by promoting melanocyte stem cell proliferation and differentiation. The early production of melanin is restricted to melanocyte stem cells at the niche base. Melanocyte stem cells more distant from the dermal papilla are unscathed, thereby preventing hair greying typical of melanocyte stem cell differentiation mutants. Furthermore, we pinpoint KIT-ligand as a dermal papilla signal promoting melanocyte stem cell differentiation. Additionally, through chromatin-immunoprecipitation with high-throughput-sequencing and transcriptional profiling, we identify endothelin 2 (Edn2) as an NFIB target aberrantly activated in NFIB-deficient hair follicle stem cells. Ectopically induced Edn2 recapitulates NFIB-deficient phenotypes in wildtype mice. Conversely, endothelin receptor antagonists and/or KIT blocking antibodies prevent precocious melanocyte stem cell differentiation in the NFIB-deficient niche. Our findings reveal how melanocyte and hair follicle stem cell behaviours maintain reliance upon cooperative factors within the niche, and how this can be uncoupled in injury, stress and disease states.	[Chang, Chiung-Ying; Pasolli, H. Amalia; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Giannopoulou, Eugenia G.; Elemento, Olivier] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Guasch, Geraldine] Univ Cincinnati, Sch Med, Div Dev Biol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Gronostajski, Richard M.] SUNY Buffalo, Dept Biochem, Dev Genom Grp, NYS Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA	Howard Hughes Medical Institute; Rockefeller University; Cornell University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; Giannopoulou, Evgenia/K-9576-2019	Gronostajski, Richard/0000-0003-4264-208X; Guasch, Geraldine/0000-0001-7362-9318; Pasolli, Hilda Amalia/0000-0003-3899-3530	NIH [R01-AR050452, R01-AR31737, R01-HL080624]; National Science Foundation [DB1054964]; Div Of Biological Infrastructure [1054964] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737, R01AR050452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Y.-C. Hsu, T. Chen, B. Keyes, S. E. Williams, A. Rodriguez-Folgueras and other Fuchs laboratory members for intellectual input and suggestions; L. Polak and N. Stokes for breeding of mouse lines and conducting in utero lentiviral injections; V.J. Hearing for providing anti-DCT,TYRP1 and TYR antibodies. We also thank Rockefeller facilities: Comparative Bioscience Center (AAALAC accredited) for care and husbandry care of mice in accordance with National Institutes of Health (NIH) guidelines; Bioimaging Center for advice on image acquisition; Flow Cytometry facility for FACS sorting. E.F. is an investigator of the Howard Hughes Medical Institute. This work was supported by grants from the NIH to E.F. (R01-AR050452 and R01-AR31737) and R.M.G. (R01-HL080624), and a CAREER grant to O.E. from the National Science Foundation (DB1054964).	Adur J, 2007, PEPTIDES, V28, P1083, DOI 10.1016/j.peptides.2007.03.009; Aoki H, 2009, DEVELOPMENT, V136, P2511, DOI 10.1242/dev.037168; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; Cotsarelis G, 2006, J CLIN INVEST, V116, P19, DOI 10.1172/JCI27490; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; Hirobe T, 2011, PIGM CELL MELANOMA R, V24, P462, DOI 10.1111/j.1755-148X.2011.00845.x; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Klipper E, 2010, ENDOCRINOLOGY, V151, P1914, DOI 10.1210/en.2009-0767; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; McDade SS, 2012, NUCLEIC ACIDS RES, V40, P7190, DOI 10.1093/nar/gks389; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; Pla P, 2003, INT J DEV BIOL, V47, P315; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Reid K, 1996, DEVELOPMENT, V122, P3911; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Weiner L, 2007, CELL, V130, P932, DOI 10.1016/j.cell.2007.07.024	30	107	114	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					98	102		10.1038/nature11847	http://dx.doi.org/10.1038/nature11847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23389444	Green Accepted			2022-12-28	WOS:000316039800047
J	Edwards, KM; Zhu, YW; Griffin, MR; Weinberg, GA; Hall, CB; Szilagyi, PG; Staat, MA; Iwane, M; Prill, MM; Williams, JV				Edwards, Kathryn M.; Zhu, Yuwei; Griffin, Marie R.; Weinberg, Geoffrey A.; Hall, Caroline B.; Szilagyi, Peter G.; Staat, Mary A.; Iwane, Marika; Prill, Mila M.; Williams, John V.		New Vaccine Surveillance Network	Burden of Human Metapneumovirus Infection in Young Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; OBSTRUCTIVE PULMONARY-DISEASE; LUNG-TRANSPLANT RECIPIENTS; POLYMERASE-CHAIN-REACTION; TERM-CARE FACILITY; HOSPITALIZED CHILDREN; TRACT INFECTIONS; HEMATOLOGIC MALIGNANCIES; INFLUENZA-VIRUS; VIRAL LOAD	BACKGROUND The inpatient and outpatient burden of human metapneumovirus (HMPV) infection among young children has not been well established. METHODS We conducted prospective, population-based surveillance for acute respiratory illness or fever among inpatient and outpatient children less than 5 years of age in three U.S. counties from 2003 through 2009. Clinical and demographic data were obtained from parents and medical records, HMPV was detected by means of a reverse-transcriptase polymerase-chain-reaction assay, and population-based rates of hospitalization and estimated rates of outpatient visits associated with HMPV infection were determined. RESULTS HMPV was detected in 200 of 3490 hospitalized children (6%), 222 of 3257 children in outpatient clinics (7%), 224 of 3001 children in the emergency department (7%), and 10 of 770 asymptomatic controls (1%). Overall annual rates of hospitalization associated with HMPV infection were 1 per 1000 children less than 5 years of age, 3 per 1000 infants less than 6 months of age, and 2 per 1000 children 6 to 11 months of age. Children hospitalized with HMPV infection, as compared with those hospitalized without HMPV infection, were older and more likely to receive a diagnosis of pneumonia or asthma, to require supplemental oxygen, and to have a longer stay in the intensive care unit. The estimated annual burden of outpatient visits associated with HMPV infection was 55 clinic visits and 13 emergency department visits per 1000 children. The majority of HMPV-positive inpatient and outpatient children had no underlying medical conditions, although premature birth and asthma were more frequent among hospitalized children with HMPV infection than among those without HMPV infection. CONCLUSIONS HMPV infection is associated with a substantial burden of hospitalizations and outpatient visits among children throughout the first 5 years of life, especially during the first year. Most children with HMPV infection were previously healthy.	[Edwards, Kathryn M.; Williams, John V.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Zhu, Yuwei] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; [Griffin, Marie R.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA; [Williams, John V.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Weinberg, Geoffrey A.; Hall, Caroline B.; Szilagyi, Peter G.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Hall, Caroline B.] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Staat, Mary A.] Cincinnati Childrens Hosp, Dept Pediat, Cincinnati, OH USA; [Iwane, Marika; Prill, Mila M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Rochester; University of Rochester; Cincinnati Children's Hospital Medical Center; Centers for Disease Control & Prevention - USA	Williams, JV (corresponding author), Vanderbilt Univ, Med Ctr, D-7235 Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	john.williams@vanderbilt.edu	Williams, John/ABE-3227-2020; Weinberg, Geoffrey A./W-7510-2019; Williams, John/F-6962-2010	Williams, John/0000-0001-8377-5175; Weinberg, Geoffrey A./0000-0002-3900-379X; Williams, John/0000-0001-8377-5175	Centers for Disease Control and Prevention; National Institutes of Health; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [U01IP000022, U01IP000147, U01IP000017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085062, R21AI082417] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Centers for Disease Control and Prevention and the National Institutes of Health.)	Ali SA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-332; Anderson Evan J, 2012, J Pediatric Infect Dis Soc, V1, P212, DOI 10.1093/jpids/pis069; Biacchesi S, 2004, J VIROL, V78, P12877, DOI 10.1128/JVI.78.23.12877-12887.2004; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2007, CLIN INFECT DIS, V44, P1152, DOI 10.1086/513204; Bosis S, 2008, J CLIN VIROL, V42, P286, DOI 10.1016/j.jcv.2008.03.029; Cane PA, 2003, BONE MARROW TRANSPL, V31, P309, DOI 10.1038/sj.bmt.1703849; Dollner H, 2004, PEDIATR INFECT DIS J, V23, P436, DOI [10.1097/01.inf.000126401.21779.7, 10.1097/01.inf.0000126401.21779.74]; Ebihara T, 2004, J CLIN MICROBIOL, V42, P126, DOI 10.1128/JCM.42.1.126-132.2004; Englund JA, 2006, ANN INTERN MED, V144, P344, DOI 10.7326/0003-4819-144-5-200603070-00010; Esper F, 2004, J INFECT DIS, V189, P1388, DOI 10.1086/382482; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Freymuth F, 2003, PEDIATR INFECT DIS J, V22, P92, DOI 10.1097/00006454-200301000-00024; Gerna G, 2007, J CLIN VIROL, V40, P236, DOI 10.1016/j.jcv.2007.08.001; Gray GC, 2006, J CLIN VIROL, V37, P269, DOI 10.1016/j.jcv.2006.08.016; Griffin Marie R, 2004, Pediatr Infect Dis J, V23, pS188, DOI 10.1097/01.inf.0000144660.53024.64; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hamelin ME, 2005, J VIROL, V79, P8894, DOI 10.1128/JVI.79.14.8894-8903.2005; Hopkins P, 2008, AM J RESP CRIT CARE, V178, P876, DOI 10.1164/rccm.200711-1657OC; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Kuiken T, 2004, AM J PATHOL, V164, P1893, DOI 10.1016/S0002-9440(10)63750-9; Kunz AN, 2008, EUR J CLIN MICROBIOL, V27, P1245, DOI 10.1007/s10096-008-0558-7; Larcher C, 2005, J HEART LUNG TRANSPL, V24, P1891, DOI 10.1016/j.healun.2005.02.014; Liao RS, 2012, J CLIN VIROL, V53, P171, DOI 10.1016/j.jcv.2011.10.010; Madhi SA, 2007, PEDIATR INFECT DIS J, V26, P693, DOI 10.1097/INF.0b013e3180621192; Martin ET, 2008, DIAGN MICR INFEC DIS, V62, P382, DOI 10.1016/j.diagmicrobio.2008.08.002; Martinello RA, 2006, J INFECTION, V53, P248, DOI 10.1016/j.jinf.2005.11.010; Martino R, 2005, BIOL BLOOD MARROW TR, V11, P781, DOI 10.1016/j.bbmt.2005.07.007; McAdam AJ, 2004, J INFECT DIS, V190, P20, DOI 10.1086/421120; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; Morrow BM, 2006, J PAEDIATR CHILD H, V42, P174, DOI 10.1111/j.1440-1754.2006.00825.x; Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555; Noyola DE, 2005, J MED MICROBIOL, V54, P969, DOI 10.1099/jmm.0.46052-0; Osterhaus A, 2003, LANCET, V361, P890, DOI 10.1016/S0140-6736(03)12785-7; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Pelletier G, 2002, EMERG INFECT DIS, V8, P976, DOI 10.3201/eid0809.020238; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Shahda S, 2011, TRANSPL INFECT DIS, V13, P324, DOI 10.1111/j.1399-3062.2010.00575.x; Sivaprakasam V, 2007, J CLIN VIROL, V39, P234, DOI 10.1016/j.jcv.2007.03.011; Skiadopoulos MH, 2004, J VIROL, V78, P6927, DOI 10.1128/JVI.78.13.6927-6937.2004; Sumino KC, 2005, J INFECT DIS, V192, P1052, DOI 10.1086/432728; Talbot HK, 2009, PEDIATR INFECT DIS J, V28, P682, DOI 10.1097/INF.0b013e31819d0d27; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Vicente D, 2004, EMERG INFECT DIS, V10, P1338, DOI 10.3201/eid1007.030633; Walsh EE, 2008, ARCH INTERN MED, V168, P2489, DOI 10.1001/archinte.168.22.2489; Weinberg GA, 2009, J PEDIATR-US, V154, P694, DOI 10.1016/j.jpeds.2008.11.034; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Williams JV, 2010, J INFECT DIS, V201, P1890, DOI 10.1086/652782; Williams JV, 2005, J INFECT DIS, V192, P1061, DOI 10.1086/432732; Williams JV, 2005, J INFECT DIS, V192, P1149, DOI 10.1086/444392; Williams JV, 2005, J VIROL, V79, P10944, DOI 10.1128/JVI.79.17.10944-10951.2005; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Wyde PR, 2005, ANTIVIR RES, V66, P57, DOI 10.1016/j.antiviral.2004.12.009	55	197	214	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					633	643		10.1056/NEJMoa1204630	http://dx.doi.org/10.1056/NEJMoa1204630			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194VA	23406028	Green Accepted			2022-12-28	WOS:000322659600008
J	Morgan, DR; Torres, J; Sexton, R; Herrero, R; Salazar-Martinez, E; Greenberg, ER; Bravo, LE; Dominguez, RL; Ferreccio, C; Lazcano-Ponce, EC; Meza-Montenegro, MM; Pena, EM; Pena, R; Correa, P; Martinez, ME; Chey, WD; Valdivieso, M; Anderson, GL; Goodman, GE; Crowley, JJ; Baker, LH				Morgan, Douglas R.; Torres, Javier; Sexton, Rachael; Herrero, Rolando; Salazar-Martinez, Eduardo; Greenberg, E. Robert; Eduardo Bravo, Luis; Dominguez, Ricardo L.; Ferreccio, Catterina; Lazcano-Ponce, Eduardo C.; Mercedes Meza-Montenegro, Maria; Pena, Edgar M.; Pena, Rodolfo; Correa, Pelayo; Martinez, Maria Elena; Chey, William D.; Valdivieso, Manuel; Anderson, Garnet L.; Goodman, Gary E.; Crowley, John J.; Baker, Laurence H.			Risk of Recurrent Helicobacter pylori Infection 1 Year After Initial Eradication Therapy in 7 Latin American Communities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVENT GASTRIC-CANCER; TERM-FOLLOW-UP; COST-EFFECTIVENESS; TRIPLE THERAPY; BACTERIAL-RESISTANCE; ULCER DISEASE; METAANALYSIS; REINFECTION; POPULATION; TRIAL	Importance The long-term effectiveness of Helicobacter pylori eradication programs for preventing gastric cancer will depend on recurrence risk and individual and community factors. Objective To estimate risk of H pylori recurrence and assess factors associated with successful eradication 1 year after treatment. Design, Setting, and Participants Cohort analysis of 1463 randomized trial participants aged 21 to 65 years from 7 Latin American communities, who were treated for H pylori and observed between September 2009 and July 2011. Interventions Randomization to 1 of 3 treatment groups: 14-day lansoprazole, amoxicillin, and clarithromycin (triple therapy); 5-day lansoprazole and amoxicillin followed by 5-day lansoprazole, clarithromycin, and metronidazole (sequential); or 5-day lansoprazole, amoxicillin, clarithromycin, and metronidazole (concomitant). Participants with a positive (13) C-urea breath test (UBT) 6 to 8 weeks posttreatment were offered voluntary re-treatment with 14-day bismuth-based quadruple therapy. Measurements Recurrent infection after a negative posttreatment UBT and factors associated with successful eradication at 1-year follow-up. Results Among participants with UBT-negative results who had a 1-year follow-up UBT (n=1091), 125 tested UBT positive, a recurrence risk of 11.5% (95% CI, 9.6%-13.5%). Recurrence was significantly associated with study site (P=.03), nonadherence to initial therapy (adjusted odds ratio [AOR], 2.94; 95% CI, 1.31-6.13; P=.01), and children in the household (AOR, 1.17; 95% CI, 1.01-1.35 per child; P=.03). Of the 281 with positive posttreatment UBT results, 138 completed re-treatment, of whom 93 tested UBT negative at 1 year. Among the 1340 who had a 1-year UBT, 80.4% (95% CI, 76.4%-83.9%), 79.8% (95% CI, 75.8%-83.5%), and 77.8% (95% CI, 73.6%-81.6%) had UBT-negative results in the triple, sequential, and concomitant groups, respectively (P=.61), with 79.3% overall effectiveness (95% CI, 77.1%-81.5%). In a single-treatment course analysis that ignored the effects of re-treatment, the percentage of UBT-negative results at 1 year was 72.4% (95% CI, 69.9%-74.8%) and was significantly associated with study site (P<.001), adherence to initial therapy (AOR, 0.26; 95% CI, 0.15-0.42; P<.001), male sex (AOR, 1.63; 95% CI, 1.25-2.13; P<.001), and age (AOR, 1.14; 95% CI, 1.02-1.27 per decade; P=.02). One-year effectiveness among all 1463 enrolled participants, considering all missing UBT results as positive, was 72.7% (95% CI, 70.3%-74.9%). Conclusions and Relevance One year after treatment for H pylori infection, recurrence occurred in 11.5% of participants who had negative posttreatment UBT results. Recurrence determinants (ie, nonadherence and demographics) may be as important as specific antibiotic regimen in determining the long-term success of H pylori eradication interventions. Study findings are relevant to the feasibility of programs for the primary prevention of gastric cancer in high-incidence regions of Latin America. Trial Registration clinicaltrials.gov Identifier: NCT01061437 JAMA. 2013;309(6):578-586 www.jama.com	[Morgan, Douglas R.; Correa, Pelayo] Vanderbilt Univ Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN USA; [Morgan, Douglas R.] Univ N Carolina, Div Gastroenterol, Chapel Hill, NC USA; [Torres, Javier] Inst Mexicano Seguro Social, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Sexton, Rachael; Greenberg, E. Robert; Anderson, Garnet L.; Crowley, John J.] SWOG Stat Ctr, Seattle, WA USA; [Herrero, Rolando] Int Agcy Res Canc, F-69372 Lyon, France; [Herrero, Rolando] Fdn INCIENSA, San Jose, Costa Rica; [Salazar-Martinez, Eduardo; Lazcano-Ponce, Eduardo C.] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Greenberg, E. Robert; Anderson, Garnet L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Eduardo Bravo, Luis] Univ Valle, Dept Patol, Cali, Colombia; [Dominguez, Ricardo L.] Hosp Reg Occidente, Santa Rosa De Copan, Honduras; [Ferreccio, Catterina] Pontificia Univ Catolica Chile, Dept Salud Publ, Santiago, Chile; [Mercedes Meza-Montenegro, Maria] Inst Tecnol Sonora, Obregon, Mexico; [Pena, Edgar M.; Pena, Rodolfo] Univ Nacl Nicaragua, Ctr Invest Demog & Salud, Leon, Nicaragua; [Martinez, Maria Elena] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Chey, William D.] Univ Michigan, Sch Med, Div Gastroenterol, Ann Arbor, MI USA; [Valdivieso, Manuel; Baker, Laurence H.] Univ Michigan, Sch Med, Dept Hematol Oncol, Ann Arbor, MI USA; [Goodman, Gary E.] Swedish Med Ctr, Inst Canc, Seattle, WA USA	Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; Instituto Mexicano del Seguro Social; Southwest Oncology Group; World Health Organization; International Agency for Research on Cancer (IARC); Instituto Nacional de Salud Publica; Fred Hutchinson Cancer Center; Universidad del Valle; Pontificia Universidad Catolica de Chile; University of California System; University of California San Diego; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Swedish Cancer Institute; Swedish Medical Center	Morgan, DR (corresponding author), Vanderbilt Univ, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA.	douglas.morgan@vanderbilt.edu	Chey, William/AAY-7766-2021; Bravo, Luis Eduardo/AAB-7209-2019; Bravo, Luis Eduardo/G-9671-2013; Bravo, Luis/K-9882-2014	Bravo, Luis Eduardo/0000-0002-9708-0312; Bravo, Luis/0000-0002-9708-0312; Anderson, Garnet/0000-0001-5087-7837; ferreccio, catterina/0000-0001-6331-5534; Pena-Galo, Edgar/0000-0003-2858-3079; Meza-Montenegro, Maria Mercedes/0000-0002-1199-9310	Bill & Melinda Gates Foundation [43930]; National Institutes of Health (NIH) [CA037429]; NATIONAL CANCER INSTITUTE [K07CA125588, P01CA028842, U10CA037429] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Bill & Melinda Gates Foundation (#43930) provided financial support for the trial, and the National Institutes of Health (NIH) (CA037429) supported the SWOG (Southwest Oncology Group) administrative and statistical infrastructure.	Camorlinga-Ponce M, 1998, AM J GASTROENTEROL, V93, P1264, DOI 10.1111/j.1572-0241.1998.00407.x; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Essa AS, 2009, HELICOBACTER, V14, P109, DOI 10.1111/j.1523-5378.2009.00671.x; Fendrick AM, 1999, ARCH INTERN MED, V159, P142, DOI 10.1001/archinte.159.2.142; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fuccio L, 2009, ANN INTERN MED, V151, P121, DOI 10.7326/0003-4819-151-2-200907210-00009; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Gail MH, 2007, HELICOBACTER, V12, P575, DOI 10.1111/j.1523-5378.2007.00528.x; Gatta L, 2009, AM J GASTROENTEROL, V104, P3069, DOI 10.1038/ajg.2009.555; Gisbert JP, 2006, ALIMENT PHARM THER, V23, P275, DOI 10.1111/j.1365-2036.2006.02741.x; Gisbert JP, 2005, AM J GASTROENTEROL, V100, P2083, DOI 10.1111/j.1572-0241.2005.50043.x; Graham DY, 2005, GUT, V54, P735, DOI 10.1136/gut.2004.056549; Greenberg ER, 2011, LANCET, V378, P507, DOI 10.1016/S0140-6736(11)60825-8; Guzman-Blanco M, 2000, INFECT DIS CLIN N AM, V14, P67, DOI 10.1016/S0891-5520(05)70218-X; Halitim F, 2006, HELICOBACTER, V11, P168, DOI 10.1111/j.1523-5378.2006.00396.x; Leal-Herrera Y, 2003, AM J GASTROENTEROL, V98, P2395, DOI 10.1111/j.1572-0241.2003.07708.x; Lee YC, 2007, CANCER EPIDEM BIOMAR, V16, P875, DOI 10.1158/1055-9965.EPI-06-0758; Luther J, 2010, AM J GASTROENTEROL, V105, P65, DOI 10.1038/ajg.2009.508; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Marugame T, 2007, JPN J CLIN ONCOL, V37, P242, DOI 10.1093/jjco/hym014; Mason J, 2002, ALIMENT PHARM THER, V16, P559, DOI 10.1046/j.1365-2036.2002.01204.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McCallion WA, 1996, GUT, V39, P18, DOI 10.1136/gut.39.1.18; Megraud F, 2013, GUT, V62, P34, DOI 10.1136/gutjnl-2012-302254; Mera R, 2005, GUT, V54, P1536, DOI 10.1136/gut.2005.072009; Morgan DR, 2010, GASTROENTEROLOGY, V138, pS386; Nawaz A, 1998, AM J GASTROENTEROL, V93, P1175, DOI 10.1111/j.1572-0241.1998.00358.x; Niv Y, 2008, HELICOBACTER, V13, P56, DOI 10.1111/j.1523-5378.2008.00571.x; Okeke IN, 1999, EMERG INFECT DIS, V5, P18, DOI 10.3201/eid0501.990103; Parsonnet J, 1996, LANCET, V348, P150, DOI 10.1016/S0140-6736(96)01501-2; Parsonnet Julie, 2003, Can J Gastroenterol, V17 Suppl B, p46B; Rollan A, 2000, AM J GASTROENTEROL, V95, P50, DOI 10.1111/j.1572-0241.2000.01700.x; Saito D, 2005, GASTROENTEROLOGY, V128, pA4; Silva FM, 2010, HELICOBACTER, V15, P46, DOI 10.1111/j.1523-5378.2009.00734.x; Sonnenberg A, 1998, ALIMENT PHARM THERAP, V12, P111, DOI 10.1111/j.1365-2036.1998.00001.x; Soto G, 2003, J INFECT DIS, V188, P1263, DOI 10.1086/379046; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Yeh JM, 2009, INT J CANCER, V124, P157, DOI 10.1002/ijc.23864	42	55	62	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					578	586		10.1001/jama.2013.311	http://dx.doi.org/10.1001/jama.2013.311			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087PH	23403682	Green Published, Green Accepted			2022-12-28	WOS:000314773700030
J	Ahimastos, AA; Walker, PJ; Askew, C; Leicht, A; Pappas, E; Blombery, P; Reid, CM; Golledge, J; Kingwell, BA				Ahimastos, Anna A.; Walker, Philip J.; Askew, Christopher; Leicht, Anthony; Pappas, Elise; Blombery, Peter; Reid, Christopher M.; Golledge, Jonathan; Kingwell, Bronwyn A.			Effect of Ramipril on Walking Times and Quality of Life Among Patients With Peripheral Artery Disease and Intermittent Claudication A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; CHRONIC HEART-FAILURE; ACE-INHIBITION; PHYSICAL FUNCTION; DOUBLE-BLIND; BLOOD-FLOW; HYPERTENSIVE PATIENTS; GLUT4 TRANSLOCATION; MULTIPLE IMPUTATION; ELDERLY-PEOPLE	Importance Approximately one-third of patients with peripheral artery disease experience intermittent claudication, with consequent loss of quality of life. Objective To determine the efficacy of ramipril for improving walking ability, patient-perceived walking performance, and quality of life in patients with claudication. Design, Setting, and Patients Randomized, double-blind, placebo-controlled trial conducted among 212 patients with peripheral artery disease (mean age, 65.5 [SD, 6.2] years), initiated in May 2008 and completed in August 2011 and conducted at 3 hospitals in Australia. Intervention Patients were randomized to receive 10 mg/d of ramipril (n=106) or matching placebo (n=106) for 24 weeks. Main OutcomeMeasures Maximum and pain-free walking times were recorded during a standard treadmill test. The Walking Impairment Questionnaire (WIQ) and Short-Form 36 Health Survey (SF-36) were used to assess walking ability and quality of life, respectively. Results At 6 months, relative to placebo, ramipril was associated with a 75-second (95% CI, 60-89 seconds) increase in mean pain-free walking time (P < .001) and a 255-second (95% CI, 215-295 seconds) increase in maximum walking time (P < .001). Relative to placebo, ramipril improved the WIQ median distance score by 13.8 (Hodges-Lehmann 95% CI, 12.2-15.5), speed score by 13.3 (95% CI, 11.9-15.2), and stair climbing score by 25.2 (95% CI, 25.1-29.4) (P < .001 for all). The overall SF-36 median Physical Component Summary score improved by 8.2 (Hodges-Lehmann 95% CI, 3.6-11.4; P=.02) in the ramipril group relative to placebo. Ramipril did not affect the overall SF-36 median Mental Component Summary score. Conclusions and Relevance Among patients with intermittent claudication, 24-week treatment with ramipril resulted in significant increases in pain-free and maximum treadmill walking times compared with placebo. This was associated with a significant increase in the physical functioning component of the SF-36 score.	[Ahimastos, Anna A.; Kingwell, Bronwyn A.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 8008, Australia; [Walker, Philip J.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Walker, Philip J.] Royal Brisbane & Womens Hosp, Herston, Qld, Australia; [Askew, Christopher] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Leicht, Anthony; Pappas, Elise; Golledge, Jonathan] James Cook Univ, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld 4811, Australia; [Blombery, Peter] Alfred Hosp, Prahran, Vic 3181, Australia; [Reid, Christopher M.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Baker Heart and Diabetes Institute; University of Queensland; Royal Brisbane & Women's Hospital; Queensland University of Technology (QUT); James Cook University; Florey Institute of Neuroscience & Mental Health; Monash University	Ahimastos, AA (corresponding author), Baker IDI Heart & Diabet Inst, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	a.ahimastos@alfred.org.au	Reid, Christopher M/AAP-8135-2021; golledge, jonathan/I-2371-2013; Leicht, Anthony/C-7187-2009; Walker, Philip J/F-3034-2010; Blombery, Peter/AAR-1849-2020	Leicht, Anthony/0000-0002-0537-5392; Reid, Christopher/0000-0001-9173-3944; Askew, Christopher/0000-0001-8076-8789	National Heart Foundation of Australia; National Health and Medical Research Council of Australia; Operational Infrastructure Support Program of the Victorian State Government, Australia	National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support Program of the Victorian State Government, Australia	This study was supported by the National Heart Foundation of Australia, the National Health and Medical Research Council of Australia, and the Operational Infrastructure Support Program of the Victorian State Government, Australia (Dr Ahimastos and Dr Kingwell).	Ahimastos AA, 2006, ANN INTERN MED, V144, P660, DOI 10.7326/0003-4819-144-9-200605020-00009; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Beebe HG, 1999, ARCH INTERN MED, V159, P2041, DOI 10.1001/archinte.159.17.2041; Castano G, 2004, ANGIOLOGY, V55, P361, DOI 10.1177/000331970405500403; Cesari M, 2010, J AM MED DIR ASSOC, V11, P26, DOI 10.1016/j.jamda.2009.09.014; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Creager MA, 2008, VASC MED, V13, P5, DOI 10.1177/1358863X07084910; Creager MA, 2011, CIRCULATION, V124, P1765, DOI 10.1161/CIRCULATIONAHA.110.009407; Dawson DL, 2000, AM J MED, V109, P523, DOI 10.1016/S0002-9343(00)00569-6; Degischer S, 2002, J VASC SURG, V36, P83, DOI 10.1067/mva.2002.123092; Di Bari M, 2004, J AM GERIATR SOC, V52, P961, DOI 10.1111/j.1532-5415.2004.52265.x; Ebrahimian TG, 2005, ARTERIOSCL THROM VAS, V25, P65, DOI 10.1161/01.ATV.0000149377.90852.d8; Elam MB, 1998, ARTERIOSCL THROM VAS, V18, P1942, DOI 10.1161/01.ATV.18.12.1942; Fabre JE, 1999, CIRCULATION, V99, P3043, DOI 10.1161/01.CIR.99.23.3043; Gray SL, 2009, J AM GERIATR SOC, V57, P297, DOI 10.1111/j.1532-5415.2008.02121.x; Grossman PM, 2007, AM HEART J, V153, P874, DOI 10.1016/j.ahj.2007.01.038; Harel O, 2007, STAT MED, V26, P3057, DOI 10.1002/sim.2787; Henriksen EJ, 2013, MOL CELL ENDOCRINOL, V378, P15, DOI 10.1016/j.mce.2012.04.011; Isami S, 1996, DIABETOLOGIA, V39, P412, DOI 10.1007/s001250050460; Kishi K, 1998, DIABETES, V47, P550, DOI 10.2337/diabetes.47.4.550; Labs KH, 1999, VASC MED, V4, P239, DOI 10.1191/135886399671094335; Lievre M, 2000, CIRCULATION, V102, P426; MANNARINO E, 1991, ANGIOLOGY, V42, P513, DOI 10.1177/000331979104200701; McDermott MM, 2008, J VASC SURG, V48, P1231, DOI 10.1016/j.jvs.2008.06.050; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Mohler ER, 2003, CIRCULATION, V108, P1481, DOI 10.1161/01.CIR.0000090686.57897.F5; Momsen AH, 2009, EUR J VASC ENDOVASC, V38, P463, DOI 10.1016/j.ejvs.2009.06.002; Money SR, 1998, J VASC SURG, V27, P267, DOI 10.1016/S0741-5214(98)70357-X; Murphy TP, 2012, CIRCULATION, V125, P130, DOI 10.1161/CIRCULATIONAHA.111.075770; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Onder G, 2002, LANCET, V359, P926, DOI 10.1016/S0140-6736(02)08024-8; OVERLACK A, 1994, AM J MED, V97, P126, DOI 10.1016/0002-9343(94)90022-1; Pande RL, 2010, VASC MED, V15, P181, DOI 10.1177/1358863X10361545; Rakusan K, 2000, MICROVASC RES, V59, P243, DOI 10.1006/mvre.1999.2224; Regensteiner JG, 1996, J VASC SURG, V23, P104, DOI 10.1016/S0741-5214(05)80040-0; Reneland R, 1999, BLOOD PRESSURE, V8, P16, DOI 10.1080/080370599438347; ROBERTS DH, 1992, ANGIOLOGY, V43, P748, DOI 10.1177/000331979204300905; SACKS D, 1992, J ULTRAS MED, V11, P95; Schaufelberger M, 1996, EUR HEART J, V17, P1678; Scheidegger KJ, 1997, J HYPERTENS, V15, P1455, DOI 10.1097/00004872-199715120-00013; Schindler C, 2007, ANGIOLOGY, V58, P710, DOI 10.1177/0003319707305962; Shahin Y, 2011, INT J SURG, V9, P209, DOI 10.1016/j.ijsu.2010.12.006; SONECHA TN, 1990, INT ANGIOL, V9, P22; Spence JD, 1993, J VASC MED BIOL, V4, P23; Spengel F, 2002, INT ANGIOL, V21, P20; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Stevens JW, 2012, BRIT J SURG, V99, P1630, DOI 10.1002/bjs.8895; SUMNER DS, 1969, SURGERY, V65, P763; Sumukadas D, 2007, CAN MED ASSOC J, V177, P867, DOI 10.1503/cmaj.061339; Takeshita S, 2001, CARDIOVASC RES, V52, P314, DOI 10.1016/S0008-6363(01)00372-8; Toblli JE, 2003, J HYPERTENS, V21, P611, DOI 10.1097/00004872-200303000-00028; VANDEVEN LLM, 1994, VASA-J VASCULAR DIS, V23, P357; Vescovo G, 1998, CIRCULATION, V98, P1742, DOI 10.1161/01.CIR.98.17.1742; Vodnala D, 2011, CARDIOL CLIN, V29, P363, DOI 10.1016/j.ccl.2011.04.003; Ware JE, 1993, SF36 HLTH SURVEY MAN; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zimmermann R, 1999, J MOL CELL CARDIOL, V31, P1447, DOI 10.1006/jmcc.1999.0976	58	78	81	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					453	460		10.1001/jama.2012.216237	http://dx.doi.org/10.1001/jama.2012.216237			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083LY	23385271	Bronze			2022-12-28	WOS:000314466900026
J	Inouye, SK; O'Connell, JJ; Puelle, MR				Inouye, Sharon K.; O'Connell, James J.; Puelle, Margaret R.			Falling Off the Edge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MENTAL-ILLNESS; HOMELESS; ADULTS		[Inouye, Sharon K.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Cambridge, MA 02138 USA; [O'Connell, James J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Cambridge, MA 02138 USA; [Inouye, Sharon K.; O'Connell, James J.] Boston Healthcare Homeless Program, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital	Inouye, SK (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Cambridge, MA 02138 USA.	agingbraincenter@hsl.harvard.edu	Inouye, Sharon/R-7216-2019					Bremner AJ, 1996, BRIT J PSYCHIAT, V169, P434, DOI 10.1192/bjp.169.4.434; Brown RT, 2012, J GEN INTERN MED, V27, P16, DOI 10.1007/s11606-011-1848-9; Burra TA, 2009, CAN J PSYCHIAT, V54, P123, DOI 10.1177/070674370905400210; Culhane DP, 2010, AGE STRUCTURE CONT H; Geddes J R, 1996, Health Bull (Edinb), V54, P276; Hahn JA, 2006, J GEN INTERN MED, V21, P775, DOI 10.1111/j.1525-1497.2006.00493.x; Helfrich CA, 2011, AM J OCCUP THER, V65, P277, DOI 10.5014/ajot.2011.001321; Joyce DP, 2009, CAN FAM PHYSICIAN, V55, P1110; Witte P, 2012, STAT HOM AM 2012	9	2	2	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					451	452		10.1001/jama.2012.214089	http://dx.doi.org/10.1001/jama.2012.214089			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083LY	23385270	Green Published			2022-12-28	WOS:000314466900025
J	Lunde, S				Lunde, Siri			Youth tobacco use: who has a say?	LANCET			English	Editorial Material									Journal Norwegian Med Assoc, N-0107 Oslo, Norway		Lunde, S (corresponding author), Journal Norwegian Med Assoc, POB 1152 Sentrum, N-0107 Oslo, Norway.	siri.lunde@legeforeningen.no						Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Patnode CD, 2013, ANN INTERN MED, V158, P253, DOI 10.7326/0003-4819-158-4-201302190-00580; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO	3	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2013	381	9864					357	357		10.1016/S0140-6736(13)60064-1	http://dx.doi.org/10.1016/S0140-6736(13)60064-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084ZA	23374463				2022-12-28	WOS:000314578900012
J	Chandra, P; Coleman, P; Flint, R				Chandra, Premala; Coleman, Piers; Flint, Rebecca			Hastatic order in the heavy-fermion compound URu2Si2	NATURE			English	Article							HIDDEN-ORDER; MAGNETIC-PROPERTIES; FIELD; SYSTEM; STATE; SUPERCONDUCTIVITY; EXCITATIONS; TRANSITION; LATTICE; PHASE	The development of collective long-range order by means of phase transitions occurs by the spontaneous breaking of fundamental symmetries. Magnetism is a consequence of broken time-reversal symmetry, whereas superfluidity results from broken gauge invariance. The broken symmetry that develops below 17.5 kelvin in the heavy-fermion compound URu2Si2 has long eluded such identification. Here we show that the recent observation of Ising quasiparticles in URu2Si2 results from a spinor order parameter that breaks double time-reversal symmetry, mixing states of integer and half-integer spin. Such 'hastatic' order hybridizes uranium-atom conduction electrons with Ising 5f(2) states to produce Ising quasiparticles; it accounts for the large entropy of condensation and the magnetic anomaly observed in torque magnetometry. Hastatic order predicts a tiny transverse moment in the conduction-electron 'sea', a colossal Ising anisotropy in the nonlinear susceptibility anomaly and a resonant, energy-dependent nematicity in the tunnelling density of states.	[Chandra, Premala; Coleman, Piers] Rutgers State Univ, Dept Phys & Astron, Ctr Mat Theory, Piscataway, NJ 08854 USA; [Coleman, Piers] Univ London, Dept Phys, Egham TW20 0EX, Surrey, England; [Flint, Rebecca] MIT, Dept Phys, Cambridge, MA 02139 USA	Rutgers State University New Brunswick; University of London; Royal Holloway University London; Massachusetts Institute of Technology (MIT)	Coleman, P (corresponding author), Rutgers State Univ, Dept Phys & Astron, Ctr Mat Theory, 136 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	coleman@physics.rutgers.edu	Flint, Rebecca/J-3628-2014		Simons Foundation; US National Science Foundation [DMR 0907179, 1066293]; US National Science Foundation I2CAM International Materials Institute [DMR-0844115]; Direct For Mathematical & Physical Scien [0907179] Funding Source: National Science Foundation	Simons Foundation; US National Science Foundation(National Science Foundation (NSF)); US National Science Foundation I2CAM International Materials Institute; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	An early version of this work was begun in collaboration with P. Fazekas, since deceased. We thank N. Andrei, S. Burdin, B. Coleman, L. Greene, N. Harrison, K. Haule, G. Kotliar, P. Lee, G. Luke, Y. Matsuda, J. Mydosh, P. Niklowitz, C. Pepin, T. Senthil, A. Toth and T. Timusk for discussions. We acknowledge funding from the Simons Foundation (R. F.), the US National Science Foundation grant DMR 0907179 (R. F., P. Coleman), the US National Science Foundation I2CAM International Materials Institute Award Grant DMR-0844115 (R. F., P. Coleman) and the US National Science Foundation grant 1066293 (all authors) while at the Aspen Center for Physics. We are grateful for the hospitality of the Aspen Center for Physics.	Altarawneh MM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.066407; Altarawneh MM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.146403; Amitsuka H, 2007, J MAGN MAGN MATER, V310, P214, DOI 10.1016/j.jmmm.2006.10.008; Amitsuka H, 2003, PHYSICA B, V326, P418, DOI 10.1016/S0921-4526(02)01654-X; AMITSUKA H, 1994, J PHYS SOC JPN, V63, P736, DOI 10.1143/JPSJ.63.736; ANDERSON PW, 1961, PHYS REV, V124, P41, DOI 10.1103/PhysRev.124.41; Aynajian P, 2010, P NATL ACAD SCI USA, V107, P10383, DOI 10.1073/pnas.1005892107; Bernal OO, 2004, J MAGN MAGN MATER, V272, pE59, DOI 10.1016/j.jmmm.2003.11.159; BRISON JP, 1995, PHYSICA C, V250, P128, DOI 10.1016/0921-4534(95)00358-4; BROHOLM C, 1991, PHYS REV B, V43, P12809, DOI 10.1103/PhysRevB.43.12809; Coleman P, 1999, PHYS REV B, V60, P3608, DOI 10.1103/PhysRevB.60.3608; COLEMAN P, 1984, PHYS REV B, V29, P3035, DOI 10.1103/PhysRevB.29.3035; Cox D L, 2002, EXOTIC KONDO EFFECTS, V5; Cox DL, 1996, J PHYS-CONDENS MAT, V8, P9825, DOI 10.1088/0953-8984/8/48/012; Dubi Y, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.086401; Flint R, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.155155; Fujimoto S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.196407; Goremychkin EA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.147201; Hassinger E, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.216409; Haule K, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/57006; Haule K, 2009, NAT PHYS, V5, P796, DOI 10.1038/NPHYS1392; Hoshino S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.247202; Ikeda H, 2012, NAT PHYS, V8, P528, DOI [10.1038/NPHYS2330, 10.1038/nphys2330]; Jo YJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.166404; MIYAKO Y, 1991, J APPL PHYS, V70, P5791, DOI 10.1063/1.350162; Mydosh JA, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1301; Nagel U, 2012, P NATL ACAD SCI USA, V109, P19161, DOI 10.1073/pnas.1208249109; NIEUWENHUYS GJ, 1987, PHYS REV B, V35, P5260, DOI 10.1103/PhysRevB.35.5260; Niklowitz P. G., 2011, ROLE COMMENSURATE IN; Ohkawa FJ, 1999, J PHYS-CONDENS MAT, V11, pL519, DOI 10.1088/0953-8984/11/46/101; Ohkuni H, 1999, PHILOS MAG B, V79, P1045, DOI 10.1080/014186399256916; Okazaki R, 2011, SCIENCE, V331, P439, DOI 10.1126/science.1197358; PALSTRA TTM, 1985, PHYS REV LETT, V55, P2727, DOI 10.1103/PhysRevLett.55.2727; Park WK, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.246403; Pepin C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.106601; RAMIREZ AP, 1992, PHYS REV LETT, V68, P2680, DOI 10.1103/PhysRevLett.68.2680; Sakurai J. J., 1994, MODERN QUANTUM MECH, P266; Santander-Syro AF, 2009, NAT PHYS, V5, P637, DOI 10.1038/NPHYS1361; SANTINI P, 1994, PHYS REV LETT, V73, P1027, DOI 10.1103/PhysRevLett.73.1027; SCHLABITZ W, 1986, Z PHYS B CON MAT, V62, P171, DOI 10.1007/BF01323427; Schmidt AR, 2010, NATURE, V465, P570, DOI 10.1038/nature09073; Schofield A. J., 2003, PHYS REV B, V72; Tonegawa S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.036401; Varma CM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036405; Villaume A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.012504; Wiebe CR, 2007, NAT PHYS, V3, P96, DOI 10.1038/nphys522; Yuan T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035129; ZOLNIEREK Z, 1978, J MAGN MAGN MATER, V8, P210, DOI 10.1016/0304-8853(78)90123-3	49	101	101	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					621	626		10.1038/nature11820	http://dx.doi.org/10.1038/nature11820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364741	Green Submitted			2022-12-28	WOS:000314219600046
J	Jiang, P; Du, WJ; Mancuso, A; Wellen, KE; Yang, XL				Jiang, Peng; Du, Wenjing; Mancuso, Anthony; Wellen, Kathryn E.; Yang, Xiaolu			Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; ATP-CITRATE LYASE; CELLULAR SENESCENCE; ONCOGENIC RAS; PREMATURE SENESCENCE; INSULIN-SECRETION; TUMOR SUPPRESSION; CELLS; RESTORATION; ACETYLATION	Cellular senescence both protects multicellular organisms from cancer and contributes to their ageing(1). The pre-eminent tumour suppressor p53 has an important role in the induction and maintenance of senescence, but how it carries out this function remains poorly understood(1-3). In addition, although increasing evidence supports the idea that metabolic changes underlie many cell-fate decisions and p53-mediated tumour suppression, few connections between metabolic enzymes and senescence have been established. Here we describe a new mechanism by which p53 links these functions. We show that p53 represses the expression of the tricarboxylic-acid-cycle-associated malic enzymes ME1 and ME2 in human and mouse cells. Both malic enzymes are important for NADPH production, lipogenesis and glutamine metabolism, but ME2 has a more profound effect. Through the inhibition of malic enzymes, p53 regulates cell metabolism and proliferation. Downregulation of ME1 and ME2 reciprocally activates p53 through distinct MDM2- and AMP-activated protein kinase-mediated mechanisms in a feed-forward manner, bolstering this pathway and enhancing p53 activation. Downregulation of ME1 and ME2 also modulates the outcome of p53 activation, leading to strong induction of senescence, but not apoptosis, whereas enforced expression of either malic enzyme suppresses senescence. Our findings define physiological functions of malic enzymes, demonstrate a positive-feedback mechanism that sustains p53 activation, and reveal a connection between metabolism and senescence mediated by p53.	[Jiang, Peng; Du, Wenjing; Mancuso, Anthony; Wellen, Kathryn E.; Yang, Xiaolu] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Jiang, Peng; Du, Wenjing; Mancuso, Anthony; Wellen, Kathryn E.; Yang, Xiaolu] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Yang, XL (corresponding author), Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA.	xyang@mail.med.upenn.edu	Jiang, Peng/A-1946-2013	Jiang, Peng/0000-0002-4218-0092	National Institutes of Health [CA088868]; US Department of Defense [W81XWH-10-1-0468]; NATIONAL CANCER INSTITUTE [P30CA016520, R01CA088868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. J. Birnbaum, B. Vogelstein, W. El-Deiry and M. Lazar for reagents; M. J. Bennett, S. Patel, A. Stonestrom and M. Brewer for technical assistance; and A. Stonestrom for help with manuscript preparation. This work was supported by grants from the National Institutes of Health (CA088868) and the US Department of Defense (W81XWH-10-1-0468) to X.Y.	Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cossarizza A, 2009, NAT PROTOC, V4, P1790, DOI 10.1038/nprot.2009.189; Ferbeyre G, 2000, GENE DEV, V14, P2015; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; NAGEL WO, 1980, J BIOL CHEM, V255, P3849; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WASILENKO WJ, 1985, CANCER LETT, V28, P35, DOI 10.1016/0304-3835(85)90089-8; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang J, 2007, J CLIN INVEST, V117, P2962, DOI 10.1172/JCI30710	33	315	330	10	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2013	493	7434					689	+		10.1038/nature11776	http://dx.doi.org/10.1038/nature11776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23334421	Green Accepted			2022-12-28	WOS:000314219600060
J	Sinha, K				Sinha, Kounteya			Mass economic migration: the greatest threat to HIV control in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Times India, New Delhi, India		Sinha, K (corresponding author), Times India, New Delhi, India.	ksinha78@gmail.com							0	2	2	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2013	346								f474	10.1136/bmj.f474	http://dx.doi.org/10.1136/bmj.f474			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BH	23360892				2022-12-28	WOS:000314510400015
J	Juhas, E; English, JC				Juhas, Elizabeth; English, Joseph C., III			Hypopigmented Patches on the Skin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MYCOSIS-FUNGOIDES		[Juhas, Elizabeth; English, Joseph C., III] Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	English, JC (corresponding author), Univ Pittsburgh, Dept Dermatol, 200 Lothrop St,Ste 3880,Presbyterian South Tower, Pittsburgh, PA 15213 USA.	englishjc@upmc.edu						Agar NS, 2010, J CLIN ONCOL, V28, P4730, DOI 10.1200/JCO.2009.27.7665; Ardigo M, 2003, J AM ACAD DERMATOL, V49, P264, DOI 10.1067/S0190-9622(03)00907-1; El Shabrawi-Caelen L, 2002, AM J SURG PATHOL, V26, P450; Galper SL, 2010, ONCOLOGY-NY, V24, P491; GOLDBERG DJ, 1986, AM J DERMATOPATH, V8, P326, DOI 10.1097/00000372-198608000-00009; LAMBROZA E, 1995, J AM ACAD DERMATOL, V32, P987, DOI 10.1016/0190-9622(95)91337-8; Santucci M, 2003, CANCER, V97, P610, DOI 10.1002/cncr.11107; Werner B, 2005, AM J DERMATOPATH, V27, P56, DOI 10.1097/01.dad.0000144161.49294.5a	8	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					392	393		10.1001/jama.2012.211717	http://dx.doi.org/10.1001/jama.2012.211717			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074FT	23340641				2022-12-28	WOS:000313799000027
J	McCarthy, D; Johnson, MB; Audet, AM				McCarthy, Douglas; Johnson, Marian Bihrle; Audet, Anne-Marie			Recasting Readmissions by Placing the Hospital Role in Community Context	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; BUSINESS; QUALITY		[McCarthy, Douglas; Johnson, Marian Bihrle] Inst Healthcare Improvement, Cambridge, MA 02138 USA; [Audet, Anne-Marie] Commonwealth Fund, New York, NY USA	Institute for Healthcare Improvement; Commonwealth Fund	McCarthy, D (corresponding author), Inst Healthcare Improvement, 20 Univ Rd,7th Floor, Cambridge, MA 02138 USA.	dmccarthy@ihi.org	McCarthy, Douglas/GSJ-0784-2022	McCarthy, Douglas/0000-0002-3295-3522				Asch DA, 2012, NEW ENGL J MED, V367, P888, DOI 10.1056/NEJMp1206862; Boutwell AE, 2011, HEALTH AFFAIR, V30, P1272, DOI 10.1377/hlthaff.2011.0111; Engelberg Center for Health Care Reform at Brookings, IMPR CAR TRANS CAS S; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Johnson MB, VISITING NURSE SERVI; Kangovi S, 2011, JAMA-J AM MED ASSOC, V306, P1796, DOI 10.1001/jama.2011.1562; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; McCarthy D, U CALIFORNIA SAN FRA; Rutherford P, GUIDE IMPROVING TRAN; Siu AL, 2009, HEALTH AFFAIR, V28, P113, DOI 10.1377/hlthaff.28.1.113	10	43	43	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					351	352		10.1001/jama.2013.1	http://dx.doi.org/10.1001/jama.2013.1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	074FT	23340635				2022-12-28	WOS:000313799000021
J	Appleby, J				Appleby, John			DATA BRIEFING How long can we expect to live?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						British Monarchy, 2013, QUEEN ANN MESS FACTS; Global Burden of Disease Study, 2012, GLOB BURD DIS STUD 2; Office for National Statistics, 2012, HIST PROJ NUMB SURV; Office for National Statistics, 2011, B1 2010 BAS PER EXP; Office for National Statistics, 2011, C1 2010 BAS PER EXP; Office for National Statistics, 2012, WHAT AR CHANC SURV A; Office for National Statistics, 2011, A1 2010 BAS PER EXP; United Nations, WORLD POP PROSP 2010; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; White Chris, 2010, Health Stat Q, P57, DOI 10.1057/hsq.2010.4	10	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2013	346								f331	10.1136/bmj.f331	http://dx.doi.org/10.1136/bmj.f331			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BG	23341569				2022-12-28	WOS:000314215600012
J	Stecker, EC				Stecker, Eric C.			The Oregon ACO Experiment - Bold Design, Challenging Execution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACCOUNTABLE CARE ORGANIZATIONS		Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA	Oregon Health & Science University	Stecker, EC (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA.							[Anonymous], 2012, OR HLTH AUTH MEM; Burns LR, 2012, HEALTH AFFAIR, V31, P2407, DOI 10.1377/hlthaff.2011.0675; Coughlin T. A., 2012, ACA IMPLEMENTATION M; Fisher ES, 2012, HEALTH AFFAIR, V31, P2368, DOI 10.1377/hlthaff.2012.0544	4	19	19	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2013	368	11					982	985		10.1056/NEJMp1214141	http://dx.doi.org/10.1056/NEJMp1214141			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104HF	23406006				2022-12-28	WOS:000315982100004
J	Smits, PC; Hofma, S; Togni, M; Vazquez, N; Valdes, M; Voudris, V; Slagboom, T; Goy, JJ; Vuillomenet, A; Serra, A; Nouche, RT; den Heijer, P; van der Ent, M				Smits, Pieter Cornelis; Hofma, Sjoerd; Togni, Mario; Vazquez, Nicolas; Valdes, Mariano; Voudris, Vassilis; Slagboom, Ton; Goy, Jean-Jaques; Vuillomenet, Andre; Serra, Antoni; Trillo Nouche, Ramiro; den Heijer, Peter; van der Ent, Martin			Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial	LANCET			English	Article							CORONARY-ARTERY-DISEASE; BARE-METAL STENTS; CLINICAL-PRACTICE; REAL-WORLD; FOLLOW-UP; THROMBOSIS; OUTCOMES; REVASCULARIZATION; LEADERS; COVERAGE	Background Drug-eluting stents with durable biocompatible or biodegradable polymers have been developed to address the risk of thrombosis associated with first-generation drug-eluting stents. We aimed to compare the safety and efficacy of a biodegradable polymer-coated biolimus-eluting stent with a thin-strut everolimus-eluting stent coated with a durable biocompatible polymer. Methods This open-label, prospective, randomised, controlled, non-inferiority trial was undertaken at 12 sites across Europe. We used limited exclusion criteria (age >18 years, life expectancy >5 years, reference vessel diameter 2.0-4.0 mm) to enrol patients eligible for percutaneous coronary intervention. Patients were randomly allocated (2: 1) by computer-generated random numbers to receive either a biodegradable polymer biolimus-eluting stent (Nobori, Terumo, Tokyo, Japan) or a durable fluoropolymer-based everolimus-eluting stent (Xience V or Prime, Abbott Vascular, Santa Clara, CA, USA, or Promus, Boston Scientific, Natick, MA, USA). The primary endpoint was a composite of safety (cardiac death and non-fatal myocardial infarction) and efficacy (clinically indicated target vessel revascularisation) at 12 months, analysed by intention to treat. Patients received dual antiplatelet therapy for 12 months after discharge. The trial is registered with ClinicalTrials.gov, number NCT01233453. Findings From Jan 12, 2009, to Feb 7, 2011, we enrolled 2707 patients (4025 lesions), 1795 of whom were assigned to receive the biolimus-eluting stent (2638 lesions) and 912 to an everolimus-eluting stent (1387 lesions). 2688 (99.3%) patients completed 12 months' follow-up. Significantly more patients in the biolimus-eluting stent group received a non-assigned stent than did those in the everolimus-eluting stent group (105 [5.9%] vs 19 [2.1%]; p<0.0001). The primary endpoint occurred in 93 (5.2%) patients in the biolimus-eluting stent group and 44 (4.8%) patients in the everolimus-eluting stent group at 12 months (relative risk 1.07 [95% CI 0.75-1.52]; p(non-inferiority)<0.0001). Analysis per protocol did not change the outcome of this trial (p(non-inferiority)<0.0001). Interpretation Biodegradable polymer biolimus-eluting stents are as safe and efficacious as the current standard of a thin-strut everolimus-eluting stent with a durable biocompatible polymer. We need to follow-up patients for longer to show whether the biolimus-eluting stent reduces the risk of stent thrombosis after 1 year when compared with the everolimus-eluting stent.	[Smits, Pieter Cornelis; van der Ent, Martin] Maasstad Ziekenhuis, Dept Cardiol, NL-3079 DZ Rotterdam, Netherlands; [Hofma, Sjoerd] Med Ctr Leeuwarden, Dept Cardiol, Leeuwarden, Netherlands; [Togni, Mario; Goy, Jean-Jaques] Hop Cantonal Fribourg, Dept Cardiol, Fribourg, Switzerland; [Vazquez, Nicolas] Hosp Juan Canalejo, Dept Cardiol, Coruna, Spain; [Valdes, Mariano] Hosp Virgen Arrixaca, Dept Cardiol, Murcia, Spain; [Voudris, Vassilis] Onassis Cardiac Surg Ctr, Dept Cardiol, Athens, Greece; [Slagboom, Ton] Onze Lieve Vrouw Hosp, Dept Cardiol, Amsterdam, Netherlands; [Vuillomenet, Andre] Kantonsspital Aarau, Dept Cardiol, Aarau, Switzerland; [Serra, Antoni] Hosp del Mar, Dept Cardiol, Barcelona, Spain; [Serra, Antoni] Hosp Santa Creu & Sant Pau, Dept Cardiol, Barcelona, Spain; [Trillo Nouche, Ramiro] Hosp Santiago de Compostela, Dept Cardiol, Santiago De Compostela, Spain; [den Heijer, Peter] Amphia Ziekenhuis, Dept Cardiol, Breda, Netherlands	Maasstad Hospital; Medical Center Leeuwarden; Complejo Hospitalario Universitario A Coruna; Hospital Clinico Universitario Virgen de la Arrixaca; Onassis Cardiac Surgery Center; Onze Lieve Vrouwe Gasthuis Hospital; Kantonsspital Aarau AG (KSA); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital of Santa Creu i Sant Pau; Complexo Hospitalario Universitario de Santiago de Compostela; Amphia Hospital	Smits, PC (corresponding author), Maasstad Ziekenhuis, Dept Cardiol, Maasstadweg 21, NL-3079 DZ Rotterdam, Netherlands.	smitsp@maasstadziekenhuis.nl			Terumo Europe (Leuven, Belgium); Research Foundation of the Cardiology Department, Maasstad Hospital (Rotterdam, Netherlands); Abbott Vascular	Terumo Europe (Leuven, Belgium); Research Foundation of the Cardiology Department, Maasstad Hospital (Rotterdam, Netherlands); Abbott Vascular(Abbott Laboratories)	Terumo Europe (Leuven, Belgium) and the Research Foundation of the Cardiology Department, Maasstad Hospital (Rotterdam, Netherlands).; PCS is a consultant for Blue Medical and has received lecture and travel fees from Abbott Vascular. All other authors declare that they have no conflicts of interest.	Barlis P, 2010, EUR HEART J, V31, P165, DOI 10.1093/eurheartj/ehp480; Byrne RA, 2009, EUR HEART J, V30, P2441, DOI 10.1093/eurheartj/ehp352; Chevalier B, 2009, CIRC-CARDIOVASC INTE, V2, P188, DOI 10.1161/CIRCINTERVENTIONS.108.823443; Christiansen EH, 2013, LANCET; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Galloe AM, 2008, JAMA-J AM MED ASSOC, V299, P409, DOI 10.1001/jama.299.4.409; Garg S, 2010, EUROINTERVENTION, V6, P233, DOI 10.4244/; Hamilos MI, 2008, J AM COLL CARDIOL, V51, P2123, DOI 10.1016/j.jacc.2007.12.059; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kadota K, 2012, CATHETER CARDIO INTE, V80, P789, DOI 10.1002/ccd.23280; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; Lemos PA, 2004, CIRCULATION, V109, P190, DOI 10.1161/01.CIR.0000109138.84579.FA; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mehilli J, 2008, EUR HEART J, V29, P1975, DOI 10.1093/eurheartj/ehn253; Meredith IT, 2012, J AM COLL CARDIOL, V59, P1362, DOI 10.1016/j.jacc.2011.12.016; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Ong ATL, 2005, J AM COLL CARDIOL, V45, P947, DOI 10.1016/j.jacc.2004.09.079; Ormiston JA, 2012, LANCET, V379, P1368, DOI 10.1016/S0140-6736(12)60440-1; Ostojic Miodrag, 2008, EuroIntervention, V3, P574, DOI 10.4244/EIJV3I5A103; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Pendyala LK, 2012, JACC-CARDIOVASC INTE, V5, P436, DOI 10.1016/j.jcin.2011.11.013; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Ruygrok Peter N, 2007, EuroIntervention, V3, P315, DOI 10.4244/EIJV3I3A58; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Smits PC, 2011, J AM COLL CARDIOL, V58, P11, DOI 10.1016/j.jacc.2011.02.023; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2011, J AM COLL CARDIOL, V58, P19, DOI 10.1016/j.jacc.2011.02.022; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Wenaweser P, 2008, J AM COLL CARDIOL, V52, P1134, DOI 10.1016/j.jacc.2008.07.006; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1	39	230	234	4	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2013	381	9867					651	660		10.1016/S0140-6736(12)61852-2	http://dx.doi.org/10.1016/S0140-6736(12)61852-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093JY	23374650				2022-12-28	WOS:000315189300035
J	Niehuis, O; Buellesbach, J; Gibson, JD; Pothmann, D; Hanner, C; Mutti, NS; Judson, AK; Gadau, J; Ruther, J; Schmitt, T				Niehuis, Oliver; Buellesbach, Jan; Gibson, Joshua D.; Pothmann, Daniela; Hanner, Christian; Mutti, Navdeep S.; Judson, Andrea K.; Gadau, Juergen; Ruther, Joachim; Schmitt, Thomas			Behavioural and genetic analyses of Nasonia shed light on the evolution of sex pheromones	NATURE			English	Article							WASP; BIOSYNTHESIS; GENOMES	Sex pheromones play a pivotal role in the communication of many sexually reproducing organisms(1). Accordingly, speciation is often accompanied by pheromone diversification enabling proper mate finding and recognition(2). Current theory implies that chemical signals are under stabilizing selection by the receivers who thereby maintain the integrity of the signals(3). How the tremendous diversity of sex pheromones seen today evolved is poorly understood(4,5). Here we unravel the genetics of a newly evolved pheromone phenotype in wasps and present results from behavioural experiments indicating how the evolution of a new pheromone component occurred in an established sender-receiver system. We show that male Nasonia vitripennis evolved an additional pheromone compound differing only in its stereochemistry from a pre-existing one. Comparative behavioural studies show that conspecific females responded neutrally to the new pheromone phenotype when it evolved. Genetic mapping and gene knockdown show that a cluster of three closely linked genes accounts for the ability to produce this new pheromone phenotype. Our data suggest that new pheromone compounds can persist in a sender's population, without being selected against by the receiver and without the receiver having a pre-existing preference for the new pheromone phenotype, by initially remaining unperceived. Out results thus contribute valuable new insights into the evolutionary mechanisms underlying the diversification of sex pheromones: Furthermore, they indicate that the genetic basis of new pheromone compounds can be simple, allowing them to persist long enough in a population for receivers to evolve chemosensory adaptations for their exploitation.	[Niehuis, Oliver] Zool Res Museum Alexander Koenig, Ctr Mol Biodivers Res, D-53113 Bonn, Germany; [Niehuis, Oliver; Buellesbach, Jan; Gibson, Joshua D.; Mutti, Navdeep S.; Judson, Andrea K.; Gadau, Juergen] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Buellesbach, Jan; Hanner, Christian; Schmitt, Thomas] Univ Freiburg, D-79104 Freiburg, Germany; [Buellesbach, Jan; Schmitt, Thomas] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Pothmann, Daniela; Ruther, Joachim] Univ Regensburg, Dept Zool, D-93053 Regensburg, Germany; [Mutti, Navdeep S.] DuPont Pioneer Agr Biotechnol, DuPont Expt Stn, Wilmington, DE 19880 USA; [Schmitt, Thomas] Tech Univ Darmstadt, Ecol Network Grp, D-64287 Darmstadt, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Arizona State University; Arizona State University-Tempe; University of Freiburg; University of Freiburg; University of Regensburg; DuPont; Technical University of Darmstadt	Niehuis, O (corresponding author), Zool Res Museum Alexander Koenig, Ctr Mol Biodivers Res, D-53113 Bonn, Germany.	o.niehuis.zfmk@uni-bonn.de	Schmitt, Thomas/H-3033-2013; Ruther, Joachim/AAE-3568-2019; Buellesbach, Jan/AAR-5635-2020	Buellesbach, Jan/0000-0001-8493-692X; Ruther, Joachim/0000-0002-1295-347X; Gibson, Joshua/0000-0002-0193-2307	Alexander von Humboldt foundation; Excellence Initiative of the German Research Foundation (Spemann Graduate School) [GSC-4]; German Research Foundation (DFG) [RU 717/10-1]	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Excellence Initiative of the German Research Foundation (Spemann Graduate School); German Research Foundation (DFG)(German Research Foundation (DFG))	We thank J. H. Werren for providing laboratory strains of Nasonia and Trichomalopsis and D. Wheeler for discussion on the gene expression data. G. Amdam and J. Liebig allowed us to use their research facilities for conducting the gene expression studies, knockdown experiments and gas chromatography analyses. We thank D. D. McKenna and R. S. Peters for comments on an earlier draft of this paper. O.N. acknowledges the Alexander von Humboldt foundation for a Feodor Lynen postdoctoral research stipend. J.B. and TS. were supported by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School). parts of this research were supported by the German Research Foundation (DFG) grant RU 717/10-1 to J.R.	Abdel-Latief M, 2008, P NATL ACAD SCI USA, V105, P8914, DOI 10.1073/pnas.0801559105; Albre J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002489; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Butlin RK, 1997, INSECT PHEROMONE RESEARCH, P548; Cho H, 2003, ARCH BIOCHEM BIOPHYS, V419, P139, DOI 10.1016/j.abb.2003.09.019; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Lienard MA, 2010, P NATL ACAD SCI USA, V107, P10955, DOI 10.1073/pnas.1000823107; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Niehuis O, 2011, HEREDITY, V107, P61, DOI 10.1038/hdy.2010.157; Niehuis O, 2008, GENETICS, V178, P413, DOI 10.1534/genetics.107.080523; Niehuis O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008597; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Ruther J, 2008, J CHEM ECOL, V34, P99, DOI 10.1007/s10886-007-9411-1; Ruther J, 2007, J EXP BIOL, V210, P2163, DOI 10.1242/jeb.02789; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Steiger S, 2011, P ROY SOC B-BIOL SCI, V278, P970, DOI 10.1098/rspb.2010.2285; Steiner S, 2009, J CHEM ECOL, V35, P416, DOI 10.1007/s10886-009-9624-6; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanner ME, 2002, ACCOUNTS CHEM RES, V35, P237, DOI 10.1021/ar000056y; WERREN JH, 2009, COLD SPRING HARB PRO, V2009, DOI DOI 10.1101/PDB.EMO134; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wyatt T. D., 2003, PHEROMONES ANIMAL BE, P37; Xue BY, 2007, P NATL ACAD SCI USA, V104, P4467, DOI 10.1073/pnas.0700422104	29	91	92	0	160	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					345	348		10.1038/nature11838	http://dx.doi.org/10.1038/nature11838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23407492				2022-12-28	WOS:000315312900036
J	Bresee, J; Hayden, FG				Bresee, Joseph; Hayden, Frederick G.			Epidemic Influenza - Responding to the Expected but Unpredictable	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VACCINE		[Bresee, Joseph] Ctr Dis Control & Prevent, Epidemiol & Prevent Branch, Influenza Div, Atlanta, GA 30333 USA; [Hayden, Frederick G.] Univ Virginia, Sch Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA	Centers for Disease Control & Prevention - USA; University of Virginia	Bresee, J (corresponding author), Ctr Dis Control & Prevent, Epidemiol & Prevent Branch, Influenza Div, Atlanta, GA 30333 USA.							[Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P32; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Muthuri SG, 2013, J INFECT DIS; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331	5	25	30	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					589	592		10.1056/NEJMp1300375	http://dx.doi.org/10.1056/NEJMp1300375			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194VA	23343038				2022-12-28	WOS:000322659600002
J	Visel, A; Taher, L; Girgis, H; May, D; Golonzhka, O; Hoch, RV; McKinsey, GL; Pattabiraman, K; Silberberg, SN; Blow, MJ; Hansen, DV; Nord, AS; Akiyama, JA; Holt, A; Hosseini, R; Phouanenavong, S; Plajzer-Frick, I; Shoukry, M; Afzal, V; Kaplan, T; Kriegstein, AR; Rubin, EM; Ovcharenko, I; Pennacchio, LA; Rubenstein, JLR				Visel, Axel; Taher, Leila; Girgis, Hani; May, Dalit; Golonzhka, Olga; Hoch, Renee V.; McKinsey, Gabriel L.; Pattabiraman, Kartik; Silberberg, Shanni N.; Blow, Matthew J.; Hansen, David V.; Nord, Alex S.; Akiyama, Jennifer A.; Holt, Amy; Hosseini, Roya; Phouanenavong, Sengthavy; Plajzer-Frick, Ingrid; Shoukry, Malak; Afzal, Veena; Kaplan, Tommy; Kriegstein, Arnold R.; Rubin, Edward M.; Ovcharenko, Ivan; Pennacchio, Len A.; Rubenstein, John L. R.			A High-Resolution Enhancer Atlas of the Developing Telencephalon	CELL			English	Article							RECOMBINASE ACTIVITY; EXPRESSION; DATABASE; AUTISM; ASSOCIATION; PHENOTYPE; REVEALS; LOCI	The mammalian telencephalon plays critical roles in cognition, motor function, and emotion. Though many of the genes required for its development have been identified, the distant-acting regulatory sequences orchestrating their in vivo expression are mostly unknown. Here, we describe a digital atlas of in vivo enhancers active in subregions of the developing telencephalon. We identified more than 4,600 candidate embryonic forebrain enhancers and studied the in vivo activity of 329 of these sequences in transgenic mouse embryos. We generated serial sets of histological brain sections for 145 reproducible forebrain enhancers, resulting in a publicly accessible web-based data collection comprising more than 32,000 sections. We also used epigenomic analysis of human and mouse cortex tissue to directly compare the genome-wide enhancer architecture in these species. These data provide a primary resource for investigating gene regulatory mechanisms of telencephalon development and enable studies of the role of distant-acting enhancers in neurodevelopmental disorders.	[Visel, Axel; May, Dalit; Nord, Alex S.; Akiyama, Jennifer A.; Holt, Amy; Hosseini, Roya; Phouanenavong, Sengthavy; Plajzer-Frick, Ingrid; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Visel, Axel; Blow, Matthew J.; Rubin, Edward M.; Pennacchio, Len A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Taher, Leila; Girgis, Hani; Ovcharenko, Ivan] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Golonzhka, Olga; Hoch, Renee V.; McKinsey, Gabriel L.; Pattabiraman, Kartik; Silberberg, Shanni N.; Rubenstein, John L. R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Hansen, David V.; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, San Francisco, CA 94143 USA; [Hansen, David V.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Kaplan, Tommy] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kaplan, Tommy] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Hebrew University of Jerusalem	Visel, A (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, MS 84-171, Berkeley, CA 94720 USA.	avisel@lbl.gov	Visel, Axel/A-9398-2009; Kaplan, Tommy/T-2528-2017; Blow, Matthew/G-6369-2012	Visel, Axel/0000-0002-4130-7784; Kaplan, Tommy/0000-0002-1892-5461; Blow, Matthew/0000-0002-8844-9149; Taher, Leila/0000-0002-2013-5426; Nord, Alexander/0000-0003-4259-7514; Hansen, David/0000-0001-9679-7189; Hoch, Renee/0000-0003-0042-3751; Pennacchio, Len/0000-0002-8748-3732	NINDS [R01NS062859A, R01NS34661, R01NS075998]; NHGRI [R01HG003988]; Nina Ireland; Weston Havens Foundation; NIMH [R01MH081880, R37MH049428]; CIRM [RB2-1602]; NARSAD; Intramural Research Program of the NIH; National Library of Medicine; Department of Energy [DE-AC02-05CH11231];  [T32 GM007449];  [T32 GMO7618];  [F32 MH081431]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007449, T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428, R01MH081880, F32MH081431, R01MH049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099099, R01NS034661, R01NS075998, R01NS062859] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200881] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Nina Ireland; Weston Havens Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); CIRM(California Institute for Regenerative Medicine); NARSAD(NARSAD); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Department of Energy(United States Department of Energy (DOE)); ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors thank Julian Golder and Noah Efron for help with digital image acquisition and data processing; Bing Ren and Zirong Li for help with chromatin immunoprecipitation from embryonic mouse tissue; Inna Dubchak, Simon Minovitsky, and Alexandre Poliakov for website support; and staff at San Francisco General Hospital Women's Options Center for their consideration in allowing us to access donated fetal tissue. A.V. and L.A.P. were supported by NINDS grant R01NS062859A and by NHGRI grant R01HG003988. J.L.R.R. was supported by the Nina Ireland, Weston Havens Foundation, NINDS grant R01NS34661, NIMH grant R01MH081880, and NIMH grant R37MH049428. J.L.R.R. and A.R.K were supported by CIRM RB2-1602. G.M. and S.N.S. were supported by T32 GM007449, K.P. was supported by T32 GMO7618, R.H. was supported by F32 MH081431, and O.G. was supported by NARSAD. A.R.K. was supported by NINDS grant R01NS075998. I.O. was supported by the Intramural Research Program of the NIH, National Library of Medicine. Research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cummings MP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-137; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Farah MH, 2000, DEVELOPMENT, V127, P693; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Kurokawa D, 2004, DEVELOPMENT, V131, P3307, DOI 10.1242/dev.01219; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Long JE, 2009, J COMP NEUROL, V512, P556, DOI 10.1002/cne.21854; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Poitras L, 2010, DEVELOPMENT, V137, P3089, DOI 10.1242/dev.051052; Portales-Casamar E, 2010, P NATL ACAD SCI USA, V107, P16589, DOI 10.1073/pnas.1009158107; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shim SB, 2012, NATURE, V486, P74, DOI 10.1038/nature11094; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052	55	166	166	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					895	908		10.1016/j.cell.2012.12.041	http://dx.doi.org/10.1016/j.cell.2012.12.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23375746	Green Accepted, Bronze			2022-12-28	WOS:000314945600022
J	Wirth, LJ; Ross, DS; Randolph, GW; Cunnane, ME; Sadow, PM				Wirth, Lori J.; Ross, Douglas S.; Randolph, Gregory W.; Cunnane, Mary Elizabeth; Sadow, Peter M.			Case 5-2013: A 52-Year-Old Woman with a Mass in the Thyroid	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARCINOEMBRYONIC ANTIGEN LEVELS; METASTATIC LYMPH-NODES; RET PROTOONCOGENE; SERUM CALCITONIN; FOLLOW-UP; COMPLETION THYROIDECTOMY; PROGNOSTIC-SIGNIFICANCE; PREOPERATIVE DIAGNOSIS; MEDULLARY CARCINOMA; RADIOACTIVE IODINE		[Wirth, Lori J.; Ross, Douglas S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sadow, Peter M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Randolph, Gregory W.] Massachusetts Eye & Ear Infirm, Dept Otol & Laryngol, Boston, MA 02114 USA; [Cunnane, Mary Elizabeth] Massachusetts Eye & Ear Infirm, Dept Radiol, Boston, MA 02114 USA; [Wirth, Lori J.; Ross, Douglas S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Randolph, Gregory W.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Cunnane, Mary Elizabeth] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sadow, Peter M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Wirth, LJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Sadow, Peter/E-7691-2015; Sadow, Peter/AAO-9878-2020	Sadow, Peter/0000-0003-1036-6367; Sadow, Peter/0000-0003-1036-6367	Bayer; Boehringer Ingelheim; Acceleron; Exelexis; Genzyme; Novo Nordisk	Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Acceleron; Exelexis; Genzyme(Sanofi-AventisGenzyme Corporation); Novo Nordisk(Novo Nordisk)	Dr. Wirth reports receiving consulting fees from Bayer, Boehringer Ingelheim, Acceleron, and Exelexis; Dr. Ross, receiving consulting fees from Genzyme and Novo Nordisk; and Dr. Randolph, providing expert testimony on behalf of patients or health care providers in medicolegal cases involving surgery. No other potential conflict of interest relevant to this article was reported.	Barbesino G, 2012, THYROID, V22, P369, DOI 10.1089/thy.2011.0198; Barbet J, 2005, J CLIN ENDOCR METAB, V90, P6077, DOI 10.1210/jc.2005-0044; Bardet S, 2008, EUR J ENDOCRINOL, V158, P551, DOI 10.1530/EJE-07-0603; BLAUGRUND JE, 1994, HUM MOL GENET, V3, P1895, DOI 10.1093/hmg/3.10.1895; Boelaert K, 2006, J CLIN ENDOCR METAB, V91, P4295, DOI 10.1210/jc.2006-0527; Borget I, 2007, J CLIN ENDOCR METAB, V92, P425, DOI 10.1210/jc.2006-2735; BUSNARDO B, 1984, CANCER, V53, P278, DOI 10.1002/1097-0142(19840115)53:2<278::AID-CNCR2820530216>3.0.CO;2-Z; Colombo C, 2012, J CLIN ENDOCR METAB, V97, P905, DOI 10.1210/jc.2011-2033; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Costante G, 2007, J CLIN ENDOCR METAB, V92, P450, DOI 10.1210/jc.2006-1590; Curtin HD, 1998, RADIOLOGY, V207, P123, DOI 10.1148/radiology.207.1.9530307; de Groot JWB, 2006, ENDOCR REV, V27, P535, DOI 10.1210/er.2006-0017; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; Dustin SM, 2012, DIAGN CYTOPATHOL, V40, P416, DOI 10.1002/dc.21802; Elisei R, 2004, J CLIN ENDOCR METAB, V89, P163, DOI 10.1210/jc.2003-030550; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P682, DOI 10.1210/jc.2007-1714; Faquin WC, 2009, HEAD NECK PATHOL, V3, P82, DOI 10.1007/s12105-009-0104-7; Gemsenjager E, 2003, J AM COLL SURGEONS, V197, P182, DOI 10.1016/S1072-7515(03)00421-6; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; Kim E, 2008, THYROID, V18, P411, DOI 10.1089/thy.2007.0269; Kloos RT, 2009, THYROID, V19, P565, DOI 10.1089/thy.2008.0403; Kurzrock R, 2011, J CLIN ONCOL, V29, P2660, DOI 10.1200/JCO.2010.32.4145; Lenders JWM, 2002, JAMA-J AM MED ASSOC, V287, P1427, DOI 10.1001/jama.287.11.1427; Machens A, 2005, J CLIN ENDOCR METAB, V90, P2029, DOI 10.1210/jc.2004-1836; Machens A, 2007, ARCH SURG-CHICAGO, V142, P289, DOI 10.1001/archsurg.142.3.289; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; MCCAFFREY TV, 1994, HEAD NECK-J SCI SPEC, V16, P165, DOI 10.1002/hed.2880160211; Meijer JAA, 2010, CLIN ENDOCRINOL, V72, P534, DOI 10.1111/j.1365-2265.2009.03666.x; MENDELSOHN G, 1984, CANCER, V54, P657, DOI 10.1002/1097-0142(1984)54:4<657::AID-CNCR2820540412>3.0.CO;2-V; Mirallie E, 1999, WORLD J SURG, V23, P970, DOI 10.1007/s002689900609; Miyauchi A, 2009, SURGERY, V146, P1056, DOI 10.1016/j.surg.2009.09.018; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; Nocera M, 2000, BRIT J CANCER, V83, P715, DOI 10.1054/bjoc.2000.1314; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Papaparaskeva K, 2000, DIAGN CYTOPATHOL, V22, P351; Pelizzo MR, 2007, EJSO-EUR J SURG ONC, V33, P493, DOI 10.1016/j.ejso.2006.10.021; Qubain SW, 2002, SURGERY, V131, P249, DOI 10.1067/msy.2002.120657; Randolph GW, 2012, THYROID, V22, P1144, DOI 10.1089/thy.2012.0043; Randolph GW, 2010, SURGERY, V148, P1108, DOI 10.1016/j.surg.2010.09.035; Randolph GW, 2006, SURGERY, V139, P357, DOI 10.1016/j.surg.2005.08.009; Randolph GW, 2002, THYROID, V12, P989, DOI 10.1089/105072502320908321; Rendl G, 2008, CLIN ENDOCRINOL, V69, P497, DOI 10.1111/j.1365-2265.2008.03229.x; ROUGIER P, 1983, CANCER, V51, P855, DOI 10.1002/1097-0142(19830301)51:5<855::AID-CNCR2820510519>3.0.CO;2-J; SAAD MF, 1984, J CLIN ENDOCR METAB, V58, P889, DOI 10.1210/jcem-58-5-889; Schoffski P, 2012, J CLIN ONCOL, V30; Shah SS, 2009, CYTOJOURNAL, V6, DOI 10.4103/1742-6413.45191; Vitagliano D, 2011, ENDOCR-RELAT CANCER, V18, P1, DOI 10.1677/ERC-09-0292; Wedge SR, 2002, CANCER RES, V62, P4645; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742; Yang GC, 2012, CYTOPATHOLOGY; Yen TWF, 2003, SURGERY, V134, P890, DOI 10.1016/S0039-6060(03)00408-2	52	7	7	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					664	673		10.1056/NEJMcpc1210080	http://dx.doi.org/10.1056/NEJMcpc1210080			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194VA	23406032				2022-12-28	WOS:000322659600012
J	Duttwyler, S; Chen, SM; Takase, MK; Wiberg, KB; Bergman, RG; Ellman, JA				Duttwyler, Simon; Chen, Shuming; Takase, Michael K.; Wiberg, Kenneth B.; Bergman, Robert G.; Ellman, Jonathan A.			Proton Donor Acidity Controls Selectivity in Nonaromatic Nitrogen Heterocycle Synthesis	SCIENCE			English	Article							C-H FUNCTIONALIZATION; ACTIVATION; CASCADE; BONDS	Piperidines are prevalent in natural products and pharmaceutical agents and are important synthetic targets for drug discovery and development. We report on a methodology that provides highly substituted piperidine derivatives with regiochemistry selectively tunable by varying the strength of acid used in the reaction. Readily available starting materials are first converted to dihydropyridines via a cascade reaction initiated by rhodium-catalyzed carbon-hydrogen bond activation. Subsequent divergent regio- and diastereoselective protonation of the dihydropyridines under either kinetic or thermodynamic control provides two distinct iminium ion intermediates that then undergo highly diastereoselective nucleophilic additions. X-ray structural characterization of both the kinetically and thermodynamically favored iminium ions along with density functional theory calculations provide a theoretical underpinning for the high selectivities achieved for the reaction sequences.	[Duttwyler, Simon; Chen, Shuming; Takase, Michael K.; Wiberg, Kenneth B.; Ellman, Jonathan A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Bergman, Robert G.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Bergman, Robert G.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Yale University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ellman, JA (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	jonathan.ellman@yale.edu	Ellman, Jonathan A/C-7732-2013		NIH [GM069559]; Office of Energy Research, Office of Basic Energy Sciences, Chemical Sciences Division, U.S. Department of Energy [DE-AC02-05CH11231]; National Science Foundation [PBZHP2-130-966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069559] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Energy Research, Office of Basic Energy Sciences, Chemical Sciences Division, U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM069559 (to J.A.E.). R. G. B. acknowledges funding from the Director, Office of Energy Research, Office of Basic Energy Sciences, Chemical Sciences Division, U.S. Department of Energy, under contract DE-AC02-05CH11231. S. D. is grateful to the Swiss National Science Foundation for a postdoctoral fellowship (PBZHP2-130-966). Metrical parameters for the structures of compounds 5a, 6a, 7e, 8a, and 8m are available free of charge from the Cambridge Crystallographic Data Centre under reference nos. CCDC 911314-911318.	Anderson P. S., 1964, TETRAHEDRON LETT, V5, P153; Bull JA, 2012, CHEM REV, V112, P2642, DOI 10.1021/cr200251d; Colby DA, 2008, J AM CHEM SOC, V130, P3645, DOI 10.1021/ja7104784; Crabtree RH, 2010, CHEM REV, V110, P575, DOI 10.1021/cr900388d; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Davies HML, 2011, CHEM SOC REV, V40, P1855, DOI 10.1039/c1cs90010b; Davies HML, 2009, CHEM SOC REV, V38, P2981, DOI 10.1039/b918568m; Doyle MP, 2012, ACCOUNTS CHEM RES, V45, P777, DOI 10.1021/ar300096z; Duttwyler S, 2012, J AM CHEM SOC, V134, P4064, DOI 10.1021/ja2119833; Evans D. A., 1984, ASYMMETRIC SYNTHESIS, V3, p[20, 65]; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Grondal C, 2010, NAT CHEM, V2, P167, DOI [10.1038/NCHEM.539, 10.1038/nchem.539]; Guimond N, 2011, J AM CHEM SOC, V133, P6449, DOI 10.1021/ja201143v; HOFFMANN RW, 1989, CHEM REV, V89, P1841, DOI 10.1021/cr00098a009; Liu HJ, 1999, TETRAHEDRON, V55, P3803, DOI 10.1016/S0040-4020(99)00114-3; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Lyle R. E., 1962, TETRAHEDRON LETT, V3, P553; Muller S, 2009, ANGEW CHEM INT EDIT, V48, P9975, DOI 10.1002/anie.200905035; Okamoto Y, 2008, CHEM SOC REV, V37, P2593, DOI 10.1039/b808881k; Ritchie TJ, 2009, DRUG DISCOV TODAY, V14, P1011, DOI 10.1016/j.drudis.2009.07.014; Thompson S, 2011, CHEM SOC REV, V40, P4217, DOI 10.1039/c1cs15022g; Tietze L. F., 2006, DOMINO REACTIONS ORG; Walters WP, 2011, J MED CHEM, V54, P6405, DOI 10.1021/jm200504p; Ward TJ, 2010, ANAL CHEM, V82, P4712, DOI 10.1021/ac1010926; Wasa M, 2010, J AM CHEM SOC, V132, P3680, DOI 10.1021/ja1010866; Yamaguchi J., 2012, ANGEW CHEM INT EDIT, V51, P8690	26	54	55	1	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					678	682		10.1126/science.1230704	http://dx.doi.org/10.1126/science.1230704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393259	Green Accepted			2022-12-28	WOS:000314585600037
J	Angrist, M				Angrist, Misha			Genetic privacy needs a more nuanced approach	NATURE			English	Editorial Material									Duke Univ, Inst Genome Sci & Policy, Durham, NC 27706 USA	Duke University	Angrist, M (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27706 USA.	misha.angrist@duke.edu						Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566	1	13	13	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2013	494	7435					7	7		10.1038/494007a	http://dx.doi.org/10.1038/494007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	087DJ	23389508	Bronze			2022-12-28	WOS:000314741200004
J	Cohen, AT; Spiro, TE; Buller, HR; Haskell, L; Hu, DY; Hull, R; Mebazaa, A; Merli, G; Schellong, S; Spyropoulos, AC; Tapson, V				Cohen, Alexander T.; Spiro, Theodore E.; Buller, Harry R.; Haskell, Lloyd; Hu, Dayi; Hull, Russell; Mebazaa, Alexandre; Merli, Geno; Schellong, Sebastian; Spyropoulos, Alex C.; Tapson, Victor		MAGELLAN Investigators	Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; RISK-FACTORS; PREVENTION; PROPHYLAXIS; ENOXAPARIN	Background The clinically appropriate duration of thromboprophylaxis in hospitalized patients with acute medical illnesses is unknown. In this multicenter, randomized, double-blind trial, we evaluated the efficacy and safety of oral rivaroxaban administered for an extended period, as compared with subcutaneous enoxaparin administered for a standard period, followed by placebo. Methods We randomly assigned patients 40 years of age or older who were hospitalized for an acute medical illness to receive subcutaneous enoxaparin, 40 mg once daily, for 10 +/- 4 days and oral placebo for 35 +/- 4 days or to receive subcutaneous placebo for 10 +/- 4 days and oral rivaroxaban, 10 mg once daily, for 35 +/- 4 days. The primary efficacy outcomes were the composite of asymptomatic proximal or symptomatic venous thromboembolism up to day 10 (noninferiority test) and up to day 35 (superiority test). The principal safety outcome was the composite of major or clinically relevant nonmajor bleeding. Results A total of 8101 patients underwent randomization. A primary efficacy outcome event occurred in 78 of 2938 patients (2.7%) receiving rivaroxaban and 82 of 2993 patients (2.7%) receiving enoxaparin at day 10 (relative risk with rivaroxaban, 0.97; 95% confidence interval [CI], 0.71 to 1.31; P = 0.003 for noninferiority) and in 131 of 2967 patients (4.4%) who received rivaroxaban and 175 of 3057 patients (5.7%) who received enoxaparin followed by placebo at day 35 (relative risk, 0.77; 95% CI, 0.62 to 0.96; P = 0.02). A principal safety outcome event occurred in 111 of 3997 patients (2.8%) in the rivaroxaban group and 49 of 4001 patients (1.2%) in the enoxaparin group at day 10 (P<0.001) and in 164 patients (4.1%) and 67 patients (1.7%) in the respective groups at day 35 (P<0.001). Conclusions In acutely ill medical patients, rivaroxaban was noninferior to enoxaparin for standard-duration thromboprophylaxis. Extended-duration rivaroxaban reduced the risk of venous thromboembolism. Rivaroxaban was associated with an increased risk of bleeding. (Funded by Bayer HealthCare Pharmaceuticals and Janssen Research and Development; MAGELLAN ClinicalTrials.gov number, NCT00571649.)	[Cohen, Alexander T.] Kings Coll Hosp, London SE5 9RS, England; [Spiro, Theodore E.] Bayer HealthCare Pharmaceut, Montville, NJ USA; [Haskell, Lloyd] Janssen Res & Dev, Raritan, NJ USA; [Buller, Harry R.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Hu, Dayi] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Hull, Russell] Foothills Prov Gen Hosp, Calgary, AB T2N 2T9, Canada; [Mebazaa, Alexandre] Hop Lariboisiere, F-75475 Paris, France; [Merli, Geno] Thomas Jefferson Med Ctr, Philadelphia, PA USA; [Schellong, Sebastian] Dresden Friedrichstadt Hosp, Dresden, Germany; [Spyropoulos, Alex C.] Hofstra N Shore Long Isl Jewish Sch Med, Manhasset, NY USA; [Tapson, Victor] Duke Univ, Med Ctr, Durham, NC USA	King's College Hospital NHS Foundation Trust; King's College Hospital; Bayer AG; Bayer Healthcare Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; University of Amsterdam; Academic Medical Center Amsterdam; Peking University; University of Calgary; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Jefferson University; Technische Universitat Dresden; Municipal Hospital Dresden; Hofstra University; Duke University	Cohen, AT (corresponding author), Kings Coll Hosp, Dept Vasc Surg, Denmark Hill, London SE5 9RS, England.	alexander.cohen@kcl.ac.uk	lambert, marc/V-7380-2017; Scharrer, Inge/N-2999-2013; Lember, Margus/H-2306-2015; Linhart, Ales/O-2375-2017; Buck, Brian H/B-8482-2009; Korzh, Oleksii/E-4291-2016; Beyer-Westendorf, Jan/K-7569-2019; Jahnz-Różyk, Karina/AAA-2560-2021; Colquhoun, David M/F-9078-2013; Quere, Isabelle/AAB-8519-2020; Lodigiani, Corrado/AAW-1964-2020; Violi, Francesco/K-1509-2016; Bettencourt, Paulo/A-4434-2018; Conrad, Steven/F-3257-2015; Bergmann, Jean-Francois/L-6044-2017	lambert, marc/0000-0002-3485-8238; Linhart, Ales/0000-0002-3372-7850; Buck, Brian H/0000-0002-7984-6062; Korzh, Oleksii/0000-0001-6838-4360; Beyer-Westendorf, Jan/0000-0002-6983-9993; Jahnz-Różyk, Karina/0000-0002-3505-1858; Quere, Isabelle/0000-0002-1492-9764; Lodigiani, Corrado/0000-0002-9152-9385; Violi, Francesco/0000-0002-6610-7068; Bettencourt, Paulo/0000-0003-1638-3993; Conrad, Steven/0000-0002-4014-969X; Dees, Adriaan/0000-0001-9164-4538; Uribe, Luis Guillermo/0000-0001-7026-9820; GALINIER, Michel/0000-0003-1735-3390; Giorgi-Pierfranceschi, Matteo/0000-0002-7988-9652; Schjesvold, Fredrik/0000-0003-1096-0569; Mebazaa, Alexandre/0000-0001-8715-7753; Laska, Ann Charlotte/0000-0002-7330-940X; Pothirat, Chaicharn/0000-0003-0616-7066; Bergmann, Jean-Francois/0000-0001-6861-9748	Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Johnson Johnson; Pfizer; Portola; Sanofi; LEO Pharma; Pronota; Alere; Edwards; Orion; Thermo Fisher; Sanofi-Aventis; Boehringer; Ingelheim; GlaxoSmithKline; Novartis; Sanofi Aventis; Covidien; Bayer HealthCare Pharmaceuticals; Janssen Research and Development	Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi Sankyo(Daiichi Sankyo Company Limited); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Pfizer(Pfizer); Portola; Sanofi; LEO Pharma(LEO Pharma); Pronota; Alere; Edwards; Orion; Thermo Fisher; Sanofi-Aventis(Sanofi-Aventis); Boehringer(Boehringer Ingelheim); Ingelheim; GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Sanofi Aventis(Sanofi-Aventis); Covidien; Bayer HealthCare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals); Janssen Research and Development	Dr. Cohen reports serving on advisory boards for Bayer, Bristol-Myers Squibb, Daiichi Sankyo, Johnson & Johnson, Pfizer, Portola, and Sanofi and receiving consulting fees, lecture fees, payment for manuscript preparation, and payment for the development of educational presentations from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Johnson & Johnson, Mitsubishi Pharma, Pfizer, Portola, Sanofi, Schering Plough, and Takeda; Dr. Spiro, being an employee of, holding stock options in, and receiving travel support from Bayer; Dr. Buller, serving on advisory boards for and receiving consulting fees and payment for manuscript preparation through his institution from Bayer and Daiichi Sankyo; Dr. Haskell, being an employee of and holding stock options in Johnson & Johnson; Dr. Hull, receiving consulting fees from LEO Pharma, Bayer, Portola, and Sanofi and lecture fees, grant support, and reimbursement for travel expenses from LEO Pharma and Sanofi; Dr. Mebazaa, serving on advisory boards for Cardiorentis and the Medicines Company, and receiving consulting fees from Pronota, lecture fees from Alere, Edwards, Orion, and Thermo Fisher, and royalties from Pronota; Dr. Merli, receiving consulting fees from Bristol-Myers Squibb and grant support through his institution from Bristol-Myers Squibb and Sanofi-Aventis, Dr. Schellong, serving on advisory boards for Bayer, Boehringer Ingelheim, and Novartis, and receiving consulting fees from Bayer, Boehringer Ingelheim, Daiichi Sankyo, GlaxoSmithKline, Novartis, and Sanofi Aventis, lecture fees from Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, GlaxoSmithKline, LEO Pharma, and Sanofi Aventis and payment for the development of educational presentations from Daiichi Sankyo and Bayer; Dr. Spyropoulos, receiving consulting fees from Astellas, Boehringer Ingelheim, Bristol-Myers Squibb, and Johnson & Johnson; and Dr. Tapson, receiving consulting fees from Bayer, Bristol-Myers Squibb, Covidien, and Sanofi, lecture fees from Covidien and Sanofi, payment for the development of educational presentations from Sanofi, and grant support through his institution from Bayer and Sanofi. No other potential conflict of interest was reported.; Funded by Bayer HealthCare Pharmaceuticals and Janssen Research and Development; MAGELLAN ClinicalTrials. gov number, NCT00571649.)	Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; Cohen AT, 2011, J THROMB THROMBOLYS, V31, P407, DOI 10.1007/s11239-011-0549-x; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; Cohen AT, 2005, THROMB HAEMOSTASIS, V94, P750, DOI 10.1160/TH05-06-0385; Decousus H, 2011, CHEST, V139, P69, DOI 10.1378/chest.09-3081; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Fraisse F, 2000, AM J RESP CRIT CARE, V161, P1109, DOI 10.1164/ajrccm.161.4.9807025; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Goldhaber SZ, 2011, NEW ENGL J MED, V365, P2167, DOI 10.1056/NEJMoa1110899; Hochberg Y, 1998, ENCY STAT SCI UPDATE, V2, P418; Hull RD, 2010, ANN INTERN MED, V153, P8, DOI 10.7326/0003-4819-153-1-201007060-00004; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Spencer FA, 2007, ARCH INTERN MED, V167, P1471, DOI 10.1001/archinte.167.14.1471	15	417	431	2	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					513	523		10.1056/NEJMoa1111096	http://dx.doi.org/10.1056/NEJMoa1111096			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083VU	23388003	Green Published			2022-12-28	WOS:000314494100002
J	Galitski, V; Spielman, IB				Galitski, Victor; Spielman, Ian B.			Spin-orbit coupling in quantum gases	NATURE			English	Review							GAUGE POTENTIALS; MAGNETIC-FIELDS; SUPERFLUID; INSULATOR; ATOMS	Spin-orbit coupling links a particle's velocity to its quantum-mechanical spin, and is essential in numerous condensed matter phenomena, including topological insulators and Majorana fermions. In solid-state materials, spin-orbit coupling originates from the movement of electrons in a crystal's intrinsic electric field, which is uniquely prescribed in any given material. In contrast, for ultracold atomic systems, the engineered 'material parameters' are tunable: a variety of synthetic spin-orbit couplings can be engineered on demand using laser fields. Here we outline the current experimental and theoretical status of spin-orbit coupling in ultracold atomic systems, discussing unique features that enable physics impossible in any other known setting.	[Galitski, Victor; Spielman, Ian B.] NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Galitski, Victor; Spielman, Ian B.] Univ Maryland, Gaithersburg, MD 20899 USA; [Galitski, Victor] Univ Maryland, Condensed Matter Theory Ctr, College Pk, MD 20742 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Spielman, IB (corresponding author), NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA.	ian.spielman@nist.gov			NSF through the Physics Frontier Center at JQI; ARO; Atomtronics MURI; DARPA's OLE Program	NSF through the Physics Frontier Center at JQI; ARO; Atomtronics MURI; DARPA's OLE Program	We acknowledge the financial support of the NSF through the Physics Frontier Center at JQI; the ARO with funds from the Atomtronics MURI, DARPA's OLE Program (I.B.S.), and directly (V.G.).	Aidelsburger M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.255301; Alicea J, 2011, NAT PHYS, V7, P412, DOI 10.1038/NPHYS1915; Anderson BM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.235301; Ashhab S, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.063612; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Bermudez A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.190404; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Cai Z, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.061605; Campbell DL, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.025602; Chaplik AV, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.126402; Cheuk LW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.095302; Cole WS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.085302; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Fu ZK, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.043609; GELLMANN M, 1962, PHYS REV, V125, P1067, DOI 10.1103/PhysRev.125.1067; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Gong M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.195303; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Higbie J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.090401; Ho TL, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.150403; Jaksch D, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/356; Jiang LA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.220402; Juzeliunas G, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.053403; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; KETTERLE W, 2008, P INT SCH PHYS ENR F, P95; Kitaev A, 2009, AIP CONF PROC, V1134, P22, DOI 10.1063/1.3149495; Kitaev AY., 2001, PHYS-USP+, V44, P131, DOI [10.1070/1063-7869/44/10S/S29, DOI 10.1070/1063-7869/44/10S/S29]; Levin M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.196803; Levinsen J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.210402; Lin YJ, 2011, NATURE, V471, P83, DOI 10.1038/nature09887; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Lindner NH, 2011, NAT PHYS, V7, P490, DOI 10.1038/NPHYS1926; Liu XJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.046402; Massignan P, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.031607; Meier L, 2007, NAT PHYS, V3, P650, DOI 10.1038/nphys675; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Osterloh K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010403; Radic J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.085303; Regal CA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.053201; Ruseckas J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010404; Sau JD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.040502; Schnyder AP, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195125; Sedrakyan TA, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.063639; Seo K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.105303; Shapere A., 1989, GEOMETRIC PHASES PHY; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Stanescu TD, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.023616; Struck J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.225304; Veillette MY, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.250401; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wang CJ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.160403; Wang PJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.095301; Williams RA, 2012, SCIENCE, V335, P314, DOI 10.1126/science.1212652; Wu CJ, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/9/097102; Yu ZQ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.195305; Zhang CW, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.160401; Zhang JY, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.115301; Zhu SL, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.240401; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	69	660	669	11	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					49	54		10.1038/nature11841	http://dx.doi.org/10.1038/nature11841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389539	Green Submitted			2022-12-28	WOS:000314741200031
J	Thibault, P; Menzel, A				Thibault, Pierre; Menzel, Andreas			Reconstructing state mixtures from diffraction measurements	NATURE			English	Article							PHASE RETRIEVAL; RAY; MICROSCOPY; COHERENCE	Progress in imaging and metrology depends on exquisite control over and comprehensive characterization of wave fields. As reflected in its name, coherent diffractive imaging relies on high coherence when reconstructing highly resolved images from diffraction intensities alone without the need for image-forming lenses(1-3). Fully coherent light can be described adequately by a single pure state. Yet partial coherence and imperfect detection often need to be accounted for, requiring statistical optics or the superposition of states(4,5). Furthermore, the dynamics of samples are increasingly the very objectives of experiments(6). Here we provide a general analytic approach to the characterization of diffractive imaging systems that can be described as low-rank mixed states. We use experimental data and simulations to show how the reconstruction technique compensates for and characterizes various sources of decoherence quantitatively. Based on ptychography(7,8), the procedure is closely related to quantum state tomography and is equally applicable to high-resolution microscopy, wave sensing and fluctuation measurements. As a result, some of the most stringent experimental conditions in ptychography can be relaxed, and susceptibility to imaging artefacts is reduced. Furthermore, the method yields high-resolution images of mixed states within the sample, which may include quantum mixtures or fast stationary stochastic processes such as vibrations, switching or steady flows.	[Thibault, Pierre] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany; [Menzel, Andreas] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Technical University of Munich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Thibault, P (corresponding author), Tech Univ Munich, Dept Phys, D-85748 Garching, Germany.	pierre.thibault@tum.de	Thibault, Pierre/B-2656-2010; Menzel, Andreas/C-4388-2012	Thibault, Pierre/0000-0003-1278-8846; Menzel, Andreas/0000-0002-0489-609X	European Research Council [279753]	European Research Council(European Research Council (ERC)European Commission)	We thank M. Dierolf for discussions and help in the algorithm implementation; A. Diaz for help during the measurements; C. Kewish for providing the sample, which had been produced by J. Vila Comamala; V. Elser for pointing us to relevant literature; and F. Pfeiffer, M. Bech and I. Zanette for helping to improve the manuscript. This work is supported in part by a European Research Council Starting Grant, under project OptImaX (no.279753).	Abbey B, 2008, NAT PHYS, V4, P394, DOI 10.1038/nphys896; Abbey B, 2011, NAT PHOTONICS, V5, P420, DOI [10.1038/nphoton.2011.125, 10.1038/NPHOTON.2011.125]; Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5; Cerbino R, 2008, NAT PHYS, V4, P238, DOI 10.1038/nphys837; Chapman HN., 1997, SCANNING MICROSCOPY, V11, P67; Clark JN, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3650265; Clark JN, 2011, OPT LETT, V36, P1954, DOI 10.1364/OL.36.001954; COWLEY JM, 1969, APPL PHYS LETT, V15, P58, DOI 10.1063/1.1652901; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Eisebitt S, 2004, NATURE, V432, P885, DOI 10.1038/nature03139; Elser V, 2003, J OPT SOC AM A, V20, P40, DOI 10.1364/JOSAA.20.000040; FIENUP JR, 1982, APPL OPTICS, V21, P2758, DOI 10.1364/AO.21.002758; Goodman J. W., 2000, STAT OPTICS; Gorelick S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/29/295303; Gross D, 2011, IEEE T INFORM THEORY, V57, P1548, DOI 10.1109/TIT.2011.2104999; Guizar-Sicairos M, 2008, OPT EXPRESS, V16, P7264, DOI 10.1364/OE.16.007264; Henrich B, 2009, NUCL INSTRUM METH A, V607, P247, DOI 10.1016/j.nima.2009.03.200; Maiden AM, 2010, OPT LETT, V35, P2585, DOI 10.1364/OL.35.002585; Maiden AM, 2009, ULTRAMICROSCOPY, V109, P1256, DOI 10.1016/j.ultramic.2009.05.012; MANDEL L, 1965, REV MOD PHYS, V37, P231, DOI 10.1103/RevModPhys.37.231; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Pfeiffer F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.164801; Putkunz CT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.073901; Raymer MG, 1997, CONTEMP PHYS, V38, P343, DOI 10.1080/001075197182315; RODENBURG JM, 1992, PHILOS T R SOC A, V339, P521, DOI 10.1098/rsta.1992.0050; Sutton M, 2008, CR PHYS, V9, P657, DOI 10.1016/j.crhy.2007.04.008; Thibault P, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063004; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Treacy MMJ, 2005, REP PROG PHYS, V68, P2899, DOI 10.1088/0034-4885/68/12/R06; von Neumann J., 1927, G TT NACH, V1, P245; Whitehead LW, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.243902; WOLF E, 1982, J OPT SOC AM, V72, P343, DOI 10.1364/JOSA.72.000343	32	352	362	14	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					68	71		10.1038/nature11806	http://dx.doi.org/10.1038/nature11806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389541				2022-12-28	WOS:000314741200035
J	Ford, TJ; Cranney, G; Li, A				Ford, Thomas Joseph; Cranney, Greg; Li, Annette			An ECG that changed in a febrile patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTIVE ENDOCARDITIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; DIAGNOSIS; GUIDELINES; ABSCESSES; PREVENTION; MANAGEMENT; SURGERY		[Ford, Thomas Joseph; Cranney, Greg] Prince Wales Hosp, Dept Cardiol, Sydney, NSW 2031, Australia; [Li, Annette] Univ New S Wales, Kensington, NSW 2052, Australia	University of New South Wales Sydney	Ford, TJ (corresponding author), Prince Wales Hosp, Dept Cardiol, Sydney, NSW 2031, Australia.	thomasjford@gmail.com	Ford, Tom/J-2419-2018	Ford, Tom/0000-0003-4009-6652				American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; ARNETT EN, 1976, CIRCULATION, V54, P140, DOI 10.1161/01.CIR.54.1.140; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; BLUMBERG EA, 1995, CHEST, V107, P898, DOI 10.1378/chest.107.4.898; Choussat R, 1999, EUR HEART J, V20, P232, DOI 10.1053/euhj.1998.1240; DANIEL WG, 1991, NEW ENGL J MED, V324, P795, DOI 10.1056/NEJM199103213241203; Feuchtner GM, 2009, J AM COLL CARDIOL, V53, P436, DOI 10.1016/j.jacc.2008.01.077; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; Gray H., 1918, ANATOMY HUMAN BODY, V20th; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hill EE, 2007, AM HEART J, V154, P923, DOI 10.1016/j.ahj.2007.06.028; Hoey ETD, 2011, AM J ROENTGENOL, V197, P103, DOI 10.2214/AJR.10.5666; Horstkotte D, 2004, EUR HEART J, V25, P267, DOI 10.1016/j.ehj.2003.11.008; Kang DH, 2012, NEW ENGL J MED, V366, P2466, DOI 10.1056/NEJMoa1112843; Lammers J, 2005, Heart, V91, P1474, DOI 10.1136/hrt.2004.059253; Lerakis S, 1998, AM J MED SCI, V316, P209, DOI 10.1016/S0002-9629(15)40404-5; Lerakis S, 2001, AM J MED SCI, V321, P152; MCCARTNEY AC, 1988, J CLIN PATHOL, V41, P44, DOI 10.1136/jcp.41.1.44; OMARI B, 1989, CHEST, V96, P1273, DOI 10.1378/chest.96.6.1273; Tleyjeh IM, 2008, AM HEART J, V156, P901, DOI 10.1016/j.ahj.2008.06.031; Wallace SM, 2002, HEART, V88, P53, DOI 10.1136/heart.88.1.53	21	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2013	346								f585	10.1136/bmj.f585	http://dx.doi.org/10.1136/bmj.f585			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088AT	23390225				2022-12-28	WOS:000314806900012
J	Boyce, N				Boyce, Niall			Chris Adrian: "kind of like Sesame Street"	LANCET			English	Biographical-Item												niall.boyce@lancet.com						ADRIAN C, PUBLICATION LIST	1	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2013	381	9864					365	365		10.1016/S0140-6736(13)60156-7	http://dx.doi.org/10.1016/S0140-6736(13)60156-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084ZA	23374465				2022-12-28	WOS:000314578900016
J	Jonathan, GE; Stoltenberg, J				Jonathan, Goodluck Ebele; Stoltenberg, Jens			A tipping point for change: saving millions of additional lives in 2013 and beyond	LANCET			English	Editorial Material									[Jonathan, Goodluck Ebele] Govt Fed Republ Nigeria, Off President, Abuja, Nigeria; [Stoltenberg, Jens] Norwegian Govt, Off Prime Minister, NO-0030 Oslo, Norway		Stoltenberg, J (corresponding author), Norwegian Govt, Off Prime Minister, NO-0030 Oslo, Norway.	tore.godal@mfa.no						[Anonymous], LEV TRENDS CHILD MOR; [Anonymous], 2005, REP SECR GEN LARG FR; Ki-moon B, 2010, GLOBAL STRATEGY WOME; Moon B., 2013, GLOBAL CAMPAIGN HLTH; Partnership for Maternal Newborn and Child Health, 2012, PARTNERSHIP MATERNAL; UNICEF, 2012, COUNTD 2015 MAT NEWB; United Nation, 2012, MILL DEV GOALS REP; United Nations Commission on Life-Saving Commodities for Women and Children, IMPL PLAN SEPT 2012; United Nations Commission on Life-Saving Commodities for Women and Children, COMM REP SEPT 2012	9	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2013	381	9864					350	352		10.1016/S0140-6736(13)60111-7	http://dx.doi.org/10.1016/S0140-6736(13)60111-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084ZA	23352750				2022-12-28	WOS:000314578900008
J	Ruston, S				Ruston, Sharon			The art of medicine When respiring gas inspired poetry	LANCET			English	Editorial Material									Univ Salford, Sch Humanities Languages & Social Sci, Salford M5 4WT, Lancs, England	University of Salford	Ruston, S (corresponding author), Univ Salford, Sch Humanities Languages & Social Sci, Salford M5 4WT, Lancs, England.	s.ruston@salford.ac.uk						Beddoes T, 1799, NOTICE OF SOME OBSER; DAVY H, 1800, RESEARCHES CHEMICAL; HOLMES RICHARD, 2008, THE AGE OF WONDER HO; Jay Mike, 2009, THE ATMOSPHERE OF HE; Knight D, 1992, HUMPHRY DAVY SCIENCE; Snow SJ, 2006, SCI TECHNOL MED MOD, P1, DOI 10.1057/9780230209497	6	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2013	381	9864					366	367		10.1016/S0140-6736(13)60157-9	http://dx.doi.org/10.1016/S0140-6736(13)60157-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	084ZA	23383414	Green Accepted			2022-12-28	WOS:000314578900017
J	Czabotar, PE; Westphal, D; Dewson, G; Ma, S; Hockings, C; Fairlie, WD; Lee, EF; Yao, SG; Robin, AY; Smith, BJ; Huang, DCS; Kluck, RM; Adams, JM; Colman, PM				Czabotar, Peter E.; Westphal, Dana; Dewson, Grant; Ma, Stephen; Hockings, Colin; Fairlie, W. Douglas; Lee, Erinna F.; Yao, Shenggen; Robin, Adeline Y.; Smith, Brian J.; Huang, David C. S.; Kluck, Ruth M.; Adams, Jerry M.; Colman, Peter M.			Bax Crystal Structures Reveal How BH3 Domains Activate Bax and Nucleate Its Oligomerization to Induce Apoptosis	CELL			English	Article							BCL-2 PROTEIN FAMILY; MEMBRANE PERMEABILIZATION; PROAPOPTOTIC BAX; PORE FORMATION; X-RAY; MITOCHONDRIA; DIMERIZATION; INTERFACE; BCL-X(L); CYTOSOL	In stressed cells, apoptosis ensues when Bcl-2 family members Bax or Bak oligomerize and permeabilize the mitochondrial outer membrane. Certain BH3-only relatives can directly activate them to mediate this pivotal, poorly understood step. To clarify the conformational changes that induce Bax oligomerization, we determined crystal structures of Bax Delta C21 treated with detergents and BH3 peptides. The peptides bound the Bax canonical surface groove but, unlike their complexes with prosurvival relatives, dissociated Bax into two domains. The structures define the sequence signature of activator BH3 domains and reveal how they can activate Bax via its groove by favoring release of its BH3 domain. Furthermore, Bax helices alpha 2-alpha 5 alone adopted a symmetric homodimer structure, supporting the proposal that two Bax molecules insert their BH3 domain into each other's surface groove to nucleate oligomerization. A planar lipophilic surface on this homodimer may engage the membrane. Our results thus define critical Bax transitions toward apoptosis.	[Czabotar, Peter E.; Westphal, Dana; Dewson, Grant; Ma, Stephen; Hockings, Colin; Fairlie, W. Douglas; Lee, Erinna F.; Yao, Shenggen; Robin, Adeline Y.; Huang, David C. S.; Kluck, Ruth M.; Adams, Jerry M.; Colman, Peter M.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Czabotar, Peter E.; Westphal, Dana; Dewson, Grant; Ma, Stephen; Hockings, Colin; Fairlie, W. Douglas; Lee, Erinna F.; Yao, Shenggen; Robin, Adeline Y.; Huang, David C. S.; Kluck, Ruth M.; Adams, Jerry M.; Colman, Peter M.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3052, Australia; [Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia	Walter & Eliza Hall Institute; University of Melbourne; La Trobe University	Czabotar, PE (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia.	czabotar@wehi.edu.au; pcolman@wehi.edu.au	Lee, Erinna/N-1523-2015; dewson, grant/C-7646-2013; Smith, Brian J/F-8282-2011; Yao, Shenggen/ABH-9989-2020; Yao, Shenggen/AAE-1602-2019; Adams, Jerry M/E-1199-2013; Fairlie, Walter/M-8401-2015; Huang, David C. S./C-7586-2013; Kluck, Ruth M/C-8413-2013	Lee, Erinna/0000-0003-1255-9808; dewson, grant/0000-0003-4251-8898; Smith, Brian J/0000-0003-0498-1910; Yao, Shenggen/0000-0002-7137-9615; Fairlie, Walter/0000-0002-2498-1160; Huang, David C. S./0000-0002-3101-4873; Kluck, Ruth M/0000-0002-7101-1925; Czabotar, Peter/0000-0002-2594-496X; Hockings, Colin/0000-0002-0248-0517; Adams, Jerry/0000-0002-4360-8628; Robin, Adeline/0000-0002-1199-2135	ARC; DFG (Germany); NHMRC (Australia); ARC (Australia); Australian Cancer Research Foundation; Cancer Council of Victoria; Leukemia and Lymphoma Society (US); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS	ARC(Australian Research Council); DFG (Germany)(German Research Foundation (DFG)); NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); ARC (Australia)(Australian Research Council); Australian Cancer Research Foundation; Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia and Lymphoma Society (US)(Leukemia and Lymphoma Society); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia)	We thank Ahmed Wardak, Geoff Thompson, Hong Yang, Eden Whitlock, and Leonie Gibson for technical support; Jacqui Gulbis for comments on the manuscript; and beamline staff at the Australian Synchrotron, where diffraction data were collected. We thank Richard Youle for the full-length Bax construct, Motoshi Suzuki and Nico Tjandra for NMR chemical shift data, and Masato Kawasaki for the pET28a-GFP vector. Crystallization experiments were performed at the Bio21 C3 Collaborative Crystallization Centre. P.E.C. acknowledges an ARC Future Fellowship, and D.W. acknowledges a DFG (Germany) Postdoctoral Fellowship. Our work is supported by NHMRC (Australia), ARC (Australia), the Australian Cancer Research Foundation, the Cancer Council of Victoria, the Leukemia and Lymphoma Society (US), the Victorian State Government Operational Infrastructure Support, and the Australian Government NHMRC IRIISS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Bennett MJ, 2004, STRUCTURE, V12, P1339, DOI 10.1016/j.str.2004.07.004; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Bogner C, 2010, CURR OPIN CELL BIOL, V22, P845, DOI 10.1016/j.ceb.2010.08.002; Cartron PF, 2002, HUM MOL GENET, V11, P675, DOI 10.1093/hmg/11.6.675; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Czabotar PE, 2011, J BIOL CHEM, V286, P7123, DOI 10.1074/jbc.M110.161281; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epand RF, 2003, BIOCHEMISTRY-US, V42, P14576, DOI 10.1021/bi035348w; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Fu NY, 2009, MOL CELL, V33, P15, DOI 10.1016/j.molcel.2008.11.025; Fuhrmans M, 2012, J AM CHEM SOC, V134, P1543, DOI 10.1021/ja207290b; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai A, 2009, J CELL BIOL, V185, P189, DOI 10.1083/jcb.200903134; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oh KJ, 2010, J BIOL CHEM, V285, P28924, DOI 10.1074/jbc.M110.135293; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang YP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00257; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Suzuki N, 2010, ACTA CRYSTALLOGR D, V66, P1059, DOI 10.1107/S0907444910032944; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456	62	399	412	3	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					519	531		10.1016/j.cell.2012.12.031	http://dx.doi.org/10.1016/j.cell.2012.12.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374347	Bronze			2022-12-28	WOS:000314362800021
J	Gwynne, P				Gwynne, Peter			DIAGNOSTICS The new risk predictors	NATURE			English	Editorial Material							ARTERY CALCIUM SCORES; SCREEN											Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Ebell MH, 2012, AM FAM PHYSICIAN, V86, P405; Murrow JR, 2012, AM FAM PHYSICIAN, V86, P398; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Qi L., 2012, THROMB VASC BIOL, V32, P2314; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	7	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S7	S8		10.1038/493S7a	http://dx.doi.org/10.1038/493S7a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364771				2022-12-28	WOS:000314219600007
J	Wang, J; Wurm, Y; Nipitwattanaphon, M; Riba-Grognuz, O; Huang, YC; Shoemaker, D; Keller, L				Wang, John; Wurm, Yannick; Nipitwattanaphon, Mingkwan; Riba-Grognuz, Oksana; Huang, Yu-Ching; Shoemaker, DeWayne; Keller, Laurent			A Y-like social chromosome causes alternative colony organization in fire ants	NATURE			English	Article							GENE; GP-9; FITNESS; GENOME; LIFE; RED	Intraspecific variability in social organization is common, yet the underlying causes are rarely known(1-3). In the fire ant Solenopsis invicta, the existence of two divergent forms of social organization is under the control of a single Mendelian genomic element marked by two variants of an odorant-binding protein gene(4-8). Here we characterize the genomic region responsible for this important social polymorphism, and show that it is part of a pair of heteromorphic chromosomes that have many of the key properties of sex chromosomes. The two variants, hereafter referred to as the social B and social b (SB and Sb) chromosomes, are characterized by a large region of approximately 13 megabases (55% of the chromosome) in which recombination is completely suppressed between SB and Sb. Recombination seems to occur normally between the SB chromosomes but not between Sb chromosomes because Sb/Sb individuals are non-viable. Genomic comparisons revealed limited differentiation between SB and Sb, and the vast majority of the 616 genes identified in the non-recombining region are present in the two variants. The lack of recombination over more than half of the two heteromorphic social chromosomes can be explained by at least one large inversion of around 9 megabases, and this absence of recombination has led to the accumulation of deleterious mutations, including repetitive elements in the non-recombining region of Sb compared with the homologous region of SB. Importantly, most of the genes with demonstrated expression differences between individuals of the two social forms reside in the non-recombining region. These findings highlight how genomic rearrangements can maintain divergent adaptive social phenotypes involving many genes acting together by locally limiting recombination.	[Wang, John; Wurm, Yannick; Nipitwattanaphon, Mingkwan; Riba-Grognuz, Oksana; Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Wang, John; Huang, Yu-Ching] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Wurm, Yannick] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Wurm, Yannick; Riba-Grognuz, Oksana] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Shoemaker, DeWayne] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA	University of Lausanne; Academia Sinica - Taiwan; University of London; Queen Mary University London; Swiss Institute of Bioinformatics; United States Department of Agriculture (USDA)	Wang, J (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	johnwang@gate.sinica.edu.tw; y.wurm@qmul.ac.uk; laurent.keller@unil.ch	keller, laurent/AAI-7175-2020; Wurm, Yannick/A-9525-2009	Wurm, Yannick/0000-0002-3140-2809; keller, laurent/0000-0002-5046-9953; Riba Grognuz, Oksana/0000-0002-2961-2655; Shoemaker, DeWayne/0000-0003-3659-8393	Biodiversity Research Center (Academia Sinica, Taiwan), Taiwan NSC [100-2311-B-001-015-MY3]; NERC; BBSRC [BB/K004204/1]; USDA; Swiss NSF; ERC; Biotechnology and Biological Sciences Research Council [BB/K004204/1] Funding Source: researchfish	Biodiversity Research Center (Academia Sinica, Taiwan), Taiwan NSC; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); USDA(United States Department of Agriculture (USDA)); Swiss NSF(Swiss National Science Foundation (SNSF)); ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank C. Stoffel, C. La Mendola, N.-C. Chang, C.-Y. Kaoand C.-C. Lee for helping with genotyping and molecular biology; the DEE-UNIL animal caretakers for ant husbandry; E. Johnson and P. Etter for RADseq advice; R. Nichols, J. Meunier and R. Verity for statistical advice; K. Harshman and M.-Y. Lu for Illumina sequencing support; R. Wang for FISH support; and B. Charlesworth, D. Charlesworth, H. Kaessmann, L. Ometto, J. Pannel, N. Perrin, M. Reuter, P. Reymond and K. Ross for comments. Some computations were performed at the Vital-IT (http://www.vital-it.ch) Center for high-performance computing (HPC) of the SIB Swiss Institute of Bioinformatics and the EPSRC-funded MidPlus HPC centre. This work was supported by the Biodiversity Research Center (Academia Sinica, Taiwan), Taiwan NSC grant 100-2311-B-001-015-MY3, grants from NERC and the BBSRC (BB/K004204/1), a USDA grant, several grants from the Swiss NSF and an ERC Advanced Grant.	Bachtrog D, 2006, CURR BIOL, V16, P1694, DOI 10.1016/j.cub.2006.07.053; Bachtrog D, 2011, TRENDS GENET, V27, P350, DOI 10.1016/j.tig.2011.05.005; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bergero R, 2011, CURR BIOL, V21, P1470, DOI 10.1016/j.cub.2011.07.032; Blomquist GJ, 2003, INSECT PHEROMONE BIO; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; CLARKE CA, 1968, PHILOS T ROY SOC B, V254, P37, DOI 10.1098/rstb.1968.0013; Correns C., 1908, BER DEUT BOT GES, P686; DeHeer CJ, 1999, AM NAT, V153, P660, DOI 10.1086/303205; FELDMAN MW, 1986, P NATL ACAD SCI USA, V83, P4824, DOI 10.1073/pnas.83.13.4824; GLANCEY BM, 1976, ANN ENTOMOL SOC AM, V69, P469, DOI 10.1093/aesa/69.3.469; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; KELLER L, 1995, TRENDS ECOL EVOL, V10, P355, DOI 10.1016/S0169-5347(00)89133-8; KELLER L, 1993, SCIENCE, V260, P1107, DOI 10.1126/science.260.5111.1107; Keller L, 1999, J EVOLUTION BIOL, V12, P672, DOI 10.1046/j.1420-9101.1999.00064.x; KELLER L, 1995, FUNCT ECOL, V9, P667, DOI 10.2307/2390159; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Krieger MJB, 2005, MOL BIOL EVOL, V22, P2090, DOI 10.1093/molbev/msi203; Lawson LP, 2012, P ROY SOC B-BIOL SCI, V279, P3217, DOI 10.1098/rspb.2012.0315; MATHER K, 1950, EVOLUTION, V4, P340, DOI 10.2307/2405601; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; Wang J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000127; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	30	247	249	5	270	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					664	668		10.1038/nature11832	http://dx.doi.org/10.1038/nature11832			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23334415	Green Published			2022-12-28	WOS:000314219600055
J	Willyard, C				Willyard, Cassandra			PATHOLOGY At the heart of the problem	NATURE			English	Editorial Material																		Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Jensen MK, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000232; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Sacks FM, 2000, CIRCULATION, V102, P1886, DOI 10.1161/01.CIR.102.16.1886; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	6	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S10	S11		10.1038/493S10a	http://dx.doi.org/10.1038/493S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364764	Bronze			2022-12-28	WOS:000314219600009
J	Brock, J; Mitchell, J; Irby, K; Stevens, B; Archibald, T; Goroski, A; Lynn, J				Brock, Jane; Mitchell, Jason; Irby, Kimberly; Stevens, Beth; Archibald, Traci; Goroski, Alicia; Lynn, Joanne		Care Transitions Project Team	Association Between Quality Improvement for Care Transitions in Communities and Rehospitalizations Among Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRIAL; INTERVENTIONS; PROGRAM; SERVICE; ELDERS; ERRORS	Importance Medicare beneficiaries experience errors during transitions among care settings, yielding harms that include unnecessary rehospitalizations. Objective To evaluate whether implementation of improved care transitions for patients with Medicare fee-for-service (FFS) insurance is associated with reduced rehospitalizations and hospitalizations in geographic communities. Design, Setting, and Participants Quality improvement initiative for care transitions by health care and social services personnel and Medicare Quality Improvement Organization staff in defined geographic areas, with monitoring by community-specific and aggregate control charts and evaluation with pre-post comparison of performance differences for 14 intervention communities and 50 comparison communities from before (2006-2008) and during (2009-2010) implementation. Intervention communities had between 22 070 and 90 843 Medicare FFS beneficiaries. Intervention Quality Improvement Organizations facilitated community-wide quality improvement activities to implement evidence-based improvements in care transitions by community organizing, technical assistance, and monitoring of participation, implementation, effectiveness, and adverse effects. Main Outcome Measures The primary outcome measure was all-cause 30-day rehospitalizations per 1000 Medicare FFS beneficiaries; secondary outcome measures were all-cause hospitalizations per 1000 Medicare FFS beneficiaries and all-cause 30-day rehospitalizations as a percentage of hospital discharges. Results The mean rate of 30-day all-cause rehospitalizations per 1000 beneficiaries per quarter was 15.21 in 2006-2008 and 14.34 in 2009-2010 in the 14 intervention communities and was 15.03 in 2006-2008 and 14.72 in 2009-2010 in the 50 comparison communities, with the pre-post between-group difference showing larger reductions in rehospitalizations in intervention communities (by 0.56/1000 per quarter; 95% CI, 0.05-1.07; P=.03). The mean rate of hospitalizations per 1000 beneficiaries per quarter was 82.27 in 2006-2008 and 77.54 in 2009-2010 in intervention communities and was 82.09 in 2006-2008 and 79.48 in 2009-2010 in comparison communities, with the pre-post between-group difference showing larger reductions in hospitalizations in intervention communities (by 2.12/1000 per quarter; 95% CI, 0.47-3.77; P=.01). Mean community-wide rates of rehospitalizations as a percentage of hospital discharges in the intervention communities were 18.97% in 2006-2008 and 18.91% in 2009-2010 and were 18.76% in 2006-2008 and 18.91% in 2009-2010 in the comparison communities, with no significant difference in the pre-post between-group differences (0.22%; 95% CI, -0.08% to 0.51%; P=.14). Process control charts signaled onset of improvement coincident with initiating intervention. Conclusions and Relevance Among Medicare beneficiaries in intervention communities, compared with those in uninvolved communities, all-cause 30-day rehospitalization and all-cause hospitalization declined. However, there was no change in the rate of all-cause 30-day rehospitalizations as a percentage of hospital discharges. JAMA. 2013; 309(4): 381-391	[Brock, Jane; Mitchell, Jason; Irby, Kimberly; Stevens, Beth; Goroski, Alicia; Lynn, Joanne] Colorado Fdn Med Care, Englewood, CO USA; [Archibald, Traci; Lynn, Joanne] Ctr Medicare Serv, Baltimore, MD USA; [Archibald, Traci; Lynn, Joanne] Ctr Medicaid Serv, Baltimore, MD USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Lynn, J (corresponding author), Altarum Inst, Ctr Elder Care & Adv Illness, 2000 M St NW,Ste 400, Washington, DC 20036 USA.	joanne.lynn@altarum.org		Sugarman, Jonathan/0000-0001-5588-0250	CMS	CMS	This project was funded through the CMS.	Alecxih L., 2010, INDIVIDUALS LIVING C; Bixby M Brian, 2010, Medsurg Nurs, V19, P62; Boutwell AE, 2011, HEALTH AFFAIR, V30, P1272, DOI 10.1377/hlthaff.2011.0111; Centers for Medicare and Medicaid Services, HCAHPS PAT PERSP CAR; Centers for Medicare & Medicaid Services, MED DEM DET COMM BAS; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Colorado Foundation for Medical Care, INT CAR POP COMM NAT; Counsell SR, 2006, J AM GERIATR SOC, V54, P1136, DOI 10.1111/j.1532-5415.2006.00791.x; Craig C, 2011, IHI INNOVATION SERIE; Deming WE, 2000, NEW EC IND GOVT ED; Epstein AM, 2011, NEW ENGL J MED, V365, P2287, DOI 10.1056/NEJMsa1101942; FedBizOpps.gov, QIO 10 STAT WORK SOL; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; HealthCare.gov, PAT PROT AFF CAR ACT; HealthCare. gov, PARTN PAT BETT CAR L; Home Health Quality Improvement, BEST PRACT INT PACK; Institute for Healthcare Improvement, PREV ADV DRUG EV MED; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; JAMAevidence, US ART QUAL IMPR; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Lu CY, 2011, INT J CLIN PRACT, V65, P733, DOI 10.1111/j.1742-1241.2011.02671.x; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Naylor MD, 2011, HEALTH AFFAIR, V30, P746, DOI 10.1377/hlthaff.2011.0041; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Ouslander JG, 2011, J AM GERIATR SOC, V59, P745, DOI 10.1111/j.1532-5415.2011.03333.x; Pawson R., 1997, REALISTIC EVALUATION; Provost LP, 2011, BMJ QUAL SAF, V20, pI92, DOI 10.1136/bmjqs.2011.051557; QualityNet, MEAS METH REP READM; Shewhart W., 1939, STAT METHOD VIEWPOIN; Social Security Administration, SOC SEC ACT TITL 11; Society of Hospital Medicine, BOOSTING CAR TRANS R; The Care Transitions Program, CAR TRANS MEAS CTM; Thor J, 2007, QUAL SAF HEALTH CARE, V16, P387, DOI 10.1136/qshc.2006.022194; US Bureau of the Census, 2003, 2003 SMALL AR INC PO; Ventura T., 2010, REMINGTON REPORT, V18, P24; Wennberg, 2008, TRACKING CARE PATIEN; Wheeler D, 1993, UNDERSTANDING VARIAT; Wheeler DJ, 1992, UNDERSTANDING STAT P, V2nd; Wilcock PM, 2000, QUAL HEALTH CARE, V9, P199, DOI 10.1136/qhc.9.4.199	39	113	114	0	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					381	391		10.1001/jama.2012.216607	http://dx.doi.org/10.1001/jama.2012.216607			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	074FT	23340640	Bronze			2022-12-28	WOS:000313799000026
J	Ferner, R				Ferner, Robin			DRUG TALES AND OTHER STORIES Beneath the surface	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England	University of Birmingham	Ferner, R (corresponding author), City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				[Anonymous], 1863, TIMES; DOYLE AC, 1890, SIGN 4; Duckworth D, 1908, LANCET, V2, P439; Gerrish FH, 1885, BOSTON MED SURG J, V113, P270; Health Protection Scotland and the Health Protection Agency, 2012, CLIN PRES ANTHR; Hunter C, 1863, LANCET, V82, P675; Hunter C, 1863, LANCET, V82, P444; Lawrence G., 2002, LANCET, V359, P1074, DOI [10.1016/S0140-6736(02)08101-1, DOI 10.1016/S0140-6736(02)08101-1]; Wood Alexander, 1855, Edinb Med Surg J, V82, P265	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2013	346								f380	10.1136/bmj.f380	http://dx.doi.org/10.1136/bmj.f380			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BA	23338009				2022-12-28	WOS:000314215000005
J	Fourage, M; Bourguignat, C; Fermond, B; Delobel, P				Fourage, Marie; Bourguignat, Christophe; Fermond, Bruno; Delobel, Pierre			A recurrent tonsillitis	LANCET			English	Editorial Material									[Fourage, Marie] CIBAM, SELAS Novescia, F-31140 St Alban, France; [Bourguignat, Christophe; Fermond, Bruno] Cabinet Med, St Alban, France; [Delobel, Pierre] Ctr Hosp Univ Toulouse, Hop Purpan, Serv Malad Infect & Trop, Toulouse, France	CHU de Toulouse	Fourage, M (corresponding author), CIBAM, SELAS Novescia, 32 Ave Villemur, F-31140 St Alban, France.		Fourage, Marie/AAA-5163-2021; Delobel, Pierre/K-3166-2014; Delobel, Pierre/Q-6028-2019	Delobel, Pierre/0000-0002-2874-3581; Delobel, Pierre/0000-0002-2874-3581					0	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2013	381	9862					266	266		10.1016/S0140-6736(12)61606-7	http://dx.doi.org/10.1016/S0140-6736(12)61606-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075LL	23332964				2022-12-28	WOS:000313887600040
J	Arias-Santiago, S; Orgaz-Molina, J; Naranjo-Sintes, R				Arias-Santiago, Salvador; Orgaz-Molina, Jacinto; Naranjo-Sintes, Ramon			Persistent swollen lip: cheilitis granulomatosa	LANCET			English	Editorial Material									[Arias-Santiago, Salvador; Orgaz-Molina, Jacinto; Naranjo-Sintes, Ramon] San Cecilio Univ Hosp, Dept Dermatol, Granada, Spain; [Arias-Santiago, Salvador] Univ Granada, Sch Med, Granada 18012, Spain; [Arias-Santiago, Salvador] Baza Gen Hosp, Granada, Spain	Hospital Universitario San Cecilio; University of Granada	Arias-Santiago, S (corresponding author), Univ Granada, Sch Med, San Cecilio Univ Hosp, Dept Dermatol, Av Madrid 11, Granada 18012, Spain.	salvadorarias@ugr.es	Arias-Santiago, Salvador/ABH-3162-2020						0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 29	2013	381	9885					2280	2280		10.1016/S0140-6736(12)61414-7	http://dx.doi.org/10.1016/S0140-6736(12)61414-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173SU	23333287				2022-12-28	WOS:000321100300032
J	Blumenthal, D				Blumenthal, David			A Tale of Two Angels	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ELECTRONIC HEALTH RECORD; INFORMATION-TECHNOLOGY; CARE		Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Blumenthal, D (corresponding author), Commonwealth Fund, 1 East 75th St, New York, NY 10021 USA.	db@cmwf.org						[Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; [Anonymous], 2010, FED REG, V75, P44313; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Centers for Medicare & Medicaid Services, 2012, EHR INC PROGR DEC 20; Chen C, 2009, HEALTH AFFAIR, V28, P323, DOI 10.1377/hlthaff.28.2.323; DesRoches CM, 2012, HEALTH AFFAIR, V31, P1092, DOI 10.1377/hlthaff.2012.0153; Evans DC, 2006, HEALTH ECON POLICY L, V1, P163, DOI 10.1017/S1744133105001210; Office of the Inspector General, 2012, OEI051100250 US DEP; Schoen C, 2012, HEALTH AFFAIR, V31, P2805, DOI 10.1377/hlthaff.2012.0884	9	0	0	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6					489	490		10.7326/0003-4819-158-6-201303190-00596	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-00596			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	112AY	23400364				2022-12-28	WOS:000316565100018
J	Kocher, RP; Adashi, EY				Kocher, Robert P.; Adashi, Eli Y.			Health Policy and the American Taxpayer Relief Act Legislation by Extension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kocher, Robert P.] Univ So Calif, Schaeffer Ctr Healthcare Policy & Econ, Los Angeles, CA USA; [Kocher, Robert P.] Venrock, Palo Alto, CA USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA	University of Southern California; Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu						Grey MR, 2009, JAMA-J AM MED ASSOC, V302, P2587, DOI 10.1001/jama.2009.1856; Jost TS, 2010, NEW ENGL J MED, V363, P103, DOI 10.1056/NEJMp1005402; Swartz K, 2011, JAMA-J AM MED ASSOC, V306, P760, DOI 10.1001/jama.2011.1173	3	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					777	778		10.1001/jama.2013.884	http://dx.doi.org/10.1001/jama.2013.884			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23377102				2022-12-28	WOS:000315332200021
J	Horn, S; Figl, A; Rachakonda, PS; Fischer, C; Sucker, A; Gast, A; Kadel, S; Moll, I; Nagore, E; Hemminki, K; Schadendorf, D; Kumar, R				Horn, Susanne; Figl, Adina; Rachakonda, P. Sivaramakrishna; Fischer, Christine; Sucker, Antje; Gast, Andreas; Kadel, Stephanie; Moll, Iris; Nagore, Eduardo; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv			TERT Promoter Mutations in Familial and Sporadic Melanoma	SCIENCE			English	Article							CANCER; GENE; TRANSCRIPTION; BINDING; ELK-1	Cutaneous melanoma occurs in both familial and sporadic forms. We investigated a melanoma-prone family through linkage analysis and high-throughput sequencing and identified a disease-segregating germline mutation in the promoter of the telomerase reverse transcriptase (TERT) gene, which encodes the catalytic subunit of telomerase. The mutation creates a new binding motif for Ets transcription factors and ternary complex factors (TCFs) near the transcription start and, in reporter gene assays, caused up to twofold increase in transcription. We then screened the TERT promoter in sporadic melanoma and observed recurrent ultraviolet signature somatic mutations in 125 of 168 (74%) of human cell lines derived from metastatic melanomas, 45 of 53 corresponding metastatic tumor tissues (85%), and 25 of 77 (33%) primary melanomas. The majority of those mutations occurred at two positions in the TERT promoter and also generated binding motifs for Ets/TCF transcription factors.	[Horn, Susanne; Figl, Adina; Rachakonda, P. Sivaramakrishna; Gast, Andreas; Kadel, Stephanie; Hemminki, Kari; Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Horn, Susanne; Figl, Adina; Sucker, Antje; Gast, Andreas; Kadel, Stephanie; Moll, Iris; Schadendorf, Dirk] Univ Hosp Essen, Dept Dermatol, D-45122 Essen, Germany; [Fischer, Christine] Heidelberg Univ, Inst Human Genet, D-69120 Heidelberg, Germany; [Nagore, Eduardo] Inst Valenciano Oncol, Dept Dermatol, Valencia, Spain; [Hemminki, Kari] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; Ruprecht Karls University Heidelberg; Instituto Valenciano De Oncologia; Lund University	Schadendorf, D (corresponding author), Univ Hosp Essen, Dept Dermatol, D-45122 Essen, Germany.	dirk.schadendorf@uk-essen.de; r.kumar@dkfz.de	Nagore, Eduardo/Z-2126-2019; Kumar, Rajiv/H-6431-2019; Schadendorf, Dirk/AAE-8206-2019	Nagore, Eduardo/0000-0003-3433-8707; Kumar, Rajiv/0000-0002-6093-0395; Rachakonda, Sivaramakrishna/0000-0002-2319-2821	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank Eurofins MWG Operon (Ebersberg, Germany) for sequencing service and M. Kircher and U. Stenzel for comments on sequence analysis. The study was partially supported by a grant from Deutsche Forschungsgemeinschaft (DFG). The mutation data reported in this manuscript are deposited in www.sanger.ac.uk/genetics/CGP/cosmic/.	AKIYAMA Y, 1995, TFSEARCH; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; JANKNECHT R, 1995, ONCOGENE, V10, P1209; Kujoth GC, 1998, CELL GROWTH DIFFER, V9, P523; Kumar R, 2003, CLIN CANCER RES, V9, P3362; LEE WK, 1991, J MOL BIOL, V220, P599, DOI 10.1016/0022-2836(91)90103-D; RAO VN, 1994, ONCOGENE, V9, P1855; SHORE P, 1995, NUCLEIC ACIDS RES, V23, P4698, DOI 10.1093/nar/23.22.4698; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200	12	1218	1251	3	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					959	961		10.1126/science.1230062	http://dx.doi.org/10.1126/science.1230062			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23348503				2022-12-28	WOS:000315149600050
J	Klose, CSN; Kiss, EA; Schwierzeck, V; Ebert, K; Hoyler, T; d'Hargues, Y; Goppert, N; Croxford, AL; Waisman, A; Tanriver, Y; Diefenbach, A				Klose, Christoph S. N.; Kiss, Elina A.; Schwierzeck, Vera; Ebert, Karolina; Hoyler, Thomas; d'Hargues, Yannick; Goeppert, Nathalie; Croxford, Andrew L.; Waisman, Ari; Tanriver, Yakup; Diefenbach, Andreas			A T-bet gradient controls the fate and function of CCR6(-)ROR gamma t(+) innate lymphoid cells	NATURE			English	Article							ROR-GAMMA-T; NKP46(+) CELLS; IFN-GAMMA; EXPRESSION; DIFFERENTIATION; DEFENSE; HOST	At mucosal surfaces, the immune system should not initiate inflammatory immune responses to the plethora of antigens constantly present in the environment, but should remain poised to unleash a potent assault on intestinal pathogens.. The transcriptional programs and regulatory factors required for immune cells to switch from homeostatic (often tissue-protective) function(1) to potent antimicrobial immunity are poorly defined. Mucosal retinoic-acidreceptor-related orphan receptor-gamma t-positive (ROR gamma t(+)) innate lymphoid cells (ILCs) are emerging as an important innate lymphocyte population required for immunity to intestinal infections(2). Various subsets of ROR gamma t(+) ILCs have been described(3-8) but the transcriptional programs controlling their specification and fate remain largely unknown. Here we provide evidence that the transcription factor T-bet determines the fate of a distinct lineage of CCR6(-)ROR gamma t(+) ILCs. Postnatally emerging CCR6(-)ROR gamma t(+) ILCs upregulated T-bet and this was controlled by cues from the commensal microbiota and interleukin-23 (IL-23). In contrast, CCR6(+)ROR gamma t(+) ILCs, which arise earlier during ontogeny, did not express T-bet. T-bet instructed the expression of T-bet target genes such as interferon-gamma (IFN-gamma) and of the natural cytotoxicity receptor NKp46. Mice genetically lacking T-bet showed normal development of CCR6(-)ROR gamma t(+) ILCs, but they could not differentiate into NKp46-expressing ROR gamma t(+) ILCs (that is, IL-22-producing natural killer (NK-22) cells)(3,9) and failed to produce IFN-gamma. The production of IFN-gamma by T-bet-expressing CCR6(-)ROR gamma t(+) ILCs was essential for the release of mucus-forming glycoproteins required to protect the epithelial barrier during Salmonella enterica infection(10,11). Salmonella infection also causes severe enterocolitis that is at least partly driven by IFN-gamma(12). Mice deficient for T-bet or depleted of ILCs developed only mild enterocolitis. Thus, graded expression of T-bet in CCR6(-)ROR gamma t(+) MCs facilitates the differentiation of IFN-gamma-producing CCR6(-)ROR gamma t(+) ILCs required to protect the epithelial barrier against Salmonella infections. Co-expression of T-bet and ROR gamma t, which is also found in subsets of IL-17-producing T-helper (T(H)17) cells(13), may be an evolutionarily conserved transcriptional program that originally developed as part of the innate defence against infections but that also confers an increased risk of immune-mediated pathology.	[Klose, Christoph S. N.; Kiss, Elina A.; Schwierzeck, Vera; Ebert, Karolina; Hoyler, Thomas; d'Hargues, Yannick; Goeppert, Nathalie; Tanriver, Yakup; Diefenbach, Andreas] Univ Freiburg, IMMH, D-79104 Freiburg, Germany; [Schwierzeck, Vera; Tanriver, Yakup; Diefenbach, Andreas] Univ Med Ctr Freiburg, CCI, D-79106 Freiburg, Germany; [Schwierzeck, Vera; Tanriver, Yakup; Diefenbach, Andreas] Univ Freiburg, D-79106 Freiburg, Germany; [Ebert, Karolina; d'Hargues, Yannick; Tanriver, Yakup] Univ Freiburg, Med Ctr, Div Renal, D-79106 Freiburg, Germany; [Croxford, Andrew L.; Waisman, Ari] Johannes Gutenberg Univ Mainz, Inst Mol Med, D-55131 Mainz, Germany; [Croxford, Andrew L.] Univ Zurich, Inst Expt Immunol, CH-8006 Zurich, Switzerland; [Diefenbach, Andreas] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Johannes Gutenberg University of Mainz; University of Zurich; University of Freiburg	Diefenbach, A (corresponding author), Univ Freiburg, IMMH, Hermann Herder Str 11, D-79104 Freiburg, Germany.	andreas.diefenbach@uniklinik-freiburg.de	Waisman, Ari/C-7383-2015; Diefenbach, Andreas/T-2589-2018; Schwierzeck, Vera/AAL-3028-2020; Tanriver, Yakup/AAU-7064-2020; Klose, Christoph/ABE-6396-2020	Waisman, Ari/0000-0003-4304-8234; Diefenbach, Andreas/0000-0002-9176-9530; Schwierzeck, Vera/0000-0003-4254-3700; Tanriver, Yakup/0000-0002-4806-2548	Deutsche Forschungsgemeinschaft [SFB620/A14, TA436/2-1]; German Federal Ministry of Education and Research [BMBF 01 EO 0803]; EFSD/Lilly grant; European Research Council; CCI Walter-Hitzig-Fellowship; EMBO Long Term Fellowship [ALTF 508-2011]; FP6 Marie Curie Research Train in Network [MRTN-CT-2004-005632]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EFSD/Lilly grant; European Research Council(European Research Council (ERC)European Commission); CCI Walter-Hitzig-Fellowship; EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); FP6 Marie Curie Research Train in Network	We thank G. Hacker for support, the members of the Diefenbach laboratory for valuable discussions, and C. A. Connor for comments on the manuscript We are grateful to M. Folio, K. Geiger and J. Bodinek-Wersing for cell sorting. The work was supported by the Deutsche Forschungsgemeinschaft (SFB620/A14 to AD. and TA436/2-1 to Y.T.), the German Federal Ministry of Education and Research (BMBF 01 EO 0803 to A.D. and Y.T.), an EFSD/Lilly grant (to Y.T.), a European Research Council Grant (to AD.), a CCI Walter-Hitzig-Fellowship (to VS.), an EMBO Long Term Fellowship (ALTF 508-2011 to A.L.C.) and the FP6 Marie Curie Research Train in Network (grant MRTN-CT-2004-005632 (IMDEMI) to A.W.).	Awoniyi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037311; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bernink J., NATURE IMMU IN PRESS; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2012, CURR OPIN IMMUNOL, V24, P290, DOI 10.1016/j.coi.2012.04.004; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Oestreich KJ, 2012, CURR OPIN IMMUNOL, V24, P191, DOI 10.1016/j.coi.2011.12.004; Rhee SJ, 2005, J IMMUNOL, V175, P1127, DOI 10.4049/jimmunol.175.2.1127; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Songhet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022459; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	31	493	508	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					261	265		10.1038/nature11813	http://dx.doi.org/10.1038/nature11813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23334414				2022-12-28	WOS:000315137700045
J	Yoder, AD				Yoder, Anne D.			Fossils Versus Clocks	SCIENCE			English	Editorial Material							DIVERSIFICATION; EXTINCTION; DIVERGENCE; RADIATION; ORIGINS; MAMMALS		Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Yoder, AD (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	anne.yoder@duke.edu						ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Archibald J. David, 2001, Journal of Mammalian Evolution, V8, P107, DOI 10.1023/A:1011317930838; Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; Dos Reis M, 2013, J SYST EVOL, V51, P30, DOI 10.1111/j.1759-6831.2012.00236.x; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Martin RD, 2000, INT J PRIMATOL, V21, P1021, DOI 10.1023/A:1005563113546; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Seiffert ER, 2003, NATURE, V422, P421, DOI 10.1038/nature01489; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024	15	9	9	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					656	658		10.1126/science.1233999	http://dx.doi.org/10.1126/science.1233999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393254				2022-12-28	WOS:000314585600029
J	Stine, NW; Chokshi, DA; Gourevitch, MN				Stine, Nicholas W.; Chokshi, Dave A.; Gourevitch, Marc N.			Improving Population Health in US Cities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stine, Nicholas W.] New York City Hlth & Hosp Corp, Off Healthcare Improvement, New York, NY 10013 USA; [Stine, Nicholas W.; Gourevitch, Marc N.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA; [Stine, Nicholas W.; Gourevitch, Marc N.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Chokshi, Dave A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	New York University; New York University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Stine, NW (corresponding author), New York City Hlth & Hosp Corp, New York, NY 10013 USA.	nicholas.stine@nychhc.org		Chokshi, Dave/0000-0001-7467-4591; Gourevitch, Marc/0000-0001-6865-2126	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000038] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Agency for Healthcare Research and Quality, SERVICE DELIVERY INN; City of Boston Inspectional Services Department, HOUSING DIVISION BRE; Institute of Medicine, 2011, FOR THE PUBLICS HEAL; Institute of Medicine, 2012, PRIMARY CARE AND PUB; Jacobson DM, 2012, COMMISSIONED PAPER; Victor RG, 2011, ARCH INTERN MED, V171, P342, DOI 10.1001/archinternmed.2010.390; Yaggy SD, 2006, GERONTOLOGIST, V46, P271, DOI 10.1093/geront/46.2.271	7	16	16	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					449	450		10.1001/jama.2012.154302	http://dx.doi.org/10.1001/jama.2012.154302			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083LY	23385269	Green Accepted			2022-12-28	WOS:000314466900024
J	Canfield, DE; Kump, LR				Canfield, Donald E.; Kump, Lee R.			Carbon Cycle Makeover	SCIENCE			English	Editorial Material									[Canfield, Donald E.] Univ So Denmark, Nord Ctr Earth Evolut, DK-5230 Odense, Denmark; [Kump, Lee R.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	University of Southern Denmark; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Canfield, DE (corresponding author), Univ So Denmark, Nord Ctr Earth Evolut, DK-5230 Odense, Denmark.	dec@biology.sdu.dk; lrk4@psu.edu	Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366				Canfield DE, 2005, ADV MAR BIOL, V48, P313; CRAIG H, 1953, GEOCHIM COSMOCHIM AC, V3, P53, DOI 10.1016/0016-7037(53)90001-5; Ebelmen J.J., 1845, ANN MIN, V7, P3; Grotzinger JP, 2011, NAT GEOSCI, V4, P285, DOI [10.1038/ngeo1138, 10.1038/NGEO1138]; Johnston DT, 2012, NATURE, V483, P320, DOI 10.1038/nature10854; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Kump LR, 2011, SCIENCE, V334, P1694, DOI 10.1126/science.1213999; Reimers CE, 1996, GEOCHIM COSMOCHIM AC, V60, P4037, DOI 10.1016/S0016-7037(96)00231-1; Schrag DP, 2013, SCIENCE, V339, P540, DOI 10.1126/science.1229578	9	15	16	1	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					533	534		10.1126/science.1231981	http://dx.doi.org/10.1126/science.1231981			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372005				2022-12-28	WOS:000314270000047
J	Gupta, S; Kim, S				Gupta, Shailvi; Kim, Sunghoon			Pulmonary Sequestration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gupta, Shailvi] Univ Calif San Francisco, Oakland, CA USA; [Kim, Sunghoon] Childrens Hosp, Oakland, CA 94609 USA; [Kim, Sunghoon] Res Ctr Oakland, Oakland, CA USA	University of California System; University of California San Francisco; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Gupta, S (corresponding author), Univ Calif San Francisco, Oakland, CA USA.	skim@mail.cho.org		kim, sunghoon/0000-0002-1570-3230					0	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					E6	E6		10.1056/NEJMicm1206677	http://dx.doi.org/10.1056/NEJMicm1206677			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BE	23363525				2022-12-28	WOS:000314215400012
J	Ma, L; Tao, YZ; Duran, A; Llado, V; Galvez, A; Barger, JF; Castilla, EA; Chen, J; Yajima, T; Porollo, A; Medvedovic, M; Brill, LM; Plas, DR; Riedl, SJ; Leitges, M; Diaz-Meco, MT; Richardson, AD; Moscat, J				Ma, Li; Tao, Yongzhen; Duran, Angeles; Llado, Victoria; Galvez, Anita; Barger, Jennifer F.; Castilla, Elias A.; Chen, Jing; Yajima, Tomoko; Porollo, Aleksey; Medvedovic, Mario; Brill, Laurence M.; Plas, David R.; Riedl, Stefan J.; Leitges, Michael; Diaz-Meco, Maria T.; Richardson, Adam D.; Moscat, Jorge			Control of Nutrient Stress-Induced Metabolic Reprogramming by PKC zeta in Tumorigenesis	CELL			English	Article							CANCER; PROTEIN; MOUSE; EXPRESSION; GLUTAMINE; PATHWAY	Tumor cells have high-energetic and anabolic needs and are known to adapt their metabolism to be able to survive and keep proliferating under conditions of nutrient stress. We show that PKC zeta deficiency promotes the plasticity necessary for cancer cells to reprogram their metabolism to utilize glutamine through the serine biosynthetic pathway in the absence of glucose. PKC zeta represses the expression of two key enzymes of the pathway, PHGDH and PSAT1, and phosphorylates PHGDH at key residues to inhibit its enzymatic activity. Interestingly, the loss of PKC zeta in mice results in enhanced intestinal tumorigenesis and increased levels of these two metabolic enzymes, whereas patients with low levels of PKC zeta have a poor prognosis. Furthermore, PKC zeta and caspase-3 activities are correlated with PHGDH levels in human intestinal tumors. Taken together, this demonstrates that PKC zeta is a critical metabolic tumor suppressor in mouse and human cancer.	[Ma, Li; Tao, Yongzhen; Duran, Angeles; Llado, Victoria; Yajima, Tomoko; Brill, Laurence M.; Riedl, Stefan J.; Diaz-Meco, Maria T.; Richardson, Adam D.; Moscat, Jorge] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Galvez, Anita; Barger, Jennifer F.; Castilla, Elias A.; Chen, Jing; Porollo, Aleksey; Medvedovic, Mario; Plas, David R.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0316 Oslo, Norway	Sanford Burnham Prebys Medical Discovery Institute; University System of Ohio; University of Cincinnati; University of Oslo	Moscat, J (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jmoscat@sanfordburnham.org	Leitges, Michael/AAN-1953-2021; Richardson, Adam D/N-7845-2014; Barger, Jennifer/N-1263-2015; Llado, Victoria/AAJ-8454-2020	Richardson, Adam D/0000-0003-3646-2584; Diaz-Meco, Maria/0000-0003-0147-0998; Porollo, Alexey/0000-0002-3202-5099; Chen, Jing/0000-0002-6227-7393; , Yongzhen/0000-0003-1710-5346; Leitges, Michael/0000-0003-4203-6995	NIH [R01CA132847, R01AI072581, R01DK088107, R01CA134530, R21CA147978]; CCSG Pilot Project Grant; NATIONAL CANCER INSTITUTE [R21CA147978, R01CA134530, R01CA132847] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCSG Pilot Project Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH Grants R01CA132847 (to J.M.), R01AI072581 (to J.M.), R01DK088107 (to J.M.), R01CA134530 (to M.T.D.-M.), R21CA147978 (to A.D.R.), and CCSG Pilot Project Grant (to J.M. and A.D.R.) funded this work. We thank Maryellen Daston for editing this manuscript, Diantha LaVine for the artwork, and the technical assistance of Tom Hudson, Jessica Leung, and Nahid Hamidy.	Baltgalvis KA, 2009, CANCER PREV RES, V2, P641, DOI 10.1158/1940-6207.CAPR-09-0017; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Fuchs BC, 2006, J SURG RES, V131, P26, DOI 10.1016/j.jss.2005.07.013; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Ma WW, 2009, J CLIN ONCOL, V27, P2697, DOI 10.1200/JCO.2008.18.8383; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Swinson DEB, 2003, J CLIN ONCOL, V21, P473, DOI 10.1200/JCO.2003.11.132; Tabatabaie L, 2009, HUM MUTAT, V30, P749, DOI 10.1002/humu.20934	21	130	136	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					599	611		10.1016/j.cell.2012.12.028	http://dx.doi.org/10.1016/j.cell.2012.12.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374352	Bronze, Green Accepted			2022-12-28	WOS:000314362800027
J	Jha, AK				Jha, Ashish K.			Time to Get Serious About Pay for Performance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOSPITALS; CARE		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Kresge 408,677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu						Chatterjee P, 2012, ARCH INTERN MED, V172, P1204, DOI 10.1001/archinternmed.2012.3158; *COMM FUND, 2005, COMM FUND HLTH CAR O; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Lee GM, 2012, NEW ENGL J MED, V367, P1428, DOI 10.1056/NEJMsa1202419; Werner RM, 2012, HEALTH AFFAIR, V31, P1932, DOI 10.1377/hlthaff.2011.0990	5	60	60	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					347	348		10.1001/jama.2012.196646	http://dx.doi.org/10.1001/jama.2012.196646			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074FT	23340633				2022-12-28	WOS:000313799000019
J	Braumuller, H; Wieder, T; Brenner, E; Assmann, S; Hahn, M; Alkhaled, M; Schilbach, K; Essmann, F; Kneilling, M; Griessinger, C; Ranta, F; Ullrich, S; Mocikat, R; Braungart, K; Mehra, T; Fehrenbacher, B; Berdel, J; Niessner, H; Meier, F; van den Broek, M; Haring, HU; Handgretinger, R; Quintanilla-Martinez, L; Fend, F; Pesic, M; Bauer, J; Zender, L; Schaller, M; Schulze-Osthoff, K; Rocken, M				Braumueller, Heidi; Wieder, Thomas; Brenner, Ellen; Assmann, Sonja; Hahn, Matthias; Alkhaled, Mohammed; Schilbach, Karin; Essmann, Frank; Kneilling, Manfred; Griessinger, Christoph; Ranta, Felicia; Ullrich, Susanne; Mocikat, Ralph; Braungart, Kilian; Mehra, Tarun; Fehrenbacher, Birgit; Berdel, Julia; Niessner, Heike; Meier, Friedegund; van den Broek, Maries; Haering, Hans-Ulrich; Handgretinger, Rupert; Quintanilla-Martinez, Leticia; Fend, Falko; Pesic, Marina; Bauer, Juergen; Zender, Lars; Schaller, Martin; Schulze-Osthoff, Klaus; Roecken, Martin			T-helper-1-cell cytokines drive cancer into senescence	NATURE			English	Article							ONCOGENE-INDUCED SENESCENCE; CD4(+) T-CELLS; TUMOR; SURVEILLANCE; REGRESSION; PATHWAY; P53	Cancer control by adaptive immunity involves a number of defined death(1-8) and clearance(9-11) mechanisms. However, efficient inhibition of exponential cancer growth by T cells and interferon-gamma (IFN-gamma) requires additional undefined mechanisms that arrest cancer cell proliferation(1-5,12,13). Here we show that the combined action of the T-helper-1-cell cytokines IFN-gamma and tumour necrosis factor (TNF) directly induces permanent growth arrest in cancers. To safely separate senescence induced by tumour immunity from oncogene-induced senescence(9-11,14-17), we used a mouse model in which the Simian virus 40 large T antigen (Tag) expressed under the control of the rat insulin promoter creates tumours by attenuating p53- and Rb-mediated cell cycle control(18,19). When combined, IFN-gamma and TNF drive Tag-expressing cancers into senescence by inducing permanent growth arrest in G1/G0, activation of p16INK4a (also known as CDKN2A), and downstream Rb hypophosphorylation at serine 795. This cytokine-induced senescence strictly requires STAT1 and TNFR1 (also known as TNFRSF1A) signalling in addition to p16INK4a. In vivo, Tag-specific T-helper 1 cells permanently arrest Tag-expressing cancers by inducing IFN-gamma- and TNFR1-dependent senescence. Conversely, Tnfr1(-/-) Tag-expressing cancers resist cytokine-induced senescence and grow aggressively, even in TNFR1-expressing hosts. Finally, as IFN-gamma and TNF induce senescence in numerous murine and human cancers, this may be a general mechanism for arresting cancer progression.	[Braumueller, Heidi; Wieder, Thomas; Brenner, Ellen; Assmann, Sonja; Hahn, Matthias; Kneilling, Manfred; Griessinger, Christoph; Braungart, Kilian; Mehra, Tarun; Fehrenbacher, Birgit; Berdel, Julia; Niessner, Heike; Meier, Friedegund; Bauer, Juergen; Schaller, Martin; Roecken, Martin] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany; [Alkhaled, Mohammed; Schilbach, Karin; Handgretinger, Rupert] Univ Tubingen, Dept Gen Pediat, D-72076 Tubingen, Germany; [Essmann, Frank] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Griessinger, Christoph] Univ Tubingen, Dept Preclin Imaging & Radiopharm, Werner Siemens Fdn, Lab Preclin Imaging & Imaging Technol, D-72076 Tubingen, Germany; [Ranta, Felicia; Ullrich, Susanne; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med 6, D-72076 Tubingen, Germany; [Mocikat, Ralph] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [van den Broek, Maries] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland; [Handgretinger, Rupert; Fend, Falko; Schulze-Osthoff, Klaus; Roecken, Martin] German Canc Consortium DKTK, Comprehens Canc Ctr Tubingen, D-72070 Tubingen, Germany; [Quintanilla-Martinez, Leticia; Fend, Falko] Univ Tubingen, Dept Pathol, D-72076 Tubingen, Germany; [Pesic, Marina; Zender, Lars] Univ Tubingen, Dept Internal Med 1, Div Mol Oncol Solid Tumors, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Siemens AG; Siemens Germany; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Zurich; University Zurich Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Rocken, M (corresponding author), Univ Tubingen, Dept Dermatol, Liebermeister Str 25, D-72076 Tubingen, Germany.	mrocken@med.uni-tuebingen.de	Alkhaled, Mohammed/D-3026-2016; Schulze-Osthoff, Klaus/N-9025-2013; van den Broek, Maries/L-6532-2019; Essmann, Frank/ABG-7409-2020; van den Broek, Maries/G-4128-2016; Bauer, Jurgen/B-4656-2008	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Essmann, Frank/0000-0003-4369-8456; Rocken, Martin/0000-0003-3795-7001; van den Broek, Maries/0000-0002-9489-3692; Brenner, Ellen/0000-0002-2019-5074; Bauer, Jurgen/0000-0001-8789-1536	Sander Stiftung [2005.043.2, 2005.043.3]; Deutsche Krebshilfe [109037]; IZKF-Promotionskolleg 'Molekulare Medizin' [1886-0-0, PK 2011-3, PK 2012-1]; Deutsche Forschungsgemeinschaft [SFB 685, SFB 773, Wi 1279/3-1]; German Federal Ministry of Education and Research (BMBF)	Sander Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); IZKF-Promotionskolleg 'Molekulare Medizin'; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors thank A. Knuth, H. G. Rammensee, K. Ghoreschi, J. Bruck, G. Riethmuller, G. Stingl, T. Biedermann and A. Yazdi for discussions, T. Haug for technical support in the chromium release assay, R. Dummer for melanoma samples, W. Kempf for technical support in the cell cycle analysis and S. Lowe for the p16-p19 shRNA concept. The technical assistance of S. Weidemann and M. Dierstein is gratefully acknowledged. This work is part of the doctoral thesis of E.B., S.A., M.H., K.B., J.Berdel and C.G., and was supported by the Sander Stiftung (2005.043.2 and 2005.043.3), the Deutsche Krebshilfe (No. 109037), the IZKF-Promotionskolleg 'Molekulare Medizin' 2010 (1886-0-0), 2011 (PK 2011-3) and 2012 (PK 2012-1), the Deutsche Forschungsgemeinschaft (SFB 685, SFB 773 and Wi 1279/3-1) and in part by the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DzD e.V.).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Zhang B, 2008, J CLIN INVEST, V118, P1398, DOI 10.1172/JCI33522; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Canova C, 2009, CANCER RES, V69, P2956, DOI 10.1158/0008-5472.CAN-08-2604; Casanovas O, 2005, ONCOGENE, V24, P6597, DOI 10.1038/sj.onc.1208823; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Critchley-Thorne RJ, 2009, P NATL ACAD SCI USA, V106, P9010, DOI 10.1073/pnas.0901329106; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Gurzov EN, 2012, ONCOGENE, V31, P1723, DOI 10.1038/onc.2011.353; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Rocken M, 2010, J CLIN INVEST, V120, P1800, DOI 10.1172/JCI43424; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Willimsky G, 2005, NATURE, V437, P141, DOI 10.1038/nature03954; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	30	451	467	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					361	365		10.1038/nature11824	http://dx.doi.org/10.1038/nature11824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23376950	Green Accepted			2022-12-28	WOS:000315312900040
J	Goldman, N; Bertone, P; Chen, SY; Dessimoz, C; LeProust, EM; Sipos, B; Birney, E				Goldman, Nick; Bertone, Paul; Chen, Siyuan; Dessimoz, Christophe; LeProust, Emily M.; Sipos, Botond; Birney, Ewan			Towards practical, high-capacity, low-maintenance information storage in synthesized DNA	NATURE			English	Article							CHAIN	Digital production, transmission and storage have revolutionized how we access and use information but have also made archiving an increasingly complex task that requires active, continuing maintenance of digital media. This challenge has focused some interest on DNA as an attractive target for information storage(1) because of its capacity for high-density information encoding, longevity under easily achieved conditions(2-4) and proven track record as an information bearer. Previous DNA-based information storage approaches have encoded only trivial amounts of information(5-7) or were not amenable to scaling-up(8), and used no robust error-correction and lacked examination of their cost-efficiency for large-scale information archival(9). Here we describe a scalable method that can reliably store more information than has been handled before. We encoded computer files totalling 739 kilobytes of hard-disk storage and with an estimated Shannon information(10) of 5.2 x 10(6) bits into a DNA code, synthesized this DNA, sequenced it and reconstructed the original files with 100% accuracy. Theoretical analysis indicates that our DNA-based storage scheme could be scaled far beyond current global information volumes and offers a realistic technology for large-scale, long-term and infrequently accessed digital archiving. In fact, current trends in technological advances are reducing DNA synthesis costs at a pace that should make our scheme cost-effective for sub-50-year archiving within a decade.	[Goldman, Nick; Bertone, Paul; Dessimoz, Christophe; Sipos, Botond; Birney, Ewan] European Bioinformat Inst, Hinxton CB10 1SD, England; [Chen, Siyuan; LeProust, Emily M.] Genom LSSU, Agilent Technol, Santa Clara, CA 95051 USA	European Molecular Biology Laboratory (EMBL); Agilent Technologies	Goldman, N (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SD, England.	goldman@ebi.ac.uk	Bertone, Paul/A-6600-2013; Chen, Siyuan/C-6163-2012; Bertone, Paul/Z-3734-2019; Dessimoz, Christophe/D-3678-2011	Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Dessimoz, Christophe/0000-0002-2170-853X; Sipos, Botond/0000-0002-9046-3302; Goldman, Nick/0000-0001-8486-2211; Birney, Ewan/0000-0001-8314-8497	Swiss National Science Foundation [136461]; EMBL	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBL	At the University of Cambridge: D. MacKay and G. Mitchison for advice on codes for run-length-limited channels. At CERN: B. Jones for discussions on data archival. At EBI: A. Loytynoja for custom multiple sequence alignment software, H. Marsden for computing base calls and for detecting an error in the original parity-check encoding, T. Massingham for computing base calls and advice on code theory and K. Gori, D. Henk, R. Loos, S. Parks and R. Schwarz for assistance with revisions to the manuscript. In the Genomics Core Facility at EMBL Heidelberg: V. Benes for advice on Next-Generation Sequencing protocols, D. Pavlinic for sequencing and J. Blake for data handling. C.D. is supported by a fellowship from the Swiss National Science Foundation (grant 136461). B.S. is supported by an EMBL Interdisciplinary Postdoctoral Fellowship under Marie Curie Actions (COFUND).	Ailenberg M, 2009, BIOTECHNIQUES, V47, P747, DOI 10.2144/000113218; Anchordoquy TJ, 2007, CELL PRESERV TECHNOL, V5, P180, DOI 10.1089/cpt.2007.0511; [Anonymous], 2012, SVALB GLOB SEED VAUL; [Anonymous], 2012, ECONOMIST, V403, P56; Baker M., 2006, P 1 ACM SIGOPS EUROS, P221; BAUM EB, 1995, SCIENCE, V268, P583, DOI 10.1126/science.7725109; Bessone N, 2010, J PHYS CONF SER, V219, DOI 10.1088/1742-6596/219/6/062038; Bonnet J, 2010, NUCLEIC ACIDS RES, V38, P1531, DOI 10.1093/nar/gkp1060; Brand S., 1999, CLOCK LONG NOW; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Cox JPL, 2001, TRENDS BIOTECHNOL, V19, P247, DOI 10.1016/S0167-7799(01)01671-7; ERLICH HA, 1991, SCIENCE, V252, P1643, DOI 10.1126/science.2047872; Gantz J., 2011, IDC IVIEW; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Kac E., 1999, GENESIS; Kari L., 2009, ALGORITHMS THEORY CO, V2, P31; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; MacKay D. J. C., 2003, INFORM THEORY INFERE; Massingham T, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r13; MONACO AP, 1994, TRENDS BIOTECHNOL, V12, P280, DOI 10.1016/0167-7799(94)90140-6; Niedringhaus TP, 2011, ANAL CHEM, V83, P4327, DOI 10.1021/ac2010857; Paun G., 1998, DNA COMPUTING NEW CO, DOI DOI 10.1007/978-3-662-03563-4; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Yuille M, 2010, CELL TISSUE BANK, V11, P241, DOI 10.1007/s10561-009-9150-3	28	490	565	37	408	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					77	80		10.1038/nature11875	http://dx.doi.org/10.1038/nature11875			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23354052	Green Accepted			2022-12-28	WOS:000314741200037
J	Selph, SS; Bougatsos, C; Blazina, I; Nelson, HD				Selph, Shelley S.; Bougatsos, Christina; Blazina, Ian; Nelson, Heidi D.			Behavioral Interventions and Counseling to Prevent Child Abuse and Neglect: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED-CONTROLLED-TRIAL; INTIMATE PARTNER VIOLENCE; PEDIATRIC PRIMARY-CARE; NURSE HOME VISITATION; TRAUMATIC BRAIN-INJURY; DOMESTIC VIOLENCE; VISITING PROGRAM; NATIONAL-SURVEY; PREGNANCY OUTCOMES; SAFE ENVIRONMENT	Background: In 2004, the U.S. Preventive Services Task Force determined that evidence was insufficient to recommend behavioral interventions and counseling to prevent child abuse and neglect. Purpose: To review new evidence on the effectiveness of behavioral interventions and counseling in health care settings for reducing child abuse and neglect and related health outcomes, as well as adverse effects of interventions. Data Sources: MEDLINE and PsycINFO (January 2002 to June 2012), Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (through the second quarter of 2012), Scopus, and reference lists. Study Selection: English-language trials of the effectiveness of behavioral interventions and counseling and studies of any design about adverse effects. Data Extraction: Investigators extracted data about study populations, designs, and outcomes and rated study quality using established criteria. Data Synthesis: Eleven fair-quality randomized trials of interventions and no studies of adverse effects met inclusion criteria. A trial of risk assessment and interventions for abuse and neglect in pediatric clinics for families with children aged 5 years or younger indicated reduced physical assault, Child Protective Services (CPS) reports, nonadherence to medical care, and immunization delay among screened children. Ten trials of early childhood home visitation reported reduced CPS reports, emergency department visits, hospitalizations, and self-reports of abuse and improved adherence to immunizations and well-child care, although results were inconsistent. Limitation: Trials were limited by heterogeneity, low adherence, high loss to follow-up, and lack of standardized measures. Conclusion: Risk assessment and behavioral interventions in pediatric clinics reduced abuse and neglect outcomes for young children. Early childhood home visitation also reduced abuse and neglect, but results were inconsistent. Additional research on interventions to prevent child abuse and neglect is needed. Primary Funding Source: Agency for Healthcare Research and Quality. Ann Intern Med. 2013;158:179-190.	[Nelson, Heidi D.] Oregon Hlth & Sci Univ, Pacific NW Evidence Based Practice Ctr, Portland, OR 97239 USA; Providence Hlth & Serv, Providence Canc Ctr, Portland, OR USA	Oregon Health & Science University	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Pacific NW Evidence Based Practice Ctr, Mail Code BICC,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu		Blazina, Ian/0000-0003-0164-6674	AHRQ [HHSA-290-2007-10057-I-EPC3]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By AHRQ under contract HHSA-290-2007-10057-I-EPC3, task order 3.	Administration for Children and Families, 2003, CHILD AB PREV TREATM; Administration for Children and Families, 2009, DEF CHILD AB NEGL SU; Administration for Children and Families, 2011, CHILD MALTR 2010; Atkins D, 2011, J CLIN EPIDEMIOL, V64, P1198, DOI 10.1016/j.jclinepi.2010.11.021; Bair-Merritt MH, 2004, AMBUL PEDIATR, V4, P24, DOI 10.1367/1539-4409(2004)004<0024:PRTODV>2.0.CO;2; Barlow J, 2007, ARCH DIS CHILD, V92, P229, DOI 10.1136/adc.2006.095117; Battle CL, 2004, J PERS DISORD, V18, P193, DOI 10.1521/pedi.18.2.193.32777; Berg AO, 2004, ANN FAM MED, V2, P156, DOI 10.1370/afm.128; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Bierer LM, 2003, CNS SPECTRUMS, V8, P737, DOI 10.1017/S1092852900019118; Brown J, 2005, CLIN J PAIN, V21, P374, DOI 10.1097/01.ajp.0000149797.16370.dc; Bugental DB, 2009, DEV PSYCHOL, V45, P284, DOI 10.1037/a0014031; Chartier MJ, 2007, AM J EPIDEMIOL, V165, P1031, DOI 10.1093/aje/kwk113; Cutajar MC, 2010, CHILD ABUSE NEGLECT, V34, P813, DOI 10.1016/j.chiabu.2010.04.004; Davis DA, 2005, CLIN J PAIN, V21, P398, DOI 10.1097/01.ajp.0000149795.08746.31; Dubowitz H, 2012, ACAD PEDIATR, V12, P259, DOI 10.1016/j.acap.2012.03.005; Dubowitz H, 2011, PEDIATRICS, V127, pE962, DOI 10.1542/peds.2010-1845; Dubowitz H, 2009, PEDIATRICS, V123, P858, DOI 10.1542/peds.2008-1376; Duggan A, 2004, CHILD ABUSE NEGLECT, V28, P623, DOI 10.1016/j.chiabu.2003.08.008; Duggan A, 2004, CHILD ABUSE NEGLECT, V28, P597, DOI 10.1016/j.chiabu.2003.08.007; Duggan A, 2007, CHILD ABUSE NEGLECT, V31, P801, DOI 10.1016/j.chiabu.2006.06.011; DuMont K, 2008, CHILD ABUSE NEGLECT, V32, P295, DOI 10.1016/j.chiabu.2007.07.007; Durrant J, 2012, CMAJ; Eckenrode J, 2000, JAMA-J AM MED ASSOC, V284, P1385, DOI 10.1001/jama.284.11.1385; El-Mohandes AAE, 2003, PEDIATRICS, V111, P1324, DOI 10.1542/peds.111.6.1324; El-Mohandes AAE, 2011, MATERN CHILD HLTH J, V15, P19, DOI [10.1007/s10995-009-0557-z, 10.1007/s10995-011-0843-4, 10.1007/s10995-011-0856-z]; El-Mohandes AAE, 2010, PEDIATRICS, V125, P721, DOI 10.1542/peds.2009-1809; Fergusson DM, 2005, PEDIATRICS, V116, pE803, DOI 10.1542/peds.2005-0948; Flaherty EG, 2006, CHILD MALTREATMENT, V11, P361, DOI 10.1177/1077559506292287; Flaherty EG, 2010, PEDIATRICS, V126, P833, DOI 10.1542/peds.2010-2087; Goodwin RD, 2004, PSYCHOL MED, V34, P509, DOI 10.1017/S003329170300134X; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hussey JM, 2005, CHILD ABUSE NEGLECT, V29, P479, DOI 10.1016/j.chiabu.2003.12.005; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Kitzman H, 1997, JAMA-J AM MED ASSOC, V278, P644, DOI 10.1001/jama.278.8.644; Koniak-Griffin D, 2003, NURS RES, V52, P127, DOI 10.1097/00006199-200303000-00009; Lane WG, 2009, CHILD ABUSE NEGLECT, V33, P76, DOI 10.1016/j.chiabu.2008.09.003; Lane WG, 2009, PEDIATRICS, V124, P1595, DOI 10.1542/peds.2009-0904; Lapidus G, 2002, ARCH PEDIAT ADOL MED, V156, P332, DOI 10.1001/archpedi.156.4.332; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Leeners B, 2010, J PSYCHOSOM RES, V69, P503, DOI 10.1016/j.jpsychores.2010.04.017; Lowell DI, 2011, CHILD DEV, V82, P193, DOI 10.1111/j.1467-8624.2010.01550.x; Lown EA, 2011, ALCOHOL CLIN EXP RES, V35, P317, DOI 10.1111/j.1530-0277.2010.01347.x; McFarlane JM, 2003, PEDIATRICS, V112, pE202, DOI 10.1542/peds.112.3.e202; Nelson HD, 2004, SYSTEMATIC EVIDENCE, V28; Nelson HD, 2013, BEHAV INTERVENTIONS; Nelson HD, 2012, SCREENING WOMEN INTI; Nelson HD, 2012, ANN INTERN MED, V156, P796, DOI 10.7326/0003-4819-156-11-201206050-00447; Nygren P, 2004, ANN FAM MED, V2, P161, DOI 10.1370/afm.113; Olds DL, 2007, PEDIATRICS, V120, pE832, DOI 10.1542/peds.2006-2111; OLDS DL, 1994, PEDIATRICS, V93, P89; OLDS DL, 1986, PEDIATRICS, V78, P65; Olds DL, 2002, PEDIATRICS, V110, P486, DOI 10.1542/peds.110.3.486; Pederson CL, 2009, PSYCHOL REP, V105, P111, DOI 10.2466/PR0.105.1.111-126; SALTZMAN LE, 1999, INTIMATE PARTNER VIO; Schneider Renee, 2007, Violence Vict, V22, P620, DOI 10.1891/088667007782312140; Shaffer A, 2008, CHILD ABUSE NEGLECT, V32, P682, DOI 10.1016/j.chiabu.2007.09.010; Sickel AE, 2002, J HEALTH PSYCHOL, V7, P583, DOI 10.1177/1359105302007005677; Starling SP, 2009, PEDIATRICS, V123, pE595, DOI 10.1542/peds.2008-2938; Taylor B, 2010, VIOLENCE VICTIMS, V25, P202, DOI 10.1891/0886-6708.25.2.202; Thompson R, 2010, CHILD ABUSE NEGLECT, V34, P907, DOI 10.1016/j.chiabu.2010.06.006; Trickett PK, 2011, DEV PSYCHOPATHOL, V23, P453, DOI 10.1017/S0954579411000174; U.S. Department of Health and Human Services, 2010, MAND REP CHILD AB NE; U.S. Department of Health and Human Services, 2019, CHILD MALTREATMENT; U.S. Preventive Services Task Force Agency for Healthcare Research and Quality, 2004, SCREEN FAM INT PARTN; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; Whitaker RC, 2007, CHILD ABUSE NEGLECT, V31, P1187, DOI 10.1016/j.chiabu.2007.04.008; Zolotor AJ, 2008, AM J PREV MED, V35, P364, DOI 10.1016/j.amepre.2008.06.031	69	39	40	1	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					179	+		10.7326/0003-4819-158-3-201302050-00590	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00590			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	087JP	23338775				2022-12-28	WOS:000314757900005
J	Spence, D				Spence, Des			Data, data everywhere	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	1	1	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2013	346								f725	10.1136/bmj.f725	http://dx.doi.org/10.1136/bmj.f725			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AL	23381205				2022-12-28	WOS:000314806100008
J	Schrag, DP; Higgins, JA; Macdonald, FA; Johnston, DT				Schrag, Daniel P.; Higgins, John. A.; Macdonald, Francis A.; Johnston, David T.			Authigenic Carbonate and the History of the Global Carbon Cycle	SCIENCE			English	Article							ATMOSPHERIC OXYGEN; ORGANIC-MATTER; SEDIMENTS; OCEAN; EARTH; EXTINCTION; DELTA-C-13; EVOLUTION; ORIGIN; RECORD	We present a framework for interpreting the carbon isotopic composition of sedimentary rocks, which in turn requires a fundamental reinterpretation of the carbon cycle and redox budgets over Earth's history. We propose that authigenic carbonate, produced in sediment pore fluids during early diagenesis, has played a major role in the carbon cycle in the past. This sink constitutes a minor component of the carbon isotope mass balance under the modern, high levels of atmospheric oxygen but was much larger in times of low atmospheric O-2 or widespread marine anoxia. Waxing and waning of a global authigenic carbonate sink helps to explain extreme carbon isotope variations in the Proterozoic, Paleozoic, and Triassic.	[Schrag, Daniel P.; Macdonald, Francis A.; Johnston, David T.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Higgins, John. A.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Harvard University; Princeton University	Schrag, DP (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	daniel_schrag@harvard.edu		Johnston, David/0000-0002-2487-1084	NSF [OCE-0961372]; Canadian Institute for Advanced Research Junior Fellowship; Henry and Wendy Breck Foundation	NSF(National Science Foundation (NSF)); Canadian Institute for Advanced Research Junior Fellowship(Canadian Institute for Advanced Research (CIFAR)); Henry and Wendy Breck Foundation	The paper benefited from reviews from J. Hayes, R. Aller, and an anonymous reviewer. The authors acknowledge P. Hoffman for his helpful comments. This work was supported by NSF grant OCE-0961372 to D. P. S. and a Canadian Institute for Advanced Research Junior Fellowship to J. A. H. D. P. S. also thanks the Henry and Wendy Breck Foundation for support.	Aller RC, 1996, CONT SHELF RES, V16, P753, DOI 10.1016/0278-4343(95)00046-1; ANDERSON LG, 1987, MAR CHEM, V20, P361, DOI 10.1016/0304-4203(87)90068-5; Berner RA, 2009, AM J SCI, V309, P603, DOI 10.2475/07.2009.03; Bjerrum CJ, 2011, P NATL ACAD SCI USA, V108, P5542, DOI 10.1073/pnas.1101755108; Bjerrum CJ, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000713; Bristow TF, 2008, GEOLOGY, V36, P863, DOI 10.1130/G24968A.1; BROECKER WS, 1970, J GEOPHYS RES, V75, P3553, DOI 10.1029/JC075i018p03553; Catling DC, 2005, EARTH PLANET SC LETT, V237, P1, DOI 10.1016/j.epsl.2005.06.013; Chow N, 2000, J SEDIMENT RES, V70, P682, DOI 10.1306/2DC40930-0E47-11D7-8643000102C1865D; Derry LA, 2010, EARTH PLANET SC LETT, V294, P152, DOI 10.1016/j.epsl.2010.03.022; Duguid SMA, 2010, J SEDIMENT RES, V80, P236, DOI 10.2110/jsr.2010.027; Grotzinger JP, 2011, NAT GEOSCI, V4, P285, DOI [10.1038/ngeo1138, 10.1038/NGEO1138]; Halverson GP, 2005, GEOL SOC AM BULL, V117, P1181, DOI 10.1130/B25630.1; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Higgins JA, 2009, EARTH PLANET SC LETT, V284, P25, DOI 10.1016/j.epsl.2009.03.039; Jiang GQ, 2007, EARTH PLANET SC LETT, V261, P303, DOI 10.1016/j.epsl.2007.07.009; Johnston DT, 2012, NATURE, V483, P320, DOI 10.1038/nature10854; Knauth LP, 2009, NATURE, V460, P728, DOI 10.1038/nature08213; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Kump LR, 2011, SCIENCE, V334, P1694, DOI 10.1126/science.1213999; Macdonald FA, 2010, SCIENCE, V327, P1241, DOI 10.1126/science.1183325; Maloof AC, 2010, GEOL SOC AM BULL, V122, P1731, DOI 10.1130/B30346.1; Meister P, 2007, SEDIMENTOLOGY, V54, P1007, DOI 10.1111/j.1365-3091.2007.00870.x; Meyer KM, 2011, EARTH PLANET SC LETT, V302, P378, DOI 10.1016/j.epsl.2010.12.033; Naehr TH, 2007, DEEP-SEA RES PT II, V54, P1268, DOI 10.1016/j.dsr2.2007.04.010; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Prokoph A, 2008, EARTH-SCI REV, V87, P113, DOI 10.1016/j.earscirev.2007.12.003; Reimers CE, 1996, GEOCHIM COSMOCHIM AC, V60, P4037, DOI 10.1016/S0016-7037(96)00231-1; ROBERTS HH, 1994, GEO-MAR LETT, V14, P135, DOI 10.1007/BF01203725; Saltzman MR, 2011, P NATL ACAD SCI USA, V108, P3876, DOI 10.1073/pnas.1011836108; Schrag DP, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000219; Shen B, 2011, GEOCHIM COSMOCHIM AC, V75, P1357, DOI 10.1016/j.gca.2010.12.015; Sivan O, 2007, GEOBIOLOGY, V5, P141, DOI 10.1111/j.1472-4669.2007.00098.x; UREY HC, 1948, SCIENCE, V108, P489, DOI 10.1126/science.108.2810.489; Zhu ZB, 2002, CONT SHELF RES, V22, P2065, DOI 10.1016/S0278-4343(02)00071-7	37	309	329	28	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					540	543		10.1126/science.1229578	http://dx.doi.org/10.1126/science.1229578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372007				2022-12-28	WOS:000314270000049
J	Smith, MI; Yatsunenko, T; Manary, MJ; Trehan, I; Mkakosya, R; Cheng, JY; Kau, AL; Rich, SS; Concannon, P; Mychaleckyj, JC; Liu, J; Houpt, E; Li, JV; Holmes, E; Nicholson, J; Knights, D; Ursell, LK; Knight, R; Gordon, JI				Smith, Michelle I.; Yatsunenko, Tanya; Manary, Mark J.; Trehan, Indi; Mkakosya, Rajhab; Cheng, Jiye; Kau, Andrew L.; Rich, Stephen S.; Concannon, Patrick; Mychaleckyj, Josyf C.; Liu, Jie; Houpt, Eric; Li, Jia V.; Holmes, Elaine; Nicholson, Jeremy; Knights, Dan; Ursell, Luke K.; Knight, Rob; Gordon, Jeffrey I.			Gut Microbiomes of Malawian Twin Pairs Discordant for Kwashiorkor	SCIENCE			English	Article							SERUM AMINO-ACIDS; CHILDREN; FOOD; FERMENTATION; BACTERIA; PLASMA; URINE; PCR	Kwashiorkor, an enigmatic form of severe acute malnutrition, is the consequence of inadequate nutrient intake plus additional environmental insults. To investigate the role of the gut microbiome, we studied 317 Malawian twin pairs during the first 3 years of life. During this time, half of the twin pairs remained well nourished, whereas 43% became discordant, and 7% manifested concordance for acute malnutrition. Both children in twin pairs discordant for kwashiorkor were treated with a peanut-based, ready-to-use therapeutic food (RUTF). Time-series metagenomic studies revealed that RUTF produced a transient maturation of metabolic functions in kwashiorkor gut microbiomes that regressed when administration of RUTF was stopped. Previously frozen fecal communities from several discordant pairs were each transplanted into gnotobiotic mice. The combination of Malawian diet and kwashiorkor microbiome produced marked weight loss in recipient mice, accompanied by perturbations in amino acid, carbohydrate, and intermediary metabolism that were only transiently ameliorated with RUTF. These findings implicate the gut microbiome as a causal factor in kwashiorkor.	[Smith, Michelle I.; Yatsunenko, Tanya; Cheng, Jiye; Kau, Andrew L.; Gordon, Jeffrey I.] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Manary, Mark J.; Trehan, Indi] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [Manary, Mark J.; Trehan, Indi] Univ Malawi, Coll Med, Dept Community Hlth, Blantyre 3, Malawi; [Manary, Mark J.; Trehan, Indi] Univ Malawi, Coll Med, Dept Pediat & Child Hlth, Blantyre 3, Malawi; [Manary, Mark J.] Baylor Coll Med, USDA, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Mkakosya, Rajhab] Univ Malawi, Coll Med, Dept Microbiol, Blantyre 3, Malawi; [Rich, Stephen S.; Concannon, Patrick; Mychaleckyj, Josyf C.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22904 USA; [Liu, Jie; Houpt, Eric] Univ Virginia, Div Infect Dis & Internal Hlth, Charlottesville, VA 22908 USA; [Li, Jia V.; Holmes, Elaine; Nicholson, Jeremy] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London SW7 2AZ, England; [Knights, Dan; Knight, Rob] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Knights, Dan; Knight, Rob] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA; [Ursell, Luke K.; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Washington University (WUSTL); Washington University (WUSTL); University of Malawi; University of Malawi; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Malawi; University of Virginia; University of Virginia; Imperial College London; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Gordon, JI (corresponding author), Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA.	jgordon@wustl.edu	Holmes, Elaine/ABE-6606-2020; Nicholson, Jeremy K/B-3395-2012; Kau, Andrew/AGX-9881-2022; Cheng, Jiye/K-2722-2013; Knight, Rob/D-1299-2010; Trehan, Indi/K-7912-2013; Holmes, Elaine/A-2189-2015	Holmes, Elaine/0000-0002-0556-8389; Nicholson, Jeremy K/0000-0002-8123-8349; Trehan, Indi/0000-0002-3364-6858; Manary, Mark/0000-0003-2733-9568; Knight, Rob/0000-0002-0975-9019; Concannon, Patrick/0000-0002-5801-1859; Kau, Andrew/0000-0002-9386-3766; Li, Jia/0000-0002-5763-6670; Rich, Stephen/0000-0003-3872-7793	Bill & Melinda Gates Foundation; NIH [DK30292, DK078669, T32-HD049338]; St. Louis Children's Discovery Institute [MD112009-201]; Imperial College Junior Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, F32DK091044, T35DK074375, R01DK030292, R37DK030292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER; Medical Research Council [G0801056B] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Louis Children's Discovery Institute; Imperial College Junior Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Wagoner, J. Manchester, and M. Meier for superb technical assistance; J. Manchester, S. Deng, and J. Hoisington-Lopez for assistance with DNA sequencing; M. Karlsson, D. O'Donnell, and S. Wagoner for help with gnotobiotic mouse husbandry; W. Van Treuren for writing several scripts, B. Mickelson (Teklad Diets) and H. Sandige for assistance with the design of the mouse diets; and members of the Gordon lab for valuable suggestions during the course of this work. This work was supported by grants from the Bill & Melinda Gates Foundation, and the NIH (DK30292, DK078669, T32-HD049338). M. I. S was the recipient of a postdoctoral fellowship from the St. Louis Children's Discovery Institute (MD112009-201). J.V.L was the recipient of an Imperial College Junior Research Fellowship. Illumina V4-16S rRNA and 454 shotgun pyrosequencing data sets have been deposited with the European Bioinformatics Institute. Specifically, human: V4-16S rRNA data sets (ERP001928) and shotgun sequencing data sets (ERP001911). Mouse: gnotobiotic recipients of discordant twin pair 196: V4-16S rRNA data sets (ERP001861); gnotobiotic recipients of discordant twin pair 196: shotgun sequencing data sets (ERP001819); gnotobiotic recipients of discordant twin pair 57: V4-16S rRNA data sets (ERP001871); gnotobiotic recipients of discordant twin pair 57: shotgun sequencing data sets (ERP001909). Twin pairs were recruited through health centers located in Makhwira, Mitondo, M'biza, Chamba, and Mayaka. Recruitment of participants for the present study, clinical protocols, sample collection procedures, and informed consent documents were all reviewed and approved by the College of Medicine Research Ethics Committee of the University of Malawi and by the Human Research Protection Office of Washington University in St. Louis. All experiments involving mice were performed using protocols approved by the Washington University Animal Studies Committee. Author contributions: M. I. S., T.Y., and J.I.G designed the experiments; M.J.M. designed and implemented the clinical monitoring and sampling for the trial; R. M. and I. T. participated in patient recruitment, sample collection, sample preservation, and clinical evaluations; M. I. S. performed experiments involving gnotobiotic mice, whereas T.Y. characterized microbiota obtained from twins; M. I. S., T.Y., J.C., A. L. K., S. S. R., P. C., J.C. M., J.L., E. Houpt, J.V.L., E. Holmes, and J.N. generated data; M. I. S., T.Y., E. Holmes, J.N., D. K, L. K. U, R. K., and J. I. G. analyzed the results; and M. I. S., T.Y., and J. I. G. wrote the paper.	Ahmed T, 2009, INDIAN J MED RES, V130, P651; ARROYAVE G, 1962, AM J CLIN NUTR, V11, P517, DOI 10.1093/ajcn/11.5.517; AWWAAD S, 1962, J TROP MED HYG, V65, P179; BAKER DH, 1986, PROG FOOD NUTR SCI, V10, P133; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Ciliberto H, 2005, BMJ-BRIT MED J, V330, P1109, DOI 10.1136/bmj.38427.404259.8F; Crum-Cianflone N, 2009, AM J MED SCI, V337, P480, DOI 10.1097/MAJ.0b013e31819f1e95; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; EDOZIEN JC, 1960, LANCET, V1, P615; Fernandez MF, 2003, J APPL MICROBIOL, V94, P449, DOI 10.1046/j.1365-2672.2003.01850.x; GOLDEN MHN, 1982, LANCET, V1, P1261; GOPALAN C, 1968, CALORIE DEFICIENCIES, P48; ITOH T, 1995, LETT APPL MICROBIOL, V21, P137, DOI 10.1111/j.1472-765X.1995.tb01025.x; ITTYERAH TR, 1965, AM J CLIN NUTR, V17, P11, DOI 10.1093/ajcn/17.1.11; ITTYERAH TR, 1969, CLIN CHIM ACTA, V25, P365, DOI 10.1016/0009-8981(69)90194-6; Kato-Mori Y, 2010, J MED FOOD, V13, P1460, DOI 10.1089/jmf.2010.1137; Lagrone L, 2010, ANN TROP PAEDIATR, V30, P103, DOI 10.1179/146532810X12703901870651; Laue H, 1997, APPL ENVIRON MICROB, V63, P2016, DOI 10.1128/AEM.63.5.2016-2021.1997; Lin CA, 2007, J PEDIATR GASTR NUTR, V44, P487, DOI 10.1097/MPG.0b013e31802c6e57; Liu J, 2012, J CLIN MICROBIOL, V50, P98, DOI 10.1128/JCM.05416-11; Mori M, 1993, Tokushima J Exp Med, V40, P35; NICHOLSON JK, 1985, MOL PHARMACOL, V27, P644; ORENTREICH N, 1993, J NUTR, V123, P269; SALYERS AA, 1977, APPL ENVIRON MICROB, V34, P529, DOI 10.1128/AEM.34.5.529-533.1977; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Taniuchi M, 2012, DIAGN MICR INFEC DIS, V73, P121, DOI 10.1016/j.diagmicrobio.2012.03.008; Taniuchi M, 2011, DIAGN MICR INFEC DIS, V71, P386, DOI 10.1016/j.diagmicrobio.2011.08.012; Taniuchi M, 2011, AM J TROP MED HYG, V84, P332, DOI 10.4269/ajtmh.2011.10-0461; United Nations Inter-agency Group for Child Mortality Estimation Levels & Trends in Child Mortality, 2011, LEV TRENDS CHILD MOR; WHITEHEAD RG, 1964, AM J CLIN NUTR, V14, P313, DOI 10.1093/ajcn/14.6.313; WILLIAMS Cicely D., 1935, Lancet, P1151; World Health Organization , 2007, COMM BAS MAN SEV AC; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	36	746	776	4	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					548	554		10.1126/science.1229000	http://dx.doi.org/10.1126/science.1229000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23363771	Green Accepted			2022-12-28	WOS:000314270000051
J	Trehan, I; Goldbach, HS; LaGrone, LN; Meuli, GJ; Wang, RJ; Maleta, KM; Manary, MJ				Trehan, Indi; Goldbach, Hayley S.; LaGrone, Lacey N.; Meuli, Guthrie J.; Wang, Richard J.; Maleta, Kenneth M.; Manary, Mark J.			Antibiotics as Part of the Management of Severe Acute Malnutrition	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							USE THERAPEUTIC FOOD; BLOOD-STREAM INFECTIONS; HOME-BASED THERAPY; COMMUNITY-ACQUIRED BACTEREMIA; MALNOURISHED CHILDREN; MALAWIAN CHILDREN; UNDERNUTRITION; POPULATION; SPREAD; AREA	BACKGROUND Severe acute malnutrition contributes to 1 million deaths among children annually. Adding routine antibiotic agents to nutritional therapy may increase recovery rates and decrease mortality among children with severe acute malnutrition treated in the community. METHODS In this randomized, double-blind, placebo-controlled trial, we randomly assigned Malawian children, 6 to 59 months of age, with severe acute malnutrition to receive amoxicillin, cef-di-nir, or placebo for 7 days in addition to ready-to-use therapeutic food for the outpatient treatment of uncomplicated severe acute malnutrition. The primary outcomes were the rate of nutritional recovery and the mortality rate. RESULTS A total of 2767 children with severe acute malnutrition were enrolled. In the amoxicillin, cef-di-nir, and placebo groups, 88.7%, 90.9%, and 85.1% of the children recovered, respectively (relative risk of treatment failure with placebo vs. amoxicillin, 1.32; 95% confidence interval [CI], 1.04 to 1.68; relative risk with placebo vs. cef-di-nir, 1.64; 95% CI, 1.27 to 2.11). The mortality rates for the three groups were 4.8%, 4.1%, and 7.4%, respectively (relative risk of death with placebo vs. amoxicillin, 1.55; 95% CI, 1.07 to 2.24; relative risk with placebo vs. cef-di-nir, 1.80; 95% CI, 1.22 to 2.64). Among children who recovered, the rate of weight gain was increased among those who received antibiotics. No interaction between type of severe acute malnutrition and intervention group was observed for either the rate of nutritional recovery or the mortality rate. CONCLUSIONS The addition of antibiotics to therapeutic regimens for uncomplicated severe acute malnutrition was associated with a significant improvement in recovery and mortality rates. (Funded by the Hickey Family Foundation and others; ClinicalTrials. gov number, NCT01000298.)	[Trehan, Indi; Meuli, Guthrie J.; Manary, Mark J.] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [Trehan, Indi] Univ Malawi, Dept Paediat & Child Hlth, Blantyre, Malawi; [Maleta, Kenneth M.; Manary, Mark J.] Univ Malawi, Dept Community Hlth, Blantyre, Malawi; [Goldbach, Hayley S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [LaGrone, Lacey N.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Wang, Richard J.] Cornell Univ, Dept Med, Weill Cornell Med Coll, New York, NY 10021 USA; [Manary, Mark J.] Baylor Coll Med, USDA, ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA	Washington University (WUSTL); University of Malawi; University of Malawi; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle; Cornell University; Baylor College of Medicine; United States Department of Agriculture (USDA)	Manary, MJ (corresponding author), Washington Univ, Dept Pediat, 1 Childrens Pl,Campus Box 8116, St Louis, MO 63110 USA.	manary@kids.wustl.edu	Trehan, Indi/K-7912-2013; Maleta, Ken M/J-2821-2016	Trehan, Indi/0000-0002-3364-6858; Maleta, Ken M/0000-0002-2536-3938; Manary, Mark/0000-0003-2733-9568; Wang, Richard/0000-0001-7814-2883	Hickey Family Foundation [GHN-A-00-08-00001-00]; Academy for Educational Development Food and Nutrition Technical Assistance 2 project (through the Office of Health, Infectious Diseases, and Nutrition, Bureau of Global Health, and Food for Peace, United States Agency for International Development) [T32-HD049338]; National Institutes of Health [UL1-RR024992]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049338] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER	Hickey Family Foundation; Academy for Educational Development Food and Nutrition Technical Assistance 2 project (through the Office of Health, Infectious Diseases, and Nutrition, Bureau of Global Health, and Food for Peace, United States Agency for International Development)(United States Agency for International Development (USAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by a grant from the Hickey Family Foundation, a cooperative agreement (GHN-A-00-08-00001-00) with the Academy for Educational Development Food and Nutrition Technical Assistance 2 project (through the Office of Health, Infectious Diseases, and Nutrition, Bureau of Global Health, and Food for Peace, United States Agency for International Development), and grants (T32-HD049338, to Dr. Trehan; and UL1-RR024992, for statistical consulting) from the National Institutes of Health.	Amthor RE, 2009, J AM DIET ASSOC, V109, P464, DOI 10.1016/j.jada.2008.11.028; Archibald LK, 2003, J INFECT DIS, V188, P202, DOI 10.1086/376507; Ashley EA, 2011, TROP MED INT HEALTH, V16, P1167, DOI 10.1111/j.1365-3156.2011.02822.x; Babirekere-Iriso E, 2006, ANN TROP PAEDIATR, V26, P319, DOI 10.1179/146532806X152845; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; BEHRENS RH, 1987, AM J CLIN NUTR, V45, P1433, DOI 10.1093/ajcn/45.6.1433; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Brewster DR, 1997, ARCH DIS CHILD, V76, P236, DOI 10.1136/adc.76.3.236; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; FRIEDLAND IR, 1992, ANN TROP PAEDIATR, V12, P433, DOI 10.1080/02724936.1992.11747610; Glennie SJ, 2010, TRENDS MICROBIOL, V18, P487, DOI 10.1016/j.tim.2010.08.002; Gross R, 2006, LANCET, V367, P1209, DOI 10.1016/S0140-6736(06)68509-7; Heikens GT, 2008, LANCET, V371, P1305, DOI 10.1016/S0140-6736(08)60565-6; JOHNSON AWBR, 1993, J TROP PEDIATRICS, V39, P97, DOI 10.1093/tropej/39.2.97; Lazzerini M, 2011, B WORLD HEALTH ORGAN, V89, P593, DOI 10.2471/BLT.10.084715; Lin CA, 2007, J PEDIATR GASTR NUTR, V44, P487, DOI 10.1097/MPG.0b013e31802c6e57; Linneman Z, 2007, MATERN CHILD NUTR, V3, P206, DOI 10.1111/j.1740-8709.2007.00095.x; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Manary MJ, 2006, FOOD NUTR BULL, V27, pS83, DOI 10.1177/15648265060273S305; Manary MJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2180; Mandomando I, 2010, AM J TROP MED HYG, V83, P152, DOI 10.4269/ajtmh.2010.09-0578; Nathoo KJ, 1996, PEDIATR INFECT DIS J, V15, P1092, DOI 10.1097/00006454-199612000-00007; Norton EB, 2004, PEDIATR INFECT DIS J, V23, P145, DOI 10.1097/01.inf.0000109258.82988.40; Oakley E, 2010, J NUTR, V140, P2248, DOI 10.3945/jn.110.123828; Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Trehan I, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/790786; Trehan I, 2010, TROP MED INT HEALTH, V15, P1022, DOI 10.1111/j.1365-3156.2010.02580.x; UNICEF, 2011, STAT WORLDS CHILDR 2; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522; WOLF BHM, 1995, EUR J PEDIATR, V154, P299, DOI 10.1007/s004310050293; World Health Organization , 2007, COMM BAS MAN SEV AC; World Health Organization, 1999, MAN SEV MALN MAN PHY	39	208	211	1	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					425	435		10.1056/NEJMoa1202851	http://dx.doi.org/10.1056/NEJMoa1202851			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BE	23363496	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000314215400007
J	Spence, D				Spence, Des			Bad medicine: food intolerance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Allergy UK, 2007, STOL LIV 3 FOOD ALL; [Anonymous], 2012, BMJ; [Anonymous], 2012, GLUTEN FREE FOODS BE; Department of Health, PRESCR COST AN DAT E; Elli L, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7360; Stapel SO, 2008, ALLERGY, V63, P793, DOI 10.1111/j.1398-9995.2008.01705.x; YorkTest, FOOD DRINKSCAN PROGR	7	2	3	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2013	346								f529	10.1136/bmj.f529	http://dx.doi.org/10.1136/bmj.f529			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BP	23364064				2022-12-28	WOS:000314511300009
J	Barnes, JC; Fahrenbach, AC; Cao, D; Dyar, SM; Frasconi, M; Giesener, MA; Benitez, D; Tkatchouk, E; Chernyashevskyy, O; Shin, WH; Li, H; Sampath, S; Stern, CL; Sarjeant, AA; Hartlieb, KJ; Liu, ZC; Carmieli, R; Botros, YY; Choi, JW; Slawin, AMZ; Ketterson, JB; Wasielewski, MR; Goddard, WA; Stoddart, JF				Barnes, Jonathan C.; Fahrenbach, Albert C.; Cao, Dennis; Dyar, Scott M.; Frasconi, Marco; Giesener, Marc A.; Benitez, Diego; Tkatchouk, Ekaterina; Chernyashevskyy, Oleksandr; Shin, Weon Ho; Li, Hao; Sampath, Srinivasan; Stern, Charlotte L.; Sarjeant, Amy A.; Hartlieb, Karel J.; Liu, Zhichang; Carmieli, Raanan; Botros, Youssry Y.; Choi, Jang Wook; Slawin, Alexandra M. Z.; Ketterson, John B.; Wasielewski, Michael R.; Goddard, William A., III; Stoddart, J. Fraser			A Radically Configurable Six-State Compound	SCIENCE			English	Article							OXIDATION-REDUCTION; MOLECULAR MATERIALS; ELECTRON-TRANSFER; BUILDING-BLOCKS; REDOX CENTERS; METHYLVIOLOGEN; VIOLOGEN; CATION; INCLUSION; NITROXIDE	Most organic radicals possess short lifetimes and quickly undergo dimerization or oxidation. Here, we report on the synthesis by radical templation of a class of air- and water-stable organic radicals, trapped within a homo[2]catenane composed of two rigid and fixed cyclobis (paraquat-p-phenylene) rings. The highly energetic octacationic homo[2] catenane, which is capable of accepting up to eight electrons, can be configured reversibly, both chemically and electrochemically, between each one of six experimentally accessible redox states (0, 2+, 4+, 6+, 7+, and 8+) from within the total of nine states evaluated by quantum mechanical methods. All six of the observable redox states have been identified by electrochemical techniques, three (4+, 6+, and 7+) have been characterized by x-ray crystallography, four (4+, 6+, 7+, and 8+) by electron paramagnetic resonance spectroscopy, one (7+) by superconducting quantum interference device magnetometry, and one (8+) by nuclear magnetic resonance spectroscopy.	[Barnes, Jonathan C.; Fahrenbach, Albert C.; Cao, Dennis; Dyar, Scott M.; Frasconi, Marco; Giesener, Marc A.; Li, Hao; Sampath, Srinivasan; Stern, Charlotte L.; Sarjeant, Amy A.; Hartlieb, Karel J.; Liu, Zhichang; Carmieli, Raanan; Botros, Youssry Y.; Wasielewski, Michael R.; Stoddart, J. Fraser] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Botros, Youssry Y.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Chernyashevskyy, Oleksandr; Ketterson, John B.] Northwestern Univ, Dept Phys, Evanston, IL 60208 USA; [Benitez, Diego; Tkatchouk, Ekaterina; Goddard, William A., III] CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; [Barnes, Jonathan C.; Fahrenbach, Albert C.; Cao, Dennis; Shin, Weon Ho; Sampath, Srinivasan; Choi, Jang Wook; Goddard, William A., III; Stoddart, J. Fraser] Korea Adv Inst Sci & Technol, NanoCentury KAIST Inst, Taejon 305701, South Korea; [Barnes, Jonathan C.; Fahrenbach, Albert C.; Cao, Dennis; Shin, Weon Ho; Sampath, Srinivasan; Choi, Jang Wook; Goddard, William A., III; Stoddart, J. Fraser] Korea Adv Inst Sci & Technol, Grad Sch EEWS WCU, Taejon 305701, South Korea; [Botros, Youssry Y.] Intel Labs, Santa Clara, CA 95054 USA; [Botros, Youssry Y.] King Abdulaziz City Sci & Technol, Natl Ctr Nano Technol Res, Riyadh 11442, Saudi Arabia; [Slawin, Alexandra M. Z.] Univ St Andrews, EaStCHEM Sch Chem, St Andrews KY16 9ST, Fife, Scotland	Northwestern University; Northwestern University; Northwestern University; California Institute of Technology; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Intel Corporation; King Abdulaziz City for Science & Technology; University of St Andrews	Stoddart, JF (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	stoddart@northwestern.edu	Cao, Dennis/C-2240-2013; Sampath, Srinivasan/C-6704-2008; Shin, Weon Ho/AAH-4031-2020; Fahrenbach, Albert/B-3042-2014; Frasconi, Marco/C-4767-2014; Choi, Jang Wook/C-1821-2011; Benitez, Diego/E-4403-2011; Liu, Zhichang/C-5495-2012; Stoddart, James Fraser/H-1518-2011; Slawin, Alexandra M Z/I-9878-2014	Cao, Dennis/0000-0002-0315-1619; Sampath, Srinivasan/0000-0002-3238-6441; Shin, Weon Ho/0000-0003-0487-5480; Frasconi, Marco/0000-0003-2010-175X; Choi, Jang Wook/0000-0001-8783-0901; Benitez, Diego/0000-0003-1212-6957; Liu, Zhichang/0000-0003-3412-512X; Stoddart, James Fraser/0000-0003-3161-3697; Slawin, Alexandra M Z/0000-0002-9527-6418; Barnes, Jonathan/0000-0003-2945-8691	Non-Equilibrium Energy Research Center, Energy Frontier Research Center (EFRC); U.S. Department of Energy, Office of Basic Energy Sciences (DOE-BES) [DESC0000989]; Argonne-Northwestern Solar Energy Research Center, EFRC; DOE-BES [DE-SC0001059]; U.S. National Science Foundation [CHE-1012378]; National Defense Science and Engineering Graduate Fellowship from the U.S. Department of Defense (DOD); Ryan Fellowship under Northwestern University International Institute for Nanotechnology; DOD [W911NF-10-1-0510]; National Science Foundation; American Chemical Society; Focus Center Research Program Center on Functional Engineered Nano Architectonics; NSF [CHE-0924620]; Engineering and Physical Sciences Research Council [EP/H003517/1]; World Class University [R-31-2008-000-10055-0]; Ministry of Education, Science and Technology, Republic of Korea; EPSRC [EP/H003517/1] Funding Source: UKRI	Non-Equilibrium Energy Research Center, Energy Frontier Research Center (EFRC); U.S. Department of Energy, Office of Basic Energy Sciences (DOE-BES)(United States Department of Energy (DOE)); Argonne-Northwestern Solar Energy Research Center, EFRC; DOE-BES(United States Department of Energy (DOE)); U.S. National Science Foundation(National Science Foundation (NSF)); National Defense Science and Engineering Graduate Fellowship from the U.S. Department of Defense (DOD); Ryan Fellowship under Northwestern University International Institute for Nanotechnology; DOD(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); American Chemical Society(American Chemical Society); Focus Center Research Program Center on Functional Engineered Nano Architectonics; NSF(National Science Foundation (NSF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); World Class University; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The data reported in this paper are tabulated in the supplementary materials, and the crystallographic parameters of each single crystal were deposited into the Cambridge Crystallographic Data Centre, where they are freely available under reference numbers 855030, 855031, 855032, and 889233. We thank S. Shafaie for his expertise and assistance with high-resolution mass spectrometry, and the Integrated Molecular Structure Education and Research Center at Northwestern University for providing access to equipment for the relevant experiments. Molecular crystal images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco. The authors acknowledge our joint collaborators Turki S. Al-Saud and M. B. Alfageeh from the King Abdulaziz City of Science and Technology in Saudi Arabia. J.F.S. is supported by the Non-Equilibrium Energy Research Center, which is an Energy Frontier Research Center (EFRC) funded by the U.S. Department of Energy, Office of Basic Energy Sciences (DOE-BES) under award DESC0000989. R. C. is supported by the Argonne-Northwestern Solar Energy Research Center, which is an EFRC funded by DOE-BES under award DE-SC0001059. M. R. W. and S. M. D. are supported by the U.S. National Science Foundation under grant CHE-1012378. J.C.B. was supported by a National Defense Science and Engineering Graduate Fellowship from the U.S. Department of Defense (DOD) and gratefully acknowledges support from the Ryan Fellowship (as does D. C.) awarded under the auspices of the Northwestern University International Institute for Nanotechnology, as well as the DOD award W911NF-10-1-0510 and the DOE-BES under award DE-SC0005462. A. C. F. and D. C. are supported by a Graduate Research Fellowship from the National Science Foundation. M. A. G. was supported by a Summer Undergraduate Research Fellowship from the American Chemical Society. J.F.S., D. B., E. T., and W. A. G. are funded through the Focus Center Research Program Center on Functional Engineered Nano Architectonics. J.F.S. and A.M.Z.S. were supported under the auspices of an international collaboration supported in the United States by the NSF under grant CHE-0924620 and in the United Kingdom by the Engineering and Physical Sciences Research Council under grant EP/H003517/1. J.C.B., A. C. F., D. C., W. A. G., and J.F.S. are also supported by the World Class University program (R-31-2008-000-10055-0) funded by the Ministry of Education, Science and Technology, Republic of Korea.	[Anonymous], 2006, JAG 7 6; BOCKMAN TM, 1990, J ORG CHEM, V55, P4127, DOI 10.1021/jo00300a033; CHIARELLI R, 1993, NATURE, V363, P147, DOI 10.1038/363147a0; Collier CP, 2000, SCIENCE, V289, P1172, DOI 10.1126/science.289.5482.1172; Connelly NG, 1996, CHEM REV, V96, P877, DOI 10.1021/cr940053x; CORDES AW, 1994, ADV MATER, V6, P798, DOI 10.1002/adma.19940061021; Coskun A, 2011, J AM CHEM SOC, V133, P4538, DOI 10.1021/ja110584c; Fahrenbach AC, 2012, J AM CHEM SOC, V134, P3061, DOI 10.1021/ja2089603; Gomberg M, 1900, J AM CHEM SOC, V22, P757, DOI 10.1021/ja02049a006; Green JE, 2007, NATURE, V445, P414, DOI 10.1038/nature05462; Hao HG, 2010, ANGEW CHEM INT EDIT, V49, P8148, DOI 10.1002/anie.201004928; Hunig S., 1967, PURE APPL CHEM, V15, P109, DOI DOI 10.1351/PAC196715010109; INOUE K, 1994, J AM CHEM SOC, V116, P3173, DOI 10.1021/ja00086a077; Itkis ME, 2002, SCIENCE, V296, P1443, DOI 10.1126/science.1071372; Jeon WS, 2002, CHEM COMMUN, P1828, DOI 10.1039/b202082c; Koivisto BD, 2005, COORDIN CHEM REV, V249, P2612, DOI 10.1016/j.ccr.2005.03.012; KOSOWER EM, 1971, J AM CHEM SOC, V93, P2534, DOI 10.1021/ja00739a030; KOSOWER EM, 1964, J AM CHEM SOC, V86, P5524, DOI 10.1021/ja01078a026; Lee J, 2011, ANGEW CHEM INT EDIT, V50, P4414, DOI 10.1002/anie.201004899; Maspoch D, 2005, CR CHIM, V8, P1213, DOI 10.1016/j.crci.2005.02.020; McKinnon SDJ, 2010, CHEM COMMUN, V46, P773, DOI 10.1039/b919920a; Michaelis L, 1933, J GEN PHYSIOL, V16, P859, DOI 10.1085/jgp.16.6.859; Michaelis L, 1935, CHEM REV, V16, P243, DOI 10.1021/cr60054a004; Morita Y, 2011, NAT MATER, V10, P947, DOI [10.1038/NMAT3142, 10.1038/nmat3142]; Nakahara K, 2011, CHEM LETT, V40, P222, DOI 10.1246/cl.2011.222; Nelsen SF, 2000, CHEM-EUR J, V6, P581, DOI 10.1002/(SICI)1521-3765(20000218)6:4<581::AID-CHEM581>3.3.CO;2-5; NETA P, 1985, J CHEM SOC FARAD T 2, V81, P1427, DOI 10.1039/f29858101427; ODELL B, 1988, ANGEW CHEM INT EDIT, V27, P1547, DOI 10.1002/anie.198815471; Porter WW, 2005, J ORG CHEM, V70, P5028, DOI 10.1021/jo050328g; Rajca A, 2001, SCIENCE, V294, P1503, DOI 10.1126/science.1065477; Ratera I, 2012, CHEM SOC REV, V41, P303, DOI 10.1039/c1cs15165g; Robinson M.B., 1967, ADV INORG CHEM, V10, P247, DOI [10.1016/S0065-2792(08)60179-X, DOI 10.1016/S0065-2792(08)60179-X]; Spruell JM, 2010, NAT CHEM, V2, P870, DOI [10.1038/NCHEM.749, 10.1038/nchem.749]; Sun D, 2004, J AM CHEM SOC, V126, P1388, DOI 10.1021/ja038746v; Sun DL, 2003, J AM CHEM SOC, V125, P15950, DOI 10.1021/ja037867s; Trabolsi A, 2010, NAT CHEM, V2, P42, DOI [10.1038/NCHEM.479, 10.1038/nchem.479]; Usta H, 2011, ACCOUNTS CHEM RES, V44, P501, DOI 10.1021/ar200006r	37	128	130	4	244	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					429	433		10.1126/science.1228429	http://dx.doi.org/10.1126/science.1228429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349286				2022-12-28	WOS:000313960700038
J	Hughson, FM				Hughson, Frederick M.			Chaperones That SNARE Neurotransmitter Release	SCIENCE			English	Editorial Material							MEMBRANE-FUSION; TETHERING FACTORS; COMPLEX		Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu						Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Li W, 2011, STRUCTURE, V19, P1443, DOI 10.1016/j.str.2011.07.012; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327	13	8	9	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					406	407		10.1126/science.1233801	http://dx.doi.org/10.1126/science.1233801			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349281				2022-12-28	WOS:000313960700030
J	Majumdar, S; Singh, A; Rio, DC				Majumdar, Sharmistha; Singh, Anita; Rio, Donald C.			The Human THAP9 Gene Encodes an Active P-Element DNA Transposase	SCIENCE			English	Article							V(D)J RECOMBINATION; BINDING DOMAIN; RAG PROTEINS; IN-VIVO; EVOLUTION; GENOME; REPAIR; MOBILE	The human genome contains similar to 50 genes that were derived from transposable elements or transposons, and many are now integral components of cellular gene expression programs. The human THAP9 gene is related to the Drosophila P-element transposase. Here, we show that human THAP9 can mobilize Drosophila P-elements in both Drosophila and human cells. Chimeric proteins formed between the Drosophila P-element transposase N-terminal THAP DNA binding domain and the C-terminal regions of human THAP9 can also mobilize Drosophila P elements. Our results indicate that human THAP9 is an active DNA transposase that, although "domesticated," still retains the catalytic activity to mobilize P transposable elements across species.	[Majumdar, Sharmistha; Singh, Anita; Rio, Donald C.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rio, Donald C.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Rio, Donald C.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rio, DC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	don_rio@berkeley.edu	MAJUMDAR, sharmistha/AAV-3512-2021; macedo santos, antónio/M-5737-2013	MAJUMDAR, sharmistha/0000-0003-4356-7237; macedo santos, antónio/0000-0003-2180-2718	NIH [R01GM48862, R01GM61987, R01 GM097352, R01GM104385, R01GM094890]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104385, R01GM097352, R01GM094890, R01GM048862, R01GM061987] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. M. Taliaferro, J. Aspden, and M. Francis for comments and discussion; R. Rawat for technical assistance; and C. J. Potter (Johns Hopkins Medical School) for helpful suggestions about the splinkerette PCR experiments. This work was supported by NIH grants R01GM48862, R01GM61987, R01 GM097352, R01GM104385, and R01GM094890. S. M. and D. C. R. conceived the experiments. S. M., A. S., and D. C. R. performed cell culture and molecular biological experiments and analyzed data. S. M. and D. C. R. wrote the paper. The authors declare no competing financial interests. Requests for materials should be addressed to the corresponding author.	Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Hagemann S, 2001, MOL BIOL EVOL, V18, P1979, DOI 10.1093/oxfordjournals.molbev.a003739; Hammer SE, 2005, MOL BIOL EVOL, V22, P833, DOI 10.1093/molbev/msi068; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Mul YM, 1997, EMBO J, V16, P4441, DOI 10.1093/emboj/16.14.4441; Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168; Quesneville H, 2005, MOL BIOL EVOL, V22, P741, DOI 10.1093/molbev/msi064; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Sabogal A, 2010, NAT STRUCT MOL BIOL, V17, P117, DOI 10.1038/nsmb.1742; Schaack S, 2010, TRENDS ECOL EVOL, V25, P537, DOI 10.1016/j.tree.2010.06.001; Shaheen M, 2010, GENETICA, V138, P559, DOI 10.1007/s10709-010-9452-1; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327	20	38	39	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					446	448		10.1126/science.1231789	http://dx.doi.org/10.1126/science.1231789			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349291	Green Accepted			2022-12-28	WOS:000313960700043
J	Margolis, HS				Margolis, Helen S.			How Big Is the Proton?	SCIENCE			English	Editorial Material									Natl Phys Lab, Teddington TW11 0LW, Middx, England	National Physical Laboratory - UK	Margolis, HS (corresponding author), Natl Phys Lab, Teddington TW11 0LW, Middx, England.	helen.margolis@npl.co.uk	Margolis, Helen/AAN-3253-2020	Margolis, Helen/0000-0002-8991-3855				Antognini A, 2013, SCIENCE, V339, P417, DOI 10.1126/science.1230016; Arnoult O, 2010, EUR PHYS J D, V60, P243, DOI 10.1140/epjd/e2010-00249-6; Biraben F, 2009, EUR PHYS J-SPEC TOP, V172, P109, DOI 10.1140/epjst/e2009-01045-3; Flowers JL, 2007, IEEE T INSTRUM MEAS, V56, P331, DOI 10.1109/TIM.2007.890598; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Parthey CG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.203001; Pohl R, 2010, NATURE, V466, P213, DOI 10.1038/nature09250; Sick I, 2012, PROG PART NUCL PHYS, V67, P473, DOI 10.1016/j.ppnp.2012.01.013; Tan JN, 2011, PHYS SCRIPTA, VT144, DOI 10.1088/0031-8949/2011/T144/014009	9	3	3	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					405	406		10.1126/science.1233202	http://dx.doi.org/10.1126/science.1233202			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349280				2022-12-28	WOS:000313960700029
J	Schwartz, MA; Chen, CS				Schwartz, Martin A.; Chen, Christopher S.			Deconstructing Dimensionality	SCIENCE			English	Editorial Material							CELL-MATRIX ADHESIONS; MORPHOGENESIS; POLARITY		[Schwartz, Martin A.] Yale Univ, Sch Med, Cardiovasc Res Ctr, New Haven, CT 06511 USA; [Chen, Christopher S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	Yale University; University of Pennsylvania	Schwartz, MA (corresponding author), Yale Univ, Sch Med, Cardiovasc Res Ctr, 300 George St, New Haven, CT 06511 USA.	martin.schwartz@yale.edu; chrischen@seas.upenn.edu	Chen, Christopher S./ABD-8499-2021	Chen, Christopher S./0000-0003-2445-8449; schwartz, martin/0000-0002-2071-1243	NHLBI NIH HHS [R01 HL075092] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075092] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; Carrel A, 1912, J EXP MED, V15, P516, DOI 10.1084/jem.15.5.516; Chen X, 2012, TISSUE ENG PT A, V18, P2528, DOI [10.1089/ten.tea.2012.0094, 10.1089/ten.TEA.2012.0094]; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Eisen R, 2006, AM J PHYSIOL-CELL PH, V290, pC1297, DOI 10.1152/ajpcell.00287.2005; Harrison RG, 1914, J EXP ZOOL, V17, P521, DOI 10.1002/jez.1400170403; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Liu KD, 2007, AM J PHYSIOL-RENAL, V293, pF1633, DOI 10.1152/ajprenal.00053.2007; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Santos E, 2012, TRENDS BIOTECHNOL, V30, P331, DOI 10.1016/j.tibtech.2012.03.005; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Wang YK, 2001, AM J PHYSIOL-CELL PH, V280, pC1440, DOI 10.1152/ajpcell.2001.280.6.C1440; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006	20	76	77	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					402	404		10.1126/science.1233814	http://dx.doi.org/10.1126/science.1233814			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349278				2022-12-28	WOS:000313960700027
J	Stafford, MR; Jackson, H; Mayo-Wilson, E; Morrison, AP; Kendall, T				Stafford, Megan R.; Jackson, Hannah; Mayo-Wilson, Evan; Morrison, Anthony P.; Kendall, Tim			Early interventions to prevent psychosis: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; ULTRA-HIGH RISK; COGNITIVE-BEHAVIORAL THERAPY; BLIND CLINICAL-TRIAL; YOUNG-PEOPLE; FOLLOW-UP; 1ST-EPISODE PSYCHOSIS; PLACEBO; OLANZAPINE; OMEGA-3-FATTY-ACIDS	Objective To determine whether any psychological, pharmacological, or nutritional interventions can prevent or delay transition to psychotic disorders for people at high risk. Design Systematic review and meta-analysis. Data sources Embase, Medline, PreMedline, PsycINFO, and CENTRAL were searched to November 2011 without restriction to publication status. Review methods Randomised trials comparing any psychological, pharmacological, nutritional, or combined intervention with usual services or another treatment. Studies of participants with a formal diagnosis of schizophrenia or bipolar disorder were excluded. Studies were assessed for bias, and relevant limitations were considered in summarising the results. Results 11 trials including 1246 participants and eight comparisons were included. Median sample size of included trials was 81 (range 51-288). Meta-analyses were performed for transition to psychosis, symptoms of psychosis, depression, and mania; quality of life; weight; and discontinuation of treatment. Evidence of moderate quality showed an effect for cognitive behavioural therapy on reducing transition to psychosis at 12 months (risk ratio 0.54 (95% confidence interval 0.34 to 0.86); risk difference -0.07 (-0.14 to -0.01). Very low quality evidence for omega-3 fatty acids and low to very low quality evidence for integrated psychotherapy also indicated that these interventions were associated with reductions in transition to psychosis at 12 months. Conclusions Although evidence of benefits for any specific intervention is not conclusive, these findings suggest that it might be possible to delay or prevent transition to psychosis. Further research should be undertaken to establish conclusively the potential for benefit of psychological interventions in the treatment of people at high risk of psychosis.	[Stafford, Megan R.; Jackson, Hannah] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London SW1X 8PG, England; [Mayo-Wilson, Evan] UCL, Res Dept Clin Educ & Hlth Psychol, Ctr Outcomes Res & Effectiveness, London, England; [Morrison, Anthony P.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Kendall, Tim] Sheffield Hlth & Social Care NHS Fdn Trust, Natl Collaborating Ctr Mental Hlth, Sheffield S10 3TH, S Yorkshire, England	University of London; University College London; University of London; University College London; University of Manchester	Kendall, T (corresponding author), Sheffield Hlth & Social Care NHS Fdn Trust, Natl Collaborating Ctr Mental Hlth, Sheffield S10 3TH, S Yorkshire, England.	tim.kendall@shsc.nhs.uk	Mayo-Wilson, Evan/J-6289-2019	Mayo-Wilson, Evan/0000-0001-6126-2459; Morrison, Anthony/0000-0002-4389-2091	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Collaborating Centre for Mental Health receives 1.4 pound million per year from the National Institute for Health and Clinical Excellence to develop guidelines for the treatment of mental health problems.	Abbasi K, 2004, BRIT MED J, V329, P637, DOI 10.1136/bmj.329.7467.637; Addington J, 2011, SCHIZOPHR RES, V125, P54, DOI 10.1016/j.schres.2010.10.015; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; [Anonymous], 1994, HDB RES SYNTHESIS; [Anonymous], 1996, COGNITIVE THERAPY DE; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bebbington P, 2000, SOC PSYCH PSYCH EPID, V35, P191, DOI 10.1007/s001270050227; Bebbington P, 2011, ADULT PSYCHIAT MORBI; Bechdolf A, 2012, BRIT J PSYCHIAT, V200, P22, DOI 10.1192/bjp.bp.109.066357; Bechdolf A, 2007, EARLY INTERV PSYCHIA, V1, P71, DOI 10.1111/j.1751-7893.2007.00013.x; Beck A.T., 1979, COGNITIVE THERAPY EM; Bird V, 2010, BRIT J PSYCHIAT, V197, P350, DOI 10.1192/bjp.bp.109.074526; Bloom DE, 2011, GLOBAL EC BURDEN NON; Fowler D, 1995, COGNITIVE BEHAV THER; Freeman MP, 2006, J CLIN PSYCHIAT, V67, P1954, DOI 10.4088/JCP.v67n1217; French P., 2004, EARLY DETECTION COGN; Fusar-Poli P, 2013, ACTA PSYCHIAT SCAND, V127, P248, DOI 10.1111/acps.12028; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P220, DOI 10.1001/archgenpsychiatry.2011.1472; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Haddock G, 1998, CLIN PSYCHOL REV, V18, P821, DOI 10.1016/S0272-7358(98)00007-5; Hansen NB, 2002, CLIN PSYCHOL-SCI PR, V9, P329, DOI 10.1093/clipsy/9.3.329; Hefner HBA, 2011, EARLY DETECTION INTE; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kingdon D, 1994, COGNITIVE BEHAV THER; Lambert M, 2007, PSYCHOTHER RES, V17, P1, DOI 10.1080/10503300601032506; Larsen Tor K, 2003, J Am Acad Psychoanal Dyn Psychiatry, V31, P209, DOI 10.1521/jaap.31.1.209.21928; Mangalore R, 2007, J MENT HEALTH POLICY, V10, P23; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marshall C, 2012, EARLY INTERV PSYCHIA, V6, P60, DOI 10.1111/j.1751-7893.2011.00299.x; Marshall M, 2011, COCHRANE DB SYST REV, V6; McCrone P, 2010, BRIT J PSYCHIAT, V196, P377, DOI 10.1192/bjp.bp.109.065896; McGlashan TH, 2006, AM J PSYCHIAT, V163, P790, DOI 10.1176/appi.ajp.163.5.790; McGlashan TH, 2003, SCHIZOPHRENIA BULL, V29, P851, DOI 10.1093/oxfordjournals.schbul.a007051; McGlashan TH, 2003, SCHIZOPHR RES, V61, P7, DOI 10.1016/S0920-9964(02)00439-5; McGorry PD, 2010, SCHIZOPHR RES, V120, P49, DOI 10.1016/j.schres.2010.03.016; McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921; Miller TJ, 2003, SCHIZOPHR RES, V61, P19, DOI 10.1016/S0920-9964(02)00440-1; Miller TJ, 2002, AM J PSYCHIAT, V159, P863, DOI 10.1176/appi.ajp.159.5.863; Morrison AP, 2007, SCHIZOPHRENIA BULL, V33, P682, DOI 10.1093/schbul/sbl042; Morrison AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2233; Morrison AP, 2011, EARLY INTERV PSYCHIA, V5, P24, DOI 10.1111/j.1751-7893.2010.00254.x; Morrison AP, 2001, BEHAV COGN PSYCHOTH, V29, P257, DOI 10.1017/S1352465801003010; Morrison AP, 2004, BRIT J PSYCHIAT, V185, P291, DOI 10.1192/bjp.185.4.291; Morrison AP, 2002, BRIT J PSYCHIAT, V181, pS78, DOI 10.1192/bjp.181.43.s78; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; National Institute for Health and Clinical Excellence, 2009, NICE GUID INT TREATM; Nordentoft Merete, 2006, Ugeskr Laeger, V168, P381; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Phillips LJ, 2007, SCHIZOPHR RES, V96, P25, DOI 10.1016/j.schres.2007.05.018; Phillips LJ, 2009, AUST NZ J PSYCHIAT, V43, P818, DOI 10.1080/00048670903107625; Rietdijk J, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-30; Ruhrmann S, 2007, BRIT J PSYCHIAT, V191, pS88, DOI 10.1192/bjp.191.51.s88; Ruhrmann S, 2010, ARCH GEN PSYCHIAT, V67, P241, DOI 10.1001/archgenpsychiatry.2009.206; STEIN LI, 1980, ARCH GEN PSYCHIAT, V37, P392; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; The Nordic Cochrane Centre The Cochrane Collaboration., 2008, REV MAN REVMAN VERS; van der Gaag M, 2012, SCHIZOPHR B; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; WHO, 2012, ICD 10 CLASS MENT BE; Woods SW, 2003, BIOL PSYCHIAT, V54, P453, DOI 10.1016/S0006-3223(03)00321-4; Yung AR, 2011, J CLIN PSYCHIAT, V72, P430, DOI 10.4088/JCP.08m04979ora; Yung AR, 2011, EARLY INTERV PSYCHIA, V5, P52, DOI 10.1111/j.1751-7893.2010.00241.x; Yung AR, 2003, SCHIZOPHR RES, V60, P21, DOI 10.1016/S0920-9964(02)00167-6; Yung AR, 2000, COMPREHENSIVE ASSESS; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; ZUBIN J, 1977, J ABNORM PSYCHOL, V86, P103, DOI 10.1037/0021-843X.86.2.103	71	188	194	1	113	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2013	346								f185	10.1136/bmj.f185	http://dx.doi.org/10.1136/bmj.f185			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075FW	23335473	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000313870300002
J	Reddi, AR; Culotta, VC				Reddi, Amit R.; Culotta, Valeria C.			SOD1 Integrates Signals from Oxygen and Glucose to Repress Respiration	CELL			English	Article							CASEIN KINASE-I; CU,ZN SUPEROXIDE-DISMUTASE; COPPER CHAPERONE CCS; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; NULL MUTANTS; H+-ATPASE; YEAST; ACTIVATION; MANGANESE	Cu/Zn superoxide dismutase (SOD1) is an abundant enzyme that has been best studied as a regulator of antioxidant defense. Using the yeast Saccharomyces cerevisiae, we report that SOD1 transmits signals from oxygen and glucose to repress respiration. The mechanism involves SOD1-mediated stabilization of two casein kinase 1-gamma (CK1 gamma) homologs, Yck1p and Yck2p, required for respiratory repression. SOD1 binds a C-terminal degron we identified in Yck1p/Yck2p and promotes kinase stability by catalyzing superoxide conversion to peroxide. The effects of SOD1 on CK1 gamma stability are also observed with mammalian SOD1 and CK1 gamma and in a human cell line. Therefore, in a single circuit, oxygen, glucose, and reactive oxygen can repress respiration through SOD1/CK1 gamma signaling. Our data therefore may provide mechanistic insight into how rapidly proliferating cells and many cancers accomplish glucose-mediated repression of respiration in favor of aerobic glycolysis.	[Reddi, Amit R.; Culotta, Valeria C.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Culotta, VC (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	vculotta@jhsph.edu			JHU NIEHS center; NIH R37 [GM50016]; NIH NIGMS fellowship [F32 GM 093550]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050016, F32GM093550, R37GM050016] Funding Source: NIH RePORTER	JHU NIEHS center; NIH R37; NIH NIGMS fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kavianpour, C. Vazquez, J. Gleason, D. Corrigan, and H. Chen for technical assistance and Professors M. Johnston, D. Thiele, L. Robinson, and J.-H. Kim for strains and plasmids. This work was supported by the JHU NIEHS center and by NIH R37 grant GM50016 (to V.C.C.). A.R.R. was supported by NIH NIGMS fellowship F32 GM 093550.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Alvarez HM, 2010, SCIENCE, V327, P331, DOI 10.1126/science.1179907; Barnese K, 2012, P NATL ACAD SCI USA, V109, P6892, DOI 10.1073/pnas.1203051109; Bensinger SJ, 2012, SEMIN CELL DEV BIOL, V23, P352, DOI 10.1016/j.semcdb.2012.02.003; BILINSKI T, 1985, BIOCHEM BIOPH RES CO, V130, P533, DOI 10.1016/0006-291X(85)90449-8; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; CHANG EC, 1990, J BACTERIOL, V172, P1840, DOI 10.1128/jb.172.4.1840-1845.1990; CHANG EC, 1989, J BIOL CHEM, V264, P12172; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; CULOTTA VC, 1995, J BIOL CHEM, V270, P29991; Davidson GS, 2011, MOL BIOL CELL, V22, P988, DOI 10.1091/mbc.E10-06-0499; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Estrada E, 1996, J BIOL CHEM, V271, P32064, DOI 10.1074/jbc.271.50.32064; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIACOMINI A, 1992, FEMS MICROBIOL LETT, V100, P87, DOI 10.1111/j.1574-6968.1992.tb05687.x; Gleason JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024741; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; Halliwell B., 2007, FREE RADICALS BIOL M; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Leitch JM, 2012, BIOCHEMISTRY-US, V51, P677, DOI 10.1021/bi201353y; Leitch JM, 2009, J BIOL CHEM, V284, P21863, DOI 10.1074/jbc.M109.000489; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Meng FJ, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-34; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Munroe W, 2007, J INORG BIOCHEM, V101, P1875, DOI 10.1016/j.jinorgbio.2007.07.008; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; Pasteur L, 1861, CR HEBD ACAD SCI, V52, P1260; Pasula S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-17; PERLIN DS, 1989, J BIOL CHEM, V264, P21857; Reddi AR, 2011, GENETICS, V189, P1261, DOI 10.1534/genetics.111.134007; Rinnerthaler M, 2012, P NATL ACAD SCI USA, V109, P8658, DOI 10.1073/pnas.1201629109; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; Ronald TKN, 2008, P NATL ACAD SCI USA, V105, P15166, DOI 10.1073/pnas.0807712105; Roth AF, 2011, MOL BIOL CELL, V22, P2702, DOI 10.1091/mbc.E11-02-0115; Sehati S, 2011, FREE RADICAL BIO MED, V50, P1591, DOI 10.1016/j.freeradbiomed.2011.03.004; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Sturtz LA, 2002, METHOD ENZYMOL, V349, P167, DOI 10.1016/S0076-6879(02)49332-9; Sun BM, 2004, MOL BIOL CELL, V15, P1397, DOI 10.1091/mbc.E03-09-0682; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Wang XT, 1996, NATURE, V383, P434, DOI 10.1038/383434a0; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; White C, 2009, J CELL SCI, V122, P1315, DOI 10.1242/jcs.043216; Wood LK, 2009, J BIOL CHEM, V284, P404, DOI 10.1074/jbc.M807027200; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007061; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; ZHAI LM, 1995, J BIOL CHEM, V270, P12717, DOI 10.1074/jbc.270.21.12717; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	59	147	152	1	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					224	235		10.1016/j.cell.2012.11.046	http://dx.doi.org/10.1016/j.cell.2012.11.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332757	Bronze, Green Accepted			2022-12-28	WOS:000313719800019
J	Chavala, SH; Williamson, JF				Chavala, Sai H.; Williamson, Jennifer F.			Bilateral exudative retinal detachments in Sturge-Weber syndrome	LANCET			English	Editorial Material									[Chavala, Sai H.; Williamson, Jennifer F.] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Chavala, SH (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27514 USA.	schavala@med.unc.edu							0	3	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 20	2013	382	9888					259	259		10.1016/S0140-6736(12)61607-9	http://dx.doi.org/10.1016/S0140-6736(12)61607-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FL	23375876				2022-12-28	WOS:000322543700035
J	Barry, CL; McGinty, EE; Vernick, JS; Webster, DW				Barry, Colleen L.; McGinty, Emma E.; Vernick, Jon S.; Webster, Daniel W.			After Newtown - Public Opinion on Gun Policy and Mental Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Barry, Colleen L.; McGinty, Emma E.; Vernick, Jon S.; Webster, Daniel W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [McGinty, Emma E.; Vernick, Jon S.; Webster, Daniel W.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Gun Policy & Res, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Barry, CL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA.							Blendon RJ, 1996, JAMA-J AM MED ASSOC, V275, P1719, DOI 10.1001/jama.275.22.1719; Davis JA, 2010, GEN SOCIAL SURVEYS 2; Sides J., 2012, WASH POST; Teret SP, 1998, NEW ENGL J MED, V339, P813, DOI 10.1056/NEJM199809173391206; VERNICK JS, 1993, HEALTH AFFAIR, V12, P198, DOI 10.1377/hlthaff.12.4.198	5	108	108	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2013	368	12					1077	1081		10.1056/NEJMp1300512	http://dx.doi.org/10.1056/NEJMp1300512			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108TH	23356490	Bronze			2022-12-28	WOS:000316318600014
J	Lee, SJ; McCormick, MS; Lippard, SJ; Cho, US				Lee, Seung Jae; McCormick, Michael S.; Lippard, Stephen J.; Cho, Uhn-Soo			Control of substrate access to the active site in methane monooxygenase	NATURE			English	Article							METHYLOCOCCUS-CAPSULATUS BATH; METHYLOSINUS-TRICHOSPORIUM OB3B; REGULATORY PROTEIN-B; HYDROXYLASE COMPONENT; DIOXYGEN ACTIVATION; CRYSTAL-STRUCTURE; OXYGEN ACTIVATION; OXIDATION	Methanotrophs consume methane as their major carbon source and have an essential role in the global carbon cycle by limiting escape of this greenhouse gas to the atmosphere(1-3). These bacteria oxidize methane to methanol by soluble and particulate methane monooxygenases (MMOs)(1-4). Soluble MMO contains three protein components, a 251-kilodalton hydroxylase (MMOH), a 38.6-kilodalton reductase (MMOR), and a 15.9-kilodalton regulatory protein (MMOB), required to couple electron consumption with substrate hydroxylation at the catalytic diiron centre of MMOH2. Until now, the role of MMOB has remained ambiguous owing to a lack of atomic-level information about the MMOH-MMOB (hereafter termed H-B) complex. Here we remedy this deficiency by providing a crystal structure of H-B, which reveals the manner by which MMOB controls the conformation of residues in MMOH crucial for substrate access to the active site. MMOB docks at the alpha(2)beta(2) interface of alpha(2)beta(2)gamma(2) MMOH, and triggers simultaneous conformational changes in the alpha-subunit that modulate oxygen and methane access as well as proton delivery to the diiron centre. Without such careful control by MMOB of these substrate routes to the diiron active site, the enzyme operates as an NADH oxidase rather than a monooxygenases(5). Biological catalysis involving small substrates is often accomplished in nature by large proteins and protein complexes. The structure presented in this work provides an elegant example of this principle.	[Lee, Seung Jae; McCormick, Michael S.; Lippard, Stephen J.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Cho, Uhn-Soo] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Lippard, SJ (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	lippard@mit.edu; uhnsoo@med.umich.edu		cho, uhn-soo/0000-0002-6992-2455	National Institute of General Medical Sciences [GM 32114]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032114, R01GM032134] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM 32114 from the National Institute of General Medical Sciences to S. J. Lippard. We thank the staff at the Advanced Light Source beamline 8.2.2. in Lawrence Berkeley National Laboratory for the data collection, S. C. Harrison for resources and comments on the manuscript, and T. C. Johnstone, A. D. Liang and T.-T. Lu for discussions.	Bailey LJ, 2008, P NATL ACAD SCI USA, V105, P19194, DOI 10.1073/pnas.0807948105; Blazyk JL, 2005, J AM CHEM SOC, V127, P17364, DOI 10.1021/ja0554054; Brandstetter H, 1999, CHEM BIOL, V6, P441, DOI 10.1016/S1074-5521(99)80062-3; Chang SL, 2001, BIOCHEMISTRY-US, V40, P9539, DOI 10.1021/bi0103462; Coufal DE, 2000, EUR J BIOCHEM, V267, P2174, DOI 10.1046/j.1432-1327.2000.01210.x; Elango N, 1997, PROTEIN SCI, V6, P556; FROLAND WA, 1992, J BIOL CHEM, V267, P17588; Gassner GT, 1999, BIOCHEMISTRY-US, V38, P12768, DOI 10.1021/bi990841m; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Leahy JG, 2003, FEMS MICROBIOL REV, V27, P449, DOI 10.1016/S0168-6445(03)00023-8; Lee SY, 1999, BIOCHEMISTRY-US, V38, P4423, DOI 10.1021/bi982712w; LIU KE, 1995, J AM CHEM SOC, V117, P10174, DOI 10.1021/ja00146a002; LIU Y, 1995, J BIOL CHEM, V270, P24662, DOI 10.1074/jbc.270.42.24662; McCormick MS, 2011, BIOCHEMISTRY-US, V50, P11058, DOI 10.1021/bi201248b; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; PAULSEN KE, 1994, BIOCHEMISTRY-US, V33, P713, DOI 10.1021/bi00169a013; RARDIN RL, 1991, NEW J CHEM, V15, P417; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Rosenzweig AC, 1997, PROTEINS, V29, P141, DOI 10.1002/(SICI)1097-0134(199710)29:2<141::AID-PROT2>3.3.CO;2-W; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P15392, DOI 10.1021/bi0618969; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Song WJ, 2010, J AM CHEM SOC, V132, P13582, DOI 10.1021/ja1063795; Tinberg CE, 2009, BIOCHEMISTRY-US, V48, P12145, DOI 10.1021/bi901672n; Valentine AM, 1999, J AM CHEM SOC, V121, P3876, DOI 10.1021/ja9839522; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Walters KJ, 1999, P NATL ACAD SCI USA, V96, P7877, DOI 10.1073/pnas.96.14.7877; Whittington DA, 2001, J AM CHEM SOC, V123, P827, DOI 10.1021/ja003240n; Whittington DA, 2001, BIOCHEMISTRY-US, V40, P3476, DOI 10.1021/bi0022487; Whittington DA, 2001, J AM CHEM SOC, V123, P1794, DOI 10.1021/ja0031725	30	93	104	3	263	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					380	384		10.1038/nature11880	http://dx.doi.org/10.1038/nature11880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23395959	Green Accepted, Green Submitted			2022-12-28	WOS:000315312900044
J	Bloom, JS; Ehrenreich, IM; Loo, WT; Lite, TLV; Kruglyak, L				Bloom, Joshua S.; Ehrenreich, Ian M.; Loo, Wesley T.; Thuy-Lan Vo Lite; Kruglyak, Leonid			Finding the sources of missing heritability in a yeast cross	NATURE			English	Article							GENETIC INTERACTIONS; COMPLEX DISEASES; HUMAN HEIGHT; VARIANTS; TRAITS; EXPRESSION; EVOLUTION	For many traits, including susceptibility to common diseases in humans, causal loci uncovered by genetic-mapping studies explain only a minority of the heritable contribution to trait variation. Multiple explanations for this 'missing heritability' have been proposed(1). Here we use a large cross between two yeast strains to accurately estimate different sources of heritable variation for 46 quantitative traits, and to detect underlying loci with high statistical power. We find that the detected loci explain nearly the entire additive contribution to heritable variation for the traits studied. We also show that the contribution to heritability of gene-gene interactions varies among traits, from near zero to approximately 50 per cent. Detected two-locus interactions explain only a minority of this contribution. These results substantially advance our understanding of the missing heritability problem and have important implications	[Bloom, Joshua S.; Ehrenreich, Ian M.; Loo, Wesley T.; Thuy-Lan Vo Lite; Kruglyak, Leonid] Princeton Uniyers, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08540 USA; [Bloom, Joshua S.; Loo, Wesley T.; Thuy-Lan Vo Lite] Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA; [Ehrenreich, Ian M.] Univ So Calif, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; [Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08540 USA	Princeton University; University of Southern California; Princeton University; Howard Hughes Medical Institute; Princeton University	Kruglyak, L (corresponding author), Princeton Uniyers, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08540 USA.	leonid@genomics.princeton.edu		Loo, Wesley/0000-0002-8281-8599	National Institutes of Health (NIH) [R37 MH59520, R01 GM102308]; James S. McDonnell Centennial Fellowship; Howard Hughes Medical Institute; National Science Foundation (NSF); NIH postdoctoral fellowship [F32 HG51762]; NIH grant [P50 GM071508]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG005176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102308, P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Centennial Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Botstein, M. McClean, E. Andersen, F. Albert, S. Treusch, R. Ghosh and X. Wang for comments on the manuscript, Y. Jia and S. Schrader for technical assistance and E. Lander for discussions. This work was supported by National Institutes of Health (NIH) grants R37 MH59520 and R01 GM102308, a James S. McDonnell Centennial Fellowship, and the Howard Hughes Medical Institute (L.K.), a National Science Foundation (NSF) fellowship (J.S.B.), NIH postdoctoral fellowship F32 HG51762 (I.M.E.) and NIH grant P50 GM071508 to the Center for Quantitative Biology at the Lewis-Sigler Institute of Princeton University.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Ehrenreich IM, 2009, COLD SH Q B, V74, P145, DOI 10.1101/sqb.2009.74.013; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Falconer DS, 1996, INTRO QUANTITATIVE G; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hill WG, 2010, PHILOS T R SOC B, V365, P73, DOI 10.1098/rstb.2009.0203; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	30	272	276	3	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					234	237		10.1038/nature11867	http://dx.doi.org/10.1038/nature11867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23376951	Green Submitted, Green Accepted			2022-12-28	WOS:000315137700039
J	Schuepbach, WMM; Rau, J; Knudsen, K; Volkmann, J; Krack, P; Timmermann, L; Halbig, TD; Hesekamp, H; Navarro, SM; Meier, N; Falk, D; Mehdorn, M; Paschen, S; Maarouf, M; Barbe, MT; Fink, GR; Kupsch, A; Gruber, D; Schneider, GH; Seigneuret, E; Kistner, A; Chaynes, P; Ory-Magne, F; Courbon, CB; Vesper, J; Schnitzler, A; Wojtecki, L; Houeto, JL; Bataille, B; Maltete, D; Damier, P; Raoul, S; Sixel-Doering, F; Hellwig, D; Gharabaghi, A; Kruger, R; Pinsker, MO; Amtage, F; Regis, JM; Witjas, T; Thobois, S; Mertens, P; Kloss, M; Hartmann, A; Oertel, WH; Post, B; Speelman, H; Agid, Y; Schade-Brittinger, C; Deuschl, G				Schuepbach, W. M. M.; Rau, J.; Knudsen, K.; Volkmann, J.; Krack, P.; Timmermann, L.; Haelbig, T. D.; Hesekamp, H.; Navarro, S. M.; Meier, N.; Falk, D.; Mehdorn, M.; Paschen, S.; Maarouf, M.; Barbe, M. T.; Fink, G. R.; Kupsch, A.; Gruber, D.; Schneider, G. -H.; Seigneuret, E.; Kistner, A.; Chaynes, P.; Ory-Magne, F.; Courbon, C. Brefel; Vesper, J.; Schnitzler, A.; Wojtecki, L.; Houeto, J-L.; Bataille, B.; Maltete, D.; Damier, P.; Raoul, S.; Sixel-Doering, F.; Hellwig, D.; Gharabaghi, A.; Krueger, R.; Pinsker, M. O.; Amtage, F.; Regis, J. -M.; Witjas, T.; Thobois, S.; Mertens, P.; Kloss, M.; Hartmann, A.; Oertel, W. H.; Post, B.; Speelman, H.; Agid, Y.; Schade-Brittinger, C.; Deuschl, G.		EARLYSTIM Study Grp	Neurostimulation for Parkinson's Disease with Early Motor Complications	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-BRAIN-STIMULATION; QUALITY-OF-LIFE; SUBTHALAMIC NUCLEUS; MOVEMENT-DISORDERS; CONTROLLED-TRIAL; RATING-SCALE; QUESTIONNAIRE; MULTICENTER; RELIABILITY; DEPRESSION	BACKGROUND Subthalamic stimulation reduces motor disability and improves quality of life in patients with advanced Parkinson's disease who have severe levodopa-induced motor complications. We hypothesized that neurostimulation would be beneficial at an earlier stage of Parkinson's disease. METHODS In this 2-year trial, we randomly assigned 251 patients with Parkinson's disease and early motor complications (mean age, 52 years; mean duration of disease, 7.5 years) to undergo neurostimulation plus medical therapy or medical therapy alone. The primary end point was quality of life, as assessed with the use of the Parkinson's Disease Questionnaire (PDQ-39) summary index (with scores ranging from 0 to 100 and higher scores indicating worse function). Major secondary outcomes included parkinsonian motor disability, activities of daily living, levodopa-induced motor complications (as assessed with the use of the Unified Parkinson's Disease Rating Scale, parts III, II, and IV, respectively), and time with good mobility and no dyskinesia. RESULTS For the primary outcome of quality of life, the mean score for the neurostimulation group improved by 7.8 points, and that for the medical-therapy group worsened by 0.2 points (between-group difference in mean change from baseline to 2 years, 8.0 points; P = 0.002). Neurostimulation was superior to medical therapy with respect to motor disability (P<0.001), activities of daily living (P<0.001), levodopa-induced motor complications (P<0.001), and time with good mobility and no dyskinesia (P = 0.01). Serious adverse events occurred in 54.8% of the patients in the neurostimulation group and in 44.1% of those in the medical-therapy group. Serious adverse events related to surgical implantation or the neurostimulation device occurred in 17.7% of patients. An expert panel confirmed that medical therapy was consistent with practice guidelines for 96.8% of the patients in the neurostimulation group and for 94.5% of those in the medical-therapy group. CONCLUSIONS Subthalamic stimulation was superior to medical therapy in patients with Parkinson's disease and early motor complications.	[Schuepbach, W. M. M.; Haelbig, T. D.; Hesekamp, H.; Meier, N.; Hartmann, A.; Agid, Y.] Univ Paris 06, AP HP, CIC 9503, Inst Cerveau & Moelle Epiniere,Dept Neurol, Paris, France; [Schuepbach, W. M. M.; Haelbig, T. D.; Hesekamp, H.; Meier, N.; Hartmann, A.; Agid, Y.] CHU Pitie Salpetriere, INSERM, Paris, France; [Navarro, S. M.] CHU Pitie Salpetriere, Dept Neurosurg, Paris, France; [Krack, P.; Kistner, A.] Univ Hosp, INSERM, U836, Dept Neurol, Grenoble, France; [Seigneuret, E.] Univ Hosp, INSERM, U836, Dept Neurosurg, Grenoble, France; [Chaynes, P.; Ory-Magne, F.; Courbon, C. Brefel] Univ Hosp, Dept Neurol Neurosurg & Pharmacol, Toulouse, France; [Houeto, J-L.] Univ Poitiers, Serv Neurol, CIC INSERM INSERM Unite 1084 0802, Lab Neurosci Expt & Clin, Poitiers, France; [Bataille, B.] Univ Poitiers, Dept Neurosurg, Poitiers, France; [Maltete, D.] Univ Hosp, Dept Neurol, Rouen, France; [Damier, P.; Raoul, S.] CHU Nantes, CIC, F-44035 Nantes 01, France; [Regis, J. -M.] Aix Marseille Univ, Dept Funct Neurosurg, Marseille, France; [Witjas, T.] Univ Hosp Timone, Dept Neurol, Marseille, France; [Thobois, S.] Univ Lyon 1, Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, F-69365 Lyon, France; [Mertens, P.] Univ Hosp, Dept Neurosurg, Lyon, France; [Rau, J.; Schade-Brittinger, C.] Philipps Univ, Coordinating Ctr Clin Trials, Marburg, Germany; [Hellwig, D.] Philipps Univ, Dept Neurosurg, Marburg, Germany; [Oertel, W. H.] Philipps Univ, Dept Neurol, Marburg, Germany; [Knudsen, K.; Volkmann, J.; Paschen, S.; Deuschl, G.] Univ Hosp Schleswig Holstein, Dept Neurol, Kiel, Germany; [Falk, D.; Mehdorn, M.] Univ Hosp Schleswig Holstein, Dept Neurosurg, Kiel, Germany; [Timmermann, L.; Barbe, M. T.; Fink, G. R.] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany; [Maarouf, M.] Univ Cologne, Dept Neurosurg, D-50931 Cologne, Germany; [Kupsch, A.; Gruber, D.] Charite Campus Virchow Hosp, Dept Neurol, Berlin, Germany; [Schneider, G. -H.] Charite Campus Virchow Hosp, Dept Neurosurg, Berlin, Germany; [Vesper, J.] Univ Dusseldorf, Dept Neurosurg, D-40225 Dusseldorf, Germany; [Schnitzler, A.; Wojtecki, L.] Univ Dusseldorf, Dept Neurol, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [Sixel-Doering, F.] Paracelsus Elena Klin, Kassel, Germany; [Gharabaghi, A.] Univ Hosp, Dept Neurosurg, Tubingen, Germany; [Krueger, R.] Univ Hosp, Ctr Neurol, Tubingen, Germany; [Krueger, R.] Univ Hosp, Hertie Inst Clin Brain Res, Tubingen, Germany; [Pinsker, M. O.] Univ Hosp, Dept Neurosurg, Freiburg, Germany; [Amtage, F.] Univ Hosp, Dept Neurol, Freiburg, Germany; [Kloss, M.] Univ Hosp, Dept Neurol, Heidelberg, Germany; [Post, B.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Speelman, H.] Univ Amsterdam, Dept Neurol, Amsterdam, Netherlands	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Poitiers; Universite de Poitiers; CHU de Rouen; Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Cologne; University of Cologne; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Freiburg; University of Freiburg; Ruprecht Karls University Heidelberg; Radboud University Nijmegen; University of Amsterdam	Deuschl, G (corresponding author), Univ Kiel, Dept Neurol, Univ Hosp Schleswig Holstein, Campus Kiel,Arnold Heller Str 3, D-24105 Kiel, Germany.	g.deuschl@neurologie.uni-kiel.de	Kistner, Andrea/AAE-8812-2020; Thobois, Stephane/H-5083-2017; Volkmann, Jens/AAK-7570-2020; Schnitzler, Alfons/Q-5520-2019; Schnitzler, Alfons/AAT-1054-2021; Deuschl, Gunther/A-7986-2010; Damier, Philippe/T-7829-2019; Schnitzler, Alfons/K-4625-2014; Fink, Gereon R./AFW-9377-2022; Corvol, Jean-Christophe/F-2124-2017; corvol, jean-christophe/I-6387-2012; Levin, Johannes/E-4052-2010; Fink, Gereon R./E-1616-2012; Wojtecki, Lars/AAT-6604-2021	Schnitzler, Alfons/0000-0002-6414-7939; Deuschl, Gunther/0000-0002-4176-9196; Schnitzler, Alfons/0000-0002-6414-7939; Fink, Gereon R./0000-0002-8230-1856; Corvol, Jean-Christophe/0000-0001-7325-0199; corvol, jean-christophe/0000-0001-7325-0199; Levin, Johannes/0000-0001-5092-4306; Fink, Gereon R./0000-0002-8230-1856; Wojtecki, Lars/0000-0002-6205-4405; Volkmann, Jens/0000-0002-9570-593X; Gharabaghi, Alireza/0000-0002-9782-5281; Mertens, Patrick/0000-0001-5272-261X; Krack, Paul/0000-0002-3508-7295; Schneider, Gerd-Helge/0000-0002-1301-2938; Barbe, Michael T./0000-0003-1149-8054; Krueger, Rejko/0000-0003-4258-6241; Timmermann, Lars/0000-0002-5301-3580	German Ministry of Research	German Ministry of Research	Funded by the German Ministry of Research and others; EARLYSTIM ClinicalTrials.gov number, NCT00354133.)	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beunckens C, 2005, CLIN TRIALS, V2, P379, DOI 10.1191/1740774505cn119oa; Daniels C, 2011, MOVEMENT DISORD, V26, P2516, DOI 10.1002/mds.23907; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Deuschl G, 2013, PARKINSONISM RELAT D, V19, P56, DOI 10.1016/j.parkreldis.2012.07.004; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Fasano A, 2010, BRAIN, V133, P2664, DOI 10.1093/brain/awq221; Fitzpatrick R, 1997, MOVEMENT DISORD, V12, P916, DOI 10.1002/mds.870120613; FLEMENBAUM A, 1973, PSYCHOL REP, V32, P783, DOI 10.2466/pr0.1973.33.3.783; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Fox SH, 2011, MOVEMENT DISORD, V26, pS2, DOI 10.1002/mds.23829; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Horstink M, 2006, EUR J NEUROL, V13, P1186, DOI 10.1111/j.1468-1331.2006.01548.x; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; Kleiner-Fisman G, 2006, MOVEMENT DISORD, V21, pS290, DOI 10.1002/mds.20962; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Mallinckrodt C H, 2001, J Biopharm Stat, V11, P9, DOI 10.1081/BIP-100104194; Marinus J, 2003, J CLIN EPIDEMIOL, V56, P61, DOI 10.1016/S0895-4356(02)00569-3; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P2371, DOI 10.1002/mds.23834; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Moro E, 2010, MOVEMENT DISORD, V25, P578, DOI 10.1002/mds.22735; Okun MS, 2012, LANCET NEUROL, V11, P208, DOI 10.1016/S1474-4422(11)70308-8; Okun MS, 2012, LANCET NEUROL, V11, P140, DOI 10.1016/S1474-4422(11)70308-8; Peto V, 2001, AGE AGEING, V30, P299, DOI 10.1093/ageing/30.4.299; Post B, 2005, MOVEMENT DISORD, V20, P1577, DOI 10.1002/mds.20640; Post B, 2011, MOVEMENT DISORD, V26, P449, DOI 10.1002/mds.23467; Schrag A, 2000, MOVEMENT DISORD, V15, P1112, DOI 10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A; Schrag A, 2009, MOVEMENT DISORD, V24, P813, DOI 10.1002/mds.22438; Schupbach WMM, 2007, NEUROLOGY, V68, P267, DOI 10.1212/01.wnl.0000250253.03919.fb; Smeding HMM, 2011, J NEUROL NEUROSUR PS, V82, P754, DOI 10.1136/jnnp.2007.140012; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Vidailhet M, 2011, NAT REV NEUROL, V7, P70, DOI 10.1038/nrneurol.2010.216; Voon V, 2008, BRAIN, V131, P2720, DOI 10.1093/brain/awn214; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4	38	833	858	2	155	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					610	622		10.1056/NEJMoa1205158	http://dx.doi.org/10.1056/NEJMoa1205158			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194VA	23406026	Green Published			2022-12-28	WOS:000322659600006
J	Spence, D				Spence, Des			FROM THE FRONTLINE Mid Staffs shames us all	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2013	346								f927	10.1136/bmj.f927	http://dx.doi.org/10.1136/bmj.f927			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZG	23403833				2022-12-28	WOS:000315087700010
J	Armstrong, FA				Armstrong, Fraser A.			Copying Biology's Ways with Hydrogen	SCIENCE			English	Editorial Material							VULGARIS MIYAZAKI-F; REACTIVITY; COMPLEX; SITE; H-2		Univ Oxford, Dept Chem, Inorgan Chem Lab, Oxford OX1 3QR, England	University of Oxford	Armstrong, FA (corresponding author), Univ Oxford, Dept Chem, Inorgan Chem Lab, S Parks Rd, Oxford OX1 3QR, England.	fraser.armstrong@chem.ox.ac.uk			Biotechnology and Biological Sciences Research Council [BB/I022309/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H019480/1] Funding Source: researchfish; BBSRC [BB/I022309/1] Funding Source: UKRI; EPSRC [EP/H019480/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Foerster S, 2005, J BIOL INORG CHEM, V10, P51, DOI 10.1007/s00775-004-0613-5; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Kubas GJ, 2007, CHEM REV, V107, P4152, DOI 10.1021/cr050197j; Ogata H, 2002, J AM CHEM SOC, V124, P11628, DOI 10.1021/ja012645k; Ogo S, 2007, SCIENCE, V316, P585, DOI 10.1126/science.1138751; Ogo S, 2013, SCIENCE, V339, P682, DOI 10.1126/science.1231345; Raugei S, 2012, CHEM-EUR J, V18, P6493, DOI 10.1002/chem.201103346; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Wu H, 2008, CR CHIM, V11, P790, DOI 10.1016/j.crci.2008.04.005	9	16	16	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					658	659		10.1126/science.1233210	http://dx.doi.org/10.1126/science.1233210			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393255				2022-12-28	WOS:000314585600030
J	Nabel, GJ				Nabel, Gary J.			GLOBAL HEALTH Designing Tomorrow's Vaccines	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BROADLY NEUTRALIZING ANTIBODIES; RATIONAL DESIGN; SIV INFECTION; HIV VACCINE; VIRUS; POTENT; PROTECTION; PROSPECTS; GLYCOPROTEIN; CONFIDENCE		[Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), Sanofi, 640 Mem Dr, Cambridge, MA 02139 USA.	gary.nabel@sanofi.com			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005003, Z01AI005002] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI005003-06, ZIA AI005058-07, Z01 AI005002-06, Z99 AI999999, ZIA AI005003-08, ZIA AI005002-08] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], WORLD MAL REP 2011 F; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Benmira S, 2010, CURR HIV RES, V8, P441, DOI 10.2174/157016210793499286; Berkley S, 2012, JOHN RING LAMONTAGNE; Black S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001738; Burns DL, 2012, CURR OPIN VIROL, V2, P353, DOI 10.1016/j.coviro.2012.01.004; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Butler NS, 2011, CELL MICROBIOL, V13, P925, DOI 10.1111/j.1462-5822.2011.01594.x; CDC, 1999, MMWR-MORBID MORTAL W, V48, P243; Chow SC, 2007, ADAPTIVE DESIGN METH; Coffey CS, 2008, DRUGS R&D, V9, P229, DOI 10.2165/00126839-200809040-00003; Corey L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001863; Delrue I, 2012, EXPERT REV VACCINES, V11, P695, DOI [10.1586/ERV.12.38, 10.1586/erv.12.38]; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Emerson SS, 2006, STAT MED, V25, P3270, DOI 10.1002/sim.2626; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; HU SL, 1992, SCIENCE, V255, P456, DOI 10.1126/science.1531159; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Joint United Nations Programme on HIV/AIDS, 2012, WORLD AIDS DAY REP 2; Kelly DF, 2005, ADV EXP MED BIOL, V568, P217; Kwong PD, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007278; Landry S, 2005, HEALTH AFFAIR, V24, P758, DOI 10.1377/hlthaff.24.3.758; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Lauring AS, 2010, NAT BIOTECHNOL, V28, P573, DOI 10.1038/nbt.1635; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Levitz SM, 2012, CELL, V148, P1284, DOI 10.1016/j.cell.2012.02.012; Mascola JR, 2005, J VIROL, V79, P771, DOI 10.1128/JVI.79.2.771-779.2005; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Nabel GJ, 2011, PHILOS T R SOC B, V366, P2759, DOI 10.1098/rstb.2011.0096; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Osterholm MT, 2012, LANCET INFECT DIS, V12, P655, DOI 10.1016/S1473-3099(12)70210-4; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Rappuoli R, 2012, NAT REV IMMUNOL, V12, P225, DOI 10.1038/nri3168; Rappuoli R, 2011, NAT REV IMMUNOL, V11, P865, DOI 10.1038/nri3085; Rappuoli R, 2011, NATURE, V473, P463, DOI 10.1038/nature10124; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Tomaras GD, 2010, CURR OPIN HIV AIDS, V5, P421, DOI 10.1097/COH.0b013e32833d2d45; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang S, 2008, VACCINE, V26, P3946, DOI 10.1016/j.vaccine.2008.04.025; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WHO, 2011 2012 TUB GLOB F; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	52	178	182	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					551	560		10.1056/NEJMra1204186	http://dx.doi.org/10.1056/NEJMra1204186			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083VU	23388006	Green Accepted			2022-12-28	WOS:000314494100006
J	Thanassoulis, G; Campbell, CY; Owens, DS; Smith, JG; Smith, AV; Peloso, GM; Kerr, KF; Pechlivanis, S; Budoff, MJ; Harris, TB; Malhotra, R; O'Brien, KD; Kamstrup, PR; Nordestgaard, BG; Tybjaerg-Hansen, A; Allison, MA; Aspelund, T; Criqui, MH; Heckbert, SR; Hwang, SJ; Liu, YM; Sjogren, M; van der Pals, J; Kalsch, H; Muhleisen, TW; Nothen, MM; Cupples, LA; Caslake, M; Di Angelantonio, E; Danesh, J; Rotter, JI; Sigurdsson, S; Wong, Q; Erbel, R; Kathiresan, S; Melander, O; Gudnason, V; O'Donnell, CJ; Post, WS				Thanassoulis, George; Campbell, Catherine Y.; Owens, David S.; Smith, J. Gustav; Smith, Albert V.; Peloso, Gina M.; Kerr, Kathleen F.; Pechlivanis, Sonali; Budoff, Matthew J.; Harris, Tamara B.; Malhotra, Rajeev; O'Brien, Kevin D.; Kamstrup, Pia R.; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne; Allison, Matthew A.; Aspelund, Thor; Criqui, Michael H.; Heckbert, Susan R.; Hwang, Shih-Jen; Liu, Yongmei; Sjogren, Marketa; van der Pals, Jesper; Kaelsch, Hagen; Muehleisen, Thomas W.; Noethen, Markus M.; Cupples, L. Adrienne; Caslake, Muriel; Di Angelantonio, Emanuele; Danesh, John; Rotter, Jerome I.; Sigurdsson, Sigurdur; Wong, Quenna; Erbel, Raimund; Kathiresan, Sekar; Melander, Olle; Gudnason, Vilmundur; O'Donnell, Christopher J.; Post, Wendy S.		CHARGE Extracoronary Calcium Worki	Genetic Associations with Valvular Calcification and Aortic Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY CALCIUM; RISK-FACTORS; VALVE SCLEROSIS; LP(A) LIPOPROTEIN; HEART; DESIGN; ATHEROSCLEROSIS; APOLIPOPROTEIN; ACCUMULATION	Background Limited information is available regarding genetic contributions to valvular calcification, which is an important precursor of clinical valve disease. Methods We determined genomewide associations with the presence of aortic-valve calcification (among 6942 participants) and mitral annular calcification (among 3795 participants), as detected by computed tomographic (CT) scanning; the study population for this analysis included persons of white European ancestry from three cohorts participating in the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium (discovery population). Findings were replicated in independent cohorts of persons with either CT-detected valvular calcification or clinical aortic stenosis. Results One SNP in the lipoprotein(a) (LPA) locus (rs10455872) reached genomewide significance for the presence of aortic-valve calcification (odds ratio per allele, 2.05; P = 9.0x10(-10)), a finding that was replicated in additional white European, African-American, and Hispanic-American cohorts (P<0.05 for all comparisons). Genetically determined Lp(a) levels, as predicted by LPA genotype, were also associated with aortic-valve calcification, supporting a causal role for Lp(a). In prospective analyses, LPA genotype was associated with incident aortic stenosis (hazard ratio per allele, 1.68; 95% confidence interval [CI], 1.32 to 2.15) and aortic-valve replacement (hazard ratio, 1.54; 95% CI, 1.05 to 2.27) in a large Swedish cohort; the association with incident aortic stenosis was also replicated in an independent Danish cohort. Two SNPs (rs17659543 and rs13415097) near the proinflammatory gene IL1F9 achieved genomewide significance for mitral annular calcification (P = 1.5x10(-8) and P = 1.8x10(-8), respectively), but the findings were not replicated consistently. Conclusions Genetic variation in the LPA locus, mediated by Lp(a) levels, is associated with aortic-valve calcification across multiple ethnic groups and with incident clinical aortic stenosis. (Funded by the National Heart, Lung, and Blood Institute and others.)	[Thanassoulis, George] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada; [Thanassoulis, George] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Hwang, Shih-Jen; O'Donnell, Christopher J.] NHLBI, Div Intramural Res, Framingham, MA USA; [Thanassoulis, George; Peloso, Gina M.; Hwang, Shih-Jen; Cupples, L. Adrienne; Kathiresan, Sekar; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Peloso, Gina M.; Malhotra, Rajeev; Kathiresan, Sekar; O'Donnell, Christopher J.] Boston Univ, Sch Med, Dept Med, Massachusetts Gen Hosp, Boston, MA 02118 USA; [Campbell, Catherine Y.; Post, Wendy S.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Budoff, Matthew J.] Harbor UCLA, Los Angeles Biomed Res Inst, Los Angeles, CA USA; [Liu, Yongmei] Wake Forest Sch Med, Winston Salem, NC USA; [Kerr, Kathleen F.; Wong, Quenna] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Heckbert, Susan R.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Allison, Matthew A.; Criqui, Michael H.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Owens, David S.; O'Brien, Kevin D.] Univ Washington, Dept Med, Seattle, WA USA; [Smith, Albert V.; Aspelund, Thor; Sigurdsson, Sigurdur; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Harris, Tamara B.] NIA, Bethesda, MD 20892 USA; [Caslake, Muriel] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Di Angelantonio, Emanuele; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Smith, J. Gustav] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Smith, J. Gustav; van der Pals, Jesper] Lund Univ, Dept Cardiol, Lund, Sweden; [Sjogren, Marketa; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Pechlivanis, Sonali] Univ Essen Gesamthsch, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Kaelsch, Hagen; Erbel, Raimund] W German Heart Ctr, Dept Cardiol, Essen, Germany; [Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Noethen, Markus M.] Univ Bonn, German Ctr Neurodegenerat Dis, Bonn, Germany; [Kamstrup, Pia R.; Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Wake Forest University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Glasgow; University of Cambridge; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Lund University; Lund University; University of Duisburg Essen; University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Post, WS (corresponding author), Carnegie 568,600 N Wolfe St, Baltimore, MD 21287 USA.	wpost@jhmi.edu	Budoff, Matthew/ABD-5175-2021; DiAngelantonio, Emanuele/ABE-6852-2020; O'Brien, Kevin Douglas/HDO-1461-2022; Rotter, Jerome/AAY-6598-2021; Hwang, Shih-Jen/HGU-5826-2022; Gudnason, Vilmundur/K-6885-2015; Smith, Albert Vernon/K-5150-2015; Gudnason, Vilmundur/AAE-7126-2019; Aspelund, Thor/K-7022-2019; Aspelund, Thor/C-5983-2008; O'Brien, Kevin/CAH-4638-2022; Kerr, Kathleen F./A-2893-2013; Nordestgaard, Borge Gronne/ABF-1310-2020	Budoff, Matthew/0000-0002-9616-1946; O'Brien, Kevin Douglas/0000-0002-2293-9196; Gudnason, Vilmundur/0000-0001-5696-0084; Smith, Albert Vernon/0000-0003-1942-5845; Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Aspelund, Thor/0000-0002-7998-5433; O'Brien, Kevin/0000-0002-2293-9196; Kerr, Kathleen F./0000-0002-6438-9583; Allison, Matthew/0000-0003-0777-8272; Di Angelantonio, Emanuele/0000-0001-8776-6719; Malhotra, Rajeev/0000-0003-0120-4630; Nordestgaard, Borge/0000-0002-1954-7220; Melander, Olle/0000-0002-2581-484X; Owens, David/0000-0002-7293-9688; Pechlivanis, Sonali/0000-0002-6181-7044; Cupples, L. Adrienne/0000-0003-0273-7965; Nothen, Markus/0000-0002-8770-2464	National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-25195, N02-HL-6-4278, N01-HC-95159, 95169, RR-024156, R01-HL-071739, R01-HL-071051, R01-HL-071205, R01-HL-071250, R01-HL-071251, R01-HL-071252, R01-HL-071258, R01-HL-071259, N01-HC-65226]; Affymetrix for genotyping services; National Institute on Aging [N01-AG-12100]; National Eye Institute; National Institute on Deafness and Other Communication Disorders; National Institute on Aging Intramural Research Program, Hjartavernd (the Icelandic Heart Association); Althingi (Icelandic parliament); MESA; MESA Family; MESA CARe; MESA SHARe project; Heinz Nixdorf Recall Study; Heinz Nixdorf Foundation; German Foundation of Research (DFG); Malmo Diet and Cancer study; Swedish Cancer Society; Swedish Medical Research Council; Swedish Dairy Association; Albert Pahlsson Foundation; Gunnar Nilsson Foundation; Malmo city council; Copenhagen City Heart Study; Danish Heart Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095167, N01HC025195, N01HC095161, N01HC095164, N01HC095169, N01HC095159, N01HC095168, N01HC095160, N01HC095166, N01HC095162, N01HC095165, N01HC095163] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071205, R43HL095169, R01HL105756, R01HL071251, R01HL071250, R01HL065226, R01HL071259, R01HL064278, R01HL071252, R01HL071051, R01HL071739, R44HL095169, R01HL071258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000, N01AG012100] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0005339] Funding Source: researchfish; MRC [MR/L003120/1] Funding Source: UKRI	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix for genotyping services; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute on Aging Intramural Research Program, Hjartavernd (the Icelandic Heart Association)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Althingi (Icelandic parliament); MESA; MESA Family; MESA CARe; MESA SHARe project; Heinz Nixdorf Recall Study; Heinz Nixdorf Foundation; German Foundation of Research (DFG)(German Research Foundation (DFG)); Malmo Diet and Cancer study; Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Dairy Association; Albert Pahlsson Foundation; Gunnar Nilsson Foundation; Malmo city council; Copenhagen City Heart Study; Danish Heart Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Framingham Heart Study was supported by a grant (N01-HC-25195) from the National Heart, Lung, and Blood Institute (NHLBI) and an NHLBI contract (N02-HL-6-4278) with Affymetrix for genotyping services; the Age, Gene/Environment Susceptibility-Reykjavik Study, by a grant from the National Institute on Aging (N01-AG-12100) and by the National Eye Institute, the National Institute on Deafness and Other Communication Disorders, the NHLBI, the National Institute on Aging Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (Icelandic parliament); the MESA, MESA Family, MESA CARe, and the MESA SHARe project, by grants (N01-HC-95159 through 95169, RR-024156, R01-HL-071739, R01-HL-071051, R01-HL-071205, R01-HL-071250, R01-HL-071251, R01-HL-071252, R01-HL-071258, R01-HL-071259, N02-HL-6-4278, and N01-HC-65226) from the NHLBI; the Heinz Nixdorf Recall Study, by the Heinz Nixdorf Foundation and the German Foundation of Research (DFG); the Malmo Diet and Cancer study, by the Swedish Cancer Society, the Swedish Medical Research Council, the Swedish Dairy Association, the Albert Pahlsson and Gunnar Nilsson Foundations, and the Malmo city council; and the Copenhagen City Heart Study, by the Danish Heart Foundation. Detailed information on support for individual authors and analyses is available in the Supplementary Appendix.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bella JN, 2007, HYPERTENSION, V49, P453, DOI 10.1161/01.HYP.0000256957.10242.75; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bozbas H, 2007, J HEART VALVE DIS, V16, P387; Capuzzi DM, 1998, AM J CARDIOL, V82, p74U, DOI 10.1016/S0002-9149(98)00731-0; Carabello BA, 2009, LANCET, V373, P956, DOI 10.1016/S0140-6736(09)60211-7; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Cosmi JE, 2002, ARCH INTERN MED, V162, P2345, DOI 10.1001/archinte.162.20.2345; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Fox CS, 2003, CIRCULATION, V107, P1492, DOI 10.1161/01.CIR.0000058168.26163.BC; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Gaudreault N, 2011, AM J CARDIOL, V108, P1305, DOI 10.1016/j.amjcard.2011.06.050; Glader CA, 2003, EUR HEART J, V24, P198, DOI 10.1016/S0195-668X(02)00385-8; GOTOH T, 1995, AM J CARDIOL, V76, P928, DOI 10.1016/S0002-9149(99)80263-X; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Hoffmann U, 2008, AM J CARDIOL, V102, P1136, DOI 10.1016/j.amjcard.2008.06.038; Horne BD, 2004, CIRCULATION, V110, P3143, DOI 10.1161/01.CIR.0000147189.85636.C3; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KREUZER J, 1994, CHEM PHYS LIPIDS, V67-8, P175, DOI 10.1016/0009-3084(94)90137-6; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Merki E, 2011, J AM COLL CARDIOL, V57, P1611, DOI 10.1016/j.jacc.2010.10.052; MILES LA, 1989, NATURE, V339, P301, DOI 10.1038/339301a0; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Nielsen LB, 1996, CIRC RES, V78, P615, DOI 10.1161/01.RES.78.4.615; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Nordstrom P, 2003, J INTERN MED, V254, P140, DOI 10.1046/j.1365-2796.2003.01179.x; Novaro GM, 2003, CIRCULATION, V108, P1804, DOI 10.1161/01.CIR.0000097560.96431.3E; OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523; Ortlepp JR, 2004, EUR HEART J, V25, P514, DOI 10.1016/j.ehj.2003.09.006; Ortlepp JR, 2001, HEART, V85, P635, DOI 10.1136/heart.85.6.635; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Owens DS, 2008, ARCH INTERN MED, V168, P1200, DOI 10.1001/archinte.168.11.1200; Probst V, 2006, CIRCULATION, V113, P856, DOI 10.1161/CIRCULATIONAHA.105.569467; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Thanassoulis G, 2010, J AM COLL CARDIOL, V55, P2491, DOI 10.1016/j.jacc.2010.03.019; Tracy RP, 2008, CURR OPIN LIPIDOL, V19, P151, DOI 10.1097/MOL.0b013e3282f73893; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175	47	569	592	3	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					503	512		10.1056/NEJMoa1109034	http://dx.doi.org/10.1056/NEJMoa1109034			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083VU	23388002	Green Accepted			2022-12-28	WOS:000314494100001
J	Bridges, CB; Woods, L; Coyne-Beasley, T				Bridges, Carolyn B.; Woods, LaDora; Coyne-Beasley, Tamera		Advisory Comm Immunization	Recommended Adult Immunization Schedule: United States, 2013	ANNALS OF INTERNAL MEDICINE			English	Article									[Bridges, Carolyn B.; Woods, LaDora] Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Coyne-Beasley, Tamera] Univ N Carolina, Chapel Hill, NC USA; Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA	Bridges, CB (corresponding author), Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd,MS A-19, Atlanta, GA 30333 USA.	cbridges@cdc.gov			ACIP, the U.S. Department of Health and Human Services	ACIP, the U.S. Department of Health and Human Services	To assure the integrity of the ACIP, the U.S. Department of Health and Human Services has taken steps to assure that there is technical adherence to ethics statutes and regulations regarding financial conflicts of interest. Concerns regarding the potential for the appearance of a conflict are addressed, or avoided altogether, through both pre- and postappointment considerations. Individuals with particular vaccine-related interests will not be considered for appointment to the committee. Potential nominees are screened for conflicts of interest, and if any are found, they are asked to divest or forgo certain vaccine-related activities. In addition, at the beginning of each ACIP meeting, each member is asked to declare his or her conflicts. Members with conflicts are not permitted to vote if the conflict involves the vaccine or biological being voted on. Disclosures for ACIP members can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum~M12-3059.	Anonymous, 2012, Morbidity and Mortality Weekly Report, V61, P468; [Anonymous], COMM GUID VACC PREV; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Centers for Disease Control and Prevention, ACIP PROV UPD REC US; Centers for Disease Control and Prevention, 2013, MMWR, V62; Reed C, 2012, VACCINE, V30, P1993, DOI 10.1016/j.vaccine.2011.12.098; Shefer Abigail, 2011, Morbidity and Mortality Weekly Report, V60, P1; Walker Deborah K., 2012, Morbidity and Mortality Weekly Report, V61, P758	8	22	21	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					191	+		10.7326/0003-4819-158-3-201302050-00584	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00584			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23358660				2022-12-28	WOS:000314757900006
J	Relman, DA				Relman, David A.			Undernutrition-Looking Within for Answers	SCIENCE			English	Editorial Material							OBESITY		[Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	relman@stanford.edu		Relman, David A./0000-0001-8331-1354	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER; NIH HHS [DP1 OD000964] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ahmed T, 2012, J HEALTH POPUL NUTR, V30, P1; Ahmed T, 2009, NUTR REV, V67, pS201, DOI 10.1111/j.1753-4887.2009.00241.x; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; United Nations Children's Fund, 2009, TRACK PROGR CHILD MA	9	2	3	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					530	532		10.1126/science.1234723	http://dx.doi.org/10.1126/science.1234723			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080UR	23363770				2022-12-28	WOS:000314270000045
J	Klattenhoff, CA; Scheuermann, JC; Surface, LE; Bradley, RK; Fields, PA; Steinhauser, ML; Ding, HM; Butty, VL; Torrey, L; Haas, S; Abo, R; Tabebordbar, M; Lee, RT; Burge, CB; Boyer, LA				Klattenhoff, Carla A.; Scheuermann, Johanna C.; Surface, Lauren E.; Bradley, Robert K.; Fields, Paul A.; Steinhauser, Matthew L.; Ding, Huiming; Butty, Vincent L.; Torrey, Lillian; Haas, Simon; Abo, Ryan; Tabebordbar, Mohammadsharif; Lee, Richard T.; Burge, Christopher B.; Boyer, Laurie A.			Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment	CELL			English	Article							STEM-CELL DIFFERENTIATION; MESENCHYMAL TRANSITIONS; MASTER REGULATOR; PROGENITOR CELLS; GENE STRUCTURE; MESP1; MOUSE; HEART; CHROMATIN; EVOLUTION	Long noncoding RNAs (lncRNAs) are often expressed in a development-specific manner, yet little is known about their roles in lineage commitment. Here, we identified Braveheart (Bvht), a heart-associated lncRNA in mouse. Using multiple embryonic stem cell (ESC) differentiation strategies, we show that Bvht is required for progression of nascentmesoderm toward a cardiac fate. We find that Bvht is necessary for activation of a core cardiovascular gene network and functions upstream of mesoderm posterior 1 (MesP1), a master regulator of a common multipotent cardiovascular progenitor. We also show that Bvht interacts with SUZ12, a component of polycombrepressive complex 2 (PRC2), during cardiomyocyte differentiation, suggesting that Bvht mediates epigenetic regulation of cardiac commitment. Finally, we demonstrate a role for Bvht in maintaining cardiac fate in neonatal cardiomyocytes. Together, our work provides evidence for a long noncoding RNA with critical roles in the establishment of the cardiovascular lineage during mammalian development.	[Klattenhoff, Carla A.; Scheuermann, Johanna C.; Surface, Lauren E.; Bradley, Robert K.; Fields, Paul A.; Ding, Huiming; Butty, Vincent L.; Torrey, Lillian; Haas, Simon; Abo, Ryan; Tabebordbar, Mohammadsharif; Burge, Christopher B.; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Bradley, Robert K.; Burge, Christopher B.] MIT, Program Computat & Syst Biol, Cambridge, MA 02139 USA; [Steinhauser, Matthew L.; Lee, Richard T.] Harvard Univ, Div Cardiovasc Med, Sch Med, Dept Med,Brigham & Womens Hosp, Cambridge, MA 02139 USA; [Tabebordbar, Mohammadsharif] ACECR, Dept Stem Cells & Dev Biol, Royan Inst Stem Cell Biol & Technol, Tehran, Iran; [Lee, Richard T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Academic Center for Education, Culture & Research (ACECR); Harvard University	Boyer, LA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lboyer@mit.edu	Burge, Christopher B./AAH-2177-2020; Steinhauser, Matthew L./GVT-6393-2022	Steinhauser, Matthew L./0000-0001-5287-9246; Surface, Lauren/0000-0003-4055-0237; Fields, Paul/0000-0002-9608-6464; Bradley, Robert/0000-0002-8046-1063; Lee, Richard/0000-0003-4687-1381; Haas, Simon/0000-0001-9227-2051; Butty, Vincent/0000-0003-1173-2429	Damon Runyon Cancer Research Foundation [DRG 2032-09, DFS 04-12]; NIH [K08 (DK090147)]; Watkins Cardiovascular Leadership Award; EMBO long-term fellowship; NHLBI Bench [U01HL098179, U01HL098188]; Richard and Susan Smith Family Foundation, Chestnut Hill, MA; Pew Scholar's Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098179, U01HL098188] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090147] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Watkins Cardiovascular Leadership Award; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); NHLBI Bench; Richard and Susan Smith Family Foundation, Chestnut Hill, MA; Pew Scholar's Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Boyer lab, especially Sera Thornton, for helpful discussions and critical evaluation of the manuscript and members of the Burge lab, especially Jason Merkin and Jessica Hurt, for sharing unpublished data. We also thank MIT BioMicro Center members Fugen Li, Kevin K. Thai, and Stuart Levine for bioinformatics and technical support. We are especially grateful to Nadya Dimitrova and Tyler Jacks for miR143/145 conditional KO ESC lines and Cedric Blanpain for inducible MesP1 and pMesP1-GFP reporter ESC lines and for providing gene expression data. R.K.B. was supported by the Damon Runyon Cancer Research Foundation (DRG 2032-09 and DFS 04-12). M.L.S. was supported by NIH K08 (DK090147) and the Watkins Cardiovascular Leadership Award. C.A.K. is a Novartis Scholar of the Life Sciences Research Foundation. J.C.S. is supported by an EMBO long-term fellowship. This work was supported by the NHLBI Bench to Bassinet Program (U01HL098179 and U01HL098188) (L.A.B.); the Richard and Susan Smith Family Foundation, Chestnut Hill, MA (L.A.B.); and the Pew Scholar's Program in the Biomedical Sciences (L.A.B.).	Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bondue A, 2011, J CELL BIOL, V192, P751, DOI 10.1083/jcb.201007063; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chang CP, 2012, ANNU REV PHYSIOL, V74, P41, DOI 10.1146/annurev-physiol-020911-153242; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Congrains A, 2012, ATHEROSCLEROSIS, V220, P449, DOI 10.1016/j.atherosclerosis.2011.11.017; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; David R, 2011, CARDIOVASC RES, V92, P115, DOI 10.1093/cvr/cvr158; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Esteban MA, 2012, CURR OPIN GENET DEV, V22, P423, DOI 10.1016/j.gde.2012.09.004; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hu WQ, 2012, EMBO REP, V13, P971, DOI 10.1038/embor.2012.145; Ishii N, 2006, J HUM GENET, V51, P1087, DOI 10.1007/s10038-006-0070-9; Islas JF, 2012, P NATL ACAD SCI USA, V109, P13016, DOI 10.1073/pnas.1120299109; Kattman SJ, 2007, TRENDS CARDIOVAS MED, V17, P240, DOI 10.1016/j.tcm.2007.08.004; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kretz M., 2012, NATURE; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Lim SM, 2009, STEM CELLS, V27, P363, DOI 10.1634/stemcells.2008-1008; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; McCulley DJ, 2012, CURR TOP DEV BIOL, V100, P253, DOI 10.1016/B978-0-12-387786-4.00008-7; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Simoes FC, 2011, DEVELOPMENT, V138, P3235, DOI 10.1242/dev.059634; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Steinhauser ML, 2011, EMBO MOL MED, V3, P701, DOI 10.1002/emmm.201100175; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]	65	688	746	3	209	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					570	583		10.1016/j.cell.2013.01.003	http://dx.doi.org/10.1016/j.cell.2013.01.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23352431	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000314362800025
J	Frobell, RB; Roos, HP; Roos, EM; Roemer, FW; Ranstam, J; Lohmander, LS				Frobell, Richard B.; Roos, Harald P.; Roos, Ewa M.; Roemer, Frank W.; Ranstam, Jonas; Lohmander, L. Stefan			Treatment for acute anterior cruciate ligament tear: five year outcome of randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							KNEE OSTEOARTHRITIS; MENISCAL TEARS; PATELLOFEMORAL OSTEOARTHRITIS; TENDON-BONE; RADIOGRAPHIC OSTEOARTHRITIS; OPERATIVE TREATMENT; HIGH PREVALENCE; SOCCER PLAYERS; CLINICAL-TRIAL; SCORE KOOS	Objective To compare, in young active adults with an acute anterior cruciate ligament (ACL) tear, the mid-term (five year) patient reported and radiographic outcomes between those treated with rehabilitation plus early ACL reconstruction and those treated with rehabilitation and optional delayed ACL reconstruction. Design Extended follow-up of prospective randomised controlled trial. Setting Orthopaedic departments at two hospitals in Sweden. Participants 121 young, active adults (mean age 26 years) with acute ACL injury to a previously uninjured knee. One patient was lost to five year follow-up. Intervention All patients received similar structured rehabilitation. In addition to rehabilitation, 62 patients were assigned to early ACL reconstruction and 59 were assigned to the option of having a delayed ACL reconstruction if needed. Main outcome measure The main outcome was the change from baseline to five years in the mean value of four of the five subscales of the knee injury and osteoarthritis outcome score (KOOS4). Other outcomes included the absolute KOOS4 score, all five KOOS subscale scores, SF-36, Tegner activity scale, meniscal surgery, and radiographic osteoarthritis at five years. Results Thirty (51%) patients assigned to optional delayed ACL reconstruction had delayed ACL reconstruction (seven between two and five years). The mean change in KOOS4 score from baseline to five years was 42.9 points for those assigned to rehabilitation plus early ACL reconstruction and 44.9 for those assigned to rehabilitation plus optional delayed reconstruction (between group difference 2.0 points, 95% confidence interval -8.5 to 4.5; P=0.54 after adjustment for baseline score). At five years, no significant between group differences were seen in KOOS4 (P=0.45), any of the KOOS subscales (P >= 0.12), SF-36 (P >= 0.34), Tegner activity scale (P=0.74), or incident radiographic osteoarthritis of the index knee (P=0.17). No between group differences were seen in the number of knees having meniscus surgery (P=0.48) or in a time to event analysis of the proportion of meniscuses operated on (P=0.77). The results were similar when analysed by treatment actually received. Conclusion In this first high quality randomised controlled trial with minimal loss to follow-up, a strategy of rehabilitation plus early ACL reconstruction did not provide better results at five years than a strategy of initial rehabilitation with the option of having a later ACL reconstruction. Results did not differ between knees surgically reconstructed early or late and those treated with rehabilitation alone. These results should encourage clinicians and young active adult patients to consider rehabilitation as a primary treatment option after an acute ACL tear.	[Frobell, Richard B.; Roos, Harald P.; Ranstam, Jonas; Lohmander, L. Stefan] Lund Univ, Dept Orthopaed, S-22100 Lund, Sweden; [Roos, Ewa M.; Lohmander, L. Stefan] Univ So Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark; [Roemer, Frank W.] Univ Erlangen Nurnberg, Dept Radiol, D-91054 Erlangen, Germany; [Roemer, Frank W.] Boston Univ, Sch Med, Dept Radiol, QIC, Boston, MA 02118 USA; [Lohmander, L. Stefan] Univ So Denmark, Dept Orthopaed & Traumatol, Odense, Denmark	Lund University; University of Southern Denmark; University of Erlangen Nuremberg; Boston University; University of Southern Denmark	Frobell, RB (corresponding author), Univ Lund Hosp, Dept Orthopaed, SE-22185 Lund, Sweden.	Richard.frobell@med.lu.se	Roos, Ewa M/A-5416-2012; Ranstam, Jonas/A-4386-2009; Lohmander, Stefan/I-8326-2012; Frobell, Richard/C-8000-2012; Roemer, Frank/AAS-6317-2020; Lohmander, Stefan/AAL-8314-2021	Roos, Ewa M/0000-0001-5425-2199; Ranstam, Jonas/0000-0002-8287-7273; Frobell, Richard/0000-0002-0639-1191; Lohmander, Stefan/0000-0002-5424-9448	Swedish Research Council; Medical Faculty of Lund University; Region Skane; Thelma Zoegas Fund; Stig & Ragna Gorthon Research Foundation; Swedish National Centre for Research in Sports; Crafoord Foundation; Tore Nilsson Research Fund; Pfizer Global Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty of Lund University; Region Skane; Thelma Zoegas Fund; Stig & Ragna Gorthon Research Foundation; Swedish National Centre for Research in Sports; Crafoord Foundation; Tore Nilsson Research Fund; Pfizer Global Research(Pfizer)	The KANON study received funding from the Swedish Research Council (RBF, LSL, EMR), Medical Faculty of Lund University (LSL, EMR), Region Skane (LSL, RBF, EMR), Thelma Zoegas Fund (RBF, HPR), Stig & Ragna Gorthon Research Foundation (RBF), Swedish National Centre for Research in Sports (LSL, RBF), Crafoord Foundation (RBF), Tore Nilsson Research Fund (RBF), and Pfizer Global Research (LSL).	Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; Ardern CL, 2011, BRIT J SPORT MED, V45, P596, DOI 10.1136/bjsm.2010.076364; Biau DJ, 2006, BRIT MED J, V332, P995, DOI 10.1136/bmj.38784.384109.2F; Boegard TL, 2003, OSTEOARTHR CARTILAGE, V11, P370, DOI 10.1016/S1063-4584(03)00030-X; Brandt KD, 2002, J RHEUMATOL, V29, P1308; Church S, 2005, J BONE JOINT SURG BR, V87B, P1639, DOI 10.1302/0301-620X.87B12.16916; Englund M, 2005, ANN RHEUM DIS, V64, P1721, DOI 10.1136/ard.2005.035568; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; Englund M, 2004, ARTHRITIS RHEUM, V50, P469, DOI 10.1002/art.20035; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Englund M, 2009, ARTHRITIS RHEUM-US, V60, P831, DOI 10.1002/art.24383; Frobell RB, 2007, CONTEMP CLIN TRIALS, V28, P295, DOI 10.1016/j.cct.2006.10.002; Frobell RB, 2010, NEW ENGL J MED, V363, P331, DOI 10.1056/NEJMoa0907797; Gossec L, 2008, OSTEOARTHR CARTILAGE, V16, P742, DOI 10.1016/j.joca.2008.02.021; Granan LP, 2009, AM J SPORT MED, V37, P955, DOI 10.1177/0363546508330136; Jarvela T, 2001, AM J SPORT MED, V29, P18; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; Meuffels DE, 2009, BRIT J SPORT MED, V43, P347, DOI 10.1136/bjsm.2008.049403; Meunier A, 2007, SCAND J MED SCI SPOR, V17, P230, DOI 10.1111/j.1600-0838.2006.00547.x; Moksnes H, 2009, SCAND J MED SCI SPOR, V19, P345, DOI 10.1111/j.1600-0838.2008.00816.x; Neuman P, 2009, OSTEOARTHR CARTILAGE, V17, P284, DOI 10.1016/j.joca.2008.07.005; Oiestad BE, 2009, AM J SPORT MED, V37, P1434, DOI 10.1177/0363546509338827; Paradowski Przemyslaw T, 2004, Health Qual Life Outcomes, V2, P38, DOI 10.1186/1477-7525-2-38; Risberg MA, 2004, PHYS THER SPORT, V5, P125, DOI 10.1016/j.ptsp.2004.02.003; Roos EM, 2008, ANN RHEUM DIS, V67, P505, DOI 10.1136/ard.2007.074088; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Roos EM, 1998, SCAND J MED SCI SPOR, V8, P439, DOI 10.1111/j.1600-0838.1998.tb00465.x; Shelbourne KD, 2009, AM J SPORT MED, V37, P246, DOI 10.1177/0363546508325665; Spindler KP, 2005, J BONE JOINT SURG AM, V87A, P1673, DOI 10.2106/JBJS.D.01842; Spindler KR, 2004, AM J SPORT MED, V32, P1986, DOI 10.1177/0363546504271211; Spindler KP, 2008, NEW ENGL J MED, V359, P2135, DOI 10.1056/NEJMcp0804745; Spindler KP, 2011, AM J SPORT MED, V39, P348, DOI 10.1177/0363546510383481; Tayton E, 2009, KNEE SURG SPORT TR A, V17, P30, DOI 10.1007/s00167-008-0622-y; TEGNER Y, 1985, CLIN ORTHOP RELAT R, V198, P43; Van de Velde SK, 2010, NEW ENGL J MED, V363, P1871, DOI 10.1056/NEJMc1010531; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yoo JC, 2009, AM J SPORT MED, V37, P1478, DOI 10.1177/0363546509332432	41	259	260	3	84	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2013	346								f232	10.1136/bmj.f232	http://dx.doi.org/10.1136/bmj.f232			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080CD	23349407	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000314217900001
J	Raman, KV; Kamerbeek, AM; Mukherjee, A; Atodiresei, N; Sen, TK; Lazic, P; Caciuc, V; Michel, R; Stalke, D; Mandal, SK; Blugel, S; Munzenberg, M; Moodera, JS				Raman, Karthik V.; Kamerbeek, Alexander M.; Mukherjee, Arup; Atodiresei, Nicolae; Sen, Tamal K.; Lazic, Predrag; Caciuc, Vasile; Michel, Reent; Stalke, Dietmar; Mandal, Swadhin K.; Bluegel, Stefan; Muenzenberg, Markus; Moodera, Jagadeesh S.			Interface-engineered templates for molecular spin memory devices	NATURE			English	Article							SINGLE-MOLECULE; SURFACE; SPINTRONICS; BISTABILITY; ANISOTROPY; CHEMISTRY; MAGNET	The use of molecular spin state as a quantum of information for storage, sensing and computing has generated considerable interest in the context of next-generation data storage and communication devices(1,2), opening avenues for developing multifunctional molecular spintronics(3). Such ideas have been researched extensively, using single-molecule magnets(4,5) and molecules with a metal ion(6) or nitrogen vacancy(7) as localized spin-carrying centres for storage and for realizing logic operations(8). However, the electronic coupling between the spin centres of these molecules is rather weak, which makes construction of quantum memory registers a challenging task(9). In this regard, delocalized carbon-based radical species with unpaired spin, such as phenalenyl(10), have shown promise. These phenalenyl moieties, which can be regarded as graphene fragments, are formed by the fusion of three benzene rings and belong to the class of open-shell systems. The spin structure of these molecules responds to external stimuli(11,12) (such as light, and electric and magnetic fields), which provides novel schemes for performing spin memory and logic operations. Here we construct a molecular device using such molecules as templates to engineer interfacial spin transfer resulting from hybridization and magnetic exchange interaction with the surface of a ferromagnet; the device shows an unexpected interfacial magnetoresistance of more than 20 per cent near room temperature. Moreover, we successfully demonstrate the formation of a nanoscale magnetic molecule with a well-defined magnetic hysteresis on ferromagnetic surfaces. Owing to strong magnetic coupling with the ferromagnet, such independent switching of an adsorbed magnetic molecule has been unsuccessful with single-molecule magnets(13). Our findings suggest the use of chemically amenable phenalenyl-based molecules as a viable and scalable platform for building molecular-scale quantum spin memory and processors for technological development.	[Raman, Karthik V.; Kamerbeek, Alexander M.; Moodera, Jagadeesh S.] MIT, Francis Bitter Natl Magnet Lab, Cambridge, MA 02139 USA; [Raman, Karthik V.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Mukherjee, Arup; Sen, Tamal K.; Mandal, Swadhin K.] Indian Inst Sci Educ & Res IISER Kolkata, Dept Chem Sci, Mohanpur 741252, India; [Atodiresei, Nicolae; Caciuc, Vasile; Bluegel, Stefan] Forschungszentrum Julich, Peter Grunberg Inst, D-52425 Julich, Germany; [Atodiresei, Nicolae; Caciuc, Vasile; Bluegel, Stefan] Forschungszentrum Julich, Inst Adv Simulat, D-52425 Julich, Germany; [Atodiresei, Nicolae; Caciuc, Vasile; Bluegel, Stefan] JARA, D-52425 Julich, Germany; [Lazic, Predrag] Rudjer Boskovic Inst, Div Theoret Phys, HR-10002 Zagreb, Croatia; [Michel, Reent; Stalke, Dietmar] Univ Gottingen, Inst Anorgan Chem, D-37077 Gottingen, Germany; [Muenzenberg, Markus] Univ Gottingen, Inst Phys 1, D-37077 Gottingen, Germany; [Moodera, Jagadeesh S.] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Indian Institute of Science Education & Research (IISER) - Kolkata; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Rudjer Boskovic Institute; University of Gottingen; University of Gottingen; Massachusetts Institute of Technology (MIT)	Raman, KV (corresponding author), IBM India Res Lab, Bangalore 560045, Karnataka, India.	vkarthik@mit.edu; n.atodiresei@fz-juelich.de; swadhin.mandal@iiserkol.ac.in; moodera@mit.edu	Blügel, Stefan/J-8323-2013; Lazic, Predrag/K-1908-2012; Stalke, Dietmar/J-2089-2019; Münzenberg, Markus/Y-5780-2019; Mukherjee, Arup/L-8660-2013; Caciuc, Vasile/H-8649-2013; Münzenberg, Markus G/B-1251-2010	Blügel, Stefan/0000-0001-9987-4733; Stalke, Dietmar/0000-0003-4392-5751; Münzenberg, Markus/0000-0002-1332-5678; Mukherjee, Arup/0000-0002-2498-8821; Caciuc, Vasile/0000-0002-4814-2417; Münzenberg, Markus G/0000-0002-1332-5678; Atodiresei, Nicolae/0000-0002-8203-1227	Office of Naval Research (ONR) [N00014-09-1-0177]; National Science Foundation [DMR 0504158, ULFR 09-0532-01]; University of Groningen; IISER-Kolkata; CSIR, India [01(2369)/10/EMR-II]; German Science foundation [SFB 602, SPP 1538]; Deutsche Forschungsgemeinschaft (DFG) [1178]; Danish National Research Foundation (DNRF); Land Niedersachsen	Office of Naval Research (ONR)(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); University of Groningen; IISER-Kolkata; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); German Science foundation(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Danish National Research Foundation (DNRF)(Danmarks Grundforskningsfond); Land Niedersachsen	We thank J. M. D. Coey of Trinity College, Ireland, for discussions. K. V. R. and J. S. M. were supported by the Office of Naval Research (ONR grant N00014-09-1-0177) and the National Science Foundation (grants DMR 0504158 and ULFR 09-0532-01). A. M. K. thanks the University of Groningen for partial financial support during his stay at MIT. N.A. and V. C. thank the Julich Supercomputing Centre, Forschungszentrum Julich (Germany), for performing calculations on JUROPA and JUGENE supercomputers. A. M. and T. K. S. thank IISER-Kolkata and CSIR, India, respectively, for research fellowships. S. K. M. thanks CSIR (sanction no. 01(2369)/10/EMR-II), India, for financial support. M. M. thanks the German Science foundation for support within SFB 602 and SPP 1538, and S. Demeshko for SQUID measurements. D. S. and R. M. thank the Deutsche Forschungsgemeinschaft (DFG) Priority Programme 1178 and the Danish National Research Foundation (DNRF) funded Center for Materials Crystallography (CMC) for support, and the Land Niedersachsen for providing a fellowship in the Catalysis for Sustainable Synthesis (CaSuS) Ph.D. program. J.S.M., M. M, S. K. M. and D. S. thank the Gottingen-Kolkata 'Open shell systems (G-KOSS)' initiative for supporting the collaboration.	Ardavan A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057201; Atodiresei N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.066601; DIMITROV DA, 1995, PHYS REV B, V51, P11947, DOI 10.1103/PhysRevB.51.11947; Fuchs GD, 2011, NAT PHYS, V7, P789, DOI 10.1038/nphys2026; Gambardella P, 2009, NAT MATER, V8, P189, DOI [10.1038/nmat2376, 10.1038/NMAT2376]; Gould C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.117203; Grunewald M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125208; Gutlich P., 2004, SPIN CROSSOVER TRANS, V1; HADDON RC, 1975, NATURE, V256, P394, DOI 10.1038/256394a0; Herrmann C, 2010, J AM CHEM SOC, V132, P3682, DOI 10.1021/ja910483b; Hicks RG, 2007, ORG BIOMOL CHEM, V5, P1321, DOI 10.1039/b617142g; Itkis ME, 2002, SCIENCE, V296, P1443, DOI 10.1126/science.1071372; Leuenberger MN, 2001, NATURE, V410, P789, DOI 10.1038/35071024; Mannini M, 2009, NAT MATER, V8, P194, DOI [10.1038/NMAT2374, 10.1038/nmat2374]; MANRIQUEZ JM, 1991, SCIENCE, V252, P1415, DOI 10.1126/science.252.5011.1415; MILLER JS, 2002, MAGNETISM MOL MAT, V3; Miyamachi T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1940; Moodera JS, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/16/165202; Morita Y, 2011, NAT MATER, V10, P947, DOI [10.1038/NMAT3142, 10.1038/nmat3142]; Morita Y, 2011, NAT CHEM, V3, P197, DOI 10.1038/NCHEM.985; Raman KV, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195212; Rocha AR, 2005, NAT MATER, V4, P335, DOI 10.1038/nmat1349; Santos TS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.016601; Sanvito S, 2010, NAT PHYS, V6, P562, DOI 10.1038/nphys1714; SESSOLI R, 1993, NATURE, V365, P141, DOI 10.1038/365141a0; Shim JH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.226603; SIEGMANN HC, 1992, J PHYS-CONDENS MAT, V4, P8395, DOI 10.1088/0953-8984/4/44/004; Verdaguer M, 1996, SCIENCE, V272, P698, DOI 10.1126/science.272.5262.698; Wende H, 2007, NAT MATER, V6, P516, DOI 10.1038/nmat1932; Xiong ZH, 2004, NATURE, V427, P821, DOI 10.1038/nature02325	30	338	341	12	694	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					509	513		10.1038/nature11719	http://dx.doi.org/10.1038/nature11719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23344361	Green Submitted			2022-12-28	WOS:000313871400033
J	Jolma, A; Yan, J; Whitington, T; Toivonen, J; Nitta, KR; Rastas, P; Morgunova, E; Enge, M; Taipale, M; Wei, GH; Palin, K; Vaquerizas, JM; Vincentelli, R; Luscombe, NM; Hughes, TR; Lemaire, P; Ukkonen, E; Kivioja, T; Taipale, J				Jolma, Arttu; Yan, Jian; Whitington, Thomas; Toivonen, Jarkko; Nitta, Kazuhiro R.; Rastas, Pasi; Morgunova, Ekaterina; Enge, Martin; Taipale, Mikko; Wei, Gonghong; Palin, Kimmo; Vaquerizas, Juan M.; Vincentelli, Renaud; Luscombe, Nicholas M.; Hughes, Timothy R.; Lemaire, Patrick; Ukkonen, Esko; Kivioja, Teemu; Taipale, Jussi			DNA-Binding Specificities of Human Transcription Factors	CELL			English	Article							STRUCTURAL BASIS; HIGH-RESOLUTION; SIMPLE-MODELS; IN-VITRO; RECOGNITION; PROTEIN; DETERMINANTS; EVOLUTION; SEQUENCE; DOMAINS	Although the proteins that read the gene regulatory code, transcription factors (TFs), have been largely identified, it is not well known which sequences TFs can recognize. We have analyzed the sequence-specific binding of human TFs using high-throughput SELEX and ChIP sequencing. A total of 830 binding profiles were obtained, describing 239 distinctly different binding specificities. The models represent the majority of human TFs, approximately doubling the coverage compared to existing systematic studies. Our results reveal additional specificity determinants for a large number of factors for which a partial specificity was known, including a commonly observed A- or T-rich stretch that flanks the core motifs. Global analysis of the data revealed that homodimer orientation and spacing preferences, and base-stacking interactions, have a larger role in TF-DNA binding than previously appreciated. We further describe a binding model incorporating these features that is required to understand binding of TFs to DNA.	[Jolma, Arttu; Yan, Jian; Whitington, Thomas; Nitta, Kazuhiro R.; Morgunova, Ekaterina; Enge, Martin; Kivioja, Teemu; Taipale, Jussi] Karolinska Inst, Sci Life Ctr, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Jolma, Arttu; Taipale, Mikko; Wei, Gonghong; Palin, Kimmo; Kivioja, Teemu; Taipale, Jussi] Univ Helsinki, Genome Scale Biol Program, Helsinki 00014, Finland; [Toivonen, Jarkko; Rastas, Pasi; Ukkonen, Esko; Kivioja, Teemu] Univ Helsinki, Dept Comp Sci, Helsinki 00014, Finland; [Vaquerizas, Juan M.; Luscombe, Nicholas M.] EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; [Vincentelli, Renaud] Univ Aix Marseille, CNRS UMR7257, F-13288 Marseille 9, France; [Hughes, Timothy R.] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Lemaire, Patrick] CRBM, F-34293 Montpellier, France	Karolinska Institutet; University of Helsinki; University of Helsinki; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Aix-Marseille Universite; University of Toronto; University of Toronto; Universite de Montpellier	Taipale, J (corresponding author), Karolinska Inst, Sci Life Ctr, Dept Biosci & Nutr, S-14183 Huddinge, Sweden.	jussi.taipale@ki.se	Vaquerizas, Juan M/F-2676-2011; Enge, Martin/GYQ-5073-2022; Vaquerizas, Juan M/AAY-2339-2020; Jolma, Arttu/AAK-9649-2021; Palin, Kimmo/ABG-5710-2020; Lemaire, Patrick/B-5560-2012; Yan, Jian/B-2631-2018; Morgunova, Ekaterina/G-2479-2018; Lemaire, Patrick/P-8228-2019; Wei, Gonghong/C-6263-2014	Vaquerizas, Juan M/0000-0002-6583-6541; Vaquerizas, Juan M/0000-0002-6583-6541; Palin, Kimmo/0000-0002-4621-6128; Lemaire, Patrick/0000-0003-4925-2009; Yan, Jian/0000-0002-1267-2870; Morgunova, Ekaterina/0000-0002-7754-9021; Lemaire, Patrick/0000-0003-4925-2009; Rastas, Pasi/0000-0003-2768-1339; Toivonen, Jarkko/0000-0002-6843-5831; Ukkonen, Esko/0000-0002-5978-1505; Wei, Gong-Hong/0000-0001-6546-9334; Nitta, Kazuhiro/0000-0003-3151-0962; Jolma, Arttu/0000-0002-2543-7490; Taipale, Mikko/0000-0003-3811-1761; Enge, Martin/0000-0001-8748-8931	Academy of Finland; Knut and Alice Wallenberg Foundation; Vetenskapsradet; Cancer-fonden; ERC Advanced Grant GROWTHCONTROL; EU FP7 project SYSCOL; CIHR Operating Grant [MOP-77721]; Cancer Research UK [16358] Funding Source: researchfish	Academy of Finland(Academy of Finland); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Vetenskapsradet(Swedish Research Council); Cancer-fonden(Swedish Cancer Society); ERC Advanced Grant GROWTHCONTROL; EU FP7 project SYSCOL; CIHR Operating Grant(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK)	We apologize to the authors of original work not cited. Due to the broad scope of this work, and editorial limits on citations, we were largely limited to citing review articles, databases, and more recent original articles not yet reviewed or incorporated into databases. We thank Drs. M. Taipale, M.O. Lombardia, and B. Schmierer for critical review of the manuscript, and R. Nurmi, S. Miettinen, A. Zetterlund, S. Talukder, G. Breard, A. Yang, A. Cote, and H. Zheng for technical assistance. This project was supported by Academy of Finland, Knut and Alice Wallenberg Foundation, Vetenskapsradet, Cancer-fonden, ERC Advanced Grant GROWTHCONTROL, the EU FP7 project SYSCOL to J. Taipale, and CIHR Operating Grant MOP-77721 to T.R.H.	AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Geggier S, 2010, P NATL ACAD SCI USA, V107, P15421, DOI 10.1073/pnas.1004809107; GIGUERE V, 1995, MOL CELL BIOL, V15, P2517; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Jolma A, 2011, SUBCELL BIOCHEM, V52, P155, DOI 10.1007/978-90-481-9069-0_7; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KIM J, 1995, NUCLEIC ACIDS RES, V23, P2531, DOI 10.1093/nar/23.13.2531; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Morris Q, 2011, NAT BIOTECHNOL, V29, P483, DOI 10.1038/nbt.1892; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Pape UJ, 2008, BIOINFORMATICS, V24, P350, DOI 10.1093/bioinformatics/btm610; Pardee K, 2011, SUBCELL BIOCHEM, V52, P123, DOI 10.1007/978-90-481-9069-0_6; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Roulet E, 2000, J MOL BIOL, V297, P833, DOI 10.1006/jmbi.2000.3614; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; STRUHL K, 1987, CELL, V50, P841, DOI 10.1016/0092-8674(87)90511-3; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Walhout AJM, 2011, METHOD CELL BIOL, V106, P271, DOI 10.1016/B978-0-12-544172-8.00010-4; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zheng GH, 2010, NUCLEIC ACIDS RES, V38, pD267, DOI 10.1093/nar/gkp959; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666	47	747	753	4	179	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					327	339		10.1016/j.cell.2012.12.009	http://dx.doi.org/10.1016/j.cell.2012.12.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332764	Bronze			2022-12-28	WOS:000313719800027
J	Record, KL; Gostin, LO				Record, Katherine L.; Gostin, Lawrence O.			A Systematic Plan for Firearms Law Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Record, Katherine L.] Harvard Univ, Sch Law, Ctr Hlth Law & Policy Innovat, Boston, MA 02115 USA; [Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Harvard University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Bureau of Alcohol Tobacco Firearms and Explosives, 2008, STAT LAWS PUBL ORD F, pi; Hoyert DL, 2012, DEATHS PRELIMINARY D; Obama B., 2012, NBC TELEVISION  1230; Steinhauer Jennifer, 2013, NY TIMES; The White House, 2013, NOW IS TIM PRES PLAN; US General Accounting Office, 2000, GUN CONTR OPT IMPR N; Wiebe DJ, 2003, ANN EMERG MED, V41, P771, DOI 10.1067/mem.2003.187	7	10	10	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2013	309	12					1231	1232		10.1001/jama.2013.1127	http://dx.doi.org/10.1001/jama.2013.1127			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112WO	23392297	Green Published			2022-12-28	WOS:000316625200019
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for Intimate Partner Violence and Abuse of Elderly and Vulnerable Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; HEALTH CONSEQUENCES; PHYSICAL HEALTH; DOMESTIC VIOLENCE; WOMEN; BIRTH; INTERVENTION; DEPRESSION; PREGNANCY; ASSAULT	Description: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for family and intimate partner violence (IPV). Methods: The USPSTF commissioned a systematic evidence review on screening women for IPV and elderly and vulnerable adults for abuse and neglect. This review examined the accuracy of screening tools for identifying IPV and the benefits and harms of screening women of childbearing age and elderly and vulnerable adults. Population: These recommendations apply to asymptomatic women (women who do not have signs or symptoms of abuse) of reproductive age and elderly and vulnerable adults. Recommendation: The USPSTF recommends that clinicians screen women of childbearing age for IPV, such as domestic violence, and provide or refer women who screen positive to intervention services (B recommendation). The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening all elderly or vulnerable adults (physically or mentally dysfunctional) for abuse and neglect (I statement). Ann Intern Med. 2013; 158: 478-486.	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.				USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	Ahmad F., 2007, COMPUTER ASSISTED SC; Ahmad F, 2009, ANN INTERN MED, V151, P93, DOI 10.7326/0003-4819-151-2-200907210-00124; American Medical Association, 2008, OP 2 02 PHYS OBL PRE; Bair-Merritt MH, 2010, ARCH PEDIAT ADOL MED, V164, P16, DOI 10.1001/archpediatrics.2009.237; Black M.C., 2011, NATL INTIMATE PARTNE; Brock K., 2003, MEN MURDER WOMEN ANA; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Campbell JC, 1997, PSYCHIAT CLIN N AM, V20, P353, DOI 10.1016/S0193-953X(05)70317-8; Centers for Disease Control and Prevention, 2010, INT PARTN VIOL RISK; Centers for Disease Control and Prevention, 2010, INT PARTN VIOL DEF; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P113; Coker AL, 2000, ARCH FAM MED, V9, P451, DOI 10.1001/archfami.9.5.451; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Cooper C, 2009, INT PSYCHOGERIATR, V21, P774, DOI 10.1017/S1041610209009387; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Dubowitz H, 2008, PEDIATRICS, V121, pE85, DOI 10.1542/peds.2007-0904; El-Mohandes AAE, 2011, MATERN CHILD HLTH J, V15, P19, DOI [10.1007/s10995-009-0557-z, 10.1007/s10995-011-0843-4, 10.1007/s10995-011-0856-z]; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Hathaway JE, 2000, AM J PREV MED, V19, P302, DOI 10.1016/S0749-3797(00)00236-1; Humphreys J, 2011, WOMEN HEALTH ISS, V21, P136, DOI 10.1016/j.whi.2010.09.006; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Lachs MS, 2004, LANCET, V364, P1263, DOI 10.1016/S0140-6736(04)17144-4; Lehmann P, 2000, CHILD YOUTH SERV REV, V22, P275, DOI 10.1016/S0190-7409(00)00078-5; Letourneau EJ, 1999, WOMEN HEALTH ISS, V9, P115, DOI 10.1016/S1049-3867(98)00031-0; Lewis-O'Connor A., 2008, THESIS BOSTON COLL B; MacMillan HL, 2006, JAMA-J AM MED ASSOC, V296, P530, DOI 10.1001/jama.296.5.530; Martin SL, 2006, VIOLENCE AGAINST WOM, V12, P823, DOI 10.1177/1077801206292672; McFarlane JM, 2006, NURS RES, V55, P52, DOI 10.1097/00006199-200601000-00007; Miller E, 2011, CONTRACEPTION, V83, P274, DOI 10.1016/j.contraception.2010.07.013; National Center on Elder Abuse, 2010, WHY SHOULD I CAR ELD; Nelson HD, 2012, AHRQ PUBLICATION, V12-05167-EF-1; Paranjape A, 2006, J NATL MED ASSOC, V98, P1663; Penelope Trickett, 2005, LONGITUDINAL STUDY C; Rhodes KV, 2006, ARCH INTERN MED, V166, P1107, DOI 10.1001/archinte.166.10.1107; Shah PS, 2010, J WOMENS HEALTH, V19, P2017, DOI 10.1089/jwh.2010.2051; Sickel AE, 2002, J HEALTH PSYCHOL, V7, P583, DOI 10.1177/1359105302007005677; Silverman ME, 2010, ARCH WOMEN MENT HLTH, V13, P411, DOI 10.1007/s00737-010-0161-7; Taft AJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-178; Thombs BD, 2007, GEN HOSP PSYCHIAT, V29, P8, DOI 10.1016/j.genhosppsych.2006.10.013; U.S. Government Accountability Office, 2011, ELD JUST STRONG FED; U.S. Preventive Service Task Force, 2004, SCREEN BEH COUNS INT; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; Wathen CN, 2008, WOMEN HEALTH ISS, V18, P423, DOI 10.1016/j.whi.2008.08.003; White House United States, 2022, FACT SHEET REAUTH VI; Wingood GM, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e72	46	236	239	0	53	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6					478	U142		10.7326/0003-4819-158-6-201303190-00588	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-00588			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	112AY	23338828				2022-12-28	WOS:000316565100016
J	Pierce, SE; Ahlberg, PE; Hutchinson, JR; Molnar, JL; Sanchez, S; Tafforeau, P; Clack, JA				Pierce, Stephanie E.; Ahlberg, Per E.; Hutchinson, John R.; Molnar, Julia L.; Sanchez, Sophie; Tafforeau, Paul; Clack, Jennifer A.			Vertebral architecture in the earliest stem tetrapods	NATURE			English	Article							AXIAL SKELETON; EVOLUTION; ICHTHYOSTEGA; MORPHOLOGY	The construction of the vertebral column has been used as a key anatomical character in defining and diagnosing early tetrapod groups(1). Rhachitomous vertebrae(2)-in which there is a dorsally placed neural arch and spine, an anteroventially placed intercentrum and paired, posterodorsally placed pleurocentra have long been considered the ancestral morphology for tetrapods(1,3-6). Nonetheless, very little is known about vertebral anatomy in the earliest stem tetrapods, because most specimens remain trapped in surrounding matrix, obscuring Important anatomical features(7-9). Here we describe the three-dimensional vertebral architecture of the Late Devonian stem tetrapod Ichthyostega using propagation phase-contrast X-ray synchrotron. microtomography. Our scans reveal a diverse array of new morphological, and associated developmental and functional, characteristics, including a possible posterior-to-anterior vertebral ossification sequence and the first evolutionary appearance of ossified sternal elements. One of the most intriguing features relates to the positional relationships between the vertebral elements, with the pleurocentra being unexpectedly sutured or fused to the intercentra that directly succeed them, indicating a 'reverse' rhachitomous design(10). Comparison of Ichthyostega with two other stem tetrapods, Acanthostegi and Pederpess, shows that reverse rhachitomous vertebrae may be the ancestral condition for limbed vertebrates. This study fundamentally revises our current understanding' of vertebral column evolution in the earliest tetrapods and raises questions about the presumed vertebral architecture of tetrapodomorph fish(12,13) and later, more crownward, tetrapods.	[Pierce, Stephanie E.; Clack, Jennifer A.] Univ Cambridge, Dept Zool, Univ Museum Zool, Cambridge CB2 3EJ, England; [Pierce, Stephanie E.; Hutchinson, John R.; Molnar, Julia L.] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, Hatfield AL9 7TA, Herts, England; [Pierce, Stephanie E.; Hutchinson, John R.; Molnar, Julia L.] Univ London Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; [Ahlberg, Per E.; Sanchez, Sophie] Uppsala Univ, Subdept Evolut & Dev, Dept Organismal Biol, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Sanchez, Sophie; Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Cambridge; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; Uppsala University; European Synchrotron Radiation Facility (ESRF)	Pierce, SE (corresponding author), Univ Cambridge, Dept Zool, Univ Museum Zool, Downing St, Cambridge CB2 3EJ, England.	spierce@rvc.ac.uk	Ahlberg, Per/E-8086-2013; Hutchinson, John/AAH-1593-2020; Sanchez, Sophie/AAE-1168-2022; Molnar, Julia/AAR-3371-2021	Tafforeau, Paul/0000-0002-5962-1683; Sanchez, Sophie/0000-0002-3611-6836; Hutchinson, John/0000-0002-6767-7038; Molnar, Julia/0000-0003-1455-0487; Ahlberg, Per/0000-0001-9054-2900	NERC [NE/G005877/1, NE/G00711X/1]; ERC [233111]; Natural Environment Research Council [NE/G00711X/1, NE/G005877/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ERC(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the European Synchrotron Radiation facility (ESRF) in Grenoble, France, for access to beamline ID19; S. Schmidt for support using the mu CT scanner at Abertay University; J. Liston and the Glasgow Huntenan Museum for access to fossils in their care; and G. Cuny for access to collections housed in the Geological Museum at the University of Copenhagen. This research was supported by NERC grants NE/G005877/1 and NE/G00711X/1 (J.A.C., J.R.H. and S.E.P.) and ERC grant 233111 (P.E.A. and S.S.).	Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Aoyama H, 2000, MECH DEVELOP, V99, P71, DOI 10.1016/S0925-4773(00)00481-0; Benton M.J., 2005, VERTEBRATE PALAEONTO; Callier V, 2009, SCIENCE, V324, P364, DOI 10.1126/science.1167542; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Carroll RL, 1999, EVOL DEV, V1, P36; Clack JA, 2002, NATURE, V418, P72, DOI 10.1038/nature00824; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Cope E. D., 1878, AM NAT, V5, P324; Cote S, 2002, J VERTEBR PALEONTOL, V22, P487, DOI 10.1671/0272-4634(2002)022[0487:VDITDS]2.0.CO;2; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Fleming A, 2004, DEVELOPMENT, V131, P873, DOI 10.1242/dev.00952; Hildebrand M., 2001, ANAL VERTEBRATE STRU; Jarvik E., 1952, Meddelelser om Gronland, V114, P1; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Jarvik Erik, 1996, Fossils and Strata, V40, P1; Long JH, 1997, J EXP BIOL, V200, P65; MILNER AR, 1994, T ROY SOC EDIN-EARTH, V84, P331; Morin-Kensicki EM, 2002, DEVELOPMENT, V129, P3851; Panchen A. L., 1977, PROBLEMS VERTEBRATE, P289; PANCHEN AL, 1967, EVOLUTION, V21, P24, DOI 10.1111/j.1558-5646.1967.tb00127.x; Pierce SE, 2011, J ANAT, V219, P502, DOI 10.1111/j.1469-7580.2011.01406.x; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; Romer A. S., 1947, B MUS COMP ZOOL HARV, V99, P368; ROMER ALFRED S., 1964, BULL MUS COMP ZOOL HARVARD UNIV, V131, P129; Shishkin M.A., 1989, Progress in Zoology, V35, P180; Slijper EJ., 1946, COMP BIOL ANATOMICAL; Vorobyeva E., 1991, P68; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286	30	43	43	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					226	229		10.1038/nature11825	http://dx.doi.org/10.1038/nature11825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23334417	Green Published			2022-12-28	WOS:000315137700037
J	Danielson, JAH; Frommer, WB				Danielson, Jonas A. H.; Frommer, Wolf B.			Jack of All Trades, Master of Flowering	SCIENCE			English	Editorial Material							TREHALOSE; TIME		[Danielson, Jonas A. H.; Frommer, Wolf B.] Carnegie Inst Sci, Stanford, CA 94305 USA	Carnegie Institution for Science	Danielson, JAH (corresponding author), Carnegie Inst Sci, 260 Panama St, Stanford, CA 94305 USA.	wfrommer@stanford.edu	Frommer, Wolf B/A-8256-2008; Frommer, Wolf B/K-5042-2017	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Danielson, Jonas/0000-0001-7000-5032				Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Childs DZ, 2010, P ROY SOC B-BIOL SCI, V277, P3055, DOI 10.1098/rspb.2010.0707; Fernandez J, 2012, MOL PLANT MICROBE IN, V25, P1286, DOI 10.1094/MPMI-12-11-0326; Friedman WE, 2009, AM J BOT, V96, P5, DOI 10.3732/ajb.0800150; Frommer WB, 2003, SCIENCE, V300, P261, DOI 10.1126/science.1084120; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; King RW, 2009, FUNCT PLANT BIOL, V36, P1027, DOI 10.1071/FP09170; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Maeterlinck Maurice., 1907, INTELLIGENCE DES FLE; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406	12	6	6	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					659	660		10.1126/science.1234601	http://dx.doi.org/10.1126/science.1234601			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393256				2022-12-28	WOS:000314585600031
J	Ramsden, CE; Zamora, D; Leelarthaepin, B; Majchrzak-Hong, SF; Faurot, KR; Suchindran, CM; Ringel, A; Davis, JM; Hibbeln, JR				Ramsden, Christopher E.; Zamora, Daisy; Leelarthaepin, Boonseng; Majchrzak-Hong, Sharon F.; Faurot, Keturah R.; Suchindran, Chirayath M.; Ringel, Amit; Davis, John M.; Hibbeln, Joseph R.			Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POLYUNSATURATED FATTY-ACIDS; CARDIOVASCULAR-DISEASE; SERUM-CHOLESTEROL; EICOSAPENTAENOIC ACID; CONTROLLED-TRIALS; OXIDIZED LDL; FOLLOW-UP; RISK; LIPIDS; WOMEN	Objective To evaluate the effectiveness of replacing dietary saturated fat with omega 6 linoleic acid, for the secondary prevention of coronary heart disease and death. Design Evaluation of recovered data from the Sydney Diet Heart Study, a single blinded, parallel group, randomized controlled trial conducted in 1966-73; and an updated meta-analysis including these previously missing data. Setting Ambulatory, coronary care clinic in Sydney, Australia. Participants 458 men aged 30-59 years with a recent coronary event. Interventions Replacement of dietary saturated fats (from animal fats, common margarines, and shortenings) with omega 6 linoleic acid (from safflower oil and safflower oil polyunsaturated margarine). Controls received no specific dietary instruction or study foods. All non-dietary aspects were designed to be equivalent in both groups. Outcome measures All cause mortality (primary outcome), cardiovascular mortality, and mortality from coronary heart disease (secondary outcomes). We used an intention to treat, survival analysis approach to compare mortality outcomes by group. Results The intervention group (n=221) had higher rates of death than controls (n=237) (all cause 17.6% v 11.8%, hazard ratio 1.62 (95% confidence interval 1.00 to 2.64), P=0.05; cardiovascular disease 17.2% v 11.0%, 1.70 (1.03 to 2.80), P=0.04; coronary heart disease 16.3% v 10.1%, 1.74 (1.04 to 2.92), P=0.04). Inclusion of these recovered data in an updated meta-analysis of linoleic acid intervention trials showed non-significant trends toward increased risks of death from coronary heart disease (hazard ratio 1.33 (0.99 to 1.79); P=0.06) and cardiovascular disease (1.27 (0.98 to 1.65); P=0.07). Conclusions Advice to substitute polyunsaturated fats for saturated fats is a key component of worldwide dietary guidelines for coronary heart disease risk reduction. However, clinical benefits of the most abundant polyunsaturated fatty acid, omega 6 linoleic acid, have not been established. In this cohort, substituting dietary linoleic acid in place of saturated fats increased the rates of death from all causes, coronary heart disease, and cardiovascular disease. An updated meta-analysis of linoleic acid intervention trials showed no evidence of cardiovascular benefit. These findings could have important implications for worldwide dietary advice to substitute omega 6 linoleic acid, or polyunsaturated fats in general, for saturated fats. Trial registration Clinical trials NCT01621087.	[Ramsden, Christopher E.; Majchrzak-Hong, Sharon F.; Ringel, Amit; Hibbeln, Joseph R.] NIAAA, Lab Membrane Biophys & Biochem, NIH, Bethesda, MD 20892 USA; [Ramsden, Christopher E.; Zamora, Daisy; Faurot, Keturah R.] Univ N Carolina, Sch Med, Dept Phys Med & Rehabil, Chapel Hill, NC USA; [Leelarthaepin, Boonseng] Univ New S Wales, Sydney, NSW, Australia; [Suchindran, Chirayath M.] Univ N Carolina, Sch Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [Davis, John M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of New South Wales Sydney; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ramsden, CE (corresponding author), NIAAA, Lab Membrane Biophys & Biochem, NIH, Bethesda, MD 20892 USA.	Chris.Ramsden@nih.gov	Ramsden, Christopher/AAW-9516-2021; Zamora, Daisy/ABG-5162-2021	Zamora, Daisy/0000-0003-2114-5156; Faurot, Keturah/0000-0001-6122-7821; Ramsden, Christopher/0000-0002-4058-7630	Life Insurance Medical Research Fund of Australia; Life Insurance Medical Research Fund of New Zealand; Intramural Program of the National Institute on Alcohol Abuse and Alcoholism; National Center for Complementary & Integrative Health [T32AT003378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000115, ZIAAA000235] Funding Source: NIH RePORTER	Life Insurance Medical Research Fund of Australia; Life Insurance Medical Research Fund of New Zealand; Intramural Program of the National Institute on Alcohol Abuse and Alcoholism; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the Life Insurance Medical Research Fund of Australia and New Zealand and the Intramural Program of the National Institute on Alcohol Abuse and Alcoholism for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Aarsetoey H, 2009, J NUTR, V139, P507, DOI 10.3945/jn.108.096446; Aarsetoy H, 2008, RESUSCITATION, V78, P258, DOI 10.1016/j.resuscitation.2008.04.007; ABELL LL, 1952, J BIOL CHEM, V195, P357; [Anonymous], 1968, LANCET, V2, P693; [Anonymous], 1961, JAMA, V175, P389; [Anonymous], 2012, USDA NAT NUTR DAT ST; Barlic J, 2007, J BIOL CHEM, V282, P19167, DOI 10.1074/jbc.M701642200; Bendsen NT, 2011, EUR J CLIN NUTR, V65, P773, DOI 10.1038/ejcn.2011.34; Blacket R B, 1973, Singapore Med J, V14, P344; BLACKET R B, 1965, Med J Aust, V1, P59; BLACKET RB, 1979, AUST NZ J MED, V9, P521, DOI 10.1111/j.1445-5994.1979.tb03388.x; BLACKET RB, 1973, MED J AUSTRALIA, V1, P969, DOI 10.5694/j.1326-5377.1973.tb110851.x; BLACKET RB, 1973, AUST NZ J MED, V3, P39, DOI 10.1111/j.1445-5994.1973.tb03956.x; Block RC, 2008, ATHEROSCLEROSIS, V197, P821, DOI 10.1016/j.atherosclerosis.2007.07.042; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; BREWER ER, 1975, CIRCULATION, V52, P269; CARPENTER DL, 1973, J AM OIL CHEM SOC, V50, P372, DOI 10.1007/BF02640843; CARPENTER KLH, 1995, BBA-LIPID LIPID MET, V1256, P141, DOI 10.1016/0005-2760(94)00247-V; Chardigny JM, 2006, CONTEMP CLIN TRIALS, V27, P364, DOI 10.1016/j.cct.2006.03.003; Chiuve SE, 2012, AM J CLIN NUTR, V96, P498, DOI 10.3945/ajcn.112.040287; Czernichow S, 2010, BRIT J NUTR, V104, P788, DOI 10.1017/S0007114510002096; DAYTON S, 1968, LANCET, V2, P1060, DOI 10.1016/S0140-6736(68)91531-6; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; de Goede J, 2012, BRIT J NUTR, V107, P1070, DOI 10.1017/S0007114511003837; Dietary Guidelines Advisory Committee, 2010, WHAT IS EFF DIET INT; ESTERBAUER H, 1987, J LIPID RES, V28, P495; FISHER M, 1970, AUST QUART, V42, P20, DOI 10.2307/20634360; FitzSimons P., 2021, SYDNEY MORNING HERAL; FOLCIK VA, 1994, J LIPID RES, V35, P1570; FRANTZ ID, 1989, ARTERIOSCLEROSIS, V9, P129, DOI 10.1161/01.ATV.9.1.129; HARLAND WA, 1971, ATHEROSCLEROSIS, V13, P239, DOI 10.1016/0021-9150(71)90026-8; Harris WS, 2013, INT J CARDIOL, V168, P53, DOI 10.1016/j.ijcard.2012.09.076; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; Heltianu C, 2011, CELL BIOCHEM BIOPHYS, V61, P209, DOI 10.1007/s12013-011-9190-8; Hooper L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002137.pub3; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Joplin GF, 1968, CARBOHYDRATE METABOL; Katan MB, 2009, AM J CLIN NUTR, V89, P1283, DOI 10.3945/ajcn.2009.27744; KEYS A, 1965, METABOLIS, V14, P747, DOI 10.1016/0026-0495(65)90001-6; Kita T, 2001, ANN NY ACAD SCI, V947, P199; KUHN H, 1992, EICOSANOIDS, V5, P17; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; LENZ ML, 1990, J LIPID RES, V31, P1043; Leren P, 1966, Acta Med Scand Suppl, V466, P1; Lucas M, 2011, AM J CLIN NUTR, V93, P1337, DOI 10.3945/ajcn.111.011817; MacIntosh BA, 2013, BR J NUTR, V18, P1; MCGILCHRIST CA, 1976, J CHRON DIS, V29, P285, DOI 10.1016/0021-9681(76)90089-8; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Natarajan R, 2001, ARTERIOSCL THROM VAS, V21, P1408, DOI 10.1161/hq0901.095278; National Heart Foundation of Australia, 2009, POS STAT DIET FATS D; NESTEL PJ, 1971, MED J AUSTRALIA, V1, P1144; Oh K, 2005, AM J EPIDEMIOL, V161, P672, DOI 10.1093/aje/kwi085; PALMER AJ, 1973, MED J AUSTRALIA, V2, P19; Palmer J, 1977, Adv Exp Med Biol, V82, P115; PALMER J, 1969, ISRAEL J MED SCI, V5, P754; Ramsden CE, 2012, PROSTAG LEUKOTR ESS, V87, P135, DOI 10.1016/j.plefa.2012.08.004; Ramsden CE, 2011, BRIT J NUTR, V106, P953, DOI 10.1017/S0007114511001061; Ramsden CE, 2011, WORLD REV NUTR DIET, V102, P30, DOI 10.1159/000327789; Ramsden CE, 2010, BRIT J NUTR, V104, P1586, DOI 10.1017/S0007114510004010; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; ROSE GA, 1965, BMJ-BRIT MED J, V1, P1531, DOI 10.1136/bmj.1.5449.1531; SHERWIN R, 1978, AM J EPIDEMIOL, V108, P92, DOI 10.1093/oxfordjournals.aje.a112607; Shibata N, 2009, ACTA HISTOCHEM CYTOC, V42, P197, DOI 10.1267/ahc.09022; *USDA, 2008, WHAT WE EAT AM NHANE; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Vangaveti V, 2010, THER ADV ENDOCRINOL, V1, P51, DOI 10.1177/2042018810375656; VANHANDEL E, 1957, J LAB CLIN MED, V50, P152; Waddington EI, 2003, ATHEROSCLEROSIS, V167, P111, DOI 10.1016/S0021-9150(02)00391-X; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; WATTS GF, 1992, LANCET, V339, P563, DOI 10.1016/0140-6736(92)90863-X; WOODHILL J, 1969, Food Technology in Australia, V21, P264; Woodhill J M, 1978, Adv Exp Med Biol, V109, P317; WOODHILL JM, 1973, MED J AUSTRALIA, V1, P973, DOI 10.5694/j.1326-5377.1973.tb110852.x; WOODHILL JM, 1970, INT Z VITAMINFORSCH, V40, P520; World Health Organization, 1957, INT CLASS DIS 7 REV; Xie S, 2009, P NATL ACAD SCI USA, V106, P13353, DOI 10.1073/pnas.0905724106; Yang LL, 2010, J BIOL CHEM, V285, P22211, DOI 10.1074/jbc.M110.119982; Yokode M, 1996, ANN NY ACAD SCI, V786, P245, DOI 10.1111/j.1749-6632.1996.tb39067.x; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	81	247	252	4	77	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2013	346								e8707	10.1136/bmj.e8707	http://dx.doi.org/10.1136/bmj.e8707			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088AR	23386268	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000314806700001
J	Lee, S; Feldstein, SB				Lee, Sukyoung; Feldstein, Steven B.			Detecting Ozone- and Greenhouse Gas-Driven Wind Trends with Observational Data	SCIENCE			English	Article							SOUTHERN ANNULAR MODE; CIRCULATION; VARIABILITY; CONTINUUM; RECOVERY; IMPACT; OCEAN	Modeling studies suggest that Antarctic ozone depletion and, to a lesser degree, greenhouse gas (GHG) increase have caused the observed poleward shift in the westerly jet during the austral summer. Similar studies have not been performed previously with observational data because of difficulties in separating the two contributions. By applying a cluster analysis to daily ERA-Interim data, we found two 7- to 11-day wind clusters, one resembling the models' responses to GHG forcing and the other resembling ozone depletion. The trends in the clusters' frequency of occurrence indicate that the ozone contributed about 50% more than GHG toward the jet shift, supporting the modeling results. Moreover, tropical convection apparently plays an important role for the GHG-driven trend.	[Lee, Sukyoung; Feldstein, Steven B.] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lee, S (corresponding author), Penn State Univ, Dept Meteorol, 503 Walker Bldg, University Pk, PA 16802 USA.	sxl31@meteo.psu.edu			NSF [AGS-1036858, AGS-1139970]; Directorate For Geosciences [1139970, 1036858] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by NSF grants AGS-1036858 and AGS-1139970. The authors acknowledge N. Johnson for providing the Matlab codes used for the SOM analysis and two anonymous reviewers for their helpful suggestions and comments.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Arblaster JM, 2006, J CLIMATE, V19, P2896, DOI 10.1175/JCLI3774.1; Black RX, 2007, J ATMOS SCI, V64, P2968, DOI 10.1175/JAS3979.1; Cane MA, 1997, SCIENCE, V275, P957, DOI 10.1126/science.275.5302.957; Chen G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031200; Clement AC, 1996, J CLIMATE, V9, P2190, DOI 10.1175/1520-0442(1996)009<2190:AODT>2.0.CO;2; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Franzke C, 2005, J ATMOS SCI, V62, P3250, DOI 10.1175/JAS3536.1; Gong TT, 2010, J ATMOS SCI, V67, P2854, DOI 10.1175/2010JAS3311.1; Grassi B, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023804; Higgins ME, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011884; Johnson NC, 2008, J CLIMATE, V21, P6354, DOI 10.1175/2008JCLI2380.1; Kang SM, 2011, SCIENCE, V332, P951, DOI 10.1126/science.1202131; Karpechko AY, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014423; Kidson JW, 1999, J CLIMATE, V12, P2808, DOI 10.1175/1520-0442(1999)012<2808:PMOSHL>2.0.CO;2; Kohonen T., 2001, SELF ORG MAPS INFORM; Kushner PJ, 2001, J CLIMATE, V14, P2238, DOI 10.1175/1520-0442(2001)014<0001:SHACRT>2.0.CO;2; L'Heureux ML, 2006, J CLIMATE, V19, P276, DOI 10.1175/JCLI3617.1; Lee S, 2011, J CLIMATE, V24, P4350, DOI 10.1175/2011JCLI4003.1; Limpasuvan V, 1999, GEOPHYS RES LETT, V26, P3133, DOI 10.1029/1999GL010478; Lorenz DJ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008087; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Polvani LM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014284; Polvani LM, 2011, J CLIMATE, V24, P795, DOI 10.1175/2010JCLI3772.1; Robinson WA, 1997, J CLIMATE, V10, P176, DOI 10.1175/1520-0442(1997)010<0176:DDOTJL>2.0.CO;2; Son SW, 2005, J ATMOS SCI, V62, P3741, DOI 10.1175/JAS3571.1; Tabazadeh A, 2004, ATMOS ENVIRON, V38, P647, DOI 10.1016/j.atmosenv.2003.10.024; Tedesco M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039186; Thompson DWJ, 2000, J CLIMATE, V13, P1018, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Weatherhead EC, 2006, NATURE, V441, P39, DOI 10.1038/nature04746	31	117	120	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					563	567		10.1126/science.1225154	http://dx.doi.org/10.1126/science.1225154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372010				2022-12-28	WOS:000314270000055
J	Neelakantan, S				Neelakantan, Shailaja			PSYCHOLOGY Mind over myocardium	NATURE			English	Editorial Material							DISEASE											Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Duivis HE, 2013, PSYCHONEUROENDOCRINO, V38, P479, DOI 10.1016/j.psyneuen.2012.07.006; Grenon SM, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002667; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nusair Maen, 2012, Mo Med, V109, P199; Sirri L, 2012, INT J CLIN PRACT, V66, P854, DOI 10.1111/j.1742-1241.2012.02993.x; Virtanen M, 2012, AM J EPIDEMIOL, V176, P586, DOI 10.1093/aje/kws139; Whalley B, 2014, INT J BEHAV MED, V21, P109, DOI 10.1007/s12529-012-9282-x	8	8	13	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S16	S17		10.1038/493S16a	http://dx.doi.org/10.1038/493S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080CU	23364767	Bronze			2022-12-28	WOS:000314219600012
J	Sohn, JW; Harris, LE; Berglund, ED; Liu, TM; Vong, L; Lowell, BB; Balthasar, N; Williams, KW; Elmquist, JK				Sohn, Jong-Woo; Harris, Louise E.; Berglund, Eric D.; Liu, Tiemin; Linh Vong; Lowell, Bradford B.; Balthasar, Nina; Williams, Kevin W.; Elmquist, Joel K.			Melanocortin 4 Receptors Reciprocally Regulate Sympathetic and Parasympathetic Preganglionic Neurons	CELL			English	Article							FRAMESHIFT MUTATION; HIPPOCAMPAL SLICES; RAPID INHIBITION; OBESITY; ACTIVATION; NUCLEUS; MICE; EXCITABILITY; PROTEIN; LEPTIN	Melanocortin 4 receptors (MC4Rs) in the central nervous system are key regulators of energy and glucose homeostasis. Notably, obese patients with MC4R mutations are hyperinsulinemic and resistant to obesity-induced hypertension. Although these effects are probably dependent upon the activity of the autonomic nervous system, the cellular effects of MC4Rs on parasympathetic and sympathetic neurons remain undefined. Here, we show that MC4R agonists inhibit parasympathetic preganglionic neurons in the brainstem. In contrast, MC4R agonists activate sympathetic preganglionic neurons in the spinal cord. Deletion of MC4Rs in cholinergic neurons resulted in elevated levels of insulin. Furthermore, re-expression of MC4Rs specifically in cholinergic neurons (including sympathetic preganglionic neurons) restores obesity-associated hypertension in MC4R null mice. These findings provide a cellular correlate of the autonomic side effects associated with MC4R agonists and demonstrate a role for MC4Rs expressed in cholinergic neurons in the regulation of insulin levels and in the development of obesity-induced hypertension.	[Sohn, Jong-Woo; Berglund, Eric D.; Liu, Tiemin; Williams, Kevin W.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Sohn, Jong-Woo; Berglund, Eric D.; Liu, Tiemin; Williams, Kevin W.; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Div Hypothalam Res, Dallas, TX 75390 USA; [Harris, Louise E.; Balthasar, Nina] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Linh Vong; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02115 USA; [Linh Vong; Lowell, Bradford B.] Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Bristol; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Balthasar, N (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England.	nina.balthasar@bristol.ac.uk; kevin.williams@utsouthwestern.edu	Williams, Kevin W/AAA-4243-2020; Williams, Kevin W/ABD-5818-2021; ç, æ /AAU-6965-2020; Sohn, Jong Woo/D-6700-2014	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658; 	American Diabetes Association [07-11-MN-16]; American Heart Association [12POST8860007]; British Heart Foundation [FS/06/057]; Lister Institute for Preventive Medicine; National Institutes of Health [F32 DK092083, K01 DK087780, P01 DK088761, RL1 DK081185, R37 DK053301, F32 DK078478, R01 DK075632, P30 DK046200, P30 DK057521]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK092083, R37DK053301, P30DK057521, P30DK046200, R01DK075632, RL1DK081185, K01DK087780, F32DK078478, R01DK088423, P01DK088761] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); British Heart Foundation(British Heart Foundation); Lister Institute for Preventive Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Diabetes Association 07-11-MN-16 (J.K.E. and T.L.); American Heart Association 12POST8860007 (J.-W.S.); British Heart Foundation FS/06/057 (N.B.); Lister Institute for Preventive Medicine (N.B.); National Institutes of Health F32 DK092083 (E.D.B), K01 DK087780 (K.W.W.), P01 DK088761(J.K.E.), RL1 DK081185 (J.K.E.), R37 DK053301 (J.K.E.), F32 DK078478 (L.V.), and R01 DK075632 (B.B.L.), P30 DK046200 (B.B.L.), and P30 DK057521 (B.B.L.).	Acuna-Goycolea C, 2004, J NEUROSCI, V24, P8141, DOI 10.1523/JNEUROSCI.1607-04.2004; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kuo JJ, 2004, HYPERTENSION, V43, P370, DOI 10.1161/01.HYP.0000111836.54204.93; Lin YW, 2003, J NEUROSCI, V23, P4173; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Ni XP, 2006, J HYPERTENS, V24, P2239, DOI 10.1097/01.hjh.0000249702.49854.fa; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Quinn KV, 2004, CIRC RES, V94, P1359, DOI 10.1161/01.RES.0000128513.34817.c4; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Smith MA, 2007, J PHYSIOL-LONDON, V578, P425, DOI 10.1113/jphysiol.2006.119479; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wan S, 2007, AM J PHYSIOL-GASTR L, V292, pG1474, DOI 10.1152/ajpgi.00562.2006; Wan S, 2008, J NEUROSCI, V28, P4957, DOI 10.1523/JNEUROSCI.5398-07.2008; Wang LH, 2008, J NEUROSCI, V28, P12445, DOI 10.1523/JNEUROSCI.2951-08.2008; Williams KW, 2007, ENDOCRINOLOGY, V148, P1868, DOI 10.1210/en.2006-1098; Williams KW, 2006, J PHYSIOL-LONDON, V573, P395, DOI 10.1113/jphysiol.2006.106336; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	29	149	150	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					612	619		10.1016/j.cell.2012.12.022	http://dx.doi.org/10.1016/j.cell.2012.12.022			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374353	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000314362800028
J	O'Brien, J; Cowan, M; Patch, D				O'Brien, Julia; Cowan, Matthew; Patch, David			Haematemesis, haemoptysis, or both?	LANCET			English	Editorial Material							PORTAL-HYPERTENSION; BRONCHIAL VARICES; SECONDARY		[O'Brien, Julia; Patch, David] Royal Free Hosp, Royal Free Sheila Sherlock Liver Ctr, London NW3 2QG, England; [O'Brien, Julia; Patch, David] UCL, London, England; [Cowan, Matthew] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Liver & Antiviral Unit, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Imperial College London	Patch, D (corresponding author), Royal Free Hosp, Royal Free Sheila Sherlock Liver Ctr, Pond St, London NW3 2QG, England.	david.patch@nhs.net						MacDonald M, 2012, J THORAC IMAG, V27, pW10, DOI 10.1097/RTI.0b013e318205a4a5; Mansilla AV, 1999, J VASC INTERV RADIOL, V10, P372, DOI 10.1016/S1051-0443(99)70045-X; Nagahiro I, 2007, RESPIRATION, V74, P460, DOI 10.1159/000088356; Otsuka T, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34, P327; YOUSSEF AI, 1994, AM J GASTROENTEROL, V89, P1562	5	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2013	381	9863					346	346		10.1016/S0140-6736(12)61890-X	http://dx.doi.org/10.1016/S0140-6736(12)61890-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23351806				2022-12-28	WOS:000314021800032
J	Delamothe, T				Delamothe, Tony			ON THE CONTRARY Learning from Winterbourne View	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com						Care Quality Commission, 2012, LEARN DIS SERV INSP; Cole A, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4634; Department of Health, 2012, TRANSF CAR NAT RESP; Flynn M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f18; Hill A., 2012, GUARDIAN	5	0	0	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2013	346								f433	10.1136/bmj.f433	http://dx.doi.org/10.1136/bmj.f433			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080CD	23349409				2022-12-28	WOS:000314217900015
J	Jha, P; Landsman, V; Rostron, B; Thun, M; Anderson, RN; McAfee, T; Peto, R				Jha, Prabhat; Landsman, Victoria; Rostron, Brian; Thun, Michael; Anderson, Robert N.; McAfee, Tim; Peto, Richard			21st-Century Hazards of Smoking and Benefits of Cessation in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CIGARETTE	Background Extrapolation from studies in the 1980s suggests that smoking causes 25% of deaths among women and men 35 to 69 years of age in the United States. Nationally representative measurements of the current risks of smoking and the benefits of cessation at various ages are unavailable. Methods We obtained smoking and smoking-cessation histories from 113,752 women and 88,496 men 25 years of age or older who were interviewed between 1997 and 2004 in the U. S. National Health Interview Survey and related these data to the causes of deaths that occurred by December 31, 2006 (8236 deaths in women and 7479 in men). Hazard ratios for death among current smokers, as compared with those who had never smoked, were adjusted for age, educational level, adiposity, and alcohol consumption. Results For participants who were 25 to 79 years of age, the rate of death from any cause among current smokers was about three times that among those who had never smoked (hazard ratio for women, 3.0; 99% confidence interval [CI], 2.7 to 3.3; hazard ratio for men, 2.8; 99% CI, 2.4 to 3.1). Most of the excess mortality among smokers was due to neoplastic, vascular, respiratory, and other diseases that can be caused by smoking. The probability of surviving from 25 to 79 years of age was about twice as great in those who had never smoked as in current smokers (70% vs. 38% among women and 61% vs. 26% among men). Life expectancy was shortened by more than 10 years among the current smokers, as compared with those who had never smoked. Adults who had quit smoking at 25 to 34, 35 to 44, or 45 to 54 years of age gained about 10, 9, and 6 years of life, respectively, as compared with those who continued to smoke. Conclusions Smokers lose at least one decade of life expectancy, as compared with those who have never smoked. Cessation before the age of 40 years reduces the risk of death associated with continued smoking by about 90%.	[Jha, Prabhat] Univ Toronto, Ctr Global Hlth Res, St Michaels Hosp, Toronto, ON M5C 1N8, Canada; [Rostron, Brian] US FDA, Rockville, MD 20857 USA; [Anderson, Robert N.] Ctr Dis Control & Prevent, Hyattsville, MD USA; [Thun, Michael] Amer Canc Soc, Atlanta, GA 30329 USA; [McAfee, Tim] Ctr Dis Control & Prevent, Atlanta, GA USA; [Peto, Richard] Univ Oxford, Clin Trial & Epidemiol Serv Unit, Oxford, England	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA; American Cancer Society; Centers for Disease Control & Prevention - USA; University of Oxford	Jha, P (corresponding author), Univ Toronto, Ctr Global Hlth Res, St Michaels Hosp, Toronto, ON M5C 1N8, Canada.		Greiver, Michelle/N-8764-2015; McAfee, Tim/GXG-1246-2022	Greiver, Michelle/0000-0001-8957-0285; Jha, Prabhat/0000-0001-7067-8341	Fogarty International Center [TW007939-01]; National Institutes of Health; Canadian Institutes of Health Research [IEG-53506]; Disease Control Priorities Project; Bill and Melinda Gates Foundation; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R01TW007939] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Disease Control Priorities Project; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Supported by a grant (TW007939-01) from the Fogarty International Center, National Institutes of Health; by a grant (IEG-53506) from the Canadian Institutes of Health Research; and by the Disease Control Priorities Project, Bill and Melinda Gates Foundation. Dr. Jha holds an endowed faculty position at the University of Toronto.	[Anonymous], 2004, HLTH CONS SMOK REP S; [Anonymous], 2011, MMWR-MORBID MORTAL W, V60, P44; Baumgardner JR, 2012, NEW ENGL J MED, V367, P2068, DOI 10.1056/NEJMp1210319; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dresler C, 2007, IARC HDB CANC PREVEN, V11, P15; Fang Jing, 2011, Morbidity and Mortality Weekly Report, V60, P1377; Forey B, 2002, INT SMOKING STAT 200; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Green J, 2012, LANCET; Hoffmann D, 1997, J TOXICOL ENV HEALTH, V50, P307, DOI 10.1080/009841097160393; Ingram Deborah D, 2008, Vital Health Stat 2, P1; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83; Jha P., 1999, CURBING EPIDEMIC GOV; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Mehta N, 2012, AM J PUBLIC HEALTH, V102, P2181, DOI 10.2105/AJPH.2011.300489; National Center for Health Statistics, 2011, NAT HLTH INT SURV; National Center for Health Statistics, 2009, NAT HLTH INT SURV 19; Pencina MJ, 2007, STAT MED, V26, P1343, DOI 10.1002/sim.2699; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; Peto R, 1994, MORTALITY SMOKING DE; Peto R, 2010, BIOGR MEMS FELL R SO, V56, P63; Rigotti NA, 2012, ANN INTERN MED; Ritter C, 2011, J PUBLIC HEALTH POL, V32, P32, DOI 10.1057/jphp.2010.47; Rostron B, 2011, EPIDEMIOLOGY, V22, P350, DOI 10.1097/EDE.0b013e3182126729; Sakatas R., 2012, BMJ-BRIT MED J, V345, pe7903; Thun M, 2012, TOB CONTROL, V21, P96, DOI 10.1136/tobaccocontrol-2011-050294; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; WHO, 2011, MPOWER POL PACK REV	29	1078	1104	7	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					341	350		10.1056/NEJMsa1211128	http://dx.doi.org/10.1056/NEJMsa1211128			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075KX	23343063	Bronze			2022-12-28	WOS:000313885900007
J	Milstone, AM; Elward, A; Song, XY; Zerr, DM; Orscheln, R; Speck, K; Obeng, D; Reich, NG; Coffin, SE; Perl, TM				Milstone, Aaron M.; Elward, Alexis; Song, Xiaoyan; Zerr, Danielle M.; Orscheln, Rachel; Speck, Kathleen; Obeng, Daniel; Reich, Nicholas G.; Coffin, Susan E.; Perl, Trish M.		Pediat SCRUB Trial Study Grp	Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial	LANCET			English	Article							BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; COAGULASE-NEGATIVE STAPHYLOCOCCI; HOSPITALIZED CHILDREN; RESOURCE UTILIZATION; CLINICAL IMPACT; SAFETY NETWORK; RISK; MORTALITY; CULTURES	Background Bacteraemia is an important cause of morbidity and mortality in critically ill children. Our objective was to assess whether daily bathing in chlorhexidine gluconate (CHG) compared with standard bathing practices would reduce bacteraemia in critically ill children. Methods In an unmasked, cluster-randomised, two-period crossover trial, ten paediatric intensive-care units at five hospitals in the USA were randomly assigned a daily bathing routine for admitted patients older than 2 months, either standard bathing practices or using a cloth impregnated with 2% CHG, for a 6-month period. Units switched to the alternative bathing method for a second 6-month period. 6482 admissions were screened for eligibility. The primary outcome was an episode of bacteraemia. We did intention-to-treat (ITT) and per-protocol (PP) analyses. This study is registered with ClinicalTrials.gov (identifier NCT00549393). Findings 1521 admitted patients were excluded because their length of stay was less than 2 days, and 14 refused to participate. 4947 admissions were eligible for analysis. In the ITT population, a non-significant reduction in incidence of bacteraemia was noted with CHG bathing (3.52 per 1000 days, 95% CI 2.64-4.61) compared with standard practices (4.93 per 1000 days, 3.91-6.15; adjusted incidence rate ratio [aIRR] 0.71, 95% CI 0.42-1.20). In the PP population, incidence of bacteraemia was lower in patients receiving CHG bathing (3.28 per 1000 days, 2.27-4.58) compared with standard practices (4.93 per 1000 days, 3.91-6.15; aIRR 0.64, 0.42-0.98). No serious study-related adverse events were recorded, and the incidence of CHG-associated skin reactions was 1.2 per 1000 days (95% CI 0.60-2.02). Interpretation Critically ill children receiving daily CHG bathing had a lower incidence of bacteraemia compared with those receiving a standard bathing routine. Furthermore, the treatment was well tolerated.	[Milstone, Aaron M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Infect Dis, Baltimore, MD 21205 USA; [Speck, Kathleen; Perl, Trish M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Milstone, Aaron M.; Reich, Nicholas G.; Perl, Trish M.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Obeng, Daniel] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Elward, Alexis; Orscheln, Rachel] Washington Univ, Sch Med, Dept Pediat, Div Pediat Infect Dis, St Louis, MO 63110 USA; [Song, Xiaoyan] George Washington Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Washington, DC 20037 USA; [Zerr, Danielle M.] Univ Washington, Sch Med, Dept Pediat, Div Pediat Infect Dis, Seattle, WA 98195 USA; [Coffin, Susan E.] Univ Penn, Sch Med, Dept Pediat, Div Pediat Infect Dis, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Washington University (WUSTL); George Washington University; University of Washington; University of Washington Seattle; University of Pennsylvania	Milstone, AM (corresponding author), JHU, Dept Pediat, Baltimore, MD 21287 USA.	amilsto1@jhmi.edu	Reich, Nicholas/L-1168-2019	Reich, Nicholas/0000-0003-3503-9899; Orscheln, Rachel/0000-0003-3865-2728; Milstone, Aaron/0000-0001-8498-8682	Sage Products; US National Institutes of Health; BioMerieux; Vioguard; Merck; Optimer Pharmaceuticals; NIH/NIAID [1 K23 AI081752]; National Center for Research Resources (NCRR), part of the National Institutes of Health (NIH) [UL1 RR 025005]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI081752] Funding Source: NIH RePORTER	Sage Products(General Electric); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioMerieux; Vioguard; Merck(Merck & Company); Optimer Pharmaceuticals; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (NCRR), part of the National Institutes of Health (NIH); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sage Products, US National Institutes of Health.; AMM, TMP, DMZ, SEC, XS, and AE have received grant support from Sage Products. Furthermore, AMM has received grant support from BioMerieux, DMZ has received grant support from Vioguard, TMP has received grant support from Merck and is on an advisory board for Pfizer and Hospira, and XS has received grant support from Optimer Pharmaceuticals. All other authors report no conflicts of interest.; This study was funded mainly by grants from Sage Products (to AE, XS, DMZ, SEC, and TMP), with additional funding from NIH/NIAID 1 K23 AI081752 (to AMM) and UL1 RR 025005 from the National Center for Research Resources (NCRR), part of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. This research does not represent the official view of NCRR or NIH. We thank Evan Anderson (Northwestern University), Howard Lederman (Johns Hopkins University), the Johns Hopkins Biostatistics Center, Michael Climo (Medical College of Virginia), the intensive-care nurses at every site, and families and patients for their participation. Data were presented in part at the annual scientific meetings of the Society of Healthcare Epidemiology of America, held in Dallas, TX, USA, April, 2011 (abstract LB-14), and the Infectious Diseases Society of America, held in Boston, MA, USA, October, 2011 (abstract LB-36).	Advani S, 2011, CLIN INFECT DIS, V52, P1108, DOI 10.1093/cid/cir145; Armenian SH, 2005, PEDIATR INFECT DIS J, V24, P309, DOI 10.1097/01.inf.0000157086.97503.bd; BATES DW, 1991, JAMA-J AM MED ASSOC, V265, P365, DOI 10.1001/jama.265.3.365; Bleasdale SC, 2005, INT C ANT AG CHEM WA; Bleasdale SC, 2007, ARCH INTERN MED, V167, P2073, DOI 10.1001/archinte.167.19.2073; Climo M, 2007, 17 ANN SCI M SOC HEA; Derde LPG, 2012, INTENS CARE MED, V38, P931, DOI 10.1007/s00134-012-2542-z; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Elward AM, 2005, PEDIATRICS, V115, P868, DOI 10.1542/peds.2004-0256; Favre B, 2005, INFECT CONT HOSP EP, V26, P697, DOI 10.1086/502605; Feudtner C, 2000, PEDIATRICS, V106, P205; Gray J, 2001, PEDIATR INFECT DIS J, V20, P416, DOI 10.1097/00006454-200104000-00009; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Krautheim AB, 2004, CONTACT DERMATITIS, V50, P113, DOI 10.1111/j.0105-1873.2004.00308.x; Lee A, 2011, INFECT CONT HOSP EP, V32, P395, DOI 10.1086/659154; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Miller MR, 2010, PEDIATRICS, V125, P206, DOI 10.1542/peds.2009-1382; Milstone AM, 2008, CLIN INFECT DIS, V46, P274, DOI 10.1086/524736; Niedner MF, 2011, INFECT CONT HOSP EP, V32, P1200, DOI 10.1086/662621; O'Horo JC, 2012, INFECT CONT HOSP EP, V33, P257, DOI 10.1086/664496; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Schulman J, 2011, PEDIATRICS, V127, P436, DOI 10.1542/peds.2010-2873; Segal GS, 2000, ARCH PEDIAT ADOL MED, V154, P469, DOI 10.1001/archpedi.154.5.469; SHUMAN RM, 1974, PEDIATRICS, V54, P689; van der Heijden YF, 2011, INFECT CONT HOSP EP, V32, P623, DOI 10.1086/660096; Waltzman ML, 2001, CLIN INFECT DIS, V33, P296, DOI 10.1086/321881	30	130	128	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 30	2013	381	9872					1099	1106		10.1016/S0140-6736(12)61687-0	http://dx.doi.org/10.1016/S0140-6736(12)61687-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WL	23363666	Green Accepted			2022-12-28	WOS:000317348900028
J	Tameris, MD; Hatherill, M; Landry, BS; Scriba, TJ; Snowden, MA; Lockhart, S; Shea, JE; McClain, JB; Hussey, GD; Hanekom, WA; Mahomed, H; McShane, H				Tameris, Michele D.; Hatherill, Mark; Landry, Bernard S.; Scriba, Thomas J.; Snowden, Margaret Ann; Lockhart, Stephen; Shea, Jacqueline E.; McClain, J. Bruce; Hussey, Gregory D.; Hanekom, Willem A.; Mahomed, Hassan; McShane, Helen			Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial	LANCET			English	Article							BACILLUS-CALMETTE-GUERIN; PROTECTIVE EFFICACY; YOUNG-CHILDREN; CAPE-TOWN; IMMUNOGENICITY; MENINGITIS; CONSENSUS; ASSAY	Background BCG vaccination provides incomplete protection against tuberculosis in infants. A new vaccine, modified Vaccinia Ankara virus expressing antigen 85A (MVA85A), was designed to enhance the protective efficacy of BCG. We aimed to assess safety, immunogenicity, and efficacy of MVA85A against tuberculosis and Mycobacterium tuberculosis infection in infants. Methods In our double-blind, randomised, placebo-controlled phase 2b trial, we enrolled healthy infants (aged 4-6 months) without HIV infection who had previously received BCG vaccination. We randomly allocated infants (1: 1), according to an independently generated sequence with block sizes of four, to receive one intradermal dose of MVA85A or an equal volume of Candida skin test antigen as placebo at a clinical facility in a rural region near Cape Town, South Africa. We actively followed up infants every 3 months for up to 37 months. The primary study outcome was safety (incidence of adverse and serious adverse events) in all vaccinated participants, but we also assessed efficacy in a protocol-defined group of participants who received at least one dose of allocated vaccine. The primary efficacy endpoint was incident tuberculosis incorporating microbiological, radiological, and clinical criteria, and the secondary efficacy endpoint was M tuberculosis infection according to QuantiFERON TB Gold In-tube conversion (Cellestis, Australia). This trial was registered with the South African National Clinical Trials Register (DOH-27-0109-2654) and with ClinicalTrials.gov on July 31, 2009, number NCT00953927 Findings Between July 15, 2009, and May 4, 2011, we enrolled 2797 infants (1399 allocated MVA85A and 1398 allocated placebo). Median follow-up in the per-protocol population was 24.6 months (IQR 19.2-28.1), and did not differ between groups. More infants who received MVA85A than controls had at least one local adverse event (1251 [89%] of 1399 MVA85A recipients and 628 [45%] of 1396 controls who received the allocated intervention) but the numbers of infants with systemic adverse events (1120 [80%] and 1059 [76%]) or serious adverse events (257 [18%] and 258 (18%) did not differ between groups. None of the 648 serious adverse events in these 515 infants was related to MVA85A. 32 (2%) of 1399 MVA85A recipients met the primary efficacy endpoint (tuberculosis incidence of 1.15 per 100 person-years [95% CI 0.79 to 1.62]; with conversion in 178 [13%] of 1398 infants [95% CI 11.0 to 14.6]) as did 39 (3%) of 1395 controls (1.39 per 100 person-years [1.00 to 1.91]; with conversion in 171 [12%] of 1394 infants [10.6 to 14.1]). Efficacy against tuberculosis was 17.3% (95% CI -31.9 to 48.2) and against M tuberculosis infection was -3.8% (-28.1 to 15.9). Interpretation MVA85A was well tolerated and induced modest cell-mediated immune responses. Reasons for the absence of MVA85A efficacy against tuberculosis or M tuberculosis infection in infants need exploration.	[Tameris, Michele D.; Hatherill, Mark; Scriba, Thomas J.; Hussey, Gregory D.; Hanekom, Willem A.; Mahomed, Hassan] Univ Cape Town, S African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Tameris, Michele D.; Hatherill, Mark; Scriba, Thomas J.; Hussey, Gregory D.; Hanekom, Willem A.; Mahomed, Hassan] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Lockhart, Stephen; Shea, Jacqueline E.] Oxford Emergent TB Consortium, Wokingham, Berks, England; [Lockhart, Stephen] Emergent Prod Dev UK, Wokingham, Berks, England; [McClain, J. Bruce] Univ Oxford, Jenner Inst, Nuffield Dept Clin Med, Oxford, England; [Hussey, Gregory D.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Hussey, Gregory D.] Univ Cape Town, Dept Med Microbiol, ZA-7925 Cape Town, South Africa; [Mahomed, Hassan] Univ Stellenbosch, Dept Hlth, Western Cape & Div Community Hlth, ZA-7600 Stellenbosch, South Africa	University of Cape Town; University of Cape Town; University of Oxford; Jenner Institute; University of Cape Town; University of Cape Town; Stellenbosch University	Tameris, MD (corresponding author), Brewelskloof Hosp, SATVI, Haarlem St, ZA-6850 Worcester, South Africa.	michele.tameris@uct.ac.za; helen.mcshane@ndm.ox.ac.uk	Tameris, Michele/AAR-6663-2021; Rivet, Catherine A/M-7978-2014; Scriba, Thomas/GPX-2573-2022; Scriba, Thomas/H-3633-2013; Scriba, Thomas/AAH-9413-2020	Tameris, Michele/0000-0002-7983-7203; Scriba, Thomas/0000-0002-0641-1359; Lockhart, Stephen/0000-0002-0805-2193; McShane, Helen/0000-0002-2126-5142; Vermaak, Samantha/0000-0003-4791-8364; Hanekom, Willem/0000-0003-3070-6154	Aeras; Wellcome Trust; Oxford-Emergent Tuberculosis Consortium (OETC); National Institute for Health Research [NF-SI-0509-10233] Funding Source: researchfish	Aeras; Wellcome Trust(Wellcome TrustEuropean Commission); Oxford-Emergent Tuberculosis Consortium (OETC); National Institute for Health Research(National Institute for Health Research (NIHR))	Aeras, Wellcome Trust, and Oxford-Emergent Tuberculosis Consortium (OETC).	Baily G V, 1980, Indian J Med Res, V72 Suppl, P1; Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7; COLDITZ GA, 1995, PEDIATRICS, V96, P29; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Hanekom WA, 2008, PLOS MED, V5, P1033, DOI 10.1371/journal.pmed.0050145; Hatherill M, SAFETY AND IMMUNOGEN; Hatherill M, 2012, CLIN INFECT DIS, V54, P493, DOI 10.1093/cid/cir823; Hawkridge A, 2008, BMJ-BRIT MED J, P1275; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kaufmann SHE, 2011, LANCET INFECT DIS, V11, P633, DOI 10.1016/S1473-3099(11)70146-3; Mahomed H, 2006, PEDIATR INFECT DIS J, V25, P1167, DOI 10.1097/01.inf.0000243765.33880.54; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Meyer J, 2013, VACCINE, V31, P1026, DOI 10.1016/j.vaccine.2012.12.042; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moyo S, 2012, INT J TUBERC LUNG D, V16, P185, DOI 10.5588/ijtld.11.0348; Moyo S, 2011, INT J TUBERC LUNG D, V15, P1176, DOI 10.5588/ijtld.10.0770; Moyo S, 2010, INT J TUBERC LUNG D, V14, P149; Ota MOC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002461; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Roy RB, 2012, AM J RESP CRIT CARE, V186, P378, DOI 10.1164/rccm.201201-0026OC; Scriba TJ, 2011, J INFECT DIS, V203, P1832, DOI 10.1093/infdis/jir195; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Stop TB Partnership, THE GLOBAL PLAN TO S; Tameris M, TUBERCULOSIS EDIN IN; Taylor JL, 2003, INFECT IMMUN, V71, P2192, DOI 10.1128/IAI.71.4.2192-2198.2003; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Williams A, 2005, INFECT IMMUN, V73, P3814, DOI 10.1128/IAI.73.6.3814-3816.2005; World Health Organization, GLOBAL TUBERCULOSIS	33	684	715	2	124	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2013	381	9871					1021	1028		10.1016/S0140-6736(13)60177-4	http://dx.doi.org/10.1016/S0140-6736(13)60177-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EU	23391465	Green Published			2022-12-28	WOS:000316936800031
J	Axelsson, E; Ratnakumar, A; Arendt, ML; Maqbool, K; Webster, MT; Perloski, M; Liberg, O; Arnemo, JM; Hedhammar, A; Lindblad-Toh, K				Axelsson, Erik; Ratnakumar, Abhirami; Arendt, Maja-Louise; Maqbool, Khurram; Webster, Matthew T.; Perloski, Michele; Liberg, Olof; Arnemo, Jon M.; Hedhammar, Ake; Lindblad-Toh, Kerstin			The genomic signature of dog domestication reveals adaptation to a starch-rich diet	NATURE			English	Article							MALTASE-GLUCOAMYLASE GENE; GLUCOSE; TRANSPORTERS; SELECTION; HISTORY; SPERM	The domestication of dogs. was an important episode in the development of human civilization. The precise timing and location of this event is debated(1-5) and little is known about the genetic changes that accompanied the transformation of ancient wolves into domestic dogs. Here we conduct whole-genome resequencimg of dogs and wolves to identify 3.8 million genetic variants used to identify 36 genomic regions that probably represent targets for selection during dog domestication. Nineteen of these regions contain genes important in brain function, eight of which belong to nervous system development pathways and potentially underlie behavioural changes central to dog domestication(6). Ten genes with key roles in starch digestion and fat metabolism also show signals of selection. We identify candidate mutations in key genes and provide functional support for an increased starch digestion in dogs relative to wolves. Our results indicate that novel adaptations allowing the early ancestors of modern dogs to thrive on a diet rich in starch, relative to the carnivorous diet of wolves, constituted a crucial step in the early domestication of dogs.	[Axelsson, Erik; Ratnakumar, Abhirami; Arendt, Maja-Louise; Maqbool, Khurram; Webster, Matthew T.; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75237 Uppsala, Sweden; [Perloski, Michele; Lindblad-Toh, Kerstin] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02139 USA; [Liberg, Olof] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, S-73091 Riddarhyttan, Sweden; [Arnemo, Jon M.] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, NO-2418 Elverum, Norway; [Arnemo, Jon M.] Swedish Univ Agr Sci, Fac Forest Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Hedhammar, Ake] Swedish Univ Agr Sci, Dept Clin Sci, Sci Life Lab, S-75651 Uppsala, Sweden	Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Swedish University of Agricultural Sciences; Inland Norway University of Applied Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Axelsson, E (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75237 Uppsala, Sweden.	Erik.Axelsson@imbim.uu.se; kersli@broadinstitute.org	Arendt, Maja/AAZ-3783-2021; Axelsson, Erik/A-6119-2009	Hedhammar, Ake/0000-0001-7048-3851; Arendt, Maja Louise/0000-0003-1404-172X; Maqbool, Khurram/0000-0003-2981-2582; Webster, Matthew/0000-0003-1141-2863	SSF; Swedish Research Council; Swedish Research Council Formas; Uppsala University; EURYI; ESF; Higher Education Commission, Pakistan	SSF(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Uppsala University; EURYI(European Science Foundation (ESF)); ESF(European Commission); Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	We thank Jarvzoo, Nordens ark and the Canine Biobank at Uppsala University and the Swedish University of Agricultural Sciences for providing samples, Uppsala Genomics Platform at SciLifeLab Uppsala for generating the resequencing data, the UPPNEX platform for assisting with computational infrastructure for data analysis and the Broad Institute Genomics Platform for validation genotyping. The project was funded by the SSF, the Swedish Research Council, the Swedish Research Council Formas, Uppsala University and a EURYI to K.L.-T. funded by the ESF supporting also E.A.; K.M. was funded by the Higher Education Commission, Pakistan.	Andersson L, 2009, COLD SH Q B, V74, P319, DOI 10.1101/sqb.2009.74.039; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; Boomgaarden I, 2009, BIOCHEM GENET, V47, P739, DOI 10.1007/s10528-009-9273-z; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Coppinger R., 2001, DOGS STARTLING NEW U; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Gardner AJ, 2006, REPROD FERT DEVELOP, V18, P53, DOI 10.1071/RD05122; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; HEDIGER MA, 1991, BIOCHIM BIOPHYS ACTA, V1064, P360, DOI 10.1016/0005-2736(91)90323-Z; Koike N, 2007, J BIOL CHEM, V282, P15843, DOI 10.1074/jbc.M701570200; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MEISLER MH, 1993, CRIT REV ORAL BIOL M, V4, P503, DOI 10.1177/10454411930040033501; Mochizuki K, 2010, MOL NUTR FOOD RES, V54, P1445, DOI 10.1002/mnfr.200900467; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SIMPSON JW, 1984, VET RES COMMUN, V8, P303, DOI 10.1007/BF02214725; Skoglund P, 2011, MOL BIOL EVOL, V28, P1505, DOI 10.1093/molbev/msq342; Tokuhiro K, 2012, P NATL ACAD SCI USA, V109, P3850, DOI 10.1073/pnas.1117963109; Varga ZM, 2001, DEVELOPMENT, V128, P3497; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Weston MC, 2011, NEURON, V69, P1147, DOI 10.1016/j.neuron.2011.02.002; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009	30	558	576	14	627	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					360	364		10.1038/nature11837	http://dx.doi.org/10.1038/nature11837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23354050				2022-12-28	WOS:000316650500041
J	Fanelli, D				Fanelli, Daniele			Redefine misconduct as distorted reporting	NATURE			English	Editorial Material									Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland	University of Edinburgh	Fanelli, D (corresponding author), Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland.	dfanelli@exseed.ed.ac.uk		Fanelli, Daniele/0000-0003-1780-1958					0	49	49	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					149	149		10.1038/494149a	http://dx.doi.org/10.1038/494149a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092QS	23407504	Bronze			2022-12-28	WOS:000315137700004
J	Johnson, PTJ; Preston, DL; Hoverman, JT; Richgels, KLD				Johnson, Pieter T. J.; Preston, Daniel L.; Hoverman, Jason T.; Richgels, Katherine L. D.			Biodiversity decreases disease through predictable changes in host community competence	NATURE			English	Article							WEST-NILE-VIRUS; SPECIES-DIVERSITY; INFECTIOUS-DISEASE; PARASITE DIVERSITY; RISK; EXTINCTION; ECOSYSTEM; INVASION; DILUTION	Accelerating rates of species extinctions and disease emergence underscore the importance of understanding how changes in bio-diversity affect disease outcomes(1-3). Over the past decade, a growing number of studies have reported negative correlations between host biodiversity and disease risk(4-8), prompting suggestions that biodiversity conservation could promote human and wildlife health(9,10). Yet the generality of the diversity-disease linkage remains conjectural(11-13), in part because empirical evidence of a relationship between host competence (the ability to maintain and transmit infections) and the order in which communities assemble has proven elusive. Here we integrate high-resolution field data with multi-scale experiments to show that host diversity inhibits transmission of the virulent pathogen Ribeiroia ondatrae and reduces amphibian disease as a result of consistent linkages among species richness, host composition and community competence. Surveys of 345 wetlands indicated that community composition changed nonrandomly with species richness, such that highly competent hosts dominated in species-poor assemblages whereas more resistant species became progressively more common in diverse assemblages. As a result, amphibian species richness strongly moderated pathogen transmission and disease pathology among 24,215 examined hosts, with a 78.4% decline in realized transmission in richer assemblages. Laboratory and mesocosm manipulations revealed an approximately 50% decrease in pathogen transmission and host pathology across a realistic diversity gradient while controlling for host density, helping to establish mechanisms underlying the diversity-disease relationship and their consequences for host fitness. By revealing a consistent link between species richness and community competence, these findings highlight the influence of biodiversity on infection risk and emphasize the benefit of a community-based approach to understanding infectious diseases.	[Johnson, Pieter T. J.; Preston, Daniel L.; Richgels, Katherine L. D.] Univ Colorado, Boulder, CO 80309 USA; [Hoverman, Jason T.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	University of Colorado System; University of Colorado Boulder; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Johnson, PTJ (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	pieter.johnson@colorado.edu	Hoverman, Jason/AGR-0056-2022; Hoverman, Jason T/D-1756-2013; Richgels, Katherine/H-3773-2013	Hoverman, Jason/0000-0002-4002-2728; Hoverman, Jason T/0000-0002-4002-2728; Richgels, Katherine/0000-0003-2834-9477; JOHNSON, PIETER/0000-0002-7997-5390	US National Science Foundation [DEB-0841758, DEB-1149308]; National Geographic Society; David and Lucile Packard Foundation	US National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	We thank B. Hoye, J. Koprivnikar, K. Medley, J. Rohr and especially Y. Springer for editorial suggestions; S. Johnson for valuable statistical advice; M. Baragona, I. Buller, K. Gietzen, B. Goodman, J. Jenkins, E. Kellermanns, B. LaFonte, T. McDevitt-Galles,J. McFarland and S. Paull for assistance in collecting data; and East Bay Regional Parks, East Bay Municipal Utility District, Santa Clara County Parks, Hopland Research and Extension Center, Blue Oak Ranch Reserve, California State Parks, The Nature Conservancy, Open Space Authority and Mid-peninsula Open Space for access to properties and logistical support. This work was supported through funds from the US National Science Foundation (DEB-0841758, DEB-1149308), the National Geographic Society, and the David and Lucile Packard Foundation.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Clay CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006467; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Graham SP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007873; Haas SE, 2011, ECOL LETT, V14, P1108, DOI 10.1111/j.1461-0248.2011.01679.x; Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767; Hechinger RF, 2005, P ROY SOC B-BIOL SCI, V272, P1059, DOI 10.1098/rspb.2005.3070; Johnson PTJ, 2012, P NATL ACAD SCI USA, V109, P9006, DOI 10.1073/pnas.1201790109; Johnson PTJ, 2012, ECOLOGY, V93, P56, DOI 10.1890/11-0636.1; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Wood C. L., 2012, TRENDS ECOL EVOL	29	241	246	13	461	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					230	233		10.1038/nature11883	http://dx.doi.org/10.1038/nature11883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23407539				2022-12-28	WOS:000315137700038
J	Zanier, K; Charbonnier, S; Sidi, AOMO; McEwen, AG; Ferrario, MG; Poussin-Courmontagne, P; Cura, V; Brimer, N; Babah, KO; Ansari, T; Muller, I; Stote, RH; Cavarelli, J; Pol, SV; Trave, G				Zanier, Katia; Charbonnier, Sebastian; Sidi, Abdellahi Ould M'hamed Ould; McEwen, Alastair G.; Ferrario, Maria Giovanna; Poussin-Courmontagne, Pierre; Cura, Vincent; Brimer, Nicole; Babah, Khaled Ould; Ansari, Tina; Muller, Isabelle; Stote, Roland H.; Cavarelli, Jean; Pol, Scott Vande; Trave, Gilles			Structural Basis for Hijacking of Cellular LxxLL Motifs by Papillomavirus E6 Oncoproteins	SCIENCE			English	Article							PAXILLIN LD MOTIFS; TYPE-1 E6; ASSOCIATION; PROTEINS; BINDING; P53; RECOGNITION; IDENTIFICATION; TRANSFORMATION; DEGRADATION	E6 viral oncoproteins are key players in epithelial tumors induced by papillomaviruses in vertebrates, including cervical cancer in humans. E6 proteins target many host proteins by specifically interacting with acidic LxxLL motifs. We solved the crystal structures of bovine (BPV1) and human (HPV16) papillomavirus E6 proteins bound to LxxLL peptides from the focal adhesion protein paxillin and the ubiquitin ligase E6AP, respectively. In both E6 proteins, two zinc domains and a linker helix form a basic-hydrophobic pocket, which captures helical LxxLL motifs in a way compatible with other interaction modes. Mutational inactivation of the LxxLL binding pocket disrupts the oncogenic activities of both E6 proteins. This work reveals the structural basis of both the multifunctionality and the oncogenicity of E6 proteins.	[Zanier, Katia; Charbonnier, Sebastian; Sidi, Abdellahi Ould M'hamed Ould; Babah, Khaled Ould; Muller, Isabelle; Trave, Gilles] Ecole Super Biotechnol Strasbourg, Biotechnol & Signalisat Cellulaire UMR 7242, F-67412 Illkirch Graffenstaden, France; [McEwen, Alastair G.; Ferrario, Maria Giovanna; Poussin-Courmontagne, Pierre; Cura, Vincent; Stote, Roland H.; Cavarelli, Jean] Univ Strasbourg, IGBMC, INSERM, CNRS,UMR 7104,U964, F-67404 Illkirch Graffenstaden, France; [Brimer, Nicole; Ansari, Tina; Pol, Scott Vande] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Virginia	Cavarelli, J (corresponding author), Univ Strasbourg, IGBMC, INSERM, CNRS,UMR 7104,U964, 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, France.	cava@igbmc.fr; vandepol@virginia.edu; gilles.trave@unistra.fr	TRAVE, Gilles/P-8577-2016; Cura, Vincent/P-4587-2016; Pol, Scott Vande/AAO-1068-2020; Cavarelli, Jean/P-3566-2016	Cura, Vincent/0000-0003-2586-510X; Pol, Scott Vande/0000-0002-0587-4802; Cavarelli, Jean/0000-0001-8620-8723; McEwen, Alastair G./0000-0003-4484-3512; Poussin-Courmontagne, Pierre/0000-0003-4813-6882; Ould M'hamed Sidi, Abdellahi/0000-0001-6535-1950; Ferrario, Maria Giovanna/0000-0003-4415-3722	CNRS; Universite de Strasbourg; INSERM; European Commission SPINE2-Complexes project [LSHG-CT-2006-031220]; Association pour la Recherche contre le Cancer (ARC) [3171]; Agence Nationale de la Recherche [ANR-MIME-2007 EPI-HPV-3D]; NIH [R01CA134737, CA120352, CA134737, CA08093]; ANR; ARC; College Doctoral Europeen; NATIONAL CANCER INSTITUTE [R01CA134737, P30CA044579, R01CA120352] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Commission SPINE2-Complexes project(European Commission); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); College Doctoral Europeen; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by institutional support from CNRS, Universite de Strasbourg, INSERM, the European Commission SPINE2-Complexes project (contract no. LSHG-CT-2006-031220) and grants from Association pour la Recherche contre le Cancer (ARC) (no. 3171), Agence Nationale de la Recherche (ANR-MIME-2007 EPI-HPV-3D), and NIH (grant R01CA134737). S. C. was supported by ANR, A.o.M.o.S. by ARC, and K.o.B. by College Doctoral Europeen. S. V. P., N.B., and T. A. were supported by NIH grants (CA120352, CA134737 and CA08093) to S. V. P. and institutional support from the University of Virginia. S. C., K.o.B., and M. G. F. were supported by NIH grant CA134737. MD calculations were performed at the Meso-Centre of the University of Strasbourg. The authors thank members of the European Synchrotron Radiation Facility-European Molecular Biology Laboratory joint Structural Biology groups for the use of beamline facilities and for help during data collection; members of the IGBMC common services for assistance; and B. Kieffer, A. Dejaegere, and all members of the Oncoproteins team for helpful discussions and advice. Coordinates and structure factors have been deposited at the Protein Data Bank with accession codes 3PY7 and 4GIZ. K.Z., S. C., N.B., A.o.M.o.S., T. A., K. o. B., I. M., A. G. McE., P. P.-C., V. C., and S. V. P. performed experiments; M. G. F. and R. H. S. performed computational analysis; and J.C. and A. G. McE. performed structure determination. S. C., K.Z., J.C., S. V. P., and G. T. analyzed the data. G. T., K.Z., S. C., S. V. P., J.C., and R. S. prepared the manuscript. G. T., S. V. P., J.C., and R.S. supervised the work.	Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Brimer N, 2012, ONCOGENE, V31, P4639, DOI 10.1038/onc.2011.589; Charbonnier S, 2011, J MOL BIOL, V406, P745, DOI 10.1016/j.jmb.2011.01.015; Chen JJ, 1998, J BIOL CHEM, V273, P13537, DOI 10.1074/jbc.273.22.13537; Das K, 2000, J VIROL, V74, P812, DOI 10.1128/JVI.74.2.812-816.2000; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Lafont V, 2007, PROTEINS, V67, P418, DOI 10.1002/prot.21259; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; Nasir L, 2008, VET DERMATOL, V19, P243, DOI 10.1111/j.1365-3164.2008.00683.x; Ned R, 1997, J VIROL, V71, P4866, DOI 10.1128/JVI.71.6.4866-4870.1997; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Pfister H, 2003, ARCH DERMATOL RES, V295, P273, DOI 10.1007/s00403-003-0435-2; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Sekaric P, 2008, J VIROL, V82, P71, DOI 10.1128/JVI.01776-07; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sidi AOMO, 2011, PROTEIN EXPRES PURIF, V80, P8, DOI 10.1016/j.pep.2011.06.013; Tan MJA, 2012, P NATL ACAD SCI USA, V109, pE1473, DOI 10.1073/pnas.1205991109; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Tong XA, 1997, P NATL ACAD SCI USA, V94, P4412, DOI 10.1073/pnas.94.9.4412; Tumbarello DA, 2002, FEBS LETT, V513, P114, DOI 10.1016/S0014-5793(01)03244-6; Tungteakkhun SS, 2008, ARCH VIROL, V153, P397, DOI 10.1007/s00705-007-0022-5; Vande Pol SB, 1998, ONCOGENE, V16, P43, DOI 10.1038/sj.onc.1201504; Wade R, 2008, J VIROL, V82, P5962, DOI 10.1128/JVI.02747-07; Zanier K, 2005, J MOL BIOL, V349, P401, DOI 10.1016/j.jmb.2005.03.071; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; Zanier K, 2010, J MOL BIOL, V396, P90, DOI 10.1016/j.jmb.2009.11.022; Zhang Y, 2007, J VIROL, V81, P3618, DOI 10.1128/JVI.02044-06; zur Hausen H, 1999, SEMIN CANCER BIOL, V9, P405, DOI 10.1006/scbi.1999.0144	33	132	137	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					694	698		10.1126/science.1229934	http://dx.doi.org/10.1126/science.1229934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393263	Green Accepted, Green Submitted			2022-12-28	WOS:000314585600042
J	De Volder, MFL; Tawfick, SH; Baughman, RH; Hart, AJ				De Volder, Michael F. L.; Tawfick, Sameh H.; Baughman, Ray H.; Hart, A. John			Carbon Nanotubes: Present and Future Commercial Applications	SCIENCE			English	Review							LABEL-FREE DETECTION; PERFORMANCE; NANOMATERIALS; TRANSPARENT; TRANSISTORS; LIGHT; VISCOELASTICITY; FABRICATION; TRANSPORT; CHIRALITY	Worldwide commercial interest in carbon nanotubes (CNTs) is reflected in a production capacity that presently exceeds several thousand tons per year. Currently, bulk CNT powders are incorporated in diverse commercial products ranging from rechargeable batteries, automotive parts, and sporting goods to boat hulls and water filters. Advances in CNT synthesis, purification, and chemical modification are enabling integration of CNTs in thin-film electronics and large-area coatings. Although not yet providing compelling mechanical strength or electrical or thermal conductivities for many applications, CNT yarns and sheets already have promising performance for applications including supercapacitors, actuators, and lightweight electromagnetic shields.	[De Volder, Michael F. L.] IMEC, B-3001 Heverlee, Belgium; [De Volder, Michael F. L.] KULeuven, Dept Mech Engn, B-3000 Louvain, Belgium; [De Volder, Michael F. L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Tawfick, Sameh H.; Hart, A. John] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Tawfick, Sameh H.; Hart, A. John] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Baughman, Ray H.] Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA; [Baughman, Ray H.] Univ Texas Dallas, Dept Chem, Richardson, TX 75083 USA	IMEC; KU Leuven; Harvard University; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	De Volder, MFL (corresponding author), IMEC, B-3001 Heverlee, Belgium.	michael.devolder@imec.be; ajohnh@umich.edu	Baughman, Ray/A-8628-2018; Funde, Adinath M./D-8169-2012; Tawfick, Sameh H/A-6249-2014; Hart, A. John/A-9027-2010; De Volder, Michael/AAC-4103-2019	Baughman, Ray/0000-0001-5845-5137; Tawfick, Sameh H/0000-0003-3645-527X; Hart, A. John/0000-0002-7372-3512; De Volder, Michael/0000-0003-1955-2270	Fund for Scientific Research-Flanders, Belgium; Office of Naval Research [N00014101055, N000141210815]; Air Force Office of Scientific Research MURI grant [R17535]; Robert A. Welch grant [AT-0029]	Fund for Scientific Research-Flanders, Belgium(FWO); Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research MURI grant; Robert A. Welch grant	M.F.L.D.V. was supported by the Fund for Scientific Research-Flanders, Belgium. S. H. T. and A.J.H. were supported by the Office of Naval Research (N00014101055 and N000141210815). R. H. B. was supported by the Air Force Office of Scientific Research MURI grant R17535 and Robert A. Welch grant AT-0029. The authors thank M. Endo, Y. Gogotsi, K. Hata, S. Joshi, Y. A. Kim, E. Meshot, M. Roberts, S. Suematsu, K. Tamamitsu, J. R. Von Ehr, B. Wardle, G. Yushin, and many companies for valuable input.	Aliev AE, 2009, SCIENCE, V323, P1575, DOI 10.1126/science.1168312; Appenzeller J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.196805; Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Bakshi SR, 2011, CARBON, V49, P533, DOI 10.1016/j.carbon.2010.09.054; Bauhofer W, 2009, COMPOS SCI TECHNOL, V69, P1486, DOI 10.1016/j.compscitech.2008.06.018; Behabtu N, 2013, SCIENCE, V339, P182, DOI 10.1126/science.1228061; Beigbeder A, 2008, BIOFOULING, V24, P291, DOI 10.1080/08927010802162885; Bianco A, 2011, CHEM COMMUN, V47, P10182, DOI 10.1039/c1cc13011k; Cao AY, 2005, SCIENCE, V310, P1307, DOI 10.1126/science.1118957; Cao Q, 2008, NATURE, V454, P495, DOI 10.1038/nature07110; Cao Q, 2009, ADV MATER, V21, P29, DOI 10.1002/adma.200801995; Chae HG, 2009, COMPOS SCI TECHNOL, V69, P406, DOI 10.1016/j.compscitech.2008.11.008; Chen PC, 2011, NANO LETT, V11, P5301, DOI 10.1021/nl202765b; Chen Z, 2008, NAT BIOTECHNOL, V26, P1285, DOI 10.1038/nbt.1501; Chou TW, 2010, COMPOS SCI TECHNOL, V70, P1, DOI 10.1016/j.compscitech.2009.10.004; Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038; Corry B, 2008, J PHYS CHEM B, V112, P1427, DOI 10.1021/jp709845u; Dai LM, 2012, SMALL, V8, P1130, DOI 10.1002/smll.201101594; De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231; De S, 2011, MRS BULL, V36, P774, DOI 10.1557/mrs.2011.236; De Volder M, 2010, ADV MATER, V22, P4384, DOI 10.1002/adma.201001893; De Volder MFL, 2012, SMALL, V8, P2006, DOI 10.1002/smll.201102683; Ding L, 2009, NANO LETT, V9, P800, DOI 10.1021/nl803496s; Endo M, 2005, NANO LETT, V5, P101, DOI 10.1012/nl0482635; Endo M, 2006, PURE APPL CHEM, V78, P1703, DOI 10.1351/pac200678091703; Esser B, 2012, ANGEW CHEM INT EDIT, V51, P5752, DOI 10.1002/anie.201201042; Evanoff K, 2012, ADV MATER, V24, P533, DOI 10.1002/adma.201103044; Franklin AD, 2012, ACS NANO, V6, P1109, DOI 10.1021/nn203516z; Franklin AD, 2012, NANO LETT, V12, P758, DOI 10.1021/nl203701g; Futaba DN, 2006, NAT MATER, V5, P987, DOI 10.1038/nmat1782; Gabor NM, 2009, SCIENCE, V325, P1367, DOI 10.1126/science.1176112; Gao G, 2011, ENVIRON SCI TECHNOL, V45, P9726, DOI 10.1021/es202271z; Garcia EJ, 2008, COMPOS SCI TECHNOL, V68, P2034, DOI 10.1016/j.compscitech.2008.02.028; Gogotsi Y, 2011, SCIENCE, V334, P917, DOI 10.1126/science.1213003; Gojny FH, 2004, COMPOS SCI TECHNOL, V64, P2363, DOI 10.1016/j.compscitech.2004.04.002; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Harris P. J. F., 2009, CARBON NANOTUBE SCI; Harutyunyan AR, 2009, SCIENCE, V326, P116, DOI 10.1126/science.1177599; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; Hayamizu Y, 2008, NAT NANOTECHNOL, V3, P289, DOI 10.1038/nnano.2008.98; Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477; Heller DA, 2009, NAT NANOTECHNOL, V4, P114, DOI [10.1038/nnano.2008.369, 10.1038/NNANO.2008.369]; Hofmann S, 2007, NANO LETT, V7, P602, DOI 10.1021/nl0624824; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Hong SW, 2011, ADV MATER, V23, P3821, DOI 10.1002/adma.201101955; Hong SY, 2010, NAT MATER, V9, P485, DOI [10.1038/NMAT2766, 10.1038/nmat2766]; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Ionescu AM, 2011, NATURE, V479, P329, DOI 10.1038/nature10679; Izadi-Najafabadi A, 2010, ADV MATER, V22, pE235, DOI 10.1002/adma.200904349; Jensen K, 2007, NANO LETT, V7, P3508, DOI 10.1021/nl0721113; Jiang KL, 2002, NATURE, V419, P801, DOI 10.1038/419801a; Jung M, 2010, IEEE T ELECTRON DEV, V57, P571, DOI 10.1109/TED.2009.2039541; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Kashiwagi T, 2005, NAT MATER, V4, P928, DOI 10.1038/nmat1502; Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174; Kim KH, 2012, NAT NANOTECHNOL, V7, P562, DOI [10.1038/NNANO.2012.118, 10.1038/nnano.2012.118]; Kohler AR, 2008, J CLEAN PROD, V16, P927, DOI 10.1016/j.jclepro.2007.04.007; Koziol K, 2007, SCIENCE, V318, P1892, DOI 10.1126/science.1147635; Kurkina T, 2011, ANGEW CHEM INT EDIT, V50, P3710, DOI 10.1002/anie.201006806; Le Goff A, 2009, SCIENCE, V326, P1384, DOI 10.1126/science.1179773; Lee JM, 2011, ADV MATER, V23, P629, DOI 10.1002/adma.201003296; LeMieux MC, 2008, SCIENCE, V321, P101, DOI 10.1126/science.1156588; Lima MD, 2012, SCIENCE, V338, P928, DOI 10.1126/science.1226762; Lima MD, 2011, SCIENCE, V331, P51, DOI 10.1126/science.1195912; Liu HP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1313; Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t; Matsumoto T, 2004, CHEM COMMUN, P840, DOI 10.1039/b400607k; McCarthy MA, 2011, SCIENCE, V332, P570, DOI 10.1126/science.1203052; Mizuno K, 2009, P NATL ACAD SCI USA, V106, P6044, DOI 10.1073/pnas.0900155106; Mutlu GM, 2010, NANO LETT, V10, P1664, DOI 10.1021/nl9042483; Nayagam DAX, 2011, SMALL, V7, P1035, DOI 10.1002/smll.201002083; Neyts EC, 2011, J AM CHEM SOC, V133, P17225, DOI 10.1021/ja204023c; Park H, 2012, NAT NANOTECHNOL, V7, P787, DOI [10.1038/nnano.2012.189, 10.1038/NNANO.2012.189]; Pauluhn J, 2010, REGUL TOXICOL PHARM, V57, P78, DOI 10.1016/j.yrtph.2009.12.012; Peng B, 2008, NAT NANOTECHNOL, V3, P626, DOI 10.1038/nnano.2008.211; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Pop E, 2006, NANO LETT, V6, P96, DOI 10.1021/nl052145f; Qu LT, 2008, SCIENCE, V322, P238, DOI 10.1126/science.1159503; Rahaman MS, 2012, ENVIRON SCI TECHNOL, V46, P1556, DOI 10.1021/es203607d; Ren L, 2009, NANO LETT, V9, P2610, DOI 10.1021/nl900815s; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; Shi XH, 2011, NAT NANOTECHNOL, V6, P714, DOI [10.1038/nnano.2011.151, 10.1038/NNANO.2011.151]; Snow ES, 2005, SCIENCE, V307, P1942, DOI 10.1126/science.1109128; Sotowa C, 2008, CHEMSUSCHEM, V1, P911, DOI 10.1002/cssc.200800170; Star A, 2006, P NATL ACAD SCI USA, V103, P921, DOI 10.1073/pnas.0504146103; Suhr J, 2005, NAT MATER, V4, P134, DOI 10.1038/nmat1293; Sun DM, 2011, NAT NANOTECHNOL, V6, P156, DOI [10.1038/nnano.2011.1, 10.1038/NNANO.2011.1]; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; van der Veen MH, 2012, IEEE INT INTERC TECH; Veedu VP, 2006, NAT MATER, V5, P457, DOI 10.1038/nmat1650; Wang XS, 2009, NANO LETT, V9, P3137, DOI 10.1021/nl901260b; Wei BQ, 2001, APPL PHYS LETT, V79, P1172, DOI 10.1063/1.1396632; Wu ZC, 2004, SCIENCE, V305, P1273, DOI 10.1126/science.1101243; Xiao L, 2008, NANO LETT, V8, P4539, DOI 10.1021/nl802750z; Xu M, 2010, SCIENCE, V330, P1364, DOI 10.1126/science.1194865; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhang Q, 2011, CHEMSUSCHEM, V4, P864, DOI 10.1002/cssc.201100177	97	3777	3835	349	6393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					535	539		10.1126/science.1222453	http://dx.doi.org/10.1126/science.1222453			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372006				2022-12-28	WOS:000314270000048
J	Zarnack, K; Konig, J; Tajnik, M; Martincorena, I; Eustermann, S; Stevant, I; Reyes, A; Anders, S; Luscombe, NM; Ule, J				Zarnack, Kathi; Koenig, Julian; Tajnik, Mojca; Martincorena, Inigo; Eustermann, Sebastian; Stevant, Isabelle; Reyes, Alejandro; Anders, Simon; Luscombe, Nicholas M.; Ule, Jernej			Direct Competition between hnRNP C and U2AF65 Protects the Transcriptome from the Exonization of Alu Elements	CELL			English	Article							PRE-MESSENGER-RNA; GENOME-WIDE ANALYSIS; HUMAN-DISEASE GENES; POLYPYRIMIDINE-TRACT; NUCLEOTIDE STRUCTURE; COMPUTATIONAL TOOLS; SPLICING REGULATION; MUTATION PATTERN; BINDING-PROTEIN; REVEALS	There are similar to 650,000 Alu elements in transcribed regions of the human genome. These elements contain cryptic splice sites, so they are in constant danger of aberrant incorporation into mature transcripts. Despite posing a major threat to transcriptome integrity, little is known about the molecular mechanisms preventing their inclusion. Here, we present a mechanism for protecting the human transcriptome from the aberrant exonization of transposable elements. Quantitative iCLIP data show that the RNA-binding protein hnRNP C competes with the splicing factor U2AF65 at many genuine and cryptic splice sites. Loss of hnRNP C leads to formation of previously suppressed Alu exons, which severely disrupt transcript function. Minigene experiments explain disease-associated mutations in Alu elements that hamper hnRNP C binding. Thus, by preventing U2AF65 binding to Alu elements, hnRNP C plays a critical role as a genome-wide sentinel protecting the transcriptome. The findings have important implications for human evolution and disease.	[Zarnack, Kathi; Martincorena, Inigo; Stevant, Isabelle; Luscombe, Nicholas M.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Koenig, Julian; Tajnik, Mojca; Eustermann, Sebastian; Ule, Jernej] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Tajnik, Mojca] Univ Ljubljana, Fac Med, SI-1104 Ljubljana, Slovenia; [Reyes, Alejandro; Anders, Simon] EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Luscombe, Nicholas M.] UCL, UCL Genet Inst, Dept Genet Environm & Evolut, London WC1E 6BT, England; [Luscombe, Nicholas M.] CancRes UK London Res Inst, London WC2A 3LY, England; [Luscombe, Nicholas M.] Grad Univ, Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan	European Molecular Biology Laboratory (EMBL); MRC Laboratory Molecular Biology; University of Ljubljana; European Molecular Biology Laboratory (EMBL); University of London; University College London; Okinawa Institute of Science & Technology Graduate University	Luscombe, NM (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	nicholas.luscombe@ucl.ac.uk; jule@mrc-lmb.cam.ac.uk	Anders, Simon/D-4087-2011; Reyes, Alejandro/D-8258-2017; Ule, Jernej/C-6315-2013	Anders, Simon/0000-0003-4868-1805; Reyes, Alejandro/0000-0001-8717-6612; Ule, Jernej/0000-0002-2452-4277; Konig, Julian/0000-0002-9398-5421; Stevant, Isabelle/0000-0002-0193-2526; Martincorena, Inigo/0000-0003-1122-4416; Zarnack, Kathi/0000-0003-3527-3378	European Research Council [206726-CLIP]; Medical Research Council [U105185858]; EMBL EIPOD fellowship; Long-term Human Frontiers Science Program fellowship; MRC [MC_U105185858] Funding Source: UKRI; Cancer Research UK [16358] Funding Source: researchfish; Medical Research Council [MC_U105185858] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBL EIPOD fellowship; Long-term Human Frontiers Science Program fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank all members of the Ule and Luscombe laboratories for assistance and discussion, in particular Zhen Wang and Miha Modic for sharing RNA samples from TIA1/TIAL and TDP-43 knockdown cells. We thank Tomaz Curk, Gregor Rot, and Crt Gorup for their work on the iCount pipeline, as well as James Hadfield for high-throughput sequencing. We are grateful for materials, data, and advice provided by Chris Smith, Miguel Coelho, Miriam Llorian, Wing-Fung (Wilfred) Wu, Michael Sattler, Yun Zhang, Frederic Allain, Zuzana Cienikova, Gene Yeo, Stephanie Huelga, Gil Ast, Galit Lev-Maor, Noa Sela, Juan Valcarcel, Joao Tavanez, and Gautier Koscielny. This work was supported by the European Research Council (grant 206726-CLIP) and the Medical Research Council (grant U105185858) (to J.U.), an EMBL EIPOD fellowship (to K.Z.), and a Long-term Human Frontiers Science Program fellowship (to J.K.).	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4250, DOI 10.1093/nar/gkm402; CARAS IW, 1987, NATURE, V325, P545, DOI 10.1038/325545a0; CHOI YD, 1986, SCIENCE, V231, P1534, DOI 10.1126/science.3952495; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dhir A, 2010, FEBS J, V277, P841, DOI 10.1111/j.1742-4658.2009.07520.x; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; Gal-Mark N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000717; GORLACH M, 1994, J BIOL CHEM, V269, P23074; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; Hedges DJ, 2007, MUTAT RES-FUND MOL M, V616, P46, DOI 10.1016/j.mrfmmm.2006.11.021; Heiner M, 2010, RNA BIOL, V7, P56, DOI 10.4161/rna.7.1.10402; HUANG M, 1994, MOL CELL BIOL, V14, P518, DOI 10.1128/MCB.14.1.518; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638; Kreahling J, 2004, TRENDS GENET, V20, P1, DOI 10.1016/j.tig.2003.11.001; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lin L, 2009, HUM MOL GENET, V18, P2204, DOI 10.1093/hmg/ddp152; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; Mackereth CD, 2011, NATURE, V475, P408, DOI 10.1038/nature10171; Meili D, 2009, HUM MUTAT, V30, P823, DOI 10.1002/humu.20969; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; NORTON PA, 1994, NUCLEIC ACIDS RES, V22, P3854, DOI 10.1093/nar/22.19.3854; Tavanez JP, 2012, MOL CELL, V45, P314, DOI 10.1016/j.molcel.2011.11.033; Sauliere J, 2006, MOL CELL BIOL, V26, P8755, DOI 10.1128/MCB.00893-06; Schmitz J, 2011, BIOCHIMIE, V93, P1928, DOI 10.1016/j.biochi.2011.07.014; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Shen SH, 2011, P NATL ACAD SCI USA, V108, P2837, DOI 10.1073/pnas.1012834108; Singh R, 2000, RNA, V6, P901, DOI 10.1017/S1355838200000376; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Varon R, 2003, NAT GENET, V35, P185, DOI 10.1038/ng1243; Vorechovsky I, 2006, NUCLEIC ACIDS RES, V34, P4630, DOI 10.1093/nar/gkl535; Vorechovsky I, 2010, HUM GENET, V127, P135, DOI 10.1007/s00439-009-0752-4; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003	59	286	299	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					453	466		10.1016/j.cell.2012.12.023	http://dx.doi.org/10.1016/j.cell.2012.12.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374342	hybrid, Green Published			2022-12-28	WOS:000314362800016
J	Costello, MJ; May, RM; Stork, NE				Costello, Mark J.; May, Robert M.; Stork, Nigel E.			Can We Name Earth's Species Before They Go Extinct?	SCIENCE			English	Review							BIODIVERSITY; CONSERVATION; DIVERSITY; MAGNITUDE; RICHNESS; IMPACTS; RATES	Some people despair that most species will go extinct before they are discovered. However, such worries result from overestimates of how many species may exist, beliefs that the expertise to describe species is decreasing, and alarmist estimates of extinction rates. We argue that the number of species on Earth today is 5 +/- 3 million, of which 1.5 million are named. New databases show that there are more taxonomists describing species than ever before, and their number is increasing faster than the rate of species description. Conservation efforts and species survival in secondary habitats are at least delaying extinctions. Extinction rates are, however, poorly quantified, ranging from 0.01 to 1% (at most 5%) per decade. We propose practical actions to improve taxonomic productivity and associated understanding and conservation of biodiversity.	[Costello, Mark J.] Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand; [May, Robert M.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Stork, Nigel E.] Griffith Univ, Sch Environm, Environm Futures Ctr, Brisbane, Qld 4111, Australia	University of Auckland; University of Oxford; Griffith University	Costello, MJ (corresponding author), Univ Auckland, Leigh Marine Lab, POB 349, Warkworth, New Zealand.	m.costello@auckland.ac.nz	Costello, Mark/C-9267-2013	Costello, Mark/0000-0003-2362-0328; Stork, Nigel/0000-0001-7812-2452				ANDERSEN RA, 1992, BIODIVERS CONSERV, V1, P267, DOI 10.1007/BF00693765; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Baillie J. E., 2004, GLOBAL SPECIES ASSES; Benton M.J., 2008, LIFE NEARLY DIED GRE; BISBY FA, 2011, SPECIES 2000 ITIS CA; Boero F, 2001, TRENDS ECOL EVOL, V16, P266, DOI 10.1016/S0169-5347(01)02133-4; Boero Ferdinando, 2010, Diversity, V2, P115; Bouchet P, 2002, BIOL J LINN SOC, V75, P421, DOI 10.1046/j.1095-8312.2002.00052.x; Boxshall G., 2011, UK TAXONOMY SYSTEMAT; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Corlett RT, 2011, TRENDS ECOL EVOL, V26, P606, DOI 10.1016/j.tree.2011.06.015; Costello MJ, 2006, MAR ECOL PROG SER, V316, P257, DOI 10.3354/meps316257; Costello MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051629; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Costello MJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P319, DOI 10.1111/j.1466-8238.2010.00603.x; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Davies TJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000620; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; de Carvalho MR, 2005, SCIENCE, V307, P353; Eschmeyer WN, 2010, ZOOTAXA, P19; Fontaine B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036881; GASTON KJ, 1992, NATURE, V356, P281, DOI 10.1038/356281a0; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Govaerts R, 2003, TAXON, V52, P583, DOI 10.2307/3647457; Haas F., 2005, CBD TECHNICAL SERIES, V21, P87; Hamilton AJ, 2011, AM NAT, V177, P544, DOI 10.1086/659643; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; International Commission on Zoological Nomenclature, 2012, ZOOTAXA, V3450, P1; Joppa LN, 2011, TRENDS ECOL EVOL, V26, P551, DOI 10.1016/j.tree.2011.07.010; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Knapp Sandra, 2011, PhytoKeys, V6, P5, DOI [10.3897/phytokeys.6.1960, 10.1111/j.1096-0031.2011.00378.x, 10.1111/j.1469-8137.2011.03914.x]; Lohrmann V, 2012, TAXONOMISCHE FORSCHU; Lovejoy T, 2010, CANADIAN TAXONOMY EX; Maddison DR, 2012, TRENDS ECOL EVOL, V27, P72, DOI 10.1016/j.tree.2011.10.010; May Robert M., 1995, P1; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Parr CS, 2012, TRENDS ECOL EVOL, V27, P94, DOI 10.1016/j.tree.2011.11.001; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Secretariat to the Convention on Biological Diversity, 2010, CONV BIOL DIV TECHN, V30; Sodhi NS, 2011, TRENDS ECOL EVOL, V26, P585, DOI 10.1016/j.tree.2011.07.002; SOLOW AR, 1995, SYST BIOL, V44, P93, DOI 10.2307/2413485; STORK NE, 1988, BIOL J LINN SOC, V35, P321, DOI 10.1111/j.1095-8312.1988.tb00474.x; Stork Nigel E., 1997, P41; Stork NE, 2010, BIODIVERS CONSERV, V19, P357, DOI 10.1007/s10531-009-9761-9; Stork NE, 2009, CONSERV BIOL, V23, P1438, DOI 10.1111/j.1523-1739.2009.01335.x; THOMAS JD, 1997, BIODIVERSITY, V2, P357; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Wheeler QD, 2012, SYST BIODIVERS, V10, P1, DOI 10.1080/14772000.2012.665095; Wheeler Q. D., 2012, 2011 STATE OBSERVED; Zhang ZQ, 2011, ZOOTAXA, P1; Zhang Zhi-Qiang, 2010, P95	56	369	392	9	428	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					413	416		10.1126/science.1230318	http://dx.doi.org/10.1126/science.1230318			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349283				2022-12-28	WOS:000313960700034
J	Korobova, F; Ramabhadran, V; Higgs, HN				Korobova, Farida; Ramabhadran, Vinay; Higgs, Henry N.			An Actin-Dependent Step in Mitochondrial Fission Mediated by the ER-Associated Formin INF2	SCIENCE			English	Article							MARIE-TOOTH-DISEASE; MUTATIONS; PROTEIN; DYNAMICS; POLYMERIZATION; MOVEMENT; FUSION; FAMILY	Mitochondrial fission is fundamentally important to cellular physiology. The dynamin-related protein Drp1 mediates fission, and interaction between mitochondrion and endoplasmic reticulum (ER) enhances fission. However, the mechanism for Drp1 recruitment to mitochondria is unclear, although previous results implicate actin involvement. Here, we found that actin polymerization through ER-localized inverted formin 2 (INF2) was required for efficient mitochondrial fission in mammalian cells. INF2 functioned upstream of Drp1. Actin filaments appeared to accumulate between mitochondria and INF2-enriched ER membranes at constriction sites. Thus, INF2-induced actin filaments may drive initial mitochondrial constriction, which allows Drp1-driven secondary constriction. Because INF2 mutations can lead to Charcot-Marie-Tooth disease, our results provide a potential cellular mechanism for this disease state.	[Korobova, Farida; Higgs, Henry N.] Dartmouth, Geisel Sch Med, Dept Biochem, Hanover, NH 03755 USA; [Ramabhadran, Vinay] Tufts Univ, Sackler Sch Grad Biomed Sci, Howard Hughes Med Inst, Boston, MA 02111 USA	Dartmouth College; Howard Hughes Medical Institute; Tufts University	Higgs, HN (corresponding author), Dartmouth, Geisel Sch Med, Dept Biochem, Hanover, NH 03755 USA.	henry.higgs@dartmouth.edu		Higgs, Henry/0000-0002-2917-9644	NIH [GM069818, DK88826]; NSF [DBI1039423]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069818] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Zick, J. Moseley, B. Wickner, and C. Barlowe for useful discussions; A. Lavanway for help with the microscopes; and M. Richio-Dalton for her tireless energy. Portions of this publication are covered in a pending patent application. "Methods for modulating mitochondrial function via INF2," H. Higgs author, Patent DC512US. L. Supported by NIH grants GM069818 and DK88826 to H.N.H. Funds to purchase the Nikon A1RSi confocal workstation were provided by NSF award DBI1039423.	Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; Correia SC, 2012, ADV EXP MED BIOL, V724, P205, DOI 10.1007/978-1-4614-0653-2_16; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Hoppins S, 2012, SCIENCE, V337, P1052, DOI 10.1126/science.1224709; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Ramabhadran V, 2011, MOL BIOL CELL, V22, P4822, DOI 10.1091/mbc.E11-05-0457; Vital A, 2012, NEUROMUSCULAR DISORD, V22, P735, DOI 10.1016/j.nmd.2012.04.001; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	25	490	499	5	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					464	467		10.1126/science.1228360	http://dx.doi.org/10.1126/science.1228360			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349293	Green Accepted			2022-12-28	WOS:000313960700048
J	Morton, A				Morton, Adam			CASE REPORT Postpartum fever and shortness of breath	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERIPARTUM CARDIOMYOPATHY; SUBSEQUENT PREGNANCY; OUTCOMES; ETIOLOGY; SHOCK		Mater Hosp, QLD Diabet Ctr, Brisbane, Qld 4101, Australia		Morton, A (corresponding author), Mater Hosp, QLD Diabet Ctr, Brisbane, Qld 4101, Australia.	adam.morton@mater.org.au	morton, adam/I-1771-2013	morton, adam/0000-0001-9887-714X				Armenti Vincent T, 2008, Transplant Rev (Orlando), V22, P223, DOI 10.1016/j.trre.2008.05.001; Boon HL, 2011, J OBSTET GYN INDIA, V61, P386, DOI 10.1007/s13224-011-0055-2; Bouhemad B, 2009, CRIT CARE MED, V37, P441, DOI 10.1097/CCM.0b013e318194ac44; Chong HW, 2010, THYROID, V20, P333, DOI 10.1089/thy.2009.0181; Conde-Agudelo A, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.052; Elkayam U, 2001, NEW ENGL J MED, V344, P1567, DOI 10.1056/NEJM200105243442101; Fasullo S, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-69; Fett JD, 2006, ANN INTERN MED, V145, P30, DOI 10.7326/0003-4819-145-1-200607040-00007; Fett JD, 2010, INT J GYNECOL OBSTET, V109, P34, DOI 10.1016/j.ijgo.2009.10.011; Fett JD, 2009, INT J GYNECOL OBSTET, V104, P125, DOI 10.1016/j.ijgo.2008.09.017; Frederick DM, 2002, J REPROD MED, V47, P591; Halperin Rabinovich Irene, 2008, Endocrinol Nutr, V55, P29; Kim J, 2004, EUR J ENDOCRINOL, V151, P771, DOI 10.1530/eje.0.1510771; Krishnagopalan Sreenandh, 2002, Curr Opin Crit Care, V8, P376, DOI 10.1097/00075198-200210000-00003; Lane CR, 2011, CLIN CHEST MED, V32, P165, DOI 10.1016/j.ccm.2010.10.006; McKay DB, 2006, NEW ENGL J MED, V354, P1281, DOI 10.1056/NEJMra050431; Pollock W, 2010, INTENS CARE MED, V36, P1465, DOI 10.1007/s00134-010-1951-0; Rasmusson K, 2012, J HEART LUNG TRANSPL, V31, P180, DOI 10.1016/j.healun.2011.11.018; Ro Angela, 2006, Cardiol Rev, V14, P35, DOI 10.1097/01.crd.0000174805.68081.f7; Romero-Bermejo FJ, 2011, CURR CARDIOL REV, V7, P163, DOI 10.2174/157340311798220494; Ruiz-Bailen M, 2010, INT J CARDIOL, V145, P615, DOI 10.1016/j.ijcard.2010.09.032; Sibai BM, 2009, SEMIN PERINATOL, V33, P196, DOI 10.1053/j.semperi.2009.02.004; Sliwa K, 2004, AM J CARDIOL, V93, P1441, DOI 10.1016/j.amjcard.2004.02.053; Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120; Sliwa K, 2010, CIRCULATION, V121, P1465, DOI 10.1161/CIRCULATIONAHA.109.901496; van Dillen J, 2010, CURR OPIN INFECT DIS, V23, P249, DOI 10.1097/QCO.0b013e328339257c; YAMASHITA Y, 1993, AM J ROENTGENOL, V161, P805, DOI 10.2214/ajr.161.4.8372764; Zieba B, 2009, KARDIOL POL, V67, P769	28	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2013	346								f391	10.1136/bmj.f391	http://dx.doi.org/10.1136/bmj.f391			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080CD	23349408				2022-12-28	WOS:000314217900003
J	Kirby, T				Kirby, Tony			Patrick Maxwell: leader of medicine at Cambridge University	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2013	381	9862					195	195		10.1016/S0140-6736(13)60077-X	http://dx.doi.org/10.1016/S0140-6736(13)60077-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075LL	23332950				2022-12-28	WOS:000313887600015
J	Farmer, PE; Nutt, CT; Wagner, CM; Sekabaraga, C; Nuthulaganti, T; Weigel, JL; Farmer, DB; Habinshuti, A; Mugeni, SD; Karasi, JC; Drobac, PC				Farmer, Paul E.; Nutt, Cameron T.; Wagner, Claire M.; Sekabaraga, Claude; Nuthulaganti, Tej; Weigel, Jonathan L.; Farmer, Didi Bertrand; Habinshuti, Antoinette; Mugeni, Soline Dusabeyesu; Karasi, Jean-Claude; Drobac, Peter C.			Reduced premature mortality in Rwanda: lessons from success	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-HEALTH-CARE; TREATMENT PROGRAM; GLOBAL HEALTH; SERVICES; HAITI		[Farmer, Paul E.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Drobac, Peter C.] Brigham & Womens Hosp, Div Global Hlth Equ, Rwanda Progammes, Boston, MA 02115 USA; [Farmer, Paul E.] Partners Hlth, Boston, MA USA; [Nutt, Cameron T.] Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH USA; [Wagner, Claire M.] Global Hlth Delivery Partnership, Boston, MA USA; [Sekabaraga, Claude] World Bank, Nairobi, Kenya; [Nuthulaganti, Tej] Clinton Hlth Access Initiat, Human Resources Hlth Program, Kigali, Rwanda; [Weigel, Jonathan L.] Harvard Univ, Dept Govt, Boston, MA 02115 USA; [Habinshuti, Antoinette; Drobac, Peter C.] Partners Hlth Inshuti Mu Buzima, Rwanda Progammes, Rwinkwavu, Rwanda; [Karasi, Jean-Claude] CRP Sante, Luxembourg, Luxembourg	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Dartmouth College; The World Bank; Harvard University; Luxembourg Institute of Health	Farmer, PE (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, 641 Huntington Ave, Boston, MA 02115 USA.	paul_farmer@hms.harvard.edu						Alsan MM, 2011, INFECT DIS CLIN N AM, V25, P611, DOI 10.1016/j.idc.2011.05.004; Amoroso CL, 2010, STUD HEALTH TECHNOL, V160, P337, DOI 10.3233/978-1-60750-588-4-337; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Binagwaho A, 2012, B WORLD HEALTH ORGAN, V90, P623, DOI 10.2471/BLT.11.097253; Bonds MH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001456; Crisafulli Patricia, 2012, RWANDA INC DEVASTATE; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Goosby E, 2012, JAIDS-J ACQ IMM DEF, V60, pS158, DOI 10.1097/QAI.0b013e31825d057c; Hirth JM, 2012, CANCER-AM CANCER SOC, V118, P5623, DOI 10.1002/cncr.27598; Kalk A, 2010, TROP MED INT HEALTH, V15, P94, DOI 10.1111/j.1365-3156.2009.02424.x; Kidder A, 2011, PARTNERS HLTH GUIDE; Logie DE, 2008, LANCET, V372, P256, DOI 10.1016/S0140-6736(08)60962-9; Lu CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039282; Ministry of Finance and Economic Planning, 2000, VIS 2020; Ministry of Health of Rwanda, RWAND HUM RES HLTH P; Ministry of Health of Rwanda, 2012, HLTH MAN INF SYST; Ministry of Health of Rwanda, 2010, RWAND COMM BAS HLTH; Ministry of Health of Rwanda, 2012, RWAND HLTH STAT BOOK; Ministry of Health of Rwanda, 2012, DISTR HOSP ACT PLANS; Mugeni C, 2011, 1 ANN INT COMM HLTH; National AIDS Control Commission of Rwanda, 2010, COUNTR PROGR REP JAN; National Institute of Statistics of Rwanda, 2012, 3 INT HOUS LIV COND; National Institute of Statistics of Rwanda Macro International, 2007, RWAND INT DEM HLTH S; National Institute of Statistics of Rwanda Ministry of Health ICF International, RWAND DEM HLTH SURV; Nsanzimana S, 2012, JAIDS-J ACQ IMM DEF, V59, pE17, DOI 10.1097/QAI.0b013e31823e2278; Porter M. E., 2009, PARTNERS HLTH HIV CA; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Rwanda Biomedical Center, 2012, COUNTR PROGR REP JOI; Rwangombwa J., 2011, DEV OUTREACH, V11, P11; United Nations Children's Fund World Health Organization World Bank United Nations Population Division, 2012, LEV TRENDS CHILD MOR; Uvin P., 1998, AIDING VIOLENCE DEV; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013; WHO, GLOB HLTH EXP DAT; Word Health Organization, GLOB TUB REP 2012; World Bank, 2012, DATABANK WORLD DEV I; World Health Organization, 2012, TRENDS MAT MORT 1990; World Health Organization, 2012, WORLD MAL REP 2012; World Health Organization, 2012, WHO UNICEF VACC COV; World Health Organization, 2010, UN ACC SCAL PRIOR HI; World Health Organization (WHO), 2012, WORLD HLTH STAT 2012	41	124	123	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2013	346								f65	10.1136/bmj.f65	http://dx.doi.org/10.1136/bmj.f65			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075FW	23335479	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000313870300012
J	Rhee, HW; Zou, P; Udeshi, ND; Martell, JD; Mootha, VK; Carr, SA; Ting, AY				Rhee, Hyun-Woo; Zou, Peng; Udeshi, Namrata D.; Martell, Jeffrey D.; Mootha, Vamsi K.; Carr, Steven A.; Ting, Alice Y.			Proteomic Mapping of Mitochondria in Living Cells via Spatially Restricted Enzymatic Tagging	SCIENCE			English	Article							PROTOPORPHYRINOGEN OXIDASE; CROSS-LINK; HEME; PEROXIDASE; BIOTINYLATION; BIOSYNTHESIS; MICROSCOPY; TYRAMIDE; DISEASE; COMPLEX	Microscopy and mass spectrometry (MS) are complementary techniques: The former provides spatiotemporal information in living cells, but only for a handful of recombinant proteins at a time, whereas the latter can detect thousands of endogenous proteins simultaneously, but only in lysed samples. Here, we introduce technology that combines these strengths by offering spatially and temporally resolved proteomic maps of endogenous proteins within living cells. Our method relies on a genetically targetable peroxidase enzyme that biotinylates nearby proteins, which are subsequently purified and identified by MS. We used this approach to identify 495 proteins within the human mitochondrial matrix, including 31 not previously linked to mitochondria. The labeling was exceptionally specific and distinguished between inner membrane proteins facing the matrix versus the intermembrane space (IMS). Several proteins previously thought to reside in the IMS or outer membrane, including protoporphyrinogen oxidase, were reassigned to the matrix by our proteomic data and confirmed by electron microscopy. The specificity of peroxidase-mediated proteomic mapping in live cells, combined with its ease of use, offers biologists a powerful tool for understanding the molecular composition of living cells.	[Rhee, Hyun-Woo; Zou, Peng; Martell, Jeffrey D.; Ting, Alice Y.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Udeshi, Namrata D.; Mootha, Vamsi K.; Carr, Steven A.; Ting, Alice Y.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA; [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ting, AY (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	ating@mit.edu	Rhee, Hyun-Woo/AAS-4268-2021; Rhee, Hyun-Woo/AAS-3508-2021; Carr, Steven A./AAH-8366-2019; Zou, Peng/S-1309-2017	Rhee, Hyun-Woo/0000-0002-3817-3455; Zou, Peng/0000-0002-9798-5242; Ting, Alice/0000-0002-8277-5226	NIH [DP1 OD003961, R01 GM077465]; Dreyfus Foundation; American Chemical Society; Broad Institute of MIT and Harvard; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003961] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dreyfus Foundation; American Chemical Society(American Chemical Society); Broad Institute of MIT and Harvard; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Watson (Whitehead Institute Keck Microscopy Facility) and E. Vasile (Koch Institute Microscopy Core Facility) for performing EM imaging, H. B. Fraser for assistance with data analysis and manuscript editing, C. Uttamapinant for picoyl azide-AF647, X. Zhuang and her lab for advice on STORM, H. A. Dailey for advice on CPOX and PPOX, and S. Calvo for assistance with data analysis. Funding was provided by the NIH (grants DP1 OD003961 to A.Y.T. and R01 GM077465 to V. K. M.), the Dreyfus Foundation (A.Y.T.), the American Chemical Society (A.Y.T.), and the Broad Institute of MIT and Harvard (S. A. C.). The authors have no conflicting financial interests. A patent application relating to the use of enzymes for proteomic mapping in live cells has been filed by MIT. Proteomic data can be found in supplementary tables S1 to S9. The authors will make the genetic constructs used in this work widely available to the academic community through Addgene (www.addgene.org/).	Amini F, 2002, ANGEW CHEM INT EDIT, V41, P356, DOI 10.1002/1521-3773(20020118)41:2<356::AID-ANIE356>3.0.CO;2-M; Bendayan M, 2001, SCIENCE, V291, P1363, DOI 10.1126/science.291.5507.1363; Bhaskar B, 2003, J MOL BIOL, V328, P157, DOI 10.1016/S0022-2836(03)00179-7; Choi-Rhee E, 2004, PROTEIN SCI, V13, P3043, DOI 10.1110/ps.04911804; DEYBACH JC, 1985, EUR J BIOCHEM, V149, P431, DOI 10.1111/j.1432-1033.1985.tb08943.x; ELDER GH, 1978, BIOCHEM J, V172, P345, DOI 10.1042/bj1720345; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; GRANDCHAMP B, 1978, BIOCHEM J, V176, P97, DOI 10.1042/bj1760097; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Mayer G, 1997, J HISTOCHEM CYTOCHEM, V45, P1449, DOI 10.1177/002215549704501101; Minamihata K, 2011, BIOCONJUGATE CHEM, V22, P2332, DOI 10.1021/bc200420v; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Mortensen A, 1997, J AGR FOOD CHEM, V45, P2970, DOI 10.1021/jf970010s; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Qin XH, 2011, FASEB J, V25, P653, DOI 10.1096/fj.10-170811; Rogers MS, 2008, BIOCHEMISTRY-US, V47, P10428, DOI 10.1021/bi8010835; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schonhuber W, 1997, APPL ENVIRON MICROB, V63, P3268; Wishart J. F., 2010, RECENT TRENDS RAD CH, P577	26	691	703	13	368	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1328	1331		10.1126/science.1230593	http://dx.doi.org/10.1126/science.1230593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23371551	Green Accepted, Green Submitted			2022-12-28	WOS:000316053400040
J	Hashem, Y; Georges, AD; Fu, J; Buss, SN; Jossinet, F; Jobe, A; Zhang, Q; Liao, HY; Grassucci, RA; Bajaj, C; Westhof, E; Madison-Antenucci, S; Frank, J				Hashem, Yaser; Georges, Amedee des; Fu, Jie; Buss, Sarah N.; Jossinet, Fabrice; Jobe, Amy; Zhang, Qin; Liao, Hstau Y.; Grassucci, Robert A.; Bajaj, Chandrajit; Westhof, Eric; Madison-Antenucci, Susan; Frank, Joachim			High-resolution cryo-electron microscopy structure of the Trypanosoma brucei ribosome	NATURE			English	Article							EUKARYOTIC RIBOSOME; CRYSTAL-STRUCTURE; ATOMIC STRUCTURES; 80S RIBOSOME; SMALL RNAS; INITIATION; SUBUNIT; PROTEINS; PARASITE; SEQUENCE	Ribosomes, the protein factories of living cells, translate genetic information carried by messenger RNAs into proteins, and are thus involved in virtually all aspects of cellular development and maintenance. The few available structures of the eukaryotic ribosome(1-6) reveal that it is more complex than its prokaryotic counterpart(7,8), owing mainly to the presence of eukaryote-specific ribosomal proteins and additional ribosomal RNA insertions, called expansion segments(9). The structures also differ among species, partly in the size and arrangement of these expansion segments. Such differences are extreme in kinetoplastids, unicellular eukaryotic parasites often infectious to humans. Here we present a high-resolution cryo-electron microscopy structure of the ribosome of Trypanosoma brucei, the parasite that is transmitted by the tsetse fly and that causes African sleeping sickness. The atomic model reveals the unique features of this ribosome, characterized mainly by the presence of unusually large expansion segments and ribosomal-protein extensions leading to the formation of four additional inter-subunit bridges. We also find additional rRNA insertions, including one large rRNA domain that is not found in other eukaryotes. Furthermore, the structure reveals the five cleavage sites of the kinetoplastid large ribosomal subunit (LSU) rRNA chain, which is known to be cleaved uniquely into six pieces(10-12), and suggests that the cleavage is important for the maintenance of the T. brucei ribosome in the observed structure. We discuss several possible implications of the large rRNA expansion segments for the translation-regulation process. The structure could serve as a basis for future experiments aimed at understanding the functional importance of these kinetoplastid-specific ribosomal features in protein-translation regulation, an essential step towards finding effective and safe kinetoplastid-specific drugs.	[Hashem, Yaser; Georges, Amedee des; Grassucci, Robert A.; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst HHMI, New York, NY 10032 USA; [Fu, Jie; Liao, Hstau Y.; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Buss, Sarah N.; Madison-Antenucci, Susan] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12201 USA; [Jossinet, Fabrice; Westhof, Eric] Univ Strasbourg, Inst Biol Mol & Cellulaire CNRS, Architecture & Reactivite ARN, F-67084 Strasbourg, France; [Jobe, Amy; Frank, Joachim] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Zhang, Qin; Bajaj, Chandrajit] Univ Texas Austin, Inst Computat Engn & Sci, Dept Comp Sci, Austin, TX 78712 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; State University of New York (SUNY) System; Wadsworth Center; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Columbia University; University of Texas System; University of Texas Austin	Frank, J (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst HHMI, 630 W 168th St, New York, NY 10032 USA.	jf2192@columbia.edu	Georges, Amédée des/C-3588-2014	Georges, Amédée des/0000-0002-9704-3781; Bajaj, Chandrajit/0000-0002-9619-3278; Madison-Antenucci, Susan/0000-0003-1748-9327	Howard Hughes Medical Institute (HHMI); National Institutes of Health (NIH) [R01 GM29169]; L'Agence Nationale de la recherche (ANR) project AMIS ARN [ANR-09-BLAN-0160]; NIH [R01-EB004873, R01-GM074258]; Centers for Disease Control (CDC) Emerging Infectious Diseases (EID) fellowship program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB004873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029169, R01GM074258, T32GM008798] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); L'Agence Nationale de la recherche (ANR) project AMIS ARN(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control (CDC) Emerging Infectious Diseases (EID) fellowship program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is dedicated to the memory of Mariano Levin, who collaborated with J.F. and S.M.A. on the ribosomes from T. cruzi and T. brucei. We thank G. Cardone for assistance in the local resolution computation, and M. Thomas for her assistance with the preparation of figures. We wish to thank N. Williams for an useful discussion about the T brucei LSU rRNA processing. This work was supported by the Howard Hughes Medical Institute (HHMI) and the National Institutes of Health (NIH) R01 GM29169 (to IF.), L'Agence Nationale de la recherche (ANR) project AMIS ARN ANR-09-BLAN-0160 (E.W. and F.J.), as well as NIH R01-EB004873 and R01-GM074258 (to Q.Z. and C.B.). S.N.B. was supported by a Centers for Disease Control (CDC) Emerging Infectious Diseases (EID) fellowship program.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; CAMPBELL DA, 1987, J MOL BIOL, V196, P113, DOI 10.1016/0022-2836(87)90514-6; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Ciganda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030029; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; CORDINGLEY JS, 1980, MOL BIOCHEM PARASIT, V1, P91, DOI 10.1016/0166-6851(80)90003-1; Gao HX, 2005, P NATL ACAD SCI USA, V102, P10206, DOI 10.1073/pnas.0500926102; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jossinet F, 2005, BIOINFORMATICS, V21, P3320, DOI 10.1093/bioinformatics/bti504; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Ayub MJ, 2009, BIOCHEM BIOPH RES CO, V382, P30, DOI 10.1016/j.bbrc.2009.02.095; Klinge S, 2012, TRENDS BIOCHEM SCI, V37, P189, DOI 10.1016/j.tibs.2012.02.007; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Lescrinier EMHP, 2003, J MOL BIOL, V331, P759, DOI 10.1016/S0022-2836(03)00787-3; Liao HY, 2010, I S BIOMED IMAGING, P169, DOI 10.1109/ISBI.2010.5490386; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/FMB.11.20, 10.2217/fmb.11.20]; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; WHITE TC, 1986, NUCLEIC ACIDS RES, V14, P9471, DOI 10.1093/nar/14.23.9471; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Yokoyama T, 2008, NUCLEIC ACIDS RES, V36, P3539, DOI 10.1093/nar/gkn224; Zhang Q, 2012, BIOPOLYMERS, V97, P709, DOI 10.1002/bip.22052	30	102	102	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					385	389		10.1038/nature11872	http://dx.doi.org/10.1038/nature11872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23395961	Green Accepted			2022-12-28	WOS:000315312900045
J	Cohen, D; Swift, G				Cohen, Deborah; Swift, Glenn			Laboratories and regulator misled over antibiotic susceptibility test discs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cohen, Deborah] BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						British In Vitro Diagnostics Association, MICR RES; British Society for Antimicrobial Chemotherapy, 2005, STAND DISC SUSC TEST; MHRA, MED DEV AL OX CEFP C; O'Dowd A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f537; Thermo Scientific, ANT SUSC TEST	5	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 13	2013	346								f837	10.1136/bmj.f837	http://dx.doi.org/10.1136/bmj.f837			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZK	23403982				2022-12-28	WOS:000315088100020
J	Ferrara, F; Schiffer, CA				Ferrara, Felicetto; Schiffer, Charles A.			Acute myeloid leukaemia in adults	LANCET			English	Article							ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; HIGH-DOSE CYTARABINE; INTERNAL TANDEM DUPLICATION; RISK MYELODYSPLASTIC SYNDROME; ACUTE PROMYELOCYTIC LEUKEMIA; MINIMAL RESIDUAL DISEASE; TRANS-RETINOIC ACID; MICRORNA-EXPRESSION SIGNATURES; ACUTE NONLYMPHOCYTIC LEUKEMIA	The outlook for patients with acute myeloid leukaemia has improved in the past 30 years. Unlike other cancers, much of this progress is attributable to refinement of supportive treatment, rather than the introduction of new drugs. New antibacterial and antifungal agents, antiemetics, and improved transfusion support have decreased the rate of early death, and morbidity and mortality from allogeneic stem cell transplantation has been substantially reduced. However, more than half of young adult patients and about 90% of older patients still die from their disease. Refractoriness to initial induction treatment and, more frequently, relapse after complete remission, are still the main obstacles to cure. Accordingly, new treatment approaches with mechanisms of action different from those of conventional chemotherapy are needed. Our knowledge of the various chromosomal and molecular abnormalities implicated in the pathogenesis of the many subtypes of the disease has greatly expanded; as a result, clinical research is moving towards the investigation of new non-cytotoxic agents in combination with chemotherapy. The goal is to target the molecular abnormalities identified at diagnosis; however, several aberrations can coexist in subclones of acute myeloid leukaemia, making the disease less likely to be inhibited by a single agent.	[Ferrara, Felicetto] Div Haematol, Naples, Italy; [Ferrara, Felicetto] Stem Cell Transplantat Unit, Naples, Italy; [Schiffer, Charles A.] Karmanos Canc Inst, Div Haematol Oncol, Detroit, MI USA	Barbara Ann Karmanos Cancer Institute	Ferrara, F (corresponding author), Cardarelli Hosp, Via Nicolo Piccinni 6, I-80128 Naples, Italy.	felicettoferrara@katamail.com			Janssen; Celgene; Genzyme; BMS; Novartis; Pfizer; Teva; Eisai; Ariad	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Celgene(Bristol-Myers SquibbCelgene Corporation); Genzyme(Sanofi-AventisGenzyme Corporation); BMS(Bristol-Myers Squibb); Novartis(Novartis); Pfizer(Pfizer); Teva(Teva Pharmaceutical Industries); Eisai(Eisai Co Ltd); Ariad	FF has received consultancy fees from Janssen, Celgene, and Genzyme.; CS has received consultancy fees from BMS, Novartis, Celgene, Genzyme, Pfizer, Teva, Genzyme, and Eisai. CS has received grants from BMS, Novartis, Celgene, Pfizer, and Ariad.	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Appelbaum FR, 2012, NAT REV CLIN ONCOL, V9, P376, DOI 10.1038/nrclinonc.2012.98; Appelbaum FR, 2008, BEST PRACT RES CL HA, V21, P667, DOI 10.1016/j.beha.2008.06.005; ARLIN Z, 1990, LEUKEMIA, V4, P177; Bacher U, 2008, BLOOD, V111, P2527, DOI 10.1182/blood-2007-05-091215; Bacher U, 2010, CURR OPIN ONCOL, V22, P646, DOI 10.1097/CCO.0b013e32833ed806; Baer MR, 2008, J CLIN ONCOL, V26, P4934, DOI 10.1200/JCO.2008.17.0472; Baer MR, 2002, BLOOD, V100, P1224, DOI 10.1182/blood.V100.4.1224.h81602001224_1224_1232; Baldus CD, 2006, J CLIN ONCOL, V24, P790, DOI 10.1200/JCO.2005.01.6253; Becker H, 2010, J CLIN ONCOL, V28, P596, DOI 10.1200/JCO.2009.25.1496; BERMAN E, 1991, BLOOD, V77, P1666; Bishop JF, 1996, BLOOD, V87, P1710, DOI 10.1182/blood.V87.5.1710.bloodjournal8751710; Bloomfield C. D., 2004, Annals of Hematology, V83, pS84; Bloomfield CD, 1998, CANCER RES, V58, P4173; Breems DA, 2005, J CLIN ONCOL, V23, P1969, DOI 10.1200/JCO.2005.06.027; Brune M, 2006, BLOOD, V108, P88, DOI 10.1182/blood-2005-10-4073; Brunet S, 2012, J CLIN ONCOL, V30, P735, DOI 10.1200/JCO.2011.36.9868; Buccisano F, 2012, BLOOD, V119, P332, DOI 10.1182/blood-2011-08-363291; Buchner T, 2006, J CLIN ONCOL, V24, P2480, DOI 10.1200/JCO.2005.04.5013; Burnett AK, 2002, BRIT J HAEMATOL, V118, P385, DOI 10.1046/j.1365-2141.2002.03724.x; Burnett AK, 2007, CANCER, V109, P1114, DOI 10.1002/cncr.22496; Burnett AK, 2012, J CLIN ONCOL, V30, P3924, DOI 10.1200/JCO.2012.42.2964; Burnett AK, 2011, CURR TREAT OPTION ON, V12, P329, DOI 10.1007/s11864-011-0169-x; Burnett AK, 2011, J CLIN ONCOL, V29, P369, DOI 10.1200/JCO.2010.31.4310; Burnett AK, 2010, BLOOD, V115, P948, DOI 10.1182/blood-2009-08-236588; Burnett AK, 2010, J CLIN ONCOL, V28, P586, DOI 10.1200/JCO.2009.22.9088; Byrd JC, 2004, J CLIN ONCOL, V22, P1087, DOI 10.1200/JCO.2004.07.012; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Cassileth PA, 1998, NEW ENGL J MED, V339, P1649, DOI 10.1056/NEJM199812033392301; Castaigne S, 2012, LANCET, V379, P1508, DOI 10.1016/S0140-6736(12)60485-1; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Chou WC, 2011, BLOOD, V118, P3803, DOI 10.1182/blood-2011-02-339747; Cornely OA, 2007, NEW ENGL J MED, V356, P348, DOI 10.1056/NEJMoa061094; Cripe LD, 2010, BLOOD, V116, P4077, DOI 10.1182/blood-2010-04-277269; D'Andrea AD, 2010, BEST PRACT RES CL HA, V23, P469, DOI 10.1016/j.beha.2010.09.005; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Dufour A, 2010, J CLIN ONCOL, V28, P570, DOI 10.1200/JCO.2008.21.6010; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Erba HP, 2010, BEST PRACT RES CL HA, V23, P495, DOI 10.1016/j.beha.2010.09.012; Estey E, 2005, BLOOD, V105, P1366, DOI 10.1182/blood-2004-09-3437; Estey EH, 2001, BLOOD, V98, P3575, DOI 10.1182/blood.V98.13.3575; Estey E, 2007, BLOOD, V109, P1395, DOI 10.1182/blood-2006-05-021907; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2011, BLOOD, V117, P1109, DOI 10.1182/blood-2010-08-299990; Fang M, 2011, BLOOD, V118, P1490, DOI 10.1182/blood-2011-02-339721; Feldman EJ, 2012, CURR HEMATOL MALIG R, V7, P74, DOI 10.1007/s11899-011-0101-2; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Ferrara F, 2004, HAEMATOLOGICA, V89, P998; Ferrara F, 2008, CRIT REV ONCOL HEMAT, V66, P181, DOI 10.1016/j.critrevonc.2007.09.008; Ferrara F, 2006, LEUKEMIA LYMPHOMA, V47, P1593, DOI 10.1080/10428190600624730; Ferrara F, 2012, EXPERT OPIN INV DRUG, V21, P179, DOI 10.1517/13543784.2012.646082; Ferrara F, 2011, CANCER-AM CANCER SOC, V117, P3879, DOI 10.1002/cncr.25934; Ferrara F, 2011, CL LYMPH MYELOM LEUK, V11, P10, DOI 10.3816/CLML.2011.n.001; Ferrara F, 2010, LANCET, V376, P1967, DOI 10.1016/S0140-6736(10)62104-6; Ferrara F, 2010, AM J HEMATOL, V85, P687, DOI 10.1002/ajh.21791; Fried I, 2012, HAEMATOL-HEMATOL J, V97, P246, DOI 10.3324/haematol.2011.051581; Gale RE, 2008, BLOOD, V111, P2776, DOI 10.1182/blood-2007-08-109090; Gardin C, 2007, BLOOD, V109, P5129, DOI 10.1182/blood-2007-02-069666; Gilliland D Gary, 2004, Hematology Am Soc Hematol Educ Program, P80; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Green CL, 2010, BLOOD, V116, P2779, DOI 10.1182/blood-2010-02-270926; Greenberg PL, 2004, J CLIN ONCOL, V22, P1078, DOI 10.1200/JCO.2004.07.048; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; Hamadani M, 2011, CANCER CONTROL, V18, P237, DOI 10.1177/107327481101800404; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Holowiecki J, 2012, J CLIN ONCOL, V30, P2441, DOI 10.1200/JCO.2011.37.1286; Hou HA, 2012, BLOOD, V119, P559, DOI 10.1182/blood-2011-07-369934; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Juliusson G, 2012, BLOOD, V119, P3890, DOI 10.1182/blood-2011-12-379008; Kantarjian HM, 2012, J CLIN ONCOL, V30, P2670, DOI 10.1200/JCO.2011.38.9429; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Knapper S, 2011, EXPERT OPIN INV DRUG, V20, P1377, DOI 10.1517/13543784.2011.611802; Kolitz JE, 2010, BLOOD, V116, P1413, DOI 10.1182/blood-2009-07-229492; Krug U, 2010, LANCET, V376, P2000, DOI 10.1016/S0140-6736(10)62105-8; Larson RA, 2012, J CLIN ONCOL, V30, P2300, DOI 10.1200/JCO.2011.41.1215; Leith CP, 1997, BLOOD, V89, P3323; Levis M, 2011, BLOOD, V117, P3294, DOI 10.1182/blood-2010-08-301796; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li W, 2012, LEUKEMIA RES, V36, P186, DOI 10.1016/j.leukres.2011.08.014; Lowenberg B, 2009, NEW ENGL J MED, V361, P1235, DOI 10.1056/NEJMoa0901409; Lubbert M, 2012, HAEMATOL-HEMATOL J, V97, P393, DOI 10.3324/haematol.2011.048231; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; LUM BL, 1992, J CLIN ONCOL, V10, P1635, DOI 10.1200/JCO.1992.10.10.1635; Lyman GH, 2010, J CLIN ONCOL, V28, P2914, DOI 10.1200/JCO.2009.25.8723; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; Marcucci G, 2008, J CLIN ONCOL, V26, P5078, DOI 10.1200/JCO.2008.17.5554; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mathews V, 2010, J CLIN ONCOL, V28, P3866, DOI 10.1200/JCO.2010.28.5031; Maurillo L, 2008, J CLIN ONCOL, V26, P4944, DOI 10.1200/JCO.2007.15.9814; MAYER RJ, 1994, NEW ENGL J MED, V331, P896, DOI 10.1056/NEJM199410063311402; Melnick AM, 2010, BEST PRACT RES CL HA, V23, P463, DOI 10.1016/j.beha.2010.09.017; Menzin J, 2002, ARCH INTERN MED, V162, P1597, DOI 10.1001/archinte.162.14.1597; Metzeler KH, 2011, BLOOD, V118, P6920, DOI 10.1182/blood-2011-08-368225; Moore JO, 2005, BLOOD, V105, P3420, DOI 10.1182/blood-2004-08-2977; Norkin M, 2011, LEUKEMIA RES, V35, P139, DOI 10.1016/j.leukres.2010.09.016; Oki Y, 2010, CANCER TREAT RES, V145, P19, DOI 10.1007/978-0-387-69259-3_2; Paschka P, 2006, J CLIN ONCOL, V24, P3904, DOI 10.1200/JCO.2006.06.9500; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pfirrmann M, 2012, LANCET ONCOL, V13, P207, DOI 10.1016/S1470-2045(11)70326-6; PLUNKETT W, 1987, CANCER RES, V47, P3005; Pollard JA, 2010, BLOOD, V115, P2372, DOI 10.1182/blood-2009-09-241075; PUI CH, 1991, NEW ENGL J MED, V325, P1682, DOI 10.1056/NEJM199112123252402; Roboz GJ, 2009, EXPERT REV HEMATOL, V2, P663, DOI [10.1586/ehm.09.53, 10.1586/EHM.09.53]; Rowe JM, 2008, BEST PRACT RES CL HA, V21, P53, DOI 10.1016/j.beha.2007.11.004; Rubnitz JE, 2010, LANCET ONCOL, V11, P543, DOI 10.1016/S1470-2045(10)70090-5; Sanz MA, 2011, J CLIN ONCOL, V29, P495, DOI 10.1200/JCO.2010.32.1067; Schaich M, 2011, J CLIN ONCOL, V29, P2696, DOI 10.1200/JCO.2010.33.7303; Schiffer C, 2010, HOLLAND FREI CANC ME; Schiffer CA, 2001, J CLIN ONCOL, V19, P1519, DOI 10.1200/JCO.2001.19.5.1519; Schiffer CA, 2010, J CLIN ONCOL, V28, P521, DOI 10.1200/JCO.2009.25.8616; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Shen Y, 2011, BLOOD, V118, P5593, DOI 10.1182/blood-2011-03-343988; Shimoni A, 2011, BEST PRACT RES CL HA, V24, P369, DOI 10.1016/j.beha.2011.05.002; Slovak ML, 2006, LEUKEMIA, V20, P1295, DOI 10.1038/sj.leu.2404233; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Stone RM, 2001, BLOOD, V98, P548, DOI 10.1182/blood.V98.3.548; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Ustun C, 2011, BLOOD, V118, P5084, DOI 10.1182/blood-2011-07-365817; van der Holt B, 2005, BLOOD, V106, P2646, DOI 10.1182/blood-2005-04-1395; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vellenga E, 2011, BLOOD, V118, P6037, DOI 10.1182/blood-2011-07-370247; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Walter RB, 2011, J CLIN ONCOL, V29, P4417, DOI 10.1200/JCO.2011.35.7525; Walter RB, 2011, J CLIN ONCOL, V29, P1190, DOI 10.1200/JCO.2010.31.8121; Walter RB, 2010, J CLIN ONCOL, V28, P1766, DOI 10.1200/JCO.2009.25.1066; Whitman SP, 2001, CANCER RES, V61, P7233; WIERNIK PH, 1992, BLOOD, V79, P313; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; YATES JW, 1973, CANCER CHEMOTH REP 1, V57, P485; ZITTOUN RA, 1995, NEW ENGL J MED, V332, P217, DOI 10.1056/NEJM199501263320403	140	372	385	3	98	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2013	381	9865					484	495		10.1016/S0140-6736(12)61727-9	http://dx.doi.org/10.1016/S0140-6736(12)61727-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088CH	23399072				2022-12-28	WOS:000314810900034
J	Bourassa, AE; Robock, A; Randel, WJ; Deshler, T; Rieger, LA; Lloyd, ND; Llewellyn, EJ; Degenstein, DA				Bourassa, Adam E.; Robock, Alan; Randel, William J.; Deshler, Terry; Rieger, Landon A.; Lloyd, Nicholas D.; Llewellyn, E. J.; Degenstein, Douglas A.			Response to Comments on "Large Volcanic Aerosol Load in the Stratosphere Linked to Asian Monsoon Transport"	SCIENCE			English	Editorial Material								Fromm et al. and Vernier et al. suggest that their analyses of satellite measurements indicate that the main part of the Nabro volcanic plume from the eruption on 13 June 2011 was directly injected into the stratosphere. We address these analyses and, in addition, show that both wind trajectories and height-resolved profiles of sulfur dioxide indicate that although the eruption column may have extended higher than the Smithsonian report we highlighted, it was overwhelmingly tropospheric. Additionally, the height-resolved sulfur dioxide profiles provide further convincing evidence for convective transport of volcanic gas to the stratosphere from deep convection associated with the Asian monsoon.	[Bourassa, Adam E.; Rieger, Landon A.; Lloyd, Nicholas D.; Llewellyn, E. J.; Degenstein, Douglas A.] Univ Saskatchewan, Inst Space & Atmospher Studies, Saskatoon, SK S7N 5E2, Canada; [Robock, Alan] Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08901 USA; [Randel, William J.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Deshler, Terry] Univ Wyoming, Dept Atmospher Sci, Laramie, WY 82071 USA	University of Saskatchewan; Rutgers State University New Brunswick; National Center Atmospheric Research (NCAR) - USA; University of Wyoming	Bourassa, AE (corresponding author), Univ Saskatchewan, Inst Space & Atmospher Studies, Saskatoon, SK S7N 5E2, Canada.	adam.bourassa@usask.ca	Randel, William J/K-3267-2016; Robock, Alan/B-6385-2016	Randel, William J/0000-0002-5999-7162; Robock, Alan/0000-0002-6319-5656	Directorate For Geosciences [1011827] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Bourassa AE, 2012, SCIENCE, V337, P78, DOI 10.1126/science.1219371; Clarisse L, 2012, ATMOS MEAS TECH, V5, P581, DOI 10.5194/amt-5-581-2012; Fromm M, 2013, SCIENCE, V339, DOI [10.1126/science.1228605, 10.1126/science.1227817]; Fueglistaler S, 2009, REV GEOPHYS, V47, DOI 10.1029/2008RG000267; Haywood JM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014447; Holasek RE, 1996, J GEOPHYS RES-SOL EA, V101, P27635, DOI 10.1029/96JB01179; Pan LL, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015462; Park M, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008294; Randel WJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002595; WOODS AW, 1992, NATURE, V355, P628, DOI 10.1038/355628a0	10	21	21	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120								10.1126/science.1227961	http://dx.doi.org/10.1126/science.1227961			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393248				2022-12-28	WOS:000314585600021
J	Palike, H				Paelike, Heiko			Impact and Extinction	SCIENCE			English	Editorial Material							ASTRONOMICAL CALIBRATION; EARTH; PALEOCENE; BOUNDARY; TIME		Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany	University of Bremen	Palike, H (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, Leobener Str, D-28359 Bremen, Germany.	hpaelike@marum.de	Palike, Heiko/A-6560-2008	Palike, Heiko/0000-0003-3386-0923				ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Hilgen FJ, 2010, EARTH PLANET SC LETT, V300, P139, DOI 10.1016/j.epsl.2010.09.044; Husson D, 2011, EARTH PLANET SC LETT, V305, P328, DOI 10.1016/j.epsl.2011.03.008; Keller G, 2007, EARTH PLANET SC LETT, V255, P339, DOI 10.1016/j.epsl.2006.12.026; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Laskar J, 2011, ASTRON ASTROPHYS, V532, DOI [10.1051/0004-6361/201116836, 10.1051/0004-6361/201117504]; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Palike H, 2008, NAT GEOSCI, V1, P282, DOI 10.1038/ngeo197; Renne PR, 2013, SCIENCE, V339, P684, DOI 10.1126/science.1230492; Renne PR, 2011, GEOCHIM COSMOCHIM AC, V75, P5097, DOI 10.1016/j.gca.2011.06.021; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Westerhold T, 2008, PALAEOGEOGR PALAEOCL, V257, P377, DOI 10.1016/j.palaeo.2007.09.016; Westerhold T, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004096; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4	15	9	9	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					655	656		10.1126/science.1233948	http://dx.doi.org/10.1126/science.1233948			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393253				2022-12-28	WOS:000314585600028
J	Kondo, T; Hayashi, S				Kondo, Takefumi; Hayashi, Shigeo			Mitotic cell rounding accelerates epithelial invagination	NATURE			English	Article							APICAL CONSTRICTION; ADHERENS JUNCTIONS; DROSOPHILA; TRACHEAL; MORPHOGENESIS; SHAPE; INTEGRATION; MIGRATION; TRIBBLES; HOMOLOG	Mitotic cells assume a spherical shape by increasing their surface tension and osmotic pressure by extensively reorganizing their interphase actin cytoskeleton into a cortical meshwork and their microtubules into the mitotic spindle(1,2). Mitotic entry is known to interfere with tissue morphogenetic events that require cell-shape changes controlled by the interphase cytoskeleton, such as apical constriction(3-5). However, here we show that mitosis plays an active role in the epithelial invagination of the Drosophila melanogaster tracheal placode. Invagination begins with a slow phase under the control of epidermal growth factor receptor (EGFR) signalling; in this process, the central apically constricted cells, which are surrounded by intercalating cells(6,7), form a shallow pit. This slow phase is followed by a fast phase, in which the pit is rapidly depressed, accompanied by mitotic entry, which leads to the internalization of all the cells in the placode. We found that mitotic cell rounding, but not cell division, of the central cells in the placode is required to accelerate invagination, in conjunction with EGFR-induced myosin II contractility in the surrounding cells. We propose that mitotic cell rounding causes the epithelium to buckle under pressure and acts as a switch for morphogenetic transition at the appropriate time.	[Kondo, Takefumi; Hayashi, Shigeo] RIKEN Ctr Dev Biol, Lab Morphogenet Signaling, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Hayashi, Shigeo] Kobe Univ, Dept Biol, Grad Sch Sci, Kobe, Hyogo 6578501, Japan	RIKEN; Kobe University	Hayashi, S (corresponding author), RIKEN Ctr Dev Biol, Lab Morphogenet Signaling, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	shayashi@cdb.riken.jp	Hayashi, Shigeo/J-9628-2019; Hayashi, Shigeo/N-5128-2015	Hayashi, Shigeo/0000-0001-7785-1290; Hayashi, Shigeo/0000-0001-7785-1290; Kondo, Takefumi/0000-0001-8127-1141	Ministry of Education, Culture, Sports, Science and Technology, Japan [22111007, 23770624]; RIKEN Special Postdoctoral Researcher Program	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Special Postdoctoral Researcher Program	We thank the Kyoto and Bloomington Drosophila Stock Centers, the Developmental Studies Hybridoma Bank, E. Wieschaus, H. Oda and T. Nishimura for fly stocks and antibodies; K. Kato and H. Wade for assistance with data analysis and experiments; G. Sheng, E. Kuranaga, K. Kato, T. Otani and B. Dong for comments on the manuscript; and members of the Hayashi, Nishimura and Kuranaga laboratories for discussions. This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (22111007 to S.H); Grant-in-Aid for Young Scientists (B) (23770624 to T.K.) from The Ministry of Education, Culture, Sports, Science and Technology, Japan; and the RIKEN Special Postdoctoral Researcher Program (T.K.)	BAKER J, 1993, J CELL SCI, V104, P415; Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706; BUNCH TA, 1992, GENETICS, V132, P519; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Corrigall D, 2007, DEV CELL, V13, P730, DOI 10.1016/j.devcel.2007.09.015; Escudero LM, 2007, DEV CELL, V13, P717, DOI 10.1016/j.devcel.2007.09.002; Garner M, 2001, CURR BIOL, V11, P1595, DOI 10.1016/S0960-9822(01)00483-3; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Kato K, 2008, DEV GROWTH DIFFER, V50, P381, DOI [10.1111/j.1440-169x.2008.01029.x, 10.1111/j.1440-169X.2008.01029.x]; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397; Oda H, 2001, J CELL SCI, V114, P493; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Thery M, 2008, HFSP J, V2, P65, DOI 10.2976/1.2895661; Vincent A, 1997, DEVELOPMENT, V124, P3747; Wang YC, 2012, NATURE, V484, P390, DOI 10.1038/nature10938	27	107	107	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					125	129		10.1038/nature11792	http://dx.doi.org/10.1038/nature11792			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23334416				2022-12-28	WOS:000314741200047
J	Rilstone, JJ; Alkhater, RA; Minassian, BA				Rilstone, Jennifer J.; Alkhater, Reem A.; Minassian, Berge A.			Brain Dopamine-Serotonin Vesicular Transport Disease and Its Treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACID DECARBOXYLASE DEFICIENCY; MONOAMINE TRANSPORTER-2; SEQUENCE VARIANTS; GENE; PARKINSONISM; AMPHETAMINE; MUTATIONS; FEATURES; VMAT2; MICE	We describe a disease encompassing infantile-onset movement disorder (including severe parkinsonism and nonambulation), mood disturbance, autonomic instability, and developmental delay, and we describe evidence supporting its causation by a mutation in SLC18A2 (which encodes vesicular monoamine transporter 2 [VMAT2]). VMAT2 translocates dopamine and serotonin into synaptic vesicles and is essential for motor control, stable mood, and autonomic function. Treatment with levodopa was associated with worsening, whereas treatment with direct dopamine agonists was followed by immediate ambulation, near-complete correction of the movement disorder, and resumption of development.	[Rilstone, Jennifer J.; Alkhater, Reem A.; Minassian, Berge A.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Rilstone, Jennifer J.; Minassian, Berge A.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Alkhater, Reem A.; Minassian, Berge A.] Hosp Sick Children, Div Neurol, Dept Pediat, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Minassian, BA (corresponding author), Hosp Sick Children, Rm 6536B,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	reema.alkhater@mail.utoronto.ca; berge.minassian@sickkids.ca			Canadian Institutes of Health Research; National Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by the Canadian Institutes of Health Research. Dr. Minassian holds the University of Toronto Michael Bahen Chair in Epilepsy Research. Ms. Rilstone was supported by the Vanier Canada Graduate Scholarship from the National Sciences and Engineering Research Council of Canada.	Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Brun L, 2010, NEUROLOGY, V75, P576; Brun L, 2010, NEUROLOGY, V75, P64, DOI 10.1212/WNL.0b013e3181e620ae; Burman J, 2004, PHARMACOGENETICS, V14, P587, DOI 10.1097/00008571-200409000-00003; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Eiden LE, 2011, ANN NY ACAD SCI, V1216, P86, DOI 10.1111/j.1749-6632.2010.05906.x; ERICKSON JD, 1993, J NEUROCHEM, V61, P2314, DOI 10.1111/j.1471-4159.1993.tb07476.x; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Fukui M, 2007, J NEUROSCI, V27, P10520, DOI 10.1523/JNEUROSCI.4388-06.2007; Glatt CE, 2001, NAT GENET, V27, P435, DOI 10.1038/86948; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hyland K, 2008, CLIN CHEM, V54, P633, DOI 10.1373/clinchem.2007.099986; Iwasa H, 2001, J HUM GENET, V46, P158, DOI 10.1007/s100380170106; Jeon Sung-Man, 2010, Exp Neurobiol, V19, P155, DOI 10.5607/en.2010.19.3.155; Kurian MA, 2011, LANCET NEUROL, V10, P721, DOI 10.1016/S1474-4422(11)70141-7; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Lee HCH, 2012, CLIN CHIM ACTA, V413, P126, DOI 10.1016/j.cca.2011.09.008; Longo N, 2009, J INHERIT METAB DIS, V32, P333, DOI 10.1007/s10545-009-1067-2; Mooslehner KA, 2001, MOL CELL BIOL, V21, P5321, DOI 10.1128/MCB.21.16.5321-5331.2001; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Pons R, 2004, NEUROLOGY, V62, P1058, DOI 10.1212/WNL.62.7.1058; Pons R, 2009, J INHERIT METAB DIS, V32, P321, DOI 10.1007/s10545-008-1007-6; Swoboda KJ, 1999, NEUROLOGY, V53, P1205, DOI 10.1212/WNL.53.6.1205; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; Yeung WL, 2012, J CHILD NEUROL, V27, P829, DOI 10.1177/0883073812448570	27	113	120	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					543	550		10.1056/NEJMoa1207281	http://dx.doi.org/10.1056/NEJMoa1207281			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083VU	23363473				2022-12-28	WOS:000314494100005
J	Coombes, BK; Bisset, L; Brooks, P; Khan, A; Vicenzino, B				Coombes, Brooke K.; Bisset, Leanne; Brooks, Peter; Khan, Asad; Vicenzino, Bill			Effect of Corticosteroid Injection, Physiotherapy, or Both on Clinical Outcomes in Patients With Unilateral Lateral Epicondylalgia A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TENNIS ELBOW; ACHILLES-TENDON; NO SIGNS; INFLAMMATION; MICRODIALYSIS; GLUTAMATE; TISSUE; TENDINOPATHY; EFFICACY; THERAPY	Importance Corticosteroid injection and physiotherapy, common treatments for lateral epicondylalgia, are frequently combined in clinical practice. However, evidence on their combined efficacy is lacking. Objective To investigate the effectiveness of corticosteroid injection, multimodal physiotherapy, or both in patients with unilateral lateral epicondylalgia. Design, Setting, and Patients A2 x 2 factorial, randomized, injection-blinded, placebocontrolled trial was conducted at a single university research center and 16 primary care settings in Brisbane, Australia. A total of 165 patients aged 18 years or older with unilateral lateral epicondylalgia of longer than 6 weeks' duration were enrolled between July 2008 and May 2010; 1-year follow-up was completed in May 2011. Interventions Corticosteroid injection (n=43), placebo injection (n=41), corticosteroid injection plus physiotherapy (n=40), or placebo injection plus physiotherapy (n=41). Main Outcome Measures The 2 primary outcomes were 1-year global rating of change scores for complete recovery or much improvement and 1-year recurrence (defined as complete recovery or much improvement at 4 or 8 weeks, but not later) analyzed on an intention-to-treat basis (P < .01). Secondary outcomes included complete recovery or much improvement at 4 and 26 weeks. Results Corticosteroid injection resulted in lower complete recovery or much improvement at 1 year vs placebo injection (83% vs 96%, respectively; relative risk [RR], 0.86 [99% CI, 0.75-0.99]; P=.01) and greater 1-year recurrence (54% vs 12%; RR, 0.23 [99% CI, 0.10-0.51]; P < .001). The physiotherapy and no physiotherapy groups did not differ on 1-year ratings of complete recovery or much improvement (91% vs 88%, respectively; RR, 1.04 [99% CI, 0.90-1.19]; P=.56) or recurrence (29% vs 38%; RR, 1.31 [99% CI, 0.73-2.35]; P=.25). Similar patterns were found at 26 weeks, with lower complete recovery or much improvement after corticosteroid injection vs placebo injection (55% vs 85%, respectively; RR, 0.79 [99% CI, 0.62-0.99]; P < .001) and no difference between the physiotherapy and no physiotherapy groups (71% vs 69%, respectively; RR, 1.22 [99% CI, 0.97-1.53]; P=.84). At 4 weeks, there was a significant interaction between corticosteroid injection and physiotherapy (P=.01), whereby patients receiving the placebo injection plus physiotherapy had greater complete recovery or much improvement vs no physiotherapy (39% vs 10%, respectively; RR, 4.00 [99% CI, 1.07-15.00]; P=.004). However, there was no difference between patients receiving the corticosteroid injection plus physiotherapy vs corticosteroid alone (68% vs 71%, respectively; RR, 0.95 [99% CI, 0.65-1.38]; P=.57). Conclusion and Relevance Among patients with chronic unilateral lateral epicondylalgia, the use of corticosteroid injection vs placebo injection resulted in worse clinical outcomes after 1 year, and physiotherapy did not result in any significant differences.	[Coombes, Brooke K.; Khan, Asad; Vicenzino, Bill] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, St Lucia, Qld 4072, Australia; [Bisset, Leanne] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4215, Australia; [Bisset, Leanne] Gold Coast Hosp & Hlth Serv, Southport, Qld, Australia; [Brooks, Peter] Univ Melbourne, Australian Hlth Workforce Inst, Melbourne, Vic 3010, Australia	University of Queensland; Griffith University; Menzies Health Institute Queensland; Gold Coast University Hospital; University of Melbourne	Vicenzino, B (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Bldg 84A, St Lucia, Qld 4072, Australia.	b.vicenzino@uq.edu.au	Vicenzino, Bill/A-8492-2011; Khan, Asad/N-7481-2019; Khan, Asad/F-8739-2010; Coombes, Brooke/AAV-9060-2021; Coombes, Brooke/D-3456-2015; Bisset, Leanne/AAS-8947-2021	Vicenzino, Bill/0000-0003-0253-5933; Khan, Asad/0000-0003-4188-2065; Khan, Asad/0000-0003-4188-2065; Coombes, Brooke/0000-0002-6163-1047; Bisset, Leanne/0000-0001-8807-7093	Australian National Health and Medical Research Council [511238]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Australian National Health and Medical Research Council grant 511238 awarded to Drs Bisset, Brooks, and Vicenzino.	Alfredson H, 1999, KNEE SURG SPORT TR A, V7, P378, DOI 10.1007/s001670050184; Alfredson H, 2000, ACTA ORTHOP SCAND, V71, P475, DOI 10.1080/000164700317381162; Alfredson H, 2001, J ORTHOPAED RES, V19, P881, DOI 10.1016/S0736-0266(01)00016-X; Bennell K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2756; Bisset L, 2006, BMJ-BRIT MED J, V333, P939, DOI 10.1136/bmj.38961.584653.AE; Cetti R, 2003, ACTA ORTHOP SCAND, V74, P78, DOI 10.1080/00016470310013707; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Coombes BK, 2010, LANCET, V376, P1751, DOI 10.1016/S0140-6736(10)61160-9; Coombes BK, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-76; Fredberg U, 2008, SCAND J MED SCI SPOR, V18, P3, DOI 10.1111/j.1600-0838.2007.00746.x; Hay EM, 1999, BRIT MED J, V319, P964, DOI 10.1136/bmj.319.7215.964; Herbert RD, 2000, AUST J PHYSIOTHER, V46, P309, DOI 10.1016/S0004-9514(14)60292-0; Hsieh FY, 2003, EVAL HEALTH PROF, V26, P239, DOI 10.1177/0163278703255230; Ljung BO, 2004, J ORTHOPAED RES, V22, P321, DOI 10.1016/S0736-0266(03)00183-9; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; Millar NL, 2010, AM J SPORT MED, V38, P2085, DOI 10.1177/0363546510372613; Newcomer Karen L, 2005, J Hand Ther, V18, P400, DOI 10.1197/j.jht.2005.07.001; Newcomer KL, 2001, CLIN J SPORT MED, V11, P214, DOI 10.1097/00042752-200110000-00002; Okcu G, 2002, CLIN RES, V13, P158; Osborne H, 2010, J SCI MED SPORT, V13, P380, DOI 10.1016/j.jsams.2009.09.009; Paavola Mika, 2002, Foot Ankle Clin, V7, P501, DOI 10.1016/S1083-7515(02)00056-6; Poltawski L, 2011, HAND THER, V16, P52, DOI 10.1258/ht.2011.011013; QUIN CE, 1954, LANCET, V2, P221; Rompe JD, 2007, J HAND THER, V20, P3, DOI 10.1197/j.jht.2006.10.003; Scott A, 2010, LANCET, V376, P1714, DOI 10.1016/S0140-6736(10)61308-6; Smidt N, 2002, LANCET, V359, P657, DOI 10.1016/S0140-6736(02)07811-X; Smidt N, 2006, J RHEUMATOL, V33, P2053; Tonks JH, 2007, INT J CLIN PRACT, V61, P240, DOI 10.1111/j.1742-1241.2006.01140.x; Vicenzino B, 2003, MANUAL THER, V8, P66, DOI 10.1016/S1356-689X(02)00157-1; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	30	193	193	2	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					461	469		10.1001/jama.2013.129	http://dx.doi.org/10.1001/jama.2013.129			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083LY	23385272	Green Submitted, Bronze			2022-12-28	WOS:000314466900027
J	Whittle, SL; Richards, BL; Buchbinder, R				Whittle, Samuel L.; Richards, Bethan L.; Buchbinder, Rachelle			Opioid Analgesics for Rheumatoid Arthritis Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK		[Whittle, Samuel L.] Queen Elizabeth Hosp, Rheumatol Unit, Woodville, SA 5011, Australia; [Richards, Bethan L.] Royal Prince Alfred Hosp, Rheumatol Unit, Camperdown, NSW 2050, Australia; [Buchbinder, Rachelle] Monash Univ, Cabrini Hosp, Monash Dept Clin Epidemiol, Dept Epidemiol & Prevent Med,Sch Publ Hlth & Prev, Malvern, Australia	University of Sydney; Cabrini Health; Monash University	Whittle, SL (corresponding author), Queen Elizabeth Hosp, Rheumatol Unit, 28 Woodville Rd, Woodville, SA 5011, Australia.	sam@whit.tl	Whittle, Samuel L/K-7861-2015; Buchbinder, Rachelle/G-2952-2011	Whittle, Samuel L/0000-0001-7417-7691; Buchbinder, Rachelle/0000-0002-0597-0933; Richards, Bethan/0000-0002-9249-8808				Boada JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003580; Grijalva CG, 2008, RHEUMATOLOGY, V47, P1061, DOI 10.1093/rheumatology/ken193; Heiberg T, 2002, ARTHRIT RHEUM-ARTHR, V47, P391, DOI 10.1002/art.10515; Moore RA, 2010, PAIN, V149, P173, DOI 10.1016/j.pain.2009.08.007; Nelson LS, 2012, JAMA-J AM MED ASSOC, V308, P457, DOI 10.1001/jama.2012.8165; Whittle SL, 2012, RHEUMATOLOGY, V51, P1416, DOI 10.1093/rheumatology/kes032; Whittle SL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003113.pub3	7	18	18	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					485	486		10.1001/jama.2012.193412	http://dx.doi.org/10.1001/jama.2012.193412			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083LY	23385275				2022-12-28	WOS:000314466900030
J	Yu, M; Bardia, A; Wittner, B; Stott, SL; Smas, ME; Ting, DT; Isakoff, SJ; Ciciliano, JC; Wells, MN; Shah, AM; Concannon, KF; Donaldson, MC; Sequist, LV; Brachtel, E; Sgroi, D; Baselga, J; Ramaswamy, S; Toner, M; Haber, DA; Maheswaran, S				Yu, Min; Bardia, Aditya; Wittner, Ben S.; Stott, Shannon L.; Smas, Malgorzata E.; Ting, David T.; Isakoff, Steven J.; Ciciliano, Jordan C.; Wells, Marissa N.; Shah, Ajay M.; Concannon, Kyle F.; Donaldson, Maria C.; Sequist, Lecia V.; Brachtel, Elena; Sgroi, Dennis; Baselga, Jose; Ramaswamy, Sridhar; Toner, Mehmet; Haber, Daniel A.; Maheswaran, Shyamala			Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition	SCIENCE			English	Article							TRANSITION; EMT; DISSEMINATION; METASTASIS	Epithelial-mesenchymal transition (EMT) of adherent epithelial cells to a migratory mesenchymal state has been implicated in tumor metastasis in preclinical models. To investigate its role in human cancer, we characterized EMT in circulating tumor cells (CTCs) from breast cancer patients. Rare primary tumor cells simultaneously expressed mesenchymal and epithelial markers, but mesenchymal cells were highly enriched in CTCs. Serial CTC monitoring in 11 patients suggested an association of mesenchymal CTCs with disease progression. In an index patient, reversible shifts between these cell fates accompanied each cycle of response to therapy and disease progression. Mesenchymal CTCs occurred as both single cells and multicellular clusters, expressing known EMT regulators, including transforming growth factor (TGF)-beta pathway components and the FOXC1 transcription factor. These data support a role for EMT in the blood-borne dissemination of human breast cancer.	[Yu, Min; Bardia, Aditya; Wittner, Ben S.; Stott, Shannon L.; Smas, Malgorzata E.; Ting, David T.; Isakoff, Steven J.; Ciciliano, Jordan C.; Wells, Marissa N.; Concannon, Kyle F.; Donaldson, Maria C.; Sequist, Lecia V.; Brachtel, Elena; Sgroi, Dennis; Baselga, Jose; Ramaswamy, Sridhar; Haber, Daniel A.; Maheswaran, Shyamala] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Stott, Shannon L.; Shah, Ajay M.; Toner, Mehmet] Harvard Univ, Sch Med, Ctr Bioengn Med, Charlestown, MA 02129 USA; [Bardia, Aditya; Isakoff, Steven J.; Sequist, Lecia V.; Baselga, Jose; Ramaswamy, Sridhar; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA; [Brachtel, Elena; Sgroi, Dennis] Harvard Univ, Sch Med, Dept Pathol, Charlestown, MA 02129 USA; [Toner, Mehmet; Maheswaran, Shyamala] Harvard Univ, Sch Med, Dept Surg, Charlestown, MA 02129 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Haber, DA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu; maheswaran@helix.mgh.harvard.edu	Stott, Shannon L./AAC-5311-2019; Isakoff, Steven/ABE-3566-2020; Sgroi, Dennis/AAV-2487-2021; Ting, David/F-4389-2017	Yu, Min/0000-0002-3969-8720; Donaldson Collier, Maria/0000-0001-6403-6713; Ting, David/0000-0002-3261-2322	Breast Cancer Research Foundation; Stand Up To Cancer; Susan G. Komen for the Cure [KG090412]; NIBIB [EB008047]; NCI [CA129933]; National Cancer Institute-MGH Federal Share Program; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [K12CA087723, R01CA129933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB012493, R01EB008047] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Stand Up To Cancer; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute-MGH Federal Share Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We are grateful to all the patients who participated in this study; we thank D. Juric, C. Koris, and the Massachusetts General Hospital (MGH) clinical research coordinators for help with clinical studies; A. Gilman, B. Brannigan, and M. Zeinali for technical support; F. Ozsolak and P. Milos (Helicos) for RNA sequencing; A. Forrest-Hay and Q. Nguyen (Affymetrix) for RNA-ISH reagents; L. Libby for mouse studies; and J. Walsh for expertise with microscopy. This work was supported by grants from the Breast Cancer Research Foundation (D. A. H.), Stand Up To Cancer (D. A. H., M. T., and S. M.), Susan G. Komen for the Cure KG090412 (S. M.), NIBIB EB008047 (M. T., D. A. H.), NCI CA129933 (D. A. H.), the National Cancer Institute-MGH Federal Share Program (S. M.), and the Howard Hughes Medical Institute (M.Y. and D. A. H.). The MGH and M. T. have filed a patent for the HB (Herringbone) microchip (U.S. patent 09816815.4). Sequencing data have been deposited in the Gene Expression Omnibus database (accession no. GSE41245).	Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Cho EH, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016001; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Ilina O, 2009, J CELL SCI, V122, P3203, DOI 10.1242/jcs.036525; Jeong H, 2012, HISTOPATHOLOGY, V60, pE87, DOI 10.1111/j.1365-2559.2012.04195.x; Jiang Z, 2011, CELL CYCLE, V10, P1563, DOI 10.4161/cc.10.10.15703; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim YN, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/306879; Krebs MG, 2012, J THORAC ONCOL, V7, P306, DOI 10.1097/JTO.0b013e31823c5c16; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lecharpentier A, 2011, BRIT J CANCER, V105, P1338, DOI 10.1038/bjc.2011.405; Ledford H, 2011, NATURE, V472, P273, DOI 10.1038/472273a; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ozsolak F, 2010, NAT METHODS, V7, P619, DOI [10.1038/NMETH.1480, 10.1038/nmeth.1480]; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Payne RE, 2012, BRIT J CANCER, V106, P1790, DOI 10.1038/bjc.2012.137; Pecot CV, 2011, CANCER DISCOV, V1, P580, DOI 10.1158/2159-8290.CD-11-0215; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Yu M, 2009, GENE DEV, V23, P1737, DOI 10.1101/gad.1809309	29	1742	1830	16	666	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					580	584		10.1126/science.1228522	http://dx.doi.org/10.1126/science.1228522			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372014	Green Accepted			2022-12-28	WOS:000314270000059
J	Barlow, JH; Faryabi, RB; Callen, E; Wong, N; Malhowski, A; Chen, HT; Gutierrez-Cruz, G; Sun, HW; McKinnon, P; Wright, G; Casellas, R; Robbiani, DF; Staudt, L; Fernandez-Capetillo, O; Nussenzweig, A				Barlow, Jacqueline H.; Faryabi, Robert B.; Callen, Elsa; Wong, Nancy; Malhowski, Amy; Chen, Hua Tang; Gutierrez-Cruz, Gustavo; Sun, Hong-Wei; McKinnon, Peter; Wright, George; Casellas, Rafael; Robbiani, Davide F.; Staudt, Louis; Fernandez-Capetillo, Oscar; Nussenzweig, Andre			Identification of Early Replicating Fragile Sites that Contribute to Genome Instability	CELL			English	Article							CYTIDINE DEAMINASE AID; CLASS-SWITCH RECOMBINATION; CHROMOSOMAL TRANSLOCATIONS; HOMOLOGOUS RECOMBINATION; SEQUENCING REVEALS; FORK PROGRESSION; DNA-REPLICATION; BREAKS; ATR; TRANSCRIPTION	DNA double-strand breaks (DSBs) in B lymphocytes arise stochastically during replication or as a result of targeted DNA damage by activation-induced cytidine deaminase (AID). Here we identify recurrent, early replicating, and AID-independent DNA lesions, termed early replication fragile sites (ERFSs), by genome-wide localization of DNA repair proteins in B cells subjected to replication stress. ERFSs colocalize with highly expressed gene clusters and are enriched for repetitive elements and CpG dinucleotides. Although distinct from late-replicating common fragile sites (CFS), the stability of ERFSs and CFSs is similarly dependent on the replication-stress response kinase ATR. ERFSs break spontaneously during replication, but their fragility is increased by hydroxyurea, ATR inhibition, or deregulated c-Myc expression. Moreover, greater than 50% of recurrent amplifications/deletions in human diffuse large B cell lymphoma map to ERFSs. In summary, we have identified a source of spontaneous DNA lesions that drives instability at preferred genomic sites.	[Barlow, Jacqueline H.; Faryabi, Robert B.; Callen, Elsa; Wong, Nancy; Malhowski, Amy; Chen, Hua Tang; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Wright, George; Staudt, Louis] NCI, Metab Branch Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Gutierrez-Cruz, Gustavo] NIAMSD, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMSD, Biodata Min & Discovery Sect, Off Sci & Technol, NIH, Bethesda, MD 20892 USA; [Casellas, Rafael] NIAMSD, Lab Immunogenet, NIH, Bethesda, MD 20892 USA; [McKinnon, Peter] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; [Robbiani, Davide F.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, E-28029 Madrid, Spain	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); St Jude Children's Research Hospital; Rockefeller University; Centro Nacional de Investigaciones Oncologicas (CNIO)	Nussenzweig, A (corresponding author), NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Faryabi, Robert/AAN-5512-2020; Wright, George W/M-1660-2017; Faryabi, Robert B/H-3544-2015; Staudt, Louis/AAC-5324-2019; Fernandez-Capetillo, Oscar/H-3508-2015; Robbiani, Davide F./AAF-7662-2019	Faryabi, Robert/0000-0002-7931-2175; Faryabi, Robert B/0000-0002-7931-2175; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Robbiani, Davide F./0000-0001-7379-3484	NIH; National Cancer Institute; Center for Cancer Research; Department of Defense [BC102335]; NATIONAL CANCER INSTITUTE [P01CA096832, ZIABC010283, ZIABC010959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173, ZIAAR041148, ZICAR041181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Rolf Jessberger and Alessandra Pernis for SWAP70<SUP>-/-</SUP> mice, Mila Jankovic for pMX-c-Myc-IRES-GFP, Jean Gautier, Mirit Aladjem, and Toren Finkel for discussions and Lars Grontved for help with DHS mapping. This work was supported by the Intramural Research Program of the NIH, the National Cancer Institute, and the Center for Cancer Research, and by a Department of Defense grant to A.N. (BC102335). This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the NIH.	Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Borggrefe T, 2001, EUR J IMMUNOL, V31, P2467, DOI 10.1002/1521-4141(200108)31:8<2467::AID-IMMU2467>3.0.CO;2-P; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costa S, 2007, EMBO REP, V8, P332, DOI 10.1038/sj.embor.7400954; Daboussi F, 2008, J CELL SCI, V121, P162, DOI 10.1242/jcs.010330; Debatisse M, 2012, TRENDS GENET, V28, P22, DOI 10.1016/j.tig.2011.10.003; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Frappart PO, 2009, P NATL ACAD SCI USA, V106, P1880, DOI 10.1073/pnas.0806882106; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hashash N, 2011, J CELL SCI, V124, P181, DOI 10.1242/jcs.077313; Helmrich A, 2006, GENOME RES, V16, P1222, DOI 10.1101/gr.5335506; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Jiang YW, 2009, HUM MOL GENET, V18, P4501, DOI 10.1093/hmg/ddp410; Jones R, 2012, BRIT J GEN PRACT, V62, P3, DOI 10.3399/bjgp12X616193; Kato L, 2012, P NATL ACAD SCI USA, V109, P2479, DOI 10.1073/pnas.1120791109; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kobayashi S, 2011, GENE CHROMOSOME CANC, V50, P207, DOI 10.1002/gcc.20845; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Ozeri-Galai E, 2011, MOL CELL, V43, P122, DOI 10.1016/j.molcel.2011.05.019; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Raveendranathan M, 2006, EMBO J, V25, P3627, DOI 10.1038/sj.emboj.7601251; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Staszewski O, 2011, MOL CELL, V41, P232, DOI 10.1016/j.molcel.2011.01.007; Stephan AK, 2011, FEBS LETT, V585, P2907, DOI 10.1016/j.febslet.2011.04.067; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Yamane A., 2013, CELL REP; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; ZHANG J, 1988, IMMUNOL LETT, V18, P297, DOI 10.1016/0165-2478(88)90178-2; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	63	278	280	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					620	632		10.1016/j.cell.2013.01.006	http://dx.doi.org/10.1016/j.cell.2013.01.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23352430	Green Accepted, Bronze			2022-12-28	WOS:000314362800029
J	Bergin, EA; Cleeves, LI; Gorti, U; Zhang, K; Blake, GA; Green, JD; Andrews, SM; Evans, NJ; Henning, T; Oberg, K; Pontoppidan, K; Qi, CH; Salyk, C; van Dishoeck, EF				Bergin, Edwin A.; Cleeves, L. Ilsedore; Gorti, Uma; Zhang, Ke; Blake, Geoffrey A.; Green, Joel D.; Andrews, Sean M.; Evans, Neal J., II; Henning, Thomas; Oeberg, Karin; Pontoppidan, Klaus; Qi, Chunhua; Salyk, Colette; van Dishoeck, Ewine F.			An old disk still capable of forming a planetary system	NATURE			English	Article							TW HYA; GAS; EMISSION; SEARCH; PACS; LINE; HD	From the masses of the planets orbiting the Sun, and the abundance of elements relative to hydrogen, it is estimated that when the Solar System formed, the circumstellar disk must have had a minimum mass of around 0.01 solar masses within about 100 astronomical units of the star(1-4). (One astronomical unit is the EarthSun distance.) The main constituent of the disk, gaseous molecular hydrogen, does not efficiently emit radiation from the disk mass reservoir(5), and so the most common measure of the disk mass is dust thermal emission and lines of gaseous carbon monoxide(6). Carbon monoxide emission generally indicates properties of the disk surface, and the conversion from dust emission to gas mass requires knowledge of the grain properties and the gas-to-dust mass ratio, which probably differ from their interstellar values(7,8). As a result, mass estimates vary by orders of magnitude, as exemplified by the relatively old (3-10 million years) star TW Hydrae(9,10), for which the range is 0.0005-0.06 solar masses(11-14). Here we report the detection of the fundamental rotational transition of hydrogen deuteride from the direction of TW Hydrae. Hydrogen deuteride is a good tracer of disk gas because it follows the distribution of molecular hydrogen and its emission is sensitive to the total mass. The detection of hydrogen deuteride, combined with existing observations and detailed models, implies a disk mass of more than 0.05 solar masses, which is enough to form a planetary system like our own.	[Bergin, Edwin A.; Cleeves, L. Ilsedore] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Gorti, Uma] SETI Inst, Mountain View, CA 94043 USA; [Gorti, Uma] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Zhang, Ke] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; [Blake, Geoffrey A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Green, Joel D.; Evans, Neal J., II] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Andrews, Sean M.; Oeberg, Karin; Qi, Chunhua] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Henning, Thomas] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Pontoppidan, Klaus] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Salyk, Colette] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [van Dishoeck, Ewine F.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [van Dishoeck, Ewine F.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands	University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; California Institute of Technology; University of Texas System; University of Texas Austin; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Max Planck Society; Space Telescope Science Institute; National Optical Astronomy Observatory; Max Planck Society; Leiden University; Leiden University - Excl LUMC	Bergin, EA (corresponding author), Univ Michigan, Dept Astron, 500 Church St, Ann Arbor, MI 48109 USA.	ebergin@umich.edu	Zhang, Ke/A-3898-2009; Henning, Thomas K/O-4372-2018	Zhang, Ke/0000-0002-0661-7517; Henning, Thomas K/0000-0002-1493-300X; Evans, Neal/0000-0001-5175-1777; Andrews, Sean/0000-0003-2253-2270; Cleeves, L. Ilsedore/0000-0003-2076-8001	NASA through JPL/Caltech; US National Science Foundation [1008800]; Division Of Astronomical Sciences [1008800] Funding Source: National Science Foundation	NASA through JPL/Caltech; US National Science Foundation(National Science Foundation (NSF)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Herschel is an ESA space observatory with science instruments provided by European-led Principal Investigator consortia and with important participation from NASA. Support for this work was provided by NASA through an award issued by JPL/Caltech and by the US National Science Foundation under grant 1008800. This paper makes use of the following Atacama Large Millimeter/submillimeter Array (ALMA) data: ADS/JAO.ALMA#2011.0.00001.SV. ALMA is a partnership of ESO (representing its member states), the NSF (USA) and NINS (Japan), together with the NRC (Canada) and the NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ.	BECKWITH SVW, 1990, ASTRON J, V99, P924, DOI 10.1086/115385; Bertoldi F, 1999, ASTRON ASTROPHYS, V346, P267; Brinch C, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/201015333; Calvet N, 2002, ASTROPHYS J, V568, P1008, DOI 10.1086/339061; Carmona A, 2008, ASTRON ASTROPHYS, V477, P839, DOI 10.1051/0004-6361:20077846; Dartois E, 2003, ASTRON ASTROPHYS, V399, P773, DOI 10.1051/0004-6361:20021638; Draine BT, 2007, ASTROPHYS J, V663, P866, DOI 10.1086/518306; Gorti U, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/90; Greaves JS, 2010, MON NOT R ASTRON SOC, V407, P1981, DOI 10.1111/j.1365-2966.2010.17043.x; Hartmann L, 2008, PHYS SCRIPTA, VT130, DOI 10.1088/0031-8949/2008/T130/014012; HAYASHI C, 1981, SUP PROG THEOR PHYS, P35; Hoff W, 1998, ASTRON ASTROPHYS, V336, P242; Hogerheijde MR, 2011, SCIENCE, V334, P338, DOI 10.1126/science.1208931; Kuiper G. P., 1956, J ROY ASTRON SOC CAN, V50, P158; KUSAKA T, 1970, PROG THEOR PHYS, V44, P1580, DOI 10.1143/PTP.44.1580; Linsky JL, 1998, SPACE SCI REV, V84, P285, DOI 10.1023/A:1005048124341; Mordasini C, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201117350; Natta A., 2007, PROTOSTARS PLANETS, VV, P767; Navascues DBY, 2006, ASTRON ASTROPHYS, V459, P511, DOI 10.1051/0004-6361:20065717; Neufeld DA, 2006, ASTROPHYS J, V647, pL33, DOI 10.1086/507130; Pilbratt G., 2010, ASTRON ASTROPHYS, V518, P3; Poglitsch A, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014535; Tachihara K, 2009, PUBL ASTRON SOC JPN, V61, P585, DOI 10.1093/pasj/61.3.585; Thi WF, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014578; Vacca WD, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/8; WEINTRAUB DA, 1989, ASTROPHYS J, V344, P915, DOI 10.1086/167859; Williams JP, 2011, ANNU REV ASTRON ASTR, V49, P67, DOI 10.1146/annurev-astro-081710-102548; Wright CM, 1999, ASTROPHYS J, V515, pL29, DOI 10.1086/311960	30	234	234	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					644	646		10.1038/nature11805	http://dx.doi.org/10.1038/nature11805			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364742	Green Submitted			2022-12-28	WOS:000314219600050
J	King, M; Essick, C; Bearman, P; Ross, JS				King, Marissa; Essick, Connor; Bearman, Peter; Ross, Joseph S.			Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATTITUDES; EXPOSURE; ADOPTION; INDUSTRY	Objective To examine the effect of attending a medical school with an active policy on restricting gifts from representatives of pharmaceutical and device industries on subsequent prescribing behavior. Design Difference-in-differences approach. Setting 14 US medical schools with an active gift restriction policy in place by 2004. Participants Prescribing patterns in 2008 and 2009 of physicians attending one of the schools compared with physicians graduating from the same schools before the implementation of the policy, as well as a set of contemporary matched controls. Main outcome measure Probability that a physician would prescribe a newly marketed medication over existing alternatives of three psychotropic classes: lisdexamfetamine among stimulants, paliperidone among antipsychotics, and desvenlafaxine among antidepressants. None of these medications represented radical breakthroughs in their respective classes. Results For two of the three medications examined, attending a medical school with an active gift restriction policy was associated with reduced prescribing of the newly marketed drug. Physicians who attended a medical school with an active conflict of interest policy were less likely to prescribe lisdexamfetamine over older stimulants (adjusted odds ratio 0.44, 95% confidence interval 0.22 to 0.88; P=0.02) and paliperidone over older antipsychotics (0.25, 0.07 to 0.85; P=0.03). A significant effect was not observed for desvenlafaxine (1.54, 0.79 to 3.03; P=0.20). Among cohorts of students who had a longer exposure to the policy or were exposed to more stringent policies, prescribing rates were further reduced. Conclusion Exposure to a gift restriction policy during medical school was associated with reduced prescribing of two out of three newly introduced psychotropic medications.	[King, Marissa; Essick, Connor] Yale Univ, Sch Management, New Haven, CT USA; [Bearman, Peter] Columbia Univ, Interdisciplinary Ctr Innovat Theories & Empir, New York, NY 10027 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06510 USA	Yale University; Columbia University; Yale University	Bearman, P (corresponding author), Columbia Univ, Interdisciplinary Ctr Innovat Theories & Empir, New York, NY 10027 USA.	psb17@columbia.edu		bearman, peter/0000-0002-3745-3164; Ross, Joseph/0000-0002-9218-3320	National Institute of Mental Health; National Institute on Aging [K08 AG032886]; American Federation of Aging Research through the Paul B Beeson Career Development Award Program; NIH, part of the NIH Roadmap for Medical Research [1 DP1 OD003635-01]; Centers of Medicare and Medicaid Services; Medtronic; Pew Charitable Trusts; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003635] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation of Aging Research through the Paul B Beeson Career Development Award Program; NIH, part of the NIH Roadmap for Medical Research; Centers of Medicare and Medicaid Services; Medtronic(Medtronic); Pew Charitable Trusts; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MK and PB received support from the National Institute of Mental Health. JSR is currently supported by the National Institute on Aging (K08 AG032886) and by the American Federation of Aging Research through the Paul B Beeson Career Development Award Program. PB is currently supported by the NIH director's pioneer award program, part of the NIH Roadmap for Medical Research (grant No 1 DP1 OD003635-01). None of the funders had a role in study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the article for publication.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; JSR receives support from the Centers of Medicare and Medicaid Services to develop and maintain performance measures that are used for public reporting, receives grant support from Medtronic, receives grant support from the Pew Charitable Trusts (which developed and continues to support the AMSA PharmFree scorecard), and is a member of a scientific advisory board for FAIR Health, a not for profit organisation with the mission to achieve fairness and transparency in healthcare reimbursement.	Advanced Medical Technology Association, 2008, COD ETH INT HLTH CAR; American Medical Association, 2008, GIFTS PHYS IND; American Medical Association, 2012, AMA PHYS MAST; American Medical Student Association, EX SUMM 2012; Association of Amercian Medical Colleges, 2008, IND FUND MED ED; Austad KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001037; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Fugh-Berman AJ, 2010, J CONTIN EDUC HEALTH, V30, P197, DOI 10.1002/chp.20081; Grande D, 2009, ARCH INTERN MED, V169, P887, DOI 10.1001/archinternmed.2009.64; Greving JP, 2006, SOC SCI MED, V63, P2890, DOI 10.1016/j.socscimed.2006.07.019; IMS National Sales Perspectives, 2008, 2008 US SAL PRESCR I; Institute of Medicine as a Profession, 2012, AC MED CTR CONFL INT; Kao AC, 2011, ACAD MED, V86, P1454, DOI 10.1097/ACM.0b013e3182303895; Manchanda P, 2008, MARKET SCI, V27, P961, DOI 10.1287/mksc.1070.0354; McCormick BB, 2001, JAMA-J AM MED ASSOC, V286, P1994, DOI 10.1001/jama.286.16.1994; Pharmaceutical Research and Manufacturers of America, 2008, COD INT HEALTHC PROF; Sierles FS, 2005, JAMA-J AM MED ASSOC, V294, P1034, DOI 10.1001/jama.294.9.1034; Vermont Attorney General, 2010, PHARM MARK DISCL REP	18	61	61	2	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2013	346								f264	10.1136/bmj.f264	http://dx.doi.org/10.1136/bmj.f264			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BQ	23372175	Green Published, hybrid			2022-12-28	WOS:000314511500002
J	Moore, S; Evans, CD; Page, SE; Garnett, MH; Jones, TG; Freeman, C; Hooijer, A; Wiltshire, AJ; Limin, SH; Gauci, V				Moore, Sam; Evans, Chris D.; Page, Susan E.; Garnett, Mark H.; Jones, Tim G.; Freeman, Chris; Hooijer, Aljosja; Wiltshire, Andrew J.; Limin, Suwido H.; Gauci, Vincent			Deep instability of deforested tropical peatlands revealed by fluvial organic carbon fluxes	NATURE			English	Article							ENVIRONMENT SIMULATOR JULES; MODEL DESCRIPTION; FOREST; EXPORT; PEAT; KALIMANTAN; INDONESIA; ACCUMULATION; VEGETATION; EMISSIONS	Tropical peatlands contain one of the largest pools of terrestrial organic carbon, amounting to about 89,000 teragrams(1) (1 Tg is a billion kilograms). Approximately 65 per cent of this carbon store is in Indonesia, where extensive anthropogenic degradation in the form of deforestation, drainage and fire are converting it into a globally significant source of atmospheric carbon dioxide(1-3). Here we quantify the annual export of fluvial organic carbon from both intact peat swamp forest and peat swamp forest subject to past anthropogenic disturbance. We find that the total fluvial organic carbon flux from disturbed peat swamp forest is about 50 per cent larger than that from intact peat swamp forest. By carbon-14 dating of dissolved organic carbon (which makes up over 91 per cent of total organic carbon), we find that leaching of dissolved organic carbon from intact peat swamp forest is derived mainly from recent primary production (plant growth). In contrast, dissolved organic carbon from disturbed peat swamp forest consists mostly of much older (centuries to millennia) carbon from deep within the peat column. When we include the fluvial carbon loss term, which is often ignored, in the peatland carbon budget, we find that it increases the estimate of total carbon lost from the disturbed peatlands in our study by 22 per cent. We further estimate that since 1990 peatland disturbance has resulted in a 32 per cent increase in fluvial organic carbon flux from southeast Asia-an increase that is more than half of the entire annual fluvial organic carbon flux from all European peatlands. Our findings emphasize the need to quantify fluvial carbon losses in order to improve estimates of the impact of deforestation and drainage on tropical peatland carbon balances.	[Moore, Sam; Gauci, Vincent] Open Univ, Dept Environm Earth & Ecosyst, CEPSAR, Milton Keynes MK7 6AA, Bucks, England; [Evans, Chris D.] Environm Ctr Wales, Ctr Ecol & Hydrol, Bangor LL57 2UW, Gwynedd, Wales; [Page, Susan E.] Univ Leicester, Dept Geog, Leicester LE1 7RH, Leics, England; [Garnett, Mark H.] Nat Environm Res Council Radiocarbon Facil, E Kilbride G75 0QF, Lanark, Scotland; [Jones, Tim G.; Freeman, Chris] Bangor Univ, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales; [Hooijer, Aljosja] Deltares, NL-2600 MH Delft, Netherlands; [Wiltshire, Andrew J.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Limin, Suwido H.] Univ Palangka Raya, CIMTROP, Palangka Raya 73112, Central Kaliman, Indonesia	Open University - UK; UK Centre for Ecology & Hydrology (UKCEH); University of Leicester; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; Bangor University; Deltares; Met Office - UK; Hadley Centre; Universitas Palangka Raya (UPR)	Gauci, V (corresponding author), Open Univ, Dept Environm Earth & Ecosyst, CEPSAR, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	v.gauci@open.ac.uk	Wiltshire, Andy/C-2848-2008; Evans, Christopher D/F-2087-2010; Garnett, Mark H/C-2377-2009	Evans, Christopher D/0000-0002-7052-354X; Garnett, Mark H/0000-0001-6486-2126; Page, Susan/0000-0002-3392-9241; Gauci, Vincent/0000-0002-2452-7291	NERC [NE/F008813/1]; Natural Environment Research Council (NERC); Open University (CEPSAR) via the NERC Radiocarbon Facility (Environment) [1323.1008, 15.91]; DECC/Defra Met Office Hadley Centre Programme [GA01101]; Royal Society; British Council; NERC [NRCF010001, earth010003] Funding Source: UKRI; Natural Environment Research Council [earth010003, NRCF010001, ceh010023] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Open University (CEPSAR) via the NERC Radiocarbon Facility (Environment); DECC/Defra Met Office Hadley Centre Programme; Royal Society(Royal Society of London); British Council(The British Council in India); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	S.M. was supported by a NERC PhD studentship (NE/F008813/1). Radiocarbon analyses were supported by the Natural Environment Research Council (NERC) and the Open University (CEPSAR) via the NERC Radiocarbon Facility (Environment), Allocations 1323.1008 and 15.91. A.J.W. was supported by the Joint DECC/Defra Met Office Hadley Centre Programme (GA01101). A. Hoscilo provided land-cover change estimates. We thank I. Mohammed, K. Kusin and L. Graham for field assistance. The Malaysian work was supported by the Royal Society and British Council and we thank P. Kuppan, N. Willis and F. Md. Yussof for field support.	Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Benner R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019251; Best MJ, 2011, GEOSCI MODEL DEV, V4, P677, DOI 10.5194/gmd-4-677-2011; Billett MF, 2010, CLIM RES, V45, P13, DOI 10.3354/cr00903; Boehm H.-D. V., 2001, 22 AS C REM SENS EME, V1, P439; Bruijnzeel L. A, 1990, HYDROLOGY MOIST TROP; Caraco N, 2010, ECOLOGY, V91, P2385, DOI 10.1890/09-0330.1; Clark DB, 2011, GEOSCI MODEL DEV, V4, P701, DOI 10.5194/gmd-4-701-2011; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Evans CD, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029431; FAO/IIASA/ISRIC/ISS-CAS/JRC, 2009, HARM WORLD SOIL DAT; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; HEDIN LO, 1995, ECOLOGY, V76, P493, DOI 10.2307/1941208; Hirano T, 2007, GLOBAL CHANGE BIOL, V13, P412, DOI 10.1111/j.1365-2486.2006.01301.x; Hooijer A, 2010, BIOGEOSCIENCES, V7, P1505, DOI 10.5194/bg-7-1505-2010; HOPE D, 1994, ENVIRON POLLUT, V84, P301, DOI 10.1016/0269-7491(94)90142-2; Hoscilo A, 2011, INT J WILDLAND FIRE, V20, P578, DOI 10.1071/WF10029; Komatsu H, 2012, J HYDROL, V420, P380, DOI 10.1016/j.jhydrol.2011.12.030; Kume T, 2011, AGR FOREST METEOROL, V151, P1183, DOI 10.1016/j.agrformet.2011.04.005; Limpens J, 2008, BIOGEOSCIENCES, V5, P1475, DOI 10.5194/bg-5-1475-2008; Mayorga E, 2005, NATURE, V436, P538, DOI 10.1038/nature03880; MCDOWELL WH, 1988, ECOL MONOGR, V58, P177, DOI 10.2307/2937024; Michalzik B, 2001, BIOGEOCHEMISTRY, V52, P173, DOI 10.1023/A:1006441620810; Miettinen J, 2010, LAND DEGRAD DEV, V21, P285, DOI 10.1002/ldr.976; Montanarella L., 2006, MIRES PEAT, V1, P1; Moore S, 2011, BIOGEOSCIENCES, V8, P901, DOI 10.5194/bg-8-901-2011; MULHOLLAND PJ, 1979, LIMNOL OCEANOGR, V24, P960, DOI 10.4319/lo.1979.24.5.0960; Murdiyarso D, 2010, P NATL ACAD SCI USA, V107, P19655, DOI 10.1073/pnas.0911966107; Nilsson M, 2008, GLOBAL CHANGE BIOL, V14, P2317, DOI 10.1111/j.1365-2486.2008.01654.x; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Page SE, 2004, J QUATERNARY SCI, V19, P625, DOI 10.1002/jqs.884; Page SE, 1999, PHILOS T R SOC B, V354, P1885, DOI 10.1098/rstb.1999.0529; Page S, 2009, ECOSYSTEMS, V12, P888, DOI 10.1007/s10021-008-9216-2; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Palmer SM, 2001, BIOGEOCHEMISTRY, V52, P321, DOI 10.1023/A:1006447706565; Raymond PA, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002934; Schellekens J, 2000, WATER RESOUR RES, V36, P2183, DOI 10.1029/2000WR900074; Schiff SL, 1997, BIOGEOCHEMISTRY, V36, P43, DOI 10.1023/A:1005744131385; Takahashi H., 2003, P INT S LAND MAN BIO, P311; Vernimmen RRE, 2012, HYDROL EARTH SYST SC, V16, P133, DOI 10.5194/hess-16-133-2012; Wagner F., 2003, IPCC GOOD PRACTICE G; Weedon GP, 2011, J HYDROMETEOROL, V12, P823, DOI 10.1175/2011JHM1369.1	42	204	208	4	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					660	+		10.1038/nature11818	http://dx.doi.org/10.1038/nature11818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364745	Green Accepted			2022-12-28	WOS:000314219600054
J	Resik, S; Tejeda, A; Sutter, RW; Diaz, M; Sarmiento, L; Alemani, N; Garcia, G; Fonseca, M; Hung, LH; Kahn, AL; Burton, A; Landaverde, JM; Aylward, RB				Resik, Sonia; Tejeda, Alina; Sutter, Roland W.; Diaz, Manuel; Sarmiento, Luis; Alemani, Nilda; Garcia, Gloria; Fonseca, Magile; Hung, Lai Heng; Kahn, Anna-Lea; Burton, Anthony; Landaverde, J. Mauricio; Aylward, R. Bruce			Priming after a Fractional Dose of Inactivated Poliovirus Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNIZATION; POLIOMYELITIS; TRIAL	Background To reduce the costs of maintaining a poliovirus immunization base in low-income areas, we assessed the extent of priming immune responses after the administration of inactivated poliovirus vaccine (IPV). Methods We compared the immunogenicity and reactogenicity of a fractional dose of IPV (one fifth of a full dose) administered intradermally with a full dose administered intramuscularly in Cuban infants at the ages of 4 and 8 months. Blood was collected from infants at the ages of 4 months, 8 months, 8 months 7 days, and 8 months 30 days to assess single-dose seroconversion, single-dose priming of immune responses, and two-dose seroconversion. Specimens were tested with a neutralization assay. Results A total of 320 infants underwent randomization, and 310 infants (96.9%) fulfilled the study requirements. In the group receiving the first fractional dose of IPV, seroconversion to poliovirus types 1, 2, and 3 occurred in 16.6%, 47.1%, and 14.7% of participants, respectively, as compared with 46.6%, 62.8%, and 32.0% in the group receiving the first full dose of IPV (P< 0.008 for all comparisons). A priming immune response to poliovirus types 1, 2, and 3 occurred in 90.8%, 94.0%, and 89.6% of participants, respectively, in the group receiving the fractional dose as compared with 97.6%, 98.3%, and 98.1% in the group receiving the full dose (P = 0.01 for the comparison with type 3). After the administration of the second dose of IPV in the group receiving fractional doses, cumulative two-dose seroconversion to poliovirus types 1, 2, and 3 occurred in 93.6%, 98.1%, and 93.0% of participants, respectively, as compared with 100.0%, 100.0%, and 99.4% in the group receiving the full dose (P< 0.006 for the comparisons of types 1 and 3). The group receiving intradermal injections had the greatest number of adverse events, most of which were minor in intensity and none of which had serious consequences. Conclusions This evaluation shows that vaccinating infants with a single fractional dose of IPV can induce priming and seroconversion in more than 90% of immunized infants. (Funded by the World Health Organization and the Pan American Health Organization; Australian New Zealand Clinical Trials Registry number, ACTRN12610001046099.)	[Resik, Sonia; Diaz, Manuel; Sarmiento, Luis; Garcia, Gloria; Fonseca, Magile; Hung, Lai Heng] Pedro Kouri Inst, Havana, Cuba; [Tejeda, Alina; Alemani, Nilda] Prov Hlth Off, Camaguey, Cuba; [Sutter, Roland W.; Kahn, Anna-Lea; Burton, Anthony; Aylward, R. Bruce] WHO, Geneva, Switzerland; [Landaverde, J. Mauricio] Pan Amer Hlth Org, Washington, DC USA	World Health Organization; Pan American Health Organization	Sutter, RW (corresponding author), 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	sutterr@who.int	Quintana, Magile C Fonseca/J-9804-2019	Quintana, Magile C Fonseca/0000-0002-5419-5136; Sarmiento, Luis/0000-0002-3694-1211; Resik, Sonia/0000-0001-7318-7206; Kahn, Anna-Lea/0000-0001-8565-2814	World Health Organization (WHO); Pan American Health Organization (PAHO); Netherlands Vaccine Institute	World Health Organization (WHO)(World Health Organization); Pan American Health Organization (PAHO); Netherlands Vaccine Institute	Supported by the World Health Organization (WHO), the Pan American Health Organization (PAHO), and the Netherlands Vaccine Institute, which donated the study vaccines.	Alexander LN, 2004, JAMA-J AM MED ASSOC, V292, P1696, DOI 10.1001/jama.292.14.1696; [Anonymous], 2004, Wkly Epidemiol Rec, V79, P401; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P195; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P497; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1393; [Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P249; [Anonymous], 1991, REPORT OF A WHO INFO; [Anonymous], 2009, JICJ, V7, P1; Aylward RB, 2006, RISK ANAL, V26, P1441, DOI 10.1111/j.1539-6924.2006.00840.x; BOTTIGER M, 1987, SCAND J INFECT DIS, V19, P595, DOI 10.3109/00365548709117192; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P222; CIRNE MD, 1995, J INFECT DIS, V171, P1097, DOI 10.1093/infdis/171.5.1097; COHENABBO A, 1995, PEDIATR INFECT DIS J, V14, P100, DOI 10.1097/00006454-199502000-00004; Conover William Jay, 1998, PRACTICAL NONPARAMET, V350; Dove AW, 1997, SCIENCE, V277, P779, DOI 10.1126/science.277.5327.779; Efron B., 1994, MONOGRAPHS STAT APPL; Grard G, 2010, EURO SURVEILL, V15; Greenwood BM, 1997, J INFECT DIS, V175, pS215; Griffiths UK, 2006, VACCINE, V24, P5670, DOI 10.1016/j.vaccine.2006.05.032; Kapusinszky B, 2010, FEMS IMMUNOL MED MIC, V58, P211, DOI 10.1111/j.1574-695X.2009.00621.x; Kreeftenberg H, 2006, BIOLOGICALS, V34, P155, DOI 10.1016/j.biologicals.2006.02.011; Lago PM, 2003, INT J EPIDEMIOL, V32, P772, DOI 10.1093/ije/dyg185; Liao GY, 2012, J INFECT DIS, V205, P237, DOI 10.1093/infdis/jir723; Mohammed AJ, 2010, NEW ENGL J MED, V362, P2351, DOI 10.1056/NEJMoa0909383; Orenstein W, 2002, CLIN INFECT DIS, V34, P72, DOI 10.1086/338262; Polio Eradication Initiative, 2005, WHO POLIO 05 02; *R DEV COR TEAM, 2006, R LANG ENV COMP; Resik S, 2010, J INFECT DIS, V201, P1344, DOI 10.1086/651611; ROBERTSON SE, 1988, LANCET, V1, P897; Sangrujee N, 2004, B WORLD HEALTH ORGAN, V82, P9; SAS Institute Inc, 1989, SAS STAT USERS GUIDE; Simizu B, 2006, BIOLOGICALS, V34, P151, DOI 10.1016/j.biologicals.2006.02.010; Sutter RW, 2010, NEW ENGL J MED, V363, P1870; Sutter RW, 2000, NEW ENGL J MED, V343, P767, DOI 10.1056/NEJM200009143431103; Sutter RW, 2004, B WORLD HEALTH ORGAN, V82, P31; Sutter RW, 2012, VACCINES, P598; 2010, EURO SURVEILL, V15	37	105	109	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					416	424		10.1056/NEJMoa1202541	http://dx.doi.org/10.1056/NEJMoa1202541			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BE	23363495				2022-12-28	WOS:000314215400006
J	Weixlbaumer, A; Leon, K; Landick, R; Darst, SA				Weixlbaumer, Albert; Leon, Katherine; Landick, Robert; Darst, Seth A.			Structural Basis of Transcriptional Pausing in Bacteria	CELL			English	Article							RNA-POLYMERASE-II; ELONGATION COMPLEXES; CRYSTAL-STRUCTURE; TRIGGER LOOP; SITE; TERMINATION; INHIBITION; MECHANISM; RHO; HOLOENZYME	Transcriptional pausing by multisubunit RNA polymerases (RNAPs) is a key mechanism for regulating gene expression in both prokaryotes and eukaryotes and is a prerequisite for transcription termination. Pausing and termination states are thought to arise through a common, elemental pause state that is inhibitory for nucleotide addition. We report three crystal structures of Thermus RNAP elemental paused elongation complexes (ePECs). The structures reveal the same relaxed, open-clamp RNAP conformation in the ePEC that may arise by failure to re-establish DNA contacts during translocation. A kinked bridge-helix sterically blocks the RNAP active site, explaining how this conformation inhibits RNAP catalytic activity. Our results provide a framework for understanding how RNA hairpin formation stabilizes the paused state and how the ePEC intermediate facilitates termination.	[Weixlbaumer, Albert; Leon, Katherine; Darst, Seth A.] Rockefeller Univ, New York, NY 10065 USA; [Landick, Robert] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Landick, Robert] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	Rockefeller University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	darst@rockefeller.edu	Weixlbaumer, Albert/P-3587-2016; Weixlbaumer, Albert/AAI-8474-2021	Weixlbaumer, Albert/0000-0001-9635-3844; Weixlbaumer, Albert/0000-0001-9635-3844	Anderson Cancer Center Postdoctoral Fellowship (The Rockefeller University); Human Frontier Science Program Long-term Postdoctoral Fellowship; U.S. Department of Energy, Office of Basic Energy Sciences; NCRR at the National Institutes of Health (NIH) [RR-15301]; NIH [RO1 GM38660, RO1 GM097458]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097458, R01GM038660] Funding Source: NIH RePORTER	Anderson Cancer Center Postdoctoral Fellowship (The Rockefeller University); Human Frontier Science Program Long-term Postdoctoral Fellowship(Human Frontier Science Program); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NCRR at the National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Hein for help with transcription assays; S. Leiman for help with Taq RNAP pausing assays; T. Terwilliger for help with Phenix cross-crystal averaging; members of the Darst laboratory for helpful discussions; K.R. Rajashankar, S. Banerjee, F. Murphy, and K. Perry at APS NE-CAT beamline 24ID-E, W. Shi at NSLS beamline X29, and A. Heroux at NSLS beamline X25 for support with synchrotron data collection. A.W. was supported by an Anderson Cancer Center Postdoctoral Fellowship (The Rockefeller University) and a Human Frontier Science Program Long-term Postdoctoral Fellowship. This work was based, in part, on research conducted at the APS and the NSLS, supported by the U.S. Department of Energy, Office of Basic Energy Sciences. The NE-CAT beamlines at the APS are supported by award RR-15301 from the NCRR at the National Institutes of Health (NIH). This work was supported by NIH RO1 GM38660 to R.L. and NIH RO1 GM097458 to S.A.D.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chiba K, 2010, EXP CELL RES, V316, P2723, DOI 10.1016/j.yexcr.2010.05.036; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; FARNHAM PJ, 1981, NUCLEIC ACIDS RES, V9, P563, DOI 10.1093/nar/9.3.563; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Hunter CA, 1996, BIOESSAYS, V18, P157, DOI 10.1002/bies.950180212; Ingham CJ, 1999, MOL MICROBIOL, V31, P651, DOI 10.1046/j.1365-2958.1999.01205.x; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Landick R, 1996, METHOD ENZYMOL, V274, P334; LANDICK R, 1985, P NATL ACAD SCI USA, V82, P4663, DOI 10.1073/pnas.82.14.4663; Landick R, 2009, P NATL ACAD SCI USA, V106, P8797, DOI 10.1073/pnas.0904373106; Lane WJ, 2010, J MOL BIOL, V395, P686, DOI 10.1016/j.jmb.2009.10.063; LAU LF, 1983, J BIOL CHEM, V258, P9391; LEE DN, 1990, J BIOL CHEM, V265, P15145; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Pan T, 1999, P NATL ACAD SCI USA, V96, P9545, DOI 10.1073/pnas.96.17.9545; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; Roberts JW, 1998, COLD SPRING HARB SYM, V63, P319, DOI 10.1101/sqb.1998.63.319; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sevostyanova A, 2011, MOL CELL, V43, P253, DOI 10.1016/j.molcel.2011.05.026; Sevostyanova A, 2007, J MOL BIOL, V366, P420, DOI 10.1016/j.jmb.2006.11.050; Shaw NN, 2008, BIOCHIMIE, V90, P1026, DOI 10.1016/j.biochi.2008.04.011; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	55	111	111	0	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					431	441		10.1016/j.cell.2012.12.020	http://dx.doi.org/10.1016/j.cell.2012.12.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374340	Green Accepted, Bronze			2022-12-28	WOS:000314362800014
J	Coutsoudis, A; Goga, A; Desmond, C; Barron, P; Black, V; Coovadia, H				Coutsoudis, Anna; Goga, Ameena; Desmond, Chris; Barron, Peter; Black, Vivian; Coovadia, Hoosen			Is Option B plus the best choice?	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY; PREGNANCY; OUTCOMES		[Coutsoudis, Anna] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Kwa Zulu, South Africa; [Goga, Ameena] MRC, Pretoria, South Africa; [Desmond, Chris] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Barron, Peter] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Black, Vivian] Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Coovadia, Hoosen] Univ Witwatersrand, ZA-4091 Durban, South Africa	University of Kwazulu Natal; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Coovadia, H (corresponding author), Univ Witwatersrand, ZA-4091 Durban, South Africa.	hcoovadia@match.org.za						AIDS 2012, 2012, AIDS 2012; Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Hargrove JW, 2010, AIDS, V24, pF11, DOI 10.1097/QAD.0b013e328335749d; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Siberry GK, 2012, AIDS, V26, P1151, DOI 10.1097/QAD.0b013e328352d135; Struik GM, 2011, INT J STD AIDS, V22, P457, DOI 10.1258/ijsa.2011.010521; Unge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013613; UNICEF, 2012, BUS CAS OPT B B EL M; Wagner BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041212; World Health Organization HIV/AIDS Programme, 2012, US ANT DRUGS TREAT P	14	63	62	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2013	381	9863					269	271		10.1016/S0140-6736(12)61807-8	http://dx.doi.org/10.1016/S0140-6736(12)61807-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23351797				2022-12-28	WOS:000314021800007
J	Hermsen, W; Hessels, JWT; Kuiper, L; van Leeuwen, J; Mitra, D; de Plaa, J; Rankin, JM; Stappers, BW; Wright, GAE; Basu, R; Alexov, A; Coenen, T; Griessmeier, JM; Hassall, TE; Karastergiou, A; Keane, E; Kondratiev, VI; Kramer, M; Kuniyoshi, M; Noutsos, A; Serylak, M; Pilia, M; Sobey, C; Weltevrede, P; Zagkouris, K; Asgekar, A; Avruch, IM; Batejat, F; Bell, ME; Bell, MR; Bentum, MJ; Bernardi, G; Best, P; Birzan, L; Bonafede, A; Breitling, F; Broderick, J; Brueggen, M; Butcher, HR; Ciardi, B; Duscha, S; Eisloffel, J; Falcke, H; Fender, R; Ferrari, C; Frieswijk, W; Garrett, MA; de Gasperin, F; de Geus, E; Gunst, AW; Heald, G; Hoeft, M; Horneffer, A; Iacobelli, M; Kuper, G; Maat, P; Macario, G; Markoff, S; McKean, JP; Mevius, M; Miller-Jones, JCA; Morganti, R; Munk, H; Orru, E; Paas, H; Pandey-Pommier, M; Pandey, VN; Pizzo, R; Polatidis, AG; Rawlings, S; Reich, W; Rottgering, H; Scaife, AMM; Schoenmakers, A; Shulevski, A; Sluman, J; Steinmetz, M; Tagger, M; Tang, Y; Tasse, C; ter Veen, S; Vermeulen, R; van de Brink, RH; van Weeren, RJ; Wijers, RAMJ; Wise, MW; Wucknitz, O; Yatawatta, S; Zarka, P				Hermsen, W.; Hessels, J. W. T.; Kuiper, L.; van Leeuwen, J.; Mitra, D.; de Plaa, J.; Rankin, J. M.; Stappers, B. W.; Wright, G. A. E.; Basu, R.; Alexov, A.; Coenen, T.; Griessmeier, J. -M.; Hassall, T. E.; Karastergiou, A.; Keane, E.; Kondratiev, V. I.; Kramer, M.; Kuniyoshi, M.; Noutsos, A.; Serylak, M.; Pilia, M.; Sobey, C.; Weltevrede, P.; Zagkouris, K.; Asgekar, A.; Avruch, I. M.; Batejat, F.; Bell, M. E.; Bell, M. R.; Bentum, M. J.; Bernardi, G.; Best, P.; Birzan, L.; Bonafede, A.; Breitling, F.; Broderick, J.; Brueggen, M.; Butcher, H. R.; Ciardi, B.; Duscha, S.; Eisloeffel, J.; Falcke, H.; Fender, R.; Ferrari, C.; Frieswijk, W.; Garrett, M. A.; de Gasperin, F.; de Geus, E.; Gunst, A. W.; Heald, G.; Hoeft, M.; Horneffer, A.; Iacobelli, M.; Kuper, G.; Maat, P.; Macario, G.; Markoff, S.; McKean, J. P.; Mevius, M.; Miller-Jones, J. C. A.; Morganti, R.; Munk, H.; Orru, E.; Paas, H.; Pandey-Pommier, M.; Pandey, V. N.; Pizzo, R.; Polatidis, A. G.; Rawlings, S.; Reich, W.; Roettgering, H.; Scaife, A. M. M.; Schoenmakers, A.; Shulevski, A.; Sluman, J.; Steinmetz, M.; Tagger, M.; Tang, Y.; Tasse, C.; ter Veen, S.; Vermeulen, R.; van de Brink, R. H.; van Weeren, R. J.; Wijers, R. A. M. J.; Wise, M. W.; Wucknitz, O.; Yatawatta, S.; Zarka, P.			Synchronous X-ray and Radio Mode Switches: A Rapid Global Transformation of the Pulsar Magnetosphere	SCIENCE			English	Article							XMM-NEWTON OBSERVATIONS; PHOTON IMAGING CAMERA; DRIFTING SUBPULSES; EMPIRICAL-THEORY; POWERED PULSARS; GAMMA-RAY; EMISSION; B0943+10; RADIATION; POLARIZATION	Pulsars emit from low-frequency radio waves up to high-energy gamma-rays, generated anywhere from the stellar surface out to the edge of the magnetosphere. Detecting correlated mode changes across the electromagnetic spectrum is therefore key to understanding the physical relationship among the emission sites. Through simultaneous observations, we detected synchronous switching in the radio and x-ray emission properties of PSR B0943+10. When the pulsar is in a sustained radio-"bright" mode, the x-rays show only an unpulsed, nonthermal component. Conversely, when the pulsar is in a radio-"quiet" mode, the x-ray luminosity more than doubles and a 100% pulsed thermal component is observed along with the nonthermal component. This indicates rapid, global changes to the conditions in the magnetosphere, which challenge all proposed pulsar emission theories.	[Hermsen, W.; Kuiper, L.; de Plaa, J.; Avruch, I. M.] SRON Netherlands Inst Space Res, SRON, NL-3584 CA Utrecht, Netherlands; [Hermsen, W.; Hessels, J. W. T.; van Leeuwen, J.; Rankin, J. M.; Coenen, T.; Markoff, S.; Miller-Jones, J. C. A.; Wijers, R. A. M. J.; Wise, M. W.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1090 GE Amsterdam, Netherlands; [Hessels, J. W. T.; van Leeuwen, J.; Kondratiev, V. I.; Pilia, M.; Asgekar, A.; Avruch, I. M.; Bentum, M. J.; Butcher, H. R.; Duscha, S.; Falcke, H.; Frieswijk, W.; Garrett, M. A.; de Geus, E.; Gunst, A. W.; Heald, G.; Kuper, G.; Maat, P.; McKean, J. P.; Mevius, M.; Morganti, R.; Munk, H.; Orru, E.; Pizzo, R.; Polatidis, A. G.; Schoenmakers, A.; Sluman, J.; Tang, Y.; Vermeulen, R.; van de Brink, R. H.; van Weeren, R. J.; Wise, M. W.; Yatawatta, S.] Netherlands Inst Radio Astron, ASTRON, NL-7990 AA Dwingeloo, Netherlands; [Mitra, D.; Basu, R.] Natl Ctr Radio Astrophys NCFRA TIFR, Pune 411007, Maharashtra, India; [Rankin, J. M.] Univ Vermont, Dept Phys, Burlington, VT 05405 USA; [Stappers, B. W.; Hassall, T. E.; Kramer, M.; Weltevrede, P.] Univ Manchester, Sch Phys & Astron, Jodrell Bank, Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Wright, G. A. E.] Univ Sussex, Ctr Astron, Brighton BN1 9QJ, E Sussex, England; [Alexov, A.] Space Telescope Sci Inst STScI, Baltimore, MD 21218 USA; [Griessmeier, J. -M.; Serylak, M.; Tagger, M.] Univ Orleans, CNRS, LPC2E, F-45071 Orleans 02, France; [Griessmeier, J. -M.; Serylak, M.] CNRS, INSU, Observ Paris, Stn Radioastron Nancay, F-18330 Nancay, France; [Hassall, T. E.; Bell, M. E.; Broderick, J.; Fender, R.; Scaife, A. M. M.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Karastergiou, A.; Zagkouris, K.; Rawlings, S.] Univ Oxford, Oxford OX1 3RH, England; [Keane, E.; Kramer, M.; Kuniyoshi, M.; Noutsos, A.; Sobey, C.; Falcke, H.; Horneffer, A.; Reich, W.; Wucknitz, O.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Kondratiev, V. I.] Ctr Astro Space, Lebedev Phys Inst, Moscow 117997, Russia; [Avruch, I. M.; Mevius, M.; Morganti, R.; Shulevski, A.] Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands; [Batejat, F.] Chalmers, Onsala Space Observ, Dept Earth & Space Sci, SE-43992 Onsala, Sweden; [Bell, M. E.] Univ Sydney, ARC Ctr Excellence All Sky Astrophys CAASTRO, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Bell, M. R.; Ciardi, B.] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Bentum, M. J.] Univ Twente, NL-7500 AE Enschede, Netherlands; [Bernardi, G.; van Weeren, R. J.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Best, P.] Univ Edinburgh, Royal Observ Edinburgh, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland; [Birzan, L.; Garrett, M. A.; Iacobelli, M.; Pandey-Pommier, M.; Roettgering, H.; van Weeren, R. J.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Bonafede, A.; Brueggen, M.; de Gasperin, F.] Univ Hamburg, Hamburger Sternwarte, D-21029 Hamburg, Germany; [Breitling, F.; Steinmetz, M.] Leibniz Inst Astrophys Potsdam AIP, D-14482 Potsdam, Germany; [Butcher, H. R.] Australian Natl Univ, Mt Stromlo Observ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; [Eisloeffel, J.; Hoeft, M.] Thuringer Landessternwarte, D-07778 Tautenburg, Germany; [Falcke, H.; Orru, E.; ter Veen, S.] Radboud Univ Nijmegen, IMAPP, Dept Astrophys, NL-6500 GL Nijmegen, Netherlands; [Ferrari, C.; Macario, G.] Univ Nice Sophia Antipolis, CNRS, Observ Cote dAzur, Lab Lagrange,UMR7293, F-06300 Nice, France; [Miller-Jones, J. C. A.] Curtin Univ Technol, Int Ctr Radio Astron Res, Perth, WA 6845, Australia; [Paas, H.] Univ Groningen, CIT, NL-9747 AJ Groningen, Netherlands; [Pandey-Pommier, M.] Observ Lyon, Ctr Rech Astrophys Lyon, F-69561 St Genis Laval, France; [Pandey, V. N.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Tasse, C.; Zarka, P.] UPMC Univ Paris Diderot, CNRS, LESIA Observ Paris, F-92190 Meudon, France; [Tasse, C.] Rhodes Univ, Dept Phys & Elect, ZA-6140 Grahamstown, South Africa; [Tasse, C.] SKA S Africa, ZA-7405 Pinelands, South Africa; [Wucknitz, O.] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany	University of Amsterdam; Tata Institute of Fundamental Research (TIFR); National Centre for Radio Astrophysics (NCRA), Pune; University of Vermont; University of Manchester; Jodrell Bank Centre for Astrophysics; University of Sussex; Space Telescope Science Institute; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; University of Southampton; University of Oxford; Max Planck Society; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; University of Groningen; Chalmers University of Technology; University of Sydney; Max Planck Society; University of Twente; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Edinburgh; Leiden University; Leiden University - Excl LUMC; University of Hamburg; Leibniz Institut fur Astrophysik Potsdam (AIP); Australian National University; Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Curtin University; University of Groningen; National Radio Astronomy Observatory (NRAO); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Rhodes University; SKA South Africa; University of Bonn	Hermsen, W (corresponding author), SRON Netherlands Inst Space Res, SRON, Sorbonnelaan 2, NL-3584 CA Utrecht, Netherlands.	w.hermsen@sron.nl	Falcke, Heino D. E./H-5262-2012; Steinmetz, Matthias/Q-7785-2019; Miller-Jones, James C. A./B-2411-2013; de Gasperin, Francesco/AFU-7350-2022; Melrose, Don/O-8766-2014; van Leeuwen, John A/G-3155-2011; Broderick, Jess/AAD-2450-2019; Shulevski, Aleksandar/E-5591-2015; Kondratiev, Vladislav I./N-1105-2015; Tagger, Michel/O-6615-2014; Hessels, Jason/GTO-3261-2022; Yatawatta, Sarod/E-6037-2013; Yatawatta, Sarod/N-1417-2019; Ciardi, Benedetta/N-7625-2015; Sobey, Charlotte/AAN-6948-2020	Falcke, Heino D. E./0000-0002-2526-6724; Steinmetz, Matthias/0000-0001-6516-7459; Miller-Jones, James C. A./0000-0003-3124-2814; de Gasperin, Francesco/0000-0003-4439-2627; van Leeuwen, John A/0000-0003-1175-5161; Broderick, Jess/0000-0002-2239-6099; Shulevski, Aleksandar/0000-0002-1827-0469; Kondratiev, Vladislav I./0000-0001-8864-7471; Tagger, Michel/0000-0003-2962-3220; Hessels, Jason/0000-0003-2317-1446; Yatawatta, Sarod/0000-0001-5619-4017; Yatawatta, Sarod/0000-0001-5619-4017; Sobey, Charlotte/0000-0002-8950-7873; Bernardi, Gianni/0000-0002-0916-7443; Pilia, Maura/0000-0001-7397-8091; Bonafede, Annalisa/0000-0002-5068-4581; Mevius, Maaijke/0000-0002-3086-8455; Basu, Rahul/0000-0003-1824-4487; Kuiper, Lucien/0000-0002-7889-6586; Heald, George/0000-0002-2155-6054; de Plaa, Jelle/0000-0002-2697-7106; Wise, Michael/0000-0002-6470-2285; Karastergiou, Aris/0000-0002-1434-9786; Wijers, Ralph/0000-0002-3101-1808; Hassall, Timothy/0000-0002-7883-3710; van Weeren, Reinout/0000-0002-0587-1660; Ferrari, Chiara/0000-0002-2917-9759; Bell, Martin/0000-0003-1767-5277; Keane, Evan/0000-0002-4553-655X; MACARIO, GIULIA/0000-0003-3985-5105; Kramer, Michael/0000-0002-4175-2271; Noutsos, Aristeidis/0000-0002-4151-3860; van Leeuwen, Joeri/0000-0001-8503-6958	ESA member states; NASA; Netherlands Organization for Scientific Research (NWO); Agence Nationale de la Recherche [ANR-09-JCJC-0001-01]; STFC [ST/G002487/1, ST/J001422/1, ST/J001562/1, ST/M001423/1, ST/J001600/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001422/1, ST/J001562/1, ST/M001423/1, ST/J001600/1, ST/G002487/1] Funding Source: researchfish; Division Of Astronomical Sciences [0807669] Funding Source: National Science Foundation	ESA member states(European Space Agency); NASA(National Aeronautics & Space Administration (NASA)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Agence Nationale de la Recherche(French National Research Agency (ANR)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the staff of XMM-Newton, GMRT, and LOFAR for making these observations possible. XMM-Newton is an ESA science mission with instruments and contributions directly funded by ESA member states and by NASA. GMRT is run by the National Centre for Radio Astrophysics of the Tata Institute of Fundamental Research. LOFAR, the Low Frequency Array designed and constructed by ASTRON, has facilities in several countries that are owned by various parties (each with their own funding sources) and are collectively operated by the International LOFAR Telescope (ILT) foundation under a joint scientific policy. ASTRON and SRON are supported financially by the Netherlands Organization for Scientific Research (NWO). Two of us (J.M.R., G. A. E. W.) thank NWO and ASTRON for visitor grants. C. F. was supported by Agence Nationale de la Recherche grant ANR-09-JCJC-0001-01. The used x-ray data can be retrieved from the XMM-Newton Science Archive at xmm.esac.esa.int/xsa. The applied B-and Q-mode window selections, derived from the GMRT and LOFAR observations, are listed in table S2.	Abdo AA, 2010, ASTROPHYS J SUPPL S, V187, P460, DOI 10.1088/0067-0049/187/2/460; ARONS J, 1979, ASTROPHYS J, V231, P854, DOI 10.1086/157250; BACKER DC, 1970, NATURE, V228, P42, DOI 10.1038/228042a0; Backus I, 2010, MON NOT R ASTRON SOC, V404, P30, DOI 10.1111/j.1365-2966.2009.16102.x; Becker W, 2004, ASTROPHYS J, V615, P908, DOI 10.1086/424498; Breton RP, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/89; Camilo F, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/63; Deshpande AA, 2001, MON NOT R ASTRON SOC, V322, P438, DOI 10.1046/j.1365-8711.2001.04079.x; Gil J, 2008, ASTROPHYS J, V686, P497, DOI 10.1086/590657; Gil JA, 2000, ASTROPHYS J, V541, P351, DOI 10.1086/309394; Gil J, 2006, ASTROPHYS J, V650, P1048, DOI 10.1086/506982; Goodwin SP, 2004, MON NOT R ASTRON SOC, V349, P213, DOI 10.1111/j.1365-2966.2004.07481.x; Harding AK, 2002, ASTROPHYS J, V568, P862, DOI 10.1086/338985; HESSE KH, 1974, ASTRON ASTROPHYS, V31, P409; Hobbs G, 2004, MON NOT R ASTRON SOC, V353, P1311, DOI 10.1111/j.1365-2966.2004.08157.x; Kramer M, 2006, SCIENCE, V312, P549, DOI 10.1126/science.1124060; Lorimer DR, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/141; Lyne A, 2010, SCIENCE, V329, P408, DOI 10.1126/science.1186683; Lyutikov M, 2005, ASTROPHYS J, V634, P1223, DOI 10.1086/432252; Rankin JM, 2006, ASTRON ASTROPHYS, V453, P679, DOI 10.1051/0004-6361:20054140; RANKIN JM, 1986, ASTROPHYS J, V301, P901, DOI 10.1086/163955; RANKIN JM, 1993, ASTROPHYS J, V405, P285, DOI 10.1086/172361; RUDERMAN MA, 1975, ASTROPHYS J, V196, P51, DOI 10.1086/153393; Shearer A, 2003, SCIENCE, V301, P493, DOI 10.1126/science.1084919; Struder L, 2001, ASTRON ASTROPHYS, V365, pL18, DOI 10.1051/0004-6361:20000066; Suleimanova S. A., 1984, Soviet Astronomy, V28, P32; Timokhin AN, 2010, MON NOT R ASTRON SOC, V408, pL41, DOI 10.1111/j.1745-3933.2010.00924.x; Timokhin AN, 2006, MON NOT R ASTRON SOC, V368, P1055, DOI 10.1111/j.1365-2966.2006.10192.x; Turner MJL, 2001, ASTRON ASTROPHYS, V365, pL27, DOI 10.1051/0004-6361:20000087; Zhang B, 2000, ASTROPHYS J, V532, P1150, DOI 10.1086/308598; Zhang B, 2005, ASTROPHYS J, V624, pL109, DOI 10.1086/430522; Zhang B, 1997, ASTROPHYS J, V478, P313, DOI 10.1086/303787; Zhu WW, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/44	33	102	102	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					436	439		10.1126/science.1230960	http://dx.doi.org/10.1126/science.1230960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349288	Green Submitted			2022-12-28	WOS:000313960700040
J	Jacobson, MZ				Jacobson, Mark Z.			Comment on "Radiative Absorption Enhancements Due to the Mixing State of Atmospheric Black Carbon"	SCIENCE			English	Editorial Material							OPTICAL-PROPERTIES; AEROSOLS	Cappa et al. (Reports, 31 August 2012, p. 1078) suggest that black carbon (BC) in a mixture absorbs only similar to 6% more sunlight than when volatile chemicals are evaporated from the mixture, and state that "many climate models may overestimate warming by BC." However, the authors misinterpret at least some model results and omit optical focusing at high relative humidity and of involatile components. Thus, their conclusion about model error is not demonstrated.	Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA	Stanford University	Jacobson, MZ (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	jacobson@stanford.edu		Jacobson, Mark/0000-0002-4315-4128				Brem BT, 2012, AEROSOL SCI TECH, V46, P178, DOI 10.1080/02786826.2011.617794; Cappa CD, 2012, SCIENCE, V337, P1078, DOI 10.1126/science.1223447; Flores JM, 2012, ATMOS CHEM PHYS, V12, P5511, DOI 10.5194/acp-12-5511-2012; Jacobson MZ, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017218; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Mikhailov EF, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006389	6	20	20	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118								10.1126/science.1229920	http://dx.doi.org/10.1126/science.1229920			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349272				2022-12-28	WOS:000313960700019
J	Hersch, J; Jansen, J; Barratt, A; Irwig, L; Houssami, N; Howard, K; Dhillon, H; McCaffery, K				Hersch, Jolyn; Jansen, Jesse; Barratt, Alexandra; Irwig, Les; Houssami, Nehmat; Howard, Kirsten; Dhillon, Haryana; McCaffery, Kirsten			Women's views on overdiagnosis in breast cancer screening: a qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA IN-SITU; RANDOMIZED-TRIAL; INFORMED CHOICE; DECISION AIDS; MAMMOGRAPHY; INFORMATION; INVITATIONS; DIAGNOSIS; PROGRAMS	Objective To elicit women's responses to information about the nature and extent of overdiagnosis in mammography screening (detecting disease that would not present clinically during the woman's lifetime) and explore how awareness of overdiagnosis might influence attitudes and intentions about screening. Design Qualitative study using focus groups that included a presentation explaining overdiagnosis, incorporating different published estimates of its rate (1-10%, 30%, 50%) and information on the mortality benefit of screening, with guided group discussions Setting Sydney, Australia Participants Fifty women aged 40-79 years with no personal history of breast cancer and with varying levels of education and participation in screening. Results Prior awareness of breast cancer overdiagnosis was minimal. Women generally reacted with surprise, but most came to understand the issue. Responses to overdiagnosis and the different estimates of its magnitude were diverse. The highest estimate (50%) made some women perceive a need for more careful personal decision making about screening. In contrast, the lower and intermediate estimates (1-10% and 30%) had limited impact on attitudes and intentions, with many women remaining committed to screening. For some women, the information raised concerns, not about whether to screen but whether to treat a screen detected cancer or consider alternative approaches (such as watchful waiting). Information preferences varied: many women considered it important to take overdiagnosis into account and make informed choices about whether to have screening, but many wanted to be encouraged to be screened. Conclusions Women from a range of socioeconomic backgrounds could comprehend the issue of overdiagnosis in mammography screening, and they generally valued information about it. Effects on screening intentions may depend heavily on the rate of overdiagnosis. Overdiagnosis will be new and counterintuitive for many people and may influence screening and treatment decisions in unintended ways, underscoring the need for careful communication.	[Hersch, Jolyn; Jansen, Jesse; Irwig, Les; Houssami, Nehmat; Howard, Kirsten; McCaffery, Kirsten] Univ Sydney, Sch Publ Hlth, STEP, Sydney, NSW 2006, Australia; [Hersch, Jolyn; Jansen, Jesse; Barratt, Alexandra; Dhillon, Haryana; McCaffery, Kirsten] Univ Sydney, Ctr Med Psychol & Evidence Based Decis Making CeM, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	McCaffery, K (corresponding author), Univ Sydney, Sch Publ Hlth, STEP, Level 1,Edward Ford Bldg,A27, Sydney, NSW 2006, Australia.	kirsten.mccaffery@sydney.edu.au	Dhillon, Haryana M/G-8503-2011; Hersch, Jolyn/H-7153-2013; Barratt, Alexandra/A-7349-2011; Houssami, Nehmat/ABC-1103-2020; McCaffery, Kirsten/K-7945-2019	Dhillon, Haryana M/0000-0003-4039-5169; Hersch, Jolyn/0000-0001-5225-6639; Barratt, Alexandra/0000-0002-2561-3319; Houssami, Nehmat/0000-0002-3641-952X; McCaffery, Kirsten/0000-0003-2696-5006; Howard, Kirsten/0000-0002-0918-7540	Informed Medical Decisions Foundation [0189-1]; National Health and Medical Research Council of Australia [633003]	Informed Medical Decisions Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a fellowship grant (No 0189-1) awarded to JH from the Informed Medical Decisions Foundation and a grant (No 633003) awarded to the Screening and Test Evaluation Program from the National Health and Medical Research Council of Australia. The funders had no role in the design or conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation or approval of the manuscript.	Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006776.pub2; Anderson R. C., 1984, HDB READING RES, P255, DOI DOI 10.1017/CBO9781139524513.007; Australian Institute of Health and Welfare, 2011, AUSTR I HLTH WELF CA; Barratt A, 2005, BMJ-BRIT MED J, V330, P936, DOI 10.1136/bmj.38398.469479.8F; Barratt A, 2004, BMJ-BRIT MED J, V329, P507, DOI 10.1136/bmj.329.7464.507; Bekker HL, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5407; Bell RJ, 2012, MED J AUSTRALIA, V196, P17, DOI 10.5694/mja11.11476; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Collins K, 2010, BRIT J CANCER, V102, P1461, DOI 10.1038/sj.bjc.6605662; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; Degner L F, 1997, Can J Nurs Res, V29, P21; Donella P, 2009, EUR J CANCER, V45, P3166, DOI 10.1016/j.ejca.2009.06.014; Duffy SW, 2006, WOMENS HEALTH, V2, P829, DOI 10.2217/17455057.2.6.829; Elmore JG, 2012, ANN INTERN MED, V156, P536, DOI 10.7326/0003-4819-156-7-201204030-00012; Entwistle VA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1591; Griffiths F, 2010, HEALTH-LONDON, V14, P653, DOI 10.1177/1363459310361599; Gummersbach E, 2010, EUR J PUBLIC HEALTH, V20, P409, DOI 10.1093/eurpub/ckp174; Heath I, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2529; Hersch J, 2011, PREV MED, V53, P144, DOI 10.1016/j.ypmed.2011.06.013; Jorgensen KJ, 2010, J ROY SOC MED, V103, P14, DOI 10.1258/jrsm.2009.090342; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Jorgensen KJ, 2006, BMJ-BRIT MED J, V332, P538, DOI 10.1136/bmj.332.7540.538; Junod B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-401; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Kuper A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1035; Lewis, 2006, QUALITATIVE RES PRAC; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Mathieu E, 2007, ARCH INTERN MED, V167, P2039, DOI 10.1001/archinte.167.19.2039; Mathieu E, 2010, PATIENT EDUC COUNS, V81, P63, DOI 10.1016/j.pec.2010.01.001; McPherson K, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d791; McPherson K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3106; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; NHS Breast Screening Programme, 2011, ANN REV 2011; Paul C, 2008, HEALTH POLICY, V85, P314, DOI 10.1016/j.healthpol.2007.08.007; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Prinjha S, 2006, J MED SCREEN, V13, P110, DOI 10.1258/096914106778440581; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Saalasti-Koskinen U, 2009, ACAD RADIOL, V16, P546, DOI 10.1016/j.acra.2009.02.002; Schonberg Mara A, 2007, BMC Geriatr, V7, P26, DOI 10.1186/1471-2318-7-26; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Thornton H, 2001, Med Sci Monit, V7, P531; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Welch HG, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b1425; Wilkinson S, 1998, WOMEN STUD INT FORUM, V21, P111, DOI 10.1016/S0277-5395(97)00080-0; Willis K, 2003, AUST NZ J PUBL HEAL, V27, P282, DOI 10.1111/j.1467-842X.2003.tb00395.x; Wu DF, 2011, ONCOL REV, V5, P143, DOI 10.1007/s12156-011-0077-0; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63; Zapka JG, 2006, PATIENT EDUC COUNS, V63, P126, DOI 10.1016/j.pec.2005.09.012	52	120	122	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2013	346								f158	10.1136/bmj.f158	http://dx.doi.org/10.1136/bmj.f158			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BX	23344309	Green Published, hybrid			2022-12-28	WOS:000314217300003
J	Vega, J				Vega, Jeanette			Universal health coverage: the post-2015 development agenda	LANCET			English	Editorial Material									Rockefeller Fdn, New York, NY 10018 USA		Vega, J (corresponding author), Rockefeller Fdn, New York, NY 10018 USA.	JVega@rockfound.org						[Anonymous], 2012, UN SYST TASK TEAM PO; Boerma T, 2012, ROCK FDN CTR BELL SE; Chopra M, 2012, LANCET, V380, P1331, DOI 10.1016/S0140-6736(12)61423-8; Schweitzer J, 2012, RESULTS DEV I OVERSE; Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8; WHO, 2010, WORLD MALARIA REPORT 2010, P1	6	82	84	2	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 19	2013	381	9862					179	180		10.1016/S0140-6736(13)60062-8	http://dx.doi.org/10.1016/S0140-6736(13)60062-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075LL	23332947				2022-12-28	WOS:000313887600005
J	Clark, VE; Erson-Omay, EZ; Serin, A; Yin, J; Cotney, J; Ozduman, K; Avsar, T; Li, J; Murray, PB; Henegariu, O; Yilmaz, S; Gunel, JM; Carrion-Grant, G; Yilmaz, B; Grady, C; Tanrikulu, B; Bakircioglu, M; Kaymakcalan, H; Caglayan, AO; Sencar, L; Ceyhun, E; Atik, AF; Bayri, Y; Bai, HW; Kolb, LE; Hebert, RM; Omay, SB; Mishra-Gorur, K; Choi, M; Overton, JD; Holland, EC; Mane, S; State, MW; Bilguevar, K; Baehring, JM; Gutin, PH; Piepmeier, JM; Vortmeyer, A; Brennan, CW; Pamir, MN; Kilic, T; Lifton, RP; Noonan, JP; Yasuno, K; Gunel, M				Clark, Victoria E.; Erson-Omay, E. Zeynep; Serin, Akdes; Yin, Jun; Cotney, Justin; Oezduman, Koray; Avsar, Timuin; Li, Jie; Murray, Phillip B.; Henegariu, Octavian; Yilmaz, Saliha; Guenel, Jennifer Moliterno; Carrion-Grant, Geneive; Yilmaz, Baran; Grady, Conor; Tanrikulu, Bahattin; Bakircioglu, Mehmet; Kaymakcalan, Hande; Caglayan, Ahmet Okay; Sencar, Leman; Ceyhun, Emre; Atik, A. Fatih; Bayri, Yasar; Bai, Hanwen; Kolb, Luis E.; Hebert, Ryan M.; Omay, S. Bulent; Mishra-Gorur, Ketu; Choi, Murim; Overton, John D.; Holland, Eric C.; Mane, Shrikant; State, Matthew W.; Bilguevar, Kaya; Baehring, Joachim M.; Gutin, Philip H.; Piepmeier, Joseph M.; Vortmeyer, Alexander; Brennan, Cameron W.; Pamir, M. Necmettin; Kilic, Tuerker; Lifton, Richard P.; Noonan, James P.; Yasuno, Katsuhito; Guenel, Murat			Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO	SCIENCE			English	Article								We report genomic analysis of 300 meningiomas, the most common primary brain tumors, leading to the discovery of mutations in TRAF7, a proapoptotic E3 ubiquitin ligase, in nearly one-fourth of all meningiomas. Mutations in TRAF7 commonly occurred with a recurrent mutation ( K409Q) in KLF4, a transcription factor known for its role in inducing pluripotency, or with AKT1(E17K), a mutation known to activate the PI3K pathway. SMO mutations, which activate Hedgehog signaling, were identified in similar to 5% of non-NF2 mutant meningiomas. These non-NF2 meningiomas were clinically distinctive-nearly always benign, with chromosomal stability, and originating from the medial skull base. In contrast, meningiomas with mutant NF2 and/or chromosome 22 loss were more likely to be atypical, showing genomic instability, and localizing to the cerebral and cerebellar hemispheres. Collectively, these findings identify distinct meningioma subtypes, suggesting avenues for targeted therapeutics.	[Clark, Victoria E.; Erson-Omay, E. Zeynep; Serin, Akdes; Murray, Phillip B.; Henegariu, Octavian; Yilmaz, Saliha; Carrion-Grant, Geneive; Grady, Conor; Tanrikulu, Bahattin; Omay, S. Bulent; Mishra-Gorur, Ketu; Bilguevar, Kaya; Yasuno, Katsuhito; Guenel, Murat] Yale Univ, Sch Med, Dept Neurosurg, Yale Program Brain Tumor Res, New Haven, CT 06510 USA; [Clark, Victoria E.; Erson-Omay, E. Zeynep; Serin, Akdes; Yin, Jun; Cotney, Justin; Murray, Phillip B.; Henegariu, Octavian; Yilmaz, Saliha; Carrion-Grant, Geneive; Grady, Conor; Bakircioglu, Mehmet; Caglayan, Ahmet Okay; Sencar, Leman; Ceyhun, Emre; Choi, Murim; Mane, Shrikant; Bilguevar, Kaya; Lifton, Richard P.; Noonan, James P.; Yasuno, Katsuhito; Guenel, Murat] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Oezduman, Koray] Acibadem Univ, Dept Neurosurg, Sch Med, TR-34848 Istanbul, Turkey; [Avsar, Timuin] Istanbul Tech Univ, Dr Orhan Ocalgiray Mol Biology Biotechnol & Genet, TR-34469 Istanbul, Turkey; [Li, Jie; Vortmeyer, Alexander] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Guenel, Jennifer Moliterno] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Guenel, Jennifer Moliterno; Gutin, Philip H.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10065 USA; [Yilmaz, Baran; Tanrikulu, Bahattin; Atik, A. Fatih; Bayri, Yasar] Marmara Univ, Dept Neurosurg, Sch Med, TR-34854 Istanbul, Turkey; [Kaymakcalan, Hande] Bahcesehir Univ, Dept Genet & Bioinformat, TR-34353 Istanbul, Turkey; [Kaymakcalan, Hande] Yale Univ, Ctr Genome Anal, Sch Med, West Haven, CT 06516 USA; [Overton, John D.; Mane, Shrikant] Yale Univ, Ctr Genome Anal, Sch Med, West Haven, CT 06516 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, Brain Tumor Ctr, New York, NY 10065 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurol & Surg, New York, NY 10065 USA; [State, Matthew W.] Yale Univ, Sch Med, Dept Genet, Yale Program Neurogenet, New Haven, CT 06510 USA; [State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, Yale Program Neurogenet, New Haven, CT 06510 USA; [State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Baehring, Joachim M.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Piepmeier, Joseph M.] Yale Univ, Sch Med, Dept Neurosurg, Yale Program Brain Tumor Res, New Haven, CT 06510 USA; [Brennan, Cameron W.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Brennan, Cameron W.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Kilic, Tuerker] Bahcesehir Univ, Dept Neurosurg, TR-34349 Istanbul, Turkey; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA; [Noonan, James P.] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA; [Guenel, Murat] Yale Univ, Sch Med, Yale Program Neurogenet, New Haven, CT 06510 USA	Yale University; Yale University; Acibadem University; Istanbul Technical University; Yale University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Marmara University; Bahcesehir University; Yale University; Yale University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yale University; Yale University; Yale University; Yale University; Yale University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Bahcesehir University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Gunel, M (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, Yale Program Brain Tumor Res, 333 Cedar St, New Haven, CT 06510 USA.	murat.gunel@yale.edu	Caglayan, Ahmet O/D-1066-2012; Yin, Jun/A-7502-2010; Kaymakcalan, Hande/AAO-4208-2021; State, Matthew/W-2256-2019; Choi, Murim/AAP-9120-2021; Brennan, Cameron/R-7082-2019; Kilic, Turker/M-3670-2018; Ceyhun, Emre/A-8025-2018; Yasuno, Katsuhito/E-1960-2012; Kaymakcalan, Hande/AFP-2191-2022; Tanrıkulu, Bahattin/E-7144-2016; AVSAR, TIMUCIN/W-2624-2019; Noonan, James/ABF-1320-2021; Cotney, Justin L/ABE-8500-2021; Ozduman, Koray/D-7007-2015; Bayri, Yasar/B-1287-2017	Caglayan, Ahmet O/0000-0002-2332-322X; Yin, Jun/0000-0003-4543-1229; Kaymakcalan, Hande/0000-0001-7736-7634; Brennan, Cameron/0000-0003-4064-8891; Kilic, Turker/0000-0003-4237-808X; Ceyhun, Emre/0000-0001-6209-1700; Yasuno, Katsuhito/0000-0002-3606-532X; Tanrıkulu, Bahattin/0000-0002-9096-8685; AVSAR, TIMUCIN/0000-0001-8841-4811; Cotney, Justin L/0000-0001-8230-2157; Pamir, M Necmettin/0000-0002-5958-8625; Carrion-Grant, Geneive/0000-0001-5465-370X; State, Matthew/0000-0003-1624-8302; Ozduman, Koray/0000-0002-3543-0401; Bayri, Yasar/0000-0003-1707-6055	Gregory M. Kiez and Mehmet Kutman Foundation; NIH [T32GM07205]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Gregory M. Kiez and Mehmet Kutman Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the patients and their families who have contributed to this study. This study was supported by the Gregory M. Kiez and Mehmet Kutman Foundation. R. P. L. is an investigator of the Howard Hughes Institute. V. E. C. is supported by NIH T32GM07205. All somatic mutations identified through exome sequencing of meningiomas are reported in the supplementary materials and submitted to the Catalogue of Somatic Mutations in Cancer (COSMIC) database (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic, submission ID COSP30702). Yale University has filed a provisional patent application based on the results of this study.	Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cui QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013180; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Schmitz U, 2001, BRIT J CANCER, V84, P199, DOI 10.1054/bjoc.2000.1583; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200	11	503	511	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1077	1080		10.1126/science.1233009	http://dx.doi.org/10.1126/science.1233009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23348505	Green Accepted			2022-12-28	WOS:000315452000042
J	Kulynych, J; Heffernan, KG				Kulynych, Jennifer; Heffernan, Kate Gallin			Community Research Partnerships Underappreciated Challenges, Unrealized Opportunities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kulynych, Jennifer] Johns Hopkins Hosp & Hlth Syst, Counsel Human Res, Baltimore, MD 21287 USA; [Heffernan, Kate Gallin] KGH Advisors LLC, Hingham, MA USA	Johns Hopkins University; Johns Hopkins Medicine	Kulynych, J (corresponding author), Johns Hopkins Hosp & Hlth Syst, Counsel Human Res, 600 N Wolfe St,Admin 400, Baltimore, MD 21287 USA.	jkulyny1@jhmi.edu						Agency for Healthcare Research and Quality, PRACT BAS RES NETW R; BAER I, 2004, CLIN TRIAL CONTRACTS; Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL; Dilts DM, 2006, J CLIN ONCOL, V24, P4545, DOI 10.1200/JCO.2005.05.0104; Frechtling J., 2012, CTSA NATL EVALUATION; Hayes H, 2012, PROG COMM HLTH PARTN, V6, P369, DOI 10.1353/cpr.2012.0033; Institute of Medicine (US) Forum on Drug Discovery Development and Translation, 2010, TRANSF CLIN RES US C; Ravina B, 2010, ANN NEUROL, V67, P258, DOI 10.1002/ana.21831; US Oncology Network, INF ONC	9	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					555	556		10.1001/jama.2012.108937	http://dx.doi.org/10.1001/jama.2012.108937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087PH	23403678				2022-12-28	WOS:000314773700026
J	Raby, S; Greaves, D; Padayatty, J; Huntly, B				Raby, Sophie; Greaves, Daniel; Padayatty, Joseph; Huntly, Brian			CASE REPORT An unexpected finding after a fall from a horse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC MYELOID-LEUKEMIA; INTERFERON-ALPHA; CHRONIC-PHASE; IMATINIB; SURVIVAL		[Raby, Sophie; Greaves, Daniel; Padayatty, Joseph; Huntly, Brian] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England	Addenbrooke's Hospital; University of Cambridge	Raby, S (corresponding author), Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England.	raby.sophie@gmail.com	huntly, brian JP/E-6725-2014	huntly, brian JP/0000-0003-0312-161X	Wellcome Trust [100140] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arceci M, 2006, PEDIAT HEMATOLOGY; Baccarani M, 2002, BLOOD, V99, P1527, DOI 10.1182/blood.V99.5.1527; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Berger U, 2005, LEUKEMIA, V19, P984, DOI 10.1038/sj.leu.2403756; BRINCKER H, 1982, SCAND J HAEMATOL, V29, P241; Cortes J, 2011, BLOOD, V118, P109; Cortes J, 2009, BLOOD, V114, P267; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Goldman J, 2007, RECOMMENDATIONS MANA; Guilhot F, 1997, NEW ENGL J MED, V337, P223, DOI 10.1056/NEJM199707243370402; Hasford J, 1998, JNCI-J NATL CANCER I, V90, P850, DOI 10.1093/jnci/90.11.850; Hasford J, 2011, BLOOD, V118, P686, DOI 10.1182/blood-2010-12-319038; Howard SC, 2011, NEW ENGL J MED, V364, P1844, DOI 10.1056/NEJMra0904569; Kantarjian H, 2012, CECIL MED, P1209; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kantarjian HM, 2003, CANCER-AM CANCER SOC, V97, P1033, DOI 10.1002/cncr.11223; Khoury HI, 2011, BLOOD, V118; Kumar V, 2007, ROBBINS BASIC PATHOL; Lucas CM, 2008, LEUKEMIA, V22, P1963, DOI 10.1038/leu.2008.225; MOLONEY WC, 1987, BLOOD, V70, P905; Nicolini F, 2008, BLOOD, V112, P403; Oki Y, 2007, CANCER, V109, P899, DOI 10.1002/cncr.22470; Phekoo KJ, 2006, HAEMATOLOGICA, V91, P1400; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Roy L, 2006, BLOOD, V108, P1835; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Savage DG, 1997, BRIT J HAEMATOL, V96, P111, DOI 10.1046/j.1365-2141.1997.d01-1982.x; Silver RT, 1999, BLOOD, V94, P1517; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199	30	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2013	346								f724	10.1136/bmj.f724	http://dx.doi.org/10.1136/bmj.f724			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091ZG	23403830				2022-12-28	WOS:000315087700004
J	Cavalli, F				Cavalli, Franco			An appeal to world leaders: stop cancer now	LANCET			English	Editorial Material							OFFLINE		Oncol Inst So Switzerland, CH-6500 Bellinzona, Switzerland	Institute of Oncology Research (IOR)	Cavalli, F (corresponding author), Oncol Inst So Switzerland, CH-6500 Bellinzona, Switzerland.	franco.cavalli@eoc.ch						Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Horton R, 2012, LANCET, V380, P1542, DOI 10.1016/S0140-6736(12)61848-0; Horton R, 2012, LANCET, V380, P1457, DOI 10.1016/S0140-6736(12)61810-8; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Sundewall J, 2011, LANCET, V377, P1222, DOI 10.1016/S0140-6736(10)60679-4; Taylor AL, 2011, NEW ENGL J MED, V365, P2348, DOI 10.1056/NEJMp1108658; WHO, WHA65 8 PREV CONTR N; World Health Organization, 2012, CANC FACT SHEET 297	12	25	27	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2013	381	9865					425	426		10.1016/S0140-6736(13)60059-8	http://dx.doi.org/10.1016/S0140-6736(13)60059-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088CH	23388078				2022-12-28	WOS:000314810900005
J	Paal, P; Brugger, H; Kaser, G; Putzer, G; Tiefenthaler, W; Wenzel, V				Paal, Peter; Brugger, Hermann; Kaser, Georg; Putzer, Gabriel; Tiefenthaler, Werner; Wenzel, Volker			Surviving 6 days in a crevasse	LANCET			English	Editorial Material									[Paal, Peter; Putzer, Gabriel; Tiefenthaler, Werner; Wenzel, Volker] Med Univ Innsbruck, Dept Anaesthesiol & Crit Care Med, A-6020 Innsbruck, Austria; [Brugger, Hermann] EURAC Inst Mt Emergency Med, Bolzano, Italy; [Kaser, Georg] Leopold Franzens Univ, Inst Meteorol & Geophys, Innsbruck, Austria	Medical University of Innsbruck; European Academy of Bozen-Bolzano; University of Innsbruck	Wenzel, V (corresponding author), Med Univ Innsbruck, Dept Anaesthesiol & Crit Care Med, Anichstr 35, A-6020 Innsbruck, Austria.	volker.wenzel@uki.at		Paal, Peter/0000-0002-2939-4782; Brugger, Hermann/0000-0003-2752-6929				Brown DJA, 2012, NEW ENGL J MED, V367, P1930, DOI 10.1056/NEJMra1114208; Henriksson O, 2012, PREHOSP DISASTER MED, V27, P53, DOI 10.1017/S1049023X12000210; Paal P, 2012, RESUSCITATION; Zentralanstalt_fur_Meteorologie_und_Geodynamik, 2012, WARMST SOMM MESSG	4	9	9	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2013	381	9865					506	506		10.1016/S0140-6736(12)62032-7	http://dx.doi.org/10.1016/S0140-6736(12)62032-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088CH	23399073				2022-12-28	WOS:000314810900036
J	Bartels, SJ; Naslund, JA				Bartels, Stephen J.; Naslund, John A.			The Underside of the Silver Tsunami - Older Adults and Mental Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISORDERS		[Bartels, Stephen J.] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA; [Bartels, Stephen J.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Hanover, NH USA; [Bartels, Stephen J.; Naslund, John A.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA	Dartmouth College; Dartmouth College; Dartmouth College	Bartels, SJ (corresponding author), Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA.							Bartels SJ, 2003, AM J GERIAT PSYCHIAT, V11, P648, DOI 10.1176/appi.ajgp.11.6.648; Diachun LL, 2012, J AM GERIATR SOC, V60, P1357, DOI 10.1111/j.1532-5415.2012.04029.x; Institute of Medicine, 2012, MENTAL HLTH SUBSTANC; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Reynolds CF, 2010, LANCET, V376, P2045, DOI 10.1016/S0140-6736(10)61886-7	5	133	134	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					493	496		10.1056/NEJMp1211456	http://dx.doi.org/10.1056/NEJMp1211456			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083VU	23343039				2022-12-28	WOS:000314494100012
J	Hickman, MA; Zeng, GS; Forche, A; Hirakawa, MP; Abbey, D; Harrison, BD; Wang, YM; Su, CH; Bennett, RJ; Wang, Y; Berman, J				Hickman, Meleah A.; Zeng, Guisheng; Forche, Anja; Hirakawa, Matthew P.; Abbey, Darren; Harrison, Benjamin D.; Wang, Yan-Ming; Su, Ching-hua; Bennett, Richard J.; Wang, Yue; Berman, Judith			The 'obligate diploid' Candida albicans forms mating-competent haploids	NATURE			English	Article							GENE DISRUPTION; CHROMOSOME LOSS; PLOIDY; HETEROZYGOSITY; MORPHOGENESIS; PROTEINS; MUTANTS; REVEAL; SYSTEM	Candida albicans, the most prevalent human fungal pathogen, is considered to be an obligate diploid that carries recessive lethal mutations throughout the genome. Here we demonstrate that C. albicans has a viable haploid state that can be derived from diploid cells under in vitro and in vivo conditions, and that seems to arise through a concerted chromosome loss mechanism. Haploids undergo morphogenetic changes like those of diploids, including the yeast-hyphal transition, chlamydospore formation and a white-opaque switch that facilitates mating. Haploid opaque cells of opposite mating type mate efficiently to regenerate the diploid form, restoring heterozygosity and fitness. Homozygous diploids arise spontaneously by auto-diploidization, and both haploids and auto-diploids show a similar reduction in fitness, in vitro and in vivo, relative to heterozygous diploids, indicating that homozygous cell types are transient in mixed populations. Finally, we constructed stable haploid strains with multiple auxotrophies that will facilitate molecular and genetic analyses of this important pathogen.	[Hickman, Meleah A.; Abbey, Darren; Harrison, Benjamin D.; Berman, Judith] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Zeng, Guisheng; Wang, Yan-Ming; Wang, Yue] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Forche, Anja] Bowdoin Coll, Brunswick, ME 04011 USA; [Hirakawa, Matthew P.; Bennett, Richard J.] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Su, Ching-hua] Taipei Med Univ, Dept Microbiol & Immunol, Taipei, Taiwan; [Berman, Judith] Tel Aviv Univ, George Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Ramat Aviv, Israel	University of Minnesota System; University of Minnesota Twin Cities; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Bowdoin College; Brown University; Taipei Medical University; Tel Aviv University	Berman, J (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	jberman@umn.edu	Berman, Judith/ABA-8528-2021; Zeng, Guisheng/GXW-1870-2022; Wang, Yue/AGN-6053-2022; Berman, Judith/AAS-5115-2021; Wang, Yue/H-2107-2011	Berman, Judith/0000-0002-8577-0084; Wang, Yue/0000-0002-1211-2822; Bennett, Richard/0000-0001-7563-484X; ZENG, GUISHENG/0000-0002-8920-5525; Hirakawa, Matthew/0000-0002-2041-9496	NRSA [F32GM096536-02]; National Institute of Allergy and Infectious Diseases (NIAID) [R15-AI090633-01A1, R01 AI0624273, AI081560, AI081704, AI0624273]; training grant for Graduate Assistance in Areas of National Need [P200A100100]; National Institute of Dental & Craniofacial Research [T32DE007288]; Burroughs Wellcome Fund; Agency for Science, Technology, & Research, Singapore; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062427, R21AI081560, R01AI081704, R15AI090633, R56AI087401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096536] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); training grant for Graduate Assistance in Areas of National Need; National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Agency for Science, Technology, & Research, Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank M. McClellan, K. Matter, E. Voigt and F. Y. Chan for technical assistance, S. Filler and J. Becker for work involving mouse models of infection, F. M. Chang and T. Y. Ou for contributing to the isolation of the progenitor of GZY792, and L. Burrack, J. Heitman, M. Kupiec, K. Nielsen and N. Pavelka for comments on the manuscript M.A.H. is supported by an NRSA post-doctoral fellowship (F32GM096536-02). A.F. is supported by the National Institute of Allergy and Infectious Diseases (NIAID) (R15-AI090633-01A1 and R01 AI0624273). M.P.H. is supported by a training grant for Graduate Assistance in Areas of National Need (P200A100100). B.D.H. is supported by the National Institute of Dental & Craniofacial Research (T32DE007288). R.J.B. is supported by the NIAID (AI081560 and AI081704) and a PATH Award from the Burroughs Wellcome Fund. Y.W. is supported by Agency for Science, Technology, & Research, Singapore. J.B. is supported by the NIAID (AI0624273).	Abbey D, 2011, G3-GENES GENOM GENET, V1, P523, DOI 10.1534/g3.111.000885; Alby K, 2009, NATURE, V460, P890, DOI 10.1038/nature08252; Andaluz E, 2011, MOL MICROBIOL, V79, P1462, DOI 10.1111/j.1365-2958.2011.07532.x; BARTON RC, 1992, MOL MICROBIOL, V6, P171, DOI 10.1111/j.1365-2958.1992.tb01998.x; Bennett RJ, 2003, EMBO J, V22, P2505, DOI 10.1093/emboj/cdg235; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Berman J, 2012, TRENDS GENET, V28, P197, DOI 10.1016/j.tig.2012.01.004; CHAFFIN WL, 1984, J GEN MICROBIOL, V130, P431; Citiulo F, 2009, FEMS YEAST RES, V9, P1051, DOI 10.1111/j.1567-1364.2009.00533.x; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; Douglas LM, 2009, INFECT IMMUN, V77, P4150, DOI 10.1128/IAI.00683-09; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Forche A, 2011, MBIO, V2, DOI 10.1128/mBio.00129-11; Forche A, 2003, FUNGAL GENET BIOL, V39, P38, DOI 10.1016/S1087-1845(02)00585-6; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; Forche A, 2009, GENETICS, V182, P799, DOI 10.1534/genetics.109.103325; FREED J J, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P337, DOI 10.1073/pnas.65.2.337; Graser Y, 1996, P NATL ACAD SCI USA, V93, P12473, DOI 10.1073/pnas.93.22.12473; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kelly MT, 2004, MOL MICROBIOL, V53, P969, DOI 10.1111/j.1365-2958.2004.04185.x; KELLY R, 1987, MOL CELL BIOL, V7, P199, DOI 10.1128/MCB.7.1.199; KURTZ MB, 1989, MOL GEN GENET, V217, P47, DOI 10.1007/BF00330941; Kwon-Chung K., 1983, GENETIC ANAL CANDIDA, P230; Lockhart SR, 2002, GENETICS, V162, P737; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Miller MG, 2002, CELL, V110, P293, DOI 10.1016/S0092-8674(02)00837-1; Morschhauser J, 1999, MOL MICROBIOL, V32, P547, DOI 10.1046/j.1365-2958.1999.01393.x; MORTIMER RK, 1958, RADIAT RES, V9, P312, DOI 10.2307/3570795; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; OLAIYA AF, 1979, J BACTERIOL, V140, P1043, DOI 10.1128/JB.140.3.1043-1049.1979; Reedy JL, 2009, CURR BIOL, V19, P891, DOI 10.1016/j.cub.2009.04.058; RIGGSBY WS, 1982, MOL CELL BIOL, V2, P853, DOI 10.1128/MCB.2.7.853; SARACHEK A, 1986, CURR GENET, V10, P685, DOI 10.1007/BF00410917; SARACHEK A, 1981, ARCH MICROBIOL, V129, P1, DOI 10.1007/BF00417169; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; SLUTSKY B, 1987, J BACTERIOL, V169, P189, DOI 10.1128/JB.169.1.189-197.1987; Solis NV, 2012, NAT PROTOC, V7, P637, DOI 10.1038/nprot.2012.011; Soll DR, 2003, EUKARYOT CELL, V2, P390, DOI 10.1128/EC.2.3.390-397.2003; SUZUKI T, 1982, J BACTERIOL, V152, P893; Tsai JH, 2011, J CELL SCI, V124, P1955, DOI 10.1242/jcs.006387; VAN DER WALT J. P., 1967, ANTONIE VAN LEEU WENHOEK J MICROBIOL SEROL, V33, P246; Wang Y, 2009, CURR OPIN MICROBIOL, V12, P644, DOI 10.1016/j.mib.2009.09.002; WHELAN WL, 1982, MOL GEN GENET, V187, P477, DOI 10.1007/BF00332632; WHELAN WL, 1980, MOL GEN GENET, V180, P107, DOI 10.1007/BF00267358; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Zeng GS, 2012, MOL BIOL CELL, V23, P3485, DOI 10.1091/mbc.E12-03-0231	50	190	196	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					55	59		10.1038/nature11865	http://dx.doi.org/10.1038/nature11865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23364695	Green Accepted			2022-12-28	WOS:000314741200032
J	Kesselheim, JC; Cassel, CK				Kesselheim, Jennifer C.; Cassel, Christine K.			Service: An Essential Component of Graduate Medical Education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kesselheim, Jennifer C.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kesselheim, Jennifer C.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Cassel, Christine K.] Amer Board Internal Med, Philadelphia, PA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; American Board of Internal Medicine	Kesselheim, JC (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.							Accreditation Council for Graduate Medical Education, PED MIL BE REP SEM; Arnold P. Gold Foundation, WHAT IS HUM MED; Holt KD, 2010, ACAD MED, V85, P512, DOI 10.1097/ACM.0b013e3181ccc1db; Ludmerer K., 1999, TIME HEAL AM MED ED; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117	5	17	18	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					500	501		10.1056/NEJMp1214850	http://dx.doi.org/10.1056/NEJMp1214850			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083VU	23388001				2022-12-28	WOS:000314494100014
J	Briesacher, BA; Tjia, J; Peterson, D; Gurwitz, JH				Briesacher, Becky A.; Tjia, Jennifer; Peterson, Daniel; Gurwitz, Jerry H.			Antipsychotic Use Among Nursing Home Residents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							REGULATIONS		Meyers Primary Care Inst, Worcester, MA USA; [Briesacher, Becky A.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Briesacher, BA (corresponding author), Univ Massachusetts, Sch Med, 377 Plantat St,Biotech 4,Ste 315, Worcester, MA 01605 USA.	becky.briesacher@umassmed.edu	Tjia, Jennifer/Y-2094-2019		AHRQ HHS [R18 HS019351, R18HS019351-01] Funding Source: Medline; NIA NIH HHS [K01 AG031836, K01AG031836] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS019351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG031836] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Briesacher BA, 2005, ARCH INTERN MED, V165, P1280, DOI 10.1001/archinte.165.11.1280; Chen Y, 2010, ARCH INTERN MED, V170, P89, DOI 10.1001/archinternmed.2009.469; Maher AR, 2011, JAMA-J AM MED ASSOC, V306, P1359, DOI 10.1001/jama.2011.1360; ROVNER BW, 1992, AM J PSYCHIAT, V149, P1390; Shorr Ronald I., 1994, JAMA (Journal of the American Medical Association), V271, P358, DOI 10.1001/jama.271.5.358	5	43	44	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					440	442		10.1001/jama.2012.211266	http://dx.doi.org/10.1001/jama.2012.211266			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083LY	23385262	Green Accepted, Bronze			2022-12-28	WOS:000314466900017
J	May, M				May, Mike			HEART HEALTH	NATURE			English	Editorial Material																			0	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2013	493	7434					S1	S1		10.1038/493S1a	http://dx.doi.org/10.1038/493S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080CU	23364763	Bronze			2022-12-28	WOS:000314219600003
J	Gigerenzer, G; Wegwarth, O				Gigerenzer, Gerd; Wegwarth, Odette			Five year survival rates can mislead	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gigerenzer, Gerd; Wegwarth, Odette] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany; [Wegwarth, Odette] Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany	Max Planck Society; Max Planck Society	Gigerenzer, G (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.	gigerenzer@mpib-berlin.mpg.de	Gigerenzer, Gerd/M-5595-2013; Gigerenzer, Gerd/A-6250-2012	Gigerenzer, Gerd/0000-0002-6163-5419				Badgwell BD, 2008, J CLIN ONCOL, V26, P2482, DOI 10.1200/JCO.2007.12.8058; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gigerenzer G., 2002, RECKONING RISK LEARN; Gigerenzer G, 2007, PSYCHOL SCI PUBLIC I, V8, P71; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Wegwarth O, 2012, ANN INTERN MED, V156, P340, DOI 10.7326/0003-4819-156-5-201203060-00005; Wegwarth O, 2011, MED DECIS MAKING, V31, P386, DOI 10.1177/0272989X10391469; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Woloshin S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5132	10	7	7	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2013	346								f548	10.1136/bmj.f548	http://dx.doi.org/10.1136/bmj.f548			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BH	23360815	Green Submitted			2022-12-28	WOS:000314510400012
J	Makani, H; Bangalore, S; Desouza, KA; Shah, A; Messerli, FH				Makani, Harikrishna; Bangalore, Sripal; Desouza, Kavit A.; Shah, Arpit; Messerli, Franz H.			Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONVERTING-ENZYME-INHIBITOR; CHRONIC HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; RECEPTOR BLOCKER; DOUBLE-BLIND; COMBINATION THERAPY; MYOCARDIAL-INFARCTION; HYPERTENSIVE PATIENTS; DIABETIC-NEPHROPATHY; ACE-INHIBITORS	Objective To compare the long term efficacy and adverse events of dual blockade of the renin-angiotensin system with monotherapy. Design Systematic review and meta-analysis. Data sources PubMed, Embase, and the Cochrane central register of controlled trials, January 1990 to August 2012. Study selection Randomised controlled trials comparing dual blockers of the renin-angiotensin system with monotherapy, reporting data on either long term efficacy (>= 1 year) or safety events (>= 4 weeks), and with a sample size of at least 50. Analysis was stratified by trials with patients with heart failure versus patients without heart failure. Results 33 randomised controlled trials with 68 405 patients (mean age 61 years, 71% men) and mean duration of 52 weeks were included. Dual blockade of the renin-angiotensin system was not associated with any significant benefit for all cause mortality (relative risk 0.97, 95% confidence interval 0.89 to 1.06) and cardiovascular mortality (0.96, 0.88 to 1.05) compared with monotherapy. Compared with monotherapy, dual therapy was associated with an 18% reduction in admissions to hospital for heart failure (0.82, 0.74 to 0.92). However, compared with monotherapy, dual therapy was associated with a 55% increase in the risk of hyperkalaemia (P<0.001), a 66% increase in the risk of hypotension (P<0.001), a 41% increase in the risk of renal failure (P=0.01), and a 27% increase in the risk of withdrawal owing to adverse events (P<0.001). Efficacy and safety results were consistent in cohorts with and without heart failure when dual therapy was compared with monotherapy except for all cause mortality, which was higher in the cohort without heart failure (P=0.04 v P=0.15), and renal failure was significantly higher in the cohort with heart failure (P<0.001 v P=0.79). Conclusion Although dual blockade of the renin-angiotensin system may have seemingly beneficial effects on certain surrogate endpoints, it failed to reduce mortality and was associated with an excessive risk of adverse events such as hyperkalaemia, hypotension, and renal failure compared with monotherapy. The risk to benefit ratio argues against the use of dual therapy.	[Makani, Harikrishna; Desouza, Kavit A.; Shah, Arpit; Messerli, Franz H.] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp, Div Cardiol, New York, NY 10019 USA; [Bangalore, Sripal] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; New York University	Messerli, FH (corresponding author), Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp, Div Cardiol, 1000 10th Ave, New York, NY 10019 USA.	messerli.f@gmail.com	Bangalore, Sripal/B-6246-2013; Messerli, Franz/AAR-4783-2021	Bangalore, Sripal/0000-0001-9485-0652				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Andersen NH, 2005, DIABETES CARE, V28, P273, DOI 10.2337/diacare.28.2.273; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; [Anonymous], 2009, Lancet, V374, P1226, DOI 10.1016/S0140-6736(09)61768-2; Azizi M, 2000, J HYPERTENS, V18, P1139, DOI 10.1097/00004872-200018080-00020; Bakris GL, 2007, KIDNEY INT, V72, P879, DOI 10.1038/sj.ki.5002455; Banerjee S, 2011, EUR J CANCER, V47, pS116, DOI 10.1016/S0959-8049(11)70155-1; Baruch L, 1999, CIRCULATION, V99, P2658, DOI 10.1161/01.CIR.99.20.2658; Cice G, 2010, J AM COLL CARDIOL, V56, P1701, DOI 10.1016/j.jacc.2010.03.105; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drummond W, 2011, AM J CARDIOVASC DRUG, V11, P327, DOI 10.2165/11591970-000000000-00000; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fried LF, 2009, CLIN J AM SOC NEPHRO, V4, P361, DOI 10.2215/CJN.03350708; Harel Ziv, 2012, BMJ, V344, pe42, DOI 10.1136/bmj.e42; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Izzo Joseph L Jr, 2004, J Clin Hypertens (Greenwich), V6, P485, DOI 10.1111/j.1524-6175.2004.03511.x; Jessup M, 2009, J AM COLL CARDIOL, V53, P1343, DOI 10.1016/j.jacc.2008.11.009; Kanno Y, 2006, CLIN J AM SOC NEPHRO, V1, P730, DOI 10.2215/CJN.01110905; Kum LCC, 2008, INT J CARDIOL, V125, P16, DOI 10.1016/j.ijcard.2007.02.016; Kunz R, 2008, LANCET, V371, P1575, DOI 10.1016/S0140-6736(08)60681-9; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Lakhdar R, 2008, J CARD FAIL, V14, P181, DOI 10.1016/j.cardfail.2007.11.008; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; McKelvie RS, 1999, CIRCULATION, V100, P1056, DOI 10.1161/01.CIR.100.10.1056; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2008, CIRC-HEART FAIL, V1, P17, DOI 10.1161/CIRCHEARTFAILURE.107.740704; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mehdi UF, 2009, J AM SOC NEPHROL, V20, P2641, DOI 10.1681/ASN.2009070737; Menard J, 1997, CIRCULATION, V96, P3072, DOI 10.1161/01.CIR.96.9.3072; Menne J, 2008, J HYPERTENS, V26, P1860, DOI 10.1097/HJH.0b013e32830508aa; Messerli FH, 2010, EUR HEART J, V31, P2205, DOI 10.1093/eurheartj/ehq255; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nakao N, 2003, LANCET, V361, P117, DOI 10.1016/S0140-6736(03)12229-5; Ogawa S, 2007, HYPERTENS RES, V30, P325, DOI 10.1291/hypres.30.325; Oparil S, 2007, LANCET, V370, P221, DOI 10.1016/S0140-6736(07)61124-6; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Piao JM, 2011, DIS ESOPHAGUS, V24, P596, DOI 10.1111/j.1442-2050.2011.01203.x; Pini P., 2003, LANCET, V361, P1265; Pool JL, 2007, AM J HYPERTENS, V20, P11, DOI 10.1016/j.amjhyper.2006.06.003; Ruilope LM, 2000, J HYPERTENS, V18, P89, DOI 10.1097/00004872-200018010-00013; Scirica BM, 2010, EUR HEART J, V31, P1993, DOI 10.1093/eurheartj/ehq190; Sever P, 2004, LANCET, V364, P933, DOI 10.1016/S0140-6736(04)17013-X; Solomon SD, 2011, EUR HEART J, V32, P1227, DOI 10.1093/eurheartj/ehq522; Solomon SD, 2009, CIRCULATION, V119, P530, DOI 10.1161/CIRCULATIONAHA.108.826214; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Titan SM, 2011, CLIN NEPHROL, V76, P273, DOI 10.5414/CN107013; Tonkon M, 2000, INT J CLIN PRACT, V54, P11; Uresin Y, 2007, J RENIN-ANGIO-ALDO S, V8, P190, DOI 10.3317/jraas.2007.028; White M, 2007, J CARD FAIL, V13, P86, DOI 10.1016/j.cardfail.2006.10.013; Yasumura Y, 2004, CIRC J, V68, P361, DOI 10.1253/circj.68.361; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	56	146	147	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2013	346								f360	10.1136/bmj.f360	http://dx.doi.org/10.1136/bmj.f360			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084AY	23358488	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000314509400001
J	Rampeearee, SD				Rampeearee, Sharmila Devi			Thomas LaVeist: framing the debate on health disparities	LANCET			English	Biographical-Item																		LAVEIST T, PUBLICATION LIST	1	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2013	381	9863					285	285		10.1016/S0140-6736(13)60122-1	http://dx.doi.org/10.1016/S0140-6736(13)60122-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23351801	Green Submitted			2022-12-28	WOS:000314021800016
J	Joynt, KE; Jha, AK				Joynt, Karen E.; Jha, Ashish K.			Characteristics of Hospitals Receiving Penalties Under the Hospital Readmissions Reduction Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							RATES; RACE; CARE		[Joynt, Karen E.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Joynt, KE (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			NHLBI NIH HHS [1K23HL109177-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109177] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Centers for Medicare & Medicaid Services, 2012, FY 2013 IPPS FIN RUL; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P2517, DOI 10.1001/jama.289.19.2517; Vartak S, 2008, MED CARE, V46, P25, DOI 10.1097/MLR.0b013e3181484927	5	381	381	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					342	343		10.1001/jama.2012.94856	http://dx.doi.org/10.1001/jama.2012.94856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074FT	23340629	Bronze			2022-12-28	WOS:000313799000015
J	Yan, J; Xiang, JL; Lin, YT; Ma, JG; Zhang, JY; Zhang, H; Sun, JS; Danial, NN; Liu, J; Lin, AN				Yan, Jie; Xiang, Jialing; Lin, Yutin; Ma, Jingui; Zhang, Jiyan; Zhang, Hao; Sun, Jisheng; Danial, Nika N.; Liu, Jing; Lin, Anning			Inactivation of BAD by IKK Inhibits TNF alpha-Induced Apoptosis Independently of NF-kappa B Activation	CELL			English	Article							TUMOR-NECROSIS-FACTOR; SEVERE LIVER DEGENERATION; CELL-DEATH; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; FEEDBACK INHIBITION; KINASE ACTIVATION; JNK ACTIVATION; DEFICIENT MICE; PHOSPHORYLATION	The I kappa B kinase complex (IKK) is a key regulator of immune responses, inflammation, cell survival, and tumorigenesis. The prosurvival function of IKK centers on activation of the transcription factor NF-kappa B, whose target gene products inhibit caspases and prevent prolonged JNK activation. Here, we report that inactivation of the BH3-only protein BAD by IKK independently of NF-kappa B activation suppresses TNF alpha-induced apoptosis. TNF alpha-treated Ikk beta(-/-) mouse embryonic fibroblasts (MEFs) undergo apoptosis significantly faster than MEFs deficient in both RelA and cRel due to lack of inhibition of BAD by IKK. IKK phosphorylates BAD at serine-26 (Ser26) and primes it for inactivation. Elimination of Ser26 phosphorylation promotes BAD proapoptotic activity, thereby accelerating TNF alpha-induced apoptosis in cultured cells and increasing mortality in animals. Our results reveal that IKK inhibits TNF alpha-induced apoptosis through two distinct but cooperative mechanisms: activation of the survival facto r NF-kappa B and inactivation of the proapoptotic BH3-only BAD protein.	[Yan, Jie; Ma, Jingui; Zhang, Jiyan; Lin, Anning] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Xiang, Jialing; Lin, Yutin] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA; [Zhang, Jiyan] Inst Basic Med Sci, Dept Mol Immunol, Beijing 100850, Peoples R China; [Zhang, Hao; Sun, Jisheng; Lin, Anning] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Danial, Nika N.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Liu, Jing] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	University of Chicago; Illinois Institute of Technology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Dana-Farber Cancer Institute; Northwestern University; Feinberg School of Medicine	Lin, AN (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	anninglin@bsd.uchicago.edu		Sun, Jisheng/0000-0003-0814-1118; Zhang, Jiyan/0000-0001-8011-8719	National Basic Research Program of China [2012CB910801]; National Natural Science Foundation of China [31130035]; Chinese Academy of Sciences [SIBS2010CSP001]; National Institutes of Health [CA100460, CA128114, GM081603]; NATIONAL CANCER INSTITUTE [R01CA100460, R01CA128114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095313, R01GM081603, R01GM103868] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Drs. David A. Brenner, Joseph A. DiDonato, Michael Karin, Stanley Korsmeyer, and Frank Mercurio for reagents that make this work possible. This work is partially supported by National Basic Research Program of China (2012CB910801), National Natural Science Foundation of China (31130035), Chinese Academy of Sciences (SIBS2010CSP001), and National Institutes of Health grants CA100460 (to A.L.), CA128114 (to J.X.), and GM081603 (to J.L.).	Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Dragovich T, 1998, ONCOGENE, V17, P3207, DOI 10.1038/sj.onc.1202587; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu J, 2007, ONCOGENE, V26, P3267, DOI 10.1038/sj.onc.1210417; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Rudolph D, 2000, GENE DEV, V14, P854; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Xiang J, 2000, J GENE MED, V2, P97, DOI 10.1002/(SICI)1521-2254(200003/04)2:2<97::AID-JGM99>3.0.CO;2-S; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	45	73	75	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					304	315		10.1016/j.cell.2012.12.021	http://dx.doi.org/10.1016/j.cell.2012.12.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332762	Green Accepted, Bronze			2022-12-28	WOS:000313719800025
J	Bellan, SE; Fiorella, KJ; Melesse, DY; Getz, WM; Williams, BG; Dushoff, J				Bellan, Steve E.; Fiorella, Kathryn J.; Melesse, Dessalegn Y.; Getz, Wayne M.; Williams, Brian G.; Dushoff, Jonathan			Extra-couple HIV transmission in sub-Saharan Africa: a mathematical modelling study of survey data	LANCET			English	Article							DISCORDANT COUPLES; SEXUAL PARTNERSHIPS; PREVENTION; RISK; INFECTIONS; PREVALENCE; EPIDEMIC; MARRIAGE; COHORT	Background The proportion of heterosexual HIV transmission in sub-Saharan Africa that occurs within cohabiting partnerships, compared with that in single people or extra-couple relationships, is widely debated. We estimated the proportional contribution of different routes of transmission to new HIV infections. As plans to use antiretroviral drugs as a strategy for population-level prevention progress, understanding the importance of different transmission routes is crucial to target intervention efforts. Methods We built a mechanistic model of HIV transmission with data from Demographic and Health Surveys (DHS) for 2003-2011, of 27 201 cohabiting couples (men aged 15-59 years and women aged 15-49 years) from 18 sub-Saharan African countries with information about relationship duration, age at sexual debut, and HIV serostatus. We combined this model with estimates of HIV survival times and country-specific estimates of HIV prevalence and coverage of antiretroviral therapy (ART). We then estimated the proportion of recorded infections in surveyed cohabiting couples that occurred before couple formation, between couple members, and because of extra-couple intercourse. Findings In surveyed couples, we estimated that extra-couple transmission accounted for 27-61% of all HIV infections in men and 21-51% of all those in women, with ranges showing intercountry variation. We estimated that in 2011, extra-couple transmission accounted for 32-65% of new incident HIV infections in men in cohabiting couples, and 10-47% of new infections in women in such couples. Our findings suggest that transmission within couples occurs largely from men to women; however, the latter sex have a very high-risk period before couple formation. Interpretation Because of the large contribution of extra-couple transmission to new HIV infections, interventions for HIV prevention should target the general sexually active population and not only serodiscordant couples.	[Bellan, Steve E.; Fiorella, Kathryn J.; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Melesse, Dessalegn Y.] Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa; [Williams, Brian G.] South African Ctr Epidemiol Modeling & Anal, Stellenbosch, South Africa; [Dushoff, Jonathan] McMaster Univ, Dept Biol, Hamilton, ON, Canada	University of California System; University of California Berkeley; University of Manitoba; University of Kwazulu Natal; McMaster University	Bellan, SE (corresponding author), Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.	steve.bellan@gmail.com	Bellan, Steve/D-6368-2013; Fiorella, Katie/N-9538-2013; Getz, Wayne/I-4521-2013	Bellan, Steve/0000-0002-4110-272X; Fiorella, Katie/0000-0002-8625-2473; Getz, Wayne/0000-0001-8784-9354; Melesse, Dessalegn Y./0000-0003-3917-5329; Williams, Brian/0000-0002-3174-4876	National Institutes of Health [R24TW008822]; Henry Wheeler Center for Emerging and Neglected Diseases; NSF-NIH Ecology of Infectious Diseases program (NSF) [1134964]; African Institute for Mathematical Sciences; South African Centre for Excellence in Epidemiological Modelling and Analysis; Chang-Lin Tien Environmental Fellowship; Andrew and Mary Thompson Rocca Fellowships; University of California; Berkeley Environmental Science, Policy and Management and Entomology Society; National Science Foundation Graduate Research Fellowship Program; UC Global Health Institute One Health Summer Research Program; Sigma Xi; Andrew and Mary Thompson Rocca Pre-Dissertation Research Award in African Studies; Sara's Wish Foundation; Centre for Global Public Health, University of Manitoba, Canada; National Institutes of Health Ecology of Infectious Disease [GM83863]; J S McDonnell Foundation; FOGARTY INTERNATIONAL CENTER [R24TW008822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry Wheeler Center for Emerging and Neglected Diseases; NSF-NIH Ecology of Infectious Diseases program (NSF); African Institute for Mathematical Sciences; South African Centre for Excellence in Epidemiological Modelling and Analysis; Chang-Lin Tien Environmental Fellowship; Andrew and Mary Thompson Rocca Fellowships; University of California(University of California System); Berkeley Environmental Science, Policy and Management and Entomology Society; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); UC Global Health Institute One Health Summer Research Program; Sigma Xi; Andrew and Mary Thompson Rocca Pre-Dissertation Research Award in African Studies; Sara's Wish Foundation; Centre for Global Public Health, University of Manitoba, Canada; National Institutes of Health Ecology of Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J S McDonnell Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The 2011 Clinic on the Meaningful Modeling of Epidemiological Data, where this work was started, was funded by the National Institutes of Health Framework Programs for Global Health Innovations (grant R24TW008822 to Lee Riley), the Henry Wheeler Center for Emerging and Neglected Diseases, the NSF-NIH Ecology of Infectious Diseases program (NSF award 1134964 to Juliet R C Pulliam), the African Institute for Mathematical Sciences, and the South African Centre for Excellence in Epidemiological Modelling and Analysis. This work was partly supported by a Chang-Lin Tien Environmental Fellowship, Andrew and Mary Thompson Rocca Fellowships, University of California, Berkeley Environmental Science, Policy and Management and Entomology Society Travel Grants to SEB; the National Science Foundation Graduate Research Fellowship Program, UC Global Health Institute One Health Summer Research Program, Sigma Xi Grants-in-Aid of Research, Andrew and Mary Thompson Rocca Pre-Dissertation Research Award in African Studies, and Sara's Wish Foundation to KJF; the Centre for Global Public Health, University of Manitoba, Canada support to DYM; National Institutes of Health Ecology of Infectious Disease grant (GM83863) to WMG; and a J S McDonnell Foundation grant to JD. We thank Juliet R C Pulliam, James C Scott, Travis C Porco, John W Hargrove, Alex Welte, and Wim Delva for their help in organising the Meaningful Modeling of Epidemiological Data workshop where this work was started; Damian Kajunguri, Mateusz Plucinski, and Zindoga Mukandavire for their comments on early versions of this work, and Savannah Nuwagaba for work on early formulations of this project; Juliet R C Pulliam, Paul Cross, Ben Bolker, Andy Lyons, and Karen Weinbaum for their feedback.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bongaarts J, 2007, POP STUD-J DEMOG, V61, P73, DOI 10.1080/00324720601048343; Busch Michael P., 1997, American Journal of Medicine, V102, P117, DOI 10.1016/S0002-9343(97)00077-6; CALDWELL JC, 1989, POPUL DEV REV, V15, P185, DOI 10.2307/1973703; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Chemaitelly H, 2013, SEX TRANSM INFECT, V89, P138, DOI 10.1136/sextrans-2012-050651; Chemaitelly H, 2012, SEX TRANSM INFECT, V88, P51, DOI 10.1136/sextrans-2011-050114; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; De Walque D, 2007, POPUL DEV REV, V33, P501, DOI 10.1111/j.1728-4457.2007.00182.x; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Hargrove JW, 2011, EPIDEMICS-NETH, V3, P88, DOI 10.1016/j.epidem.2011.02.004; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Ndase P, 2012, JAIDS-J ACQ IMM DEF, V59, P65, DOI 10.1097/QAI.0b013e318237b864; Padian NS, 2012, JAIDS-J ACQ IMM DEF, V60, pS22, DOI 10.1097/QAI.0b013e31825b7100; Shelton JD, 2008, LANCET, V372, P1299, DOI 10.1016/S0140-6736(08)61545-7; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; UNAIDS, 2010, GLOB REP UNAIDS REP; World Health Organization, 2012, GUID OR PREEXP PROPH; Zachariah R, 2010, T ROY SOC TROP MED H, V104, P387, DOI 10.1016/j.trstmh.2010.01.004	32	47	47	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2013	381	9877					1561	1569		10.1016/S0140-6736(12)61960-6	http://dx.doi.org/10.1016/S0140-6736(12)61960-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139UF	23391466	Green Accepted			2022-12-28	WOS:000318609600031
J	Doherty, RB				Doherty, Robert B.			The Road to Health Reform: What Can Physicians Expect Over the Next 4 Years?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Amer Coll Physicians, Washington, DC 20001 USA	American College of Physicians	Doherty, RB (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.							[Anonymous], 2013, EACH STAT STANDS ACA; [Anonymous], WASHINGTON POST; Centers for Medicare and Medicaid Services, 2012, PHYS QUAL REP SYST; DeBor G, 2010, MASSACHUSETTS HLTH C; Institute of Medicine, 2013, US HLTH INT PERSP SH, P1; Kaiser Commission on Medicaid and the Uninsured, 2012, MUCH WILL MED PHYS F; Kliff S, 2012, WASHINGTON POST; Viebeck E, 2013, HILL            0108	8	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6					487	U145		10.7326/0003-4819-158-6-201303190-00591	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-00591			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23338848				2022-12-28	WOS:000316565100017
J	Domnisoru, C; Kinkhabwala, AA; Tank, DW				Domnisoru, Cristina; Kinkhabwala, Amina A.; Tank, David W.			Membrane potential dynamics of grid cells	NATURE			English	Article							HIPPOCAMPAL PLACE CELLS; SPATIAL REPRESENTATION; ENTORHINAL CORTEX; PATH-INTEGRATION; THETA RHYTHM; PHASE PRECESSION; INTERFERENCE; OSCILLATIONS; MODELS; PERIODICITY	During navigation, grid cells increase their spike rates in firing fields arranged on a markedly regular triangular lattice, whereas their spike timing is often modulated by theta oscillations. Oscillatory interference models of grid cells predict theta amplitude modulations of membrane potential during firing field traversals, whereas competing attractor network models predict slow depolarizing ramps. Here, using in vivo whole-cell recordings, we tested these models by directly measuring grid cell intracellular potentials in mice running along linear tracks in virtual reality. Grid cells had large and reproducible ramps of membrane potential depolarization that were the characteristic signature tightly correlated with firing fields. Grid cells also demonstrated intracellular theta oscillations that influenced their spike timing. However, the properties of theta amplitude modulations were not consistent with the view that they determine firing field locations. Our results support cellular and network mechanisms in which grid fields are produced by slow ramps, as in attractor models, whereas theta oscillations control spike timing.	[Domnisoru, Cristina; Kinkhabwala, Amina A.; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Domnisoru, Cristina; Kinkhabwala, Amina A.; Tank, David W.] Princeton Univ, Bezos Ctr Neural Circuit Dynam, Princeton, NJ 08544 USA; [Domnisoru, Cristina; Kinkhabwala, Amina A.; Tank, David W.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Domnisoru, Cristina; Kinkhabwala, Amina A.; Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University; Princeton University	Tank, DW (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	dwtank@princeton.edu			NINDS [5RC1NS068148-02, 1R37NS081242-01]; NIMH [5R01MH083686-04]; NIH [F32NS070514-01A1]; NSF; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068148, F32NS070514, R37NS081242] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Harvey, R. Low, A. Miri, S. Lewallen, J. Rickgauer, D. Little, a Barson, D. Aronov, W. Bialek, I. Fiete and G. Buzsaki for helpful discussions. This work was supported by NINDS grant 5RC1NS068148-02 and 1R37NS081242-01, NIMH grant 5R01MH083686-04, NIH Postdoctoral Fellowship grant F32NS070514-01A1 (A.A.K.), and an NSF Graduate Research Fellowship (C.D.).	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Barry C, 2012, NATURE, V488, pE1, DOI 10.1038/nature11276; Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00030, 10.3389/fncir.2012.00005]; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2008, HIPPOCAMPUS, V18, P1230, DOI 10.1002/hipo.20472; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Giocomo LM, 2011, CURR BIOL, V21, pR962, DOI 10.1016/j.cub.2011.10.024; Giocomo LM, 2011, CELL, V147, P1159, DOI 10.1016/j.cell.2011.08.051; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Giocomo LM, 2008, HIPPOCAMPUS, V18, P1186, DOI 10.1002/hipo.20501; Guanella A, 2007, INT J NEURAL SYST, V17, P231, DOI 10.1142/S0129065707001093; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Kinkhabwala A. A., 2011, SPATIAL PATTERNING G; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; Welinder PE, 2008, HIPPOCAMPUS, V18, P1283, DOI 10.1002/hipo.20519; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Zilli EA, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00016	41	205	209	3	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2013	495	7440					199	204		10.1038/nature11973	http://dx.doi.org/10.1038/nature11973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113FP	23395984	Green Accepted			2022-12-28	WOS:000316652300043
J	Talbot, TR; Talbot, HK				Talbot, Thomas R.; Talbot, H. Keipp			Influenza Prevention Update Examining Common Arguments Against Influenza Vaccination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Talbot, Thomas R.; Talbot, H. Keipp] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Talbot, Thomas R.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Talbot, TR (corresponding author), Vanderbilt Univ, Med Ctr, A-2200 Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	tom.talbot@vanderbilt.edu		Talbot, Thomas/0000-0002-6139-212X				Ball Sarah W., 2012, Morbidity and Mortality Weekly Report, V61, P753; Centers for Disease Control and Prevention, 2011, SIT UPD SUMM WEEKL F; Centers for Disease Control and Prevention, PREV STRAT SEAS INFL; Grohskopf Lisa, 2012, Morbidity and Mortality Weekly Report, V61, P613; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P32; Jain VK, 2012, IDWEEK SCI M OCT 17; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Talbot TR, 2012, INFECT CONT HOSP EP, V33, P981, DOI 10.1086/667772; Williams Walter W., 2012, Morbidity and Mortality Weekly Report, V61, P66	10	10	11	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					881	882		10.1001/jama.2013.453	http://dx.doi.org/10.1001/jama.2013.453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23334755				2022-12-28	WOS:000315632700021
J	Palacci, J; Sacanna, S; Steinberg, AP; Pine, DJ; Chaikin, PM				Palacci, Jeremie; Sacanna, Stefano; Steinberg, Asher Preska; Pine, David J.; Chaikin, Paul M.			Living Crystals of Light-Activated Colloidal Surfers	SCIENCE			English	Article							PHASE-SEPARATION; FLUCTUATIONS; PARTICLES; MOTION	Spontaneous formation of colonies of bacteria or flocks of birds are examples of self-organization in active living matter. Here, we demonstrate a form of self-organization from nonequilibrium driving forces in a suspension of synthetic photoactivated colloidal particles. They lead to two-dimensional "living crystals," which form, break, explode, and re-form elsewhere. The dynamic assembly results from a competition between self-propulsion of particles and an attractive interaction induced respectively by osmotic and phoretic effects and activated by light. We measured a transition from normal to giant-number fluctuations. Our experiments are quantitatively described by simple numerical simulations. We show that the existence of the living crystals is intrinsically related to the out-of-equilibrium collisions of the self-propelled particles.	[Palacci, Jeremie; Sacanna, Stefano; Pine, David J.; Chaikin, Paul M.] NYU, Dept Phys, New York, NY 10003 USA; [Steinberg, Asher Preska] Brandeis Univ, Dept Phys & Chem, Waltham, MA 02453 USA	New York University; Brandeis University	Palacci, J (corresponding author), NYU, Dept Phys, 4 Washington Pl, New York, NY 10003 USA.	jp153@nyu.edu	palacci, jeremie/B-8476-2012; Palacci, Jérémie/T-9065-2019; Sacanna, Stefano/D-4683-2012; Sacanna, Stefano/ABE-9434-2021; Pine, David J/B-7740-2016	palacci, jeremie/0000-0002-7253-9465; Palacci, Jérémie/0000-0002-7253-9465; Sacanna, Stefano/0000-0002-8399-3524; Pine, David J/0000-0002-3304-6684; Preska Steinberg, Asher/0000-0002-8694-7224	Materials Research Science and Engineering Centers program of the NSF [DMR-0820341]; U.S. Army Research Office [W911NF-10-1-0518]; NASA [NNX08AK04G]	Materials Research Science and Engineering Centers program of the NSF(National Science Foundation (NSF)); U.S. Army Research Office; NASA(National Aeronautics & Space Administration (NASA))	We thank J. Layne, K. Hanson, A. Grosberg, R. Dreyfus, E. Lerner, A. Baskaran, and L. Bocquet for fruitful discussions. This work was supported by the Materials Research Science and Engineering Centers program of the NSF under award number DMR-0820341 and by the U.S. Army Research Office under grant award no. W911NF-10-1-0518. We acknowledge partial support from the NASA under grant award NNX08AK04G.	ANDERSON JL, 1989, ANNU REV FLUID MECH, V21, P61; Bialke J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.168301; Cates ME, 2010, P NATL ACAD SCI USA, V107, P11715, DOI 10.1073/pnas.1001994107; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Corte L, 2008, NAT PHYS, V4, P420, DOI 10.1038/nphys891; Deseigne J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.098001; Dreyfus R, 2005, NATURE, V437, P862, DOI 10.1038/nature04090; Farrell FDC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.248101; Fily Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.235702; Franceschini A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.250603; Golestanian R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.220801; Gregoire G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025702; Howse JR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.048102; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Joanny JF, 2010, NATURE, V467, P33, DOI 10.1038/467033a; McCandlish SR, 2012, SOFT MATTER, V8, P2527, DOI 10.1039/c2sm06960a; Michaelis L, 1913, BIOCHEM Z, V49, P333; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Palacci J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.088304; Paxton WF, 2004, J AM CHEM SOC, V126, P13424, DOI 10.1021/ja047697z; Polin M, 2009, SCIENCE, V325, P487, DOI 10.1126/science.1172667; Saintillan D, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.3041776; Schwarz-Linek J, 2012, P NATL ACAD SCI USA, V109, P4052, DOI 10.1073/pnas.1116334109; Tailleur J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.218103; Theurkauff I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.268303; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107	27	1134	1143	20	533	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					936	940		10.1126/science.1230020	http://dx.doi.org/10.1126/science.1230020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092UX	23371555				2022-12-28	WOS:000315149600043
J	Sinha, K				Sinha, Kounteya			A pulse oximeter for every operating theatre in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ksinha78@gmail.com						Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2013	346								f676	10.1136/bmj.f676	http://dx.doi.org/10.1136/bmj.f676			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AL	23381203				2022-12-28	WOS:000314806100010
J	Mugoni, V; Postel, R; Catanzaro, V; De Luca, E; Turco, E; Digilio, G; Silengo, L; Murphy, MP; Medana, C; Stainier, DYR; Bakkers, J; Santoro, MM				Mugoni, Vera; Postel, Ruben; Catanzaro, Valeria; De Luca, Elisa; Turco, Emilia; Digilio, Giuseppe; Silengo, Lorenzo; Murphy, Michael P.; Medana, Claudio; Stainier, Didier Y. R.; Bakkers, Jeroen; Santoro, Massimo M.			Ubiad1 Is an Antioxidant Enzyme that Regulates eNOS Activity by CoQ10 Synthesis	CELL			English	Article							CRYSTALLINE CORNEAL-DYSTROPHY; NITRIC-OXIDE SYNTHASE; PROTEIN S-NITROSYLATION; COENZYME-Q; OXIDATIVE STRESS; CARDIOVASCULAR-SYSTEM; VASCULAR-DISEASE; BLOOD-FLOW; RAT-LIVER; IN-VIVO	Protection against oxidative damage caused by excessive reactive oxygen species (ROS) by an antioxidant network is essential for the health of tissues, especially in the cardiovascular system. Here, we identified a gene with important antioxidant features by analyzing a null allele of zebrafish ubiad1, called barolo (bar). bar mutants show specific cardiovascular failure due to oxidative stress and ROS-mediated cellular damage. Human UBIAD1 is a nonmitochondrial prenyltransferase that synthesizes CoQ10 in the Golgi membrane compartment. Loss of UBIAD1 reduces the cytosolic pool of the antioxidant CoQ10 and leads to ROS-mediated lipid peroxidation in vascular cells. Surprisingly, inhibition of eNOS prevents Ubiad1-dependent cardiovascular oxidative damage, suggesting a crucial role for this enzyme and nonmitochondrial CoQ10 in NO signaling. These findings identify UBIAD1 as a nonmitochondrial CoQ10-forming enzyme with specific cardiovascular protective function via the modulation of eNOS activity.	[Mugoni, Vera; Catanzaro, Valeria; De Luca, Elisa; Turco, Emilia; Digilio, Giuseppe; Silengo, Lorenzo; Santoro, Massimo M.] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, I-10126 Turin, Italy; [Medana, Claudio] Univ Turin, Dept Chem, I-10126 Turin, Italy; [Postel, Ruben; Bakkers, Jeroen] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Postel, Ruben; Bakkers, Jeroen] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Postel, Ruben; Bakkers, Jeroen] Netherlands Heart Inst, NL-3584 CT Utrecht, Netherlands; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Stainier, Didier Y. R.] Max Planck Inst Heart & Lung Res, Dept Dev Genet, D-61231 Bad Nauheim, Germany	University of Turin; University of Turin; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Max Planck Society	Santoro, MM (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, I-10126 Turin, Italy.	massimo.santoro@unito.it	Murphy, Michael P/C-2120-2009; Digilio, Giuseppe/HGU-5278-2022; Bakkers, Jeroen/H-5551-2011; SANTORO, MARIA/K-3250-2018; Medana, Claudio/A-6587-2010; De Luca, Elisa/L-2491-2017	Murphy, Michael P/0000-0003-1115-9618; Bakkers, Jeroen/0000-0002-9418-0422; SANTORO, MARIA/0000-0002-6228-1114; Medana, Claudio/0000-0002-9772-6814; Stainier, Didier/0000-0002-0382-0026; SANTORO, Massimo Mattia/0000-0003-4605-5085; De Luca, Elisa/0000-0001-9849-0703; Digilio, Giuseppe/0000-0003-2397-2913	HFSP Career Developmental Award; Marie Curie Action IRG [247852]; Telethon [GGP10185]; AIRC-MFAG [8911, FP7-NMP-2007-214539]; MRC [MC_U105663142] Funding Source: UKRI; Medical Research Council [MC_U105663142] Funding Source: researchfish	HFSP Career Developmental Award; Marie Curie Action IRG; Telethon(Fondazione Telethon); AIRC-MFAG(Fondazione AIRC per la ricerca sul cancro); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Federica Logrand, Marco Vincenti, Annalisa Camporeale, and Ellen Jane Corcoran for technical assistances as well as Pier Paolo Pandolfi, Guido Serini, Massimiliano Mazzone, Franz Enzmann and Silvio Aime for discussion, technical support and reagents. This work was supported by a HFSP Career Developmental Award (MMS), Marie Curie Action IRG 247852 (MMS), Telethon GGP10185(MMS), AIRC-MFAG 8911(MMS) and FP7-NMP-2007-214539 (JB). VM and MMS planned and discussed the whole project. RP positionally cloned the t31131 allele in JB's lab. Independently, MMS identified the s847 allele in DYRS' lab. RP performed ubiad1 expression analyses and cell transplantation experiments in zebrafish. MPM provided the MitoQ. ET produced the Ubiad1 MAb. VM and MMS performed all other experiments together with VC, GD, CM, EDL and LS. MMS wrote the manuscript and all authors commented on it. The authors declare no conflict of interests.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P413, DOI 10.1161/01.ATV.0000110785.96039.f6; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; Bentinger M, 2008, BIOFACTORS, V32, P99, DOI 10.1002/biof.5520320112; Browning EA, 2012, ANNU REV PHYSIOL, V74, P403, DOI 10.1146/annurev-physiol-020911-153324; Chew GT, 2004, QJM-INT J MED, V97, P537, DOI 10.1093/qjmed/hch089; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Crane F.L., 1977, BIOMEDICAL CLIN ASPE, P3; Crane FL, 2001, J AM COLL NUTR, V20, P591, DOI 10.1080/07315724.2001.10719063; Crane FL, 2007, MITOCHONDRION, V7, pS2, DOI 10.1016/j.mito.2007.02.011; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forsgren M, 2004, BIOCHEM J, V382, P519, DOI 10.1042/BJ20040261; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Fritsche R, 2000, AM J PHYSIOL-REG I, V279, pR2200, DOI 10.1152/ajpregu.2000.279.6.R2200; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526; Jonassen T., 2000, COENZYME Q MOL MECH, P185; KALEN A, 1990, J BIOL CHEM, V265, P1158; KALEN A, 1987, ACTA CHEM SCAND B, V41, P70, DOI 10.3891/acta.chem.scand.41b-0070; Kumar A, 2009, PHARMACOL THERAPEUT, V124, P259, DOI 10.1016/j.pharmthera.2009.07.003; Kuster GM, 2010, ANTIOXID REDOX SIGN, V13, P1899, DOI 10.1089/ars.2010.3464; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Liu JY, 2011, J GENET GENOMICS, V38, P225, DOI 10.1016/j.jgg.2011.05.002; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Matlung HL, 2009, ANTIOXID REDOX SIGN, V11, P1699, DOI [10.1089/ars.2008.2408, 10.1089/ARS.2008.2408]; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Navas P, 2007, MITOCHONDRION, V7, pS34, DOI 10.1016/j.mito.2007.02.010; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Pelster B, 2005, COMP BIOCHEM PHYS A, V142, P215, DOI 10.1016/j.cbpb.2005.05.036; Pepe S, 2007, MITOCHONDRION, V7, pS154, DOI 10.1016/j.mito.2007.02.005; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; Sun JH, 2010, CIRC RES, V106, P285, DOI 10.1161/CIRCRESAHA.109.209452; SWIEZEWSKA E, 1993, J BIOL CHEM, V268, P1494; Trevisson E, 2011, CURR OPIN NEUROL, V24, P449, DOI 10.1097/WCO.0b013e32834ab528; Tsai KL, 2012, J NUTR BIOCHEM, V23, P458, DOI 10.1016/j.jnutbio.2011.01.011; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Wang L, 2011, BLOOD, V118, P4102, DOI 10.1182/blood-2011-05-353235; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; Werner E, 2004, J CELL SCI, V117, P143, DOI 10.1242/jcs.00937; Yellore VS, 2007, MOL VIS, V13, P1777	63	141	153	1	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					504	518		10.1016/j.cell.2013.01.013	http://dx.doi.org/10.1016/j.cell.2013.01.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374346	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000314362800020
J	Hirano, Y; Masuda, T; Naganos, S; Matsuno, M; Ueno, K; Miyashita, T; Horiuchi, J; Saitoe, M				Hirano, Yukinori; Masuda, Tomoko; Naganos, Shintaro; Matsuno, Motomi; Ueno, Kohei; Miyashita, Tomoyuki; Horiuchi, Junjiro; Saitoe, Minoru			Fasting Launches CRTC to Facilitate Long-Term Memory Formation in Drosophila	SCIENCE			English	Article							SENSITIVE COINCIDENCE DETECTOR; RUBINSTEIN-TAYBI-SYNDROME; ELEMENT-BINDING PROTEIN; COACTIVATOR TORC2; GENE-EXPRESSION; CREB; INSULIN; CONSOLIDATION; INDUCTION; MECHANISM	Canonical aversive long-term memory (LTM) formation in Drosophila requires multiple spaced trainings, whereas appetitive LTM can be formed after a single training. Appetitive LTM requires fasting prior to training, which increases motivation for food intake. However, we found that fasting facilitated LTM formation in general; aversive LTM formation also occurred after single-cycle training when mild fasting was applied before training. Both fasting-dependent LTM (fLTM) and spaced training-dependent LTM (spLTM) required protein synthesis and cyclic adenosine monophosphate response element-binding protein (CREB) activity. However, spLTM required CREB activity in two neural populations-mushroom body and DAL neurons-whereas fLTM required CREB activity only in mushroom body neurons. fLTM uses the CREB coactivator CRTC, whereas spLTM uses the coactivator CBP. Thus, flies use distinct LTM machinery depending on their hunger state.	[Hirano, Yukinori; Masuda, Tomoko; Naganos, Shintaro; Matsuno, Motomi; Ueno, Kohei; Miyashita, Tomoyuki; Saitoe, Minoru] Tokyo Metropolitan Inst Med Sci, Dept Sensory & Motor Syst, Tokyo 1560057, Japan; [Hirano, Yukinori] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Naganos, Shintaro; Horiuchi, Junjiro] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Tokyo Metropolitan University	Hirano, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Sensory & Motor Syst, 2-1-6 Kamikitazawa, Tokyo 1560057, Japan.	hirano-yk@igakuken.or.jp; saito-mn@igakuken.or.jp	hirano, yukinori/M-6473-2018	hirano, yukinori/0000-0003-3313-637X; Saitoe, Minoru/0000-0001-9731-4214	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [21300144]; Japan Science and Technology Agency; PRESTO; MEXT/Japan Society for the Promotion of Science [24700415, 23700405]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); PRESTO; MEXT/Japan Society for the Promotion of Science	We thank M. Montminy, J. Yin, R. Davis, and T. Tabata for materials, and H. Tanimoto and H. Takemori for suggestions. Supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (grant-in-aid in innovative areas "Systems Molecular Ethology" and KAKENHI grant 21300144) (M. S.); the Japan Science and Technology Agency and PRESTO (Y.H.); and MEXT/Japan Society for the Promotion of Science KAKENHI grants 24700415 and 23700405 (M. M. and K.U.).	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Chen CC, 2012, SCIENCE, V335, P678, DOI 10.1126/science.1212735; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Miyashita T, 2012, NEURON, V74, P887, DOI 10.1016/j.neuron.2012.03.039; Naganos S, 2012, NEUROSCI RES, V73, P49, DOI 10.1016/j.neures.2012.02.001; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; Placais PY, 2013, SCIENCE, V339, P440, DOI 10.1126/science.1226018; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	29	92	93	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					443	446		10.1126/science.1227170	http://dx.doi.org/10.1126/science.1227170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349290				2022-12-28	WOS:000313960700042
J	Gelfand, I; Sahajpal, R; Zhang, XS; Izaurralde, RC; Gross, KL; Robertson, GP				Gelfand, Ilya; Sahajpal, Ritvik; Zhang, Xuesong; Izaurralde, R. Cesar; Gross, Katherine L.; Robertson, G. Philip			Sustainable bioenergy production from marginal lands in the US Midwest	NATURE			English	Article							LIFE-CYCLE ASSESSMENT; CLIMATE-CHANGE; PART II; BIOFUELS; ETHANOL; CORN; AGRICULTURE; GRASSLANDS; DIVERSITY; EMISSIONS	Legislation on biofuels production in the USA(1) and Europe(2,3) is directing food crops towards the production of grain-based ethanol(2,3), which can have detrimental consequences for soil carbon sequestration(4), nitrous oxide emissions(5), nitrate pollution(6), biodiversity(7) and human health(8). An alternative is to grow lignocellulosic (cellulosic) crops on 'marginal' lands(9). Cellulosic feedstocks can have positive environmental outcomes(10,11) and could make up a substantial proportion of future energy portfolios(12,13). However, the availability of marginal lands for cellulosic feedstock production, and the resulting greenhouse gas (GHG) emissions, remains uncertain. Here we evaluate the potential for marginal lands in ten Midwestern US states to produce sizeable amounts of biomass and concurrently mitigate GHG emissions. In a comparative assessment of six alternative cropping systems over 20 years, we found that successional herbaceous vegetation, once well established, has a direct GHG emissions mitigation capacity that rivals that of purpose-grown crops (-851 +/- 46 grams of CO2 equivalent emissions per square metre per year (gCO(2)e m(-2) yr(-1))). If fertilized, these communities have the capacity to produce about 63 +/- 5 gigajoules of ethanol energy per hectare per year. By contrast, an adjacent, no-till corn-soybean-wheat rotation produces on average 41 +/- 1 gigajoules of biofuel energy per hectare per year and has a net direct mitigation capacity of -397 +/- 32 gCO(2)e m(-2) yr(-1); a continuous corn rotation would probably produce about 62 +/- 7 gigajoules of biofuel energy per hectare per year, with 13% less mitigation. We also perform quantitative modelling of successional vegetation on marginal lands in the region at a resolution of 0.4 hectares, constrained by the requirement that each modelled location be within 80 kilometres of a potential biorefinery. Our results suggest that such vegetation could produce about 21 gigalitres of ethanol per year from around 11 million hectares, or approximately 25 per cent of the 2022 target for cellulosic biofuel mandated by the US Energy Independence and Security Act of 2007, with no initial carbon debt nor the indirect land-use costs associated with food-based biofuels. Other regional-scale aspects of biofuel sustainability(2), such as water quality(11,14) and biodiversity(15), await future study.	[Gelfand, Ilya; Sahajpal, Ritvik; Zhang, Xuesong; Izaurralde, R. Cesar; Gross, Katherine L.; Robertson, G. Philip] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Gelfand, Ilya; Gross, Katherine L.; Robertson, G. Philip] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Sahajpal, Ritvik; Zhang, Xuesong; Izaurralde, R. Cesar] Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Sahajpal, Ritvik; Izaurralde, R. Cesar] Univ Maryland, Dept Geog Sci, College Pk, MD 20740 USA; [Gross, Katherine L.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Robertson, G. Philip] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA	Michigan State University; United States Department of Energy (DOE); Michigan State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park; Michigan State University; Michigan State University	Gelfand, I (corresponding author), Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA.	igelfand@msu.edu; robert30@msu.edu	zhang, xuesong/B-7907-2009; Sahajpal, Ritvik/N-4565-2013; Gelfand, Ilya/J-9017-2012; Gelfand, Ilya/AAT-1776-2020; Zhang, Xuesong/AAR-2455-2020; Robertson, G Philip/H-3885-2011; Izaurralde, Roberto César/E-5257-2019	zhang, xuesong/0000-0003-4711-7751; Sahajpal, Ritvik/0000-0002-6418-289X; Gelfand, Ilya/0000-0002-8576-0978; Gelfand, Ilya/0000-0002-8576-0978; Robertson, G Philip/0000-0001-9771-9895; Izaurralde, Roberto/0000-0002-8797-9500	US DOE Office of Science [DE-FC02-07ER64494, KP1601050, DE-AC05-76RL01830]; US DOE Office of Energy Efficiency and Renewable Energy [DE-AC05-76RL01830, OBP 20469-19145]; US National Science Foundation LTER program [DEB 1027253]; NASA [NNH08ZDA001N]; MSU AgBioResearch	US DOE Office of Science(United States Department of Energy (DOE)); US DOE Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); US National Science Foundation LTER program; NASA(National Aeronautics & Space Administration (NASA)); MSU AgBioResearch	We thank S. Bohm, K. A. Kahmark, I. Shcherbak, and S. VanderWulp for help with data assembly; C. McMinn, J. Simmons and many others for field and laboratory assistance; J. R. Williams for EPIC model advice; and D. H. Manowitz for programming and computational assistance. We are additionally indebted to B. Bond-Lamberty, B. E. Dale, V. H. Dale, J. D. Hill, W. M. Post and T. O. West for comments on an earlier version of the manuscript. Financial support for this work was provided by the US DOE Office of Science (DE-FC02-07ER64494, KP1601050) and Office of Energy Efficiency and Renewable Energy (DE-AC05-76RL01830, OBP 20469-19145), the US National Science Foundation LTER program (DEB 1027253), NASA (NNH08ZDA001N), and MSU AgBioResearch. EPIC simulations were performed on the PNNL Evergreen computer cluster, which is supported by the US DOE Office of Science (DE-AC05-76RL01830).	Bailey C, 2011, BIOMASS BIOENERG, V35, P1408, DOI 10.1016/j.biombioe.2010.11.033; Clark CM, 2007, ECOL LETT, V10, P596, DOI 10.1111/j.1461-0248.2007.01053.x; Coleman M, 2006, BIOMASS BIOENERG, V30, P740, DOI 10.1016/j.biombioe.2006.01.001; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Dominguez-Faus R, 2009, ENVIRON SCI TECHNOL, V43, P3005, DOI 10.1021/es802162x; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Eggemeyer KD, 2006, INT J PLANT SCI, V167, P991, DOI 10.1086/505797; Eranki PL, 2011, GCB BIOENERGY, V3, P427, DOI 10.1111/j.1757-1707.2011.01096.x; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Fischer G, 2010, BIOMASS BIOENERG, V34, P173, DOI 10.1016/j.biombioe.2009.07.009; Fornara DA, 2009, ECOLOGY, V90, P408, DOI 10.1890/08-0325.1; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gelfand I, 2011, P NATL ACAD SCI USA, V108, P13864, DOI 10.1073/pnas.1017277108; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Huo H, 2009, ENVIRON SCI TECHNOL, V43, P750, DOI 10.1021/es8011436; Izaurralde RC, 2006, ECOL MODEL, V192, P362, DOI 10.1016/j.ecolmodel.2005.07.010; Izaurralde RC, 2003, AGR FOREST METEOROL, V117, P97, DOI 10.1016/S0168-1923(03)00024-8; Johnson DM, 2010, PHOTOGRAMM ENG REM S, V76, P1201; Kim S, 2005, BIOMASS BIOENERG, V29, P426, DOI 10.1016/j.biombioe.2005.06.004; Klingebiel AA, 1961, USDA AGR HDB, V210; Kosola KR, 2001, OECOLOGIA, V129, P65, DOI 10.1007/s004420100694; Lal R, 2004, ENVIRON INT, V30, P981, DOI 10.1016/j.envint.2004.03.005; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Oak Ridge National Laboratory, 2011, BIOEN CONV FACT; Ohlrogge J, 2009, SCIENCE, V324, P1019, DOI 10.1126/science.1171740; Ortin WGN, 2009, J SCI FOOD AGR, V89, P1754, DOI 10.1002/jsfa.3652; Patzek T. W., 2009, Bulletin of Science, Technology and Society, V29, P194, DOI 10.1177/0270467609334022; Perlack RD, 2011, ORNLTM2011224 US DOE; Plevin R. J., ENCY BIODIV IN PRESS; Plevin RJ, 2009, J IND ECOL, V13, P495, DOI 10.1111/j.1530-9290.2009.00138.x; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Robertson GP, 2011, ECOL APPL, V21, P1055, DOI 10.1890/09-0456.1; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Searchinger TD, 2009, SCIENCE, V326, P527, DOI 10.1126/science.1178797; Sheehan J, 1998, NRELSR58024089 USDA; Sinclair TR, 1999, ADV AGRON, V65, P215, DOI 10.1016/S0065-2113(08)60914-1; Soil Survey Staff, 2011, SOIL SURV GEOGR DAT; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Stein D, 2009, 2008 2009 CUSTOM MAC; Stoffel JL, 2010, FOREST ECOL MANAG, V259, P257, DOI 10.1016/j.foreco.2009.10.004; Syswerda SP, 2012, AGR ECOSYST ENVIRON, V149, P10, DOI 10.1016/j.agee.2011.12.007; Syswerda SP, 2011, SOIL SCI SOC AM J, V75, P92, DOI 10.2136/sssaj2009.0414; Tagil Sermin, 2008, Journal of Applied Sciences, V8, P910, DOI 10.3923/jas.2008.910.921; Tan GX, 2003, ECOL MODEL, V168, P357, DOI 10.1016/S0304-3800(03)00146-7; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Webster CR, 2010, BIOFUELS-UK, V1, P451, DOI 10.4155/BFS.10.18; West TO, 2002, AGR ECOSYST ENVIRON, V91, P217, DOI 10.1016/S0167-8809(01)00233-X; Williams J. R., 1995, Computer models of watershed hydrology., P909; Zhang X, 2010, GCB BIOENERGY, V2, P258, DOI 10.1111/j.1757-1707.2010.01046.x; Zhang X, 2010, OPEN STEM CELL J, V2, P2, DOI DOI 10.1155/2010/507560	55	483	490	21	903	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					514	+		10.1038/nature11811	http://dx.doi.org/10.1038/nature11811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23334409				2022-12-28	WOS:000313871400034
J	van de Vooren, K; Curto, A; Garattini, L				van de Vooren, Katelijne; Curto, Alessandro; Garattini, Livio			Optional copayments on anti-cancer drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; EXPERIENCE; CARE		[van de Vooren, Katelijne; Curto, Alessandro; Garattini, Livio] Mario Negri Inst Pharmacol Res, Ctr Hlth Econ, I-24020 Ranica, BG, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, L (corresponding author), Mario Negri Inst Pharmacol Res, Ctr Hlth Econ, I-24020 Ranica, BG, Italy.	livio.garattini@marionegri.it						de Souza JA, 2011, LANCET ONCOL, V12, P321, DOI 10.1016/S1470-2045(11)70043-2; Drummond M, 2012, EUR J HEALTH ECON, V13, P1, DOI 10.1007/s10198-011-0353-8; Drummond M, 2011, EUR J HEALTH ECON, V12, P263, DOI 10.1007/s10198-010-0274-y; Freemantle N, 1996, BRIT MED J, V312, P1469, DOI 10.1136/bmj.312.7044.1469; Galizzi MM, 2011, PHARMACOECONOMICS, V29, P17, DOI 10.2165/11537860-000000000-00000; Garattini L, 2012, J SEX MED; Garattini L, 2012, BMJ; Garattini L, 2012, EUR J HLTH EC; Garattini Livio, 2006, Eur J Health Econ, V7, P79, DOI 10.1007/s10198-005-0335-9; Garattini L, 2013, HEALTH POLICY, V109, P97, DOI 10.1016/j.healthpol.2012.08.017; Gemmill MC, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-12; Giuliani G, 1998, HEALTH POLICY, V44, P73, DOI 10.1016/S0168-8510(98)00012-8; NICE, 2012, CET BEV PAN TREATM M; NICE, 2008, APPR LIF EXT END LIF; Raftery J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b67; Richards M, 2008, REPORT SECRETARY STA; Stargardt T, 2010, EUR J HEALTH ECON, V11, P267, DOI 10.1007/s10198-009-0172-3; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Tappenden P, 2007, HEALTH TECHNOL ASSES, V11, P1; Trivedi AN, 2010, NEW ENGL J MED, V362, P320, DOI 10.1056/NEJMsa0904533; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917	21	10	11	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2013	346								f349	10.1136/bmj.f349	http://dx.doi.org/10.1136/bmj.f349			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080CD	23347986				2022-12-28	WOS:000314217900002
J	Iacobucci, G				Iacobucci, Gareth			INTEGRATED CARE Are Darzi-style clinics set to make a comeback?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Iacobucci, G (corresponding author), BMJ, London WC1H 9JR, England.	giacobucci@bmj.com						Darzi A, HEALTHCARE LONDON FR; Darzi A., 2008, HIGH QUALITY CARE AL; Davies P, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6287; Hakin B, 2011, COMMUNICATION   0203; Iacobucci G, 2009, PULSE           0701; Imison C., 2008, ONE ROOF WILL POLYCL; O'Dowd A, 2008, BMJ-BRIT MED J, V336, P1399	7	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2013	346								f343	10.1136/bmj.f343	http://dx.doi.org/10.1136/bmj.f343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BA	23338008				2022-12-28	WOS:000314215000009
J	Javaid, MK; Cooper, C				Javaid, M. Kassim; Cooper, Cyrus			Commentary: Opportunities to prevent fracture are being missed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Javaid, M. Kassim; Cooper, Cyrus] Univ Oxford, Oxford NIHR Musculoskeletal Biomed Res Unit, Oxford, England	University of Oxford	Javaid, MK (corresponding author), Univ Oxford, Oxford NIHR Musculoskeletal Biomed Res Unit, Oxford, England.	kassim.javaid@ndorms.ox.ac.uk		Cooper, Cyrus/0000-0003-3510-0709	Medical Research Council [U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; Medical Research Council [MC_UP_A620_1014, MC_U147585824, MC_UU_12011/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bolland MJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8669; Strom O, 2011, Arch Osteoporos, V6, P59, DOI 10.1007/s11657-011-0060-1; Treml J, FALLING STANDARDS BR	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2013	346								f278	10.1136/bmj.f278	http://dx.doi.org/10.1136/bmj.f278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BA	23338006				2022-12-28	WOS:000314215000004
J	Ralston, ME; Day, LT; Slusher, TM; Musa, NL; Doss, HS				Ralston, Mark E.; Day, Louise T.; Slusher, Tina M.; Musa, Ndidiamaka L.; Doss, Helen S.			Global paediatric advanced life support: improving child survival in limited-resource settings	LANCET			English	Review							COMMUNITY-ACQUIRED PNEUMONIA; ACUTE RESPIRATORY-INFECTIONS; EMERGENCY TRIAGE ASSESSMENT; POSITIVE AIRWAY PRESSURE; CRITICALLY-ILL CHILDREN; DENGUE-SHOCK-SYNDROME; DEVELOPING-COUNTRIES; CLINICAL SIGNS; INTENSIVE-CARE; HOSPITAL-CARE	Nearly all global mortality in children younger than 5 years (99%) occurs in developing countries. The leading causes of mortality in children younger than 5 years worldwide, pneumonia and diarrhoeal illness, account for 1.396 and 0.801 million annual deaths, respectively. Although important advances in prevention are being made, advanced life support management in children in developing countries is often incomplete because of limited resources. Existing advanced life support management guidelines for children in limited-resource settings are mainly empirical, rather than evidence-based, written for the hospital setting, not standardised with a systematic approach to patient assessment and categorisation of illness, and taught in current paediatric advanced life support training courses from the perspective of full-resource settings. In this Review, we focus on extension of higher quality emergency and critical care services to children in developing countries. When integrated into existing primary care programmes, simple inexpensive advanced life support management can improve child survival worldwide.	[Ralston, Mark E.] Naval Hosp, Dept Pediat, Oak Harbor, WA 98278 USA; [Ralston, Mark E.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Day, Louise T.] LAMB Hosp, Dept Pediat, Parbatipur 5250, Dinajpur, Bangladesh; [Slusher, Tina M.] Univ Minnesota, Hennepin Cty Med Ctr, Pediat Intens Care Unit, Ctr Global Pediat, Minneapolis, MN 55415 USA; [Musa, Ndidiamaka L.] Med Coll Wisconsin, Dept Pediat, Div Crit Care, Milwaukee, WI 53226 USA; [Doss, Helen S.] SIL Clin, Ukarumpa, Papua N Guinea	United States Department of Defense; United States Navy; Uniformed Services University of the Health Sciences - USA; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Medical College of Wisconsin	Ralston, ME (corresponding author), Naval Hosp, Dept Pediat, Oak Harbor, WA 98278 USA.	mark.ralston@med.navy.mil						Akech S, 2010, BMJ-BRIT MED J, V341, pc4416; Akech SO, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-71; American Heart Association, 2011, PED ADV LIF SUPP PRO; American Heart Association, 2006, PED ADV LIF SUPP PRO; [Anonymous], 2005, HOSP CAR CHILDR GUID; [Anonymous], 2011, MILL DEV GOALS REP; [Anonymous], 2010, INT MAN CHILDH ILLN; Baker T, 2009, PEDIATR ANESTH, V19, P23, DOI 10.1111/j.1460-9592.2008.02868.x; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Bataar O, 2010, B WORLD HEALTH ORGAN, V88, P839, DOI 10.2471/BLT.10.077073; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Cam BV, 2002, J TROP PEDIATRICS, V48, P335, DOI 10.1093/tropej/48.6.335; Campbell H, 2008, PEDIATRICS, V121, pE984, DOI 10.1542/peds.2007-1395; Carcillo JA, 2006, INTENS CARE MED, V32, P958, DOI 10.1007/s00134-006-0189-3; Chan PWK, 2001, PEDIATR INT, V43, P53, DOI 10.1046/j.1442-200x.2001.01340.x; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; DAI YH, 1995, PEDIATR INFECT DIS J, V14, P48, DOI 10.1097/00006454-199501000-00010; Demers AM, 2000, PEDIATR INFECT DIS J, V19, P424, DOI 10.1097/00006454-200005000-00007; Dubey SP, 1999, J LARYNGOL OTOL, V113, P645, DOI 10.1017/S0022215100144743; Duke T, 2010, INT J TUBERC LUNG D, V14, P1362; Duke T, 2009, ANN TROP PAEDIATR, V29, P165, DOI 10.1179/027249309X12467994190011; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; Duke T, 2002, ARCH DIS CHILD, V86, P108, DOI 10.1136/adc.86.2.108; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Dung NM, 1999, CLIN INFECT DIS, V29, P787, DOI 10.1086/520435; Dunser MW, 2006, CRIT CARE MED, V34, P1234, DOI 10.1097/01.CCM.0000208360.70835.87; Edejer TTT, 2005, BMJ-BRIT MED J, V331, P1177, DOI 10.1136/bmj.38652.550278.7C; Enarson P, 2008, B WORLD HEALTH ORGAN, V86, P344, DOI 10.2471/BLT.07.048017; English M, 2004, LANCET, V364, P1622, DOI 10.1016/S0140-6736(04)17318-2; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; English M, 2011, ARCH DIS CHILD, V96, P285, DOI 10.1136/adc.2010.189126; English M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-42; FALADE AG, 1995, B WORLD HEALTH ORGAN, V73, P299; Font Fidel, 2002, BMC Int Health Hum Rights, V2, P4, DOI 10.1186/1472-698X-2-4; FULTON DR, 1985, AM J CARDIOL, V55, P1328, DOI 10.1016/0002-9149(85)90498-9; George Ige Abraham, 2007, Indian J Med Sci, V61, P495; Gove S, 1999, ARCH DIS CHILD, V81, P473, DOI 10.1136/adc.81.6.473; Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512; Gray D, 2009, EXPERT REV ANTI-INFE, V7, P437, DOI [10.1586/eri.09.14, 10.1586/ERI.09.14]; Guiscafre H, 2001, B WORLD HEALTH ORGAN, V79, P434; Hahn S., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002847; Hatherill M, 2003, INTENS CARE MED, V29, P1547, DOI 10.1007/s00134-003-1888-7; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; Hildenwall H, 2009, ANN TROP PAEDIATR, V29, P281, DOI 10.1179/027249309X12547917869005; Hodges SC, 2007, ANAESTHESIA, V62, P4, DOI 10.1111/j.1365-2044.2006.04907.x; Hussain H, 2006, INT J HEALTH PLAN M, V21, P229, DOI 10.1002/hpm.847; Irimu G, 2008, ARCH DIS CHILD, V93, P799, DOI 10.1136/adc.2007.126508; Jochberger S, 2008, ANESTH ANALG, V106, P942, DOI 10.1213/ane.0b013e318166ecb8; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; KALTER HD, 1990, INT J EPIDEMIOL, V19, P380, DOI 10.1093/ije/19.2.380; Kalter HD, 1997, B WORLD HEALTH ORGAN, V75, P65; Khan WA, 2002, LANCET, V360, P1722, DOI 10.1016/S0140-6736(02)11680-1; Khilnani P, 2008, INDIAN J PEDIATR, V75, P591, DOI 10.1007/s12098-008-0115-5; Khilnani P, 2010, INDIAN J CRIT CARE M, V14, P41, DOI 10.4103/0972-5229.63029; Kissoon N, 2008, SAUDI MED J, V29, P1383; Kobusingye OC, 2005, B WORLD HEALTH ORGAN, V83, P626; Kolstad PR, 1997, B WORLD HEALTH ORGAN, V75, P77; Koyamaibole L, 2006, J TROP PEDIATRICS, V52, P249, DOI 10.1093/tropej/fmi109; Kugler JD, 1996, J PEDIATR-US, V129, P324, DOI 10.1016/S0022-3476(96)70063-X; Liu L, 2012, LANCET, V375, P1969; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Maitland K, 2009, P NUTR SOC, V68, P274, DOI 10.1017/S0029665109001359; Mamtani M, 2009, PEDIATR PULM, V44, P379, DOI 10.1002/ppul.21014; Maternova&TRADE;, INSP LOW COST BREATH; Mathers C. D., 2004, 54 WHO GLOB PROGR EV; McCollum ED, 2011, INT J TUBERC LUNG D, V15, P562, DOI 10.5588/ijtld.10.0583; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; Molyneux E, 2001, LANCET, V357, P86, DOI 10.1016/S0140-6736(00)03536-4; Muhe L, 2001, INT J TUBERC LUNG D, V5, P527; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Murray C.J.L., 2004, COMP QUANTIFICATION, V1, P257, DOI DOI 10.1007/S12263-011-0248-4; Nhan NT, 2001, CLIN INFECT DIS, V32, P204, DOI 10.1086/318479; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Nutrition Division Ministry of Health Malaysia, 2015, GUID REH PROGR MALN; Oliveira CF, 2008, PEDIATR EMERG CARE, V24, P810, DOI 10.1097/PEC.0b013e31818e9f3a; Olotu A, 2009, RESUSCITATION, V80, P69, DOI 10.1016/j.resuscitation.2008.09.019; OPIYO N, 2010, COCHRANE DB SYST REV, V4; Otieno H, 2004, ARCH DIS CHILD, V89, P977, DOI 10.1136/adc.2003.043901; Peterson S, 2004, LANCET, V363, P1955, DOI 10.1016/S0140-6736(04)16411-8; Raimer PL, 2011, J PEDIATR-US, V158, P968, DOI 10.1016/j.jpeds.2010.11.062; Ranjit Suchitra, 2005, Pediatr Crit Care Med, V6, P412, DOI 10.1097/01.PCC.0000163676.75693.BF; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Reyes H, 1997, HEALTH POLICY PLANN, V12, P214, DOI 10.1093/heapol/12.3.214; Rice AL., 2004, COMP QUANTIFICATION, V1, P0211; Robertson MA, 2001, ARCH DIS CHILD, V85, P208, DOI 10.1136/adc.85.3.208; ROCCHINI AP, 1981, AM J CARDIOL, V47, P1091, DOI 10.1016/0002-9149(81)90218-6; ROJAS MX, 2009, COCHRANE DB SYST REV, V1; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; SHANN F, 1989, PEDIATR INFECT DIS J, V8, P852, DOI 10.1097/00006454-198912000-00005; Simoes EAF, 2003, B WORLD HEALTH ORGAN, V81, P522; SINGHI S, 1994, ANN TROP PAEDIATR, V14, P53, DOI 10.1080/02724936.1994.11747692; Smart K, 2009, J TROP PEDIATRICS, V55, P145, DOI 10.1093/tropej/fmp046; Sodemann M, 1997, B WORLD HEALTH ORGAN, V75, P205; Soni Arun, 2001, Indian Journal of Pediatrics, V68, P1051, DOI 10.1007/BF02722356; Su L, 2010, MANAGEMENT SEPTIC SH; Tamburlini G, 1999, ARCH DIS CHILD, V81, P478, DOI 10.1136/adc.81.6.478; Tecklenburg FW, 2010, PEDIATR EMERG CARE, V26, P554, DOI 10.1097/PEC.0b013e3181ea71ca; Thirsk ER, 2003, SAMJ S AFR MED J, V93, P617; Thomson N, 2005, RESUSCITATION, V65, P15, DOI 10.1016/j.resuscitation.2005.01.008; Towey RM, 2007, ANAESTHESIA, V62, P32, DOI 10.1111/j.1365-2044.2007.05295.x; UNICEF, LEV TRENDS CHILD MOR; UNICEF, 2010, STAT AR CHILD SURV H; Van den Heuvel M, 2011, ANN TROP PAEDIATR, V31, P59, DOI 10.1179/1465328110Y.0000000001; Van der Merwe D M, 2004, Cardiovasc J S Afr, V15, P64; Viana ME, 1998, NEW HORIZ-SCI PRACT, V6, P226; WAISMAN Y, 1992, PEDIATRICS, V89, P302; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; Wandi F, 2006, ANN TROP PAEDIATR, V26, P277, DOI 10.1179/146532806X152791; WHO, 2012, REC MAN COMM CHILDH; WHO, 2005, HDB IMCI INT MAN CHI; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; World Health Organization, 2005, EM TRIAG ASS TREATM; World Health Organization, 2005, TREATM DIARRH MAN PH; Zar HJ, 2004, CURR OPIN PULM MED, V10, P176, DOI 10.1097/00063198-200405000-00006; Zar HJ, 1999, LANCET, V354, P979, DOI 10.1016/S0140-6736(98)12445-5	116	49	51	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2013	381	9862					256	265		10.1016/S0140-6736(12)61191-X	http://dx.doi.org/10.1016/S0140-6736(12)61191-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075LL	23332963				2022-12-28	WOS:000313887600037
J	Yu, Y; Chen, Y; Kim, B; Wang, H; Zhao, C; He, X; Liu, L; Liu, W; Wu, LMN; Mao, M; Chan, JR; Wu, J; Lu, QR				Yu, Yang; Chen, Ying; Kim, Bongwoo; Wang, Haibo; Zhao, Chuntao; He, Xuelian; Liu, Lei; Liu, Wei; Wu, Lai Man N.; Mao, Meng; Chan, Jonah R.; Wu, Jiang; Lu, Q. Richard			Olig2 Targets Chromatin Remodelers to Enhancers to Initiate Oligodendrocyte Differentiation	CELL			English	Article							COMPLEX; TRANSCRIPTION; MYELINATION; BIOLOGY; LESIONS; ROLES; CNS	Establishment of oligodendrocyte identity is crucial for subsequent events of myelination in the CNS. Here, we demonstrate that activation of ATP-dependent SWI/SNF chromatin-remodeling enzyme Smarca4/Brg1 at the differentiation onset is necessary and sufficient to initiate and promote oligodendrocyte lineage progression and maturation. Genome-wide multistage studies by ChIP-seq reveal that oligodendrocyte-lineage determination factor Olig2 functions as a prepatterning factor to direct Smarca4/Brg1 to oligodendrocyte-specific enhancers. Recruitment of Smarca4/Brg1 to distinct subsets of myelination regulatory genes is developmentally regulated. Functional analyses of Smarca4/Brg1 and Olig2 co-occupancy relative to chromatin epigenetic marking uncover stage-specific cis-regulatory elements that predict sets of transcriptional regulators controlling oligodendrocyte differentiation. Together, our results demonstrate that regulation of the functional specificity and activity of a Smarca4/Brg1-dependent chromatin-remodeling complex by Olig2, coupled with transcriptionally linked chromatin modifications, is critical to precisely initiate and establish the transcriptional program that promotes oligodendrocyte differentiation and subsequent myelination of the CNS.	[Yu, Yang; He, Xuelian; Liu, Lei; Liu, Wei; Mao, Meng] Sichuan Univ, W China Hosp 2, Key Lab Pediat Dis & Birth Defects, Inst Stem Cell & Dev Biol,Minist Educ,Dept Pediat, Chengdu 61004, Peoples R China; [Yu, Yang; He, Xuelian; Liu, Lei; Liu, Wei; Mao, Meng] Sichuan Univ, W China Hosp 2, Key Lab Pediat Dis & Birth Defects, Inst Stem Cell & Dev Biol,Minist Educ,Dept Obstet, Chengdu 61004, Peoples R China; [Yu, Yang; Chen, Ying; Kim, Bongwoo; Wang, Haibo; Zhao, Chuntao; He, Xuelian; Liu, Lei; Liu, Wei; Wu, Lai Man N.; Wu, Jiang; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Yu, Yang; Chen, Ying; Kim, Bongwoo; Wang, Haibo; Zhao, Chuntao; He, Xuelian; Liu, Lei; Liu, Wei; Wu, Lai Man N.; Wu, Jiang; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA; [Wu, Jiang] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Kim, Bongwoo; Chan, Jonah R.] Konkuk Univ, Dept Anim Biotechnol, Seoul 143701, South Korea; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	Sichuan University; Sichuan University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Konkuk University; University of California System; University of California San Francisco	Lu, QR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	qrichard.lu@utsouthwestern.edu		zhao, chuntao/0000-0002-2226-3827	US National Institutes of Health [R01NS072427, R01NS075243]; National Multiple Sclerosis Society [RG4568]; National Science Foundation of China [NSFC: 81270757]; program for Changjiang scholars and innovative research team in University [IRT0935]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072427, R01NS078092, R01NS075243] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for Changjiang scholars and innovative research team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank Tom Hu, Nana Li, Shujun Bai, Akiko Nishiyama, Huashun Li, Vanessa Schmid, and Sara Hildebrand for experimental support. We thank Drs. Lee Kraus, Charles Stiles, John Svaren, Jianrong Li, and Ed Hurlock for critical comments and suggestions. This study was funded in part by grants from the US National Institutes of Health (R01NS072427 and R01NS075243) and the National Multiple Sclerosis Society (RG4568) to Q.R.L., and National Science Foundation of China (NSFC: 81270757) to M.M., and program for Changjiang scholars and innovative research team in University (IRT0935).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Berger J, 2001, CURR OPIN NEUROL, V14, P305, DOI 10.1097/00019052-200106000-00007; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li HL, 2011, NEURON, V69, P918, DOI 10.1016/j.neuron.2011.01.030; Li HL, 2009, CURR OPIN NEUROBIOL, V19, P479, DOI 10.1016/j.conb.2009.08.004; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mazzoni EO, 2011, NAT METHODS, V8, P1056, DOI [10.1038/NMETH.1775, 10.1038/nmeth.1775]; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Nielsen JA, 2002, J CELL SCI, V115, P4071, DOI 10.1242/jcs.00103; PETERSON CL, 1994, P NATL ACAD SCI USA, V91, P2905, DOI 10.1073/pnas.91.8.2905; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Weider M, 2012, DEV CELL, V23, P193, DOI 10.1016/j.devcel.2012.05.017; Weng QJ, 2012, NEURON, V73, P713, DOI 10.1016/j.neuron.2011.12.021; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Yue T, 2006, J NEUROSCI, V26, P1275, DOI 10.1523/JNEUROSCI.4717-05.2006; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	46	226	235	1	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					248	261		10.1016/j.cell.2012.12.006	http://dx.doi.org/10.1016/j.cell.2012.12.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332759	Green Accepted, Bronze			2022-12-28	WOS:000313719800021
J	Consani, C; Aubock, G; van Mourik, F; Chergui, M				Consani, Cristina; Auboeck, Gerald; van Mourik, Frank; Chergui, Majed			Ultrafast Tryptophan-to-Heme Electron Transfer in Myoglobins Revealed by UV 2D Spectroscopy	SCIENCE			English	Article							RESONANCE ENERGY-TRANSFER; PICOSECOND FLUORESCENCE; DYNAMICS; PROTEINS; FEMTOSECOND; HEMOGLOBIN; SOLVATION; COMPLEXES; COHERENCE; BINDING	Tryptophan is commonly used to study protein structure and dynamics, such as protein folding, as a donor in fluorescence resonant energy transfer (FRET) studies. By using ultra-broadband ultrafast two-dimensional (2D) spectroscopy in the ultraviolet (UV) and transient absorption in the visible range, we have disentangled the excited state decay pathways of the tryptophan amino acid residues in ferric myoglobins (MbCN and metMb). Whereas the more distant tryptophan (Trp(7)) relaxes by energy transfer to the heme, Trp(14) excitation predominantly decays by electron transfer to the heme. The excited Trp(14)-> heme electron transfer occurs in <40 picoseconds with a quantum yield of more than 60%, over an edge-to-edge distance below similar to 10 angstroms, outcompeting the FRET process. Our results raise the question of whether such electron transfer pathways occur in a larger class of proteins.	[Consani, Cristina; Auboeck, Gerald; van Mourik, Frank; Chergui, Majed] Ecole Polytech Fed Lausanne, Lab Ultrafast Spect, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Chergui, M (corresponding author), Ecole Polytech Fed Lausanne, Lab Ultrafast Spect, CH-1015 Lausanne, Switzerland.	majed.chergui@epfl.ch		Consani, Cristina/0000-0002-4244-7324; Aubock, Gerald/0000-0001-8462-6825	National Center of Competence in Research-Molecular Ultrafast Science and Technology of the Swiss National Science Foundation;  [206021-121300]	National Center of Competence in Research-Molecular Ultrafast Science and Technology of the Swiss National Science Foundation; 	This work was supported by contract 206021-121300 and the National Center of Competence in Research-Molecular Ultrafast Science and Technology of the Swiss National Science Foundation.	Aubock G, 2012, OPT LETT, V37, P2337, DOI 10.1364/OL.37.002337; Balabin IA, 2012, J COMPUT CHEM, V33, P906, DOI 10.1002/jcc.22927; Baldwin J, 2000, J AM CHEM SOC, V122, P12195, DOI 10.1021/ja001278u; Balzani V., 2001, ELECT TRANSFER CHEM; BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Chang CW, 2010, P NATL ACAD SCI USA, V107, P2914, DOI 10.1073/pnas.1000001107; CHEN LXQ, 1987, CHEM PHYS LETT, V139, P55, DOI 10.1016/0009-2614(87)80150-1; Cordes M, 2009, CHEM SOC REV, V38, P892, DOI 10.1039/b805743p; DOSREMEDIOS CG, 1995, J STRUCT BIOL, V115, P175, DOI 10.1006/jsbi.1995.1042; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gruia F, 2008, BIOPHYS J, V94, P2252, DOI 10.1529/biophysj.107.122119; GU YG, 1993, J AM CHEM SOC, V115, P4993, DOI 10.1021/ja00065a007; Hamm P., 2011, CONCEPTS METHODS 2D, V1st; Helbing J, 2004, BIOPHYS J, V87, P1881, DOI 10.1529/biophysj.103.036236; HOCHSTRASSER RM, 1984, P NATL ACAD SCI-BIOL, V81, P4399, DOI 10.1073/pnas.81.14.4399; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MAYO SL, 1986, SCIENCE, V233, P948, DOI 10.1126/science.3016897; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PETRICH JW, 1991, BIOCHEMISTRY-US, V30, P3975, DOI 10.1021/bi00230a025; PETRICH JW, 1988, BIOPHYS J, V53, pA281; PETRICH JW, 1987, BIOCHEMISTRY-US, V26, P2711, DOI 10.1021/bi00384a010; Prytkova TR, 2007, SCIENCE, V315, P622, DOI 10.1126/science.1134862; Qiu WH, 2008, CHEM PHYS, V350, P154, DOI 10.1016/j.chemphys.2008.01.061; Reddy KS, 1996, BIOCHEMISTRY-US, V35, P5562, DOI 10.1021/bi952596m; Shih C, 2008, SCIENCE, V320, P1760, DOI 10.1126/science.1158241; Stevens JA, 2012, J PHYS CHEM A, V116, P2610, DOI 10.1021/jp206106j; Stevens JA, 2010, J PHYS CHEM B, V114, P1498, DOI 10.1021/jp910013f; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; WEBER G, 1959, DISCUSS FARADAY SOC, P134; WILLIS KJ, 1990, BIOCHEMISTRY-US, V29, P5270, DOI 10.1021/bi00474a008; Zhang LY, 2006, J PHYS CHEM B, V110, P18097, DOI 10.1021/jp063025e	35	107	108	1	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2013	339	6127					1586	1589		10.1126/science.1230758	http://dx.doi.org/10.1126/science.1230758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114HL	23393092				2022-12-28	WOS:000316731600043
J	Zhu, FC; Liang, ZL; Li, XL; Ge, HM; Meng, FY; Mao, QY; Zhang, YT; Hu, YM; Zhang, ZY; Li, JX; Gao, F; Chen, QH; Zhu, QY; Chu, K; Wu, X; Guo, YHJ; Chen, XQ; Liu, P; Dong, YY; Li, FX; Shen, XL; Wang, JZ				Zhu, Feng-Cai; Liang, Zheng-Lun; Li, Xiu-Ling; Ge, Heng-Ming; Meng, Fan-Yue; Mao, Qun-Ying; Zhang, Yun-Tao; Hu, Yue-Mei; Zhang, Zhen-Yu; Li, Jing-Xin; Gao, Fan; Chen, Qing-Hua; Zhu, Qi-Yan; Chu, Kai; Wu, Xing; Guo, Yao Hui-Jie; Chen, Xiao-Qin; Liu, Pei; Dong, Yu-Ying; Li, Feng-Xiang; Shen, Xin-Liang; Wang, Jun-Zhi			Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial	LANCET			English	Article							MOUTH-DISEASE; FOOT; HAND; TOLERABILITY; INFECTION; SCHEDULES; ANTIBODY	Background Enterovirus 71 (EV71) outbreaks are a socioeconomic burden, especially in the western Pacific region. Results of phase 1 clinical trials suggest an EV71 vaccine has a clinically acceptable safety profile and immunogenicity. We aimed to assess the best possible dose and formulation, immunogenicity, and safety profile of this EV71 vaccine in healthy Chinese children. Methods This randomised, double-blind, placebo-controlled, phase 2 trial was undertaken at one site in Donghai County, Jiangsu Province, China. Eligible participants were healthy boys or girls aged 6-36 months. Participants were randomly assigned (1: 1: 1: 1: 1) to receive either 160 U, 320 U, or 640 U alum-adjuvant EV71 vaccine, 640 U adjuvant-free EV71 vaccine, or a placebo (containing alum adjuvant only), according to a blocked randomisation list generated by SAS 9.1. Participants and investigators were masked to the assignment. The primary endpoint was anti-EV71 neutralising antibody geometric mean titres (GMTs) at day 56, analysed according to protocol. The study is registered with ClinicalTrials.gov, number NCT01399853. Findings We randomly assigned 1200 participants, 240 (120 aged 6-11 months [infants] and 120 aged 12-36 months [children]) of whom were assigned to each dose. 1106 participants completed the study and were included in the according-to-protocol analysis. The main reasons for dropout were withdrawal of consent and refusal to donate a blood sample. Infants who received the 640 U adjuvant vaccine had the highest GMTs on day 56 (742.2 [95% CI 577.3-954.3]), followed by those who received the 320 U formulation (497.9 [383.1-647.0]). For children, those who received the 320 U formulation had the highest GMTs on day 56 (1383.2 [1037.3-1844.5]). Participants who received the vaccine had significantly higher GMTs than did who received placebo (p<0.0001). For the subgroup of participants who were seronegative at baseline, both infants and children who received the 640 U adjuvant vaccine had the highest GMTs on day 56 (522.8 [403.9-676.6] in infants and 708.4 [524.1-957.6] in children), followed by those who received the 320 U adjuvant vaccine (358.2 [280.5-457.5] in infants and 498.0 [383.4-646.9] in children). 549 (45.8%) of 1200 participants (95 CI 42.9-48.6%) reported at least one injection-site or systemic adverse reaction, but the incidence of adverse reactions did not differ significantly between groups (p=0.36). The 640 U alum-adjuvant vaccine group had a significantly higher incidence of induration than did the 640 U adjuvant-free group (p=0.001). Interpretation Taking immunogenicity, safety, and production capacity into account, the 320 U alum-adjuvant formulation of the EV71 vaccine is probably the best possible formulation for phase 3 trials.	[Zhu, Feng-Cai; Meng, Fan-Yue; Li, Jing-Xin; Chu, Kai] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Liang, Zheng-Lun; Mao, Qun-Ying; Gao, Fan; Wu, Xing] Natl Inst Food & Drug Control, Beijing, Peoples R China; [Li, Xiu-Ling; Zhang, Yun-Tao; Chen, Qing-Hua; Guo, Yao Hui-Jie; Shen, Xin-Liang] Beijing Vigoo Biol, Beijing 100024, Peoples R China; [Ge, Heng-Ming; Zhang, Zhen-Yu; Zhu, Qi-Yan; Chen, Xiao-Qin] Donghai Country Ctr Dis Control & Prevent, Liangyungang, Jiangsu, Peoples R China; [Liu, Pei; Dong, Yu-Ying] Southeast Univ, Dept Publ Hlth, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; National Institute of Food & Drug Control - China; Southeast University - China	Shen, XL (corresponding author), Beijing Vigoo Biol, 4 Sanjianfangnanli, Beijing 100024, Peoples R China.	hen54@x263.net; wangjz@nicpbp.org.cn	li, xiu/GXV-1745-2022; Hu, Yue/HGE-1673-2022		National Science and Technology Major Project of the Chinese Ministry of Science and Technology [2011ZX10004-902]; China's 12-5 National Major Infectious Disease Program [2012ZX10002-001]; Beijing Vigoo Biological	National Science and Technology Major Project of the Chinese Ministry of Science and Technology; China's 12-5 National Major Infectious Disease Program; Beijing Vigoo Biological	The National Science and Technology Major Project (2011ZX10004-902) of the Chinese Ministry of Science and Technology, China's 12-5 National Major Infectious Disease Program (2012ZX10002-001), and Beijing Vigoo Biological.	AbuBakar S, 2000, NEW ENGL J MED, V342, P355; Asturias EJ, 2007, J INFECT DIS, V196, P692, DOI 10.1086/520546; Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; Bonnet MC, 2008, VACCINE, V26, P4978, DOI 10.1016/j.vaccine.2008.07.026; Chen CW, 2011, VACCINE, V29, P2772, DOI 10.1016/j.vaccine.2011.01.094; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Cordey S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002826; Deng CY, 2011, CLIN VACCINE IMMUNOL, V18, P1589, DOI 10.1128/CVI.05132-11; Gossger N, 2012, JAMA-J AM MED ASSOC, V307, P573, DOI 10.1001/jama.2012.85; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang WC, 2012, J MICROBIOL IMMUNOL, V45, P96, DOI 10.1016/j.jmii.2011.09.025; Koroleva G. A., 2010, Voprosy Virusologii, V55, P4; Leng Q, 2011, BMC P S1, V5, P27, DOI DOI 10.1186/1753-6561-5-S1-P27; Li YP, 2012, VACCINE, V30, P3295, DOI 10.1016/j.vaccine.2012.03.010; Liang ZL, 2011, VACCINE, V29, P9668, DOI 10.1016/j.vaccine.2011.10.018; Ma E, 2010, JPN J INFECT DIS, V63, P422; Mao QY, 2010, CHINESE MED J-PEKING, V123, P1679, DOI 10.3760/cma.j.issn.0366-6999.2010.13.012; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; Meng FY, 2012, HUM VACC IMMUNOTHER, V8, P669, DOI 10.4161/hv.19521; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Sarma Nilendu, 2009, Indian J Dermatol, V54, P26, DOI 10.4103/0019-5154.48982; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; State Food and Drug Administration, 2005, STAND GUID ADV REACT; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; WHO Weekly Epidemiological Record, 2010, WHO WEEKL EP REC POL; World Health Organization, 2004, POL LAB MAN, V4th; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Zhu FC, 2012, PEDIATR INFECT DIS J, V31, P1158, DOI 10.1097/INF.0b013e31826eba74	30	64	70	1	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2013	381	9871					1037	1045		10.1016/S0140-6736(12)61764-4	http://dx.doi.org/10.1016/S0140-6736(12)61764-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EU	23352749				2022-12-28	WOS:000316936800033
J	Mori, K; Weng, SM; Arzberger, T; May, S; Rentzsch, K; Kremmer, E; Schmid, B; Kretzschmar, HA; Cruts, M; Van Broeckhoven, C; Haass, C; Edbauer, D				Mori, Kohji; Weng, Shih-Ming; Arzberger, Thomas; May, Stephanie; Rentzsch, Kristin; Kremmer, Elisabeth; Schmid, Bettina; Kretzschmar, Hans A.; Cruts, Marc; Van Broeckhoven, Christine; Haass, Christian; Edbauer, Dieter			The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL DEMENTIA; HEXANUCLEOTIDE REPEAT; EXPANSION; IDENTIFICATION; INITIATION; FTD; ALS	Expansion of a GGGGCC hexanucleotide repeat upstream of the C9orf72 coding region is the most common cause of familial frontotemporal lobar degeneration and amyotrophic lateral sclerosis (FTLD/ALS), but the pathomechanisms involved are unknown. As in other FTLD/ALS variants, characteristic intracellular inclusions of misfolded proteins define C9orf72 pathology, but the core proteins of the majority of inclusions are still unknown. Here, we found that most of these characteristic inclusions contain poly-(Gly-Ala) and, to a lesser extent, poly-(Gly-Pro) and poly-(Gly-Arg) dipeptide-repeat proteins presumably generated by non-ATG-initiated translation from the expanded GGGGCC repeat in three reading frames. These findings directly link the FTLD/ALS-associated genetic mutation to the predominant pathology in patients with C9orf72 hexanucleotide expansion.	[Mori, Kohji; Haass, Christian; Edbauer, Dieter] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Weng, Shih-Ming; May, Stephanie; Rentzsch, Kristin; Schmid, Bettina; Haass, Christian; Edbauer, Dieter] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Arzberger, Thomas; Kretzschmar, Hans A.] Univ Munich, Ctr Neuropathol & Prion Res, D-81377 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Schmid, Bettina; Haass, Christian; Edbauer, Dieter] Univ Munich, Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Cruts, Marc; Van Broeckhoven, Christine] Univ Antwerp VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, B-2610 Antwerp, Belgium; [Cruts, Marc; Van Broeckhoven, Christine] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2610 Antwerp, Belgium	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp	Edbauer, D (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	dieter.edbauer@dzne.de	Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017; Cruts, Marc/J-6161-2013; Edbauer, Dieter/M-9906-2019; Mori, Kohji/AAM-8471-2020	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Cruts, Marc/0000-0002-1338-992X; Edbauer, Dieter/0000-0002-7186-4653; Mori, Kohji/0000-0003-2629-0723	Centres of Excellence in Neurodegeneration Research (CoEN); Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF); Alexander von Humboldt Foundation; Helmholtz Young Investigator program; MetLife Foundation Award; Belgian Science Policy Office Interuniversity Attraction Poles program; Foundation for Alzheimer Research (SAO/FRA); Medical Foundation Queen Elisabeth; Flemish Government Methusalem excellence program; Research Foundation Flanders (FWO); University Research Fund of the University of Antwerp	Centres of Excellence in Neurodegeneration Research (CoEN); Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Helmholtz Young Investigator program; MetLife Foundation Award; Belgian Science Policy Office Interuniversity Attraction Poles program; Foundation for Alzheimer Research (SAO/FRA); Medical Foundation Queen Elisabeth; Flemish Government Methusalem excellence program; Research Foundation Flanders (FWO)(FWO); University Research Fund of the University of Antwerp	We thank I. Pigur for technical assistance, M. Neumann for genotyping of some of the LMU cases, and J. Banzhaf-Strathmann, F. van Bebber, E. Bentmann, D. Dormann, J. Herms, A. Hruscha, G. Kleinberger, J. McCarter, D. Orozco, and B. Schwenk for critical comments. This project was supported by a grant from the Centres of Excellence in Neurodegeneration Research (CoEN) to M. C., C. H., C. V. B., B. S., and D. E., and the Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF) to C. H. K. M. was supported by a postdoctoral fellowship from the Alexander von Humboldt Foundation. D. E. was supported by the Helmholtz Young Investigator program. We thank all clinicians recruiting brain donors, in particular H.-H. Klunemann (Bezirksklinikum Regensburg) and, most notably, all brain donors and their next of kin. We acknowledge the Antwerp biobank of the Institute Born-Bunge for brain samples, as well as T. Van Langenhove, J. van der Zee, S. Engelborghs, P. P. De Deyn, A. Sieben, and J.-J. Martin for genetic, clinical, and pathological diagnoses. The Antwerp site is supported by the MetLife Foundation Award (to C. V. B.), the Belgian Science Policy Office Interuniversity Attraction Poles program, the Foundation for Alzheimer Research (SAO/FRA), the Medical Foundation Queen Elisabeth, the Flemish Government Methusalem excellence program, the Research Foundation Flanders (FWO), and the University Research Fund of the University of Antwerp. A patent application concerning DPR-based diagnosis and therapy of neurodegenerative disorders has been filed by K. M., S.-M. W., T. A., K. R., E. K., C.H., and D.E.	Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Bigio EH, 2013, NEUROPATHOLOGY, V33, P122, DOI 10.1111/j.1440-1789.2012.01332.x; Boxer AL, 2011, J NEUROL NEUROSUR PS, V82, P196, DOI 10.1136/jnnp.2009.204081; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Josephs KA, 2011, ACTA NEUROPATHOL, V122, P137, DOI 10.1007/s00401-011-0839-6; KREMMER E, 1995, VIROLOGY, V208, P336, DOI 10.1006/viro.1995.1157; Li H, 2003, HUM MOL GENET, V12, P2021, DOI 10.1093/hmg/ddg218; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mahoney CJ, 2012, BRAIN, V135, P736, DOI 10.1093/brain/awr361; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Pearson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002018; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; van der Zee J, 2013, HUM MUTAT, V34, P363, DOI 10.1002/humu.22244; Whitwell JL, 2012, BRAIN, V135, P794, DOI 10.1093/brain/aws001; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	20	842	862	5	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2013	339	6125					1335	1338		10.1126/science.1232927	http://dx.doi.org/10.1126/science.1232927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23393093				2022-12-28	WOS:000316053400042
J	Chen, LM; Kennedy, EH; Sales, A; Hofer, TP				Chen, Lena M.; Kennedy, Edward H.; Sales, Anne; Hofer, Timothy P.			Use of Health IT for Higher-Value Critical Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Chen, Lena M.; Hofer, Timothy P.] Univ Michigan, Dept Internal Med, Div Gen Med, Ann Arbor, MI 48109 USA; [Sales, Anne] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Chen, Lena M.; Kennedy, Edward H.; Sales, Anne; Hofer, Timothy P.] VA Ann Arbor Healthcare Syst, VA Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Chen, LM (corresponding author), Univ Michigan, Dept Internal Med, Div Gen Med, Ann Arbor, MI 48109 USA.		Hofer, Timothy Philip/AAC-9238-2022; Kennedy, Edward/B-5371-2018; Sales, Anne E/D-9678-2012	Kennedy, Edward/0000-0002-0227-158X; Sales, Anne E/0000-0001-9360-3334; Hofer, Timothy/0000-0003-0434-8787	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS020671] Funding Source: NIH RePORTER; AHRQ HHS [K08 HS020671] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		American Thoracic Society, WHAT IS PURP INT CAR; Chen LM, 2012, ARCH INTERN MED, V172, P1220, DOI 10.1001/archinternmed.2012.2606; Lilly CM, 2011, CHEST, V140, P1232, DOI 10.1378/chest.11-0718; The Leapfrog Group, FACTSH ICU PHYS STAF; Wunsch H, 2011, AM J RESP CRIT CARE, V183, P1666, DOI 10.1164/rccm.201012-1961OC	5	19	20	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					594	597		10.1056/NEJMp1213273	http://dx.doi.org/10.1056/NEJMp1213273			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194VA	23363474				2022-12-28	WOS:000322659600004
J	Huch, M; Dorrell, C; Boj, SF; van Es, JH; Li, VSW; van de Wetering, M; Sato, T; Hamer, K; Sasaki, N; Finegold, MJ; Haft, A; Vries, RG; Grompe, M; Clevers, H				Huch, Meritxell; Dorrell, Craig; Boj, Sylvia F.; van Es, Johan H.; Li, Vivian S. W.; van de Wetering, Marc; Sato, Toshiro; Hamer, Karien; Sasaki, Nobuo; Finegold, Milton J.; Haft, Annelise; Vries, Robert G.; Grompe, Markus; Clevers, Hans			In vitro expansion of single Lgr5(+) liver stem cells induced by Wnt-driven regeneration	NATURE			English	Article							PROGENITOR CELLS; MOUSE-LIVER; DIFFERENTIATION; EXPRESSION; MICE; HEPATOCYTES; EPITHELIUM; RECEPTORS; COLON; GENE	The Wnt target gene Lgr5 (leucine-rich-repeat-containing G-protein-coupled receptor 5) marks actively dividing stem cells in Wnt-driven, self-renewing tissues such as small intestine and colon(1), stomach(2) and hair follicles(3). A three-dimensional culture system allows long-term clonal expansion of single Lgr5(+) stem cells into transplantable organoids (budding cysts) that retain many characteristics of the original epithelial architecture(2,4,5). A crucial component of the culture medium is the Wnt agonist RSPO1(6), the recently discovered ligand of LGR5(7,8). Here we show that Lgr5-lacZ is not expressed in healthy adult liver, however, small Lgr5-LacZ(+) cells appear near bile ducts upon damage, coinciding with robust activation of Wnt signalling. As shown by mouse lineage tracing using a new Lgr5-IRES-creERT2 knock-in allele, damage-induced Lgr5(+) cells generate hepatocytes and bile ducts in vivo. Single Lgr5(+) cells from damaged mouse liver can be clonally expanded as organoids in Rspo1-based culture medium over several months. Such clonal organoids can be induced to differentiate in vitro and to generate functional hepatocytes upon transplantation into Fah(-/-) mice. These findings indicate that previous observations concerning Lgr5(+) stem cells in actively self-renewing tissues can also be extended to damage-induced stem cells in a tissue with a low rate of spontaneous proliferation.	[Huch, Meritxell; Boj, Sylvia F.; van Es, Johan H.; Li, Vivian S. W.; van de Wetering, Marc; Sato, Toshiro; Hamer, Karien; Sasaki, Nobuo; Vries, Robert G.; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [Huch, Meritxell; Boj, Sylvia F.; van Es, Johan H.; Li, Vivian S. W.; van de Wetering, Marc; Sato, Toshiro; Hamer, Karien; Sasaki, Nobuo; Vries, Robert G.; Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Dorrell, Craig; Haft, Annelise; Grompe, Markus] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Pape Family Pediat Res Inst, Portland, OR 97239 USA; [Finegold, Milton J.] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Oregon Health & Science University; Baylor College of Medicine	Clevers, H (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	van+Es, Johan/ABD-5411-2021; Sato, Toshiro/J-3522-2014; Sasaki, Nobuo/HDO-8251-2022	Sato, Toshiro/0000-0001-8353-8137; Sasaki, Nobuo/0000-0002-8798-7244; Grompe, Markus/0000-0002-6616-4345; Li, Vivian/0000-0003-2041-0085	 [EU/236954];  [EU/232814];  [Ti Pharma/T3-106]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK051592] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Begthel, A. Buijs, W. Karthaus, C. Kroon-Veenboer, M. van den Born, S. van der Brink, and L. Zeinstra for technical assistance. This work was supported by grants to M.H. (EU/236954), S.F.B. (EU/232814), and V.S.W.L. and J.H.v.E. (Ti Pharma/T3-106).	Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kamiya A, 2009, GASTROENTEROLOGY, V137, P1114, DOI 10.1053/j.gastro.2009.06.001; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Michalopoulos GK, 2001, AM J PATHOL, V159, P1877, DOI 10.1016/S0002-9440(10)63034-9; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Preisegger KH, 1999, LAB INVEST, V79, P103; Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STOWELL RE, 1950, AMA ARCH PATHOL, V50, P519; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318	30	915	984	9	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					247	250		10.1038/nature11826	http://dx.doi.org/10.1038/nature11826			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23354049	Green Accepted			2022-12-28	WOS:000315137700042
J	Venkatakrishnan, AJ; Deupi, X; Lebon, G; Tate, CG; Schertler, GF; Babu, MM				Venkatakrishnan, A. J.; Deupi, Xavier; Lebon, Guillaume; Tate, Christopher G.; Schertler, Gebhard F.; Babu, M. Madan			Molecular signatures of G-protein-coupled receptors	NATURE			English	Review							RESOLUTION CRYSTAL-STRUCTURE; ADENOSINE A(2A) RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; STRUCTURAL INSIGHTS; ALLOSTERIC COMMUNICATION; DISTINCT CONFORMATIONS; TRANSMEMBRANE HELICES; ACTIVATED STATE; COMPLEX; AGONIST	G-protein-coupled receptors (GPCRs) are physiologically important membrane proteins that sense signalling molecules such as hormones and neurotransmitters, and are the targets of several prescribed drugs. Recent exciting developments are providing unprecedented insights into the structure and function of several medically important GPCRs. Here, through a systematic analysis of high-resolution GPCR structures, we uncover a conserved network of non-covalent contacts that defines the GPCR fold. Furthermore, our comparative analysis reveals characteristic features of ligand binding and conformational changes during receptor activation. A holistic understanding that integrates molecular and systems biology of GPCRs holds promise for new therapeutics and personalized medicine.	[Venkatakrishnan, A. J.; Lebon, Guillaume; Tate, Christopher G.; Babu, M. Madan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Deupi, Xavier; Schertler, Gebhard F.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Lebon, Guillaume] CNRS, UMR 5203, Inst Genom Fonct, F-34094 Montpellier, France; [Lebon, Guillaume] CNRS, INSERM, U661, F-34094 Montpellier, France; [Lebon, Guillaume] Univ Montpellier I, UMR 5203, F-34094 Montpellier, France; [Lebon, Guillaume] Univ Montpellier 2, UMR 5203, F-34094 Montpellier, France; [Schertler, Gebhard F.] ETH, Dept Biol, CH-8093 Zurich, Switzerland	MRC Laboratory Molecular Biology; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Swiss Federal Institutes of Technology Domain; ETH Zurich	Venkatakrishnan, AJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ajv@mrc-lmb.cam.ac.uk; madanm@mrc-lmb.cam.ac.uk	Mohan, Babu P./I-7362-2019; Schertler, Gebhard/M-9512-2014; Centeno, Patricia Pacios/O-8368-2016; Deupi, Xavier/B-2424-2009; Lebon, Guillaume/AAZ-4486-2020	Deupi, Xavier/0000-0003-4572-9316; Guillaume, Lebon/0000-0003-1162-5148; Schertler, Gebhard F.X./0000-0002-5846-6810; Tate, Christopher/0000-0002-2008-9183	UK Medical Research Council [U105185859, U105197215]; HFSP [RGY0073/2010]; EMBO Young Investigator Program; ERASysBio+ (GRAPPLE); LMB Cambridge Scholarship; St. John's College Benefactor Scholarship; Heptares Therapeutics; CNRS; Agence Nationale de la Recherche [ANR-09-BLAN-0272]; Swiss National Science Foundation [31003A_132815]; ETH Zurich within the framework of the National Center for Competence in Research in Structural Biology Program; Medical Research Council Technology Development Gap Fund; Pfizer; Medical Research Council [MC_U105197215, MC_U105185859] Funding Source: researchfish; MRC [MC_U105197215, MC_U105185859] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HFSP(Human Frontier Science Program); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); ERASysBio+ (GRAPPLE); LMB Cambridge Scholarship; St. John's College Benefactor Scholarship; Heptares Therapeutics; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich within the framework of the National Center for Competence in Research in Structural Biology Program; Medical Research Council Technology Development Gap Fund(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Deonarine, C. Chothia, D. Ghosal, J. Marsh, J. Garcia-Nafria, K. R. Vinothkumar, R. Henderson, R. Hegde, S. Balaji, S. Chavali and T. Flock for their comments on this work. This work was supported by the UK Medical Research Council (U105185859), HFSP (RGY0073/2010; M.M.B.), the EMBO Young Investigator Program (M.M.B), and ERASysBio+ (GRAPPLE; M.M.B.). A.J.V. acknowledges LMB Cambridge Scholarship and St. John's College Benefactor Scholarship for financial support. G.L. was funded by Heptares Therapeutics, the UK Medical Research Council and by the CNRS and Agence Nationale de la Recherche (grant ANR-09-BLAN-0272). X.D. and G.F.S. acknowledge the Swiss National Science Foundation (grant 31003A_132815) and the ETH Zurich within the framework of the National Center for Competence in Research in Structural Biology Program for financial support. C.G.T. acknowledges the Medical Research Council Technology Development Gap Fund, Pfizer, and core funding from the UK Medical Research Council (U105197215). We apologize to our colleagues whose work was not cited owing to space limitations.	Ahles A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001681; Ahuja S, 2009, J BIOL CHEM, V284, P10190, DOI 10.1074/jbc.M805725200; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Bockenhauer S, 2011, J PHYS CHEM B, V115, P13328, DOI 10.1021/jp204843r; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Congreve M, 2012, J MED CHEM, V55, P1898, DOI 10.1021/jm201376w; Congreve M, 2011, J MED CHEM, V54, P4283, DOI 10.1021/jm200371q; Deupi X, 2012, BIOCHEM SOC T, V40, P383, DOI 10.1042/BST20120001; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Gonzalez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023815; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Heinis C, 2009, NAT CHEM BIOL, V5, P502, DOI 10.1038/nchembio.184; Heitz F, 1999, EUR J PHARMACOL, V380, P183, DOI 10.1016/S0014-2999(99)00439-2; Herr DR, 2012, INT REV CEL MOL BIO, V297, P45, DOI 10.1016/B978-0-12-394308-8.00002-9; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Huber T, 2011, TRENDS PHARMACOL SCI, V32, P410, DOI 10.1016/j.tips.2011.03.004; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jaakola VP, 2005, PROTEIN ENG DES SEL, V18, P103, DOI 10.1093/protein/gzi004; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kiel C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.83; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lebon G, 2012, CURR OPIN STRUC BIOL, V22, P482, DOI 10.1016/j.sbi.2012.03.007; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Manglik A, 2012, NATURE; Moukhametzianov R, 2008, ACTA CRYSTALLOGR D, V64, P158, DOI 10.1107/S090744490705812X; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Provasi D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002193; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schlinkmann KM, 2012, P NATL ACAD SCI USA, V109, P9810, DOI 10.1073/pnas.1202107109; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501; Vaidehi N, 2010, CURR OPIN PHARMACOL, V10, P775, DOI 10.1016/j.coph.2010.09.004; Valant C, 2012, ANNU REV PHARMACOL, V52, P153, DOI 10.1146/annurev-pharmtox-010611-134514; VALIQUETTE M, 1995, EMBO J, V14, P5542, DOI 10.1002/j.1460-2075.1995.tb00241.x; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; West GM, 2011, STRUCTURE, V19, P1424, DOI 10.1016/j.str.2011.08.001; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	100	1013	1037	18	709	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					185	194		10.1038/nature11896	http://dx.doi.org/10.1038/nature11896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23407534				2022-12-28	WOS:000315137700030
J	Goldenfeld, N; Pace, NR				Goldenfeld, Nigel; Pace, Norman R.			Carl R. Woese (1928-2012) RETROSPECTIVE	SCIENCE			English	Biographical-Item									[Goldenfeld, Nigel] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Goldenfeld, Nigel] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Pace, Norman R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Colorado System; University of Colorado Boulder	Goldenfeld, N (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	nigel@illinois.edu							0	3	3	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					661	661		10.1126/science.1235219	http://dx.doi.org/10.1126/science.1235219			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393257				2022-12-28	WOS:000314585600032
J	Renne, PR; Deino, AL; Hilgen, FJ; Kuiper, KF; Mark, DF; Mitchell, WS; Morgan, LE; Mundil, R; Smit, J				Renne, Paul R.; Deino, Alan L.; Hilgen, Frederik J.; Kuiper, Klaudia F.; Mark, Darren F.; Mitchell, William S., III; Morgan, Leah E.; Mundil, Roland; Smit, Jan			Time Scales of Critical Events Around the Cretaceous-Paleogene Boundary	SCIENCE			English	Article							TERTIARY BOUNDARY; MASS EXTINCTION; CHICXULUB CRATER; ASTEROID IMPACT; HELL CREEK; TERRESTRIAL; CLIMATE; AGES; CONSEQUENCES; VOLCANISM	Mass extinctions manifest in Earth's geologic record were turning points in biotic evolution. We present 40Ar/39Ar data that establish synchrony between the Cretaceous-Paleogene boundary and associated mass extinctions with the Chicxulub bolide impact to within 32,000 years. Perturbation of the atmospheric carbon cycle at the boundary likely lasted less than 5000 years, exhibiting a recovery time scale two to three orders of magnitude shorter than that of the major ocean basins. Low-diversity mammalian fauna in the western Williston Basin persisted for as little as 20,000 years after the impact. The Chicxulub impact likely triggered a state shift of ecosystems already under near-critical stress.	[Renne, Paul R.; Deino, Alan L.; Mundil, Roland] Berkeley Geochronol Ctr BGC, Berkeley, CA 94709 USA; [Renne, Paul R.; Mitchell, William S., III] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Hilgen, Frederik J.] Univ Utrecht, Dept Earth Sci, Fac Geosci, NL-3584 CD Utrecht, Netherlands; [Kuiper, Klaudia F.; Smit, Jan] Vrije Univ Amsterdam, Inst Earth Sci, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands; [Mark, Darren F.; Morgan, Leah E.] Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland; [Mitchell, William S., III] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Berkeley Geochronolgy Center; University of California System; University of California Berkeley; Utrecht University; Vrije Universiteit Amsterdam; Scottish Universities Research & Reactor Center; University of California System; University of California Berkeley	Renne, PR (corresponding author), Berkeley Geochronol Ctr BGC, 2455 Ridge Rd, Berkeley, CA 94709 USA.	prenne@bgc.org		Renne, Paul/0000-0003-1769-5235; Mitchell, William/0000-0002-0845-7051; Smit, Jan/0000-0002-6070-4865; Hilgen, Frits/0000-0002-5683-259X; Morgan, Leah/0000-0001-9930-524X	Ann and Gordon Getty Foundation; U.C. Berkeley's Esper S. Larsen Jr. Fund; NSF [EAR 0844098, EAR 0451802]; Natural Environment Research Council of the Argon Isotope Facility at the Scottish Universities Environmental Research Centre; Marie Curie Foundation; Marie Curie Fellowship program; Netherlands Organisation for Scientific Research [863.07.009]; Natural Environment Research Council [aif10001] Funding Source: researchfish; NERC [aif10001] Funding Source: UKRI	Ann and Gordon Getty Foundation; U.C. Berkeley's Esper S. Larsen Jr. Fund; NSF(National Science Foundation (NSF)); Natural Environment Research Council of the Argon Isotope Facility at the Scottish Universities Environmental Research Centre; Marie Curie Foundation(European Commission); Marie Curie Fellowship program(European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Ann and Gordon Getty Foundation, U.C. Berkeley's Esper S. Larsen Jr. Fund, and NSF (grants EAR 0844098 and EAR 0451802) for support of B.G.C.'s work; the Natural Environment Research Council for continued funding of the Argon Isotope Facility at the Scottish Universities Environmental Research Centre; the GTSNext project of the Marie Curie Foundation; the Marie Curie Fellowship program for support of L.E.M.; the Netherlands Organisation for Scientific Research (grant 863.07.009) for support of K.F.K.; F. Maurrasse for providing the tektites; W. Alvarez, A. Barnosky, W. Clemens, T. White, and G. Wilson for discussion and comments on the manuscript; and three anonymous reviewers for helpful suggestions. Data are available in the supplementary materials.	ALVAREZ LW, 1983, P NATL ACAD SCI USA, V80, P627, DOI 10.1073/pnas.80.2.627; Archibald JD, 2010, SCIENCE, V328, P973, DOI 10.1126/science.328.5981.973-a; Arens NC, 2008, PALEOBIOLOGY, V34, P456, DOI 10.1666/07034.1; Arens NC, 2000, PALAIOS, V15, P314, DOI 10.2307/3515539; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; BAADSGAARD H, 1988, CAN J EARTH SCI, V25, P1088, DOI 10.1139/e88-106; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barrera E, 1999, GEOL S AM S, P245; Chenet AL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005644; Clemens WA, 2002, GEOL S AM S, P217; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Courtillot V, 2010, SCIENCE, V328, P973, DOI 10.1126/science.328.5981.973-b; D'Hondt S, 2005, ANNU REV ECOL EVOL S, V36, P295, DOI 10.1146/annurev.ecolsys.35.021103.105715; Dalrymple GB, 1993, US GEOL SURV B, V2065, p1 ; HILDEBRAND AR, 1991, GEOLOGY, V19, P867, DOI 10.1130/0091-7613(1991)019<0867:CCAPCT>2.3.CO;2; Husson D, 2011, EARTH PLANET SC LETT, V305, P328, DOI 10.1016/j.epsl.2011.03.008; Keller G, 2008, CRETACEOUS RES, V29, P754, DOI 10.1016/j.cretres.2008.05.030; Keller G, 2007, EARTH PLANET SC LETT, V255, P339, DOI 10.1016/j.epsl.2006.12.026; Keller G, 2010, SCIENCE, V328, P974, DOI 10.1126/science.328.5981.974-a; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Li LQ, 1998, MAR MICROPALEONTOL, V33, P55, DOI 10.1016/S0377-8398(97)00027-3; MAURRASSE FJMR, 1991, SCIENCE, V252, P1690, DOI 10.1126/science.252.5013.1690; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Murphy EC, 2002, GEOL S AM S, P9; Renne PR, 2011, GEOCHIM COSMOCHIM AC, V75, P5097, DOI 10.1016/j.gca.2011.06.021; Robinson N, 2009, EARTH PLANET SC LETT, V281, P159, DOI 10.1016/j.epsl.2009.02.019; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Self S, 2006, PHILOS T R SOC A, V364, P2073, DOI 10.1098/rsta.2006.1814; SIGURDSSON H, 1991, NATURE, V353, P839, DOI 10.1038/353839a0; SMIT J, 1990, GEOL MIJNBOUW, V69, P187; SMIT J, 1984, SCIENCE, V223, P1177, DOI 10.1126/science.223.4641.1177; SWISHER CC, 1992, SCIENCE, V257, P954, DOI 10.1126/science.257.5072.954; SWISHER CC, 1993, CAN J EARTH SCI, V30, P1981, DOI 10.1139/e93-174; Tobin TS, 2012, PALAEOGEOGR PALAEOCL, V350, P180, DOI 10.1016/j.palaeo.2012.06.029; Westerhold T, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004096; Wilf P, 2003, P NATL ACAD SCI USA, V100, P599, DOI 10.1073/pnas.0234701100; Wilson Gregory P., 2005, Journal of Mammalian Evolution, V12, P53, DOI 10.1007/s10914-005-6943-4	39	372	388	5	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					684	687		10.1126/science.1230492	http://dx.doi.org/10.1126/science.1230492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393261				2022-12-28	WOS:000314585600039
J	Patel, K				Patel, Kinesh			End the silence on animal products in drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk						Humane Research Council, 2012, VEG FOODS MARK ASS 2	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2013	346								f722	10.1136/bmj.f722	http://dx.doi.org/10.1136/bmj.f722			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AR	23386407				2022-12-28	WOS:000314806700009
J	McGorry, P; van Os, J				McGorry, Patrick; van Os, Jim			Redeeming diagnosis in psychiatry: timing versus specificity	LANCET			English	Editorial Material							ATTENUATED PSYCHOSIS SYNDROME; DISORDERS		[McGorry, Patrick] Univ Melbourne, Orygen Youth Hlth Res Ctr, Melbourne, Vic, Australia; [McGorry, Patrick] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia; [van Os, Jim] Maastricht Univ, European Grad Sch Neurosci, Dept Psychiat & Psychol, S Limburg Mental Hlth Res & Teaching Network, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Maastricht University; University of London; King's College London	McGorry, P (corresponding author), Univ Melbourne, Orygen Youth Hlth Res Ctr, Parkville, Vic 3052, Australia.	pmcgorry@unimelb.edu.au	van Os, Jim/C-2113-2014; McGorry, Patrick/O-4115-2019; van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	van Os, Jim/0000-0002-7245-1586; McGorry, Patrick/0000-0002-3789-6168				Ahuja A, 2012, AUSTR FINANCIAL 0323; Angell M, ILLUSIONS PSYCHIAT; Boseley S., 2012, PSYCHOL FEAR US MANU; Carey B., 2012, NEW DEFINITION AUTIS; Carpenter WT, 2011, AM J PSYCHIAT, V168, P460, DOI 10.1176/appi.ajp.2011.10121816; Cuthbert BN, 2010, SCHIZOPHRENIA BULL, V36, P1061, DOI 10.1093/schbul/sbq108; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; EATON WW, 1995, AM J PSYCHIAT, V152, P967; EISENBERG L, 1986, BRIT J PSYCHIAT, V148, P497, DOI 10.1192/bjp.148.5.497; Frances A., 2012, GOOD GRIEF; Fusar-Poli P, 2012, LANCET, V379, P591, DOI 10.1016/S0140-6736(11)61507-9; Judd LL, 2002, PSYCHIAT CLIN N AM, V25, P685, DOI 10.1016/S0193-953X(02)00026-6; Kaymaz N, 2012, PSYCHOL MED, V20, P1; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; Kendler KS, 2010, PSYCHOL MED, V40, P801, DOI 10.1017/S0033291709991140; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; McGorry PD, 2006, AUST NZ J PSYCHIAT, V40, P616, DOI 10.1111/j.1440-1614.2006.01860.x; McGorry PD, 2011, CURR OPIN PSYCHIATR, V24, P301, DOI 10.1097/YCO.0b013e3283477a09; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Rutledge R, 1998, J TRAUMA, V45, P791, DOI 10.1097/00005373-199810000-00032; van Os J, 2012, SCHIZOPHRENIA BULL, V38, P227, DOI 10.1093/schbul/sbr188; Woods SW, 2010, SCHIZOPHR RES, V123, P199, DOI 10.1016/j.schres.2010.08.012	22	133	135	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2013	381	9863					343	345		10.1016/S0140-6736(12)61268-9	http://dx.doi.org/10.1016/S0140-6736(12)61268-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23351805				2022-12-28	WOS:000314021800031
J	Cirtain, JW; Golub, L; Winebarger, AR; De Pontieu, B; Kobayashi, K; Moore, RL; Walsh, RW; Korreck, KE; Weber, M; McCauley, P; Title, A; Kuzin, S; DeForest, CE				Cirtain, J. W.; Golub, L.; Winebarger, A. R.; De Pontieu, B.; Kobayashi, K.; Moore, R. L.; Walsh, R. W.; Korreck, K. E.; Weber, M.; McCauley, P.; Title, A.; Kuzin, S.; DeForest, C. E.			Energy release in the solar corona from spatially resolved magnetic braids	NATURE			English	Article							EVOLVING FIELDS; ALFVENIC WAVES; NEUTRAL SHEETS; POWER	It is now apparent that there are at least two heating mechanisms in the Sun's outer atmosphere, or corona(1-5). Wave heating may be the prevalent mechanism in quiet solar periods and may contribute to heating the corona to 1,500,000K (refs 1-3). The active corona needs additional heating to reach 2,000,000-4,000,000 K; this heat has been theoretically proposed(6-12) to come from the reconnection and unravelling of magnetic 'braids'. Evidence favouring that process has been inferred(13,14), but has not been generally accepted because observations are sparse and, in general, the braided magnetic strands that are thought(1-3,15-17) to have an angular width of about 0.2 arc seconds have not been resolved(10,18-20). Fine-scale braiding has been seen(21,22) in the chromosphere but not, until now, in the corona. Here we report observations, at a resolution of 0.2 arc seconds, of magnetic braids in a coronal active region that are reconnecting, relaxing and dissipating sufficient energy to heat the structures to about 4,000,000K. Although our 5-minute observations cannot unambiguously identify the field reconnection and subsequent relaxation as the dominant heating mechanism throughout active regions, the energy available from the observed field relaxation in our example is ample for the observed heating.	[Golub, L.; Korreck, K. E.; Weber, M.; McCauley, P.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [De Pontieu, B.; Title, A.] Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA; [Kobayashi, K.] Univ Alabama Huntsville, Ctr Space & Aeronaut Res, Huntsville, AL 35812 USA; [Walsh, R. W.] Univ Cent Lancashire, Preston PR1 2HE, Lancs, England; [Kuzin, S.] PN Lebedev Phys Inst, Moscow 119991, Russia; [DeForest, C. E.] SW Res Inst, Instrumentat & Space Res Div, Boulder, CO 80302 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Lockheed Martin; University of Alabama System; University of Alabama Huntsville; University of Central Lancashire; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute		jonathan.w.cirtain@nasa.gov	Kuzin, Sergey/M-3435-2015; McCauley, Patrick/P-7747-2015	McCauley, Patrick/0000-0002-1450-7350; Golub, Leon/0000-0001-9638-3082; Kobayashi, Ken/0000-0003-1057-7113; Walsh, Robert/0000-0002-1025-9863	Russian Foundation for Basic Research [11-02-01079-a]; Presidium of the Russian Academy of Sciences [22]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	We thank the NASA Low-Cost Access to Space programme for supporting the development of the Hi-C instrument, the NASA Sounding Rocket Office for the launch of the instrument and the NASA Marshall Space Flight Center for instrument development support. This LPI work was supported in part by the Russian Foundation for Basic Research (project 11-02-01079-a), Program No. 22 of the Presidium of the Russian Academy of Sciences.	Berger MA, 2009, ASTROPHYS J, V705, P347, DOI 10.1088/0004-637X/705/1/347; Cirtain JW, 2007, SCIENCE, V318, P1580, DOI 10.1126/science.1147050; Culhane JL, 2007, SOL PHYS, V243, P19, DOI 10.1007/s01007-007-0293-1; De Pontieu B, 2007, SCIENCE, V318, P1574, DOI 10.1126/science.1151747; De Pontieu B, 2011, SCIENCE, V331, P55, DOI 10.1126/science.1197738; De Pontieu B, 2009, ASTROPHYS J LETT, V701, pL1, DOI 10.1088/0004-637X/701/1/L1; DeForest CE, 2007, ASTROPHYS J, V661, P532, DOI 10.1086/515561; Gold T, 1965, P IAU S, V22; Gudiksen BV, 2005, ASTROPHYS J, V618, P1020, DOI 10.1086/426063; Klimchuk JA, 2006, SOL PHYS, V234, P41, DOI 10.1007/s11207-006-0055-z; Lee JW, 1998, ASTROPHYS J, V501, P853, DOI 10.1086/305851; Lemen JR, 2012, SOL PHYS, V275, P17, DOI 10.1007/s11207-011-9776-8; Malanushenko A, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/97; Martin SF, 1998, SOL PHYS, V182, P107, DOI 10.1023/A:1005026814076; McIntosh SW, 2011, NATURE, V475, P477, DOI 10.1038/nature10235; PARKER EN, 1983, ASTROPHYS J, V264, P635, DOI 10.1086/160636; PARKER EN, 1983, ASTROPHYS J, V264, P642, DOI 10.1086/160637; Priest ER, 1998, NATURE, V393, P545, DOI 10.1038/31166; Rutten RJ, 2008, ASTR SOC P, V397, P54; Schrijver CJ, 2007, ASTROPHYS J, V662, pL119, DOI 10.1086/519455; Schrijver CJ, 1998, NATURE, V394, P152, DOI 10.1038/28108; van Ballegooijen AA, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/3; Warren HP, 2002, ASTROPHYS J, V579, pL41, DOI 10.1086/344921; Wedemeyer-Bohm S, 2012, NATURE, V486, P505, DOI 10.1038/nature11202	24	205	208	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					501	503		10.1038/nature11772	http://dx.doi.org/10.1038/nature11772			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23344359				2022-12-28	WOS:000313871400031
J	Steele, DJR; Kasmar, AG; Guimaraes, AR; Dekker, JP				Steele, David J. R.; Kasmar, Anne G.; Guimaraes, Alexander R.; Dekker, John P.			Case 3-2013: A 72-Year-Old Woman with Abdominal Pain and Distention after Peritoneal Dialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAGE RENAL-DISEASE; OF-THE-LITERATURE; TUBERCULOUS PERITONITIS; SIMILAR OUTCOMES; ASCITIC FLUID; HEMODIALYSIS; DIAGNOSIS; FAILURE		[Steele, David J. R.] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; [Kasmar, Anne G.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Guimaraes, Alexander R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Dekker, John P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Guimaraes, Alexander R.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Dekker, John P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Steele, DJR (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA.				NIAID NIH HHS [K08 AI089858] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089858] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Balasubramaniam G, 2009, NEPHROL DIAL TRANSPL, V24, P3209, DOI 10.1093/ndt/gfp008; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chau TN, 2007, CLIN INFECT DIS, V45, pE141, DOI 10.1086/523727; Chow KM, 2003, AM J SURG, V185, P567, DOI 10.1016/S0002-9610(03)00079-5; Chow KM, 2002, CLIN INFECT DIS, V35, P409, DOI 10.1086/341898; Fang JT, 2004, RENAL FAILURE, V26, P189, DOI 10.1081/JDI-120038521; Hussein MM, 2003, SEMIN DIALYSIS, V16, P38, DOI 10.1046/j.1525-139X.2003.03010.x; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lew SQ, 2007, PERITON DIALYSIS INT, V27, P226; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; McLellan DGJ, 2000, AM J MED SCI, V319, P250, DOI 10.1097/00000441-200004000-00009; Mehrotra R, 2011, ARCH INTERN MED, V171, P110, DOI 10.1001/archinternmed.2010.352; Menzies D, 2008, INT J TUBERC LUNG D, V12, P498; Moore DAJ, 2002, EMERG INFECT DIS, V8, P77, DOI 10.3201/eid0801.010017; Prakash J, 2011, Indian J Nephrol, V21, P112, DOI 10.4103/0971-4065.82125; Riquelme A, 2006, J CLIN GASTROENTEROL, V40, P705, DOI 10.1097/00004836-200609000-00009; Sanai FM, 2005, ALIMENT PHARM THER, V22, P685, DOI 10.1111/j.1365-2036.2005.02645.x; Simsek H, 1997, AM J GASTROENTEROL, V92, P1174; Smirnoff M, 1998, CHEST, V113, P25, DOI 10.1378/chest.113.1.25; Stuart S, 2009, RADIOGRAPHICS, V29, P441, DOI 10.1148/rg.292085136; Talwani R, 2000, CLIN INFECT DIS, V31, P70, DOI 10.1086/313919; Teitelbaum I, 2003, AM J KIDNEY DIS, V42, P1082, DOI 10.1016/j.ajkd.2003.08.036; US Renal Data System, 2010, 2010 ANN DAT REP ATL; Uzunkoy A, 2004, WORLD J GASTROENTERO, V10, P3647, DOI 10.3748/wjg.v10.i24.3647; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; Vas SI, 1989, PERITONEAL DIALYSIS, V3rd, P261; Yeates K, 2012, NEPHROL DIAL TRANSPL, V27, P3568, DOI 10.1093/ndt/gfr674	28	1	1	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					375	385		10.1056/NEJMcpc1208142	http://dx.doi.org/10.1056/NEJMcpc1208142			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075KX	23343067				2022-12-28	WOS:000313885900012
J	Berry, JG; Toomey, SL; Zaslavsky, AM; Jha, AK; Nakamura, MM; Klein, DJ; Feng, JY; Shulman, S; Chiang, VK; Kaplan, W; Hall, M; Schuster, MA				Berry, Jay G.; Toomey, Sara L.; Zaslavsky, Alan M.; Jha, Ashish K.; Nakamura, Mari M.; Klein, David J.; Feng, Jeremy Y.; Shulman, Shanna; Chiang, Vincent K.; Kaplan, William; Hall, Matt; Schuster, Mark A.			Pediatric Readmission Prevalence and Variability Across Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE; CHILDRENS HOSPITALS; SOCIOECONOMIC-STATUS; QUALITY MEASURES; HEART-FAILURE; INSURANCE; OUTCOMES; PROGRAM; INITIATIVES; PERFORMANCE	Importance Readmission rates are used as an indicator of the quality of care that patients receive during a hospital admission and after discharge. Objective To determine the prevalence of pediatric readmissions and the magnitude of variation in pediatric readmission rates across hospitals. Design, Setting, and Patients We analyzed 568 845 admissions at 72 children's hospitals between July 1, 2009, and June 30, 2010, in the National Association of Children's Hospitals and Related Institutions Case Mix Comparative data set. We estimated hierarchical regression models for 30-day readmission rates by hospital, accounting for age and Chronic Condition Indicators. Hospitals with adjusted readmission rates that were 1 SD above and below the mean were defined as having "high" and "low" rates, respectively. Main Outcome Measures Thirty-day unplanned readmissions following admission for any diagnosis and for the 10 admission diagnoses with the highest readmission prevalence. Planned readmissions were identified with procedure codes from the International Classification of Diseases, Ninth Revision, Clinical Modification. Results The 30-day unadjusted readmission rate for all hospitalized children was 6.5% (n=36 734). Adjusted rates were 28.6% greater in hospitals with high vs low readmission rates (7.2% [95% CI, 7.1%-7.2%] vs 5.6% [95% CI, 5.6%-5.6%]). For the 10 admission diagnoses with the highest readmission prevalence, the adjusted rates were 17.0% to 66.0% greater in hospitals with high vs low readmission rates. For example, sickle cell rates were 20.1% (95% CI, 20.0%-20.3%) vs 12.7% (95% CI, 12.6%-12.8%) in high vs low hospitals, respectively. Conclusions and Relevance Among patients admitted to acute care pediatric hospitals, the rate of unplanned readmissions at 30 days was 6.5%. There was significant variability in readmission rates across conditions and hospitals. These data may be useful for hospitals' quality improvement efforts. JAMA. 2013;309(4):372-380 www.jama.com	[Berry, Jay G.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA; [Nakamura, Mari M.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Chiang, Vincent K.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Zaslavsky, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Berry, Jay G.; Toomey, Sara L.; Nakamura, Mari M.; Chiang, Vincent K.; Schuster, Mark A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Hall, Matt] Childrens Hosp Assoc, Overland Pk, KS USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Children's Mercy Hospital	Berry, JG (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Gen Pediat, 300 Longwood Ave, Boston, MA 02115 USA.	jay.berry@childrens.harvard.edu	Hall, Matt/AAT-1349-2021; Feng, Jeremy Y/A-4592-2014	Hall, Matt/0000-0001-7778-5887; Feng, Jeremy Y/0000-0002-6912-1922	Agency for Healthcare Research and Quality [U18 HS020513]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K23 HD058092]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS020513] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD058092] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding was provided by the Agency for Healthcare Research and Quality (U18 HS020513, Principal Investigator: Dr Schuster). Dr Berry was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K23 HD058092).	3M Health Information Systems, ALL PAT REF DIAGN RE; Agency for Healthcare Research and Quality, CHIPRA MEAS CHIPRA C; Agency for Healthcare Research and Quality, CHRON COND IND; Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project, 2016, INTR HCUP KIDS INP D; [Anonymous], US ADM DAT MON ACC I; [Anonymous], CREAT NAT CHILDR HOS; [Anonymous], CAS MIX PROGR DAT; [Anonymous], HOSP CAR OUTC EFF ME; [Anonymous], VAR HEALTHC DOES IT; Axon RN, 2011, JAMA-J AM MED ASSOC, V305, P504, DOI 10.1001/jama.2011.72; Bautista J, 2012, 2012 AM ASS NEUR M A; Bernheim SM, 2011, 2011 MEASURES MAINTE; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Berry JG, 2008, NEUROSURGERY, V62, P445, DOI 10.1227/01.neu.0000316012.20797.04; Berry JG, 2011, JAMA-J AM MED ASSOC, V305, P682, DOI 10.1001/jama.2011.122; BILLINGS J, 1993, HEALTH AFFAIR, V12, P162, DOI 10.1377/hlthaff.12.1.162; Bourgeois FC, 2010, ARCH INTERN MED, V170, P1989, DOI 10.1001/archinternmed.2010.439; Bradley EH, 2012, J AM COLL CARDIOL, V60, P607, DOI 10.1016/j.jacc.2012.03.067; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Carrns Ann, 2010, US News World Rep, V147, P22; Cassedy A, 2008, AMBUL PEDIATR, V8, P321, DOI 10.1016/j.ambp.2008.04.007; Castro M, 2003, AM J RESP CRIT CARE, V168, P1095, DOI 10.1164/rccm.200208-877OC; Cheney J, 2005, J PEDIATR-US, V147, P622, DOI 10.1016/j.jpeds.2005.06.040; Chi MJ, 2011, ARCH GERONTOL GERIAT, V52, P284, DOI 10.1016/j.archger.2010.04.017; Cohen E, 2011, PEDIATRICS, V127, P529, DOI 10.1542/peds.2010-0910; Coye Molly Joel, 2008, Hosp Health Netw, V82, P24; Dougherty D, 2011, ACAD PEDIATR, V11, pS1, DOI 10.1016/j.acap.2011.02.009; Eselius LL, 2008, HEALTH SERV RES, V43, P2014, DOI 10.1111/j.1475-6773.2008.00894.x; Farewell Carrns A., 2010, US NEWS WORLD REP, V147, P22; Favole JA, 2009, WALL STREET J, pD4; Feudtner C, 2010, J PEDIATR-US, V157, P98, DOI 10.1016/j.jpeds.2010.01.049; Feudtner C, 2009, PEDIATRICS, V123, P286, DOI 10.1542/peds.2007-3395; Frei-Jones MJ, 2009, PEDIATR BLOOD CANCER, V52, P481, DOI 10.1002/pbc.21854; Friedman B, 2006, MED CARE RES REV, V63, P327, DOI 10.1177/1077558706287042; Fung V, 2010, MED CARE, V48, P140, DOI 10.1097/MLR.0b013e3181bd4dc3; HealthCare. gov, PARTN PAT BETT CAR L; Hernandez AF, 2011, JAMA-J AM MED ASSOC, V305, P715, DOI 10.1001/jama.2011.167; Ho C, 2013, J CHILD NEUROL, V28, P40, DOI 10.1177/0883073812439345; Hong R, 2007, J EMERG MED, V32, P149, DOI 10.1016/j.jemermed.2006.05.042; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Morse RB, 2011, JAMA-J AM MED ASSOC, V306, P1454, DOI 10.1001/jama.2011.1385; Nasir K, 2010, MED CARE, V48, P477, DOI 10.1097/MLR.0b013e3181d5fb24; Parker JD, 2000, PEDIATRICS, V106, P942; Rice-Townsend S, 2013, ANN SURG, V257, P758, DOI 10.1097/SLA.0b013e318268a663; Rice-Townsend S, 2012, J PEDIATR SURG, V47, P1170, DOI 10.1016/j.jpedsurg.2012.03.025; Schuster MA, 2008, JAMA-J AM MED ASSOC, V300, P1047, DOI 10.1001/jama.300.9.1047; Sedman AB, 2004, PEDIATRICS, V114, P965, DOI 10.1542/peds.2004-0650; Sommers A, PHYS VISITS HOSP DIS; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; VINSON JM, 1990, J AM GERIATR SOC, V38, P1290, DOI 10.1111/j.1532-5415.1990.tb03450.x; Wennberg JE, 2002, BRIT MED J, V325, P961, DOI 10.1136/bmj.325.7370.961; Zickafoose JS, 2011, ACAD PEDIATR, V11, P305, DOI 10.1016/j.acap.2011.03.006	54	273	273	3	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					372	380		10.1001/jama.2012.188351	http://dx.doi.org/10.1001/jama.2012.188351			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	074FT	23340639	Bronze, Green Accepted			2022-12-28	WOS:000313799000025
J	Walther, TH; Gottselig, C; Grage, SL; Wolf, M; Vargiu, AV; Klein, MJ; Vollmer, S; Prock, S; Hartmann, M; Afonin, S; Stockwald, E; Heinzmann, H; Nolandt, OV; Wenzel, W; Ruggerone, P; Ulrich, AS				Walther, Torsten H.; Gottselig, Christina; Grage, Stephan L.; Wolf, Moritz; Vargiu, Attilio V.; Klein, Marco J.; Vollmer, Stefanie; Prock, Sebastian; Hartmann, Mareike; Afonin, Sergiy; Stockwald, Eva; Heinzmann, Hartmut; Nolandt, Olga V.; Wenzel, Wolfgang; Ruggerone, Paolo; Ulrich, Anne S.			Folding and Self-Assembly of the TatA Translocation Pore Based on a Charge Zipper Mechanism	CELL			English	Article							PROTEIN-TRANSPORT SYSTEM; TWIN-ARGININE TRANSLOCASE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; MULTIENZYME COMPLEX; FOLDED PROTEINS; SIGNAL PEPTIDE; SALT BRIDGES; MEMBRANE; COMPONENT	We propose a concept for the folding and self-assembly of the pore-forming TatA complex from the Twin-arginine translocase and of other membrane proteins based on electrostatic "charge zippers." Each subunit of TatA consists of a transmembrane segment, an amphiphilic helix (APH), and a C-terminal densely charged region (DCR). The sequence of charges in the DCR is complementary to the charge pattern on the APH, suggesting that the protein can be "zipped up" by a ladder of seven salt bridges. The length of the resulting hairpin matches the lipid bilayer thickness, hence a transmembrane pore could self-assemble via intra- and intermolecular salt bridges. The steric feasibility was rationalized by molecular dynamics simulations, and experimental evidence was obtained by monitoring the monomer-oligomer equilibrium of specific charge mutants. Similar "charge zippers" are proposed for other membrane-associated proteins, e.g., the biofilm-inducing peptide TisB, the human antimicrobial peptide dermcidin, and the pestiviral E-RNS protein.	[Walther, Torsten H.; Gottselig, Christina; Grage, Stephan L.; Klein, Marco J.; Vollmer, Stefanie; Prock, Sebastian; Hartmann, Mareike; Afonin, Sergiy; Stockwald, Eva; Heinzmann, Hartmut; Nolandt, Olga V.; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, Inst Organ Chem, D-76131 Karlsruhe, Germany; [Walther, Torsten H.; Gottselig, Christina; Grage, Stephan L.; Klein, Marco J.; Vollmer, Stefanie; Prock, Sebastian; Hartmann, Mareike; Afonin, Sergiy; Stockwald, Eva; Heinzmann, Hartmut; Nolandt, Olga V.; Ulrich, Anne S.] CFN, D-76131 Karlsruhe, Germany; [Wolf, Moritz; Wenzel, Wolfgang] KIT, Inst Nanotechnol, D-76021 Karlsruhe, Germany; [Wolf, Moritz; Wenzel, Wolfgang] CFN, D-76021 Karlsruhe, Germany; [Ruggerone, Paolo] Univ Cagliari, Ist Officina Mat, CNR UOS SLACS, I-09042 Monserrato, CA, Italy; [Ruggerone, Paolo] Univ Cagliari, Dipartimento Fis, I-09042 Monserrato, CA, Italy	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Cagliari; University of Cagliari	Ulrich, AS (corresponding author), Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, Inst Organ Chem, Fritz Haber Weg 6, D-76131 Karlsruhe, Germany.	anne.ulrich@kit.edu	Ruggerone, Paolo/AAN-6032-2021; Vargiu, Attilio/G-2321-2011; Afonin, Sergii/T-2737-2019; Ulrich, Anne S/H-5519-2013; Wenzel, Wolfgang/B-3207-2009	Ruggerone, Paolo/0000-0003-0825-0824; Vargiu, Attilio/0000-0003-4013-8867; Afonin, Sergii/0000-0002-2356-4226; Ulrich, Anne S/0000-0001-5571-9483; Wenzel, Wolfgang/0000-0001-9487-4689; Walther, Torsten H./0000-0002-3708-0839; Klein, Marco Jan/0000-0003-1842-7590	YIG grant (KIT Karlsruhe, Germany); HPC Programme of the BW Stiftung; "Regione Autonoma della Sardegna" through a Research Fellow on fundings "PO Sardegna FSE Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna" [L.R.7/2007]	YIG grant (KIT Karlsruhe, Germany); HPC Programme of the BW Stiftung; "Regione Autonoma della Sardegna" through a Research Fellow on fundings "PO Sardegna FSE Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna"	We thank Ralf Heinzmann for the assistance in preparing the Graphical Abstract. A.S.U. and S.L.G. thank the DFG-Center for Functional Nanostructures (TP E1.2 & E3.4). T.H.W. is supported by a YIG grant (KIT Karlsruhe, Germany). M.W. and W.W. acknowledge funding by the HPC Programme of the BW Stiftung. P.R. and A.V.V. thank CINECA for computational support. A.V.V. acknowledges financial support from "Regione Autonoma della Sardegna" through a Research Fellow on fundings "PO Sardegna FSE 2007-2013, L.R.7/2007 Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna".	Alder NN, 2003, CELL, V112, P231, DOI 10.1016/S0092-8674(03)00032-1; Barnett JP, 2008, J BIOL CHEM, V283, P2534, DOI 10.1074/jbc.M708134200; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berthelmann F, 2008, J BIOL CHEM, V283, P25281, DOI 10.1074/jbc.M707757200; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Burrack S, 2012, FASEB J, V26, P3292, DOI 10.1096/fj.12-207191; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Dabney-Smith C, 2003, J BIOL CHEM, V278, P43027, DOI 10.1074/jbc.M307923200; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Frank RAW, 2005, STRUCTURE, V13, P1119, DOI 10.1016/j.str.2005.04.021; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; GO N, 1976, MACROMOLECULES, V9, P535, DOI 10.1021/ma60052a001; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Kim H, 2010, STRUCTURE, V18, P1443, DOI 10.1016/j.str.2010.09.011; Lange C, 2007, BBA-BIOMEMBRANES, V1768, P2627, DOI 10.1016/j.bbamem.2007.06.021; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Li YD, 2009, PROTEIN PEPTIDE LETT, V16, P706, DOI 10.2174/092986609788490096; MACK JW, 1993, J MOL BIOL, V232, P50, DOI 10.1006/jmbi.1993.1369; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; Mori H, 2001, BBA-MOL CELL RES, V1541, P80, DOI 10.1016/S0167-4889(01)00150-1; Muller SD, 2007, BBA-BIOMEMBRANES, V1768, P3071, DOI 10.1016/j.bbamem.2007.09.008; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; Musser SM, 2000, EUR J BIOCHEM, V267, P2588, DOI 10.1046/j.1432-1327.2000.01269.x; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Paulmann M, 2012, J BIOL CHEM, V287, P8434, DOI 10.1074/jbc.M111.332270; Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Steinbrecher T, 2012, BIOPHYS J, V103, P1460, DOI 10.1016/j.bpj.2012.07.060; Tews BA, 2007, J BIOL CHEM, V282, P32730, DOI 10.1074/jbc.M706803200; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; van der Ploeg R, 2011, J BIOL CHEM, V286, P43759, DOI 10.1074/jbc.M111.243824; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Warren G, 2009, J MOL BIOL, V388, P122, DOI 10.1016/j.jmb.2009.02.060; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westermann M, 2006, BBA-BIOMEMBRANES, V1758, P443, DOI 10.1016/j.bbamem.2006.03.018; White GF, 2010, J BIOL CHEM, V285, P2294, DOI 10.1074/jbc.M109.065458; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zhang LJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-114	57	57	60	1	93	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					316	326		10.1016/j.cell.2012.12.017	http://dx.doi.org/10.1016/j.cell.2012.12.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332763	Bronze			2022-12-28	WOS:000313719800026
J	Sundaram, GM; Common, JEA; Gopal, FE; Srikanta, S; Lakshman, K; Lunny, DP; Lim, TC; Tanavde, V; Lane, EB; Sampath, P				Sundaram, Gopinath M.; Common, John E. A.; Gopal, Felicia E.; Srikanta, Satyanarayana; Lakshman, Krishnaswamy; Lunny, Declan P.; Lim, Thiam C.; Tanavde, Vivek; Lane, E. Birgitte; Sampath, Prabha			'See-saw' expression of microRNA-198 and FSTL1 from a single transcript in wound healing	NATURE			English	Article							DIABETIC FOOT ULCERS; CELL-MIGRATION; KERATINOCYTES; PATHWAY	Post-transcriptional switches are flexible effectors of dynamic changes in gene expression(1). Here we report a new post-transcriptional switch that dictates the spatiotemporal and mutually exclusive expression of two alternative gene products from a single transcript. Expression of primate-specific exonic microRNA-198 (miR-198)(2), located in the 3'-untranslated region of follistatin-like 1 (FSTL1)(3) messenger RNA, switches to expression of the linked open reading frame of FSTL1 upon wounding in a human ex vivo organ culture system. We show that binding of a KH-type splicing regulatory protein (KSRP, also known as KHSRP) to the primary transcript determines the fate of the transcript and is essential for the processing of miR-198: transforming growth factor-beta signalling switches off miR-198 expression by downregulating KSRP, and promotes FSTL1 protein expression. We also show that FSTL1 expression promotes keratinocyte migration, whereas miR-198 expression has the opposite effect by targeting and inhibiting DIAPH1, PLAU and LAMC2. A clear inverse correlation between the expression pattern of FSTL1 (pro-migratory) and miR-198 (anti-migratory) highlights the importance of this regulatory switch in controlling context-specific gene expression to orchestrate wound re-epithelialization. The deleterious effect of failure of this switch is apparent in non-healing chronic diabetic ulcers, in which expression of miR-198 persists, FSTL1 is absent, and keratinocyte migration, re-epithelialization and wound healing all fail to occur.	[Sundaram, Gopinath M.; Common, John E. A.; Gopal, Felicia E.; Lunny, Declan P.; Tanavde, Vivek; Lane, E. Birgitte; Sampath, Prabha] ASTAR, Inst Med Biol, Singapore 138648, Singapore; [Srikanta, Satyanarayana; Lakshman, Krishnaswamy] Jnana Sanjeevini Diabet Ctr, Bangalore 560078, Karnataka, India; [Lim, Thiam C.] Natl Univ Hlth Syst, Div Plast Reconstruct & Aesthet Surg, Singapore 119074, Singapore; [Lim, Thiam C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 119228, Singapore; [Tanavde, Vivek] ASTAR, Bioinformat Inst, Singapore 138671, Singapore; [Lane, E. Birgitte] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 119074, Singapore; [Lane, E. Birgitte; Sampath, Prabha] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; National University of Singapore	Sampath, P (corresponding author), ASTAR, Inst Med Biol, Singapore 138648, Singapore.	prabha.sampath@imb.a-star.edu.sg	Tanavde, Vivek/B-4758-2011; Lim, Thiam Chye/B-5323-2011; Common, John/Q-6412-2018; Sundaram, Gopi/AAE-5427-2020	Tanavde, Vivek/0000-0001-7404-5568; Common, John/0000-0002-3280-7365; Sundaram, Gopi/0000-0002-8074-6624	A*STAR Investigatorship award; Biomedical Research Council of Singapore; Skin Biology Cluster Platform, A*STAR	A*STAR Investigatorship award(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Skin Biology Cluster Platform, A*STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by an A*STAR Investigatorship award to P.S., the Biomedical Research Council of Singapore and the Skin Biology Cluster Platform, A*STAR. We thank T. Kamala, S. Nama, M. Hisyam and C. Vaz for experimental support and B. Knowles for critical reading of the manuscript.	Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Banerjee J, 2011, PHYSIOL GENOMICS, V43, P543, DOI 10.1152/physiolgenomics.00157.2010; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Daniel RJ, 2002, J INVEST DERMATOL, V119, P1304, DOI 10.1046/j.1523-1747.2002.19533.x; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; He YH, 2011, AM J PATHOL, V178, P975, DOI 10.1016/j.ajpath.2010.11.053; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Jude EB, 2002, DIABETIC MED, V19, P440, DOI 10.1046/j.1464-5491.2002.00692.x; Kroeze KL, 2012, J INVEST DERMATOL, V132, P216, DOI 10.1038/jid.2011.245; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Marutsuka K, 1998, CORONARY ARTERY DIS, V9, P177, DOI 10.1097/00019501-199809040-00002; Pastar I, 2010, MOL MED, V16, P92, DOI 10.2119/molmed.2009.00149; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Tan S, 2011, FEBS LETT, V585, P2229, DOI 10.1016/j.febslet.2011.05.042; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194; Usui ML, 2005, WOUND REPAIR REGEN, V13, P468, DOI 10.1111/j.1067-1927.2005.00067.x; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Zorio E., 2008, CURR MED CHEM, V15, P923	28	148	159	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					103	106		10.1038/nature11890	http://dx.doi.org/10.1038/nature11890			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23395958				2022-12-28	WOS:000316039800048
J	Bell, BP; Khabbaz, RF				Bell, Beth P.; Khabbaz, Rima F.			Responding to the Outbreak of Invasive Fungal Infections The Value of Public Health to Americans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bell, Beth P.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Khabbaz, Rima F.] Ctr Dis Control & Prevent, Off Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Bell, BP (corresponding author), Ctr Dis Control & Prevent, Mailstop C-12,1600 Clifton Rd, Atlanta, GA 30333 USA.	bzb8@cdc.gov						Centers for Disease Control and Prevention, MULT FUNG MEN OUTBR; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; National Association of County and City Health Officials, 2012, WNYC 0202; Smith RM, NEW ENGL J MED, DOI [10.1056/NEJMoa1213978, DOI 10.1056/NEJMOA1213978]; The Association of State and Territorial Health Officials, BUDG CUTS CONT AFF H	5	14	14	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2013	309	9					883	884		10.1001/jama.2013.526	http://dx.doi.org/10.1001/jama.2013.526			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099PC	23364868				2022-12-28	WOS:000315632700022
J	Ferguson, ND; Cook, DJ; Guyatt, GH; Mehta, S; Hand, L; Austin, P; Zhou, Q; Matte, A; Walter, SD; Lamontagne, F; Granton, JT; Arabi, YM; Arroliga, AC; Stewart, TE; Slutsky, AS; Meade, MO				Ferguson, Niall D.; Cook, Deborah J.; Guyatt, Gordon H.; Mehta, Sangeeta; Hand, Lori; Austin, Peggy; Zhou, Qi; Matte, Andrea; Walter, Stephen D.; Lamontagne, Francois; Granton, John T.; Arabi, Yaseen M.; Arroliga, Alejandro C.; Stewart, Thomas E.; Slutsky, Arthur S.; Meade, Maureen O.		OSCILLATE Trial Investigators; Canadian Critical Care Trials Grp	High-Frequency Oscillation in Early Acute Respiratory Distress Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE LUNG INJURY; END-EXPIRATORY PRESSURE; CONVENTIONAL MECHANICAL VENTILATION; RECRUITMENT MANEUVERS; ADULTS; STRATEGY	Background Previous trials suggesting that high-frequency oscillatory ventilation (HFOV) reduced mortality among adults with the acute respiratory distress syndrome (ARDS) were limited by the use of outdated comparator ventilation strategies and small sample sizes. Methods In a multicenter, randomized, controlled trial conducted at 39 intensive care units in five countries, we randomly assigned adults with new-onset, moderate-to-severe ARDS to HFOV targeting lung recruitment or to a control ventilation strategy targeting lung recruitment with the use of low tidal volumes and high positive end-expiratory pressure. The primary outcome was the rate of in-hospital death from any cause. Results On the recommendation of the data monitoring committee, we stopped the trial after 548 of a planned 1200 patients had undergone randomization. The two study groups were well matched at baseline. The HFOV group underwent HFOV for a median of 3 days (interquartile range, 2 to 8); in addition, 34 of 273 patients (12%) in the control group received HFOV for refractory hypoxemia. In-hospital mortality was 47% in the HFOV group, as compared with 35% in the control group (relative risk of death with HFOV, 1.33; 95% confidence interval, 1.09 to 1.64; P = 0.005). This finding was independent of baseline abnormalities in oxygenation or respiratory compliance. Patients in the HFOV group received higher doses of midazolam than did patients in the control group (199 mg per day [interquartile range, 100 to 382] vs. 141 mg per day [interquartile range, 68 to 240], P<0.001), and more patients in the HFOV group than in the control group received neuromuscular blockers (83% vs. 68%, P<0.001). In addition, more patients in the HFOV group received vasoactive drugs (91% vs. 84%, P = 0.01) and received them for a longer period than did patients in the control group (5 days vs. 3 days, P = 0.01). Conclusions In adults with moderate-to-severe ARDS, early application of HFOV, as compared with a ventilation strategy of low tidal volume and high positive end-expiratory pressure, does not reduce, and may increase, in-hospital mortality. (Funded by the Canadian Institutes of Health Research; Current Controlled Trials numbers, ISRCTN42992782 and ISRCTN87124254, and ClinicalTrials.gov numbers, NCT00474656 and NCT01506401.)	[Ferguson, Niall D.; Mehta, Sangeeta; Granton, John T.; Stewart, Thomas E.; Slutsky, Arthur S.] Univ Toronto, Univ Hlth Network, Interdept Div Crit Care Med, Toronto, ON, Canada; [Ferguson, Niall D.; Slutsky, Arthur S.] Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Ferguson, Niall D.] Univ Toronto, Univ Hlth Network, Dept Physiol, Toronto, ON, Canada; [Mehta, Sangeeta; Granton, John T.; Stewart, Thomas E.] Univ Toronto, Univ Hlth Network, Dept Med, Div Respirol, Toronto, ON, Canada; [Slutsky, Arthur S.] Univ Toronto, Univ Hlth Network, Dept Surg, Toronto, ON, Canada; [Slutsky, Arthur S.] Univ Toronto, Univ Hlth Network, Dept Biomed Engn, Toronto, ON, Canada; [Ferguson, Niall D.; Mehta, Sangeeta; Granton, John T.; Stewart, Thomas E.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Slutsky, Arthur S.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Matte, Andrea] Univ Hlth Network, Crit Care Program, Toronto, ON, Canada; [Cook, Deborah J.; Meade, Maureen O.] McMaster Univ, Interdept Div Crit Care, Hamilton, ON, Canada; [Cook, Deborah J.; Guyatt, Gordon H.; Walter, Stephen D.; Meade, Maureen O.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Cook, Deborah J.; Guyatt, Gordon H.; Walter, Stephen D.; Meade, Maureen O.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Cook, Deborah J.; Guyatt, Gordon H.; Hand, Lori; Austin, Peggy; Zhou, Qi; Walter, Stephen D.; Meade, Maureen O.] McMaster Univ, CLAR Res Ctr, Hamilton, ON, Canada; [Lamontagne, Francois] Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel, Sherbrooke, PQ J1K 2R1, Canada; [Arabi, Yaseen M.] King Saud bin Abdulaziz Univ Hlth Sci, Dept Intens Care, Riyadh, Saudi Arabia; [Arroliga, Alejandro C.] Scott & White Mem Hosp & Clin, Dept Med, Temple, TX 76508 USA; [Arroliga, Alejandro C.] Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; McMaster University; McMaster University; McMaster University; University of Sherbrooke; King Saud Bin Abdulaziz University for Health Sciences; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Meade, MO (corresponding author), 1280 Main St W, Hamilton, ON L8N 3Z5, Canada.	meadema@hhsc.ca	Danesh, Valerie/AAZ-3014-2021; Ferguson, Niall/D-7619-2019; Mehta, Sangeeta/C-4623-2015; Arroliga, Alejandro/AAX-3933-2021; Bosma, Karen/G-3281-2011; Arabi, Yaseen/ABF-3316-2020; Slutsky, Arthur/M-3325-2019; Zhou, Qi/GSM-9583-2022; Skrobik, Yoanna/K-8165-2014; Walter, Stephen/AAB-5548-2022	Danesh, Valerie/0000-0002-2078-2578; Ferguson, Niall/0000-0002-6213-5264; Arabi, Yaseen/0000-0001-5735-6241; Skrobik, Yoanna/0000-0002-5315-6020; Walter, Stephen/0000-0003-4157-8928; Lamontagne, Francois/0000-0002-0360-3427; Henzler, Dietrich/0000-0001-5511-6885; Friedrich, Jan/0000-0001-7248-2350	Canadian Institutes of Health Research; Randomized Controlled Trial (RCT) Program (Ottawa); King Abdullah International Medical Research Center (Riyadh, Saudi Arabia); Canada Research Chair; Fonds de Recherche de Quebec-Sante Research Career Award; Physicians Services Incorporated Foundation; Ikaria; Actelion; Eli Lilly; Pfizer; GlaxoSmithKline; Bayer; Maquet Medical; Novalung; Gambro; Hemodec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Randomized Controlled Trial (RCT) Program (Ottawa); King Abdullah International Medical Research Center (Riyadh, Saudi Arabia); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Fonds de Recherche de Quebec-Sante Research Career Award; Physicians Services Incorporated Foundation; Ikaria; Actelion; Eli Lilly(Eli Lilly); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Bayer(Bayer AG); Maquet Medical; Novalung; Gambro; Hemodec	Funded by the Canadian Institutes of Health Research; Supported by the Canadian Institutes of Health Research, Randomized Controlled Trial (RCT) Program (Ottawa) and the King Abdullah International Medical Research Center (Riyadh, Saudi Arabia). Dr. Ferguson is supported by a Canadian Institutes of Health Research New Investigator Award; Dr. Cook holds a Canada Research Chair; Dr. Lamontagne is supported by a Fonds de Recherche de Quebec-Sante Research Career Award; and Drs. Ferguson and Meade and Drs. Lamontagne and Meade were supported by Canadian Institutes of Health Research RCT Mentorship awards.; Dr. Ferguson reports receiving grant support through his institution from the Physicians Services Incorporated Foundation; Dr. Granton, receiving consulting fees from Ikaria, lecture fees from Actelion and Eli Lilly, grant support through his institution from Pfizer, Actelion, Eli Lilly, GlaxoSmithKline, and Bayer, payment through his institution from Telus for the sale of a software site license, and support from Actelion for his hospital foundation for pulmonary hypertension research and providing expert testimony for Pfizer regarding patent legal action; and Dr. Slutsky, receiving consulting fees from Maquet Medical, Novalung, Gambro, Ikaria, and Hemodec. No other potential conflict of interest relevant to this article was reported.	Adhikari NKJ, 2011, CRIT CARE MED, V39, P2631, DOI 10.1097/CCM.0b013e318226675e; Bollen CW, 2005, CRIT CARE, V9, pR430, DOI 10.1186/cc3737; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; BRYAN AC, 1991, PEDIATRICS, V87, P565; Derdak S, 2002, AM J RESP CRIT CARE, V166, P801, DOI 10.1164/rccm.2108052; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Ferguson ND, 2005, CRIT CARE MED, V33, P479, DOI 10.1097/01.CCM.0000155785.23200.9E; Ferguson ND, 2008, J APPL PHYSIOL, V104, P1230, DOI 10.1152/japplphysiol.01226.2007; Fessler HE, 2008, CRIT CARE MED, V36, P1043, DOI 10.1097/01.CCM.0b013e318168fcab; Fessler HE, 2007, CRIT CARE MED, V35, P1649, DOI 10.1097/01.CCM.0000269026.40739.2E; Fort P, 1997, CRIT CARE MED, V25, P937, DOI 10.1097/00003246-199706000-00008; Froese AB, 1997, CRIT CARE MED, V25, P906, DOI 10.1097/00003246-199706000-00004; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Guervilly C, 2012, CRIT CARE MED, V40, P1539, DOI 10.1097/CCM.0b013e3182451b4a; Hager DN, 2007, CRIT CARE MED, V35, P1522, DOI 10.1097/01.CCM.0000266586.04676.55; Hatcher D, 1998, CRIT CARE MED, V26, P1081, DOI 10.1097/00003246-199806000-00032; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; HIFI Study Group, 1989, N Engl J Med, V320, P88; Imai Y, 2001, J APPL PHYSIOL, V91, P1836, DOI 10.1152/jappl.2001.91.4.1836; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Mehta S, 2004, CHEST, V126, P518, DOI 10.1378/chest.126.2.518; Mentzelopoulos SD, 2010, INTENS CARE MED, V36, P810, DOI 10.1007/s00134-010-1822-8; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Muellenbach RM, 2007, INTENS CARE MED, V33, P1423, DOI 10.1007/s00134-007-0708-x; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; Pillow JJ, 1999, J APPL PHYSIOL, V87, P407, DOI 10.1152/jappl.1999.87.1.407; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rimensberger PC, 2000, INTENS CARE MED, V26, P745, DOI 10.1007/s001340051242; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sedeek KA, 2003, ANESTHESIOLOGY, V99, P1102, DOI 10.1097/00000542-200311000-00016; Sud S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2327; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8; Young D, 2013, NEW ENGL J MED, V368, P806, DOI 10.1056/NEJMoa1215716	39	527	573	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					795	805		10.1056/NEJMoa1215554	http://dx.doi.org/10.1056/NEJMoa1215554			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096ET	23339639				2022-12-28	WOS:000315387700005
J	Maybury, C; Craythorne, E				Maybury, Catriona; Craythorne, Emma			Peri-oral papules	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MOLLUSCUM-CONTAGIOSUM; CIDOFOVIR		[Maybury, Catriona; Craythorne, Emma] Guys & St Thomas Hosp Trust, St Johns Inst Dermatol, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Maybury, C (corresponding author), Guys & St Thomas Hosp Trust, St Johns Inst Dermatol, London SE1 9RT, England.	Catriona.maybury@kcl.ac.uk						[Anonymous], 2011, DERMATOLOGY SECRETS; Bhatia A, 2012, MEDSCAPE; Burkitt HG, 1996, WHEATERS BASIC HISTO; Costner M, 1998, ARCH DERMATOL, V134, P1290, DOI 10.1001/archderm.134.10.1290; Erickson C, 2011, ARCH DERMATOL, V147, P652, DOI 10.1001/archdermatol.2011.20; Gamble RG, 2012, ARCH DERMATOL, V148, P109, DOI 10.1001/archdermatol.2011.1241; Gur I, 2008, INT J STD AIDS, V19, P503, DOI 10.1258/ijsa.2008.008186; Hanson Daniel, 2003, Dermatol Online J, V9, P2; Ianhez M, 2011, AN BRAS DERMATOL, V86, P69; Millard LG, 2010, ROOKS TXB DERMATOLOG, P1; Pereira Barbara, 2007, Dermatol Online J, V13, P6; SCHWARTZ JJ, 1992, J AM ACAD DERMATOL, V27, P583, DOI 10.1016/0190-9622(92)70226-6; Singh Harminder, 2009, Indian J Dermatol, V54, P338, DOI 10.4103/0019-5154.57609; Sisneros Silver Cree, 2010, Top HIV Med, V18, P169; van der Wouden JC, 2009, COCHRANE DB SYST REV, V7; Vermi W, 2011, J INVEST DERMATOL, V131, P426, DOI 10.1038/jid.2010.256; Watanabe T, 2008, J INVEST DERMATOL, V128, P1327, DOI 10.1038/sj.jid.5701161	17	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2013	346								f750	10.1136/bmj.f750	http://dx.doi.org/10.1136/bmj.f750			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091ZD	23401332				2022-12-28	WOS:000315087400002
J	Dor, Y; Glaser, B				Dor, Yuval; Glaser, Benjamin			Beta-Cell Dedifferentiation and Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROLIFERATION		[Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Serv Endocrinol, IL-91010 Jerusalem, Israel; [Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Metab Serv, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Dor, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel.		Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000				Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654	5	57	60	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					572	573		10.1056/NEJMcibr1214034	http://dx.doi.org/10.1056/NEJMcibr1214034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083VU	23388011				2022-12-28	WOS:000314494100011
J	DePaolo, JS; Barbeau, JM				DePaolo, John S.; Barbeau, James M.			Enhanced Tracking of Tissue for Transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[DePaolo, John S.; Barbeau, James M.] Louisiana State Univ, Sch Med, New Orleans, LA 70112 USA	Louisiana State University System	Barbeau, JM (corresponding author), Louisiana State Univ, Sch Med, Dept Pathol, 1901 Perdido St,Room 5121, New Orleans, LA 70112 USA.	jbarb4@lsuhsc.edu		Barbeau, James/0000-0002-5679-6525				[Anonymous], BOSTON GLOBE; Cartwright EJ, 2010, J BONE JOINT SURG AM, V92A, P1501, DOI 10.2106/JBJS.I.00502; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1697; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P564; Witten C, 2007, DEP HLTH HUMAN SERVI	5	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					443	444		10.1001/jama.2012.145043	http://dx.doi.org/10.1001/jama.2012.145043			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083LY	23385266				2022-12-28	WOS:000314466900021
J	Marusyk, A; Polyak, K				Marusyk, Andriy; Polyak, Kornelia			Cancer Cell Phenotypes, in Fifty Shades of Grey	SCIENCE			English	Editorial Material							TUMOR HETEROGENEITY; STEM-CELLS		[Marusyk, Andriy] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Marusyk, A (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	kornelia_polyak@dfci.harvard.edu						Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Kern SE, 2007, CANCER RES, V67, P8985, DOI 10.1158/0008-5472.CAN-07-1971; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027	8	46	49	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					528	529		10.1126/science.1234415	http://dx.doi.org/10.1126/science.1234415			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372002				2022-12-28	WOS:000314270000043
J	Bhaumik, S				Bhaumik, Soumyadeep			NEGLECTED DISEASES Snakebite: a forgotten problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												soumyadeepbhaumik@rediffmail.com		Bhaumik, Soumyadeep/0000-0001-9579-4453				Agarwal R, 2005, EMERG MED J, V22, P397, DOI 10.1136/emj.2004.020727; [Anonymous], 2012, INDIAN EXPRESS; Ariaratnam CA, 2001, T ROY SOC TROP MED H, V95, P74, DOI 10.1016/S0035-9203(01)90339-6; de Silva HA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000435; Mohapatra B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001018; South Asian Cochrane Network and Centre, 2012, INT SNAK BIT OV CURR; Warrell DA, 2011, NATL MED J INDIA, V24, P321; World Health Organization, 2008, GLOB BURD SNAK LIT A; World Health Organization, 2010, WHO GUIDELINES PRODU; [No title captured]	10	5	5	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2013	346								f628	10.1136/bmj.f628	http://dx.doi.org/10.1136/bmj.f628			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BQ	23369843				2022-12-28	WOS:000314511500009
J	Black, N				Black, Nick			Patient reported outcome measures could help transform healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY-OF-LIFE; REPLACEMENT SURGERY; KNEE REPLACEMENT; HIP; PROVIDERS; IMPACT	Routine use of patient reported outcome measures (PROMs) has the potential to help transform healthcare, says Nick Black. Not only can PROMs help patients and clinicians make better decisions, but they can also enable comparisons of providers' performances to stimulate improvements in services Patient reported outcome measures (PROMs) can drive the changes in how healthcare is organised and delivered. Key to this will be to link doctors' use of PROMs in the treatment of their patients with collection and aggregation of the data for assessing and comparing the performance of providers-all to improve healthcare quality.	Univ London London Sch Hyg & Trop Med, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Black, N (corresponding author), Univ London London Sch Hyg & Trop Med, London WC1H 9SH, England.	nick.black@lshtm.ac.uk						Allwood D, 2013, J EVAL CLIN PRACT, V19, P86, DOI 10.1111/j.1365-2753.2011.01777.x; [Anonymous], HELPS PAT DOCT MAN L; Baker PN, 2012, J BONE JOINT SURG BR, V94B, P919, DOI 10.1302/0301-620X.94B7.28436; Centers for Medicare & Medicaid Services (CMS), MED HLTH OUTC SURV; Chard J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6404; Coulter A, 2010, BRIT MED J, V341, pc4989; Frie KG, 2012, BRIT J SURG, V99, P1156, DOI 10.1002/bjs.8830; Frie KG, 2012, J CLIN EPIDEMIOL, V65, P619, DOI 10.1016/j.jclinepi.2011.12.001; Hahn EA, 2007, MAYO CLIN PROC, V82, P1244, DOI 10.4065/82.10.1244; Hildon Z, 2012, PATIENT EDUC COUNS, V88, P298, DOI 10.1016/j.pec.2012.02.006; Hostetter M, 2012, QUALITY MATTERS  JAN; Hutchings A, 2013, J CLIN EPIDEMIOL, V66, P218, DOI 10.1016/j.jclinepi.2012.09.001; Jeevan R, 2011, 4 ANN NAT MAST BREAS; Nelson EC, 2012, USING PATIENT REPORT; Neuburger J, 2012, J PUBLIC HEALTH-UK, V34, P421, DOI 10.1093/pubmed/fdr119; NHS Information Centre, NAT PAT REP OUTC PRO; Porter ME, 2009, NEW ENGL J MED, V361, P109, DOI 10.1056/NEJMp0904131; Rolfson O, 2011, J BONE JOINT SURG BR, V93B, P867, DOI 10.1302/0301-620X.93B7.25737; Rolfson O, 2011, VALUE HEALTH, V14, P316, DOI 10.1016/j.jval.2010.08.004; Royal College of Obstetricians and Gynaecologists London School of Hygiene & Tropical Medicine Ipsos MORI., 2012, NAT HEAV MENSTR BLEE; Smith PC, 2013, HEALTH ECON, V22, P119, DOI 10.1002/hec.2793; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; The Swedish Association of Local Authorities and Region, QUAL REG; Valderas JM, 2008, QUAL LIFE RES, V17, P179, DOI 10.1007/s11136-007-9295-0; West D, 2009, HLTH SERVICES J 0514	25	633	634	0	66	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2013	346								f167	10.1136/bmj.f167	http://dx.doi.org/10.1136/bmj.f167			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084AY	23358487	Green Accepted			2022-12-28	WOS:000314509400008
J	Farmer, SA; Black, B; Bonow, RO				Farmer, Steven A.; Black, Bernard; Bonow, Robert O.			Tension Between Quality Measurement, Public Quality Reporting, and Pay for Performance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICARE POLICY; INFECTIONS		[Farmer, Steven A.; Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Med, Chicago, IL 60611 USA; [Farmer, Steven A.; Black, Bernard] Northwestern Univ, Kellogg Sch Management, Chicago, IL 60611 USA; [Black, Bernard] Northwestern Univ, Sch Law, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Farmer, SA (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Dept Med, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	sfarmer@nmff.org						Black B, 2012, 1119 NW U LAW SCH; Dismuke CE, 2005, MED CARE, V43, P713, DOI 10.1097/01.mlr.0000167175.72130.a7; Hartmann CW, 2012, MED CARE RES REV, V69, P45, DOI 10.1177/1077558711413606; Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626; Institute for Healthcare Improvement, INTR TRIGG TOOLS ID; Lee GM, 2012, NEW ENGL J MED, V367, P1428, DOI 10.1056/NEJMsa1202419; McNair PD, 2009, HEALTH AFFAIR, V28, P1485, DOI 10.1377/hlthaff.28.5.1485; Wright S., 2012, FEW ADVERSE EVENTS H	8	38	38	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					349	350		10.1001/jama.2012.191276	http://dx.doi.org/10.1001/jama.2012.191276			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	074FT	23340634				2022-12-28	WOS:000313799000020
J	Roehr, B				Roehr, Bob			RESEARCH IN PRACTICE Research versus the patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2013	346								f332	10.1136/bmj.f332	http://dx.doi.org/10.1136/bmj.f332			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BA	23338007				2022-12-28	WOS:000314215000008
J	Bocquillon, E; Freulon, V; Berroir, JM; Degiovanni, P; Placais, B; Cavanna, A; Jin, Y; Feve, G				Bocquillon, E.; Freulon, V.; Berroir, J. -M; Degiovanni, P.; Placais, B.; Cavanna, A.; Jin, Y.; Feve, G.			Coherence and Indistinguishability of Single Electrons Emitted by Independent Sources	SCIENCE			English	Article							HANBURY-BROWN; QUANTUM; INTERFERENCE; PHOTONS	The on-demand emission of coherent and indistinguishable electrons by independent synchronized sources is a challenging task of quantum electronics, in particular regarding its application for quantum information processing. Using two independent on-demand electron sources, we triggered the emission of two single-electron wave packets at different inputs of an electronic beam splitter. Whereas classical particles would be randomly partitioned by the splitter, we observed two-particle interference resulting from quantum exchange. Both electrons, emitted in indistinguishable wave packets with synchronized arrival time on the splitter, exited in different outputs as recorded by the low-frequency current noise. The demonstration of two-electron interference provides the possibility of manipulating coherent and indistinguishable single-electron wave packets in quantum conductors.	[Bocquillon, E.; Freulon, V.; Berroir, J. -M; Placais, B.; Feve, G.] Univ Paris Diderot, Lab Pierre Aigrain, Ecole Normale Super, Univ Paris 06,CNRS UMR8551, F-75231 Paris 24, France; [Degiovanni, P.] Univ Lyon, Fed Phys Andre Marie Ampere, CNRS Lab Phys, Ecole Normale Super Lyon, F-69364 Lyon 07, France; [Cavanna, A.; Jin, Y.] CNRS Lab Photon & Nanostruct, F-91460 Marcoussis, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS)	Feve, G (corresponding author), Univ Paris Diderot, Lab Pierre Aigrain, Ecole Normale Super, Univ Paris 06,CNRS UMR8551, 24 Rue Lhomond, F-75231 Paris 24, France.	feve@lpa.ens.fr	Berroir, Jean-Marc/F-8090-2016; Bocquillon, Erwann/ABF-9509-2021; Placais, Bernard/U-7000-2018; Placais, Bernard/E-3014-2016; Degiovanni, Pascal/L-8577-2019; Feve, Gwendal/E-2796-2016	Berroir, Jean-Marc/0000-0001-7344-0929; Placais, Bernard/0000-0003-2408-7393; Placais, Bernard/0000-0003-2408-7393; Degiovanni, Pascal/0000-0003-1460-3817; Feve, Gwendal/0000-0001-5587-7537; Bocquillon, Erwann/0000-0002-5875-1718	Agence Nationale de la Recherche grant "1shot" [ANR-2010-BLANC-0412]	Agence Nationale de la Recherche grant "1shot"(French National Research Agency (ANR))	This work is supported by the Agence Nationale de la Recherche grant "1shot," ANR-2010-BLANC-0412.	Albert M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.041407; Bertoni A, 2000, PHYS REV LETT, V84, P5912, DOI 10.1103/PhysRevLett.84.5912; Beugnon J, 2006, NATURE, V440, P779, DOI 10.1038/nature04628; Blanter YM, 2000, PHYS REP, V336, P1, DOI 10.1016/S0370-1573(99)00123-4; Blumenthal MD, 2007, NAT PHYS, V3, P343, DOI 10.1038/nphys582; Bocquillon E, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196803; Degiovanni P, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.241307; Feve G, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035308; Feve G, 2007, SCIENCE, V316, P1169, DOI 10.1126/science.1141243; Grenier C, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/093007; Haack G, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.081303; Henny M, 1999, SCIENCE, V284, P296, DOI 10.1126/science.284.5412.296; Hermelin S, 2011, NATURE, V477, P435, DOI 10.1038/nature10416; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Ji Y, 2003, NATURE, V422, P415, DOI 10.1038/nature01503; Jonckheere T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.125425; Jonckheere T, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045321; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Leicht C, 2011, SEMICOND SCI TECH, V26, DOI 10.1088/0268-1242/26/5/055010; Liu RC, 1998, NATURE, V391, P263, DOI 10.1038/34611; Mahe A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.201309; McNeil RPG, 2011, NATURE, V477, P439, DOI 10.1038/nature10444; Moskalets M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.086601; Neder I, 2007, NATURE, V448, P333, DOI 10.1038/nature05955; Ol'khovskaya S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.166802; Oliver WD, 1999, SCIENCE, V284, P299, DOI 10.1126/science.284.5412.299; Parmentier FD, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.165438; Roulleau P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.126802; Samuelsson P., 2004, PHYS REV LETT, V92, P02685; Yamamoto M, 2012, NAT NANOTECHNOL, V7, P247, DOI [10.1038/nnano.2012.28, 10.1038/NNANO.2012.28]	30	271	273	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1054	1057		10.1126/science.1232572	http://dx.doi.org/10.1126/science.1232572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23348504	Green Submitted			2022-12-28	WOS:000315452000035
J	Young, D; Lamb, SE; Shah, S; MacKenzie, I; Tunnicliffe, W; Lall, R; Rowan, K; Cuthbertson, BH				Young, Duncan; Lamb, Sarah E.; Shah, Sanjoy; MacKenzie, Iain; Tunnicliffe, William; Lall, Ranjit; Rowan, Kathy; Cuthbertson, Brian H.		Oscar Study Grp	High-Frequency Oscillation for Acute Respiratory Distress Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE LUNG INJURY; TRIAL; ARDS; VENTILATION; MORTALITY; PRESSURE; OUTCOMES	BACKGROUND Patients with the acute respiratory distress syndrome (ARDS) require mechanical ventilation to maintain arterial oxygenation, but this treatment may produce secondary lung injury. High-frequency oscillatory ventilation (HFOV) may reduce this secondary damage. METHODS In a multicenter study, we randomly assigned adults requiring mechanical ventilation for ARDS to undergo either HFOV with a Novalung R100 ventilator (Metran) or usual ventilatory care. All the patients had a ratio of the partial pressure of arterial oxygen (Pao(2)) to the fraction of inspired oxygen (F-IO2) of 200 mm Hg (26.7 kPa) or less and an expected duration of ventilation of at least 2 days. The primary outcome was all-cause mortality 30 days after randomization. RESULTS There was no significant between-group difference in the primary outcome, which occurred in 166 of 398 patients (41.7%) in the HFOV group and 163 of 397 patients (41.1%) in the conventional-ventilation group (P = 0.85 by the chi-square test). After adjustment for study center, sex, score on the Acute Physiology and Chronic Health Evaluation (APACHE) II, and the initial Pao2:F-IO2 ratio, the odds ratio for survival in the conventional-ventilation group was 1.03 (95% confidence interval, 0.75 to 1.40; P = 0.87 by logistic regression). CONCLUSIONS The use of HFOV had no significant effect on 30-day mortality in patients undergoing mechanical ventilation for ARDS. (Funded by the National Institute for Health Research Health Technology Assessment Programme; OSCAR Current Controlled Trials number, ISRCTN10416500.)	[Young, Duncan] John Radcliffe Hosp, Oxford OX3 9DU, England; [Young, Duncan; Lamb, Sarah E.] Univ Oxford, Oxford, England; [Shah, Sanjoy] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England; [MacKenzie, Iain; Tunnicliffe, William] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; [Lall, Ranjit] Univ Warwick, Warwick Clin Trials Unit, Warwick, England; [Rowan, Kathy] Intens Care Natl Audit & Res Ctr, London, England; [Cuthbertson, Brian H.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Cuthbertson, Brian H.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada	University of Oxford; University of Oxford; Bristol Royal Infirmary; University of Birmingham; University of Warwick; Intensive Care National Audit & Research Centre; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Young, D (corresponding author), John Radcliffe Hosp, Adult Intens Care Unit, Headley Way, Oxford OX3 9DU, England.	duncan.young@nda.ox.ac.uk	Young, John D/M-9756-2016	Lall, Ranjit/0000-0003-1737-2866; Lamb, Sarah/0000-0003-4349-7195; Rowan, Kathryn/0000-0001-8217-5602; Young, John Duncan/0000-0002-6838-4835	National Institute for Health Research Health Technology Assessment Programme [06/04/01]; National Institute for Health Research [06/04/01, 06/04/501] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by the National Institute for Health Research Health Technology Assessment Programme (project number 06/04/01).	BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bollen CW, 2005, CRIT CARE, V9, pR430, DOI 10.1186/cc3737; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Derdak S, 2002, AM J RESP CRIT CARE, V166, P801, DOI 10.1164/rccm.2108052; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Ferguson ND, 2013, NEW ENGL J MED, V368, P795, DOI 10.1056/NEJMoa1215554; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LUNKENHEIMER PP, 1972, BRIT J ANAESTH, V44, P627, DOI 10.1093/bja/44.6.627; Mehta S, 2001, CRIT CARE MED, V29, P1360, DOI 10.1097/00003246-200107000-00011; Metran, 2012, PROD INF R100; Perkins GD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-113; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Sud S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2327; Thorpe KE, 2009, CAN MED ASSOC J, V180, pE47, DOI 10.1503/cmaj.090523; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Villar J, 2011, RESP CARE, V56, P420, DOI 10.4187/respcare.00811	18	389	433	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2013	368	9					806	813		10.1056/NEJMoa1215716	http://dx.doi.org/10.1056/NEJMoa1215716			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096ET	23339638				2022-12-28	WOS:000315387700006
J	Jubran, A; Grant, BJB; Duffner, LA; Collins, EG; Lanuza, DM; Hoffman, LA; Tobin, MJ				Jubran, Amal; Grant, Brydon J. B.; Duffner, Lisa A.; Collins, Eileen G.; Lanuza, Dorothy M.; Hoffman, Leslie A.; Tobin, Martin J.			Effect of Pressure Support vs Unassisted Breathing Through a Tracheostomy Collar on Weaning Duration in Patients Requiring Prolonged Mechanical Ventilation A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CRITICALLY ILL; CARE; FAILURE; FACILITIES; OUTCOMES	Importance Patients requiring prolonged mechanical ventilation (> 21 days) are commonly weaned at long-term acute care hospitals (LTACHs). The most effective method of weaning such patients has not been investigated. Objective To compare weaning duration with pressure support vs unassisted breathing through a tracheostomy collar in patients transferred to an LTACH for weaning from prolonged ventilation. Design, Setting, and Participants Between 2000 and 2010, a randomized study was conducted in tracheotomized patients transferred to a single LTACH for weaning from prolonged ventilation. Of 500 patients who underwent a 5-day screening procedure, 316 did not tolerate the procedure and were randomly assigned to receive weaning with pressure support (n=155) or a tracheostomy collar (n=161). Survival at 6- and 12-month time points was also determined. Main Outcome Measure Primary outcome was weaning duration. Secondary outcome was survival at 6 and 12 months after enrollment. Results Of 316 patients, 4 were withdrawn and not included in analysis. Of 152 patients in the pressure-support group, 68 (44.7%) were weaned; 22 (14.5%) died. Of 160 patients in the tracheostomy collar group, 85 (53.1%) were weaned; 16 (10.0%) died. Median weaning time was shorter with tracheostomy collar use (15 days; interquartile range [IQR], 8-25) than with pressure support (19 days; IQR, 12-31), P = .004. The hazard ratio (HR) for successful weaning rate was higher with tracheostomy collar use than with pressure support (HR, 1.43; 95% CI, 1.03-1.98; P = .033) after adjusting for baseline clinical covariates. Use of the tracheostomy collar achieved faster weaning than did pressure support among patients who did not tolerate the screening procedure between 12 and 120 hours (HR, 3.33; 95% CI, 1.44-7.70; P = .005), whereas weaning time was equivalent with the 2 methods in patients who did not tolerate the screening procedure within 0 to 12 hours. Mortality was equivalent in the pressure-support and tracheostomy collar groups at 6 months (55.92% vs 51.25%; 4.67% difference, 95% CI, -6.4% to 15.7%) and at 12 months (66.45% vs 60.00%; 6.45% difference, 95% CI, -4.2% to 17.1%). Conclusion and Relevance Among patients requiring prolonged mechanical ventilation and treated at a single long-term care facility, unassisted breathing through a tracheostomy, compared with pressure support, resulted in shorter median weaning time, although weaning mode had no effect on survival at 6 and 12 months.	[Jubran, Amal; Collins, Eileen G.; Tobin, Martin J.] Edward Hines Jr VA Hosp, Div Pulm & Crit Care Med, Hines, IL 60141 USA; [Jubran, Amal; Collins, Eileen G.; Tobin, Martin J.] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA; [Grant, Brydon J. B.] Fayetteville VA Med Ctr, Fayetteville, NC USA; [Grant, Brydon J. B.] SUNY Buffalo, Buffalo, NY 14260 USA; [Duffner, Lisa A.] RML Specialty Hosp, Hinsdale, IL USA; [Collins, Eileen G.] Univ Illinois, Chicago, IL USA; [Lanuza, Dorothy M.] Univ Wisconsin, Madison, WI 53706 USA; [Hoffman, Leslie A.] Univ Pittsburgh, Pittsburgh, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jubran, A (corresponding author), Edward Hines Jr VA Hosp, Div Pulm & Crit Care Med, 111N,5000 5th Ave, Hines, IL 60141 USA.	mtobin2@lumc.edu			National Institute of Nursing Research [RO1 NR008782]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR008782] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by funding from the National Institute of Nursing Research (RO1 NR008782).	Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; Cabello B, 2010, INTENS CARE MED, V36, P1171, DOI 10.1007/s00134-010-1870-0; Carson SS, 2008, CRIT CARE MED, V36, P2061, DOI 10.1097/CCM.0b013e31817b8925; COX DR, 1972, J R STAT SOC B, V34, P187; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Hill NS, 2001, AM J RESP CRIT CARE, V164, P186, DOI 10.1164/ajrccm.164.2.2105010b; Jubran A, 1997, AM J RESP CRIT CARE, V155, P906, DOI 10.1164/ajrccm.155.3.9117025; Jubran A, 2005, AM J RESP CRIT CARE, V171, P1252, DOI 10.1164/rccm.200503-356OC; JUBRAN A, 1995, AM J RESP CRIT CARE, V152, P129, DOI 10.1164/ajrccm.152.1.7599811; Jubran A, 1997, AM J RESP CRIT CARE, V155, P916, DOI 10.1164/ajrccm.155.3.9117026; Kahn JM, 2010, JAMA-J AM MED ASSOC, V303, P2253, DOI 10.1001/jama.2010.761; Kahn JM, 2010, INTENS CARE MED, V36, P8, DOI 10.1007/s00134-009-1672-4; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Laghi F, 2003, AM J RESP CRIT CARE, V167, P120, DOI 10.1164/rccm.200210-1246OC; Lellouche F, 2006, AM J RESP CRIT CARE, V174, P894, DOI 10.1164/rccm.200511-1780OC; Leung P, 1997, AM J RESP CRIT CARE, V155, P1940, DOI 10.1164/ajrccm.155.6.9196100; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; MARINI J J, 1986, Journal of Critical Care, V1, P32, DOI 10.1016/S0883-9441(86)80114-9; Parthasarathy S, 2002, AM J RESP CRIT CARE, V166, P1423, DOI 10.1164/rccm.200209-999OC; Parthasarathy S, 2007, J APPL PHYSIOL, V103, P140, DOI 10.1152/japplphysiol.00904.2006; Polverino E, 2010, INTENS CARE MED, V36, P137, DOI 10.1007/s00134-009-1658-2; Rothman K, 1986, MODERN EPIDEMIOLOGY; SASSOON CSH, 1991, AM REV RESPIR DIS, V143, P469, DOI 10.1164/ajrccm/143.3.469; Scheinhorn DJ, 2007, CHEST, V131, P85, DOI 10.1378/chest.06-1081; Scheinhorn DJ, 1997, CHEST, V111, P1654, DOI 10.1378/chest.111.6.1654; Seneff MG, 2000, CRIT CARE MED, V28, P342, DOI 10.1097/00003246-200002000-00009; STAUFFER JL, 1993, CHEST, V104, P1222, DOI 10.1378/chest.104.4.1222; Tobin MJ, 2012, COMPR PHYSIOL, V2, P2871, DOI 10.1002/cphy.c110030; Tobin MJ, 2012, AM J RESP CRIT CARE, V185, P349, DOI 10.1164/rccm.201201-0050ED; Tobin MJ, 2012, PRINCIPLES PRACTICE, V3, P1307; Vitacca M, 2001, AM J RESP CRIT CARE, V164, P225, DOI 10.1164/ajrccm.164.2.2008160; Wagner D P, 1989, Am Rev Respir Dis, V140, pS14; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101	34	95	101	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2013	309	7					671	677		10.1001/jama.2013.159	http://dx.doi.org/10.1001/jama.2013.159			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091EK	23340588	Green Accepted, Bronze			2022-12-28	WOS:000315032000022
J	Simons, FER; Sheikh, A				Simons, F. Estelle R.; Sheikh, Aziz			Anaphylaxis: the acute episode and beyond	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ORAL IMMUNOTHERAPY; ALLERGY; MANAGEMENT; GUIDELINES; DIAGNOSIS; RISK; DESENSITIZATION; RESUSCITATION; EPIDEMIOLOGY; EPINEPHRINE		[Simons, F. Estelle R.] Univ Manitoba, Fac Med, Winnipeg, MB R3A 1R9, Canada; [Sheikh, Aziz] Univ Edinburgh, Allergy & Resp Res Grp, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	University of Manitoba; University of Edinburgh	Simons, FER (corresponding author), Univ Manitoba, Fac Med, Winnipeg, MB R3A 1R9, Canada.	lmcniven@hsc.mb.ca	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056	Chief Scientist Office [CZH/4/429] Funding Source: Medline	Chief Scientist Office		Akin C, 2010, CURR ALLERGY ASTHM R, V10, P34, DOI 10.1007/s11882-009-0080-8; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Arroabarren E, 2011, PEDIAT ALLERG IMM-UK, V22, P708, DOI 10.1111/j.1399-3038.2011.01181.x; Bilo MB, 2011, ALLERGY, V66, P35, DOI 10.1111/j.1398-9995.2011.02630.x; Brown SGA, 2011, CLIN EXP ALLERGY, V41, P1660, DOI 10.1111/j.1365-2222.2011.03893.x; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Campbell RL, 2012, J ALLERGY CLIN IMMUN, V129, P748, DOI 10.1016/j.jaci.2011.09.030; Campbell RL, 2011, ANN ALLERG ASTHMA IM, V106, P401, DOI 10.1016/j.anai.2011.01.011; Choo KJ, 2012, COCHRANE DB SYST REV, V4; Clark A, 2011, ARCH DIS CHILD, V96, pI6, DOI 10.1136/adc.2011.212662; Ellis AK, 2007, ANN ALLERG ASTHMA IM, V98, P64, DOI 10.1016/S1081-1206(10)60861-7; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Gallagher M, 2012, PRIM CARE RESP J, V21, P392, DOI 10.4104/pcrj.2012.00072; Gibbison B, 2012, ANAESTHESIA, V67, P833, DOI 10.1111/j.1365-2044.2012.07159.x; Golden DBK, 2011, J ALLERGY CLIN IMMUN, V127, P852, DOI 10.1016/j.jaci.2011.01.025; Gonzalez-Perez A, 2010, J ALLERGY CLIN IMMUN, V125, P1098, DOI 10.1016/j.jaci.2010.02.009; Gupta R, 2007, THORAX, V62, P91, DOI 10.1136/thx.2004.038844; Harduar-Morano L, 2010, J ALLERGY CLIN IMMUN, V126, P98, DOI 10.1016/j.jaci.2010.04.017; Hompes S, 2011, PEDIAT ALLERG IMM-UK, V22, P568, DOI 10.1111/j.1399-3038.2011.01154.x; Keet CA, 2012, J ALLERGY CLIN IMMUN, V129, P448, DOI 10.1016/j.jaci.2011.10.023; Khan DA, 2010, J ALLERGY CLIN IMMUN, V125, pS126, DOI 10.1016/j.jaci.2009.10.028; Lieberman P, 2006, ANN ALLERG ASTHMA IM, V97, P596, DOI 10.1016/S1081-1206(10)61086-1; Liu A, 2011, CLIN EXP ALLERGY, V41, P1679, DOI 10.1111/j.1365-2222.2011.03825.x; Lowe G, 2010, SCOT MED J, V55, P11, DOI 10.1258/rsmsmj.55.3.11; McLean-Tooke APC, 2003, BMJ-BRIT MED J, V327, P1332, DOI 10.1136/bmj.327.7427.1332; Nowak-Wegrzyn A, 2011, J ALLERGY CLIN IMMUN, V127, P558, DOI 10.1016/j.jaci.2010.12.1098; Phillips JF, 2011, ALLERGY ASTHMA PROC, V32, P288, DOI 10.2500/aap.2011.32.3446; Pumphrey R, 2004, CURR OPIN ALLERGY CL, V4, P285, DOI 10.1097/01.all.0000136762.89313.0b; Pumphrey RSH, 2000, CLIN EXP ALLERGY, V30, P1144, DOI 10.1046/j.1365-2222.2000.00864.x; Rueff F, 2009, J ALLERGY CLIN IMMUN, V124, P1047, DOI 10.1016/j.jaci.2009.08.027; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Schwartz LB, 2006, IMMUNOL ALLERGY CLIN, V26, P451, DOI 10.1016/j.iac.2006.05.010; Sheikh A, 2007, ALLERGY, V62, P830, DOI 10.1111/j.1398-9995.2007.01435.x; Sheikh A, 2012, COCHRANE DB SYST REV, V8; Sheikh A, 2008, J ROY SOC MED, V101, P139, DOI 10.1258/jrsm.2008.070306; Shreffler WG, 2011, J ALLERGY CLIN IMMUN, V127, P843, DOI 10.1016/j.jaci.2011.02.011; Simons FER, 2007, J ALLERGY CLIN IMMUN, V120, pS2, DOI [10.1016/j.jaci.2007.05.001, 10.1016/j.jaci.2007.05.016]; Simons FER, 2007, J ALLERGY CLIN IMMUN, V120, P537, DOI 10.1016/j.jaci.2007.06.025; Simons FER, 2012, J ALLERGY CLIN IMMUN, V130, P597, DOI 10.1016/j.jaci.2012.06.035; Simons FER, 2012, CURR OPIN ALLERGY CL, V12, P389, DOI 10.1097/ACI.0b013e328355b7e4; Simons FER, 2010, ANN ALLERG ASTHMA IM, V104, P405, DOI 10.1016/j.anai.2010.01.023; Simons FER, 2010, J ALLERGY CLIN IMMUN, V125, pS161, DOI 10.1016/j.jaci.2009.12.981; Simons FER, 2011, J ALLERGY CLIN IMMUN, V127; Simons KJ, 2010, CURR OPIN ALLERGY CL, V10, P354, DOI 10.1097/ACI.0b013e32833bc670; Soar J, 2008, RESUSCITATION, V77, P157, DOI 10.1016/j.resuscitation.2008.02.001; Soar J, 2010, RESUSCITATION, V81, P1400, DOI 10.1016/j.resuscitation.2010.08.015; Tanno LK, 2012, ALLERGY, V67, P783, DOI 10.1111/j.1398-9995.2012.02829.x; Triggiani M, 2008, CLIN EXP IMMUNOL, V153, P7, DOI 10.1111/j.1365-2249.2008.03714.x; Vadas P, 2012, J ALLERGY CLIN IMMUN, V129, P1329, DOI 10.1016/j.jaci.2012.02.027; Varshney P, 2011, J ALLERGY CLIN IMMUN, V127, P654, DOI 10.1016/j.jaci.2010.12.1111	50	37	37	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2013	346								f602	10.1136/bmj.f602	http://dx.doi.org/10.1136/bmj.f602			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091ZG	23403828	Green Submitted			2022-12-28	WOS:000315087700002
J	Hess, O; Tsakmakidis, KL				Hess, Ortwin; Tsakmakidis, Kosmas L.			Metamaterials with Quantum Gain	SCIENCE			English	Editorial Material							NANOPLASMONIC METAMATERIALS		[Hess, Ortwin; Tsakmakidis, Kosmas L.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Blackett Lab, London SW7 2AZ, England	Imperial College London	Hess, O (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Phys, Blackett Lab, London SW7 2AZ, England.	o.hess@imperial.ac.uk	Hess, Ortwin/O-1345-2019; Tsakmakidis, Kosmas L./I-7651-2019	Hess, Ortwin/0000-0002-6024-0677; Tsakmakidis, Kosmas L./0000-0003-2141-1338	EPSRC [EP/H006869/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H006869/2] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Fang A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.121102; Hamm JM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.167405; Hess O, 2012, NAT MATER, V11, P573, DOI [10.1038/nmat3356, 10.1038/NMAT3356]; Kats MA, 2013, NAT MATER, V12, P20, DOI [10.1038/NMAT3443, 10.1038/nmat3443]; Khurgin JB, 2012, OPT EXPRESS, V20, P15309, DOI 10.1364/OE.20.015309; Lau EK, 2009, OPT EXPRESS, V17, P7790, DOI 10.1364/OE.17.007790; Lu YJ, 2012, SCIENCE, V337, P450, DOI 10.1126/science.1223504; Pusch A, 2012, ACS NANO, V6, P2420, DOI 10.1021/nn204692x; Wuestner S, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.201406; Wuestner S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.127401; Xiao SM, 2010, NATURE, V466, P735, DOI 10.1038/nature09278	11	54	54	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					654	655		10.1126/science.1231254	http://dx.doi.org/10.1126/science.1231254			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393252				2022-12-28	WOS:000314585600027
J	Hingorani, AD; van der Windt, DA; Riley, RD; Abrams, K; Moons, KGM; Steyerberg, EW; Schroter, S; Sauerbrei, W; Altman, DG; Hemingway, H				Hingorani, Aroon D.; van der Windt, Danielle A.; Riley, Richard D.; Abrams, Keith; Moons, Karel G. M.; Steyerberg, Ewout W.; Schroter, Sara; Sauerbrei, Willi; Altman, Douglas G.; Hemingway, Harry		PROGRESS Grp	Prognosis research strategy (PROGRESS) 4: Stratified medicine research	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN; CONTINUOUS PREDICTORS; AMERICAN-SOCIETY; CLINICAL-TRIALS; BREAST-CANCER; TRASTUZUMAB; SUBGROUPS; ASSOCIATION; VALIDATION; SURVIVAL		[Hingorani, Aroon D.; Hemingway, Harry] UCL, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England; [van der Windt, Danielle A.] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Riley, Richard D.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Abrams, Keith] Univ Leicester, Ctr Biostat & Genet Epidemiol, Dept Hlth Sci, Sch Med, Leicester LE1 7RH, Leics, England; [Moons, Karel G. M.] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Schroter, Sara] BMA House, BMJ, London WC1H 9JR, England; [Sauerbrei, Willi] Univ Med Ctr Freiburg, Inst Med Biometry & Informat, D-79104 Freiburg, Germany; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England	University of London; University College London; Keele University; University of Birmingham; University of Leicester; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Freiburg; University of Oxford	Hemingway, H (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England.	h.hemingway@ucl.ac.uk	Schroter, Sara/G-3427-2012; Riley, Richard David/ABE-5877-2020; Steyerberg, Ewout W/C-1509-2018; Peat, George/AAE-5869-2020; Abrams, Keith/AAA-2557-2020; Briggs, Andrew/ABA-9009-2020; Riley, Richard/G-2406-2011; Malats, Nuria/H-7041-2015; Hemingway, Harry/C-1219-2009	Schroter, Sara/0000-0002-8791-8564; Riley, Richard David/0000-0001-8699-0735; Steyerberg, Ewout W/0000-0002-7787-0122; Peat, George/0000-0002-9008-0184; Briggs, Andrew/0000-0002-0777-1997; Malats, Nuria/0000-0003-2538-3784; Hemingway, Harry/0000-0003-2279-0624; Hingorani, Aroon/0000-0001-8365-0081; Sauerbrei, Willi/0000-0002-6792-4123; Hayden, Jill Alison/0000-0001-7026-144X; /0000-0002-2342-301X; Kyzas, Panayiotis/0000-0003-1034-9145; Abrams, Keith/0000-0002-7557-1567; van der Windt, Danielle/0000-0002-7248-6703	Medical Research Council [G0902393]; University College London; Oxford University; Birmingham University; London School of Hygiene and Tropical Medicine; Keele University; Queen Mary University London; Cancer Research UK [C5529]; UK National Institute for Health Research [RP-PG-0407-10314]; Wellcome Trust [086091/Z/08/Z]; Health eResearch Centre Network (HERC-UK); Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute of Health Research; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); Netherlands Organization for Scientific Research [9120.8004]; Center for Translational Molecular Medicine (PCMM project) [03O-203]; MRC Midlands Hub for Trials Methodology Research (MRC) [G0800808]; Arthritis Research UK Centre of Excellence in Primary Care; Medical Research Council [MR/K006584/1, G0800808] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10159, RP-PG-0407-10386, RP-PG-0407-10314, NF-SI-0509-10183] Funding Source: researchfish; MRC [G0902393, G0800808] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London(General Electric); Oxford University; Birmingham University; London School of Hygiene and Tropical Medicine; Keele University; Queen Mary University London; Cancer Research UK(Cancer Research UK); UK National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Health eResearch Centre Network (HERC-UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Center for Translational Molecular Medicine (PCMM project); MRC Midlands Hub for Trials Methodology Research (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK Centre of Excellence in Primary Care; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This series had no explicit funding, but some of the authors were supported by research grants: PROGRESS is supported by a Partnership grant from the Medical Research Council (G0902393), involving University College London (HH, AH), Oxford University (DGA), Birmingham University (RDR), London School of Hygiene and Tropical Medicine (I Roberts, P Perel), Keele University (P Croft, DAvdW), and Queen Mary University London (A Timmis). DGA is supported by a programme grant from Cancer Research UK (C5529). HH is supported by grants from the UK National Institute for Health Research (RP-PG-0407-10314) and the Wellcome Trust (086091/Z/08/Z). The work of HH and ADH is supported by the Health eResearch Centre Network (HERC-UK), funded by the Medical Research Council in partnership with Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates) and the Wellcome Trust (the views expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health). EWS was supported by The Netherlands Organization for Scientific Research (grant 9120.8004) and the Center for Translational Molecular Medicine (PCMM project, grant 03O-203). RDR is supported by the MRC Midlands Hub for Trials Methodology Research (MRC Grant G0800808). DAvdW is supported by the Arthritis Research UK Centre of Excellence in Primary Care.	Almirall D, 2012, STAT MED, V31, P1887, DOI 10.1002/sim.4512; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Assimes TL, 2010, J AM COLL CARDIOL, V56, P1552, DOI 10.1016/j.jacc.2010.06.022; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Brennan GP, 2006, SPINE, V31, P623, DOI 10.1097/01.brs.0000202807.72292.a8; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Childs JD, 2004, ANN INTERN MED, V141, P920, DOI 10.7326/0003-4819-141-12-200412210-00008; Clark GM, 2008, MOL ONCOL, V1, P406, DOI 10.1016/j.molonc.2007.12.001; Clarke M, 1998, LANCET, V351, P1451; Danese MD, 2010, CANCER-AM CANCER SOC, V116, P5575, DOI 10.1002/cncr.25347; Fayers PM, 2009, QUAL LIFE RES, V18, P527, DOI 10.1007/s11136-009-9473-3; Flynn MR, 2005, EUR HEART J, V26, P308, DOI 10.1093/eurheartj/ehi079; Guillemin F, 2007, NAT CLIN PRACT RHEUM, V3, P407, DOI 10.1038/ncprheum0528; Guyatt G., 2008, USERS GUIDES MEDICAL; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Hankey GJ, 2006, LANCET, V367, P606, DOI 10.1016/S0140-6736(06)68040-9; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Henderson R, 2005, J MED ETHICS, V31, P703, DOI 10.1136/jme.2005.012427; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hingorani AD, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c6244; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Holmes MV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007960; House of Lords Science and Technology Committee, 2009, GEN MED, VII; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Kangelaris KN, 2009, J GEN INTERN MED, V24, P656, DOI 10.1007/s11606-009-0949-1; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Li YH, 2010, AM J CARDIOL, V106, P994, DOI 10.1016/j.amjcard.2010.05.033; Lidgren M, 2008, ANN ONCOL, V19, P487, DOI 10.1093/annonc/mdm488; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mandrekar JN, 2008, J THORAC ONCOL, V3, P1371, DOI 10.1097/JTO.0b013e31818dd97b; Mandrekar SJ, 2010, CLIN TRIALS, V7, P567, DOI 10.1177/1740774510368574; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Moons KGM, 2010, CLIN CHEM, V56, P537, DOI 10.1373/clinchem.2009.134155; Nakhleh RE, 2010, ARCH PATHOL LAB MED, V134, P728, DOI 10.1043/1543-2165-134.5.728; Riley RD, 2008, STAT MED, V27, P1870, DOI 10.1002/sim.3165; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Rothwell PM, 2005, LANCET, V365, P256; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Royston P, 2004, STAT MED, V23, P2509, DOI 10.1002/sim.1815; Royston P, 2004, BRIT J CANCER, V90, P794, DOI 10.1038/sj.bjc.6601622; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148; Sauerbrei W, 2007, STAT MED, V26, P4989, DOI 10.1002/sim.2954; Senn S, 2004, BMJ-BRIT MED J, V329, P966, DOI 10.1136/bmj.329.7472.966; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Steyerberg EW, 2013, PLOS MED, DOI 10.1371.journal/pmed.1001381; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Trusheim MR, 2007, NAT REV DRUG DISCOV, V6, P287, DOI 10.1038/nrd2251; Von Korff M, 2001, ANN INTERN MED, V134, P911, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00016; Willett WC, 2008, EPIDEMIOLOGY, V19, P655, DOI 10.1097/EDE.0b013e318181b877; Williams AH, 2006, INT J TECHNOL ASSESS, V22, P1; Woelderink A, 2006, PHARMACOGENOMICS J, V6, P3, DOI 10.1038/sj.tpj.6500341; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	55	268	268	0	45	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2013	346								e5793	10.1136/bmj.e5793	http://dx.doi.org/10.1136/bmj.e5793			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088AR	23386361	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000314806700017
J	Arai, S; Saijo, S; Suzuki, K; Mizutani, K; Kakinuma, Y; Ishizuka-Katsura, Y; Ohsawa, N; Terada, T; Shirouzu, M; Yokoyama, S; Iwata, S; Yamato, I; Murata, T				Arai, Satoshi; Saijo, Shinya; Suzuki, Kano; Mizutani, Kenji; Kakinuma, Yoshimi; Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki; Iwata, So; Yamato, Ichiro; Murata, Takeshi			Rotation mechanism of Enterococcus hirae V-1-ATPase based on asymmetric crystal structures	NATURE			English	Article							ROTOR RING; V-ATPASE; NA+-ATPASE; F-1-ATPASE; COMPLEX; F-1; VALIDATION; RESOLUTION; F1-ATPASE; BINDING	In various cellular membrane systems, vacuolar ATPases (V-ATPases) function as proton pumps, which are involved in many processes such as bone resorption and cancer metastasis, and these membrane proteins represent attractive drug targets for osteoporosis and cancer(1). The hydrophilic V-1 portion is known as a rotary motor, in which a central axis DF complex rotates inside a hexagonally arranged catalytic A(3)B(3) complex using ATP hydrolysis energy, but the molecular mechanism is not well defined owing to a lack of high-resolution structural information. We previously reported on the in vitro expression, purification and reconstitution of Enterococcus hirae V-1-ATPase from the A(3)B(3) and DF complexes(2,3). Here we report the asymmetric structures of the nucleotide-free (2.8 angstrom) and nucleotide-bound (3.4 angstrom) A(3)B(3) complex that demonstrate conformational changes induced by nucleotide binding, suggesting a binding order in the right-handed rotational orientation in a cooperative manner. The crystal structures of the nucleotide-free (2.2 angstrom) and nucleotide-bound (2.7 angstrom) V-1-ATPase are also reported. The more tightly packed nucleotide-binding site seems to be induced by DF binding, and ATP hydrolysis seems to be stimulated by the approach of a conserved arginine residue. To our knowledge, these asymmetric structures represent the first high-resolution view of the rotational mechanism of V-1-ATPase.	[Arai, Satoshi; Suzuki, Kano; Mizutani, Kenji; Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan; [Arai, Satoshi; Saijo, Shinya; Mizutani, Kenji; Yamato, Ichiro] Tokyo Univ Sci, Dept Biol Sci & Technol, Noda, Chiba 2788510, Japan; [Saijo, Shinya] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Mizutani, Kenji; Iwata, So] Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Kakinuma, Yoshimi] Ehime Univ, Fac Agr, Lab Mol Physiol & Genet, Matsuyama, Ehime 7908566, Japan; [Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki; Iwata, So; Murata, Takeshi] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Murata, Takeshi] JST, PRESTO, Inage Ku, Chiba 2638522, Japan	Chiba University; Tokyo University of Science; RIKEN; Kyoto University; Ehime University; RIKEN; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Murata, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	t.murata@faculty.chiba-u.jp	Shirouzu, Mikako/A-6521-2016; Murata, Takeshi/J-6181-2017; Yokoyama, Shigeyuki/N-6911-2015	Murata, Takeshi/0000-0002-5748-4670; Yokoyama, Shigeyuki/0000-0003-3133-7338; Mizutani, Kenji/0000-0002-7337-2134	Targeted Proteins Research Program [23370047, 23118705]; Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; Biotechnology and Biological Sciences Research Council [BBS/B/06458] Funding Source: researchfish	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. E. Walker for his suggestions, especially through the structural studies of F1-ATPase. The synchrotron radiation experiments were performed at SPring-8 and Photon Factory (proposals 2008S2-001, 2011S2-005, 2009G660, 2009B1031 and 2012G132). We also thank the beamline staff at BL41XU of SPring-8 (Harima, Japan) and NE3A, NW12A and BL1A of Photon Factory (Tsukuba, Japan) for help during data collection. This work was supported by the Targeted Proteins Research Program, grants-in-aid (23370047, 23118705), Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arai S, 2009, BIOCHEM BIOPH RES CO, V390, P698, DOI 10.1016/j.bbrc.2009.10.032; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; DeLuca M., 1978, Methods in Enzymology, V37, P3; Dittrich M, 2003, BIOPHYS J, V85, P2253, DOI 10.1016/S0006-3495(03)74650-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kabaleeswaran V, 2009, J BIOL CHEM, V284, P10546, DOI 10.1074/jbc.M900544200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mizutani K, 2011, P NATL ACAD SCI USA, V108, P13474, DOI 10.1073/pnas.1103287108; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Murata T, 2005, J BIOENERG BIOMEMBR, V37, P411, DOI 10.1007/s10863-005-9481-0; Murata T, 2000, J BIOL CHEM, V275, P13415, DOI 10.1074/jbc.275.18.13415; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 2008, P NATL ACAD SCI USA, V105, P8607, DOI 10.1073/pnas.0800992105; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walker JE, 1998, ANGEW CHEM INT EDIT, V37, P2309, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2308::AID-ANIE2308>3.0.CO;2-W; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Zhou M, 2011, SCIENCE, V334, P380, DOI 10.1126/science.1210148	42	89	89	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					703	+		10.1038/nature11778	http://dx.doi.org/10.1038/nature11778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23334411				2022-12-28	WOS:000314219600063
J	Perk, J				Perk, Joep			PERSPECTIVE The power of disease prevention	NATURE			English	Editorial Material							RISK		Linnaeus Univ, Kalmar, Sweden	Linnaeus University	Perk, J (corresponding author), Linnaeus Univ, Kalmar, Sweden.	joep.perk@lnu.se						Banegas JR, 2011, EUR HEART J, V32, P2143, DOI 10.1093/eurheartj/ehr080; Chow CK, 2010, CIRCULATION, V121, P750, DOI 10.1161/CIRCULATIONAHA.109.891523; Di Chiara A, 2009, EUR HEART J, V30, P1027, DOI 10.1093/eurheartj/ehp025; Jorgensen T, 2013, EUR J PREV CARDIOL, V20, P409, DOI 10.1177/2047487312441726; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; WHO, 2002, DIET NUTR PREV CHRON; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	7	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S6	S6		10.1038/493S6a	http://dx.doi.org/10.1038/493S6a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080CU	23364770				2022-12-28	WOS:000314219600006
J	Boyle, R				Boyle, Roger			Clinical networks are effective, work in patients' interests, and shouldn't be disbanded	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Boyle, Roger] UCL, Natl Ctr Cardiovasc Prevent & Outcomes, London WC1E 6BT, England	University of London; University College London	Boyle, R (corresponding author), UCL, Natl Ctr Cardiovasc Prevent & Outcomes, London WC1E 6BT, England.	roger.boyle5@btinternet.com						Calkin S., 2012, HLTH SERVICE J; Department of Health, 2013, NHS OUTC FRAM 2013 1; Dreaper J, 2012, BBC NEWS; Myocardial Ischaemia National Audit Project, NHS CAR PAT HEART AT; NHS Commissioning Board, CLIN REF GROUPS MEMB; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059	6	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2013	346								f565	10.1136/bmj.f565	http://dx.doi.org/10.1136/bmj.f565			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084AY	23358491				2022-12-28	WOS:000314509400009
J	Mashour, GA; Avidan, MS				Mashour, George A.; Avidan, Michael S.			Capturing covert consciousness	LANCET			English	Editorial Material							VEGETATIVE STATE; INTRAOPERATIVE AWARENESS; SURGICAL POPULATION; PREVENTION		[Mashour, George A.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Avidan, Michael S.] Washington Univ, Dept Anesthesiol, St Louis, MO USA	University of Michigan System; University of Michigan; Washington University (WUSTL)	Mashour, GA (corresponding author), Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA.	gmashour@med.umich.edu		Avidan, Michael/0000-0001-6248-044X				Avidan MS, 2011, NEW ENGL J MED, V365, P591, DOI 10.1056/NEJMoa1100403; BEECHER HK, 1968, NEW ENGL J MED, V278, P1425, DOI 10.1056/NEJM196806272782605; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Goldfine AM, 2013, LANCET, V381, P289, DOI 10.1016/S0140-6736(13)60125-7; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Mashour GA, 2012, ANESTHESIOLOGY, V117, P717, DOI 10.1097/ALN.0b013e31826904a6; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197	12	12	12	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2013	381	9863					271	272		10.1016/S0140-6736(13)60094-X	http://dx.doi.org/10.1016/S0140-6736(13)60094-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23351798				2022-12-28	WOS:000314021800008
J	Ivanova, N; Justham, S; Nandez, JLA; Lombardi, JC				Ivanova, N.; Justham, S.; Nandez, J. L. Avendano; Lombardi, J. C., Jr.			Identification of the Long-Sought Common-Envelope Events	SCIENCE			English	Article							II SUPERNOVAE; OPTICAL TRANSIENT; PLATEAU STAGE; NGC 300; EVOLUTION; M85; BINARY; MODEL; MASS; NOVA	Common-envelope events (CEEs), during which two stars temporarily orbit within a shared envelope, are believed to be vital for the formation of a wide range of close binaries. For decades, the only evidence that CEEs actually occur has been indirect, based on the existence of systems that could not be otherwise explained. Here we propose a direct observational signature of CEEs arising from a physical model where emission from matter ejected in a CEE is controlled by a recombination front as the matter cools. The natural range of time scales and energies from this model, as well as the expected colors, light-curve shapes, ejection velocities, and event rate, match those of a recently recognized class of red transient outbursts.	[Ivanova, N.; Nandez, J. L. Avendano] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E7, Canada; [Justham, S.] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; [Lombardi, J. C., Jr.] Allegheny Coll, Dept Phys, Meadville, PA 16335 USA	University of Alberta; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Allegheny College	Ivanova, N (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB T6G 2E7, Canada.	nata.ivanova@ualberta.ca		Lombardi, James/0000-0002-7444-7599	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Chinese Academy of Sciences; National Natural Science Foundation of China; Consejo Nacional de Ciencia y Tecnologia; NSF [OCI-1053575]; Direct For Computer & Info Scie & Enginr [0910735] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NSF(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	N.I. acknowledges support from the Natural Sciences and Engineering Research Council of Canada and Canada Research Chairs Program. S.J. acknowledges support from the Chinese Academy of Sciences and National Natural Science Foundation of China. J.L.A.N. acknowledges support from Consejo Nacional de Ciencia y Tecnologia. J.C.L. thanks R. Scruggs for useful discussions. This research has been enabled by the use of computing resources provided by WestGrid and Compute/Calcul Canada as well as the Extreme Science and Engineering Discovery Environment (supported by NSF grant OCI-1053575).	Berger E, 2009, ASTROPHYS J, V699, P1850, DOI 10.1088/0004-637X/699/2/1850; Bond HE, 2003, NATURE, V422, P405, DOI 10.1038/nature01508; Bond HE, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/17; Bond HE, 2009, ASTROPHYS J LETT, V695, pL154, DOI 10.1088/0004-637X/695/2/L154; CHUGAI NN, 1991, SOV ASTRON LETT+, V17, P210; HAN ZW, 1994, MON NOT R ASTRON SOC, V270, P121, DOI 10.1093/mnras/270.1.121; Hurley JR, 2000, MON NOT R ASTRON SOC, V315, P543, DOI 10.1046/j.1365-8711.2000.03426.x; IBEN I, 1993, PUBL ASTRON SOC PAC, V105, P1373, DOI 10.1086/133321; Ivanova N, 2011, ASTR SOC P, V447, P91; Kasen D, 2010, ASTROPHYS J, V714, P155, DOI 10.1088/0004-637X/714/1/155; Kasliwal MM, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/134; Kulkarni SR, 2007, NATURE, V447, P458, DOI 10.1038/nature05822; Martini P, 1999, ASTRON J, V118, P1034, DOI 10.1086/300951; Mould J., 1990, Astrophysical Journal, Letters, V353, pL35, DOI 10.1086/185702; Ofek EO, 2008, ASTROPHYS J, V674, P447, DOI 10.1086/524350; Pastorello A, 2007, NATURE, V449, pE1, DOI 10.1038/nature06282; POPOV DV, 1993, ASTROPHYS J, V414, P712, DOI 10.1086/173117; Rau A, 2007, ASTROPHYS J, V659, P1536, DOI 10.1086/512672; Rau A, 2009, PUBL ASTRON SOC PAC, V121, P1334, DOI 10.1086/605911; Stepien K, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201116689; Tylenda R, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201016221; Webbink RF, 2008, ASTROPHYS SPACE SC L, V352, P233	23	107	108	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					433	435		10.1126/science.1225540	http://dx.doi.org/10.1126/science.1225540			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349287	Green Submitted			2022-12-28	WOS:000313960700039
J	Keogh, P; Wood, J				Keogh, Peter; Wood, James			Hemifacial Flushing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Keogh, Peter] Dartford & Gravesham Natl Hlth Serv Trust, Dartford, England; [Wood, James] Maidstone & Tunbridge Wells Natl Hlth Serv Trust, Maidstone, Kent, England		Keogh, P (corresponding author), Dartford & Gravesham Natl Hlth Serv Trust, Dartford, England.	peterdkeogh@googlemail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					374	374		10.1056/NEJMicm1202165	http://dx.doi.org/10.1056/NEJMicm1202165			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075KX	23343066				2022-12-28	WOS:000313885900010
J	Axelrod, L; Shah, DJ; Jena, AB				Axelrod, Lloyd; Shah, Deep J.; Jena, Anupam B.			The European Working Time Directive An Uncontrolled Experiment in Medical Care and Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Axelrod, Lloyd; Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Axelrod, Lloyd] Massachusetts Gen Hosp, Div Endocrine, Boston, MA 02114 USA; [Shah, Deep J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Jena, Anupam B.] Hlth Care Policy, Boston, MA USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Bureau of Economic Research	Axelrod, L (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Endocrine, Boston, MA 02114 USA.	laxelrod@partners.org						[Anonymous], 2010, SEC20101610; Meltzer DO, 2007, JAMA-J AM MED ASSOC, V298, P1055, DOI 10.1001/jama.298.9.1055; Moonesinghe SR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1580; Nuckols TK, 2009, NEW ENGL J MED, V360, P2202, DOI 10.1056/NEJMsa0810251; Royal College of Surgeons of England, IMP DOCT WORK TIM CA; Shapira I., 2010, WASHINGTON POST; Temple J., 2010, TIME TRAINING REV IM; [No title captured]	8	25	25	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					447	448		10.1001/jama.2012.148065	http://dx.doi.org/10.1001/jama.2012.148065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083LY	23385268				2022-12-28	WOS:000314466900023
J	Spack, NP				Spack, Norman P.			Management of Transgenderism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENDER IDENTITY DISORDER; TRANSSEXUALS RECEIVING TREATMENT; TO-MALE TRANSSEXUALS; PUBERTY SUPPRESSION; SEX REASSIGNMENT; FOLLOW-UP; ADOLESCENTS; SURGERY; DIAGNOSIS; HORMONES	Gender identity disorder (transgenderism) is poorly understood from both mechanistic and clinical standpoints. Awareness of the condition appears to be increasing, probably because of greater societal acceptance and available hormonal treatment. Therapeutic options include hormone and surgical treatments but may be limited by insurance coverage because costs are high. For patients seeking male-to-female (MTF) change, hormone treatment includes estrogens, finasteride, spironolactone, and gonadotropin-releasing hormone (GnRH) analogs. Surgical options include feminizing genital and facial surgery, breast augmentation, and various fat transplantations. For patients seeking a female-to-male (FTM) gender change, medical therapy includes testosterone and GnRH analogs and surgical therapy includes mammoplasty and phalloplasty. Medical therapy for both FTM and MTF can be started in early puberty, although long-term effects are not known. All patients considering treatment need counseling and medical monitoring. JAMA. 2013;309(5):478-484 www.jama.com	[Spack, Norman P.] Boston Childrens Hosp, Div Endocrine, Boston, MA USA; [Spack, Norman P.] Hosp Gender Management Serv, Boston, MA USA; [Spack, Norman P.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Spack, NP (corresponding author), Childrens Hosp, Div Endocrine, 300 Longwood Ave, Boston, MA 02115 USA.	norman.spack@childrens.harvard.edu						Ainsworth TA, 2010, QUAL LIFE RES, V19, P1019, DOI 10.1007/s11136-010-9668-7; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Asscheman H, 2011, EUR J ENDOCRINOL, V164, P635, DOI 10.1530/EJE-10-1038; Berenbaum SA, 2003, J CLIN ENDOCR METAB, V88, P1102, DOI 10.1210/jc.2002-020782; Cohen-Kettenis PT, 2008, J SEX MED, V5, P1892, DOI 10.1111/j.1743-6109.2008.00870.x; Cohen-Kettenis PT, 2010, ARCH SEX BEHAV, V39, P499, DOI 10.1007/s10508-009-9562-y; Cohen-Kettenis PT, 1998, EUR CHILD ADOLES PSY, V7, P246, DOI 10.1007/s007870050073; De Sutter P, 2001, HUM REPROD, V16, P612, DOI 10.1093/humrep/16.4.612; de Vries ALC, 2011, J SEX MED, V8, P2276, DOI 10.1111/j.1743-6109.2010.01943.x; Delemarre-van de Waal HA, 2006, EUR J ENDOCRINOL, V155, pS131, DOI 10.1530/eje.1.02231; Gooren LJ, 2008, J CLIN ENDOCR METAB, V93, P19, DOI 10.1210/jc.2007-1809; Gooren LJ, 2011, NEW ENGL J MED, V364, P1251, DOI 10.1056/NEJMcp1008161; HAGE JJ, 1995, ANN PLAS SURG, V34, P59, DOI 10.1097/00000637-199501000-00012; Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345; Heylens G, 2012, J SEX MED, V9, P751, DOI 10.1111/j.1743-6109.2011.02567.x; Klein C, 2009, J SEX MED, V6, P2922, DOI 10.1111/j.1743-6109.2009.01370.x; Kreukels BPC, 2011, NAT REV ENDOCRINOL, V7, P466, DOI 10.1038/nrendo.2011.78; Lawrence AA, 2006, ARCH SEX BEHAV, V35, P717, DOI 10.1007/s10508-006-9104-9; MANASCO PK, 1988, J CLIN ENDOCR METAB, V67, P368, DOI 10.1210/jcem-67-2-368; Meyer W., 2001, H BENJAMIN INT GENDE; MEYERBAHLBURG HFL, 1994, ARCH SEX BEHAV, V23, P21, DOI 10.1007/BF01541616; Mueller A, 2008, EUR J ENDOCRINOL, V159, P197, DOI 10.1530/EJE-08-0289; Nelson L, 2009, J PLAST RECONSTR AES, V62, P331, DOI 10.1016/j.bjps.2007.10.049; Perovic S, 2009, CURR OPIN UROL, V19, P571, DOI 10.1097/MOU.0b013e3283312eb3; Rametti G, 2011, J PSYCHIATR RES, V45, P199, DOI 10.1016/j.jpsychires.2010.05.006; Rehman J, 1999, ARCH SEX BEHAV, V28, P71, DOI 10.1023/A:1018745706354; Smith YLS, 2005, PSYCHOL MED, V35, P89, DOI 10.1017/S0033291704002776; Toorians AWFT, 2003, J CLIN ENDOCR METAB, V88, P5723, DOI 10.1210/jc.2003-030520; vanKesteren PJ, 1996, ARCH SEX BEHAV, V25, P589, DOI 10.1007/BF02437841; Wallien MSC, 2008, J AM ACAD CHILD PSY, V47, P1413, DOI 10.1097/CHI.0b013e31818956b9; World Professional Association for Transgender Health, 2011, STAND CAR HLTH TRANS; YAGER JD, 1991, P SOC EXP BIOL MED, V198, P667; ZHOU JN, 1995, NATURE, V378, P68, DOI 10.1038/378068a0; Zucker KJ, 2005, ANNU REV CLIN PSYCHO, V1, P467, DOI 10.1146/annurev.clinpsy.1.102803.144050; Zucker KJ, 2010, J GAY LESBIAN MENT H, V15, P58, DOI 10.1080/19359705.2011.530574; Zucker KJ, 2009, INT J TRANSGENDERISM, V11, P8, DOI 10.1080/15532730902799946	36	65	68	0	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2013	309	5					478	484		10.1001/jama.2012.165234	http://dx.doi.org/10.1001/jama.2012.165234			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083LY	23385274				2022-12-28	WOS:000314466900029
J	Noel, S; Dua, J; Kaushal, G				Noel, Sophie; Dua, Janet; Kaushal, Ghazia			PICTURE QUIZ An 81 year old man with a blistering rash	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK-FACTORS; SKIN		[Noel, Sophie; Dua, Janet; Kaushal, Ghazia] Royal Berkshire Hosp, Dept Dermatol, Reading RG1 5AN, Berks, England	Royal Berkshire Hospital	Dua, J (corresponding author), Royal Berkshire Hosp, Dept Dermatol, Reading RG1 5AN, Berks, England.	Janetdua3000@yahoo.co.uk						Bastuji-Garin S, 2011, J INVEST DERMATOL, V131, P637, DOI 10.1038/jid.2010.301; BastujiGarin S, 1996, ARCH DERMATOL, V132, P272, DOI 10.1001/archderm.132.3.272; Bernard P, 2009, ARCH DERMATOL, V145, P537, DOI 10.1001/archdermatol.2009.53; Bickle KM, 2002, AM FAM PHYSICIAN, V65, P1861; Borradori L, 2008, DERMATOLOGY, P431; Bystryn JC, 2005, J INVEST DERMATOL, V124, pXX, DOI 10.1111/j.0022-202X.2005.23677.x; Chaidemenos GC, 1998, INT J DERMATOL, V37, P206, DOI 10.1046/j.1365-4362.1998.00271.x; Chen YJ, 2011, BRIT J DERMATOL, V165, P593, DOI 10.1111/j.1365-2133.2011.10386.x; GAMMON WR, 1984, J AM ACAD DERMATOL, V11, P820, DOI 10.1016/S0190-9622(84)80459-4; Gurcan HM, 2011, EXPERT OPIN PHARMACO, V12, P1259, DOI 10.1517/14656566.2011.549127; Hall III RP, 1999, FITZPATRICKS DERMATO, P680; Hertl M, 2008, J DTSCH DERMATOL GES, V6, P366, DOI 10.1111/j.1610-0387.2007.06602.x; Joly P, 2002, NEW ENGL J MED, V346, P321, DOI 10.1056/NEJMoa011592; Jung M, 1999, J AM ACAD DERMATOL, V41, P266, DOI 10.1016/S0190-9622(99)70061-7; Kirtschig G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002292.pub3; Korman NJ, 2000, DERMATOL CLIN, V18, P127, DOI 10.1016/S0733-8635(05)70153-4; Marazza G, 2009, BRIT J DERMATOL, V161, P861, DOI 10.1111/j.1365-2133.2009.09300.x; Mul VEM, 2007, RADIOTHER ONCOL, V82, P5, DOI 10.1016/j.radonc.2006.11.014; ROSS JS, 1992, J CUTAN PATHOL, V19, P212, DOI 10.1111/j.1600-0560.1992.tb01661.x; Rzany B, 2002, ARCH DERMATOL, V138, P903, DOI 10.1001/archderm.138.7.903; Rzany B, 2001, AUTOIMMUNE DISEASES OF THE SKIN, P21; SALOMON RJ, 1987, ARCH DERMATOL, V123, P389, DOI 10.1001/archderm.123.3.389; Savin J A, 1987, Clin Dermatol, V5, P52, DOI 10.1016/0738-081X(87)90049-6; Sun CH, 2009, J DERMATOL TREAT, V20, P233, DOI 10.1080/09546630802683876; Tampoia M, 2012, AUTOIMMUNE REV; TAYLOR G, 1993, J AM ACAD DERMATOL, V29, P181, DOI 10.1016/0190-9622(93)70164-O; Venning VA, 2012, BRIT J DERMATOL, V167, P1200, DOI 10.1111/bjd.12072; Yang BQ, 2011, INDIAN J DERMATOL VE, V77, P677, DOI 10.4103/0378-6323.86479	28	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2013	346								f522	10.1136/bmj.f522	http://dx.doi.org/10.1136/bmj.f522			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084BQ	23369776				2022-12-28	WOS:000314511500008
J	Castro, VM; Clements, CC; Murphy, SN; Gainer, VS; Fava, M; Weilburg, JB; Erb, JL; Churchill, SE; Kohane, IS; Iosifescu, DV; Smoller, JW; Perlis, RH				Castro, Victor M.; Clements, Caitlin C.; Murphy, Shawn N.; Gainer, Vivian S.; Fava, Maurizio; Weilburg, Jeffrey B.; Erb, Jane L.; Churchill, Susanne E.; Kohane, Isaac S.; Iosifescu, Dan V.; Smoller, Jordan W.; Perlis, Roy H.			QT interval and antidepressant use: a cross sectional study of electronic health records	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VENTRICULAR-ARRHYTHMIA; ANTIPSYCHOTIC-DRUGS; PROLONGATION; DEPRESSION; VALIDATION; ENTERPRISE; SERTRALINE; SAFETY; DEATH	Objective To quantify the impact of citalopram and other selective serotonin reuptake inhibitors on corrected QT interval (QTc), a marker of risk for ventricular arrhythmia, in a large and diverse clinical population. Design A cross sectional study using electrocardiographic, prescribing, and clinical data from electronic health records to explore the relation between antidepressant dose and QTc. Methadone, an opioid known to prolong QT, was included to demonstrate assay sensitivity. Setting A large New England healthcare system comprising two academic medical centres and outpatient clinics. Participants 38 397 adult patients with an electrocardiogram recorded after prescription of antidepressant or methadone between February 1990 and August 2011. Main outcome measures Relation between antidepressant dose and QTc interval in linear regression, adjusting for potential clinical and demographic confounding variables. For a subset of patients, change in QTc after drug dose was also examined. Results Dose-response association with QTc prolongation was identified for citalopram (adjusted beta 0.10 (SE 0.04), P<0.01), escitalopram (adjusted beta 0.58 (0.15), P<0.001), and amitriptyline (adjusted beta 0.11 (0.03), P<0.001), but not for other antidepressants examined. An association with QTc shortening was identified for bupropion (adjusted beta 0.02 (0.01) P<0.05). Within-subject paired observations supported the QTc prolonging effect of citalopram (10 mg to 20 mg, mean QTc increase 7.8 (SE 3.6) ms, adjusted P<0.05; and 20 mg to 40 mg, mean QTc increase 10.3 (4.0) ms, adjusted P<0.01). Conclusions This study confirmed a modest prolongation of QT interval with citalopram, and identified additional antidepressants with similar observed risk. Pharmacovigilance studies using electronic health record data may be a useful method of identifying potential risk associated with treatments.	[Castro, Victor M.; Gainer, Vivian S.] Partners HealthCare Syst, Partners Res Comp, Constitut Ctr 1, Boston, MA 02129 USA; [Clements, Caitlin C.; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Clements, Caitlin C.; Perlis, Roy H.] Massachusetts Gen Hosp, Dept Psychiat, Ctr Expt Drugs & Diagnost, Boston, MA 02114 USA; [Murphy, Shawn N.] Massachusetts Gen Hosp, Comp Sci Lab, Boston, MA 02114 USA; [Murphy, Shawn N.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Fava, Maurizio; Weilburg, Jeffrey B.] Massachusetts Gen Hosp, Dept Psychiat, Depress Clin, Boston, MA 02114 USA; [Fava, Maurizio; Weilburg, Jeffrey B.] Massachusetts Gen Hosp, Dept Psychiat, Res Program, Boston, MA 02114 USA; [Erb, Jane L.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02215 USA; [Churchill, Susanne E.] Partners HealthCare Syst, Informat Syst, Natl Ctr Biomed Comp I2b2, Boston, MA 02215 USA; [Kohane, Isaac S.] Brigham & Womens Hosp, Dept Med, Natl Ctr Biomed Comp I2b2, Boston, MA 02215 USA; [Iosifescu, Dan V.] Mt Sinai Sch Med, Dept Psychiat, Mood & Anxiety Disorders Program, New York, NY 10029 USA	Partners Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Icahn School of Medicine at Mount Sinai	Perlis, RH (corresponding author), Massachusetts Gen Hosp, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	rperlis@partners.org	Fava, Maurizio/AAH-3548-2020; Castro, Victor M/CAF-9395-2022; Iosifescu, Dan Vlad/L-3305-2019; Castro, Victor M/CAH-3428-2022	Castro, Victor M/0000-0001-7390-6354; Iosifescu, Dan Vlad/0000-0002-2512-2835; Castro, Victor M/0000-0001-7390-6354	NIH/National Library of Medicine [2U54LM008748]; National Institute of Mental Health [R01MH086026]; Proteus Biomedical; Pamlab; Genomind; RIDventures; Concordant Rater Systems; Massachusetts General Hospital Psychiatry Academy; Abbott Laboratories; Affectis Pharmaceuticals AG; Alkermes; Amarin Pharma; Aspect Medical Systems; AstraZeneca; Auspex Pharmaceuticals; Bayer AG; Best Practice Project Management; BioMarin Pharmaceuticals; Biovail Corporation; BrainCells; Bristol-Myers Squibb; CeNeRx BioPharma; Cephalon; CNS Response; Compellis Pharmaceuticals; Cypress Pharmaceutical; DiagnoSearch Life Sciences; Dinippon Sumitomo Pharma; Dov Pharmaceuticals; Edgemont Pharmaceuticals; Eisai; Eli Lilly; EnVivo Pharmaceuticals; ePharmaSolutions; EPIX Pharmaceuticals; Euthymics Bioscience; Fabre-Kramer Pharmaceuticals; Forest Pharmaceuticals; GlaxoSmithKline; Grunenthal GmbH; i3 Innovus/Ingenis; Janssen Pharmaceutica; Jazz Pharmaceuticals; Johnson & Johnson Pharmaceutical Research Development; Knoll Pharmaceuticals; Labopharm; Lorex Pharmaceuticals; Lundbeck; MedAvante; Merck; MSI Methylation Sciences; Naurex; Neuralstem; Neuronetics; NextWave Pharmaceuticals; Novartis AG; Nutrition 21; Orexigen Therapeutics; Organon Pharmaceuticals; Otsuka Pharmaceuticals; Pfizer; PharmaStar; Pharmavite; PharmoRx Therapeutics; Precision Human Biolaboratory; Prexa Pharmaceuticals; Puretech Ventures; PsychoGenics; Psylin Neurosciences; Rexahn Pharmaceuticals; Ridge Diagnostics; Roche; Sanofi-Aventis US; Sepracor; Servier Laboratories; Schering-Plough; Solvay Pharmaceuticals; Somaxon Pharmaceuticals; Somerset Pharmaceuticals; Sunovion Pharmaceuticals; Supernus Pharmaceuticals; Synthelabo; Takeda Pharmaceutical; Tal Medical; Tetragenex Pharmaceuticals; TransForm Pharmaceuticals; Transcept Pharmaceuticals; Vanda Pharmaceuticals; Abbot Laboratories; BioResearch; Clintara; Covance; Covidien; ElMindA; Euthymics; Bioscience; Ganeden Biotech; Icon Clinical Research; i3 Innovus/Ingenix; Lichtwer Pharma GmbH; National Alliance for Research on Schizophrenia & Depression (NARSAD); National Center for Complementary and Alternative Medicine (NCCAM); National Institute of Drug Abuse (NIDA); National Institute of Mental Health (NIMH); Photothera; Roche Pharmaceuticals; RCT Logic; Sanofi-Aventis; Shire; Wyeth-Ayerst Laboratories; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086026] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	NIH/National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Proteus Biomedical; Pamlab; Genomind; RIDventures; Concordant Rater Systems; Massachusetts General Hospital Psychiatry Academy; Abbott Laboratories(Abbott Laboratories); Affectis Pharmaceuticals AG; Alkermes; Amarin Pharma(Dexcel Pharma); Aspect Medical Systems; AstraZeneca(AstraZeneca); Auspex Pharmaceuticals; Bayer AG(Bayer AG); Best Practice Project Management; BioMarin Pharmaceuticals; Biovail Corporation; BrainCells; Bristol-Myers Squibb(Bristol-Myers Squibb); CeNeRx BioPharma; Cephalon; CNS Response; Compellis Pharmaceuticals; Cypress Pharmaceutical; DiagnoSearch Life Sciences; Dinippon Sumitomo Pharma; Dov Pharmaceuticals; Edgemont Pharmaceuticals; Eisai(Eisai Co Ltd); Eli Lilly(Eli Lilly); EnVivo Pharmaceuticals; ePharmaSolutions; EPIX Pharmaceuticals; Euthymics Bioscience; Fabre-Kramer Pharmaceuticals; Forest Pharmaceuticals; GlaxoSmithKline(GlaxoSmithKline); Grunenthal GmbH; i3 Innovus/Ingenis; Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Jazz Pharmaceuticals(Jazz Pharmaceuticals); Johnson & Johnson Pharmaceutical Research Development(Johnson & JohnsonJohnson & Johnson USA); Knoll Pharmaceuticals(Abbott Laboratories); Labopharm; Lorex Pharmaceuticals; Lundbeck(Lundbeck Corporation); MedAvante; Merck(Merck & Company); MSI Methylation Sciences; Naurex; Neuralstem; Neuronetics; NextWave Pharmaceuticals; Novartis AG; Nutrition 21; Orexigen Therapeutics; Organon Pharmaceuticals; Otsuka Pharmaceuticals(Otsuka Pharmaceutical); Pfizer(Pfizer); PharmaStar; Pharmavite; PharmoRx Therapeutics; Precision Human Biolaboratory; Prexa Pharmaceuticals; Puretech Ventures; PsychoGenics; Psylin Neurosciences; Rexahn Pharmaceuticals; Ridge Diagnostics; Roche(Roche Holding); Sanofi-Aventis US(Sanofi-Aventis); Sepracor; Servier Laboratories; Schering-Plough(Merck & CompanySchering Plough Corporation); Solvay Pharmaceuticals(Solvay SA); Somaxon Pharmaceuticals; Somerset Pharmaceuticals; Sunovion Pharmaceuticals; Supernus Pharmaceuticals; Synthelabo; Takeda Pharmaceutical(Takeda Pharmaceutical Company Ltd); Tal Medical; Tetragenex Pharmaceuticals; TransForm Pharmaceuticals; Transcept Pharmaceuticals; Vanda Pharmaceuticals; Abbot Laboratories; BioResearch; Clintara; Covance; Covidien; ElMindA; Euthymics; Bioscience; Ganeden Biotech; Icon Clinical Research; i3 Innovus/Ingenix; Lichtwer Pharma GmbH; National Alliance for Research on Schizophrenia & Depression (NARSAD)(NARSAD); National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Photothera; Roche Pharmaceuticals(Roche Holding); RCT Logic; Sanofi-Aventis(Sanofi-Aventis); Shire; Wyeth-Ayerst Laboratories(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The project was supported by the NIH/National Library of Medicine (award No 2U54LM008748 to ISK) and the National Institute of Mental Health (award No R01MH086026 to RHP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Library of Medicine or the National Institutes of Health.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: RHP has received consulting fees from or served on scientific advisory boards for Proteus Biomedical, Pamlab, Genomind, and RIDventures, and has received research grant support from Proteus Biomedical and royalties from Concordant Rater Systems. JWS has served as a consultant for the Medical Letter. DVI has received payment for lectures including service on speakers' bureaus from the Massachusetts General Hospital Psychiatry Academy and has served as a consultant for CNS Response. MF has received consulting fees from or served on scientific advisor boards for Abbott Laboratories, Affectis Pharmaceuticals AG, Alkermes, Amarin Pharma, Aspect Medical Systems, AstraZeneca, Auspex Pharmaceuticals, Bayer AG, Best Practice Project Management, BioMarin Pharmaceuticals, Biovail Corporation, BrainCells, Bristol-Myers Squibb, CeNeRx BioPharma, Cephalon, CNS Response, Compellis Pharmaceuticals, Cypress Pharmaceutical, DiagnoSearch Life Sciences, Dinippon Sumitomo Pharma, Dov Pharmaceuticals, Edgemont Pharmaceuticals, Eisai, Eli Lilly, EnVivo Pharmaceuticals, ePharmaSolutions, EPIX Pharmaceuticals, Euthymics Bioscience, Fabre-Kramer Pharmaceuticals, Forest Pharmaceuticals, GenOmind, GlaxoSmithKline, Grunenthal GmbH, i3 Innovus/Ingenis, Janssen Pharmaceutica, Jazz Pharmaceuticals, Johnson & Johnson Pharmaceutical Research & Development, Knoll Pharmaceuticals, Labopharm, Lorex Pharmaceuticals, Lundbeck, MedAvante, Merck, MSI Methylation Sciences, Naurex, Neuralstem, Neuronetics, NextWave Pharmaceuticals, Novartis AG, Nutrition 21, Orexigen Therapeutics, Organon Pharmaceuticals, Otsuka Pharmaceuticals, Pamlab, Pfizer, PharmaStar, Pharmavite, PharmoRx Therapeutics, Precision Human Biolaboratory, Prexa Pharmaceuticals, Puretech Ventures, PsychoGenics, Psylin Neurosciences, Rexahn Pharmaceuticals, Ridge Diagnostics, Roche, Sanofi-Aventis US, Sepracor, Servier Laboratories, Schering-Plough, Solvay Pharmaceuticals, Somaxon Pharmaceuticals, Somerset Pharmaceuticals, Sunovion Pharmaceuticals, Supernus Pharmaceuticals, Synthelabo, Takeda Pharmaceutical, Tal Medical, Tetragenex Pharmaceuticals, TransForm Pharmaceuticals, Transcept Pharmaceuticals, Vanda Pharmaceuticals. MF has equity holdings in Compellis and has received research grant support from Abbot Laboratories, Alkermes, Aspect Medical Systems, AstraZeneca, BioResearch, BrainCells, Bristol-Myers Squibb, CeNeRx BioPharma, Cephalon, Clintara, Covance, Covidien, Eli Lilly, ElMindA, EnVivo Pharmaceuticals, Euthymics Bioscience, Forest Pharmaceuticals, Ganeden Biotech, GlaxoSmithKline, Icon Clinical Research, i3 Innovus/Ingenix, Johnson & Johnson Pharmaceutical Research & Development, Lichtwer Pharma GmbH, Lorex Pharmaceuticals, National Alliance for Research on Schizophrenia & Depression (NARSAD), National Center for Complementary and Alternative Medicine (NCCAM), National Institute of Drug Abuse (NIDA), National Institute of Mental Health (NIMH), Novartis AG, Organon Pharmaceuticals, PamLab, Pfizer, Pharmavite, Photothera, Roche Pharmaceuticals, RCT Logic (formerly Clinical Trials Solutions), Sanofi-Aventis, Shire, Solvay Pharmaceuticals, Synthelabo, Wyeth-Ayerst Laboratories.; MF also holds a patent for Sequential Parallel Comparison Design (SPCD), which is licensed by MGH to RCT Logic, and copyright for the MGH Cognitive & Physical Functioning Questionnaire (CPFQ), Sexual Functioning Inventory (SFI), Antidepressant Treatment Response Questionnaire (ATRQ), Discontinuation-Emergent Signs & Symptoms (DESS), and SAFER; Lippincott, Williams & Wilkins; Wolkers Kluwer; World Scientific Publishing.	[Anonymous], 1997, POINTS CONS ASS POT, P986; Arizona Center for Education and Research on Therapeutics, QT DRUG LISTS RISK G; Brownstein JS, 2010, DIABETES CARE, V33, P526, DOI 10.2337/dc09-1506; Castro VM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000544; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Enger C, 2002, PHARMACOEPIDEM DR S, V11, P477, DOI 10.1002/pds.725; FDA, 2011, FDA DRUG SAF COMM AB; Food and Drug Administration, 2011, FDA DRUG SAF COMM RE; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Glassman AH, 2001, AM J PSYCHIAT, V158, P1774, DOI 10.1176/appi.ajp.158.11.1774; Hennessy S, 2002, BRIT MED J, V325, P1070, DOI 10.1136/bmj.325.7372.1070; Hennessy S, 2008, PHARMACOEPIDEM DR S, V17, P1131, DOI 10.1002/pds.1632; IMS Institute for Healthcare Informatics, 2012, US MED US REV 2011; Jeon SH, 2011, HUM EXP TOXICOL, V30, P1649, DOI 10.1177/0960327110396528; Kiev A, 1994, Ann Clin Psychiatry, V6, P107, DOI 10.3109/10401239409148989; Kornbluh R, 2001, Psychopharmacol Bull, V35, P150; Leonard CE, 2011, PHARMACOEPIDEM DR S, V20, P903, DOI 10.1002/pds.2181; Murphy S, 2009, GENOME RES, V19, P1675, DOI 10.1101/gr.094615.109; Murphy Shawn N, 2007, AMIA Annu Symp Proc, P548; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; O'Connor CM, 2010, J AM COLL CARDIOL, V56, P692, DOI 10.1016/j.jacc.2010.03.068; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Sala Michela, 2009, Ther Adv Cardiovasc Dis, V3, P29, DOI 10.1177/1753944708096282; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Tatonetti NP, 2011, CLIN PHARMACOL THER, V90, P133, DOI 10.1038/clpt.2011.83; Tyl B, 2011, J ELECTROCARDIOL, V44, P320, DOI 10.1016/j.jelectrocard.2010.11.006; van Noord C, 2010, BRIT J CLIN PHARMACO, V70, P16, DOI 10.1111/j.1365-2125.2010.03660.x; WENGER TL, 1983, J CLIN PSYCHIAT, V44, P174; Willis CD, 2012, J CLIN EPIDEMIOL, V65, P121, DOI 10.1016/j.jclinepi.2011.06.017	30	174	182	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2013	346								f288	10.1136/bmj.f288	http://dx.doi.org/10.1136/bmj.f288			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084BH	23360890	Green Published, hybrid			2022-12-28	WOS:000314510400001
J	Bonnell, DA				Bonnell, Dawn A.			Ferroelectric Organic Materials Catch Up with Oxides	SCIENCE			English	Editorial Material									Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania	Bonnell, DA (corresponding author), Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA.	bonnell@lrsm.upenn.edu						Bonnell DA, 2012, REV MOD PHYS, V84, DOI 10.1103/RevModPhys.84.1343; Fu DW, 2013, SCIENCE, V339, P425, DOI [10.1126/science.1230473, 10.1126/science.1229675]; Kalinin SV, 2007, ANNU REV MATER RES, V37, P189, DOI 10.1146/annurev.matsci.37.052506.084323; Kalinin SV, 2004, ADV MATER, V16, P795, DOI 10.1002/adma.200305702; Li DB, 2008, ANNU REV MATER RES, V38, P351, DOI 10.1146/annurev.matsci.37.052506.084303; Liu YM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.078103; MEGAW HD, 1945, NATURE, V155, P484; Schlom DG, 2007, ANNU REV MATER RES, V37, P589, DOI 10.1146/annurev.matsci.37.061206.113016; Scott JF, 2007, SCIENCE, V315, P954, DOI 10.1126/science.1129564; SCOTT JF, 1989, SCIENCE, V246, P1400, DOI 10.1126/science.246.4936.1400; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615	11	35	35	2	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					401	402		10.1126/science.1232939	http://dx.doi.org/10.1126/science.1232939			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349277				2022-12-28	WOS:000313960700026
J	Kendall, T; Hollis, C; Stafford, M; Taylor, C				Kendall, Tim; Hollis, Chris; Stafford, Megan; Taylor, Clare		Guideline Dev Grp	GUIDELINES Recognition and management of psychosis and schizophrenia in children and young people: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDHOOD; ONSET		[Kendall, Tim; Stafford, Megan; Taylor, Clare] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England; [Kendall, Tim] Sheffield Hlth & Social Care NHS Fdn Trust, Sheffield S10 3TH, S Yorkshire, England; [Hollis, Chris] Univ Nottingham, Sch Community Hlth Sci, Div Psychiat, Nottingham NG7 2UH, England; [Hollis, Chris] Univ Nottingham, Sch Community Hlth Sci, Inst Mental Hlth, Nottingham NG7 2UH, England	University of London; University College London; University of Nottingham; University of Nottingham	Kendall, T (corresponding author), UCL, London WC1E 7HB, England.	tim2.kendall@virgin.net	Birchwood, Max/E-3474-2017	Birchwood, Max/0000-0002-7476-0171; Hollis, Chris/0000-0003-1083-6744; shiers, david/0000-0003-2531-5837				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Borneo A., 2008, YOUR CHOICE RESULTS; Brown S, 2010, BRIT J PSYCHIAT, V196, P116, DOI 10.1192/bjp.bp.109.067512; BURD L, 1987, J AM ACAD CHILD PSY, V26, P347, DOI 10.1097/00004583-198705000-00012; De Hert M, 2011, EUR PSYCHIAT, V26, P144, DOI 10.1016/j.eurpsy.2010.09.011; Gillberg C, 2001, CA CH AD PS, P43; National Institute for Health and Clinical Excellence, 2010, ALC US DIS PREV DEV, V24; National Institute for Health and Clinical Excellence, 2010, ALC US DIS DIAGN CLI, V100; National Institute for Health and Clinical Excellence, 2011, ALC US DIS DIAGN ASS, V115; National Institute for Health and Clinical Excellence, 2013, PSYCH SCHIZ CHILDR Y, V155; National Institute for Health and Clinical Excellence, 2005, POSTTR STRESS DIS PT; National Institute for Health and Clinical Excellence, 2009, BORD PERS DIS TREATM, V78; National Institute for Health and Clinical Excellence, 2009, SCHIZ COR INT TREATM, V82; National Institute for Health and Clinical Excellence, 2005, OBS COMP DIS COR INT, V31; National Institute for Health and Clinical Excellence, 2009, DRUG MIS OP DET CLIN, V52; National Institute for Health and Clinical Excellence, 2005, DEPR CHILDR YOUNG PE, V28; National Institute for Health and Clinical Excellence, 2009, ANT PERS DIS TREATM, V77; National Institute for Health and Clinical Excellence, 2007, DRUG MIS PSYCH INT C, V51; Pinfold V, 2007, PSYCHIATR BULL, V31, P7, DOI 10.1192/pb.31.1.7; Prescribing Observatory for Mental Health, 2012, TOP 10B REAUD REP PR; Ruhrmann S, 2010, ARCH GEN PSYCHIAT, V67, P241, DOI 10.1001/archgenpsychiatry.2009.206; Thomsen PH, 1996, ACTA PSYCHIAT SCAND, V94, P187, DOI 10.1111/j.1600-0447.1996.tb09847.x; *WHO, 1990, GLOB EST HLTH SIT AS; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	24	28	29	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2013	346								f150	10.1136/bmj.f150	http://dx.doi.org/10.1136/bmj.f150			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BX	23344308	Green Accepted			2022-12-28	WOS:000314217300008
J	Bernardeschi, C; Le Cleach, L; Delaunay, P; Chosidow, O				Bernardeschi, Celine; Le Cleach, Laurence; Delaunay, Pascal; Chosidow, Olivier			Bed bug infestation	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CIMEX-LECTULARIUS; HETEROPTERA CIMICIDAE; RESISTANCE; BEDBUGS; DERMATITIS; BITES		[Bernardeschi, Celine; Le Cleach, Laurence; Chosidow, Olivier] Grp Hosp Henri Mondor, AP HP, Dept Dermatol, Creteil, France; [Delaunay, Pascal] Univ Nice Sophia Antipolis, Ctr Hosp Univ Nice, Lab Parasitol Mycol, Hop Archet,Inserm,U1065, Nice, France; [Chosidow, Olivier] UPEC, Val De Marne, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Chosidow, O (corresponding author), Hop Henri Mondor, Serv Dermatol, 51 Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France.	olivier.chosidow@hmn.aphp.fr		le cleach, Laurence/0000-0003-1385-6839				[Anonymous], 2012, Drug Ther Bull, V50, P45, DOI 10.1136/dtb.2012.04.0099; Chosidow O, 2000, LANCET, V355, P819, DOI 10.1016/S0140-6736(99)09458-1; Davies TGE, 2012, MED VET ENTOMOL, V26, P241, DOI 10.1111/j.1365-2915.2011.01006.x; Del Giudice P, 2008, EMERG INFECT DIS, V14, P1759, DOI 10.3201/eid1411.080288; Delaunay P, 2011, CLIN INFECT DIS, V52, P200, DOI 10.1093/cid/ciq102; Delaunay P, 2009, EMERG INFECT DIS, V15, P989, DOI 10.3201/eid1506.081480; deShazo RD, 2012, AM J MED, V125, P688, DOI 10.1016/j.amjmed.2011.11.020; Doggett S., 2011, CODE PRACTICE CONTRO; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Doggett SL, 2012, CLIN MICROBIOL REV, V25, P164, DOI 10.1128/CMR.05015-11; Goddard J, 2009, JAMA-J AM MED ASSOC, V301, P1358, DOI 10.1001/jama.2009.405; Heukelbach J, 2009, CLIN DERMATOL, V27, P285, DOI 10.1016/j.clindermatol.2008.10.008; Jacobson James B., 2011, Morbidity and Mortality Weekly Report, V60, P1269; Kilpinen O., 2008, 6th International Conference on Urban Pests, Budapest, Hungary, 13-16 July 2008, P395; Kilpinen O, 2011, PARASITOL RES, V109, P1461, DOI 10.1007/s00436-011-2423-3; Koning S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003261.pub3; Lehnert MP, 2011, MED VET ENTOMOL, V25, P460, DOI 10.1111/j.1365-2915.2011.00944.x; Lowe CF, 2011, EMERG INFECT DIS, V17, P1132, DOI [10.3201/eid1706.101978, 10.3201/eid/1706.101978]; Michael, 2010, Pest Control Technology, V38, P70; Naylor RA, 2010, J ECON ENTOMOL, V103, P136, DOI 10.1603/EC09288; Reinhardt K, 2009, MED VET ENTOMOL, V23, P163, DOI 10.1111/j.1365-2915.2008.00793.x; Reinhardt K, 2008, J MED ENTOMOL, V45, P956, DOI 10.1603/0022-2585(2008)45[956:WKTBBK]2.0.CO;2; Richards L, 2009, J ENV HLTH RES, V9, P17; Romero A., 2009, PEST MANAG PROF, V77, P22; Silverman AL, 2001, AM J GASTROENTEROL, V96, P2194, DOI 10.1111/j.1572-0241.2001.03955.x; Steen CJ, 2004, J AM ACAD DERMATOL, V50, P819, DOI 10.1016/j.jaad.2003.12.019; Tawatsin A, 2011, J MED ENTOMOL, V48, P1023, DOI 10.1603/ME11003; Tony Burns, 2010, BREATHNACH STEPHEN C; US Department of Health and Human Services, 2010, JOINT STAT BED BUG C; Wang C, 2011, PEST CONTROL TECHNOL, V39, P76; Wang C, 2011, PEST CONTROL TECHNOL, V39, P74; Wang C, 2011, PEST CONTROL TECHNOL, V39, P78; Wang C. L., 2011, Pest Control Technology, V39, P112; Wang CL, 2009, J ECON ENTOMOL, V102, P1580, DOI 10.1603/029.102.0423; Wang CL, 2009, J MED ENTOMOL, V46, P566, DOI 10.1603/033.046.0322; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355	36	20	21	1	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2013	346								f138	10.1136/bmj.f138	http://dx.doi.org/10.1136/bmj.f138			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BG	23341545				2022-12-28	WOS:000314215600009
J	Spence, D				Spence, Des			Are antidepressants overprescribed? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEROTONIN REUPTAKE INHIBITORS; PRIMARY-CARE; DEPRESSION; SEVERITY		Maryhill Hlth Ctr, Green Area, Glasgow G20 9DR, Lanark, Scotland		Spence, D (corresponding author), Maryhill Hlth Ctr, Green Area, Glasgow G20 9DR, Lanark, Scotland.	destwo@yahoo.co.uk						Arroll B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007954; Barr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5142; Cameron IM, 2009, BRIT J GEN PRACT, V59, P644, DOI 10.3399/bjgp09X454061; Centers for Disease Control and Prevention, CDC MENT ILLN SURV; Cosgrove L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001190; Deshauer D, 2008, CAN MED ASSOC J, V178, P1293, DOI 10.1503/cmaj.071068; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Haddad PM., 2007, ADV PSYCHIAT TREATME, V13, P447, DOI [10.1192/apt.bp.105.001966, DOI 10.1192/APT.BP.105.001966]; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Lacasse JR, 2005, PLOS MED, V2, P1211, DOI 10.1371/journal.pmed.0020392; MacDonald TM, 1996, BRIT MED J, V313, P860; National Institute for Health and Clinical Excellence (NICE), 2009, QUICK REF GUID DEPR; NHS Health and Social Care Information Centre, 2012, PRESCR DISP COMM ENG; NHS Health and Social Care Information Centre, HLTH CAR STAT PRESCR; Reid IC., 2011, BMJ; Reid S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1468; Reseland S, 2006, BRIT J PSYCHIAT, V188, P354, DOI 10.1192/bjp.188.4.354	18	19	20	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2013	346								f191	10.1136/bmj.f191	http://dx.doi.org/10.1136/bmj.f191			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BG	23341568				2022-12-28	WOS:000314215600011
J	Kim, J; Kim, YC; Fang, C; Russell, RC; Kim, JH; Fan, W; Liu, R; Zhong, Q; Guan, KL				Kim, Joungmok; Kim, Young Chul; Fang, Chong; Russell, Ryan C.; Kim, Jeong Hee; Fan, Weiliang; Liu, Rong; Zhong, Qing; Guan, Kun-Liang			Differential Regulation of Distinct Vps34 Complexes by AMPK in Nutrient Stress and Autophagy	CELL			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; BECLIN 1; MEDIATED PHOSPHORYLATION; MAMMALIAN AUTOPHAGY; ATG PROTEINS; UVRAG; HVPS34; RUBICON	Autophagy is a stress response protecting cells from unfavorable conditions, such as nutrient starvation. The class III phosphatidylinositol-3 kinase, Vps34, forms multiple complexes and regulates both intra-cellular vesicle trafficking and autophagy induction. Here, we show that AMPK plays a key role in regulating different Vps34 complexes. AMPK inhibits the nonautophagy Vps34 complex by phosphorylating T163/S165 in Vps34 and therefore suppresses overall PI(3) P production and protects cells from starvation. In parallel, AMPK activates the proautophagy Vps34 complex by phosphorylating S91/S94 in Beclin1 to induce autophagy. Atg14L, an autophagy-essential gene present only in the proautophagy Vps34 complex, inhibits Vps34 phosphorylation but increases Beclin1 phosphorylation by AMPK. As such, Atg14L dictates the differential regulation (either inhibition or activation) of different Vps34 complexes in response to glucose starvation. Our study reveals an intricate molecular regulation of Vps34 complexes by AMPK in nutrient stress response and autophagy.	[Kim, Joungmok; Kim, Jeong Hee] Kyung Hee Univ, Sch Dent, Res Ctr Tooth & Periodontal Tissue Regenerat, Dept Oral Biochem & Mol Biol, Seoul 130701, South Korea; [Kim, Joungmok; Kim, Young Chul; Fang, Chong; Russell, Ryan C.; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92130 USA; [Kim, Joungmok; Kim, Young Chul; Fang, Chong; Russell, Ryan C.; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92130 USA; [Fan, Weiliang; Liu, Rong; Zhong, Qing] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem Biophys & Struct Biol, Berkeley, CA 94720 USA	Kyung Hee University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Berkeley	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92130 USA.	kuguan@ucsd.edu	Zhong, Qing/GLT-4858-2022; Guan, Kun-Liang/ADK-7088-2022	Zhong, Qing/0000-0001-6979-955X; Kim, Jeong Hee/0000-0002-3884-4503; Kim, Young Chul/0000-0002-6782-2186; Russell, Ryan/0000-0003-3364-8869	National Institutes of Health (NIH); Department of Defense (DOD); Bio & Medical Technology Development Program of National Research Foundation of Korea (NRF); Korean government (MEST) [2012M3A9C6049936]; NATIONAL CANCER INSTITUTE [R01CA108941, R01CA133228, R01CA132809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); Bio & Medical Technology Development Program of National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Guan lab for discussions and reagents. This work was supported by grants from the National Institutes of Health (NIH) and the Department of Defense (DOD) (K.-L.G.) and by the Bio & Medical Technology Development Program of National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST, No. 2012M3A9C6049936 to J.K.).	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kwon KY, 2011, BIOCHEM BIOPH RES CO, V416, P343, DOI 10.1016/j.bbrc.2011.11.038; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noble CG, 2008, J BIOL CHEM, V283, P26274, DOI 10.1074/jbc.M804723200; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Obara K, 2011, J LIPIDS, V2011, DOI 10.1155/2011/498768; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Vergne I, 2010, FEBS LETT, V584, P1313, DOI 10.1016/j.febslet.2010.02.054; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	34	531	567	1	101	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					290	303		10.1016/j.cell.2012.12.016	http://dx.doi.org/10.1016/j.cell.2012.12.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332761	Green Accepted, Bronze			2022-12-28	WOS:000313719800024
J	Frattaroli, S; Webster, DW; Wintemute, GJ				Frattaroli, Shannon; Webster, Daniel W.; Wintemute, Garen J.			Implementing a Public Health Approach to Gun Violence Prevention: The Importance of Physician Engagement	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Frattaroli, Shannon] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Univ Calif Davis, Davis, CA 95616 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Davis	Frattaroli, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 624 North Broadway, Baltimore, MD 21205 USA.	sfrattar@jhsph.edu						Barry CL, 2013, N ENGL J MED; Centers for Disease Control and Prevention, 2005, WEB BAS INJ STAT QUE; Cook PJ, 1996, GUND AM RESULTS COMP; Davidoff F, 1998, ANN INTERN MED, V128, P234, DOI 10.7326/0003-4819-128-3-199802010-00011; Gun Violence Archive, 2022, SUMM LEDG; Kellermann AL, 1996, NEW ENGL J MED, V335, P1438, DOI 10.1056/NEJM199611073351906; Laine C, 2013, ANN INTERN MED, V158, P493, DOI 10.7326/0003-4819-158-6-201303190-00586; Vittes KA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8672; Wintemute GJ, 2013, NEW ENGL J MED, V368, P397, DOI 10.1056/NEJMp1215491	9	26	27	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2013	158	9					697	+		10.7326/0003-4819-158-9-201305070-00597	http://dx.doi.org/10.7326/0003-4819-158-9-201305070-00597			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146WV	23400374				2022-12-28	WOS:000319126900007
J	Christiansen, EH; Jensen, LO; Thayssen, P; Tilsted, HH; Krusell, LR; Hansen, KN; Kaltoft, A; Maeng, M; Kristensen, SD; Botker, HE; Terkelsen, CJ; Villadsen, AB; Ravkilde, J; Aaroe, J; Madsen, M; Thuesen, L; Lassen, JF				Christiansen, Evald Hoj; Jensen, Lisette Okkels; Thayssen, Per; Tilsted, Hans-Henrik; Krusell, Lars Romer; Hansen, Knud Norregaard; Kaltoft, Anne; Maeng, Michael; Kristensen, Steen Dalby; Botker, Hans Erik; Terkelsen, Christian Juhl; Villadsen, Anton Boel; Ravkilde, Jan; Aaroe, Jens; Madsen, Morten; Thuesen, Leif; Lassen, Jens Flensted		Scandinavian Org Randomized Trials	Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial	LANCET			English	Article							ARTERY-DISEASE; CLINICAL-OUTCOMES; PACLITAXEL; THROMBOSIS; LEADERS; RISK	Background Third-generation biodegradable polymer drug-eluting stents might reduce the risk of stent thrombosis compared with first-generation permanent polymer drug-eluting stents. We aimed to further investigate the effects of a biodegradable polymer biolimus-eluting stent compared with a durable polymer-coated sirolimus-eluting stent in a population-based setting. Methods This randomised, multicentre, all-comer, non-inferiority trial was undertaken at three sites across western Denmark. Eligible patients were aged 18 years or older with chronic stable coronary artery disease or acute coronary syndromes, and at least one coronary artery lesion (>50% diameter stenosis). We randomly assigned patients (1: 1) using an independently managed computer-generated allocation sequence to receive either a biolimus-eluting biodegradable polymer stent (Nobori, Terumo, Tokyo, Japan) or a sirolimus-eluting permanent polymer stent (Cypher Select Plus, Cordis, Johnson & Johnson, Warren, NJ, USA). The primary endpoint was a composite of safety (cardiac death, myocardial infarction, definite stent thrombosis) and efficacy (target vessel revascularisation) at 9 months, analysed by intention to treat (non-inferiority margin of 0.02). This trial is registered with ClinicalTrials.gov, number NCT01254981. Findings From July, 2009, to January, 2011, we assigned 1229 patients (1532 lesions) to receive the biolimus-eluting stent and 1239 (1555 lesions) to receive the sirolimus-eluting stent. One patient was lost to follow-up because of emigration. Intention-to-treat analysis showed that 50 (4.1%) patients who were assigned the biolimus-eluting stent and 39 (3.1%) who were assigned the sirolimus-eluting stent met the primary endpoint (risk difference 0.9% [upper limit of one-sided 95% CI 2.1%]; p(non-inferiority)=0.06). Significantly more patients in the biolimus-eluting stent group had definite stent thrombosis at 12 months than did those in the sirolimus-eluting stent group (9 [0.7%] vs 2 [0.2%], risk difference 0.6% [95% CI 0.0-1.1]; p=0.034). Per-protocol analysis showed that 45 (3.8%) of 1193 patients who received a biolimus-eluting stent and 39 (3.2%) of 1208 who received a sirolimus-eluting stent met the primary endpoint (risk difference 0.5% [upper limit of one-sided 95% CI 1.8%]; p(non-inferiority)=0.03). Interpretation At 1 year follow-up, the biodegradable polymer biolimus-eluting Nobori stent did not improve clinical results compared with a first-generation sirolimus-eluting stent. We will need to obtain long-term data before we can make recommendations for the role of this biolimus-eluting stent in routine clinical practice.	[Christiansen, Evald Hoj; Krusell, Lars Romer; Kaltoft, Anne; Maeng, Michael; Kristensen, Steen Dalby; Botker, Hans Erik; Terkelsen, Christian Juhl; Thuesen, Leif; Lassen, Jens Flensted] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Jensen, Lisette Okkels; Thayssen, Per; Hansen, Knud Norregaard] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark; [Tilsted, Hans-Henrik; Villadsen, Anton Boel; Ravkilde, Jan; Aaroe, Jens] Aalborg Hosp, Aarhus Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Madsen, Morten] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark	Aarhus University; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University	Christiansen, EH (corresponding author), Aarhus Univ Hosp, Dept Cardiol, DK-8200 Skejby, Denmark.	evald.christiansen@dadlnet.dk	Lassen, Jens Flensted/AAY-2127-2021; Maeng, Michael/AAY-2135-2021; terkelsen, christian/ABD-6294-2021	Lassen, Jens Flensted/0000-0001-7972-9192; Maeng, Michael/0000-0002-4310-6433; Christiansen, Evald/0000-0002-8740-4862; Jensen, Lisette Okkels/0000-0002-4838-2429; Botker, Hans Erik/0000-0001-6358-8962; terkelsen, christian juhl/0000-0003-0205-9551; Madsen, Morten/0000-0002-6036-8240	Terumo; Cordis (Johnson Johnson); Cordis; Abbott Vascular; Boston Scientific; Medtronic; Novo Nordisk Fonden [NNF13OC0007447] Funding Source: researchfish	Terumo; Cordis (Johnson Johnson)(Johnson & JohnsonJohnson & Johnson USA); Cordis; Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific); Medtronic(Medtronic); Novo Nordisk Fonden(Novo Nordisk Foundation)	Terumo and Cordis (Johnson & Johnson).; EHC has received honoraria from Terumo and Cordis and travel grants from both companies. LOJ has received unrestricted grants from Terumo for her institution and honoraria from Cordis (Clincal Event Committee member). PT, ABV, and JA have received unrestricted grants from Terumo and Cordis for their institutions. H-HT has received travel grants from Terumo and Cordis for his institution, and he is married to a Terumo employee. AK has received unrestricted grants from Abbott Vascular, Boston Scientific, and Cordis for her institution, and honoraria from Cordis. MiM has received travel grants from Cordis, Medtronic, and Boston Scientific. SDK has received honoraria from AstraZeneca, Eli Lilly, Daichii Sankyo, and The Medicines Company. JR has received unrestricted grants from Terumo, Abbott Vascular, and Cordis for his institution, and honoraria from Abbott Vascular. LT has received unrestricted grants from Abbott Vascular, Boston Scientific, and Cordis for his institution and honoraria from Abbott Vascular, Cordis, and Boston Scientific. JFL has received unrestricted grants from Abbott Vascular, Boston Scientific, and Cordis for his institution and speaking honoraria from Abbott Vascular, Cordis, Medtronic, Eli Lilly, Boston Scientific, and AstraZeneca. LRK, KNH, HEB, CJT, and MoM declare that they have no conflicts of interest.	Andersen TF, 1999, DAN MED BULL, V46, P263; Byrne RA, 2011, J AM COLL CARDIOL, V58, P1325, DOI 10.1016/j.jacc.2011.06.027; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Danzi GB, 2012, DES BIODEGRADABLE PO; Danzi GB, 2012, EUROINTERVENTION, V8, P109, DOI 10.4244/EIJV8I1A17; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Jensen LO, 2010, EUROINTERVENTION, V5, P898, DOI 10.4244/; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Juel K, 1999, DAN MED BULL, V46, P354; Kaltoft A, 2009, J AM COLL CARDIOL, V53, P658, DOI 10.1016/j.jacc.2008.09.058; Moher D, 2005, EXPLORE-NY, V1, P40, DOI 10.1016/j.explore.2004.11.001; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Ostojic Miodrag, 2008, EuroIntervention, V3, P574, DOI 10.4244/EIJV3I5A103; Ostojic M, 2008, CATHETER CARDIO INTE, V72, P901, DOI 10.1002/ccd.21775; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Rasmussen K, 2010, LANCET, V375, P1090, DOI 10.1016/S0140-6736(10)60208-5; Ruygrok PN, 1999, J AM COLL CARDIOL, V34, P1507, DOI 10.1016/S0735-1097(99)00380-0; Schmidt Morten, 2010, Clin Epidemiol, V2, P137; Smits PC, 2013, LANCET; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Thygesen K, 2007, EUR HEART J, V28, P2525; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1	29	146	151	0	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2013	381	9867					661	669		10.1016/S0140-6736(12)61962-X	http://dx.doi.org/10.1016/S0140-6736(12)61962-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093JY	23374649	Green Submitted			2022-12-28	WOS:000315189300036
J	Suren, P; Roth, C; Bresnahan, M; Haugen, M; Hornig, M; Hirtz, D; Lie, KK; Lipkin, WI; Magnus, P; Reichborn-Kjennerud, T; Schjolberg, S; Smith, GD; Oyen, AS; Susser, E; Stoltenberg, C				Suren, Pal; Roth, Christine; Bresnahan, Michaeline; Haugen, Margaretha; Hornig, Mady; Hirtz, Deborah; Lie, Kari Kveim; Lipkin, W. Ian; Magnus, Per; Reichborn-Kjennerud, Ted; Schjolberg, Synnve; Smith, George Davey; Oyen, Anne-Siri; Susser, Ezra; Stoltenberg, Camilla			Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEURAL-TUBE DEFECTS; NORWEGIAN MOTHER; PREGNANT-WOMEN; COHORT; PREVALENCE; FOLATE; DELAY	Importance Prenatal folic acid supplements reduce the risk of neural tube defects in children, but it has not been determined whether they protect against other neurodevelopmental disorders. Objective To examine the association between maternal use of prenatal folic acid supplements and subsequent risk of autism spectrum disorders (ASDs) (autistic disorder, Asperger syndrome, pervasive developmental disorder-not otherwise specified [PDD-NOS]) in children. Design, Setting, and Patients The study sample of 85 176 children was derived from the population-based, prospective Norwegian Mother and Child Cohort Study (MoBa). The children were born in 2002-2008; by the end of follow-up on March 31, 2012, the age range was 3.3 through 10.2 years (mean, 6.4 years). The exposure of primary interest was use of folic acid from 4 weeks before to 8 weeks after the start of pregnancy, defined as the first day of the last menstrual period before conception. Relative risks of ASDs were estimated by odds ratios (ORs) with 95% CIs in a logistic regression analysis. Analyses were adjusted for maternal education level, year of birth, and parity. Main Outcome Measure Specialist-confirmed diagnosis of ASDs. Results At the end of follow-up, 270 children in the study sample had been diagnosed with ASDs: 114 with autistic disorder, 56 with Asperger syndrome, and 100 with PDD-NOS. In children whose mothers took folic acid, 0.10% (64/61 042) had autistic disorder, compared with 0.21% (50/24 134) in those unexposed to folic acid. The adjusted OR for autistic disorder in children of folic acid users was 0.61 (95% CI, 0.41-0.90). No association was found with Asperger syndrome or PDD-NOS, but power was limited. Similar analyses for prenatal fish oil supplements showed no such association with autistic disorder, even though fish oil use was associated with the same maternal characteristics as folic acid use. Conclusions and Relevance Use of prenatal folic acid supplements around the time of conception was associated with a lower risk of autistic disorder in the MoBa cohort. Although these findings cannot establish causality, they do support prenatal folic acid supplementation. JAMA. 2013;309(6):570-577 www.jama.com	[Suren, Pal; Roth, Christine; Haugen, Margaretha; Lie, Kari Kveim; Magnus, Per; Reichborn-Kjennerud, Ted; Schjolberg, Synnve; Oyen, Anne-Siri; Stoltenberg, Camilla] Norwegian Inst Publ Hlth, N-0403 Oslo, Norway; [Suren, Pal] UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Roth, Christine; Bresnahan, Michaeline; Hornig, Mady; Lipkin, W. Ian; Susser, Ezra] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Bresnahan, Michaeline; Susser, Ezra] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Hirtz, Deborah] NINDS, Bethesda, MD 20892 USA; [Reichborn-Kjennerud, Ted] Univ Oslo, Inst Psychiat, Oslo, Norway; [Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Oyen, Anne-Siri] Lovisenberg Hosp, Nic Waals Inst, Oslo, Norway; [Stoltenberg, Camilla] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway	Norwegian Institute of Public Health (NIPH); University of London; University College London; Columbia University; New York State Psychiatry Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Oslo; University of Bristol; University of Bergen	Suren, P (corresponding author), Norwegian Inst Publ Hlth, POB 4404, N-0403 Oslo, Norway.	pal.suren@fhi.no	Davey Smith, George/A-7407-2013; Hornig, Mady/AAE-8431-2020; Lipkin, W. Ian/ABE-6216-2020; Stoltenberg, Camilla/G-5090-2017; Haugen, Margaretha/H-7007-2016	Davey Smith, George/0000-0002-1407-8314; Hornig, Mady/0000-0001-7572-3092; Lipkin, W. Ian/0000-0002-8768-9386; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Haugen, Margaretha/0000-0001-5924-5000; Oyen, Anne-Siri/0000-0002-1637-992X	Norwegian Ministry of Health and Care Services; Norwegian Ministry of Education and Research; Research Council of Norway/FUGE [151918]; National Institute of Neurological Disorders and Stroke (NINDS) [NS47537]; National Institute of Environmental Health Sciences (NIEHS) [NO-ES-75558]; NINDS [NS47537]; Research Council of Norway [185476, 190694]; Medical Research Council [G9815508] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	Norwegian Ministry of Health and Care Services; Norwegian Ministry of Education and Research; Research Council of Norway/FUGE(Research Council of Norway); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Research Council of Norway(Research Council of Norway); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Norwegian Mother and Child Cohort is supported by the Norwegian Ministry of Health and Care Services, the Norwegian Ministry of Education and Research, the Research Council of Norway/FUGE (grant 151918), the National Institute of Neurological Disorders and Stroke (NINDS) (grant NS47537 [Dr Lipkin]), and the National Institute of Environmental Health Sciences (NIEHS) (contract NO-ES-75558). The Autism Birth Cohort study is funded by the NINDS (grant NS47537 [Dr Lipkin]). Dr Suren's salary is funded by the Research Council of Norway (grants 185476 and 190694).	Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Brantsaeter AL, 2008, MATERN CHILD NUTR, V4, P28, DOI 10.1111/j.1740-8709.2007.00103.x; Cordero A., 2010, Morbidity and Mortality Weekly Report, V59, P980; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 2012, ARCH GEN PSYCHIAT, V69, P306, DOI 10.1001/archgenpsychiatry.2011.148; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Meltzer HM, 2008, MATERN CHILD NUTR, V4, P14, DOI 10.1111/j.1740-8709.2007.00104.x; MILUNSKY A, 1989, JAMA-J AM MED ASSOC, V262, P2847, DOI 10.1001/jama.262.20.2847; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Roth C, 2011, JAMA-J AM MED ASSOC, V306, P1566, DOI 10.1001/jama.2011.1433; Sadler TW., 2010, LANGMANS MED EMBRYOL, V11th; Schmidt RJ, 2012, AM J CLIN NUTR, V96, P80, DOI 10.3945/ajcn.110.004416; Schmidt RJ, 2011, EPIDEMIOLOGY, V22, P476, DOI 10.1097/EDE.0b013e31821d0e30; Scientific Advisory Committee on Nutrition, FOL DIS PREV; SHAW GM, 1995, EPIDEMIOLOGY, V6, P219, DOI 10.1097/00001648-199505000-00005; Smith GD, 2008, BASIC CLIN PHARMACOL, V102, P245, DOI 10.1111/j.1742-7843.2007.00191.x; Stoltenberg C, 2010, MOL PSYCHIATR, V15, P676, DOI 10.1038/mp.2009.143; Suren P, 2012, PEDIATRICS, V130, pE152, DOI 10.1542/peds.2011-3217; WALD N, 1991, LANCET, V338, P131; WERLER MM, 1993, JAMA-J AM MED ASSOC, V269, P1257, DOI 10.1001/jama.269.10.1257	25	318	346	7	131	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					570	577		10.1001/jama.2012.155925	http://dx.doi.org/10.1001/jama.2012.155925			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087PH	23403681	Green Accepted, Bronze			2022-12-28	WOS:000314773700029
J	MacDougall, AS; McCann, KS; Gellner, G; Turkington, R				MacDougall, A. S.; McCann, K. S.; Gellner, G.; Turkington, R.			Diversity loss with persistent human disturbance increases vulnerability to ecosystem collapse	NATURE			English	Article							BIODIVERSITY; STABILITY; SHIFTS	Long-term and persistent human disturbances have simultaneously altered the stability and diversity of ecological systems, with disturbances directly reducing functional attributes such as invasion resistance, while eliminating the buffering effects of high species diversity(1-4). Theory predicts that this combination of environmental change and diversity loss increases the risk of abrupt and potentially irreversible ecosystem collapse(1-3,5-7), but long-term empirical evidence from natural systems is lacking. Here we demonstrate this relationship in a degraded but species-rich pyrogenic grassland in which the combined effects of fire suppression, invasion and trophic collapse have created a species-poor grassland that is highly productive, resilient to yearly climatic fluctuations, and resistant to invasion, but vulnerable to rapid collapse after the re-introduction of fire. We initially show how human disturbance has created a negative relationship between diversity and function, contrary to theoretical predictions(3,4). Fire prevention since the mid-nineteenth century is associated with the loss of plant species but it has stabilized high-yield annual production and invasion resistance, comparable to a managed high-yield low-diversity agricultural system. In managing for fire suppression, however, a hidden vulnerability to sudden environmental change emerges that is explained by the elimination of the buffering effects of high species diversity. With the re-introduction of fire, grasslands only persist in areas with remnant concentrations of native species, in which a range of rare and mostly functionally redundant plants proliferate after burning and prevent extensive invasion including a rapid conversion towards woodland. This research shows how biodiversity can be crucial for ecosystem stability despite appearing functionally insignificant beforehand, a relationship probably applicable to many ecosystems given the globally prevalent combination of intensive long-term land management and species loss.	[MacDougall, A. S.; McCann, K. S.; Gellner, G.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Turkington, R.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Turkington, R.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada	University of Guelph; University of British Columbia; University of British Columbia	MacDougall, AS (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	amacdo02@uoguelph.ca	MacDougall, Andrew S/F-2037-2011	Gellner, Gabriel/0000-0001-8170-1463	NSERC; World Wildlife Fund Endangered Species Recovery Fund; Mountain Equipment Co-Op Environmental Research Fund; University of Guelph	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); World Wildlife Fund Endangered Species Recovery Fund; Mountain Equipment Co-Op Environmental Research Fund; University of Guelph	We thank I. Banman, T. Ennis and C. Elder; the Garry Oak Ecosystem Recovery Team; the British Columbia Ministry of Forests, Lands, and Natural Resource Operations; the Municipality of North Cowichan, British Columbia; the Maple Bay Fire Department; and the many field technicians over ten years who assisted with this project. All burning was conducted with the assistance and approval of the Municipality of North Cowichan and the BC Ministry of Forests, Lands, and Natural Resource Operations. Thanks also to B. Gilbert, Y. Hautier, E. Harvey, L. Keshet, P. Arcese, M. Fuchs, D. Fraser, R. Hebda, H. Roemer, B. Costanzo, B. Beckwith, G. Douglas, A. Ceska and M. Fairbarns. Funding was provided by NSERC, World Wildlife Fund Endangered Species Recovery Fund, Mountain Equipment Co-Op Environmental Research Fund, and the University of Guelph, with significant in-kind contributions from the Nature Conservancy of Canada.	Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Elton C. S., 1958, ECOLOGY INVASIONS AN; Harley CDG, 2009, P NATL ACAD SCI USA, V106, P11172, DOI 10.1073/pnas.0904946106; Hector A, 2011, NATURE, V472, P45, DOI 10.1038/472045a; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Loreau M., 2010, POPULATIONS ECOSYSTE; MacDougall AS, 2005, ECOLOGY, V86, P3354, DOI 10.1890/04-1733; MacDougall AS, 2004, CONSERV BIOL, V18, P455, DOI 10.1111/j.1523-1739.2004.00483.x; May R.M., 1973, STABILITY COMPLEXITY; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Wohl DL, 2004, ECOLOGY, V85, P1534, DOI 10.1890/03-3050; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	25	186	200	12	557	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					86	89		10.1038/nature11869	http://dx.doi.org/10.1038/nature11869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389543				2022-12-28	WOS:000314741200039
J	Ofek, EO; Sullivan, M; Cenko, SB; Kasliwal, MM; Gal-Yam, A; Kulkarni, SR; Arcavi, I; Bildsten, L; Bloom, JS; Horesh, A; Howell, DA; Filippenko, AV; Laher, R; Murray, D; Nakar, E; Nugent, PE; Silverman, JM; Shaviv, NJ; Surace, J; Yaron, O				Ofek, E. O.; Sullivan, M.; Cenko, S. B.; Kasliwal, M. M.; Gal-Yam, A.; Kulkarni, S. R.; Arcavi, I.; Bildsten, L.; Bloom, J. S.; Horesh, A.; Howell, D. A.; Filippenko, A. V.; Laher, R.; Murray, D.; Nakar, E.; Nugent, P. E.; Silverman, J. M.; Shaviv, N. J.; Surace, J.; Yaron, O.			An outburst from a massive star 40 days before a supernova explosion	NATURE			English	Article							LUMINOUS SUPERNOVA; ENVELOPE; DISCOVERY; SN-2006GY	Some observations suggest that very massive stars experience extreme mass-loss episodes shortly before they explode as supernovae(1-4), as do several models(5-7). Establishing a causal connection between these mass-loss episodes and the final explosion would provide a novel way to study pre-supernova massive-star evolution. Here we report. observations of a mass-loss event detected 40 days before the explosion of the type IIn supernova SN 2010mc (also known as PTF 10tel). Our photometric and spectroscopic data suggest that this event is a result of an energetic outburst, radiating at least 6 x 10(47) erg of energy and releasing about 10(-2) solar masses of material at typical velocities of 2,000 km s(-1). The temporal proximity of the mass-loss outburst and the supernova explosion implies a causal connection between them. Moreover, we find that the outburst luminosity and velocity are consistent with the predictions of the wave-driven pulsation model(6), and disfavour alternative suggestions(7).	[Ofek, E. O.; Gal-Yam, A.; Arcavi, I.; Yaron, O.] Weizmann Inst Sci, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel; [Sullivan, M.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Sullivan, M.] Univ Oxford, Dept Phys Astrophys, Oxford OX1 3RH, England; [Cenko, S. B.; Bloom, J. S.; Filippenko, A. V.; Nugent, P. E.; Silverman, J. M.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Kasliwal, M. M.] Observ Carnegie Inst Sci, Pasadena, CA 91101 USA; [Kulkarni, S. R.; Horesh, A.] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; [Bildsten, L.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Bildsten, L.; Howell, D. A.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Bloom, J. S.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Howell, D. A.] Las Cumbres Observ Global Telescope Network, Goleta, CA 93117 USA; [Laher, R.; Surace, J.] CALTECH, Spitzer Sci Ctr, Pasadena, CA 91125 USA; [Murray, D.] Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA; [Nakar, E.] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Silverman, J. M.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Shaviv, N. J.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Weizmann Institute of Science; University of Southampton; University of Oxford; University of California System; University of California Berkeley; Carnegie Institution for Science; California Institute of Technology; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California Institute of Technology; University of Wisconsin System; University of Wisconsin Milwaukee; Tel Aviv University; University of Texas System; University of Texas Austin; Hebrew University of Jerusalem	Ofek, EO (corresponding author), Weizmann Inst Sci, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel.	eran@astro.caltech.edu	Horesh, Assaf/O-9873-2016; Nugent, Peter Edward/AGG-8472-2022; Howell, Andy/ABE-6446-2020	Horesh, Assaf/0000-0002-5936-1156; Kasliwal, Tamay/0000-0001-5634-7167; Shaviv, Nir/0000-0003-3894-8422; Nugent, Peter/0000-0002-3389-0586; Nakar, Ehud/0000-0002-4534-7089; Bloom, Joshua/0000-0002-7777-216X; Sullivan, Mark/0000-0001-9053-4820	Arye Dissentshik career development chair; Helen Kimmel Center for Planetary Science; Israeli Ministry of Science; Royal Society; NSF; Israeli Science Foundation; German-Israeli Foundation; ERC; US Department of Energy; Gary and Cynthia Bengier, the Richard and Rhoda Goldman Fund; Christopher R. Redlich Fund; TABASGO Foundation; Division Of Astronomical Sciences [1109174, 1211916] Funding Source: National Science Foundation	Arye Dissentshik career development chair; Helen Kimmel Center for Planetary Science; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Royal Society(Royal Society of London); NSF(National Science Foundation (NSF)); Israeli Science Foundation(Israel Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); ERC(European Research Council (ERC)European Commission); US Department of Energy(United States Department of Energy (DOE)); Gary and Cynthia Bengier, the Richard and Rhoda Goldman Fund; Christopher R. Redlich Fund; TABASGO Foundation; Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank E. Quataert and M. Cantiello for discussions. The VLA is operated by the National Radio Astronomy Observatory, a facility of the US National Science Foundation (NSF) operated under cooperative agreement by Associated Universities, Inc. This paper is based on observations obtained with the Samuel Oschin Telescope as part of the Palomar Transient Factory project. We are grateful for the assistance of the staff at the various observatories where data were obtained. We acknowledge support from the Arye Dissentshik career development chair, the Helen Kimmel Center for Planetary Science, the Israeli Ministry of Science, the Royal Society, the NSF, the Israeli Science Foundation, the German-Israeli Foundation, ERC, the US Department of Energy, Gary and Cynthia Bengier, the Richard and Rhoda Goldman Fund, the Christopher R. Redlich Fund, and the TABASGO Foundation.	Chevalier RA, 2012, ASTROPHYS J LETT, V752, DOI 10.1088/2041-8205/752/1/L2; CHUGAI NN, 1994, MON NOT R ASTRON SOC, V268, P173, DOI 10.1093/mnras/268.1.173; Chugai NN, 2003, ASTRON LETT+, V29, P649, DOI 10.1134/1.1615333; DOPITA MA, 1984, ASTROPHYS J, V287, pL69, DOI 10.1086/184400; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Foley RJ, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/32; Gal-Yam A, 2009, NATURE, V458, P865, DOI 10.1038/nature07934; Kiewe M, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/10; Law NM, 2009, PUBL ASTRON SOC PAC, V121, P1395, DOI 10.1086/648598; Mauerhan J. C., 2012, PREPRINT; Ofek EO, 2007, ASTROPHYS J, V659, pL13, DOI 10.1086/516749; Ofek EO, 2012, PUBL ASTRON SOC PAC, V124, P854, DOI 10.1086/666978; Ofek EO, 2012, PUBL ASTRON SOC PAC, V124, P62, DOI 10.1086/664065; Ofek EO, 2010, ASTROPHYS J, V724, P1396, DOI 10.1088/0004-637X/724/2/1396; Ofek E. O., 2012, PREPRINT; Ofek E. O., ASTROPHYS J UNPUB; Owocki S, 2010, ASTR SOC P, V425, P199; Pastorello A, 2010, MON NOT R ASTRON SOC, V408, P181, DOI 10.1111/j.1365-2966.2010.17142.x; Prieto J. L., 2012, PREPRINT; Quataert E, 2012, MON NOT R ASTRON SOC, V423, pL92, DOI 10.1111/j.1745-3933.2012.01264.x; Quimby RM, 2011, NATURE, V474, P487, DOI 10.1038/nature10095; RAKAVY G, 1967, ASTROPHYS J, V150, P131, DOI 10.1086/149318; Rau A, 2009, PUBL ASTRON SOC PAC, V121, P1334, DOI 10.1086/605911; SCHLEGEL EM, 1990, MON NOT R ASTRON SOC, V244, P269; Smith N, 2007, ASTROPHYS J, V666, P1116, DOI 10.1086/519949; Smith N, 2010, ASTRON J, V139, P1451, DOI 10.1088/0004-6256/139/4/1451; Taam RE, 2010, NEW ASTRON REV, V54, P65, DOI 10.1016/j.newar.2010.09.027; Woosley SE, 2007, NATURE, V450, P390, DOI 10.1038/nature06333; Yaron O, 2012, PUBL ASTRON SOC PAC, V124, P668, DOI 10.1086/666656	29	158	159	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					65	67		10.1038/nature11877	http://dx.doi.org/10.1038/nature11877			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389540	Green Submitted, Green Accepted			2022-12-28	WOS:000314741200034
J	Perencevich, M; Saltzman, JR; Levy, BD; Loscalzo, J				Perencevich, Molly; Saltzman, John R.; Levy, Bruce D.; Loscalzo, Joseph			The Search Is On	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AORTOENTERIC FISTULA	An 81-year-old man presented to the emergency department with hematochezia and hematemesis. He had been feeling well until he woke up with the urge to have a bowel movement; initially, he had diarrhea with brown stool. Soon afterward, he again had urgency, and this time red blood filled the toilet bowl. He later vomited a small amount of blood. He did not have abdominal pain, black stools, constipation, heartburn, dysphagia, or odynophagia. He reported no fevers, weight loss, or anorexia. He felt weak and light-headed but did not have chest pain or shortness of breath.	[Perencevich, Molly; Saltzman, John R.; Levy, Bruce D.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Perencevich, Molly; Saltzman, John R.] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Levy, BD (corresponding author), Brigham & Womens Hosp, Harvard Inst Med Bldg,77 Ave Louis Pasteur,HIM 85, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021		Cook Endoscopy	Cook Endoscopy	Dr. Saltzman reports receiving consulting fees from Cook Endoscopy. No other potential conflict of interest relevant to this article was reported.	Antoniou GA, 2009, J VASC SURG, V49, P782, DOI 10.1016/j.jvs.2008.08.068; Baril DT, 2006, J VASC SURG, V44, P250, DOI 10.1016/j.jvs.2006.04.031; Hughes FM, 2007, ABDOM IMAGING, V32, P398, DOI 10.1007/s00261-006-9062-7; Kakkos SK, 2011, EUR J VASC ENDOVASC, V41, P625, DOI 10.1016/j.ejvs.2010.12.026; Lemos DW, 2003, J VASC SURG, V37, P686, DOI 10.1067/mva.2003.101; Odemis B, 2008, NAT CLIN PRACT GASTR, V5, P226, DOI 10.1038/ncpgasthep1075; Raju Gottumukkala S, 2007, Gastroenterology, V133, P1697, DOI 10.1053/j.gastro.2007.06.007; Rockey DC, 1999, NEW ENGL J MED, V341, P38, DOI 10.1056/NEJM199907013410107; Senadhi Viplove, 2010, Case Rep Gastroenterol, V4, P510, DOI 10.1159/000322662; Vu QDM, 2009, RADIOGRAPHICS, V29, P197, DOI 10.1148/rg.291075185	10	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					562	567		10.1056/NEJMcps1200126	http://dx.doi.org/10.1056/NEJMcps1200126			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083VU	23388008				2022-12-28	WOS:000314494100009
J	Shenoy, BH; Mandal, AK				Shenoy, Bhamy Hariprasad; Mandal, Anil Kumar			Stickler syndrome associated with congenital glaucoma	LANCET			English	Editorial Material									[Shenoy, Bhamy Hariprasad; Mandal, Anil Kumar] LV Prasad Eye Inst, Dept Paediat Ophthalmol Strabismus & Neuroophthal, Jasti Ramanamma Childrens Eye Care Ctr, Hyderabad 500034, Andhra Pradesh, India; [Mandal, Anil Kumar] LV Prasad Eye Inst, VST Glaucoma Serv, Jasti Ramanamma Childrens Eye Care Ctr, Hyderabad 500034, Andhra Pradesh, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Shenoy, BH (corresponding author), LV Prasad Eye Inst, Dept Paediat Ophthalmol Strabismus & Neuroophthal, LV Prasad Marg,Banjara Hills, Hyderabad 500034, Andhra Pradesh, India.	drbhamy@gmail.com	Mandal, Anil/AAY-4809-2020					OPITZ JM, 1972, NEW ENGL J MED, V286, P546; Ortlepp J, 1966, KLIN MONBL AUGENHEIL, V148, P469; Saraux H, 1968, Arch Ophtalmol Rev Gen Ophtalmol, V28, P793; SPALLONE A, 1987, BRIT J OPHTHALMOL, V71, P504, DOI 10.1136/bjo.71.7.504; Ziakas NG, 1998, OPHTHALMIC GENET, V19, P55, DOI 10.1076/opge.19.1.55.2177	5	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2013	381	9864					422	422		10.1016/S0140-6736(12)61813-3	http://dx.doi.org/10.1016/S0140-6736(12)61813-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084ZA	23374481				2022-12-28	WOS:000314578900040
J	Mamin, HJ; Kim, M; Sherwood, MH; Rettner, CT; Ohno, K; Awschalom, DD; Rugar, D				Mamin, H. J.; Kim, M.; Sherwood, M. H.; Rettner, C. T.; Ohno, K.; Awschalom, D. D.; Rugar, D.			Nanoscale Nuclear Magnetic Resonance with a Nitrogen-Vacancy Spin Sensor	SCIENCE			English	Article							DIAMOND; MICROSCOPY; CENTERS; MAGNETOMETRY	Extension of nuclear magnetic resonance (NMR) to nanoscale samples has been a longstanding challenge because of the insensitivity of conventional detection methods. We demonstrated the use of an individual, near-surface nitrogen-vacancy (NV) center in diamond as a sensor to detect proton NMR in an organic sample located external to the diamond. Using a combination of electron spin echoes and proton spin manipulation, we showed that the NV center senses the nanotesla field fluctuations from the protons, enabling both time-domain and spectroscopic NMR measurements on the nanometer scale.	[Mamin, H. J.; Kim, M.; Sherwood, M. H.; Rettner, C. T.; Rugar, D.] IBM Corp, Almaden Res Ctr, Div Res, San Jose, CA 95120 USA; [Kim, M.] Stanford Univ, Ctr Probing Nanoscale, Stanford, CA 94305 USA; [Ohno, K.; Awschalom, D. D.] Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA	International Business Machines (IBM); Stanford University; University of California System; University of California Santa Barbara	Rugar, D (corresponding author), IBM Corp, Almaden Res Ctr, Div Res, San Jose, CA 95120 USA.	rugar@us.ibm.com			Defense Advanced Research Projects Agency QuASAR program; Air Force Office of Scientific Research; Center for Probing the Nanoscale at Stanford University (NSF) [PHY-0830228]	Defense Advanced Research Projects Agency QuASAR program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Center for Probing the Nanoscale at Stanford University (NSF)(National Science Foundation (NSF))	We thank F. Reinhard, J. Wrachtrup, P. Hemmer, and A. Bleszynski Jayich for helpful discussions. This work was supported by the Defense Advanced Research Projects Agency QuASAR program, the Air Force Office of Scientific Research, and the Center for Probing the Nanoscale at Stanford University (NSF grant PHY-0830228).	Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Chernobrod BM, 2005, J APPL PHYS, V97, DOI 10.1063/1.1829373; Degen CL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2943282; Degen CL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250601; Degen CL, 2009, P NATL ACAD SCI USA, V106, P1313, DOI 10.1073/pnas.0812068106; Epstein RJ, 2005, NAT PHYS, V1, P94, DOI 10.1038/nphys141; Ernst R. R., 1987, NUCL MAGNETIC RESONA; Glover P, 2002, REP PROG PHYS, V65, P1489, DOI 10.1088/0034-4885/65/10/203; Grinolds MS, 2011, NAT PHYS, V7, P687, DOI [10.1038/nphys1999, 10.1038/NPHYS1999]; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Grotz B, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/055004; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Hadden JP, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3519847; Hall LT, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.220802; Jelezko F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130501; Kolkowitz S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.137601; Laraoui A, 2012, NANO LETT, V12, P3477, DOI 10.1021/nl300964g; Laraoui A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.104301; Maletinsky P, 2012, NAT NANOTECHNOL, V7, P320, DOI [10.1038/nnano.2012.50, 10.1038/NNANO.2012.50]; Mamin HJ, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195422; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Meriles CA, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3483676; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Ohno K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4748280; Taminiau TH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.137602; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Tocheva EI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003442; Zhao N, 2012, NAT NANOTECHNOL, V7, P657, DOI [10.1038/nnano.2012.152, 10.1038/NNANO.2012.152]	29	514	559	25	578	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					557	560		10.1126/science.1231540	http://dx.doi.org/10.1126/science.1231540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372008				2022-12-28	WOS:000314270000053
J	Greka, A; Bhatia, RS; Sabir, SH; Dekker, JP				Greka, Anna; Bhatia, R. Sacha; Sabir, Sharjeel H.; Dekker, John P.			Case 4-2013: A 50-Year-Old Man with Acute Flank Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE RENAL INFARCTION; ACUTE LOIN PAIN; FIBROMUSCULAR DYSPLASIA; CLINICAL CHARACTERISTICS; POSTSPLENECTOMY SEPSIS; ATRIAL-FIBRILLATION; ARTERIES; BABESIOSIS; EMBOLISM		[Greka, Anna; Bhatia, R. Sacha] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sabir, Sharjeel H.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Dekker, John P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Greka, Anna; Bhatia, R. Sacha] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sabir, Sharjeel H.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Dekker, John P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greka, A (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.			Sabir, Sharjeel/0000-0002-4049-9614				BISHOP MC, 1990, BRIT MED J, V300, P817, DOI 10.1136/bmj.300.6727.817; Bockler D, 2003, J ENDOVASC THER, V10, P1054, DOI 10.1583/1545-1550(2003)010<1054:IORIAE>2.0.CO;2; Chu PL, 2006, NEPHROLOGY, V11, P336, DOI 10.1111/j.1440-1797.2006.00586.x; COSBY RL, 1986, AM J MED, V81, P890, DOI 10.1016/0002-9343(86)90363-3; Domanovits H, 1999, MEDICINE, V78, P386, DOI 10.1097/00005792-199911000-00004; Frost L, 2001, ARCH INTERN MED, V161, P272, DOI 10.1001/archinte.161.2.272; Hazanov N, 2004, MEDICINE, V83, P292, DOI 10.1097/01.md.0000141097.08000.99; HOLDSWORTH RJ, 1991, BRIT J SURG, V78, P1031, DOI 10.1002/bjs.1800780904; HOSEA SW, 1981, NEW ENGL J MED, V304, P245, DOI 10.1056/NEJM198101293040501; Krause PJ, 2008, CLIN INFECT DIS, V46, P370, DOI 10.1086/525852; LESSMAN RK, 1978, ANN INTERN MED, V89, P477, DOI 10.7326/0003-4819-89-4-477; MARTONE WJ, 1980, ANN INTERN MED, V93, P457, DOI 10.7326/0003-4819-93-3-457; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Nasser NJ, 2007, NAT CLIN PRACT NEPHR, V3, P631, DOI 10.1038/ncpneph0624; Paris B, 2006, J HYPERTENS, V24, P1649, DOI 10.1097/01.hjh.0000239302.55754.1f; ROSNER F, 1984, AM J MED, V76, P696, DOI 10.1016/0002-9343(84)90298-5; Shepard CW, 2004, CLIN INFECT DIS, V38, P799, DOI 10.1086/381888; Spellerberg B, 2011, MANUAL CLIN MICROBIO, V1, P331; Stawicki SP, 2006, J HUM HYPERTENS, V20, P710, DOI 10.1038/sj.jhh.1002045; STINCHCOMBE SJ, 1990, BRIT MED J, V300, P183, DOI 10.1136/bmj.300.6718.183; STINCHCOMBE SJ, 1992, BRIT J RADIOL, V65, P81, DOI 10.1259/0007-1285-65-769-81	21	1	1	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					466	472		10.1056/NEJMcpc1201414	http://dx.doi.org/10.1056/NEJMcpc1201414			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BE	23343037				2022-12-28	WOS:000314215400013
J	Tabach, Y; Billi, AC; Hayes, GD; Newman, MA; Zuk, O; Gabel, H; Kamath, R; Yacoby, K; Chapman, B; Garcia, SM; Borowsky, M; Kim, JK; Ruvkun, G				Tabach, Yuval; Billi, Allison C.; Hayes, Gabriel D.; Newman, Martin A.; Zuk, Or; Gabel, Harrison; Kamath, Ravi; Yacoby, Keren; Chapman, Brad; Garcia, Susana M.; Borowsky, Mark; Kim, John K.; Ruvkun, Gary			Identification of small RNA pathway genes using patterns of phylogenetic conservation and divergence	NATURE			English	Article							SYSTEMATIC IDENTIFICATION; INTERFERENCE; POLYMERASE; PROTEINS; COMPLEX; DCR-1; SIRNA	Genetic and biochemical analyses of RNA interference (RNAi) and microRNA (miRNA) pathways have revealed proteins such as Argonaute and Dicer as essential cofactors that process and present small RNAs to their targets. Well-validated small RNA pathway cofactors such as these show distinctive patterns of conservation or divergence in particular animal, plant, fungal and protist species. We compared 86 divergent eukaryotic genome sequences to discern sets of proteins that show similar phylogenetic profiles with known small RNA cofactors. A large set of additional candidate small RNA cofactors have emerged from functional genomic screens for defects in miRNA-or short interfering RNA (siRNA)-mediated repression in Caenorhabditis elegans and Dro-sophila melanogaster(1,2), and from proteomic analyses of proteins co-purifying with validated small RNA pathway proteins(3,4). The phylogenetic profiles of many of these candidate small RNA pathway proteins are similar to those of known small RNA cofactor proteins. We used a Bayesian approach to integrate the phylogenetic profile analysis with predictions from diverse transcriptional coregulation and proteome interaction data sets to assign a probability for each protein for a role in a small RNA pathway. Testing high-confidence candidates from this analysis for defects in RNAi silencing, we found that about one-half of the predicted small RNA cofactors are required for RNAi silencing. Many of the newly identified small RNA pathway proteins are orthologues of proteins implicated in RNA splicing. In support of a deep connection between the mechanism of RNA splicing and small-RNA-mediated gene silencing, the presence of the Argonaute proteins and other small RNA components in the many species analysed strongly correlates with the number of introns in those species.	[Tabach, Yuval; Hayes, Gabriel D.; Newman, Martin A.; Gabel, Harrison; Kamath, Ravi; Yacoby, Keren; Chapman, Brad; Garcia, Susana M.; Borowsky, Mark; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Tabach, Yuval; Hayes, Gabriel D.; Newman, Martin A.; Gabel, Harrison; Kamath, Ravi; Garcia, Susana M.; Borowsky, Mark; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Billi, Allison C.; Kim, John K.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Billi, Allison C.; Kim, John K.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Zuk, Or] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Tabach, Yuval/Q-8488-2019; Billi, Allison/AAP-1684-2021	D. A. Garcia, Susana Maria/0000-0002-1638-7575; Chapman, Brad/0000-0002-3026-1856	NIH [GM088565, GM44619, GM098647]; Pew Charitable Trusts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044619, R01GM098647, T32GM007544, R01GM088565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Duchaine for access to his ERI-1 proteomic data before it was published and to S. Fischer, C. Zhang and T. Montgomery for helpful discussions. The work was supported by NIH GM088565 and the Pew Charitable Trusts (J.K.K.) and NIH GM44619 and GM098647 (G.R.).	Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Bernstein DA, 2012, P NATL ACAD SCI USA, V109, P523, DOI 10.1073/pnas.1118859109; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Drinnenberg IA, 2011, SCIENCE, V333, P1592, DOI 10.1126/science.1209575; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Enault F, 2003, BIOINFORMATICS, V19, pi105, DOI 10.1093/bioinformatics/btg1013; Gabaldon T, 2005, EVOL BIOINFORM, V1, P51; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Montgomery TA, 2012, PLOS GENET, V8, P72, DOI 10.1371/journal.pgen.1002616; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pontes O, 2008, CURR OPIN GENET DEV, V18, P197, DOI 10.1016/j.gde.2008.01.008; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Thivierge C, 2012, NAT STRUCT MOL BIOL, V19, P90, DOI 10.1038/nsmb.2186; Yelina NE, 2010, P NATL ACAD SCI USA, V107, P13948, DOI 10.1073/pnas.0911341107; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018	28	102	102	1	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					694	698		10.1038/nature11779	http://dx.doi.org/10.1038/nature11779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364702	Green Accepted, Green Submitted			2022-12-28	WOS:000314219600061
J	Duncan, RG; Rivet, AE				Duncan, Ravit Golan; Rivet, Ann E.			Science Learning Progressions	SCIENCE			English	Editorial Material							INQUIRY; INSTRUCTION; FRAMEWORK; MODELS		[Duncan, Ravit Golan] Rutgers State Univ, Grad Sch Educ, New Brunswick, NJ 08901 USA; [Rivet, Ann E.] Columbia Univ, Teachers Coll, New York, NY 10027 USA	Rutgers State University New Brunswick; Columbia University; Columbia University Teachers College	Duncan, RG (corresponding author), Rutgers State Univ, Grad Sch Educ, New Brunswick, NJ 08901 USA.	ravit.duncan@gse.rutgers.edu						Alberts B, 2010, SCIENCE, V329, P491, DOI 10.1126/science.1195444; Alonzo A.C., 2012, LEARNING PROGR SCI C; Berland LK, 2009, SCI EDUC, V93, P26, DOI 10.1002/sce.20286; Chinn CA, 2002, SCI EDUC, V86, P175, DOI 10.1002/sce.10001; Corcoran T.B., 2009, LEARNING PROGR SCI E; Duncan RG, 2009, J RES SCI TEACH, V46, P655, DOI 10.1002/tea.20312; Duncan RG, 2009, J RES SCI TEACH, V46, P606, DOI 10.1002/tea.20316; Duschl R. A., 2007, TAKING SCI SCH LEARN, DOI DOI 10.17226/11625; Edelson DC, 2001, J RES SCI TEACH, V38, P355, DOI 10.1002/1098-2736(200103)38:3<355::AID-TEA1010>3.0.CO;2-M; Ford M, 2008, SCI EDUC, V92, P404, DOI 10.1002/sce.20263; Foster J, 2012, LEARNING PROGR SCI C, P435; Giere RN, 2004, PHILOS SCI, V71, P742, DOI 10.1086/425063; Kitcher Philip., 1993, OBJECTIVITY; Lehrer R, 2012, SCI EDUC, V96, P701, DOI 10.1002/sce.20475; National Research Council, 2011, FRAM K 12 SCI ED PRA; National Research Council (NRC), 1996, NAT SCI ED STAND; Rivet AE, 2008, J RES SCI TEACH, V45, P79, DOI 10.1002/tea.20203; Rivet AE, 2012, J RES SCI TEACH, V49, P713, DOI 10.1002/tea.21029; Sandoval WA, 2005, SCI EDUC, V89, P634, DOI 10.1002/sce.20065; Steedle JT, 2009, J RES SCI TEACH, V46, P699, DOI 10.1002/tea.20308; Wilson M., 2005, CONSTRUCTING MEASURE; Wiser M., 2012, LEARNING PROGR SCI C, P357, DOI [10.1007/978-94-6091-824-7_16, DOI 10.1007/978-94-6091-824-7_16]	22	58	61	6	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					396	397		10.1126/science.1228692	http://dx.doi.org/10.1126/science.1228692			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	076MN	23349274				2022-12-28	WOS:000313960700023
J	Gillingham, K; Kotchen, MJ; Rapson, DS; Wagner, G				Gillingham, Kenneth; Kotchen, Matthew J.; Rapson, David S.; Wagner, Gernot			The rebound effect is overplayed	NATURE			English	Editorial Material									[Gillingham, Kenneth; Kotchen, Matthew J.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06520 USA; [Rapson, David S.] Univ Calif Davis, Dept Econ, Davis, CA 95616 USA; [Wagner, Gernot] Environm Def Fund, New York, NY USA	Yale University; University of California System; University of California Davis; Environmental Defense Fund	Gillingham, K (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06520 USA.	kenneth.gillingham@yale.edu		Wagner, Gernot/0000-0001-6059-0688; Gillingham, Kenneth/0000-0002-7329-2660				Barker T, 2007, ENERG POLICY, V35, P4935, DOI 10.1016/j.enpol.2007.04.009; Barker T, 2009, ENERG EFFIC, V2, P411, DOI 10.1007/s12053-009-9053-y; Chetty R, 2009, AM ECON REV, V99, P1145, DOI 10.1257/aer.99.4.1145; Gillingham, 2011, THESIS STANFORD U; International Energy Agency, 2012, WORLD EN OUTL 2012; Jessoe Katrina, 2012, 18344 NBER; Jevons W.S., 1865, COAL QUESTION; Thomas B., ECOL EC IN PRESS; Tierney John., 2011, NY TIMES 0208	9	212	212	4	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					475	476		10.1038/493475a	http://dx.doi.org/10.1038/493475a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GF	23344343	Bronze			2022-12-28	WOS:000313871400014
J	Burt, RK; Oliveira, MC; Shah, SJ; Moraes, DA; Simoes, B; Gheorghiade, M; Schroeder, J; Ruderman, E; Farge, D; Chai, ZJ; Marjanovic, Z; Jain, S; Morgan, A; Milanetti, F; Han, XQ; Jovanovic, B; Helenowski, IB; Voltarelli, J				Burt, Richard K.; Oliveira, Maria Carolina; Shah, Sanjiv J.; Moraes, Daniela A.; Simoes, Belinda; Gheorghiade, Mihai; Schroeder, James; Ruderman, Eric; Farge, Dominique; Chai, Z. Jessie; Marjanovic, Zora; Jain, Sandeep; Morgan, Amy; Milanetti, Francesca; Han, Xiaoqiang; Jovanovic, Borko; Helenowski, Irene B.; Voltarelli, Julio			Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis	LANCET			English	Article							PULMONARY ARTERIAL-HYPERTENSION; RIGHT HEART CATHETERIZATION; TERM-FOLLOW-UP; MARROW TRANSPLANTATION; PULSE CYCLOPHOSPHAMIDE; MULTICENTER; DIAGNOSIS; DISEASE; GUIDELINES; RESPONSES	Background Autologous haemopoietic stem-cell transplantation (HSCT) benefits patients with systemic sclerosis but has been associated with significant treatment-related mortality and failure to improve diffusion capacity of carbon monoxide (DLCO). We aimed to assess efficacy of HSCT and use of rigorous cardiac screening in this group. Methods We assessed patients with diffuse systemic sclerosis or limited systemic sclerosis and interstitial lung disease who were treated with HSCT as part of a study or on a compassionate basis at Northwestern University (Chicago, IL, USA) or the University of Sao Paulo (Ribeirao Preto, Brazil). Unselected peripheral blood stem cells were harvested with cyclophosphamide (2 g/m(2)) and filgrastim. The transplant regimen was a non-myeloablative regimen of cyclophosphamide (200 mg/kg) and rabbit anti-thymocyte globulin (rATG; 4.5-6.5 mg/kg). We followed patients up to 5 years for overall survival, relapse-free survival, modified Rodnan skin score, and pulmonary function tests. Findings Five (6%) of 90 patients died from treatment-related causes. Despite standard guidelines that recommend echocardiogram for screening before transplantation, four treatment-related deaths occurred because of cardiovascular complications (one constrictive pericarditis, two right heart failures without underlying infection, and one heart failure during mobilisation), and one death was secondary to sepsis without documented underlying heart disease. Kaplan-Meier analysis showed survival was 78% at 5 years (after eight relapse-related deaths) and relapse-free survival was 70% at 5 years. Compared with baseline, we noted improvements after HSCT in modified Rodnan skin scores at 1 year (58 patients; p<0.0001), 2 years (42 patients; p<0.0001), and 3 years (27 patients; p<0.0001) and forced vital capacity at 1 year (58 patients; p=0.009), 2 years (40 patients; p=0.02), and 3 years (28 patients; p=0.004), but total lung capacity and DLCO were not improved significantly after HSCT. Overall mean DLCO was significantly improved in patients with normal baseline echocardiograms (p=0.005) or electrocardiographs (p=0.05). Interpretation Autologous HSCT with a non-myeloablative regimen of cyclophosphamide and rATG with a non-selected autograft results in sustained improvement in skin thickness and forced vital capacity. DLCO is affected by baseline cardiac function. Guidelines for cardiac screening of patients with systemic sclerosis to assess treatment-related risk from pulmonary artery hypertension, primary cardiac involvement, or pericardial disease should be reconsidered and updated.	[Burt, Richard K.; Jain, Sandeep; Morgan, Amy; Han, Xiaoqiang] Northwestern Univ, Dept Med, Div Immunotherapy, Feinberg Sch Med, Chicago, IL 60611 USA; [Shah, Sanjiv J.; Chai, Z. Jessie] Northwestern Univ, Dept Med, Div Cardiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Gheorghiade, Mihai] Northwestern Univ, Dept Med, Ctr Cardiovasc Innovat, Feinberg Sch Med, Chicago, IL 60611 USA; [Schroeder, James; Ruderman, Eric] Northwestern Univ, Dept Med, Div Rheumatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Oliveira, Maria Carolina; Moraes, Daniela A.; Simoes, Belinda; Voltarelli, Julio] Univ Sao Paulo, Dept Clin Med, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Farge, Dominique] Univ Paris 07, St Louis Hosp, AP HP, INSERM,Unite Med Interne & Pathol Vasc,U976, F-75221 Paris 05, France; [Marjanovic, Zora] Univ Paris 06, St Antoine Hosp, AP HP, Dept Hematol, Paris, France; [Milanetti, Francesca] Univ Rome, Div Clin Immunol & Rheumatol, St Andrea Hosp, Rome, Italy; [Jovanovic, Borko; Helenowski, Irene B.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Northwestern University; Feinberg School of Medicine	Burt, RK (corresponding author), Northwestern Univ, Dept Med, Div Immunotherapy, Feinberg Sch Med, Chicago, IL 60611 USA.	rburt@northwestern.edu	Rodrigues, Maria Carolina Oliveira/A-2302-2012; Shah, Sanjiv J./AFQ-9480-2022; SIMOES, BELINDA/A-1896-2014; Simoes, Belinda P/M-7469-2016; CTC USP, CEPID 13 18/J-8951-2014	Rodrigues, Maria Carolina Oliveira/0000-0003-0691-2222; SIMOES, BELINDA/0000-0003-4508-8934; CTC USP, CEPID 13 18/0000-0002-7123-9524; Burt, Richard K/0000-0002-0922-4145				Agostoni P, 2006, EUR HEART J, V27, P2538, DOI 10.1093/eurheartj/ehl302; Burt RK, 2011, CURR OPIN RHEUMATOL, V23, P519, DOI 10.1097/BOR.0b013e32834aa45f; Burt RK, 2011, LANCET, V378, P498, DOI 10.1016/S0140-6736(11)60982-3; BUSH CA, 1977, CIRCULATION, V56, P924, DOI 10.1161/01.CIR.56.6.924; Champion HC, 2009, CIRCULATION, V120, P992, DOI 10.1161/CIRCULATIONAHA.106.674028; CLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892; Coghlan JG, 2007, BEST PRACT RES CL HA, V20, P247, DOI 10.1016/j.beha.2006.09.005; Denton CP, 1997, BRIT J RHEUMATOL, V36, P239; Desai CS, 2011, CURR OPIN RHEUMATOL, V23, P545, DOI 10.1097/BOR.0b013e32834b8975; Englert H, 2008, INTERN MED J, V38, P692, DOI 10.1111/j.1445-5994.2007.01593.x; Farge D, 2004, ANN RHEUM DIS, V63, P974, DOI 10.1136/ard.2003.011205; Farge D, 2002, BRIT J HAEMATOL, V119, P726, DOI 10.1046/j.1365-2141.2002.03895.x; Frea S, 2011, ECHOCARDIOGR-J CARD, V28, P860, DOI 10.1111/j.1540-8175.2011.01467.x; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Guazzi M, 2000, Ital Heart J, V1, P169; Hachulla AL, 2009, ANN RHEUM DIS, V68, P1878, DOI 10.1136/ard.2008.095836; Hachulla E, 2005, ARTHRITIS RHEUM-US, V52, P3792, DOI 10.1002/art.21433; Henes JC, 2012, J RHEUMATOL, V39, P269, DOI 10.3899/jrheum.110868; Hesselstrand R, 2011, SCAND J RHEUMATOL, V40, P133, DOI 10.3109/03009742.2010.507217; Hoeper MM, 2006, J AM COLL CARDIOL, V48, P2546, DOI 10.1016/j.jacc.2006.07.061; Huegle T, 2012, ANN RHEUM DIS, V71, P1582, DOI 10.1136/annrheumdis-2011-200809; Kuo PC, 1996, CLIN TRANSPLANT, V10, P521; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Moore J, 2012, BONE MARROW TRANSPL, V47, P1486, DOI 10.1038/bmt.2012.67; Mouthon L, 2011, CLIN REV ALLERG IMMU, V40, P84, DOI 10.1007/s12016-009-8191-5; Nash RA, 2007, BLOOD, V110, P1388, DOI 10.1182/blood-2007-02-072389; Oyama Y, 2007, BONE MARROW TRANSPL, V40, P549, DOI 10.1038/sj.bmt.1705782; PURI S, 1995, CIRCULATION, V91, P2769, DOI 10.1161/01.CIR.91.11.2769; Saccardi R, 2004, Bone Marrow Transplant, V34, P877, DOI 10.1038/sj.bmt.1704656; Scott PA, 2011, CIRC-ARRHYTHMIA ELEC, V4, P324, DOI 10.1161/CIRCEP.110.959544; Snowden JA, 2012, BONE MARROW TRANSPL, V47, P770, DOI 10.1038/bmt.2011.185; van Laar JM, 2005, ANN RHEUM DIS, V64, P1515, DOI 10.1136/ard.2005.043240; Vonk MC, 2008, ANN RHEUM DIS, V67, P98, DOI 10.1136/ard.2007.071464	33	107	113	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 30	2013	381	9872					1116	1124		10.1016/S0140-6736(12)62114-X	http://dx.doi.org/10.1016/S0140-6736(12)62114-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WL	23363664				2022-12-28	WOS:000317348900030
J	Parks, JM; Johs, A; Podar, M; Bridou, R; Hurt, RA; Smith, SD; Tomanicek, SJ; Qian, Y; Brown, SD; Brandt, CC; Palumbo, AV; Smith, JC; Wall, JD; Elias, DA; Liang, LY				Parks, Jerry M.; Johs, Alexander; Podar, Mircea; Bridou, Romain; Hurt, Richard A., Jr.; Smith, Steven D.; Tomanicek, Stephen J.; Qian, Yun; Brown, Steven D.; Brandt, Craig C.; Palumbo, Anthony V.; Smith, Jeremy C.; Wall, Judy D.; Elias, Dwayne A.; Liang, Liyuan			The Genetic Basis for Bacterial Mercury Methylation	SCIENCE			English	Article							SP NOV.; PRINCIPAL METHYLATORS; REDUCING BACTERIA; ACETYL-COENZYME; GEN. NOV.; SULFATE; METHYLTETRAHYDROFOLATE; PATHWAYS; ELECTRON; ACETATE	Methylmercury is a potent neurotoxin produced in natural environments from inorganic mercury by anaerobic bacteria. However, until now the genes and proteins involved have remained unidentified. Here, we report a two-gene cluster, hgcA and hgcB, required for mercury methylation by Desulfovibrio desulfuricans ND132 and Geobacter sulfurreducens PCA. In either bacterium, deletion of hgcA, hgcB, or both genes abolishes mercury methylation. The genes encode a putative corrinoid protein, HgcA, and a 2[4Fe-4S] ferredoxin, HgcB, consistent with roles as a methyl carrier and an electron donor required for corrinoid cofactor reduction, respectively. Among bacteria and archaea with sequenced genomes, gene orthologs are present in confirmed methylators but absent in nonmethylators, suggesting a common mercury methylation pathway in all methylating bacteria and archaea sequenced to date.	[Parks, Jerry M.; Podar, Mircea; Hurt, Richard A., Jr.; Brown, Steven D.; Brandt, Craig C.; Palumbo, Anthony V.; Smith, Jeremy C.; Elias, Dwayne A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Johs, Alexander; Tomanicek, Stephen J.; Qian, Yun; Liang, Liyuan] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Podar, Mircea] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Bridou, Romain; Smith, Steven D.; Wall, Judy D.] Univ Missouri, Div Biochem, Columbia, MO 65211 USA; [Brown, Steven D.; Smith, Jeremy C.; Elias, Dwayne A.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Missouri System; University of Missouri Columbia; University of Tennessee System; University of Tennessee Knoxville	Elias, DA (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	eliasda@ornl.gov; liangl@ornl.gov	Liang, Liyuan/O-7213-2014; Johs, Alexander/F-1229-2011; smith, jeremy c/B-7287-2012; Palumbo, Anthony V/A-4764-2011; Elias, Dwayne/GZL-8202-2022; Bridou, Romain/S-2454-2016; Podar, Mircea/B-7299-2012; Elias, Dwayne A/B-5190-2011; Parks, Jerry M./B-7488-2009; Brown, Steven D/A-6792-2011	Liang, Liyuan/0000-0003-1338-0324; Johs, Alexander/0000-0003-0098-2254; smith, jeremy c/0000-0002-2978-3227; Palumbo, Anthony V/0000-0002-1102-3975; Podar, Mircea/0000-0003-2776-0205; Elias, Dwayne A/0000-0002-4469-6391; Parks, Jerry M./0000-0002-3103-9333; Brown, Steven D/0000-0002-9281-3898	U.S. Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research, through the Mercury Scientific Focus Area Program at Oak Ridge National Laboratory (ORNL); DOE [DE-AC05-00OR22725]	U.S. Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research, through the Mercury Scientific Focus Area Program at Oak Ridge National Laboratory (ORNL)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	We thank S. Miller, C. Gilmour, and T. Barkay for helpful discussions, and K. Rush, X. Yin, G. Christensen, and Q. Gui for experimental assistance. Supported by the U.S. Department of Energy (DOE), Office of Science, Office of Biological and Environmental Research, through the Mercury Scientific Focus Area Program at Oak Ridge National Laboratory (ORNL). ORNL is managed by UT Battelle, LLC, for DOE under contract DE-AC05-00OR22725. All other data are available online in the supplementary materials. Author contributions: J.M.P., A.J., R. B., J.C.S., A. V. P., D. A. E., S. D. B., M. P., J.D.W., and L. L. designed the research. M. P., S. D. B., and C. C. B. performed the comparative genomic analyses. A.J. and J.M.P. performed the bioinformatics and biochemical interpretations. R. B., R. A. H., S. D. S., S.J.T., A.J., and Y.Q. performed the experiments. J.M.P., A.J., R. B., J.C.S., D. A. E., J.D.W., and L.L. wrote the paper.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brown SD, 2011, J BACTERIOL, V193, P2078, DOI 10.1128/JB.00170-11; Cardiano P, 2011, J CHEM ENG DATA, V56, P4741, DOI 10.1021/je200735r; CHOI SC, 1994, APPL ENVIRON MICROB, V60, P1342, DOI 10.1128/AEM.60.4.1342-1346.1994; CHOI SC, 1994, APPL ENVIRON MICROB, V60, P4072, DOI 10.1128/AEM.60.11.4072-4077.1994; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; DESIMONE RE, 1973, BIOCHIM BIOPHYS ACTA, V304, P851, DOI 10.1016/0304-4165(73)90232-8; Doukov T, 2000, STRUCTURE, V8, P817, DOI 10.1016/S0969-2126(00)00172-6; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; DRAKE HL, 1981, J BIOL CHEM, V256, P1137; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Ekstrom EB, 2003, APPL ENVIRON MICROB, V69, P5414, DOI 10.1128/AEM.69.9.5414-5422.2003; Fleming EJ, 2006, APPL ENVIRON MICROB, V72, P457, DOI 10.1128/AEM.72.1.457-464.2006; GILMOUR CC, 1992, ENVIRON SCI TECHNOL, V26, P2281, DOI 10.1021/es00035a029; Gilmour CC, 2011, APPL ENVIRON MICROB, V77, P3938, DOI 10.1128/AEM.02993-10; Goetzl S, 2011, J MOL BIOL, V411, P96, DOI 10.1016/j.jmb.2011.05.025; Hamelin S, 2011, ENVIRON SCI TECHNOL, V45, P7693, DOI 10.1021/es2010072; HILL HAO, 1970, J CHEM SOC CHEM COMM, P341, DOI 10.1039/c29700000341; Hintelmann H, 2010, METAL IONS LIFE SCI, V7, P365, DOI 10.1039/BK9781847551771-00365; Kerin EJ, 2006, APPL ENVIRON MICROB, V72, P7919, DOI 10.1128/AEM.01602-06; Kung Y, 2012, NATURE, V484, P265, DOI 10.1038/nature10916; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; Ranchou-Peyruse M, 2009, GEOMICROBIOL J, V26, P1, DOI 10.1080/01490450802599227; Schaefer JK, 2011, P NATL ACAD SCI USA, V108, P8714, DOI 10.1073/pnas.1105781108; SCHRAUZE.GN, 1970, J AM CHEM SOC, V92, P3509, DOI 10.1021/ja00714a070; Slobodkina GB, 2012, INT J SYST EVOL MICR, V62, P2463, DOI 10.1099/ijs.0.038372-0; Svetlitchnaia T, 2006, P NATL ACAD SCI USA, V103, P14331, DOI 10.1073/pnas.0601420103; WOOD JM, 1968, NATURE, V220, P173, DOI 10.1038/220173a0; WOOD JM, 1974, SCIENCE, V183, P1049, DOI 10.1126/science.183.4129.1049; Yu RQ, 2012, ENVIRON SCI TECHNOL, V46, P2684, DOI 10.1021/es2033718; Zhang GS, 2008, APPL ENVIRON MICROB, V74, P6114, DOI 10.1128/AEM.01146-08	31	563	593	61	848	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2013	339	6125					1332	1335		10.1126/science.1230667	http://dx.doi.org/10.1126/science.1230667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GC	23393089				2022-12-28	WOS:000316053400041
J	Kidwell, CS; Jahan, R; Gornbein, J; Alger, JR; Nenov, V; Ajani, Z; Feng, L; Meyer, BC; Olson, S; Schwamm, LH; Yoo, AJ; Marshall, RS; Meyers, PM; Yavagal, DR; Wintermark, M; Guzy, J; Starkman, S; Saver, JL				Kidwell, Chelsea S.; Jahan, Reza; Gornbein, Jeffrey; Alger, Jeffry R.; Nenov, Val; Ajani, Zahra; Feng, Lei; Meyer, Brett C.; Olson, Scott; Schwamm, Lee H.; Yoo, Albert J.; Marshall, Randolph S.; Meyers, Philip M.; Yavagal, Dileep R.; Wintermark, Max; Guzy, Judy; Starkman, Sidney; Saver, Jeffrey L.		MR RESCUE Investigators	A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THROMBECTOMY; ALTEPLASE; REVASCULARIZATION; REPERFUSION; MANAGEMENT; DIFFUSION; PERFUSION; DEVICE; SAFETY; MRI	BACKGROUND Whether brain imaging can identify patients who are most likely to benefit from therapies for acute ischemic stroke and whether endovascular thrombectomy improves clinical outcomes in such patients remains unclear. METHODS In this study, we randomly assigned patients within 8 hours after the onset of large-vessel, anterior-circulation strokes to undergo mechanical embolectomy (Merci Retriever or Penumbra System) or receive standard care. All patients underwent pretreatment computed tomography or magnetic resonance imaging of the brain. Randomization was stratified according to whether the patient had a favorable penumbral pattern (substantial salvageable tissue and small infarct core) or a nonpenumbral pattern (large core or small or absent penumbra). We assessed outcomes using the 90-day modified Rankin scale, ranging from 0 (no symptoms) to 6 (dead). RESULTS Among 118 eligible patients, the mean age was 65.5 years, the mean time to enrollment was 5.5 hours, and 58% had a favorable penumbral pattern. Revascularization in the embolectomy group was achieved in 67% of the patients. Ninety-day mortality was 21%, and the rate of symptomatic intracranial hemorrhage was 4%; neither rate differed across groups. Among all patients, mean scores on the modified Rankin scale did not differ between embolectomy and standard care (3.9 vs. 3.9, P = 0.99). Embolectomy was not superior to standard care in patients with either a favorable penumbral pattern (mean score, 3.9 vs. 3.4; P = 0.23) or a nonpenumbral pattern (mean score, 4.0 vs. 4.4; P = 0.32). In the primary analysis of scores on the 90-day modified Rankin scale, there was no interaction between the pretreatment imaging pattern and treatment assignment (P = 0.14). CONCLUSIONS A favorable penumbral pattern on neuroimaging did not identify patients who would differentially benefit from endovascular therapy for acute ischemic stroke, nor was embolectomy shown to be superior to standard care. (Funded by the National Institute of Neurological Disorders and Stroke; MR RESCUE ClinicalTrials.gov number, NCT00389467.)	[Kidwell, Chelsea S.] Georgetown Univ, Dept Neurol, Washington, DC 20007 USA; [Kidwell, Chelsea S.] Georgetown Univ, Stroke Ctr, Washington, DC 20007 USA; [Jahan, Reza] Univ Calif Los Angeles, Dept Radiol & Neurosurg, Los Angeles, CA USA; [Gornbein, Jeffrey] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA; [Alger, Jeffry R.; Saver, Jeffrey L.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Nenov, Val] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Guzy, Judy; Starkman, Sidney] Univ Calif Los Angeles, Dept Emergency Med & Neurol, Los Angeles, CA USA; [Jahan, Reza; Alger, Jeffry R.; Guzy, Judy; Starkman, Sidney; Saver, Jeffrey L.] Univ Calif Los Angeles, Stroke Ctr, Los Angeles, CA USA; [Ajani, Zahra] Kaiser Permanente, Dept Neurol, Los Angeles, CA USA; [Feng, Lei] Kaiser Permanente, Dept Radiol, Los Angeles, CA USA; [Meyer, Brett C.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Olson, Scott] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Meyer, Brett C.] Univ Calif San Diego, Stroke Ctr, San Diego, CA 92103 USA; [Olson, Scott] Scripps Clin, Div Neurosurg, La Jolla, CA 92037 USA; [Schwamm, Lee H.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Yoo, Albert J.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; [Marshall, Randolph S.] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Meyers, Philip M.] Columbia Univ Coll Phys & Surg, Dept Neurol Surg & Radiol, New York, NY 10032 USA; [Yavagal, Dileep R.] Univ Miami, Jackson Mem Hosp, Dept Neurol, Miami, FL 33136 USA; [Yavagal, Dileep R.] Univ Miami, Jackson Mem Hosp, Dept Neurosurg, Miami, FL 33136 USA; [Wintermark, Max] Univ Virginia, Dept Radiol, Neuroradiol Div, Charlottesville, VA USA	Georgetown University; Georgetown University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Kaiser Permanente; Kaiser Permanente; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Columbia University; Columbia University; University of Miami; University of Miami; University of Virginia	Kidwell, CS (corresponding author), Georgetown Univ, Bldg D,Suite 150,4000 Reservoir Rd NW, Washington, DC 20007 USA.	ck256@georgetown.edu	Demchuk, Andrew M/E-1103-2012; Meyers, Philip M./N-9776-2019; Buck, Brian H/B-8482-2009; McCullough-Hicks, Margy/AAG-6566-2019	Demchuk, Andrew M/0000-0002-4930-7789; Meyers, Philip M./0000-0002-3250-5543; Buck, Brian H/0000-0002-7984-6062; Barest, Glenn/0000-0002-5402-5372; Gonzalez, Nestor/0000-0002-8277-6317; Schwamm, Lee/0000-0003-0592-9145; Kummer, Terrance/0000-0001-8938-8280; Wintermark, Max/0000-0002-6726-3951; McCullough-Hicks, Margy/0000-0003-3770-8689; Hayakawa, Minako/0000-0002-9498-4711; Saver, Jeffrey/0000-0001-9141-2251; Hsia, Amie/0000-0002-0214-9736; Molyneaux, Bradley/0000-0002-3377-1229; Ajani, Zahra/0000-0001-6187-5204; Jumaa, Mouhammad/0000-0002-7165-797X; Mir, Osman/0000-0002-0226-3299	National Institute of Neurological Disorders and Stroke; NINDS [P50 NS044378]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS072272, P50NS044378] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institute of Neurological Disorders and Stroke; MR RESCUE ClinicalTrials.gov number, NCT00389467.); Supported by a grant (P50 NS044378) from NINDS. Concentric Medical provided study catheters and devices from the initiation of the study until August 2007; thereafter, costs for all study catheters and devices were covered by study funds or third-party payers.	Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Barber PA, 1998, NEUROLOGY, V51, P418, DOI 10.1212/WNL.51.2.418; Bateman BT, 2003, STROKE, V34, P1317, DOI 10.1161/01.STR.0000065230.00053.B4; Costalat V, 2011, STROKE, V42, P1929, DOI 10.1161/STROKEAHA.110.608976; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Fisher M, 1997, STROKE, V28, P866, DOI 10.1161/01.STR.28.4.866; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Kidwell CS, 2013, STROKE, V44, P73, DOI 10.1161/STROKEAHA.112.670034; Kidwell CS, 2012, STROKE; Kidwell CS, 2012, INT J STROKE; Langer D, 2009, STROKE, V40, P2761, DOI 10.1161/STROKEAHA.108.544957; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Lansberg MG, 2012, STROKE, V43, pA73; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Parsons M, 2012, NEW ENGL J MED, V366, P1099, DOI 10.1056/NEJMoa1109842; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Tomsick T, 2008, AM J NEURORADIOL, V29, P582, DOI 10.3174/ajnr.A0843	22	969	1011	6	120	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2013	368	10					914	923		10.1056/NEJMoa1212793	http://dx.doi.org/10.1056/NEJMoa1212793			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100BG	23394476	Green Accepted			2022-12-28	WOS:000315669100007
J	Rosenzweig, R; Moradi, S; Zarrine-Afsar, A; Glover, JR; Kay, LE				Rosenzweig, Rina; Moradi, Shoeib; Zarrine-Afsar, Arash; Glover, John R.; Kay, Lewis E.			Unraveling the Mechanism of Protein Disaggregation Through a ClpB-DnaK Interaction	SCIENCE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; MOLECULAR CHAPERONE; THERMUS-THERMOPHILUS; AGGREGATED PROTEINS; FACTOR GRPE; M-DOMAINS; HSP70; ATPASE; THERMOTOLERANCE; SOLUBILIZATION	HSP-100 protein machines, such as ClpB, play an essential role in reactivating protein aggregates that can otherwise be lethal to cells. Although the players involved are known, including the DnaK/DnaJ/GrpE chaperone system in bacteria, details of the molecular interactions are not well understood. Using methyl-transverse relaxation-optimized nuclear magnetic resonance spectroscopy, we present an atomic-resolution model for the ClpB-DnaK complex, which we verified by mutagenesis and functional assays. ClpB and GrpE compete for binding to the DnaK nucleotide binding domain, with GrpE binding inhibiting disaggregation. DnaK, in turn, plays a dual role in both disaggregation and subsequent refolding of polypeptide chains as they emerge from the aggregate. On the basis of a combined structural-biochemical analysis, we propose a model for the mechanism of protein aggregate reactivation by ClpB.	[Rosenzweig, Rina; Moradi, Shoeib; Glover, John R.; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rosenzweig, Rina; Zarrine-Afsar, Arash; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Rosenzweig, Rina; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Kay, Lewis E.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Rosenzweig, R (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	rina.rosenzweig@utoronto.ca; kay@pound.med.utoronto.ca		Rosenzweig, Rina/0000-0002-4019-5135; Moradi, Shoeib/0000-0003-2808-4579	European Molecular Biology Organization [ALTF-570-2010]; Government of Canada (Banting); Canadian Institutes of Health Research	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Government of Canada (Banting); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank J. Forman-Kay for providing laboratory space and for valuable discussions, R. Muhandiram for NMR support, and M. Latham for helpful discussions. wt-ClpB and GroEL/ES constructs were generously provided by F. Tsai (Baylor College of Medicine, Texas) and A. Horwich (Yale School of Medicine, Connecticut). R. R. acknowledges the European Molecular Biology Organization (ALTF-570-2010) and the Government of Canada (Banting) for postdoctoral fellowships. L. E. K. holds a Canada Research Chair in Biochemistry. This work was supported by a grant from the Canadian Institutes of Health Research. Coordinates for the ClpB-DnaK complex are available as supplementary material.	Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Grimshaw JPA, 2001, J BIOL CHEM, V276, P6098, DOI 10.1074/jbc.M009290200; Groemping Y, 2001, J MOL BIOL, V305, P1173, DOI 10.1006/jmbi.2000.4373; Groemping Y, 2001, J MOL BIOL, V314, P167, DOI 10.1006/jmbi.2001.5116; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schlieker C, 2004, FEBS LETT, V578, P351, DOI 10.1016/j.febslet.2004.11.051; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Tugarinov V, 2004, J BIOMOL NMR, V28, P165, DOI 10.1023/B:JNMR.0000013824.93994.1f; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	30	187	188	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1080	1083		10.1126/science.1233066	http://dx.doi.org/10.1126/science.1233066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23393091				2022-12-28	WOS:000315452000043
J	Oka, Y; Butnaru, M; von Buchholtz, L; Ryba, NJP; Zuker, CS				Oka, Yuki; Butnaru, Matthew; von Buchholtz, Lars; Ryba, Nicholas J. P.; Zuker, Charles S.			High salt recruits aversive taste pathways	NATURE			English	Article							CARBONIC-ANHYDRASE; IN-VIVO; AMILORIDE; CELLS; RECEPTORS; BITTER; DISCRIMINATION; TRANSDUCTION; SPECIFICITY; SUPPRESSION	In the tongue, distinct classes of taste receptor cells detect the five basic tastes; sweet, sour, bitter, sodium salt and umami(1,2). Among these qualities, bitter and sour stimuli are innately aversive, whereas sweet and umami are appetitive and generally attractive to animals. By contrast, salty taste is unique in that increasing salt concentration fundamentally transforms an innately appetitive stimulus into a powerfully aversive one(3-7). This appetitive-aversive balance helps to maintain appropriate salt consumption(3,4,6,8), and represents an important part of fluid and electrolyte homeostasis. We have shown previously that the appetitive responses to NaCl are mediated by taste receptor cells expressing the epithelial sodium channel, ENaCs8, but the cellular substrate for salt aversion was unknown. Here we examine the cellular and molecular basis for the rejection of high concentrations of salts. We show that high salt recruits the two primary aversive taste pathways by activating the sour- and bitter-taste-sensing cells. We also demonstrate that genetic silencing of these pathways abolishes behavioural aversion to concentrated salt, without impairing salt attraction. Notably, mice devoid of salt-aversion pathways show unimpeded, continuous attraction even to very high concentrations of NaCl. We propose that the 'co-opting' of sour and bitter neural pathways evolved as a means to ensure that high levels of salt reliably trigger robust behavioural rejection, thus preventing its potentially detrimental effects on health.	[Oka, Yuki; Butnaru, Matthew; Zuker, Charles S.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Oka, Yuki; Butnaru, Matthew; Zuker, Charles S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Oka, Yuki; Butnaru, Matthew; Zuker, Charles S.] Columbia Univ, Dept Neurosci, Columbia Coll Phys & Surg, New York, NY 10032 USA; [von Buchholtz, Lars; Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.	nick.ryba@nih.gov; cz2195@columbia.edu		Oka, Yuki/0000-0003-2686-0677; Ryba, Nicholas/0000-0002-2060-8393	Japan Society for Promotion of Science; National Institutes of Health and National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health and National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank E. Vitalis and N. Propp for the generation and maintenance of mouse lines, and K. Mueller for the construction of T2R-Sapphire lines. We also thank J. Chandrashekar, W. Sly and A. Waheed for advice and discussions, and K. Scott and members of our laboratories for comments. Y.O. was supported by the Japan Society for Promotion of Science. This research was supported in part by the intramural research program of the National Institutes of Health and National Institute of Dental and Craniofacial Research (to N.J.P.R.). C.S.Z. is an investigator of the Howard Hughes Medical Institute.	Baird TT, 1997, BIOCHEMISTRY-US, V36, P2669, DOI 10.1021/bi962663s; BEAUCHAMP GK, 1990, AM J CLIN NUTR, V51, P881, DOI 10.1093/ajcn/51.5.881; Breslin PAS, 1995, CHEM SENSES, V20, P609, DOI 10.1093/chemse/20.6.609; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Contreras RJ, 1989, NEURAL MECHANISMS TA, P119; Doolin RE, 1996, J GEN PHYSIOL, V107, P545, DOI 10.1085/jgp.107.4.545; DUNCAN C. J., 1962, PHYSIOL ZOOL, V35, P120; Eylam S, 2005, AM J PHYSIOL-REG I, V288, pR1361, DOI 10.1152/ajpregu.00796.2004; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P661, DOI 10.1016/S0006-2952(00)00357-9; Hallock RM, 2009, CHEM SENSES, V34, P799, DOI 10.1093/chemse/bjp069; Halpern BP, 1998, NEUROSCI BIOBEHAV R, V23, P5, DOI 10.1016/S0149-7634(97)00063-8; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hellekant G, 1997, PHYSIOL BEHAV, V61, P829, DOI 10.1016/S0031-9384(96)00562-8; HETTINGER TP, 1990, BRAIN RES, V513, P24, DOI 10.1016/0006-8993(90)91085-U; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Ohkuri T, 2012, CHEM SENSES, V37, P523, DOI 10.1093/chemse/bjs004; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Spector AC, 1996, J NEUROSCI, V16, P8115; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ugawa S, 2005, CHEM SENSES, V30, pI195, DOI 10.1093/chemse/bjh181; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; ZHU XL, 1990, J BIOL CHEM, V265, P8795	30	214	226	3	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					472	475		10.1038/nature11905	http://dx.doi.org/10.1038/nature11905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23407495	Green Accepted			2022-12-28	WOS:000315661500037
J	Kastrati, A; Neumann, FJ				Kastrati, Adnan; Neumann, Franz-Josef			SORT OUT V: a new episode in the DES wars	LANCET			English	Editorial Material							SIROLIMUS-ELUTING STENTS; BIODEGRADABLE POLYMER; CORONARY STENT; RANDOMIZED-TRIALS; PERMANENT POLYMER; CLINICAL-PRACTICE; THROMBOSIS		[Kastrati, Adnan] Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany; [Kastrati, Adnan] Tech Univ Munich, Klinikum Rechts Isar, D-80636 Munich, Germany; [Neumann, Franz-Josef] Univ Herzzentrum Freiburg Bad Krozingen, Klin Kardiol & Angiol 2, Bad Krozingen, Germany	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Universitats Herzzentrum Freiburg; University of Freiburg	Kastrati, A (corresponding author), Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany.	kastrati@dhm.mhn.de	, Kastrati/Y-2389-2019					Byrne RA, 2009, JACC-CARDIOVASC INTE, V2, P291, DOI 10.1016/j.jcin.2008.11.015; Chevalier Bernard, 2007, EuroIntervention, V2, P426; Chevalier B, 2009, CIRC-CARDIOVASC INTE, V2, P188, DOI 10.1161/CIRCINTERVENTIONS.108.823443; Christiansen EH, 2013, LANCET; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Danzi GB, 2012, EUROINTERVENTION, V8, P109, DOI 10.4244/EIJV8I1A17; de Waha A, 2012, CLIN RES CARDIOL, V101, P461, DOI 10.1007/s00392-012-0414-8; Galloe AM, 2008, JAMA-J AM MED ASSOC, V299, P409, DOI 10.1001/jama.299.4.409; Kadota K, 2012, CATHETER CARDIO INTE, V80, P789, DOI 10.1002/ccd.23280; Koppara T, 2012, THROMB HAEMOSTASIS, V107, P1161, DOI 10.1160/TH12-01-0043; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Pendyala LK, 2012, JACC-CARDIOVASC INTE, V5, P436, DOI 10.1016/j.jcin.2011.11.013; Smits PC, 2013, LANCET; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3	15	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 23	2013	381	9867					609	611		10.1016/S0140-6736(13)60055-0	http://dx.doi.org/10.1016/S0140-6736(13)60055-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	093JY	23374648				2022-12-28	WOS:000315189300008
J	Song, RS; Peng, W; Zhang, Y; Lv, FX; Wu, HK; Guo, JJ; Cao, YX; Pi, YB; Zhang, X; Jin, L; Zhang, M; Jiang, P; Liu, FH; Meng, SS; Zhang, XQ; Jiang, P; Cao, CM; Xiao, RP				Song, Ruisheng; Peng, Wei; Zhang, Yan; Lv, Fengxiang; Wu, Hong-Kun; Guo, Jiaojiao; Cao, Yongxing; Pi, Yanbin; Zhang, Xin; Jin, Li; Zhang, Mao; Jiang, Peng; Liu, Fenghua; Meng, Shaoshuai; Zhang, Xiuqin; Jiang, Ping; Cao, Chun-Mei; Xiao, Rui-Ping			Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders	NATURE			English	Article							SKELETAL-MUSCLE; NEGATIVE REGULATOR; RECEPTOR; GLUCOSE; OBESE; DEGRADATION; IRS1; CBL	Insulin resistance is a fundamental pathogenic factor present in various metabolic disorders including obesity and type 2 diabetes(1). Although skeletal muscle accounts for 70-90% of insulin-stimulated glucose disposal(2,3), the mechanism underlying muscle insulin resistance is poorly understood. Here we show in mice that muscle-specific mitsugumin 53 (MG53; also called TRIM72) mediates the degradation of the insulin receptor and insulin receptor substrate 1 (IRS1); and when upregulated, causes metabolic syndrome featuring insulin resistance, obesity, hypertension and dyslipidaemia. MG53 expression is markedly elevated in models of insulin resistance, and MG53 overexpression suffices to trigger muscle insulin resistance and metabolic syndrome sequentially. Conversely, ablation of MG53 prevents diet-induced metabolic syndrome by preserving the insulin receptor, IRS1 and insulin signalling integrity. Mechanistically, MG53 acts as an E3 ligase targeting the insulin receptor and IRS1 for ubiquitin-dependent degradation, comprising a central mechanism controlling insulin signal strength in skeletal muscle. These findings define MG53 as a novel therapeutic target for treating metabolic disorders and associated cardiovascular complications.	[Song, Ruisheng; Peng, Wei; Zhang, Yan; Lv, Fengxiang; Wu, Hong-Kun; Guo, Jiaojiao; Jin, Li; Zhang, Mao; Jiang, Peng; Liu, Fenghua; Meng, Shaoshuai; Zhang, Xiuqin; Jiang, Ping; Cao, Chun-Mei; Xiao, Rui-Ping] Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Song, Ruisheng] Peking Univ, Hlth Sci Ctr, Inst Cardiovasc Sci, Beijing 100083, Peoples R China; [Cao, Yongxing; Pi, Yanbin; Zhang, Xin] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100191, Peoples R China; [Xiao, Rui-Ping] Peking Univ, Ctr Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Xiao, RP (corresponding author), Peking Univ, Inst Mol Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China.	caochunmei@pku.edu.cn; xiaor@pku.edu.cn	Xiao, Rui-Ping/AAE-2629-2019; SONG, RUISHENG/W-4784-2019; Yimei, Wang/AAE-4083-2019	SONG, RUISHENG/0000-0002-6856-4721; Zhang, Mao/0000-0002-5283-6497; Wu, Hong-Kun/0000-0002-9459-6583; Meng, Shao-Shuai/0000-0002-1926-8483; Zhang, Xiuqin/0000-0001-8692-7146	National Basic Research Program of China [2012CB518000, 2013CB531200, 2012CB944501]; National Natural Science Foundation of China [81070674, 81070116, 3/22/002, 81130073]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank H. P. Cheng, G. Feng, X. Fu and L. P. Wei for discussions, and S. L. Guo, T. Zhang, X. H. Wang, D. Y. Chen, J. Y. Peng, L Huang, W. Q. Zhang, N. Hou, L. Pan, L. Chen and Y. L. Liu for their technical support. Special thanks to H. Takeshima and J. J. Ma for their support in providing MG53<SUP>-/-</SUP> mice. This work was supported by the National Basic Research Program of China (2012CB518000, 2013CB531200, 2012CB944501) and the National Natural Science Foundation of China (81070674, 81070116, 3/22/002 and 81130073).	Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC1317, DOI 10.1152/ajpcell.00489.2004; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Laustsen PG, 2007, MOL CELL BIOL, V27, P1649, DOI 10.1128/MCB.01110-06; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; OLEFSKY J, 1976, METABOLISM, V25, P179, DOI 10.1016/0026-0495(76)90048-2; Ramos FJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1262, DOI 10.1152/ajpendo.00609.2005; RAO RH, 1993, DIABETES, V42, P1364, DOI 10.2337/diabetes.42.9.1364; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shi J, 2011, DEV CELL, V21, P835, DOI 10.1016/j.devcel.2011.09.011; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Zhang XQ, 2011, CIRCULATION, V124, P77, DOI 10.1161/CIRCULATIONAHA.110.990333; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	29	184	196	1	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					375	379		10.1038/nature11834	http://dx.doi.org/10.1038/nature11834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23354051				2022-12-28	WOS:000315312900043
J	Zhao, YL; Temperton, B; Thrash, JC; Schwalbach, MS; Vergin, KL; Landry, ZC; Ellisman, M; Deerinck, T; Sullivan, MB; Giovannoni, SJ				Zhao, Yanlin; Temperton, Ben; Thrash, J. Cameron; Schwalbach, Michael S.; Vergin, Kevin L.; Landry, Zachary C.; Ellisman, Mark; Deerinck, Tom; Sullivan, Matthew B.; Giovannoni, Stephen J.			Abundant SAR11 viruses in the ocean	NATURE			English	Article							MARINE; POPULATION; DIVERSITY; DYNAMICS	Several reports proposed that the extraordinary dominance of the SAR11 bacterial clade in ocean ecosystems could be a consequence of unusual mechanisms of resistance to bacteriophage infection, including 'cryptic escape' through reduced cell size(1) and/or K-strategist defence specialism(2). Alternatively, the evolution of high surface-to-volume ratios coupled with minimal genomes containing high-affinity transporters enables unusually efficient metabolism for oxidizing dissolved organic matter in the world's oceans that could support vast population sizes despite phage susceptibility. These ideas are important for understanding plankton ecology because they emphasize the potentially important role of top-down mechanisms in predation, thus determining the size of SAR11 populations and their concomitant role in biogeochemical cycling. Here we report the isolation of diverse SAR11 viruses belonging to two virus families in culture, for which we propose the name 'pelagiphage', after their host. Notably; the pelagiphage genomes were highly represented in marine viral metagenomes, demonstrating their importance in nature. One of the new phages, HTVC010P, represents a new podovirus subfamily more abundant than any seen previously, in all data sets tested, and may represent one of the most abundant virus subfamilies in the biosphere. This discovery disproves the theory that SAR11 cells are immune to viral predation and is consistent with the interpretation that the success of this highly abundant microbial clade is the result of successfully evolved adaptation to resource competition.	[Zhao, Yanlin; Temperton, Ben; Thrash, J. Cameron; Vergin, Kevin L.; Landry, Zachary C.; Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Schwalbach, Michael S.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Ellisman, Mark; Deerinck, Tom] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, San Diego, CA 92093 USA; [Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	Oregon State University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego; University of Arizona	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	Temperton, Ben/AAE-2785-2021; Sullivan, Matthew B/H-3256-2011	Sullivan, Matthew B/0000-0003-4040-9831; Thrash, Cameron/0000-0003-0896-9986; VERGIN, KEVIN/0000-0002-8972-2813; Temperton, Ben/0000-0002-3667-8302	Gordon and Betty Moore Foundation Marine Microbiology Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation Marine Microbiology Initiative(Gordon and Betty Moore Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the Tucson Marine Phage Lab and B. Hurwitz for early access to the Pacific-Ocean virome datasets and J. Yan for her assistance in isolating HTVC011P. This work was supported by an investigator award to S.J.G. from the Gordon and Betty Moore Foundation Marine Microbiology Initiative.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Chow CET, 2012, ENVIRON MICROBIOL, V14, P2171, DOI 10.1111/j.1462-2920.2012.02744.x; Duhaime MB, 2012, ENVIRON MICROBIOL, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Fuhrman JA, 2003, BIOL BULL-US, V204, P192, DOI 10.2307/1543557; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Hurwitz B. L., 2013, PLOS ONE IN PRESS; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; Kunin V, 2008, GENOME RES, V18, P293, DOI 10.1101/gr.6835308; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Malmstrom RR, 2005, APPL ENVIRON MICROB, V71, P2979, DOI 10.1128/AEM.71.6.2979-2986.2005; Marston MF, 2012, P NATL ACAD SCI USA, V109, P4544, DOI 10.1073/pnas.1120310109; Parsons RJ, 2012, ISME J, V6, P273, DOI 10.1038/ismej.2011.101; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2009, ENVIRON MICROBIOL, V11, P2935, DOI 10.1111/j.1462-2920.2009.02081.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Suttle CA, 2010, MANUAL AQUATIC VIRAL, P92, DOI DOI 10.4319/MAVE.2010.978-0-9845591-0-7.92; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Vergin KL, 2007, ENVIRON MICROBIOL, V9, P2430, DOI 10.1111/j.1462-2920.2007.01361.x; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wang LR, 2011, P NATL ACAD SCI USA, V108, P2963, DOI 10.1073/pnas.1017261108; Wilhelm LJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-27; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530	30	224	227	8	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					357	360		10.1038/nature11921	http://dx.doi.org/10.1038/nature11921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23407494				2022-12-28	WOS:000315312900039
J	Jutzi, M; Asphaug, E; Gillet, P; Barrat, JA; Benz, W				Jutzi, M.; Asphaug, E.; Gillet, P.; Barrat, J. -A.; Benz, W.			The structure of the asteroid 4 Vesta as revealed by models of planet-scale collisions	NATURE			English	Article							PARENT BODY; SIMULATIONS; DAWN; GEOCHEMISTRY; DIOGENITES; HOWARDITE; CORE	Asteroid 4 Vesta seems to be a major intact protoplanet, with a surface composition similar to that of the HED (howardite-eucrite-diogenite) meteorites(1-4). The southern hemisphere is dominated by a giant impact scar(5), but previous impact models(6-8) have failed to reproduce the observed topography. The recent discovery that Vesta's southern hemisphere is dominated by two overlapping basins' provides an opportunity to model Vesta's topography more accurately. Here we report three-dimensional simulations of Vesta's global evolution under two overlapping planet-scale collisions. We closely reproduce its observed shape, and provide maps of impact excavation and ejecta deposition. Spiral patterns observed in the younger basin Rheasilvia(9), about one billion years old(10), are attributed to Coriolis forces during crater collapse. Surface materials exposed in the north come from a depth of about 20 kilometres, according to our models, whereas materials exposed inside the southern double-excavation come from depths of about 60-100 kilometres. If Vesta began as a layered, completely differentiated protoplanet, then our model predicts large areas of pure diogenites and olivine-rich rocks. These are not seen(11-13), possibly implying that the outer 100 kilometres or so of Vesta is composed mainly of a basaltic crust (eucrites) with ultramafic intrusions (diogenites).	[Jutzi, M.; Benz, W.] Univ Bern, Inst Phys, Ctr Space & Habitabil, CH-3012 Bern, Switzerland; [Asphaug, E.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Gillet, P.] Ecole Polytech Fed Lausanne, Inst Condensed Matter Phys, CH-1015 Lausanne, Switzerland; [Barrat, J. -A.] Univ Bretagne Occidentale, Inst Univ Europeen Mer, CNRS, UMR 6538, F-29280 Plouzane, France	University of Bern; Arizona State University; Arizona State University-Tempe; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Jutzi, M (corresponding author), Univ Bern, Inst Phys, Ctr Space & Habitabil, Sidlerstr 5, CH-3012 Bern, Switzerland.	martin.jutzi@space.unibe.ch	Asphaug, Erik/AAC-9455-2020; Barrat, Jean-Alix/C-8416-2017	Barrat, Jean-Alix/0000-0003-3158-3109; Jutzi, Martin/0000-0002-1800-2974	Ambizione programme of the Swiss National Science Foundation; NASA's Planetary Geology and Geophysics Program; Programme National de Planetologie de l'JNSU; Swiss National Science Foundation	Ambizione programme of the Swiss National Science Foundation; NASA's Planetary Geology and Geophysics Program(National Aeronautics & Space Administration (NASA)); Programme National de Planetologie de l'JNSU; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	M.J. acknowledges support from the Ambizione programme of the Swiss National Science Foundation. E.A. was supported by NASA's Planetary Geology and Geophysics Program. J.-A.B. acknowledges support from the Programme National de Planetologie de l'JNSU. W.B. acknowledges support from the Swiss National Science Foundation.	Asphaug E, 1997, METEORIT PLANET SCI, V32, P965, DOI 10.1111/j.1945-5100.1997.tb01584.x; Barrat JA, 2010, GEOCHIM COSMOCHIM AC, V74, P6218, DOI 10.1016/j.gca.2010.07.028; Beck P, 2011, ICARUS, V216, P560, DOI 10.1016/j.icarus.2011.09.015; Collins GS, 2004, METEORIT PLANET SCI, V39, P217, DOI 10.1111/j.1945-5100.2004.tb00337.x; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; HOUSEN KR, 1983, J GEOPHYS RES, V88, P2485, DOI 10.1029/JB088iB03p02485; Ivanov B. A., 2012, LUNAR PLANET SCI C, V43, P2148; Ivanov B. A., 2011, LUNAR PLANET SCI C, V42, P1717; Jaumann R, 2012, SCIENCE, V336, P687, DOI 10.1126/science.1219122; Jutzi M, 2008, ICARUS, V198, P242, DOI 10.1016/j.icarus.2008.06.013; Jutzi M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045517; Keil K., 2002, ASTEROIDS 3, P573; Marchi S, 2012, SCIENCE, V336, P690, DOI 10.1126/science.1218757; McCord TB, 2012, NATURE, V491, P83, DOI 10.1038/nature11561; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; McSween H. Y. J., 2012, 75 ANN MET SOC M; Melosh HJ, 1999, ANNU REV EARTH PL SC, V27, P385, DOI 10.1146/annurev.earth.27.1.385; Mittlefehldt DW, 2000, METEORIT PLANET SCI, V35, P901, DOI 10.1111/j.1945-5100.2000.tb01479.x; Prettyman TH, 2012, SCIENCE, V338, P242, DOI 10.1126/science.1225354; Preusker F., 2012, LUNAR PLANET SCI C, V43, P2012; Reddy V, 2012, SCIENCE, V336, P700, DOI 10.1126/science.1219088; Righter K, 1997, METEORIT PLANET SCI, V32, P929, DOI 10.1111/j.1945-5100.1997.tb01582.x; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Ruzicka A, 1997, METEORIT PLANET SCI, V32, P825, DOI 10.1111/j.1945-5100.1997.tb01573.x; Schenk P, 2012, SCIENCE, V336, P694, DOI 10.1126/science.1223272; TAKEDA H, 1979, ICARUS, V40, P455, DOI 10.1016/0019-1035(79)90039-3; Thomas PC, 1997, SCIENCE, V277, P1492, DOI 10.1126/science.277.5331.1492; Yamaguchi A, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003753	29	67	68	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					207	210		10.1038/nature11892	http://dx.doi.org/10.1038/nature11892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23407535				2022-12-28	WOS:000315137700033
J	Shoji-Kawata, S; Sumpter, R; Leveno, M; Campbell, GR; Zou, ZJ; Kinch, L; Wilkins, AD; Sun, QH; Pallauf, K; MacDuff, D; Huerta, C; Virgin, HW; Helms, JB; Eerland, R; Tooze, SA; Xavier, R; Lenschow, DJ; Yamamoto, A; King, D; Lichtarge, O; Grishin, NV; Spector, SA; Kaloyanova, DV; Levine, B				Shoji-Kawata, Sanae; Sumpter, Rhea, Jr.; Leveno, Matthew; Campbell, Grant R.; Zou, Zhongju; Kinch, Lisa; Wilkins, Angela D.; Sun, Qihua; Pallauf, Kathrin; MacDuff, Donna; Huerta, Carlos; Virgin, Herbert W.; Helms, J. Bernd; Eerland, Ruud; Tooze, Sharon A.; Xavier, Ramnik; Lenschow, Deborah J.; Yamamoto, Ai; King, David; Lichtarge, Olivier; Grishin, Nick V.; Spector, Stephen A.; Kaloyanova, Dora V.; Levine, Beth			Identification of a candidate therapeutic autophagy-inducing peptide	NATURE			English	Article							PROTEIN; DISEASE; PATHOGENESIS; MACROPHAGES; LOCALIZES; INFECTION; BECLIN-1; PATHWAY; COMPLEX; BINDING	The lysosomal degradation pathway of autophagy has a crucial role in defence against infection, neurodegenerative disorders, cancer and ageing. Accordingly, agents that induce autophagy may have broad therapeutic applications. One approach to developing such agents is to exploit autophagy manipulation strategies used by microbial virulence factors. Here we show that a peptide, Tat-beclin 1-derived from a region of the autophagy protein, beclin 1, which binds human immunodeficiency virus (HIV)-1 Nef-is a potent inducer of autophagy, and interacts with a newly identified negative regulator of autophagy, GAPR-1 (also called GLIPR2). Tat-beclin 1 decreases the accumulation of polyglutamine expansion protein aggregates and the replication of several pathogens (including HIV-1) in vitro, and reduces mortality in mice infected with chikungunya or West Nile virus. Thus, through the characterization of a domain of beclin 1 that interacts with HIV-1 Nef, we have developed an autophagy-inducing peptide that has potential efficacy in the treatment of human diseases.	[Shoji-Kawata, Sanae; Sumpter, Rhea, Jr.; Leveno, Matthew; Zou, Zhongju; Sun, Qihua; Pallauf, Kathrin; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Shoji-Kawata, Sanae; Sumpter, Rhea, Jr.; Leveno, Matthew; Zou, Zhongju; Sun, Qihua; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Campbell, Grant R.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Campbell, Grant R.; Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA 92123 USA; [Zou, Zhongju; Kinch, Lisa; Grishin, Nick V.; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Kinch, Lisa; Huerta, Carlos; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wilkins, Angela D.; Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [MacDuff, Donna; Virgin, Herbert W.; Lenschow, Deborah J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Helms, J. Bernd; Eerland, Ruud; Kaloyanova, Dora V.] Univ Utrecht, Dept Biochem & Cell Biol, NL-3508 TD Utrecht, Netherlands; [Helms, J. Bernd; Eerland, Ruud; Kaloyanova, Dora V.] Univ Utrecht, Inst Biomembranes, NL-3508 TD Utrecht, Netherlands; [Tooze, Sharon A.] Canc Res UK, London Res Inst, London EC1V 4AD, England; [Xavier, Ramnik] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Lenschow, Deborah J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Yamamoto, Ai] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [King, David] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Washington University (WUSTL); Utrecht University; Utrecht University; Cancer Research UK; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL); Columbia University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Texas System; University of Texas Southwestern Medical Center Dallas	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	Campbell, Grant/C-9018-2011; Sumpter, Jr., Rhea/N-8152-2018; Pallauf, Kathrin/Z-5966-2019; MacDuff, Donna/AAD-2786-2019	Campbell, Grant/0000-0003-3927-1994; Pallauf, Kathrin/0000-0002-7223-2738; MacDuff, Donna/0000-0002-6183-6827; Virgin, Herbert/0000-0001-8580-7628; Kinch, Lisa/0000-0003-3041-2615; Tooze, Sharon/0000-0002-2182-3116	NIH [U54AI057156, K08 AI099150, ROI NS077874, RO1 GM094575, ROI GM066099, ROI GM079656, ROI NS063973, ROI NS050199, U54AI057160, ROI DK083756, ROI DK086502, T32 GM008297]; NSF [CCF-0905536]; NWO-ALW Open Program [817.02.023]; Cancer Research UK; Welch Foundation [I-15-5]; Cancer Research UK [15153] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, U54AI057160, K08AI099150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086502, R01DK083756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079656, T32GM008297, R01GM094575, R01GM066099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063973, R01NS077874, R01NS050199, R01NS077111, R01NS084912] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NWO-ALW Open Program; Cancer Research UK(Cancer Research UK); Welch Foundation(The Welch Foundation); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Diamond, J. L Foster, M. Gale, N. Mizushima, D. Sabatini, M. Shiloh and T. Yoshimori for supplying critical reagent; and H. Ball, A. Bugde and E.-L Eskelinen for assistance with-peptide synthesis, infrared imaging and EM interpretation, respectively. This work was supported by NIH grants U54AI057156 (B.L), K08 AI099150 (R.S.), ROI NS077874 (S.A.S), RO1 GM094575 (N.V.G.), ROI GM066099 (O.L.), ROI GM079656 (O.L.), ROI NS063973 (A.Y.), ROI NS050199 (A.Y.), U54AI057160 (H.W.V., D.J.L.), ROI DK083756 (R.X), ROI DK086502 (R.X.), and T32 GM008297 (C.H.); NSF CCF-0905536 (O.L); an NWO-ALW Open Program Grant 817.02.023 (J.B.H.); Cancer Research UK (SAT.); and a Welch Foundation Award I-15-5 (N.V.G.).	BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Campbell GR, 2011, J BIOL CHEM, V286, P18890, DOI 10.1074/jbc.M110.206110; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Eberle HB, 2002, J CELL SCI, V115, P827; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Griffin DE, 2010, PROG NEUROBIOL, V91, P95, DOI 10.1016/j.pneurobio.2009.12.003; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24; Johnson RT, 1996, CLIN INFECT DIS, V23, P219, DOI 10.1093/clinids/23.2.219; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	27	539	569	3	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					201	206		10.1038/nature11866	http://dx.doi.org/10.1038/nature11866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23364696	Green Accepted			2022-12-28	WOS:000315137700032
J	Kayentao, K; Garner, P; van Eijk, AM; Naidoo, I; Roper, C; Mulokozi, A; MacArthur, JR; Luntamo, M; Ashorn, P; Doumbo, OK; ter Kuile, FO				Kayentao, Kassoum; Garner, Paul; van Eijk, Anne Maria; Naidoo, Inbarani; Roper, Cally; Mulokozi, Abdunoor; MacArthur, John R.; Luntamo, Mari; Ashorn, Per; Doumbo, Ogobara K.; ter Kuile, Feiko O.			Intermittent Preventive Therapy for Malaria During Pregnancy Using 2 vs 3 or More Doses of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in Africa Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLASMODIUM-FALCIPARUM MALARIA; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; DRUG-RESISTANCE; BURKINA-FASO; MOLECULAR MARKERS; ZAMBIAN WOMEN; EFFICACY; BURDEN; ANEMIA	Importance Intermittent preventive therapy with sulfadoxine-pyrimethamine to control malaria during pregnancy is used in 37 countries in sub-Saharan Africa, and 31 of those countries use the standard 2-dose regimen. However, 2 doses may not provide protection during the last 4 to 10 weeks of pregnancy, a pivotal period for fetal weight gain. Objective To perform a systematic review and meta-analysis of trials to determine whether regimens containing 3 or more doses of sulfadoxine-pyrimethamine for intermittent preventive therapy during pregnancy are associated with a higher birth weight or lower risk of low birth weight (LBW) (<2500 g) than standard 2-dose regimens. Data Sources and Study Selection ISI Web of Knowledge, EMBASE, SCOPUS, PubMed, LILACS, the Malaria in Pregnancy Library, Cochrane CENTRAL, and trial registries from their inception to December 2012, without language restriction. Eligible studies included randomized and quasi-randomized trials of intermittent preventive therapy during pregnancy with sulfadoxine-pyrimethamine monotherapy. Data Extraction Data were independently abstracted by 2 investigators. Relative risk (RR), mean differences, and 95% CIs were calculated with random-effects models. Results Of 241 screened studies, 7 trials of 6281 pregnancies were included. The median birth weight in the 2-dose group was 2870 g (range, 2722-3239 g) and on average 56 g higher (95% CI, 29-83 g; I-2=0%) in the >= 3-dose group. Three or more doses were associated with fewer LBW births (RR, 0.80; 95% CI, 0.69-0.94; I-2=0%), with a median LBW risk per 1000 women in the 2-dose group (assumed control group risk) of 167 per 1000 vs 134 per 1000 in the >= 3-dose group (absolute risk reduction, 33 per 1000 [95% CI, 10-52]; number needed to treat=31). The association was consistent across a wide range of sulfadoxine-pyrimethamine resistance (0% to 96% dihydropteroate-synthase K540E mutations). There was no evidence of small-study bias. The >= 3-dose group had less placental malaria (RR, 0.51; 95% CI, 0.38-0.68; I-2=0%, in 6 trials, 63 vs 32 per 1000; absolute risk reduction, 31 per 1000[95% CI, 20-39]). In primigravid plus secundigravid women, the risk of moderate to severe maternal anemia was lower in the >= 3-dose group (RR, 0.60; 95% CI, 0.36-0.99; I-2=20%; in 6 trials, 36 vs 22 per 1000; absolute risk reduction, 14 per 1000 [95% CI, 0.4-23]). There were no differences in rates of serious adverse events. Conclusions and Relevance Among pregnant women in sub-Saharan Africa, intermittent preventive therapy with 3 or more doses of sulfadoxine-pyrimethamine was associated with a higher birth weight and lower risk of LBW than the standard 2-dose regimens. These data provide support for the new WHO recommendations to provide at least 3 doses of intermittent preventive therapy during pregnancy at each scheduled antenatal care visit in the second and third trimester. JAMA. 2013;309(6):594-604 www.jama.com	[Kayentao, Kassoum; Garner, Paul; van Eijk, Anne Maria; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Kayentao, Kassoum; Doumbo, Ogobara K.] Univ Bamako, Fac Med Pharm & Dent, Dept Epidemiol Parasit Dis, Malaria Res & Training Ctr, Bamako, Mali; [Naidoo, Inbarani] MRC, Malaria Res Unit, Overport, South Africa; [Roper, Cally] London Sch Hyg & Trop Med, London WC1, England; [Mulokozi, Abdunoor] Ifakara Hlth Res & Dev Ctr, Dar Es Salaam, Tanzania; [MacArthur, John R.] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA; [Ashorn, Per] Univ Tampere, Sch Med, Dept Int Hlth, FIN-33101 Tampere, Finland	Liverpool School of Tropical Medicine; University of Liverpool; University of Bamako; University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; Centers for Disease Control & Prevention - USA; Tampere University	ter Kuile, FO (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	terkuile@liv.ac.uk	van Eijk, Anna Maria/AAQ-9894-2021; Kuile, Feiko ter/ABD-6681-2020; Garner, Paul/Y-8385-2019; Garner, Paul/HII-5856-2022; Roper, Cally/K-2989-2013	Kuile, Feiko ter/0000-0003-3663-5617; Garner, Paul/0000-0002-0607-6941; Ashorn, Per/0000-0003-2311-2593; Roper, Cally/0000-0002-6545-309X; Naidoo, Inbarani/0000-0001-7590-0618; van Eijk, Anna Maria/0000-0003-1635-1289; Kayentao, Kassoum/0000-0001-6877-0093	Centers for Disease Control and Prevention; Academy of Finland; Finnish Cultural Foundation; European and Developing Countries Clinical Trials Partnership, The Hague, the Netherlands; Malaria in Pregnancy Consortium; Bill & Melinda Gates Foundation; National Institute of Allergy and Infectious Diseases (NIH)	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); European and Developing Countries Clinical Trials Partnership, The Hague, the Netherlands; Malaria in Pregnancy Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institute of Allergy and Infectious Diseases (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This review was funded by a grant from the Centers for Disease Control and Prevention for salary support through a cooperative agreement between the Division of Parasitic Diseases and Malaria (Centers for Disease Control and Prevention, USA) and the Malaria Epidemiology Unit of the Child and Reproductive Health Group, Liverpool School of Tropical Medicine (LSTM), held by Dr ter Kuile. Dr Ashorn and Dr Luntamo were supported by grants from the Academy of Finland and the Finnish Cultural Foundation. Dr Kayentao was supported by a PhD training grant from the European and Developing Countries Clinical Trials Partnership, The Hague, the Netherlands. Drs ter Kuile and van Eijk are partly funded by the Malaria in Pregnancy Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the LSTM. Dr Doumbo reports receiving support from National Institute of Allergy and Infectious Diseases (NIH).	[Anonymous], 2004, MAL HIV INT THEIR IM; [Anonymous], 2008, COCHRANE HDB SYSTEMA; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; *COCHR COLL, 2008, COCHR HDB SYST REV I; Coulibaly SO, 2007, AM J TROP MED HYG, V77, P56, DOI 10.4269/ajtmh.2007.77.56; Deeks JJ, 2010, STAT ALGORITHMS REV, V5; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dokomajilar C, 2006, AM J TROP MED HYG, V75, P162, DOI 10.4269/ajtmh.2006.75.162; Dzinjalamala FK, 2005, ANTIMICROB AGENTS CH, V49, P3601, DOI 10.1128/AAC.49.9.3601-3606.2005; Filler SJ, 2006, J INFECT DIS, V194, P286, DOI 10.1086/505080; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Gesase S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004569; Gill CJ, 2007, J INFECT DIS, V196, P1577, DOI 10.1086/522137; Hamer DH, 2007, J INFECT DIS, V196, P1585, DOI 10.1086/522142; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Iriemenam NC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-134; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kabanywanyi AM, 2007, 56 ANN M AM SOC TROP; Kalilani L, 2011, 60 ANN M AM SOC TROP; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Leke RGF, 2011, CLIN INFECT DIS, V53, P231, DOI 10.1093/cid/cir383; Lin JT, 2012, TROP MED INT HLTH; Luntamo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041123; Luntamo M, 2010, AM J TROP MED HYG, V83, P1212, DOI 10.4269/ajtmh.2010.10-0264; Maiga OM, 2011, CLIN INFECT DIS, V53, P215, DOI 10.1093/cid/cir374; Mbaye A, 2006, TROP MED INT HEALTH, V11, P992, DOI 10.1111/j.1365-3156.2006.01649.x; Mbugi EV, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-94; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Naidoo I, 2011, PARASITOLOGY, V138, P1469, DOI 10.1017/S0031182011000746; Njagi JK, 2003, T ROY SOC TROP MED H, V97, P277, DOI 10.1016/S0035-9203(03)90141-6; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Pearce RJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000055; Peters PJ, 2007, DRUG SAFETY, V30, P481, DOI 10.2165/00002018-200730060-00003; Picot S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-89; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Valea I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-324; van Eijk AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-362; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; World Health Organization, 2004, AFRMAL0401 WHO REG O; World Health Organization, 2012, UPD WHO POL REC OCT; World Health Organization, 2006, REC US SULF PYR SP I	48	174	176	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					594	604		10.1001/jama.2012.216231	http://dx.doi.org/10.1001/jama.2012.216231			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087PH	23403684	Green Accepted			2022-12-28	WOS:000314773700032
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC How Cure the NHS became the true professionals at Mid Staffs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2013	346								f930	10.1136/bmj.f930	http://dx.doi.org/10.1136/bmj.f930			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZG	23403834				2022-12-28	WOS:000315087700011
J	Panagiotou, OA; Contopoulos-Ioannidis, DG; Ioannidis, JPA; Rehnborg, CF				Panagiotou, Orestis A.; Contopoulos-Ioannidis, Despina G.; Ioannidis, John P. A.; Rehnborg, C. F.			Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; CLINICAL-TRIALS; SYSTEMATIC REVIEWS; HIGH-RISK; METAANALYSES; WOMEN; BIAS; CORTICOSTEROIDS; PREECLAMPSIA; DISEASE	Objective To compare treatment effects from randomised trials conducted in more developed versus less developed countries. Design Meta-epidemiological study. Data sources Cochrane Database of Systematic Reviews (August 2012). Data extraction Meta-analyses with mortality outcomes including data from at least one randomised trial conducted in a less developed country and one in a more developed country. Relative risk estimates of more versus less developed countries were compared by calculating the relative relative risks for each topic and the summary relative relative risks across all topics. Similar analyses were performed for the primary binary outcome of each topic. Results 139 meta-analyses with mortality outcomes were eligible. No nominally significant differences between more developed and less developed countries were found for 128 (92%) meta-analyses. However, differences were beyond chance in 11 (8%) cases, always showing more favourable treatment effects in trials from less developed countries. The summary relative relative risk was 1.12 (95% confidence interval 1.06 to 1.18; P<0.001; I-2=0%), suggesting significantly more favourable mortality effects in trials from less developed countries. Results were similar for meta-analyses with nominally significant treatment effects for mortality (1.15), meta-analyses with recent trials (1.14), and when excluding trials from less developed countries that subsequently became more developed (1.12). For the primary binary outcomes (127 meta-analyses), 20 topics had differences in treatment effects beyond chance (more favourable in less developed countries in 15/20 cases). Conclusions Trials from less developed countries in a few cases show significantly more favourable treatment effects than trials in more developed countries and, on average, treatment effects are more favourable in less developed countries. These discrepancies may reflect biases in reporting or study design as well as genuine differences in baseline risk or treatment implementation and should be considers when generalising evidence across different settings.	[Panagiotou, Orestis A.] Univ Ioannina, Sch Med, Clin Trials & Evidence Based Med Unit, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Contopoulos-Ioannidis, Despina G.] Stanford Univ, Sch Med, Div Infect Dis, Dept Pediat, Stanford, CA 94305 USA; [Contopoulos-Ioannidis, Despina G.] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA; [Rehnborg, C. F.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	University of Ioannina; Stanford University; Palo Alto Medical Foundation Research Institute; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA.	jioannid@stanford.edu	Panagiotou, Orestis A/I-5934-2015; Panagiotou, Orestis/AAI-1268-2021; Ioannidis, John P. A./G-9836-2011	Panagiotou, Orestis A/0000-0001-9604-8380; 				Annane D., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002243.pub2, DOI 10.1002/14651858.CD002243.PUB2]; Aung PP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000123.pub2; Bajpai Vikas, 2009, Trop Gastroenterol, V30, P177; Bell J, 2003, BRIT MED J, V327, P1041, DOI 10.1136/bmj.327.7422.1041; Bjelakovic G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007176.pub2, 10.1590/1516-3180.20151332T1]; Bjelakovic Goran, 2008, Cochrane Database Syst Rev, pCD004183, DOI 10.1002/14651858.CD004183.pub3; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chavez-Tapia NC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002907.pub2; Clerihew L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003850.pub3; Contopoulos-Ioannidis DG, 2012, EUR J CLIN INVEST, V42, P233, DOI 10.1111/j.1365-2362.2011.02584.x; Crowther CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000110.pub2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; Dowswell Therese, 2010, Cochrane Database Syst Rev, pCD000934, DOI 10.1002/14651858.CD000934.pub2; Drabu S, 2010, CONTEMP CLIN TRIALS, V31, P419, DOI 10.1016/j.cct.2010.06.008; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Glenny AM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006387.pub2; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; International Clinical Trials Registry Platform (ICTRP), 2012, INT CLIN TRIALS REGI; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4875; Ioannidis JPA, 2004, BMJ-BRIT MED J, V329, P789; Ioannidis JPA, 1997, J CLIN EPIDEMIOL, V50, P1089, DOI 10.1016/S0895-4356(97)00149-2; Isaakidis P, 2002, BRIT MED J, V324, P702, DOI 10.1136/bmj.324.7339.702; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Lorenzo C, 2010, J MED ETHICS, V36, P111, DOI 10.1136/jme.2009.031708; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Magee L A, 2003, Cochrane Database Syst Rev, pCD002863; Malakoff D, 2008, SCIENCE, V322, P210, DOI 10.1126/science.322.5899.210; McGee RG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008716.pub2; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Murray C.J, 1996, GLOBAL BURDEN DIS CO; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Ohlsson A, 2004, Cochrane Database Syst Rev, pCD000361; Oliveri RS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004787.pub2; Pablos-Mendez A, 2002, B WORLD HEALTH ORGAN, V80, P489; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Patsopoulos Nikolaos A, 2009, Open Med, V3, pe62; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Pereira TV, 2011, J CLIN EPIDEMIOL, V64, P1060, DOI 10.1016/j.jclinepi.2010.12.012; Platonov P, 2003, INT J CLIN PHARM TH, V41, P277; Playford EG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004920.pub2; Rinkel G J, 2002, Cochrane Database Syst Rev, pCD000277; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rumbold A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004069.pub2; Rumbold A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004227.pub3; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Smith R, 2002, STAT MED, V21, P2869, DOI 10.1002/sim.1291; Soares-Weiser K, 2004, COCHRANE DB SYST REV; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stewart L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002142.pub2; Subtil D, 2003, BJOG-INT J OBSTET GY, V110, P475, DOI 10.1016/S1470-0328(03)02996-3; Swingler GH, 2005, B WORLD HEALTH ORGAN, V83, P511; Tang JL, 1999, BMJ-BRIT MED J, V319, P160, DOI 10.1136/bmj.319.7203.160; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; United Nations Statistics Division, 2012, COMP MACR CONT REG G; Varawalla N, 2007, IDRUGS, V10, P391; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; Walt G, 1998, LANCET, V351, P434, DOI 10.1016/S0140-6736(97)05546-3; Watson R, 2007, BRIT MED J, V334, P1076, DOI 10.1136/bmj.39220.615127.DB; Wikipedia, 2012, DEV COUNTR; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46; Zhang DL, 2011, J CLIN EPIDEMIOL, V64, P90, DOI 10.1016/j.jclinepi.2010.02.010	79	55	55	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2013	346								f707	10.1136/bmj.f707	http://dx.doi.org/10.1136/bmj.f707			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091ZG	23403829	hybrid, Green Published			2022-12-28	WOS:000315087700003
J	Balmford, A				Balmford, Andrew			Pollution, Politics, and Vultures	SCIENCE			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DICLOFENAC RESIDUES; GYPS VULTURES; THREAT; INDIA; DECLINE; POPULATION; PAKISTAN		Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England	University of Cambridge	Balmford, A (corresponding author), Dept Zool, Conservat Sci Grp, Downing St, Cambridge CB2 3EJ, England.	a.balmford@zoo.cam.ac.uk		Balmford, Andrew/0000-0002-0144-3589				Chaudhry MJI, 2012, BIRD CONSERV INT, V22, P389, DOI 10.1017/S0959270912000445; Cuthbert R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019069; Cuthbert RJ, 2011, ORYX, V45, P420, DOI 10.1017/S0030605311000135; Gilbert N, 2012, NATURE, V491, P503, DOI 10.1038/491503a; Green RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000686; Markandya A, 2008, ECOL ECON, V67, P194, DOI 10.1016/j.ecolecon.2008.04.020; Naidoo V, 2010, BIOL LETTERS, V6, P339, DOI 10.1098/rsbl.2009.0818; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Prakash V., 2007, J BOMBAY NAT HIST SO, V104, P129; Prakash V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049118; Sharma P, 2012, J RAPTOR RES, V46, P314, DOI 10.3356/JRR-11-66.1; Swan G, 2006, PLOS BIOL, V4, P395, DOI 10.1371/journal.pbio.0040066	12	15	17	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					653	654		10.1126/science.1234193	http://dx.doi.org/10.1126/science.1234193			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085BM	23393251				2022-12-28	WOS:000314585600026
J	Chessa, A; Morescalchi, A; Pammolli, F; Penner, O; Petersen, AM; Riccaboni, M				Chessa, A.; Morescalchi, A.; Pammolli, F.; Penner, O.; Petersen, A. M.; Riccaboni, M.			Is Europe Evolving Toward an Integrated Research Area?	SCIENCE			English	Editorial Material									[Chessa, A.; Morescalchi, A.; Pammolli, F.; Penner, O.; Petersen, A. M.; Riccaboni, M.] IMT Inst Markets Technol Inst Adv Studies Lucca, I-55100 Lucca, Italy	IMT School for Advanced Studies Lucca	Pammolli, F (corresponding author), IMT Inst Markets Technol Inst Adv Studies Lucca, I-55100 Lucca, Italy.	f.pammolli@imtlucca.it; m.riccaboni@imtlucca.it	Petersen, Alexander/D-9243-2012; Morescalchi, Andrea/AAW-9135-2020; Penner, Orion/E-5071-2012	Petersen, Alexander/0000-0002-0955-3483; Morescalchi, Andrea/0000-0001-6028-1404; Penner, Orion/0000-0003-3382-9491; RICCABONI, Massimo/0000-0003-4979-8933; Pammolli, Fabio/0000-0001-7056-1303				[Anonymous], 2012, MEMORANDUM UNDERSTAN; [Anonymous], IMP ASS; Breschi S, 2004, INT J TECHNOL MANAGE, V27, P747, DOI 10.1504/IJTM.2004.004992; Delanghe H, 2009, EUROPEAN SCIENCE AND TECHNOLOGY POLICY: TOWARD INTEGRATION OR FRAGMENTATION?, P1; Hoekman J, 2013, J ECON GEOGR, V13, P23, DOI 10.1093/jeg/lbs011; Maraut S, 2008, 20082 STI OECD; National Science Board, 2012, 1201 NSB; Nedeva M, 2012, SCIENCE, V336, P982, DOI 10.1126/science.1216878; Owen-Smith J, 2002, MANAGE SCI, V48, P24, DOI 10.1287/mnsc.48.1.24.14275; Richard Nelson R, 1993, NATL INNOVATION SYST; Scherngell T, 2013, PAP REG SCI, V92, P555, DOI 10.1111/j.1435-5957.2012.00419.x; Scherngell T, 2011, ANN REGIONAL SCI, V46, P247, DOI 10.1007/s00168-009-0334-3	12	55	55	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					650	651		10.1126/science.1227970	http://dx.doi.org/10.1126/science.1227970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085BM	23393249	Green Submitted, Green Accepted			2022-12-28	WOS:000314585600024
J	O'Leary, MA; Bloch, JI; Flynn, JJ; Gaudin, TJ; Giallombardo, A; Giannini, NP; Goldberg, SL; Kraatz, BP; Luo, ZX; Meng, J; Ni, XJ; Novacek, MJ; Perini, FA; Randall, ZS; Rougier, GW; Sargis, EJ; Silcox, MT; Simmons, NB; Spaulding, M; Velazco, PM; Weksler, M; Wible, JR; Cirranello, AL				O'Leary, Maureen A.; Bloch, Jonathan I.; Flynn, John J.; Gaudin, Timothy J.; Giallombardo, Andres; Giannini, Norberto P.; Goldberg, Suzann L.; Kraatz, Brian P.; Luo, Zhe-Xi; Meng, Jin; Ni, Xijun; Novacek, Michael J.; Perini, Fernando A.; Randall, Zachary S.; Rougier, Guillermo W.; Sargis, Eric J.; Silcox, Mary T.; Simmons, Nancy B.; Spaulding, Michelle; Velazco, Paul M.; Weksler, Marcelo; Wible, John R.; Cirranello, Andrea L.			The Placental Mammal Ancestor and the Post-K-Pg Radiation of Placentals	SCIENCE			English	Article							EVOLUTION; CLASSIFICATION; PHYLOGENETICS; EXTINCTION; ANTIQUITY; ORIGINS; PLANT; BATS; END	To discover interordinal relationships of living and fossil placental mammals and the time of origin of placentals relative to the Cretaceous-Paleogene (K-Pg) boundary, we scored 4541 phenomic characters de novo for 86 fossil and living species. Combining these data with molecular sequences, we obtained a phylogenetic tree that, when calibrated with fossils, shows that crown clade Placentalia and placental orders originated after the K-Pg boundary. Many nodes discovered using molecular data are upheld, but phenomic signals overturn molecular signals to show Sundatheria (Dermoptera + Scandentia) as the sister taxon of Primates, a close link between Proboscidea (elephants) and Sirenia (sea cows), and the monophyly of echolocating Chiroptera (bats). Our tree suggests that Placentalia first split into Xenarthra and Epitheria; extinct New World species are the oldest members of Afrotheria.	[O'Leary, Maureen A.; Cirranello, Andrea L.] SUNY Stony Brook, Sch Med, Dept Anat Sci, Stony Brook, NY 11794 USA; [Bloch, Jonathan I.; Randall, Zachary S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [O'Leary, Maureen A.; Flynn, John J.; Giallombardo, Andres; Goldberg, Suzann L.; Kraatz, Brian P.; Meng, Jin; Ni, Xijun; Novacek, Michael J.; Perini, Fernando A.; Spaulding, Michelle; Weksler, Marcelo; Cirranello, Andrea L.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Gaudin, Timothy J.] Univ Tennessee, Dept Biol & Environm Sci, Chattanooga, TN 37403 USA; [Giannini, Norberto P.; Simmons, Nancy B.; Velazco, Paul M.] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA; [Kraatz, Brian P.] Western Univ Hlth Sci, Dept Anat, Pomona, CA 91766 USA; [Luo, Zhe-Xi] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; [Rougier, Guillermo W.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Sargis, Eric J.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Silcox, Mary T.] Univ Toronto, Dept Anthropol, Scarborough, ON M1C 1A4, Canada; [Spaulding, Michelle; Wible, John R.] Carnegie Museum Nat Hist, Sect Mammals, Pittsburgh, PA 15206 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; University of Florida; American Museum of Natural History (AMNH); University of Tennessee System; University of Tennessee at Chattanooga; American Museum of Natural History (AMNH); Western University of Health Sciences; University of Louisville; Yale University; University of Toronto; University Toronto Scarborough	O'Leary, MA (corresponding author), SUNY Stony Brook, Sch Med, Dept Anat Sci, HSC T-8 040, Stony Brook, NY 11794 USA.	maureen.oleary@stonybrook.edu	Weksler, Marcelo/A-7420-2010; Luo, Zhe-XI/AAU-2263-2021; Perini, Fernando/I-1452-2012; Velazco, Paúl/P-7283-2019	Weksler, Marcelo/0000-0001-8111-4779; Perini, Fernando/0000-0002-4336-9284; Velazco, Paúl/0000-0001-7195-7422; Simmons, Nancy B./0000-0001-8807-7499; Bloch, Jonathan/0000-0003-1484-6931; Giannini, Norberto/0000-0002-8402-0126; Silcox, Mary/0000-0002-4174-9435	NSF [0743309, 0827993]; "Assembling the Tree of Life" program of the Divisions of Environmental Biology and Earth Sciences [0629959, 0629836, 0629811]; Division Of Environmental Biology [0946430] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); "Assembling the Tree of Life" program of the Divisions of Environmental Biology and Earth Sciences; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Asher, L. Jurgielewicz, M. Marotta, S. Parent, E. Seiffert, and E. Woodruff for data collection; K. Johnson for paleobotanical contributions; K. de Queiroz and A. Turner for discussion; and S. Kaufman, K. Alphonse, M. Passarotti, and D. Ferguson for software development. Artist C. Buell drew Fig. 2A and L. Betti-Nash all other figures. Research assistance came from P. Bowden, D. Malinzak, S. B. McLaren, N. Milbrodt, R. Morgan, and J. Morgan Scott. Data are archived in the supplementary materials and in Project 773 of the public repository MorphoBank.org. Supported by NSF grants 0743309 and 0827993, and by 0629959, 0629836, and 0629811 from the "Assembling the Tree of Life" program of the Divisions of Environmental Biology and Earth Sciences.	Agnolin FL, 2011, MAMM BIOL, V76, P101, DOI 10.1016/j.mambio.2010.12.001; [Anonymous], 1999, WALKERS MAMMALS WORL; Archibald J. David, 2001, Journal of Mammalian Evolution, V8, P107, DOI 10.1023/A:1011317930838; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Asher Robert J., 2003, Journal of Mammalian Evolution, V10, P131, DOI 10.1023/A:1025504124129; Berggren WA, 2005, J FORAMIN RES, V35, P279, DOI 10.2113/35.4.279; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; De Queiroz K, 2007, SYST BIOL, V56, P956, DOI 10.1080/10635150701656378; Eberle Jaelyn J., 2003, Rocky Mountain Geology, V38, P143, DOI 10.2113/gsrocky.38.1.143; Gaudin TJ, 2009, J MAMM EVOL, V16, P235, DOI 10.1007/s10914-009-9119-9; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Lofgren Donald L., 2004, P43; LUCKETT WP, 1993, MAMMAL PHYLOGENY, P182; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; Martin T, 2011, J VERTEBR PALEONTOL, V31, P153; McKenna M. C., 1975, PHYLOGENY PRIMATES, P21, DOI DOI 10.1007/978-1-4684-2166-8_2; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Miller-Butterworth CM, 2007, MOL BIOL EVOL, V24, P1553, DOI 10.1093/molbev/msm076; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Norell Mark A., 1992, P89; Novacek MJ, 1999, ANN MO BOT GARD, V86, P230, DOI 10.2307/2666178; NOVACEK MJ, 1986, B AM MUS NAT HIST, V183, P1; O'Leary MA, 2004, ASSEMBLING THE TREE OF LIFE, P490; O'Leary MA, 2011, CLADISTICS, V27, P529, DOI 10.1111/j.1096-0031.2011.00355.x; Owen Richard, 1868, ANATOMY VERTEBRATES, V3; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Rose KD, 2008, P ROY SOC B-BIOL SCI, V275, P1203, DOI 10.1098/rspb.2007.1661; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Sole F, 2009, ZOOL J LINN SOC-LOND, V156, P827, DOI 10.1111/j.1096-3642.2008.00501.x; Springer Mark S., 1997, Journal of Mammalian Evolution, V4, P285, DOI 10.1023/A:1027378615412; Springer MS, 2001, SCIENCE, V291, P1709, DOI 10.1126/science.1059434; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Wible JR, 2009, B AM MUS NAT HIST, P1, DOI 10.1206/623.1; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Wilf P, 2004, PALEOBIOLOGY, V30, P347, DOI 10.1666/0094-8373(2004)030<0347:LPEATE>2.0.CO;2; Wilf P, 2006, SCIENCE, V313, P1112, DOI 10.1126/science.1129569	42	763	791	4	457	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					662	667		10.1126/science.1229237	http://dx.doi.org/10.1126/science.1229237			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393258	Green Published			2022-12-28	WOS:000314585600033
J	Siosaki, MD; Souza, AT				Siosaki, Marcos Duarte; Souza, Ana Tarsila			Virchow's Node	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Siosaki, Marcos Duarte] Barretos Canc Hosp, Sao Paulo, Brazil; [Souza, Ana Tarsila] Bauru Radiotherapy Ctr, Sao Paulo, Brazil	Hospital de Cancer de Barretos	Siosaki, MD (corresponding author), Barretos Canc Hosp, Sao Paulo, Brazil.	marcossiosake@yahoo.com.br							0	8	8	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					E7	E7		10.1056/NEJMicm1204740	http://dx.doi.org/10.1056/NEJMicm1204740			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083VU	23388028				2022-12-28	WOS:000314494100008
J	Wood, H				Wood, Heather			Mid Staffs is evidence of all that is wrong with NHS management	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												heatherawood@btinternet.com						Hawkes N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f562; Hawkes N, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1396; Hawkes N, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d8034; Jarman B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8239	4	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 6	2013	346								f774	10.1136/bmj.f774	http://dx.doi.org/10.1136/bmj.f774			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AT	23390244				2022-12-28	WOS:000314806900011
J	Staudacher, T; Shi, F; Pezzagna, S; Meijer, J; Du, J; Meriles, CA; Reinhard, F; Wrachtrup, J				Staudacher, T.; Shi, F.; Pezzagna, S.; Meijer, J.; Du, J.; Meriles, C. A.; Reinhard, F.; Wrachtrup, J.			Nuclear Magnetic Resonance Spectroscopy on a (5-Nanometer)(3) Sample Volume	SCIENCE			English	Article							SPIN; MICROSCOPY; COHERENCE; DYNAMICS	Application of nuclear magnetic resonance (NMR) spectroscopy to nanoscale samples has remained an elusive goal, achieved only with great experimental effort at subkelvin temperatures. We demonstrated detection of NMR signals from a (5-nanometer)(3) voxel of various fluid and solid organic samples under ambient conditions. We used an atomic-size magnetic field sensor, a single nitrogen-vacancy defect center, embedded similar to 7 nanometers under the surface of a bulk diamond to record NMR spectra of various samples placed on the diamond surface. Its detection volume consisted of only 10(4) nuclear spins with a net magnetization of only 10(2) statistically polarized spins.	[Staudacher, T.; Reinhard, F.; Wrachtrup, J.] Univ Stuttgart, Inst Phys 3, D-70569 Stuttgart, Germany; [Staudacher, T.; Reinhard, F.; Wrachtrup, J.] Univ Stuttgart, Res Ctr SCoPE, D-70569 Stuttgart, Germany; [Staudacher, T.] Max Planck Inst Solid State Res, D-70174 Stuttgart, Germany; [Shi, F.; Du, J.] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Shi, F.; Du, J.] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Pezzagna, S.; Meijer, J.] Ruhr Univ Bochum, RUBION, D-44801 Bochum, Germany; [Meriles, C. A.] CUNY City Coll, Dept Phys, New York, NY 10031 USA	University of Stuttgart; University of Stuttgart; Max Planck Society; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Ruhr University Bochum; City University of New York (CUNY) System; City College of New York (CUNY)	Reinhard, F (corresponding author), Univ Stuttgart, Inst Phys 3, D-70569 Stuttgart, Germany.	f.reinhard@physik.uni-stuttgart.de		Reinhard, Friedemann/0000-0001-6273-7399	European Union (SQUTEC); European Union (DIAMANT); Max Planck Society; Deutsche Forschungsgemeinschaft [SFB/TR21, 1493, 1482, SPP1601]; Defense Advanced Research Projects Agency (QUASAR program); Volkswagen Foundation; Baden-Wurttemberg foundation ("Methoden fur die Lebenswissenschaften"); 973 Program [2013CB921800]; NNSFC [11227901, 91021005, 10834005]; Chinese Academy of Sciences; IMPRS-AM; Humboldt Foundation; NSF [NSF-1111410]	European Union (SQUTEC); European Union (DIAMANT); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Defense Advanced Research Projects Agency (QUASAR program)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Volkswagen Foundation(Volkswagen); Baden-Wurttemberg foundation ("Methoden fur die Lebenswissenschaften"); 973 Program(National Basic Research Program of China); NNSFC(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); IMPRS-AM; Humboldt Foundation(Alexander von Humboldt Foundation); NSF(National Science Foundation (NSF))	We thank L. Haussler, D. Antonov, A. Denisenko, and A. Aird for sharing cTRIM and molecular dynamics simulation data and G. Majer and T. Brauninger for bulk NMR measurements, as well as H. J. Mamin, D. Rugar, and P.-G. Reinhard for helpful discussions. This work was supported by the European Union (SQUTEC, DIAMANT), the Max Planck Society, Deutsche Forschungsgemeinschaft (SFB/TR21, Research groups 1493 and 1482, SPP1601), Defense Advanced Research Projects Agency (QUASAR program), Volkswagen Foundation, contract research of the Baden-Wurttemberg foundation ("Methoden fur die Lebenswissenschaften"), the 973 Program (2013CB921800), NNSFC (11227901, 91021005, 10834005), and Chinese Academy of Sciences. T. S. acknowledges financial support from the IMPRS-AM and C.A.M. from the Humboldt Foundation and the NSF (NSF-1111410).	Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Bar-Gill N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1856; Blank A, 2006, ISR J CHEM, V46, P423, DOI 10.1560/IJC_46_4_423; BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; Ciobanu L, 2002, J MAGN RESON, V158, P178, DOI 10.1016/S1090-7807(02)00071-X; Cywinski L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.174509; de Lange G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.080802; Degen CL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250601; Degen CL, 2009, P NATL ACAD SCI USA, V106, P1313, DOI 10.1073/pnas.0812068106; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Hall LT, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.220802; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Kolkowitz S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.137601; Kotler S, 2011, NATURE, V473, P61, DOI 10.1038/nature10010; Laraoui A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3497004; Ledbetter MP, 2008, P NATL ACAD SCI USA, V105, P2286, DOI 10.1073/pnas.0711505105; Maletinsky P, 2012, NAT NANOTECHNOL, V7, P320, DOI [10.1038/nnano.2012.50, 10.1038/NNANO.2012.50]; Meijer J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2103389; Meriles CA, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3483676; PURCELL EM, 1946, PHYS REV, V69, P37, DOI 10.1103/PhysRev.69.37; Reinhard F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.200402; Reynhardt EC, 1998, J CHEM PHYS, V109, P8471, DOI 10.1063/1.477511; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; SINNOTT KM, 1960, J POLYM SCI, V42, P3, DOI 10.1002/pol.1960.1204213902; Taminiau TH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.137602; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Zhao N, 2012, NAT NANOTECHNOL, V7, P657, DOI [10.1038/nnano.2012.152, 10.1038/NNANO.2012.152]	30	520	538	12	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					561	563		10.1126/science.1231675	http://dx.doi.org/10.1126/science.1231675			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23372009				2022-12-28	WOS:000314270000054
J	Cannon, B				Cannon, Bill			BIOCHEMISTRY TO BEHAVIOUR	NATURE			English	Editorial Material																			0	51	54	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2013	493	7434					S2	S3		10.1038/493S2a	http://dx.doi.org/10.1038/493S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080CU	23364768	Bronze			2022-12-28	WOS:000314219600004
J	Giacomini, HC; Shuter, BJ; de Kerckhove, DT; Abrams, PA				Giacomini, Henrique C.; Shuter, Brian J.; de Kerckhove, Derrick T.; Abrams, Peter A.			Does consumption rate scale superlinearly?	NATURE			English	Letter							METABOLIC-RATE; 3/4-POWER LAW; BODY-SIZE; EVOLUTION		[Giacomini, Henrique C.; Shuter, Brian J.; de Kerckhove, Derrick T.; Abrams, Peter A.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3G5, Canada; [Shuter, Brian J.] Ontario Minist Nat Resources, Harkness Lab Fisheries Res, Peterborough, ON K9J 7B8, Canada	University of Toronto; Ministry of Natural Resources & Forestry	Giacomini, HC (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, 25 Harbord St, Toronto, ON M5S 3G5, Canada.	hgiacomini@gmail.com	Abrams, Peter A/A-5240-2008	Abrams, Peter A/0000-0002-1828-326X				ABRAMS PA, 1982, AM NAT, V120, P382, DOI 10.1086/283996; Andersen KH, 2009, ICES J MAR SCI, V66, P1978, DOI 10.1093/icesjms/fsp161; Charnov EL, 2001, P NATL ACAD SCI USA, V98, P9460, DOI 10.1073/pnas.161294498; FUIMAN LA, 1994, J FISH BIOL, V45, P55, DOI 10.1111/j.1095-8649.1994.tb01084.x; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Glazier DS, 2006, BIOSCIENCE, V56, P325, DOI 10.1641/0006-3568(2006)56[325:TPLINU]2.0.CO;2; Kozlowski J, 2004, INTEGR COMP BIOL, V44, P480, DOI 10.1093/icb/44.6.480; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Pawar S, 2012, NATURE, V486, P485, DOI 10.1038/nature11131; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Quince C, 2008, J THEOR BIOL, V254, P197, DOI 10.1016/j.jtbi.2008.05.029; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380	15	4	4	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					E1	E2		10.1038/nature11829	http://dx.doi.org/10.1038/nature11829			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364748				2022-12-28	WOS:000314219600001
J	Lamb, HM; Hardwick, JM				Lamb, Heather M.; Hardwick, J. Marie			Unlatched BAX Pairs for Death	CELL			English	Editorial Material							ACTIVATION	Self-interacting BAX proteins permeabilize outer mitochondrial membranes to trigger apoptotic cell death. Czabotar et al. present two revealing structures of BAX dimers: one dimer has an activator BH3 helix bound into its canonical cleft, and the other dimer exposes a planar hydrophobic face potentially critical for membrane interactions.	[Lamb, Heather M.; Hardwick, J. Marie] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hardwick, JM (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	mhardwic@jhsph.edu		Lamb, Heather/0000-0002-8060-0633	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037402] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM095253, F31 GM095253] Funding Source: Medline; NINDS NIH HHS [R01 NS037402] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aouacheria A., 2012, P NATL ACAD SCI USA; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Poncet D, 2004, J BIOL CHEM, V279, P22605, DOI 10.1074/jbc.M308408200	8	6	6	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 31	2013	152	3					383	384		10.1016/j.cell.2013.01.018	http://dx.doi.org/10.1016/j.cell.2013.01.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374333	Bronze, Green Accepted			2022-12-28	WOS:000314362800007
J	Nygaard, R; Zou, YZ; Dror, RO; Mildorf, TJ; Arlow, DH; Manglik, A; Pan, AC; Liu, CW; Fung, JJ; Bokoch, MP; Thian, FS; Kobilka, TS; Shaw, DE; Mueller, L; Prosser, RS; Kobilka, BK				Nygaard, Rie; Zou, Yaozhong; Dror, Ron O.; Mildorf, Thomas J.; Arlow, Daniel H.; Manglik, Aashish; Pan, Albert C.; Liu, Corey W.; Fung, Juan Jose; Bokoch, Michael P.; Thian, Foon Sun; Kobilka, Tong Sun; Shaw, David E.; Mueller, Luciano; Prosser, R. Scott; Kobilka, Brian K.			The Dynamic Process of beta(2)-Adrenergic Receptor Activation	CELL			English	Article							PROTEIN-COUPLED RECEPTOR; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; MECHANISM; EFFICACY; REVEALS; STATE	G-protein-coupled receptors (GPCRs) can modulate diverse signaling pathways, often in a ligand-specific manner. The full range of functionally relevant GPCR conformations is poorly understood. Here, we use NMR spectroscopy to characterize the conformational dynamics of the transmembrane core of the beta(2)-adrenergic receptor (beta(2)AR), a prototypical GPCR. We labeled beta(2)AR with (CH3)-C-13 epsilon-methionine and obtained HSQC spectra of unliganded receptor as well as receptor bound to an inverse agonist, an agonist, and a G-protein-mimetic nanobody. These studies provide evidence for conformational states not observed in crystal structures, as well as substantial conformational heterogeneity in agonistand inverse-agonist-bound preparations. They also show that for beta(2)AR, unlike rhodopsin, an agonist alone does not stabilize a fully active conformation, suggesting that the conformational link between the agonist-binding pocket and the G-proteincoupling surface is not rigid. The observed heterogeneity may be important for beta(2)AR's ability to engage multiple signaling and regulatory proteins.	[Nygaard, Rie; Zou, Yaozhong; Manglik, Aashish; Fung, Juan Jose; Bokoch, Michael P.; Thian, Foon Sun; Kobilka, Tong Sun; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Liu, Corey W.] Stanford Univ, Stanford Magnet Resonance Lab, Sch Med, Stanford, CA 94305 USA; [Dror, Ron O.; Mildorf, Thomas J.; Arlow, Daniel H.; Pan, Albert C.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Prosser, R. Scott] Univ Toronto, UTM, Dept Chem, Mississauga, ON L5L 1C6, Canada; [Mueller, Luciano] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA	Stanford University; Stanford University; D. E. Shaw Research; University of Toronto; University Toronto Mississauga; Bristol-Myers Squibb	Kobilka, BK (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.	kobilka@stanford.edu	Nygaard, Rie/B-7351-2013; Pan, Albert/G-1475-2013; Bokoch, Michael P./J-2637-2019	Bokoch, Michael P./0000-0003-1387-9547; Kobilka, Brian/0000-0001-5958-3990; Dror, Ron/0000-0002-6418-2793; Pan, Albert/0000-0001-5050-5603	National Institutes of Health [NS028471]; Mathers Foundation; Lundbeck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from National Institutes of Health Grant NS028471 (B.K.K.) and the Mathers Foundation (B.K.K.). We thank Prof. Joseph Puglisi for encouragement and advice. We thank Dr. Soren Rasmussen for help with protein preparation. We acknowledge support from the Lundbeck Foundation (R.N.). We thank Paul Maragakis and Kresten Lindorff-Larsen for helpful comments.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bose-Basu B, 2004, BIOCHEMISTRY-US, V43, P8911, DOI 10.1021/bi049641n; Butterfoss GL, 2010, J BIOMOL NMR, V48, P31, DOI 10.1007/s10858-010-9436-6; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DellaVecchia MJ, 2007, J MOL BIOL, V373, P282, DOI 10.1016/j.jmb.2007.07.045; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Dror RO, 2010, J GEN PHYSIOL, V135, P555, DOI 10.1085/jgp.200910373; Farrens DL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1466, DOI 10.1039/c0pp00283f; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Hansen DF, 2008, J BIOMOL NMR, V41, P113, DOI 10.1007/s10858-008-9251-5; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rajagopal K, 2005, J CLIN INVEST, V115, P2971, DOI 10.1172/JCI26950; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Shaw D. E., 2009, P C HIGH PERF COMP N, V39, P1, DOI DOI 10.1145/1654059.1654099; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Wishart DS, 2011, PROG NUCL MAG RES SP, V58, P62, DOI 10.1016/j.pnmrs.2010.07.004; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	40	575	584	13	369	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					532	542		10.1016/j.cell.2013.01.008	http://dx.doi.org/10.1016/j.cell.2013.01.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374348	Bronze, Green Accepted			2022-12-28	WOS:000314362800022
J	Tantivess, S; Werayingyong, P; Chuengsaman, P; Teerawattananon, Y				Tantivess, Sripen; Werayingyong, Pitsaphun; Chuengsaman, Piyatida; Teerawattananon, Yot			Universal coverage of renal dialysis in Thailand: promise, progress, and prospects	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERITONEAL-DIALYSIS; SIMILAR OUTCOMES; HEMODIALYSIS; DISEASE; PACKAGE	Thailand's experience in introducing renal replacement therapy as part of its universal health coverage scheme shows the importance of evidence and stakeholders' active participation in all phases of policy development, say Sripen Tantivess and colleagues	[Tantivess, Sripen; Werayingyong, Pitsaphun; Teerawattananon, Yot] Minist Publ Hlth, HITAP, Nonthaburi, Thailand; [Chuengsaman, Piyatida] Banphaeo Hosp Publ Org, CAPD Serv, Bangkok, Thailand; [Chuengsaman, Piyatida] Training Ctr, Bangkok, Thailand	Ministry of Public Health - Thailand	Teerawattananon, Y (corresponding author), Minist Publ Hlth, HITAP, Nonthaburi, Thailand.	yot.t@hitap.net		Teerawattananon, Yot/0000-0003-2217-2930				[Anonymous], 2010, B WORLD HEALTH ORGAN, V88, P84, DOI 10.2471/BLT.10.010210; [Anonymous], STAK M 2012 SEPT 28; Anothayanon K, 2002, J HEALTH SCI, V11, P826; Dhanakijcharoen Prateep, 2011, J Med Assoc Thai, V94 Suppl 4, pS153; Evans T. G., 2012, INDEPENDENT ASSESSME, V10, P2001; Kearkiat P, 2012, REPORT THAILAND RENA; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Mehrotra R, 2011, ARCH INTERN MED, V171, P110, DOI 10.1001/archinternmed.2010.352; National Health Security Office, 2007, FUND MAN MAN NAT HLT; Patcharanarumol W, 2011, GOOD HLTH LOW COST 2; Praditpornsilp K, 2008, THAILAND RENAL REPLA; Praditpornsilpa Kearkiat, 2011, J Med Assoc Thai, V94 Suppl 4, pS1; Prakongsai P, 2006, J HEALTH SCI, V15, P617; Prakongsai P, 2009, J INT DEV, V21, P291, DOI 10.1002/jid.1553; Teerawattananon Y, 2004, HEALTH POLICY PLANN, V19, pI31, DOI 10.1093/heapol/czh043; Teerawattananon Y, 2007, VALUE HEALTH, V10, P61, DOI 10.1111/j.1524-4733.2006.00145.x; Thai Renal Replacement Therayp (TRT) Committee, 2005, TRT REG ANN REP; Tungsiripat R, 2003, 0403 HEFP LOND SCH H; United States Renal Data System, 2004, ANN DAT REP 2001 INC; WHO, 2010, WOR HEALT REP, P1; Yeates K, 2012, NEPHROL DIAL TRANSPL, V27, P3568, DOI 10.1093/ndt/gfr674	21	49	51	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2013	346								f462	10.1136/bmj.f462	http://dx.doi.org/10.1136/bmj.f462			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BQ	23369775	Bronze			2022-12-28	WOS:000314511500007
J	Zhu, J; Adli, M; Zou, JY; Verstappen, G; Coyne, M; Zhang, XL; Durham, T; Miri, M; Deshpande, V; De Jager, PL; Bennett, DA; Houmard, JA; Muoio, DM; Onder, TT; Camahort, R; Cowan, CA; Meissner, A; Epstein, CB; Shoresh, N; Bernstein, BE				Zhu, Jiang; Adli, Mazhar; Zou, James Y.; Verstappen, Griet; Coyne, Michael; Zhang, Xiaolan; Durham, Timothy; Miri, Mohammad; Deshpande, Vikram; De Jager, Philip L.; Bennett, David A.; Houmard, Joseph A.; Muoio, Deborah M.; Onder, Tamer T.; Camahort, Ray; Cowan, Chad A.; Meissner, Alexander; Epstein, Charles B.; Shoresh, Noam; Bernstein, Bradley E.			Genome-wide Chromatin State Transitions Associated with Developmental and Environmental Cues	CELL			English	Article							EPIGENETIC SIGNATURE; PLURIPOTENT; ORGANIZATION; SENESCENCE; DYNAMICS; REVEALS; COMPLEX; IMPACT; GENES; CELLS	Differences in chromatin organization are key to the multiplicity of cell states that arise from a single genetic background, yet the landscapes of in vivo tissues remain largely uncharted. Here, we mapped chromatin genome-wide in a large and diverse collection of human tissues and stem cells. The maps yield unprecedented annotations of functional genomic elements and their regulation across developmental stages, lineages, and cellular environments. They also reveal global features of the epigenome, related to nuclear architecture, that also vary across cellular phenotypes. Specifically, developmental specification is accompanied by progressive chromatin restriction as the default state transitions from dynamic remodeling to generalized compaction. Exposure to serum in vitro triggers a distinct transition that involves de novo establishment of domains with features of constitutive heterochromatin. We describe how these global chromatin state transitions relate to chromosome and nuclear architecture, and discuss their implications for lineage fidelity, cellular senescence, and reprogramming.	[Zhu, Jiang; Adli, Mazhar; Zou, James Y.; Verstappen, Griet; Coyne, Michael; Zhang, Xiaolan; Durham, Timothy; De Jager, Philip L.; Camahort, Ray; Cowan, Chad A.; Meissner, Alexander; Epstein, Charles B.; Shoresh, Noam; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zhu, Jiang; Adli, Mazhar; Zou, James Y.; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Zhu, Jiang; Adli, Mazhar; Zou, James Y.; Miri, Mohammad; Deshpande, Vikram; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Zhu, Jiang; Adli, Mazhar; Zou, James Y.; Miri, Mohammad; Deshpande, Vikram; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Zhu, Jiang; Adli, Mazhar; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Zhu, Jiang; Adli, Mazhar; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Zou, James Y.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Verstappen, Griet; Camahort, Ray; Cowan, Chad A.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Inst Neurosci, Dept Neurol, Boston, MA 02215 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Inst Neurosci, Dept Psychiat, Boston, MA 02215 USA; [De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Houmard, Joseph A.] E Carolina Univ, Dept Exercise & Sport Sci, Greenville, NC 27858 USA; [Muoio, Deborah M.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Onder, Tamer T.] Koc Univ, Sch Med, Istanbul, Turkey	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rush University; University of North Carolina; East Carolina University; Duke University; Koc University	Adli, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	adli@virginia.edu; bernstein.bradley@mgh.harvard.edu	Onder, Tamer T/H-3330-2013; Onder, Tamer/O-3669-2019; Muoio, Debbie Marie/E-1147-2012; Zhu, Jiang/E-3049-2013	Onder, Tamer T/0000-0002-2372-9158; Onder, Tamer/0000-0002-2372-9158; Muoio, Deborah/0000-0003-3760-9277; Epstein, Charles B./0000-0001-8358-8345	NIH Common Fund [U01 ES017155]; National Human Genome Research Institute [U54 HG004570]; National Heart, Lung and Blood Institute [U01 HL100395]; National Institute on Aging [P30 AG10161]; Howard Hughes Medical Institute; Starr Cancer Consortium; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100395] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015819, P30AG010161, R01AG036042] Funding Source: NIH RePORTER	NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Starr Cancer Consortium; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge members of the Broad Institute's Epigenomics Program and Genome Sequencing and Analysis Program, and the NIH Epigenomics Mapping Consortium for constructive comments. We thank Kevin Eggan for ES and iPS lines; Allen Powe and Steve Stice for neural cells; Greg Lauwers and the MGH Tissue Repository for tissue procurement; and David Flowers, Irwin Bernstein, John Stamatoyannopoulos and Shelly Heimfeld for blood samples. We also thank Leslie Gaffney and Lauren Solomon for assistance with figures. This research was supported by the NIH Common Fund (U01 ES017155); the National Human Genome Research Institute (U54 HG004570); the National Heart, Lung and Blood Institute (U01 HL100395); the National Institute on Aging (P30 AG10161); the Howard Hughes Medical Institute; the Starr Cancer Consortium; and the Burroughs Wellcome Fund.	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	42	374	380	1	118	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					642	654		10.1016/j.cell.2012.12.033	http://dx.doi.org/10.1016/j.cell.2012.12.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23333102	Bronze, Green Accepted			2022-12-28	WOS:000314362800031
J	Davis, A; Obi, B; Ingram, M				Davis, A.; Obi, B.; Ingram, M.			Investigating urinary tract infections in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VESICOURETERAL REFLUX		[Davis, A.] St Georges Hosp NHS Trust, London SW17 0QT, England; [Obi, B.; Ingram, M.] Royal Surrey Cty Hosp, Guildford GU2 7XX, Surrey, England	St Georges University London; Royal Surrey County Hospital	Davis, A (corresponding author), St Georges Hosp NHS Trust, London SW17 0QT, England.	adavis@bmj.com						Cleper R, 2004, CLIN PEDIATR, V43, P619, DOI 10.1177/000992280404300706; Lim R, 2009, AM J ROENTGENOL, V192, P1197, DOI 10.2214/AJR.08.2187; Mahant S, 2002, ARCH DIS CHILD, V86, P419, DOI 10.1136/adc.86.6.419; Mori R, 2007, BRIT MED J, V335, P395, DOI 10.1136/bmj.39286.700891.AD; ROSENBERG AR, 1992, J UROLOGY, V148, P1746, DOI 10.1016/S0022-5347(17)37019-2; Urinary tract infection in children, 2007, UR TRACT INF CHILDR; Whiting P, 2006, HEALTH TECHNOL ASSES, V10, P1	7	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2013	346								e8654	10.1136/bmj.e8654	http://dx.doi.org/10.1136/bmj.e8654			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BP	23364051				2022-12-28	WOS:000314511300006
J	Campion, EW; Morrissey, S				Campion, Edward W.; Morrissey, Stephen			A Different Model - Medical Care in Cuba	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Morrissey, Stephen/0000-0001-6351-906X				Central Intelligence Agency, 2012, WORLD FACTB; Drain PK, 2010, SCIENCE, V328, P572, DOI 10.1126/science.1189680; Gorry C, 2008, MEDICC REV, V10, P10, DOI 10.37757/MR2008.V10.N4.4; Keck C William, 2012, Am J Public Health, V102, pe13, DOI 10.2105/AJPH.2012.300822; United Nations, WORLD POP PROSP 2011	5	35	36	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					297	299		10.1056/NEJMp1215226	http://dx.doi.org/10.1056/NEJMp1215226			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075KX	23343058				2022-12-28	WOS:000313885900001
J	Macdougall, IC; Provenzano, R; Sharma, A; Spinowitz, BS; Schmidt, RJ; Pergola, PE; Zabaneh, RI; Tong-Starksen, S; Mayo, MR; Tang, H; Polu, KR; Duliege, AM; Fishbane, S				Macdougall, Iain C.; Provenzano, Robert; Sharma, Amit; Spinowitz, Bruce S.; Schmidt, Rebecca J.; Pergola, Pablo E.; Zabaneh, Raja I.; Tong-Starksen, Sandra; Mayo, Martha R.; Tang, Hong; Polu, Krishna R.; Duliege, Anne-Marie; Fishbane, Steven		PEARL Study Grp	Peginesatide for Anemia in Patients with Chronic Kidney Disease Not Receiving Dialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERYTHROPOIESIS-STIMULATING AGENT; STAGE RENAL-DISEASE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; CARDIOVASCULAR-DISEASE; CLINICAL-TRIAL; EPOETIN-ALPHA; EPIDEMIOLOGY; PREVENTION; OUTCOMES; DEATH	Background Peginesatide is a peptide-based erythropoiesis-stimulating agent (ESA) that may have therapeutic potential for anemia in patients with advanced chronic kidney disease. We evaluated the safety and efficacy of Peginesatide, as compared with another ESA, darbepoetin, in 983 such patients who were not undergoing dialysis. Methods In two randomized, controlled, open-label studies (PEARL 1 and 2), patients received Peginesatide once a month, at a starting dose of 0.025 mg or 0.04 mg per kilogram of body weight, or darbepoetin once every 2 weeks, at a starting dose of 0.75 mu g per kilogram. Doses of both drugs were adjusted to achieve and maintain hemoglobin levels between 11.0 and 12.0 g per deciliter for 52 weeks or more. The primary efficacy end point was the mean change from the baseline hemoglobin level to the mean level during the evaluation period; noninferiority was established if the lower limit of the two-sided 97.5% confidence interval was -1.0 g per deciliter or higher. Cardiovascular safety was evaluated on the basis of an adjudicated composite end point. Results In both studies and at both starting doses, Peginesatide was noninferior to darbepoetin in increasing and maintaining hemoglobin levels. The mean differences in the hemoglobin level with Peginesatide as compared with darbepoetin in PEARL 1 were 0.03 g per deciliter (97.5% confidence interval [CI], -0.19 to 0.26) for the lower starting dose of Peginesatide and 0.26 g per deciliter (97.5% CI, 0.04 to 0.48) for the higher starting dose, and in PEARL 2 they were 0.14 g per deciliter (97.5% CI, -0.09 to 0.36) and 0.31 g per deciliter (97.5% CI, 0.08 to 0.54), respectively. The hazard ratio for the cardiovascular safety end point was 1.32 (95% CI, 0.97 to 1.81) for Peginesatide relative to darbepoetin, with higher incidences of death, unstable angina, and arrhythmia with Peginesatide. Conclusions The efficacy of Peginesatide (administered monthly) was similar to that of darbepoetin (administered every 2 weeks) in increasing and maintaining hemoglobin levels. However, cardiovascular events and mortality were increased with Peginesatide in patients with chronic kidney disease who were not undergoing dialysis. (Funded by Affymax and Takeda Pharmaceutical; ClinicalTrials.govnumbers, NCT00598273 [PEARL 1], NCT00598442 [PEARL 2], NCT00597753 [EMERALD 1], and NCT00597584 [EMERALD 2].)	[Macdougall, Iain C.] Kings Coll Hosp London, Renal Unit, London SE5 9RS, England; [Provenzano, Robert] St Clair Specialty Phys, Detroit, MI USA; [Sharma, Amit] Boise Kidney & Hypertens Inst, Meridian, ID USA; [Spinowitz, Bruce S.] Nephrol Associates, Flushing, NY USA; [Fishbane, Steven] Hofstra N Shore LIJ Sch Med, Great Neck, NY USA; [Schmidt, Rebecca J.] W Virginia Univ, Sch Med, Nephrol Dept, Morgantown, WV 26506 USA; [Schmidt, Rebecca J.] Robert C Byrd Hlth Sci Ctr, Morgantown, WV USA; [Pergola, Pablo E.] Renal Associates, San Antonio, TX USA; [Zabaneh, Raja I.] NW Louisiana Nephrol Res, Shreveport, LA USA; [Tong-Starksen, Sandra; Mayo, Martha R.; Tang, Hong; Polu, Krishna R.; Duliege, Anne-Marie] Affymax, Palo Alto, CA USA	King's College Hospital NHS Foundation Trust; King's College Hospital; Hofstra University; Northwell Health; West Virginia University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Macdougall, IC (corresponding author), Kings Coll Hosp London, Renal Unit, Denmark Hill, London SE5 9RS, England.	iain.macdougall@nhs.net	Covic, Adrian/G-5017-2016	Covic, Adrian/0000-0002-9985-2486; Al-Makki, Akram/0000-0002-4510-8010	Affymax; Takeda Pharmaceutical	Affymax; Takeda Pharmaceutical(Takeda Pharmaceutical Company Ltd)	Supported by Affymax and Takeda Pharmaceutical.	Chang A, 2011, NEPHRON CLIN PRACT, V119, pC171, DOI 10.1159/000325669; Clarkson MR, 2007, BRENNER RECTORS KIDN, P943; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Eckardt KU, 2009, AM J KIDNEY DIS, V53, P915, DOI 10.1053/j.ajkd.2009.04.001; Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; ESCHBACH JW, 1989, ANN INTERN MED, V111, P992, DOI 10.7326/0003-4819-111-12-992; Fan Q, 2006, EXP HEMATOL, V34, P1303, DOI 10.1016/j.exphem.2006.05.012; Finkelstein FO, 2009, CLIN J AM SOC NEPHRO, V4, P33, DOI 10.2215/CJN.00630208; Fishbane S, 2013, NEW ENGL J MED, V368, P307, DOI 10.1056/NEJMoa1203165; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Herzog CA, 2008, NEPHROL DIAL TRANSPL, V23, P2629, DOI 10.1093/ndt/gfn038; Kiss Z, 2010, EUR J CLIN PHARMACOL, V66, P331, DOI 10.1007/s00228-009-0780-y; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Macdougall IC, 2008, CLIN J AM SOC NEPHRO, V3, P200, DOI 10.2215/CJN.03840907; Macdougall Iain C, 2005, Curr Hematol Rep, V4, P436; Macdougall IC, 2011, CLIN J AM SOC NEPHRO, V6, P2579, DOI 10.2215/CJN.10831210; MACDOUGALL IC, 1990, LANCET, V335, P489, DOI 10.1016/0140-6736(90)90733-L; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Postorino M, 2007, NEPHROL DIAL TRANSPL, V22, P1377, DOI 10.1093/ndt/gfl813; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Shamseddin MK, 2011, NAT REV NEPHROL, V7, P145, DOI 10.1038/nrneph.2010.191; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Solomon SD, 2010, NEW ENGL J MED, V363, P1146, DOI 10.1056/NEJMoa1005109; Szczech LA, 2008, KIDNEY INT, V74, P791, DOI 10.1038/ki.2008.295; U.S. Renal Data System, 2010, 2011 ANN DAT REP ATL; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6; Woodburn KW, 2008, HAEMATOL-HEMATOL J, V93, P1376, DOI 10.3324/haematol.12896; Woodburn KW, 2012, XENOBIOTICA, V42, P660, DOI 10.3109/00498254.2011.649310	29	70	75	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					320	332		10.1056/NEJMoa1203166	http://dx.doi.org/10.1056/NEJMoa1203166			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075KX	23343062				2022-12-28	WOS:000313885900005
J	Shelton, JD				Shelton, James D.			Ensuring health in universal health coverage	NATURE			English	Editorial Material									US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	jshelton@usaid.gov							0	5	5	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					453	453		10.1038/493453a	http://dx.doi.org/10.1038/493453a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	075GF	23344323	Bronze			2022-12-28	WOS:000313871400004
J	Bell, ML; Kenward, MG; Fairclough, DL; Horton, NJ				Bell, Melanie L.; Kenward, Michael G.; Fairclough, Diane L.; Horton, Nicholas J.			Differential dropout and bias in randomised controlled trials: when it matters and when it may not	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; IMPUTATION		[Bell, Melanie L.] Univ Sydney, Psychooncol Cooperat Res Grp PoCoG, Sydney, NSW 2006, Australia; [Kenward, Michael G.] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Fairclough, Diane L.] Univ Colorado, Dept Prevent Med & Biometry, Denver, CO 80202 USA; [Horton, Nicholas J.] Smith Coll, Dept Math & Stat, Northampton, MA 01063 USA	University of Sydney; University of London; London School of Hygiene & Tropical Medicine; University of Colorado System; University of Colorado Denver; Smith College	Bell, ML (corresponding author), Univ Sydney, Psychooncol Cooperat Res Grp PoCoG, Sydney, NSW 2006, Australia.	melanie.bell@sydney.edu.au	Bell, Melanie L/D-1839-2011; Bell, Melanie/N-4166-2019; Horton, Nicholas/A-2493-2008	Bell, Melanie L/0000-0003-4821-4094; Bell, Melanie/0000-0003-4821-4094; Horton, Nicholas/0000-0003-3332-4311	National Cancer Institute [CA-05826]; NATIONAL CANCER INSTITUTE [P01CA005826] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Data presented are derived (and used with permission) from a trial conducted by Memorial Sloan-Kettering Cancer Center and Eastern Cooperative Oncology Group funded by the National Cancer Institute grant CA-05826.	Au HJ, 2010, EXPERT REV PHARM OUT, V10, P119, DOI 10.1586/ERP.10.15; CARPENTER J, 2008, MISSING DATA RANDOMI; Carpenter JR, 2006, J R STAT SOC A STAT, V169, P571, DOI 10.1111/j.1467-985X.2006.00407.x; Fairclough DL, 2010, DESIGN AND ANALYSIS OF QUALITY OF LIFE STUDIES IN CLINICAL TRIALS, SECOND EDITION, P1, DOI 10.1201/9781420061185; Fielding S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-51; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Heneghan C, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-18; Joly F, 2007, ANN ONCOL, V18, P1935, DOI 10.1093/annonc/mdm121; Kenward M., J BIOPHARM IN PRESS; Mallinckrodt Craig H, 2003, J Biopharm Stat, V13, P179, DOI 10.1081/BIP-120019265; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Molenberghs G, 2004, BIOSTATISTICS, V5, P445, DOI 10.1093/biostatistics/kxh001; Molnar Frank J, 2009, Open Med, V3, pe31; National Research Council Panel on Handling Missing Data in Clinical Trials, 2010, PREV TREATM MISS DAT; ROBINS JM, 1995, J AM STAT ASSOC, V90, P122, DOI 10.2307/2291135; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Thomas RE, 2006, CAN J AGING, V25, P271, DOI 10.1353/cja.2007.0011; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40; Wood Angela M, 2004, Clin Trials, V1, P368	19	174	174	2	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2013	346								e8668	10.1136/bmj.e8668	http://dx.doi.org/10.1136/bmj.e8668			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BA	23338004	Green Published, Bronze			2022-12-28	WOS:000314215000010
J	Schwanhausser, B; Busse, D; Li, N; Dittmar, G; Schuchhardt, J; Wolf, J; Chen, W; Selbach, M				Schwanhaeusser, Bjoern; Busse, Dorothea; Li, Na; Dittmar, Gunnar; Schuchhardt, Johannes; Wolf, Jana; Chen, Wei; Selbach, Matthias			Global quantification of mammalian gene expression control (vol 473, pg 337, 2011)	NATURE			English	Correction													Dittmar, Gunnar/C-6333-2019; Dittmar, Gunnar/B-6383-2016	Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623				Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098	1	131	138	5	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2013	495	7439					126	127		10.1038/nature11848	http://dx.doi.org/10.1038/nature11848			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105BE	23407496	Bronze			2022-12-28	WOS:000316039800053
J	Lindsey, HA; Gallie, J; Taylor, S; Kerr, B				Lindsey, Haley A.; Gallie, Jenna; Taylor, Susan; Kerr, Benjamin			Evolutionary rescue from extinction is contingent on a lower rate of environmental change	NATURE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; RIFAMPICIN-RESISTANCE; PREVENT EXTINCTION; NATURAL-SELECTION; SIGN EPISTASIS; CLIMATE-CHANGE; ADAPTATION; MUTATIONS; MODEL	The extinction rate of populations is predicted to rise under increasing rates of environmental change(1-3). If a population experiencing increasingly stressful conditions lacks appropriate phenotypic plasticity or access to more suitable habitats, then genetic change may be the only way to avoid extinction(1). Evolutionary rescue from extinction occurs when natural selection enriches a population for more stress-tolerant genetic variants(1,3). Some experimental studies have shown that lower rates of environmental change lead to more adapted populations or fewer extinctions(4-9). However, there has been little focus on the genetic changes that underlie evolutionary rescue. Here we demonstrate that some evolutionary trajectories are contingent on a lower rate of environmental change. We allowed hundreds of populations of Escherichia coli to evolve under variable rates of increase in concentration of the antibiotic rifampicin. We then genetically engineered all combinations of mutations from isolates evolved under lower rates of environmental change. By assessing fitness of these engineered strains across a range of drug concentrations, we show that certain genotypes are evolutionarily inaccessible under rapid environmental change. Rapidly deteriorating environments not only limit mutational opportunities by lowering population size, but they can also eliminate sets of mutations as evolutionary options. As anthropogenic activities are leading to environmental change at unprecedented rapidity(1), it is critical to understand how the rate of environmental change affects both demographic and genetic underpinnings of evolutionary rescue.	[Lindsey, Haley A.; Gallie, Jenna; Taylor, Susan; Kerr, Benjamin] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Lindsey, Haley A.; Gallie, Jenna; Taylor, Susan; Kerr, Benjamin] Univ Washington, BEACON Ctr Study Evolut Act, Seattle, WA 98195 USA; [Gallie, Jenna] Eawag, Dept Environm Microbiol, CH-8600 Dubendorf, Switzerland; [Gallie, Jenna] ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Kerr, B (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	kerrb@uw.edu	Gallie, Jenna/ABH-7516-2020		National Science Foundation [DBI-0939454]; NSF CAREER [DEB0952825]; UW Royalty Research Fund [A74107]	National Science Foundation(National Science Foundation (NSF)); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); UW Royalty Research Fund	We thank T. Bradshaw, J. Martiny and J. Tewksbury for sharing ideas that inspired this work; the Church laboratory for supplying the pKOV vector; C. Adams, S. DeCew, K. Dickinson, S. Drescher, C. Eshelman, K. Hobbs, C. Muerdter, B. Rogers and C. Shyue for help in the laboratory; and F. Bertels, C. Eshelman, C. Glenney and S. Singhal for comments on the manuscript. This material is based in part on work supported by the National Science Foundation under Cooperative Agreement Number DBI-0939454, a NSF CAREER Award Grant (DEB0952825), and a UW Royalty Research Fund Award (A74107).	Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Bell G, 2011, SCIENCE, V332, P1327, DOI 10.1126/science.1203105; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Collins S, 2009, EVOLUTION, V63, P2952, DOI 10.1111/j.1558-5646.2009.00770.x; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Dallinger W. H., 1887, J R MICROSC SOC, V7, P185; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; GILLESPIE JH, 1983, THEOR POPUL BIOL, V23, P202, DOI 10.1016/0040-5809(83)90014-X; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Hall AR, 2011, EVOLUTION, V65, P2370, DOI 10.1111/j.1558-5646.2011.01302.x; HUEY RB, 1991, EVOLUTION, V45, P751, DOI 10.1111/j.1558-5646.1991.tb04343.x; Klironomos JN, 2005, NATURE, V433, P621, DOI 10.1038/nature03268; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lalic J, 2012, HEREDITY, V109, P71, DOI 10.1038/hdy.2012.15; Lalic J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0396; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051; MacLean RC, 2010, GENETICS, V186, P1345, DOI 10.1534/genetics.110.123083; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Perron GG, 2008, J EVOLUTION BIOL, V21, P1724, DOI 10.1111/j.1420-9101.2008.01596.x; Remold SK, 2004, NAT GENET, V36, P423, DOI 10.1038/ng1324; Reynolds MG, 2000, GENETICS, V156, P1471; Roels SAB, 2011, EVOLUTION, V65, P2541, DOI 10.1111/j.1558-5646.2011.01326.x; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165	30	166	167	3	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2013	494	7438					463	467		10.1038/nature11879	http://dx.doi.org/10.1038/nature11879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099YI	23395960				2022-12-28	WOS:000315661500035
J	Munoz, J; Kurzrock, R				Munoz, Javier; Kurzrock, Razelle			Unilateral Proptosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Munoz, Javier; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut Phase Clin Trials Program 1, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Munoz, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut Phase Clin Trials Program 1, 1515 Holcombe Blvd,Unit 455, Houston, TX 77030 USA.	jlmunoz@mdanderson.org	Kurzrock, Razelle/AAU-9782-2020					DALLOW RL, 1976, T AM ACAD OPHTHALMOL, V81, P305; Epstein O, 2003, CLINICAL EXAMINATION; Lanternier F, 2012, CLIN INFECT DIS, V54, pS35, DOI 10.1093/cid/cir880; Levy J, 2005, Minerva Endocrinol, V30, P247; Lutt JR, 2008, SEMIN ARTHRITIS RHEU, V37, P207, DOI 10.1016/j.semarthrit.2007.06.003; National Comprehensive Cancer Network (NNCN), NEUROENDOCRINE TUMOR; Warrier S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1669, DOI 10.1001/archophthalmol.2008.501; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377	8	2	2	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					605	606		10.1001/jama.2013.233	http://dx.doi.org/10.1001/jama.2013.233			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087PH	23403685				2022-12-28	WOS:000314773700033
J	Pengelly, AR; Copur, O; Jackle, H; Herzig, A; Muller, J				Pengelly, Ana Raquel; Copur, Oemer; Jaeckle, Herbert; Herzig, Alf; Mueller, Juerg			A Histone Mutant Reproduces the Phenotype Caused by Loss of Histone-Modifying Factor Polycomb	SCIENCE			English	Article							METHYLATION; MECHANISMS	Although many metazoan enzymes that add or remove specific modifications on histone proteins are essential transcriptional regulators, the functional significance of posttranslational modifications on histone proteins is not well understood. Here, we show in Drosophila that a point mutation in lysine 27 of histone H3 (H3-K27) fails to repress transcription of genes that are normally repressed by Polycomb repressive complex 2 (PRC2), the methyltransferase that modifies H3-K27. Moreover, differentiated H3-K27 mutant cells show homeotic transformations like those seen in PRC2 mutant cells. Taken together, these analyses demonstrate that H3-K27 is the crucial physiological substrate that PRC2 modifies for Polycomb repression.	[Pengelly, Ana Raquel; Copur, Oemer; Mueller, Juerg] Max Planck Inst Biochem, Chromatin & Chromosome Biol Res Grp, D-82152 Martinsried, Germany; [Jaeckle, Herbert; Herzig, Alf] Max Planck Inst Biophys Chem, Dept Mol Dev Biol, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Herzig, A (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Dev Biol, Fassberg 11, D-37077 Gottingen, Germany.	herzig@mpiib-berlin.mpg.de; muellerj@biochem.mpg.de	Müller, Jürg/ABB-3007-2020; ÇOPUR, Ömer Utku/AAG-8336-2021	Müller, Jürg/0000-0003-2391-4641; Pengelly, Ana Raquel/0000-0002-4822-4367; Herzig, Alf/0000-0003-4246-4666	Max Planck Society; Marie Curie Initial Training Network Nucleosome4D	Max Planck Society(Max Planck Society); Marie Curie Initial Training Network Nucleosome4D	The authors are supported by the Max Planck Society and a fellowship from the Marie Curie Initial Training Network Nucleosome4D (A.R.P.).	Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Gunesdogan U, 2010, EMBO REP, V11, P772, DOI 10.1038/embor.2010.124; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763	7	200	204	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					698	699		10.1126/science.1231382	http://dx.doi.org/10.1126/science.1231382			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393264				2022-12-28	WOS:000314585600043
J	Wahl, V; Ponnu, J; Schlereth, A; Arrivault, S; Langenecker, T; Franke, A; Feil, R; Lunn, JE; Stitt, M; Schmid, M				Wahl, Vanessa; Ponnu, Jathish; Schlereth, Armin; Arrivault, Stephanie; Langenecker, Tobias; Franke, Annika; Feil, Regina; Lunn, John E.; Stitt, Mark; Schmid, Markus			Regulation of Flowering by Trehalose-6-Phosphate Signaling in Arabidopsis thaliana	SCIENCE			English	Article							FLORAL INDUCTION; FT PROTEIN; TREHALOSE 6-PHOSPHATE; VEGETATIVE GROWTH; CONSTANS; PATHWAY; SYNTHASE-1; ACTIVATION; TRANSITION; GENES	The timing of the induction of flowering determines to a large extent the reproductive success of plants. Plants integrate diverse environmental and endogenous signals to ensure the timely transition from vegetative growth to flowering. Carbohydrates are thought to play a crucial role in the regulation of flowering, and trehalose-6-phosphate (T6P) has been suggested to function as a proxy for carbohydrate status in plants. The loss of TREHALOSE-6-PHOSPHATE SYNTHASE 1 (TPS1) causes Arabidopsis thaliana to flower extremely late, even under otherwise inductive environmental conditions. This suggests that TPS1 is required for the timely initiation of flowering. We show that the T6P pathway affects flowering both in the leaves and at the shoot meristem, and integrate TPS1 into the existing genetic framework of flowering-time control.	[Wahl, Vanessa; Schlereth, Armin; Arrivault, Stephanie; Franke, Annika; Feil, Regina; Lunn, John E.; Stitt, Mark] Max Planck Inst Mol Plant Physiol, Dept Metab Networks, D-14476 Potsdam, Germany; [Ponnu, Jathish; Langenecker, Tobias; Schmid, Markus] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Max Planck Society; Max Planck Society	Wahl, V (corresponding author), Max Planck Inst Mol Plant Physiol, Dept Metab Networks, Muhlenberg 1, D-14476 Potsdam, Germany.	vanessa.wahl@mpimp-golm.mpg.de; maschmid@tuebingen.mpg.de	Wahl, Vanessa/ABC-3341-2020; Lunn, John Edward/AAE-9516-2019; Ponnu, Jathish/ABC-4175-2020; Schmid, Markus/I-4384-2015; Stitt, Mark/GVT-1242-2022	Lunn, John Edward/0000-0001-8533-3004; Ponnu, Jathish/0000-0002-3276-7068; Schmid, Markus/0000-0002-0068-2967; Stitt, Mark/0000-0002-4900-1763; Feil, Regina/0000-0002-9936-1337; Wahl, Vanessa/0000-0001-7421-8801	Deutsche Forschungsgemeinschaft [SCHM-1560/6]; Priority Program 1530 (SPP1530) [SCHM-1560/8]; European Commission [245143]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Priority Program 1530 (SPP1530); European Commission(European CommissionEuropean Commission Joint Research Centre); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank C. Abel and J. Olas for help with plant work, and U. Krause for assistance with sample collection. The tps1-2 GVG:TPS1 mutant was obtained from the Smeekens laboratory, University of Utrecht, Netherlands. Microarray data reported in this study have been deposited with EBI ArrayExpress (E-MEXP-3727). Supported by Deutsche Forschungsgemeinschaft grant SCHM-1560/6 and Priority Program 1530 (SPP1530) grant SCHM-1560/8 (M.S.), European Commission FP7 collaborative project TiMet contract 245143 (M.St.), and the Max Planck Society. The authors declare no conflict of interest.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Corbesier L, 1998, PLANTA, V206, P131, DOI 10.1007/s004250050383; Corbesier L, 1996, PLANT J, V9, P947, DOI 10.1046/j.1365-313X.1996.9060947.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Eastmond PJ, 2002, PLANT J, V29, P225, DOI 10.1046/j.1365-313x.2002.01220.x; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gomez LD, 2010, PLANT J, V64, P1, DOI 10.1111/j.1365-313X.2010.04312.x; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Ponnu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00070; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Yang ZF, 2008, GENE, V407, P1, DOI 10.1016/j.gene.2007.02.034	29	417	443	19	389	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					704	707		10.1126/science.1230406	http://dx.doi.org/10.1126/science.1230406			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393265				2022-12-28	WOS:000314585600045
J	Diehl, GE; Longman, RS; Zhang, JX; Breart, B; Galan, C; Cuesta, A; Schwab, SR; Littman, DR				Diehl, Gretchen E.; Longman, Randy S.; Zhang, Jing-Xin; Breart, Beatrice; Galan, Carolina; Cuesta, Adolfo; Schwab, Susan R.; Littman, Dan R.			Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells	NATURE			English	Article							DENDRITIC CELLS; HOST; SALMONELLA; INFLAMMATION; TOLERANCE; RESPONSES; TISSUE	The intestinal microbiota has a critical role in immune system and metabolic homeostasis, but it must be tolerated by the host to avoid inflammatory responses that can damage the epithelial barrier separating the host from the luminal contents(1-6). Breakdown of this regulation and the resulting inappropriate immune response to commensals are thought to lead to the development of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis(7). We proposed that the intestinal immune system is instructed by the microbiota to limit responses to luminal antigens. Here we demonstrate in mice that, at steady state, the microbiota inhibits the transport of both commensal and pathogenic bacteria from the lumen to a key immune inductive site, the mesenteric lymph nodes (MLNs). However, in the absence of Myd88 or under conditions of antibiotic-induced dysbiosis, non-invasive bacteria were trafficked to the MLNs in a CCR7-dependent manner, and induced both T-cell responses and IgA production. Trafficking was carried out by CX(3)CR1(hi) mononuclear phagocytes, an intestinal-cell population previously reported to be non-migratory(8). These findings define a central role for commensals in regulating the migration to the MLNs of CX(3)CR1(hi) mononuclear phagocytes endowed with the ability to capture luminal bacteria, thereby compartmentalizing the intestinal immune response to avoid inflammation.	[Diehl, Gretchen E.; Longman, Randy S.; Zhang, Jing-Xin; Breart, Beatrice; Galan, Carolina; Cuesta, Adolfo; Schwab, Susan R.; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Mol Pathogenesis Program,Skirball Inst, New York, NY 10016 USA; [Longman, Randy S.] Columbia Univ, Dept Med, Div Digest & Liver Dis, New York, NY 10032 USA; [Cuesta, Adolfo; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; Columbia University; Howard Hughes Medical Institute; New York University	Diehl, GE (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Mol Pathogenesis Program,Skirball Inst, New York, NY 10016 USA.	Gretchen.Diehl@med.nyu.edu	Breart, Beatrice/M-7123-2014	Schwab, Susan/0000-0002-0834-0822; Diehl, Gretchen/0000-0002-1841-2842	National Cancer Institute [5P30CA016087-32]; American Cancer Society; National Institutes of Health (NIH) [T32 CA009161, T32 DK083256-02, R01AI085166]; Human Frontier Science Program Long-Term Fellowship; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA016087, T32CA009161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK083256] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Yue and J. Hall for comments on the manuscript and members of the Littman laboratory for their suggestions. We thank the NYU Histology Core, which is supported in part by grant 5P30CA016087-32 from the National Cancer Institute. Supported by the American Cancer Society and National Institutes of Health (NIH) T32 CA009161 (G.E.D.), NIH T32 DK083256-02 (R.S.L.), Human Frontier Science Program Long-Term Fellowship (B.B.), NIH R01AI085166 (S.R.S) and the Howard Hughes Medical Institute (D.R.L.).	Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Griffin AJ, 2011, MUCOSAL IMMUNOL, V4, P371, DOI 10.1038/mi.2011.2; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; MacPherson AJ, 2004, ANN NY ACAD SCI, V1029, P36, DOI 10.1196/annals.1309.005; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rydstrom A, 2007, J IMMUNOL, V178, P5789, DOI 10.4049/jimmunol.178.9.5789; Sartor RB, 2007, J CLIN GASTROENTEROL, V41, pS37, DOI 10.1097/MCG.0b013e31802db364; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Thiennimitr P, 2012, CURR OPIN MICROBIOL, V15, P108, DOI 10.1016/j.mib.2011.10.002; Valdez Y, 2008, CELL MICROBIOL, V10, P1646, DOI 10.1111/j.1462-5822.2008.01155.x; Vallon-Eberhard A, 2006, J IMMUNOL, V176, P2465, DOI 10.4049/jimmunol.176.4.2465; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	30	306	323	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					116	120		10.1038/nature11809	http://dx.doi.org/10.1038/nature11809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23334413	Green Accepted			2022-12-28	WOS:000314741200045
J	Joo, S; Kim, T; Shin, SH; Lim, JY; Hong, J; Song, JD; Chang, J; Lee, HW; Rhie, K; Han, SH; Shin, KH; Johnson, M				Joo, Sungjung; Kim, Taeyueb; Shin, Sang Hoon; Lim, Ju Young; Hong, Jinki; Song, Jin Dong; Chang, Joonyeon; Lee, Hyun-Woo; Rhie, Kungwon; Han, Suk Hee; Shin, Kyung-Ho; Johnson, Mark			Magnetic-field-controlled reconfigurable semiconductor logic	NATURE			English	Article							MAGNETOCONCENTRATION	Logic devices based on magnetism show promise for increasing computational efficiency while decreasing consumed power. They offer zero quiescent power and yet combine novel functions such as programmable logic operation and non-volatile built-in memory(1-5). However, practical efforts to adapt a magnetic device to logic suffer from a low signal-to-noise ratio and other performance attributes that are not adequate for logic gates. Rather than exploiting magnetoresistive effects that result from spin-dependent transport of carriers, we have approached the development of a magnetic logic device in a different way: we use the phenomenon of large magnetoresistance found in non-magnetic semiconductors in high electric fields(6,7). Here we report a device showing a strong diode characteristic that is highly sensitive to both the sign and the magnitude of an external magnetic field, offering a reversible change between two different characteristic states by the application of a magnetic field. This feature results from magnetic control of carrier generation(8) and recombination in an InSb p-n bilayer channel(9). Simple circuits combining such elementary devices are fabricated and tested, and Boolean logic functions including AND, OR, NAND and NOR are performed. They are programmed dynamically by external electric or magnetic signals, demonstrating magnetic-field-controlled semiconductor reconfigurable logic at room temperature. This magnetic technology permits a new kind of spintronic device, characterized as a current switch rather than a voltage switch, and provides a simple and compact platform for non-volatile reconfigurable logic devices.	[Joo, Sungjung; Kim, Taeyueb; Chang, Joonyeon; Han, Suk Hee; Shin, Kyung-Ho] KIST, Spin Convergence Res Ctr, Seoul 130650, South Korea; [Joo, Sungjung; Kim, Taeyueb; Hong, Jinki; Rhie, Kungwon] Korea Univ, Dept Display & Semicond Phys, Sejong 339700, South Korea; [Shin, Sang Hoon; Lim, Ju Young; Song, Jin Dong] KIST, Nano Photon Res Ctr, Seoul 130650, South Korea; [Lee, Hyun-Woo] Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea; [Johnson, Mark] USN, Res Lab, Washington, DC 20375 USA	Korea Institute of Science & Technology (KIST); Korea University; Korea Institute of Science & Technology (KIST); Pohang University of Science & Technology (POSTECH); United States Department of Defense; United States Navy; Naval Research Laboratory	Hong, J (corresponding author), Korea Univ, Dept Display & Semicond Phys, Sejong 339700, South Korea.	jkhongjkhong@korea.ac.kr; jdsong@kist.re.kr	Song, Jin/HHS-8731-2022; Lee, Hyun-Woo/B-8995-2008	Lee, Hyun-Woo/0000-0002-1648-8093	KIST; NRF; MEST [2010-0000506, 2011-0012386, 2012-0005631, 2012K001280]; industrial strategic technology development programme; MKE [KI002182]; GRL; Office of Naval Research	KIST(Korea Institute of Science & Technology Information (KISTI)); NRF; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); industrial strategic technology development programme; MKE(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); GRL; Office of Naval Research(Office of Naval Research)	This work was supported by the KIST vision 21 programme, NRF grants funded by MEST (2010-0000506,2011-0012386 and 2012-0005631), the industrial strategic technology development programme funded by MKE (KI002182), the Dream project, MEST (2012K001280), GRL and the Office of Naval Research.	Behin-Aein B, 2010, NAT NANOTECHNOL, V5, P266, DOI [10.1038/nnano.2010.31, 10.1038/NNANO.2010.31]; CHOVET A, 1975, PHYS STATUS SOLIDI A, V28, P633, DOI 10.1002/pssa.2210280230; Ciccarelli C, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3475771; CRISTOLOVEANU S, 1980, J PHYS C SOLID STATE, V13, P5983, DOI 10.1088/0022-3719/13/32/020; Delmo MP, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238361; Delmo MP, 2009, NATURE, V457, P1112, DOI 10.1038/nature07711; Dery H, 2007, NATURE, V447, P573, DOI 10.1038/nature05833; Fulling S. A., 2000, LINEARITY MATH SEVER, V343; Hong J., 2012, PREPRINT; Hong J, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2416000; Hosomi M, 2005, INT EL DEVICES MEET, P473; Lee J, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3532105; Lim JY, 2012, THIN SOLID FILMS, V520, P6589, DOI 10.1016/j.tsf.2012.06.077; Massey DJ, 2004, J APPL PHYS, V95, P5931, DOI 10.1063/1.1691177; Moodera JS, 2003, NAT MATER, V2, P707, DOI 10.1038/nmat1006; Ney A, 2003, NATURE, V425, P485, DOI 10.1038/nature02014; Schoonus JJHM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.127202; Sze S. M., 2002, SEMICONDUCTOR DEVICE, V78, P118; Wan CH, 2011, NATURE, V477, P304, DOI 10.1038/nature10375; Xie JJ, 2012, IEEE T ELECTRON DEV, V59, P1475, DOI 10.1109/TED.2012.2187211; Xu P, 2008, NAT NANOTECHNOL, V3, P97, DOI 10.1038/nnano.2008.1	21	82	83	2	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					72	76		10.1038/nature11817	http://dx.doi.org/10.1038/nature11817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23364687				2022-12-28	WOS:000314741200036
J	Kim, C; Wong, J; Wen, JY; Wang, SR; Wang, C; Spiering, S; Kan, NG; Forcales, S; Puri, PL; Leone, TC; Marine, JE; Calkins, H; Kelly, DP; Judge, DP; Chen, HSV				Kim, Changsung; Wong, Johnson; Wen, Jianyan; Wang, Shirong; Wang, Cheng; Spiering, Sean; Kan, Natalia G.; Forcales, Sonia; Puri, Pier Lorenzo; Leone, Teresa C.; Marine, Joseph E.; Calkins, Hugh; Kelly, Daniel P.; Judge, Daniel P.; Chen, Huei-Sheng Vincent			Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs	NATURE			English	Article							PLURIPOTENT STEM-CELLS; DIFFERENTIATION; MECHANISMS; DISEASE; METABOLISM; MODELS; HEART; GAMMA	Cellular reprogramming of somatic cells to patient-specific induced pluripotent stem cells.(iPSCs) enables in vitro modelling of human genetic disorders for pathogenic investigations and therapeutic screens(1-7). However, using iPSC-derived cardiomyocytes (iPSC-CMs) to model an adult-onset heart disease remains challenging owing to the uncertainty regarding the ability of relatively immature iPSC-CMs to fully recapitulate adult disease phenotypes. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited heart disease characterized by pathological fatty infiltration and cardiomyocyte loss predominantly in the right ventricles(8), which is associated with life-threatening ventricular arrhythmias. Over 50% of affected individuals have desmosome gene mutations, most commonly in PKP2, encoding plakophilin-2 (ref. 9). The median age at presentation of ARVD/C is 26 years(8). We used previously published methods(1,10) to generate iPSC lines from fibroblasts of two patients with ARVD/C and PKP2 mutations(11,12). Mutant PKP2 iPSC-CMs demonstrate abnormal plakoglobin nuclear translocation and decreased beta-catenin activity(13) in cardiogenic conditions; yet, these abnormal features are insufficient to reproduce the pathological phenotypes of ARVD/C in standard cardiogenic conditions. Here we show that induction of adult-like metabolic energetics from an embryonic/glycolytic state and abnormal peroxisome proliferator-activated receptor gamma (PPAR-gamma) activation underlie the pathogenesis of ARVD/C. By co-activating normal PPAR-alpha-dependent metabolism and abnormal PPAR-gamma pathway in beating embryoid bodies (EBs) with defined media, we established an efficient ARVD/C in vitro model within 2 months. This model manifests exaggerated lipogenesis and apoptosis in mutant PKP2 iPSC-CMs. iPSC-CMs with a homozygous PKP2 mutation also had calcium-handling deficits. Our study is the first to demonstrate that induction of adult-like metabolism has a critical role in establishing an adult-onset disease model using patient-specific iPSCs. Using this model, we revealed crucial pathogenic insights that metabolic derangement in adult-like metabolic milieu underlies ARVD/C pathologies, enabling us to propose novel disease-modifying therapeutic strategies.	[Kim, Changsung; Wong, Johnson; Wen, Jianyan; Wang, Shirong; Wang, Cheng; Chen, Huei-Sheng Vincent] Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, La Jolla, CA 92037 USA; [Wen, Jianyan] China Japan Friendship Hosp, Dept Cardiovasc Surg, Beijing 100029, Peoples R China; [Spiering, Sean; Kan, Natalia G.; Forcales, Sonia; Puri, Pier Lorenzo] Sanford Burnham Med Res Inst, Muscle Regenerat & Dev Program, La Jolla, CA 92037 USA; [Puri, Pier Lorenzo] IRCCS Fdn Santa Lucia, Dulbecco Telethon Inst, I-00179 Rome, Italy; [Leone, Teresa C.; Kelly, Daniel P.] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA; [Marine, Joseph E.; Calkins, Hugh; Judge, Daniel P.] Johns Hopkins Univ, Sch Med, Dept Med Cardiol, Baltimore, MD 21287 USA; [Chen, Huei-Sheng Vincent] Univ Calif San Diego, Dept Med Cardiol, San Diego, CA 92103 USA	Sanford Burnham Prebys Medical Discovery Institute; China-Japan Friendship Hospital; Sanford Burnham Prebys Medical Discovery Institute; Fondazione Telethon; Dulbecco Telethon Institute (DTI); IRCCS Santa Lucia; Sanford Burnham Prebys Medical Discovery Institute; Johns Hopkins University; University of California System; University of California San Diego	Chen, HSV (corresponding author), Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, La Jolla, CA 92037 USA.	hsv_chen@burnham.org	Forcales, Sonia-V./B-2157-2013; Kelly, Daniel/ABG-2056-2021; Forcales, Sonia/AAU-8996-2020	Forcales, Sonia-V./0000-0002-7111-4959; Forcales, Sonia/0000-0002-7111-4959; Wong, Johnson/0000-0002-5838-8453; Judge, Daniel/0000-0002-3407-0248; wen, jianyan/0000-0001-5762-6504	Scripps Research Institute; NIH [RO1 HL058493, RO1 HL101189, RO1 AR056712, RO1 AR052779, RO1 HL105194]; California Institute of Regenerative Medicine (CIRM) [RS1-00171-1, RB2-01512, RB4-06276]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105194, R01HL058493, R01HL101189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052779, R01AR056712] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	Scripps Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Fondazione Telethon(Fondazione Telethon)	We thank the patients for their participation, microarray core facilities at SBMRI and Scripps Research Institute for their support T. Yi for technical assistance, and G. W. Rogers for assistance in metabolic assays. This work was supported by NIH grants (RO1 HL058493 and RO1 HL101189) (to D.P.K); NIH grants (RO1 AR056712 and RO1 AR052779) (to P.L.P); California Institute of Regenerative Medicine (CIRM) grants (RS1-00171-1, RB2-01512 and RB4-06276) and NIH grant (RO1 HL105194) (to H.-S.V.C).	Ali AT, 2006, ANAL BIOCHEM, V354, P247, DOI 10.1016/j.ab.2006.04.028; Awad MM, 2008, NAT CLIN PRACT CARD, V5, P258, DOI 10.1038/ncpcardio1182; Awad Mark M, 2006, Hum Mutat, V27, P1157, DOI 10.1002/humu.9461; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Calkins Hugh, 2008, Curr Cardiol Rep, V10, P367, DOI 10.1007/s11886-008-0059-4; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Dalal D, 2006, CIRCULATION, V113, P1641, DOI 10.1161/CIRCULATIONAHA.105.568642; Djouadi F, 2009, CARDIOVASC RES, V84, P83, DOI 10.1093/cvr/cvp183; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Lombardi R, 2009, CIRC RES, V104, P1076, DOI 10.1161/CIRCRESAHA.109.196899; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Onay-Besikci A, 2006, MOL CELL BIOCHEM, V287, P1, DOI 10.1007/s11010-006-9123-9; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Scolletta S, 2010, BIOMED PHARMACOTHER, V64, P203, DOI 10.1016/j.biopha.2009.10.002; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Waku T, 2010, EMBO J, V29, P3395, DOI 10.1038/emboj.2010.197; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	30	362	378	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					105	110		10.1038/nature11799	http://dx.doi.org/10.1038/nature11799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23354045	Green Accepted			2022-12-28	WOS:000314741200043
J	O'Garra, A				O'Garra, Anne			Brigitte Askonas (1923-2013) OBITUARY	NATURE			English	Biographical-Item									MRC, Natl Inst Med Res Mill Hill, Div Immunoregulat, London W1N 4AL, England		O'Garra, A (corresponding author), MRC, Natl Inst Med Res Mill Hill, Div Immunoregulat, London W1N 4AL, England.	aogarra@nimr.mrc.ac.uk		O'Garra, Anne/0000-0001-9845-6134	Medical Research Council [MC_U117565642] Funding Source: Medline; MRC [MC_U117565642] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2013	494	7435					37	37		10.1038/494037a	http://dx.doi.org/10.1038/494037a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389536	Bronze			2022-12-28	WOS:000314741200024
J	Hemingway, H; Croft, P; Perel, P; Hayden, JA; Abrams, K; Timmis, A; Briggs, A; Udumyan, R; Moons, KGM; Steyerberg, EW; Roberts, I; Schroter, S; Altman, DG; Riley, RD				Hemingway, Harry; Croft, Peter; Perel, Pablo; Hayden, Jill A.; Abrams, Keith; Timmis, Adam; Briggs, Andrew; Udumyan, Ruzan; Moons, Karel G. M.; Steyerberg, Ewout W.; Roberts, Ian; Schroter, Sara; Altman, Douglas G.; Riley, Richard D.		PROGRESS Grp	Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN; POPULATION-BASED INTERVENTION; CORONARY-HEART-DISEASE; ANGINA-PECTORIS; FOLLOW-UP; MORTALITY; SURVIVAL; RISK; PREDICTION; MANAGEMENT		[Hemingway, Harry; Udumyan, Ruzan] UCL, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England; [Croft, Peter] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Perel, Pablo; Roberts, Ian] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Hayden, Jill A.] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS B3H 1V7, Canada; [Abrams, Keith] Univ Leicester, Ctr Biostat & Genet Epidemiol, Dept Hlth Sci, Sch Med, Leicester LE1 7RH, Leics, England; [Timmis, Adam] London Chest Hosp, London E2 9JX, England; [Briggs, Andrew] Univ Glasgow, Ctr Populat & Hlth Sci, Glasgow G12 8RZ, Lanark, Scotland; [Moons, Karel G. M.] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Schroter, Sara] BMA House, BMJ, London WC1H 9JR, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England; [Riley, Richard D.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of London; University College London; Keele University; University of London; London School of Hygiene & Tropical Medicine; Dalhousie University; University of Leicester; University of London; Queen Mary University London; University of Glasgow; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Oxford; University of Birmingham	Hemingway, H (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England.	h.hemingway@ucl.ac.uk	Riley, Richard David/ABE-5877-2020; Peat, George/AAE-5869-2020; Riley, Richard/G-2406-2011; Abrams, Keith/AAA-2557-2020; Schroter, Sara/G-3427-2012; Steyerberg, Ewout W/C-1509-2018; Briggs, Andrew/ABA-9009-2020; Malats, Nuria/H-7041-2015; Udumyan, Ruzan/ABG-1943-2021; Hemingway, Harry/C-1219-2009	Riley, Richard David/0000-0001-8699-0735; Peat, George/0000-0002-9008-0184; Schroter, Sara/0000-0002-8791-8564; Steyerberg, Ewout W/0000-0002-7787-0122; Briggs, Andrew/0000-0002-0777-1997; Malats, Nuria/0000-0003-2538-3784; Hemingway, Harry/0000-0003-2279-0624; Abrams, Keith/0000-0002-7557-1567; Hayden, Jill Alison/0000-0001-7026-144X; Kyzas, Panayiotis/0000-0003-1034-9145; /0000-0002-2342-301X; Hingorani, Aroon/0000-0001-8365-0081; Sauerbrei, Willi/0000-0002-6792-4123	Medical Research Council [G0902393]; University College London; Oxford University; Birmingham University; London School of Hygiene and Tropical Medicine; Keele University; Queen Mary University London; Cancer Research UK [C5529]; UK National Institute for Health Research [RP-PG-0407-10314]; Wellcome Trust [086091/Z/08/Z]; Health eResearch Centre Network (HERC-UK); Arthritis Research UK; British Heart Foundation; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute of Health Research; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); MRC Midlands Hub for Trials Methodology Research; Canadian Institutes of Health Research; Nova Scotia Health Research Foundation; Netherlands Organization for Scientific Research [ZON-MW 918.10.615, 9120.8004]; UK National Institute of Health Research Senior Investigator Award [NI-SI-0509-10183, NI-SI-0508-10061]; Medical Research Council [MR/K006584/1, G0800808] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10386, NF-SI-0509-10183, RP-PG-0407-10314, NF-SI-0512-10159] Funding Source: researchfish; MRC [G0902393, G0800808] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London(General Electric); Oxford University; Birmingham University; London School of Hygiene and Tropical Medicine; Keele University; Queen Mary University London; Cancer Research UK(Cancer Research UK); UK National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Health eResearch Centre Network (HERC-UK); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); MRC Midlands Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); UK National Institute of Health Research Senior Investigator Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This series had no explicit funding, but some of the authors were supported by research grants: PROGRESS is supported by a Partnership grant from the Medical Research Council (G0902393), involving University College London (HH, AH), Oxford University (DGA), Birmingham University (RDR), London School of Hygiene and Tropical Medicine (IR, PP), Keele University (PC, D van der Windt), and Queen Mary University London (ADT). DGA is supported by a programme grant from Cancer Research UK (C5529). HH is supported by grants from the UK National Institute for Health Research (RP-PG-0407-10314) and the Wellcome Trust (086091/Z/08/Z). The work of HH and AT is supported by the Health eResearch Centre Network (HERC-UK), funded by the Medical Research Council in partnership with Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates) and the Wellcome Trust (the views expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health). RDR is supported by the MRC Midlands Hub for Trials Methodology Research. JAH is supported by a New Investigator Award from the Canadian Institutes of Health Research and a grant from the Nova Scotia Health Research Foundation, and holds a Dalhousie University/CCRF research professorship. KGMM is supported by The Netherlands Organization for Scientific Research (ZON-MW 918.10.615 and 9120.8004). EWS was supported by The Netherlands Organization for Scientific Research (grant 9120.8004). PC holds a UK National Institute of Health Research Senior Investigator Award (NI-SI-0509-10183). KA holds a UK National Institute of Health Research Senior Investigator Award (NI-SI-0508-10061).	[Anonymous], DEC MAK TOOLS HLTH C; [Anonymous], PROGNOSTIC FACTORS C; Bajaj A, 2010, CANCER CAUSE CONTROL, V21, P697, DOI 10.1007/s10552-009-9497-6; Buchbinder R, 2004, BRIT MED J, V328, P321, DOI 10.1136/bmj.328.7435.321; Buchbinder R, 2001, BRIT MED J, V322, P1516, DOI 10.1136/bmj.322.7301.1516; Cancer Research UK, 2009, LANCET ONCOLOGY; CancerGuide: Statistics, STAT MED ISNT MESS; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Clarke M, 1998, LANCET, V351, P1451; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Costa LDM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3829; Croft PR, 1998, BRIT MED J, V316, P1356, DOI 10.1136/bmj.316.7141.1356; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Department of Health, 2010, EQ EXC LIB NHS; Dunn KM, 2006, PAIN, V121, P126, DOI 10.1016/j.pain.2005.12.012; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Griffin SC, 2007, BMJ-BRIT MED J, V334, P624, DOI 10.1136/bmj.39129.442164.55; Guyatt G., 2008, USERS GUIDES MEDICAL; Hanauer DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005203; Hemingway H, 2003, BRIT MED J, V327, P895, DOI 10.1136/bmj.327.7420.895; Hemingway H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000286; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Henderson R, 2005, J MED ETHICS, V31, P703, DOI 10.1136/jme.2005.012427; Hestbaek L, 2003, EUR SPINE J, V12, P149, DOI 10.1007/s00586-002-0508-5; Hingorani AD, 2013, BMJ-BRIT MED J, V346, pe5793; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Kroenke K, 2001, ANN INTERN MED, V134, P801, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00001; Krumholz HM, 2008, CIRCULATION, V118, P309, DOI 10.1161/CIRCULATIONAHA.107.690917; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; National Cancer Institute, SURV EP END RES; National Institute for Health and Clinical Excellence, CHEST PAIN REC ONS A; Nissen H, 2002, LETT APPL MICROBIOL, V35, P433, DOI 10.1046/j.1472-765X.2002.01218.x; O'Neill CJ, 2010, J SURG ONCOL, V102, P450, DOI 10.1002/jso.21553; Probst V, 2010, CIRCULATION, V121, P635, DOI 10.1161/CIRCULATIONAHA.109.887026; Repping-Wuts H, 2008, INT J NURS STUD, V45, P995, DOI 10.1016/j.ijnurstu.2007.06.007; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Rose G., 1993, STRATEGY PREVENTIVE; Royston P, 2008, JNCI-J NATL CANCER I, V100, P92, DOI 10.1093/jnci/djm265; SCADDING JG, 1967, LANCET, V2, P877; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Steyerberg EW, 2013, PLOS MED, DOI 10.1371.journal/pmed.1001381; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Tsai HP, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-42; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; Von Korff M, 2005, PAIN, V117, P304, DOI 10.1016/j.pain.2005.06.017; VONKORFF M, 1993, SPINE, V18, P855, DOI 10.1097/00007632-199306000-00008; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Wiesemann C, 1998, THEOR MED BIOETH, V19, P253, DOI 10.1023/A:1009913915839	61	314	315	3	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2013	346								e5595	10.1136/bmj.e5595	http://dx.doi.org/10.1136/bmj.e5595			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088AR	23386360	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000314806700016
J	Marshall, M; Pronovost, P; Dixon-Woods, M				Marshall, Martin; Pronovost, Peter; Dixon-Woods, Mary			Promotion of improvement as a science	LANCET			English	Editorial Material							BLOOD-STREAM INFECTIONS; QUALITY IMPROVEMENT; HEALTH-CARE; PROGRAM; SAFETY		[Marshall, Martin] UCL, London W1T 7HA, England; [Pronovost, Peter] Johns Hopkins Univ, Sch Med, Dept Anesthesiol Crit Care Med, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Pronovost, Peter] Johns Hopkins Univ, Sch Med, Dept Surg, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Dixon-Woods, Mary] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of London; University College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Leicester	Marshall, M (corresponding author), UCL, 3rd Floor,170 Tottenham Court Rd, London W1T 7HA, England.	martin.marshall@islondon.org		Dixon-Woods, Mary/0000-0002-5915-0041	Wellcome Trust [097899] Funding Source: Medline; WETP NIH HHS [WT097899MF] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); WETP NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abbasi, 2011, IMPROVEMENT PRACTICE; Alexander JA, 2011, MED CARE, V49, pS6, DOI 10.1097/MLR.0b013e3181e1709c; Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Dixon-Woods M, 2011, MILBANK Q, V89, P167, DOI 10.1111/j.1468-0009.2011.00625.x; Faden RR, 2011, HASTINGS CENT REP, V41, P3; Feder G, 2011, LANCET, V378, P1788, DOI 10.1016/S0140-6736(11)61179-3; Institute of Medicine, 2012, BEST CAR LOW COST PA; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; LIPSEY M, 1990, RES METHODOLOGY STRE, P33; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; QIPP/ Right Care, 2010, NHS ATL VAR HEALTHC; Shojania KG, 2005, HEALTH AFFAIR, V24, P138, DOI 10.1377/hlthaff.24.1.138; The Health Foundation, 2011, IMPR SCI RES SCAN; Varkey P, 2007, MAYO CLIN PROC, V82, P735, DOI 10.4065/82.6.735; Wachter RM, 2010, HEALTH AFFAIR, V29, P165, DOI 10.1377/hlthaff.2009.0785	19	107	110	1	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2013	381	9864					419	421		10.1016/S0140-6736(12)61850-9	http://dx.doi.org/10.1016/S0140-6736(12)61850-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084ZA	23374480	Green Submitted			2022-12-28	WOS:000314578900039
J	Foulquier, S; Steckelings, UM; Unger, T				Foulquier, Sebastien; Steckelings, Ulrike Muscha; Unger, Thomas			PERSPECTIVE A tale of two receptors	NATURE			English	Editorial Material							ANGIOTENSIN; STIMULATION		[Foulquier, Sebastien] Maastricht Univ, Sch Cardiovasc Dis, CARIM, Maastricht, Netherlands; [Steckelings, Ulrike Muscha] Univ So Denmark, Inst Mol Med, Odense, Denmark	Maastricht University; Maastricht University Medical Centre (MUMC); University of Southern Denmark	Foulquier, S (corresponding author), Maastricht Univ, Sch Cardiovasc Dis, CARIM, Maastricht, Netherlands.	s.foulquier@maastrichtuniversity.nl	Foulquier, Sébastien/AAE-6998-2019	Foulquier, Sébastien/0000-0002-2523-0748; Steckelings, Ulrike Muscha/0000-0002-5430-4275				Altarche-Xifro W, 2009, STEM CELLS, V27, P2488, DOI 10.1002/stem.171; Curato C, 2010, J IMMUNOL, V185, P6286, DOI 10.4049/jimmunol.0903681; Foulquier S, 2012, CURR HYPERTENS REP, V14, P403, DOI 10.1007/s11906-012-0291-6; Kaschina E, 2008, CIRCULATION, V118, P2523, DOI 10.1161/CIRCULATIONAHA.108.784868; Paulis L, 2012, HYPERTENSION, V59, P485, DOI 10.1161/HYPERTENSIONAHA.111.185496; Rehman A, 2012, HYPERTENSION, V59, P291, DOI 10.1161/HYPERTENSIONAHA.111.180158; Steckelings UM, 2010, J HYPERTENS, V28, pS50, DOI 10.1097/01.hjh.0000388495.66330.63	7	14	15	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S9	S9		10.1038/493S9a	http://dx.doi.org/10.1038/493S9a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364772	Bronze			2022-12-28	WOS:000314219600008
J	Zala, D; Hinckelmann, MV; Yu, H; da Cunha, MML; Liot, G; Cordelieres, FP; Marco, S; Saudou, F				Zala, Diana; Hinckelmann, Maria-Victoria; Yu, Hua; da Cunha, Marcel Menezes Lyra; Liot, Geraldine; Cordelieres, Fabrice P.; Marco, Sergio; Saudou, Frederic			Vesicular Glycolysis Provides On-Board Energy for Fast Axonal Transport	CELL			English	Article							CULTURED HIPPOCAMPAL-NEURONS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PROTEOMIC ANALYSIS; ENZYME-ACTIVITY; MICROTUBULES; PROTEINS; KINESIN; DISEASE; DYNEIN; BRAIN	Fast axonal transport (FAT) requires consistent energy over long distances to fuel the molecular motors that transport vesicles. We demonstrate that glycolysis provides ATP for the FAT of vesicles. Although inhibiting ATP production from mitochondria did not affect vesicles motility, pharmacological or genetic inhibition of the glycolytic enzyme GAPDH reduced transport in cultured neurons and in Drosophila larvae. GAPDH localizes on vesicles via a huntingtin-dependent mechanism and is transported on fast-moving vesicles within axons. Purified motile vesicles showed GAPDH enzymatic activity and produced ATP. Finally, we show that vesicular GAPDH is necessary and sufficient to provide on-board energy for fast vesicular transport. Although detaching GAPDH from vesicles reduced transport, targeting GAPDH to vesicles was sufficient to promote FAT in GAPDH deficient neurons. This specifically localized glycolytic machinery may supply constant energy, independent of mitochondria, for the processive movement of vesicles over long distances in axons.	[Zala, Diana; Hinckelmann, Maria-Victoria; Yu, Hua; da Cunha, Marcel Menezes Lyra; Liot, Geraldine; Cordelieres, Fabrice P.; Marco, Sergio; Saudou, Frederic] Inst Curie, F-91405 Orsay, France; [Zala, Diana; Hinckelmann, Maria-Victoria; Yu, Hua; Liot, Geraldine; Saudou, Frederic] CNRS, UMR3306, F-91405 Orsay, France; [Zala, Diana; Hinckelmann, Maria-Victoria; Yu, Hua; Liot, Geraldine; Saudou, Frederic] INSERM, U1005, F-91405 Orsay, France; [da Cunha, Marcel Menezes Lyra; Marco, Sergio] INSERM, U759, F-91405 Orsay, France; [Cordelieres, Fabrice P.] Inst Curie, IBiSA Cell & Tissue Imaging Facil, F-91405 Orsay, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Saudou, F (corresponding author), Inst Curie, F-91405 Orsay, France.	frederic.saudou@curie.fr	Cordelières, Fabrice P/G-3574-2017; ZALA, Diana/L-4651-2017; marco, SERGIO/E-4875-2017; Zala, Diana/R-8196-2019; Cunha, Marcel/J-3929-2014; marco garrido, sergio/F-5876-2013; SAUDOU, Frédéric/L-3454-2014	Cordelières, Fabrice P/0000-0002-5383-5816; ZALA, Diana/0000-0002-0052-8011; Zala, Diana/0000-0002-0052-8011; SAUDOU, Frédéric/0000-0001-6107-1046; Liot, Geraldine/0000-0002-4784-7693	Agence Nationale pour la Recherche [ANR-08-MNP-039]; Association pour la Recherche sur le Cancer [ARC 4950]; Fondation pour la Recherche Medicale (FRM, equipe labellisee); CNRS; INSERM; Institut Curie; Association Huntington France; CHDI Foundation Inc.; Fondation Pierre-Gilles de Gennes pour la Recherche	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale (FRM, equipe labellisee); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Curie; Association Huntington France; CHDI Foundation Inc.; Fondation Pierre-Gilles de Gennes pour la Recherche	We thank S. Humbert for support and discussions; E. Brouillet, A. Echard, A. Gautreau, F. Mochel, F. Perez, and, members of the Saudou and Humbert labs for helpful comments and/or reading of the manuscript; P. Pla, Y. Elipot, S. Bertho, C. Benstaali, and C. Lemercier for help with experiments; M. Chao, J.L. Dreyer, E.L. Holzbaur, M.A. Silverman, M.-L. Parmentier, M. Piel, A. Sawa, T. Schwarz, H. Yano, and G. Yellen for reagents and/or discussions. This work was supported by grants from Agence Nationale pour la Recherche (ANR-08-MNP-039, F.S.), Association pour la Recherche sur le Cancer (ARC 4950, F.S.), Fondation pour la Recherche Medicale (FRM, equipe labellisee) (F.S.), CNRS, INSERM, and the Institut Curie (F.S.). For fellowship support we thank: Association Huntington France (M.-V.H.), Institut Curie (D.Z.), CHDI Foundation Inc. (D.Z., G.L.), and Fondation Pierre-Gilles de Gennes pour la Recherche (D.Z., G.L.). F.C. and H.Y. are CNRS engineers and F.S. is an INSERM investigator. The authors declare no competing financial interests.	Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Bae Y, 2006, P NATL ACAD SCI USA, V103, P3405, DOI 10.1073/pnas.0511316103; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; Burre J, 2007, J NEUROCHEM, V101, P1448, DOI 10.1111/j.1471-4159.2007.04453.x; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Culver BP, 2012, J BIOL CHEM, V287, P21599, DOI 10.1074/jbc.M112.359307; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; DURRIEU C, 1987, ARCH BIOCHEM BIOPHYS, V252, P32, DOI 10.1016/0003-9861(87)90005-1; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; HUITOREL P, 1985, EUR J BIOCHEM, V150, P265, DOI 10.1111/j.1432-1033.1985.tb09016.x; Ikemoto A, 2003, J BIOL CHEM, V278, P5929, DOI 10.1074/jbc.M211617200; Kaasik A, 2007, J BIOL CHEM, V282, P32821, DOI 10.1074/jbc.M702295200; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kwinter DM, 2009, NEUROSCIENCE, V162, P1001, DOI 10.1016/j.neuroscience.2009.05.038; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Ratovitski T, 2012, CELL CYCLE, V11, P2006, DOI 10.4161/cc.20423; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Schmidt Maike M, 2009, Front Neuroenergetics, V1, P1, DOI 10.3389/neuro.14.001.2009; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Yang JY, 2005, BIOCHEMISTRY-US, V44, P11903, DOI 10.1021/bi0508082	39	310	311	0	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					479	491		10.1016/j.cell.2012.12.029	http://dx.doi.org/10.1016/j.cell.2012.12.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374344	Bronze			2022-12-28	WOS:000314362800018
J	Benniston, A				Benniston, Andrew			Corralling Positively Charged Molecular Radicals	SCIENCE			English	Editorial Material									Newcastle Univ, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Benniston, A (corresponding author), Newcastle Univ, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	andrew.benniston@newcastle.ac.uk	Benniston, Andrew/AAH-6219-2021	Benniston, Andrew/0000-0001-8878-5014				Amabilino DB, 1995, CHEM REV, V95, P2725, DOI 10.1021/cr00040a005; Barnes JC, 2013, SCIENCE, V339, P429, DOI 10.1126/science.1228429; Kay ER, 2005, TOP CURR CHEM, V262, P133, DOI 10.1007/128_011; SAUVAGE JP, 1990, ACCOUNTS CHEM RES, V23, P319, DOI 10.1021/ar00178a001; Schill G., 1971, CATENANES ROTAXANES; Vickers MS, 2007, CHEM SOC REV, V36, P211, DOI 10.1039/b518077p	6	2	2	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					404	405		10.1126/science.1233633	http://dx.doi.org/10.1126/science.1233633			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349279				2022-12-28	WOS:000313960700028
J	Dharmarajan, K; Hsieh, AF; Lin, ZQ; Bueno, H; Ross, JS; Horwitz, LI; Barreto, JA; Kim, N; Bernheim, SM; Suter, LG; Drye, EE; Krumholz, HM				Dharmarajan, Kumar; Hsieh, Angela F.; Lin, Zhenqiu; Bueno, Hector; Ross, Joseph S.; Horwitz, Leora I.; Barreto-Filho, Jose Augusto; Kim, Nancy; Bernheim, Susannah M.; Suter, Lisa G.; Drye, Elizabeth E.; Krumholz, Harlan M.			Diagnoses and Timing of 30-Day Readmissions After Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESTRICTED ACTIVITY; INPATIENT CARE; RISK-FACTORS; REHOSPITALIZATION; QUALITY; MANAGEMENT; RATES; INTERVENTION; ASSOCIATION; PERFORMANCE	Importance To better guide strategies intended to reduce high rates of 30-day readmission after hospitalization for heart failure (HF), acute myocardial infarction (MI), or pneumonia, further information is needed about readmission diagnoses, readmission timing, and the relationship of both to patient age, sex, and race. Objective To examine readmission diagnoses and timing among Medicare beneficiaries readmitted within 30 days after hospitalization for HF, acute MI, or pneumonia. Design, Setting, and Patients We analyzed 2007-2009 Medicare fee-for-service claims data to identify patterns of 30-day readmission by patient demographic characteristics and time after hospitalization for HF, acute MI, or pneumonia. Readmission diagnoses were categorized using an aggregated version of the Centers for Medicare & Medicaid Services' Condition Categories. Readmission timing was determined by day after discharge. Main Outcome Measures We examined the percentage of 30-day readmissions occurring on each day (0-30) after discharge; the most common readmission diagnoses occurring during cumulative periods (days 0-3, 0-7, 0-15, and 0-30) and consecutive periods (days 0-3, 4-7, 8-15, and 16-30) after hospitalization; median time to readmission for common readmission diagnoses; and the relationship between patient demographic characteristics and readmission diagnoses and timing. Results From 2007 through 2009, we identified 329 308 30-day readmissions after 1 330 157 HF hospitalizations (24.8% readmitted), 108 992 30-day readmissions after 548 834 acute MI hospitalizations (19.9% readmitted), and 214 239 30-day readmissions after 1 168 624 pneumonia hospitalizations (18.3% readmitted). The proportion of patients readmitted for the same condition was 35.2% after the index HF hospitalization, 10.0% after the index acute MI hospitalization, and 22.4% after the index pneumonia hospitalization. Of all readmissions within 30 days of hospitalization, the majority occurred within 15 days of hospitalization: 61.0%, HF cohort; 67.6%, acute MI cohort; and 62.6%, pneumonia cohort. The diverse spectrum of readmission diagnoses was largely similar in both cumulative and consecutive periods after discharge. Median time to 30-day readmission was 12 days for patients initially hospitalized for HF, 10 days for patients initially hospitalized for acute MI, and 12 days for patients initially hospitalized for pneumonia and was comparable across common readmission diagnoses. Neither readmission diagnoses nor timing substantively varied by age, sex, or race. Conclusion and Relevance Among Medicare fee-for-service beneficiaries hospitalized for HF, acute MI, or pneumonia, 30-day readmissions were frequent throughout the month after hospitalization and resulted from a similar spectrum of readmission diagnoses regardless of age, sex, race, or time after discharge. JAMA. 2013;309(4):355-363 www.jama.com	[Dharmarajan, Kumar] Columbia Univ, Med Ctr, Dept Internal Med, Div Cardiol, New York, NY USA; [Dharmarajan, Kumar; Hsieh, Angela F.; Lin, Zhenqiu; Ross, Joseph S.; Horwitz, Leora I.; Barreto-Filho, Jose Augusto; Kim, Nancy; Bernheim, Susannah M.; Drye, Elizabeth E.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Bueno, Hector] Hosp Gen Univ Gregorio Maranon, Dept Cardiol, Madrid, Spain; [Ross, Joseph S.; Horwitz, Leora I.; Kim, Nancy] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT USA	Columbia University; Yale University; General University Gregorio Maranon Hospital; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	Horwitz, Leora/A-6959-2009; , Harlan/AAI-2875-2020; Horwitz, Leora/ABD-1292-2020; Bueno, Hector/I-3910-2015	Horwitz, Leora/0000-0003-1800-6040; Bueno, Hector/0000-0003-0277-7596; Ross, Joseph/0000-0002-9218-3320	AstraZeneca; Bayer; DaiichiSankyo; Eli Lilly; Novartis; Roche; Medtronic through Yale University; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute [1U01HL105270-03]; National Heart, Lung, and Blood Institute [T32 HL007854]; National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program [K08 AG032886, K08 AG038336]; CAPES (Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior, Ministry of Education, Brazil) [3436-10-1]; Federal University of Sergipe, Brazil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270, T32HL007854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG038336, K08AG032886] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); Bayer(Bayer AG); DaiichiSankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Novartis(Novartis); Roche(Roche Holding); Medtronic through Yale University; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; CAPES (Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior, Ministry of Education, Brazil); Federal University of Sergipe, Brazil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Bernheim, Drye, Horwitz, Kim, Krumholz, Lin, Ross, and Suter work under contract with the Centers for Medicare & Medicaid Services to develop and maintain performance measures. Dr Bueno reported that he has received speaking or advisory fees from AstraZeneca, Bayer, DaiichiSankyo, Eli Lilly, Novartis, and Roche. Dr Krumholz reported that he is chair of a cardiac scientific advisory board for UnitedHealth. Dr Ross reported that he is a member of a scientific advisory board for FAIR Health. Drs Krumholz and Ross are the recipients of a research grant from Medtronic through Yale University.; This study was funded by grant 1U01HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. Dr Dharmarajan is supported by grant T32 HL007854 from the National Heart, Lung, and Blood Institute; he is also supported as a Centers of Excellence Scholar in Geriatric Medicine at Yale by the John A. Hartford Foundation and the American Federation for Aging Research. Drs Ross and Horwitz are supported by grants K08 AG032886 and K08 AG038336 from the National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program, respectively. Dr Barreto-Filho is supported by grant 3436-10-1 from CAPES (Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior, Ministry of Education, Brazil) and the Federal University of Sergipe, Brazil.	Ashton CM, 1996, SOC SCI MED, V43, P1533, DOI 10.1016/S0277-9536(96)00049-4; ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; Ashton CM, 1997, MED CARE, V35, P1044, DOI 10.1097/00005650-199710000-00006; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; Centers for Medicare & Medicaid Services, 2011, MED HOSP QUAL CHARTB; Centers for Medicare & Medicaid Services Hospital Pay-for-Performance Workgroup, 2007, 1 PUBL SESS WASH DC; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Dunlay SM, 2012, ANN INTERN MED, V157, P11, DOI 10.7326/0003-4819-157-1-201207030-00004; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Friedman MM, 1997, HEART LUNG, V26, P169, DOI 10.1016/S0147-9563(97)90053-4; Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jasti H, 2008, CLIN INFECT DIS, V46, P550, DOI 10.1086/526526; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kiely DK, 2003, J GERONTOL A-BIOL, V58, P441, DOI 10.1093/gerona/58.5.M441; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Koehler F, 2011, CIRCULATION, V123, P1873, DOI 10.1161/CIRCULATIONAHA.111.018473; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; McBean A Marshall, 2006, Medicare Brief, P1; Medicare Payment Advisory Commission, 2007, PROM GREAT EFF MED; National Quality Forum, 2008, NAT VOL CONS STAND H; NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005; O'Connor CM, 2010, AM HEART J, V159, P841, DOI 10.1016/j.ahj.2010.02.023; Poch DS, 2009, SEMIN RESP CRIT CARE, V30, P26, DOI 10.1055/s-0028-1119806; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Riegel B, 2006, J CARD FAIL, V12, P211, DOI 10.1016/j.cardfail.2006.01.005; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; Skull SA, 2008, EPIDEMIOL INFECT, V136, P232, DOI 10.1017/S0950268807008564; Sochalski J, 2009, HEALTH AFFAIR, V28, P179, DOI 10.1377/hlthaff.28.1.179; Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013; Witte KKA, 2006, HEART, V92, P481, DOI 10.1136/hrt.2004.058073; Wong FKY, 2008, J ADV NURS, V62, P585, DOI 10.1111/j.1365-2648.2008.04631.x; Yoder JC, 2012, ARCH INTERN MED, V172, P68, DOI 10.1001/archinternmed.2011.603	49	700	710	4	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					355	363		10.1001/jama.2012.216476	http://dx.doi.org/10.1001/jama.2012.216476			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074FT	23340637	Bronze, Green Accepted			2022-12-28	WOS:000313799000023
J	Reid, IC				Reid, Ian C.			Are antidepressants overprescribed? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EFFICACY		Univ Aberdeen, Div Appl Med, Aberdeen, Scotland	University of Aberdeen	Reid, IC (corresponding author), Univ Aberdeen, Div Appl Med, Aberdeen, Scotland.	i.reid@abdn.ac.uk						Anderson IM, 2008, J PSYCHOPHARMACOL, V22, P343, DOI 10.1177/0269881107088441; Cameron IM, 2009, BRIT J GEN PRACT, V59, P644, DOI 10.3399/bjgp09X454061; Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114; Fountoulakis KN, 2011, INT J NEUROPSYCHOPH, V14, P405, DOI 10.1017/S1461145710000957; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P572, DOI 10.1001/archgenpsychiatry.2011.2044; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Lockhart P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593848; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Munoz-Arroyo R, 2006, BRIT J GEN PRACT, V56, P423; NHS Scotland, 2012, PRESCR MED MED US ME; Penn E, 2012, THER ADV PSYCHOPHARM, V2, P179, DOI 10.1177/2045125312445469; Robinson P, 2009, HLTH SERV J     0209; Scottish Parliament, 2010, 3 SCOTT PARL PUBL AU	15	15	15	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2013	346								f190	10.1136/bmj.f190	http://dx.doi.org/10.1136/bmj.f190			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BG	23341567				2022-12-28	WOS:000314215600010
J	Davis, TA; Bureau, M; Cappellari, M; Sarzi, M; Blitz, L				Davis, Timothy A.; Bureau, Martin; Cappellari, Michele; Sarzi, Marc; Blitz, Leo			A black-hole mass measurement from molecular gas kinematics in NGC4526	NATURE			English	Article							SAURON PROJECT; STAR-FORMATION; IV	The masses of the supermassive black holes found in galaxy bulges are correlated with a multitude of galaxy properties(1,2), leading to suggestions that galaxies and black holes may evolve together(3). The number of reliably measured black-hole masses is small, and the number of methods for measuring them is limited(4), holding back attempts to understand this co-evolution. Directly measuring black-hole masses is currently possible with stellar kinematics (in early-type galaxies), ionized-gas kinematics (in some spiral and early-type galaxies(5-7)) and in rare objects that have central maser emission(8). Here we report that by modelling the effect of a black hole on the kinematics of molecular gas it is possible to fit interferometric observations of CO emission and thereby accurately estimate black-hole masses. We study the dynamics of the gas in the early-type galaxy NGC 4526, and obtain a best fit that requires the presence of a central dark object of 4.5(-3.1)(+4.2) x 10(8) solar masses, (3 sigma confidence limit). With the next-generation millimetre-wavelength interferometers these observations could be reproduced in galaxies out to 75 megaparsecs in less than 5 hours of observing time. The use of molecular gas as a kinematic tracer should thus allow one to estimate black-hole masses in hundreds of galaxies in the local Universe, many more than are accessible with current techniques.	[Davis, Timothy A.] European So Observ, D-85748 Garching, Germany; [Bureau, Martin; Cappellari, Michele] Univ Oxford, Dept Phys, Subdept Astrophys, Oxford OX1 3RH, England; [Sarzi, Marc] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL1 9AB, Herts, England; [Blitz, Leo] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	European Southern Observatory; University of Oxford; University of Hertfordshire; University of California System; University of California Berkeley	Davis, TA (corresponding author), European So Observ, Karl Schwarzschild Str 2, D-85748 Garching, Germany.	tdavis@eso.org	Cappellari, Michele/AAB-5062-2019; Sarzi, Marc/HGB-2092-2022	Cappellari, Michele/0000-0002-1283-8420; Davis, Timothy/0000-0003-4932-9379	European Community; 'Astrophysics at Oxford' and from the UK Research Councils; Royal Society University Research Fellowship; Science and Technology Facilities Council; National Science Foundation; CARMA partner universities; STFC [ST/K00106X/1, ST/G004331/1, PP/E003427/1, ST/H002456/1, ST/F009186/1, ST/I003673/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F009186/1, ST/H002456/1, PP/E003427/1, ST/K00106X/1, ST/I003673/1, ST/G004331/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [0838258, 1140031] Funding Source: National Science Foundation	European Community(European Commission); 'Astrophysics at Oxford' and from the UK Research Councils; Royal Society University Research Fellowship(Royal Society of London); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); National Science Foundation(National Science Foundation (NSF)); CARMA partner universities; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The research leading to these results has received funding from the European Community's Seventh Framework Programme. M.B. is supported by the rolling grants 'Astrophysics at Oxford' and from the UK Research Councils. M.G. acknowledges support from a Royal Society University Research Fellowship. MS. acknowledges support from a Science and Technology Facilities Council Advanced Fellowship. Support for the construction of CARMA was derived from the states of California, Illinois and Maryland, the James S. McDonnell Foundation, the Gordon and Betty Moore Foundation, the Kenneth T. and Eileen L Norris Foundation, the University of Chicago, the Associates of the California Institute of Technology, and the National Science Foundation. Ongoing development and operations of CARMA are supported by the National Science Foundation under a cooperative agreement, and by the CARMA partner universities.	Alatalo K., 2012, PREPRINT; Barth AJ, 2001, ASTROPHYS J, V555, P685, DOI 10.1086/321523; Bock D.C.-J, 2006, P SOC PHOTO-OPT INS, V6267, P13; Cappellari M, 2006, MON NOT R ASTRON SOC, V366, P1126, DOI 10.1111/j.1365-2966.2005.09981.x; Combes F, 2007, MON NOT R ASTRON SOC, V377, P1795, DOI 10.1111/j.1365-2966.2007.11759.x; Crocker AF, 2011, MON NOT R ASTRON SOC, V410, P1197, DOI 10.1111/j.1365-2966.2010.17537.x; Davii T.A., 2012, PREPRINT; Davis TA, 2011, MON NOT R ASTRON SOC, V417, P882, DOI 10.1111/j.1365-2966.2011.19355.x; Davis TA, 2011, MON NOT R ASTRON SOC, V414, P968, DOI 10.1111/j.1365-2966.2011.18284.x; Ferrarese L, 2005, SPACE SCI REV, V116, P523, DOI 10.1007/s11214-005-3947-6; Ghez AM, 2008, ASTROPHYS J, V689, P1044, DOI 10.1086/592738; Graham AW, 2001, ASTROPHYS J, V563, pL11, DOI 10.1086/338500; Gultekin K, 2009, ASTROPHYS J, V698, P198, DOI 10.1088/0004-637X/698/1/198; Ho LC, 2002, PUBL ASTRON SOC PAC, V114, P137, DOI 10.1086/338546; Kuntschner H, 2010, MON NOT R ASTRON SOC, V408, P97, DOI 10.1111/j.1365-2966.2010.17161.x; Lo KY, 2005, ANNU REV ASTRON ASTR, V43, P625, DOI 10.1146/annurev.astro.41.011802.094927; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Neumayer N, 2007, ASTROPHYS J, V671, P1329, DOI 10.1086/523039; Sarzi M, 2001, ASTROPHYS J, V550, P65, DOI 10.1086/319724; Sault RJ, 1995, ASTR SOC P, V77, P433; Silk J, 1998, ASTRON ASTROPHYS, V331, pL1; Sofue Y, 2003, PUBL ASTRON SOC JPN, V55, P59, DOI 10.1093/pasj/55.1.59; Tonry JL, 2001, ASTROPHYS J, V546, P681, DOI 10.1086/318301; Young LM, 2008, ASTROPHYS J, V676, P317, DOI 10.1086/529019	24	70	71	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					328	330		10.1038/nature11819	http://dx.doi.org/10.1038/nature11819			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23364690	Green Submitted			2022-12-28	WOS:000315312900032
J	Waugh, DW; Primeau, F; DeVries, T; Holzer, M				Waugh, Darryn W.; Primeau, Francois; DeVries, Tim; Holzer, Mark			Recent Changes in the Ventilation of the Southern Oceans	SCIENCE			English	Article							RECENT CLIMATE-CHANGE; ANTHROPOGENIC CO2; DECADAL CHANGES; ANNULAR MODE; DISTRIBUTIONS; CIRCULATION; THERMOCLINE; ATMOSPHERE; AGES; ICE	Surface westerly winds in the Southern Hemisphere have intensified over the past few decades, primarily in response to the formation of the Antarctic ozone hole, and there is intense debate on the impact of this on the ocean's circulation and uptake and redistribution of atmospheric gases. We used measurements of chlorofluorocarbon-12 (CFC-12) made in the southern oceans in the early 1990s and mid-to late 2000s to examine changes in ocean ventilation. Our analysis of the CFC-12 data reveals a decrease in the age of subtropical subantarctic mode waters and an increase in the age of circumpolar deep waters, suggesting that the formation of the Antarctic ozone hole has caused large-scale coherent changes in the ventilation of the southern oceans.	[Waugh, Darryn W.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Primeau, Francois] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [DeVries, Tim] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Holzer, Mark] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Holzer, Mark] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA	Johns Hopkins University; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of New South Wales Sydney; Columbia University	Waugh, DW (corresponding author), Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA.	waugh@jhu.edu	Primeau, Francois W/A-7310-2011; Waugh, Darryn W/K-3688-2016; Holzer, Mark/E-8735-2011	Primeau, Francois W/0000-0001-7452-9415; Waugh, Darryn W/0000-0001-7692-2798; Holzer, Mark/0000-0002-9568-1763; DeVries, Tim/0000-0002-7771-9430	NSF [ANT-1043307, OCE-0928395, ATM-0854711]; Australian Research Council [DP120100674]; Div Atmospheric & Geospace Sciences [0854711] Funding Source: National Science Foundation; Division Of Ocean Sciences [0928395] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Australian Research Council(Australian Research Council); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank A. Gnanadesikan, T. Haine, and E. Y. Kwon for helpful conversations and J. Bullister, M. Warner, R. Fine, and the other scientists who provided the CFC-12 data for the WOCE and CLIVAR programs. D. W. W. acknowledges support from NSF grant ANT-1043307, F. P. acknowledges support from NSF grant OCE-0928395, and M. H. acknowledges support from NSF grant ATM-0854711 and Australian Research Council grant DP120100674.	Alvarez M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006475; Aoki S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022220; Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; Bryan FO, 2006, OCEAN MODEL, V15, P141, DOI 10.1016/j.ocemod.2006.01.002; DeVries T, 2011, J PHYS OCEANOGR, V41, P2381, DOI 10.1175/JPO-D-10-05011.1; Fine RA, 2011, ANNU REV MAR SCI, V3, P173, DOI 10.1146/annurev.marine.010908.163933; Gille ST, 2008, J CLIMATE, V21, P4749, DOI 10.1175/2008JCLI2131.1; Gnanadesikan A, 2007, OCEAN SCI, V3, P43, DOI 10.5194/os-3-43-2007; Hall A, 2002, J CLIMATE, V15, P3043, DOI 10.1175/1520-0442(2002)015<3043:SVITSH>2.0.CO;2; Ito T, 2010, NATURE, V463, P80, DOI 10.1038/nature08687; Khatiwala S, 2009, NATURE, V462, P346, DOI 10.1038/nature08526; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Lenton A, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002714; Lovenduski NS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022727; Matear RJ, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000086; McDonagh EL, 2005, J CLIMATE, V18, P1575, DOI 10.1175/JCLI3350.1; McLandress C, 2011, J CLIMATE, V24, P1850, DOI 10.1175/2010JCLI3958.1; Meredith MP, 2012, J CLIMATE, V25, P99, DOI 10.1175/2011JCLI4204.1; Orsi A., 2001, LOCATIONS VARIOUS FR; Roemmich D, 2007, J PHYS OCEANOGR, V37, P162, DOI 10.1175/JPO3004.1; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Schlosser P., 2001, OCEAN CIRCULATION CL; Sen Gupta A, 2006, J CLIMATE, V19, P4457, DOI 10.1175/JCLI3843.1; Sigmond M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047120; Son SW, 2008, SCIENCE, V320, P1486, DOI 10.1126/science.1155939; Thompson DWJ, 2011, NAT GEOSCI, V4, P741, DOI [10.1038/ngeo1296, 10.1038/NGEO1296]; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590; Waugh DW, 2006, TELLUS B, V58, P376, DOI 10.1111/j.1600-0889.2006.00222.x; Waugh DW, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001325	29	104	106	5	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					568	570		10.1126/science.1225411	http://dx.doi.org/10.1126/science.1225411			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129MC	23372011	Green Published			2022-12-28	WOS:000317843300001
J	Bracht, JR; Fang, WW; Goldman, AD; Dolzhenko, E; Stein, EM; Landweber, LF				Bracht, John R.; Fang, Wenwen; Goldman, Aaron David; Dolzhenko, Egor; Stein, Elizabeth M.; Landweber, Laura F.			Genomes on the Edge: Programmed Genome Instability in Ciliates	CELL			English	Review							INTERNAL ELIMINATED SEQUENCES; DNA ELIMINATION; EUPLOTES-CRASSUS; SMALL RNAS; NUCLEAR DIFFERENTIATION; DEVELOPMENTAL EXCISION; CYTOSINE METHYLATION; H3K27 METHYLATION; SURFACE-ANTIGEN; TETRAHYMENA	Ciliates are an ancient and diverse group of microbial eukaryotes that have emerged as powerful models for RNA-mediated epigenetic inheritance. They possess extensive sets of both tiny and long noncoding RNAs that, together with a suite of proteins that includes transposases, orchestrate a broad cascade of genome rearrangements during somatic nuclear development. This Review emphasizes three important themes: the remarkable role of RNA in shaping genome structure, recent discoveries that unify many deeply diverged ciliate genetic systems, and a surprising evolutionary "sign change" in the role of small RNAs between major species groups.	[Bracht, John R.; Fang, Wenwen; Goldman, Aaron David; Dolzhenko, Egor; Stein, Elizabeth M.; Landweber, Laura F.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Landweber, LF (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lfl@princeton.edu	Fang, Wenwen/B-8422-2016		NSF [0923810, 0900544]; NIH [GM59708, 1F32GM099462]; DOD [W81XWH-10-1-0122]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059708, F32GM099462] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge support from NSF grants 0923810 and 0900544 and NIH grants GM59708 (to L.F.L.) and 1F32GM099462 (to J.R.B.). W.F. was supported by DOD predoctoral fellowship W81XWH-10-1-0122, and A.D.G. is a NASA postdoctoral fellow. The content is solely the responsibility of the authors and does not necessarily represent the official views of any funding agency.	Angeleska A, 2007, J THEOR BIOL, V248, P706, DOI 10.1016/j.jtbi.2007.06.007; Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; BAIRD SE, 1989, MOL CELL BIOL, V9, P3793, DOI 10.1128/MCB.9.9.3793; Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Bracht JR, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r99; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Caron DA, 2012, ANNU REV MAR SCI, V4, P467, DOI 10.1146/annurev-marine-120709-142802; Casacuberta JM, 2003, GENE, V311, P1, DOI 10.1016/S0378-1119(03)00557-2; Chalker DL, 2005, GENETICS, V169, P149, DOI 10.1534/genetics.104.032300; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; Chalker DL, 2008, BBA-MOL CELL RES, V1783, P2130, DOI 10.1016/j.bbamcr.2008.07.012; Chalker DL, 2011, ANNU REV GENET, V45, P227, DOI 10.1146/annurev-genet-110410-132432; Chang WJ, 2005, P NATL ACAD SCI USA, V102, P15149, DOI 10.1073/pnas.0507682102; Cheng CY, 2010, MOL BIOL CELL, V21, P1753, DOI 10.1091/mbc.E09-12-1079; Chung PH, 2012, EUKARYOT CELL, V11, P601, DOI 10.1128/EC.05290-11; Coyne RS, 2012, METHOD CELL BIOL, V109, P53, DOI 10.1016/B978-0-12-385967-9.00004-9; Coyne RS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r100; DOAK TG, 1994, P NATL ACAD SCI USA, V91, P942, DOI 10.1073/pnas.91.3.942; Duharcourt S, 1998, MOL CELL BIOL, V18, P7075, DOI 10.1128/MCB.18.12.7075; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Duharcourt S, 2009, TRENDS GENET, V25, P344, DOI 10.1016/j.tig.2009.05.007; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; EPSTEIN LM, 1984, MOL CELL BIOL, V4, P1583, DOI 10.1128/MCB.4.8.1583; Fang WW, 2012, CELL, V151, P1243, DOI 10.1016/j.cell.2012.10.045; Fass JN, 2011, G3-GENES GENOM GENET, V1, P515, DOI 10.1534/g3.111.000927; Finlay BJ, 1998, INT J PARASITOL, V28, P29, DOI 10.1016/S0020-7519(97)00167-7; Finlay Bland J., 2001, International Microbiology, V4, P125; Foissner W, 2008, BIODIVERS CONSERV, V17, P345, DOI 10.1007/s10531-007-9254-7; Fokin SI, 2012, EUR J PROTISTOL, V48, P138, DOI 10.1016/j.ejop.2011.12.001; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Garnier O, 2004, MOL CELL BIOL, V24, P7370, DOI 10.1128/MCB.24.17.7370-7379.2004; GIBBONS IR, 1965, SCIENCE, V149, P424, DOI 10.1126/science.149.3682.424; Goldman AD, 2012, TRENDS GENET, V28, P382, DOI 10.1016/j.tig.2012.03.010; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Gutierrez Juan C., 2000, International Microbiology, V3, P139; HERRICK G, 1985, CELL, V43, P759, DOI 10.1016/0092-8674(85)90249-1; Heyse G, 2010, P NATL ACAD SCI USA, V107, P22134, DOI 10.1073/pnas.1009284107; Jacobs ME, 2003, EUKARYOT CELL, V2, P103, DOI 10.1128/EC.2.1.103-114.2003; JAHN CL, 1993, GENE, V133, P71, DOI 10.1016/0378-1119(93)90226-S; JARACZEWSKI JW, 1993, GENE DEV, V7, P95, DOI 10.1101/gad.7.1.95; Juranek S, 2003, NUCLEIC ACIDS RES, V31, P1387, DOI 10.1093/nar/gkg233; Kapusta A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002049; Kataoka K, 2011, ADV EXP MED BIOL, V722, P156, DOI 10.1007/978-1-4614-0332-6_10; Katz LA, 2010, J EXP ZOOL PART B, V314B, P480, DOI 10.1002/jez.b.21354; Klobutcher LA, 2005, EUKARYOT CELL, V4, P2098, DOI 10.1128/EC.4.12.2098-2105.2005; Klobutcher LA, 2002, CELL, V111, P763, DOI 10.1016/S0092-8674(02)01138-8; Klobutcher LA, 1997, PROG NUCLEIC ACID RE, V56, P1, DOI 10.1016/S0079-6603(08)61001-6; KLOBUTCHER LA, 1995, NUCLEIC ACIDS RES, V23, P2006, DOI 10.1093/nar/23.11.2006; KOIZUMI S, 1989, MOL CELL BIOL, V9, P4398, DOI 10.1128/MCB.9.10.4398; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Le Mouel A, 2003, EUKARYOT CELL, V2, P1076, DOI 10.1128/EC.2.5.1076-1090.2003; Lee SR, 2006, GENE DEV, V20, P28, DOI 10.1101/gad.1377006; Lepere G, 2008, GENE DEV, V22, P1501, DOI 10.1101/gad.473008; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Lin IT, 2012, MOL BIOL CELL, V23, P2213, DOI 10.1091/mbc.E11-11-0952; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Lozupone CA, 2001, CURR BIOL, V11, P65, DOI 10.1016/S0960-9822(01)00028-8; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; MEYER E, 1992, GENE DEV, V6, P211, DOI 10.1101/gad.6.2.211; Meyer E, 1997, MOL CELL BIOL, V17, P3589, DOI 10.1128/MCB.17.7.3589; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mochizuki K, 2010, WIRES RNA, V1, P376, DOI 10.1002/wrna.34; Mollenbeck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002330; NANNEY DL, 1953, P NATL ACAD SCI USA, V39, P113, DOI 10.1073/pnas.39.2.113; Nikiforov MA, 2000, MOL CELL BIOL, V20, P4128, DOI 10.1128/MCB.20.11.4128-4134.2000; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Nowacki M, 2011, ANNU REV GENOM HUM G, V12, P367, DOI 10.1146/annurev-genom-082410-101420; Nowacki M, 2010, P NATL ACAD SCI USA, V107, P22140, DOI 10.1073/pnas.1012236107; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Paschka AG, 2003, EUR J PROTISTOL, V39, P449, DOI 10.1078/0932-4739-00019; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Prescott DM, 2003, J THEOR BIOL, V222, P323, DOI 10.1016/S0022-5193(03)00037-7; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Rexer CH, 2007, EUKARYOT CELL, V6, P1320, DOI 10.1128/EC.00157-07; Ricard G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-587; Riley JL, 2001, MOL BIOL EVOL, V18, P1372, DOI 10.1093/oxfordjournals.molbev.a003921; Rowley JD, 2008, SCIENCE, V321, P1302, DOI 10.1126/science.1163791; Schoeberl UE, 2012, GENE DEV, V26, P1729, DOI 10.1101/gad.196493.112; SCOTT JM, 1994, MOL CELL BIOL, V14, P2479, DOI 10.1128/MCB.14.4.2479; Smith JK, 2012, PSYCHOL AESTHET CREA, V6, P1, DOI 10.1037/a0027241; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; Tan M, 1999, GENE, V233, P131, DOI 10.1016/S0378-1119(99)00146-8; Tan M, 2001, J EUKARYOT MICROBIOL, V48, P80, DOI 10.1111/j.1550-7408.2001.tb00418.x; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Vinogradov DV, 2012, MOL BIOL+, V46, P328, DOI 10.1134/S0026893312020197; Wang JB, 2012, DEV CELL, V23, P1072, DOI 10.1016/j.devcel.2012.09.020; Wang W, 2005, BIOSCI BIOTECH BIOCH, V69, P649, DOI 10.1271/bbb.69.649; Wessler SR, 2006, P NATL ACAD SCI USA, V103, P17600, DOI 10.1073/pnas.0607612103; Wichterman R, 1937, J MORPHOL, V60, P563, DOI 10.1002/jmor.1050600212; Yang GJ, 2009, SCIENCE, V325, P1391, DOI 10.1126/science.1175688; YAO M, 1974, CHROMOSOMA, V48, P1; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Yao MC, 2002, MOBILE DNA, P730; Yao MC, 2007, J CELL SCI, V120, P1978, DOI 10.1242/jcs.006502; Zahler AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042371; Zufall RA, 2006, MOL BIOL EVOL, V23, P1681, DOI 10.1093/molbev/msl032	106	61	63	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					406	416		10.1016/j.cell.2013.01.005	http://dx.doi.org/10.1016/j.cell.2013.01.005			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374338	Green Accepted, Bronze			2022-12-28	WOS:000314362800012
J	Endres, NF; Das, R; Smith, AW; Arkhipov, A; Kovacs, E; Huang, YJ; Pelton, JG; Shan, YB; Shaw, DE; Wemmer, DE; Groves, JT; Kuriyan, J				Endres, Nicholas F.; Das, Rahul; Smith, Adam W.; Arkhipov, Anton; Kovacs, Erika; Huang, Yongjian; Pelton, Jeffrey G.; Shan, Yibing; Shaw, David E.; Wemmer, David E.; Groves, Jay T.; Kuriyan, John			Conformational Coupling across the Plasma Membrane in Activation of the EGF Receptor	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; NEGATIVE COOPERATIVITY; TRANSMEMBRANE DOMAIN; JUXTAMEMBRANE REGION; KINASE ACTIVATION; CRYSTAL-STRUCTURE; LIGAND; BINDING; MODEL; FLUORESCENCE	How the epidermal growth factor receptor (EGFR) activates is incompletely understood. The intracellular portion of the receptor is intrinsically active in solution, and to study its regulation, we measured autophosphorylation as a function of EGFR surface density in cells. Without EGF, intact EGFR escapes inhibition only at high surface densities. Although the transmembrane helix and the intracellular module together suffice for constitutive activity even at low densities, the intracellular module is inactivated when tethered on its own to the plasma membrane, and fluorescence cross-correlation shows that it fails to dimerize. NMR and functional data indicate that activation requires an N-terminal interaction between the transmembrane helices, which promotes an antiparallel interaction between juxtamembrane segments and release of inhibition by the membrane. We conclude that EGF binding removes steric constraints in the extracellular module, promoting activation through N-terminal association of the transmembrane helices.	[Endres, Nicholas F.; Das, Rahul; Kovacs, Erika; Huang, Yongjian; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Smith, Adam W.; Wemmer, David E.; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Endres, Nicholas F.; Das, Rahul; Kovacs, Erika; Huang, Yongjian; Pelton, Jeffrey G.; Wemmer, David E.; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Huang, Yongjian; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Smith, Adam W.; Wemmer, David E.; Groves, Jay T.; Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Arkhipov, Anton; Shan, Yibing; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; D. E. Shaw Research; Columbia University	Groves, JT (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jtgroves@lbl.gov; kuriyan@berkeley.edu	Huang, Yongjian/GPK-5986-2022; Das, Rahul/AAU-5123-2020; Arkhipov, Anton/AAE-7801-2020; Smith, Adam/B-7156-2016	Huang, Yongjian/0000-0002-1168-6111; Das, Rahul/0000-0001-7841-8229; Arkhipov, Anton/0000-0003-1106-8310; Smith, Adam/0000-0001-5216-9017	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; National Cancer Institute (NCI) [2-R01-CA096504- 06, U54 CA143836]; Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences of the U.S. Department of Energy [DE-AC02-05CH11231]; National Science Foundation [BBS 87-20134l]; National Institutes of Health [GM68933]; NATIONAL CANCER INSTITUTE [U54CA143836, R01CA096504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM068933] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences of the U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jeff Iwig, Brian Kelch, Meg Stratton, and Julie Zorn for feedback on the manuscript, Eliza Zhang for initial work on the immunofluorescence assay, and David King for mass spectrometry. N.F.E. was a Leukemia and Lymphoma Society Fellow. R.D. was supported by postdoctoral fellowships from the Natural Sciences and Engineering Research Council of Canada (2009-2011) and the Canadian Institutes of Health Research (2011-2012). Y.H. is a Howard Hughes Medical Institute International Student Research fellow. This work was supported by a grant from the National Cancer Institute (NCI) to J.K. (2-R01-CA096504- 06) and by award U54 CA143836 from NCI to J.T.G. Additional support for the fluorescence spectroscopy system was provided by the Director, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. Grants from the National Science Foundation (BBS 87-20134l; 600 MHz NMR) and the National Institutes of Health (GM68933; 900 MHz) supported the NMR instrumentation. N.F.E., Y.H., E. K., and J.K. developed the cell-based assays for EGFR activity. A.W.S. and J.T.G. developed the live-cell spectroscopy and built the PIE-FCCS microscope. R.D. conducted the NMR experiments, with guidance from D.E.W. and J.G.P., A.A., Y.S., and D.E.S. helped couple the interpretation of experimental data and the molecular dynamics simulations. All authors were responsible for editing and writing the paper.	Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Becker W, 2005, REV FLUORESCENCE, V2, P77; Bocharov EV, 2008, J BIOL CHEM, V283, P6950, DOI 10.1074/jbc.M709202200; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Choowongkomon K, 2005, J BIOL CHEM, V280, P24043, DOI 10.1074/jbc.M502698200; Clayton AHA, 2008, GROWTH FACTORS, V26, P316, DOI 10.1080/08977190802442187; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; HAIGLER H, 1978, P NATL ACAD SCI USA, V75, P3317, DOI 10.1073/pnas.75.7.3317; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; Larson DR, 2005, J CELL BIOL, V171, P527, DOI 10.1083/jcb.200503110; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Lu CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414391; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Mineev KS, 2010, J MOL BIOL, V400, P231, DOI 10.1016/j.jmb.2010.05.016; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Reuther GW, 2000, METHOD ENZYMOL, V327, P331, DOI 10.1016/S0076-6879(00)27288-1; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Scheck RA, 2012, ACS CHEM BIOL, V7, P1367, DOI 10.1021/cb300216f; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SILVERMAN L, 1992, J CELL BIOL, V119, P415, DOI 10.1083/jcb.119.2.415; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; SOROKIN A, 1995, ONCOGENE, V11, P1531; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; Stuart AC, 1999, J AM CHEM SOC, V121, P5346, DOI 10.1021/ja984172w; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhu HJ, 2003, GROWTH FACTORS, V21, P15, DOI 10.1080/0897719031000096424	51	335	341	3	168	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					543	556		10.1016/j.cell.2012.12.032	http://dx.doi.org/10.1016/j.cell.2012.12.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374349	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000314362800023
J	Li, QY; Seo, JH; Stranger, B; McKenna, A; Pe'er, I; LaFramboise, T; Brown, M; Tyekucheva, S; Freedman, ML				Li, Qiyuan; Seo, Ji-Heui; Stranger, Barbara; McKenna, Aaron; Pe'er, Itsik; LaFramboise, Thomas; Brown, Myles; Tyekucheva, Svitlana; Freedman, Matthew L.			Integrative eQTL-Based Analyses Reveal the Biology of Breast Cancer Risk Loci	CELL			English	Article							ALLELIC EXPRESSION IMBALANCE; LONG-RANGE INTERACTION; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; FGFR2 EXPRESSION; CIS; CELLS; GROWTH; MYC; IDENTIFICATION	Germline determinants of gene expression in tumors are infrequently studied due to the complexity of transcript regulation caused by somatically acquired alterations. We performed expression quantitative trait locus (eQTL)-based analyses using the multi-level information provided in The Cancer Genome Atlas (TCGA). Of the factors we measured, cis-acting eQTLs accounted for 1.2% of the total variation of tumor gene expression, while somatic copy-number alteration and CpG methylation accounted for 7.3% and 3.3%, respectively. eQTL analyses of 15 previously reported breast cancer risk loci resulted in the discovery of three variants that are significantly associated with transcript levels (false discovery rate [FDR] < 0.1). Our trans-based analysis identified an additional three risk loci to act through ESR1, MYC, and KLF4. These findings provide a more comprehensive picture of gene expression determinants in breast cancer as well as insights into the underlying biology of breast cancer risk loci.	[Li, Qiyuan; Seo, Ji-Heui; Brown, Myles; Freedman, Matthew L.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Dept Med Oncol, Boston, MA 02215 USA; [Li, Qiyuan; Seo, Ji-Heui; Freedman, Matthew L.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA; [Tyekucheva, Svitlana] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Li, Qiyuan; Freedman, Matthew L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [McKenna, Aaron] Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Stranger, Barbara] Harvard Univ, Div Genet, Dept Med, Sch Med, Boston, MA 02115 USA; [Stranger, Barbara] Brigham & Womens Hosp, Boston, MA 02115 USA; [McKenna, Aaron] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Pe'er, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [LaFramboise, Thomas] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Tyekucheva, Svitlana] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; Columbia University; Case Western Reserve University; Harvard University; Harvard T.H. Chan School of Public Health	Freedman, ML (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Dept Med Oncol, Boston, MA 02215 USA.	freedman@broadinstitute.org	Brown, Myles/AAX-5332-2021; Brown, Myles/B-6906-2008	Brown, Myles/0000-0002-8213-1658; Stranger, Barbara/0000-0001-9021-7331	Howard Hughes Medical Institute Physician-Scientist Early Career Awardee; Claudia Adams Barr award; U.S. National Institutes of Health (NIH) [ELLIPSE/GAME-ON-U19 CA148537, R01 CA131341]; Mayer Foundation; H.L. Snyder Medical Foundation; Kohlberg Foundation; A. David Mazzone Awards Program; NATIONAL CANCER INSTITUTE [U19CA148537, R01CA131341, R01CA129435] Funding Source: NIH RePORTER	Howard Hughes Medical Institute Physician-Scientist Early Career Awardee(Howard Hughes Medical Institute); Claudia Adams Barr award; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayer Foundation; H.L. Snyder Medical Foundation; Kohlberg Foundation; A. David Mazzone Awards Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Giovanni Parmigiani for his suggestions with respect to the statistical modeling. We thank Dr. Gad Getz for suggestions on data processing. M.L.F. is a Howard Hughes Medical Institute Physician-Scientist Early Career Awardee (www.hhmi.org) and a recipient of a 2009 Claudia Adams Barr award (www.dana-farber.org). This work was supported by grants from the U.S. National Institutes of Health (NIH) (ELLIPSE/GAME-ON-U19 CA148537 to M.L.F. and R01 CA131341 to T.L. and I.P.), the Mayer Foundation (to M.L.F.), the H.L. Snyder Medical Foundation (to M.L.F.), the Kohlberg Foundation, and the A. David Mazzone Awards Program (to M.L.F.).	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Babak T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-473; Becker MA, 2012, CLIN CANCER RES, V18, P1808, DOI 10.1158/1078-0432.CCR-11-1806; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Butt AJ, 2003, J BIOL CHEM, V278, P29676, DOI 10.1074/jbc.M301965200; Campino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004105; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fogarty MP, 2010, HUM MOL GENET, V19, P1921, DOI 10.1093/hmg/ddq067; Forton JT, 2007, GENOME RES, V17, P82, DOI 10.1101/gr.5663007; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Grisanzio C, 2012, P NATL ACAD SCI USA, V109, P11252, DOI 10.1073/pnas.1200853109; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Hindorff L, 2012, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huijts PEA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2917; Kristensen VN, 2006, P NATL ACAD SCI USA, V103, P7735, DOI 10.1073/pnas.0601893103; Lefebvre JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038667; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Martin Amy J, 2011, BMC Res Notes, V4, P72, DOI 10.1186/1756-0500-4-72; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pomerantz MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001204; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Riaz M, 2012, BREAST CANCER RES TR, V133, P843, DOI 10.1007/s10549-011-1663-3; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Sun C, 2010, CANCER GENET CYTOGEN, V197, P193, DOI 10.1016/j.cancergencyto.2009.11.006; Tonner E, 2002, DEVELOPMENT, V129, P4547; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591	47	239	243	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					633	641		10.1016/j.cell.2012.12.034	http://dx.doi.org/10.1016/j.cell.2012.12.034			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374354	Green Accepted, Bronze			2022-12-28	WOS:000314362800030
J	Resnick, MJ; Koyama, T; Fan, KH; Albertsen, PC; Goodman, M; Hamilton, AS; Hoffman, RM; Potosky, AL; Stanford, JL; Stroup, AM; Van Horn, RL; Penson, DF				Resnick, Matthew J.; Koyama, Tatsuki; Fan, Kang-Hsien; Albertsen, Peter C.; Goodman, Michael; Hamilton, Ann S.; Hoffman, Richard M.; Potosky, Arnold L.; Stanford, Janet L.; Stroup, Antoinette M.; Van Horn, R. Lawrence; Penson, David F.			Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; MEN; RADIOTHERAPY; VALIDATION; INDEX	Background The purpose of this analysis was to compare long-term urinary, bowel, and sexual function after radical prostatectomy or external-beam radiation therapy. Methods The Prostate Cancer Outcomes Study (PCOS) enrolled 3533 men in whom prostate cancer had been diagnosed in 1994 or 1995. The current cohort comprised 1655 men in whom localized prostate cancer had been diagnosed between the ages of 55 and 74 years and who had undergone either surgery (1164 men) or radiotherapy (491 men). Functional status was assessed at baseline and at 2, 5, and 15 years after diagnosis. We used multivariable propensity scoring to compare functional outcomes according to treatment. Results Patients undergoing prostatectomy were more likely to have urinary incontinence than were those undergoing radiotherapy at 2 years (odds ratio, 6.22; 95% confidence interval [CI], 1.92 to 20.29) and 5 years (odds ratio, 5.10; 95% CI, 2.29 to 11.36). However, no significant between-group difference in the odds of urinary incontinence was noted at 15 years. Similarly, although patients undergoing prostatectomy were more likely to have erectile dysfunction at 2 years (odds ratio, 3.46; 95% CI, 1.93 to 6.17) and 5 years (odds ratio, 1.96; 95% CI, 1.05 to 3.63), no significant between-group difference was noted at 15 years. Patients undergoing prostatectomy were less likely to have bowel urgency at 2 years (odds ratio, 0.39; 95% CI, 0.22 to 0.68) and 5 years (odds ratio, 0.47; 95% CI, 0.26 to 0.84), again with no significant between-group difference in the odds of bowel urgency at 15 years. Conclusions At 15 years, no significant relative differences in disease-specific functional outcomes were observed among men undergoing prostatectomy or radiotherapy. Nonetheless, men treated for localized prostate cancer commonly had declines in all functional domains during 15 years of follow-up. (Funded by the National Cancer Institute.)	[Resnick, Matthew J.; Penson, David F.] Vanderbilt Univ, Dept Urol Surg, Nashville, TN 37203 USA; [Penson, David F.] Vanderbilt Univ, Ctr Surg Qual & Outcomes Res, Med Ctr, Nashville, TN 37203 USA; [Van Horn, R. Lawrence] Vanderbilt Univ, Dept Biostat, Nashville, TN 37203 USA; [Koyama, Tatsuki; Fan, Kang-Hsien] Vanderbilt Univ, Ctr Quantitat Sci, Nashville, TN 37203 USA; [Van Horn, R. Lawrence] Vanderbilt Univ, Owen Grad Sch Management, Nashville, TN 37203 USA; [Resnick, Matthew J.; Penson, David F.] Vet Affairs VA Tennessee Valley Geriatr Res Educ, Nashville, TN USA; [Albertsen, Peter C.] Univ Connecticut, Sch Med, Dept Surg, Div Urol, Farmington, CT USA; [Goodman, Michael] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Hamilton, Ann S.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Hoffman, Richard M.] Univ New Mexico, Dept Med, Albuquerque, NM 87131 USA; [Hoffman, Richard M.] New Mexico VA Healthcare Syst, Med Serv, Albuquerque, NM USA; [Potosky, Arnold L.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Stanford, Janet L.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Stroup, Antoinette M.] Univ Utah, Salt Lake City, UT USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of Connecticut; Emory University; Rollins School Public Health; University of Southern California; University of New Mexico; Georgetown University; Fred Hutchinson Cancer Center; Utah System of Higher Education; University of Utah	Penson, DF (corresponding author), Vanderbilt Univ, Ctr Surg Qual & Outcomes Res, Med Ctr, 2525 W End Ave,Suite 1200, Nashville, TN 37203 USA.	david.penson@vanderbilt.edu		Hoffman, Richard/0000-0002-4714-7726; Fan, Kang-hsien/0000-0003-0121-3959; Penson, David/0000-0002-2580-2697	National Cancer Institute, National Institutes of Health [R01-CA114524]; Veterans Affairs National Quality Scholars Program; T.J. Martell Foundation;  [N01-PC-67007];  [N01-PC-67009];  [N01-PC-67010];  [N01-PC-67006];  [N01-PC-67005];  [N01-PC-67000]; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067007, N01PC067009, N01PC067010, N01PC067006, N01PC067005, N01PC067000] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA142934, R01CA114524] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs National Quality Scholars Program; T.J. Martell Foundation; ; ; ; ; ; ; DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a grant from the National Cancer Institute, National Institutes of Health (R01-CA114524), and the following contracts with each of the participating institutions: N01-PC-67007, N01-PC-67009, N01-PC-67010, N01-PC-67006, N01-PC-67005, and N01-PC-67000. Dr. Resnick was supported by the Veterans Affairs National Quality Scholars Program (with use of facilities at Veterans Health Administration Tennessee Valley Healthcare System) and the T.J. Martell Foundation.	Alicikus ZA, 2011, CANCER-AM CANCER SOC, V117, P1429, DOI 10.1002/cncr.25467; Birkhahn M, 2011, BJU INT, V108, P660, DOI 10.1111/j.1464-410X.2010.09978.x; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Fleming C, 1993, JAMA, V269, P2650; FOWLER FJ, 1993, UROLOGY, V42, P622, DOI 10.1016/0090-4295(93)90524-E; Gore JL, 2009, J NATL CANCER I, V101, P888, DOI 10.1093/jnci/djp114; Hoffman RM, 2004, CANCER, V101, P2011, DOI 10.1002/cncr.20608; Huang GJ, 2010, J UROLOGY, V183, P2206, DOI 10.1016/j.juro.2010.02.013; Ihrig A, 2011, BJU INT, V108, P1274, DOI 10.1111/j.1464-410X.2011.10082.x; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Knight SJ, 2007, CANCER, V109, P1769, DOI 10.1002/cncr.22597; Legler J, 2000, MED CARE, V38, P847, DOI 10.1097/00005650-200008000-00008; Litwin MS, 1998, MED CARE, V36, P1002, DOI 10.1097/00005650-199807000-00007; Litwin MS, 1999, J UROLOGY, V161, P1180, DOI 10.1016/S0022-5347(01)61624-0; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Lumley T., 2012, ANAL COMPLEX SURVEY; Pardo, 2011, J CLIN ONCOL, V29, P779, DOI 10.1200/JCO.2011.34.7377; Pardo Y, 2010, J CLIN ONCOL, V28, P4687, DOI 10.1200/JCO.2009.25.3245; Potosky AL, 2000, JNCI-J NATL CANCER I, V92, P1582, DOI 10.1093/jnci/92.19.1582; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Potosky AL, 1999, JNCI-J NATL CANCER I, V91, P1719, DOI 10.1093/jnci/91.20.1719; R Foundation for Statistical Computing, 2012, R LANG ENV STAT COMP; Reeve BB, 2006, UROLOGY, V68, P599, DOI 10.1016/j.urology.2006.03.037; Rice K, 2010, UROLOGY, V76, P1231, DOI 10.1016/j.urology.2010.03.087; RUBIN DB, 1984, J AM STAT ASSOC, V79, P79, DOI 10.2307/2288338; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Sommers BD, 2008, CANCER, V113, P2058, DOI 10.1002/cncr.23807; Song L, 2012, CANCER; Szymanski KM, 2010, UROLOGY, V76, P1245, DOI 10.1016/j.urology.2010.01.027; Taylor KL, 2012, J CLIN ONCOL, V30, P2768, DOI 10.1200/JCO.2011.41.2767; Walz J, 2007, J CLIN ONCOL, V25, P3576, DOI 10.1200/JCO.2006.10.3820; Wei JT, 2000, UROLOGY, V56, P899, DOI 10.1016/S0090-4295(00)00858-X; Zeliadt SB, 2010, AM J MANAG CARE, V16, pE121	33	631	652	3	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					436	445		10.1056/NEJMoa1209978	http://dx.doi.org/10.1056/NEJMoa1209978			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BE	23363497	Green Accepted			2022-12-28	WOS:000314215400008
J	Ciani, O; Buyse, M; Garside, R; Pavey, T; Stein, K; Sterne, JAC; Taylor, RS				Ciani, Oriana; Buyse, Marc; Garside, Ruth; Pavey, Toby; Stein, Ken; Sterne, Jonathan A. C.; Taylor, Rod S.			Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CELL LUNG-CANCER; CLINICAL-TRIALS; COST-EFFECTIVENESS; END-POINTS; HIERARCHICAL LEVELS; EMPIRICAL-EVIDENCE; FREE SURVIVAL; METAANALYSIS; BIAS; INTERVENTION	Objective To quantify and compare the treatment effect and risk of bias of trials reporting biomarkers or intermediate outcomes (surrogate outcomes) versus trials using final patient relevant primary outcomes. Design Meta-epidemiological study. Data sources All randomised clinical trials published in 2005 and 2006 in six high impact medical journals: Annals of Internal Medicine, BMJ, Journal of the American Medical Association, Lancet, New England Journal of Medicine, and PLoS Medicine. Study selection Two independent reviewers selected trials. Data extraction Trial characteristics, risk of bias, and outcomes were recorded according to a predefined form. Two reviewers independently checked data extraction. The ratio of odds ratios was used to quantify the degree of difference in treatment effects between the trials using surrogate outcomes and those using patient relevant outcomes, also adjusted for trial characteristics. A ratio of odds ratios >1.0 implies that trials with surrogate outcomes report larger intervention effects than trials with patient relevant outcomes. Results 84 trials using surrogate outcomes and 101 using patient relevant outcomes were considered for analyses. Study characteristics of trials using surrogate outcomes and those using patient relevant outcomes were well balanced, except for median sample size (371 v 741) and single centre status (23% v 9%). Their risk of bias did not differ. Primary analysis showed trials reporting surrogate endpoints to have larger treatment effects (odds ratio 0.51, 95% confidence interval 0.42 to 0.60) than trials reporting patient relevant outcomes (0.76, 0.70 to 0.82), with an unadjusted ratio of odds ratios of 1.47 (1.07 to 2.01) and adjusted ratio of odds ratios of 1.46 (1.05 to 2.04). This result was consistent across sensitivity and secondary analyses. Conclusions Trials reporting surrogate primary outcomes are more likely to report larger treatment effects than trials reporting final patient relevant primary outcomes. This finding was not explained by differences in the risk of bias or characteristics of the two groups of trials.	[Ciani, Oriana; Garside, Ruth; Stein, Ken; Taylor, Rod S.] Univ Exeter, Sch Med, Inst Hlth Serv Res, PenTAG, Exeter EX2 4SG, Devon, England; [Buyse, Marc] Int Inst Drug Dev, Louvain, Belgium; [Buyse, Marc] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium; [Pavey, Toby] Univ Queensland, Sch Human Movement Studies, Brisbane, Qld, Australia; [Sterne, Jonathan A. C.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Exeter; International Drug Development Institute; Hasselt University; University of Queensland; University of Bristol	Ciani, O (corresponding author), Univ Exeter, Sch Med, Inst Hlth Serv Res, PenTAG, Exeter EX2 4SG, Devon, England.	oriana.ciani@pcmd.ac.uk	Buyse, Marc/J-4658-2013; Sterne, Jonathan/Z-3106-2019; Pavey, Toby/G-1299-2012; Ciani, Oriana/D-1455-2015; Taylor, Rod/R-9581-2019	Sterne, Jonathan/0000-0001-8496-6053; Pavey, Toby/0000-0002-4946-6683; Ciani, Oriana/0000-0002-3607-0508; Taylor, Rod/0000-0002-3043-6011; Buyse, Marc/0000-0002-4559-0994; Garside, Ruth/0000-0003-1649-4773	Peninsula College of Medicine and Dentistry Doctoral studentship; Medical Research Council [G0800800] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10168] Funding Source: researchfish; MRC [G0800800] Funding Source: UKRI	Peninsula College of Medicine and Dentistry Doctoral studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. OC is currently receiving a Peninsula College of Medicine and Dentistry Doctoral studentship.	Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446; [Anonymous], 1989, NEW ENGL J MED, V321, P406; [Anonymous], 2008, GUID METH TECHN APPR; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bafeta A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e813; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Bucher HC, 1999, JAMA-J AM MED ASSOC, V282, P771, DOI 10.1001/jama.282.8.771; Burzykowski T, 2005, STAT BIOL HEALTH, P323; Buyse M, 2007, J CLIN ONCOL, V25, P5218, DOI 10.1200/JCO.2007.11.8836; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Chakravarty A, 2005, STAT BIOL HEALTH, P13; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Ciani O, 2013, HEALTH ECON, V22, P251, DOI 10.1002/hec.2826; Czoski-Murray C, 2004, HEALTH TECHNOL ASSES, V8, P1; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Elston J, 2009, INT J TECHNOL ASSESS, V25, P6, DOI 10.1017/S0266462309090023; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Herbison P, 2011, J CLIN EPIDEMIOL, V64, P1070, DOI 10.1016/j.jclinepi.2010.12.018; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Hughes MD, 1998, AIDS, V12, P1823, DOI 10.1097/00002030-199814000-00014; Johnson KR, 2006, LANCET ONCOL, V7, P741, DOI 10.1016/S1470-2045(06)70800-2; Johnson KR, 2009, J CLIN EPIDEMIOL, V62, P328, DOI 10.1016/j.jclinepi.2008.06.004; la Cour JL, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3653; Lassere MN, 2008, STAT METHODS MED RES, V17, P303, DOI 10.1177/0962280207082719; Lassere MN, 2007, J RHEUMATOL, V34, P607; Mangiapane Sandra, 2009, GMS Health Technol Assess, V5, pDoc12, DOI 10.3205/hta000074; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Moynihan R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5160; National Institute for Health and Clinical Excellence, 2012, 2011 12 REV GUID MET; National Institute for Health and Clinical Excellence, 2004, REN TRANSPL IMM SUPP; National Institute for Health and Clinical Excellence, 2012, REV GUID METH TECHN; National Institute for Health and Clinical Excellence, 2012, LEUK CHRON MYEL 1 LI; National Institute for Health and Clinical Excellence, 2006, HEP B CHRON AD DIP P; Naylor CD, 1997, BMJ-BRIT MED J, V315, P617, DOI 10.1136/bmj.315.7109.617; Nobre MR, 2011, EVID BASED MED, V17, P3; Pavey T, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16420; Pocock S, 1996, CLIN TRIALS PRACTICA; Poustie VJ, 2006, BMJ-BRIT MED J, V332, P632, DOI 10.1136/bmj.38737.600880.AE; Renfro LA, 2012, BIOMETRICS, V68, P258, DOI 10.1111/j.1541-0420.2011.01647.x; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Tonstad S, 2006, JAMA-J AM MED ASSOC, V296, P64, DOI 10.1001/jama.296.1.64; Tucker GT, 1995, CLIN MEASUREMENT DRU; US Food and Drug Administration, 2005, GEF MARK IR INF; US Food and Drug Administration, 2003, LAB APPR HIST IR; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Yudkin JS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7995	57	107	108	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2013	346								f457	10.1136/bmj.f457	http://dx.doi.org/10.1136/bmj.f457			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084BH	23360719	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000314510400004
J	Kobayashi, SA				Kobayashi, Sow Alfred			Perioral Myokymia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Diego, San Diego, CA 92103 USA	University of California System; University of California San Diego	Kobayashi, SA (corresponding author), Univ Calif San Diego, San Diego, CA 92103 USA.	s2kobayashi@ucsd.edu							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					E5	E5		10.1056/NEJMicm1202778	http://dx.doi.org/10.1056/NEJMicm1202778			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075KX	23343078				2022-12-28	WOS:000313885900011
J	Baum, M				Baum, Michael			PERSONAL VIEW Harms from breast cancer screening outweigh benefits if death caused by treatment is included	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RADIOTHERAPY; MORTALITY		UCL, Div Surg & Intervent Sci, London WC1E 6BT, England	University of London; University College London	Baum, M (corresponding author), UCL, Div Surg & Intervent Sci, Mortimer St, London WC1E 6BT, England.	michael@mbaum.freeserve.co.uk						Abe O, 2005, LANCET, V366, P2087; [Anonymous], ALL CAUS MORT RAT MO; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Burton RC, 2012, BREAST CANCER RES TR, V131, P949, DOI 10.1007/s10549-011-1794-6; Cancer Research UK, 2011, CANCERSTATS CANC STA; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; HAYBITTLE JL, 1989, BRIT MED J, V298, P1611, DOI 10.1136/bmj.298.6688.1611; Jones LW, 2012, J CLIN ONCOL, V30, P2530, DOI 10.1200/JCO.2011.39.9014; Lane JA, 2010, EUR J CANCER, V46, P3095, DOI 10.1016/j.ejca.2010.09.016; Law M, 2003, Health Technol Assess, V7, P1; Lind PA, 2003, INT J RADIAT ONCOL, V55, P914, DOI 10.1016/S0360-3016(02)04156-1; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; NHS Breast Screening & Association of Breast Surgery, 2011, AUD SCREEN DET BREAS; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	15	51	51	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2013	346								f385	10.1136/bmj.f385	http://dx.doi.org/10.1136/bmj.f385			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BX	23344314				2022-12-28	WOS:000314217300010
J	Silverman, E				Silverman, Ed			DRUG MARKETING Off-label marketing: free speech or illegal promotion?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Pharmalot, Millburn, NJ USA		Silverman, E (corresponding author), Pharmalot, Millburn, NJ USA.	pharmalot@gmail.com							0	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2013	346								f320	10.1136/bmj.f320	http://dx.doi.org/10.1136/bmj.f320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BG	23341546				2022-12-28	WOS:000314215600015
J	Toltzis, P; Goldmann, D				Toltzis, Philip; Goldmann, Don			Rethinking infection prevention research	LANCET			English	Editorial Material							BLOOD-STREAM INFECTIONS; RANDOMIZED TRIAL; POVIDONE-IODINE; CARE; CHLORHEXIDINE; CATHETERS; RATES		[Toltzis, Philip] Rainbow Babies & Childrens Hosp, Cleveland, OH 44122 USA; [Goldmann, Don] Inst Healthcare Improvement, Cambridge, MA USA; [Goldmann, Don] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Institute for Healthcare Improvement; Harvard University; Boston Children's Hospital	Toltzis, P (corresponding author), Rainbow Babies & Childrens Hosp, Cleveland, OH 44122 USA.	philip.toltzis@UHHospitals.org						Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Bleasdale SC, 2007, ARCH INTERN MED, V167, P2073, DOI 10.1001/archinte.167.19.2073; Brook RH, 2012, J GEN INTERN MED, DOI 10.1007/s11606-012-2242-y; Casey AL, 2008, LANCET INFECT DIS, V8, P763, DOI 10.1016/S1473-3099(08)70280-9; Dixon-Woods M, 2011, MILBANK Q, V89, P167, DOI 10.1111/j.1468-0009.2011.00625.x; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P349, DOI 10.1016/j.ajic.2011.04.011; Garland JS, 2001, PEDIATRICS, V107, P1431, DOI 10.1542/peds.107.6.1431; Institute for Healthcare Improvement, 2012, BREAKTHR SER IHIS CO; LAFFEL G, 1989, JAMA-J AM MED ASSOC, V262, P2869, DOI DOI 10.1001/JAMA.1989.03430200113036; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Luce BR, 2009, ANN INTERN MED, V151, P206, DOI 10.7326/0003-4819-151-3-200908040-00126; MAKI DG, 1991, LANCET, V338, P339, DOI 10.1016/0140-6736(91)90479-9; Miller MR, 2010, PEDIATRICS, V125, P206, DOI 10.1542/peds.2009-1382; Milstone AM, 2013, LANCET; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Schulman J, 2011, PEDIATRICS, V127, P436, DOI 10.1542/peds.2010-2873	16	3	2	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 30	2013	381	9872					1078	1079		10.1016/S0140-6736(12)61996-5	http://dx.doi.org/10.1016/S0140-6736(12)61996-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122WL	23363665				2022-12-28	WOS:000317348900007
J	Johnson, DG; Dent, SYR				Johnson, David G.; Dent, Sharon Y. R.			Chromatin: Receiver and Quarterback for Cellular Signals	CELL			English	Review							DNA-DAMAGE-RESPONSE; HISTONE H2B UBIQUITINATION; HOMOLOGOUS RECOMBINATION; MODIFYING ENZYMES; GENE-EXPRESSION; STRAND BREAKS; METHYLATION; H3; PHOSPHORYLATION; ATM	Signal transduction pathways converge upon sequence-specific DNA binding factors to reprogram gene expression. Transcription factors, in turn, team up with chromatin modifying activities. However, chromatin is not simply an endpoint for signaling pathways. Histone modifications relay signals to other proteins to trigger more immediate responses than can be achieved through altered gene transcription, which might be especially important to time-urgent processes such as the execution of cell-cycle check points, chromosome segregation, or exit from mitosis. In addition, histone-modifying enzymes often have multiple nonhistone substrates, and coordination of activity toward different targets might direct signals both to and from chromatin.	[Johnson, David G.; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Johnson, David G.; Dent, Sharon Y. R.] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Smithville, TX 78957 USA; [Johnson, David G.; Dent, Sharon Y. R.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Dent, SYR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX 78957 USA.	sroth@mdanderson.org	Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269; Johnson, David/0000-0002-6223-1790	National Institutes of Health [CA079648, GM096472, GM067718]; MD Anderson's Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [R01CA079648, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051189, R01GM067718, R01GM096472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson's Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Becky Brooks for preparation of the manuscript, Chris Brown for graphics, and Mark Bedford and Boyko Atanassov for suggestions and insightful comments. This research is supported, in part, by grants from the National Institutes of Health (CA079648 to D.G.J. and GM096472 and GM067718 to S.R.D.) and through MD Anderson's Cancer Center Support Grant (CA016672).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Burrows AE, 2008, GENE DEV, V22, P1416, DOI 10.1101/gad.1685108; Butler JS, 2012, EPIGENOMICS-UK, V4, P163, DOI [10.2217/EPI.12.3, 10.2217/epi.12.3]; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chernikova SB, 2012, CANCER RES, V72, P2111, DOI 10.1158/0008-5472.CAN-11-2209; D'Amours D, 2004, GENE DEV, V18, P2581, DOI 10.1101/gad.1247304; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Game JC, 2009, DNA REPAIR, V8, P470, DOI 10.1016/j.dnarep.2009.01.007; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Hwang WW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000588; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Laribee RN, 2007, GENE DEV, V21, P737, DOI 10.1101/gad.1541507; Latham JA, 2011, CELL, V146, P709, DOI 10.1016/j.cell.2011.07.025; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Lin WC, 2001, GENE DEV, V15, P1833; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Mohan M, 2010, NAT REV CANCER, V10, P720, DOI 10.1038/nrc2915; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zha S, 2009, NAT STRUCT MOL BIOL, V16, P798, DOI 10.1038/nsmb0809-798; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	54	52	53	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 14	2013	152	4					685	689		10.1016/j.cell.2013.01.017	http://dx.doi.org/10.1016/j.cell.2013.01.017			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23375745	Bronze, Green Accepted			2022-12-28	WOS:000314945600005
J	Teeples, TJ; Tabibian, JH				Teeples, Tyson J.; Tabibian, James H.			Mesenteric Abscess in Crohn's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Teeples, Tyson J.; Tabibian, James H.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Teeples, TJ (corresponding author), Mayo Clin, Rochester, MN 55905 USA.								0	2	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					663	663		10.1056/NEJMicm1110648	http://dx.doi.org/10.1056/NEJMicm1110648			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194VA	23406031				2022-12-28	WOS:000322659600011
J	Cummings, JR; Wen, HF; Druss, BG				Cummings, Janet R.; Wen, Hefei; Druss, Benjamin G.			Improving Access to Mental Health Services for Youth in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cummings, Janet R.; Wen, Hefei; Druss, Benjamin G.] Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Cummings, JR (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, 1518 Clifton Rd NE,Room 650, Atlanta, GA 30322 USA.	jrcummi@emory.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH095823] Funding Source: NIH RePORTER; NIMH NIH HHS [1K01MH09582301, K01 MH095823] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cauce AM, 2002, J CONSULT CLIN PSYCH, V70, P44, DOI 10.1037//0022-006X.70.1.44; Center for Mental Health Services, 2008, 2008 NAT SURV MENT H; Honberg R., 2011, STATE MENTAL HLTH CU; Jacobs S, 2005, PSYCHIAT SERV, V56, P1356, DOI 10.1176/appi.ps.56.11.1356; Oliff P., 2012, NEW SCH YEAR BRINGS; US Department of Health and Human Services, 2011 2012 AR RES FIL; Viebeck E, 2012, HILL            1220; Wells R, 2010, PSYCHIAT SERV, V61, P759, DOI 10.1176/ps.2010.61.8.759	8	62	62	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					553	554		10.1001/jama.2013.437	http://dx.doi.org/10.1001/jama.2013.437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	087PH	23403677	Green Accepted			2022-12-28	WOS:000314773700025
J	Abbas, YM; Pichmair, A; Gorna, MW; Superti-Furga, G; Nagar, B				Abbas, Yazan M.; Pichmair, Andreas; Gorna, Maria W.; Superti-Furga, Giulio; Nagar, Bhushan			Structural basis for viral 5 '-PPP-RNA recognition by human IFIT proteins	NATURE			English	Article							RIG-I; PATTERN-RECOGNITION; CRYSTAL-STRUCTURE; RNA RECOGNITION; STRANDED-RNA; ACTIVATION; INSIGHTS; ISG54	Interferon-induced proteins with tetratricopeptide repeats (IFITs) are innate immune effector molecules that are thought to confer antiviral defence through disruption of protein-protein interactions in the host translation-initiation machinery. However, it was recently discovered that IFITs can directly recognize viral RNA bearing a 5'-triphosphate group (PPP-RNA), which is a molecular signature that distinguishes it from host RNA. Here we report crystal structures of human IFIT5, its complex with PPP-RNAs, and an amino-terminal fragment of IFIT1. The structures reveal a new helical domain that houses a positively charged cavity designed to specifically engage only single-stranded PPP-RNA, thus, distinguishing it from the canonical cytosolic sensor of double-stranded viral PPP-RNA, retinoic acid-inducible gene I (RIG-I, also known as DDX58). Mutational analysis, proteolysis and gel-shift assays reveal that PPP-RNA is bound in a non-sequence-specific manner and requires a 5'-overhang of approximately three nucleotides. Abrogation of PPP-RNA binding in Inn and IFIT5 was found to cause a defect in the antiviral response by human embryonic kidney cells. These results demonstrate the mechanism by which IFIT proteins selectively recognize viral RNA, and lend insight into their downstream effector function.	[Abbas, Yazan M.; Nagar, Bhushan] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Abbas, Yazan M.; Nagar, Bhushan] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Pichmair, Andreas; Gorna, Maria W.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Pichmair, Andreas] Max Planck Inst Biochem, D-82152 Martinsried, Germany	McGill University; McGill University; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Max Planck Society	Nagar, B (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada.	gsuperti@cemm.oeaw.ac.at; bhushan.nagar@mcgill.ca	Górna, Maria/F-4269-2014; Superti-Furga, Giulio/AAE-5681-2019; Superti-Furga, Giulio/F-4755-2015	Górna, Maria/0000-0002-1769-4542; Superti-Furga, Giulio/0000-0002-0570-1768	Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research (CIHR) [MOP-82929]; Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan; Canada Research Chair; Career Development Award from the Human Frontiers Science Program [CDA 0018/2006-C/1]; Austrian Academy of Sciences; i-FIVE ERC grant; EMBO [ATLF 463-2008]; CIHR Strategic Training Initiative in Chemical Biology	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Career Development Award from the Human Frontiers Science Program; Austrian Academy of Sciences; i-FIVE ERC grant; EMBO(European Molecular Biology Organization (EMBO)); CIHR Strategic Training Initiative in Chemical Biology(Canadian Institutes of Health Research (CIHR))	We thank S. Labiuk and P. Grochulski for X-ray data collection performed on beamline 08ID-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research (CIHR), the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. Thanks also to all laboratory members for discussions and technical assistance. B.N. is supported by a Canada Research Chair, a Career Development Award from the Human Frontiers Science Program (CDA 0018/2006-C/1) and an operating grant from the CIHR (CIHR grant MOP-82929). Work in the G.S.-F. laboratory is funded by the Austrian Academy of Sciences and the i-FIVE ERC grant. A.P. is an EMBO Long-Term Fellowship recipient (ATLF 463-2008). Y.M.A. was supported by the CIHR Strategic Training Initiative in Chemical Biology.	Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352; Yang ZL, 2012, CELL RES, V22, P1328, DOI 10.1038/cr.2012.111; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	28	160	167	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					60	64		10.1038/nature11783	http://dx.doi.org/10.1038/nature11783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23334420	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000314741200033
J	Gerber, A; Esnault, C; Aubert, G; Treisman, R; Pralong, F; Schibler, U				Gerber, Alan; Esnault, Cyril; Aubert, Gregory; Treisman, Richard; Pralong, Francois; Schibler, Ueli			Blood-Borne Circadian Signal Stimulates Daily Oscillations in Actin Dynamics and SRF Activity	CELL			English	Article							SERUM RESPONSE FACTOR; NUCLEAR ACTIN; BINDING PROTEINS; TRANSCRIPTION; LIVER; GENE; RHYTHMS; TEMPERATURE; PHASE	In peripheral tissues circadian gene expression can be driven either by local oscillators or by cyclic systemic cues controlled by the master clock in the brain's suprachiasmatic nucleus. In the latter case, systemic signals can activate immediate early transcription factors (IETFs) and thereby control rhythmic transcription. In order to identify IETFs induced by diurnal blood-borne signals, we developed an unbiased experimental strategy, dubbed Synthetic TAndem Repeat PROMoter (STAR-PROM) screening. This technique relies on the observation that most transcription factor binding sites exist at a relatively high frequency in random DNA sequences. Using STAR-PROM we identified serum response factor (SRF) as an IETF responding to oscillating signaling proteins present in human and rodent sera. Our data suggest that in mouse liver SRF is regulated via dramatic diurnal changes of actin dynamics, leading to the rhythmic translocation of the SRF coactivator Myocardin-related transcription factor-B (MRTF-B) into the nucleus.	[Gerber, Alan; Schibler, Ueli] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Gerber, Alan; Schibler, Ueli] Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland; [Esnault, Cyril; Treisman, Richard] London Res Inst, London WC2A 3LY, England; [Aubert, Gregory; Pralong, Francois] Univ Hosp Lausanne CHUV, Serv Endocrinol Diabetol & Metab, Dept Med, CH-1011 Lausanne, Switzerland	University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland.	ueli.schibler@unige.ch	Aubert, Gregory/S-7075-2019	Gerber, Alan/0000-0003-3909-3606; Esnault, Cyril/0000-0002-7358-8760; Treisman, Richard/0000-0002-9658-0067; Aubert, Gregory/0000-0002-5539-0224	Swiss National Science Foundation [SNF 31-113565, SNF 31-128656/1, SNF 310000-122094, SNF 320030-124886]; Swiss National Science Foundation (NCCR program grant Frontiers in Genetics); European Research Council [ERC-AdG 250117, ERC-Ad-G 268690]; State of Geneva; Louis Jeantet Foundation of Medicine; EMBO; Cancer Research UK; Cancer Research UK [15687] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation (NCCR program grant Frontiers in Genetics)(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); State of Geneva; Louis Jeantet Foundation of Medicine; EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	We would like to thank Pascal Gos for transcardial perfusion, Jean-Marc Matter for his help with tissue preparation, Nicolas Roggli for the artwork, and David Suter (Harvard University, Boston) for critical comments on the manuscript. Work in the laboratory of U.S. was supported by the Swiss National Science Foundation (SNF 31-113565, SNF 31-128656/1 and the NCCR program grant Frontiers in Genetics), the European Research Council (ERC-AdG 250117), the State of Geneva, and the Louis Jeantet Foundation of Medicine. C.E. was funded in part by a long-term fellowship from EMBO. Work in the laboratory of R.T. was supported by core funding from Cancer Research UK and the European Research Council (ERC-Ad-G 268690). Work in the laboratory of F. P. was supported by the Swiss National Science Foundation (SNF grants 310000-122094 and 320030-124886).	Bailey MJ, 2004, J BIOL CHEM, V279, P52247, DOI 10.1074/jbc.M405679200; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cochran B H, 1993, NIDA Res Monogr, V125, P3; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de Lanerolle P, 2011, NAT CELL BIOL, V13, P1282, DOI 10.1038/ncb2364; Diaz-Munoz Mauricio, 2010, Comp Hepatol, V9, P5, DOI 10.1186/1476-5926-9-5; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; FOX JEB, 1981, ANAL BIOCHEM, V117, P170, DOI 10.1016/0003-2697(81)90707-7; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; HAN TH, 1992, MOL CELL BIOL, V12, P4472, DOI 10.1128/MCB.12.10.4472; Hriscu M.L., 2004, J APPL BIOMED, V2, P199; KAST A, 1988, CHRONOBIOL INT, V5, P363, DOI 10.3109/07420528809067782; Kornmann B, 2007, COLD SPRING HARB SYM, V72, P319, DOI 10.1101/sqb.2007.72.041; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kotarsky K, 2001, ANAL BIOCHEM, V288, P209, DOI 10.1006/abio.2000.4898; Lange K, 2006, J CELL PHYSIOL, V209, P270, DOI 10.1002/jcp.20717; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; MADER S, 1993, P NATL ACAD SCI USA, V90, P5603, DOI 10.1073/pnas.90.12.5603; May RC, 2001, J CELL SCI, V114, P1061; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; SAMBROOK J, 2000, MOL CLONING LAB MANU; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sukumaran S, 2011, J APPL PHYSIOL, V110, P1732, DOI 10.1152/japplphysiol.00079.2011; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; UCHIYAMA Y, 1990, J GASTROEN HEPATOL, V5, P321, DOI 10.1111/j.1440-1746.1990.tb01634.x; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Vujovic N, 2008, AM J PHYSIOL-REG I, V295, pR355, DOI 10.1152/ajpregu.00498.2007; Wang B, 2005, J CLIN MICROBIOL, V43, P2339, DOI 10.1128/JCM.43.5.2339-2344.2005; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	44	96	97	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					492	503		10.1016/j.cell.2012.12.027	http://dx.doi.org/10.1016/j.cell.2012.12.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374345	Bronze			2022-12-28	WOS:000314362800019
J	Spellberg, B; Bartlett, JG; Gilbert, DN				Spellberg, Brad; Bartlett, John G.; Gilbert, David N.			The Future of Antibiotics and Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Spellberg, Brad] Harbor Univ Calif Angeles UCLA, Med Ctr, Div Gen Internal Med, Los Angeles Biomed Res Inst, Los Angeles, CA USA; [Spellberg, Brad] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bartlett, John G.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Gilbert, David N.] Providence Portland Med Ctr, Dept Med Educ, Portland, OR USA; [Gilbert, David N.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Providence Portland Medical Center; Oregon Health & Science University	Spellberg, B (corresponding author), Harbor Univ Calif Angeles UCLA, Med Ctr, Div Gen Internal Med, Los Angeles Biomed Res Inst, Los Angeles, CA USA.				NIAID NIH HHS [R21 AI101750, R01 AI081719] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101750, R01AI081719] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Howell L., 2013, GLOBAL RISKS 2013; Lin L, 2012, MBIO, V3, DOI 10.1128/mBio.00312-12; Spellberg B, 2012, CLIN INFECT DIS, V55, P1031, DOI 10.1093/cid/cis688	5	387	407	4	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					299	302		10.1056/NEJMp1215093	http://dx.doi.org/10.1056/NEJMp1215093			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075KX	23343059	Green Accepted, Bronze			2022-12-28	WOS:000313885900002
J	Pinto, RZ; Maher, CG; Ferreira, ML; Hancock, M; Oliveira, VC; McLachlan, AJ; Koes, B; Ferreira, PH				Pinto, Rafael Zambelli; Maher, Chris G.; Ferreira, Manuela L.; Hancock, Mark; Oliveira, Vinicius C.; McLachlan, Andrew J.; Koes, Bart; Ferreira, Paulo H.			Epidural Corticosteroid Injections in the Management of Sciatica A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							LOW-BACK-PAIN; LUMBAR DISC HERNIATION; DOUBLE-BLIND; STEROID INJECTIONS; RADICULAR PAIN; PERIRADICULAR INFILTRATION; TRANSFORAMINAL INJECTION; INTERVENTIONAL THERAPIES; RATING QUALITY; RISK-FACTORS	Background: Existing guidelines and systematic reviews provide inconsistent recommendations on epidural corticosteroid injections for sciatica. Key limitations of existing reviews are the inclusion of trials with active controls of unknown efficacy and failure to provide an estimate of the size of the treatment effect. Purpose: To determine the efficacy of epidural corticosteroid injections for sciatica compared with placebo. Data Sources: International Pharmaceutical Abstracts, PsycINFO, MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and CINAHL. Study Selection: Randomized, placebo-controlled trials assessing the efficacy of epidural corticosteroid injections in participants with sciatica. Data Extraction: Two independent reviewers extracted data and assessed risk of bias. Leg pain, back pain, and disability were converted to common scales from 0 (no pain or disability) to 100 (worst possible pain or disability). Thresholds for clinically important change in the range of 10 to 30 have been proposed for these outcomes. Effects were calculated for short-term (>2 weeks but <= 3 months) and long-term (>= 12 months) follow-up. Data Synthesis: Data were pooled with a random-effects model, and the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach was used in summary conclusions. Twenty-five published reports (23 trials) were included. The pooled results showed a significant, although small, effect of epidural corticosteroid injections compared with placebo for leg pain in the short term (mean difference, -6.2 [95% CI, -9.4 to -3.0]) and also for disability in the short term (mean difference, -3.1 [CI, -5.0 to -1.2]). The long-term pooled effects were smaller and not statistically significant. The overall quality of evidence according to the GRADE classification was rated as high. Limitation: The review included only English-language trials and could not incorporate dichotomous outcome measures into the analysis. Conclusion: The available evidence suggests that epidural corticosteroid injections offer only short-term relief of leg pain and disability for patients with sciatica. The small size of the treatment effects, however, raises questions about the clinical utility of this procedure in the target population.	[Pinto, Rafael Zambelli; Maher, Chris G.; Ferreira, Manuela L.] Georgia Inst Global Hlth, Sydney, NSW 2050, Australia; Univ Sydney, Sydney Med Sch, Sydney, NSW 2050, Australia; Macquarie Univ, Ctr Educ & Res Ageing, N Ryde, NSW, Australia; Concord Hosp, Sydney, NSW 2109, Australia; Erasmus MC, Rotterdam, Netherlands; [Hancock, Mark] Macquarie Univ, Fac Human Sci, Sydney, NSW 2050, Australia; [Oliveira, Vinicius C.; Ferreira, Paulo H.] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2141, Australia; [McLachlan, Andrew J.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Koes, Bart] Erasmus MC, Dept Gen Practice, NL-3000 CA Rotterdam, Netherlands	University of Sydney; Macquarie University; Concord Repatriation General Hospital; Erasmus University Rotterdam; Erasmus MC; Macquarie University; University of Sydney; University of Sydney; Erasmus University Rotterdam; Erasmus MC	Pinto, RZ (corresponding author), Georgia Inst Global Hlth, POB M201,Missenden Rd,Camperdown, Sydney, NSW 2050, Australia.	rafaelzambelli@gmail.com	Pinto, Rafael/GWC-5559-2022; Ferreira, Manuela/AAQ-5446-2020; OLIVEIRA, VINICIUS CUNHA/E-1366-2014; Ferreira, Paulo H/N-3061-2017; Maher, Christopher/AAC-6267-2019; Koes, Bart w/K-4614-2016; Pinto, Rafael Zambelli/I-2892-2012	Ferreira, Manuela/0000-0002-3479-0683; OLIVEIRA, VINICIUS CUNHA/0000-0002-8658-3774; Ferreira, Paulo H/0000-0002-5861-7770; Maher, Christopher/0000-0002-1628-7857; Koes, Bart w/0000-0002-0450-9969; Pinto, Rafael Zambelli/0000-0002-2775-860X; McLachlan, Andrew/0000-0003-4674-0242; Hancock, Mark/0000-0002-9277-5377	Capes Foundation, Ministry of Education of Brazil; Australian Research Council	Capes Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Australian Research Council(Australian Research Council)	Mr. Pinto is a PhD student supported by Capes Foundation, Ministry of Education of Brazil. Dr. Maher is supported by a research fellowship funded by the Australian Research Council.	Abdi Salahadin, 2007, Pain Physician, V10, P185; Abram SE, 1996, REGION ANESTH, V21, P149; Arden NK, 2005, RHEUMATOLOGY, V44, P1399, DOI 10.1093/rheumatology/kei028; Armon C, 2007, NEUROLOGY, V68, P723, DOI 10.1212/01.wnl.0000256734.34238.e7; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Autio RA, 2004, SPINE, V29, P1601, DOI 10.1097/01.BRS.0000132511.46818.67; Benny B, 2011, J BACK MUSCULOSKELET, V24, P67, DOI [10.3233/BMR20110279, 10.3233/BMR-2011-0279]; Bijur PE, 2003, ACAD EMERG MED, V10, P390, DOI 10.1111/j.1553-2712.2003.tb01355.x; Bollini P, 1999, BRIT J PSYCHIAT, V174, P297, DOI 10.1192/bjp.174.4.297; Buenaventura RM, 2009, PAIN PHYSICIAN, V12, P233; BUSH K, 1991, SPINE, V16, P572, DOI 10.1097/00007632-199105000-00015; Carette S, 1997, NEW ENGL J MED, V336, P1634, DOI 10.1056/NEJM199706053362303; Chou R, 2009, SPINE, V34, P1078, DOI 10.1097/BRS.0b013e3181a103b1; Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; Cohen SP, 2012, ANN INTERN MED, V156, P551, DOI [10.7326/0003-4819-156-8-201204170-00397, 10.7326/0003-4819-156-8-201204170-00002]; Conn A, 2009, PAIN PHYSICIAN, V12, P109; CUCKLER JM, 1985, J BONE JOINT SURG AM, V67A, P63, DOI 10.2106/00004623-198567010-00009; DePalma MJ, 2005, ARCH PHYS MED REHAB, V86, P1477, DOI 10.1016/j.apmr.2005.01.006; DILKE TFW, 1973, BRIT MED J, V2, P635, DOI 10.1136/bmj.2.5867.635; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Farmer K., 2010, EFFECT VOLUNATARY EX; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Freynhagen R, 2009, CURR PAIN HEADACHE R, V13, P185, DOI 10.1007/s11916-009-0032-y; Ghahreman A, 2010, PAIN MED, V11, P1149, DOI 10.1111/j.1526-4637.2010.00908.x; Giraudeau B, 2004, ANN RHEUM DIS, V63, P1180, DOI 10.1136/ard.2003.015792; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Goodman BS, 2008, CURR REV MUSCULOSKE, V1, P212, DOI 10.1007/s12178-008-9035-2; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hahne AJ, 2010, SPINE, V35, pE488, DOI 10.1097/BRS.0b013e3181cc3f56; Health and Social Care Information Centre, HOSP EP STAT HESONLI; HELLIWELL M, 1985, BRIT J CLIN PRACT, V39, P228; Henschke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub3; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Houten John K, 2002, Spine J, V2, P70, DOI 10.1016/S1529-9430(01)00159-0; Iversen T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5278; Jacobs WCH, 2011, EUR SPINE J, V20, P513, DOI 10.1007/s00586-010-1603-7; Karaman H, 2011, SPINE, V36, pE819, DOI 10.1097/BRS.0b013e3181f32bae; Karppinen J, 2001, SPINE, V26, P1059, DOI 10.1097/00007632-200105010-00015; KLENERMAN L, 1984, BRIT J RHEUMATOL, V23, P35; Koes BW, 2007, BMJ-BRIT MED J, V334, P1313, DOI 10.1136/bmj.39223.428495.BE; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kraemer J, 1997, Eur Spine J, V6, P357, DOI 10.1007/BF01142687; Luijsterburg PAJ, 2007, EUR SPINE J, V16, P881, DOI 10.1007/s00586-007-0367-1; Macedo LG, 2010, J CLIN EPIDEMIOL, V63, P920, DOI 10.1016/j.jclinepi.2009.10.005; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Manchikanti L, 2012, PAIN PHYSICIAN, V15, P131; Manchikanti L, 2011, SPINE, V36, P1897, DOI 10.1097/BRS.0b013e31823294f2; Manchikanti L, 2010, PAIN PHYSICIAN, V13, P343; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P699; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P171; Manchikanti L, 2008, PAIN PHYSICIAN, V11, P801; MATHEWS JA, 1987, BRIT J RHEUMATOL, V26, P416; Ng L, 2005, SPINE, V30, P857, DOI 10.1097/01.brs.0000158878.93445.a0; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Palmer KT, 2003, OCCUP ENVIRON MED, V60, P715, DOI 10.1136/oem.60.10.715; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Parr AT, 2009, PAIN PHYSICIAN, V12, P163; Pinto RZ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e497; Price C, 2005, HEALTH TECHNOL ASSES, V9, P1; Quraishi NA, 2012, EUR SPINE J, V21, P214, DOI 10.1007/s00586-011-2008-y; RIDLEY MG, 1988, BRIT J RHEUMATOL, V27, P295; Riew KD, 2000, J BONE JOINT SURG AM, V82A, P1589, DOI 10.2106/00004623-200011000-00012; ROGERS P, 1992, Pain Clinic, V5, P67; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Rosenquist RW, 2010, ANESTHESIOLOGY, V112, P810, DOI 10.1097/ALN.0b013e3181c43103; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Selim AJ, 1998, SPINE, V23, P470, DOI 10.1097/00007632-199802150-00013; SNOEK W, 1977, ACTA ORTHOP SCAND, V48, P635, DOI 10.3109/17453677708994810; SWERDLOW M, 1970, ANAESTHESIA, V25, P341, DOI 10.1111/j.1365-2044.1970.tb00218.x; Tafazal S, 2009, EUR SPINE J, V18, P1220, DOI 10.1007/s00586-009-1000-2; Tubach F, 2004, J CLIN EPIDEMIOL, V57, P174, DOI 10.1016/S0895-4356(03)00257-9; Vad VB, 2002, SPINE, V27, P11, DOI 10.1097/00007632-200201010-00005; Valat JP, 2010, BEST PRACT RES CL RH, V24, P241, DOI 10.1016/j.berh.2009.11.005; Valat JP, 2003, ANN RHEUM DIS, V62, P639, DOI 10.1136/ard.62.7.639; Waddell G, 2004, BACK PAIN REVOLUTION; Wilson-MacDonald J, 2005, J BONE JOINT SURG BR, V87B, P352, DOI 10.1302/0301-620X.87B3.15338; Wybier M, 2010, EUR RADIOL, V20, P181, DOI 10.1007/s00330-009-1539-7; Younes M, 2006, JOINT BONE SPINE, V73, P538, DOI 10.1016/j.jbspin.2005.10.022	83	194	203	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12					865	U211		10.7326/0003-4819-157-12-201212180-00564	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-00564			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23362516				2022-12-28	WOS:000312583200016
J	Shapiro, MD; Kronenberg, Z; Li, C; Domyan, ET; Pan, HL; Campbell, M; Tan, H; Huff, CD; Hu, HF; Vickrey, AI; Nielsen, SCA; Stringham, SA; Hu, H; Willerslev, E; Gilbert, MTP; Yandell, M; Zhang, GJ; Wang, J				Shapiro, Michael D.; Kronenberg, Zev; Li, Cai; Domyan, Eric T.; Pan, Hailin; Campbell, Michael; Tan, Hao; Huff, Chad D.; Hu, Haofu; Vickrey, Anna I.; Nielsen, Sandra C. A.; Stringham, Sydney A.; Hu, Hao; Willerslev, Eske; Gilbert, M. Thomas P.; Yandell, Mark; Zhang, Guojie; Wang, Jun			Genomic Diversity and Evolution of the Head Crest in the Rock Pigeon	SCIENCE			English	Article							LINKAGE DISEQUILIBRIUM; POPULATIONS; DIVERGENCE; SPECIATION; ANCESTRY; BIRDS; MODEL	The geographic origins of breeds and the genetic basis of variation within the widely distributed and phenotypically diverse domestic rock pigeon (Columba livia) remain largely unknown. We generated a rock pigeon reference genome and additional genome sequences representing domestic and feral populations. We found evidence for the origins of major breed groups in the Middle East and contributions from a racing breed to North American feral populations. We identified the gene EphB2 as a strong candidate for the derived head crest phenotype shared by numerous breeds, an important trait in mate selection in many avian species. We also found evidence that this trait evolved just once and spread throughout the species, and that the crest originates early in development by the localized molecular reversal of feather bud polarity.	[Shapiro, Michael D.; Domyan, Eric T.; Vickrey, Anna I.; Stringham, Sydney A.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Kronenberg, Zev; Campbell, Michael; Huff, Chad D.; Yandell, Mark] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Li, Cai; Pan, Hailin; Tan, Hao; Hu, Haofu; Zhang, Guojie; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Li, Cai; Nielsen, Sandra C. A.; Willerslev, Eske; Gilbert, M. Thomas P.] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Huff, Chad D.; Hu, Hao] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Gilbert, M. Thomas P.] Murdoch Univ, Ancient DNA Lab, Perth, WA 6150, Australia; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-1165 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-1165 Copenhagen, Denmark	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Beijing Genomics Institute (BGI); University of Copenhagen; University of Texas System; UTMD Anderson Cancer Center; Murdoch University; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Shapiro, MD (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	mike.shapiro@utah.edu; wangj@genomics.org.cn	Wang, Jun/A-7261-2013; Gilbert, Marcus TP/A-8936-2013; Willerslev, Eske/A-9619-2011; Zhang, Guojie/B-6188-2014; Zhang, Guojie/J-7273-2019; Hu, Hao/I-4399-2014; Willerslev, Eske/AAA-5686-2019; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Gilbert, Marcus TP/0000-0002-5805-7195; Willerslev, Eske/0000-0002-7081-6748; Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Hu, Haofu/0000-0001-8145-3009; Li, Cai/0000-0001-7843-2151; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	Burroughs Wellcome Fund Career Award in the Biomedical Sciences; NSF CAREER [DEB-1149160]; University of Utah Research Foundation; NIH [T32GM007464, T32HD07491]; NSF EDEN internship; NIH/NHGRI [R01HG004694]; NIH ARRA GO [RC2HG005619]; Danish National Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007491] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG006579, RC2HG005619, R01HG004694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464, R01GM104390] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); University of Utah Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF EDEN internship; NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH ARRA GO; Danish National Research Foundation(Danmarks Grundforskningsfond); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the University of Washington Burke Museum for the C. rupestris tissue sample (UWBM 59803); J. Oldham, K. Wright, the Utah Pigeon Club, the National Pigeon Association, and A. and H. O. Christiansen for domestic pigeon samples; D. Clayton for feral samples; and D. Clayton, M. Horvath, D. Kingsley, R. Nielsen, and W. Warren for discussion and comments. Supported by a Burroughs Wellcome Fund Career Award in the Biomedical Sciences, NSF CAREER DEB-1149160, University of Utah Research Foundation (M. D. S.); NIH training grant T32GM007464 (S. A. S.); NIH training grant T32HD07491 (E. T. D.); an NSF EDEN internship (A. I. V.); NIH/NHGRI R01HG004694 and NIH ARRA GO RC2HG005619 (M.Y.); and the Danish National Research Foundation (M. T. P. G. and E. W.). We acknowledge a computer time allocation from the Center for High Performance Computing at the University of Utah. This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under accession no. AKCR00000000 (the first version described here is AKCR01000000; raw reads, SRA052637); RNA-seq data for annotation, accession no. GSE39333; and raw reads for resequenced genomes, accession no. SRA054391.	Aerts J, 2007, CYTOGENET GENOME RES, V117, P338, DOI 10.1159/000103196; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; [Anonymous], 1861, ORIGIN SPECIES MEANS; Balakrishnan CN, 2009, GENETICS, V181, P645, DOI 10.1534/genetics.108.094250; BAPTISTA Luis Felipe, 2009, Acta Zool. Mex, V25, P719; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Darwin C., 1868, VARIATION ANIMALS PL, V1; Driscoll CA, 2009, P NATL ACAD SCI USA, V106, P9971, DOI 10.1073/pnas.0901586106; Elder ME, 2001, J IMMUNOL, V166, P656, DOI 10.4049/jimmunol.166.1.656; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Johnson KP, 2001, AUK, V118, P874, DOI 10.1642/0004-8038(2001)118[0874:AMPOTD]2.0.CO;2; Kelsh RN, 2009, SEMIN CELL DEV BIOL, V20, P90, DOI 10.1016/j.semcdb.2008.10.001; Levi Wendell M., 1986, PIGEON; McKinnell IW, 2004, DEV BIOL, V270, P94, DOI 10.1016/j.ydbio.2004.02.007; Morgan TH, 1911, BIOL BULL-US, V21, P0215, DOI 10.2307/1536043; Mou C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001028; Price TD, 2002, GENETICA, V116, P311, DOI 10.1023/A:1021248913179; Sell A., 1994, BREEDING INHERITANCE; Stringham SA, 2012, CURR BIOL, V22, P302, DOI 10.1016/j.cub.2011.12.045; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Wang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034012; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111	24	175	183	7	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1063	1067		10.1126/science.1230422	http://dx.doi.org/10.1126/science.1230422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23371554	Green Accepted			2022-12-28	WOS:000315452000038
J	Yin, QZ				Yin, Qiuzhen			Insolation-induced mid-Brunhes transition in Southern Ocean ventilation and deep-ocean temperature	NATURE			English	Article							MIDPLEISTOCENE TRANSITION; CARBON-DIOXIDE; CLIMATE; RECORD; HEMISPHERE; ATLANTIC; FRONT	Glacial-interglacial cycles characterized by long cold periods interrupted by short periods of warmth are the dominant feature of Pleistocene climate, with the relative intensity and duration of past and future interglacials being of particular interest for civilization. The interglacials after 430,000 years ago were characterized by warmer climates(1,2) and higher atmospheric concentrations of carbon dioxide(3) than the interglacials before, but the cause of this climatic transition (the so-called mid-Brunhes event (MBE)) is unknown. Here I show, on the basis of model simulations, that in response to insolation changes only, feedbacks between sea ice, temperature, evaporation and salinity caused vigorous pre-MBE Antarctic bottom water formation and Southern Ocean ventilation. My results also show that strong westerlies increased the pre-MBE overturning in the Southern Ocean via an increased latitudinal insolation gradient created by changes in eccentricity during austral winter and by changes in obliquity during austral summer. The stronger bottom water formation led to a cooler deep ocean during the older interglacials. These insolation-induced differences in the deep-sea temperature and in the Southern Ocean ventilation between the more recent interglacials and the older ones were not expected, because there is no straightforward systematic difference in the astronomical parameters between the Interglacials before and after 430,000 years ago(4). Rather than being a real 'event', the apparent MBE seems to have resulted from a series of individual interglacial responses including notable exceptions to the general pattern to various combinations of insolation conditions. Consequently, assuming no anthropogenic interference, future interglacials may have pre- or post-MBE characteristics without there being a systematic change in forcings. These findings are a first step towards understanding the magnitude change of the interglacial carbon dioxide concentration around 430,000 years ago.	Catholic Univ Louvain, Earth & Life Inst, Georges Lemaitre Ctr Earth & Climate Res, B-1348 Louvain, Belgium	Universite Catholique Louvain	Yin, QZ (corresponding author), Catholic Univ Louvain, Earth & Life Inst, Georges Lemaitre Ctr Earth & Climate Res, Chemin Cyclotron 2, B-1348 Louvain, Belgium.	qiuzhen.yin@uclouvain.be		Yin, Qiuzhen/0000-0002-7189-8335	European Research Council [227348]; Belgian National Fund for Scientific Research (FRS-FNRS); S. A. Electrabel, Belgium	European Research Council(European Research Council (ERC)European Commission); Belgian National Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); S. A. Electrabel, Belgium	Thanks to A. Berger, M. Crucifix, A. Ganopolski and D. Paillard for their comments on the previous draft of this paper, to A. Mouchet for her help on the water age calculation in LOVECLIM, and to A. Timmermann for his comments on the results. Thanks also to N. Herold for help with English. This work is supported by the European Research Council Advanced Grant EMIS (no. 227348 of the Programme 'Ideas'). The author is supported by the Belgian National Fund for Scientific Research (FRS-FNRS). Access to computer facilities was made easier through sponsorship from S. A. Electrabel, Belgium.	Becquey S, 2002, PALAEOGEOGR PALAEOCL, V182, P221, DOI 10.1016/S0031-0182(01)00497-7; Berger A, 1996, CR ACAD SCI II A, V323, P1; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Ganopolski A, 2011, CLIM PAST, V7, P1415, DOI 10.5194/cp-7-1415-2011; Goosse H, 2010, GEOSCI MODEL DEV, V3, P603, DOI 10.5194/gmd-3-603-2010; Guo ZT, 2009, CLIM PAST, V5, P21, DOI 10.5194/cp-5-21-2009; JANSEN JHF, 1986, SCIENCE, V232, P619, DOI 10.1126/science.232.4750.619; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kemp AES, 2010, QUATERNARY SCI REV, V29, P1993, DOI 10.1016/j.quascirev.2010.04.027; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Martin P, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2003PA000914; Menviel L, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001604; Rahmstorf S, 1997, J PHYS OCEANOGR, V27, P2040, DOI 10.1175/1520-0485(1997)027<2040:IOSHWO>2.0.CO;2; Schaefer G, 2005, MAR MICROPALEONTOL, V54, P191, DOI 10.1016/j.marmicro.2004.12.001; Siddall M, 2010, QUATERNARY SCI REV, V29, P170, DOI 10.1016/j.quascirev.2009.05.011; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Stott L, 2007, SCIENCE, V318, P435, DOI 10.1126/science.1143791; Tzedakis PC, 2010, CLIM PAST, V6, P131, DOI 10.5194/cp-6-131-2010; Wolff EW, 2006, NATURE, V440, P491, DOI 10.1038/nature04614; Yin QZ, 2010, NAT GEOSCI, V3, P243, DOI 10.1038/NGEO771; Yin QZ, 2012, CLIM DYNAM, V38, P709, DOI 10.1007/s00382-011-1013-5	22	50	55	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					222	225		10.1038/nature11790	http://dx.doi.org/10.1038/nature11790			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23407538				2022-12-28	WOS:000315137700036
J	Spencer, R				Spencer, Robert			Portrait of an Artist	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									NYU, Sch Med, New York, NY 10003 USA	New York University	Spencer, R (corresponding author), NYU, Sch Med, New York, NY 10003 USA.	robert.spencer@nyumc.org		Spencer, Robert/0000-0001-5711-0612					0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					557	558		10.1001/jama.2012.217484	http://dx.doi.org/10.1001/jama.2012.217484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087PH	23403679				2022-12-28	WOS:000314773700027
J	Padela, AI				Padela, Aasim I.			Software Caring for Muslim patients with the help of an app	LANCET			English	Editorial Material									[Padela, Aasim I.] Univ Chicago, Maclean Ctr Clin Med Eth, Sect Emergency Med, Chicago, IL 60637 USA; [Padela, Aasim I.] Univ Chicago, Maclean Ctr Clin Med Eth, Gen Internal Med Sect, Chicago, IL 60637 USA; [Padela, Aasim I.] Univ Chicago, Initiat Islam & Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Padela, AI (corresponding author), Univ Chicago, Maclean Ctr Clin Med Eth, Sect Emergency Med, Chicago, IL 60637 USA.	apadela@uchicago.edu							0	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2013	381	9865					443	443		10.1016/S0140-6736(13)60234-2	http://dx.doi.org/10.1016/S0140-6736(13)60234-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088CH	23405416				2022-12-28	WOS:000314810900017
J	Winter, SE; Winter, MG; Xavier, MN; Thiennimitr, P; Poon, V; Keestra, AM; Laughlin, RC; Gomez, G; Wu, J; Lawhon, SD; Popova, IE; Parikh, SJ; Adams, LG; Tsolis, RM; Stewart, VJ; Baumler, AJ				Winter, Sebastian E.; Winter, Maria G.; Xavier, Mariana N.; Thiennimitr, Parameth; Poon, Victor; Keestra, A. Marijke; Laughlin, Richard C.; Gomez, Gabriel; Wu, Jing; Lawhon, Sara D.; Popova, Ina E.; Parikh, Sanjai J.; Adams, L. Garry; Tsolis, Renee M.; Stewart, Valley J.; Baeumler, Andreas J.			Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut	SCIENCE			English	Article							CROHNS-DISEASE; NITRIC-OXIDE; MICROBIOTA; OXIDATION; DISRUPTS; FLORA	Changes in the microbial community structure are observed in individuals with intestinal inflammatory disorders. These changes are often characterized by a depletion of obligate anaerobic bacteria, whereas the relative abundance of facultative anaerobic Enterobacteriaceae increases. The mechanisms by which the host response shapes the microbial community structure, however, remain unknown. We show that nitrate generated as a by-product of the inflammatory response conferred a growth advantage to the commensal bacterium Escherichia coli in the large intestine of mice. Mice deficient in inducible nitric oxide synthase did not support the growth of E. coli by nitrate respiration, suggesting that the nitrate generated during inflammation was host-derived. Thus, the inflammatory host response selectively enhances the growth of commensal Enterobacteriaceae by generating electron acceptors for anaerobic respiration.	[Winter, Sebastian E.; Winter, Maria G.; Xavier, Mariana N.; Thiennimitr, Parameth; Poon, Victor; Keestra, A. Marijke; Tsolis, Renee M.; Baeumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Thiennimitr, Parameth] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Laughlin, Richard C.; Gomez, Gabriel; Wu, Jing; Lawhon, Sara D.; Adams, L. Garry] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Popova, Ina E.; Parikh, Sanjai J.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Stewart, Valley J.] Univ Calif Davis, Coll Biol Sci, Dept Microbiol, Davis, CA 95616 USA	University of California System; University of California Davis; Chiang Mai University; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Davis; University of California System; University of California Davis	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, 1 Shields Ave, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Keestra-Gounder, A. Marijke/H-4394-2012; Thiennimitr, Parameth/AAH-1761-2019; Winter, Sebastian E/A-4118-2009; Byndloss, Mariana X/D-9890-2014; Jung, Kirsten/K-4196-2014; Parikh, Sanjai J/F-3476-2011; Lawhon, Sara D./G-5147-2011; Byndloss, Mariana Xavier/ABD-5506-2021; Baumler, Andreas J/H-2301-2011	Keestra-Gounder, A. Marijke/0000-0002-2231-652X; Winter, Sebastian E/0000-0003-1532-9178; Byndloss, Mariana X/0000-0002-2122-4156; Jung, Kirsten/0000-0003-0779-6841; Parikh, Sanjai J/0000-0002-5260-0417; Lawhon, Sara D./0000-0001-9154-8909; Byndloss, Mariana Xavier/0000-0002-2122-4156; Baumler, Andreas J/0000-0001-9152-7809; Laughlin, Richard/0000-0002-3321-8642; Tsolis, Renee/0000-0001-9131-6657; Popova, Inna/0000-0002-2004-1411; Thiennimitr, Parameth/0000-0002-6339-8744	California Agricultural Experiment Station; Public Health Service [AI090387, AI076246, AI088122]; Faculty of Medicine, Chiang Mai University, Thailand; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI090387, R01AI076246, R21AI088122, R21AI107393] Funding Source: NIH RePORTER	California Agricultural Experiment Station; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Faculty of Medicine, Chiang Mai University, Thailand; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Muller for providing Il10<SUP>flox</SUP>/<SUP>flox</SUP> Cd4-cre mice and E. Romao for technical assistance. The data reported in the manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by the California Agricultural Experiment Station (I.E.P. and S.J.P.) and Public Health Service grants AI090387 (R.M.T), AI076246 (L.G.A and A.J.B.), and AI088122 (A.J.B.). P.T. was supported by a scholarship from the Faculty of Medicine, Chiang Mai University, Thailand.	Balagam B, 2008, INORG CHEM, V47, P1173, DOI 10.1021/ic701402h; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Enocksson A, 2004, CLIN DIAGN LAB IMMUN, V11, P250, DOI 10.1128/CDLI.11.2.250-254.2004; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gennis R. B., 1996, CELLULAR MOL BIOL, V1, P217; GIAFFER MH, 1991, J MED MICROBIOL, V35, P238, DOI 10.1099/00222615-35-4-238; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; KROOK A, 1981, J CLIN PATHOL, V34, P645, DOI 10.1136/jcp.34.6.645; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; LUNDBERG JON, 1994, LANCET, V344, P1673, DOI 10.1016/S0140-6736(94)90460-X; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Pils MC, 2011, INFLAMM BOWEL DIS, V17, P2038, DOI 10.1002/ibd.21587; Schoneich C, 2005, BBA-PROTEINS PROTEOM, V1703, P111, DOI 10.1016/j.bbapap.2004.09.009; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Singer II, 1996, GASTROENTEROLOGY, V111, P871, DOI 10.1016/S0016-5085(96)70055-0; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222	21	560	575	11	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					708	711		10.1126/science.1232467	http://dx.doi.org/10.1126/science.1232467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23393266	Green Accepted			2022-12-28	WOS:000314585600046
J	Climo, MW; Yokoe, DS; Warren, DK; Perl, TM; Bolon, M; Herwaldt, LA; Weinstein, RA; Sepkowitz, KA; Jernigan, JA; Sanogo, K; Wong, ES				Climo, Michael W.; Yokoe, Deborah S.; Warren, David K.; Perl, Trish M.; Bolon, Maureen; Herwaldt, Loreen A.; Weinstein, Robert A.; Sepkowitz, Kent A.; Jernigan, John A.; Sanogo, Kakotan; Wong, Edward S.			Effect of Daily Chlorhexidine Bathing on Hospital-Acquired Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; GENES QACA; SUSCEPTIBILITIES; INTERVENTION; ENTEROCOCCUS; NETWORK; REDUCE	BACKGROUND Results of previous single-center, observational studies suggest that daily bathing of patients with chlorhexidine may prevent hospital-acquired bloodstream infections and the acquisition of multidrug-resistant organisms (MDROs). METHODS We conducted a multicenter, cluster-randomized, nonblinded crossover trial to evaluate the effect of daily bathing with chlorhexidine-impregnated washcloths on the acquisition of MDROs and the incidence of hospital-acquired bloodstream infections. Nine intensive care and bone marrow transplantation units in six hospitals were randomly assigned to bathe patients either with no-rinse 2% chlorhexidine-impregnated washcloths or with nonantimicrobial washcloths for a 6-month period, exchanged for the alternate product during the subsequent 6 months. The incidence rates of acquisition of MDROs and the rates of hospital-acquired bloodstream infections were compared between the two periods by means of Poisson regression analysis. RESULTS A total of 7727 patients were enrolled during the study. The overall rate of MDRO acquisition was 5.10 cases per 1000 patient-days with chlorhexidine bathing versus 6.60 cases per 1000 patient-days with nonantimicrobial washcloths (P = 0.03), the equivalent of a 23% lower rate with chlorhexidine bathing. The overall rate of hospital-acquired bloodstream infections was 4.78 cases per 1000 patient-days with chlorhexidine bathing versus 6.60 cases per 1000 patient-days with nonantimicrobial washcloths (P = 0.007), a 28% lower rate with chlorhexidine-impregnated washcloths. No serious skin reactions were noted during either study period. CONCLUSIONS Daily bathing with chlorhexidine-impregnated washcloths significantly reduced the risks of acquisition of MDROs and development of hospital-acquired bloodstream infections. (Funded by the Centers for Disease Control and Prevention and Sage Products; ClinicalTrials.gov number, NCT00502476.)	[Climo, Michael W.; Wong, Edward S.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Climo, Michael W.; Sanogo, Kakotan; Wong, Edward S.] Virginia Commonwealth Univ, Med Ctr, Richmond, VA 23284 USA; [Yokoe, Deborah S.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Yokoe, Deborah S.] Harvard Univ, Sch Med, Boston, MA USA; [Warren, David K.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Perl, Trish M.] Johns Hopkins Univ, Baltimore, MD USA; [Bolon, Maureen] Northwestern Univ, Chicago, IL 60611 USA; [Weinstein, Robert A.] Cook Cty Hlth & Hosp Syst, Chicago, IL USA; [Herwaldt, Loreen A.] Iowa Univ Hosp, Iowa City, IA USA; [Sepkowitz, Kent A.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Jernigan, John A.] Ctr Dis Control & Prevent, Prevent Epictr Program, Atlanta, GA USA	Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL); Johns Hopkins University; Northwestern University; John H Stroger Junior Hospital Cook County; Memorial Sloan Kettering Cancer Center; Centers for Disease Control & Prevention - USA	Climo, MW (corresponding author), McGuire Vet Affairs Med Ctr, 1201 Broad Rock Blvd,Sect 111-C, Richmond, VA 23249 USA.	michael.climo@va.gov	卢, 悄佳/Z-5223-2019	Warren, David/0000-0001-8679-8241; Herwaldt, Loreen/0000-0002-9530-6859; Jernigan, John/0000-0001-8163-925X	Centers for Disease Control and Prevention [5UO1C1000395-02]; Sage Products; Centene; C.R. Bard; Cardinal Health; Sagentia; 3M Health Care; Cubist Pharmaceuticals; bioMerieux; Merck; Foglia Family Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000395] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Sage Products(General Electric); Centene; C.R. Bard; Cardinal Health; Sagentia; 3M Health Care(3M); Cubist Pharmaceuticals; bioMerieux; Merck(Merck & Company); Foglia Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by a cooperative program award from the Centers for Disease Control and Prevention (5UO1C1000395-02) and Sage Products.; Dr. Climo reports receiving grant support from Sage Products. Dr. Warren reports receiving consulting fees from Centene, C.R. Bard, Cardinal Health, and Sagentia; lecture fees from 3M Health Care; and grant support through his institution from Cubist Pharmaceuticals and bioMerieux. Dr. Perl reports holding board memberships for Hospira and Pfizer and receiving grant support from Merck. Dr. Weinstein reports serving as an unpaid consultant for Sage Products and receiving grant support from the Foglia Family Foundation. No other potential conflict of interest relevant to this article was reported.	Alam MM, 2003, MICROB DRUG RESIST, V9, P109, DOI 10.1089/107662903765826697; Bleasdale SC, 2007, ARCH INTERN MED, V167, P2073, DOI 10.1001/archinte.167.19.2073; Bouchillon SK, 2004, INT J ANTIMICROB AG, V24, P119, DOI 10.1016/j.ijantimicag.2004.01.010; Espuny XB, 2010, PEDIATR DERMATOL, V27, P676, DOI 10.1111/j.1525-1470.2010.01178.x; Cheng CE, 2011, CLIN DERMATOL, V29, P622, DOI 10.1016/j.clindermatol.2011.08.006; Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d; Funuro JP, 2008, AM J INFECT CONTROL, V36, P468, DOI [10.1016/j.ajic:2008.01.003, 10.1016/j.ajic.2008.01.003]; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kreman T, 2005, INFECT CONT HOSP EP, V26, P811, DOI 10.1086/502498; Lee AS, 2011, CLIN INFECT DIS, V52, P1422, DOI 10.1093/cid/cir233; Liippo J, 2011, CONTACT DERMATITIS, V64, P229, DOI 10.1111/j.1600-0536.2010.01851.x; Lockhart SR, 2011, J CLIN MICROBIOL, V49, P2404, DOI 10.1128/JCM.02474-10; Longtin J, 2011, ANTIMICROB AGENTS CH, V55, P2999, DOI 10.1128/AAC.01707-10; McDonnell G, 2001, CLIN MICROBIOL REV, V14, P227; McGann P, 2011, INFECT CONT HOSP EP, V32, P1116, DOI 10.1086/662380; Munoz-Price LS, 2009, INFECT CONT HOSP EP, V30, P1031, DOI 10.1086/644751; National Committee for Clinical Laboratory Standards, 2004, M100S14 NAT COMM CLI; Noguchi N, 2006, J CLIN MICROBIOL, V44, P2119, DOI 10.1128/JCM.02690-05; Popovich KJ, 2009, INFECT CONT HOSP EP, V30, P959, DOI 10.1086/605925; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2007, NEW ENGL J MED, V356, P1268; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, pc309; Roberts RR, 2010, MED CARE, V48, P1026, DOI 10.1097/MLR.0b013e3181ef60a2; Sheng WH, 2009, DIAGN MICR INFEC DIS, V63, P309, DOI 10.1016/j.diagmicrobio.2008.11.014; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Sijbesma T, 2011, HIP INT, V21, P630, DOI 10.5301/HIP.2011.8644; Sipkoff Martin, 2007, Manag Care, V16, P35; Smith K, 2008, J ANTIMICROB CHEMOTH, V61, P78, DOI 10.1093/jac/dkm395; Stone PW, 2010, MED CARE, V48, P433, DOI 10.1097/MLR.0b013e3181d5fb3f; Streit JM, 2004, INT J ANTIMICROB AG, V24, P111, DOI 10.1016/j.ijantimicag.2003.12.019; Vali L, 2008, J ANTIMICROB CHEMOTH, V61, P524, DOI 10.1093/jac/dkm520; Vernon MO, 2006, ARCH INTERN MED, V166, P306, DOI 10.1001/archinte.166.3.306; Warren DK, 2006, INFECT CONT HOSP EP, V27, P662, DOI 10.1086/506184; Warren DK, 2006, CRIT CARE MED, V34, P2084, DOI 10.1097/01.CCM.0000227648.15804.2D; Weber DJ, 2007, ANTIMICROB AGENTS CH, V51, P4217, DOI 10.1128/AAC.00138-07	36	398	414	4	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					533	542		10.1056/NEJMoa1113849	http://dx.doi.org/10.1056/NEJMoa1113849			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	083VU	23388005	Green Accepted, Green Published			2022-12-28	WOS:000314494100004
J	He, F; Shakun, JD; Clark, PU; Carlson, AE; Liu, ZY; Otto-Bliesner, BL; Kutzbach, JE				He, Feng; Shakun, Jeremy D.; Clark, Peter U.; Carlson, Anders E.; Liu, Zhengyu; Otto-Bliesner, Bette L.; Kutzbach, John E.			Northern Hemisphere forcing of Southern Hemisphere climate during the last deglaciation	NATURE			English	Article							ANTARCTIC TEMPERATURE; ATMOSPHERIC CO2; DEEP; SURFACE; CYCLES	According to the Milankovitch theory, changes in summer insolation in. the high-latitude Northern Hemisphere caused glacial cycles through their impact on ice-sheet mass balance(1). Statistical analyses of long climate records supported this theory, but they also posed a substantial challenge by showing that changes in Southern Hemisphere climate were in phase with or led those in the north(2). Although an orbitally forced Northern Hemisphere signal may have been transmitted to the Southern Hemisphere(3), insolation forcing can also directly influence local Southern Hemisphere climate, potentially intensified by sea-ice feedback(4-6), suggesting that the hemispheres may have responded independently to different aspects of orbital forcing. Signal processing of climate records cannot distinguish between these conditions, however, because the proposed insolation forcings share essentially identical variability(7). Here we use transient simulations with a coupled atmosphere-ocean general circulation model to identify the impacts of forcing from changes in orbits, atmospheric CO2 concentration, ice sheets and the Atlantic meridional overturning circulation (AMOC) on hemispheric temperatures during the first half of the last deglaciation (22-14.3 kyr BP). Although based on a single model, our transient simulation with only orbital changes supports the Milankovitch theory in showing that the last deglaciation was initiated by rising insolation during spring and summer in the mid-latitude to high-latitude Northern Hemisphere and by terrestrial snow-albedo feedback. The simulation with all forcings best reproduces the;timing and magnitude of surface temperature evolution in the Southern Hemisphere in deglacial proxy records(8,9). AMOC changes associated with an orbitally induced retreat of Northern Hemisphere ice sheets(10) is the most plausible explanation for the early Southern Hemisphere deglacial warming and its lead over Northern Hemisphere temperature; the ensuing rise in atmospheric CO2 concentration provided the critical feedback on global deglaciation(9,11).	[He, Feng; Carlson, Anders E.; Liu, Zhengyu; Kutzbach, John E.] Univ Wisconsin, Nelson Inst Environm Studies, Ctr Climat Res, Madison, WI 53706 USA; [Shakun, Jeremy D.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Clark, Peter U.; Carlson, Anders E.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Carlson, Anders E.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA; [Liu, Zhengyu] Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI 53706 USA; [Otto-Bliesner, Bette L.] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80307 USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Oregon State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Center Atmospheric Research (NCAR) - USA	He, F (corresponding author), Univ Wisconsin, Nelson Inst Environm Studies, Ctr Climat Res, Madison, WI 53706 USA.	fenghe@wisc.edu	Otto-Bliesner, Bette/AAY-7691-2020; He, Feng/B-3583-2008	He, Feng/0000-0002-3355-6406	Office of Science of the Department of Energy [DE-AC05-00OR22725]; US National Science Foundation [AGS-0902802, AGS-1203430]; Climate, People, and the Environment Program; National Science Foundation [06023950-ATM]	Office of Science of the Department of Energy(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); Climate, People, and the Environment Program; National Science Foundation(National Science Foundation (NSF))	We thank O. Timm and A. Timmermann for fruitful discussions, and G. Chen for providing the conversion code for fix-angular calendar. We thank the University Corporation for Atmospheric Research for continuous development of the community Earth system model. This research used resources of the Oak Ridge Leadership Computing Facility, located in the National Center for Computational Sciences at Oak Ridge National Laboratory, which is supported by the Office of Science of the Department of Energy under contract DE-AC05-00OR22725. F.H. is supported by the US National Science Foundation (AGS-0902802, AGS-1203430) and the Climate, People, and the Environment Program. P.U.C. and J.D.S. were supported by the Paleoclimate Program of the National Science Foundation through project PALEOVAR (06023950-ATM). This is CCR contribution no. 1130.	BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Caillon N, 2003, SCIENCE, V299, P1728, DOI 10.1126/science.1078758; Carlson AE, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000371; Chen GS, 2011, CLIM DYNAM, V37, P1949, DOI 10.1007/s00382-010-0944-6; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Fischer H, 2010, QUATERNARY SCI REV, V29, P193, DOI 10.1016/j.quascirev.2009.06.007; Hansen J, 2007, PHILOS T R SOC A, V365, P1925, DOI 10.1098/rsta.2007.2052; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Huybers P, 2005, NATURE, V434, P491, DOI 10.1038/nature03401; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; Huybers P, 2009, SCIENCE, V325, P1085, DOI 10.1126/science.1176186; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Martrat B, 2007, SCIENCE, V317, P502, DOI 10.1126/science.1139994; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Milankovic M., 1969, CANON INSOLATION ICE; Pedro JB, 2012, CLIM PAST, V8, P1213, DOI 10.5194/cp-8-1213-2012; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Ruddiman WF, 2006, CLIM PAST, V2, P43; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Shakun JD, 2010, QUATERNARY SCI REV, V29, P1801, DOI 10.1016/j.quascirev.2010.03.016; Stott L, 2007, SCIENCE, V318, P435, DOI 10.1126/science.1143791; Timm O, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001461; Timmermann A, 2009, J CLIMATE, V22, P1626, DOI 10.1175/2008JCLI2161.1	30	146	157	2	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					81	85		10.1038/nature11822	http://dx.doi.org/10.1038/nature11822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389542				2022-12-28	WOS:000314741200038
J	Workowski, K				Workowski, Kimberly			Chlamydia and Gonorrhea	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SEXUALLY-TRANSMITTED INFECTIONS; NONGONOCOCCAL URETHRITIS; NEISSERIA-GONORRHOEAE; BACTERIAL VAGINOSIS; UNITED-STATES; MEN; TRACHOMATIS; SEX; ASSOCIATION; RESISTANCE											[Anonymous], SEX TRANSM DIS SURV; Anschuetz GL, 2012, J ADOLESCENT HEALTH, V51, P80, DOI 10.1016/j.jadohealth.2011.11.002; Bachmann LH, 2010, J CLIN MICROBIOL, V48, P1827, DOI 10.1128/JCM.02398-09; Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; Bernstein KT, 2009, CLIN INFECT DIS, V49, P1793, DOI 10.1086/648427; Bradshaw CS, 2006, J INFECT DIS, V193, P336, DOI 10.1086/499434; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Burstein GR, 2005, OBSTET GYNECOL, V106, P327, DOI 10.1097/01.AOG.0000171119.81704.51; Calonge N, 2005, ANN FAM MED, V3, P263, DOI 10.1370/afm.337; Calonge N, 2008, ANN INTERN MED, V149, P491, DOI 10.7326/0003-4819-149-7-200810070-00016; *CTR DIS CONTR PRE, 2012, MMWR-MORBID MORTAL W, V61, P590; *CTR DIS CONTR PRE, 2007, MAL CHLAM SCREEN CON; Fung M, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.024059; Gaydos C, 2009, SEX TRANSM DIS, V36, P598, DOI 10.1097/OLQ.0b013e3181b01948; Geisler WM, 2008, SEX TRANSM DIS, V35, P119, DOI 10.1097/OLQ.0b013e318151497d; Gift TL, 2008, SEX TRANSM DIS, V35, pS51, DOI 10.1097/OLQ.0b013e3181723dba; Guy R, 2012, SEX TRANSM DIS, V39, P136, DOI 10.1097/OLQ.0b013e31823ed4ec; HAMMERSCHLAG MR, 2011, CLIN INFECT DIS, V53; Hoover KW, 2013, CLIN INFECT DIS, V56, P51, DOI 10.1093/cid/cis771; Hoover KW, 2010, J ADOLESCENT HEALTH, V46, P324, DOI 10.1016/j.jadohealth.2009.09.002; Hosenfeld CB, 2009, SEX TRANSM DIS, V36, P478, DOI 10.1097/OLQ.0b013e3181a2a933; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Klausner JD, 2004, CLIN INFECT DIS, V38, P300, DOI 10.1086/380838; Lau CY, 2002, SEX TRANSM DIS, V29, P497, DOI 10.1097/00007435-200209000-00001; Lyss SB, 2003, ANN INTERN MED, V139, P178, DOI 10.7326/0003-4819-139-3-200308050-00007; Manhart LE, 2011, CLIN INFECT DIS, V53, pS129, DOI 10.1093/cid/cir702; Marrazzo JM, 2002, OBSTET GYNECOL, V100, P579, DOI 10.1016/S0029-7844(02)02140-3; Martin David H, 2008, Curr Infect Dis Rep, V10, P128, DOI 10.1007/s11908-008-0023-x; Meyers DS, 2007, ANN INTERN MED, V147, P135, DOI 10.7326/0003-4819-147-2-200707170-00173; Mimiaga MJ, 2009, SEX TRANSM DIS, V36, P507, DOI 10.1097/OLQ.0b013e3181a2ad98; Peterman TA, 2006, ANN INTERN MED, V145, P564, DOI 10.7326/0003-4819-145-8-200610170-00005; Schachter J, 2008, SEX TRANSM DIS, V35, P637, DOI 10.1097/OLQ.0b013e31817bdd7e; Schwebke JR, 2011, CLIN INFECT DIS, V52, P163, DOI 10.1093/cid/ciq074; Sena AC, 2012, J INFECT DIS, V206, P357, DOI 10.1093/infdis/jis356; Shafer MAB, 2002, JAMA-J AM MED ASSOC, V288, P2846, DOI 10.1001/jama.288.22.2846; Steinhandler L, 2002, OBSTET GYNECOL, V99, P603, DOI 10.1016/S0029-7844(01)01788-4; Stupiansky NW, 2011, SEX TRANSM DIS, V38, P750, DOI 10.1097/OLQ.0b013e31820ff9a4; Walker J, 2010, SEX TRANSM DIS, V37, P445, DOI 10.1097/OLQ.0b013e3181cfcb4c; Workowski KA, 2008, ANN INTERN MED, V148, P606, DOI 10.7326/0003-4819-148-8-200804150-00005; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Zou HC, 2012, SEX TRANSM DIS, V39, P382, DOI 10.1097/OLQ.0b013e318248e3ff	41	9	10	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3							ITC2	10.7326/0003-4819-158-3-201302050-01002	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-01002			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23381058				2022-12-28	WOS:000314757900020
J	Pennathur, A; Gibson, MK; Jobe, BA; Luketich, JD				Pennathur, Arjun; Gibson, Michael K.; Jobe, Blair A.; Luketich, James D.			Oesophageal carcinoma	LANCET			English	Article							SQUAMOUS-CELL CARCINOMA; MINIMALLY INVASIVE ESOPHAGECTOMY; LIMITED TRANSHIATAL RESECTION; POSITRON-EMISSION-TOMOGRAPHY; PROSPECTIVE RANDOMIZED-TRIAL; LYMPH-NODE DISSECTION; HIGH-GRADE DYSPLASIA; PHASE-II TRIAL; BARRETTS-ESOPHAGUS; GASTROESOPHAGEAL-REFLUX	Oesophageal carcinoma affects more than 450 000 people worldwide and the incidence is rapidly increasing. Squamous-cell carcinoma is the predominant form of oesophageal carcinoma worldwide, but a shift in epidemiology has been seen in Australia, the UK, the USA, and some western European countries (eg, Finland, France, and the Netherlands), where the incidence of adenocarcinoma now exceeds that of squamous-cell types. The overall 5-year survival of patients with oesophageal carcinoma ranges from 15% to 25%. Diagnoses made at earlier stages are associated with better outcomes than those made at later stages. In this Seminar we discuss the epidemiology, pathophysiology, diagnosis and staging, management, prevention, and advances in the treatment of oesophageal carcinoma.	[Pennathur, Arjun; Jobe, Blair A.; Luketich, James D.] Univ Pittsburgh, Dept Cardiothorac Surg, Sch Med, Pittsburgh, PA 15213 USA; [Gibson, Michael K.] Univ Pittsburgh, Div Hematol Oncol, Dept Med, Sch Med, Pittsburgh, PA 15213 USA; [Pennathur, Arjun; Gibson, Michael K.; Jobe, Blair A.; Luketich, James D.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Luketich, JD (corresponding author), Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA 15213 USA.	luketichjd@upmc.edu	luketich, james/AAY-6230-2020		NIH [5RO1 CA090665 09]; NATIONAL CANCER INSTITUTE [R01CA090665] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the work of numerous investigators on oesophageal carcinoma that we were unable to cite owing to limitations of space. We thank Shannon Wyszomierski, University of Pittsburgh Medical Center, Pittsburgh, PA, USA, for editorial support during manuscript preparation. This work is supported by NIH grant 5RO1 CA090665 09.	Abnet CC, 2005, JNCI-J NATL CANCER I, V97, P301, DOI 10.1093/jnci/dji042; Abnet CC, 2001, CANCER CAUSE CONTROL, V12, P847, DOI 10.1023/A:1012290009545; Ahsan H, 1998, ANN INTERN MED, V128, P114, DOI 10.7326/0003-4819-128-2-199801150-00007; Altorki N, 2002, ANN SURG, V236, P177, DOI 10.1097/00000658-200208000-00005; Altorki NK, 2008, ANN SURG, V247, P434, DOI 10.1097/SLA.0b013e318163a2ff; Anderson LA, 2007, WORLD J GASTROENTERO, V13, P1585, DOI 10.3748/wjg.v13.i10.1585; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; Ando N, 1997, J THORAC CARDIOV SUR, V114, P205, DOI 10.1016/S0022-5223(97)70146-6; [Anonymous], 2008, AM J GASTROENTEROL, V103, P850, DOI 10.1111/j.1572-0241.2007.01746.x; APINOP C, 1994, HEPATO-GASTROENTEROL, V41, P391; Armanios M, 2004, J CLIN ONCOL, V22, P4495, DOI 10.1200/JCO.2004.06.533; Bancewicz J, 2002, LANCET, V359, P1727; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Bosset JF, 1997, NEW ENGL J MED, V337, P161, DOI 10.1056/NEJM199707173370304; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Burmeister BH, 2005, LANCET ONCOL, V6, P659, DOI 10.1016/S1470-2045(05)70288-6; Christie NA, 2005, SURG CLIN N AM, V85, P569, DOI 10.1016/j.suc.2005.02.001; Christie NA, 2001, ANN THORAC SURG, V71, P1797, DOI 10.1016/S0003-4975(01)02619-4; Chu KM, 1997, AM J SURG, V174, P320, DOI 10.1016/S0002-9610(97)00105-0; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Corey KE, 2003, AM J GASTROENTEROL, V98, P2390, DOI 10.1016/j.amjgastroenterol.2003.08.008; Crane LMA, 2007, EUR J CANCER, V43, P1445, DOI 10.1016/j.ejca.2007.03.024; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Daly JM, 2000, J AM COLL SURGEONS, V190, P562, DOI 10.1016/S1072-7515(00)00238-6; Das D, 2009, RECENT RES CANCER, V181, P161; DESTEFANI E, 1993, EUR J CANCER, V29A, P763, DOI 10.1016/S0959-8049(05)80363-6; Dimick JB, 2001, CRIT CARE MED, V29, P753, DOI 10.1097/00003246-200104000-00012; Edelstein ZR, 2007, GASTROENTEROLOGY, V133, P403, DOI 10.1053/j.gastro.2007.05.026; Edge S., 2010, AJCC CANC STAGING MA, V7th; Ell C, 2007, GASTROINTEST ENDOSC, V65, P3, DOI 10.1016/j.gie.2006.04.033; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Enzinger PC, 2000, ONCOLOGY-NY, V14, P26; Enzinger PC, 1998, ONCOLOGY-NY, V12, P110; Enzinger PC, 1999, SEMIN ONCOL, V26, P12; Eslick GD, 2009, GASTROENTEROL CLIN N, V38, pvii; Eslick GD, 2009, GASTROENTEROL CLIN N, V38, P17, DOI 10.1016/j.gtc.2009.01.008; Faigel DO, 1998, AM J GASTROENTEROL, V93, P2257; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fisher BL, 1999, DIGEST DIS SCI, V44, P2290, DOI 10.1023/A:1026617106755; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; GOLDMINC M, 1993, BRIT J SURG, V80, P367, DOI 10.1002/bjs.1800800335; Hagen JA, 2001, ANN SURG, V234, P520, DOI 10.1097/00000658-200110000-00011; Heath EI, 2007, J NATL CANCER I, V99, P545, DOI 10.1093/jnci/djk112; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Homs MYV, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004063.pub2; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Hulscher JBF, 2001, ANN THORAC SURG, V72, P306, DOI 10.1016/S0003-4975(00)02570-4; IASCONE C, 1983, ARCH SURG-CHICAGO, V118, P543; Islami F, 2008, CANCER PREV RES, V1, P329, DOI 10.1158/1940-6207.CAPR-08-0109; Jankowski J, 2006, BRIT MED J, V332, P1512, DOI 10.1136/bmj.332.7556.1512; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jovov B, 2007, AM J PHYSIOL-GASTR L, V293, pG1106, DOI 10.1152/ajpgi.00158.2007; Kahrilas PJ, 1996, JAMA-J AM MED ASSOC, V276, P983, DOI 10.1001/jama.276.12.983; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kaushik N, 2007, ANN THORAC SURG, V83, P2000, DOI 10.1016/j.athoracsur.2007.02.023; Kelsen DP, 1998, NEW ENGL J MED, V339, P1979, DOI 10.1056/NEJM199812313392704; Khushalani NI, 2002, J CLIN ONCOL, V20, P2844, DOI 10.1200/JCO.2002.12.032; Kleinberg L, 2007, NAT CLIN PRACT ONCOL, V4, P282, DOI 10.1038/ncponc0796; Krasna MJ, 1999, ANN THORAC SURG, V68, P1136; Krasna MJ, 2001, ANN THORAC SURG, V71, P1073, DOI 10.1016/S0003-4975(00)02680-1; Kubo A, 2006, CANCER EPIDEM BIOMAR, V15, P872, DOI 10.1158/1055-9965.EPI-05-0860; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 2000, ANN INTERN MED, V133, P165, DOI 10.7326/0003-4819-133-3-200008010-00007; Lee CH, 2007, EUR J CANCER, V43, P1188, DOI 10.1016/j.ejca.2007.01.039; Lepage C, 2008, AM J GASTROENTEROL, V103, P2694, DOI 10.1111/j.1572-0241.2008.02191.x; LEPRISE E, 1994, CANCER, V73, P1779; Lerut T, 2004, ANN SURG, V240, P962, DOI 10.1097/01.sla.0000145925.70409.d7; Levine MS, 1997, AM J ROENTGENOL, V168, P1423, DOI 10.2214/ajr.168.6.9168701; LIGHTDALE CJ, 1995, GASTROINTEST ENDOSC, V42, P507, DOI 10.1016/S0016-5107(95)70002-1; Limburg PJ, 2005, GASTROENTEROLOGY, V129, P863, DOI 10.1053/j.gastro.2005.06.024; Litle VR, 2003, ANN THORAC SURG, V76, P1687, DOI 10.1016/S0003-4975(03)01299-2; Lordick F, 2007, LANCET ONCOL, V8, P797, DOI 10.1016/S1470-2045(07)70244-9; Luketich JD, 2012, ANN SURG, V256, P95, DOI 10.1097/SLA.0b013e3182590603; Luketich JD, 1997, J THORAC CARDIOV SUR, V114, P817, DOI 10.1016/S0022-5223(97)70086-2; Luketich JD, 1999, ANN THORAC SURG, V68, P1133; Luketich JD, 2009, J CLIN ONCOL S, V27, p15s; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; MATHISEN DJ, 1988, ANN THORAC SURG, V45, P137, DOI 10.1016/S0003-4975(10)62424-1; Meyers BF, 2007, J THORAC CARDIOV SUR, V133, P738, DOI 10.1016/j.jtcvs.2006.09.079; Morales CP, 2002, LANCET, V360, P1587, DOI 10.1016/S0140-6736(02)11569-8; MUNOZ N, 1985, LANCET, V2, P111; Naunheim KS, 2001, ANN THORAC SURG, V72, P1924; Nguyen NT, 2000, ARCH SURG-CHICAGO, V135, P920, DOI 10.1001/archsurg.135.8.920; Nishihira T, 1998, AM J SURG, V175, P47, DOI 10.1016/S0002-9610(97)00227-4; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Omloo JMT, 2007, ANN SURG, V246, P992, DOI 10.1097/SLA.0b013e31815c4037; Orringer MB, 1999, ANN SURG, V230, P392, DOI 10.1097/00000658-199909000-00012; Overholt BF, 2007, GASTROINTEST ENDOSC, V66, P460, DOI 10.1016/j.gie.2006.12.037; Parrilla P, 2003, ANN SURG, V237, P291, DOI 10.1097/00000658-200303000-00001; Pellegrini CA, 1999, ANN SURG, V230, P400; Pennathur A, 2010, AM ASS THOR SURG AAT; Pennathur A, 2008, ANN THORAC SURG, V85, P1930, DOI 10.1016/j.athoracsur.2008.01.097; Pennathur A, 2008, ANN THORAC SURG, V85, pS751, DOI 10.1016/j.athoracsur.2007.11.078; Pennathur A, 2005, SEMIN THORAC CARDIOV, V17, P326, DOI 10.1053/j.semtcvs.2005.10.003; Pennathur A, 2010, ANN THORAC SURG, V89, pS2163, DOI 10.1016/j.athoracsur.2010.03.068; Pennathur A, 2009, ANN THORAC SURG, V87, P1048, DOI 10.1016/j.athoracsur.2008.12.060; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Polednak AP, 2003, INT J CANCER, V105, P98, DOI 10.1002/ijc.11029; Portale G, 2006, J AM COLL SURGEONS, V202, P588, DOI 10.1016/j.jamcollsurg.2005.12.022; Poynton AR, 1996, AM J GASTROENTEROL, V91, P1855; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; Rastogi A, 2008, GASTROINTEST ENDOSC, V67, P394, DOI 10.1016/j.gie.2007.07.019; Rees JR, 2010, COCHRANE DB SYST REV, V1; REID BJ, 1988, GASTROENTEROLOGY, V94, P81, DOI 10.1016/0016-5085(88)90613-0; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Rice TW, 2010, J THORAC CARDIOV SUR, V139, P527, DOI 10.1016/j.jtcvs.2009.11.002; Rice TW, 1997, J THORAC CARDIOV SUR, V114, P821; Rice TW, 2008, PEARSONS THORACIC ES, P454; Risk JM, 1999, DIS ESOPHAGUS, V12, P173, DOI 10.1046/j.1442-2050.1999.00042.x; Rizk N, 2006, J THORAC CARDIOV SUR, V132, P1374, DOI 10.1016/j.jtcvs.2006.07.039; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Rosch T, 1995, Gastrointest Endosc Clin N Am, V5, P537; Schnell TG, 2001, GASTROENTEROLOGY, V120, P1607, DOI 10.1053/gast.2001.25065; Shah MA, 2006, J CLIN ONCOL, V24, P5201, DOI 10.1200/JCO.2006.08.0887; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Shaheen NJ, 2009, LANCET, V373, P850, DOI 10.1016/S0140-6736(09)60487-6; Sharma P, 2009, NEW ENGL J MED, V361, P2548, DOI 10.1056/NEJMcp0902173; Siewert JR, 2001, ANN SURG, V234, P530; Sikkema M, 2009, AM J GASTROENTEROL, V104, P2673, DOI 10.1038/ajg.2009.437; Stahl M, 2005, J CLIN ONCOL, V23, P2310, DOI 10.1200/JCO.2005.00.034; Stavrou EP, 2009, MED J AUSTRALIA, V191, P310, DOI 10.5694/j.1326-5377.2009.tb02813.x; Stoner GD, 2007, SEMIN CANCER BIOL, V17, P403, DOI 10.1016/j.semcancer.2007.05.001; Swanson SJ, 2001, ANN THORAC SURG, V72, P1918, DOI 10.1016/S0003-4975(01)03203-9; Taylor PR, 2003, J NATL CANCER I, V95, P1414, DOI 10.1093/jnci/djg044; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Urba SG, 2001, J CLIN ONCOL, V19, P305, DOI 10.1200/JCO.2001.19.2.305; Vaezi MF, 1996, GASTROENTEROLOGY, V111, P1192, DOI 10.1053/gast.1996.v111.pm8898632; Vallieres E, 2003, ANN THORAC SURG, V76, P1692; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; van Meerten E, 2007, BRIT J CANCER, V96, P1348, DOI 10.1038/sj.bjc.6603750; Vaughan TL, 2005, LANCET ONCOL, V6, P945, DOI 10.1016/S1470-2045(05)70431-9; VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P85; Verhage RJJ, 2009, MINERVA CHIR, V64, P135; Visbal AL, 2001, ANN THORAC SURG, V71, P1803, DOI 10.1016/S0003-4975(01)02601-7; Voutilainen M, 2000, DIGESTION, V61, P6, DOI 10.1159/000007730; Walsh TN, 1996, NEW ENGL J MED, V335, P462, DOI 10.1056/NEJM199608153350702; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Watson AHR, 2005, GUIDELINES DIAGNOSIS; Wetstein L, 2001, ANN THORAC SURG, V71, P1801; Whiteman DC, 2008, GUT, V57, P173, DOI 10.1136/gut.2007.131375; Wolfsen HC, 2008, GASTROENTEROLOGY, V135, P24, DOI 10.1053/j.gastro.2008.03.019; Xi LQ, 2005, CLIN CANCER RES, V11, P1099; Yang SJ, 2007, WORLD J GASTROENTERO, V13, P5760, DOI 10.3748/wjg.v13.i43.5760	150	1743	1857	8	139	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2013	381	9864					400	412		10.1016/S0140-6736(12)60643-6	http://dx.doi.org/10.1016/S0140-6736(12)60643-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084ZA	23374478				2022-12-28	WOS:000314578900037
J	Chen, WL; Han, CF; Xie, B; Hu, X; Yu, Q; Shi, LY; Wang, QQ; Li, DL; Wang, JL; Zheng, P; Liu, Y; Cao, XT				Chen, Weilin; Han, Chaofeng; Xie, Bin; Hu, Xiang; Yu, Qian; Shi, Liyun; Wang, Qingqing; Li, Dongling; Wang, Jianli; Zheng, Pan; Liu, Yang; Cao, Xuetao			Induction of Siglec-G by RNA Viruses Inhibits the Innate Immune Response by Promoting RIG-I Degradation	CELL			English	Article							NF-KAPPA-B; STRUCTURAL BASIS; NEGATIVE REGULATOR; UBIQUITIN LIGASE; C-CBL; RECOGNITION; ACTIVATION; PROTEIN; RECEPTORS; IDENTIFICATION	RIG-I is a critical RNA virus sensor that serves to initiate antiviral innate immunity. However, post-translational regulation of RIG-I signaling remains to be fully understood. We report here that RNA viruses, but not DNA viruses or bacteria, specifically upregulate lectin family member Siglecg expression in macrophages by RIG-I-or NF-kappa B-dependent mechanisms. Siglec-G-induced recruitment of SHP2 and the E3 ubiquitin ligase c-Cbl to RIG-I leads to RIG-I degradation via K48-linked ubiquitination at Lys813 by c-Cbl. By increasing type I interferon production, targeted inactivation of Siglecg protects mice against lethal RNA virus infection. Taken together, our data reveal a negative feedback loop of RIG-I signaling and identify a Siglec-G-mediated immune evasion pathway exploited by RNA viruses with implication in antiviral applications. These findings also provide insights into the functions and crosstalk of Siglec-G, a known adaptive response regulator, in innate immunity.	[Chen, Weilin; Xie, Bin; Shi, Liyun; Wang, Qingqing; Wang, Jianli; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Han, Chaofeng; Yu, Qian; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Han, Chaofeng; Yu, Qian; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Hu, Xiang; Li, Dongling; Zheng, Pan; Liu, Yang; Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Hu, Xiang; Li, Dongling; Zheng, Pan; Liu, Yang; Cao, Xuetao] Chinese Acad Med Sci, Dept Immunol, Beijing 100005, Peoples R China	Zhejiang University; Naval Medical University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Cao, XT (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China.	caoxt@immunol.org	Zheng, Pan/E-8691-2011; wang, jian/GVS-0711-2022	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X; Han, Chaofeng/0000-0002-8489-6478; Shi, Liyun/0000-0003-3538-1571; Shi, Liyun/0000-0003-1767-0126	National Key Basic Research Program of China [2013CB530500, 2012CB910202]; National Natural Science Foundation of China [81273222, 81230074, 81123006]; National 125 Key Project [2012ZX10002-014, 2012AA020901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036690] Funding Source: NIH RePORTER	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 125 Key Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Chanrong Ni for histological processing, Dr. Jing Jin, Dr. Nan Li for helpful discussion, Dr. Zhugang Wang for providing Rigi<SUP>-/-</SUP>mice, and Dr. Gensheng Feng for providing Shp2<SUP>fl</SUP> mice. This work was supported by the National Key Basic Research Program of China (2013CB530500 and 2012CB910202), the National Natural Science Foundation of China (81273222, 81230074, and 81123006), and the National 125 Key Project (2012ZX10002-014 and 2012AA020901). X.C. designed and supervised the research. W.C., C.H., B.X., X.H., and Q.Y. performed research. L.S., Q.W., D.L., J.W., P.Z., and Y.L. contributed new reagents/analytical tools. W.C., C.H., B.X., and X.C. analyzed data. W.C., C.H., and X.C. wrote the paper.	An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Chen GY, 2011, NAT BIOTECHNOL, V29, P428, DOI 10.1038/nbt.1846; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chernock RD, 2001, BLOOD, V97, P608, DOI 10.1182/blood.V97.3.608; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Ding C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000997; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Munday J, 2001, BIOCHEM J, V355, P489, DOI 10.1042/0264-6021:3550489; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; O'Neill LAJ, 2011, CELL, V147, P259, DOI 10.1016/j.cell.2011.09.027; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Whitney G, 2001, EUR J BIOCHEM, V268, P6083, DOI 10.1046/j.0014-2956.2001.02543.x; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	42	195	210	8	122	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 31	2013	152	3					467	478		10.1016/j.cell.2013.01.011	http://dx.doi.org/10.1016/j.cell.2013.01.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374343	Bronze			2022-12-28	WOS:000314362800017
J	Rani, M; Kaka, A				Rani, Monica; Kaka, Anjum			Lobular Panniculitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rani, Monica] Univ Minnesota, Minneapolis, MN 55455 USA; [Kaka, Anjum] Vet Affairs Med Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Rani, M (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	monica.rani@gmail.com							0	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					465	465		10.1056/NEJMicm1205025	http://dx.doi.org/10.1056/NEJMicm1205025			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BE	23363500				2022-12-28	WOS:000314215400011
J	Savage, N				Savage, Neil			PHYSIOLOGY Beating stroke	NATURE			English	Editorial Material							ATRIAL-FIBRILLATION; LIFETIME RISK; ABLATION											Furie KL, 2012, STROKE, V43, P3442, DOI 10.1161/STR.0b013e318266722a; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Narayan S. M., 2012, EP LAB DIGEST, V12, P1; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Rettmann ME, 2012, ACAD RADIOL, V19, P1332, DOI 10.1016/j.acra.2012.06.009	8	2	2	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					S12	S13		10.1038/493S12a	http://dx.doi.org/10.1038/493S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364765	Bronze			2022-12-28	WOS:000314219600010
J	Rao, M				Rao, Mala			After aid: the NHS can also learn from India and China	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-HEALTH-CARE		Univ E London, Inst Hlth & Human Dev, London E15 4LZ, England	University of East London	Rao, M (corresponding author), Univ E London, Inst Hlth & Human Dev, Stratford Campus, London E15 4LZ, England.	m.rao@uel.ac.uk						Crisp Nigel., 2010, TURNING WORLD UPSIDE; Dandona L, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3410; Department for International Development, WE WORK; Department for International Development, 2011, STAND BRIEF HLTH NUT; Department for International Development, 2009, WHIT PAP EL WORLD PO; Department of Health, 2007, GLOB HLTH PARTN; Ghosh J, 2013, BRIT MED J, V346, P21; Government of India Planning Commission, 2011, FAST SUST MOR INCL G; HM Government, 2008, HLTH IS GLOB UK GOV; International Partnership for Innovative Healthcare Delivery, AR EYE CAR SYST; Lakshman N, 2011, HINDU            NOV; Lees C, 2012, 17 BIS DEP BUS INN S; Milne S, 2011, GUARDIAN; Paruzzolo S, TARGETING POVERTY GE; Rao M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3151	15	0	0	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2013	346								f601	10.1136/bmj.f601	http://dx.doi.org/10.1136/bmj.f601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BP	23364071				2022-12-28	WOS:000314511300008
J	Nitsch, D; Grams, M; Sang, YY; Black, C; Cirillo, M; Djurdjev, O; Iseki, K; Jassal, SK; Kimm, H; Kronenberg, F; Oien, CM; Levey, AS; Levin, A; Woodward, M; Hemmelgarn, BR				Nitsch, Dorothea; Grams, Morgan; Sang, Yingying; Black, Corri; Cirillo, Massimo; Djurdjev, Ognjenka; Iseki, Kunitoshi; Jassal, Simerjot K.; Kimm, Heejin; Kronenberg, Florian; Oien, Cecilia M.; Levey, Andrew S.; Levin, Adeera; Woodward, Mark; Hemmelgarn, Brenda R.		Chronic Kidney Dis Prognosis Conso	Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; COLLABORATIVE METAANALYSIS; ESTIMATED GFR; RISK-FACTORS; ALL-CAUSE; PREVALENCE; WOMEN; EQUATION	Objective To assess for the presence of a sex interaction in the associations of estimated glomerular filtration rate and albuminuria with all-cause mortality, cardiovascular mortality, and end stage renal disease. Design Random effects meta-analysis using pooled individual participant data. Setting 46 cohorts from Europe, North and South America, Asia, and Australasia. Participants 2 051 158 participants (54% women) from general population cohorts (n=1 861 052), high risk cohorts (n=151 494), and chronic kidney disease cohorts (n=38 612). Eligible cohorts (except chronic kidney disease cohorts) had at least 1000 participants, outcomes of either mortality or end stage renal disease of >= 50 events, and baseline measurements of estimated glomerular filtration rate according to the Chronic Kidney Disease Epidemiology Collaboration equation (mL/min/1.73 m(2)) and urinary albumin-creatinine ratio (mg/g). Results Risks of all-cause mortality and cardiovascular mortality were higher in men at all levels of estimated glomerular filtration rate and albumin-creatinine ratio. While higher risk was associated with lower estimated glomerular filtration rate and higher albumin-creatinine ratio in both sexes, the slope of the risk relationship for all-cause mortality and for cardiovascular mortality were steeper in women than in men. Compared with an estimated glomerular filtration rate of 95, the adjusted hazard ratio for all-cause mortality at estimated glomerular filtration rate 45 was 1.32 (95% CI 1.08 to 1.61) in women and 1.22 (1.00 to 1.48) in men (P-interaction<0.01). Compared with a urinary albumin-creatinine ratio of 5, the adjusted hazard ratio for all-cause mortality at urinary albumin-creatinine ratio 30 was 1.69 (1.54 to 1.84) in women and 1.43 (1.31 to 1.57) in men (P-interaction<0.01). Conversely, there was no evidence of a sex difference in associations of estimated glomerular filtration rate and urinary albumin-creatinine ratio with end stage renal disease risk. Conclusions Both sexes face increased risk of all-cause mortality, cardiovascular mortality, and end stage renal disease with lower estimated glomerular filtration rates and higher albuminuria. These findings were robust across a large global consortium.	[Nitsch, Dorothea] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Grams, Morgan] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Sang, Yingying] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Black, Corri] Univ Aberdeen, Sch Med, Chron Dis Res Grp, Aberdeen AB9 2ZD, Scotland; [Cirillo, Massimo] Univ Salerno, Dept Med Nephrol, I-84081 Baronissi, SA, Italy; [Djurdjev, Ognjenka] Prov Hlth Serv Author, Vancouver, BC, Canada; [Levin, Adeera] St Pauls Hosp, Div Nephrol UBC, Vancouver, BC V6Z 1Y6, Canada; [Iseki, Kunitoshi] Univ Hosp Ryukyus, Dialysis Unit, Ryukyus, Okinawa, Japan; [Jassal, Simerjot K.] VA San Diego Healthcare Syst, Div GIM G, San Diego, CA USA; [Kimm, Heejin] Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Inst Hlth Promot, Seoul 120749, South Korea; [Kronenberg, Florian] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Oien, Cecilia M.] St Olavs Hosp, Dept Med, Nephrol Sect, Trondheim, Norway; [Levey, Andrew S.] Tufts Med Ctr, Dept Med, Div Nephrol, Boston, MA USA; [Woodward, Mark] George Inst Global Hlth, Camperdown, NSW, Australia; [Hemmelgarn, Brenda R.] Foothills Med Ctr, Div Nephrol, Calgary, AB, Canada	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Aberdeen; University of Salerno; St. Paul's Hospital; University of Saskatchewan; University of the Ryukyus; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Yonsei University; Yonsei University Health System; Medical University of Innsbruck; Norwegian University of Science & Technology (NTNU); Tufts Medical Center; George Institute for Global Health; University of Sydney; University of Calgary	Levey, AS (corresponding author), Chron Kidney Dis Prognosis Consortium, 615 N Wolfe St, Baltimore, MD 21205 USA.	ckdpc@jhmi.edu	Woodward, Mark/L-6817-2017; Bello, Aminu K/D-2213-2013; de Zeeuw, Dick/E-9080-2014; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Schöttker, Ben/F-8183-2014; Kikuya, Masahiro/X-5662-2018; Kronenberg, Florian/B-1736-2008; Woodward, Mark/D-8492-2015; Stengel, Benedicte/G-5730-2015; Marks, Angharad/H-5657-2019; Metzger, Marie/K-9772-2018; Cirillo, Massimo/G-5480-2018; Froissart, Marc/L-7493-2014	de Zeeuw, Dick/0000-0003-3434-7777; Schöttker, Ben/0000-0002-1217-4521; Kikuya, Masahiro/0000-0002-3080-6107; Kronenberg, Florian/0000-0003-2229-1120; Stengel, Benedicte/0000-0001-9469-0804; Marks, Angharad/0000-0003-1910-462X; Rothenbacher, Dietrich/0000-0002-3563-2791; Grams, Morgan/0000-0002-4430-6023; Sairenchi, Toshimi/0000-0001-8896-6501; Prescott, Gordon/0000-0002-9156-2361; Kleefstra, Nanne/0000-0003-1473-8519; Woodward, Mark/0000-0001-9800-5296; Klein, Ronald/0000-0002-4428-6237; Townend, Jonathan/0000-0002-5881-5806; Emberson, Jonathan/0000-0001-7792-9422; Metzger, Marie/0000-0003-3597-5409; Cirillo, Massimo/0000-0002-6409-3504; Nitsch, Dorothea/0000-0001-5767-248X; rossing, peter/0000-0002-1531-4294; Yatsuya, Hiroshi/0000-0002-6220-9251; Froissart, Marc/0000-0002-4010-3173	US National Kidney Foundation; Abbott; Amgen; national institutes of health; Scottish Chief Scientist office; CKD-PC/the National Kidney Foundation; National Kidney Foundation; NIH; Kidney Research UK [RP34/2009] Funding Source: researchfish; Chief Scientist Office [CZH/4/656] Funding Source: researchfish	US National Kidney Foundation; Abbott(Abbott Laboratories); Amgen(Amgen); national institutes of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scottish Chief Scientist office; CKD-PC/the National Kidney Foundation; National Kidney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kidney Research UK(Kidney Research UK (KRUK)); Chief Scientist Office	The CKD-PC Data Coordinating Center is funded in part by a programme grant from the US National Kidney Foundation (NKF funding sources include Abbott) and an investigator initiated research grant from Amgen. Various sources have supported enrolment and data collection including laboratory measurements, and follow-up in the collaborating cohorts of the CKD-PC, including government agencies such as national institutes of health and medical research councils as well as foundations and industry sponsors listed in appendix 3 on bmj.com. The funders had no role in the design, analysis, interpretation of this study, and did not contribute to the writing of this report and the decision to submit the article for publication.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare financial support for the submitted work from the Scottish Chief Scientist office (CB) and CKD-PC/the National Kidney Foundation for data extraction (CB) and travel to research related meetings (ASL, DN); ASL has grants pending with the National Kidney Foundation, and NIH; FK received a research grant for the ARO consortium from Amgen and speaker honoraria from Genzyme; No other relationships or activities that could appear to have influenced the submitted work.	Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Glassock RJ, 2008, CLIN J AM SOC NEPHRO, V3, P1563, DOI 10.2215/CJN.00960208; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Guthrie JR, 2004, CLIMACTERIC, V7, P375, DOI 10.1080/13697130400012163; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P1151, DOI 10.1001/jama.2010.303; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; IDF Clinical Guidelines Task Force, 2005, GLOB GUID TYP 2 DIAB; James MT, 2009, AM J KIDNEY DIS, V54, P24, DOI 10.1053/j.ajkd.2009.04.005; Jassal SK, 2008, AM J CARDIOL, V101, P1275, DOI 10.1016/j.amjcard.2007.12.030; Jneid H, 2008, CIRCULATION, V118, P2803, DOI 10.1161/CIRCULATIONAHA.108.789800; Kurth T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2392; Lee HY, 2008, J MANAGE CARE PHARM, V14, P271, DOI 10.18553/jmcp.2008.14.3.271; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; National Institute for Health and Clinical Excellence, 2008, CHRON KIDN DIS EARL; Nitsch D, 2006, NEPHROL DIAL TRANSPL, V21, P935, DOI 10.1093/ndt/gfk021; Perkovic V, 2008, KIDNEY INT, V73, P473, DOI 10.1038/sj.ki.5002701; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; Richards N, 2008, NEPHROL DIAL TRANSPL, V23, P556, DOI 10.1093/ndt/gfm839; Roderick PJ, 2009, AM J KIDNEY DIS, V53, P950, DOI 10.1053/j.ajkd.2008.12.036; US Renal Data System, 2010, USRDS 2010 ANN DAT R; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; van Dijk PCW, 2007, KIDNEY INT, V71, P53, DOI 10.1038/sj.ki.5002008; Verhave JC, 2005, KIDNEY INT, V67, P1967, DOI 10.1111/j.1523-1755.2005.00296.x; Weaver WD, 1996, JAMA-J AM MED ASSOC, V275, P777, DOI 10.1001/jama.275.10.777; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Woodward M., 2013, EPIDEMIOLOGY STUDY D; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1	42	255	265	4	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2013	346								f324	10.1136/bmj.f324	http://dx.doi.org/10.1136/bmj.f324			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084BH	23360717	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000314510400003
J	Salisbury, C; Montgomery, AA; Hollinghurst, S; Hopper, C; Bishop, A; Franchini, A; Kaur, S; Coast, J; Hall, J; Grove, S; Foster, NE				Salisbury, Chris; Montgomery, Alan A.; Hollinghurst, Sandra; Hopper, Cherida; Bishop, Annette; Franchini, Angelo; Kaur, Surinder; Coast, Joanna; Hall, Jeanette; Grove, Sean; Foster, Nadine E.			Effectiveness of PhysioDirect telephone assessment and advice services for patients with musculoskeletal problems: pragmatic randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; PRIMARY-CARE; HEALTH; OSTEOARTHRITIS; SF-36; RESPONSIVENESS; CONSULTATION; INDEX	Objectives To assess the clinical effectiveness, effect on waiting times, and patient acceptability of PhysioDirect services in patients with musculoskeletal problems, compared with usual care. Design Pragmatic randomised controlled trial to assess equivalence in clinical effectiveness. Patients were individually randomised in a 2:1 ratio to PhysioDirect or usual care. Setting Four physiotherapy services in England. Participants Adults (aged >= 18 years) referred by general practitioners or self referred for musculoskeletal physiotherapy. Interventions PhysioDirect services invited patients to telephone a physiotherapist for initial assessment and advice, followed by face-to-face physiotherapy if necessary. Usual care involved patients joining a waiting list for face-to-face treatment. Main outcome measures Numbers of appointments, waiting time for treatment, and non-attendance rates. Primary outcome was physical health (SF-36v2 physical component score) at six months. Secondary outcomes included four other measures of health outcome, mental component score and scales from the SF-36v2, time lost from work, and patient satisfaction and preference. Participants were not blind to allocation, but outcome data were collected blind to allocation. Results Of 1506 patients allocated to PhysioDirect and 743 to usual care, 85% provided primary outcome data at six months (1283 and 629 patients, respectively). PhysioDirect patients had fewer face-to-face appointments than usual care patients (mean 1.91 v 3.11; incidence rate ratio 0.59 (95% confidence interval 0.53 to 0.65)), a shorter waiting time (median 7 days v 34 days; arm time ratio 0.32 (0.29 to 0.35)), and lower rates of non-attendance (incidence rate ratio 0.55 (0.41 to 0.73)). After six months' follow-up, the SF-36v2 physical component score was equivalent between groups (adjusted difference in means -0.01 (-0.80 to 0.79)). Health outcome measures suggested a trend towards slightly greater improvement in the PhysioDirect arm at six week follow-up and no difference at six months. There was no difference in time lost from work. PhysioDirect patients were no more satisfied with access to physiotherapy than usual care patients, but had slightly lower satisfaction overall at six months (difference in satisfaction -3.8% (-7.3% to -0.3%); P=0.031). PhysioDirect patients were more likely than usual care patients to prefer PhysioDirect in future. No adverse events were detected. Conclusions PhysioDirect is equally clinically effective compared with usual care, provides faster access to physiotherapy, and seems to be safe. However, it could be associated with slightly lower patient satisfaction.	[Salisbury, Chris; Hollinghurst, Sandra; Hopper, Cherida; Kaur, Surinder] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol BS8 2PS, Avon, England; [Montgomery, Alan A.; Franchini, Angelo] Univ Bristol, Bristol Randomised Controlled Trials Collaborat, Bristol BS8 2PS, Avon, England; [Bishop, Annette; Foster, Nadine E.] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Coast, Joanna] Univ Birmingham, Sch Hlth & Populat Sci, Hlth Econ Unit, Birmingham, W Midlands, England; [Hall, Jeanette; Grove, Sean] Bristol Community Hlth, Musculoskeletal Outpatient Dept, Bristol, Avon, England	University of Bristol; University of Bristol; Keele University; University of Birmingham	Salisbury, C (corresponding author), Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol BS8 2PS, Avon, England.	c.salisbury@bristol.ac.uk	Salisbury, Chris/C-6724-2008	Salisbury, Chris/0000-0002-4378-3960; Coast, Joanna/0000-0002-3537-5166; Foster, Nadine/0000-0003-4429-9756; Montgomery, Alan/0000-0003-0450-1606; Franchini, Angelo/0000-0002-7340-5266	Medical Research Council (MRC); Medical Research Council [G0800800, G0701575] Funding Source: researchfish; MRC [G0800800, G0701575] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was funded by the Medical Research Council (MRC) and managed by the National Institute for Health Research (NIHR) on behalf of the MRC-NIHR partnership. The funder had no role in the study design; the collection, analysis, or interpretation of data; the writing of the report; or the decision to submit the paper for publication. The researchers are all independent of the funders. All researchers had access to all the data.	Angst F, 2001, ANN RHEUM DIS, V60, P834; [Anonymous], 2012, STAND INSTR US MEAS; Bishop A, 2013, PHYSIOTHERAPY, V99, P113, DOI 10.1016/j.physio.2012.08.002; Black N, 1996, BRIT MED J, V312, P1215; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Bunn F, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004180.PUB2, 10.1002/14651858.CD004180.pub2]; Conaghan PG, 2008, BRIT MED J, V336, P502, DOI 10.1136/bmj.39490.608009.AD; Consulting J, 2011, SURVEY NHS PHYS WAIT; Department of Health, 2008, SELF REF PIL MUSC PH; Foster NE, 2011, PHYSIOTHERAPY, V97, P78, DOI 10.1016/j.physio.2010.05.003; Gamlin J, 2005, DIRECT ACCESS PHYSIO; Green S, 2003, Cochrane Database Syst Rev, pCD004258; Health and Social Care Information Centre, 2005, NHS PSYS SERV SUMM I; Holdsworth LK, 2009, INT MULTICENTRED INV; Jordan KP, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-144; Kvien TK, 1998, J CLIN EPIDEMIOL, V51, P1077, DOI 10.1016/S0895-4356(98)00099-7; Lurie J, 2000, SPINE, V25, P3125, DOI 10.1097/00007632-200012150-00007; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; Miller J, 2010, MANUAL THER, V15, P334, DOI 10.1016/j.math.2010.02.007; Paterson C, 1996, BRIT MED J, V312, P1016; Pham T, 2003, J RHEUMATOL, V30, P1648; Salisbury C, 2013, HLTH TECHNOL ASSESS, P17; Salisbury C, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-136; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Taylor S., 2002, PHYSIOTHERAPY, V88, P645; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Walsh TL, 2003, SPINE, V28, P607, DOI 10.1097/00007632-200303150-00017; Ware J, 2007, USERS MANUAL SF36V2	29	40	40	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2013	346								f43	10.1136/bmj.f43	http://dx.doi.org/10.1136/bmj.f43			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084BH	23360891	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000314510400002
J	Antognini, A; Nez, F; Schuhmann, K; Amaro, FD; Biraben, F; Cardoso, JMR; Covita, DS; Dax, A; Dhawan, S; Diepold, M; Fernandes, LMP; Giesen, A; Gouvea, AL; Graf, T; Hansch, TW; Indelicato, P; Julien, L; Kao, CY; Knowles, P; Kottmann, F; Le Bigot, EO; Liu, YW; Lopes, JAM; Ludhova, L; Monteiro, CMB; Mulhauser, F; Nebel, T; Rabinowitz, P; dos Santos, JMF; Schaller, LA; Schwob, C; Taqqu, D; Veloso, JFCA; Vogelsang, J; Pohl, R				Antognini, Aldo; Nez, Francois; Schuhmann, Karsten; Amaro, Fernando D.; Biraben, Francois; Cardoso, Joao M. R.; Covita, Daniel S.; Dax, Andreas; Dhawan, Satish; Diepold, Marc; Fernandes, Luis M. P.; Giesen, Adolf; Gouvea, Andrea L.; Graf, Thomas; Haensch, Theodor W.; Indelicato, Paul; Julien, Lucile; Kao, Cheng-Yang; Knowles, Paul; Kottmann, Franz; Le Bigot, Eric-Olivier; Liu, Yi-Wei; Lopes, Jose A. M.; Ludhova, Livia; Monteiro, Cristina M. B.; Mulhauser, Francoise; Nebel, Tobias; Rabinowitz, Paul; dos Santos, Joaquim M. F.; Schaller, Lukas A.; Schwob, Catherine; Taqqu, David; Veloso, Joao F. C. A.; Vogelsang, Jan; Pohl, Randolf			Proton Structure from the Measurement of 2S-2P Transition Frequencies of Muonic Hydrogen	SCIENCE			English	Article							LAMB SHIFT; POLARIZABILITY CONTRIBUTION; RADIUS; ATOMS; ZEMACH; SIZE	Accurate knowledge of the charge and Zemach radii of the proton is essential, not only for understanding its structure but also as input for tests of bound-state quantum electrodynamics and its predictions for the energy levels of hydrogen. These radii may be extracted from the laser spectroscopy of muonic hydrogen (mu p, that is, a proton orbited by a muon). We measured the 2S(1/2)(F=0)-2P(3/2)(F=1) transition frequency in mu p to be 54611.16(1.05) gigahertz (numbers in parentheses indicate one standard deviation of uncertainty) and reevaluated the 2S(1/2)(F=1)-2P(3/2)(F=2) transition frequency, yielding 49881.35(65) gigahertz. From the measurements, we determined the Zemach radius, r(Z) = 1.082(37) femtometers, and the magnetic radius, r(M) = 0.87(6) femtometer, of the proton. We also extracted the charge radius, r(E) = 0.84087(39) femtometer, with an order of magnitude more precision than the 2010-CODATA value and at 7 sigma variance with respect to it, thus reinforcing the proton radius puzzle.	[Antognini, Aldo; Diepold, Marc; Haensch, Theodor W.; Nebel, Tobias; Vogelsang, Jan; Pohl, Randolf] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Antognini, Aldo; Schuhmann, Karsten; Kottmann, Franz] ETH, Inst Particle Phys, CH-8093 Zurich, Switzerland; [Nez, Francois; Biraben, Francois; Indelicato, Paul; Julien, Lucile; Le Bigot, Eric-Olivier; Schwob, Catherine] Ecole Normale Super, CNRS, Lab Kastler Brossel, F-75252 Paris 05, France; [Nez, Francois; Biraben, Francois; Indelicato, Paul; Julien, Lucile; Le Bigot, Eric-Olivier; Schwob, Catherine] Univ Paris 06, F-75252 Paris 05, France; [Schuhmann, Karsten; Giesen, Adolf] Dausinger & Giesen GmbH, D-70178 Stuttgart, Germany; [Amaro, Fernando D.; Cardoso, Joao M. R.; Covita, Daniel S.; Fernandes, Luis M. P.; Gouvea, Andrea L.; Lopes, Jose A. M.; Monteiro, Cristina M. B.; dos Santos, Joaquim M. F.] Univ Coimbra, Dept Fis, P-3004516 Coimbra, Portugal; [Covita, Daniel S.; Veloso, Joao F. C. A.] Univ Aveiro, Dept Fis, I3N, P-3810193 Aveiro, Portugal; [Dax, Andreas; Dhawan, Satish] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Giesen, Adolf; Graf, Thomas] Univ Stuttgart, Inst Strahlwerkzeuge, D-70569 Stuttgart, Germany; [Haensch, Theodor W.] Univ Munich, Munich, Germany; [Kao, Cheng-Yang; Liu, Yi-Wei] Natl Tsing Hua Univ, Dept Phys, Hsinchu 300, Taiwan; [Knowles, Paul; Ludhova, Livia; Mulhauser, Francoise; Schaller, Lukas A.] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland; [Rabinowitz, Paul] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Taqqu, David] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universidade de Coimbra; Universidade de Aveiro; Yale University; University of Stuttgart; University of Munich; National Tsing Hua University; University of Fribourg; Princeton University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Antognini, A (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.	aldo@phys.ethz.ch	Pohl, Randolf/F-3612-2011; Fernandes, Luis M P/E-2372-2011; matias-lopes, jose a/H-6074-2012; Covita, Daniel/J-5627-2013; Indelicato, Paul J/D-7636-2011; Monteiro, Cristina Maria Bernardes/ABH-3547-2020; Amaro, Fernando/M-3250-2013; Monteiro, Cristina Maria/R-2097-2017; dos Santos, Joaquim M F/B-3058-2015; Graf, Thomas/F-2963-2012; INDELICATO, PAUL/GVT-5812-2022; veloso, joao fca/J-4478-2013; Ludhova, Livia/AAE-4487-2020; Cardoso, Joao M R/J-4486-2013; Biraben, François/AFR-7960-2022; Vogelsang, Jan/I-3487-2013; Liu, Yi-wei/C-6825-2013	Pohl, Randolf/0000-0001-6435-659X; Fernandes, Luis M P/0000-0002-7061-8768; matias-lopes, jose a/0000-0002-6366-2963; Indelicato, Paul J/0000-0003-4668-8958; Monteiro, Cristina Maria Bernardes/0000-0002-1912-2804; Amaro, Fernando/0000-0001-7315-0550; Monteiro, Cristina Maria/0000-0002-1912-2804; Graf, Thomas/0000-0002-8466-073X; veloso, joao fca/0000-0002-7107-7203; Cardoso, Joao M R/0000-0002-8832-8208; antognini, aldo/0000-0002-1837-0419; Vogelsang, Jan/0000-0002-9664-6265; Liu, Yi-wei/0000-0002-1090-0665; dos Santos, Joaquim Marques Ferreira/0000-0002-8841-6523; Ludhova, Livia/0000-0002-3875-0590	Max Planck Society; Max Planck Foundation; Swiss National Science Foundation [200020-100632, 200021L-138175/1]; Swiss Academy of Engineering Sciences; Bonus Qualite Recherche de l'Unites de Formations et de Recherche de physique fondamentale et appliquee de l'UPMC; program PAI Germaine de Stael du ministere des affaires etrangeres France [07819NH]; Ecole Normale Superieure (ENS); UPMC; CNRS; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal); Fundo Europeu De Desenvolvimento Regional [PTDC/FIS/102110/2008, SFRH/BPD/46611/2008]; ExtreMe Matter Institute; Helmholtz Alliance [HA216/EMMI]; European Research Council (ERC) [279765]; FCT [SFRH/BD/66731/2009]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Foundation(Foundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Academy of Engineering Sciences; Bonus Qualite Recherche de l'Unites de Formations et de Recherche de physique fondamentale et appliquee de l'UPMC; program PAI Germaine de Stael du ministere des affaires etrangeres France; Ecole Normale Superieure (ENS); UPMC; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); Fundo Europeu De Desenvolvimento Regional; ExtreMe Matter Institute; Helmholtz Alliance; European Research Council (ERC)(European Research Council (ERC)European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	We thank L. M. Simons, B. Leoni, H. Bruckner, K. Linner, W. Simon, J. Alpstag, Z. Hochman, N. Schlumpf, U. Hartmann, S. Ritt, M. Gaspar, M. Horisberger, B. Weichelt, J. Fruchtenicht, A. Voss, M. Larionov, F. Dausinger, and K. Kirch for their contributions. We acknowledge support from the Max Planck Society and the Max Planck Foundation, the Swiss National Science Foundation (projects 200020-100632 and 200021L-138175/1), the Swiss Academy of Engineering Sciences, the Bonus Qualite Recherche de l'Unites de Formations et de Recherche de physique fondamentale et appliquee de l'UPMC, the program PAI Germaine de Stael no. 07819NH du ministere des affaires etrangeres France, the Ecole Normale Superieure (ENS), UPMC, CNRS, and the Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) and Fundo Europeu De Desenvolvimento Regional (project PTDC/FIS/102110/2008 and grant SFRH/BPD/46611/2008). P. I. acknowledges support by the ExtreMe Matter Institute, Helmholtz Alliance HA216/EMMI. T. N. and R. P. were in part supported by the European Research Council (ERC) Starting Grant no. 279765. A. L. G. received support from FCT through program grant SFRH/BD/66731/2009.	Antognini A, 2005, OPT COMMUN, V253, P362, DOI 10.1016/j.optcom.2005.04.079; Antognini A, 2013, ANN PHYS-NEW YORK, V331, P127, DOI 10.1016/j.aop.2012.12.003; Antognini A, 2009, IEEE J QUANTUM ELECT, V45, P983, DOI 10.1109/JQE.2009.2014881; Batell B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.011803; Bernauer JC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.119102; Bernauer JC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.242001; Birse MC, 2012, EUR PHYS J A, V48, DOI 10.1140/epja/i2012-12120-8; Blunden PG, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.057601; Borie E, 2012, ANN PHYS-NEW YORK, V327, P733, DOI 10.1016/j.aop.2011.11.017; Carlson CE, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.035013; Carlson CE, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.020102; Carlson CE, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.042509; Cherednikova EV, 2002, NUCL PHYS A, V703, P365, DOI 10.1016/S0375-9474(01)01461-0; Cloet IC, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.012201; De Rujula A, 2011, PHYS LETT B, V697, P26, DOI 10.1016/j.physletb.2011.01.025; Distler MO, 2011, PHYS LETT B, V696, P343, DOI 10.1016/j.physletb.2010.12.067; Dupays A, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.052503; Eides MI, 2001, PHYS REP, V342, P63, DOI 10.1016/S0370-1573(00)00077-6; Friar JL, 2004, PHYS LETT B, V579, P285, DOI 10.1016/j.physletb.2003.11.018; Friar JL, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.040502; Hill RJ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.160402; Hill RJ, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.113005; Jentschura UD, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.012505; Jentschura UD, 2011, ANN PHYS-NEW YORK, V326, P500, DOI 10.1016/j.aop.2010.11.012; Jentschura UD, 2011, ANN PHYS-NEW YORK, V326, P516, DOI 10.1016/j.aop.2010.11.011; Jentschura UD, 2011, EUR PHYS J D, V61, P7, DOI 10.1140/epjd/e2010-10414-6; Karr JP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.103401; Karshenboim SG, 2010, JETP LETT+, V92, P8, DOI 10.1134/S0021364010130023; Karshenboim SG, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.032509; Lorenz IT, 2012, EUR PHYS J A, V48, DOI 10.1140/epja/i2012-12151-1; Martynenko AP, 2008, PHYS ATOM NUCL+, V71, P125, DOI 10.1134/S1063778808010146; Martynenko AP, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022506; Miller GA, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.020101; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Pachucki K, 1996, PHYS REV A, V53, P2092, DOI 10.1103/PhysRevA.53.2092; Pachucki K, 1999, PHYS REV A, V60, P3593, DOI 10.1103/PhysRevA.60.3593; Parthey CG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.203001; Parthey CG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.233001; Pineda A, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevB.71.065205; Pohl R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.193402; Pohl R, 2009, HYPERFINE INTERACT, V193, P115, DOI 10.1007/s10751-009-0054-1; Pohl R, 2010, NATURE, V466, P213, DOI 10.1038/nature09250; Sick I, 1998, NUCL PHYS A, V637, P559, DOI 10.1016/S0375-9474(98)00334-0; Volotka AV, 2005, EUR PHYS J D, V33, P23, DOI 10.1140/epjd/e2005-00025-9; Zhan X, 2011, PHYS LETT B, V705, P59, DOI 10.1016/j.physletb.2011.10.002	45	552	559	3	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					417	420		10.1126/science.1230016	http://dx.doi.org/10.1126/science.1230016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349284	Green Published, Green Submitted			2022-12-28	WOS:000313960700035
J	Bowie, JU				Bowie, James U.			Membrane Protein Twists and Turns	SCIENCE			English	Editorial Material							TOPOLOGY; EVOLUTION		[Bowie, James U.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Bowie, James U.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bowie, JU (corresponding author), Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	bowie@mbi.ucla.edu			NIGMS NIH HHS [R01GM063919] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063919] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Cao Z, 2012, P NATL ACAD SCI USA, V109, P8121, DOI 10.1073/pnas.1201298109; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; Luirink J, 2012, BBA-BIOENERGETICS, V1817, P965, DOI 10.1016/j.bbabio.2011.12.006; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101	15	25	25	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					398	399		10.1126/science.1228655	http://dx.doi.org/10.1126/science.1228655			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349275				2022-12-28	WOS:000313960700024
J	Placais, PY; Preat, T				Placais, Pierre-Yves; Preat, Thomas			To Favor Survival Under Food Shortage, the Brain Disables Costly Memory	SCIENCE			English	Article							LONG-TERM-MEMORY; CONSOLIDATED MEMORY; PROTEIN-SYNTHESIS; DOPAMINE NEURONS; DROSOPHILA; POTENTIATION; PLASTICITY; RESOURCES; RECEPTORS; PHASES	The brain regulates energy homeostasis in the organism. Under resource shortage, the brain takes priority over peripheral organs for energy supply. But can the brain also down-regulate its own consumption to favor survival? We show that the brain of Drosophila specifically disables the costly formation of aversive long-term memory (LTM) upon starvation, a physiological state required for appetitive LTM formation. At the neural circuit level, the slow oscillations normally triggered in two pairs of dopaminergic neurons to enable aversive LTM formation were abolished in starved flies. Transient artificial activation of these neurons during training restored LTM formation in starved flies but at the price of a reduced survival. LTM formation is thus subject to adaptive plasticity that helps survival under food shortage.	[Placais, Pierre-Yves; Preat, Thomas] Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7637, Neurobiol Unit, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Preat, T (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7637, Neurobiol Unit, 10 Rue Vauquelin, F-75005 Paris, France.	thomas.preat@espci.fr		Preat, Thomas/0000-0001-9976-1763	Region Ile-de-France; French Agence Nationale de la Recherche	Region Ile-de-France(Region Ile-de-France); French Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank G. Belliart-Guerin and V. Goguel for valuable discussion, E. Le Glou for assistance in handling the Trikinetics device, and members of the Genes and Dynamics of Memory Systems group for critical comments on the manuscript. The authors declare no conflict of interest. P.-Y.P. was supported by a postdoctoral fellowship from Region Ile-de-France. T. P. was supported by a grant from the French Agence Nationale de la Recherche.	Aso Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002768; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Colomb J, 2009, GENES BRAIN BEHAV, V8, P407, DOI 10.1111/j.1601-183X.2009.00482.x; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Dorn LA, 2000, EVOLUTION, V54, P1982, DOI 10.1111/j.0014-3820.2000.tb01242.x; Fehm HL, 2006, PROG BRAIN RES, V153, P129, DOI 10.1016/S0079-6123(06)53007-9; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hirano Y, 2013, SCIENCE, V339, P443, DOI 10.1126/science.1227170; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Lagasse F, 2012, P ROY SOC B-BIOL SCI, V279, P4015, DOI 10.1098/rspb.2012.1457; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Mallon EB, 2003, P ROY SOC B-BIOL SCI, V270, P2471, DOI 10.1098/rspb.2003.2456; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Oltmanns KM, 2008, AM J PHYSIOL-REG I, V294, pR12, DOI 10.1152/ajpregu.00093.2007; PAVLIDES C, 1995, NEUROSCIENCE, V68, P387, DOI 10.1016/0306-4522(95)00151-8; Pavlides C, 1999, BRAIN RES, V851, P204, DOI 10.1016/S0006-8993(99)02188-5; Placais PY, 2012, NAT NEUROSCI, V15, P592, DOI 10.1038/nn.3055; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Schwabe L, 2012, NEUROSCI BIOBEHAV R, V36, P1740, DOI 10.1016/j.neubiorev.2011.07.002; Shi WX, 2009, J NEURAL TRANSM-SUPP, P103, DOI 10.1007/978-3-211-92660-4_8; Shi WX, 2005, J NEUROPHYSIOL, V94, P3516, DOI 10.1152/jn.00317.2005; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Valadares CT, 2005, NUTR NEUROSCI, V8, P39, DOI 10.1080/10284150500047302; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015	34	96	96	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					440	442		10.1126/science.1226018	http://dx.doi.org/10.1126/science.1226018			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349289				2022-12-28	WOS:000313960700041
J	Fontanarosa, PB; McNutt, RA				Fontanarosa, Phil B.; McNutt, Robert A.			Revisiting Hospital Readmissions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McNutt, Robert A.] Rush Univ, Sch Med, Dept Med, Chicago, IL 60612 USA	Rush University		phil.fontanarosa@jamanetwork.org						[Anonymous], NY TIMES; Berry JG, 2013, JAMA-J AM MED ASSOC, V309, P372, DOI 10.1001/jama.2012.188351; Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Farmer SA, 2013, JAMA-J AM MED ASSOC, V309, P349, DOI 10.1001/jama.2012.191276; Jha AK, 2013, JAMA-J AM MED ASSOC, V309, P347, DOI 10.1001/jama.2012.196646; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; McCarthy D, 2013, JAMA-J AM MED ASSOC, V309, P351, DOI 10.1001/jama.2013.1; Medicare, MED; Srivastava R, 2013, JAMA-J AM MED ASSOC, V309, P396, DOI 10.1001/jama.2012.217006; Vaduganathan M, 2013, JAMA-J AM MED ASSOC, V309, P345, DOI 10.1001/jama.2012.205110; Vashi AA, 2013, JAMA-J AM MED ASSOC, V309, P364, DOI 10.1001/jama.2012.216219; Williams MV, 2013, JAMA-J AM MED ASSOC, V309, P394, DOI 10.1001/jama.2012.233964	13	88	88	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					398	400		10.1001/jama.2013.42	http://dx.doi.org/10.1001/jama.2013.42			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074FT	23340644				2022-12-28	WOS:000313799000030
J	Vashi, AA; Fox, JP; Carr, BG; D'Onofrio, G; Pines, JM; Ross, JS; Gross, CP				Vashi, Anita A.; Fox, Justin P.; Carr, Brendan G.; D'Onofrio, Gail; Pines, Jesse M.; Ross, Joseph S.; Gross, Cary P.			Use of Hospital-Based Acute Care Among Patients Recently Discharged From the Hospital	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY; REHOSPITALIZATIONS; READMISSIONS; QUALITY; INTERVENTION; VISITS	Importance Current efforts to improve health care focus on hospital readmission rates as a marker of quality and on the effectiveness of transitions in care during the period after acute care is received. Emergency department (ED) visits are also a marker of hospital-based acute care following discharge but little is known about ED use during this period. Objectives To determine the degree to which ED visits and hospital readmissions contribute to overall use of acute care services within 30 days of discharge from acute care hospitals, to describe the reasons patients return for ED visits, and to describe these patterns among Medicare beneficiaries and those not covered by Medicare insurance. Design, Setting, and Participants Prospective study of patients aged 18 years or older (mean age: 53.4 years) who were discharged between July 1, 2008, and September 31, 2009, from acute care hospitals in 3 large, geographically diverse states (California, Florida, and Nebraska) with data recorded in the Healthcare Cost and Utilization Project state inpatient and ED databases. Main Outcome Measures The 3 primary outcomes during the 30-day period after hospital discharge were ED visits not resulting in admission (treat-and-release encounters), hospital readmissions from any source, and a combined measure of ED visits and hospital readmissions termed hospital-based acute care. Results The final cohort included 5 032 254 index hospitalizations among 4 028 555 unique patients. In the 30 days following discharge, 17.9% (95% CI, 17.9%-18.0%) of hospitalizations resulted in at least 1 acute care encounter. Of these 1 233 402 postdischarge acute care encounters, ED visits comprised 39.8% (95% CI, 39.7%-39.9%). For every 1000 discharges, there were 97.5 (95% CI, 97.2-97.8) ED treat-and-release visits and 147.6 (95% CI, 147.3-147.9) hospital readmissions in the 30 days following discharge. The number of ED treat-and-release visits ranged from a low of 22.4 (95% CI, 4.6-65.4) encounters per 1000 discharges for breast malignancy to a high of 282.5 (95% CI, 209.7-372.4) encounters per 1000 discharges for uncomplicated benign prostatic hypertrophy. Among the highest volume discharges, the most common reason patients returned to the ED was always related to their index hospitalization. Conclusions and Relevance After discharge from acute care hospitals in 3 states, ED visits within 30 days were common among adults and accounted for 39.8% of postdischarge hospital-based acute care visits. Improving care transitions should focus not only on decreasing readmissions but also on ED visits. JAMA. 2013;309(4):364-371 www.jama.com	[Vashi, Anita A.; Ross, Joseph S.; Gross, Cary P.] Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, New Haven, CT 06520 USA; [Vashi, Anita A.; D'Onofrio, Gail] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06520 USA; [Ross, Joseph S.; Gross, Cary P.] Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Gross, Cary P.] Yale Univ, Sch Med, Canc Outcomes Policy & Effectiveness Res Ctr, New Haven, CT 06520 USA; [Gross, Cary P.] Yale Comprehens Canc Ctr, New Haven, CT USA; [Vashi, Anita A.] VA Connecticut Healthcare Syst, Dept Vet Affairs, West Haven, CT USA; [Fox, Justin P.] Wright State Univ, Boonshoft Sch Med, Dept Surg, Dayton, OH 45435 USA; [Carr, Brendan G.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Carr, Brendan G.] Univ Penn, Dept Biostat, Philadelphia, PA 19104 USA; [Carr, Brendan G.] Univ Penn, Dept Epidemiol, Philadelphia, PA 19104 USA; [Pines, Jesse M.] George Washington Univ, Dept Emergency Med, Washington, DC USA; [Pines, Jesse M.] George Washington Univ, Dept Hlth Policy, Washington, DC USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University System of Ohio; Wright State University Dayton; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; George Washington University; George Washington University; Yale University	Vashi, AA (corresponding author), Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, 333 Cedar St,SHM 1E-61, New Haven, CT 06520 USA.	anita.vashi@yale.edu		Ross, Joseph/0000-0002-9218-3320; D'Onofrio, Gail/0000-0002-3833-1871	Pew Charitable Trusts; Agency for Healthcare Research and Quality [K08 AG032886]; National Institute on Aging; American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Pew Charitable Trusts; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Carr reported being a senior policy advisor for the Office of the Assistant Secretary for Preparedness and Response. Dr Pines reported working as a senior advisor for the Centers for Medicare & Medicaid Services Innovation Center during the writing of this article. Dr Ross reported receiving funding from the Centers for Medicare & Medicaid Services to develop and maintain performance measures that are used for public reporting; and receiving funding from the Pew Charitable Trusts to examine regulatory issues at the US Food and Drug Administration. Drs Ross and Gross reported receiving funding as collaborators on the Yale University Open Access project, which is facilitating the objective analysis of Medtronic clinical trial data. Drs Ross and Gross are members of a scientific advisory board for FAIR Health Inc. No other disclosures were reported.; Dr Carr is supported by career development award K08 AG032886 from the Agency for Healthcare Research and Quality. Dr Ross is supported by the National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program.	Abarca F, 2011, AM SURGEON, V77, P65; Baer RB, 2001, ACAD EMERG MED, V8, P1091, DOI 10.1111/j.1553-2712.2001.tb01121.x; Brousseau DC, 2010, JAMA-J AM MED ASSOC, V303, P1288, DOI 10.1001/jama.2010.378; Brown R, RES DESIGN EVALUATIO; Bundled Payments for Care Improvement (BPCI) Initiative: General Information, BUNDL PAYM CAR IMPR; Burt Catharine W, 2008, Natl Health Stat Report, P1; Clark SL, 2010, AM J OBSTET GYNECOL, V203, pe1, DOI DOI 10.1155/2012/252676.5.K0REN; Clark SL, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.033; Coleman E A, 2001, Eff Clin Pract, V4, P49; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Coleman Eric A, 2007, Home Health Care Serv Q, V26, P93, DOI 10.1300/J027v26n04_07; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Friedman B, 2009, MED CARE, V47, P583, DOI 10.1097/MLR.0b013e31819434da; Goodman DC, 2011, HOSPITALIZATION DART; Harrison PL, 2011, POPUL HEALTH MANAG, V14, P27, DOI 10.1089/pop.2009.0076; Healthcare Cost and Utilization Project, STAT PAT DAT; Healthcare Cost and Utilization Project, STAT EM DEP DAT; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Lautz TB, 2011, J PEDIATR SURG, V46, P1918, DOI 10.1016/j.jpedsurg.2011.04.012; Legrain S, 2011, J AM GERIATR SOC, V59, P2017, DOI 10.1111/j.1532-5415.2011.03628.x; Martin RCG, 2011, ANN SURG, V254, P591, DOI 10.1097/SLA.0b013e3182300a38; McCall N, 2010, EVALUATION MEDICARE; Morse RB, 2011, JAMA-J AM MED ASSOC, V306, P1454, DOI 10.1001/jama.2011.1385; Naylor MD, 2012, HEALTH AFFAIR, V31, P1623, DOI 10.1377/hlthaff.2012.0110; Peikes D, C EV MED COORD CAR D; Practice Management Information Corporation, 2005, INT CLASS DIS; Sharma G, 2010, ARCH INTERN MED, V170, P1664, DOI 10.1001/archinternmed.2010.345; Sommers A, 2011, PHYS VISITS HOSP DIS; Stone J, 2010, C MED HOSP READM ISS; US Department of Health and Human Services, PARTN PAT BETT CAR L	32	140	140	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					364	371		10.1001/jama.2012.216219	http://dx.doi.org/10.1001/jama.2012.216219			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074FT	23340638	Green Accepted, Bronze			2022-12-28	WOS:000313799000024
J	Mukhopadhyay, S; Wen, XH; Ratti, N; Loktev, A; Rangell, L; Scales, SJ; Jackson, PK				Mukhopadhyay, Saikat; Wen, Xiaohui; Ratti, Navneet; Loktev, Alexander; Rangell, Linda; Scales, Suzie J.; Jackson, Peter K.			The Ciliary G-Protein-Coupled Receptor Gpr161 Negatively Regulates the Sonic Hedgehog Pathway via cAMP Signaling	CELL			English	Article							IFT-A COMPLEX; INTRAFLAGELLAR TRANSPORT; PRIMARY CILIUM; IDENTIFICATION; SUPPRESSOR; MUTANTS; TULP3; SHH; LOCALIZATION; TRANSDUCTION	The primary cilium is required for Sonic hedgehog (Shh) signaling in vertebrates. In contrast to mutants affecting ciliary assembly, mutations in the intraflagellar transport complex A (IFT-A) paradoxically cause increased Shh signaling. We previously showed that the IFT-A complex, in addition to its canonical role in retrograde IFT, binds to the tubby-like protein, Tulp3, and recruits it to cilia. Here, we describe a conserved vertebrate G-protein-coupled receptor, Gpr161, which localizes to primary cilia in a Tulp3/IFT-A-dependent manner. Complete loss of Gpr161 in mouse causes midgestation lethality and increased Shh signaling in the neural tube, phenocopying Tulp3/IFT-A mutants. Constitutive Gpr161 activity increases cAMP levels and represses Shh signaling by determining the processing of Gli3 to its repressor form. Conversely, Shh signaling directs Gpr161 to be internalized from cilia, preventing its activity. Thus, Gpr161 defines a morphogenetic pathway coupling protein kinase A activation to Shh signaling during neural tube development.	[Mukhopadhyay, Saikat; Loktev, Alexander; Jackson, Peter K.] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Wen, Xiaohui; Scales, Suzie J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Ratti, Navneet; Rangell, Linda] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Mukhopadhyay, S (corresponding author), UT SW Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	saikat.mukhopadhyay@utsouthwestern.edu; pjackson@gene.com	Scales, Suzie J./H-4507-2019	Scales, Suzie J./0000-0003-2544-0283; Jackson, Peter/0000-0002-1742-2539; Mukhopadhyay, Saikat/0000-0003-4790-3090				Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bananis E, 2004, MOL BIOL CELL, V15, P3688, DOI 10.1091/mbc.E04-04-0278; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; BRAY P, 1986, P NATL ACAD SCI USA, V83, P8893, DOI 10.1073/pnas.83.23.8893; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Damaj BB, 1996, FASEB J, V10, P1426, DOI 10.1096/fasebj.10.12.8903513; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Greasley PJ, 2001, J BIOL CHEM, V276, P46485, DOI 10.1074/jbc.M105791200; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Leung T, 2008, DEV BIOL, V323, P31, DOI 10.1016/j.ydbio.2008.08.001; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Matteson PG, 2008, P NATL ACAD SCI USA, V105, P2088, DOI 10.1073/pnas.0705657105; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Norman RX, 2009, HUM MOL GENET, V18, P1740, DOI 10.1093/hmg/ddp113; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Patterson VL, 2009, HUM MOL GENET, V18, P1719, DOI 10.1093/hmg/ddp075; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; WILSON DB, 1986, J NEUROPATH EXP NEUR, V45, P43, DOI 10.1097/00005072-198601000-00004; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	45	285	294	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					210	223		10.1016/j.cell.2012.12.026	http://dx.doi.org/10.1016/j.cell.2012.12.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332756	Bronze			2022-12-28	WOS:000313719800018
J	Dye, C; Fine, PEM				Dye, Christopher; Fine, Paul E. M.			A major event for new tuberculosis vaccines	LANCET			English	Editorial Material							PROTECTION		[Dye, Christopher] WHO, CH-1211 Geneva, Switzerland; [Fine, Paul E. M.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Dye, C (corresponding author), WHO, CH-1211 Geneva, Switzerland.	dyec@who.int	Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793				Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Aeras, DEV NEW TUB VACC WOR; [Anonymous], GLOB TUB CONTR WHO R; Brennan MJ, 2012, INT J TUBERC LUNG D, V16, P1566, DOI 10.5588/ijtld.12.0569; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; McShane H, 2011, PHILOS T R SOC B, V366, P2782, DOI 10.1098/rstb.2011.0097; Tameris MD, 2013, LANCET; Treatment Action Group, 2012, TUB RES DEV 2011 REP; Young D, 2006, CELL, V124, P683, DOI 10.1016/j.cell.2006.02.013	10	20	22	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2013	381	9871					972	974		10.1016/S0140-6736(13)60137-3	http://dx.doi.org/10.1016/S0140-6736(13)60137-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117EU	23391464				2022-12-28	WOS:000316936800006
J	Vollset, SE; Clarke, R; Lewington, S; Ebbing, M; Halsey, J; Lonn, E; Armitage, J; Manson, JE; Hankey, GJ; Spence, JD; Galan, P; Bonaa, KH; Jamison, R; Gaziano, JM; Guarino, P; Baron, JA; Logan, RFA; Giovannucci, EL; den Heijer, M; Ueland, PM; Bennett, D; Collins, R; Peto, R				Vollset, Stein Emil; Clarke, Robert; Lewington, Sarah; Ebbing, Marta; Halsey, Jim; Lonn, Eva; Armitage, Jane; Manson, Joann E.; Hankey, Graeme J.; Spence, J. David; Galan, Pilar; Bonaa, Kaare H.; Jamison, Rex; Gaziano, J. Michael; Guarino, Peter; Baron, John A.; Logan, Richard F. A.; Giovannucci, Edward L.; den Heijer, Martin; Ueland, Per M.; Bennett, Derrick; Collins, Rory; Peto, Richard		B-Vitamin Treatment Trialists' Co	Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals	LANCET			English	Article							NEURAL-TUBE DEFECTS; PERICONCEPTIONAL VITAMIN SUPPLEMENTATION; PLACEBO-CONTROLLED TRIAL; B-VITAMINS; MYOCARDIAL-INFARCTION; VASCULAR-DISEASE; RISK-FACTOR; CARDIOVASCULAR-DISEASE; LOWERING HOMOCYSTEINE; FLOUR FORTIFICATION	Background Some countries fortify flour with folic acid to prevent neural tube defects but others do not, partly because of concerns about possible cancer risks. We aimed to assess any effects on site-specific cancer rates in the randomised trials of folic acid supplementation, at doses higher than those from fortification. Methods In these meta-analyses, we sought all trials completed before 2011 that compared folic acid versus placebo, had scheduled treatment duration at least 1 year, included at least 500 participants, and recorded data on cancer incidence. We obtained individual participant datasets that included 49 621 participants in all 13 such trials (ten trials of folic acid for prevention of cardiovascular disease [n=46 969] and three trials in patients with colorectal adenoma [n=2652]). All these trials were evenly randomised. The main outcome was incident cancer (ignoring non-melanoma skin cancer) during the scheduled treatment period (among participants who were still free of cancer). We compared those allocated folic acid with those allocated placebo, and used log-rank analyses to calculate the cancer incidence rate ratio (RR). Findings During a weighted average scheduled treatment duration of 5.2 years, allocation to folic acid quadrupled plasma concentrations of folic acid (57.3 nmol/L for the folic acid groups vs 13.5 nmol/L for the placebo groups), but had no significant effect on overall cancer incidence (1904 cancers in the folic acid groups vs 1809 cancers in the placebo groups, RR 1.06, 95% CI 0.99-1.13, p=0.10). There was no trend towards greater effect with longer treatment. There was no significant heterogeneity between the results of the 13 individual trials (p=0.23), or between the two overall results in the cadiovascular prevention trials and the adenoma trials (p=0.13). Moreover, there was no significant effect of folic acid supplementation on the incidence of cancer of the large intestine, prostate, lung, breast, or any other specific site. Interpretation Folic acid supplementation does not substantially increase or decrease incidence of site-specific cancer during the first 5 years of treatment. Fortification of flour and other cereal products involves doses of folic acid that are, on average, an order of magnitude smaller than the doses used in these trials.	[Vollset, Stein Emil] Univ Bergen, Norwegian Inst Publ Hlth, Bergen, Norway; [Vollset, Stein Emil] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Clarke, Robert; Lewington, Sarah; Halsey, Jim; Armitage, Jane; Bennett, Derrick; Collins, Rory; Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Clarke, Robert; Lewington, Sarah; Halsey, Jim; Armitage, Jane; Bennett, Derrick; Collins, Rory; Peto, Richard] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford OX3 7LF, England; [Ebbing, Marta] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Lonn, Eva] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Lonn, Eva] McMaster Univ, Dept Med, Div Cardiol, Hamilton, ON, Canada; [Manson, Joann E.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Hankey, Graeme J.] Royal Perth Hosp, Dept Neurol, Perth, WA, Australia; [Spence, J. David] Univ Western Ontario, Dept Neurol, Robarts Res Inst, London, ON, Canada; [Bonaa, Kaare H.] Univ Hosp Northern Norway, Dept Heart Dis, Tromso, Norway; [Jamison, Rex] Vet Affairs Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA USA; [Jamison, Rex] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Guarino, Peter] Connecticut VA Healthcare Syst, Dept Vet airs, Cooperat Studies Program, West Haven, CT USA; [Baron, John A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Logan, Richard F. A.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Giovannucci, Edward L.] Harvard Univ, Sch Med, Dept Epidemiol, Boston, MA USA; [Giovannucci, Edward L.] Harvard Univ, Sch Med, Dept Nutr, Boston, MA USA; [den Heijer, Martin] Radboud Univ Nijmegen, Dept Endocrinol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Ueland, Per M.] Haukeland Hosp, Lab Clin Biochem, N-5021 Bergen, Norway	Norwegian Institute of Public Health (NIPH); University of Bergen; University of Bergen; University of Oxford; University of Oxford; University of Bergen; Haukeland University Hospital; McMaster University; Population Health Research Institute; McMaster University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Royal Perth Hospital; University of Western Australia; Western University (University of Western Ontario); UiT The Arctic University of Tromso; University Hospital of North Norway; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of North Carolina; University of North Carolina Chapel Hill; University of Nottingham; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Radboud University Nijmegen; University of Bergen; Haukeland University Hospital	Clarke, R (corresponding author), Univ Oxford, Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	robert.clarke@ctsu.ox.ac.uk	Hankey, Graeme J/H-4968-2014; Spence, J. David/K-6396-2013; Ueland, Per M/C-7340-2013; Pilar, Galan/F-2908-2017; , Bennett/O-7998-2019; Bennett, Derrick/AFL-9254-2022; Refsum, Helga/A-4073-2010; Bennett, Derrick/AAH-1220-2022; Collins, Rory/ABA-8487-2020; den Heijer, Martin/J-8036-2015	Hankey, Graeme J/0000-0002-6044-7328; Spence, J. David/0000-0001-7478-1098; Pilar, Galan/0000-0003-1706-3107; Bennett, Derrick/0000-0002-9170-8447; Bennett, Derrick/0000-0002-9170-8447; Yusuf, Salim/0000-0003-4776-5601; Ueland, Per Magne/0000-0002-1903-0571; Lewington, Sarah/0000-0002-4496-4771; Blom, Henk/0000-0001-5202-9241; den Heijer, Martin/0000-0003-3620-5617	British Heart Foundation; Medical Research Council; Cancer Research UK; Food Standards Agency; UK Medical Research Council; UK Food Standards Agency [N05072]; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA059005, P30CA016086] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Food Standards Agency; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Food Standards Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	British Heart Foundation, Medical Research Council, Cancer Research UK, Food Standards Agency.; Sources of funding for individual trials are described in their separate publications. The Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), where the BVTT secretariat is located, has a policy of not accepting fees, honoraria, or paid consultancies directly or indirectly from any industry. It receives its core funding from the British Heart Foundation, UK Medical Research Council, and Cancer Research UK. Support for this project was also provided by a grant from the UK Food Standards Agency (N05072).	[Anonymous], 2010, EFSA MEETING SUMMARY; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Australian Institute of Health and Welfare (AIHW), 2011, MANDATORY FOLIC ACID; Baigent C, 2011, OXFORD TXB MED; Baker F, 2002, CIRCULATION, V106, P741; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Bostom AG, 2011, CIRCULATION, V123, P1763, DOI 10.1161/CIRCULATIONAHA.110.000588; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BOWER C, 1989, MED J AUSTRALIA, V150, P613, DOI 10.5694/j.1326-5377.1989.tb136723.x; Clarke R, 2006, AM HEART J, V151, P282, DOI 10.1016/j.ahj.2005.04.025; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; den Heijer M, 2007, BLOOD, V109, P139, DOI 10.1182/blood-2006-04-014654; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Figueiredo JC, 2009, JNCI-J NATL CANCER I, V101, P432, DOI 10.1093/jnci/djp019; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; HIBBARD BM, 1964, J OBSTET GYN BR COMM, V71, P529; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Jamison RL, 2007, JAMA-J AM MED ASSOC, V298, P1163, DOI 10.1001/jama.298.10.1163; Kim YI, 2004, AM J CLIN NUTR, V80, P1123, DOI 10.1093/ajcn/80.5.1123; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Lopez-Camelo JS, 2010, AM J MED GENET A, V152A, P2444, DOI 10.1002/ajmg.a.33479; Maberly G., 2008, Morbidity and Mortality Weekly Report, V57, P8; Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329; MOLLOY AM, 1985, ARCH DIS CHILD, V60, P660, DOI 10.1136/adc.60.7.660; Peto R, 2008, NEW ENGL J MED, V359, P1357, DOI 10.1056/NEJMsa0806603; Sanjoaquin MA, 2005, INT J CANCER, V113, P825, DOI 10.1002/ijc.20648; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Sayed AR, 2008, BIRTH DEFECTS RES A, V82, P211, DOI 10.1002/bdra.20442; Scientifi c Advisory Committee on Nutrition, 2006, FOLATE AND DISEASE P; Scientific Advisory Committee on Nutrition, 2009, FOLIC ACID AND COLOR; SMITHELLS RW, 1980, LANCET, V1, P339; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; WALD N, 1991, LANCET, V338, P131; Wien TN, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000653; Wu K, 2009, AM J CLIN NUTR, V90, P1623, DOI 10.3945/ajcn.2009.28319; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zhang SMM, 2008, JAMA-J AM MED ASSOC, V300, P2012, DOI 10.1001/jama.2008.555	43	212	224	0	75	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 23	2013	381	9871					1029	1036		10.1016/S0140-6736(12)62001-7	http://dx.doi.org/10.1016/S0140-6736(12)62001-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EU	23352552	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000316936800032
J	Costa, Y; Ding, JJ; Theunissen, TW; Faiola, F; Hore, TA; Shliaha, PV; Fidalgo, M; Saunders, A; Lawrence, M; Dietmann, S; Das, S; Levasseur, DN; Li, Z; Xu, MJ; Reik, W; Silva, JCR; Wang, JL				Costa, Yael; Ding, Junjun; Theunissen, Thorold W.; Faiola, Francesco; Hore, Timothy A.; Shliaha, Pavel V.; Fidalgo, Miguel; Saunders, Arven; Lawrence, Moyra; Dietmann, Sabine; Das, Satyabrata; Levasseur, Dana N.; Li, Zhe; Xu, Mingjiang; Reik, Wolf; Silva, Jose C. R.; Wang, Jianlong			NANOG-dependent function of TET1 and TET2 in establishment of pluripotency	NATURE			English	Article							CELL SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; PROTEIN; DNA; CONVERSION; NETWORK; GENES	Molecular control of the pluripotent state is thought to reside in a core circuitry of master transcription factors including the homeodomain-containing protein NANOG(1,2), which has an essential role in establishing ground state pluripotency during somatic cell reprogramming(3,4). Whereas the genomic occupancy of NANOG has been extensively investigated, comparatively little is known about NANOG-associated proteins(5) and their contribution to the NANOG-mediated reprogramming process. Using enhanced purification techniques and a stringent computational algorithm, we identify 27 high-confidence protein interaction partners of NANOG in mouse embryonic stem cells. These consist of 19 previously unknown partners of NANOG that have not been reported before, including the ten-eleven translocation (TET) family methylcytosine hydroxylase TET1. We confirm physical association of NANOG with TET1, and demonstrate that TET1, in synergy with NANO G, enhances the efficiency of reprogramming. We also find physical associatinn and reprogramming synergy of TET2 with NANOG, and demonstrate that knockdown of TET2 abolishes the reprogramming synergy of NANOG with a catalytically deficient mutant of TET1. These results indicate that the physical interaction between NANOG and TET1/TET2 proteins facilitates reprogramming in a manner that is dependent on the catalytic activity of TET1/TET2. TET1 and NANOG co-occupy genomic loci of genes associated with both maintenance of pluripotency and lineage commitment in embryonic stem cells, and TET1 binding is reduced upon NANOG depletion. Co-expression of NANOG and TET1 increases 5-hydroxymethylcytosine levels at the top-ranked common target loci Esrrb and Oct4 (also called Pou5f1), resulting in priming of their expression before reprogramming to naive pluripotency. We propose that TET1 is recruited by NANOG to enhance the expression of a subset of key reprogramming target genes. These results provide an insight into the reprogramming mechanism of NANOG and uncover a new role for 5-methykytosine hydroxylases in the establishment of naive pluripotency.	[Costa, Yael; Theunissen, Thorold W.; Lawrence, Moyra; Dietmann, Sabine; Silva, Jose C. R.] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England; [Ding, Junjun; Faiola, Francesco; Fidalgo, Miguel; Saunders, Arven; Wang, Jianlong] Mt Sinai Sch Med, Black Family Stem Cell Inst, Grad Sch Biol Sci, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Theunissen, Thorold W.; Lawrence, Moyra; Silva, Jose C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Hore, Timothy A.; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Shliaha, Pavel V.] Univ Cambridge, Cambridge Ctr Prote, Cambridge Syst Biol Ctr, Cambridge CB2 1QR, England; [Das, Satyabrata; Levasseur, Dana N.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Li, Zhe; Xu, Mingjiang] Indiana Univ, Dept Pediat, Indianapolis, IN 46202 USA; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England	University of Cambridge; Icahn School of Medicine at Mount Sinai; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; University of Iowa; Indiana University System; Indiana University-Purdue University Indianapolis; University of Cambridge	Wang, JL (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, Grad Sch Biol Sci, Dept Dev & Regenerat Biol, New York, NY 10029 USA.	jcs64@cam.ac.uk; jianlong.wang@mssm.edu	Wang, Jianlong/GQR-1191-2022; Ding, Junjun/F-8618-2015; Fidalgo, Miguel/I-7006-2019; Reik, Wolf/I-6794-2012; Faiola, Francesco/Q-4218-2018; Silva, Jose/G-1920-2014; Ding, Junjun/C-4098-2012; Silva, Jose C R/X-5140-2019; Lawrence, Moyra/AAC-6198-2019; Wang, Jianlong/AAG-9425-2020; Das, Satyabrata/J-2629-2019	Wang, Jianlong/0000-0002-1317-6457; Fidalgo, Miguel/0000-0003-1134-2674; Faiola, Francesco/0000-0002-3512-8253; Silva, Jose/0000-0001-5487-1117; Silva, Jose C R/0000-0001-5487-1117; Lawrence, Moyra/0000-0001-9386-5633; Theunissen, Thorold/0000-0001-6943-7858; Ding, Junjun/0000-0002-9936-882X; Shliaha, Pavel/0000-0003-3092-0724; Reik, Wolf/0000-0003-0216-9881; Dietmann, Sabine./0000-0001-6672-8457; Hore, Timothy/0000-0002-6735-225X; Costa, Yael/0000-0002-3327-4580	NIH [1R01-GM095942-01A1]; New York state Department of Health (NYSTEM) [C026420]; Black Family Stem Cell Institute; Wellcome Trust [WT086692MA, WT079249]; Isaac Newton Trust [11.19(ad)]; BBSRC; MRC; Wellcome Trust; EU; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095942] Funding Source: NIH RePORTER; BBSRC [BB/H008071/1] Funding Source: UKRI; MRC [G0700098] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H008071/1] Funding Source: researchfish; Medical Research Council [G0700098] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York state Department of Health (NYSTEM); Black Family Stem Cell Institute; Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank W. Mansfield for blastocyst injections, A. Radzisheuskaya for cell culture assistance, and R. Jaenisch for Tet1<SUP>-/-</SUP> embryonic stem cells. This study was supported by a grant from the NIH (1R01-GM095942-01A1), a grant from New York state Department of Health (NYSTEM#C026420), and a seed fund from the Black Family Stem Cell Institute to J.W., by the Wellcome Trust Fellowship (WT086692MA) and the Isaac Newton Trust Grant (11.19(ad)) to J.C.R.S., who is a Wellcome Trust Career Development Fellow, by the BBSRC, the MRC, the Wellcome Trust, and EU Epigenesys and BLUEPRINT to W.R., and by the Wellcome Trust Fellowship WT079249 to T.W.T.	Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Das S, 2011, J BIOL CHEM, V286, P42690, DOI 10.1074/jbc.M111.290189; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kallin EM, 2012, MOL CELL, V48, P266, DOI 10.1016/j.molcel.2012.08.007; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Pereira C. F., 2009, CURR PROTOC STEM CEL, V9; Rees J. S., 2011, MOL CELL PROTEOMICS; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	26	307	321	1	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2013	495	7441					370	374		10.1038/nature11925	http://dx.doi.org/10.1038/nature11925			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EY	23395962	Green Accepted, Green Published			2022-12-28	WOS:000316650500043
J	Howard, J; Malfroy, M; Llewelyn, C; Choo, L; Hodge, R; Johnson, T; Purohit, S; Rees, DC; Tillyer, L; Walker, I; Fijnvandraat, K; Kirby-Allen, M; Spackman, E; Davies, SC; Williamson, LM				Howard, Jo; Malfroy, Moira; Llewelyn, Charlotte; Choo, Louise; Hodge, Renate; Johnson, Tony; Purohit, Shilpi; Rees, David C.; Tillyer, Louise; Walker, Isabeau; Fijnvandraat, Karin; Kirby-Allen, Melanie; Spackman, Eldon; Davies, Sally C.; Williamson, Lorna M.			The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; ACUTE CHEST SYNDROME; WEST-NILE VIRUS; PERIOPERATIVE MANAGEMENT; GENERAL-ANESTHESIA; BLOOD-TRANSFUSION; UNITED-STATES; SURGERY; CHILDREN; CHOLECYSTECTOMY	Background No consensus exists on whether preoperative blood transfusions are beneficial in patients with sickle-cell disease. We assessed whether perioperative complication rates would be altered by preoperative transfusion. Methods We did a multicentre, randomised trial. Eligible patients were aged at least 1 year, had haemoglobin SS or S beta(0)thalassaemia sickle-cell-disease subtypes, and were scheduled for low-risk or medium-risk operations. Patients were randomly assigned no transfusion or transfusion no more than 10 days before surgery. The primary outcome was the proportion of clinically important complications between randomisation and 30 days after surgery. Analysis was by intention to treat. Findings 67 (96%) of 70 enrolled patients-33 no preoperative transfusion and 34 preoperative transfusion-were assessed. 65 (97%) of 67 patients had the haemoglobin SS subtype and 54 (81%) were scheduled to undergo medium-risk surgery. 13 (39%) of 33 patients in the no-preoperative-transfusion group had clinically important complications, compared with five (15%) in the preoperative-transfusion group (p=0.023). Of these, 10 (30%) and one (3%), respectively, had serious adverse events. The unadjusted odds ratio of clinically important complications was 3.8 (95% CI 1.2-12.2, p=0.027). 10 (91%) of 11 serious adverse events were acute chest syndrome (nine in the no-preoperative-transfusion group and one in the preoperative-transfusion group). Duration of hospital stay and readmission rates did not differ between study groups. Interpretation Preoperative transfusion was associated with decreased perioperative complications in patients with sickle-cell disease in this trial. This approach could, therefore, be beneficial for patients with the haemoglobin SS subtype who are scheduled to undergo low-risk and medium-risk surgeries.	[Howard, Jo] Guys & St Thomas Hosp, Dept Haematol, London SE1 9RT, England; [Malfroy, Moira; Llewelyn, Charlotte; Hodge, Renate; Purohit, Shilpi; Williamson, Lorna M.] NHS Blood & Transplant, London, England; [Choo, Louise; Johnson, Tony] MRC Clin Trials Unit, London, England; [Rees, David C.] Kings Coll Hosp London, Dept Paediat Haematol, London, England; [Tillyer, Louise] Royal Brompton Hosp, Dept Haematol, London SW3 6LY, England; [Walker, Isabeau] Great Ormond St Hosp Children NHS Fdn Trust, Dept Anaesthesia, London, England; [Walker, Isabeau] UCL, Inst Child Hlth, Portex Dept Anaesthesia, London, England; [Fijnvandraat, Karin] Univ Amsterdam, Acad Med Ctr, Dept Paediat Haematol, NL-1105 AZ Amsterdam, Netherlands; [Kirby-Allen, Melanie] Hosp Sick Kids, Div Haematol Oncol, Toronto, ON, Canada; [Spackman, Eldon] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Davies, Sally C.] Dept Hlth, London SE1 6TE, England	Guy's & St Thomas' NHS Foundation Trust; Medical Research Council Clinical Trials Unit; King's College Hospital NHS Foundation Trust; King's College Hospital; Royal Brompton Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of York - UK	Howard, J (corresponding author), Guys Hosp, Dept Haematol, London SE1 9RT, England.	jo.howard@gstt.nhs.uk	; Rees, David/B-6789-2011	Choo, Louise/0000-0003-4040-1522; Rees, David/0000-0003-3647-1050; Spackman, David Eldon/0000-0001-8558-5973	NHS Blood and Transplant [BS00/1/RB00]; UK Sickle Cell Society; Dutch Medicines for Children Research Network; Canadian Hospital for Sick Children, Toronto, ON; MRC [MC_U122870183] Funding Source: UKRI; Medical Research Council [MC_U122870183] Funding Source: researchfish	NHS Blood and Transplant; UK Sickle Cell Society; Dutch Medicines for Children Research Network; Canadian Hospital for Sick Children, Toronto, ON; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	LMW and SCD were supported by NHS Blood and Transplant (grant BS00/1/RB00). We thank Jackie Buck and Angela Casbard for assistance in trial planning, and the UK Sickle Cell Society for support and publicity to the sickle-cell community. The Dutch Medicines for Children Research Network and Canadian Hospital for Sick Children, Toronto, ON, gave support as overseas collaborating centres. The trial was managed by the NHS Blood and Transplant/MRC Clinical Trials Unit, Cambridge, UK. The study was coadopted by the National Institute for Health Research Medicines for Children Research Network, and the Comprehensive Clinical Research Network (Blood group). Support at sites in London was given by the London South East, North Central and East (SENCE) Local Research Network.	Adekile AD, 2011, HEMOGLOBIN, V35, P607, DOI 10.3109/03630269.2011.617230; Al-Jaouni SK, 2006, BAHRAIN MED B, V28; American Society of Anesthesiologists, ASA PHYS STAT CLASS; Ballas SK, 2010, AM J HEMATOL, V85, P6, DOI 10.1002/ajh.21550; BHATTACHARYYA N, 1993, J PEDIATR SURG, V28, P72, DOI 10.1016/S0022-3468(05)80359-8; BUCHANAN GR, 1995, NEW ENGL J MED, V333, P1641; Buck J, 2005, EUR J HAEMATOL, V75, P14, DOI 10.1111/j.1600-0609.2005.00412.x; Dinan MA, 2009, AM J HEMATOL, V84, P703, DOI 10.1002/ajh.21520; Firth PG, 2011, PEDIATR ANESTH, V21, P43, DOI 10.1111/j.1460-9592.2010.03415.x; Fu T, 2005, PEDIATR BLOOD CANCER, V45, P43, DOI 10.1002/pbc.20283; GRIFFIN TC, 1993, J PEDIATR SURG, V28, P681, DOI 10.1016/0022-3468(93)90031-F; Haberkern CM, 1997, BLOOD, V89, P1533; Harrington T, 2003, TRANSFUSION, V43, P1018, DOI 10.1046/j.1537-2995.2003.00481.x; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; HIRST C, 2012, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003149.PUB2; HOMI J, 1979, BMJ-BRIT MED J, V1, P1599, DOI 10.1136/bmj.1.6178.1599; Jayaraman S, 2010, TRANSFUSION, V50, P433, DOI 10.1111/j.1537-2995.2009.002402.x; KOSHY M, 1995, BLOOD, V86, P3676, DOI 10.1182/blood.V86.10.3676.bloodjournal86103676; Li G, 2009, ANESTHESIOLOGY, V110, P759, DOI 10.1097/ALN.0b013e31819b5bdc; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Neumayr L, 1998, AM J HEMATOL, V57, P101, DOI 10.1002/(SICI)1096-8652(199802)57:2<101::AID-AJH2>3.0.CO;2-#; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Saklad MD, 2012, ANESTHESIOLOGY, V2, P281; VICHINSKY EP, 1995, NEW ENGL J MED, V333, P206, DOI 10.1056/NEJM199507273330402; Vichinsky EP, 1997, BLOOD, V89, P1787, DOI 10.1182/blood.V89.5.1787.1787_1787_1792; Waldron P, 1999, J PEDIAT HEMATOL ONC, V21, P129, DOI 10.1097/00043426-199903000-00009; Wales PW, 2001, J PEDIATR SURG, V36, P718, DOI 10.1053/jpsu.2001.22944; Whitehead J, 1999, STAT MED, V18, P2271; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	29	130	131	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					930	938		10.1016/S0140-6736(12)61726-7	http://dx.doi.org/10.1016/S0140-6736(12)61726-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105LB	23352054				2022-12-28	WOS:000316069700028
J	Markoff, L				Markoff, Lewis			Yellow Fever Outbreak in Sudan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Ctr Biol Evaluat & Res, Lab Vector Borne Virus Dis, Bethesda, MD USA	US Food & Drug Administration (FDA)	Markoff, L (corresponding author), US FDA, Ctr Biol Evaluat & Res, Lab Vector Borne Virus Dis, Bethesda, MD USA.							[Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P477; Centers for Disease Control and Prevention, YELL FEV SUD TRAV HL; Ellis BR, 2008, REV MED VIROL, V18, P331, DOI 10.1002/rmv.584; Monath TP, 2012, EXPERT REV VACCINES, V11, P427, DOI [10.1586/ERV.12.6, 10.1586/erv.12.6]; World Health Organization, YELL FEV SUD UPD	5	34	36	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					689	691		10.1056/NEJMp1300772	http://dx.doi.org/10.1056/NEJMp1300772			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	092CG	23387798				2022-12-28	WOS:000315095800001
J	Bassik, MC; Kampmann, M; Lebbink, RJ; Wang, SY; Hein, MY; Poser, I; Weibezahn, J; Horlbeck, MA; Chen, SY; Mann, M; Hyman, AA; LeProust, EM; McManus, MT; Weissman, JS				Bassik, Michael C.; Kampmann, Martin; Lebbink, Robert Jan; Wang, Shuyi; Hein, Marco Y.; Poser, Ina; Weibezahn, Jimena; Horlbeck, Max A.; Chen, Siyuan; Mann, Matthias; Hyman, Anthony A.; LeProust, Emily M.; McManus, Michael T.; Weissman, Jonathan S.			A Systematic Mammalian Genetic Interaction Map Reveals Pathways Underlying Ricin Susceptibility	CELL			English	Article							ENDOPLASMIC-RETICULUM; TRANSLATION INITIATION; RETROGRADE TRANSPORT; SHRNA LIBRARIES; PROTEIN TOXINS; OVARIAN-CANCER; HUMAN-CELLS; E. COLI; RNAI; ORGANIZATION	Genetic interaction (GI) maps, comprising pairwise measures of how strongly the function of one gene depends on the presence of a second, have enabled the systematic exploration of gene function in microorganisms. Here, we present a two-stage strategy to construct high-density GI maps in mammalian cells. First, we use ultracomplex pooled shRNA libraries (25 shRNAs/gene) to identify high-confidence hit genes for a given phenotype and effective shRNAs. We then construct double-shRNA libraries from these to systematically measure GIs between hits. A GI map focused on ricin susceptibility broadly recapitulates known pathways and provides many unexpected insights. These include a noncanonical role for COPI, a previously uncharacterized protein complex affecting toxin clearance, a specialized role for the ribosomal protein RPS25, and functionally distinct mammalian TRAPP complexes. The ability to rapidly generate mammalian GI maps provides a potentially transformative tool for defining gene function and designing combination therapies based on synergistic pairs.	[Bassik, Michael C.; Kampmann, Martin; Wang, Shuyi; Weibezahn, Jimena; Horlbeck, Max A.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biomed Res, San Francisco, CA 94122 USA; [Bassik, Michael C.; Kampmann, Martin; Wang, Shuyi; Weibezahn, Jimena; Horlbeck, Max A.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94122 USA; [Lebbink, Robert Jan; McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94122 USA; [Lebbink, Robert Jan; McManus, Michael T.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94122 USA; [Hein, Marco Y.; Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Poser, Ina; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Chen, Siyuan; LeProust, Emily M.] Agilent Technol, Genom Solut Unit, Santa Clara, CA 95051 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Max Planck Society; Max Planck Society; Agilent Technologies	Bassik, MC (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biomed Res, San Francisco, CA 94122 USA.	bassik@cmp.ucsf.edu; martin.kampmann@ucsf.edu	Mann, Matthias/A-3454-2013; Hein, Marco/C-2994-2014; Hyman, Anthony A/B-3917-2017; Chen, Siyuan/C-6163-2012; Lebbink, Robert Jan/GNH-5209-2022; Hyman, Tony/F-1923-2011; mcmanus, michael/AAB-1239-2020	Mann, Matthias/0000-0003-1292-4799; Hein, Marco/0000-0002-9490-2261; Hyman, Anthony A/0000-0003-3664-154X; mcmanus, michael/0000-0003-3013-6569; Kampmann, Martin/0000-0002-3819-7019; Lebbink, Robert Jan/0000-0002-1981-0420; Weissman, Jonathan/0000-0003-2445-670X	Jane Coffin Childs Memorial Fund; UCSF Program for Breakthrough Biomedical Research; Leukemia and Lymphoma Society; German medical genome research grant [FKZ01GS0861]; European Community [241548]; HHMI; NIH [1U01CA168370-01, RO1 GM80783]; Howard Hughes Collaborative Initiative Award; NATIONAL CANCER INSTITUTE [U01CA168370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618, R01GM080783] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; UCSF Program for Breakthrough Biomedical Research; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); German medical genome research grant; European Community(European Commission); HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Collaborative Initiative Award(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Augsburg, O. Chen, C. Chu, S. Churchman, S. Collins, R. Geiger, A. Heidersbach, N. Ingolia, M. Leuscher, J. Lund, L. Mitic, W. Patena, M. Pham, D. Root, M. Schuldiner, A. Ssykor, N. Stern-Ginossar, K. Thorn, and X. Wang for technical advice and assistance and S. Collins, A. Frost, M. Jonikas, C. Jan, G. Ku, N. Shariat, P. Temkin, M. von Zastrow, D. Acosta-Alvear, and members of the McManus and Weissman labs for helpful discussions and critical reading of the manuscript. The work is supported by the Jane Coffin Childs Memorial Fund and the UCSF Program for Breakthrough Biomedical Research (M.K. and M.T.M and J.S.W.), the Leukemia and Lymphoma Society (M.C.B.), The German medical genome research grant FKZ01GS0861 (M.M. and A.A.H.), the European Community's FP7/2007-2013 under grant agreement 241548 (MitoSys Project, A.A.H.), the HHMI (J.S.W.), the NIH (1U01CA168370-01, J.S.W. and M.T.M; RO1 GM80783, M.T.M.), and a Howard Hughes Collaborative Initiative Award (J.S.W.). E.M.L. and S.C. are employees of Agilent Technologies.	Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/NMETH.1330, 10.1038/nmeth.1330]; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bonifacino JS, 2011, TRENDS CELL BIOL, V21, P159, DOI 10.1016/j.tcb.2010.11.003; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen A, 2002, BBA-MOL CELL RES, V1589, P124, DOI 10.1016/S0167-4889(02)00163-5; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Choi C, 2011, TRAFFIC, V12, P715, DOI 10.1111/j.1600-0854.2011.01181.x; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Collins SR, 2009, NAT METHODS, V6, P721, DOI 10.1038/nmeth1009-721; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Frost A, 2012, CELL, V149, P1339, DOI 10.1016/j.cell.2012.04.028; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geiger R, 2011, NAT CELL BIOL, V13, P1305, DOI 10.1038/ncb2339; Grimmer S, 2000, MOL BIOL CELL, V11, P4205, DOI 10.1091/mbc.11.12.4205; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Kim HG, 2010, AM J HUM GENET, V87, P465, DOI 10.1016/j.ajhg.2010.08.018; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Llorente A, 2003, J BIOL CHEM, V278, P35850, DOI 10.1074/jbc.M303425200; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Merrill MK, 2006, J VIROL, V80, P6936, DOI 10.1128/JVI.00243-06; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moreau D, 2011, DEV CELL, V21, P231, DOI 10.1016/j.devcel.2011.06.014; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Pawar V, 2011, J BIOMOL SCREEN, V16, P436, DOI 10.1177/1087057110397890; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Scrivens PJ, 2011, MOL BIOL CELL, V22, P2083, DOI 10.1091/mbc.E10-11-0873; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Yamasaki A, 2009, MOL BIOL CELL, V20, P4205, DOI 10.1091/mbc.E09-05-0387; Zong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023350; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	52	250	256	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 14	2013	152	4					909	922		10.1016/j.cell.2013.01.030	http://dx.doi.org/10.1016/j.cell.2013.01.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	089YJ	23394947	Green Accepted, Bronze			2022-12-28	WOS:000314945600023
J	Picotti, P; Clement-Ziza, M; Lam, H; Campbell, DS; Schmidt, A; Deutsch, EW; Rost, H; Sun, Z; Rinner, O; Reiter, L; Shen, Q; Michaelson, JJ; Frei, A; Alberti, S; Kusebauch, U; Wollscheid, B; Moritz, RL; Beyer, A; Aebersold, R				Picotti, Paola; Clement-Ziza, Mathieu; Lam, Henry; Campbell, David S.; Schmidt, Alexander; Deutsch, Eric W.; Roest, Hannes; Sun, Zhi; Rinner, Oliver; Reiter, Lukas; Shen, Qin; Michaelson, Jacob J.; Frei, Andreas; Alberti, Simon; Kusebauch, Ulrike; Wollscheid, Bernd; Moritz, Robert L.; Beyer, Andreas; Aebersold, Ruedi			A complete mass-spectrometric map of the yeast proteome applied to quantitative trait analysis	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PEPTIDE IDENTIFICATION; BUDDING YEAST; EXPRESSION; PREDICTION; LIBRARIES; PROTEINS; SEQUENCE; TANDEM; ASSAYS	Experience from different fields of life sciences suggests that accessible, complete reference maps of the components of the system under study are highly beneficial research tools. Examples of such maps include libraries of the spectroscopic properties of molecules, or databases of drug structures in analytical or forensic chemistry. Such maps, and methods to navigate them, constitute reliable assays to probe any sample for the presence and amount of molecules contained in the map. So far, attempts to generate such maps for any proteome have failed to reach complete proteome coverage(1-3). Here we use a strategy based on high-throughput peptide synthesis and mass spectrometry to generate an almost complete reference map (97% of the genome-predicted proteins) of the Saccharomyces cerevisiae proteome. We generated two versions of this mass-spectrometric map, one supporting discovery-driven (shotgun)(3,4) and the other supporting hypothesis-driven (targeted)(5,6) proteomic measurements. Together, the two versions of the map constitute a complete set of proteomic assays to support most studies performed with contemporary proteomic technologies. To show the utility of the maps, we applied them to a protein quantitative trait locus (QTL) analysis(7), which requires precise measurement of the same set of peptides over a large number of samples. Protein measurements over 78 S. cerevisiae strains revealed a complex relationship between independent genetic loci, influencing the levels of related proteins. Our results suggest that selective pressure favours the acquisition of sets of polymorphisms that adapt protein levels but also maintain the stoichiometry of functionally related pathway members.	[Picotti, Paola; Roest, Hannes; Rinner, Oliver; Reiter, Lukas; Shen, Qin; Frei, Andreas; Wollscheid, Bernd; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Picotti, Paola] ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland; [Clement-Ziza, Mathieu; Michaelson, Jacob J.; Beyer, Andreas] Tech Univ Dresden, Ctr Biotechnol, D-01069 Dresden, Germany; [Lam, Henry] Hong Kong Univ Sci & Technol, Dept Chem & Biomol Engn, Hong Kong, Hong Kong, Peoples R China; [Lam, Henry] Hong Kong Univ Sci & Technol, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Campbell, David S.; Deutsch, Eric W.; Sun, Zhi; Kusebauch, Ulrike; Moritz, Robert L.] Inst Syst Biol, Seattle, WA 98103 USA; [Schmidt, Alexander] Univ Basel, Prote Core Facil Biozentrum, CH-4056 Basel, Switzerland; [Rinner, Oliver; Reiter, Lukas] Biognosys AG, CH-8093 Zurich, Switzerland; [Shen, Qin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [Alberti, Simon] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technische Universitat Dresden; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Institute for Systems Biology (ISB); University of Basel; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; University of Zurich	Aebersold, R (corresponding author), ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland.	paola.picotti@bc.biol.ethz.ch; andreas.beyer@biotec.tu-dresden.de; aebersold@imsb.biol.ethz.ch	Moritz, Robert L/B-9222-2011; Röst, Hannes/L-2056-2019; Clément-Ziza, Mathieu/J-4146-2012; Deutsch, Eric/AAF-5912-2020; Wollscheid, Bernd/E-8909-2010; Alberti, Simon/ABB-8277-2021; Röst, Hannes L/E-9564-2013; Lam, Henry/D-8629-2011; Beyer, Andreas/A-3352-2009; Beyer, Andreas/AAQ-5519-2020; Alberti, Simon/B-2822-2017	Röst, Hannes/0000-0003-0990-7488; Clément-Ziza, Mathieu/0000-0003-2763-249X; Wollscheid, Bernd/0000-0002-3923-1610; Röst, Hannes L/0000-0003-0990-7488; Lam, Henry/0000-0001-7928-0364; Beyer, Andreas/0000-0002-3891-2123; Beyer, Andreas/0000-0002-3891-2123; Michaelson, Jacob/0000-0001-9713-0992; Alberti, Simon/0000-0003-4017-6505; Deutsch, Eric/0000-0001-8732-0928	ETH Zurich; Swiss National Science Foundation [3100A0-107679]; National Heart, Lung and Blood Institute, National Institutes of Health [N01-HV-28179]; National Science Foundation MRI [0923536]; Luxembourg Centre for Systems Biomedicine; University of Luxembourg; SystemsX.ch; Swiss initiative for systems biology; Foerderungsprofessur grant from the Swiss National Science Foundation [PP00P3_133670]; European Union Seventh Framework Program Reintegration grant [FP7-PEOPLE-2010-RG-277147]; Promedica Stiftung [2-70669-11]; University Grant Council of the Hong Kong Special Administrative Region Government, China [HKUST DAG08/09.EG02]; Klaus Tschira Foundation; European Union FP7 HEALTH grant [HEALTH-F4-2008-223539]; European Research Council [ERC-2008-AdG 233226]; SystemsX.ch, the Swiss Initiative for Systems Biolod; Div Of Biological Infrastructure [0923536] Funding Source: National Science Foundation; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation MRI(National Science Foundation (NSF)); Luxembourg Centre for Systems Biomedicine; University of Luxembourg; SystemsX.ch; Swiss initiative for systems biology; Foerderungsprofessur grant from the Swiss National Science Foundation; European Union Seventh Framework Program Reintegration grant; Promedica Stiftung; University Grant Council of the Hong Kong Special Administrative Region Government, China; Klaus Tschira Foundation; European Union FP7 HEALTH grant; European Research Council(European Research Council (ERC)European Commission); SystemsX.ch, the Swiss Initiative for Systems Biolod; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded in part by ETH Zurich, the Swiss National Science Foundation (3100A0-107679), the National Heart, Lung and Blood Institute, National Institutes of Health (N01-HV-28179), the National Science Foundation MRI (grant 0923536); the Luxembourg Centre for Systems Biomedicine and the University of Luxembourg, and by SystemsX.ch, the Swiss initiative for systems biology. PP. is supported by a Foerderungsprofessur grant from the Swiss National Science Foundation (PP00P3_133670), by a European Union Seventh Framework Program Reintegration grant (FP7-PEOPLE-2010-RG-277147) and by a Promedica Stiftung (2-70669-11), H. L is supported by the University Grant Council of the Hong Kong Special Administrative Region Government, China (HKUST DAG08/09.EG02). A.B. is supported by the Klaus Tschira Foundation and by a European Union FP7 HEALTH grant (HEALTH-F4-2008-223539). R.A. is supported by the European Research Council (ERC-2008-AdG 233226) and by SystemsX.ch, the Swiss Initiative for Systems Biolod.	Ackermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040916; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Ahrens CH, 2010, NAT REV MOL CELL BIO, V11, P789, DOI 10.1038/nrm2973; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Colon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016099; Craig R, 2006, J PROTEOME RES, V5, P1843, DOI 10.1021/pr0602085; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; de Smidt O, 2012, FEMS YEAST RES, V12, P33, DOI 10.1111/j.1567-1364.2011.00760.x; Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56; Deutsch EW, 2010, METHODS MOL BIOL, V604, P285, DOI 10.1007/978-1-60761-444-9_19; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Fraser HB, 2010, P NATL ACAD SCI USA, V107, P2977, DOI 10.1073/pnas.0912245107; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Krokhin OV, 2006, ANAL CHEM, V78, P7785, DOI 10.1021/ac060777w; Lam H, 2008, NAT METHODS, V5, P873, DOI 10.1038/NMETH.1254; Lam H, 2010, METHODS MOL BIOL, V604, P95, DOI 10.1007/978-1-60761-444-9_7; Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Michaelson JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-502; Picotti P, 2008, NAT METHODS, V5, P913, DOI 10.1038/nmeth1108-913; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]; Rost H, 2012, MOL CELL PROTEOMICS, V11, P540, DOI 10.1074/mcp.M111.013045; Taussig M. J., 2007, NATURE METHODS, V4, p[13, 187]; YOUNG ET, 1985, MOL CELL BIOL, V5, P3024, DOI 10.1128/MCB.5.11.3024; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	30	212	218	5	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					266	270		10.1038/nature11835	http://dx.doi.org/10.1038/nature11835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23334424	Green Accepted			2022-12-28	WOS:000315137700046
J	Pirkkalainen, JM; Cho, SU; Li, J; Paraoanu, GS; Hakonen, PJ; Sillanpaa, MA				Pirkkalainen, J. -M.; Cho, S. U.; Li, Jian; Paraoanu, G. S.; Hakonen, P. J.; Sillanpaa, M. A.			Hybrid circuit cavity quantum electrodynamics with a micromechanical resonator	NATURE			English	Article							GROUND-STATE; SUPERCONDUCTING QUBIT; FLUX QUBIT; ENTANGLEMENT; OSCILLATOR; DYNAMICS; MOTION	Hybrid quantum systems with inherently distinct degrees of freedom have a key role in many physical phenomena. Well-known examples include cavity quantum electrodynamics(1), trapped ions(2), and electrons and phonons in the solid state. In those systems, strong coupling makes the constituents lose their individual character and form dressed states, which represent a collective form of dynamics. As well as having fundamental importance, hybrid systems also have practical applications, notably in the emerging field of quantum information control. A promising approach is to combine long-lived atomic states(2,3) with the accessible electrical degrees of freedom in superconducting cavities and quantum bits(4,5) (qubits). Here we integrate circuit cavity quantum electrodynamics(6,7) with phonons. Apart from coupling to a microwave cavity, our superconducting transmon qubit(8), consisting of tunnel junctions and a capacitor, interacts with a phonon mode in a micromechanical resonator, and thus acts like an atom coupled to two different cavities. We measure the phonon Stark shift, as well as the splitting of the qubit spectral line into motional sidebands, which feature transitions between the dressed electromechanical states. In the time domain, we observe coherent conversion of qubit excitation to phonons as sideband Rabi oscillations. This is a model system with potential for a quantum interface, which may allow for storage of quantum information in long-lived phonon states, coupling to optical photons or for investigations of strongly coupled quantum systems near the classical limit.	[Pirkkalainen, J. -M.; Cho, S. U.; Li, Jian; Paraoanu, G. S.; Hakonen, P. J.; Sillanpaa, M. A.] Aalto Univ, Low Temp Lab, FI-00076 Aalto, Finland	Aalto University	Pirkkalainen, JM (corresponding author), Aalto Univ, Low Temp Lab, POB 15100, FI-00076 Aalto, Finland.	juha.pirkkalainen@aalto.fi	Li, Jian/J-8081-2014; Sillanpaa, Mika/A-3554-2013; Hakonen, Pertti J/E-7688-2012; Pirkkalainen, Juha-Matti/J-1792-2012; Paraoanu, Gheorghe Sorin/F-9142-2013	Hakonen, Pertti J/0000-0002-8247-4108; Pirkkalainen, Juha-Matti/0000-0002-8631-7767; Paraoanu, Gheorghe Sorin/0000-0003-0057-7275; Li, Jian/0000-0001-5335-9832	Academy of Finland under CoE in Low Temperature Quantum Phenomena and Devices [141559]; European Research Council [240387-NEMSQED]; Vaisala Foundation; Emil Aaltonen Foundation; Kaute Foundation; NGSMP;  [EU-FP7-NMP-246026]	Academy of Finland under CoE in Low Temperature Quantum Phenomena and Devices; European Research Council(European Research Council (ERC)European Commission); Vaisala Foundation; Emil Aaltonen Foundation; Kaute Foundation; NGSMP; 	We thank M. Silveri, E. Thuneberg and T. Heikkila for discussions. This work was supported by the Academy of Finland under CoE in Low Temperature Quantum Phenomena and Devices and project 141559, and by the European Research Council (grant number 240387-NEMSQED) and EU-FP7-NMP-246026. The work benefited from the facilities at the Micronova Nanofabrication Center. J.-M.P. acknowledges support from the Vaisala Foundation, the Emil Aaltonen Foundation and the Kaute Foundation, and J.L. acknowledges support from NGSMP.	Andre A, 2006, NAT PHYS, V2, P636, DOI 10.1038/nphys386; Armour AD, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148301; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Chiorescu I, 2004, NATURE, V431, P159, DOI 10.1038/nature02831; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Dewes A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.140503; Etaki S, 2008, NAT PHYS, V4, P785, DOI 10.1038/nphys1057; Fedorov A, 2012, NATURE, V481, P170, DOI 10.1038/nature10713; Goryachev M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729292; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Kubo Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.220501; LaHaye MD, 2009, NATURE, V459, P960, DOI 10.1038/nature08093; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Li TF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2838749; Mariantoni M, 2011, SCIENCE, V334, P61, DOI 10.1126/science.1208517; Monroe C, 1996, SCIENCE, V272, P1131, DOI 10.1126/science.272.5265.1131; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Niemczyk T, 2010, NAT PHYS, V6, P772, DOI 10.1038/NPHYS1730; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Reed MD, 2012, NATURE, V482, P382, DOI 10.1038/nature10786; Roos C, 1999, PHYS REV LETT, V83, P4713, DOI 10.1103/PhysRevLett.83.4713; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Tian L, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.195411; Tuorila J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.257003; Ursin R, 2007, NAT PHYS, V3, P481, DOI 10.1038/nphys629; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Zhu XB, 2011, NATURE, V478, P221, DOI 10.1038/nature10462	30	198	199	4	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					211	215		10.1038/nature11821	http://dx.doi.org/10.1038/nature11821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23407536	Green Submitted			2022-12-28	WOS:000315137700034
J	Rao, S; Chun, C; Fan, JQ; Kofron, JM; Yang, MB; Hegde, RS; Ferrara, N; Copenhagen, DR; Lang, RA				Rao, Sujata; Chun, Christina; Fan, Jieqing; Kofron, J. Matthew; Yang, Michael B.; Hegde, Rashmi S.; Ferrara, Napoleone; Copenhagen, David R.; Lang, Richard A.			A direct and melanopsin-dependent fetal light response regulates mouse eye development	NATURE			English	Article							VEGF; APOPTOSIS; VESSEL; OPSIN; CELLS	Vascular patterning is critical for organ function. In the eye, there is simultaneous regression of embryonic hyaloid vasculature(1) (important to clear the optical path) and formation of the retinal vasculature (important for the high metabolic demands of retinal neurons). These events occur postnatally in the mouse. Here we have identified a light-response pathway that regulates both processes. We show that when mice are mutated in the gene (Opn4) for the atypical opsin melanopsin(3-5), or are dark-reared from late gestation, the hyaloid vessels are persistent at 8 days post-partum and the retinal vasculature overgrows. We provide evidence that these vascular anomalies are explained by a light-response pathway that suppresses retinal neuron number, limits hypoxia and, as a consequence, holds local expression of vascular endothelial growth factor (VEGFA) in check. We also show that the light response for this pathway occurs in late gestation at about embryonic day 16 and requires the photopigment in the fetus and not the mother. Measurements show that visceral cavity photon flux is probably sufficient to activate melanopsin-expressing retinal ganglion cells in the mouse fetus. These data thus show that light the stimulus for function of the mature eye is also critical in preparing the eye for vision by regulating retinal neuron number and initiating a series of events that ultimately pattern the ocular blood vessels.	[Rao, Sujata; Fan, Jieqing; Yang, Michael B.; Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Ophthalmol, Abrahamson Pediat Eye Inst, Visual Syst Grp, Cincinnati, OH 45229 USA; [Chun, Christina; Copenhagen, David R.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94158 USA; [Chun, Christina; Copenhagen, David R.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Kofron, J. Matthew; Hegde, Rashmi S.; Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Yang, Michael B.; Lang, Richard A.] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA	Cincinnati Children's Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Roche Holding; Genentech	Lang, RA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Ophthalmol, Abrahamson Pediat Eye Inst, Visual Syst Grp, Cincinnati, OH 45229 USA.	cope@phy.ucsf.edu; richard.lang@cchmc.org		Lang, Richard/0000-0002-5212-254X; Kofron, Matthew/0000-0001-6427-4148	NIH [AR-47363]; Abrahamson Pediatric Eye Institute of CCHMC; That Man May See at UCSF; Research to Prevent Blindness; March of Dimes; NATIONAL EYE INSTITUTE [R01EY021636, R01EY023179, R01EY022917, R01EY014648, R01EY001869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abrahamson Pediatric Eye Institute of CCHMC; That Man May See at UCSF; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); March of Dimes(March of Dimes); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Bredl, P. Speeg and M. Sarangdhar for technical assistance, A. Delwig and N. Brown for advice. We acknowledge the assistance of the Research Flow Cytometry Core in the Division of Rheumatology at CCHMC, supported in part by NIH AR-47363. This work was supported by the NIH (R.A.L, D.R.C., J.M.K and R.S.H.) with additional funding from the Abrahamson Pediatric Eye Institute of CCHMC, That Man May See at UCSF, Research to Prevent Blindness (D.R.C.) and March of Dimes (D.R.C.).	ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Edwards MM, 2012, EXP EYE RES, V96, P147, DOI 10.1016/j.exer.2011.12.005; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Kurihara T, 2010, DEVELOPMENT, V137, P1563, DOI 10.1242/dev.049015; Lange C, 2011, NEUROBIOL DIS, V41, P119, DOI 10.1016/j.nbd.2010.08.028; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Meeson AP, 1999, DEVELOPMENT, V126, P1407; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Tarttelin EE, 2003, EXP EYE RES, V76, P393, DOI 10.1016/S0014-4835(02)00300-7; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Wong KY, 2012, J NEUROSCI, V32, P11478, DOI 10.1523/JNEUROSCI.1423-12.2012	25	123	127	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					243	246		10.1038/nature11823	http://dx.doi.org/10.1038/nature11823			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23334418	Green Accepted			2022-12-28	WOS:000315137700041
J	Wise, C				Wise, Chris			Build with an eye on nature	NATURE			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Wise, C (corresponding author), UCL, London WC1E 6BT, England.	chris.w@expedition.uk.com							0	7	7	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2013	494	7436					172	173		10.1038/494172a	http://dx.doi.org/10.1038/494172a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092QS	23407524	Bronze			2022-12-28	WOS:000315137700016
J	Krumholz, HM; Lin, ZQ; Keenan, PS; Chen, J; Ross, JS; Drye, EE; Bernheim, SM; Wang, Y; Bradley, EH; Han, LF; Normand, SLT				Krumholz, Harlan M.; Lin, Zhenqiu; Keenan, Patricia S.; Chen, Jersey; Ross, Joseph S.; Drye, Elizabeth E.; Bernheim, Susannah M.; Wang, Yun; Bradley, Elizabeth H.; Han, Lein F.; Normand, Sharon-Lise T.			Relationship Between Hospital Readmission and Mortality Rates for Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, or Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE; CARE; QUALITY; SYSTEM; URBAN	Importance The Centers for Medicare & Medicaid Services publicly reports hospital 30-day, all-cause, risk-standardized mortality rates (RSMRs) and 30-day, all-cause, risk-standardized readmission rates (RSRRs) for acute myocardial infarction, heart failure, and pneumonia. The evaluation of hospital performance as measured by RSMRs and RSRRs has not been well characterized. Objective To determine the relationship between hospital RSMRs and RSRRs overall and within subgroups defined by hospital characteristics. Design, Setting, and Participants We studied Medicare fee-for-service beneficiaries discharged with acute myocardial infarction, heart failure, or pneumonia between July 1, 2005, and June 30, 2008 (4506 hospitals for acute myocardial infarction, 4767 hospitals for heart failure, and 4811 hospitals for pneumonia). We quantified the correlation between hospital RSMRs and RSRRs using weighted linear correlation; evaluated correlations in groups defined by hospital characteristics; and determined the proportion of hospitals with better and worse performance on both measures. Main Outcome Measures Hospital 30-day RSMRs and RSRRs. Results Mean RSMRs and RSRRs, respectively, were 16.60% and 19.94% for acute myocardial infarction, 11.17% and 24.56% for heart failure, and 11.64% and 18.22% for pneumonia. The correlations between RSMRs and RSRRs were 0.03 (95% CI, -0.002 to 0.06) for acute myocardial infarction, -0.17 (95% CI, -0.20 to -0.14) for heart failure, and 0.002 (95% CI, -0.03 to 0.03) for pneumonia. The results were similar for subgroups defined by hospital characteristics. Although there was a significant negative linear relationship between RSMRs and RSRRs for heart failure, the shared variance between them was only 2.9% (r(2)=0.029), with the correlation most prominent for hospitals with RSMR <11%. Conclusion and Relevance Risk-standardized mortality rates and readmission rates were not associated for patients admitted with an acute myocardial infarction or pneumonia and were only weakly associated, within a certain range, for patients admitted with heart failure. JAMA. 2013;309(6):587-593 www.jama.com	[Krumholz, Harlan M.; Drye, Elizabeth E.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Ross, Joseph S.; Bernheim, Susannah M.] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06510 USA; [Krumholz, Harlan M.; Lin, Zhenqiu; Ross, Joseph S.; Drye, Elizabeth E.; Bernheim, Susannah M.; Wang, Yun] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Krumholz, Harlan M.; Keenan, Patricia S.; Bradley, Elizabeth H.] Yale Univ, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Wang, Yun; Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Han, Lein F.] Ctr Medicare Serv, Baltimore, MD USA; [Han, Lein F.] Ctr Medicaid Serv, Baltimore, MD USA; [Chen, Jersey] Yale Univ, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320; Normand, Sharon-Lise/0000-0001-7027-4769	National Heart, Lung, and Blood Institute [U01 HL105270-03]; Agency for Healthcare Research and Quality [K08 HS018781-03]; National Institute on Aging [K08 AG032886-05]; American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; CMS, an agency of the US Department of Health and Human Services [HHSM-500-2008-0025I/HHSM-500-T0001, 000007]; Medtronic through Yale University; CMS; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018781] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B. Beeson Career Development Award Program; CMS, an agency of the US Department of Health and Human Services; Medtronic through Yale University; CMS; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Krumholz and Ross report that they are recipients of a research grant from Medtronic through Yale University. Dr Krumholz chairs a cardiac scientific advisory board for United-Health. Dr Ross is a member of a scientific advisory board for FAIR Health. Dr Normand reports being a member of the Board of Directors of Frontier Science & Technology Research Foundation. Drs Drye, Krumholz, Lin, Bernheim, Wang, and Normand report that they receive contract funding from CMS to develop and maintain quality measures. No other disclosures were reported.; Dr Krumholz is supported by grant U01 HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. Dr Chen is supported by Career Development Award K08 HS018781-03 from the Agency for Healthcare Research and Quality. Dr Ross is supported by grant K08 AG032886-05 from the National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program. The analyses on which this publication is based were performed under contract HHSM-500-2008-0025I/HHSM-500-T0001, Modification No. 000007, entitled "Measure Instrument Development and Support," funded by CMS, an agency of the US Department of Health and Human Services.	[Anonymous], FED REG; Ash AS, STAT ISSUES ASSESSIN; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Centers for Medicare and Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P51476; Desai MM, 2009, 2009 MEASURES MAINTE; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Hadley J, 2004, HEALTH SERV RES, V39, P1527, DOI 10.1111/j.1475-6773.2004.00302.x; Hart LG, 2005, AM J PUBLIC HEALTH, V95, P1149, DOI 10.2105/AJPH.2004.042432; Heidenreich PA, 2010, J AM COLL CARDIOL, V56, P362, DOI 10.1016/j.jacc.2010.02.053; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; Krumholz HM, 2000, AM HEART J, V139, P72, DOI 10.1016/S0002-8703(00)90311-9; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Morrill R, 1999, URBAN GEOGR, V20, P727, DOI 10.2747/0272-3638.20.8.727; Normand SLT, 2002, STAT MED, V21, P331, DOI 10.1002/sim.1020; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Ross JS, 2007, HEALTH AFFAIR, V26, P238, DOI 10.1377/hlthaff.26.1.238; Serrie J, 2012, MORE 2200 HOSP FACE	23	267	269	2	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					587	593		10.1001/jama.2013.333	http://dx.doi.org/10.1001/jama.2013.333			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087PH	23403683	Green Accepted			2022-12-28	WOS:000314773700031
J	Large, M				Large, Matthew			MAUDSLEY DEBATE Does the emphasis on risk in psychiatry serve the interests of patients or the public? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUICIDE		Prince Wales Hosp, Mental Hlth Serv, Sydney, NSW 2031, Australia		Large, M (corresponding author), Prince Wales Hosp, Mental Hlth Serv, Sydney, NSW 2031, Australia.	mmbl@bigpond.com						Large M, 2012, PSYCHIATRIST, V23, P413; Large M, 2012, PSYCHOL MED, V42, P2011, DOI 10.1017/S0033291712001377; Large MM, 2011, HARVARD REV PSYCHIAT, V19, P25, DOI 10.3109/10673229.2011.549770; Madsen T, 2012, J CLIN PSYCHIAT, V73, P1034, DOI 10.4088/JCP.12lr07795a; POKORNY AD, 1983, ARCH GEN PSYCHIAT, V40, P249; Wootton L, 2008, SCHIZOPHR RES, V101, P176, DOI 10.1016/j.schres.2007.12.490	6	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 12	2013	346								f857	10.1136/bmj.f857	http://dx.doi.org/10.1136/bmj.f857			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	091ZG	23404162				2022-12-28	WOS:000315087700005
J	Coutts, A; McKee, M; Stuckler, D				Coutts, Adam; McKee, Martin; Stuckler, David			The emerging Syrian health crisis	LANCET			English	Editorial Material									[Coutts, Adam; Stuckler, David] Univ Cambridge, Dept Sociol, Cambridge CB3 3RQ, England; [McKee, Martin] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England	University of Cambridge; University of London; London School of Hygiene & Tropical Medicine	Coutts, A (corresponding author), Univ Cambridge, Dept Sociol, Cambridge CB3 3RQ, England.	apc31@cam.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Stuckler, David/0000-0002-1288-8401				[Anonymous], 2012, HURRIYET DAILY  1208; Center for Strategic and International Studies, 2008, INT 21 CENT DEV SEC; Doctors Without Borders, 2013, SYR WAR HLTH WORK SE; International Rescue Committee, 2013, SYR REG CRIS IRC COM; Kuwaiti news agency, 2013, FRANC URG MOR SUPP S; Migration Information Source, 2013, HOSP DOCT ATT SYR Q; Office for the Coordination of Humanitarian Affairs, 2012, HUM ASS RESP PLAN SY; Office for the Coordination of Humanitarian Affairs, 2013, SYR AR REP CIV UNR 2; Office of the Special Adviser on the Prevention of Genocide, RESP PROT; Organization for Economic Cooperation and Development, 2012, DEV AID DEV COUNTR F; Price M, 2013, REPUBLIC; Tropical Medical Bureau, 2012, LEISHM TUB BOTH INCR; United Nations, 2012, 1 SYR RESP PLAN; United Nations, 2012, SYR REG RESP PLAN JA	14	17	17	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2013	381	9865					E6	E7		10.1016/S0140-6736(13)60053-7	http://dx.doi.org/10.1016/S0140-6736(13)60053-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088CH	23375240				2022-12-28	WOS:000314810900001
J	Gillam, S; Steel, N				Gillam, Stephen; Steel, Nicholas			The Quality and Outcomes Framework-where next?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PAY-FOR-PERFORMANCE; PRIMARY-CARE; FINANCIAL INCENTIVES; HEALTH-CARE; PAYMENTS		[Gillam, Stephen] Lea Vale Med Grp, Luton, Beds, England; [Gillam, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge CB2 2SR, England; [Steel, Nicholas] Univ E Anglia, Norwich Med Sch, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England	University of Cambridge; University of East Anglia	Gillam, S (corresponding author), Lea Vale Med Grp, Luton, Beds, England.	sjg67@medschl.cam.ac.uk	Steel, Nicholas/K-1592-2014	Steel, Nicholas/0000-0003-1528-140X				Ariely D, 2009, REV ECON STUD, V76, P451, DOI 10.1111/j.1467-937X.2009.00534.x; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bunker JP, 2001, INT J EPIDEMIOL, V30, P1260, DOI 10.1093/ije/30.6.1260; Campbell S, 2011, QUALITY OUTCOMES FRA, P137; Campbell SA, 2008, ANN FAM MED, V6, P228, DOI 10.1370/afm.844; Dixon-Woods M, 2012, BMJ QUAL SAF, V21, P876, DOI 10.1136/bmjqs-2011-000760; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Fleetcroft Robert, 2010, Br J Gen Pract, V60, pe345, DOI 10.3399/bjgp10X515359; Fleetcroft R, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-94; Fleetcroft R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-131; Gerstein H, 2011, NEW ENGL J MED, V364, P831; Gillam S, 2011, QUALITY OUTCOMES FRA, P156; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Glasziou PP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5047; Greene SE, 2009, AM J MED QUAL, V24, P140, DOI 10.1177/1062860608326517; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; Hakin B, 2012, COMMUNICATION; Heath I, 2011, DIVIDED WE FAIL HARV; Hippisley-Cox J, 2007, TIME SERIES ANAL 200; MacBride-Stewart SP, 2008, FAM PRACT, V25, P27, DOI 10.1093/fampra/cmm074; Maisey S, 2008, J HEALTH SERV RES PO, V13, P133, DOI 10.1258/jhsrp.2008.007118; Mercer SW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4152; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; NHS Employers and the General Practitioners Committee BMA, 2012, QUAL OUTC FRAM 2012; Primary Care Quality and Outcomes Framework Indicator Advisory Committee, COMM M HELD 8 JUN 20; Scott A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD008451.PUB2; Scullard P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X561177; Shohet C, 2007, SEIZURE-EUR J EPILEP, V16, P351, DOI 10.1016/j.seizure.2007.02.005; Steel N, 2007, BRIT J GEN PRACT, V57, P449; Sutcliffe Daniel, 2012, Qual Prim Care, V20, P47; Sutherland K., 2007, FINANCIAL INCENTIVES; Walker S, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X501859; Woolhandler S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5015	35	23	23	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2013	346								f659	10.1136/bmj.f659	http://dx.doi.org/10.1136/bmj.f659			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AV	23393112				2022-12-28	WOS:000314807100010
J	Marx, V				Marx, Vivien			TRACKING METASTASIS AND TRICKING CANCER	NATURE			English	Editorial Material																		Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217	6	54	72	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					131	+		10.1038/494131a	http://dx.doi.org/10.1038/494131a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23389545	Bronze			2022-12-28	WOS:000314741200051
J	Gulati, R; Gore, JL; Etzioni, R				Gulati, Roman; Gore, John L.; Etzioni, Ruth			Comparative Effectiveness of Alternative Prostate-Specific Antigen-Based Prostate Cancer Screening Strategies Model Estimates of Potential Benefits and Harms	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES TASK-FORCE; QUALITY-OF-LIFE; RANDOMIZED PROSTATE; FOLLOW-UP; MORTALITY; TRIAL; POPULATION; US; VIEWPOINT; BIOPSIES	Background: The U.S. Preventive Services Task Force recently concluded that the harms of existing prostate-specific antigen (PSA) screening strategies outweigh the benefits. Objective: To evaluate comparative effectiveness of alternative PSA screening strategies. Design: Microsimulation model of prostate cancer incidence and mortality quantifying harms and lives saved for alternative PSA screening strategies. Data Sources: National and trial data on PSA growth, screening and biopsy patterns, incidence, treatment distributions, treatment efficacy, and mortality. Target Population: A contemporary cohort of U.S. men. Time Horizon: Lifetime. Perspective: Societal. Intervention: 35 screening strategies that vary by start and stop ages, screening intervals, and thresholds for biopsy referral. Outcome Measures: PSA tests, false-positive test results, cancer detected, overdiagnoses, prostate cancer deaths, lives saved, and months of life saved. Results of Base-Case Analysis: Without screening, the risk for prostate cancer death is 2.86%. A reference strategy that screens men aged 50 to 74 years annually with a PSA threshold for biopsy referral of 4 mu g/L reduces the risk for prostate cancer death to 2.15%, with risk for overdiagnosis of 3.3%. A strategy that uses higher PSA thresholds for biopsy referral in older men achieves a similar risk for prostate cancer death (2.23%) but reduces the risk for overdiagnosis to 2.3%. A strategy that screens biennially with longer screening intervals for men with low PSA levels achieves similar risks for prostate cancer death (2.27%) and overdiagnosis (2.4%), but reduces total tests by 59% and false-positive results by 50%. Results of Sensitivity Analysis: Varying incidence inputs or reducing the survival improvement due to screening did not change conclusions. Limitation: The model is a simplification of the natural history of prostate cancer, and improvement in survival due to screening is uncertain. Conclusion: Compared with standard screening, PSA screening strategies that use higher thresholds for biopsy referral for older men and that screen men with low PSA levels less frequently can reduce harms while preserving lives. Primary Funding Source: National Cancer Institute and Centers for Disease Control and Prevention. Ann Intern Med. 2013;158:145-153.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Etzioni, R (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave N,M2-B230,POB 19024, Seattle, WA 98109 USA.	retzioni@fhcrc.org	Gulati, Roman/AAE-4298-2019	Gulati, Roman/0000-0002-7592-6567; Gore, John/0000-0002-2847-5062	National Cancer Institute [R01 CA131874, U01 CA88160]; National Cancer Institute and the Centers for Disease Control and Prevention [U01 CA157224]; NATIONAL CANCER INSTITUTE [R01CA131874, U01CA088160, U01CA157224] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute and the Centers for Disease Control and Prevention; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By awards R01 CA131874 and U01 CA88160 (National Cancer Institute) and U01 CA157224 (National Cancer Institute and the Centers for Disease Control and Prevention).	Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Babaian RJ, 2000, J UROLOGY, V163, P152, DOI 10.1016/S0022-5347(05)67993-1; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Carter HB, 1997, JAMA-J AM MED ASSOC, V277, P1456, DOI 10.1001/jama.277.18.1456; Catalona WJ, 2006, ANN INTERN MED, V144, P441, DOI 10.7326/0003-4819-144-6-200603210-00012; Ciatto S, 2003, BJU INT, V92, P97, DOI 10.1111/j.1464-410X.2003.04407.x; Cooperberg MR, 2010, CANCER-AM CANCER SOC, V116, P5226, DOI 10.1002/cncr.25456; Crawford ED, 2011, J CLIN ONCOL, V29, P355, DOI 10.1200/JCO.2010.30.5979; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Eichler K, 2006, J UROLOGY, V175, P1605, DOI 10.1016/S0022-5347(05)00957-2; Etzioni R, 1999, J UROLOGY, V162, P741, DOI 10.1097/00005392-199909010-00032; Etzioni R, 2009, 2 GEN M INT MICR ASS; Etzioni R, 2012, CANCER; Glied S, 2010, ANNU REV PUBL HEALTH, V31, P439, DOI 10.1146/annurev.publhealth.012809.103542; Gore JL, 2001, J UROLOGY, V165, P1554, DOI 10.1016/S0022-5347(05)66347-1; Gulati R, 2012, CANCER CAUSE CONTROL, V23, P827, DOI 10.1007/s10552-012-9951-8; Gulati R, 2011, J CLIN EPIDEMIOL, V64, P1412, DOI 10.1016/j.jclinepi.2011.06.011; Gulati R, 2010, BIOSTATISTICS, V11, P707, DOI 10.1093/biostatistics/kxq036; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Hoffman RM, 2006, ANN INTERN MED, V144, P438, DOI 10.7326/0003-4819-144-6-200603210-00011; Kawachi MH, 2010, J NATL COMPR CANC NE, V8, P240, DOI 10.6004/jnccn.2010.0016; Loeb S, 2012, NAT REV UROL, V9, P183, DOI 10.1038/nrurol.2012.34; Loeb S, 2011, J CLIN ONCOL, V29, P464, DOI 10.1200/JCO.2010.30.6373; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mariotto AB, 2007, CANCER-AM CANCER SOC, V109, P1877, DOI 10.1002/cncr.22607; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; National Cancer Institute, 2012, DEVCAN PROB DEV DYIN; National Center for Health Statistics, VIT STAT US A, VII; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; Pinsky PF, 2005, J UROLOGY, V173, P746, DOI 10.1097/01.ju.0000152697.25708.71; Presti JC, 2000, J UROLOGY, V163, P163, DOI 10.1016/S0022-5347(05)67995-5; Ross KS, 2000, JAMA-J AM MED ASSOC, V284, P1399, DOI 10.1001/jama.284.11.1399; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sox HC, 2012, NEW ENGL J MED, V367, P669, DOI 10.1056/NEJMe1207165; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Tsodikov A, 2006, STAT MED, V25, P2846, DOI 10.1002/sim.2257; Vickers AJ, 2009, NAT REV UROL, V6, P301, DOI 10.1038/nrurol.2009.95; Weinstein M C, 2001, Value Health, V4, P348, DOI 10.1046/j.1524-4733.2001.45061.x; Welch HG, 2011, JAMA-J AM MED ASSOC, V306, P2649, DOI 10.1001/jama.2011.1898; Wever EM, 2011, MED DECIS MAKING, V31, P550, DOI 10.1177/0272989X10396717; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Wu GHM, 2012, EUR UROL, V61, P1011, DOI 10.1016/j.eururo.2012.01.008; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	45	118	121	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					145	+		10.7326/0003-4819-158-3-201302050-00003	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00003			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23381039	Green Accepted			2022-12-28	WOS:000314757900001
J	Scally, G				Scally, Gabriel			Chief medical officers: the need for public health at the heart of government	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ W England, WHO Collaborating Ctr Healthy Urban Environm, Bristol BS16 1QY, Avon, England	University of West England	Scally, G (corresponding author), Univ W England, WHO Collaborating Ctr Healthy Urban Environm, Bristol BS16 1QY, Avon, England.	gabriel.scally@btinternet.com						BRECHT B, 1980, LIFE GALILEO; Commission on Social Determinants of Health, 2008, CSDH FIN REP CLOS GA; Department of Health, 2010, FAIR SOC HLTH LIV MA; Institute for Government, 2011, RED SMOK RAT POL REU; Jakubowski E, 2010, CLIN MED, V10, P560, DOI 10.7861/clinmedicine.10-6-560; Lambert RJ, 1963, J SIMON 1816 1904 EN; Richter P, 1994, LA TIMES        1210; Sheard S., 2005, NATIONS DOCTOR ROLE	8	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 5	2013	346								f688	10.1136/bmj.f688	http://dx.doi.org/10.1136/bmj.f688			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088AR	23386406				2022-12-28	WOS:000314806700008
J	Simonton, DK				Simonton, Dean Keith			After Einstein: Scientific genius is extinct	NATURE			English	Editorial Material									Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis	Simonton, DK (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	dksimonton@ucdavis.edu						Kuhn T.S., 1962, STRUCTURE SCI REVOLU, V1st ed; Simonton D.K., 2004, CREATIVITY SCI CHANC; Simonton DK., 1988, SCI GENIUS PSYCHOL S	3	40	42	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					602	602		10.1038/493602a	http://dx.doi.org/10.1038/493602a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	080CU	23364725	Bronze			2022-12-28	WOS:000314219600027
J	Malik, A				Malik, Ankita			More temples than toilets?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mail.ankitamalik@gmail.com						Government of India, HOUS HOUS CENS DAT T; Government of India, AV TYP LATR FAC 2001; Government of India, SELF EMPL SCHEM REH; Government of India Planning Commission, URBAN DEV; Water and Sanitation Program, 2010, EC IMP IN SAN IND; Water and Sanitation Program. Union Ministry of Urban Development, 2010, NAT CIT RAT RANK CIT; World Health Organization, PROGR SAN DRINK WAT, P14	7	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2013	346								f525	10.1136/bmj.f525	http://dx.doi.org/10.1136/bmj.f525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BP	23364063				2022-12-28	WOS:000314511300011
J	McCall, B				McCall, Becky			Profile: The King's College London unit tackling eating disorders	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2013	381	9863					282	282		10.1016/S0140-6736(13)60119-1	http://dx.doi.org/10.1016/S0140-6736(13)60119-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	077IT	23359893				2022-12-28	WOS:000314021800015
J	Hao, N; Budnik, BA; Gunawardena, J; O'Shea, EK				Hao, Nan; Budnik, Bogdan A.; Gunawardena, Jeremy; O'Shea, Erin K.			Tunable Signal Processing Through Modular Control of Transcription Factor Translocation	SCIENCE			English	Article							MAP KINASE PATHWAY; NUCLEAR-LOCALIZATION; PROTEIN-KINASE; GENE-REGULATION; STRESS; DYNAMICS; YEAST; PHOSPHORYLATION; SWITCH; P53	Signaling pathways can induce different dynamics of transcription factor (TF) activation. We explored how TFs process signaling inputs to generate diverse dynamic responses. The budding yeast general stress-responsive TF Msn2 acted as a tunable signal processor that could track, filter, or integrate signals in an input-dependent manner. This tunable signal processing appears to originate from dual regulation of both nuclear import and export by phosphorylation, as mutants with one form of regulation sustained only one signal-processing function. Versatile signal processing by Msn2 is crucial for generating distinct dynamic responses to different natural stresses. Our findings reveal how complex signal-processing functions are integrated into a single molecule and provide a guide for the design of TFs with "programmable" signal-processing functions.	[Hao, Nan; Budnik, Bogdan A.; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Hao, Nan; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hao, Nan; O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Gunawardena, Jeremy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard Medical School	O'Shea, EK (corresponding author), Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu	Budnik, Bogdan/AGG-8824-2022; Budnik, Bogdan/AAH-9987-2019; Hao, Nan/O-3462-2016	Budnik, Bogdan/0000-0003-3622-2003; Hao, Nan/0000-0003-2857-4789	NIH [R01 GM081578]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081578] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Murray, P. Cluzel, S. Ramanathan, B. Stern, and M. Rust for comments on the manuscript and S. Mukherji, X. Zhou, A. S. Hansen, and other members of the O'Shea lab for helpful discussions. J.G. is supported by NIH R01 GM081578. E.K.O. is an Investigator of the Howard Hughes Medical Institute.	ADAMS JA, 1993, J BIOL CHEM, V268, P7747; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chen XC, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-40; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Levy S, 2011, SCIENCE, V334, P1408, DOI 10.1126/science.1207154; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Locke JCW, 2011, SCIENCE, V334, P366, DOI 10.1126/science.1208144; Longo Diane M, 2010, Syst Synth Biol, V4, P15, DOI 10.1007/s11693-009-9044-5; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tudisca V, 2010, EUR J CELL BIOL, V89, P339, DOI 10.1016/j.ejcb.2009.08.005; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319	29	92	94	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					460	464		10.1126/science.1227299	http://dx.doi.org/10.1126/science.1227299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23349292	Green Accepted			2022-12-28	WOS:000313960700047
J	Fishbane, S; Schiller, B; Locatelli, F; Covic, AC; Provenzano, R; Wiecek, A; Levin, NW; Kaplan, M; Macdougall, IC; Francisco, C; Mayo, MR; Polu, KR; Duliege, AM; Besarab, A				Fishbane, Steven; Schiller, Brigitte; Locatelli, Francesco; Covic, Adrian C.; Provenzano, Robert; Wiecek, Andrzej; Levin, Nathan W.; Kaplan, Mark; Macdougall, Iain C.; Francisco, Carol; Mayo, Martha R.; Polu, Krishna R.; Duliege, Anne-Marie; Besarab, Anatole		EMERALD Study Grp	Peginesatide in Patients with Anemia Undergoing Hemodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC KIDNEY-DISEASE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; STAGE RENAL-DISEASE; RED-CELL APLASIA; RECEIVING HEMODIALYSIS; ASSOCIATION; HEMATIDE; EPOETIN; TRIAL; AGENT	Background Peginesatide, a synthetic peptide-based erythropoiesis-stimulating agent (ESA), is a potential therapy for anemia in patients with advanced chronic kidney disease. Methods We conducted two randomized, controlled, open-label studies (EMERALD 1 and EMERALD 2) involving patients undergoing hemodialysis. Cardiovascular safety was evaluated by analysis of an adjudicated composite safety end point - death from any cause, stroke, myocardial infarction, or serious adverse events of congestive heart failure, unstable angina, or arrhythmia - with the use of pooled data from the two EMERALD studies and two studies involving patients not undergoing dialysis. In the EMERALD studies, 1608 patients received peginesatide once monthly or continued to receive epoetin one to three times a week, with the doses adjusted as necessary to maintain a hemoglobin level between 10.0 and 12.0 g per deciliter for 52 weeks or more. The primary efficacy end point was the mean change from the baseline hemoglobin level to the mean level during the evaluation period; noninferiority was established if the lower limit of the two-sided 95% confidence interval was -1.0 g per deciliter or higher in the comparison of peginesatide with epoetin. The aim of evaluating the composite safety end point in the pooled cohort was to exclude a hazard ratio with peginesatide relative to the comparator ESA of more than 1.3. Results In an analysis involving 693 patients from EMERALD 1 and 725 from EMERALD 2, peginesatide was noninferior to epoetin in maintaining hemoglobin levels (mean between-group difference, -0.15 g per deciliter; 95% confidence interval [CI], -0.30 to -0.01 in EMERALD 1; and 0.10 g per deciliter; 95% CI, -0.05 to 0.26 in EMERALD 2). The hazard ratio for the composite safety end point was 1.06 (95% CI, 0.89 to 1.26) with peginesatide relative to the comparator ESA in the four pooled studies (2591 patients) and 0.95 (95% CI, 0.77 to 1.17) in the EMERALD studies. The proportions of patients with adverse and serious adverse events were similar in the treatment groups in the EMERALD studies. The cardiovascular safety of peg-in-es-a-tide was similar to that of the comparator ESA in the pooled cohort. Conclusions Peginesatide, administered monthly, was as effective as epoetin, administered one to three times per week, in maintaining hemoglobin levels in patients undergoing hemodialysis. (Funded by Affymax and Takeda Pharmaceutical; ClinicalTrials.gov numbers, NCT00597753 [EMERALD 1], NCT00597584 [EMERALD 2], NCT00598273 [PEARL 1], and NCT00598442 [PEARL 2].)	[Fishbane, Steven] Hofstra N Shore LIJ Sch Med, Great Neck, NY 11021 USA; [Schiller, Brigitte] Satellite Healthcare, San Jose, CA USA; [Francisco, Carol; Mayo, Martha R.; Polu, Krishna R.; Duliege, Anne-Marie] Affymax, Palo Alto, CA USA; [Locatelli, Francesco] A Manzoni Hosp, Dept Nephrol Dialysis & Renal Transplant, Lecce, Italy; [Covic, Adrian C.] Dr CI Parhon, Spitalul Clin, Iasi, Romania; [Provenzano, Robert] Henry Ford Hosp, St Clair Specialty Phys, Detroit, MI 48202 USA; [Besarab, Anatole] Henry Ford Hosp, Henry Ford Hlth Syst, Detroit, MI 48202 USA; [Besarab, Anatole] Wayne State Univ, Sch Med, Detroit, MI USA; [Wiecek, Andrzej] Med Univ Silesia, Katowice, Poland; [Levin, Nathan W.] Renal Res Inst, New York, NY USA; [Kaplan, Mark] Nephrol Associates, Nashville, TN USA; [Macdougall, Iain C.] Kings Coll Hosp, Renal Unit, London, England	Hofstra University; Northwell Health; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Wayne State University; Medical University Silesia; Renal Research Institute; King's College Hospital NHS Foundation Trust; King's College Hospital	Fishbane, S (corresponding author), Hofstra N Shore LIJ Sch Med, 100 Community Dr,2nd Fl, Great Neck, NY 11021 USA.	sfishbane@nshs.edu	Besarab, Anatole/AAP-2569-2020; Covic, Adrian/G-5017-2016; Schiller, Brigitte/AAW-3230-2021; Portoles, Jose/C-3337-2013	Covic, Adrian/0000-0002-9985-2486; Portoles, Jose/0000-0002-2114-1385; phanish, mysore/0000-0001-8402-8286; MacPhee, Iain/0000-0003-2322-7622	Affymax and Takeda Pharmaceutical; Rockwell Medical; Akebia Therapeutics; Amgen; Roche; Janssen; Pharmacosmos; Fresenius Medical Care; Abbott; Boehringer Ingelheim; RoFAR; Aethlon Medical; FibroGen	Affymax and Takeda Pharmaceutical; Rockwell Medical; Akebia Therapeutics; Amgen(Amgen); Roche(Roche Holding); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pharmacosmos; Fresenius Medical Care; Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); RoFAR; Aethlon Medical; FibroGen	Supported by Affymax and Takeda Pharmaceutical.; Dr. Fishbane reports receiving consulting fees from Affymax, Rockwell Medical, and Akebia Therapeutics and receiving grant support on behalf of his institution from Affymax and Rockwell Medical; Dr. Schiller, receiving consulting and lecture fees from Affymax and owning stock in Affymax; Dr. Locatelli, receiving payment for board membership from Affymax, Amgen, Roche, Takeda Pharmaceutical, Janssen, and Sandoz and lecture fees from Amgen, Roche, Janssen, Takeda Pharmaceutical, Pharmacosmos, and Fresenius Medical Care; Dr. Provenzano, owning stock in DaVita; Dr. Wiecek, receiving payment for board membership from Affymax, Sandoz, Boehringer Ingelheim, and Abbott, consulting fees from Affymax, Abbott, and Boehringer Ingelheim, and lecture fees from Amgen, Abbott, Boehringer Ingelheim, and Roche; Dr. Levin, receiving consulting fees from RoFAR, Roche, Aethlon Medical, FibroGen, and Affymax, being an employee of the Renal Research Institute, and owning stock in Fresenius Medical Care North America; Dr. Kaplan, being a former employee of Fresenius Medical Care North America and DSI Renal and a current employee of DaVita and Nephrology Associates and receiving payment on behalf of his employer, Nephrology Associates, for his participation in studies with Amgen, Abbott, Otsuka, Reata Pharmaceuticals, Mitsubishi, Keryx Biopharmaceuticals, Rockwell Medical, Celgene, Dynavax Technologies, Roche, and Merck; Dr. Macdougall, receiving payment for board membership from Affymax; Drs. Francisco, Mayo, Polu and Duliege, being employees of and owning stock in Affymax; and Dr. Besarab, receiving consulting fees, reimbursement for travel expenses, and payment for the development of educational presentations from Affymax and Takeda Pharmaceutical and grant support on behalf of his institution from Affymax and serving as an expert witness at the Food and Drug Administration on behalf of Affymax regarding anemia and kidney diseases. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2010, 2010 ANN REP DIAL OU; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Besarab A, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-95; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; LAUPACIS A, 1990, BMJ-BRIT MED J, V300, P573; Macdougall Iain C, 2005, Curr Hematol Rep, V4, P436; Macdougall IC, 2013, NEW ENGL J MED, V368, P320, DOI 10.1056/NEJMoa1203166; Macdougall IC, 2011, CLIN J AM SOC NEPHRO, V6, P2579, DOI 10.2215/CJN.10831210; Macdougall IC, 2009, NEW ENGL J MED, V361, P1848, DOI 10.1056/NEJMoa074037; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Postorino M, 2007, NEPHROL DIAL TRANSPL, V22, P1377, DOI 10.1093/ndt/gfl813; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Stead RB, 2006, BLOOD, V108, P1830, DOI 10.1182/blood-2006-04-015818; WINEARLS CG, 1995, NEPHROL DIAL TRANSPL, V10, P3, DOI 10.1093/ndt/10.supp2.3; Woodburn KW, 2007, EXP HEMATOL, V35, P1201, DOI 10.1016/j.exphem.2007.05.007; Woodburn KW, 2012, XENOBIOTICA, V42, P660, DOI 10.3109/00498254.2011.649310	17	60	61	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					307	319		10.1056/NEJMoa1203165	http://dx.doi.org/10.1056/NEJMoa1203165			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075KX	23343061	Green Published			2022-12-28	WOS:000313885900004
J	Rutledge, RK				Rutledge, Renee K.			Hating Hope	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Oregon Hlth & Sci Univ, Div Hosp Med, Portland, OR 97201 USA	Oregon Health & Science University	Rutledge, RK (corresponding author), Oregon Hlth & Sci Univ, Div Hosp Med, Portland, OR 97201 USA.	rutledgr@ohsu.edu							0	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2013	309	4					353	354		10.1001/jama.2012.185447	http://dx.doi.org/10.1001/jama.2012.185447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	074FT	23340636				2022-12-28	WOS:000313799000022
J	Caverzagie, KJ; Iobst, WF; Aagaard, EM; Hood, S; Chick, DA; Kane, GC; Brigham, TP; Swing, SR; Meade, LB; Bazari, H; Bush, RW; Kirk, LM; Green, ML; Hinchey, KT; Smith, CD				Caverzagie, Kelly J.; Iobst, William F.; Aagaard, Eva M.; Hood, Sarah; Chick, Davoren A.; Kane, Gregory C.; Brigham, Timothy P.; Swing, Susan R.; Meade, Lauren B.; Bazari, Hasan; Bush, Roger W.; Kirk, Lynne M.; Green, Michael L.; Hinchey, Kevin T.; Smith, Cynthia D.			The Internal Medicine Reporting Milestones and the Next Accreditation System	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Nebraska Med Ctr, Omaha, NE 68198 USA; Thomas Jefferson Univ, Jefferson Med Coll, Amer Board Internal Med, Philadelphia, PA 19107 USA; Amer Coll Physicians, Philadelphia, PA USA; Univ Colorado, Sch Med, Aurora, CO USA; Univ Michigan, Sch Med, Ann Arbor, MI USA; Accreditat Council Grad Med Educ, Chicago, IL 60654 USA; Baystate Med Ctr, Springfield, MA 01199 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Virginia Mason Med Ctr, Seattle, WA 98101 USA; Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; Yale Univ, Sch Med, New Haven, CT USA	University of Nebraska System; University of Nebraska Medical Center; American Board of Internal Medicine; Jefferson University; American College of Physicians; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Michigan System; University of Michigan; Baystate Medical Center; Harvard University; Massachusetts General Hospital; Virginia Mason Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University	Caverzagie, KJ (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, 985185 Nebraska Med Ctr, Omaha, NE 68198 USA.	kelly.caverzagie@unmc.edu	Chick, Davoren/ABF-2059-2021; Meade, Lauren/AAP-4508-2021					Accreditation Council for Graduate Medical Education, CAT COMM PROGR REQ; Accreditation Council for Graduate Medical Education, 2011, COMM PROGR REQ; Alliance for Academic Internal Medicine, BUILD ASS EPA 3 STEP; Green Michael L, 2009, J Grad Med Educ, V1, P5, DOI 10.4300/01.01.0003; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117; NASCA TJ, 2008, ACGME B, P2; Regehr G, 2007, J SOC WORK EDUC, V43, P327, DOI 10.5175/JSWE.2007.200600607; Swing SR, 2007, MED TEACH, V29, P648, DOI 10.1080/01421590701392903	8	49	49	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2013	158	7					557	+		10.7326/0003-4819-158-7-201304020-00593	http://dx.doi.org/10.7326/0003-4819-158-7-201304020-00593			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	123VM	23358671				2022-12-28	WOS:000317419400007
J	Huang, XD; McGann, JC; Liu, BY; Hannoush, RN; Lill, JR; Pham, V; Newton, K; Kakunda, M; Liu, JF; Yu, C; Hymowitz, SG; Hongo, JA; Wynshaw-Boris, A; Polakis, P; Harland, RM; Dixit, VM				Huang, XiaoDong; McGann, James C.; Liu, Bob Y.; Hannoush, Rami N.; Lill, Jennie R.; Pham, Victoria; Newton, Kim; Kakunda, Michael; Liu, Jinfeng; Yu, Christine; Hymowitz, Sarah G.; Hongo, Jo-Anne; Wynshaw-Boris, Anthony; Polakis, Paul; Harland, Richard M.; Dixit, Vishva M.			Phosphorylation of Dishevelled by Protein Kinase RIPK4 Regulates Wnt Signaling	SCIENCE			English	Article							BETA-CATENIN; MUTATIONS; FORM	Receptor-interacting protein kinase 4 (RIPK4) is required for epidermal differentiation and is mutated in Bartsocas-Papas syndrome. RIPK4 binds to protein kinase C, but its signaling mechanisms are largely unknown. Ectopic RIPK4, but not catalytically inactive or Bartsocas-Papas RIPK4 mutants, induced accumulation of cytosolic beta-catenin and a transcriptional program similar to that caused by Wnt3a. In Xenopus embryos, Ripk4 synergized with coexpressed Xwnt8, whereas Ripk4 morpholinos or catalytic inactive Ripk4 antagonized Wnt signaling. RIPK4 interacted constitutively with the adaptor protein DVL2 and, after Wnt3a stimulation, with the co-receptor LRP6. Phosphorylation of DVL2 by RIPK4 favored canonical Wnt signaling. Wnt-dependent growth of xenografted human tumor cells was suppressed by RIPK4 knockdown, suggesting that RIPK4 overexpression may contribute to the growth of certain tumor types.	[Huang, XiaoDong; Newton, Kim; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Huang, XiaoDong; Kakunda, Michael] Genentech Inc, Dept Mol Diagnost & Canc Cell Biol, San Francisco, CA 94080 USA; [McGann, James C.; Harland, Richard M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [McGann, James C.; Harland, Richard M.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Liu, Bob Y.; Polakis, Paul] Genentech Inc, Dept Canc Targets, San Francisco, CA 94080 USA; [Hannoush, Rami N.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Lill, Jennie R.; Pham, Victoria] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Liu, Jinfeng] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Yu, Christine; Hymowitz, Sarah G.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Hongo, Jo-Anne] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Wynshaw-Boris, Anthony] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; [Wynshaw-Boris, Anthony] Univ Calif San Francisco, Sch Med, Inst Human Genet, San Francisco, CA 94143 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; McGann, James/0000-0003-0895-0994; Liu, Jinfeng/0000-0002-0343-8222	NIGMS NIH HHS [R01 GM042341] Funding Source: Medline; NINDS NIH HHS [R01 NS073159] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073159] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Holland PM, 2002, CURR BIOL, V12, P1424, DOI 10.1016/S0960-9822(02)01075-8; Kalay E, 2012, AM J HUM GENET, V90, P76, DOI 10.1016/j.ajhg.2011.11.014; Kitaeva MN, 1997, CANCER RES, V57, P4478; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Mitchell K, 2012, AM J HUM GENET, V90, P69, DOI 10.1016/j.ajhg.2011.11.013; Montross WT, 2000, J CELL SCI, V113, P1759; Polakis P, 2000, GENE DEV, V14, P1837; Satoh K, 2004, P NATL ACAD SCI USA, V101, P8017, DOI 10.1073/pnas.0401733101; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	13	74	81	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2013	339	6126					1441	1445		10.1126/science.1232253	http://dx.doi.org/10.1126/science.1232253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	114KU	23371553	Green Accepted			2022-12-28	WOS:000316740700045
J	Meyer, RE; Kim, S; Obeso, D; Straight, PD; Winey, M; Dawson, DS				Meyer, Regis E.; Kim, Seoyoung; Obeso, David; Straight, Paul D.; Winey, Mark; Dawson, Dean S.			Mps1 and Ipl1/Aurora B Act Sequentially to Correctly Orient Chromosomes on the Meiotic Spindle of Budding Yeast	SCIENCE			English	Article							CHECKPOINT; MEIOSIS; PHOSPHORYLATION; KINETOCHORES; INTERPHASE; TELOMERES	The conserved kinases Mps1 and Ipl1/Aurora B are critical for enabling chromosomes to attach to microtubules so that partner chromosomes will be segregated correctly from each other, but the precise roles of these kinases have been unclear. We imaged live yeast cells to elucidate the stages of chromosome-microtubule interactions and their regulation by Ipl1 and Mps1 through meiosis I. Ipl1 was found to release kinetochore-microtubule (kMT) associations after meiotic entry, liberating chromosomes to begin homologous pairing. Surprisingly, most chromosome pairs began their spindle interactions with incorrect kMT attachments. Ipl1 released these improper connections, whereas Mps1 triggered the formation of new force-generating microtubule attachments. This microtubule release and reattachment cycle could prevent catastrophic chromosome segregation errors in meiosis.	[Meyer, Regis E.; Kim, Seoyoung; Obeso, David; Dawson, Dean S.] Oklahoma Med Res Fdn, Dept Cell Cycle & Canc Biol, Oklahoma City, OK 73104 USA; [Kim, Seoyoung; Obeso, David; Dawson, Dean S.] Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Straight, Paul D.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Colorado System; University of Colorado Boulder	Dawson, DS (corresponding author), Oklahoma Med Res Fdn, Dept Cell Cycle & Canc Biol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	dawsond@omrf.org		Straight, Paul/0000-0003-2460-8240; Meyer, Regis E/0000-0003-1530-4763	NIH [GM-07135, GM087377]; March of Dimes Birth Defects Foundation [FY98.409/FY99.617]; NSF [0950005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087377, R01GM051312, T32GM007135] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Birth Defects Foundation(March of Dimes); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Jaspersen for critically reading the manuscript; K. Benjamin, S. Biggins, M. Dresser, M. Knop, K. Nasmyth, and A. Straight for providing strains and reagents; and current and past laboratory members for reagents and discussions of our work. P. D. S. was supported in part by NIH training grant GM-07135. This work was supported by March of Dimes Birth Defects Foundation grant FY98.409/FY99.617 to M. W. and NSF grant 0950005 and NIH grant GM087377 to D. D. Data used in this paper are available in the supplementary materials.	Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Bock LJ, 2012, NAT CELL BIOL, V14, P614, DOI 10.1038/ncb2495; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Cowan CR, 2001, PLANT PHYSIOL, V125, P532, DOI 10.1104/pp.125.2.532; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; Hayashi A, 1998, GENES CELLS, V3, P587, DOI 10.1046/j.1365-2443.1998.00215.x; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Maure JF, 2011, CURR BIOL, V21, P207, DOI 10.1016/j.cub.2010.12.050; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765	24	45	45	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1071	1074		10.1126/science.1232518	http://dx.doi.org/10.1126/science.1232518			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23371552	Green Accepted			2022-12-28	WOS:000315452000040
J	Hu, HB; Brittain, GC; Chang, JH; Puebla-Osorio, N; Jin, J; Zal, A; Xiao, YC; Cheng, XH; Chang, MY; Fu, YX; Zal, T; Zhu, CM; Sun, SC				Hu, Hongbo; Brittain, George C.; Chang, Jae-Hoon; Puebla-Osorio, Nahum; Jin, Jin; Zal, Anna; Xiao, Yichuan; Cheng, Xuhong; Chang, Mikyoung; Fu, Yang-Xin; Zal, Tomasz; Zhu, Chengming; Sun, Shao-Cong			OTUD7B controls non-canonical NF-kappa B activation through deubiquitination of TRAF3	NATURE			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; HOMEOSTASIS; PATHWAY; KINASE; RESPONSES; CEZANNE; NIK	The non-canonical NF-kappa B pathway forms a major arm of NF-kappa B signalling that mediates important biological functions, including lymphoid organogenesis, B-lymphocyte function, and cell growth and survival(1-3). Activation of the non-canonical NF-kappa B pathway involves degradation of an inhibitory protein, TNF receptor-associated factor 3 (TRAF3), but how this signalling event is controlled is still unknown(1,2). Here we have identified the deubiquitinase OTUD7B as a pivotal regulator of the non-canonical NF-kappa B pathway. OTUD7B deficiency in mice has no appreciable effect on canonical NF-kappa B activation but causes hyperactivation of non-canonical NF-kappa B. In response to non-canonical NF-kappa B stimuli, OTUD7B binds and deubiquitinates TRAF3, thereby inhibiting TRAF3 proteolysis and preventing aberrant non-canonical NF-kappa B activation. Consequently, the OTUD7B deficiency results in B-cell hyper-responsiveness to antigens, lymphoid follicular hyperplasia in the intestinal mucosa, and elevated host-defence ability against an intestinal bacterial pathogen, Citrobacter rodentium. These findings establish OTUD7B as a crucial regulator of signal-induced non-canonical NF-kappa B activation and indicate a mechanism of immune regulation that involves OTUD7B-mediated deubiquitination and stabilization of TRAF3.	[Hu, Hongbo; Brittain, George C.; Chang, Jae-Hoon; Puebla-Osorio, Nahum; Jin, Jin; Zal, Anna; Xiao, Yichuan; Cheng, Xuhong; Chang, Mikyoung; Zal, Tomasz; Zhu, Chengming; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Zal, Tomasz; Zhu, Chengming; Sun, Shao-Cong] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Chicago; University of Texas System; University of Texas Health Science Center Houston	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, 7455 Fannin St,Box 902, Houston, TX 77030 USA.	ssun@mdanderson.org	Hu, Hongbo/J-8059-2016	Hu, Hongbo/0000-0002-8177-7641; Zal, Tomasz/0000-0002-3469-4261; Puebla, Nahum/0000-0001-6498-5230; fu, yang-xin/0000-0001-8441-6617; Jin, Jin/0000-0001-7887-5972	National Institutes of Health [AI057555, AI064639, GM84459, CA137059, T32CA009598]; Sister Institution Network Fund of MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA137059, P30CA016672, T32CA009598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064639, R01AI057555, R37AI064639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sister Institution Network Fund of MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Chen and P. Evans for expression vectors and J. Browning and Biogen for the anti-LT beta R antibody. We also thank the personnel from the flow cytometry, DNA analysis, animal facility, and histology Core facilities at The MD Anderson Cancer Center for technical assistance. This study was supported by grants from the National Institutes of Health (AI057555, AI064639 and GM84459 to S.-C.S.; CA137059 to T.Z.; T32CA009598 to G.C.B.) and the Sister Institution Network Fund of MD Anderson Cancer Center.	Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Dohi T, 2001, J IMMUNOL, V167, P2781, DOI 10.4049/jimmunol.167.5.2781; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Evans PC, 2001, BIOCHEM J, V357, P617, DOI 10.1042/0264-6021:3570617; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012; Xie P, 2011, J IMMUNOL, V186, P143, DOI 10.4049/jimmunol.1000290; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	27	150	164	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2013	494	7437					371	374		10.1038/nature11831	http://dx.doi.org/10.1038/nature11831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095CS	23334419	Green Accepted			2022-12-28	WOS:000315312900042
J	Hanson, CM; Furrer, E; Schwalbe, N; Berkley, S				Hanson, Celina M.; Furrer, Eliane; Schwalbe, Nina; Berkley, Seth			Prediction of immunisation performance	LANCET			English	Editorial Material									[Hanson, Celina M.] NYU, Global Inst Publ Hlth, New York, NY 10003 USA; [Furrer, Eliane; Schwalbe, Nina; Berkley, Seth] GAVI Alliance, CH-1202 Geneva, Switzerland	New York University	Furrer, E (corresponding author), GAVI Alliance, Chemin Mines 2, CH-1202 Geneva, Switzerland.	efurrer@gavialliance.org						Duclos P, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S2; Pascale R. T., 2010, POWER POSITIVE DEVIA; Shearer JC, 2012, VACCINE, V30, P7582, DOI 10.1016/j.vaccine.2012.10.036; WHO UNICEF, 2012, GLOB IMM DAT SUMM GL; World Bank, 2012, WORLDW GOV IND	5	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2013	381	9864					349	350		10.1016/S0140-6736(12)62165-5	http://dx.doi.org/10.1016/S0140-6736(12)62165-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084ZA	23374462				2022-12-28	WOS:000314578900007
J	Liu, J; Wang, B; Cane, MA; Yim, SY; Lee, JY				Liu, Jian; Wang, Bin; Cane, Mark A.; Yim, So-Young; Lee, June-Yi			Divergent global precipitation changes induced by natural versus anthropogenic forcing	NATURE			English	Article							NORTHERN-HEMISPHERE TEMPERATURES; SEA-SURFACE TEMPERATURE; TROPICAL PACIFIC; CLIMATE-CHANGE; PAST MILLENNIUM; OSCILLATION; PATTERNS	As a result of global warming, precipitation is likely to increase in high latitudes and the tropics and to decrease in already dry subtropical regions(1). The absolute magnitude and regional details of such changes, however, remain intensely debated(2,3). As is well known from El Nino studies, sea-surface-temperature gradients across the tropical Pacific Ocean can strongly influence global rainfall(4,5). Palaeoproxy evidence indicates that the difference between the warm west Pacific and the colder east Pacific increased in past periods when the Earth warmed as a result of increased solar radiation(6-9). In contrast, in most model projections of future greenhouse warming this gradient weakens(2,10,11). It has not been clear how to reconcile these two findings. Here we show in climate model simulations that the tropical Pacific sea-surface-temperature gradient increases when the warming is due to increased solar radiation and decreases when it is due to increased greenhouse-gas forcing. For the same global surface temperature increase the latter pattern produces less rainfall, notably over tropical land, which explains why in the model the late twentieth century is warmer than in the Medieval Warm Period (around AD 1000-1250) but precipitation is less. This difference is consistent with the global tropospheric energy budget(12), which requires a balance between the latent heat released in precipitation and radiative cooling. The tropospheric cooling is less for increased greenhouse gases, which add radiative absorbers to the troposphere, than for increased solar heating, which is concentrated at the Earth's surface. Thus warming due to increased greenhouse gases produces a climate signature different from that of warming due to solar radiation changes.	[Liu, Jian] Nanjing Normal Univ, Sch Geog Sci, Minist Educ, Key Lab Virtual Geog Environm, Nanjing 210023, Jiangsu, Peoples R China; [Liu, Jian] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Bin; Yim, So-Young; Lee, June-Yi] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96825 USA; [Wang, Bin; Yim, So-Young; Lee, June-Yi] Univ Hawaii Manoa, Dept Meteorol, Honolulu, HI 96825 USA; [Cane, Mark A.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Nanjing Normal University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Columbia University	Cane, MA (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	jliu@njnu.edu.cn; mcane@ldeo.columbia.edu	Lee, June-Yi/AAT-3407-2021; Lee, June-Yi/D-5752-2012	Lee, June-Yi/0000-0002-3986-9753; Lee, June-Yi/0000-0002-3986-9753; Cane, Mark/0000-0001-5408-2388	National Basic Research Program [2010CB950102, XDA05080800]; Natural Science Foundation of China [40871007]; Korean Ministry of Education, Science and Technology (MEST) [2011-0021927]; Department of Energy and NOAA [DE-SC0005108, NA08OAR4320912]; International Pacific Research Center; JAMSTEC; NOAA; NASA	National Basic Research Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Korean Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Department of Energy and NOAA; International Pacific Research Center; JAMSTEC; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by the National Basic Research Program (award numbers 2010CB950102 and XDA05080800 to J.L.) and Natural Science Foundation of China (award number 40871007 to J.L. and B. W.). B. W. and J.-Y.L. acknowledge the Global Research Laboratory (GRL) Program from the Korean Ministry of Education, Science and Technology (MEST, 2011-0021927). M. A. C. was supported by grant DE-SC0005108 from the Department of Energy and NOAA grant NA08OAR4320912. B. W., S.-Y.Y. and J.-Y.L. acknowledge support from the International Pacific Research Center, which is funded jointly by JAMSTEC, NOAA and NASA. We thank E. Zorita for providing ECHO-G millennium run data, and A. Hense and S.-K. Min for providing ECHO-G A1B and greenhouse-gas run data.	Adams JB, 2003, NATURE, V426, P274, DOI 10.1038/nature02101; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Bauer E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016639; Cane MA, 1997, SCIENCE, V275, P957, DOI 10.1126/science.275.5302.957; Clement AC, 1996, J CLIMATE, V9, P2190, DOI 10.1175/1520-0442(1996)009<2190:AODT>2.0.CO;2; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; Emile-Geay J, 2008, J CLIMATE, V21, P3134, DOI 10.1175/2007JCLI1884.1; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Lee JY, 2014, CLIM DYNAM, V42, P101, DOI 10.1007/s00382-012-1564-0; Legutke S., 1999, 18 ECHO G, P1; Liu J, 2009, J CLIMATE, V22, P2356, DOI 10.1175/2008JCLI2353.1; Mann ME, 2005, J CLIMATE, V18, P447, DOI 10.1175/JCLI-3276.1; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Mann ME, 2007, ANNU REV EARTH PL SC, V35, P111, DOI 10.1146/annurev.earth.35.031306.140042; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Meehl GA, 1996, NATURE, V382, P56, DOI 10.1038/382056a0; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Min SK, 2006, J CLIMATE, V19, P3237, DOI 10.1175/JCLI3784.1; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Pauling A, 2006, CLIM DYNAM, V26, P387, DOI 10.1007/s00382-005-0090-8; Rodgers KB, 2004, J CLIMATE, V17, P3761, DOI 10.1175/1520-0442(2004)017<3761:TPDVAI>2.0.CO;2; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Ropelewski CF, 1996, J CLIMATE, V9, P1043, DOI 10.1175/1520-0442(1996)009<1043:QSOPR>2.0.CO;2; Vecchi G. A., 2008, EOS T AM GEOPHYS UN, V89, P81, DOI DOI 10.1029/2008EO090002; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; von Storch H, 2004, SCIENCE, V306, P679, DOI 10.1126/science.1096109; WALLACE JM, 1992, J CLIMATE, V5, P561, DOI 10.1175/1520-0442(1992)005<0561:SVDOWS>2.0.CO;2; Wentz FJ, 2007, SCIENCE, V317, P233, DOI 10.1126/science.1140746; Zorita E, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021563	30	139	173	9	253	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					656	659		10.1038/nature11784	http://dx.doi.org/10.1038/nature11784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23364744				2022-12-28	WOS:000314219600053
J	Solovei, I; Wang, AS; Thanisch, K; Schmidt, CS; Krebs, S; Zwerger, M; Cohen, TV; Devys, D; Foisner, R; Peichl, L; Herrmann, H; Blum, H; Engelkamp, D; Stewart, CL; Leonhardt, H; Joffe, B				Solovei, Irina; Wang, Audrey S.; Thanisch, Katharina; Schmidt, Christine S.; Krebs, Stefan; Zwerger, Monika; Cohen, Tatiana V.; Devys, Didier; Foisner, Roland; Peichl, Leo; Herrmann, Harald; Blum, Helmut; Engelkamp, Dieter; Stewart, Colin L.; Leonhardt, Heinrich; Joffe, Boris			LBR and Lamin A/C Sequentially Tether Peripheral Heterochromatin and Inversely Regulate Differentiation	CELL			English	Article							B RECEPTOR; NUCLEAR-ENVELOPE; CHROMATIN-STRUCTURE; EMERIN; EXPRESSION; CELLS; PROLIFERATION; MATURATION; INTEGRITY; MEMBRANE	Eukaryotic cells have a layer of heterochromatin at the nuclear periphery. To investigate mechanisms regulating chromatin distribution, we analyzed heterochromatin organization in different tissues and species, including mice with mutations in the lamin B receptor (Lbr) and lamin A (Lmna) genes that encode nuclear envelope (NE) proteins. We identified LBR- and lamin-A/C-dependent mechanisms tethering heterochromatin to the NE. The two tethers are sequentially used during cellular differentiation and development: first the LBR -and then the lamin-A/C-dependent tether. The absence of both LBR and lamin A/C leads to loss of peripheral heterochromatin and an inverted architecture with heterochromatin localizing to the nuclear interior. Myoblast transcriptome analyses indicated that selective disruption of the LBR- or lamin-A-dependent heterochromatin tethers have opposite effects on muscle gene expression, either increasing or decreasing, respectively. These results show how changes in NE composition contribute to regulating heterochromatin positioning, gene expression, and cellular differentiation during development.	[Solovei, Irina; Thanisch, Katharina; Schmidt, Christine S.; Leonhardt, Heinrich; Joffe, Boris] Univ Munich, Dept Biol 2, CIPSM, D-82152 Martinsried, Germany; [Wang, Audrey S.; Stewart, Colin L.] Inst Med Biol, Singapore 138648, Singapore; [Wang, Audrey S.; Stewart, Colin L.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Krebs, Stefan; Blum, Helmut] Univ Munich, Lab Funct Genome Anal LAFUGA, Gene Ctr Munich, D-81377 Munich, Germany; [Zwerger, Monika; Herrmann, Harald] German Canc Res Ctr DKFC, Dept Mol Genet, D-69120 Heidelberg, Germany; [Cohen, Tatiana V.] Childrens Natl Med Ctr, Ctr Genet Med, Washington, DC 20010 USA; [Devys, Didier] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, UMR 7104,INSERM,U964, F-67404 Illkirch Graffenstaden, France; [Foisner, Roland] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Peichl, Leo] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany; [Engelkamp, Dieter] Univ Erlangen Nurnberg, Transgen Serv Facil, BTE, Franz Penzoldt Ctr, D-91058 Erlangen, Germany	University of Munich; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; University of Munich; Children's National Health System; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Max Planck Society; University of Erlangen Nuremberg	Stewart, CL (corresponding author), Inst Med Biol, 8A Biomed Grove, Singapore 138648, Singapore.	colin.stewart@imb.a-star.edu.sg; h.leonhardt@lmu.de; boris.joffe@lmu.de	Foisner, Roland/AAD-1833-2019; Leonhardt, Heinrich/B-2791-2014; Solovei, Irina/K-1191-2014	Foisner, Roland/0000-0003-4734-4647; Devys, Didier/0000-0001-9655-3512; Peichl, Leo/0000-0002-8141-0911; Wang, Audrey/0000-0001-5077-3456; Solovei, Irina/0000-0002-6813-7279	DFG [SO1054/1, HE1853, SFB/TR5, JO903/1]; German-Israeli-Foundation for Scientific Research and Development [111/2007]; International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); BMBF (German agriculture network Phaenomics) [0315536F]; Austrian Science Research Fund [FWF P22403-B12]; Singapore Biomedical Research Council; Singapore Agency for Science, Technology, and Research (A*STAR); Austrian Science Fund (FWF) [P 22043] Funding Source: researchfish	DFG(German Research Foundation (DFG)); German-Israeli-Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); BMBF (German agriculture network Phaenomics)(Federal Ministry of Education & Research (BMBF)); Austrian Science Research Fund(Austrian Science Fund (FWF)); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to Stephen Young and Loren Fong (University of California, Los Angeles) for tissue samples of lamin-C-only mice, Yixian Zheng (Carnegie Institution for Science, Baltimore) for Lmnb1/Lmnb2 double-knockout tissue samples, Anand Swaroop (National Eye Institute, Bethesda) for NRL-L-plasmid, and Barbara Knowles (Institute of Medical Biology, Singapore) for Zp3-Cre mice. We gratefully acknowledge the support by the DFG (SO1054/1 to IS, HE1853 to HH, SFB/TR5 to HL, and JO903/1 to BJ); by the German-Israeli-Foundation for Scientific Research and Development (111/2007 to HH); by the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS) to C.S.S. and K.T.; by BMBF (German agriculture network Phaenomics, 0315536F to H.B.); by Austrian Science Research Fund (FWF P22403-B12 to R.F.); and by the Singapore Biomedical Research Council and the Singapore Agency for Science, Technology, and Research (A*STAR) to C.L.S. and A.W.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Barkan R, 2012, MOL BIOL CELL, V23, P543, DOI 10.1091/mbc.E11-06-0505; Bertrand AT, 2012, HUM MOL GENET, V21, P1037, DOI 10.1093/hmg/ddr534; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Cohen TV, 2008, HUM MOL GENET, V17, P2921, DOI 10.1093/hmg/ddn191; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Demmerle J, 2012, J BIOL CHEM, V287, P22080, DOI 10.1074/jbc.M111.325308; Deniaud E, 2009, CURR OPIN GENET DEV, V19, P187, DOI 10.1016/j.gde.2009.01.005; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Hirano Y, 2012, J BIOL CHEM, V287, P42654, DOI 10.1074/jbc.M112.397950; Huber MD, 2009, MOL CELL BIOL, V29, P5718, DOI 10.1128/MCB.00270-09; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kizilyaprak C, 2011, NUCLEUS-AUSTIN, V2, P444, DOI 10.4161/nucl.2.5.17843; Kubben N, 2012, CHROMOSOMA, V121, P447, DOI 10.1007/s00412-012-0376-7; Kubben N, 2011, NUCLEUS-PHILA, V2, P195, DOI 10.4161/nucl.2.3.15731; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Mattout A, 2011, CURR BIOL, V21, P1603, DOI 10.1016/j.cub.2011.08.030; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Olins AL, 2010, NUCLEUS-PHILA, V1, P53, DOI 10.4161/nucl.1.1.10515; Ozawa R, 2006, AM J PATHOL, V168, P907, DOI 10.2353/ajpath.2006.050564; Park YE, 2009, NEUROMUSCULAR DISORD, V19, P29, DOI 10.1016/j.nmd.2008.09.018; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; ROBER RA, 1990, J CELL SCI, V95, P587; Shultz LD, 2003, HUM MOL GENET, V12, P61, DOI 10.1093/hmg/ddg003; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tifft KE, 2009, J CELL SCI, V122, P3780, DOI 10.1242/jcs.048397; Towbin BD, 2010, COLD SH Q B, V75, P555, DOI 10.1101/sqb.2010.75.041; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Verhagen AM, 2012, J IMMUNOL, V188, P122, DOI 10.4049/jimmunol.1100942; Yang SH, 2011, HUM MOL GENET, V20, P3537, DOI 10.1093/hmg/ddr266; Yao J, 2011, GENE DEV, V25, P569, DOI 10.1101/gad.2021411; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	41	503	511	2	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 31	2013	152	3					584	598		10.1016/j.cell.2013.01.009	http://dx.doi.org/10.1016/j.cell.2013.01.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23374351	Bronze			2022-12-28	WOS:000314362800026
J	Hawkes, N				Hawkes, Nigel			How the message from mortality figures was missed at Mid Staffs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Dr Foster Intelligence, HOSP GUID 2012; Girling AJ, 2012, BMJ QUAL SAF, V21, P1052, DOI 10.1136/bmjqs-2012-001202; Kark T, 2011, CLOSING SUBMISSIONS; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; Robinson P, 2008, HEALTH SERV J   1211	5	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2013	346								f562	10.1136/bmj.f562	http://dx.doi.org/10.1136/bmj.f562			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BP	23364069				2022-12-28	WOS:000314511300012
J	Spence, D				Spence, Des			Imagine all the people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2013	346								f584	10.1136/bmj.f584	http://dx.doi.org/10.1136/bmj.f584			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084BP	23364070				2022-12-28	WOS:000314511300007
J	Hopwood, N				Hopwood, Nick			Anatomist and embryo: a portrait sculpture	LANCET			English	Editorial Material									Univ Cambridge, Dept Hist & Philosophy Sci, Cambridge CB2 3RH, England	University of Cambridge	Hopwood, N (corresponding author), Univ Cambridge, Dept Hist & Philosophy Sci, Cambridge CB2 3RH, England.	ndh12@cam.ac.uk		Hopwood, Nick/0000-0001-7069-7497				His W., 1874, WILHELM HIS TO ANTON; His W., 1878, WILHELM HIS TO FRIED; Hopwood N, 2000, B HIST MED, V74, P29; Hopwood N., 2002, EMBRYOS IN WAX MODEL; Hopwood N, 2012, HIST WORKSHOP J, P5, DOI 10.1093/hwj/dbq051; Jordanova Ludmilla, 2000, DEFINING FEATURES SC	6	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2013	381	9863					286	287		10.1016/S0140-6736(13)60123-3	http://dx.doi.org/10.1016/S0140-6736(13)60123-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23359894				2022-12-28	WOS:000314021800017
J	Doria, A; Gatto, M; Punzi, L				Doria, Andrea; Gatto, Mariele; Punzi, Leonardo			Autophagy in Human Health and Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							IMMUNITY		[Doria, Andrea; Gatto, Mariele; Punzi, Leonardo] Univ Padua, Padua, Italy	University of Padua	Doria, A (corresponding author), Univ Padua, Padua, Italy.	adoria@unipd.it		Doria, Andrea/0000-0003-0548-4983; GATTO, MARIELE/0000-0003-4012-1248; PUNZI, LEONARDO/0000-0002-8853-516X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bachetti T, 2012, ANN RHEUM DIS; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Pierdominici M, 2012, FASEB J, V26, P1400, DOI 10.1096/fj.11-194175; Zhou XJ, 2012, AUTOPHAGY, V8, P1286, DOI 10.4161/auto.21212	5	1775	1872	20	402	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1845	1845		10.1056/NEJMc1303158	http://dx.doi.org/10.1056/NEJMc1303158			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138WA	23406030				2022-12-28	WOS:000318540000023
J	Kwok, R				Kwok, Roberta			Once more, with feeling	NATURE			English	News Item							NEURAL-CONTROL; INTERFACE; AMPUTEES; ARM							Waldrop, M Mitchell/0000-0002-8063-1472				Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Dhillon GS, 2004, J HAND SURG-AM, V29A, P605, DOI 10.1016/j.jhsa.2004.02.006; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Horch K, 2011, IEEE T NEUR SYS REH, V19, P483, DOI 10.1109/TNSRE.2011.2162635; Kuiken TA, 2007, P NATL ACAD SCI USA, V104, P20061, DOI 10.1073/pnas.0706525104; O'Doherty JE, 2011, NATURE, V479, P228, DOI 10.1038/nature10489; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Tyler DJ, 2002, IEEE T NEUR SYS REH, V10, P294, DOI 10.1109/TNSRE.2002.806840	8	37	38	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					176	178		10.1038/497176a	http://dx.doi.org/10.1038/497176a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23393652	Bronze			2022-12-28	WOS:000318558200010
J	Trempolec, N; Dave-Coll, N; Nebreda, AR				Trempolec, Natalia; Dave-Coll, Natalia; Nebreda, Angel R.			SnapShot: p38 MAPK Signaling	CELL			English	Editorial Material							ACTIVATED PROTEIN-KINASE; PATHWAY		[Trempolec, Natalia; Dave-Coll, Natalia; Nebreda, Angel R.] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Nebreda, Angel R.] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Trempolec, N (corresponding author), Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.		Nebreda, Angel Rodriguez/R-9594-2019		ICREA Funding Source: Custom	ICREA(ICREA)		Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Oeztuerk-Winder F, 2012, BIOCHEM J, V445, P1, DOI 10.1042/BJ20120401; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694	10	86	90	5	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 31	2013	152	3					656	+	656.e1	10.1016/j.cell.2013.01.029	http://dx.doi.org/10.1016/j.cell.2013.01.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	081ZZ	23415236	Bronze			2022-12-28	WOS:000314362800032
J	Friedmann, PD				Friedmann, Peter D.			Alcohol Use in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRIEF INTERVENTION; OUTPATIENT TREATMENT; CONTROLLED-TRIAL; RISK DRINKING; UNITED-STATES; PRIMARY-CARE; FOLLOW-UP; DEPENDENCE; RELAPSE; PHARMACOTHERAPIES	A 57-year-old man with a history of alcohol dependence comes for an annual examination. He reports that he has reduced his drinking to two beers two to three times per week and has not had five or more drinks on any occasion or any adverse consequences for the past 2 years. He states that he drinks "for his health" and that "it is under control." How should his case be assessed and managed?	[Friedmann, Peter D.] Vet Affairs Med Ctr, Ctr Syst Outcomes & Qual Chron Dis & Rehabil, Res Serv, Providence, RI USA; [Friedmann, Peter D.] Rhode Isl Hosp, Div Gen Internal Med, Providence, RI 02903 USA; [Friedmann, Peter D.] Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA; [Friedmann, Peter D.] Brown Univ, Dept Hlth Serv Policy & Practice, Alpert Med Sch, Providence, RI 02912 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Friedmann, PD (corresponding author), Rhode Isl Hosp, Div Gen Internal Med, 593 Eddy St,Plain St Bldg,Rm 123, Providence, RI 02903 USA.	pfriedmann@lifespan.org			HSRD VA [I01 HX000444] Funding Source: Medline; Veterans Affairs [I01HX000444] Funding Source: NIH RePORTER	HSRD VA; Veterans Affairs(US Department of Veterans Affairs)		Amato L., 2011, COCHRANE DB SYST REV, V6; American Psychiatric, 2000, DIAGN STAT MAN MENT; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Beich A, 2003, BMJ-BRIT MED J, V327, P536, DOI 10.1136/bmj.327.7414.536; Bertholet N, 2010, J GEN INTERN MED, V25, P1024, DOI 10.1007/s11606-010-1382-1; Boschloo L, 2012, ADDICTION, V107, P1590, DOI 10.1111/j.1360-0443.2012.03860.x; Botteri E, 2012, ANN ONCOL; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Brown RL, 2007, ALCOHOL CLIN EXP RES, V31, P1372, DOI 10.1111/j.1530-0277.2007.00430.x; Centers for Disease Control and Prevention, 2008, ALC REL DIS IMP ARDI; Cohen E, 2007, DRUG ALCOHOL DEPEN, V86, P214, DOI 10.1016/j.drugalcdep.2006.06.008; Community Preventive Services Task Force, 2021, GUID COMM PREV SERV; Dawson DA, 2005, ADDICTION, V100, P281, DOI 10.1111/j.1360-0443.2004.00964.x; Dawson DA, 2008, DRUG ALCOHOL DEPEN, V95, P62, DOI 10.1016/j.drugalcdep.2007.12.007; Dawson DA, 2007, ALCOHOL CLIN EXP RES, V31, P2036, DOI 10.1111/j.1530-0277.2007.00536.x; Ducharme LJ, 2006, J CLIN PSYCHOPHARM, V26, pS13, DOI 10.1097/01.jcp.0000246209.18777.14; Edwards SM, 2011, CURR PHARM DESIGN, V17, P1323; Field CA, 2010, ALCOHOL CLIN EXP RES, V34, P2004, DOI 10.1111/j.1530-0277.2010.01297.x; Friedmann PD, 2001, J STUD ALCOHOL, V62, P234, DOI 10.15288/jsa.2001.62.234; Friedmann PD, 1998, JAMA-J AM MED ASSOC, V279, P1227, DOI 10.1001/jama.279.15.1227; Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1978; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Hasin D, 2005, ADDICTION, V100, P295, DOI 10.1111/j.1360-0443.2005.01016.x; Hasin DS, 2012, DRUG ALCOHOL DEPEN, V122, P28, DOI 10.1016/j.drugalcdep.2011.09.005; Johnson BA, 2007, JAMA-J AM MED ASSOC, V298, P1641, DOI 10.1001/jama.298.14.1641; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Jorgensen CH, 2011, ALCOHOL CLIN EXP RES, V35, P1749, DOI 10.1111/j.1530-0277.2011.01523.x; Kelly JF, 2012, ADDICTION, V107, P289, DOI 10.1111/j.1360-0443.2011.03593.x; Kirshenbaum AP, 2009, J SUBST ABUSE TREAT, V36, P8, DOI 10.1016/j.jsat.2008.04.001; Kranzler HR, 2012, ALCOHOL CLIN EXP RES, V36, P509, DOI 10.1111/j.1530-0277.2011.01609.x; KRISTENSON H, 1983, ALCOHOL CLIN EXP RES, V7, P203, DOI 10.1111/j.1530-0277.1983.tb05441.x; Mason BJ, 2012, ALCOHOL CLIN EXP RES, V36, P497, DOI 10.1111/j.1530-0277.2011.01616.x; McQueen J, 2011, COCHRANE DB SYST REV, V8; Miller WR, 2001, J STUD ALCOHOL, V62, P211, DOI 10.15288/jsa.2001.62.211; Moos RH, 2006, ADDICTION, V101, P212, DOI 10.1111/j.1360-0443.2006.01310.x; Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011; National Institute on Alcohol Abuse and Alcoholism, 2007, HELP PAT WHO DRINK T; Nilsen P, 2011, ADDICTION, V106, P1748, DOI 10.1111/j.1360-0443.2011.03476.x; Nunes EV, 2004, JAMA-J AM MED ASSOC, V291, P1887, DOI 10.1001/jama.291.15.1887; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Riper H, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1691; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001867.pub3; Rollnick S, 2007, MOTIVATION INTERVIEW; Rubinsky AD, 2010, DRUG ALCOHOL DEPEN, V108, P29, DOI 10.1016/j.drugalcdep.2009.11.009; Saha TD, 2006, PSYCHOL MED, V36, P931, DOI 10.1017/S003329170600746X; Saitz R, 2010, DRUG ALCOHOL REV, V29, P631, DOI 10.1111/j.1465-3362.2010.00217.x; Smith PC, 2010, J GEN INTERN MED, V25, P375, DOI 10.1007/s11606-010-1255-7; Soderstrom CA, 2007, J TRAUMA, V62, P1102, DOI 10.1097/TA.0b013e31804bdb26; Turner BJ, 2009, J GEN INTERN MED, V24, P1156, DOI 10.1007/s11606-009-1072-z; Vaillant GE, 2003, ADDICTION, V98, P1043, DOI 10.1046/j.1360-0443.2003.00422.x; Vinson DC, 2007, ALCOHOL CLIN EXP RES, V31, P1392, DOI 10.1111/j.1530-0277.2007.00440.x; Walitzer KS, 2009, ADDICTION, V104, P391, DOI 10.1111/j.1360-0443.2008.02467.x; Willenbring ML, 1999, ARCH INTERN MED, V159, P1946, DOI 10.1001/archinte.159.16.1946; Witbrodt J, 2012, J SUBST ABUSE TREAT, V43, P30, DOI 10.1016/j.jsat.2011.10.004	55	90	93	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					365	373		10.1056/NEJMcp1204714	http://dx.doi.org/10.1056/NEJMcp1204714			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075KX	23343065				2022-12-28	WOS:000313885900009
J	Strandberg, TE; Pitkala, KH				Strandberg, Timo E.; Pitkala, Kaisu H.			Frailty in elderly people	LANCET			English	Editorial Material							OLDER-ADULTS; CATABOLISM; HEALTH		Univ Oulu, FIN-90014 Oulu, Finland; Univ Helsinki, Helsinki, Finland	University of Oulu; University of Helsinki	Strandberg, TE (corresponding author), Univ Oulu, FIN-90014 Oulu, Finland.	timo.strandberg@oulu.fi		young, john/0000-0003-4085-9306; Pitkala, Kaisu/0000-0001-9659-6985; Iliffe, Stephen/0000-0003-2806-3997; Clegg, Andrew/0000-0001-5972-1097	The Dunhill Medical Trust [RCP/DMT 2ND ROUND (2)] Funding Source: Medline	The Dunhill Medical Trust(Dunhill Medical Trust)		Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Boockvar KS, 2006, JAMA-J AM MED ASSOC, V296, P2245, DOI 10.1001/jama.296.18.2245; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Ferrucci L, 2002, J Endocrinol Invest, V25, P10; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; Omwancha J, 2006, CURR OPIN INVEST DR, V7, P873; Ozaki A, 2007, J AM GERIATR SOC, V55, P95, DOI 10.1111/j.1532-5415.2006.01019.x; Purser JL, 2006, J AM GERIATR SOC, V54, P1674, DOI 10.1111/j.1532-5415.2006.00914.x; Roubenoff R, 2003, CURR OPIN CLIN NUTR, V6, P295, DOI 10.1097/01.mco.0000068965.34812.62; Sanders PM, 2005, BRIT J CANCER, V93, P425, DOI 10.1038/sj.bjc.6602725; Sullivan DH, 2007, J AM GERIATR SOC, V55, P20, DOI 10.1111/j.1532-5415.2006.01010.x	14	1175	1254	5	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1328	1329		10.1016/S0140-6736(07)60613-8	http://dx.doi.org/10.1016/S0140-6736(07)60613-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	23395245				2022-12-28	WOS:000245856100009
J	Choi, AMK; Ryter, SW; Levine, B				Choi, Augustine M. K.; Ryter, Stefan W.; Levine, Beth			MECHANISMS OF DISEASE Autophagy in Human Health and Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GENOME-WIDE ASSOCIATION; LIFE-SPAN EXTENSION; BECLIN 1; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SUSCEPTIBILITY LOCI; HUNTINGTONS-DISEASE; TUMOR-SUPPRESSOR; CHROMOSOME 17Q; CROHNS-DISEASE		[Choi, Augustine M. K.; Ryter, Stefan W.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75390 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Choi, AMK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.	amchoi@rics.bwh.harvard.edu		Doria, Andrea/0000-0003-0548-4983; GATTO, MARIELE/0000-0003-4012-1248; PUNZI, LEONARDO/0000-0002-8853-516X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		[Anonymous], 2012, PLOS PATHOG, V8; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Campbell GR, 2011, J BIOL CHEM, V286, P18890, DOI 10.1074/jbc.M110.206110; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; GAO X, 1995, CANCER RES, V55, P1002; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Giatromanolaki A, 2011, GYNECOL ONCOL, V123, P147, DOI 10.1016/j.ygyno.2011.06.023; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Jagannath C, 2010, NAT MED, V16, P828, DOI 10.1038/nm0710-828b; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Kaushik S, 2011, CELL METAB, V14, P173, DOI 10.1016/j.cmet.2011.06.008; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim JJ, 2012, CELL HOST MICROBE, V11, P457, DOI 10.1016/j.chom.2012.03.008; Kim MS, 2011, APMIS, V119, P802, DOI 10.1111/j.1600-0463.2011.02812.x; Kirshenbaum LA, 2012, J CARDIOVASC PHARM, V60, P109, DOI 10.1097/FJC.0b013e31825f6faa; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Koukourakis MI, 2010, BRIT J CANCER, V103, P1209, DOI 10.1038/sj.bjc.6605904; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Ladoire S, 2012, AUTOPHAGY, V8, P1175, DOI 10.4161/auto.20353; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Lee SJ, 2011, AM J RESP CRIT CARE, V183, P649, DOI 10.1164/rccm.201005-0746OC; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Lynch-Day MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009357; Ma JF, 2010, NEUROPATH APPL NEURO, V36, P312, DOI 10.1111/j.1365-2990.2010.01067.x; Martin LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033454; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Morris HR, 2005, ANN MED, V37, P86, DOI 10.1080/07853890510007269; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Poon A, 2012, AUTOPHAGY, V8, P694, DOI 10.4161/auto.19315; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; SAITO H, 1993, CANCER RES, V53, P3382; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Teckman JH, 2004, AM J PHYSIOL-GASTR L, V286, pG851, DOI 10.1152/ajpgi.00175.2003; Trancikova A, 2012, ANTIOXID REDOX SIGN, V16, P896, DOI 10.1089/ars.2011.4200; True O, 2012, IMMUNOL CELL BIOL, V90, P78, DOI 10.1038/icb.2011.103; Verheye S, 2007, J AM COLL CARDIOL, V49, P706, DOI 10.1016/j.jacc.2006.09.047; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	92	1775	1872	20	402	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					651	662		10.1056/NEJMra1205406	http://dx.doi.org/10.1056/NEJMra1205406			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194VA	23406030				2022-12-28	WOS:000322659600010
J	Kaijser, M; Andersson, T				Kaijser, Magnus; Andersson, Tommy			Endovascular Treatment for Acute Ischemic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Kaijser, Magnus; Andersson, Tommy] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Kaijser, M (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.	magnus.kaijser@ki.se	Demchuk, Andrew M/E-1103-2012; Campbell, Bruce/J-1220-2019; Kaijser, Magnus/ABB-5970-2021; valvassori, luca/AAC-5772-2022; Leker, Ronen/ABC-6096-2020; Ciccone, Alfonso/AAB-6942-2022; Davis, Stephen M/L-5260-2013; Castellan, Lucio/AAA-7601-2020; bersano, anna/J-8315-2018	Demchuk, Andrew M/0000-0002-4930-7789; Campbell, Bruce/0000-0003-3632-9433; Kaijser, Magnus/0000-0003-4064-0822; Leker, Ronen/0000-0003-4794-0334; Davis, Stephen M/0000-0003-0962-2300; Castellan, Lucio/0000-0002-5463-8785; Chiumarulo, Luigi/0000-0001-5790-2353; Ciceri, Elisa Francesca Maria/0000-0002-6716-2923; pero, guglielmo/0000-0002-8932-6909; Donnan, Geoffrey/0000-0001-6324-3403; Valvassori, Luca Piero/0000-0002-0519-775X; Anticoli, Sabrina/0000-0003-4401-1695; bersano, anna/0000-0002-2493-628X; SALETTI, ANDREA/0000-0001-6984-113X; Piano, Mariangela/0000-0003-0470-1202; VIVIEN, DENIS/0000-0002-7636-2185; Ciccone, Alfonso/0000-0002-4590-3575; De Vito, Alessandro/0000-0002-7572-819X; pezzella, francesca romana/0000-0002-5902-2795	NINDS NIH HHS [R01 NS053716, R37 NS038710] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Broderick JP, 2013, NEW ENGL J MED, V368, P1265; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Chimowitz MI, 2013, NEW ENGL J MED, V368, P952, DOI 10.1056/NEJMe1215730; Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Knottnerus JA, 2011, EVIDENCE BASE CLIN D	6	229	238	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2430	2430						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782187				2022-12-28	WOS:000320601700016
J	Arnold, M; Schroth, G; Gralla, J				Arnold, Marcel; Schroth, Gerhard; Gralla, Jan			Endovascular Treatment for Acute Ischemic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Arnold, Marcel; Schroth, Gerhard; Gralla, Jan] Univ Hosp Bern, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Arnold, M (corresponding author), Univ Hosp Bern, CH-3010 Bern, Switzerland.	marcel.arnold@insel.ch	Demchuk, Andrew M/E-1103-2012; Campbell, Bruce/J-1220-2019; Kaijser, Magnus/ABB-5970-2021; valvassori, luca/AAC-5772-2022; Leker, Ronen/ABC-6096-2020; Ciccone, Alfonso/AAB-6942-2022; Davis, Stephen M/L-5260-2013; Castellan, Lucio/AAA-7601-2020; bersano, anna/J-8315-2018	Demchuk, Andrew M/0000-0002-4930-7789; Campbell, Bruce/0000-0003-3632-9433; Kaijser, Magnus/0000-0003-4064-0822; Leker, Ronen/0000-0003-4794-0334; Davis, Stephen M/0000-0003-0962-2300; Castellan, Lucio/0000-0002-5463-8785; Chiumarulo, Luigi/0000-0001-5790-2353; Ciceri, Elisa Francesca Maria/0000-0002-6716-2923; pero, guglielmo/0000-0002-8932-6909; Donnan, Geoffrey/0000-0001-6324-3403; Valvassori, Luca Piero/0000-0002-0519-775X; Anticoli, Sabrina/0000-0003-4401-1695; bersano, anna/0000-0002-2493-628X; SALETTI, ANDREA/0000-0001-6984-113X; Piano, Mariangela/0000-0003-0470-1202; VIVIEN, DENIS/0000-0002-7636-2185; Ciccone, Alfonso/0000-0002-4590-3575; De Vito, Alessandro/0000-0002-7572-819X; pezzella, francesca romana/0000-0002-5902-2795	NINDS NIH HHS [R01 NS053716, R37 NS038710] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Nogueira RG, 2012, LANCET, V380, P1230; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1	2	229	238	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2431	2431						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782187				2022-12-28	WOS:000320601700018
J	Gakuba, C; Gauberti, M; Vivien, D				Gakuba, Clement; Gauberti, Maxime; Vivien, Denis			Endovascular Treatment for Acute Ischemic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							THERAPY; OUTCOMES		[Gakuba, Clement] Ctr Hosp Univ Cote Nacre, Caen, France; [Gauberti, Maxime; Vivien, Denis] INSERM, U919, Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gakuba, C (corresponding author), Ctr Hosp Univ Cote Nacre, Caen, France.	clement.gakuba@yahoo.fr	Demchuk, Andrew M/E-1103-2012; Campbell, Bruce/J-1220-2019; Kaijser, Magnus/ABB-5970-2021; valvassori, luca/AAC-5772-2022; Leker, Ronen/ABC-6096-2020; Ciccone, Alfonso/AAB-6942-2022; Davis, Stephen M/L-5260-2013; Castellan, Lucio/AAA-7601-2020; bersano, anna/J-8315-2018	Demchuk, Andrew M/0000-0002-4930-7789; Campbell, Bruce/0000-0003-3632-9433; Kaijser, Magnus/0000-0003-4064-0822; Leker, Ronen/0000-0003-4794-0334; Davis, Stephen M/0000-0003-0962-2300; Castellan, Lucio/0000-0002-5463-8785; Chiumarulo, Luigi/0000-0001-5790-2353; Ciceri, Elisa Francesca Maria/0000-0002-6716-2923; pero, guglielmo/0000-0002-8932-6909; Donnan, Geoffrey/0000-0001-6324-3403; Valvassori, Luca Piero/0000-0002-0519-775X; Anticoli, Sabrina/0000-0003-4401-1695; bersano, anna/0000-0002-2493-628X; SALETTI, ANDREA/0000-0001-6984-113X; Piano, Mariangela/0000-0003-0470-1202; VIVIEN, DENIS/0000-0002-7636-2185; Ciccone, Alfonso/0000-0002-4590-3575; De Vito, Alessandro/0000-0002-7572-819X; pezzella, francesca romana/0000-0002-5902-2795	NINDS NIH HHS [R01 NS053716, R37 NS038710] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abou-Chebl A, 2010, STROKE, V41, P1175, DOI 10.1161/STROKEAHA.109.574129; Davis MJ, 2012, ANESTHESIOLOGY, V116, P396, DOI 10.1097/ALN.0b013e318242a5d2; Gakuba C, 2011, STROKE, V42, P2947, DOI 10.1161/STROKEAHA.111.620468; Jumaa MA, 2010, STROKE, V41, P1180, DOI 10.1161/STROKEAHA.109.574194; Nichols C, 2010, J NEUROINTERV SURG, V2, P67, DOI 10.1136/jnis.2009.001768	5	229	238	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2430	2431						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782187				2022-12-28	WOS:000320601700017
J	Cohen, JE; Leker, RR				Cohen, Jose E.; Leker, Ronen R.			Endovascular Treatment for Acute Ischemic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Cohen, Jose E.; Leker, Ronen R.] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Cohen, JE (corresponding author), Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel.	jcohenns@yahoo.com	Demchuk, Andrew M/E-1103-2012; Campbell, Bruce/J-1220-2019; Kaijser, Magnus/ABB-5970-2021; valvassori, luca/AAC-5772-2022; Leker, Ronen/ABC-6096-2020; Ciccone, Alfonso/AAB-6942-2022; Davis, Stephen M/L-5260-2013; Castellan, Lucio/AAA-7601-2020; bersano, anna/J-8315-2018	Demchuk, Andrew M/0000-0002-4930-7789; Campbell, Bruce/0000-0003-3632-9433; Kaijser, Magnus/0000-0003-4064-0822; Leker, Ronen/0000-0003-4794-0334; Davis, Stephen M/0000-0003-0962-2300; Castellan, Lucio/0000-0002-5463-8785; Chiumarulo, Luigi/0000-0001-5790-2353; Ciceri, Elisa Francesca Maria/0000-0002-6716-2923; pero, guglielmo/0000-0002-8932-6909; Donnan, Geoffrey/0000-0001-6324-3403; Valvassori, Luca Piero/0000-0002-0519-775X; Anticoli, Sabrina/0000-0003-4401-1695; bersano, anna/0000-0002-2493-628X; SALETTI, ANDREA/0000-0001-6984-113X; Piano, Mariangela/0000-0003-0470-1202; VIVIEN, DENIS/0000-0002-7636-2185; Ciccone, Alfonso/0000-0002-4590-3575; De Vito, Alessandro/0000-0002-7572-819X; pezzella, francesca romana/0000-0002-5902-2795	NINDS NIH HHS [R01 NS053716, R37 NS038710] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cohen JE, 2013, J CLIN NEUROSCI; Leker RR, 2012, STROKE, V43, P3389, DOI 10.1161/STROKEAHA.112.673665; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1	3	229	238	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2432	2432						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782187				2022-12-28	WOS:000320601700020
J	Campbell, BC; Donnan, GA; Davis, SM				Campbell, Bruce C.; Donnan, Geoffrey A.; Davis, Stephen M.			Endovascular Treatment for Acute Ischemic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							REPERFUSION; DEFUSE; TRIAL		[Campbell, Bruce C.; Davis, Stephen M.] Univ Melbourne, Parkville, Vic 3052, Australia; [Donnan, Geoffrey A.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health	Campbell, BC (corresponding author), Univ Melbourne, Parkville, Vic 3052, Australia.	bruce.campbell@mh.org.au	Demchuk, Andrew M/E-1103-2012; Campbell, Bruce/J-1220-2019; Kaijser, Magnus/ABB-5970-2021; valvassori, luca/AAC-5772-2022; Leker, Ronen/ABC-6096-2020; Ciccone, Alfonso/AAB-6942-2022; Davis, Stephen M/L-5260-2013; Castellan, Lucio/AAA-7601-2020; bersano, anna/J-8315-2018	Demchuk, Andrew M/0000-0002-4930-7789; Campbell, Bruce/0000-0003-3632-9433; Kaijser, Magnus/0000-0003-4064-0822; Leker, Ronen/0000-0003-4794-0334; Davis, Stephen M/0000-0003-0962-2300; Castellan, Lucio/0000-0002-5463-8785; Chiumarulo, Luigi/0000-0001-5790-2353; Ciceri, Elisa Francesca Maria/0000-0002-6716-2923; pero, guglielmo/0000-0002-8932-6909; Donnan, Geoffrey/0000-0001-6324-3403; Valvassori, Luca Piero/0000-0002-0519-775X; Anticoli, Sabrina/0000-0003-4401-1695; bersano, anna/0000-0002-2493-628X; SALETTI, ANDREA/0000-0001-6984-113X; Piano, Mariangela/0000-0003-0470-1202; VIVIEN, DENIS/0000-0002-7636-2185; Ciccone, Alfonso/0000-0002-4590-3575; De Vito, Alessandro/0000-0002-7572-819X; pezzella, francesca romana/0000-0002-5902-2795	NINDS NIH HHS [R01 NS053716, R37 NS038710] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1	4	229	238	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2431	2432						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782187				2022-12-28	WOS:000320601700019
J	Kidwell, CS; Jahan, R; Saver, JL				Kidwell, Chelsea S.; Jahan, Reza; Saver, Jeffrey L.			Endovascular Treatment for Acute Ischemic Stroke REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							RANDOMIZED-TRIAL; REPERFUSION; ALTEPLASE; DEFUSE		[Kidwell, Chelsea S.] Georgetown Univ, Washington, DC 20007 USA; [Jahan, Reza; Saver, Jeffrey L.] Univ Calif Los Angeles, Los Angeles, CA USA	Georgetown University; University of California System; University of California Los Angeles	Kidwell, CS (corresponding author), Georgetown Univ, Washington, DC 20007 USA.	ck256@georgetown.edu	Demchuk, Andrew M/E-1103-2012; Campbell, Bruce/J-1220-2019; Kaijser, Magnus/ABB-5970-2021; valvassori, luca/AAC-5772-2022; Leker, Ronen/ABC-6096-2020; Ciccone, Alfonso/AAB-6942-2022; Davis, Stephen M/L-5260-2013; Castellan, Lucio/AAA-7601-2020; bersano, anna/J-8315-2018	Demchuk, Andrew M/0000-0002-4930-7789; Campbell, Bruce/0000-0003-3632-9433; Kaijser, Magnus/0000-0003-4064-0822; Leker, Ronen/0000-0003-4794-0334; Davis, Stephen M/0000-0003-0962-2300; Castellan, Lucio/0000-0002-5463-8785; Chiumarulo, Luigi/0000-0001-5790-2353; Ciceri, Elisa Francesca Maria/0000-0002-6716-2923; pero, guglielmo/0000-0002-8932-6909; Donnan, Geoffrey/0000-0001-6324-3403; Valvassori, Luca Piero/0000-0002-0519-775X; Anticoli, Sabrina/0000-0003-4401-1695; bersano, anna/0000-0002-2493-628X; SALETTI, ANDREA/0000-0001-6984-113X; Piano, Mariangela/0000-0003-0470-1202; VIVIEN, DENIS/0000-0002-7636-2185; Ciccone, Alfonso/0000-0002-4590-3575; De Vito, Alessandro/0000-0002-7572-819X; pezzella, francesca romana/0000-0002-5902-2795	NINDS NIH HHS [R01 NS053716, R37 NS038710] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Parsons M, 2012, NEW ENGL J MED, V366, P1099, DOI 10.1056/NEJMoa1109842	4	229	238	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2434	2435						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782187				2022-12-28	WOS:000320601700023
J	Broderick, JP; Tomsick, TA; Palesch, YY				Broderick, Joseph P.; Tomsick, Thomas A.; Palesch, Yuko Y.			Endovascular Treatment for Acute Ischemic Stroke REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							INTERVENTIONAL MANAGEMENT		[Broderick, Joseph P.; Tomsick, Thomas A.] Univ Cincinnati, Inst Neurosci, Cincinnati, OH 45221 USA; [Palesch, Yuko Y.] Med Univ S Carolina, Charleston, SC 29425 USA	University System of Ohio; University of Cincinnati; Medical University of South Carolina	Broderick, JP (corresponding author), Univ Cincinnati, Inst Neurosci, Cincinnati, OH 45221 USA.	joseph.broderick@uc.edu	Demchuk, Andrew M/E-1103-2012; Campbell, Bruce/J-1220-2019; Kaijser, Magnus/ABB-5970-2021; valvassori, luca/AAC-5772-2022; Leker, Ronen/ABC-6096-2020; Ciccone, Alfonso/AAB-6942-2022; Davis, Stephen M/L-5260-2013; Castellan, Lucio/AAA-7601-2020; bersano, anna/J-8315-2018	Demchuk, Andrew M/0000-0002-4930-7789; Campbell, Bruce/0000-0003-3632-9433; Kaijser, Magnus/0000-0003-4064-0822; Leker, Ronen/0000-0003-4794-0334; Davis, Stephen M/0000-0003-0962-2300; Castellan, Lucio/0000-0002-5463-8785; Chiumarulo, Luigi/0000-0001-5790-2353; Ciceri, Elisa Francesca Maria/0000-0002-6716-2923; pero, guglielmo/0000-0002-8932-6909; Donnan, Geoffrey/0000-0001-6324-3403; Valvassori, Luca Piero/0000-0002-0519-775X; Anticoli, Sabrina/0000-0003-4401-1695; bersano, anna/0000-0002-2493-628X; SALETTI, ANDREA/0000-0001-6984-113X; Piano, Mariangela/0000-0003-0470-1202; VIVIEN, DENIS/0000-0002-7636-2185; Ciccone, Alfonso/0000-0002-4590-3575; De Vito, Alessandro/0000-0002-7572-819X; pezzella, francesca romana/0000-0002-5902-2795	NINDS NIH HHS [R01 NS053716, R37 NS038710] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Broderick J, 2004, STROKE, V35, P904, DOI 10.1161/01.STR.0000121641.77121.98; Broderick JP, 2007, STROKE, V38, P2127, DOI 10.1161/STROKEAHA.107.483131; Mackey J, 2010, AJNR Am J Neuroradiol, V31, pE34, DOI 10.3174/ajnr.A1996	3	229	238	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2432	2433						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782187				2022-12-28	WOS:000320601700021
J	Ciccone, A; Valvassori, L				Ciccone, Alfonso; Valvassori, Luca		SYNTH Expansion Investigators	Endovascular Treatment for Acute Ischemic Stroke REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Ciccone, Alfonso] Carlo Poma Hosp, Mantua, Italy; [Valvassori, Luca] Osped Niguarda Ca Granda, Milan, Italy	Hospital Carlo Poma; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Ciccone, A (corresponding author), Carlo Poma Hosp, Mantua, Italy.	alfonso.ciccone@aopoma.it	Demchuk, Andrew M/E-1103-2012; Campbell, Bruce/J-1220-2019; Kaijser, Magnus/ABB-5970-2021; valvassori, luca/AAC-5772-2022; Leker, Ronen/ABC-6096-2020; Ciccone, Alfonso/AAB-6942-2022; Davis, Stephen M/L-5260-2013; Castellan, Lucio/AAA-7601-2020; bersano, anna/J-8315-2018	Demchuk, Andrew M/0000-0002-4930-7789; Campbell, Bruce/0000-0003-3632-9433; Kaijser, Magnus/0000-0003-4064-0822; Leker, Ronen/0000-0003-4794-0334; Davis, Stephen M/0000-0003-0962-2300; Castellan, Lucio/0000-0002-5463-8785; Chiumarulo, Luigi/0000-0001-5790-2353; Ciceri, Elisa Francesca Maria/0000-0002-6716-2923; pero, guglielmo/0000-0002-8932-6909; Donnan, Geoffrey/0000-0001-6324-3403; Valvassori, Luca Piero/0000-0002-0519-775X; Anticoli, Sabrina/0000-0003-4401-1695; bersano, anna/0000-0002-2493-628X; SALETTI, ANDREA/0000-0001-6984-113X; Piano, Mariangela/0000-0003-0470-1202; VIVIEN, DENIS/0000-0002-7636-2185; Ciccone, Alfonso/0000-0002-4590-3575; De Vito, Alessandro/0000-0002-7572-819X; pezzella, francesca romana/0000-0002-5902-2795	NINDS NIH HHS [R01 NS053716, R37 NS038710] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Mullen MT, 2012, STROKE, V43, P2350, DOI 10.1161/STROKEAHA.111.639211	1	229	238	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2013	368	25					2433	2434						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167AE	23782187				2022-12-28	WOS:000320601700022
